1	In	_	_	FW	O	[-1]	['none']	_	_
2	vitro	_	_	FW	O	[-1]	['none']	_	_
3	methylation	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	reporter	_	_	NN	O	[-1]	['none']	_	_
6	gene	_	_	NN	O	[-1]	['none']	_	_
7	assays	_	_	NNS	O	[-1]	['none']	_	_
8	The	_	_	DT	O	[-1]	['none']	_	_
9	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
10	promoter	_	_	NN	O	[-1]	['none']	_	_
11	reporter	_	_	NN	O	[-1]	['none']	_	_
12	gene	_	_	NN	O	[-1]	['none']	_	_
13	construct	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	generously	_	_	RB	O	[-1]	['none']	_	_
16	provided	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	J.	_	_	NNP	O	[-1]	['none']	_	_
19	Hiscott	_	_	NNP	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	31	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Constructs	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	methylated	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	FW	O	[-1]	['none']	_	_
5	vitro	_	_	FW	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	CpG	_	_	NN	Protein	[8]	['multitoken']	_	_
8	Methylase	_	_	NN	Protein	[0]	['root']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	M.Sss	_	_	NN	Protein	[11]	['multitoken']	_	_
11	I	_	_	PRP	Protein	[0]	['root']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	recommended	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	manufacturer	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	NE	_	_	NNS	O	[-1]	['none']	_	_
20	Biolabs	_	_	JJ	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	complete	_	_	JJ	O	[-1]	['none']	_	_
24	methylation	_	_	NN	O	[-1]	['none']	_	_
25	was	_	_	VBD	O	[-1]	['none']	_	_
26	checked	_	_	VBN	O	[-1]	['none']	_	_
27	via	_	_	IN	O	[-1]	['none']	_	_
28	restriction	_	_	NN	O	[-1]	['none']	_	_
29	analysis	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Reporter	_	_	NN	O	[-1]	['none']	_	_
2	gene	_	_	NN	O	[-1]	['none']	_	_
3	assays	_	_	NNS	O	[-1]	['none']	_	_
4	using	_	_	VBG	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	dual	_	_	JJ	O	[-1]	['none']	_	_
7	luciferase	_	_	NN	Protein	[0]	['root']	_	_
8	assay	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	Promega	_	_	NNP	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	performed	_	_	VBN	O	[-1]	['none']	_	_
14	similar	_	_	JJ	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	previous	_	_	JJ	O	[-1]	['none']	_	_
17	reports	_	_	NNS	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	29	_	_	CD	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	5	_	_	CD	O	[-1]	['none']	_	_
4	nM	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	reporter	_	_	NN	O	[-1]	['none']	_	_
8	construct	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	transfection	_	_	NN	O	[-1]	['none']	_	_
12	control	_	_	NN	O	[-1]	['none']	_	_
13	construct	_	_	NN	O	[-1]	['none']	_	_
14	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	renilla	_	_	NN	O	[-1]	['none']	_	_
17	luciferase	_	_	NN	Protein	[14, 21]	['Theme', 'Theme']	_	_
18	gene	_	_	NN	O	[-1]	['none']	_	_
19	were	_	_	VBD	O	[-1]	['none']	_	_
20	transientlyco	_	_	RB	O	[-1]	['none']	_	_
21	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
22	via	_	_	IN	O	[-1]	['none']	_	_
23	electroporation	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	control	_	_	NN	O	[-1]	['none']	_	_
3	construct	_	_	NN	O	[-1]	['none']	_	_
4	served	_	_	VBD	O	[-1]	['none']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	an	_	_	DT	O	[-1]	['none']	_	_
7	internal	_	_	JJ	O	[-1]	['none']	_	_
8	reference	_	_	NN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	transfection	_	_	NN	O	[-1]	['none']	_	_
11	efficiency	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Forty-eight	_	_	CD	O	[-1]	['none']	_	_
2	hours	_	_	NNS	O	[-1]	['none']	_	_
3	after	_	_	IN	O	[-1]	['none']	_	_
4	transfection	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	luciferase	_	_	NN	Protein	[0]	['root']	_	_
7	activity	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	measured	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	LB	_	_	NN	O	[-1]	['none']	_	_
13	96	_	_	CD	O	[-1]	['none']	_	_
14	P	_	_	NN	O	[-1]	['none']	_	_
15	microlumat	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	EG&G	_	_	NNP	O	[-1]	['none']	_	_
18	Berthold	_	_	NNP	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	Bad	_	_	NNP	O	[-1]	['none']	_	_
21	Wildbad	_	_	NNP	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	Germany	_	_	NNP	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	IRF-4	_	_	NNP	Protein	[3]	['Theme']	_	_
2	promoter	_	_	NN	Entity	[3]	['Site']	_	_
3	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	quantified	_	_	VBN	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	ratio	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	measured	_	_	VBN	O	[-1]	['none']	_	_
11	firefly	_	_	RB	O	[-1]	['none']	_	_
12	light	_	_	JJ	O	[-1]	['none']	_	_
13	units	_	_	NNS	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	flu	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	relative	_	_	JJ	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	renilla	_	_	VB	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	rlu	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Each	_	_	DT	O	[-1]	['none']	_	_
2	experiment	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	carried	_	_	VBN	O	[-1]	['none']	_	_
5	out	_	_	RP	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	least	_	_	JJS	O	[-1]	['none']	_	_
8	three	_	_	CD	O	[-1]	['none']	_	_
9	times	_	_	NNS	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	IL-12	_	_	NNP	Protein	[0]	['root']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	High	_	_	JJ	O	[-1]	['none']	_	_
4	Doses	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Antigen	_	_	NN	O	[-1]	['none']	_	_
7	Induce	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	Development	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	Th1	_	_	NN	O	[-1]	['none']	_	_
12	Cells	_	_	NNS	O	[-1]	['none']	_	_
13	Producing	_	_	NNP	Gene_expression	[0]	['root']	_	_
14	IL-10	_	_	NN	Protein	[13]	['Theme']	_	_
15	To	_	_	TO	O	[-1]	['none']	_	_
16	study	_	_	VB	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	differentiation	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	Th1	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	coproducing	_	_	VBG	Gene_expression	[0]	['root']	_	_
23	IFN-gamma	_	_	NN	Protein	[22]	['Theme']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	IL-10	_	_	NN	Protein	[22]	['Theme']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	we	_	_	PRP	O	[-1]	['none']	_	_
28	cultured	_	_	VBD	O	[-1]	['none']	_	_
29	purified	_	_	VBN	O	[-1]	['none']	_	_
30	TCR-transgenic	_	_	JJ	O	[-1]	['none']	_	_
31	DO11	_	_	NN	O	[-1]	['none']	_	_
32	.10	_	_	CD	O	[-1]	['none']	_	_
33	naive	_	_	JJ	O	[-1]	['none']	_	_
34	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
35	T	_	_	NN	O	[-1]	['none']	_	_
36	cells	_	_	NNS	O	[-1]	['none']	_	_
37	with	_	_	IN	O	[-1]	['none']	_	_
38	purified	_	_	VBN	O	[-1]	['none']	_	_
39	DCs	_	_	NNS	O	[-1]	['none']	_	_
40	as	_	_	IN	O	[-1]	['none']	_	_
41	APCs	_	_	NNS	O	[-1]	['none']	_	_
42	and	_	_	CC	O	[-1]	['none']	_	_
43	increasing	_	_	VBG	O	[-1]	['none']	_	_
44	doses	_	_	NNS	O	[-1]	['none']	_	_
45	of	_	_	IN	O	[-1]	['none']	_	_
46	ovalbumin	_	_	JJ	Protein	[0]	['root']	_	_
47	peptide	_	_	NN	O	[-1]	['none']	_	_
48	323-339	_	_	CD	O	[-1]	['none']	_	_
49	(	_	_	-LRB-	O	[-1]	['none']	_	_
50	OVA	_	_	NN	Protein	[0]	['root']	_	_
51	)	_	_	-RRB-	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	Culture	_	_	NN	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	high	_	_	JJ	O	[-1]	['none']	_	_
4	doses	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	antigen	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	7	_	_	CD	O	[-1]	['none']	_	_
9	days	_	_	NNS	O	[-1]	['none']	_	_
10	gave	_	_	VBD	O	[-1]	['none']	_	_
11	rise	_	_	NN	Positive_regulation	[0]	['root']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	Th1	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	expressing	_	_	VBG	Gene_expression	[11]	['Theme']	_	_
16	IFN-gamma	_	_	NN	Protein	[15]	['Theme']	_	_
17	upon	_	_	IN	O	[-1]	['none']	_	_
18	restimulation	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Constant	_	_	JJ	O	[-1]	['none']	_	_
21	et	_	_	FW	O	[-1]	['none']	_	_
22	al.	_	_	FW	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	1995	_	_	CD	O	[-1]	['none']	_	_
25	;	_	_	:	O	[-1]	['none']	_	_
26	Hosken	_	_	NNP	O	[-1]	['none']	_	_
27	et	_	_	FW	O	[-1]	['none']	_	_
28	al.	_	_	FW	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	1995	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	but	_	_	CC	O	[-1]	['none']	_	_
34	not	_	_	RB	O	[-1]	['none']	_	_
35	IL-10	_	_	NN	Protein	[15]	['Theme']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Culture	_	_	NN	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	low	_	_	JJ	O	[-1]	['none']	_	_
4	antigen	_	_	NN	O	[-1]	['none']	_	_
5	doses	_	_	NNS	O	[-1]	['none']	_	_
6	under	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	same	_	_	JJ	O	[-1]	['none']	_	_
9	conditions	_	_	NNS	O	[-1]	['none']	_	_
10	led	_	_	VBD	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	differentiation	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	Th2	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	which	_	_	WDT	O	[-1]	['none']	_	_
19	expressed	_	_	VBD	Gene_expression	[0]	['root']	_	_
20	both	_	_	CC	O	[-1]	['none']	_	_
21	IL-4	_	_	NN	Protein	[19]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	IL-10	_	_	NN	Protein	[19]	['Theme']	_	_
24	upon	_	_	IN	O	[-1]	['none']	_	_
25	restimulation	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Culture	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	naive	_	_	JJ	O	[-1]	['none']	_	_
4	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	APC-free	_	_	JJ	O	[-1]	['none']	_	_
10	system	_	_	NN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	stimulation	_	_	NN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	anti-CD3	_	_	JJ	Protein	[0]	['root']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	anti-CD28	_	_	JJ	Protein	[0]	['root']	_	_
17	antibodies	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	presence	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	IL-12	_	_	NN	Protein	[23]	['Cause']	_	_
23	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	IFN-gamma-producing	_	_	JJ	Gene_expression	[23]	['Theme']	_	_
26	Th1	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	a	_	_	DT	O	[-1]	['none']	_	_
30	proportion	_	_	NN	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	which	_	_	WDT	O	[-1]	['none']	_	_
33	coproduced	_	_	VBD	Gene_expression	[23]	['Theme']	_	_
34	IL-10	_	_	NN	Protein	[33]	['Theme']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	as	_	_	IN	O	[-1]	['none']	_	_
37	did	_	_	VBD	O	[-1]	['none']	_	_
38	Th2	_	_	NN	O	[-1]	['none']	_	_
39	cells	_	_	NNS	O	[-1]	['none']	_	_
40	resulting	_	_	VBG	O	[-1]	['none']	_	_
41	from	_	_	IN	O	[-1]	['none']	_	_
42	culture	_	_	NN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	IL-4	_	_	NN	Protein	[0]	['root']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	investigate	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	lack	_	_	NN	Negative_regulation	[12]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IL-10	_	_	NN	Protein	[5, 8]	['Theme', 'Theme']	_	_
8	produced	_	_	VBN	Gene_expression	[0]	['root']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	inhibition	_	_	NN	Negative_regulation	[12]	['Cause']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IL-10	_	_	NN	Protein	[17]	['Theme']	_	_
17	production	_	_	NN	Gene_expression	[14]	['Theme']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	DCs	_	_	NNS	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	high	_	_	JJ	O	[-1]	['none']	_	_
22	antigen	_	_	NN	O	[-1]	['none']	_	_
23	dose	_	_	NN	O	[-1]	['none']	_	_
24	or	_	_	CC	O	[-1]	['none']	_	_
25	alternatively	_	_	RB	O	[-1]	['none']	_	_
26	required	_	_	VBN	O	[-1]	['none']	_	_
27	IL-12	_	_	NN	Protein	[0]	['root']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	we	_	_	PRP	O	[-1]	['none']	_	_
30	cultured	_	_	VBD	O	[-1]	['none']	_	_
31	naive	_	_	JJ	O	[-1]	['none']	_	_
32	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
33	T	_	_	NN	O	[-1]	['none']	_	_
34	cells	_	_	NNS	O	[-1]	['none']	_	_
35	with	_	_	IN	O	[-1]	['none']	_	_
36	increasing	_	_	VBG	O	[-1]	['none']	_	_
37	doses	_	_	NNS	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	antigen	_	_	NN	O	[-1]	['none']	_	_
40	presented	_	_	VBN	O	[-1]	['none']	_	_
41	by	_	_	IN	O	[-1]	['none']	_	_
42	DC	_	_	NN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	presence	_	_	NN	O	[-1]	['none']	_	_
46	of	_	_	IN	O	[-1]	['none']	_	_
47	IL-12	_	_	NN	Protein	[0]	['root']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	low	_	_	JJ	O	[-1]	['none']	_	_
3	doses	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	antigen	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	IL-12	_	_	NN	Protein	[15]	['Cause']	_	_
8	abrogated	_	_	VBD	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	development	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	Th2	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
16	IFN-gamma	_	_	NN	Protein	[17]	['Theme']	_	_
17	expression	_	_	NN	Gene_expression	[15]	['Theme']	_	_
18	but	_	_	CC	O	[-1]	['none']	_	_
19	only	_	_	RB	O	[-1]	['none']	_	_
20	low	_	_	JJ	O	[-1]	['none']	_	_
21	levels	_	_	NNS	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IL-10	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[15]	['Theme']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	suggesting	_	_	VBG	O	[-1]	['none']	_	_
27	that	_	_	IN	O	[-1]	['none']	_	_
28	IL-12	_	_	NN	Protein	[35]	['Cause']	_	_
29	per	_	_	FW	O	[-1]	['none']	_	_
30	se	_	_	FW	O	[-1]	['none']	_	_
31	was	_	_	VBD	O	[-1]	['none']	_	_
32	not	_	_	RB	O	[-1]	['none']	_	_
33	sufficient	_	_	JJ	O	[-1]	['none']	_	_
34	to	_	_	TO	O	[-1]	['none']	_	_
35	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
36	significant	_	_	JJ	O	[-1]	['none']	_	_
37	IL-10	_	_	NN	Protein	[38]	['Theme']	_	_
38	production	_	_	NN	Gene_expression	[35]	['Theme']	_	_
39	in	_	_	IN	O	[-1]	['none']	_	_
40	Th1	_	_	NN	O	[-1]	['none']	_	_
41	cells	_	_	NNS	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Strikingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	as	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	antigen	_	_	NN	O	[-1]	['none']	_	_
6	dose	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	increased	_	_	VBN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	populations	_	_	NNS	O	[-1]	['none']	_	_
12	driven	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	IL-12	_	_	NN	Protein	[0]	['root']	_	_
15	now	_	_	RB	O	[-1]	['none']	_	_
16	contained	_	_	VBD	O	[-1]	['none']	_	_
17	higher	_	_	JJR	O	[-1]	['none']	_	_
18	numbers	_	_	NNS	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	produced	_	_	VBD	Gene_expression	[24]	['Theme']	_	_
24	more	_	_	JJR	Positive_regulation	[0]	['root']	_	_
25	IL-10	_	_	NN	Protein	[23]	['Theme']	_	_
26	protein	_	_	NN	O	[-1]	['none']	_	_
27	upon	_	_	IN	O	[-1]	['none']	_	_
28	restimulation	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	development	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Th1	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	producing	_	_	VBG	Gene_expression	[10]	['Theme']	_	_
9	IL-10	_	_	NN	Protein	[8]	['Theme']	_	_
10	required	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	both	_	_	CC	O	[-1]	['none']	_	_
12	IL-12	_	_	NN	Protein	[10]	['Cause']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	high	_	_	JJ	O	[-1]	['none']	_	_
15	doses	_	_	NNS	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	antigen	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Th1	_	_	NN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	differentiated	_	_	VBN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	produce	_	_	VB	Gene_expression	[0]	['root']	_	_
6	large	_	_	JJ	O	[-1]	['none']	_	_
7	amounts	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	IL-10	_	_	NN	Protein	[5]	['Theme']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	IFN-gamma	_	_	NN	Protein	[5]	['Theme']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	lost	_	_	VBD	Negative_regulation	[0]	['root']	_	_
14	their	_	_	PRP$	O	[-1]	['none']	_	_
15	capacity	_	_	NN	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	produce	_	_	VB	Gene_expression	[13]	['Theme']	_	_
18	IL-2	_	_	NN	Protein	[17]	['Theme']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Because	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	presence	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	IL-12	_	_	NN	Protein	[0]	['root']	_	_
6	reduced	_	_	VBD	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	proliferation	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
11	T	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	both	_	_	DT	O	[-1]	['none']	_	_
15	high	_	_	JJ	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	low	_	_	JJ	O	[-1]	['none']	_	_
18	antigen	_	_	NN	O	[-1]	['none']	_	_
19	doses	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	only	_	_	RB	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	former	_	_	JJ	O	[-1]	['none']	_	_
25	showed	_	_	VBD	O	[-1]	['none']	_	_
26	IL-10	_	_	NN	Protein	[27]	['Theme']	_	_
27	production	_	_	NN	Gene_expression	[0]	['root']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	development	_	_	NN	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	high	_	_	JJ	O	[-1]	['none']	_	_
33	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
34	cells	_	_	NNS	O	[-1]	['none']	_	_
35	is	_	_	VBZ	O	[-1]	['none']	_	_
36	most	_	_	RBS	O	[-1]	['none']	_	_
37	likely	_	_	JJ	O	[-1]	['none']	_	_
38	not	_	_	RB	O	[-1]	['none']	_	_
39	related	_	_	JJ	O	[-1]	['none']	_	_
40	to	_	_	TO	O	[-1]	['none']	_	_
41	limited	_	_	JJ	Negative_regulation	[0]	['root']	_	_
42	IL-2	_	_	NN	Protein	[41]	['Theme']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	Naive	_	_	JJ	O	[-1]	['none']	_	_
2	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
3	T	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	DO11	_	_	NN	O	[-1]	['none']	_	_
7	.10/recombination-activating	_	_	JJ	Protein	[9]	['multitoken']	_	_
8	gene	_	_	NN	Protein	[9]	['multitoken']	_	_
9	1	_	_	CD	Protein	[12]	['Theme']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Rag1	_	_	NN	Protein	[0]	['root']	_	_
12	)-deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
13	animals	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	cultured	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	high	_	_	JJ	O	[-1]	['none']	_	_
18	doses	_	_	NNS	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	antigen	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	presence	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	IL-12	_	_	NN	Protein	[28]	['Cause']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	also	_	_	RB	O	[-1]	['none']	_	_
28	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	IL-10	_	_	NN	Protein	[31]	['Theme']	_	_
31	expression	_	_	NN	Gene_expression	[28, 42]	['Theme', 'Theme']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	Th1	_	_	NN	O	[-1]	['none']	_	_
34	cells	_	_	NNS	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	showing	_	_	VBG	O	[-1]	['none']	_	_
37	that	_	_	IN	O	[-1]	['none']	_	_
38	this	_	_	DT	Anaphora	[39]	['multitoken']	_	_
39	expression	_	_	NN	Anaphora	[0]	['root']	_	_
40	was	_	_	VBD	O	[-1]	['none']	_	_
41	not	_	_	RB	O	[-1]	['none']	_	_
42	dependent	_	_	JJ	Positive_regulation	[0]	['root']	_	_
43	on	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	presence	_	_	NN	O	[-1]	['none']	_	_
46	of	_	_	IN	O	[-1]	['none']	_	_
47	effector	_	_	NN	O	[-1]	['none']	_	_
48	or	_	_	CC	O	[-1]	['none']	_	_
49	memory	_	_	NN	O	[-1]	['none']	_	_
50	T	_	_	NN	O	[-1]	['none']	_	_
51	cells	_	_	NNS	O	[-1]	['none']	_	_
52	or	_	_	CC	O	[-1]	['none']	_	_
53	Treg	_	_	NN	O	[-1]	['none']	_	_
54	cells	_	_	NNS	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	it	_	_	PRP	O	[-1]	['none']	_	_
3	has	_	_	VBZ	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	suggested	_	_	VBN	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	TGF-beta	_	_	NN	Protein	[9]	['Cause']	_	_
8	can	_	_	MD	O	[-1]	['none']	_	_
9	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
10	IL-10	_	_	NN	Protein	[9]	['Theme']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
13	T	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	Kitani	_	_	NNP	O	[-1]	['none']	_	_
17	et	_	_	FW	O	[-1]	['none']	_	_
18	al.	_	_	FW	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	2003	_	_	CD	O	[-1]	['none']	_	_
21	;	_	_	:	O	[-1]	['none']	_	_
22	Schiott	_	_	NNP	O	[-1]	['none']	_	_
23	et	_	_	FW	O	[-1]	['none']	_	_
24	al.	_	_	FW	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	2000	_	_	CD	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	we	_	_	PRP	O	[-1]	['none']	_	_
30	found	_	_	VBD	O	[-1]	['none']	_	_
31	that	_	_	IN	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	developing	_	_	VBG	O	[-1]	['none']	_	_
34	Th1	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	Th2	_	_	NN	O	[-1]	['none']	_	_
37	cells	_	_	NNS	O	[-1]	['none']	_	_
38	this	_	_	DT	O	[-1]	['none']	_	_
39	was	_	_	VBD	O	[-1]	['none']	_	_
40	not	_	_	RB	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	case	_	_	NN	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	data	_	_	NNS	O	[-1]	['none']	_	_
45	not	_	_	RB	O	[-1]	['none']	_	_
46	shown	_	_	VBN	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	fact	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	neutralization	_	_	NN	Negative_regulation	[9]	['Cause']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	TGF-beta	_	_	NN	Protein	[4]	['Theme']	_	_
7	led	_	_	VBD	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
10	IL-10	_	_	NN	Protein	[11]	['Theme']	_	_
11	production	_	_	NN	Gene_expression	[9]	['Theme']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	both	_	_	CC	O	[-1]	['none']	_	_
14	T	_	_	NN	O	[-1]	['none']	_	_
15	cell	_	_	NN	O	[-1]	['none']	_	_
16	subsets	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	development	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	IL-10-producing	_	_	JJ	Gene_expression	[10]	['Theme']	_	_
7	Th1	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	only	_	_	RB	O	[-1]	['none']	_	_
10	depended	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	presence	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IL-12	_	_	NN	Protein	[10]	['Cause']	_	_
16	together	_	_	RB	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	high	_	_	JJ	O	[-1]	['none']	_	_
19	antigen	_	_	NN	O	[-1]	['none']	_	_
20	dose	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	not	_	_	RB	O	[-1]	['none']	_	_
23	on	_	_	IN	O	[-1]	['none']	_	_
24	other	_	_	JJ	Anaphora	[26]	['multitoken']	_	_
25	soluble	_	_	JJ	Anaphora	[26]	['multitoken']	_	_
26	factors	_	_	NNS	Anaphora	[0]	['root']	_	_
27	such	_	_	JJ	O	[-1]	['none']	_	_
28	as	_	_	IN	O	[-1]	['none']	_	_
29	IL-2	_	_	NN	Protein	[10]	['Cause']	_	_
30	or	_	_	CC	O	[-1]	['none']	_	_
31	TGF-beta	_	_	NN	Protein	[10]	['Cause']	_	_
32	or	_	_	CC	O	[-1]	['none']	_	_
33	on	_	_	IN	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	presence	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	other	_	_	JJ	O	[-1]	['none']	_	_
38	T	_	_	NN	O	[-1]	['none']	_	_
39	cell	_	_	NN	O	[-1]	['none']	_	_
40	types	_	_	NNS	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Distinct	_	_	JJ	O	[-1]	['none']	_	_
2	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	kinetics	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	perforin	_	_	NN	Protein	[2]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	granzyme	_	_	NN	Protein	[8]	['multitoken']	_	_
8	B	_	_	NN	Protein	[2]	['Theme']	_	_
9	during	_	_	IN	O	[-1]	['none']	_	_
10	CTL	_	_	NN	O	[-1]	['none']	_	_
11	development	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	culture	_	_	NN	O	[-1]	['none']	_	_
14	Our	_	_	PRP$	O	[-1]	['none']	_	_
15	experiments	_	_	NNS	O	[-1]	['none']	_	_
16	revealed	_	_	VBD	O	[-1]	['none']	_	_
17	clear	_	_	JJ	O	[-1]	['none']	_	_
18	differences	_	_	NNS	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	kinetics	_	_	NNS	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	perforin	_	_	NN	Protein	[30]	['Theme']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	granzyme	_	_	NN	Protein	[26]	['multitoken']	_	_
26	B	_	_	NN	Protein	[30]	['Theme']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	cytokine	_	_	NN	O	[-1]	['none']	_	_
30	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
31	during	_	_	IN	O	[-1]	['none']	_	_
32	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
33	T	_	_	NN	O	[-1]	['none']	_	_
34	cell	_	_	NN	O	[-1]	['none']	_	_
35	activation	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Naive	_	_	JJ	O	[-1]	['none']	_	_
2	T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	showed	_	_	VBD	O	[-1]	['none']	_	_
5	detectable	_	_	JJ	O	[-1]	['none']	_	_
6	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	perforin	_	_	NN	Protein	[6]	['Theme']	_	_
9	mRNA	_	_	NN	O	[-1]	['none']	_	_
10	as	_	_	RB	O	[-1]	['none']	_	_
11	well	_	_	RB	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	perforin	_	_	NN	Protein	[6]	['Theme']	_	_
14	protein	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Relative	_	_	JJ	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
4	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	naive	_	_	JJ	O	[-1]	['none']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	perforin	_	_	NN	Protein	[4, 15]	['Theme', 'Theme']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Prf1	_	_	NN	Protein	[0]	['root']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	mRNA	_	_	NN	Transcription	[15]	['multitoken']	_	_
15	expression	_	_	NN	Transcription	[18, 27, 35]	['Theme', 'Theme', 'Theme']	_	_
16	did	_	_	VBD	O	[-1]	['none']	_	_
17	not	_	_	RB	O	[-1]	['none']	_	_
18	increase	_	_	VB	Positive_regulation	[0]	['root']	_	_
19	appreciably	_	_	RB	O	[-1]	['none']	_	_
20	at	_	_	IN	O	[-1]	['none']	_	_
21	day	_	_	NN	O	[-1]	['none']	_	_
22	2	_	_	CD	O	[-1]	['none']	_	_
23	but	_	_	CC	O	[-1]	['none']	_	_
24	showed	_	_	VBD	O	[-1]	['none']	_	_
25	a	_	_	DT	O	[-1]	['none']	_	_
26	reproducible	_	_	JJ	O	[-1]	['none']	_	_
27	decrease	_	_	NN	Negative_regulation	[0]	['root']	_	_
28	at	_	_	IN	O	[-1]	['none']	_	_
29	day	_	_	NN	O	[-1]	['none']	_	_
30	4	_	_	CD	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	followed	_	_	VBN	O	[-1]	['none']	_	_
33	by	_	_	IN	O	[-1]	['none']	_	_
34	robust	_	_	JJ	O	[-1]	['none']	_	_
35	reexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
36	between	_	_	IN	O	[-1]	['none']	_	_
37	days	_	_	NNS	O	[-1]	['none']	_	_
38	4	_	_	CD	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	8	_	_	CD	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	granzyme	_	_	NN	Protein	[5]	['multitoken']	_	_
5	B	_	_	NN	Protein	[13, 21, 28]	['Theme', 'Theme', 'Theme']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	Gzmb	_	_	NNP	Protein	[0]	['root']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	mRNA	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	low	_	_	JJ	Transcription	[13]	['multitoken']	_	_
12	or	_	_	CC	Transcription	[13]	['multitoken']	_	_
13	undetectable	_	_	JJ	Transcription	[0]	['root']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	naive	_	_	JJ	O	[-1]	['none']	_	_
16	T	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	but	_	_	CC	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	strongly	_	_	RB	O	[-1]	['none']	_	_
21	up-regulated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	day	_	_	NN	O	[-1]	['none']	_	_
24	2	_	_	CD	O	[-1]	['none']	_	_
25	after	_	_	IN	O	[-1]	['none']	_	_
26	stimulation	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
29	progressively	_	_	RB	O	[-1]	['none']	_	_
30	until	_	_	IN	O	[-1]	['none']	_	_
31	day	_	_	NN	O	[-1]	['none']	_	_
32	6	_	_	CD	O	[-1]	['none']	_	_
33	;	_	_	:	O	[-1]	['none']	_	_
34	similarly	_	_	RB	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	granzyme	_	_	NN	Protein	[37]	['multitoken']	_	_
37	B	_	_	NN	Protein	[46]	['Theme']	_	_
38	protein	_	_	NN	O	[-1]	['none']	_	_
39	was	_	_	VBD	O	[-1]	['none']	_	_
40	expressed	_	_	VBN	O	[-1]	['none']	_	_
41	by	_	_	IN	O	[-1]	['none']	_	_
42	day	_	_	NN	O	[-1]	['none']	_	_
43	4	_	_	CD	O	[-1]	['none']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	remained	_	_	VBD	Positive_regulation	[46]	['multitoken']	_	_
46	high	_	_	JJ	Positive_regulation	[0]	['root']	_	_
47	until	_	_	IN	O	[-1]	['none']	_	_
48	day	_	_	NN	O	[-1]	['none']	_	_
49	6	_	_	CD	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	small	_	_	JJ	O	[-1]	['none']	_	_
6	fraction	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	naive	_	_	JJ	O	[-1]	['none']	_	_
9	T	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	expressed	_	_	VBD	Gene_expression	[25]	['Theme']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	cytokines	_	_	NNS	O	[-1]	['none']	_	_
14	IFN-gamma	_	_	NN	Protein	[11]	['Theme']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	TNF	_	_	NN	Protein	[11]	['Theme']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	response	_	_	NN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	stimulation	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	this	_	_	DT	Anaphora	[24]	['multitoken']	_	_
24	capacity	_	_	NN	Anaphora	[0]	['root']	_	_
25	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
26	significantly	_	_	RB	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	differentiated	_	_	VBN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	evaluated	_	_	VBD	O	[-1]	['none']	_	_
3	antigen	_	_	NN	O	[-1]	['none']	_	_
4	dependent	_	_	JJ	O	[-1]	['none']	_	_
5	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
6	function	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	short-term	_	_	JJ	O	[-1]	['none']	_	_
10	assay	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	which	_	_	WDT	O	[-1]	['none']	_	_
13	target	_	_	NN	O	[-1]	['none']	_	_
14	cell	_	_	NN	O	[-1]	['none']	_	_
15	death	_	_	NN	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	measured	_	_	VBN	O	[-1]	['none']	_	_
18	within	_	_	IN	O	[-1]	['none']	_	_
19	2	_	_	CD	O	[-1]	['none']	_	_
20	h	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	By	_	_	IN	O	[-1]	['none']	_	_
2	limiting	_	_	VBG	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	duration	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	TCR	_	_	NN	O	[-1]	['none']	_	_
7	stimulation	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	this	_	_	DT	O	[-1]	['none']	_	_
10	strategy	_	_	NN	O	[-1]	['none']	_	_
11	minimizes	_	_	VBZ	O	[-1]	['none']	_	_
12	cytolysis	_	_	NN	O	[-1]	['none']	_	_
13	secondary	_	_	JJ	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	new	_	_	JJ	O	[-1]	['none']	_	_
16	gene	_	_	NN	O	[-1]	['none']	_	_
17	expression	_	_	NN	O	[-1]	['none']	_	_
18	during	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	period	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	assay	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Naive	_	_	JJ	O	[-1]	['none']	_	_
2	T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	did	_	_	VBD	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	display	_	_	VB	O	[-1]	['none']	_	_
7	significant	_	_	JJ	O	[-1]	['none']	_	_
8	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
9	function	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	this	_	_	DT	O	[-1]	['none']	_	_
12	short-term	_	_	JJ	O	[-1]	['none']	_	_
13	assay	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	unpublished	_	_	JJ	O	[-1]	['none']	_	_
16	data	_	_	NNS	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	most	_	_	RBS	O	[-1]	['none']	_	_
20	likely	_	_	RB	O	[-1]	['none']	_	_
21	because	_	_	IN	O	[-1]	['none']	_	_
22	they	_	_	PRP	O	[-1]	['none']	_	_
23	express	_	_	VBP	Gene_expression	[0]	['root']	_	_
24	immature	_	_	JJ	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	unprocessed	_	_	JJ	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	forms	_	_	NNS	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	perforin	_	_	NN	Protein	[23]	['Theme']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	lack	_	_	VBP	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	capacity	_	_	NN	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	degranulate	_	_	VB	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	18	_	_	CD	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	19	_	_	CD	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Even	_	_	RB	O	[-1]	['none']	_	_
2	after	_	_	IN	O	[-1]	['none']	_	_
3	activation	_	_	NN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	2	_	_	CD	O	[-1]	['none']	_	_
6	or	_	_	CC	O	[-1]	['none']	_	_
7	4	_	_	CD	O	[-1]	['none']	_	_
8	d	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	showed	_	_	VBD	O	[-1]	['none']	_	_
13	poor	_	_	JJ	O	[-1]	['none']	_	_
14	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
15	activity	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	striking	_	_	JJ	O	[-1]	['none']	_	_
19	contrast	_	_	NN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	their	_	_	PRP$	O	[-1]	['none']	_	_
22	capacity	_	_	NN	O	[-1]	['none']	_	_
23	for	_	_	IN	O	[-1]	['none']	_	_
24	efficient	_	_	JJ	O	[-1]	['none']	_	_
25	cytokine	_	_	NN	O	[-1]	['none']	_	_
26	production	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Only	_	_	RB	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	cultured	_	_	VBN	O	[-1]	['none']	_	_
4	until	_	_	IN	O	[-1]	['none']	_	_
5	day	_	_	NN	O	[-1]	['none']	_	_
6	6	_	_	CD	O	[-1]	['none']	_	_
7	displayed	_	_	VBD	O	[-1]	['none']	_	_
8	robust	_	_	JJ	O	[-1]	['none']	_	_
9	cytotoxicity	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	judged	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	their	_	_	PRP$	O	[-1]	['none']	_	_
15	ability	_	_	NN	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	induce	_	_	VB	O	[-1]	['none']	_	_
18	apoptosis	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	large	_	_	JJ	O	[-1]	['none']	_	_
22	number	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	target	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	show	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	after	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	strong	_	_	JJ	O	[-1]	['none']	_	_
8	priming	_	_	NN	O	[-1]	['none']	_	_
9	stimulus	_	_	NN	O	[-1]	['none']	_	_
10	through	_	_	IN	O	[-1]	['none']	_	_
11	TCRs	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	co-stimulatory	_	_	JJ	O	[-1]	['none']	_	_
14	receptors	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	FW	O	[-1]	['none']	_	_
16	vitro	_	_	FW	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	granzyme	_	_	NN	Protein	[19]	['multitoken']	_	_
19	B	_	_	NN	Protein	[20]	['Theme']	_	_
20	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	ability	_	_	NN	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	produce	_	_	VB	O	[-1]	['none']	_	_
26	effector	_	_	NN	O	[-1]	['none']	_	_
27	cytokines	_	_	NNS	O	[-1]	['none']	_	_
28	are	_	_	VBP	O	[-1]	['none']	_	_
29	programmed	_	_	VBN	O	[-1]	['none']	_	_
30	early	_	_	RB	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	whereas	_	_	IN	O	[-1]	['none']	_	_
33	perforin	_	_	NN	Protein	[34]	['Theme']	_	_
34	expression	_	_	NN	Gene_expression	[39]	['Theme']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
37	function	_	_	NN	O	[-1]	['none']	_	_
38	are	_	_	VBP	O	[-1]	['none']	_	_
39	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
40	later	_	_	RB	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	during	_	_	IN	O	[-1]	['none']	_	_
43	the	_	_	DT	O	[-1]	['none']	_	_
44	phase	_	_	NN	O	[-1]	['none']	_	_
45	of	_	_	IN	O	[-1]	['none']	_	_
46	clonal	_	_	JJ	O	[-1]	['none']	_	_
47	expansion	_	_	NN	O	[-1]	['none']	_	_
48	in	_	_	IN	O	[-1]	['none']	_	_
49	IL-2	_	_	NN	Protein	[0]	['root']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	two	_	_	CD	O	[-1]	['none']	_	_
5	major	_	_	JJ	O	[-1]	['none']	_	_
6	effector	_	_	NN	O	[-1]	['none']	_	_
7	functions	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	CTL	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	cytokine	_	_	NN	O	[-1]	['none']	_	_
12	production	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
15	activity	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	are	_	_	VBP	O	[-1]	['none']	_	_
18	not	_	_	RB	O	[-1]	['none']	_	_
19	intrinsically	_	_	RB	O	[-1]	['none']	_	_
20	coregulated	_	_	JJ	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	HOIL-1L	_	_	NNP	Protein	[3]	['multitoken']	_	_
2	Interacting	_	_	VBG	Protein	[3]	['multitoken']	_	_
3	Protein	_	_	NN	Protein	[0]	['root']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[0]	['root']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	Is	_	_	VBZ	O	[-1]	['none']	_	_
8	Essential	_	_	JJ	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	CD40	_	_	NN	Protein	[0]	['root']	_	_
11	Signaling	_	_	NN	O	[-1]	['none']	_	_
12	CD40	_	_	NN	Protein	[0]	['root']	_	_
13	is	_	_	VBZ	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	cell	_	_	NN	O	[-1]	['none']	_	_
16	surface	_	_	NN	O	[-1]	['none']	_	_
17	receptor	_	_	NN	O	[-1]	['none']	_	_
18	important	_	_	JJ	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	activation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	antigen	_	_	NN	O	[-1]	['none']	_	_
24	presenting	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	during	_	_	IN	O	[-1]	['none']	_	_
27	immune	_	_	JJ	O	[-1]	['none']	_	_
28	responses	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	macrophages	_	_	NNS	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	dendritic	_	_	JJ	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	engagement	_	_	NN	Binding	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	CD40	_	_	NN	Protein	[7]	['Theme']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	its	_	_	PRP$	O	[-1]	['none']	_	_
12	ligand	_	_	NN	Protein	[0]	['root']	_	_
13	CD154	_	_	NN	Protein	[7]	['Theme']	_	_
14	provides	_	_	VBZ	O	[-1]	['none']	_	_
15	signals	_	_	NNS	O	[-1]	['none']	_	_
16	critical	_	_	JJ	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	anti-microbial	_	_	JJ	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	T	_	_	NN	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	mediated	_	_	JJ	O	[-1]	['none']	_	_
23	immune	_	_	JJ	O	[-1]	['none']	_	_
24	responses	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	respectively	_	_	RB	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[0]	['root']	_	_
6	signaling	_	_	NN	O	[-1]	['none']	_	_
7	has	_	_	VBZ	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	major	_	_	JJ	O	[-1]	['none']	_	_
10	role	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	regulating	_	_	VBG	O	[-1]	['none']	_	_
13	cell	_	_	NN	O	[-1]	['none']	_	_
14	proliferation	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	antibody	_	_	NN	O	[-1]	['none']	_	_
17	production	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	memory	_	_	NN	O	[-1]	['none']	_	_
21	B	_	_	NN	O	[-1]	['none']	_	_
22	cell	_	_	NN	O	[-1]	['none']	_	_
23	development	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[2]	['Theme']	_	_
2	engagement	_	_	NN	Binding	[0]	['root']	_	_
3	results	_	_	VBZ	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	formation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	receptor	_	_	NN	O	[-1]	['none']	_	_
10	associated	_	_	VBN	O	[-1]	['none']	_	_
11	complex	_	_	NN	O	[-1]	['none']	_	_
12	that	_	_	WDT	O	[-1]	['none']	_	_
13	mediates	_	_	VBZ	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	stress	_	_	NN	O	[-1]	['none']	_	_
19	activated	_	_	VBD	O	[-1]	['none']	_	_
20	protein	_	_	NN	O	[-1]	['none']	_	_
21	kinases	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	other	_	_	JJ	O	[-1]	['none']	_	_
25	signaling	_	_	VBG	O	[-1]	['none']	_	_
26	molecules	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
5	that	_	_	WDT	O	[-1]	['none']	_	_
6	link	_	_	VBP	O	[-1]	['none']	_	_
7	CD40	_	_	NN	Protein	[0]	['root']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	these	_	_	DT	O	[-1]	['none']	_	_
10	signaling	_	_	NN	O	[-1]	['none']	_	_
11	events	_	_	NNS	O	[-1]	['none']	_	_
12	have	_	_	VBP	O	[-1]	['none']	_	_
13	been	_	_	VBN	O	[-1]	['none']	_	_
14	only	_	_	RB	O	[-1]	['none']	_	_
15	partially	_	_	RB	O	[-1]	['none']	_	_
16	characterized	_	_	VBN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Known	_	_	VBN	O	[-1]	['none']	_	_
2	components	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	CD40	_	_	NN	O	[-1]	['none']	_	_
6	signaling	_	_	NN	O	[-1]	['none']	_	_
7	complex	_	_	NN	O	[-1]	['none']	_	_
8	include	_	_	VBP	O	[-1]	['none']	_	_
9	members	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	TNF	_	_	NN	O	[-1]	['none']	_	_
13	receptor	_	_	NN	O	[-1]	['none']	_	_
14	associated	_	_	JJ	O	[-1]	['none']	_	_
15	factor	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	TRAF	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	family	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	proteins	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	previously	_	_	RB	O	[-1]	['none']	_	_
3	showed	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	TRAF	_	_	NN	O	[-1]	['none']	_	_
7	family	_	_	NN	O	[-1]	['none']	_	_
8	member	_	_	NN	O	[-1]	['none']	_	_
9	TRAF2	_	_	NN	Protein	[10]	['Cause']	_	_
10	mediates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
11	recruitment	_	_	NN	Binding	[10]	['Theme']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	HOIL-1L-interacting	_	_	JJ	Protein	[14]	['multitoken']	_	_
14	protein	_	_	NN	Protein	[11]	['Theme']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	HOIP	_	_	NN	Protein	[0]	['root']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	cytoplasmic	_	_	JJ	Entity	[21]	['multitoken']	_	_
21	domain	_	_	NN	Entity	[11]	['Site']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	CD40	_	_	NN	Protein	[11]	['Theme']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	suggesting	_	_	VBG	O	[-1]	['none']	_	_
26	that	_	_	IN	O	[-1]	['none']	_	_
27	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
28	has	_	_	VBZ	O	[-1]	['none']	_	_
29	a	_	_	DT	O	[-1]	['none']	_	_
30	role	_	_	NN	O	[-1]	['none']	_	_
31	in	_	_	IN	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	CD40	_	_	NN	Protein	[0]	['root']	_	_
34	signaling	_	_	NN	O	[-1]	['none']	_	_
35	pathway	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	role	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	CD40	_	_	NN	Protein	[0]	['root']	_	_
9	signaling	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	we	_	_	PRP	O	[-1]	['none']	_	_
12	used	_	_	VBD	O	[-1]	['none']	_	_
13	somatic	_	_	JJ	O	[-1]	['none']	_	_
14	cell	_	_	NN	O	[-1]	['none']	_	_
15	gene	_	_	NN	O	[-1]	['none']	_	_
16	targeting	_	_	VBG	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	generate	_	_	VB	O	[-1]	['none']	_	_
19	mouse	_	_	NN	O	[-1]	['none']	_	_
20	B	_	_	NN	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	lines	_	_	NNS	O	[-1]	['none']	_	_
23	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	HOIP	_	_	NNP	Protein	[23]	['Theme']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	found	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[6]	['Cause']	_	_
6	induced	_	_	VBD	Positive_regulation	[18]	['Theme']	_	_
7	upregulation	_	_	NN	Positive_regulation	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	CD80	_	_	NN	Protein	[7]	['Theme']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	germline	_	_	NN	O	[-1]	['none']	_	_
14	immunoglobulin	_	_	NN	O	[-1]	['none']	_	_
15	epsilon	_	_	NN	O	[-1]	['none']	_	_
16	transcription	_	_	NN	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	defective	_	_	JJ	Negative_regulation	[0]	['root']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	HOIP	_	_	NN	Protein	[21]	['Theme']	_	_
21	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	found	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	CD40	_	_	NN	Protein	[0]	['root']	_	_
7	mediated	_	_	JJ	O	[-1]	['none']	_	_
8	activation	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	c-Jun	_	_	NN	O	[-1]	['none']	_	_
13	kinase	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	impaired	_	_	JJ	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Recruitment	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	IkappaB	_	_	NN	O	[-1]	['none']	_	_
4	kinase	_	_	NN	O	[-1]	['none']	_	_
5	proteins	_	_	NNS	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	CD40	_	_	NN	O	[-1]	['none']	_	_
9	signaling	_	_	NN	O	[-1]	['none']	_	_
10	complex	_	_	NN	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	undetectable	_	_	JJ	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	HOIP	_	_	NN	Protein	[15]	['Theme']	_	_
15	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	potentially	_	_	RB	O	[-1]	['none']	_	_
19	explaining	_	_	VBG	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	defect	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	activation	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Restoration	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	HOIP	_	_	NN	Protein	[4]	['Theme']	_	_
4	expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
5	reversed	_	_	VBD	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	defects	_	_	NNS	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	cellular	_	_	JJ	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	signaling	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	reveal	_	_	VBP	O	[-1]	['none']	_	_
4	HOIP	_	_	NN	Protein	[0]	['root']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	key	_	_	JJ	O	[-1]	['none']	_	_
8	component	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	CD40	_	_	NN	Protein	[0]	['root']	_	_
12	signaling	_	_	NN	O	[-1]	['none']	_	_
13	pathway	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Immunohistochemistry	_	_	NN	O	[-1]	['none']	_	_
2	.	_	_	.	O	[-1]	['none']	_	_

1	Paraffin	_	_	NN	O	[-1]	['none']	_	_
2	embedded	_	_	JJ	O	[-1]	['none']	_	_
3	spleen	_	_	NN	O	[-1]	['none']	_	_
4	sections	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	deparaffinized	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	Histoclear	_	_	JJ	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	National	_	_	NNP	O	[-1]	['none']	_	_
11	Diagnostics	_	_	NNPS	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	rehydrated	_	_	VBN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	graded	_	_	VBN	O	[-1]	['none']	_	_
17	ethanol	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Sections	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	antigen	_	_	NN	O	[-1]	['none']	_	_
4	retrieved	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	microwaving	_	_	VBG	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	citrate	_	_	NN	O	[-1]	['none']	_	_
9	buffer	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	pH	_	_	NN	O	[-1]	['none']	_	_
12	6.0	_	_	CD	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	15	_	_	CD	O	[-1]	['none']	_	_
16	min	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	LMP1	_	_	NN	Protein	[0]	['root']	_	_
19	staining	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	10	_	_	CD	O	[-1]	['none']	_	_
23	min	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	pStat3	_	_	NN	O	[-1]	['none']	_	_
26	staining	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	LMP1	_	_	NN	Protein	[0]	['root']	_	_
3	staining	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	sections	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	blocked	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	1	_	_	CD	O	[-1]	['none']	_	_
10	%	_	_	NN	O	[-1]	['none']	_	_
11	BSA	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	0.1	_	_	CD	O	[-1]	['none']	_	_
14	%	_	_	NN	O	[-1]	['none']	_	_
15	cold	_	_	JJ	O	[-1]	['none']	_	_
16	fish	_	_	NN	O	[-1]	['none']	_	_
17	skin	_	_	NN	O	[-1]	['none']	_	_
18	gelatin	_	_	NN	O	[-1]	['none']	_	_
19	followed	_	_	VBD	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	streptavidin	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	biotin	_	_	NN	O	[-1]	['none']	_	_
24	block	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	Vector	_	_	NNP	O	[-1]	['none']	_	_
27	Labs	_	_	NNPS	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Rat	_	_	NN	O	[-1]	['none']	_	_
2	IgG	_	_	NN	O	[-1]	['none']	_	_
3	anti-LMP1	_	_	JJ	Protein	[0]	['root']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	clones	_	_	NNS	O	[-1]	['none']	_	_
6	8G3	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	1G6	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	Ascenion	_	_	NNP	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	used	_	_	VBN	O	[-1]	['none']	_	_
14	at	_	_	IN	O	[-1]	['none']	_	_
15	1:10	_	_	CD	O	[-1]	['none']	_	_
16	dilution	_	_	NN	O	[-1]	['none']	_	_
17	from	_	_	IN	O	[-1]	['none']	_	_
18	tissue	_	_	NN	O	[-1]	['none']	_	_
19	culture	_	_	NN	O	[-1]	['none']	_	_
20	supernatants	_	_	NNS	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	followed	_	_	VBD	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	8	_	_	CD	O	[-1]	['none']	_	_
25	mug/ml	_	_	NN	O	[-1]	['none']	_	_
26	biotinylated	_	_	VBN	O	[-1]	['none']	_	_
27	mouse	_	_	NN	O	[-1]	['none']	_	_
28	F	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	ab	_	_	NN	O	[-1]	['none']	_	_
31	'	_	_	''	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	anti-rat	_	_	JJ	O	[-1]	['none']	_	_
34	IgG	_	_	NN	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	H+L	_	_	NN	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	pre-adsorbed	_	_	JJ	O	[-1]	['none']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	mouse	_	_	NN	O	[-1]	['none']	_	_
41	serum	_	_	NN	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	Jackson	_	_	NNP	O	[-1]	['none']	_	_
44	ImmunoResearch	_	_	NNP	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	and	_	_	CC	O	[-1]	['none']	_	_
47	2	_	_	CD	O	[-1]	['none']	_	_
48	mug/ml	_	_	JJ	O	[-1]	['none']	_	_
49	streptavidin-alkaline	_	_	JJ	O	[-1]	['none']	_	_
50	phosphatase	_	_	NN	O	[-1]	['none']	_	_
51	conjugate	_	_	NN	O	[-1]	['none']	_	_
52	(	_	_	-LRB-	O	[-1]	['none']	_	_
53	Jackson	_	_	NNP	O	[-1]	['none']	_	_
54	ImmunoResearch	_	_	NNP	O	[-1]	['none']	_	_
55	)	_	_	-RRB-	O	[-1]	['none']	_	_
56	.	_	_	.	O	[-1]	['none']	_	_

1	Stains	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	developed	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	BCIP	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	NBT	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	counterstained	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	Nuclear	_	_	JJ	O	[-1]	['none']	_	_
12	Fast	_	_	JJ	O	[-1]	['none']	_	_
13	Red	_	_	NNP	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Dako	_	_	NNP	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Phospho-Stat3	_	_	NNP	Protein	[0]	['root']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	detected	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	4	_	_	CD	O	[-1]	['none']	_	_
6	mug/ml	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	pStat3	_	_	NN	O	[-1]	['none']	_	_
9	antibody	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Tyr705	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	Cell	_	_	NN	O	[-1]	['none']	_	_
14	Signaling	_	_	NN	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	detected	_	_	VBN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	anti-rabbit	_	_	JJ	O	[-1]	['none']	_	_
20	Poly-HRP	_	_	NN	O	[-1]	['none']	_	_
21	IHC	_	_	NN	O	[-1]	['none']	_	_
22	detection	_	_	NN	O	[-1]	['none']	_	_
23	kit	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	Chemicon	_	_	NNP	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	PKCalpha	_	_	NN	Protein	[2]	['Cause']	_	_
2	regulates	_	_	VBZ	Regulation	[0]	['root']	_	_
3	phosphorylation	_	_	NN	Phosphorylation	[2]	['Theme']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	p65	_	_	NN	Protein	[3]	['Theme']	_	_
7	at	_	_	IN	O	[-1]	['none']	_	_
8	Ser276	_	_	NN	Entity	[3]	['Site']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	MDM	_	_	NN	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	B	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	RAW	_	_	NN	O	[-1]	['none']	_	_
10	264.7	_	_	CD	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	transiently	_	_	RB	O	[-1]	['none']	_	_
14	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
17	along	_	_	IN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	either	_	_	CC	O	[-1]	['none']	_	_
20	WT-PKCalpha	_	_	NN	Protein	[14]	['Theme']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	kinase	_	_	NN	Negative_regulation	[24]	['multitoken']	_	_
24	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	KD	_	_	NN	O	[-1]	['none']	_	_
27	)-PKCalpha	_	_	NN	Protein	[14, 24]	['Theme', 'Theme']	_	_
28	construct	_	_	NN	O	[-1]	['none']	_	_
29	at	_	_	IN	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	1:5	_	_	CD	O	[-1]	['none']	_	_
32	ratio	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	serum	_	_	NN	O	[-1]	['none']	_	_
4	starved	_	_	VBN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	stimulated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	M-CSF	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	then	_	_	RB	O	[-1]	['none']	_	_
11	SEAP	_	_	NN	O	[-1]	['none']	_	_
12	secretion	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	medium	_	_	NN	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	measured	_	_	VBN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	three	_	_	CD	O	[-1]	['none']	_	_
6	independent	_	_	JJ	O	[-1]	['none']	_	_
7	experiments	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	p-value	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	transfected	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	KD	_	_	NN	O	[-1]	['none']	_	_
8	compared	_	_	VBN	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	those	_	_	DT	O	[-1]	['none']	_	_
11	transfected	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	WT	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	0.05	_	_	CD	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	MDMs	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	removed	_	_	VBN	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	plate	_	_	NN	O	[-1]	['none']	_	_
10	using	_	_	VBG	O	[-1]	['none']	_	_
11	accutase	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	apoptosis	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	MDMs	_	_	NNS	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	measured	_	_	VBN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	flow	_	_	NN	O	[-1]	['none']	_	_
20	cytometry	_	_	NN	O	[-1]	['none']	_	_
21	using	_	_	VBG	O	[-1]	['none']	_	_
22	Annexin	_	_	NN	Protein	[23]	['multitoken']	_	_
23	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	propidium	_	_	NN	O	[-1]	['none']	_	_
26	iodine	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	PI	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	D	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Whole	_	_	JJ	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	lysates	_	_	NNS	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	transfected	_	_	JJ	O	[-1]	['none']	_	_
10	RAW	_	_	NN	O	[-1]	['none']	_	_
11	264.7	_	_	CD	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	subjected	_	_	VBN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	Western	_	_	NN	O	[-1]	['none']	_	_
17	blot	_	_	NN	O	[-1]	['none']	_	_
18	analysis	_	_	NN	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	phospho-Ser276	_	_	NN	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	phospho-Ser536	_	_	NN	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	p65	_	_	NN	O	[-1]	['none']	_	_
25	antibodies	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Blots	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	immunoblotted	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	determine	_	_	VB	O	[-1]	['none']	_	_
8	equal	_	_	JJ	O	[-1]	['none']	_	_
9	protein	_	_	NN	O	[-1]	['none']	_	_
10	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	PKCalpha	_	_	NN	Protein	[10]	['Theme']	_	_
14	constructs	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	beta-actin	_	_	NN	Protein	[0]	['root']	_	_
2	served	_	_	VBD	O	[-1]	['none']	_	_
3	as	_	_	IN	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	loading	_	_	VBG	O	[-1]	['none']	_	_
6	control	_	_	NN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Shown	_	_	VBN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	representative	_	_	NN	O	[-1]	['none']	_	_
5	blot	_	_	NN	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	three	_	_	CD	O	[-1]	['none']	_	_
8	independent	_	_	JJ	O	[-1]	['none']	_	_
9	experiments	_	_	NNS	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	E	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	MDM	_	_	NN	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	F	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	RAW	_	_	NN	O	[-1]	['none']	_	_
10	264.7	_	_	CD	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	transiently	_	_	RB	O	[-1]	['none']	_	_
14	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
18	along	_	_	IN	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	either	_	_	CC	O	[-1]	['none']	_	_
21	100	_	_	CD	O	[-1]	['none']	_	_
22	nM	_	_	NN	O	[-1]	['none']	_	_
23	PKCalpha	_	_	NN	Protein	[24]	['multitoken']	_	_
24	siRNA	_	_	NN	Protein	[14]	['Theme']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	control	_	_	NN	O	[-1]	['none']	_	_
27	siRNA	_	_	NN	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	20-24	_	_	CD	O	[-1]	['none']	_	_
30	hours	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	serum	_	_	NN	O	[-1]	['none']	_	_
4	starved	_	_	VBN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	2-4	_	_	CD	O	[-1]	['none']	_	_
7	hours	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	stimulated	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	100	_	_	CD	O	[-1]	['none']	_	_
12	ng/ml	_	_	NN	O	[-1]	['none']	_	_
13	M-CSF	_	_	NN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	6	_	_	CD	O	[-1]	['none']	_	_
16	hours	_	_	NNS	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	MDM	_	_	NN	O	[-1]	['none']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	RAW	_	_	NN	O	[-1]	['none']	_	_
21	264.7	_	_	CD	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	2	_	_	CD	O	[-1]	['none']	_	_
24	hours	_	_	NNS	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	then	_	_	RB	O	[-1]	['none']	_	_
27	SEAP	_	_	NN	O	[-1]	['none']	_	_
28	secretion	_	_	NN	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	medium	_	_	NN	O	[-1]	['none']	_	_
32	was	_	_	VBD	O	[-1]	['none']	_	_
33	measured	_	_	VBN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Shown	_	_	VBN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	data	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	three	_	_	CD	O	[-1]	['none']	_	_
6	independent	_	_	JJ	O	[-1]	['none']	_	_
7	experiments	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	G	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	MDMs	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	removed	_	_	VBN	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	plate	_	_	NN	O	[-1]	['none']	_	_
10	using	_	_	VBG	O	[-1]	['none']	_	_
11	accutase	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	apoptosis	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	MDMs	_	_	NNS	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	measured	_	_	VBN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	Annexin	_	_	NN	Protein	[20]	['multitoken']	_	_
20	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	propidium	_	_	NN	O	[-1]	['none']	_	_
23	iodine	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	PI	_	_	NN	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	staining	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	analyzed	_	_	VBN	O	[-1]	['none']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	flow	_	_	NN	O	[-1]	['none']	_	_
32	cytometry	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	H	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Whole	_	_	JJ	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	lysates	_	_	NNS	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	transfected	_	_	JJ	O	[-1]	['none']	_	_
10	MDM	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	RAW	_	_	NN	O	[-1]	['none']	_	_
13	264.7	_	_	CD	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	subjected	_	_	VBN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	Western	_	_	NN	O	[-1]	['none']	_	_
19	blot	_	_	NN	O	[-1]	['none']	_	_
20	analysis	_	_	NN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	PKCalpha	_	_	NN	O	[-1]	['none']	_	_
23	antibody	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	beta-actin	_	_	NN	Protein	[0]	['root']	_	_
2	served	_	_	VBD	O	[-1]	['none']	_	_
3	as	_	_	IN	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	loading	_	_	VBG	O	[-1]	['none']	_	_
6	control	_	_	NN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Shown	_	_	VBN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	representative	_	_	NN	O	[-1]	['none']	_	_
5	blot	_	_	NN	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	at	_	_	IN	O	[-1]	['none']	_	_
8	least	_	_	JJS	O	[-1]	['none']	_	_
9	three	_	_	CD	O	[-1]	['none']	_	_
10	independent	_	_	JJ	O	[-1]	['none']	_	_
11	experiments	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Heat	_	_	NN	O	[-1]	['none']	_	_
2	killed	_	_	VBD	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	HK	_	_	JJ	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	Escherichia	_	_	FW	O	[-1]	['none']	_	_
7	coli	_	_	FW	O	[-1]	['none']	_	_
8	E.	_	_	FW	O	[-1]	['none']	_	_
9	coli	_	_	FW	O	[-1]	['none']	_	_
10	MG1655	_	_	NN	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	grown	_	_	VBN	O	[-1]	['none']	_	_
13	on	_	_	IN	O	[-1]	['none']	_	_
14	Luria-Bertani	_	_	JJ	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	LB	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	agar	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	incubated	_	_	VBN	O	[-1]	['none']	_	_
21	at	_	_	IN	O	[-1]	['none']	_	_
22	37degreesC	_	_	NN	O	[-1]	['none']	_	_
23	overnight	_	_	JJ	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	One	_	_	CD	O	[-1]	['none']	_	_
2	colony	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	inoculated	_	_	VBN	O	[-1]	['none']	_	_
5	into	_	_	IN	O	[-1]	['none']	_	_
6	10	_	_	CD	O	[-1]	['none']	_	_
7	ml	_	_	NN	O	[-1]	['none']	_	_
8	LB	_	_	NN	O	[-1]	['none']	_	_
9	broth	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	incubated	_	_	VBN	O	[-1]	['none']	_	_
12	on	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	shaker	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	200	_	_	CD	O	[-1]	['none']	_	_
17	rpm	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	37degreesC	_	_	NN	O	[-1]	['none']	_	_
21	overnight	_	_	JJ	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	bacteria	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	10	_	_	CD	O	[-1]	['none']	_	_
7	min	_	_	NN	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	3000	_	_	CD	O	[-1]	['none']	_	_
10	x	_	_	CC	O	[-1]	['none']	_	_
11	g	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	washed	_	_	VBN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	3	_	_	CD	O	[-1]	['none']	_	_
16	ml	_	_	NN	O	[-1]	['none']	_	_
17	phosphate	_	_	NN	O	[-1]	['none']	_	_
18	buffered	_	_	VBN	O	[-1]	['none']	_	_
19	saline	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	PBS	_	_	NNP	O	[-1]	['none']	_	_
22	;	_	_	:	O	[-1]	['none']	_	_
23	8	_	_	CD	O	[-1]	['none']	_	_
24	g	_	_	NN	O	[-1]	['none']	_	_
25	NaCl	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	1.16	_	_	CD	O	[-1]	['none']	_	_
28	g	_	_	NN	O	[-1]	['none']	_	_
29	Na2HPO4	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	0.2	_	_	CD	O	[-1]	['none']	_	_
32	g	_	_	NN	O	[-1]	['none']	_	_
33	KH2PO4	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	0.2	_	_	CD	O	[-1]	['none']	_	_
36	g	_	_	NN	O	[-1]	['none']	_	_
37	KCl	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	pH7	_	_	NN	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	resuspended	_	_	VBN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	50	_	_	CD	O	[-1]	['none']	_	_
45	mul	_	_	NN	O	[-1]	['none']	_	_
46	PBS	_	_	NNP	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	bacteria	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	killed	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	heating	_	_	VBG	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	70degreesC	_	_	NNP	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	1	_	_	CD	O	[-1]	['none']	_	_
11	h.	_	_	NN	O	[-1]	['none']	_	_
12	To	_	_	TO	O	[-1]	['none']	_	_
13	ensure	_	_	VB	O	[-1]	['none']	_	_
14	that	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	bacteria	_	_	NNS	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	killed	_	_	VBN	O	[-1]	['none']	_	_
19	;	_	_	:	O	[-1]	['none']	_	_
20	10	_	_	CD	O	[-1]	['none']	_	_
21	mul	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	heat	_	_	NN	O	[-1]	['none']	_	_
25	killed	_	_	VBD	O	[-1]	['none']	_	_
26	suspension	_	_	NN	O	[-1]	['none']	_	_
27	was	_	_	VBD	O	[-1]	['none']	_	_
28	spread	_	_	VBN	O	[-1]	['none']	_	_
29	on	_	_	IN	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	LB	_	_	NN	O	[-1]	['none']	_	_
32	plate	_	_	NN	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	incubated	_	_	VBN	O	[-1]	['none']	_	_
35	overnight	_	_	JJ	O	[-1]	['none']	_	_
36	at	_	_	IN	O	[-1]	['none']	_	_
37	37degreesC	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[5]	['Theme']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
4	Tax	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
6	analysis	_	_	NN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	real-time	_	_	JJ	O	[-1]	['none']	_	_
9	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	Real-time	_	_	JJ	O	[-1]	['none']	_	_
2	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[9]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
8	Tax	_	_	NN	Protein	[9]	['Theme']	_	_
9	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	performed	_	_	VBN	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	previously	_	_	RB	O	[-1]	['none']	_	_
14	described	_	_	VBN	O	[-1]	['none']	_	_
15	[	_	_	CD	O	[-1]	['none']	_	_
16	8,47	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	total	_	_	JJ	O	[-1]	['none']	_	_
4	RNA	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	extracted	_	_	VBN	O	[-1]	['none']	_	_
7	using	_	_	VBG	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	RNeasy	_	_	NNP	O	[-1]	['none']	_	_
10	Mini	_	_	NNP	O	[-1]	['none']	_	_
11	Kit	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	Qiagen	_	_	NNP	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	Valencia	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	California	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	United	_	_	NNP	O	[-1]	['none']	_	_
20	States	_	_	NNPS	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	according	_	_	VBG	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	manufacturer	_	_	NN	O	[-1]	['none']	_	_
25	's	_	_	POS	O	[-1]	['none']	_	_
26	guidelines	_	_	NNS	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	cDNA	_	_	NN	O	[-1]	['none']	_	_
30	was	_	_	VBD	O	[-1]	['none']	_	_
31	synthesized	_	_	VBN	O	[-1]	['none']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	reverse	_	_	JJ	O	[-1]	['none']	_	_
34	transcription	_	_	NN	O	[-1]	['none']	_	_
35	using	_	_	VBG	O	[-1]	['none']	_	_
36	TaqMan	_	_	NNP	O	[-1]	['none']	_	_
37	Gold	_	_	NNP	O	[-1]	['none']	_	_
38	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
39	Kit	_	_	NN	O	[-1]	['none']	_	_
40	using	_	_	VBG	O	[-1]	['none']	_	_
41	random	_	_	JJ	O	[-1]	['none']	_	_
42	hexamer	_	_	NN	O	[-1]	['none']	_	_
43	primers	_	_	NNS	O	[-1]	['none']	_	_
44	(	_	_	-LRB-	O	[-1]	['none']	_	_
45	Applied	_	_	NNP	O	[-1]	['none']	_	_
46	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	Foster	_	_	NNP	O	[-1]	['none']	_	_
49	City	_	_	NNP	O	[-1]	['none']	_	_
50	,	_	_	,	O	[-1]	['none']	_	_
51	California	_	_	NNP	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	United	_	_	NNP	O	[-1]	['none']	_	_
54	States	_	_	NNPS	O	[-1]	['none']	_	_
55	)	_	_	-RRB-	O	[-1]	['none']	_	_
56	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[6]	['Theme']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
4	Tax	_	_	NN	Protein	[6]	['Theme']	_	_
5	mRNA	_	_	NN	Transcription	[6]	['multitoken']	_	_
6	expression	_	_	NN	Transcription	[0]	['root']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	quantified	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	real-time	_	_	JJ	O	[-1]	['none']	_	_
11	PCR	_	_	NN	O	[-1]	['none']	_	_
12	using	_	_	VBG	O	[-1]	['none']	_	_
13	ABI	_	_	NNP	O	[-1]	['none']	_	_
14	PRISM	_	_	NNP	O	[-1]	['none']	_	_
15	7700	_	_	CD	O	[-1]	['none']	_	_
16	Sequence	_	_	NN	O	[-1]	['none']	_	_
17	Detection	_	_	NN	O	[-1]	['none']	_	_
18	System	_	_	NNP	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Applied	_	_	NNP	O	[-1]	['none']	_	_
21	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	normalized	_	_	JJ	O	[-1]	['none']	_	_
3	values	_	_	NNS	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	each	_	_	DT	O	[-1]	['none']	_	_
6	sample	_	_	NN	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	calculated	_	_	VBN	O	[-1]	['none']	_	_
9	as	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	relative	_	_	JJ	O	[-1]	['none']	_	_
12	quantity	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[19]	['Theme']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
17	Tax	_	_	NN	Protein	[19]	['Theme']	_	_
18	mRNA	_	_	NN	Transcription	[19]	['multitoken']	_	_
19	expression	_	_	NN	Transcription	[0]	['root']	_	_
20	divided	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	relative	_	_	JJ	O	[-1]	['none']	_	_
24	quantity	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	HPRT	_	_	NN	Protein	[28]	['Theme']	_	_
27	mRNA	_	_	NN	Transcription	[28]	['multitoken']	_	_
28	expression	_	_	NN	Transcription	[0]	['root']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	values	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	calculated	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	following	_	_	VBG	O	[-1]	['none']	_	_
8	formula	_	_	NN	O	[-1]	['none']	_	_
9	:	_	_	:	O	[-1]	['none']	_	_
10	normalized	_	_	VBD	O	[-1]	['none']	_	_
11	Foxp3	_	_	NN	Protein	[15]	['Theme']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
14	Tax	_	_	NN	Protein	[15]	['Theme']	_	_
15	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
16	=	_	_	JJ	O	[-1]	['none']	_	_
17	2Ct	_	_	NN	O	[-1]	['none']	_	_
18	value	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	HPRT	_	_	NN	Protein	[0]	['root']	_	_
21	-	_	_	:	O	[-1]	['none']	_	_
22	Ct	_	_	NN	O	[-1]	['none']	_	_
23	value	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
26	or	_	_	CC	O	[-1]	['none']	_	_
27	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
28	Tax	_	_	NN	Protein	[0]	['root']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Retroviral	_	_	JJ	O	[-1]	['none']	_	_
2	transduction	_	_	NN	O	[-1]	['none']	_	_
3	A	_	_	DT	O	[-1]	['none']	_	_
4	retroviral	_	_	JJ	O	[-1]	['none']	_	_
5	vector	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	pMIP	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	used	_	_	VBN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	stable	_	_	JJ	O	[-1]	['none']	_	_
14	transduction	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	HOIP	_	_	NN	Protein	[0]	['root']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
21	cDNA	_	_	NN	O	[-1]	['none']	_	_
22	constructs	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	pMIP	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	constructed	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	replacing	_	_	VBG	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	IRES	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	GFP	_	_	NN	O	[-1]	['none']	_	_
10	encoding	_	_	NN	O	[-1]	['none']	_	_
11	sequences	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	pMIG	_	_	NN	O	[-1]	['none']	_	_
14	[	_	_	CD	O	[-1]	['none']	_	_
15	31	_	_	CD	O	[-1]	['none']	_	_
16	]	_	_	NN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	IRES	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	puromycin	_	_	NN	O	[-1]	['none']	_	_
22	resistance	_	_	NN	O	[-1]	['none']	_	_
23	gene	_	_	NN	O	[-1]	['none']	_	_
24	from	_	_	IN	O	[-1]	['none']	_	_
25	pIRESpuro2	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	Clontech	_	_	NNP	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	FLAG	_	_	NN	O	[-1]	['none']	_	_
2	tagged	_	_	VBD	O	[-1]	['none']	_	_
3	mouse	_	_	NN	O	[-1]	['none']	_	_
4	HOIP	_	_	NN	Protein	[0]	['root']	_	_
5	cDNA	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	inserted	_	_	VBN	O	[-1]	['none']	_	_
8	into	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	multiple	_	_	JJ	O	[-1]	['none']	_	_
11	cloning	_	_	NN	O	[-1]	['none']	_	_
12	site	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	pMIP	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	pMIP	_	_	NN	O	[-1]	['none']	_	_
3	construct	_	_	NN	O	[-1]	['none']	_	_
4	encoding	_	_	VBG	O	[-1]	['none']	_	_
5	mouse	_	_	NN	O	[-1]	['none']	_	_
6	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	amino	_	_	NN	O	[-1]	['none']	_	_
10	terminal	_	_	JJ	O	[-1]	['none']	_	_
11	birch	_	_	NN	O	[-1]	['none']	_	_
12	profilin	_	_	NN	O	[-1]	['none']	_	_
13	peptide	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	BP	_	_	NN	O	[-1]	['none']	_	_
16	)-tag	_	_	NN	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	also	_	_	RB	O	[-1]	['none']	_	_
19	prepared	_	_	VBN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Retroviral	_	_	JJ	O	[-1]	['none']	_	_
2	particles	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	generated	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	transient	_	_	JJ	O	[-1]	['none']	_	_
7	transfection	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	293T	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	pMIP	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	pMIP-HOIP	_	_	NN	Protein	[0]	['root']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	or	_	_	CC	O	[-1]	['none']	_	_
17	pMIP-IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	packaging	_	_	NN	O	[-1]	['none']	_	_
21	vector	_	_	NN	O	[-1]	['none']	_	_
22	pCL-Eco	_	_	NN	O	[-1]	['none']	_	_
23	[	_	_	CD	O	[-1]	['none']	_	_
24	32	_	_	CD	O	[-1]	['none']	_	_
25	]	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Two	_	_	CD	O	[-1]	['none']	_	_
2	days	_	_	NNS	O	[-1]	['none']	_	_
3	after	_	_	IN	O	[-1]	['none']	_	_
4	transfection	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	culture	_	_	NN	O	[-1]	['none']	_	_
7	supernatants	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	harvested	_	_	VBN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	filtered	_	_	VBN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	A20	_	_	NN	O	[-1]	['none']	_	_
2	.2	_	_	NN	O	[-1]	['none']	_	_
3	J	_	_	NN	O	[-1]	['none']	_	_
4	or	_	_	CC	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[6]	['Theme']	_	_
6	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	added	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	24-well	_	_	JJ	O	[-1]	['none']	_	_
12	plates	_	_	NNS	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	2.5	_	_	CD	O	[-1]	['none']	_	_
15	x105	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	well	_	_	RB	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	1	_	_	CD	O	[-1]	['none']	_	_
22	ml	_	_	NN	O	[-1]	['none']	_	_
23	virus	_	_	NN	O	[-1]	['none']	_	_
24	containing	_	_	VBG	O	[-1]	['none']	_	_
25	supernatant	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	8	_	_	CD	O	[-1]	['none']	_	_
28	microg/ml	_	_	NN	O	[-1]	['none']	_	_
29	polybrene	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Plates	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
4	at	_	_	IN	O	[-1]	['none']	_	_
5	500	_	_	CD	O	[-1]	['none']	_	_
6	x	_	_	CC	O	[-1]	['none']	_	_
7	g	_	_	NN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	2	_	_	CD	O	[-1]	['none']	_	_
10	hrs	_	_	NNS	O	[-1]	['none']	_	_
11	at	_	_	IN	O	[-1]	['none']	_	_
12	room	_	_	NN	O	[-1]	['none']	_	_
13	temperature	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	cultured	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	B	_	_	NN	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	culture	_	_	NN	O	[-1]	['none']	_	_
8	medium	_	_	NN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	48	_	_	CD	O	[-1]	['none']	_	_
11	hrs	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	after	_	_	IN	O	[-1]	['none']	_	_
14	which	_	_	WDT	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	transduced	_	_	JJ	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	selected	_	_	VBN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	3	_	_	CD	O	[-1]	['none']	_	_
22	microg/ml	_	_	NN	O	[-1]	['none']	_	_
23	puromycin	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Jurkat	_	_	NN	O	[-1]	['none']	_	_
2	T-cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	stimulated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	162	_	_	CD	O	[-1]	['none']	_	_
7	nM	_	_	NN	O	[-1]	['none']	_	_
8	PMA	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	5	_	_	CD	O	[-1]	['none']	_	_
11	x	_	_	CC	O	[-1]	['none']	_	_
12	107	_	_	CD	O	[-1]	['none']	_	_
13	CFU/ml	_	_	NN	O	[-1]	['none']	_	_
14	HK	_	_	NNP	O	[-1]	['none']	_	_
15	E.	_	_	NNP	O	[-1]	['none']	_	_
16	coli	_	_	NN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	24	_	_	CD	O	[-1]	['none']	_	_
19	h.	_	_	NN	O	[-1]	['none']	_	_

1	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	.	_	_	.	O	[-1]	['none']	_	_

1	Whole	_	_	JJ	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	lysates	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	prepared	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	radioimmunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
8	assay	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	RIPA	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	buffer	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	20	_	_	CD	O	[-1]	['none']	_	_
15	mM	_	_	NN	O	[-1]	['none']	_	_
16	Tris-HCl	_	_	NN	O	[-1]	['none']	_	_
17	[	_	_	CD	O	[-1]	['none']	_	_
18	pH	_	_	NN	O	[-1]	['none']	_	_
19	7.5	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	150	_	_	CD	O	[-1]	['none']	_	_
23	mM	_	_	NN	O	[-1]	['none']	_	_
24	NaCl	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	1	_	_	CD	O	[-1]	['none']	_	_
27	mM	_	_	NN	O	[-1]	['none']	_	_
28	EDTA	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	1	_	_	CD	O	[-1]	['none']	_	_
31	%	_	_	NN	O	[-1]	['none']	_	_
32	NP-40	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	0.1	_	_	CD	O	[-1]	['none']	_	_
35	%	_	_	NN	O	[-1]	['none']	_	_
36	SDS	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	0.1	_	_	CD	O	[-1]	['none']	_	_
39	%	_	_	NN	O	[-1]	['none']	_	_
40	sodium	_	_	NN	O	[-1]	['none']	_	_
41	deoxycholate	_	_	NN	O	[-1]	['none']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	supplemented	_	_	VBN	O	[-1]	['none']	_	_
44	with	_	_	IN	O	[-1]	['none']	_	_
45	2	_	_	CD	O	[-1]	['none']	_	_
46	mM	_	_	NN	O	[-1]	['none']	_	_
47	phenylmethylsulfonyl	_	_	NN	O	[-1]	['none']	_	_
48	fluoride	_	_	NN	O	[-1]	['none']	_	_
49	,	_	_	,	O	[-1]	['none']	_	_
50	1	_	_	CD	O	[-1]	['none']	_	_
51	mM	_	_	NN	O	[-1]	['none']	_	_
52	Na3VO4	_	_	NN	O	[-1]	['none']	_	_
53	,	_	_	,	O	[-1]	['none']	_	_
54	and	_	_	CC	O	[-1]	['none']	_	_
55	1:100	_	_	CD	O	[-1]	['none']	_	_
56	protease	_	_	NN	O	[-1]	['none']	_	_
57	and	_	_	CC	O	[-1]	['none']	_	_
58	phosphatase	_	_	NN	O	[-1]	['none']	_	_
59	inhibitor	_	_	NN	O	[-1]	['none']	_	_
60	cocktails	_	_	NNS	O	[-1]	['none']	_	_
61	(	_	_	-LRB-	O	[-1]	['none']	_	_
62	Sigma	_	_	NNP	O	[-1]	['none']	_	_
63	)	_	_	-RRB-	O	[-1]	['none']	_	_
64	.	_	_	.	O	[-1]	['none']	_	_

1	Crude	_	_	JJ	O	[-1]	['none']	_	_
2	lysates	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	13,000	_	_	CD	O	[-1]	['none']	_	_
7	rpm	_	_	NN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	10	_	_	CD	O	[-1]	['none']	_	_
10	min	_	_	NN	O	[-1]	['none']	_	_
11	at	_	_	IN	O	[-1]	['none']	_	_
12	4	_	_	CD	O	[-1]	['none']	_	_
13	degreesC	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	supernatants	_	_	NNS	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	collected	_	_	VBN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	further	_	_	JJ	O	[-1]	['none']	_	_
21	analysis	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Protein	_	_	NN	O	[-1]	['none']	_	_
2	concentrations	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	determined	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	Bio-Rad	_	_	NNP	O	[-1]	['none']	_	_
8	DC	_	_	NN	O	[-1]	['none']	_	_
9	protein	_	_	NN	O	[-1]	['none']	_	_
10	assay	_	_	NN	O	[-1]	['none']	_	_
11	system	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Lysates	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	boiled	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	presence	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	2.5	_	_	CD	O	[-1]	['none']	_	_
9	%	_	_	NN	O	[-1]	['none']	_	_
10	beta-mecaptoethanol	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	separated	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	denaturing	_	_	VBG	O	[-1]	['none']	_	_
15	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	transferred	_	_	VBN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	0.45-mum	_	_	JJ	O	[-1]	['none']	_	_
21	Optitran	_	_	NN	O	[-1]	['none']	_	_
22	membranes	_	_	NNS	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	Schleicher	_	_	NNP	O	[-1]	['none']	_	_
25	&	_	_	CC	O	[-1]	['none']	_	_
26	Schuell	_	_	NNP	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	a	_	_	DT	O	[-1]	['none']	_	_
30	Bio-Rad	_	_	NNP	O	[-1]	['none']	_	_
31	transfer	_	_	NN	O	[-1]	['none']	_	_
32	unit	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Membranes	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	immunoblotted	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	appropriate	_	_	JJ	O	[-1]	['none']	_	_
7	primary	_	_	JJ	O	[-1]	['none']	_	_
8	antibody	_	_	NN	O	[-1]	['none']	_	_
9	followed	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	horseradish	_	_	NN	O	[-1]	['none']	_	_
12	peroxidase	_	_	NN	Protein	[0]	['root']	_	_
13	tagged	_	_	VBD	O	[-1]	['none']	_	_
14	secondary	_	_	JJ	O	[-1]	['none']	_	_
15	antibodies	_	_	NNS	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	Amersham	_	_	NNP	O	[-1]	['none']	_	_
18	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	Dako	_	_	NNP	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	detected	_	_	VBN	O	[-1]	['none']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	SuperSignal	_	_	NNP	O	[-1]	['none']	_	_
27	West	_	_	NNP	O	[-1]	['none']	_	_
28	Pico	_	_	NNP	O	[-1]	['none']	_	_
29	System	_	_	NNP	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	Pierce	_	_	NNP	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Immunoprecipitations	_	_	NNS	O	[-1]	['none']	_	_
2	Immunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	CD40	_	_	NN	Protein	[0]	['root']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	performed	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	activated	_	_	VBN	O	[-1]	['none']	_	_
9	receptor	_	_	NN	O	[-1]	['none']	_	_
10	capture	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	previously	_	_	RB	O	[-1]	['none']	_	_
14	described	_	_	VBN	O	[-1]	['none']	_	_
15	[	_	_	NN	O	[-1]	['none']	_	_
16	6	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	3x107	_	_	JJ	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	A20	_	_	NN	O	[-1]	['none']	_	_
7	.2	_	_	NN	O	[-1]	['none']	_	_
8	J	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	derivatives	_	_	NNS	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	incubated	_	_	VBN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	60	_	_	CD	O	[-1]	['none']	_	_
16	minutes	_	_	NNS	O	[-1]	['none']	_	_
17	at	_	_	IN	O	[-1]	['none']	_	_
18	room	_	_	NN	O	[-1]	['none']	_	_
19	temperature	_	_	NN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	10	_	_	CD	O	[-1]	['none']	_	_
22	microl	_	_	NN	O	[-1]	['none']	_	_
23	magnetic	_	_	JJ	O	[-1]	['none']	_	_
24	protein	_	_	NN	O	[-1]	['none']	_	_
25	G	_	_	NN	O	[-1]	['none']	_	_
26	beads	_	_	NNS	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	Dynal	_	_	JJ	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	pre-coated	_	_	JJ	O	[-1]	['none']	_	_
31	with	_	_	IN	O	[-1]	['none']	_	_
32	10	_	_	CD	O	[-1]	['none']	_	_
33	microg	_	_	NN	O	[-1]	['none']	_	_
34	goat	_	_	NN	O	[-1]	['none']	_	_
35	anti-rat	_	_	JJ	O	[-1]	['none']	_	_
36	IgG	_	_	NN	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	Jackson	_	_	NNP	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	10	_	_	CD	O	[-1]	['none']	_	_
43	microg	_	_	NN	O	[-1]	['none']	_	_
44	anti-CD40	_	_	NN	O	[-1]	['none']	_	_
45	(	_	_	-LRB-	O	[-1]	['none']	_	_
46	1C10	_	_	NN	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	or	_	_	CC	O	[-1]	['none']	_	_
49	an	_	_	DT	O	[-1]	['none']	_	_
50	isotype	_	_	NN	O	[-1]	['none']	_	_
51	control	_	_	NN	O	[-1]	['none']	_	_
52	antibody	_	_	NN	O	[-1]	['none']	_	_
53	(	_	_	-LRB-	O	[-1]	['none']	_	_
54	mAb72	_	_	NN	O	[-1]	['none']	_	_
55	)	_	_	-RRB-	O	[-1]	['none']	_	_
56	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	beads	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	then	_	_	RB	O	[-1]	['none']	_	_
6	pelleted	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	centrifugation	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	lysed	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	buffer	_	_	NN	O	[-1]	['none']	_	_
13	containing	_	_	VBG	O	[-1]	['none']	_	_
14	1	_	_	CD	O	[-1]	['none']	_	_
15	%	_	_	NN	O	[-1]	['none']	_	_
16	Triton	_	_	NNP	O	[-1]	['none']	_	_
17	X100	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Beads	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	washed	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	lysis	_	_	NN	O	[-1]	['none']	_	_
6	buffer	_	_	NN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	remove	_	_	VB	O	[-1]	['none']	_	_
9	unbound	_	_	JJ	O	[-1]	['none']	_	_
10	material	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	some	_	_	DT	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	material	_	_	NN	O	[-1]	['none']	_	_
6	associated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	beads	_	_	NNS	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	dephosphorylated	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	lambda	_	_	NN	O	[-1]	['none']	_	_
14	phosphatase	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	New	_	_	NNP	O	[-1]	['none']	_	_
17	England	_	_	NNP	O	[-1]	['none']	_	_
18	BioLabs	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	per	_	_	IN	O	[-1]	['none']	_	_
22	manufacturer	_	_	NN	O	[-1]	['none']	_	_
23	's	_	_	POS	O	[-1]	['none']	_	_
24	instructions	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Beads	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	resuspended	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	2X	_	_	NN	O	[-1]	['none']	_	_
6	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
7	sample	_	_	NN	O	[-1]	['none']	_	_
8	buffer	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	heated	_	_	VBN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	5	_	_	CD	O	[-1]	['none']	_	_
13	minutes	_	_	NNS	O	[-1]	['none']	_	_
14	at	_	_	IN	O	[-1]	['none']	_	_
15	95degreesC	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Material	_	_	NN	O	[-1]	['none']	_	_
2	eluted	_	_	VBD	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	beads	_	_	NNS	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	fractionated	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	transferred	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	PVDF	_	_	NN	O	[-1]	['none']	_	_
14	membranes	_	_	NNS	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	Western	_	_	NN	O	[-1]	['none']	_	_
17	blotting	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	some	_	_	DT	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	cultured	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	6	_	_	CD	O	[-1]	['none']	_	_
10	hrs	_	_	NNS	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	25	_	_	CD	O	[-1]	['none']	_	_
13	microM	_	_	NN	O	[-1]	['none']	_	_
14	antennapedia	_	_	NN	O	[-1]	['none']	_	_
15	linked	_	_	VBN	O	[-1]	['none']	_	_
16	SMAC-N7	_	_	NN	O	[-1]	['none']	_	_
17	peptide	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	Calbiochem	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	an	_	_	DT	O	[-1]	['none']	_	_
23	appropriate	_	_	JJ	O	[-1]	['none']	_	_
24	volume	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	solvent	_	_	JJ	O	[-1]	['none']	_	_
28	used	_	_	VBN	O	[-1]	['none']	_	_
29	for	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	peptide	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	DMSO	_	_	NN	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	incubation	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	peptide-	_	_	NN	O	[-1]	['none']	_	_
8	or	_	_	CC	O	[-1]	['none']	_	_
9	DMSO	_	_	NN	O	[-1]	['none']	_	_
10	containing	_	_	VBG	O	[-1]	['none']	_	_
11	medium	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	stimulated	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	antibody	_	_	NN	O	[-1]	['none']	_	_
17	coated	_	_	JJ	O	[-1]	['none']	_	_
18	beads	_	_	NNS	O	[-1]	['none']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	outlined	_	_	VBN	O	[-1]	['none']	_	_
21	above	_	_	IN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Patients	_	_	NNS	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	cell	_	_	NN	O	[-1]	['none']	_	_
4	preparation	_	_	NN	O	[-1]	['none']	_	_
5	.	_	_	.	O	[-1]	['none']	_	_

1	PBMCs	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	prepared	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	centrifugation	_	_	NN	O	[-1]	['none']	_	_
6	over	_	_	IN	O	[-1]	['none']	_	_
7	Ficoll-Hypaque	_	_	JJ	O	[-1]	['none']	_	_
8	gradients	_	_	NNS	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	BioWhittaker	_	_	NNP	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	Walkersville	_	_	NNP	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	Maryland	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	United	_	_	NNP	O	[-1]	['none']	_	_
17	States	_	_	NNPS	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	from	_	_	IN	O	[-1]	['none']	_	_
20	eight	_	_	CD	O	[-1]	['none']	_	_
21	HAM	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	TSP	_	_	NN	O	[-1]	['none']	_	_
24	patients	_	_	NNS	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	eight	_	_	CD	O	[-1]	['none']	_	_
27	ACs	_	_	NNS	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	were	_	_	VBD	O	[-1]	['none']	_	_
33	viably	_	_	RB	O	[-1]	['none']	_	_
34	cryopreserved	_	_	VBN	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	liquid	_	_	JJ	O	[-1]	['none']	_	_
37	nitrogen	_	_	NN	O	[-1]	['none']	_	_
38	until	_	_	IN	O	[-1]	['none']	_	_
39	tested	_	_	VBN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	HAM	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	TSP	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	diagnosed	_	_	VBN	O	[-1]	['none']	_	_
6	according	_	_	VBG	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	WHO	_	_	WP	O	[-1]	['none']	_	_
9	guidelines	_	_	NNS	O	[-1]	['none']	_	_
10	[	_	_	VBP	O	[-1]	['none']	_	_
11	49	_	_	CD	O	[-1]	['none']	_	_
12	]	_	_	CD	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	HTLV-I	_	_	NNP	O	[-1]	['none']	_	_
2	seropositivity	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	determined	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	ELISA	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	Abbott	_	_	NNP	O	[-1]	['none']	_	_
9	Laboratories	_	_	NNP	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	Abbott	_	_	NNP	O	[-1]	['none']	_	_
12	Park	_	_	NNP	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	Illinois	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	United	_	_	NNP	O	[-1]	['none']	_	_
17	States	_	_	NNPS	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	confirmation	_	_	NN	O	[-1]	['none']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	Western	_	_	NN	O	[-1]	['none']	_	_
24	blot	_	_	NN	O	[-1]	['none']	_	_
25	analysis	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	Genelabs	_	_	NNP	O	[-1]	['none']	_	_
28	Technologies	_	_	NNPS	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	Redwood	_	_	NNP	O	[-1]	['none']	_	_
31	City	_	_	NNP	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	California	_	_	NNP	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	United	_	_	NNP	O	[-1]	['none']	_	_
36	States	_	_	NNPS	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Blood	_	_	NN	O	[-1]	['none']	_	_
2	samples	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	obtained	_	_	VBN	O	[-1]	['none']	_	_
5	after	_	_	IN	O	[-1]	['none']	_	_
6	informed	_	_	VBN	O	[-1]	['none']	_	_
7	consent	_	_	NN	O	[-1]	['none']	_	_
8	as	_	_	IN	O	[-1]	['none']	_	_
9	part	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	clinical	_	_	JJ	O	[-1]	['none']	_	_
13	protocol	_	_	NN	O	[-1]	['none']	_	_
14	reviewed	_	_	VBN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	approved	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	NIH	_	_	NNP	O	[-1]	['none']	_	_
20	institutional	_	_	JJ	O	[-1]	['none']	_	_
21	review	_	_	NN	O	[-1]	['none']	_	_
22	panel	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF-dependent	_	_	NNP	O	[-1]	['none']	_	_
2	PKC	_	_	NN	O	[-1]	['none']	_	_
3	Regulates	_	_	VBZ	O	[-1]	['none']	_	_
4	NF-kappaB-targeted	_	_	JJ	O	[-1]	['none']	_	_
5	Genes	_	_	NNS	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	induces	_	_	VBZ	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	number	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	downstream	_	_	JJ	O	[-1]	['none']	_	_
12	genes	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	including	_	_	VBG	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	IkappaB	_	_	NN	O	[-1]	['none']	_	_
17	family	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Among	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	IkappaB	_	_	NN	O	[-1]	['none']	_	_
4	molecules	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	IkappaBalpha	_	_	NN	Protein	[9]	['Theme']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	highly	_	_	RB	O	[-1]	['none']	_	_
9	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	activation	_	_	NN	O	[-1]	['none']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	40	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Having	_	_	VBG	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	PKC	_	_	NN	O	[-1]	['none']	_	_
5	regulated	_	_	VBD	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	activity	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	M-CSF-stimulated	_	_	JJ	O	[-1]	['none']	_	_
10	MDMs	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	we	_	_	PRP	O	[-1]	['none']	_	_
13	next	_	_	RB	O	[-1]	['none']	_	_
14	determined	_	_	VBD	O	[-1]	['none']	_	_
15	whether	_	_	IN	O	[-1]	['none']	_	_
16	inhibition	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	PKC	_	_	NN	O	[-1]	['none']	_	_
19	activity	_	_	NN	O	[-1]	['none']	_	_
20	decreased	_	_	VBD	O	[-1]	['none']	_	_
21	expression	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	NF-kappaB-regulated	_	_	JJ	O	[-1]	['none']	_	_
24	genes	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	treated	_	_	VBD	O	[-1]	['none']	_	_
3	both	_	_	CC	O	[-1]	['none']	_	_
4	MDMs	_	_	NNS	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	RAW	_	_	NN	O	[-1]	['none']	_	_
7	264.7	_	_	CD	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	PKC	_	_	NN	O	[-1]	['none']	_	_
12	inhibitor	_	_	NN	O	[-1]	['none']	_	_
13	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	30	_	_	CD	O	[-1]	['none']	_	_
16	minutes	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	then	_	_	RB	O	[-1]	['none']	_	_
19	stimulated	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	M-CSF	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
2	gene	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	measured	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	qRT-PCR	_	_	NN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figures	_	_	NNS	O	[-1]	['none']	_	_
5	6A	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	6B	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	M-CSF	_	_	NN	O	[-1]	['none']	_	_
10	enhanced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	IkappaBalpha	_	_	NN	Protein	[13]	['Theme']	_	_
12	gene	_	_	NN	O	[-1]	['none']	_	_
13	expression	_	_	NN	Gene_expression	[10]	['Theme']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	PKC	_	_	NN	O	[-1]	['none']	_	_
16	inhibition	_	_	NN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
19	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
20	IkappaBalpha	_	_	NN	Protein	[22]	['Theme']	_	_
21	gene	_	_	NN	O	[-1]	['none']	_	_
22	expression	_	_	NN	Gene_expression	[19]	['Theme']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	both	_	_	CC	O	[-1]	['none']	_	_
25	MDMs	_	_	NNS	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	RAW	_	_	NN	O	[-1]	['none']	_	_
28	264.7	_	_	CD	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	p	_	_	NN	O	[-1]	['none']	_	_
32	<	_	_	JJR	O	[-1]	['none']	_	_
33	0.01	_	_	CD	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	demonstrating	_	_	VBG	O	[-1]	['none']	_	_
37	that	_	_	IN	O	[-1]	['none']	_	_
38	PKC	_	_	NN	O	[-1]	['none']	_	_
39	affected	_	_	VBD	O	[-1]	['none']	_	_
40	NF-kappaB-regulated	_	_	JJ	O	[-1]	['none']	_	_
41	gene	_	_	NN	O	[-1]	['none']	_	_
42	expression	_	_	NN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	macrophages	_	_	NNS	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	further	_	_	RB	O	[-1]	['none']	_	_
3	define	_	_	VB	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	role	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	PKC	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	mediating	_	_	VBG	O	[-1]	['none']	_	_
10	human	_	_	NN	O	[-1]	['none']	_	_
11	MDM	_	_	NN	O	[-1]	['none']	_	_
12	survival	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	response	_	_	NN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	M-CSF	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	we	_	_	PRP	O	[-1]	['none']	_	_
19	examined	_	_	VBD	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	Anaphora	[25]	['multitoken']	_	_
24	anti-apoptotic	_	_	JJ	Anaphora	[25]	['multitoken']	_	_
25	gene	_	_	NN	Anaphora	[0]	['root']	_	_
26	BCL-xL	_	_	NN	Protein	[21, 31]	['Theme', 'Theme']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	which	_	_	WDT	Anaphora	[0]	['root']	_	_
29	is	_	_	VBZ	O	[-1]	['none']	_	_
30	also	_	_	RB	O	[-1]	['none']	_	_
31	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	6C	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
8	reduced	_	_	VBD	Negative_regulation	[0]	['root']	_	_
9	M-CSF-stimulated	_	_	JJ	Positive_regulation	[8]	['Theme']	_	_
10	BCL-xL	_	_	NN	Protein	[11]	['Theme']	_	_
11	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
12	compared	_	_	VBN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	treated	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	M-CSF	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	vehicle	_	_	NN	O	[-1]	['none']	_	_
21	control	_	_	NN	O	[-1]	['none']	_	_
22	DMSO	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	p	_	_	NN	O	[-1]	['none']	_	_
25	<	_	_	JJR	O	[-1]	['none']	_	_
26	0.05	_	_	CD	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	PTX	_	_	NN	O	[-1]	['none']	_	_
2	decreases	_	_	VBZ	O	[-1]	['none']	_	_
3	LPS	_	_	NN	O	[-1]	['none']	_	_
4	induced	_	_	VBD	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	activation	_	_	NN	O	[-1]	['none']	_	_
7	Since	_	_	IN	O	[-1]	['none']	_	_
8	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
9	leads	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	ubiquitination	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	degradation	_	_	NN	Protein_catabolism	[9]	['Theme']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	I-kappaBalpha	_	_	NN	Protein	[13]	['Theme']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	subsequent	_	_	JJ	O	[-1]	['none']	_	_
18	nuclear	_	_	JJ	O	[-1]	['none']	_	_
19	translocation	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	we	_	_	PRP	O	[-1]	['none']	_	_
24	first	_	_	RB	O	[-1]	['none']	_	_
25	examined	_	_	VBD	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	effects	_	_	NNS	Regulation	[0]	['root']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	PTX	_	_	NN	O	[-1]	['none']	_	_
30	on	_	_	IN	O	[-1]	['none']	_	_
31	I-kappaBalpha	_	_	NN	Protein	[27]	['Theme']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
2	I-kappaBalpha	_	_	NN	Protein	[3]	['Theme']	_	_
3	phosphorylation	_	_	NN	Phosphorylation	[6]	['Theme']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	markedly	_	_	RB	O	[-1]	['none']	_	_
6	increased	_	_	VBN	Positive_regulation	[7]	['Theme']	_	_
7	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
8	LPS	_	_	NN	O	[-1]	['none']	_	_
9	stimulation	_	_	NN	O	[-1]	['none']	_	_
10	when	_	_	WRB	O	[-1]	['none']	_	_
11	compared	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	control	_	_	VB	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	100	_	_	CD	O	[-1]	['none']	_	_
16	+/-	_	_	CC	O	[-1]	['none']	_	_
17	0	_	_	CD	O	[-1]	['none']	_	_
18	vs.	_	_	CC	O	[-1]	['none']	_	_
19	20	_	_	CD	O	[-1]	['none']	_	_
20	+/-	_	_	CC	O	[-1]	['none']	_	_
21	18	_	_	CD	O	[-1]	['none']	_	_
22	;	_	_	:	O	[-1]	['none']	_	_
23	P	_	_	NN	O	[-1]	['none']	_	_
24	<	_	_	JJR	O	[-1]	['none']	_	_
25	0.05	_	_	CD	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	PTX	_	_	NN	O	[-1]	['none']	_	_
5	significantly	_	_	RB	O	[-1]	['none']	_	_
6	downregulated	_	_	VBD	Negative_regulation	[0]	['root']	_	_
7	LPS	_	_	NN	O	[-1]	['none']	_	_
8	induced	_	_	VBD	Positive_regulation	[6]	['Theme']	_	_
9	I-kappaBalpha	_	_	NN	Protein	[10]	['Theme']	_	_
10	phosphorylation	_	_	NN	Phosphorylation	[8]	['Theme']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	P	_	_	NN	O	[-1]	['none']	_	_
13	=	_	_	JJ	O	[-1]	['none']	_	_
14	0.02	_	_	CD	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	Figure	_	_	NNP	O	[-1]	['none']	_	_
17	2	_	_	CD	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	In	_	_	IN	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	similar	_	_	JJ	O	[-1]	['none']	_	_
22	fashion	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	nuclear	_	_	JJ	O	[-1]	['none']	_	_
25	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
26	p65	_	_	NN	Protein	[27]	['Theme']	_	_
27	phosphorylation	_	_	NN	Phosphorylation	[29]	['Theme']	_	_
28	was	_	_	VBD	O	[-1]	['none']	_	_
29	increased	_	_	VBN	Positive_regulation	[30]	['Theme']	_	_
30	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
31	LPS	_	_	NN	O	[-1]	['none']	_	_
32	stimulation	_	_	NN	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	100	_	_	CD	O	[-1]	['none']	_	_
35	+/-	_	_	CC	O	[-1]	['none']	_	_
36	0	_	_	CD	O	[-1]	['none']	_	_
37	vs.	_	_	CC	O	[-1]	['none']	_	_
38	38	_	_	CD	O	[-1]	['none']	_	_
39	+/-	_	_	CC	O	[-1]	['none']	_	_
40	20	_	_	CD	O	[-1]	['none']	_	_
41	;	_	_	:	O	[-1]	['none']	_	_
42	P	_	_	NN	O	[-1]	['none']	_	_
43	<	_	_	JJR	O	[-1]	['none']	_	_
44	0.01	_	_	CD	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	PTX	_	_	NN	O	[-1]	['none']	_	_
2	similarly	_	_	RB	O	[-1]	['none']	_	_
3	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
4	LPS	_	_	NN	O	[-1]	['none']	_	_
5	induced	_	_	VBD	Positive_regulation	[3]	['Theme']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	p65	_	_	NN	Protein	[9]	['Theme']	_	_
8	nuclear	_	_	JJ	O	[-1]	['none']	_	_
9	phosphorylation	_	_	NN	Phosphorylation	[5]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	marker	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	activation	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	nuclear	_	_	JJ	O	[-1]	['none']	_	_
18	translocation	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	100	_	_	CD	O	[-1]	['none']	_	_
21	+/-	_	_	CC	O	[-1]	['none']	_	_
22	0	_	_	CD	O	[-1]	['none']	_	_
23	vs.	_	_	CC	O	[-1]	['none']	_	_
24	40	_	_	CD	O	[-1]	['none']	_	_
25	+/-	_	_	CC	O	[-1]	['none']	_	_
26	6	_	_	CD	O	[-1]	['none']	_	_
27	;	_	_	:	O	[-1]	['none']	_	_
28	P	_	_	NN	O	[-1]	['none']	_	_
29	=	_	_	JJ	O	[-1]	['none']	_	_
30	0.03	_	_	CD	O	[-1]	['none']	_	_
31	;	_	_	:	O	[-1]	['none']	_	_
32	Figure	_	_	NNP	O	[-1]	['none']	_	_
33	3A	_	_	NN	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	EMSAs	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	then	_	_	RB	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	verify	_	_	VB	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	PTX	_	_	NN	O	[-1]	['none']	_	_
9	induced	_	_	VBD	O	[-1]	['none']	_	_
10	alterations	_	_	NNS	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	nuclear	_	_	JJ	O	[-1]	['none']	_	_
13	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
14	resulted	_	_	VBD	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	similar	_	_	JJ	O	[-1]	['none']	_	_
17	effects	_	_	NNS	O	[-1]	['none']	_	_
18	on	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	DNA	_	_	NN	O	[-1]	['none']	_	_
21	binding	_	_	NN	O	[-1]	['none']	_	_
22	activity	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	PTX	_	_	NN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	LPS	_	_	NN	O	[-1]	['none']	_	_
7	stimulated	_	_	VBD	O	[-1]	['none']	_	_
8	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	resulted	_	_	VBD	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	comparable	_	_	JJ	O	[-1]	['none']	_	_
13	downregulation	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	DNA	_	_	NN	O	[-1]	['none']	_	_
16	binding	_	_	NN	O	[-1]	['none']	_	_
17	activity	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	similar	_	_	JJ	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	observed	_	_	JJ	O	[-1]	['none']	_	_
23	downregulation	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
26	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Jurkat	_	_	NN	O	[-1]	['none']	_	_
2	T-cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	treated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	10	_	_	CD	O	[-1]	['none']	_	_
7	nM	_	_	NN	O	[-1]	['none']	_	_
8	NAI	_	_	NNP	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	10	_	_	CD	O	[-1]	['none']	_	_
11	muM	_	_	JJ	O	[-1]	['none']	_	_
12	JNK-I	_	_	NN	O	[-1]	['none']	_	_
13	or10	_	_	NN	O	[-1]	['none']	_	_
14	nM	_	_	NN	O	[-1]	['none']	_	_
15	PKC-I	_	_	NN	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	2	_	_	CD	O	[-1]	['none']	_	_
18	h	_	_	NN	O	[-1]	['none']	_	_
19	followed	_	_	VBN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	induction	_	_	NN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	162	_	_	CD	O	[-1]	['none']	_	_
24	nM	_	_	NN	O	[-1]	['none']	_	_
25	PMA	_	_	NN	O	[-1]	['none']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	24	_	_	CD	O	[-1]	['none']	_	_
28	h.	_	_	NN	O	[-1]	['none']	_	_

1	Differential	_	_	JJ	O	[-1]	['none']	_	_
2	cytokine	_	_	NN	O	[-1]	['none']	_	_
3	regulation	_	_	NN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	AP-1	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	Jurkat	_	_	NN	O	[-1]	['none']	_	_
10	T-cells	_	_	NNS	O	[-1]	['none']	_	_
11	Background	_	_	NN	O	[-1]	['none']	_	_
12	Activator	_	_	NN	O	[-1]	['none']	_	_
13	protein	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	AP	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	-1	_	_	CD	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	nuclear	_	_	JJ	O	[-1]	['none']	_	_
20	factor	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	NF	_	_	NN	O	[-1]	['none']	_	_
23	)-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	largely	_	_	RB	O	[-1]	['none']	_	_
25	control	_	_	JJ	O	[-1]	['none']	_	_
26	T-cell	_	_	NN	O	[-1]	['none']	_	_
27	activation	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	following	_	_	VBG	O	[-1]	['none']	_	_
30	binding	_	_	NN	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	foreign	_	_	JJ	O	[-1]	['none']	_	_
33	antigens	_	_	NNS	O	[-1]	['none']	_	_
34	to	_	_	TO	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	T-cell	_	_	NN	O	[-1]	['none']	_	_
37	receptor	_	_	NN	O	[-1]	['none']	_	_
38	leading	_	_	VBG	O	[-1]	['none']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	cytokine	_	_	NN	O	[-1]	['none']	_	_
41	secretion	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Elevated	_	_	JJ	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	pro	_	_	JJ	O	[-1]	['none']	_	_
5	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
6	cytokines	_	_	NNS	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	chemokines	_	_	NNS	O	[-1]	['none']	_	_
9	such	_	_	JJ	O	[-1]	['none']	_	_
10	as	_	_	IN	O	[-1]	['none']	_	_
11	TNF	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	IL-6	_	_	NN	Protein	[0]	['root']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
16	are	_	_	VBP	O	[-1]	['none']	_	_
17	associated	_	_	VBN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	several	_	_	JJ	O	[-1]	['none']	_	_
20	human	_	_	NN	O	[-1]	['none']	_	_
21	diseases	_	_	NNS	O	[-1]	['none']	_	_
22	including	_	_	VBG	O	[-1]	['none']	_	_
23	cystic	_	_	JJ	O	[-1]	['none']	_	_
24	fibrosis	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	pulmonary	_	_	JJ	O	[-1]	['none']	_	_
27	fibrosis	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	AIDS	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	aim	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	this	_	_	DT	O	[-1]	['none']	_	_
5	study	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	investigate	_	_	VB	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	role	_	_	NN	Regulation	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	transcription	_	_	NN	O	[-1]	['none']	_	_
14	factors	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	AP-1	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	IL-6	_	_	NN	Protein	[24]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	CXCL8	_	_	NN	Protein	[24]	['Theme']	_	_
24	regulation	_	_	NN	Regulation	[10]	['Theme']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	Jurkat	_	_	NN	O	[-1]	['none']	_	_
27	T-cells	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Results	_	_	NNS	O	[-1]	['none']	_	_
2	Phorbol	_	_	NN	O	[-1]	['none']	_	_
3	myristate	_	_	NN	O	[-1]	['none']	_	_
4	acetate	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	PMA	_	_	NN	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	exposure	_	_	NN	O	[-1]	['none']	_	_
9	resulted	_	_	VBD	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	an	_	_	DT	O	[-1]	['none']	_	_
12	up-regulation	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	AP-1	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	down-regulation	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	activity	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	however	_	_	RB	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	exposure	_	_	NN	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	heat	_	_	NN	O	[-1]	['none']	_	_
26	killed	_	_	VBD	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	HK	_	_	JJ	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	Escherichia	_	_	FW	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	coli	_	_	NN	O	[-1]	['none']	_	_
2	MG1655	_	_	NN	O	[-1]	['none']	_	_
3	resulted	_	_	VBD	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	dose	_	_	NN	O	[-1]	['none']	_	_
7	dependent	_	_	JJ	O	[-1]	['none']	_	_
8	increase	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	activity	_	_	NN	O	[-1]	['none']	_	_
12	without	_	_	IN	O	[-1]	['none']	_	_
13	affecting	_	_	VBG	O	[-1]	['none']	_	_
14	AP-1	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cytokine	_	_	NN	O	[-1]	['none']	_	_
3	profile	_	_	NN	O	[-1]	['none']	_	_
4	revealed	_	_	VBD	O	[-1]	['none']	_	_
5	an	_	_	DT	O	[-1]	['none']	_	_
6	up-regulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	chemokine	_	_	NN	O	[-1]	['none']	_	_
10	CXCL8	_	_	NN	Protein	[6]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	pro	_	_	JJ	O	[-1]	['none']	_	_
14	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
15	cytokines	_	_	NNS	O	[-1]	['none']	_	_
16	TNF	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	IL-2	_	_	NN	Protein	[6]	['Theme']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	IL-6	_	_	NN	Protein	[6]	['Theme']	_	_
21	following	_	_	JJ	O	[-1]	['none']	_	_
22	treatment	_	_	NN	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	both	_	_	CC	O	[-1]	['none']	_	_
25	PMA	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	HK	_	_	NNP	O	[-1]	['none']	_	_
28	E.	_	_	NNP	O	[-1]	['none']	_	_
29	coli	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	while	_	_	IN	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	levels	_	_	NNS	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
37	cytokine	_	_	NN	O	[-1]	['none']	_	_
38	IL-10	_	_	NN	Protein	[41, 47]	['Theme', 'Theme']	_	_
39	were	_	_	VBD	O	[-1]	['none']	_	_
40	not	_	_	RB	O	[-1]	['none']	_	_
41	affected	_	_	VBN	Regulation	[0]	['root']	_	_
42	by	_	_	IN	O	[-1]	['none']	_	_
43	PMA	_	_	NN	O	[-1]	['none']	_	_
44	but	_	_	CC	O	[-1]	['none']	_	_
45	were	_	_	VBD	O	[-1]	['none']	_	_
46	significantly	_	_	RB	O	[-1]	['none']	_	_
47	down-regulated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
48	by	_	_	IN	O	[-1]	['none']	_	_
49	HK	_	_	NNP	O	[-1]	['none']	_	_
50	E.	_	_	NNP	O	[-1]	['none']	_	_
51	coli	_	_	NN	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	AP-1	_	_	NNP	O	[-1]	['none']	_	_
2	activation	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	significantly	_	_	RB	O	[-1]	['none']	_	_
5	increased	_	_	VBN	O	[-1]	['none']	_	_
6	2	_	_	CD	O	[-1]	['none']	_	_
7	h	_	_	NN	O	[-1]	['none']	_	_
8	after	_	_	IN	O	[-1]	['none']	_	_
9	PMA	_	_	NN	O	[-1]	['none']	_	_
10	exposure	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	continued	_	_	VBD	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	increase	_	_	VB	O	[-1]	['none']	_	_
15	thereafter	_	_	RB	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	responded	_	_	VBD	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	PMA	_	_	NN	O	[-1]	['none']	_	_
8	exposure	_	_	NN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	rapid	_	_	JJ	O	[-1]	['none']	_	_
12	up-regulation	_	_	NN	O	[-1]	['none']	_	_
13	followed	_	_	VBN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	subsequent	_	_	JJ	O	[-1]	['none']	_	_
17	down-regulation	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Increased	_	_	VBN	O	[-1]	['none']	_	_
2	intracellular	_	_	JJ	O	[-1]	['none']	_	_
3	Ca2+	_	_	NN	O	[-1]	['none']	_	_
4	concentrations	_	_	NNS	O	[-1]	['none']	_	_
5	countered	_	_	VBD	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	down-regulation	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	PMA	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	while	_	_	IN	O	[-1]	['none']	_	_
14	similar	_	_	JJ	O	[-1]	['none']	_	_
15	treatment	_	_	NN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	calcium	_	_	NN	O	[-1]	['none']	_	_
18	ionophore	_	_	NN	O	[-1]	['none']	_	_
19	resulted	_	_	VBD	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	reduced	_	_	JJ	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	activity	_	_	NN	O	[-1]	['none']	_	_
25	following	_	_	VBG	O	[-1]	['none']	_	_
26	induction	_	_	NN	O	[-1]	['none']	_	_
27	with	_	_	IN	O	[-1]	['none']	_	_
28	HK	_	_	NNP	O	[-1]	['none']	_	_
29	E.	_	_	NNP	O	[-1]	['none']	_	_
30	coli	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	order	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	further	_	_	JJ	O	[-1]	['none']	_	_
5	study	_	_	NN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	we	_	_	PRP	O	[-1]	['none']	_	_
10	considered	_	_	VBD	O	[-1]	['none']	_	_
11	two	_	_	CD	O	[-1]	['none']	_	_
12	up-stream	_	_	JJ	O	[-1]	['none']	_	_
13	signalling	_	_	NN	O	[-1]	['none']	_	_
14	proteins	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	PKC	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	Bcl10	_	_	NN	Protein	[0]	['root']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Phosphorylated-PKC	_	_	NNP	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	increased	_	_	VBD	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	response	_	_	NN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	PMA	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	HK	_	_	NNP	O	[-1]	['none']	_	_
10	E.	_	_	NNP	O	[-1]	['none']	_	_
11	coli	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	while	_	_	IN	O	[-1]	['none']	_	_
14	Bcl10	_	_	NN	Protein	[17]	['Theme']	_	_
15	levels	_	_	NNS	O	[-1]	['none']	_	_
16	significantly	_	_	RB	O	[-1]	['none']	_	_
17	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
18	following	_	_	VBG	O	[-1]	['none']	_	_
19	PMA	_	_	NN	O	[-1]	['none']	_	_
20	treatment	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Using	_	_	VBG	O	[-1]	['none']	_	_
2	an	_	_	DT	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	inhibitor	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	we	_	_	PRP	O	[-1]	['none']	_	_
8	observed	_	_	VBD	O	[-1]	['none']	_	_
9	complete	_	_	JJ	O	[-1]	['none']	_	_
10	inhibition	_	_	NN	Negative_regulation	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	IL-6	_	_	NN	Protein	[13]	['Theme']	_	_
13	expression	_	_	NN	Gene_expression	[10]	['Theme']	_	_
14	while	_	_	IN	O	[-1]	['none']	_	_
15	CXCL8	_	_	NN	Protein	[18]	['Theme']	_	_
16	levels	_	_	NNS	O	[-1]	['none']	_	_
17	only	_	_	RB	O	[-1]	['none']	_	_
18	decreased	_	_	VBN	Negative_regulation	[0]	['root']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	40	_	_	CD	O	[-1]	['none']	_	_
21	%	_	_	NN	O	[-1]	['none']	_	_
22	at	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	highest	_	_	JJS	O	[-1]	['none']	_	_
25	concentration	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Treatment	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Jurkat	_	_	NN	O	[-1]	['none']	_	_
4	T-cells	_	_	NNS	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	PMA	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	presence	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	JNK-inhibitor	_	_	NN	O	[-1]	['none']	_	_
12	suppressed	_	_	VBD	Negative_regulation	[0]	['root']	_	_
13	both	_	_	CC	O	[-1]	['none']	_	_
14	CXCL8	_	_	NN	Protein	[12]	['Theme']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	IL-6	_	_	NN	Protein	[12]	['Theme']	_	_
17	while	_	_	IN	O	[-1]	['none']	_	_
18	PKC-inhibitor	_	_	NN	O	[-1]	['none']	_	_
19	primarily	_	_	RB	O	[-1]	['none']	_	_
20	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
21	CXCL8	_	_	NN	Protein	[22]	['Theme']	_	_
22	expression	_	_	NN	Gene_expression	[20]	['Theme']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Conclusion	_	_	NN	O	[-1]	['none']	_	_
2	The	_	_	DT	O	[-1]	['none']	_	_
3	present	_	_	JJ	O	[-1]	['none']	_	_
4	study	_	_	NN	O	[-1]	['none']	_	_
5	shows	_	_	VBZ	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
9	IL-6	_	_	NN	Protein	[8]	['Theme']	_	_
10	but	_	_	CC	O	[-1]	['none']	_	_
11	not	_	_	RB	O	[-1]	['none']	_	_
12	CXCL8	_	_	NN	Protein	[8]	['Theme']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	complex	_	_	JJ	O	[-1]	['none']	_	_
3	regulation	_	_	NN	Regulation	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	CXCL8	_	_	NN	Protein	[3]	['Theme']	_	_
6	suggests	_	_	VBZ	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	there	_	_	EX	O	[-1]	['none']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	need	_	_	NN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	further	_	_	JJ	O	[-1]	['none']	_	_
14	evaluate	_	_	VB	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	signalling	_	_	NN	O	[-1]	['none']	_	_
17	pathways	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	order	_	_	NN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	develop	_	_	VB	O	[-1]	['none']	_	_
22	new	_	_	JJ	O	[-1]	['none']	_	_
23	treatment	_	_	NN	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	diseases	_	_	NNS	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	elevated	_	_	JJ	Positive_regulation	[0]	['root']	_	_
28	CXCL8	_	_	NN	Protein	[27]	['Theme']	_	_
29	levels	_	_	NNS	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	such	_	_	JJ	O	[-1]	['none']	_	_
32	as	_	_	IN	O	[-1]	['none']	_	_
33	AIDS	_	_	NNP	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	autoimmune	_	_	JJ	O	[-1]	['none']	_	_
36	diseases	_	_	NNS	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[2]	['Cause']	_	_
2	controls	_	_	NNS	Regulation	[0]	['root']	_	_
3	Eomes	_	_	NNS	Protein	[12]	['Theme']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	perforin	_	_	NN	Protein	[12]	['Theme']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	granzyme	_	_	NN	Protein	[8]	['multitoken']	_	_
8	B	_	_	NN	Protein	[12]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	IFN-gamma	_	_	NN	Protein	[12]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[2]	['Theme']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	effector	_	_	NN	O	[-1]	['none']	_	_
15	CTLs	_	_	NNS	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[0]	['root']	_	_
2	+/+	_	_	CD	O	[-1]	['none']	_	_
3	or	_	_	CC	O	[-1]	['none']	_	_
4	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
5	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
6	T	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	activated	_	_	VBN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	transduced	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	retroviruses	_	_	NNS	O	[-1]	['none']	_	_
14	bearing	_	_	VBG	O	[-1]	['none']	_	_
15	an	_	_	DT	O	[-1]	['none']	_	_
16	empty	_	_	JJ	O	[-1]	['none']	_	_
17	IRES-GFP	_	_	NN	Protein	[0]	['root']	_	_
18	cassette	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	GFP	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	also	_	_	RB	O	[-1]	['none']	_	_
24	encoding	_	_	VBG	O	[-1]	['none']	_	_
25	Eomes-VP16	_	_	NN	Protein	[0]	['root']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	Eo-VP16	_	_	NN	Protein	[0]	['root']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	or	_	_	CC	O	[-1]	['none']	_	_
30	Myc-Runx3	_	_	NN	Protein	[0]	['root']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	Runx3	_	_	NN	Protein	[0]	['root']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	frequency	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	transduced	_	_	VBN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	cultures	_	_	NNS	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	equivalent	_	_	JJ	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	all	_	_	DT	O	[-1]	['none']	_	_
13	constructs	_	_	NNS	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	~	_	_	CD	O	[-1]	['none']	_	_
16	75-90	_	_	CD	O	[-1]	['none']	_	_
17	%	_	_	NN	O	[-1]	['none']	_	_
18	GFP+	_	_	JJ	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	;	_	_	:	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	depicted	_	_	VBN	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Protein	_	_	NN	O	[-1]	['none']	_	_
5	expression	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	whole-cell	_	_	JJ	O	[-1]	['none']	_	_
8	extracts	_	_	NNS	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	day	_	_	NN	O	[-1]	['none']	_	_
11	6	_	_	CD	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	analyzed	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	immunoblotting	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Eomes-VP16	_	_	NN	Protein	[1]	['Theme']	_	_
4	can	_	_	MD	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	be	_	_	VB	O	[-1]	['none']	_	_
7	detected	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	Eomes	_	_	NNS	Protein	[0]	['root']	_	_
11	antibody	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	C-terminal	_	_	JJ	O	[-1]	['none']	_	_
16	epitope	_	_	NN	O	[-1]	['none']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	within	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	region	_	_	NN	O	[-1]	['none']	_	_
21	that	_	_	WDT	O	[-1]	['none']	_	_
22	has	_	_	VBZ	O	[-1]	['none']	_	_
23	been	_	_	VBN	O	[-1]	['none']	_	_
24	replaced	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	VP16	_	_	NN	Protein	[0]	['root']	_	_
28	transactivation	_	_	NN	O	[-1]	['none']	_	_
29	domain	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Expression	_	_	NN	Gene_expression	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	granzyme	_	_	NN	Protein	[7]	['multitoken']	_	_
7	B	_	_	NN	Protein	[4]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	IFN-gamma	_	_	NN	Protein	[4]	['Theme']	_	_
10	after	_	_	IN	O	[-1]	['none']	_	_
11	culture	_	_	NN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	6	_	_	CD	O	[-1]	['none']	_	_
14	d	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	restimulation	_	_	NN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	4	_	_	CD	O	[-1]	['none']	_	_
19	h	_	_	NN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	PMA	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	ionomycin	_	_	NN	O	[-1]	['none']	_	_
24	was	_	_	VBD	O	[-1]	['none']	_	_
25	determined	_	_	VBN	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	intracellular	_	_	JJ	O	[-1]	['none']	_	_
28	staining	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	percentage	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	positively	_	_	RB	O	[-1]	['none']	_	_
5	stained	_	_	VBN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	shown	_	_	VBN	O	[-1]	['none']	_	_
9	above	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	gate	_	_	NN	O	[-1]	['none']	_	_
12	;	_	_	:	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	mean	_	_	NN	O	[-1]	['none']	_	_
15	fluorescence	_	_	NN	O	[-1]	['none']	_	_
16	intensity	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	MFI	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	granzyme	_	_	NN	Protein	[22]	['multitoken']	_	_
22	B	_	_	NN	Protein	[23]	['Theme']	_	_
23	staining	_	_	NN	Gene_expression	[0]	['root']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	total	_	_	JJ	O	[-1]	['none']	_	_
27	population	_	_	NN	O	[-1]	['none']	_	_
28	is	_	_	VBZ	O	[-1]	['none']	_	_
29	shown	_	_	VBN	O	[-1]	['none']	_	_
30	below	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	gate	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	vertical	_	_	JJ	O	[-1]	['none']	_	_
3	gray	_	_	JJ	O	[-1]	['none']	_	_
4	lines	_	_	NNS	O	[-1]	['none']	_	_
5	indicate	_	_	VBP	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	MFI	_	_	NNP	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	WT	_	_	NNP	O	[-1]	['none']	_	_
10	GFP+	_	_	JJ	Protein	[0]	['root']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Results	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	representative	_	_	JJ	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	least	_	_	JJS	O	[-1]	['none']	_	_
7	two	_	_	CD	O	[-1]	['none']	_	_
8	independent	_	_	JJ	O	[-1]	['none']	_	_
9	experiments	_	_	NNS	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Schematic	_	_	JJ	O	[-1]	['none']	_	_
5	diagram	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
9	network	_	_	NN	O	[-1]	['none']	_	_
10	involving	_	_	VBG	O	[-1]	['none']	_	_
11	Runx3	_	_	NN	Protein	[0]	['root']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	T-box	_	_	NN	O	[-1]	['none']	_	_
14	factors	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	T-bet	_	_	NN	Protein	[3, 9]	['Theme', 'Cause']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	TCR	_	_	NN	O	[-1]	['none']	_	_
6	signals	_	_	NNS	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	essential	_	_	JJ	Positive_regulation	[0]	['root']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	early	_	_	JJ	O	[-1]	['none']	_	_
12	IFN-gamma	_	_	NN	Protein	[13]	['Theme']	_	_
13	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[3, 10, 13]	['Theme', 'Cause', 'Cause']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	present	_	_	JJ	Gene_expression	[0]	['root']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	naive	_	_	JJ	O	[-1]	['none']	_	_
6	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	represses	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
11	Runx1	_	_	NN	Protein	[10]	['Theme']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	induces	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
14	Eomes	_	_	NNS	Protein	[23]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	perforin	_	_	NN	Protein	[23]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	granzyme	_	_	NN	Protein	[19]	['multitoken']	_	_
19	B	_	_	NN	Protein	[23]	['Theme']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	IFN-gamma	_	_	NN	Protein	[23]	['Theme']	_	_
23	expression	_	_	NN	Gene_expression	[13]	['Theme']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Eomes	_	_	NNS	Protein	[3]	['Cause']	_	_
2	may	_	_	MD	O	[-1]	['none']	_	_
3	participate	_	_	VB	Regulation	[0]	['root']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	sustaining	_	_	VBG	O	[-1]	['none']	_	_
6	late	_	_	JJ	O	[-1]	['none']	_	_
7	IFN-gamma	_	_	NN	Protein	[8]	['Theme']	_	_
8	expression	_	_	NN	Gene_expression	[3]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	whereas	_	_	IN	O	[-1]	['none']	_	_
11	Runx3	_	_	NN	Protein	[22]	['Cause']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	Eomes	_	_	NNS	Protein	[22]	['Cause']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	but	_	_	CC	O	[-1]	['none']	_	_
16	not	_	_	RB	O	[-1]	['none']	_	_
17	T-bet	_	_	JJ	Protein	[22]	['Cause']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	may	_	_	MD	O	[-1]	['none']	_	_
20	cooperate	_	_	VB	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	activate	_	_	VB	Positive_regulation	[0]	['root']	_	_
23	perforin	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[22]	['Theme']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	dotted	_	_	JJ	O	[-1]	['none']	_	_
3	line	_	_	NN	O	[-1]	['none']	_	_
4	indicates	_	_	VBZ	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	partial	_	_	JJ	O	[-1]	['none']	_	_
7	effect	_	_	NN	Regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	T-bet	_	_	JJ	Protein	[10]	['Theme']	_	_
10	deficiency	_	_	NN	Negative_regulation	[7]	['Cause']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	Gzmb	_	_	NN	Protein	[19]	['Theme']	_	_
13	mRNA	_	_	NN	O	[-1]	['none']	_	_
14	but	_	_	CC	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	granzyme	_	_	NN	Protein	[17]	['multitoken']	_	_
17	B	_	_	NN	Protein	[19]	['Theme']	_	_
18	protein	_	_	NN	O	[-1]	['none']	_	_
19	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	CXCL8	_	_	NN	Protein	[6]	['Theme']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL-6	_	_	NN	Protein	[6]	['Theme']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	TNF	_	_	NN	O	[-1]	['none']	_	_
6	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
7	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
8	long-term	_	_	JJ	O	[-1]	['none']	_	_
9	stimulation	_	_	NN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	PMA	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Jurkat	_	_	NN	O	[-1]	['none']	_	_
2	T-cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	either	_	_	RB	O	[-1]	['none']	_	_
5	treated	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	media	_	_	NNS	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	white	_	_	JJ	O	[-1]	['none']	_	_
10	bars	_	_	NNS	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	stimulated	_	_	VBN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	PMA	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	black	_	_	JJ	O	[-1]	['none']	_	_
18	bars	_	_	NNS	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	incubated	_	_	VBN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	1	_	_	CD	O	[-1]	['none']	_	_
24	h	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	2	_	_	CD	O	[-1]	['none']	_	_
27	h	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	6	_	_	CD	O	[-1]	['none']	_	_
30	h	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	24	_	_	CD	O	[-1]	['none']	_	_
33	h.	_	_	NN	O	[-1]	['none']	_	_
34	Aged	_	_	VBN	O	[-1]	['none']	_	_
35	media	_	_	NNS	O	[-1]	['none']	_	_
36	was	_	_	VBD	O	[-1]	['none']	_	_
37	added	_	_	VBN	O	[-1]	['none']	_	_
38	following	_	_	VBG	O	[-1]	['none']	_	_
39	each	_	_	DT	O	[-1]	['none']	_	_
40	centrifugation	_	_	NN	O	[-1]	['none']	_	_
41	step	_	_	NN	O	[-1]	['none']	_	_
42	representative	_	_	NN	O	[-1]	['none']	_	_
43	to	_	_	TO	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	stimulation	_	_	NN	O	[-1]	['none']	_	_
46	time	_	_	NN	O	[-1]	['none']	_	_
47	(	_	_	-LRB-	O	[-1]	['none']	_	_
48	see	_	_	VBP	O	[-1]	['none']	_	_
49	Materials	_	_	NNPS	O	[-1]	['none']	_	_
50	and	_	_	CC	O	[-1]	['none']	_	_
51	methods	_	_	NNS	O	[-1]	['none']	_	_
52	)	_	_	-RRB-	O	[-1]	['none']	_	_
53	.	_	_	.	O	[-1]	['none']	_	_

1	Cytokine	_	_	NN	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	A	_	_	DT	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	B	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	IL-6	_	_	NN	Protein	[0]	['root']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	C	_	_	NN	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	TNF	_	_	NN	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	detected	_	_	VBN	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	ELISA	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	significance	_	_	NN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	control	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	determined	_	_	VBN	O	[-1]	['none']	_	_
8	using	_	_	VBG	O	[-1]	['none']	_	_
9	Student	_	_	NN	O	[-1]	['none']	_	_
10	's	_	_	POS	O	[-1]	['none']	_	_
11	t-test	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	n	_	_	NN	O	[-1]	['none']	_	_
3	=	_	_	JJ	O	[-1]	['none']	_	_
4	3	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	Online	_	_	JJ	O	[-1]	['none']	_	_
2	supplemental	_	_	JJ	O	[-1]	['none']	_	_
3	material	_	_	NN	O	[-1]	['none']	_	_
4	.	_	_	.	O	[-1]	['none']	_	_

1	Fig	_	_	NN	O	[-1]	['none']	_	_
2	.	_	_	.	O	[-1]	['none']	_	_

1	S1	_	_	NN	O	[-1]	['none']	_	_
2	shows	_	_	VBZ	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	characterization	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	peripheral	_	_	JJ	O	[-1]	['none']	_	_
7	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
8	T	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	from	_	_	IN	O	[-1]	['none']	_	_
11	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
12	mice	_	_	NNS	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Fig	_	_	NN	O	[-1]	['none']	_	_
2	.	_	_	.	O	[-1]	['none']	_	_

1	S2	_	_	NN	O	[-1]	['none']	_	_
2	shows	_	_	VBZ	O	[-1]	['none']	_	_
3	effector	_	_	NN	O	[-1]	['none']	_	_
4	protein	_	_	NN	O	[-1]	['none']	_	_
5	expression	_	_	NN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	Runx3	_	_	NN	Protein	[0]	['root']	_	_
8	WT	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	KO	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	day	_	_	NN	O	[-1]	['none']	_	_
14	4	_	_	CD	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	in	_	_	FW	O	[-1]	['none']	_	_
17	vitro	_	_	FW	O	[-1]	['none']	_	_
18	culture	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Primer	_	_	NN	O	[-1]	['none']	_	_
2	sequences	_	_	NNS	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	ChIP	_	_	NN	O	[-1]	['none']	_	_
6	experiments	_	_	NNS	O	[-1]	['none']	_	_
7	are	_	_	VBP	O	[-1]	['none']	_	_
8	shown	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	Table	_	_	NNP	O	[-1]	['none']	_	_
11	S1	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Online	_	_	JJ	O	[-1]	['none']	_	_
2	supplemental	_	_	JJ	O	[-1]	['none']	_	_
3	material	_	_	NN	O	[-1]	['none']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	available	_	_	JJ	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	http://www.jem.org/cgi/content/full/jem.20081242/DC1	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[0]	['root']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	T-box	_	_	NN	O	[-1]	['none']	_	_
4	proteins	_	_	NNS	O	[-1]	['none']	_	_
5	cooperate	_	_	VBP	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	establish	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
10	program	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	effector	_	_	NN	O	[-1]	['none']	_	_
13	CTLs	_	_	NNS	O	[-1]	['none']	_	_
14	Activation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	naive	_	_	JJ	O	[-1]	['none']	_	_
17	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
18	T	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	antigen	_	_	NN	O	[-1]	['none']	_	_
22	induces	_	_	VBZ	O	[-1]	['none']	_	_
23	their	_	_	PRP$	O	[-1]	['none']	_	_
24	differentiation	_	_	NN	O	[-1]	['none']	_	_
25	into	_	_	IN	O	[-1]	['none']	_	_
26	effector	_	_	NN	O	[-1]	['none']	_	_
27	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
28	T	_	_	NN	O	[-1]	['none']	_	_
29	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	CTLs	_	_	NNS	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	CTLs	_	_	NNS	O	[-1]	['none']	_	_
2	lyse	_	_	VBP	O	[-1]	['none']	_	_
3	infected	_	_	JJ	O	[-1]	['none']	_	_
4	or	_	_	CC	O	[-1]	['none']	_	_
5	aberrant	_	_	JJ	O	[-1]	['none']	_	_
6	target	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	exocytosis	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	lytic	_	_	JJ	O	[-1]	['none']	_	_
12	granules	_	_	NNS	O	[-1]	['none']	_	_
13	containing	_	_	VBG	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	pore	_	_	NN	O	[-1]	['none']	_	_
16	forming	_	_	VBG	O	[-1]	['none']	_	_
17	protein	_	_	NN	O	[-1]	['none']	_	_
18	perforin	_	_	NN	Protein	[0]	['root']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	family	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	proteases	_	_	NNS	O	[-1]	['none']	_	_
24	termed	_	_	VBN	O	[-1]	['none']	_	_
25	granzymes	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	show	_	_	VBP	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	effector	_	_	NN	O	[-1]	['none']	_	_
5	CTL	_	_	NN	O	[-1]	['none']	_	_
6	differentiation	_	_	NN	O	[-1]	['none']	_	_
7	occurs	_	_	VBZ	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	two	_	_	CD	O	[-1]	['none']	_	_
10	sequential	_	_	JJ	O	[-1]	['none']	_	_
11	phases	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	FW	O	[-1]	['none']	_	_
13	vitro	_	_	FW	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	characterized	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	early	_	_	JJ	O	[-1]	['none']	_	_
18	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	T-bet	_	_	NN	Protein	[18, 34]	['Theme', 'Cause']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	late	_	_	JJ	O	[-1]	['none']	_	_
23	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	Eomesodermin	_	_	JJ	Protein	[23, 34]	['Theme', 'Cause']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	Eomes	_	_	NNS	Protein	[0]	['root']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	T-box	_	_	JJ	Anaphora	[32]	['multitoken']	_	_
31	transcription	_	_	NN	Anaphora	[32]	['multitoken']	_	_
32	factors	_	_	NNS	Anaphora	[0]	['root']	_	_
33	that	_	_	WDT	O	[-1]	['none']	_	_
34	regulate	_	_	VBP	Regulation	[0]	['root']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	early	_	_	JJ	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	late	_	_	JJ	O	[-1]	['none']	_	_
39	phases	_	_	NNS	O	[-1]	['none']	_	_
40	of	_	_	IN	O	[-1]	['none']	_	_
41	interferon	_	_	NN	Protein	[45]	['multitoken']	_	_
42	(	_	_	-LRB-	Protein	[45]	['multitoken']	_	_
43	IFN	_	_	NN	Protein	[45]	['multitoken']	_	_
44	)	_	_	-RRB-	Protein	[45]	['multitoken']	_	_
45	gamma	_	_	NN	Protein	[46]	['Theme']	_	_
46	expression	_	_	NN	Gene_expression	[34]	['Theme']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	respectively	_	_	RB	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	we	_	_	PRP	O	[-1]	['none']	_	_
5	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	critical	_	_	JJ	O	[-1]	['none']	_	_
8	role	_	_	NN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	transcription	_	_	NN	O	[-1]	['none']	_	_
12	factor	_	_	NN	O	[-1]	['none']	_	_
13	Runx3	_	_	NN	Protein	[0]	['root']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	CTL	_	_	NN	O	[-1]	['none']	_	_
16	differentiation	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[2]	['Cause']	_	_
2	regulates	_	_	VBZ	Regulation	[0]	['root']	_	_
3	Eomes	_	_	NNS	Protein	[4]	['Theme']	_	_
4	expression	_	_	NN	Gene_expression	[2]	['Theme']	_	_
5	as	_	_	RB	O	[-1]	['none']	_	_
6	well	_	_	RB	O	[-1]	['none']	_	_
7	as	_	_	IN	O	[-1]	['none']	_	_
8	expression	_	_	NN	Gene_expression	[2]	['Theme']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	three	_	_	CD	Anaphora	[12]	['multitoken']	_	_
11	cardinal	_	_	JJ	Anaphora	[12]	['multitoken']	_	_
12	markers	_	_	NNS	Anaphora	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	effector	_	_	NN	O	[-1]	['none']	_	_
16	CTL	_	_	NN	O	[-1]	['none']	_	_
17	program	_	_	NN	O	[-1]	['none']	_	_
18	:	_	_	:	O	[-1]	['none']	_	_
19	IFN-gamma	_	_	NN	Protein	[8]	['Theme']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	perforin	_	_	NN	Protein	[8]	['Theme']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	granzyme	_	_	NN	Protein	[25]	['multitoken']	_	_
25	B	_	_	NN	Protein	[8]	['Theme']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	point	_	_	VBP	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	existence	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	elaborate	_	_	JJ	O	[-1]	['none']	_	_
10	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
11	network	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	which	_	_	WDT	O	[-1]	['none']	_	_
14	Runx3	_	_	NN	Protein	[0]	['root']	_	_
15	initially	_	_	RB	O	[-1]	['none']	_	_
16	induces	_	_	VBZ	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	then	_	_	RB	O	[-1]	['none']	_	_
19	cooperates	_	_	VBZ	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	T-box	_	_	JJ	O	[-1]	['none']	_	_
22	transcription	_	_	NN	O	[-1]	['none']	_	_
23	factors	_	_	NNS	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	regulate	_	_	VB	O	[-1]	['none']	_	_
26	gene	_	_	NN	O	[-1]	['none']	_	_
27	transcription	_	_	NN	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	differentiating	_	_	VBG	O	[-1]	['none']	_	_
30	CTLs	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Sequencing	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
5	promoter	_	_	NN	O	[-1]	['none']	_	_
6	For	_	_	IN	O	[-1]	['none']	_	_
7	analysis	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
11	promoter	_	_	NN	O	[-1]	['none']	_	_
12	region	_	_	NN	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	permanent	_	_	JJ	O	[-1]	['none']	_	_
15	aberrations	_	_	NNS	O	[-1]	['none']	_	_
16	such	_	_	JJ	O	[-1]	['none']	_	_
17	as	_	_	IN	O	[-1]	['none']	_	_
18	insertions	_	_	NNS	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	deletions	_	_	NNS	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	mutation	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	we	_	_	PRP	O	[-1]	['none']	_	_
25	PCR	_	_	NN	O	[-1]	['none']	_	_
26	amplified	_	_	VBD	O	[-1]	['none']	_	_
27	two	_	_	CD	O	[-1]	['none']	_	_
28	fragments	_	_	NNS	O	[-1]	['none']	_	_
29	from	_	_	IN	O	[-1]	['none']	_	_
30	genomic	_	_	JJ	O	[-1]	['none']	_	_
31	DNA	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	which	_	_	WDT	O	[-1]	['none']	_	_
34	was	_	_	VBD	O	[-1]	['none']	_	_
35	extracted	_	_	VBN	O	[-1]	['none']	_	_
36	from	_	_	IN	O	[-1]	['none']	_	_
37	depicted	_	_	VBN	O	[-1]	['none']	_	_
38	cell	_	_	NN	O	[-1]	['none']	_	_
39	lines	_	_	NNS	O	[-1]	['none']	_	_
40	with	_	_	IN	O	[-1]	['none']	_	_
41	a	_	_	DT	O	[-1]	['none']	_	_
42	commercial	_	_	JJ	O	[-1]	['none']	_	_
43	kit	_	_	NN	O	[-1]	['none']	_	_
44	(	_	_	-LRB-	O	[-1]	['none']	_	_
45	Qiagen	_	_	NNP	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	Hilde	_	_	NNP	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	Germany	_	_	NNP	O	[-1]	['none']	_	_
50	)	_	_	-RRB-	O	[-1]	['none']	_	_
51	as	_	_	IN	O	[-1]	['none']	_	_
52	recommended	_	_	VBN	O	[-1]	['none']	_	_
53	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	primers	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	1-forward	_	_	JJ	O	[-1]	['none']	_	_
5	:	_	_	:	O	[-1]	['none']	_	_
6	5	_	_	CD	O	[-1]	['none']	_	_
7	'-TTGAGATGGAGTCTTGCTCTGT-3	_	_	NN	O	[-1]	['none']	_	_
8	'	_	_	''	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	1-reverse	_	_	JJ	O	[-1]	['none']	_	_
11	:	_	_	:	O	[-1]	['none']	_	_
12	5	_	_	CD	O	[-1]	['none']	_	_
13	'-CCAGGACCTCAGGAGGCCAGTCA-3	_	_	NN	O	[-1]	['none']	_	_
14	'	_	_	''	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	2-forward	_	_	JJ	O	[-1]	['none']	_	_
17	:	_	_	:	O	[-1]	['none']	_	_
18	5	_	_	CD	O	[-1]	['none']	_	_
19	'-AGCGGTGAAACTGAGAGTGCGAGGT-3	_	_	NN	O	[-1]	['none']	_	_
20	'	_	_	''	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	2-reverse	_	_	JJ	O	[-1]	['none']	_	_
23	:	_	_	:	O	[-1]	['none']	_	_
24	5	_	_	CD	O	[-1]	['none']	_	_
25	'-GCCACATCGCTGCAGTTTAG-3	_	_	NN	O	[-1]	['none']	_	_
26	'	_	_	''	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	products	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	cloned	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	'	_	_	''	O	[-1]	['none']	_	_
8	TOPO	_	_	NNP	O	[-1]	['none']	_	_
9	TA	_	_	NNP	O	[-1]	['none']	_	_
10	cloning	_	_	VBG	O	[-1]	['none']	_	_
11	kit	_	_	NN	O	[-1]	['none']	_	_
12	'	_	_	''	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	Groningen	_	_	NNP	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	The	_	_	DT	O	[-1]	['none']	_	_
19	Netherlands	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	bacterial	_	_	JJ	O	[-1]	['none']	_	_
3	amplification	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	cloned	_	_	JJ	O	[-1]	['none']	_	_
7	PCR	_	_	NN	O	[-1]	['none']	_	_
8	fragments	_	_	NNS	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	standard	_	_	JJ	O	[-1]	['none']	_	_
11	procedures	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	least	_	_	JJS	O	[-1]	['none']	_	_
15	three	_	_	CD	O	[-1]	['none']	_	_
16	clones	_	_	NNS	O	[-1]	['none']	_	_
17	from	_	_	IN	O	[-1]	['none']	_	_
18	each	_	_	DT	O	[-1]	['none']	_	_
19	sample	_	_	NN	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	sequenced	_	_	VBN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	an	_	_	DT	O	[-1]	['none']	_	_
24	automated	_	_	JJ	O	[-1]	['none']	_	_
25	sequencer	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	ABI	_	_	NNP	O	[-1]	['none']	_	_
28	Prism	_	_	NN	O	[-1]	['none']	_	_
29	377	_	_	CD	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	Applied	_	_	NNP	O	[-1]	['none']	_	_
32	Bio-systems	_	_	NNS	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	Foster	_	_	NNP	O	[-1]	['none']	_	_
35	City	_	_	NNP	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	USA	_	_	NNP	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	as	_	_	IN	O	[-1]	['none']	_	_
40	recommended	_	_	VBN	O	[-1]	['none']	_	_
41	by	_	_	IN	O	[-1]	['none']	_	_
42	the	_	_	DT	O	[-1]	['none']	_	_
43	manufacturer	_	_	NN	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	Naive	_	_	JJ	O	[-1]	['none']	_	_
2	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
3	T	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	differentiate	_	_	VBP	O	[-1]	['none']	_	_
6	into	_	_	IN	O	[-1]	['none']	_	_
7	effector	_	_	NN	O	[-1]	['none']	_	_
8	CTLs	_	_	NNS	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	ability	_	_	NN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	lyse	_	_	VB	O	[-1]	['none']	_	_
14	antigen	_	_	NN	O	[-1]	['none']	_	_
15	bearing	_	_	NN	O	[-1]	['none']	_	_
16	target	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	exocytosis	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	lytic	_	_	JJ	O	[-1]	['none']	_	_
22	granules	_	_	NNS	O	[-1]	['none']	_	_
23	containing	_	_	VBG	O	[-1]	['none']	_	_
24	perforin	_	_	NN	Protein	[0]	['root']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	granzymes	_	_	NNS	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	produce	_	_	VB	Gene_expression	[0]	['root']	_	_
31	inflammatory	_	_	JJ	Anaphora	[32]	['multitoken']	_	_
32	cytokines	_	_	NNS	Anaphora	[0]	['root']	_	_
33	such	_	_	JJ	O	[-1]	['none']	_	_
34	as	_	_	IN	O	[-1]	['none']	_	_
35	IFN-gamma	_	_	NN	Protein	[30]	['Theme']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	TNF	_	_	NN	Protein	[30]	['Theme']	_	_
38	upon	_	_	IN	O	[-1]	['none']	_	_
39	restimulation	_	_	NN	O	[-1]	['none']	_	_
40	through	_	_	IN	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	TCR	_	_	NN	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	1,2	_	_	CD	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vivo	_	_	FW	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	have	_	_	VBP	O	[-1]	['none']	_	_
5	elucidated	_	_	VBN	O	[-1]	['none']	_	_
6	many	_	_	JJ	O	[-1]	['none']	_	_
7	critical	_	_	JJ	O	[-1]	['none']	_	_
8	parameters	_	_	NNS	O	[-1]	['none']	_	_
9	governing	_	_	VBG	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	development	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	evolution	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	primary	_	_	JJ	O	[-1]	['none']	_	_
16	CTL	_	_	NN	O	[-1]	['none']	_	_
17	responses	_	_	NNS	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	3,4	_	_	CD	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	study	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	we	_	_	PRP	O	[-1]	['none']	_	_
6	have	_	_	VBP	O	[-1]	['none']	_	_
7	used	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	FW	O	[-1]	['none']	_	_
9	vitro	_	_	FW	O	[-1]	['none']	_	_
10	systems	_	_	NNS	O	[-1]	['none']	_	_
11	such	_	_	JJ	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	those	_	_	DT	O	[-1]	['none']	_	_
14	developed	_	_	VBN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	study	_	_	VB	O	[-1]	['none']	_	_
17	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
18	T	_	_	NN	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	differentiation	_	_	NN	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	define	_	_	VB	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	molecular	_	_	JJ	O	[-1]	['none']	_	_
25	basis	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	effector	_	_	NN	O	[-1]	['none']	_	_
28	CTL	_	_	NN	O	[-1]	['none']	_	_
29	differentiation	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	5,6	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	T-box	_	_	JJ	O	[-1]	['none']	_	_
3	transcription	_	_	NN	O	[-1]	['none']	_	_
4	factors	_	_	NNS	O	[-1]	['none']	_	_
5	Eomesodermin	_	_	JJ	Protein	[0]	['root']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	Eomes	_	_	NNS	Protein	[0]	['root']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	T-bet	_	_	NN	Protein	[0]	['root']	_	_
11	are	_	_	VBP	O	[-1]	['none']	_	_
12	needed	_	_	VBN	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	important	_	_	JJ	O	[-1]	['none']	_	_
15	aspects	_	_	NNS	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	effector	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	memory	_	_	NN	O	[-1]	['none']	_	_
20	CTL	_	_	NN	O	[-1]	['none']	_	_
21	differentiation	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	7	_	_	CD	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	uninfected	_	_	JJ	O	[-1]	['none']	_	_
3	mice	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	compound	_	_	NN	O	[-1]	['none']	_	_
6	deletion	_	_	NN	Negative_regulation	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	theTbx21	_	_	NN	Protein	[6]	['Theme']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	encoding	_	_	VBG	O	[-1]	['none']	_	_
11	T-bet	_	_	JJ	Protein	[0]	['root']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	andeomesodermingenes	_	_	NNS	Protein	[0]	['root']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	associated	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	selective	_	_	JJ	O	[-1]	['none']	_	_
19	loss	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
22	T	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	an	_	_	DT	O	[-1]	['none']	_	_
26	IL-2Rbeta-high	_	_	NN	Protein	[0]	['root']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	memory	_	_	NN	O	[-1]	['none']	_	_
29	phenotype	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	8	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Mice	_	_	NNS	O	[-1]	['none']	_	_
2	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
3	for	_	_	IN	O	[-1]	['none']	_	_
4	both	_	_	DT	O	[-1]	['none']	_	_
5	T-bet	_	_	NN	Protein	[2]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	Eomes	_	_	NNS	Protein	[2]	['Theme']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	T	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	have	_	_	VBP	O	[-1]	['none']	_	_
12	impaired	_	_	VBN	O	[-1]	['none']	_	_
13	expression	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
16	mediators	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	manifest	_	_	JJ	O	[-1]	['none']	_	_
19	poor	_	_	JJ	O	[-1]	['none']	_	_
20	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
21	activity	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	fail	_	_	VBP	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	control	_	_	VB	O	[-1]	['none']	_	_
27	acute	_	_	JJ	O	[-1]	['none']	_	_
28	lymphocytic	_	_	JJ	O	[-1]	['none']	_	_
29	choriomeningitis	_	_	NN	O	[-1]	['none']	_	_
30	virus	_	_	NN	O	[-1]	['none']	_	_
31	infection	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	9	_	_	CD	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Nevertheless	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	specific	_	_	JJ	O	[-1]	['none']	_	_
5	roles	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	T-bet	_	_	NN	Protein	[50]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	Eomes	_	_	NNS	Protein	[50]	['Theme']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	clonal	_	_	JJ	O	[-1]	['none']	_	_
12	expansion	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	CTL	_	_	NN	O	[-1]	['none']	_	_
15	differentiation	_	_	NN	O	[-1]	['none']	_	_
16	have	_	_	VBP	O	[-1]	['none']	_	_
17	not	_	_	RB	O	[-1]	['none']	_	_
18	yet	_	_	RB	O	[-1]	['none']	_	_
19	been	_	_	VBN	O	[-1]	['none']	_	_
20	resolved	_	_	VBN	O	[-1]	['none']	_	_
21	:	_	_	:	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	particular	_	_	JJ	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	it	_	_	PRP	O	[-1]	['none']	_	_
26	is	_	_	VBZ	O	[-1]	['none']	_	_
27	not	_	_	RB	O	[-1]	['none']	_	_
28	known	_	_	VBN	O	[-1]	['none']	_	_
29	whether	_	_	IN	O	[-1]	['none']	_	_
30	these	_	_	DT	O	[-1]	['none']	_	_
31	transcription	_	_	NN	O	[-1]	['none']	_	_
32	factors	_	_	NNS	O	[-1]	['none']	_	_
33	function	_	_	VBP	O	[-1]	['none']	_	_
34	redundantly	_	_	RB	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	control	_	_	VB	O	[-1]	['none']	_	_
37	effector	_	_	NN	O	[-1]	['none']	_	_
38	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
39	T	_	_	NN	O	[-1]	['none']	_	_
40	cell	_	_	NN	O	[-1]	['none']	_	_
41	differentiation	_	_	NN	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	and	_	_	CC	O	[-1]	['none']	_	_
44	whether	_	_	IN	O	[-1]	['none']	_	_
45	they	_	_	PRP	Anaphora	[0]	['root']	_	_
46	do	_	_	VBP	O	[-1]	['none']	_	_
47	so	_	_	RB	O	[-1]	['none']	_	_
48	directly	_	_	RB	O	[-1]	['none']	_	_
49	by	_	_	IN	O	[-1]	['none']	_	_
50	targeting	_	_	VBG	Binding	[0]	['root']	_	_
51	specific	_	_	JJ	O	[-1]	['none']	_	_
52	effector	_	_	NN	O	[-1]	['none']	_	_
53	cytokine	_	_	NN	O	[-1]	['none']	_	_
54	and	_	_	CC	O	[-1]	['none']	_	_
55	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
56	genes.Runx	_	_	NN	O	[-1]	['none']	_	_
57	proteins	_	_	NNS	O	[-1]	['none']	_	_
58	,	_	_	,	O	[-1]	['none']	_	_
59	a	_	_	DT	O	[-1]	['none']	_	_
60	family	_	_	NN	O	[-1]	['none']	_	_
61	of	_	_	IN	O	[-1]	['none']	_	_
62	three	_	_	CD	O	[-1]	['none']	_	_
63	DNA	_	_	NN	O	[-1]	['none']	_	_
64	binding	_	_	NN	O	[-1]	['none']	_	_
65	transcription	_	_	NN	O	[-1]	['none']	_	_
66	factors	_	_	NNS	O	[-1]	['none']	_	_
67	,	_	_	,	O	[-1]	['none']	_	_
68	control	_	_	NN	O	[-1]	['none']	_	_
69	thymocyte	_	_	NN	O	[-1]	['none']	_	_
70	differentiation	_	_	NN	O	[-1]	['none']	_	_
71	and	_	_	CC	O	[-1]	['none']	_	_
72	the	_	_	DT	O	[-1]	['none']	_	_
73	CD4	_	_	NN	Protein	[0]	['root']	_	_
74	and	_	_	CC	O	[-1]	['none']	_	_
75	CD8	_	_	NN	Protein	[0]	['root']	_	_
76	lineage	_	_	NN	O	[-1]	['none']	_	_
77	decision	_	_	NN	O	[-1]	['none']	_	_
78	(	_	_	-LRB-	O	[-1]	['none']	_	_
79	10-13	_	_	CD	O	[-1]	['none']	_	_
80	)	_	_	-RRB-	O	[-1]	['none']	_	_
81	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[6]	['Theme']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	perforin	_	_	NN	Protein	[6]	['Theme']	_	_
4	mRNA	_	_	NN	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	expressed	_	_	VBN	Transcription	[0]	['root']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	double	_	_	JJ	O	[-1]	['none']	_	_
9	positive	_	_	JJ	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	DP	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	thymocytes	_	_	NNS	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
16	single	_	_	JJ	O	[-1]	['none']	_	_
17	positive	_	_	JJ	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	SP	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	thymocytes	_	_	NNS	O	[-1]	['none']	_	_
22	but	_	_	CC	O	[-1]	['none']	_	_
23	not	_	_	RB	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
26	SP	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	14	_	_	CD	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	Runx3	_	_	NN	Protein	[5, 13]	['Theme', 'Theme']	_	_
3	is	_	_	VBZ	O	[-1]	['none']	_	_
4	not	_	_	RB	O	[-1]	['none']	_	_
5	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	naive	_	_	JJ	O	[-1]	['none']	_	_
8	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
9	T	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
13	expression	_	_	NN	Gene_expression	[15]	['Theme']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	up-regulated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
16	during	_	_	IN	O	[-1]	['none']	_	_
17	Th1	_	_	NN	O	[-1]	['none']	_	_
18	cell	_	_	NN	O	[-1]	['none']	_	_
19	differentiation	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	Runx3	_	_	NN	Protein	[31]	['Cause']	_	_
23	influences	_	_	VBZ	O	[-1]	['none']	_	_
24	Th1	_	_	NN	O	[-1]	['none']	_	_
25	cell	_	_	NN	O	[-1]	['none']	_	_
26	differentiation	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	function	_	_	NN	O	[-1]	['none']	_	_
29	through	_	_	IN	O	[-1]	['none']	_	_
30	direct	_	_	JJ	O	[-1]	['none']	_	_
31	regulation	_	_	NN	Regulation	[0]	['root']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	theIl4andIfngcytokine	_	_	NN	Protein	[0]	['root']	_	_
34	genes	_	_	NNS	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	15,16	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	all	_	_	DT	O	[-1]	['none']	_	_
5	three	_	_	CD	O	[-1]	['none']	_	_
6	Runx	_	_	NN	O	[-1]	['none']	_	_
7	proteins	_	_	NNS	O	[-1]	['none']	_	_
8	are	_	_	VBP	O	[-1]	['none']	_	_
9	expressed	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	mature	_	_	JJ	O	[-1]	['none']	_	_
12	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
13	T	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	10,12	_	_	CD	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	Runx3	_	_	NN	Protein	[21]	['Theme']	_	_
21	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
22	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
23	T	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	show	_	_	VBP	O	[-1]	['none']	_	_
26	reduced	_	_	VBN	O	[-1]	['none']	_	_
27	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
28	activity	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	12,13	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	therefore	_	_	RB	O	[-1]	['none']	_	_
3	tested	_	_	VBD	O	[-1]	['none']	_	_
4	whether	_	_	IN	O	[-1]	['none']	_	_
5	Runx3	_	_	NN	Protein	[0]	['root']	_	_
6	influenced	_	_	VBD	O	[-1]	['none']	_	_
7	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
8	T	_	_	NN	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	differentiation.In	_	_	NN	O	[-1]	['none']	_	_
11	this	_	_	DT	O	[-1]	['none']	_	_
12	report	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	we	_	_	PRP	O	[-1]	['none']	_	_
15	show	_	_	VBP	O	[-1]	['none']	_	_
16	that	_	_	IN	O	[-1]	['none']	_	_
17	Runx3	_	_	NN	Protein	[0]	['root']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	T-box	_	_	NN	O	[-1]	['none']	_	_
20	factors	_	_	NNS	O	[-1]	['none']	_	_
21	synergistically	_	_	RB	O	[-1]	['none']	_	_
22	regulate	_	_	VBP	O	[-1]	['none']	_	_
23	CTL	_	_	NN	O	[-1]	['none']	_	_
24	differentiation	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	function	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	T-bet	_	_	NN	Protein	[3]	['Theme']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
4	quickly	_	_	RB	O	[-1]	['none']	_	_
5	upon	_	_	IN	O	[-1]	['none']	_	_
6	TCR	_	_	NN	O	[-1]	['none']	_	_
7	stimulation	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	required	_	_	VBN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	early	_	_	JJ	O	[-1]	['none']	_	_
13	programming	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	cytokine	_	_	NN	O	[-1]	['none']	_	_
16	production	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	17	_	_	CD	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	whereas	_	_	IN	O	[-1]	['none']	_	_
22	Eomes	_	_	NNS	Protein	[24, 29]	['Theme', 'Cause']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
25	later	_	_	RB	O	[-1]	['none']	_	_
26	during	_	_	IN	O	[-1]	['none']	_	_
27	differentiation	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	sustains	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
30	IFN-gamma	_	_	NN	Protein	[31]	['Theme']	_	_
31	expression	_	_	NN	Gene_expression	[29]	['Theme']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[3]	['Cause']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	Eomes	_	_	NNS	Protein	[8]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	perforin	_	_	NN	Protein	[8]	['Theme']	_	_
8	expression	_	_	NN	Gene_expression	[3]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	both	_	_	DT	O	[-1]	['none']	_	_
12	Eomes	_	_	NNS	Protein	[15]	['Theme']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	Runx3	_	_	NN	Protein	[15]	['Theme']	_	_
15	bind	_	_	VBP	Binding	[0]	['root']	_	_
16	at	_	_	IN	O	[-1]	['none']	_	_
17	thePrf1locus	_	_	NN	Protein	[0]	['root']	_	_
18	;	_	_	:	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	contrast	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	perforin	_	_	NN	Protein	[23]	['Theme']	_	_
23	expression	_	_	NN	Gene_expression	[25]	['Theme']	_	_
24	is	_	_	VBZ	O	[-1]	['none']	_	_
25	unaffected	_	_	JJ	Regulation	[0]	['root']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	T-bet-deficient	_	_	JJ	Negative_regulation	[25]	['Cause']	_	_
28	cells	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	T	_	_	NN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	lacking	_	_	VBG	Negative_regulation	[6]	['Cause']	_	_
4	Runx3	_	_	NN	Protein	[3]	['Theme']	_	_
5	show	_	_	NN	O	[-1]	['none']	_	_
6	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
7	expression	_	_	NN	Gene_expression	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	IFN-gamma	_	_	NN	Protein	[7]	['Theme']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	granzyme	_	_	NN	Protein	[12]	['multitoken']	_	_
12	B	_	_	NN	Protein	[7]	['Theme']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	Runx3	_	_	NN	Protein	[17]	['Theme']	_	_
16	also	_	_	RB	O	[-1]	['none']	_	_
17	binds	_	_	VBZ	Binding	[0]	['root']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	promoter	_	_	NN	Entity	[20]	['multitoken']	_	_
20	regions	_	_	NNS	Entity	[17]	['Site']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	theIfngandGzmbgenes	_	_	NNS	Protein	[0]	['root']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Collectively	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	results	_	_	NNS	O	[-1]	['none']	_	_
5	provide	_	_	VBP	O	[-1]	['none']	_	_
6	evidence	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	complex	_	_	JJ	O	[-1]	['none']	_	_
10	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
11	network	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	which	_	_	WDT	O	[-1]	['none']	_	_
14	Runx3	_	_	NN	Protein	[18]	['Cause']	_	_
15	is	_	_	VBZ	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	primary	_	_	JJ	O	[-1]	['none']	_	_
18	regulator	_	_	NN	Regulation	[0]	['root']	_	_
19	ofGzmbexpression	_	_	NN	Gene_expression	[18]	['Theme']	_	_
20	but	_	_	CC	O	[-1]	['none']	_	_
21	synergizes	_	_	VBZ	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	T-bet	_	_	NN	Protein	[30]	['Cause']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	Eomes	_	_	NNS	Protein	[30]	['Cause']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	respectively	_	_	RB	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	promote	_	_	VB	Positive_regulation	[0]	['root']	_	_
31	transcription	_	_	NN	Transcription	[30]	['Theme']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	theIfngandPrf1genes	_	_	NNS	Protein	[0]	['root']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Induction	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
4	responses	_	_	NNS	O	[-1]	['none']	_	_
5	The	_	_	DT	O	[-1]	['none']	_	_
6	ability	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	PMA	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	HK	_	_	NNP	O	[-1]	['none']	_	_
11	E.	_	_	NNP	O	[-1]	['none']	_	_
12	coli	_	_	NN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	induce	_	_	VB	O	[-1]	['none']	_	_
15	an	_	_	DT	O	[-1]	['none']	_	_
16	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
17	response	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	Jurkat	_	_	NN	O	[-1]	['none']	_	_
20	T-cells	_	_	NNS	O	[-1]	['none']	_	_
21	was	_	_	VBD	O	[-1]	['none']	_	_
22	evaluated	_	_	VBN	O	[-1]	['none']	_	_
23	using	_	_	VBG	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	multiplex	_	_	JJ	O	[-1]	['none']	_	_
26	cytokine	_	_	NN	O	[-1]	['none']	_	_
27	assay	_	_	NN	O	[-1]	['none']	_	_
28	following	_	_	VBG	O	[-1]	['none']	_	_
29	24	_	_	CD	O	[-1]	['none']	_	_
30	h	_	_	NN	O	[-1]	['none']	_	_
31	stimulation	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cytokine	_	_	NN	O	[-1]	['none']	_	_
3	profile	_	_	NN	O	[-1]	['none']	_	_
4	revealed	_	_	VBD	O	[-1]	['none']	_	_
5	an	_	_	DT	O	[-1]	['none']	_	_
6	enhanced	_	_	JJ	Positive_regulation	[0]	['root']	_	_
7	induction	_	_	NN	Positive_regulation	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	pro	_	_	JJ	O	[-1]	['none']	_	_
11	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
12	cytokines	_	_	NNS	O	[-1]	['none']	_	_
13	IL-2	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	IL-6	_	_	NN	Protein	[0]	['root']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	TNF	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	chemokine	_	_	NN	O	[-1]	['none']	_	_
21	CXCL8	_	_	NN	Protein	[7]	['Theme']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
6	cytokine	_	_	NN	O	[-1]	['none']	_	_
7	IL-10	_	_	NN	Protein	[9, 15]	['Theme', 'Theme']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	unaffected	_	_	JJ	Regulation	[0]	['root']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	PMA	_	_	NN	O	[-1]	['none']	_	_
12	but	_	_	CC	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	significantly	_	_	RB	O	[-1]	['none']	_	_
15	decreased	_	_	VBN	Negative_regulation	[0]	['root']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	HK	_	_	NNP	O	[-1]	['none']	_	_
18	E.	_	_	NNP	O	[-1]	['none']	_	_
19	coli	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	confirmed	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	PMA	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	HK	_	_	NNP	O	[-1]	['none']	_	_
8	E.	_	_	NNP	O	[-1]	['none']	_	_
9	coli	_	_	NN	O	[-1]	['none']	_	_
10	induced	_	_	VBD	O	[-1]	['none']	_	_
11	an	_	_	DT	O	[-1]	['none']	_	_
12	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
13	response	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	Jurkat	_	_	NN	O	[-1]	['none']	_	_
17	T-cells	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	interesting	_	_	JJ	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	note	_	_	VB	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	PMA	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	120-fold	_	_	RB	O	[-1]	['none']	_	_
10	more	_	_	RBR	O	[-1]	['none']	_	_
11	effective	_	_	JJ	Positive_regulation	[0]	['root']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	inducing	_	_	VBG	Positive_regulation	[11]	['Theme']	_	_
14	CXCL8	_	_	NN	Protein	[13]	['Theme']	_	_
15	than	_	_	IN	O	[-1]	['none']	_	_
16	HK	_	_	JJ	O	[-1]	['none']	_	_
17	E.	_	_	FW	O	[-1]	['none']	_	_
18	coli	_	_	FW	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	PMA	_	_	NN	O	[-1]	['none']	_	_
2	dependent	_	_	JJ	O	[-1]	['none']	_	_
3	induction	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	AP-1	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	down-regulation	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	suggests	_	_	VBZ	O	[-1]	['none']	_	_
11	an	_	_	DT	O	[-1]	['none']	_	_
12	involvement	_	_	NN	Regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	AP-1	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	CXCL8	_	_	NN	Protein	[17]	['Theme']	_	_
17	regulation	_	_	NN	Regulation	[12]	['Theme']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Determination	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	time	_	_	NN	O	[-1]	['none']	_	_
5	course	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	cytokine	_	_	NN	O	[-1]	['none']	_	_
8	induction	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	response	_	_	NN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	showed	_	_	VBD	O	[-1]	['none']	_	_
14	that	_	_	IN	O	[-1]	['none']	_	_
15	CXCL8	_	_	NN	Protein	[18]	['Theme']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	already	_	_	RB	O	[-1]	['none']	_	_
18	released	_	_	VBN	Localization	[0]	['root']	_	_
19	between	_	_	IN	O	[-1]	['none']	_	_
20	2-6	_	_	CD	O	[-1]	['none']	_	_
21	h	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	while	_	_	IN	O	[-1]	['none']	_	_
24	TNF	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	IL-6	_	_	NN	Protein	[28]	['Theme']	_	_
27	were	_	_	VBD	O	[-1]	['none']	_	_
28	released	_	_	VBN	Localization	[0]	['root']	_	_
29	between	_	_	IN	O	[-1]	['none']	_	_
30	6-24	_	_	CD	O	[-1]	['none']	_	_
31	h	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	indicated	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	Anaphora	[6]	['multitoken']	_	_
6	cytokines	_	_	NNS	Anaphora	[0]	['root']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	differentially	_	_	RB	O	[-1]	['none']	_	_
9	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	that	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	release	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	associated	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	early	_	_	JJ	O	[-1]	['none']	_	_
20	transient	_	_	JJ	O	[-1]	['none']	_	_
21	induction	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	temporal	_	_	JJ	O	[-1]	['none']	_	_
3	induction	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	AP-1	_	_	NN	O	[-1]	['none']	_	_
6	correlated	_	_	VBD	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
10	levels	_	_	NNS	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	preceded	_	_	VBD	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	TNF	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	IL-6	_	_	NN	Protein	[17]	['Theme']	_	_
17	release	_	_	NN	Localization	[0]	['root']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	suggests	_	_	VBZ	O	[-1]	['none']	_	_
3	an	_	_	DT	O	[-1]	['none']	_	_
4	association	_	_	NN	O	[-1]	['none']	_	_
5	between	_	_	IN	O	[-1]	['none']	_	_
6	CXCL8	_	_	NN	Protein	[7]	['Theme']	_	_
7	release	_	_	NN	Localization	[0]	['root']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	AP-1	_	_	NN	O	[-1]	['none']	_	_
10	signalling	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF-Induces	_	_	NNP	O	[-1]	['none']	_	_
2	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
3	Kinase	_	_	NN	O	[-1]	['none']	_	_
4	Activity	_	_	NN	O	[-1]	['none']	_	_
5	Since	_	_	IN	O	[-1]	['none']	_	_
6	our	_	_	PRP$	O	[-1]	['none']	_	_
7	data	_	_	NNS	O	[-1]	['none']	_	_
8	suggested	_	_	VBD	O	[-1]	['none']	_	_
9	that	_	_	IN	O	[-1]	['none']	_	_
10	conventional	_	_	JJ	O	[-1]	['none']	_	_
11	PKCs	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	involved	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	activating	_	_	VBG	O	[-1]	['none']	_	_
16	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	response	_	_	NN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	M-CSF	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	primary	_	_	JJ	O	[-1]	['none']	_	_
23	human	_	_	NN	O	[-1]	['none']	_	_
24	macrophages	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	we	_	_	PRP	O	[-1]	['none']	_	_
27	next	_	_	RB	O	[-1]	['none']	_	_
28	investigated	_	_	VBD	O	[-1]	['none']	_	_
29	whether	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	conventional	_	_	JJ	O	[-1]	['none']	_	_
32	PKC	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	PKCalpha	_	_	NN	Protein	[38]	['Theme']	_	_
35	was	_	_	VBD	O	[-1]	['none']	_	_
36	a	_	_	DT	O	[-1]	['none']	_	_
37	downstream	_	_	JJ	Regulation	[38]	['multitoken']	_	_
38	target	_	_	NN	Regulation	[0]	['root']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	M-CSF	_	_	NN	O	[-1]	['none']	_	_
41	in	_	_	IN	O	[-1]	['none']	_	_
42	human	_	_	NN	O	[-1]	['none']	_	_
43	MDMs	_	_	NNS	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	PKCalpha	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	human	_	_	NN	O	[-1]	['none']	_	_
6	MDMs	_	_	NNS	O	[-1]	['none']	_	_
7	at	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	indicated	_	_	JJ	O	[-1]	['none']	_	_
10	time	_	_	NN	O	[-1]	['none']	_	_
11	points	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	then	_	_	RB	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	PKC	_	_	NN	O	[-1]	['none']	_	_
17	kinase	_	_	NN	O	[-1]	['none']	_	_
18	assay	_	_	NN	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	performed	_	_	VBN	O	[-1]	['none']	_	_
21	using	_	_	VBG	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	fluorescein	_	_	NN	O	[-1]	['none']	_	_
24	tagged	_	_	VBD	O	[-1]	['none']	_	_
25	peptide	_	_	NN	O	[-1]	['none']	_	_
26	as	_	_	IN	O	[-1]	['none']	_	_
27	a	_	_	DT	O	[-1]	['none']	_	_
28	substrate	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	4	_	_	CD	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	upper	_	_	JJ	O	[-1]	['none']	_	_
8	panel	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	peptide	_	_	NN	O	[-1]	['none']	_	_
13	substrate	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	maximally	_	_	RB	O	[-1]	['none']	_	_
16	phosphorylated	_	_	VBN	O	[-1]	['none']	_	_
17	within	_	_	IN	O	[-1]	['none']	_	_
18	10	_	_	CD	O	[-1]	['none']	_	_
19	minutes	_	_	NNS	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	stimulation	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	1.8-fold	_	_	RB	O	[-1]	['none']	_	_
24	over	_	_	IN	O	[-1]	['none']	_	_
25	resting	_	_	VBG	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	lower	_	_	JJR	O	[-1]	['none']	_	_
29	panel	_	_	NN	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	then	_	_	RB	O	[-1]	['none']	_	_
34	returned	_	_	VBD	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	basal	_	_	JJ	O	[-1]	['none']	_	_
37	levels	_	_	NNS	O	[-1]	['none']	_	_
38	by	_	_	IN	O	[-1]	['none']	_	_
39	15	_	_	CD	O	[-1]	['none']	_	_
40	minutes	_	_	NNS	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	effect	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	not	_	_	RB	O	[-1]	['none']	_	_
5	seen	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	M-CSF-stimulated	_	_	JJ	O	[-1]	['none']	_	_
8	monocytes	_	_	NNS	O	[-1]	['none']	_	_
9	when	_	_	WRB	O	[-1]	['none']	_	_
10	isogenic	_	_	JJ	O	[-1]	['none']	_	_
11	antibodies	_	_	NNS	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	IgG	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	used	_	_	VBN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	immunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	NN	O	[-1]	['none']	_	_
2	blots	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	identical	_	_	JJ	O	[-1]	['none']	_	_
5	samples	_	_	NNS	O	[-1]	['none']	_	_
6	using	_	_	VBG	O	[-1]	['none']	_	_
7	an	_	_	DT	O	[-1]	['none']	_	_
8	antibody	_	_	NN	O	[-1]	['none']	_	_
9	recognizing	_	_	VBG	O	[-1]	['none']	_	_
10	PKCalpha	_	_	NN	O	[-1]	['none']	_	_
11	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
12	that	_	_	IN	O	[-1]	['none']	_	_
13	equal	_	_	JJ	O	[-1]	['none']	_	_
14	amounts	_	_	NNS	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	PKCalpha	_	_	NN	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	assayed	_	_	VBN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
2	Is	_	_	VBZ	O	[-1]	['none']	_	_
3	Essential	_	_	JJ	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	Cytokine	_	_	NN	O	[-1]	['none']	_	_
6	Production	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	Signaling	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	Induction	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Th1	_	_	NN	O	[-1]	['none']	_	_
15	Differentiation	_	_	NN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	Dendritic	_	_	JJ	O	[-1]	['none']	_	_
18	Cells	_	_	NNS	O	[-1]	['none']	_	_
19	Spontaneous	_	_	JJ	O	[-1]	['none']	_	_
20	mutations	_	_	NNS	Negative_regulation	[0]	['root']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	Sharpin	_	_	NNP	Protein	[20]	['Theme']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	SHANK	_	_	NNP	Protein	[30]	['multitoken']	_	_
26	associated	_	_	VBN	Protein	[30]	['multitoken']	_	_
27	RH	_	_	NN	Protein	[30]	['multitoken']	_	_
28	domain	_	_	NN	Protein	[30]	['multitoken']	_	_
29	interacting	_	_	VBG	Protein	[30]	['multitoken']	_	_
30	protein	_	_	NN	Protein	[0]	['root']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	other	_	_	JJ	O	[-1]	['none']	_	_
33	aliases	_	_	NNS	O	[-1]	['none']	_	_
34	:	_	_	:	O	[-1]	['none']	_	_
35	Rbckl1	_	_	NN	Protein	[0]	['root']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	Sipl1	_	_	NN	Protein	[0]	['root']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	gene	_	_	NN	O	[-1]	['none']	_	_
40	in	_	_	IN	O	[-1]	['none']	_	_
41	mice	_	_	NNS	O	[-1]	['none']	_	_
42	result	_	_	VBP	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	systemic	_	_	JJ	O	[-1]	['none']	_	_
45	inflammation	_	_	NN	O	[-1]	['none']	_	_
46	that	_	_	WDT	O	[-1]	['none']	_	_
47	is	_	_	VBZ	O	[-1]	['none']	_	_
48	characterized	_	_	VBN	O	[-1]	['none']	_	_
49	by	_	_	IN	O	[-1]	['none']	_	_
50	chronic	_	_	JJ	O	[-1]	['none']	_	_
51	proliferative	_	_	JJ	O	[-1]	['none']	_	_
52	dermatitis	_	_	NN	O	[-1]	['none']	_	_
53	and	_	_	CC	O	[-1]	['none']	_	_
54	dysregulated	_	_	VBN	O	[-1]	['none']	_	_
55	secretion	_	_	NN	O	[-1]	['none']	_	_
56	of	_	_	IN	O	[-1]	['none']	_	_
57	T	_	_	NN	O	[-1]	['none']	_	_
58	helper1	_	_	CD	O	[-1]	['none']	_	_
59	(	_	_	-LRB-	O	[-1]	['none']	_	_
60	Th1	_	_	NN	O	[-1]	['none']	_	_
61	)	_	_	-RRB-	O	[-1]	['none']	_	_
62	and	_	_	CC	O	[-1]	['none']	_	_
63	Th2	_	_	NN	O	[-1]	['none']	_	_
64	cytokines	_	_	NNS	O	[-1]	['none']	_	_
65	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cellular	_	_	JJ	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	molecular	_	_	JJ	O	[-1]	['none']	_	_
5	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
6	underlying	_	_	VBG	O	[-1]	['none']	_	_
7	this	_	_	DT	O	[-1]	['none']	_	_
8	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
9	phenotype	_	_	NN	O	[-1]	['none']	_	_
10	remain	_	_	VBP	O	[-1]	['none']	_	_
11	elusive	_	_	JJ	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Dendritic	_	_	JJ	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	may	_	_	MD	O	[-1]	['none']	_	_
4	contribute	_	_	VB	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	initiation	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	progression	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	phenotype	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	SHARPIN	_	_	NNP	Protein	[15]	['Theme']	_	_
15	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
16	mice	_	_	NNS	O	[-1]	['none']	_	_
17	because	_	_	IN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	their	_	_	PRP$	O	[-1]	['none']	_	_
20	pivotal	_	_	JJ	O	[-1]	['none']	_	_
21	role	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	innate	_	_	JJ	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	adaptive	_	_	JJ	O	[-1]	['none']	_	_
26	immunity	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Here	_	_	RB	O	[-1]	['none']	_	_
2	we	_	_	PRP	O	[-1]	['none']	_	_
3	show	_	_	VBP	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	flow	_	_	NN	O	[-1]	['none']	_	_
6	cytometry	_	_	NN	O	[-1]	['none']	_	_
7	that	_	_	WDT	O	[-1]	['none']	_	_
8	SHARPIN-	_	_	NN	Protein	[0]	['root']	_	_
9	deficiency	_	_	NN	Negative_regulation	[0]	['root']	_	_
10	did	_	_	VBD	O	[-1]	['none']	_	_
11	not	_	_	RB	O	[-1]	['none']	_	_
12	alter	_	_	VB	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	distribution	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	different	_	_	JJ	O	[-1]	['none']	_	_
17	DC	_	_	NN	O	[-1]	['none']	_	_
18	subtypes	_	_	NNS	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	spleen	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	response	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	TOLL	_	_	NN	O	[-1]	['none']	_	_
5	like	_	_	IN	O	[-1]	['none']	_	_
6	receptor	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	TLR	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	agonists	_	_	NNS	O	[-1]	['none']	_	_
11	LPS	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	poly	_	_	NN	O	[-1]	['none']	_	_
14	I	_	_	NN	O	[-1]	['none']	_	_
15	:	_	_	:	O	[-1]	['none']	_	_
16	C	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	cultured	_	_	VBN	O	[-1]	['none']	_	_
19	bone	_	_	NN	O	[-1]	['none']	_	_
20	marrow	_	_	NN	O	[-1]	['none']	_	_
21	derived	_	_	VBN	O	[-1]	['none']	_	_
22	dendritic	_	_	JJ	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	BMDC	_	_	NN	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	from	_	_	IN	O	[-1]	['none']	_	_
28	WT	_	_	NNP	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	mutant	_	_	NN	O	[-1]	['none']	_	_
31	mice	_	_	NNS	O	[-1]	['none']	_	_
32	exhibited	_	_	VBD	O	[-1]	['none']	_	_
33	similar	_	_	JJ	O	[-1]	['none']	_	_
34	increases	_	_	NNS	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	expression	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	co-stimulatory	_	_	JJ	O	[-1]	['none']	_	_
39	molecules	_	_	NNS	O	[-1]	['none']	_	_
40	CD40	_	_	NN	Protein	[0]	['root']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	CD80	_	_	NN	Protein	[0]	['root']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	CD86	_	_	NN	Protein	[0]	['root']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	stimulated	_	_	VBD	O	[-1]	['none']	_	_
4	SHARPIN	_	_	NNP	Protein	[5]	['Theme']	_	_
5	deficient	_	_	JJ	Negative_regulation	[8]	['Cause']	_	_
6	BMDC	_	_	NNP	O	[-1]	['none']	_	_
7	had	_	_	VBD	O	[-1]	['none']	_	_
8	reduced	_	_	VBN	Negative_regulation	[0]	['root']	_	_
9	transcription	_	_	NN	Transcription	[8]	['Theme']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	secretion	_	_	NN	Gene_expression	[8]	['Theme']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	pro	_	_	JJ	O	[-1]	['none']	_	_
14	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
15	mediators	_	_	NNS	O	[-1]	['none']	_	_
16	IL6	_	_	NN	Protein	[9, 11]	['Theme', 'Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	IL12P70	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	GMCSF	_	_	NN	Protein	[9, 11]	['Theme', 'Theme']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	nitric	_	_	JJ	O	[-1]	['none']	_	_
24	oxide	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Mutant	_	_	NN	O	[-1]	['none']	_	_
2	BMDC	_	_	NN	O	[-1]	['none']	_	_
3	had	_	_	VBD	O	[-1]	['none']	_	_
4	defective	_	_	JJ	O	[-1]	['none']	_	_
5	activation	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	signaling	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	whereas	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	MAPK1/3	_	_	NN	Protein	[0]	['root']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	ERK1/2	_	_	NN	Protein	[0]	['root']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	MAPK11/12/13/14	_	_	NN	Protein	[0]	['root']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	p38	_	_	NN	O	[-1]	['none']	_	_
20	MAP	_	_	NN	O	[-1]	['none']	_	_
21	kinase	_	_	NN	O	[-1]	['none']	_	_
22	isoforms	_	_	NNS	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	TBK1	_	_	NN	Protein	[0]	['root']	_	_
26	signaling	_	_	NN	O	[-1]	['none']	_	_
27	pathways	_	_	NNS	O	[-1]	['none']	_	_
28	were	_	_	VBD	O	[-1]	['none']	_	_
29	intact	_	_	JJ	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	mixed	_	_	JJ	O	[-1]	['none']	_	_
3	lymphocyte	_	_	NN	O	[-1]	['none']	_	_
4	reaction	_	_	NN	O	[-1]	['none']	_	_
5	showed	_	_	VBD	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	mutant	_	_	NN	O	[-1]	['none']	_	_
8	BMDC	_	_	NN	O	[-1]	['none']	_	_
9	only	_	_	RB	O	[-1]	['none']	_	_
10	induced	_	_	VBD	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	weak	_	_	JJ	O	[-1]	['none']	_	_
13	Th1	_	_	NN	O	[-1]	['none']	_	_
14	immune	_	_	JJ	O	[-1]	['none']	_	_
15	response	_	_	NN	O	[-1]	['none']	_	_
16	but	_	_	CC	O	[-1]	['none']	_	_
17	stimulated	_	_	VBD	O	[-1]	['none']	_	_
18	increased	_	_	VBN	O	[-1]	['none']	_	_
19	Th2	_	_	NN	O	[-1]	['none']	_	_
20	cytokine	_	_	NN	O	[-1]	['none']	_	_
21	production	_	_	NN	O	[-1]	['none']	_	_
22	from	_	_	IN	O	[-1]	['none']	_	_
23	allogeneic	_	_	JJ	O	[-1]	['none']	_	_
24	naive	_	_	JJ	O	[-1]	['none']	_	_
25	CD4+	_	_	JJ	O	[-1]	['none']	_	_
26	T	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	conclusion	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	loss	_	_	NN	Negative_regulation	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Sharpin	_	_	NNP	Protein	[4]	['Theme']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	mice	_	_	NNS	O	[-1]	['none']	_	_
9	significantly	_	_	RB	O	[-1]	['none']	_	_
10	affects	_	_	VBZ	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	immune	_	_	JJ	O	[-1]	['none']	_	_
13	function	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	DC	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	this	_	_	DT	O	[-1]	['none']	_	_
18	may	_	_	MD	O	[-1]	['none']	_	_
19	partially	_	_	RB	O	[-1]	['none']	_	_
20	account	_	_	VB	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	systemic	_	_	JJ	O	[-1]	['none']	_	_
24	inflammation	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	Th2	_	_	NN	O	[-1]	['none']	_	_
27	biased	_	_	VBD	O	[-1]	['none']	_	_
28	immune	_	_	JJ	O	[-1]	['none']	_	_
29	response	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Monocytes	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	produced	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	bone	_	_	NN	O	[-1]	['none']	_	_
7	marrow	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	circulate	_	_	VB	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	blood	_	_	NN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	24-48	_	_	CD	O	[-1]	['none']	_	_
14	hours	_	_	NNS	O	[-1]	['none']	_	_
15	[	_	_	VBP	O	[-1]	['none']	_	_
16	1	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	CD	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	absence	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	serum	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	monocytes	_	_	NNS	O	[-1]	['none']	_	_
8	die	_	_	VBP	O	[-1]	['none']	_	_
9	via	_	_	IN	O	[-1]	['none']	_	_
10	apoptosis	_	_	NN	O	[-1]	['none']	_	_
11	[	_	_	CD	O	[-1]	['none']	_	_
12	1	_	_	CD	O	[-1]	['none']	_	_
13	]	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	[	_	_	NN	O	[-1]	['none']	_	_
16	2	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Macrophage	_	_	NN	O	[-1]	['none']	_	_
2	colony	_	_	NN	O	[-1]	['none']	_	_
3	stimulating	_	_	NN	O	[-1]	['none']	_	_
4	factor	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	M-CSF	_	_	NN	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	stimulates	_	_	VBZ	O	[-1]	['none']	_	_
9	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
10	phagocyte	_	_	NN	O	[-1]	['none']	_	_
11	survival	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	differentiation	_	_	NN	O	[-1]	['none']	_	_
14	[	_	_	CD	O	[-1]	['none']	_	_
15	3	_	_	CD	O	[-1]	['none']	_	_
16	]	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Importantly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	M-CSF-mediated	_	_	JJ	O	[-1]	['none']	_	_
4	cell	_	_	NN	O	[-1]	['none']	_	_
5	survival	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	associated	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	variety	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	human	_	_	NN	O	[-1]	['none']	_	_
15	diseases	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	including	_	_	VBG	O	[-1]	['none']	_	_
18	atherosclerosis	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	transplant	_	_	NN	O	[-1]	['none']	_	_
21	vascular	_	_	JJ	O	[-1]	['none']	_	_
22	sclerosis	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	breast	_	_	NN	O	[-1]	['none']	_	_
25	cancer	_	_	NN	O	[-1]	['none']	_	_
26	metastasis	_	_	NN	O	[-1]	['none']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	4	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	[	_	_	CD	O	[-1]	['none']	_	_
32	5	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	[	_	_	CD	O	[-1]	['none']	_	_
36	6	_	_	CD	O	[-1]	['none']	_	_
37	]	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	previously	_	_	RB	O	[-1]	['none']	_	_
3	identified	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	activation	_	_	NN	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	important	_	_	JJ	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
11	monocyte	_	_	NN	O	[-1]	['none']	_	_
12	survival	_	_	NN	O	[-1]	['none']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	7	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	its	_	_	PRP$	O	[-1]	['none']	_	_
5	role	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
8	phagocyte	_	_	NN	O	[-1]	['none']	_	_
9	survival	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	transcription	_	_	NN	O	[-1]	['none']	_	_
13	factor	_	_	NN	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	regulates	_	_	VBZ	O	[-1]	['none']	_	_
16	numerous	_	_	JJ	O	[-1]	['none']	_	_
17	genes	_	_	NNS	O	[-1]	['none']	_	_
18	that	_	_	WDT	O	[-1]	['none']	_	_
19	play	_	_	VBP	O	[-1]	['none']	_	_
20	important	_	_	JJ	O	[-1]	['none']	_	_
21	roles	_	_	NNS	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	cellular	_	_	JJ	O	[-1]	['none']	_	_
24	signaling	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	stress	_	_	NN	O	[-1]	['none']	_	_
27	response	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	cell	_	_	NN	O	[-1]	['none']	_	_
30	growth	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	survival	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	differentiation	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	inflammation	_	_	NN	O	[-1]	['none']	_	_
37	[	_	_	CD	O	[-1]	['none']	_	_
38	8	_	_	CD	O	[-1]	['none']	_	_
39	]	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	There	_	_	EX	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	five	_	_	CD	O	[-1]	['none']	_	_
4	members	_	_	NNS	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	family	_	_	NN	O	[-1]	['none']	_	_
9	:	_	_	:	O	[-1]	['none']	_	_
10	RelA	_	_	NN	Protein	[0]	['root']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	p65	_	_	NN	Protein	[0]	['root']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	p50	_	_	NN	Protein	[0]	['root']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	p52	_	_	NN	Protein	[0]	['root']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	c-Rel	_	_	NN	Protein	[0]	['root']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	RelB	_	_	NN	Protein	[0]	['root']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	most	_	_	RBS	O	[-1]	['none']	_	_
3	common	_	_	JJ	O	[-1]	['none']	_	_
4	activating	_	_	VBG	O	[-1]	['none']	_	_
5	complex	_	_	NN	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	p50	_	_	NN	Protein	[0]	['root']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[0]	['root']	_	_
11	heterodimer	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	driven	_	_	VBN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	activation	_	_	NN	O	[-1]	['none']	_	_
17	domain	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	p65	_	_	NN	Protein	[0]	['root']	_	_
22	subunit	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	p65	_	_	NN	Protein	[0]	['root']	_	_
3	regulates	_	_	VBZ	O	[-1]	['none']	_	_
4	important	_	_	JJ	O	[-1]	['none']	_	_
5	developmental	_	_	JJ	O	[-1]	['none']	_	_
6	processes	_	_	NNS	O	[-1]	['none']	_	_
7	[	_	_	VBP	O	[-1]	['none']	_	_
8	9	_	_	CD	O	[-1]	['none']	_	_
9	]	_	_	CD	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	[	_	_	CD	O	[-1]	['none']	_	_
12	10	_	_	CD	O	[-1]	['none']	_	_
13	]	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Mice	_	_	NNS	O	[-1]	['none']	_	_
2	lacking	_	_	VBG	Negative_regulation	[0]	['root']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	p65	_	_	NN	Protein	[2]	['Theme']	_	_
5	die	_	_	VB	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	utero	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	have	_	_	VBP	O	[-1]	['none']	_	_
10	extensive	_	_	JJ	O	[-1]	['none']	_	_
11	liver	_	_	NN	O	[-1]	['none']	_	_
12	damage	_	_	NN	O	[-1]	['none']	_	_
13	via	_	_	IN	O	[-1]	['none']	_	_
14	enhanced	_	_	VBN	O	[-1]	['none']	_	_
15	apoptosis	_	_	NN	O	[-1]	['none']	_	_
16	[	_	_	CD	O	[-1]	['none']	_	_
17	9	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Embryonic	_	_	JJ	O	[-1]	['none']	_	_
2	macrophages	_	_	NNS	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	p65	_	_	NN	Protein	[6]	['Theme']	_	_
6	null	_	_	JJ	Negative_regulation	[0]	['root']	_	_
7	mice	_	_	NNS	O	[-1]	['none']	_	_
8	are	_	_	VBP	O	[-1]	['none']	_	_
9	susceptible	_	_	JJ	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
12	induced	_	_	VBD	O	[-1]	['none']	_	_
13	apoptosis	_	_	NN	O	[-1]	['none']	_	_
14	which	_	_	WDT	O	[-1]	['none']	_	_
15	is	_	_	VBZ	O	[-1]	['none']	_	_
16	rescued	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	overexpressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	p65	_	_	NN	Protein	[18]	['Theme']	_	_
22	subunit	_	_	NN	O	[-1]	['none']	_	_
23	[	_	_	CD	O	[-1]	['none']	_	_
24	10	_	_	CD	O	[-1]	['none']	_	_
25	]	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Moreover	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	inhibiting	_	_	VBG	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	induces	_	_	VBZ	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	death	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	many	_	_	JJ	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	types	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	cytokine	_	_	NN	O	[-1]	['none']	_	_
14	independent	_	_	JJ	O	[-1]	['none']	_	_
15	survival	_	_	NN	O	[-1]	['none']	_	_
16	is	_	_	VBZ	O	[-1]	['none']	_	_
17	mediated	_	_	VBN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	constitutively	_	_	RB	O	[-1]	['none']	_	_
20	active	_	_	JJ	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	murine	_	_	JJ	O	[-1]	['none']	_	_
24	macrophages	_	_	NNS	O	[-1]	['none']	_	_
25	[	_	_	VBP	O	[-1]	['none']	_	_
26	11	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	CD	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	monocytes	_	_	NNS	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	macrophages	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	important	_	_	JJ	O	[-1]	['none']	_	_
10	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
11	factor	_	_	NN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	expression	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	cytokines	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	cell	_	_	NN	O	[-1]	['none']	_	_
18	surface	_	_	NN	O	[-1]	['none']	_	_
19	receptors	_	_	NNS	O	[-1]	['none']	_	_
20	[	_	_	VBP	O	[-1]	['none']	_	_
21	12	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	CD	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	unlike	_	_	IN	O	[-1]	['none']	_	_
4	resting	_	_	VBG	O	[-1]	['none']	_	_
5	T-cells	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	constitutively	_	_	RB	O	[-1]	['none']	_	_
10	present	_	_	JJ	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	nuclei	_	_	NNS	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	primary	_	_	JJ	O	[-1]	['none']	_	_
16	monocytes	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	monocytic	_	_	JJ	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	lines	_	_	NNS	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	absence	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	exogenous	_	_	JJ	O	[-1]	['none']	_	_
26	stimuli	_	_	NNS	O	[-1]	['none']	_	_
27	as	_	_	IN	O	[-1]	['none']	_	_
28	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
29	by	_	_	IN	O	[-1]	['none']	_	_
30	mobility	_	_	NN	O	[-1]	['none']	_	_
31	shift	_	_	NN	O	[-1]	['none']	_	_
32	analysis	_	_	NN	O	[-1]	['none']	_	_
33	[	_	_	CD	O	[-1]	['none']	_	_
34	13	_	_	CD	O	[-1]	['none']	_	_
35	]	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Similarly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	constitutively	_	_	RB	O	[-1]	['none']	_	_
4	active	_	_	JJ	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	observed	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	human	_	_	NN	O	[-1]	['none']	_	_
10	alveolar	_	_	JJ	O	[-1]	['none']	_	_
11	macrophages	_	_	NNS	O	[-1]	['none']	_	_
12	[	_	_	VBP	O	[-1]	['none']	_	_
13	14	_	_	CD	O	[-1]	['none']	_	_
14	]	_	_	CD	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	classic	_	_	JJ	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	canonical	_	_	JJ	O	[-1]	['none']	_	_
6	pathway	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p50	_	_	NN	Protein	[0]	['root']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	p65	_	_	NN	Protein	[0]	['root']	_	_
13	complex	_	_	NN	O	[-1]	['none']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	sequestered	_	_	VBN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	cytosol	_	_	NN	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	15	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Upon	_	_	IN	Positive_regulation	[0]	['root']	_	_
2	stimulation	_	_	NN	O	[-1]	['none']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	cytokines	_	_	NNS	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	UV	_	_	NN	O	[-1]	['none']	_	_
7	radiation	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	IkappaBalpha	_	_	NN	Protein	[11, 16]	['Theme', 'Theme']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	phosphorylated	_	_	VBN	Phosphorylation	[1]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	ubiquitinated	_	_	VBN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	degraded	_	_	VBN	Protein_catabolism	[1]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	releasing	_	_	VBG	O	[-1]	['none']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	p50	_	_	NN	Protein	[0]	['root']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	p65	_	_	NN	Protein	[0]	['root']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	translocate	_	_	VB	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	nucleus	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	transactivate	_	_	VB	O	[-1]	['none']	_	_
30	target	_	_	NN	O	[-1]	['none']	_	_
31	genes	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
3	release	_	_	NN	Localization	[0]	['root']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[3, 12]	['Theme', 'Theme']	_	_
9	can	_	_	MD	O	[-1]	['none']	_	_
10	undergo	_	_	VB	O	[-1]	['none']	_	_
11	post-translational	_	_	JJ	Protein_modification	[12]	['multitoken']	_	_
12	modification	_	_	NN	Protein_modification	[0]	['root']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	activate	_	_	VB	O	[-1]	['none']	_	_
15	gene	_	_	NN	O	[-1]	['none']	_	_
16	transcription	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	role	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	p65	_	_	NN	Protein	[6]	['Theme']	_	_
6	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
7	on	_	_	IN	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
10	activity	_	_	NN	O	[-1]	['none']	_	_
11	varies	_	_	VBZ	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	stimulus	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	time	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	stimulation	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	type	_	_	NN	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	16	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Previous	_	_	JJ	O	[-1]	['none']	_	_
2	research	_	_	NN	O	[-1]	['none']	_	_
3	shows	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[5]	['Theme']	_	_
9	at	_	_	IN	O	[-1]	['none']	_	_
10	Ser276	_	_	NN	Entity	[5]	['Site']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	Ser529	_	_	NN	Entity	[5]	['Site']	_	_
13	or	_	_	CC	O	[-1]	['none']	_	_
14	Ser536	_	_	NN	Entity	[5]	['Site']	_	_
15	plays	_	_	VBZ	O	[-1]	['none']	_	_
16	an	_	_	DT	O	[-1]	['none']	_	_
17	important	_	_	JJ	O	[-1]	['none']	_	_
18	role	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	regulating	_	_	VBG	O	[-1]	['none']	_	_
21	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
22	activity	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	17	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	TNFalpha	_	_	NN	O	[-1]	['none']	_	_
3	treated	_	_	JJ	O	[-1]	['none']	_	_
4	murine	_	_	JJ	O	[-1]	['none']	_	_
5	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	Ser276	_	_	NN	Entity	[12]	['Site']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[12]	['Theme']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	MSK1	_	_	NN	Protein	[12]	['Cause']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	enhance	_	_	VB	O	[-1]	['none']	_	_
17	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
18	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
19	activity	_	_	NN	O	[-1]	['none']	_	_
20	[	_	_	CD	O	[-1]	['none']	_	_
21	18	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	macrophages	_	_	NNS	O	[-1]	['none']	_	_
3	treated	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	endotoxin	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	transcription	_	_	NN	O	[-1]	['none']	_	_
9	activity	_	_	NN	O	[-1]	['none']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	associated	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	phosphorylation	_	_	NN	Phosphorylation	[20]	['Theme']	_	_
14	on	_	_	IN	O	[-1]	['none']	_	_
15	Ser276	_	_	NN	Entity	[13]	['Site']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	Ser536	_	_	NN	Entity	[13]	['Site']	_	_
18	that	_	_	WDT	Anaphora	[0]	['root']	_	_
19	is	_	_	VBZ	O	[-1]	['none']	_	_
20	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
21	through	_	_	IN	O	[-1]	['none']	_	_
22	protein	_	_	NN	O	[-1]	['none']	_	_
23	kinase	_	_	NN	O	[-1]	['none']	_	_
24	A	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	PKA	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	IKKbeta	_	_	NN	Protein	[20]	['Cause']	_	_
30	respectively	_	_	RB	O	[-1]	['none']	_	_
31	[	_	_	CD	O	[-1]	['none']	_	_
32	16	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	[	_	_	CD	O	[-1]	['none']	_	_
36	19	_	_	CD	O	[-1]	['none']	_	_
37	]	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	human	_	_	NN	O	[-1]	['none']	_	_
3	T	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	p65	_	_	NN	Protein	[10]	['Theme']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	constitutively	_	_	RB	O	[-1]	['none']	_	_
10	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	Ser536	_	_	NN	Entity	[10]	['Site']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	facilitate	_	_	VB	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	p65	_	_	NN	Protein	[18]	['Theme']	_	_
17	nuclear	_	_	JJ	Entity	[18]	['ToLoc']	_	_
18	translocation	_	_	NN	Localization	[0]	['root']	_	_
19	following	_	_	VBG	O	[-1]	['none']	_	_
20	cellular	_	_	JJ	O	[-1]	['none']	_	_
21	stimulation	_	_	NN	O	[-1]	['none']	_	_
22	[	_	_	CD	O	[-1]	['none']	_	_
23	20	_	_	CD	O	[-1]	['none']	_	_
24	]	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Accumulating	_	_	VBG	O	[-1]	['none']	_	_
2	evidence	_	_	NN	O	[-1]	['none']	_	_
3	reveals	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	p65	_	_	NN	Protein	[7]	['Theme']	_	_
7	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	Ser276	_	_	NN	Entity	[7]	['Site']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	crucial	_	_	JJ	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	its	_	_	PRP$	O	[-1]	['none']	_	_
14	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
15	activity	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Upon	_	_	IN	O	[-1]	['none']	_	_
2	nuclear	_	_	JJ	O	[-1]	['none']	_	_
3	translocation	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	phosphorylation	_	_	NN	Phosphorylation	[11]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Ser276	_	_	NN	Entity	[5]	['Site']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[5]	['Theme']	_	_
11	by	_	_	IN	Positive_regulation	[0]	['root']	_	_
12	PKA	_	_	NN	O	[-1]	['none']	_	_
13	recruits	_	_	VBZ	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	transcription	_	_	NN	O	[-1]	['none']	_	_
16	co-activator	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	p300	_	_	NN	Protein	[0]	['root']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	potentiate	_	_	VB	O	[-1]	['none']	_	_
21	NF-kappaB-regulated	_	_	JJ	O	[-1]	['none']	_	_
22	gene	_	_	NN	O	[-1]	['none']	_	_
23	transcription	_	_	NN	O	[-1]	['none']	_	_
24	[	_	_	NN	O	[-1]	['none']	_	_
25	21	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	other	_	_	JJ	O	[-1]	['none']	_	_
4	studies	_	_	NNS	O	[-1]	['none']	_	_
5	show	_	_	VBP	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	PKA	_	_	NN	O	[-1]	['none']	_	_
8	inhibits	_	_	VBZ	O	[-1]	['none']	_	_
9	NF-kappaB-regulated	_	_	JJ	O	[-1]	['none']	_	_
10	gene	_	_	NN	O	[-1]	['none']	_	_
11	expression	_	_	NN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	stabilizing	_	_	VBG	Positive_regulation	[0]	['root']	_	_
14	IkappaBalpha	_	_	NN	Protein	[13]	['Theme']	_	_
15	[	_	_	CD	O	[-1]	['none']	_	_
16	22	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	[	_	_	CD	O	[-1]	['none']	_	_
20	23	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	serine/threonine	_	_	NN	O	[-1]	['none']	_	_
5	kinase	_	_	NN	O	[-1]	['none']	_	_
6	Pim-1	_	_	NN	Protein	[8]	['Cause']	_	_
7	directly	_	_	RB	O	[-1]	['none']	_	_
8	phosphorylates	_	_	VBZ	Phosphorylation	[0]	['root']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[8]	['Theme']	_	_
11	at	_	_	IN	O	[-1]	['none']	_	_
12	Ser276	_	_	NN	Entity	[8]	['Site']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	stabilizing	_	_	VBG	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	prevent	_	_	VB	O	[-1]	['none']	_	_
17	ubiquitin-proteasome	_	_	JJ	O	[-1]	['none']	_	_
18	degradation	_	_	NN	O	[-1]	['none']	_	_
19	[	_	_	CD	O	[-1]	['none']	_	_
20	24	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Several	_	_	JJ	O	[-1]	['none']	_	_
2	other	_	_	JJ	O	[-1]	['none']	_	_
3	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
4	sites	_	_	NNS	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	also	_	_	RB	O	[-1]	['none']	_	_
7	described	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	enhance	_	_	VB	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	gene	_	_	NN	O	[-1]	['none']	_	_
12	transactivation	_	_	NN	O	[-1]	['none']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	25	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Here	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	investigate	_	_	VBP	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	role	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	protein	_	_	NN	O	[-1]	['none']	_	_
9	kinase	_	_	NN	O	[-1]	['none']	_	_
10	C	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	PKC	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	M-CSF-stimulated	_	_	JJ	O	[-1]	['none']	_	_
16	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
17	activation	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	PKC	_	_	NN	O	[-1]	['none']	_	_
2	proteins	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	multifunctional	_	_	JJ	O	[-1]	['none']	_	_
5	kinases	_	_	NNS	O	[-1]	['none']	_	_
6	that	_	_	WDT	O	[-1]	['none']	_	_
7	differ	_	_	VBP	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	structure	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	function	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	co-factor	_	_	NN	O	[-1]	['none']	_	_
14	requirement	_	_	NN	O	[-1]	['none']	_	_
15	[	_	_	CD	O	[-1]	['none']	_	_
16	26	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	PKCs	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	involved	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	diverse	_	_	JJ	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	responses	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	including	_	_	VBG	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	growth	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	survival	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	differentiation	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	development	_	_	NN	O	[-1]	['none']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	27	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	12	_	_	CD	O	[-1]	['none']	_	_
3	closely	_	_	RB	O	[-1]	['none']	_	_
4	related	_	_	JJ	O	[-1]	['none']	_	_
5	enzymes	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	PKC	_	_	NN	O	[-1]	['none']	_	_
9	family	_	_	NN	O	[-1]	['none']	_	_
10	are	_	_	VBP	O	[-1]	['none']	_	_
11	divided	_	_	VBN	O	[-1]	['none']	_	_
12	into	_	_	IN	O	[-1]	['none']	_	_
13	three	_	_	CD	O	[-1]	['none']	_	_
14	classes	_	_	NNS	O	[-1]	['none']	_	_
15	:	_	_	:	O	[-1]	['none']	_	_
16	conventional	_	_	JJ	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	cPKCs	_	_	NNS	O	[-1]	['none']	_	_
19	:	_	_	:	O	[-1]	['none']	_	_
20	alpha	_	_	NN	Protein	[0]	['root']	_	_
21	betaI	_	_	NN	Protein	[22]	['multitoken']	_	_
22	betaII	_	_	NN	Protein	[0]	['root']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	gamma	_	_	NN	Protein	[0]	['root']	_	_
25	require	_	_	VBP	O	[-1]	['none']	_	_
26	Ca2+	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	diacylglycerol	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	DAG	_	_	NN	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	;	_	_	:	O	[-1]	['none']	_	_
33	novel	_	_	JJ	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	nPKCs	_	_	NNS	O	[-1]	['none']	_	_
36	:	_	_	:	O	[-1]	['none']	_	_
37	delta	_	_	NN	Protein	[0]	['root']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	epsilon	_	_	NN	Protein	[0]	['root']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	eta	_	_	NN	Protein	[0]	['root']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	theta	_	_	NN	Protein	[0]	['root']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	mu	_	_	NN	Protein	[0]	['root']	_	_
46	)	_	_	-RRB-	O	[-1]	['none']	_	_
47	require	_	_	VBP	O	[-1]	['none']	_	_
48	DAG	_	_	NN	O	[-1]	['none']	_	_
49	;	_	_	:	O	[-1]	['none']	_	_
50	and	_	_	CC	O	[-1]	['none']	_	_
51	atypical	_	_	JJ	O	[-1]	['none']	_	_
52	(	_	_	-LRB-	O	[-1]	['none']	_	_
53	aPKCs	_	_	NNS	O	[-1]	['none']	_	_
54	:	_	_	:	O	[-1]	['none']	_	_
55	xi	_	_	NN	Protein	[0]	['root']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	iota	_	_	NN	Protein	[0]	['root']	_	_
58	and	_	_	CC	O	[-1]	['none']	_	_
59	lambda	_	_	NN	Protein	[0]	['root']	_	_
60	)	_	_	-RRB-	O	[-1]	['none']	_	_
61	require	_	_	VBP	O	[-1]	['none']	_	_
62	neither	_	_	CC	O	[-1]	['none']	_	_
63	Ca2+	_	_	NN	O	[-1]	['none']	_	_
64	nor	_	_	CC	O	[-1]	['none']	_	_
65	DAG	_	_	NN	O	[-1]	['none']	_	_
66	.	_	_	.	O	[-1]	['none']	_	_

1	Monocytes	_	_	NNS	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	macrophages	_	_	NNS	O	[-1]	['none']	_	_
4	predominantly	_	_	RB	O	[-1]	['none']	_	_
5	express	_	_	VBP	O	[-1]	['none']	_	_
6	conventional	_	_	JJ	O	[-1]	['none']	_	_
7	PKC	_	_	NN	O	[-1]	['none']	_	_
8	isoforms	_	_	NNS	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
11	PKCbetaI	_	_	NN	Protein	[0]	['root']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	PKCbetaII	_	_	NN	Protein	[0]	['root']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	novel	_	_	JJ	O	[-1]	['none']	_	_
17	PKCs	_	_	NNS	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	PKCdelta	_	_	NN	Protein	[0]	['root']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	PKCepsilon	_	_	NN	Protein	[0]	['root']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Conventional	_	_	JJ	O	[-1]	['none']	_	_
2	PKCs	_	_	NNS	O	[-1]	['none']	_	_
3	regulate	_	_	VBP	O	[-1]	['none']	_	_
4	differentiation	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	human	_	_	NN	O	[-1]	['none']	_	_
8	promyelocytic	_	_	JJ	O	[-1]	['none']	_	_
9	leukemia	_	_	NN	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	line	_	_	NN	O	[-1]	['none']	_	_
12	HL60	_	_	NN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	macrophages	_	_	NNS	O	[-1]	['none']	_	_
15	[	_	_	VBP	O	[-1]	['none']	_	_
16	28	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	CD	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	PKCalpha	_	_	NN	Protein	[2]	['Cause']	_	_
2	induces	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
3	IL-1alpha	_	_	NN	Protein	[9]	['Theme']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	iNOS	_	_	NN	Protein	[9]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	TNFalpha	_	_	NN	Protein	[9]	['Theme']	_	_
8	mRNA	_	_	NN	O	[-1]	['none']	_	_
9	production	_	_	NN	Transcription	[2]	['Theme']	_	_
10	after	_	_	IN	O	[-1]	['none']	_	_
11	lipopolysaccharide	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	LPS	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	exposure	_	_	NN	O	[-1]	['none']	_	_
16	[	_	_	CD	O	[-1]	['none']	_	_
17	29	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	accumulating	_	_	VBG	O	[-1]	['none']	_	_
5	evidence	_	_	NN	O	[-1]	['none']	_	_
6	suggests	_	_	VBZ	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	conventional	_	_	JJ	O	[-1]	['none']	_	_
9	PKCs	_	_	NNS	O	[-1]	['none']	_	_
10	like	_	_	IN	O	[-1]	['none']	_	_
11	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
12	have	_	_	VBP	O	[-1]	['none']	_	_
13	anti-apoptotic	_	_	JJ	O	[-1]	['none']	_	_
14	functions	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	example	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	PKCalpha	_	_	NN	Protein	[6]	['Theme']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	overexpressed	_	_	VBN	Positive_regulation	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	variety	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	tumor	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	including	_	_	VBG	O	[-1]	['none']	_	_
14	gliomas	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	liver	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	lung	_	_	NN	O	[-1]	['none']	_	_
20	[	_	_	CD	O	[-1]	['none']	_	_
21	30	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	31	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	epithelial	_	_	JJ	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	inhibition	_	_	NN	Negative_regulation	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	PKCalpha	_	_	NN	Protein	[5]	['Theme']	_	_
8	induces	_	_	VBZ	O	[-1]	['none']	_	_
9	PKCdelta	_	_	NN	Protein	[0]	['root']	_	_
10	dependent	_	_	JJ	O	[-1]	['none']	_	_
11	apoptosis	_	_	NN	O	[-1]	['none']	_	_
12	[	_	_	NN	O	[-1]	['none']	_	_
13	31	_	_	CD	O	[-1]	['none']	_	_
14	]	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	human	_	_	NN	O	[-1]	['none']	_	_
5	monocytes	_	_	NNS	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	premonocytic	_	_	JJ	O	[-1]	['none']	_	_
8	THP-1	_	_	NN	O	[-1]	['none']	_	_
9	leukemia	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	novel	_	_	JJ	O	[-1]	['none']	_	_
13	PKCs	_	_	NNS	O	[-1]	['none']	_	_
14	like	_	_	IN	O	[-1]	['none']	_	_
15	PKCdelta	_	_	NN	Protein	[0]	['root']	_	_
16	have	_	_	VBP	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	opposite	_	_	JJ	O	[-1]	['none']	_	_
19	effect	_	_	NN	O	[-1]	['none']	_	_
20	on	_	_	IN	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	survival	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	Voss	_	_	NNP	O	[-1]	['none']	_	_
25	et	_	_	FW	O	[-1]	['none']	_	_
26	al	_	_	FW	O	[-1]	['none']	_	_
27	showed	_	_	VBD	O	[-1]	['none']	_	_
28	that	_	_	IN	O	[-1]	['none']	_	_
29	PKCdelta	_	_	NN	Protein	[31]	['Cause']	_	_
30	directly	_	_	RB	O	[-1]	['none']	_	_
31	phosphorylates	_	_	VBZ	Phosphorylation	[0]	['root']	_	_
32	caspase-3	_	_	NN	Protein	[31]	['Theme']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	promotes	_	_	VBZ	O	[-1]	['none']	_	_
35	etoposide	_	_	NN	O	[-1]	['none']	_	_
36	induced	_	_	JJ	O	[-1]	['none']	_	_
37	apoptosis	_	_	NN	O	[-1]	['none']	_	_
38	[	_	_	NN	O	[-1]	['none']	_	_
39	32	_	_	CD	O	[-1]	['none']	_	_
40	]	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Moreover	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	knockout	_	_	JJ	O	[-1]	['none']	_	_
4	mouse	_	_	NN	O	[-1]	['none']	_	_
5	studies	_	_	NNS	O	[-1]	['none']	_	_
6	suggest	_	_	VBP	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	another	_	_	DT	O	[-1]	['none']	_	_
9	novel	_	_	JJ	O	[-1]	['none']	_	_
10	PKC	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	PKCepsilon	_	_	NN	Protein	[0]	['root']	_	_
13	is	_	_	VBZ	O	[-1]	['none']	_	_
14	critically	_	_	RB	O	[-1]	['none']	_	_
15	involved	_	_	VBN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	early	_	_	JJ	O	[-1]	['none']	_	_
18	LPS	_	_	NN	O	[-1]	['none']	_	_
19	mediated	_	_	VBN	O	[-1]	['none']	_	_
20	signaling	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	activated	_	_	VBN	O	[-1]	['none']	_	_
23	macrophages	_	_	NNS	O	[-1]	['none']	_	_
24	[	_	_	VBP	O	[-1]	['none']	_	_
25	33	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	CD	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Previously	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	reported	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	M-CSF	_	_	NN	O	[-1]	['none']	_	_
7	promotes	_	_	VBZ	O	[-1]	['none']	_	_
8	monocyte	_	_	NN	O	[-1]	['none']	_	_
9	survival	_	_	NN	O	[-1]	['none']	_	_
10	through	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	activation	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	PI3-K	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	AKT	_	_	NN	O	[-1]	['none']	_	_
18	pathway	_	_	NN	O	[-1]	['none']	_	_
19	[	_	_	CD	O	[-1]	['none']	_	_
20	3	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	AKT	_	_	NN	O	[-1]	['none']	_	_
5	activation	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	M-CSF	_	_	NN	O	[-1]	['none']	_	_
8	stimulates	_	_	VBZ	O	[-1]	['none']	_	_
9	PKC	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	human	_	_	NN	O	[-1]	['none']	_	_
12	monocytes	_	_	NNS	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	increases	_	_	VBZ	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	DNA	_	_	NN	O	[-1]	['none']	_	_
17	binding	_	_	NN	O	[-1]	['none']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	34	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	PKC	_	_	NN	O	[-1]	['none']	_	_
5	and/or	_	_	CC	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	critical	_	_	JJ	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	M-CSF-stimulated	_	_	JJ	O	[-1]	['none']	_	_
12	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
13	phagocyte	_	_	NN	O	[-1]	['none']	_	_
14	survival	_	_	NN	O	[-1]	['none']	_	_
15	and/or	_	_	CC	O	[-1]	['none']	_	_
16	differentiation	_	_	NN	O	[-1]	['none']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	unclear	_	_	JJ	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	other	_	_	JJ	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	PKC	_	_	NN	O	[-1]	['none']	_	_
6	plays	_	_	VBZ	O	[-1]	['none']	_	_
7	an	_	_	DT	O	[-1]	['none']	_	_
8	important	_	_	JJ	O	[-1]	['none']	_	_
9	role	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	activation	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	cell	_	_	NN	O	[-1]	['none']	_	_
15	survival	_	_	NN	O	[-1]	['none']	_	_
16	[	_	_	CD	O	[-1]	['none']	_	_
17	35	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	however	_	_	RB	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	specific	_	_	JJ	O	[-1]	['none']	_	_
23	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	this	_	_	DT	O	[-1]	['none']	_	_
26	activation	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	biological	_	_	JJ	O	[-1]	['none']	_	_
30	effects	_	_	NNS	O	[-1]	['none']	_	_
31	on	_	_	IN	O	[-1]	['none']	_	_
32	cellular	_	_	JJ	O	[-1]	['none']	_	_
33	phenotype	_	_	NN	O	[-1]	['none']	_	_
34	are	_	_	VBP	O	[-1]	['none']	_	_
35	not	_	_	RB	O	[-1]	['none']	_	_
36	known	_	_	VBN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	focused	_	_	VBD	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	understanding	_	_	VBG	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	role	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	PKC	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	regulation	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	activation	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
19	monocyte	_	_	NN	O	[-1]	['none']	_	_
20	survival	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Here	_	_	RB	O	[-1]	['none']	_	_
2	we	_	_	PRP	O	[-1]	['none']	_	_
3	demonstrates	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	M-CSF	_	_	NN	O	[-1]	['none']	_	_
6	upregulated	_	_	VBD	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	transcription	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	cell	_	_	NN	O	[-1]	['none']	_	_
12	survival	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	human	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	mouse	_	_	NN	O	[-1]	['none']	_	_
17	macrophages	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	activity	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	reduced	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	conventional	_	_	JJ	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	but	_	_	CC	O	[-1]	['none']	_	_
10	not	_	_	RB	O	[-1]	['none']	_	_
11	novel	_	_	JJ	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	PKC	_	_	NN	O	[-1]	['none']	_	_
14	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	dominant	_	_	JJ	Protein	[18]	['multitoken']	_	_
17	negative	_	_	JJ	Protein	[18]	['multitoken']	_	_
18	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
19	constructs	_	_	NNS	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	PKCalpha	_	_	NN	Protein	[22]	['multitoken']	_	_
22	siRNA	_	_	NN	Protein	[0]	['root']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Conventional	_	_	JJ	O	[-1]	['none']	_	_
2	PKC	_	_	NN	O	[-1]	['none']	_	_
3	regulated	_	_	VBN	Regulation	[17]	['Theme']	_	_
4	NF-kappaB-regulated	_	_	JJ	O	[-1]	['none']	_	_
5	gene	_	_	NN	O	[-1]	['none']	_	_
6	expression	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	phosphorylation	_	_	NN	Phosphorylation	[3]	['Theme']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Ser276	_	_	NN	Entity	[8]	['Site']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	p65	_	_	NN	Protein	[8]	['Theme']	_	_
14	occurred	_	_	VBD	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	an	_	_	DT	O	[-1]	['none']	_	_
17	M-CSF-dependent	_	_	JJ	Regulation	[0]	['root']	_	_
18	fashion	_	_	NN	O	[-1]	['none']	_	_
19	correlating	_	_	VBG	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	its	_	_	PRP$	O	[-1]	['none']	_	_
22	maximal	_	_	JJ	O	[-1]	['none']	_	_
23	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
24	activity	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	PKCalpha	_	_	NN	O	[-1]	['none']	_	_
4	regulated	_	_	VBD	Regulation	[0]	['root']	_	_
5	phosphorylation	_	_	NN	Phosphorylation	[4]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Ser276	_	_	NN	Entity	[5]	['Site']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[5]	['Theme']	_	_
11	plays	_	_	VBZ	O	[-1]	['none']	_	_
12	an	_	_	DT	O	[-1]	['none']	_	_
13	important	_	_	JJ	O	[-1]	['none']	_	_
14	role	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	regulating	_	_	VBG	O	[-1]	['none']	_	_
17	its	_	_	PRP$	O	[-1]	['none']	_	_
18	activity	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
21	phagocytes	_	_	NNS	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	murine	_	_	JJ	O	[-1]	['none']	_	_
24	embryonic	_	_	JJ	O	[-1]	['none']	_	_
25	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Increase	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	IRF-4	_	_	NN	Protein	[4]	['Theme']	_	_
4	expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	hematopoietic	_	_	JJ	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	after	_	_	IN	O	[-1]	['none']	_	_
9	demethylating	_	_	VBG	O	[-1]	['none']	_	_
10	treatment	_	_	NN	O	[-1]	['none']	_	_
11	We	_	_	PRP	O	[-1]	['none']	_	_
12	next	_	_	IN	O	[-1]	['none']	_	_
13	analyzed	_	_	VBN	O	[-1]	['none']	_	_
14	whether	_	_	IN	O	[-1]	['none']	_	_
15	promoter	_	_	NN	O	[-1]	['none']	_	_
16	methylation	_	_	NN	O	[-1]	['none']	_	_
17	could	_	_	MD	O	[-1]	['none']	_	_
18	be	_	_	VB	O	[-1]	['none']	_	_
19	responsible	_	_	JJ	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	down-regulation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IRF-4	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	region	_	_	NN	O	[-1]	['none']	_	_
3	including	_	_	VBG	O	[-1]	['none']	_	_
4	exon1	_	_	NN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
8	promoter	_	_	NN	O	[-1]	['none']	_	_
9	exhibited	_	_	VBD	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	large	_	_	JJ	O	[-1]	['none']	_	_
12	number	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	CpG	_	_	NN	O	[-1]	['none']	_	_
15	rich	_	_	JJ	O	[-1]	['none']	_	_
16	sequences	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Several	_	_	JJ	O	[-1]	['none']	_	_
2	chemical	_	_	NN	O	[-1]	['none']	_	_
3	substances	_	_	NNS	O	[-1]	['none']	_	_
4	such	_	_	JJ	O	[-1]	['none']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	5-aza-2-deoxycytidine	_	_	JJ	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	AzadC	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	5-azacytidine	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	AzaC	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	inhibit	_	_	VBP	O	[-1]	['none']	_	_
16	de	_	_	FW	O	[-1]	['none']	_	_
17	novo	_	_	FW	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	maintenance	_	_	NN	O	[-1]	['none']	_	_
20	methylation	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	thus	_	_	RB	O	[-1]	['none']	_	_
24	can	_	_	MD	O	[-1]	['none']	_	_
25	be	_	_	VB	O	[-1]	['none']	_	_
26	used	_	_	VBN	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	discern	_	_	VB	O	[-1]	['none']	_	_
29	promoter	_	_	NN	O	[-1]	['none']	_	_
30	methylation	_	_	NN	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	32,33	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	used	_	_	VBD	O	[-1]	['none']	_	_
3	AzadC	_	_	NN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	generate	_	_	VB	O	[-1]	['none']	_	_
6	unmethylated	_	_	JJ	O	[-1]	['none']	_	_
7	DNA	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	72	_	_	CD	O	[-1]	['none']	_	_
3	h	_	_	NN	O	[-1]	['none']	_	_
4	AzadC-treatment	_	_	NN	O	[-1]	['none']	_	_
5	resulted	_	_	VBD	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	concentration	_	_	NN	O	[-1]	['none']	_	_
9	dependent	_	_	JJ	O	[-1]	['none']	_	_
10	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	IRF-4	_	_	NN	Protein	[13]	['Theme']	_	_
13	transcription	_	_	NN	Transcription	[10]	['Theme']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	Jurkat	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	CML-T1	_	_	NN	O	[-1]	['none']	_	_
18	T-cells	_	_	NNS	O	[-1]	['none']	_	_
19	as	_	_	RB	O	[-1]	['none']	_	_
20	well	_	_	RB	O	[-1]	['none']	_	_
21	as	_	_	IN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	U-937	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	K-562	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	EM-2	_	_	NN	O	[-1]	['none']	_	_
28	cell	_	_	NN	O	[-1]	['none']	_	_
29	lines	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	IRF-4	_	_	NNP	Protein	[2]	['Theme']	_	_
2	transcription	_	_	NN	Transcription	[4, 23]	['Theme', 'Theme']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	time	_	_	NN	O	[-1]	['none']	_	_
8	dependent	_	_	JJ	O	[-1]	['none']	_	_
9	manner	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	observed	_	_	VBN	O	[-1]	['none']	_	_
13	as	_	_	RB	O	[-1]	['none']	_	_
14	early	_	_	RB	O	[-1]	['none']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	24	_	_	CD	O	[-1]	['none']	_	_
17	h	_	_	NN	O	[-1]	['none']	_	_
18	after	_	_	IN	O	[-1]	['none']	_	_
19	treatment	_	_	NN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	AzadC	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
24	over	_	_	IN	O	[-1]	['none']	_	_
25	time	_	_	NN	O	[-1]	['none']	_	_
26	until	_	_	IN	O	[-1]	['none']	_	_
27	72	_	_	CD	O	[-1]	['none']	_	_
28	h	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Time	_	_	NNP	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	strength	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	appearance	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	IRF-4	_	_	NN	Protein	[9]	['Theme']	_	_
9	transcripts	_	_	NNS	Transcription	[0]	['root']	_	_
10	varied	_	_	VBD	O	[-1]	['none']	_	_
11	among	_	_	IN	O	[-1]	['none']	_	_
12	cell	_	_	NN	O	[-1]	['none']	_	_
13	lines	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	i.e.	_	_	FW	O	[-1]	['none']	_	_
16	CML-T1	_	_	NN	O	[-1]	['none']	_	_
17	responded	_	_	VBD	O	[-1]	['none']	_	_
18	strongest	_	_	JJS	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	AzadC-treatment	_	_	NNP	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	data	_	_	NNS	O	[-1]	['none']	_	_
23	not	_	_	RB	O	[-1]	['none']	_	_
24	shown	_	_	VBN	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	line	_	_	NN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	this	_	_	DT	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	AzadC-treatment	_	_	NNP	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	CML-T1	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	LAMA-84	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	also	_	_	RB	O	[-1]	['none']	_	_
13	translated	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	an	_	_	DT	O	[-1]	['none']	_	_
16	induction	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
19	protein	_	_	NN	O	[-1]	['none']	_	_
20	expression	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Accordingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	treatment	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
7	cell	_	_	NN	O	[-1]	['none']	_	_
8	line	_	_	NN	O	[-1]	['none']	_	_
9	BV-173	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	SD-1	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	RPMI-8226	_	_	NN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	AzadC	_	_	NN	O	[-1]	['none']	_	_
16	had	_	_	VBD	O	[-1]	['none']	_	_
17	no	_	_	DT	O	[-1]	['none']	_	_
18	effect	_	_	NN	Regulation	[0]	['root']	_	_
19	on	_	_	IN	O	[-1]	['none']	_	_
20	IRF-4	_	_	NN	Protein	[21]	['Theme']	_	_
21	expression	_	_	NN	Gene_expression	[18]	['Theme']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	There	_	_	EX	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	no	_	_	DT	O	[-1]	['none']	_	_
4	difference	_	_	NN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	effects	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	AzaC	_	_	NN	O	[-1]	['none']	_	_
10	versus	_	_	CC	O	[-1]	['none']	_	_
11	AzadC	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	both	_	_	DT	O	[-1]	['none']	_	_
15	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	IRF-4	_	_	NN	Protein	[19]	['Theme']	_	_
18	mRNA	_	_	NN	Transcription	[19]	['multitoken']	_	_
19	level	_	_	NN	Transcription	[15]	['Theme']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	CML-T1	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	as	_	_	RB	O	[-1]	['none']	_	_
24	well	_	_	RB	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	data	_	_	NNS	O	[-1]	['none']	_	_
27	not	_	_	RB	O	[-1]	['none']	_	_
28	shown	_	_	VBN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	implied	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	promoter	_	_	NN	O	[-1]	['none']	_	_
5	methylation	_	_	NN	O	[-1]	['none']	_	_
6	may	_	_	MD	O	[-1]	['none']	_	_
7	control	_	_	VB	Regulation	[0]	['root']	_	_
8	IRF-4	_	_	NN	Protein	[9]	['Theme']	_	_
9	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	but	_	_	CC	O	[-1]	['none']	_	_
12	an	_	_	DT	O	[-1]	['none']	_	_
13	alternative	_	_	JJ	O	[-1]	['none']	_	_
14	explanation	_	_	NN	O	[-1]	['none']	_	_
15	may	_	_	MD	O	[-1]	['none']	_	_
16	be	_	_	VB	O	[-1]	['none']	_	_
17	activation	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	positive	_	_	JJ	O	[-1]	['none']	_	_
20	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
21	regulators	_	_	NNS	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	AzadC	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	or	_	_	CC	O	[-1]	['none']	_	_
28	AzaC	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Cytokine	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	surface	_	_	NN	O	[-1]	['none']	_	_
4	marker	_	_	NN	O	[-1]	['none']	_	_
5	staining	_	_	NN	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	assess	_	_	VB	O	[-1]	['none']	_	_
3	cytokine	_	_	NN	O	[-1]	['none']	_	_
4	production	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	restimulated	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	10	_	_	CD	O	[-1]	['none']	_	_
11	nM	_	_	NN	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	+	_	_	CC	O	[-1]	['none']	_	_
14	1	_	_	CD	O	[-1]	['none']	_	_
15	muM	_	_	NN	O	[-1]	['none']	_	_
16	ionomycin	_	_	NN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	6	_	_	CD	O	[-1]	['none']	_	_
19	h	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	unless	_	_	IN	O	[-1]	['none']	_	_
22	indicated	_	_	VBN	O	[-1]	['none']	_	_
23	otherwise	_	_	RB	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	figures	_	_	NNS	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	intracellular	_	_	JJ	O	[-1]	['none']	_	_
31	cytokine	_	_	NN	O	[-1]	['none']	_	_
32	stains	_	_	NNS	O	[-1]	['none']	_	_
33	were	_	_	VBD	O	[-1]	['none']	_	_
34	performed	_	_	VBN	O	[-1]	['none']	_	_
35	as	_	_	IN	O	[-1]	['none']	_	_
36	previously	_	_	RB	O	[-1]	['none']	_	_
37	described	_	_	VBN	O	[-1]	['none']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	28	_	_	CD	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	detect	_	_	VB	O	[-1]	['none']	_	_
3	expression	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	surface	_	_	NN	O	[-1]	['none']	_	_
6	molecules	_	_	NNS	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	washed	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	PBS	_	_	NNP	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	resuspended	_	_	VBN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	FACS	_	_	NN	O	[-1]	['none']	_	_
17	wash	_	_	NN	O	[-1]	['none']	_	_
18	buffer	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	3	_	_	CD	O	[-1]	['none']	_	_
21	%	_	_	NN	O	[-1]	['none']	_	_
22	FBS	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	0.1	_	_	CD	O	[-1]	['none']	_	_
25	%	_	_	NN	O	[-1]	['none']	_	_
26	sodium	_	_	NN	O	[-1]	['none']	_	_
27	azide	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	30	_	_	CD	O	[-1]	['none']	_	_
30	mM	_	_	NN	O	[-1]	['none']	_	_
31	Hepes	_	_	NNS	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	1x	_	_	NN	O	[-1]	['none']	_	_
34	PBS	_	_	NNP	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	containing	_	_	VBG	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	antibodies	_	_	NNS	O	[-1]	['none']	_	_
39	indicated	_	_	VBD	O	[-1]	['none']	_	_
40	in	_	_	IN	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	figures	_	_	NNS	O	[-1]	['none']	_	_
43	at	_	_	IN	O	[-1]	['none']	_	_
44	previously	_	_	RB	O	[-1]	['none']	_	_
45	optimized	_	_	VBN	O	[-1]	['none']	_	_
46	concentrations	_	_	NNS	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	incubated	_	_	VBN	O	[-1]	['none']	_	_
49	for	_	_	IN	O	[-1]	['none']	_	_
50	15	_	_	CD	O	[-1]	['none']	_	_
51	min	_	_	NN	O	[-1]	['none']	_	_
52	at	_	_	IN	O	[-1]	['none']	_	_
53	room	_	_	NN	O	[-1]	['none']	_	_
54	temperature	_	_	NN	O	[-1]	['none']	_	_
55	(	_	_	-LRB-	O	[-1]	['none']	_	_
56	RT	_	_	NN	O	[-1]	['none']	_	_
57	)	_	_	-RRB-	O	[-1]	['none']	_	_
58	,	_	_	,	O	[-1]	['none']	_	_
59	washed	_	_	VBN	O	[-1]	['none']	_	_
60	,	_	_	,	O	[-1]	['none']	_	_
61	and	_	_	CC	O	[-1]	['none']	_	_
62	resuspended	_	_	VBN	O	[-1]	['none']	_	_
63	in	_	_	IN	O	[-1]	['none']	_	_
64	2	_	_	CD	O	[-1]	['none']	_	_
65	%	_	_	NN	O	[-1]	['none']	_	_
66	formaldehyde	_	_	NN	O	[-1]	['none']	_	_
67	fixative	_	_	JJ	O	[-1]	['none']	_	_
68	solution	_	_	NN	O	[-1]	['none']	_	_
69	before	_	_	IN	O	[-1]	['none']	_	_
70	acquisition	_	_	NN	O	[-1]	['none']	_	_
71	on	_	_	IN	O	[-1]	['none']	_	_
72	a	_	_	DT	O	[-1]	['none']	_	_
73	FACSCalibur	_	_	NN	O	[-1]	['none']	_	_
74	(	_	_	-LRB-	O	[-1]	['none']	_	_
75	BD	_	_	NN	O	[-1]	['none']	_	_
76	)	_	_	-RRB-	O	[-1]	['none']	_	_
77	.	_	_	.	O	[-1]	['none']	_	_

1	Flow	_	_	NN	O	[-1]	['none']	_	_
2	cytometric	_	_	JJ	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[7]	['Theme']	_	_
6	protein	_	_	NN	O	[-1]	['none']	_	_
7	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	Cryopreserved	_	_	VBN	O	[-1]	['none']	_	_
2	PBMCs	_	_	NNS	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	HAM	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	TSP	_	_	NN	O	[-1]	['none']	_	_
7	patients	_	_	NNS	O	[-1]	['none']	_	_
8	or	_	_	CC	O	[-1]	['none']	_	_
9	HTLV-I-infected	_	_	JJ	O	[-1]	['none']	_	_
10	ACs	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	thawed	_	_	VBN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	washed	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	FACS	_	_	NN	O	[-1]	['none']	_	_
17	buffer	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	1x	_	_	NN	O	[-1]	['none']	_	_
20	PBS	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	0.1	_	_	CD	O	[-1]	['none']	_	_
23	%	_	_	NN	O	[-1]	['none']	_	_
24	NaN3	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	5	_	_	CD	O	[-1]	['none']	_	_
27	%	_	_	NN	O	[-1]	['none']	_	_
28	FBS	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	1.5	_	_	CD	O	[-1]	['none']	_	_
4	x	_	_	CC	O	[-1]	['none']	_	_
5	106	_	_	CD	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	fixed	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	sequential	_	_	JJ	O	[-1]	['none']	_	_
11	formaldehyde	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	methanol	_	_	NN	O	[-1]	['none']	_	_
14	fixation	_	_	NN	O	[-1]	['none']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	follows	_	_	VBZ	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	carefully	_	_	RB	O	[-1]	['none']	_	_
4	resuspended	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	FACS	_	_	NN	O	[-1]	['none']	_	_
7	buffer	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	fixed	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	100	_	_	CD	O	[-1]	['none']	_	_
12	mul	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	reagent	_	_	NN	O	[-1]	['none']	_	_
15	A	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	Fix	_	_	VB	O	[-1]	['none']	_	_
18	&	_	_	CC	O	[-1]	['none']	_	_
19	Perm	_	_	NNP	O	[-1]	['none']	_	_
20	kit	_	_	NN	O	[-1]	['none']	_	_
21	;	_	_	:	O	[-1]	['none']	_	_
22	Caltag	_	_	NNP	O	[-1]	['none']	_	_
23	Laboratories	_	_	NNPS	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	Burlingame	_	_	NNP	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	California	_	_	NNP	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	United	_	_	NNP	O	[-1]	['none']	_	_
30	States	_	_	NNPS	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	at	_	_	IN	O	[-1]	['none']	_	_
33	room	_	_	NN	O	[-1]	['none']	_	_
34	temperature	_	_	NN	O	[-1]	['none']	_	_
35	for	_	_	IN	O	[-1]	['none']	_	_
36	3	_	_	CD	O	[-1]	['none']	_	_
37	min	_	_	NN	O	[-1]	['none']	_	_
38	followed	_	_	VBN	O	[-1]	['none']	_	_
39	by	_	_	IN	O	[-1]	['none']	_	_
40	2	_	_	CD	O	[-1]	['none']	_	_
41	ml	_	_	NN	O	[-1]	['none']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	70	_	_	CD	O	[-1]	['none']	_	_
44	%	_	_	NN	O	[-1]	['none']	_	_
45	methanol	_	_	NN	O	[-1]	['none']	_	_
46	for	_	_	IN	O	[-1]	['none']	_	_
47	5	_	_	CD	O	[-1]	['none']	_	_
48	min	_	_	NN	O	[-1]	['none']	_	_
49	at	_	_	IN	O	[-1]	['none']	_	_
50	4	_	_	CD	O	[-1]	['none']	_	_
51	degreesC	_	_	NN	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	washed	_	_	VBN	O	[-1]	['none']	_	_
4	twice	_	_	RB	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	permeabilized	_	_	JJ	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	100	_	_	CD	O	[-1]	['none']	_	_
9	mul	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	reagent	_	_	NN	O	[-1]	['none']	_	_
12	B	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Fix	_	_	VB	O	[-1]	['none']	_	_
15	&	_	_	CC	O	[-1]	['none']	_	_
16	Perm	_	_	NNP	O	[-1]	['none']	_	_
17	kit	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	stained	_	_	VBN	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	intracellular	_	_	JJ	O	[-1]	['none']	_	_
23	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	mouse	_	_	NN	O	[-1]	['none']	_	_
26	anti-human	_	_	JJ	O	[-1]	['none']	_	_
27	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
28	monoclonal	_	_	JJ	O	[-1]	['none']	_	_
29	antibody	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	0.5	_	_	CD	O	[-1]	['none']	_	_
32	mug	_	_	NN	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	ab22510	_	_	NN	O	[-1]	['none']	_	_
35	;	_	_	:	O	[-1]	['none']	_	_
36	Abcam	_	_	NNP	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	or	_	_	CC	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	appropriate	_	_	JJ	O	[-1]	['none']	_	_
41	isotype	_	_	NN	O	[-1]	['none']	_	_
42	control	_	_	NN	O	[-1]	['none']	_	_
43	for	_	_	IN	O	[-1]	['none']	_	_
44	30	_	_	CD	O	[-1]	['none']	_	_
45	min	_	_	NN	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	washed	_	_	VBN	O	[-1]	['none']	_	_
4	twice	_	_	RB	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	stained	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	Cy5	_	_	NN	O	[-1]	['none']	_	_
9	conjugated	_	_	VBN	O	[-1]	['none']	_	_
10	goat	_	_	NN	O	[-1]	['none']	_	_
11	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
12	immunoglobulin	_	_	NN	O	[-1]	['none']	_	_
13	F	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	ab	_	_	NN	O	[-1]	['none']	_	_
16	'	_	_	''	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	2	_	_	CD	O	[-1]	['none']	_	_
19	secondary	_	_	JJ	O	[-1]	['none']	_	_
20	antibody	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	Caltag	_	_	NNP	O	[-1]	['none']	_	_
23	Laboratories	_	_	NNPS	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	for	_	_	IN	O	[-1]	['none']	_	_
26	an	_	_	DT	O	[-1]	['none']	_	_
27	additional	_	_	JJ	O	[-1]	['none']	_	_
28	30	_	_	CD	O	[-1]	['none']	_	_
29	min	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	washed	_	_	VBN	O	[-1]	['none']	_	_
4	twice	_	_	RB	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	stained	_	_	VBN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	surface	_	_	NN	O	[-1]	['none']	_	_
9	CD4	_	_	NN	Protein	[10]	['Theme']	_	_
10	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	PE	_	_	NN	O	[-1]	['none']	_	_
13	labeled	_	_	VBN	O	[-1]	['none']	_	_
14	anti-CD4	_	_	JJ	Protein	[0]	['root']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	BD	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	CD25	_	_	NN	Protein	[20]	['Theme']	_	_
20	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	FITC	_	_	NN	O	[-1]	['none']	_	_
23	labeled	_	_	VBN	O	[-1]	['none']	_	_
24	anti-CD25	_	_	JJ	Protein	[0]	['root']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	BD	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	washed	_	_	VBN	O	[-1]	['none']	_	_
4	twice	_	_	RB	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	analyzed	_	_	VBN	O	[-1]	['none']	_	_
7	on	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	FACSCalibur	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	BD	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	FlowJo	_	_	NNP	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	Tree	_	_	NNP	O	[-1]	['none']	_	_
9	Star	_	_	NNP	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	Ashland	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	Oregon	_	_	NNP	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	United	_	_	NNP	O	[-1]	['none']	_	_
16	States	_	_	NNPS	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Absence	_	_	NN	Negative_regulation	[10]	['Theme']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	IRF-4	_	_	NN	Protein	[4]	['Theme']	_	_
4	expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	leukemia	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	not	_	_	RB	O	[-1]	['none']	_	_
10	due	_	_	JJ	Positive_regulation	[0]	['root']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	promoter	_	_	NN	O	[-1]	['none']	_	_
13	alterations	_	_	NNS	O	[-1]	['none']	_	_
14	We	_	_	PRP	O	[-1]	['none']	_	_
15	have	_	_	VBP	O	[-1]	['none']	_	_
16	previously	_	_	RB	O	[-1]	['none']	_	_
17	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	lack	_	_	NN	Negative_regulation	[0]	['root']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	IRF-4	_	_	NN	Protein	[22]	['Theme']	_	_
22	expression	_	_	NN	Gene_expression	[19]	['Theme']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	leukemia	_	_	NN	O	[-1]	['none']	_	_
25	patients	_	_	NNS	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	specifically	_	_	RB	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	CML	_	_	NN	O	[-1]	['none']	_	_
30	T-cells	_	_	NNS	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	3	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Here	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	absence	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	IRF-4	_	_	NN	Protein	[9]	['Theme']	_	_
9	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	various	_	_	JJ	O	[-1]	['none']	_	_
12	hematopoietic	_	_	JJ	O	[-1]	['none']	_	_
13	cell	_	_	NN	O	[-1]	['none']	_	_
14	lines	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	such	_	_	JJ	O	[-1]	['none']	_	_
17	as	_	_	IN	O	[-1]	['none']	_	_
18	Jurkat	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	T-cell	_	_	NN	O	[-1]	['none']	_	_
22	leukemia	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	CML-T1	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	a	_	_	DT	O	[-1]	['none']	_	_
27	bcr-abl-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
28	T-cell	_	_	NN	O	[-1]	['none']	_	_
29	line	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	K-562	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	bcr-abl-positve	_	_	JJ	Gene_expression	[0]	['root']	_	_
35	erythroleukemia	_	_	NN	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	U-937	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	a	_	_	DT	O	[-1]	['none']	_	_
40	monocytic	_	_	JJ	O	[-1]	['none']	_	_
41	leukemia	_	_	NN	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	EM-2	_	_	NN	O	[-1]	['none']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	LAMA-84	_	_	NN	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	bcr-abl-positve	_	_	JJ	Gene_expression	[0]	['root']	_	_
48	myeloid	_	_	JJ	O	[-1]	['none']	_	_
49	leukemia	_	_	NN	O	[-1]	['none']	_	_
50	,	_	_	,	O	[-1]	['none']	_	_
51	but	_	_	CC	O	[-1]	['none']	_	_
52	not	_	_	RB	O	[-1]	['none']	_	_
53	in	_	_	IN	O	[-1]	['none']	_	_
54	SD-1	_	_	NN	O	[-1]	['none']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	a	_	_	DT	O	[-1]	['none']	_	_
57	bcr-abl-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
58	acute	_	_	JJ	O	[-1]	['none']	_	_
59	lymphoblastic	_	_	JJ	O	[-1]	['none']	_	_
60	leukemia	_	_	NN	O	[-1]	['none']	_	_
61	(	_	_	-LRB-	O	[-1]	['none']	_	_
62	pre	_	_	JJ	O	[-1]	['none']	_	_
63	B-ALL	_	_	NN	O	[-1]	['none']	_	_
64	)	_	_	-RRB-	O	[-1]	['none']	_	_
65	,	_	_	,	O	[-1]	['none']	_	_
66	RPMI-8226	_	_	NN	O	[-1]	['none']	_	_
67	,	_	_	,	O	[-1]	['none']	_	_
68	a	_	_	DT	O	[-1]	['none']	_	_
69	multiple	_	_	JJ	O	[-1]	['none']	_	_
70	myeloma	_	_	NN	O	[-1]	['none']	_	_
71	and	_	_	CC	O	[-1]	['none']	_	_
72	BV-173	_	_	NN	O	[-1]	['none']	_	_
73	,	_	_	,	O	[-1]	['none']	_	_
74	a	_	_	DT	O	[-1]	['none']	_	_
75	bcr-abl-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
76	B-cell	_	_	NN	O	[-1]	['none']	_	_
77	line	_	_	NN	O	[-1]	['none']	_	_
78	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	sequencing	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
6	promoter	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	it	_	_	PRP	O	[-1]	['none']	_	_
9	could	_	_	MD	O	[-1]	['none']	_	_
10	be	_	_	VB	O	[-1]	['none']	_	_
11	excluded	_	_	VBN	O	[-1]	['none']	_	_
12	that	_	_	IN	O	[-1]	['none']	_	_
13	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IRF-4	_	_	NN	Protein	[16]	['Theme']	_	_
16	expression	_	_	NN	Gene_expression	[13]	['Theme']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	any	_	_	DT	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	above	_	_	JJ	O	[-1]	['none']	_	_
22	cell	_	_	NN	O	[-1]	['none']	_	_
23	lines	_	_	NNS	O	[-1]	['none']	_	_
24	was	_	_	VBD	O	[-1]	['none']	_	_
25	due	_	_	JJ	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	genetic	_	_	JJ	O	[-1]	['none']	_	_
28	aberrations	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	2	_	_	CD	O	[-1]	['none']	_	_
4	bp	_	_	NN	O	[-1]	['none']	_	_
5	changes	_	_	NNS	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	nucleotide	_	_	NN	O	[-1]	['none']	_	_
8	-1081	_	_	CD	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	T	_	_	NN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	C	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	-1068	_	_	CD	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	A	_	_	DT	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	C	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	could	_	_	MD	O	[-1]	['none']	_	_
21	be	_	_	VB	O	[-1]	['none']	_	_
22	detected	_	_	VBN	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	both	_	_	CC	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
27	BV-173	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
31	LAMA-84	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	EM-2	_	_	NN	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	K-562	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	position	_	_	NN	O	[-1]	['none']	_	_
3	-116	_	_	CD	O	[-1]	['none']	_	_
4	an	_	_	DT	O	[-1]	['none']	_	_
5	A	_	_	NN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	C	_	_	NN	O	[-1]	['none']	_	_
8	substitution	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	found	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	EM-2	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	K-562	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	CML-T1	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	whereas	_	_	IN	O	[-1]	['none']	_	_
19	Jurkat	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	BV-173	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	SD-1	_	_	NN	O	[-1]	['none']	_	_
24	exhibited	_	_	VBD	O	[-1]	['none']	_	_
25	a	_	_	DT	O	[-1]	['none']	_	_
26	mixed	_	_	JJ	O	[-1]	['none']	_	_
27	A/C	_	_	NN	O	[-1]	['none']	_	_
28	sequence	_	_	NN	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	U-937	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	LAMA-84	_	_	NN	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	RPMI-8226	_	_	NN	O	[-1]	['none']	_	_
35	no	_	_	DT	O	[-1]	['none']	_	_
36	substitution	_	_	NN	O	[-1]	['none']	_	_
37	at	_	_	IN	O	[-1]	['none']	_	_
38	all	_	_	DT	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Consequently	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	alterations	_	_	NNS	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	unlikely	_	_	JJ	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	affect	_	_	VB	Regulation	[0]	['root']	_	_
9	IRF-4	_	_	NN	Protein	[10]	['Theme']	_	_
10	expression	_	_	NN	Gene_expression	[8]	['Theme']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Generation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	BMDC	_	_	NNP	O	[-1]	['none']	_	_
4	BMDC	_	_	NNP	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	developed	_	_	VBN	O	[-1]	['none']	_	_
7	as	_	_	IN	O	[-1]	['none']	_	_
8	previously	_	_	RB	O	[-1]	['none']	_	_
9	reported	_	_	VBN	O	[-1]	['none']	_	_
10	[	_	_	NN	O	[-1]	['none']	_	_
11	54	_	_	CD	O	[-1]	['none']	_	_
12	]	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	[	_	_	CD	O	[-1]	['none']	_	_
15	55	_	_	CD	O	[-1]	['none']	_	_
16	]	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	collected	_	_	VBN	O	[-1]	['none']	_	_
4	after	_	_	IN	O	[-1]	['none']	_	_
5	10-12	_	_	CD	O	[-1]	['none']	_	_
6	days	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	culture	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	yield	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	2-3x107	_	_	JJ	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	mouse	_	_	NN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	80-95	_	_	CD	O	[-1]	['none']	_	_
11	%	_	_	NN	O	[-1]	['none']	_	_
12	BMDC	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	Promotes	_	_	VBZ	O	[-1]	['none']	_	_
3	Tumor	_	_	NN	O	[-1]	['none']	_	_
4	Growth	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Survival	_	_	NN	O	[-1]	['none']	_	_
7	through	_	_	IN	O	[-1]	['none']	_	_
8	Activation	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Akt	_	_	NN	Protein	[0]	['root']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	Stat3	_	_	NN	Protein	[0]	['root']	_	_
16	Pathways	_	_	NNS	O	[-1]	['none']	_	_
17	To	_	_	TO	O	[-1]	['none']	_	_
18	explore	_	_	VB	O	[-1]	['none']	_	_
19	which	_	_	WDT	O	[-1]	['none']	_	_
20	pathways	_	_	NNS	O	[-1]	['none']	_	_
21	were	_	_	VBD	O	[-1]	['none']	_	_
22	required	_	_	VBN	O	[-1]	['none']	_	_
23	for	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	enhanced	_	_	JJ	O	[-1]	['none']	_	_
26	growth	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	survival	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	LMP1	_	_	NN	Protein	[0]	['root']	_	_
31	induced	_	_	VBD	O	[-1]	['none']	_	_
32	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
35	from	_	_	IN	O	[-1]	['none']	_	_
36	wild-type	_	_	JJ	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	LMP1	_	_	NN	Protein	[0]	['root']	_	_
39	transgenic	_	_	JJ	O	[-1]	['none']	_	_
40	mice	_	_	NNS	O	[-1]	['none']	_	_
41	were	_	_	VBD	O	[-1]	['none']	_	_
42	cultured	_	_	VBN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	presence	_	_	NN	O	[-1]	['none']	_	_
46	of	_	_	IN	O	[-1]	['none']	_	_
47	inhibitors	_	_	NNS	Negative_regulation	[0]	['root']	_	_
48	for	_	_	IN	O	[-1]	['none']	_	_
49	Akt	_	_	NN	Protein	[47]	['Theme']	_	_
50	,	_	_	,	O	[-1]	['none']	_	_
51	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	Stat3	_	_	NN	Protein	[47]	['Theme']	_	_
54	,	_	_	,	O	[-1]	['none']	_	_
55	mTOR	_	_	NN	Protein	[47]	['Theme']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	or	_	_	CC	O	[-1]	['none']	_	_
58	MAPK	_	_	NN	O	[-1]	['none']	_	_
59	and	_	_	CC	O	[-1]	['none']	_	_
60	assayed	_	_	VBN	O	[-1]	['none']	_	_
61	for	_	_	IN	O	[-1]	['none']	_	_
62	growth	_	_	NN	O	[-1]	['none']	_	_
63	and	_	_	CC	O	[-1]	['none']	_	_
64	survival	_	_	NN	O	[-1]	['none']	_	_
65	by	_	_	IN	O	[-1]	['none']	_	_
66	the	_	_	DT	O	[-1]	['none']	_	_
67	MTS	_	_	NNP	O	[-1]	['none']	_	_
68	assay	_	_	NN	O	[-1]	['none']	_	_
69	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	previously	_	_	RB	O	[-1]	['none']	_	_
3	shown	_	_	VBN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	wild-type	_	_	JJ	O	[-1]	['none']	_	_
6	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	viable	_	_	JJ	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	culture	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	could	_	_	MD	O	[-1]	['none']	_	_
14	not	_	_	RB	O	[-1]	['none']	_	_
15	be	_	_	VB	O	[-1]	['none']	_	_
16	tested	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	enhanced	_	_	JJ	O	[-1]	['none']	_	_
5	viability	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	LMP1	_	_	NN	Protein	[0]	['root']	_	_
8	transgenic	_	_	JJ	O	[-1]	['none']	_	_
9	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	effectively	_	_	RB	O	[-1]	['none']	_	_
12	blocked	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	treatment	_	_	NN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	triciribine	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	BAY11-7085	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	cucurbitacin	_	_	NN	O	[-1]	['none']	_	_
21	I	_	_	PRP	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	slightly	_	_	RB	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	SB203580	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	but	_	_	CC	O	[-1]	['none']	_	_
29	not	_	_	RB	O	[-1]	['none']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	treatment	_	_	NN	O	[-1]	['none']	_	_
32	with	_	_	IN	O	[-1]	['none']	_	_
33	rapamycin	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	U0126	_	_	NN	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	or	_	_	CC	O	[-1]	['none']	_	_
38	AG490	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Triciribine	_	_	NN	O	[-1]	['none']	_	_
2	inhibits	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	activation	_	_	NN	Positive_regulation	[2]	['Theme']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Akt	_	_	NN	Protein	[4]	['Theme']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	20	_	_	CD	O	[-1]	['none']	_	_
10	muM	_	_	NN	O	[-1]	['none']	_	_
11	has	_	_	VBZ	O	[-1]	['none']	_	_
12	been	_	_	VBN	O	[-1]	['none']	_	_
13	shown	_	_	VBN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	induce	_	_	VB	O	[-1]	['none']	_	_
16	growth	_	_	NN	O	[-1]	['none']	_	_
17	arrest	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	cancer	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	aberrant	_	_	JJ	O	[-1]	['none']	_	_
23	Akt	_	_	NN	Protein	[0]	['root']	_	_
24	activity	_	_	NN	O	[-1]	['none']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	46	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	effects	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	triciribine	_	_	NN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	growth	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	transgenic	_	_	JJ	O	[-1]	['none']	_	_
11	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	apparent	_	_	JJ	O	[-1]	['none']	_	_
16	as	_	_	RB	O	[-1]	['none']	_	_
17	low	_	_	JJ	O	[-1]	['none']	_	_
18	as	_	_	IN	O	[-1]	['none']	_	_
19	1	_	_	CD	O	[-1]	['none']	_	_
20	muM	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	suggesting	_	_	VBG	O	[-1]	['none']	_	_
23	that	_	_	IN	O	[-1]	['none']	_	_
24	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	Akt	_	_	NN	Protein	[24]	['Theme']	_	_
27	is	_	_	VBZ	O	[-1]	['none']	_	_
28	required	_	_	VBN	O	[-1]	['none']	_	_
29	for	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	survival	_	_	NN	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	growth	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	LMP1	_	_	NN	Protein	[0]	['root']	_	_
36	transgenic	_	_	JJ	O	[-1]	['none']	_	_
37	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	lymphoma	_	_	NN	O	[-1]	['none']	_	_
40	cells	_	_	NNS	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	effects	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	assessed	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	identifying	_	_	VBG	O	[-1]	['none']	_	_
10	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
11	Akt	_	_	NN	Protein	[10]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	Stat3	_	_	NN	Protein	[10]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	total	_	_	JJ	O	[-1]	['none']	_	_
17	levels	_	_	NNS	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Treatment	_	_	NN	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	triciribine	_	_	NN	O	[-1]	['none']	_	_
4	effectively	_	_	RB	O	[-1]	['none']	_	_
5	blocked	_	_	VBD	Negative_regulation	[0]	['root']	_	_
6	phosphorylation	_	_	NN	Phosphorylation	[5]	['Theme']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Akt	_	_	NN	Protein	[6]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	phosphorylated	_	_	VBN	Phosphorylation	[16]	['Theme']	_	_
12	Akt	_	_	NN	Protein	[11]	['Theme']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	no	_	_	RB	O	[-1]	['none']	_	_
15	longer	_	_	RB	O	[-1]	['none']	_	_
16	detected	_	_	VBN	Positive_regulation	[0]	['root']	_	_
17	past	_	_	IN	O	[-1]	['none']	_	_
18	5	_	_	CD	O	[-1]	['none']	_	_
19	muM	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
2	Stat3	_	_	NN	Protein	[1]	['Theme']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	IkappaBalpha	_	_	NN	Protein	[1]	['Theme']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	still	_	_	RB	O	[-1]	['none']	_	_
7	present	_	_	JJ	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	25	_	_	CD	O	[-1]	['none']	_	_
10	muM	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	findings	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	triciribine	_	_	NN	O	[-1]	['none']	_	_
6	specifically	_	_	RB	O	[-1]	['none']	_	_
7	targets	_	_	VBZ	Regulation	[0]	['root']	_	_
8	Akt	_	_	NN	Protein	[7]	['Theme']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	Akt	_	_	NN	Protein	[12]	['Theme']	_	_
12	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
13	is	_	_	VBZ	O	[-1]	['none']	_	_
14	required	_	_	VBN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	enhanced	_	_	JJ	O	[-1]	['none']	_	_
18	viability	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	transgenic	_	_	JJ	O	[-1]	['none']	_	_
22	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	lymphoma	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Inhibition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
4	signaling	_	_	NN	O	[-1]	['none']	_	_
5	rapidly	_	_	RB	O	[-1]	['none']	_	_
6	induces	_	_	VBZ	O	[-1]	['none']	_	_
7	cell	_	_	NN	O	[-1]	['none']	_	_
8	death	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	EBV	_	_	NN	O	[-1]	['none']	_	_
11	transformed	_	_	VBN	O	[-1]	['none']	_	_
12	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
13	[	_	_	VBP	O	[-1]	['none']	_	_
14	17,18	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	CD	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	BAY11-7085	_	_	NNP	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	an	_	_	DT	O	[-1]	['none']	_	_
4	inhibitor	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
7	signaling	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	also	_	_	RB	O	[-1]	['none']	_	_
10	greatly	_	_	RB	O	[-1]	['none']	_	_
11	decreased	_	_	VBD	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	viability	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	LMP1	_	_	NN	Protein	[0]	['root']	_	_
17	transgenic	_	_	JJ	O	[-1]	['none']	_	_
18	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	lymphoma	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	at	_	_	IN	O	[-1]	['none']	_	_
23	doses	_	_	NNS	O	[-1]	['none']	_	_
24	as	_	_	RB	O	[-1]	['none']	_	_
25	low	_	_	JJ	O	[-1]	['none']	_	_
26	as	_	_	IN	O	[-1]	['none']	_	_
27	1	_	_	CD	O	[-1]	['none']	_	_
28	muM	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	at	_	_	IN	O	[-1]	['none']	_	_
32	5	_	_	CD	O	[-1]	['none']	_	_
33	muM	_	_	NN	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	cells	_	_	NNS	O	[-1]	['none']	_	_
36	were	_	_	VBD	O	[-1]	['none']	_	_
37	completely	_	_	RB	O	[-1]	['none']	_	_
38	nonviable	_	_	JJ	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	well	_	_	RB	O	[-1]	['none']	_	_
4	within	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	reported	_	_	JJ	O	[-1]	['none']	_	_
7	IC50	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	10	_	_	CD	O	[-1]	['none']	_	_
10	muM	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Phosphorylated	_	_	VBN	Phosphorylation	[11, 23]	['Theme', 'Theme']	_	_
2	Akt	_	_	NN	Protein	[1]	['Theme']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	Stat3	_	_	NN	Protein	[1]	['Theme']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	total	_	_	JJ	O	[-1]	['none']	_	_
8	IkappaBalpha	_	_	NN	Protein	[11, 23]	['Theme', 'Theme']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	still	_	_	RB	O	[-1]	['none']	_	_
11	present	_	_	JJ	Positive_regulation	[0]	['root']	_	_
12	up	_	_	IN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	treatment	_	_	NN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	15	_	_	CD	O	[-1]	['none']	_	_
17	muM	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	then	_	_	RB	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	no	_	_	RB	O	[-1]	['none']	_	_
22	longer	_	_	RB	O	[-1]	['none']	_	_
23	detected	_	_	VBN	Positive_regulation	[0]	['root']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	finding	_	_	NN	O	[-1]	['none']	_	_
3	suggests	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	inhibition	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
8	can	_	_	MD	O	[-1]	['none']	_	_
9	induce	_	_	VB	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	death	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	LMP1	_	_	NN	Protein	[0]	['root']	_	_
14	transgenic	_	_	JJ	O	[-1]	['none']	_	_
15	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	lymphoma	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	without	_	_	IN	O	[-1]	['none']	_	_
20	significant	_	_	JJ	O	[-1]	['none']	_	_
21	effects	_	_	NNS	Regulation	[0]	['root']	_	_
22	on	_	_	IN	O	[-1]	['none']	_	_
23	activation	_	_	NN	Positive_regulation	[21]	['Theme']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	Akt	_	_	NN	Protein	[23]	['Theme']	_	_
26	or	_	_	CC	O	[-1]	['none']	_	_
27	Stat3	_	_	NN	Protein	[23]	['Theme']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Cucurbitacin	_	_	NN	O	[-1]	['none']	_	_
2	I	_	_	NN	O	[-1]	['none']	_	_
3	inhibits	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
4	activation	_	_	NN	Positive_regulation	[3]	['Theme']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Stat3	_	_	NN	Protein	[4]	['Theme']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	suppressing	_	_	VBG	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	its	_	_	PRP$	O	[-1]	['none']	_	_
13	kinase	_	_	NN	O	[-1]	['none']	_	_
14	JAK2	_	_	NN	Protein	[0]	['root']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	been	_	_	VBN	O	[-1]	['none']	_	_
4	shown	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	selectively	_	_	RB	O	[-1]	['none']	_	_
7	inhibit	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	growth	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	tumors	_	_	NNS	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	constitutively	_	_	RB	O	[-1]	['none']	_	_
14	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
15	Stat3	_	_	NN	Protein	[14]	['Theme']	_	_
16	[	_	_	CD	O	[-1]	['none']	_	_
17	47	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Similarly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	LMP1	_	_	NN	Protein	[0]	['root']	_	_
4	transgenic	_	_	JJ	O	[-1]	['none']	_	_
5	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	lymphoma	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	susceptible	_	_	JJ	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	cucurbitacin	_	_	NN	O	[-1]	['none']	_	_
13	I	_	_	NN	O	[-1]	['none']	_	_
14	treatment	_	_	NN	O	[-1]	['none']	_	_
15	starting	_	_	VBG	O	[-1]	['none']	_	_
16	at	_	_	IN	O	[-1]	['none']	_	_
17	0.1	_	_	CD	O	[-1]	['none']	_	_
18	muM	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	dose	_	_	NN	O	[-1]	['none']	_	_
22	that	_	_	WDT	O	[-1]	['none']	_	_
23	corresponds	_	_	VBZ	O	[-1]	['none']	_	_
24	closely	_	_	RB	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	reported	_	_	JJ	O	[-1]	['none']	_	_
28	IC50	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	500	_	_	CD	O	[-1]	['none']	_	_
31	nM	_	_	NN	O	[-1]	['none']	_	_
32	[	_	_	CD	O	[-1]	['none']	_	_
33	47	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
2	Akt	_	_	NN	Protein	[1, 11, 24]	['Theme', 'Theme', 'Theme']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	Stat3	_	_	NN	Protein	[1, 11, 24]	['Theme', 'Theme', 'Theme']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	total	_	_	JJ	O	[-1]	['none']	_	_
8	IkappaBalpha	_	_	NN	Protein	[11, 24]	['Theme', 'Theme']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	not	_	_	RB	O	[-1]	['none']	_	_
11	detectable	_	_	JJ	Positive_regulation	[0]	['root']	_	_
12	past	_	_	IN	O	[-1]	['none']	_	_
13	1	_	_	CD	O	[-1]	['none']	_	_
14	muM	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	at	_	_	IN	O	[-1]	['none']	_	_
17	higher	_	_	JJR	O	[-1]	['none']	_	_
18	doses	_	_	NNS	O	[-1]	['none']	_	_
19	all	_	_	DT	Anaphora	[20]	['multitoken']	_	_
20	protein	_	_	NN	Anaphora	[0]	['root']	_	_
21	levels	_	_	NNS	O	[-1]	['none']	_	_
22	were	_	_	VBD	O	[-1]	['none']	_	_
23	greatly	_	_	RB	O	[-1]	['none']	_	_
24	decreased	_	_	VBN	Negative_regulation	[0]	['root']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	indicative	_	_	JJ	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	total	_	_	JJ	O	[-1]	['none']	_	_
30	loss	_	_	NN	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	viability	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	second	_	_	NN	O	[-1]	['none']	_	_
3	reported	_	_	VBD	O	[-1]	['none']	_	_
4	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Stat3	_	_	NN	Protein	[4]	['Theme']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	AG490	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	had	_	_	VBD	O	[-1]	['none']	_	_
11	no	_	_	DT	O	[-1]	['none']	_	_
12	effect	_	_	NN	O	[-1]	['none']	_	_
13	on	_	_	IN	O	[-1]	['none']	_	_
14	growth	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	but	_	_	CC	O	[-1]	['none']	_	_
17	activation	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	Akt	_	_	NN	Protein	[0]	['root']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	Stat3	_	_	NN	Protein	[0]	['root']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	or	_	_	CC	O	[-1]	['none']	_	_
24	levels	_	_	NNS	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	IkappaBalpha	_	_	NN	Protein	[30]	['Theme']	_	_
27	were	_	_	VBD	O	[-1]	['none']	_	_
28	also	_	_	RB	O	[-1]	['none']	_	_
29	not	_	_	RB	O	[-1]	['none']	_	_
30	affected	_	_	VBN	Regulation	[0]	['root']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	findings	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	inhibition	_	_	NN	Negative_regulation	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Stat3	_	_	NN	Protein	[5]	['Theme']	_	_
8	can	_	_	MD	O	[-1]	['none']	_	_
9	induce	_	_	VB	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	death	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	LMP1	_	_	NN	Protein	[0]	['root']	_	_
14	transgenic	_	_	JJ	O	[-1]	['none']	_	_
15	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	lymphoma	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	but	_	_	CC	O	[-1]	['none']	_	_
21	Stat3	_	_	NN	Protein	[22]	['Theme']	_	_
22	inhibition	_	_	NN	Negative_regulation	[0]	['root']	_	_
23	also	_	_	RB	O	[-1]	['none']	_	_
24	has	_	_	VBZ	O	[-1]	['none']	_	_
25	considerable	_	_	JJ	O	[-1]	['none']	_	_
26	crossover	_	_	NN	O	[-1]	['none']	_	_
27	effects	_	_	NNS	O	[-1]	['none']	_	_
28	on	_	_	IN	O	[-1]	['none']	_	_
29	Akt	_	_	NN	Protein	[0]	['root']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
32	signaling	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	shown	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	activate	_	_	VB	O	[-1]	['none']	_	_
8	JNK	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	p38	_	_	NN	O	[-1]	['none']	_	_
11	MAPK	_	_	NN	O	[-1]	['none']	_	_
12	pathways	_	_	NNS	O	[-1]	['none']	_	_
13	[	_	_	VBP	O	[-1]	['none']	_	_
14	13,48	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	CD	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	LMP1	_	_	NN	Protein	[0]	['root']	_	_
19	transgenic	_	_	JJ	O	[-1]	['none']	_	_
20	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
21	were	_	_	VBD	O	[-1]	['none']	_	_
22	mildly	_	_	RB	O	[-1]	['none']	_	_
23	susceptible	_	_	JJ	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	growth	_	_	NN	O	[-1]	['none']	_	_
26	inhibition	_	_	NN	O	[-1]	['none']	_	_
27	by	_	_	IN	O	[-1]	['none']	_	_
28	SB202190	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	an	_	_	DT	O	[-1]	['none']	_	_
31	inhibitor	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	p38	_	_	NN	O	[-1]	['none']	_	_
34	MAPK	_	_	NN	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	but	_	_	CC	O	[-1]	['none']	_	_
37	not	_	_	RB	O	[-1]	['none']	_	_
38	U0126	_	_	NN	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	an	_	_	DT	O	[-1]	['none']	_	_
41	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	MEK1/2	_	_	NN	Protein	[41]	['Theme']	_	_
44	activity	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	effects	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	SB202190	_	_	NN	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	only	_	_	RB	O	[-1]	['none']	_	_
8	apparent	_	_	JJ	O	[-1]	['none']	_	_
9	at	_	_	IN	O	[-1]	['none']	_	_
10	high	_	_	JJ	O	[-1]	['none']	_	_
11	doses	_	_	NNS	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	>	_	_	JJR	O	[-1]	['none']	_	_
14	10	_	_	CD	O	[-1]	['none']	_	_
15	muM	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	much	_	_	RB	O	[-1]	['none']	_	_
19	higher	_	_	JJR	O	[-1]	['none']	_	_
20	than	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	reported	_	_	JJ	O	[-1]	['none']	_	_
23	IC50	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	0.35	_	_	CD	O	[-1]	['none']	_	_
26	muM	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	suggesting	_	_	VBG	O	[-1]	['none']	_	_
29	that	_	_	IN	O	[-1]	['none']	_	_
30	p38	_	_	NN	O	[-1]	['none']	_	_
31	MAPK	_	_	NN	O	[-1]	['none']	_	_
32	does	_	_	VBZ	O	[-1]	['none']	_	_
33	not	_	_	RB	O	[-1]	['none']	_	_
34	significantly	_	_	RB	O	[-1]	['none']	_	_
35	contribute	_	_	VB	O	[-1]	['none']	_	_
36	to	_	_	TO	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	enhanced	_	_	JJ	O	[-1]	['none']	_	_
39	viability	_	_	NN	O	[-1]	['none']	_	_
40	in	_	_	IN	O	[-1]	['none']	_	_
41	LMP1	_	_	NN	Protein	[0]	['root']	_	_
42	transgenic	_	_	JJ	O	[-1]	['none']	_	_
43	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
44	or	_	_	CC	O	[-1]	['none']	_	_
45	lymphoma	_	_	NN	O	[-1]	['none']	_	_
46	cells	_	_	NNS	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	both	_	_	CC	O	[-1]	['none']	_	_
4	wild-type	_	_	JJ	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	LMP1	_	_	NN	Protein	[0]	['root']	_	_
7	transgenic	_	_	JJ	O	[-1]	['none']	_	_
8	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	similarly	_	_	RB	O	[-1]	['none']	_	_
11	susceptible	_	_	JJ	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	triciribine	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	BAY11-7085	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	cucurbitacin	_	_	NN	O	[-1]	['none']	_	_
19	I	_	_	PRP	O	[-1]	['none']	_	_
20	treatments	_	_	NNS	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	but	_	_	CC	O	[-1]	['none']	_	_
23	not	_	_	RB	O	[-1]	['none']	_	_
24	SB202190	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	AG490	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	U0126	_	_	NN	O	[-1]	['none']	_	_
30	treatment	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	suggesting	_	_	VBG	O	[-1]	['none']	_	_
33	that	_	_	IN	O	[-1]	['none']	_	_
34	activation	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	Akt	_	_	NN	Protein	[0]	['root']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	Stat3	_	_	NN	Protein	[0]	['root']	_	_
42	but	_	_	CC	O	[-1]	['none']	_	_
43	not	_	_	RB	O	[-1]	['none']	_	_
44	MAPK	_	_	NN	O	[-1]	['none']	_	_
45	pathways	_	_	NNS	O	[-1]	['none']	_	_
46	are	_	_	VBP	O	[-1]	['none']	_	_
47	characteristics	_	_	NNS	O	[-1]	['none']	_	_
48	associated	_	_	VBN	O	[-1]	['none']	_	_
49	with	_	_	IN	O	[-1]	['none']	_	_
50	malignant	_	_	JJ	O	[-1]	['none']	_	_
51	transformation	_	_	NN	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	rapamycin	_	_	NN	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	an	_	_	DT	O	[-1]	['none']	_	_
4	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	mTOR	_	_	NN	Protein	[4]	['Theme']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	did	_	_	VBD	O	[-1]	['none']	_	_
9	not	_	_	RB	O	[-1]	['none']	_	_
10	affect	_	_	VB	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	viability	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	transgenic	_	_	JJ	O	[-1]	['none']	_	_
16	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	lymphoma	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	confirming	_	_	VBG	O	[-1]	['none']	_	_
22	that	_	_	IN	O	[-1]	['none']	_	_
23	mTOR	_	_	NN	Protein	[26]	['Theme']	_	_
24	is	_	_	VBZ	O	[-1]	['none']	_	_
25	not	_	_	RB	O	[-1]	['none']	_	_
26	targeted	_	_	VBN	Regulation	[0]	['root']	_	_
27	by	_	_	IN	O	[-1]	['none']	_	_
28	Akt	_	_	NN	Protein	[0]	['root']	_	_
29	activation	_	_	NN	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	LMP1	_	_	NN	Protein	[0]	['root']	_	_
32	transgenic	_	_	JJ	O	[-1]	['none']	_	_
33	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
34	or	_	_	CC	O	[-1]	['none']	_	_
35	malignant	_	_	JJ	O	[-1]	['none']	_	_
36	lymphoma	_	_	NN	O	[-1]	['none']	_	_
37	cells	_	_	NNS	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	SDS-PAGE	_	_	NNP	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	Immunoblotting	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	I-kappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[0]	['root']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	CREB	_	_	NN	Protein	[0]	['root']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	Following	_	_	VBG	O	[-1]	['none']	_	_
14	stimulation	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	PBMCs	_	_	NNS	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	washed	_	_	VBN	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	ice-cold	_	_	JJ	O	[-1]	['none']	_	_
21	PBS	_	_	NNP	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	collect	_	_	VB	O	[-1]	['none']	_	_
26	a	_	_	DT	O	[-1]	['none']	_	_
27	cell	_	_	NN	O	[-1]	['none']	_	_
28	pellet	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	pellet	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	resuspended	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	ice-cold	_	_	JJ	O	[-1]	['none']	_	_
7	SDS	_	_	NN	O	[-1]	['none']	_	_
8	sample	_	_	NN	O	[-1]	['none']	_	_
9	buffer	_	_	NN	O	[-1]	['none']	_	_
10	supplemented	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	100	_	_	CD	O	[-1]	['none']	_	_
13	mM	_	_	NN	O	[-1]	['none']	_	_
14	dithiothreitol	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	nuclear	_	_	JJ	O	[-1]	['none']	_	_
4	extracts	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	isolated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	NE-PER	_	_	NN	O	[-1]	['none']	_	_
9	nuclear	_	_	JJ	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
12	extraction	_	_	NN	O	[-1]	['none']	_	_
13	reagents	_	_	NNS	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	1x	_	_	NN	O	[-1]	['none']	_	_
16	Halt	_	_	NN	O	[-1]	['none']	_	_
17	Protease	_	_	NN	O	[-1]	['none']	_	_
18	Inhibitor	_	_	NNP	O	[-1]	['none']	_	_
19	Cocktail	_	_	NNP	O	[-1]	['none']	_	_
20	according	_	_	VBG	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	manufacturer	_	_	NN	O	[-1]	['none']	_	_
24	's	_	_	POS	O	[-1]	['none']	_	_
25	instructions	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Protein	_	_	NN	O	[-1]	['none']	_	_
2	concentrations	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	determined	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	BCA	_	_	NN	O	[-1]	['none']	_	_
8	protein	_	_	NN	O	[-1]	['none']	_	_
9	reagent	_	_	NN	O	[-1]	['none']	_	_
10	kit	_	_	NN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	each	_	_	DT	O	[-1]	['none']	_	_
13	sample	_	_	NN	O	[-1]	['none']	_	_
14	according	_	_	VBG	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	standardized	_	_	JJ	O	[-1]	['none']	_	_
18	curve	_	_	NN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	albumin	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	lysates	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	collected	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	boiling	_	_	VBG	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	samples	_	_	NNS	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	100degreesC	_	_	NN	O	[-1]	['none']	_	_
12	water	_	_	NN	O	[-1]	['none']	_	_
13	bath	_	_	NN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	5	_	_	CD	O	[-1]	['none']	_	_
16	minutes	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Ten	_	_	CD	O	[-1]	['none']	_	_
2	mug	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	protein	_	_	NN	O	[-1]	['none']	_	_
5	per	_	_	IN	O	[-1]	['none']	_	_
6	sample	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	separated	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	SDS-polyacrylamide	_	_	NN	O	[-1]	['none']	_	_
11	gel	_	_	NN	O	[-1]	['none']	_	_
12	electrophoresis	_	_	NN	O	[-1]	['none']	_	_
13	through	_	_	IN	O	[-1]	['none']	_	_
14	8-16	_	_	CD	O	[-1]	['none']	_	_
15	%	_	_	NN	O	[-1]	['none']	_	_
16	tris-glycine	_	_	JJ	O	[-1]	['none']	_	_
17	polyacrylamide	_	_	NN	O	[-1]	['none']	_	_
18	gradient	_	_	NN	O	[-1]	['none']	_	_
19	gels	_	_	NNS	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	transferred	_	_	VBN	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	nitrocellulose	_	_	VB	O	[-1]	['none']	_	_
24	membranes	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	membranes	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	blocked	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	5	_	_	CD	O	[-1]	['none']	_	_
7	%	_	_	NN	O	[-1]	['none']	_	_
8	milk	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	Tris	_	_	NNP	O	[-1]	['none']	_	_
11	buffered	_	_	VBD	O	[-1]	['none']	_	_
12	saline	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	Tween	_	_	NNP	O	[-1]	['none']	_	_
15	20	_	_	CD	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	Fischer	_	_	NNP	O	[-1]	['none']	_	_
18	Scientific	_	_	NNP	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	Pittsburgh	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	PA	_	_	NN	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	1	_	_	CD	O	[-1]	['none']	_	_
26	hour	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
2	extracts	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	incubated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
7	I-kappaBalpha	_	_	NN	Protein	[6]	['Theme']	_	_
8	antibody	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	1:200	_	_	CD	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	while	_	_	IN	O	[-1]	['none']	_	_
14	nuclear	_	_	JJ	O	[-1]	['none']	_	_
15	extracts	_	_	NNS	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	incubated	_	_	VBN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	either	_	_	CC	O	[-1]	['none']	_	_
20	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	p65	_	_	NN	Protein	[20]	['Theme']	_	_
23	antibody	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	1:500	_	_	CD	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	or	_	_	CC	O	[-1]	['none']	_	_
28	phosphorylated	_	_	VBN	O	[-1]	['none']	_	_
29	CREB	_	_	NN	O	[-1]	['none']	_	_
30	antibody	_	_	NN	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	1:500	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	overnight	_	_	JJ	O	[-1]	['none']	_	_
35	at	_	_	IN	O	[-1]	['none']	_	_
36	4degreesC	_	_	NN	O	[-1]	['none']	_	_
37	in	_	_	IN	O	[-1]	['none']	_	_
38	separate	_	_	JJ	O	[-1]	['none']	_	_
39	experiments	_	_	NNS	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	membranes	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	washed	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	Tris	_	_	NN	O	[-1]	['none']	_	_
7	buffered	_	_	VBN	O	[-1]	['none']	_	_
8	saline	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	Tween	_	_	NNP	O	[-1]	['none']	_	_
11	20	_	_	CD	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	incubated	_	_	VBN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	1	_	_	CD	O	[-1]	['none']	_	_
16	hour	_	_	NN	O	[-1]	['none']	_	_
17	at	_	_	IN	O	[-1]	['none']	_	_
18	room	_	_	NN	O	[-1]	['none']	_	_
19	temperature	_	_	NN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	secondary	_	_	JJ	O	[-1]	['none']	_	_
23	antibody	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	horseradish	_	_	NN	O	[-1]	['none']	_	_
26	peroxidase	_	_	NN	O	[-1]	['none']	_	_
27	linked	_	_	VBN	O	[-1]	['none']	_	_
28	anti-rabbit	_	_	JJ	O	[-1]	['none']	_	_
29	IgG	_	_	NN	O	[-1]	['none']	_	_
30	diluted	_	_	VBN	O	[-1]	['none']	_	_
31	1:2000	_	_	CD	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	blocking	_	_	VBG	O	[-1]	['none']	_	_
34	solution	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	repeated	_	_	VBN	O	[-1]	['none']	_	_
3	washing	_	_	VBG	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	membrane	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	Supersignal	_	_	NNP	O	[-1]	['none']	_	_
10	West	_	_	NNP	O	[-1]	['none']	_	_
11	Pico	_	_	NNP	O	[-1]	['none']	_	_
12	Chemiluminescent	_	_	NNP	O	[-1]	['none']	_	_
13	Kit	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	applied	_	_	VBN	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	antibody	_	_	NN	O	[-1]	['none']	_	_
18	detection	_	_	NN	O	[-1]	['none']	_	_
19	per	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	manufacturer	_	_	NN	O	[-1]	['none']	_	_
22	's	_	_	POS	O	[-1]	['none']	_	_
23	instructions	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	NN	O	[-1]	['none']	_	_
2	blot	_	_	NN	O	[-1]	['none']	_	_
3	data	_	_	NNS	O	[-1]	['none']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	presented	_	_	VBN	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	percentage	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	LPS	_	_	NN	O	[-1]	['none']	_	_
11	stimulation	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	percentage	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	LPS	_	_	NN	O	[-1]	['none']	_	_
5	stimulation	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	calculated	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	dividing	_	_	VBG	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	mean	_	_	JJ	O	[-1]	['none']	_	_
12	band	_	_	NN	O	[-1]	['none']	_	_
13	pixel	_	_	NN	O	[-1]	['none']	_	_
14	total	_	_	NN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	each	_	_	DT	O	[-1]	['none']	_	_
17	treatment	_	_	NN	O	[-1]	['none']	_	_
18	arm	_	_	NN	O	[-1]	['none']	_	_
19	divided	_	_	VBN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	mean	_	_	NN	O	[-1]	['none']	_	_
23	pixel	_	_	NN	O	[-1]	['none']	_	_
24	total	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	samples	_	_	NNS	O	[-1]	['none']	_	_
27	stimulated	_	_	VBN	O	[-1]	['none']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	LPS	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	multiplying	_	_	VBG	O	[-1]	['none']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	100	_	_	CD	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	LPS	_	_	NN	O	[-1]	['none']	_	_
4	stimulation	_	_	NN	O	[-1]	['none']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	reported	_	_	VBN	O	[-1]	['none']	_	_
7	as	_	_	IN	O	[-1]	['none']	_	_
8	100	_	_	CD	O	[-1]	['none']	_	_
9	%	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	each	_	_	DT	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	treatment	_	_	NN	O	[-1]	['none']	_	_
15	arms	_	_	NNS	O	[-1]	['none']	_	_
16	is	_	_	VBZ	O	[-1]	['none']	_	_
17	reported	_	_	VBN	O	[-1]	['none']	_	_
18	as	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	percent	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	LPS	_	_	NN	O	[-1]	['none']	_	_
23	stimulation	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Materials	_	_	NNPS	O	[-1]	['none']	_	_
2	Recombinant	_	_	JJ	O	[-1]	['none']	_	_
3	human	_	_	NN	O	[-1]	['none']	_	_
4	M-CSF	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	purchased	_	_	VBN	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	R&D	_	_	NNP	O	[-1]	['none']	_	_
9	Systems	_	_	NNP	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Minneapolis	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	MN	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Ro-31-8220	_	_	NNP	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Go-6976	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	Rotterin	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	BAPTA/AM	_	_	NN	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	obtained	_	_	VBN	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	Calbiochem	_	_	FW	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	San	_	_	NNP	O	[-1]	['none']	_	_
15	Diego	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	CA	_	_	NNP	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Low	_	_	JJ	O	[-1]	['none']	_	_
2	endotoxin	_	_	NN	O	[-1]	['none']	_	_
3	RPMI	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	X-vivo	_	_	NN	O	[-1]	['none']	_	_
6	serum	_	_	NN	O	[-1]	['none']	_	_
7	free	_	_	JJ	O	[-1]	['none']	_	_
8	medium	_	_	NN	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	obtained	_	_	VBN	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	Lonza	_	_	NNP	O	[-1]	['none']	_	_
13	Walkersville	_	_	NNP	O	[-1]	['none']	_	_
14	Inc	_	_	NNP	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	Walkersville	_	_	NNP	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	MD	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Fetal	_	_	JJ	O	[-1]	['none']	_	_
2	bovine	_	_	JJ	O	[-1]	['none']	_	_
3	serum	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	FBS	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	certified	_	_	VBD	O	[-1]	['none']	_	_
8	<	_	_	JJR	O	[-1]	['none']	_	_
9	0.06	_	_	CD	O	[-1]	['none']	_	_
10	endotoxin	_	_	NN	O	[-1]	['none']	_	_
11	units/ml	_	_	NNS	O	[-1]	['none']	_	_
12	endotoxin	_	_	NN	O	[-1]	['none']	_	_
13	levels	_	_	NNS	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	purchased	_	_	VBN	O	[-1]	['none']	_	_
17	from	_	_	IN	O	[-1]	['none']	_	_
18	Atlanta	_	_	NNP	O	[-1]	['none']	_	_
19	Biological	_	_	JJ	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	Lawrenceville	_	_	NNP	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	GA	_	_	NNP	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	All	_	_	DT	O	[-1]	['none']	_	_
2	other	_	_	JJ	O	[-1]	['none']	_	_
3	cell	_	_	NN	O	[-1]	['none']	_	_
4	culture	_	_	NN	O	[-1]	['none']	_	_
5	reagents	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	obtained	_	_	VBN	O	[-1]	['none']	_	_
8	through	_	_	IN	O	[-1]	['none']	_	_
9	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Carlsbad	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	CA	_	_	NNP	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	PKCalpha	_	_	NN	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	p65	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	Lamin	_	_	NN	O	[-1]	['none']	_	_
6	B	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	beta-actin	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	GAPDH	_	_	NN	O	[-1]	['none']	_	_
12	antibodies	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	rabbit	_	_	NN	O	[-1]	['none']	_	_
17	IgG-HRP	_	_	NN	O	[-1]	['none']	_	_
18	conjugated	_	_	VBN	O	[-1]	['none']	_	_
19	antibodies	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	PKCalpha	_	_	NN	Protein	[23]	['multitoken']	_	_
23	siRNA	_	_	NN	Protein	[0]	['root']	_	_
24	were	_	_	VBD	O	[-1]	['none']	_	_
25	obtained	_	_	VBN	O	[-1]	['none']	_	_
26	from	_	_	IN	O	[-1]	['none']	_	_
27	Santa	_	_	NNP	O	[-1]	['none']	_	_
28	Cruz	_	_	NNP	O	[-1]	['none']	_	_
29	Biotechnology	_	_	NNP	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	Santa	_	_	NNP	O	[-1]	['none']	_	_
32	Cruz	_	_	NNP	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	CA	_	_	NNP	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Phospho-NFkappaB	_	_	NNP	O	[-1]	['none']	_	_
2	p65	_	_	NN	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	Ser276	_	_	NN	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	Ser536	_	_	NN	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	antibodies	_	_	NNS	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	purchased	_	_	VBN	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	Cell	_	_	NN	O	[-1]	['none']	_	_
13	Signaling	_	_	NN	O	[-1]	['none']	_	_
14	Technology	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	Danvers	_	_	NNP	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	MA	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	DNA	_	_	NN	O	[-1]	['none']	_	_
2	constructs	_	_	NNS	O	[-1]	['none']	_	_
3	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	obtained	_	_	VBN	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	Clontech	_	_	NNP	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Mountian	_	_	NNP	O	[-1]	['none']	_	_
12	View	_	_	NNP	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	CA	_	_	NNP	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	O	[-1]	['none']	_	_
2	vectors	_	_	NNS	O	[-1]	['none']	_	_
3	containing	_	_	VBG	O	[-1]	['none']	_	_
4	CMV-p65	_	_	NN	Protein	[0]	['root']	_	_
5	WT	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	CMV-p65	_	_	NN	Protein	[0]	['root']	_	_
8	276S/A	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	CMV-p65	_	_	NN	Protein	[0]	['root']	_	_
11	536S/A	_	_	NN	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	cloned	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	pBa5e	_	_	NN	O	[-1]	['none']	_	_
16	Puro	_	_	NN	O	[-1]	['none']	_	_
17	vector	_	_	NN	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	pFLAG-CMV-2	_	_	NN	O	[-1]	['none']	_	_
20	vector	_	_	NN	O	[-1]	['none']	_	_
21	as	_	_	IN	O	[-1]	['none']	_	_
22	described	_	_	VBN	O	[-1]	['none']	_	_
23	previously	_	_	RB	O	[-1]	['none']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	49	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Kinase	_	_	NN	Negative_regulation	[2]	['multitoken']	_	_
2	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
3	CMV-PKCalpha	_	_	NN	Protein	[2]	['Theme']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	KD-PKCalpha	_	_	NN	Negative_regulation	[0]	['root']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	or	_	_	CC	O	[-1]	['none']	_	_
8	wild	_	_	JJ	O	[-1]	['none']	_	_
9	type	_	_	NN	O	[-1]	['none']	_	_
10	pCMV-PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	WT-PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	generous	_	_	JJ	O	[-1]	['none']	_	_
16	gifts	_	_	NNS	O	[-1]	['none']	_	_
17	from	_	_	IN	O	[-1]	['none']	_	_
18	Alexandra	_	_	NNP	O	[-1]	['none']	_	_
19	C.	_	_	NNP	O	[-1]	['none']	_	_
20	Newton	_	_	NNP	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	University	_	_	NNP	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	California	_	_	NNP	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	San	_	_	NNP	O	[-1]	['none']	_	_
27	Diego	_	_	NNP	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	CA	_	_	NNP	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	NFKBIA	_	_	NN	O	[-1]	['none']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	GAPDH	_	_	NN	O	[-1]	['none']	_	_
7	primers	_	_	NNS	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	real-time	_	_	JJ	O	[-1]	['none']	_	_
10	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	obtained	_	_	VBN	O	[-1]	['none']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	SABiosciences	_	_	NNS	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	Frederick	_	_	NNP	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	MD	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	pool	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	mouse	_	_	NN	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	human	_	_	NN	O	[-1]	['none']	_	_
7	PKCalpha	_	_	NN	Protein	[9]	['multitoken']	_	_
8	specific	_	_	JJ	Protein	[9]	['multitoken']	_	_
9	siRNA	_	_	NN	Protein	[0]	['root']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	purchased	_	_	VBN	O	[-1]	['none']	_	_
12	from	_	_	IN	O	[-1]	['none']	_	_
13	Santa	_	_	NNP	O	[-1]	['none']	_	_
14	Cruz	_	_	NNP	O	[-1]	['none']	_	_
15	Biotechnology	_	_	NNP	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	Santa	_	_	NNP	O	[-1]	['none']	_	_
18	cruz	_	_	NNP	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	CA	_	_	NNP	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	present	_	_	JJ	O	[-1]	['none']	_	_
4	study	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	we	_	_	PRP	O	[-1]	['none']	_	_
7	show	_	_	VBP	O	[-1]	['none']	_	_
8	that	_	_	IN	O	[-1]	['none']	_	_
9	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
10	functions	_	_	NNS	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	potent	_	_	JJ	O	[-1]	['none']	_	_
14	repressor	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	NF-kappaB-	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	CREB	_	_	NN	O	[-1]	['none']	_	_
19	dependent	_	_	JJ	O	[-1]	['none']	_	_
20	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
21	activation	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	carboxyl-terminal	_	_	JJ	O	[-1]	['none']	_	_
5	FKH	_	_	NN	O	[-1]	['none']	_	_
6	domain	_	_	NN	O	[-1]	['none']	_	_
7	appears	_	_	VBZ	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	be	_	_	VB	O	[-1]	['none']	_	_
10	dispensable	_	_	JJ	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	mediating	_	_	VBG	O	[-1]	['none']	_	_
13	these	_	_	DT	O	[-1]	['none']	_	_
14	effects	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	at	_	_	IN	O	[-1]	['none']	_	_
17	least	_	_	JJS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	T	_	_	NN	O	[-1]	['none']	_	_
20	cell	_	_	NN	O	[-1]	['none']	_	_
21	populations	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	observation	_	_	NN	O	[-1]	['none']	_	_
3	may	_	_	MD	O	[-1]	['none']	_	_
4	become	_	_	VB	O	[-1]	['none']	_	_
5	important	_	_	JJ	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	light	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	recent	_	_	JJ	O	[-1]	['none']	_	_
10	reports	_	_	NNS	O	[-1]	['none']	_	_
11	suggesting	_	_	VBG	O	[-1]	['none']	_	_
12	that	_	_	IN	O	[-1]	['none']	_	_
13	Foxp3	_	_	NN	Protein	[14]	['Theme']	_	_
14	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	thymic	_	_	JJ	O	[-1]	['none']	_	_
17	epithelial	_	_	JJ	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	crucial	_	_	JJ	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	directing	_	_	VBG	O	[-1]	['none']	_	_
23	development	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	T	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	thymus	_	_	NN	O	[-1]	['none']	_	_
30	[	_	_	NN	O	[-1]	['none']	_	_
31	42	_	_	CD	O	[-1]	['none']	_	_
32	]	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	majority	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	genetic	_	_	JJ	O	[-1]	['none']	_	_
8	mutations	_	_	NNS	O	[-1]	['none']	_	_
9	associated	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	IPEX	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	severe	_	_	JJ	O	[-1]	['none']	_	_
15	autoimmune	_	_	JJ	O	[-1]	['none']	_	_
16	disorder	_	_	NN	O	[-1]	['none']	_	_
17	caused	_	_	VBN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	functional	_	_	JJ	O	[-1]	['none']	_	_
20	inactivation	_	_	NN	Negative_regulation	[0]	['root']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	Foxp3	_	_	NN	Protein	[20]	['Theme']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	map	_	_	NN	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	carboxyl-terminal	_	_	JJ	O	[-1]	['none']	_	_
28	FKH	_	_	NN	O	[-1]	['none']	_	_
29	domain	_	_	NN	O	[-1]	['none']	_	_
30	or	_	_	CC	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	leucine	_	_	NN	O	[-1]	['none']	_	_
33	zipper	_	_	NN	O	[-1]	['none']	_	_
34	domain	_	_	NN	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	central	_	_	JJ	O	[-1]	['none']	_	_
38	region	_	_	NN	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	the	_	_	DT	O	[-1]	['none']	_	_
41	protein	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Only	_	_	RB	O	[-1]	['none']	_	_
2	one	_	_	CD	O	[-1]	['none']	_	_
3	mutation	_	_	NN	O	[-1]	['none']	_	_
4	associated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	IPEX	_	_	NNP	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	date	_	_	NN	O	[-1]	['none']	_	_
9	has	_	_	VBZ	O	[-1]	['none']	_	_
10	been	_	_	VBN	O	[-1]	['none']	_	_
11	mapped	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	amino-terminal	_	_	JJ	O	[-1]	['none']	_	_
15	proline	_	_	NN	O	[-1]	['none']	_	_
16	rich	_	_	JJ	O	[-1]	['none']	_	_
17	region	_	_	NN	O	[-1]	['none']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	43	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	possible	_	_	JJ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	FKH	_	_	NN	O	[-1]	['none']	_	_
7	domain	_	_	NN	O	[-1]	['none']	_	_
8	has	_	_	VBZ	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	complex	_	_	JJ	O	[-1]	['none']	_	_
11	tertiary	_	_	JJ	O	[-1]	['none']	_	_
12	structure	_	_	NN	O	[-1]	['none']	_	_
13	that	_	_	WDT	O	[-1]	['none']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	particularly	_	_	RB	O	[-1]	['none']	_	_
16	sensitive	_	_	JJ	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	misfolding	_	_	NN	O	[-1]	['none']	_	_
19	caused	_	_	VBN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	genetic	_	_	JJ	O	[-1]	['none']	_	_
22	mutations	_	_	NNS	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	that	_	_	IN	O	[-1]	['none']	_	_
25	an	_	_	DT	O	[-1]	['none']	_	_
26	intact	_	_	JJ	O	[-1]	['none']	_	_
27	FKH	_	_	NN	O	[-1]	['none']	_	_
28	domain	_	_	NN	O	[-1]	['none']	_	_
29	is	_	_	VBZ	O	[-1]	['none']	_	_
30	absolutely	_	_	RB	O	[-1]	['none']	_	_
31	critical	_	_	JJ	O	[-1]	['none']	_	_
32	for	_	_	IN	O	[-1]	['none']	_	_
33	promoting	_	_	VBG	O	[-1]	['none']	_	_
34	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
35	function	_	_	NN	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	nucleus	_	_	NN	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	whereas	_	_	IN	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	structure	_	_	NN	O	[-1]	['none']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	amino-terminal	_	_	JJ	O	[-1]	['none']	_	_
46	proline	_	_	NN	O	[-1]	['none']	_	_
47	rich	_	_	JJ	O	[-1]	['none']	_	_
48	region	_	_	NN	O	[-1]	['none']	_	_
49	may	_	_	MD	O	[-1]	['none']	_	_
50	tolerate	_	_	VB	O	[-1]	['none']	_	_
51	certain	_	_	JJ	O	[-1]	['none']	_	_
52	mutations	_	_	NNS	O	[-1]	['none']	_	_
53	as	_	_	RB	O	[-1]	['none']	_	_
54	long	_	_	RB	O	[-1]	['none']	_	_
55	as	_	_	IN	O	[-1]	['none']	_	_
56	the	_	_	DT	O	[-1]	['none']	_	_
57	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
58	and	_	_	CC	O	[-1]	['none']	_	_
59	NF-AT	_	_	NN	O	[-1]	['none']	_	_
60	binding	_	_	NN	O	[-1]	['none']	_	_
61	motif	_	_	NN	O	[-1]	['none']	_	_
62	remains	_	_	VBZ	O	[-1]	['none']	_	_
63	unaltered	_	_	JJ	O	[-1]	['none']	_	_
64	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	motif	_	_	NN	O	[-1]	['none']	_	_
3	may	_	_	MD	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	include	_	_	VB	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	zinc	_	_	NN	O	[-1]	['none']	_	_
8	finger	_	_	NN	O	[-1]	['none']	_	_
9	domain	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	logical	_	_	JJ	O	[-1]	['none']	_	_
3	region	_	_	NN	O	[-1]	['none']	_	_
4	that	_	_	WDT	O	[-1]	['none']	_	_
5	may	_	_	MD	O	[-1]	['none']	_	_
6	be	_	_	VB	O	[-1]	['none']	_	_
7	targeted	_	_	VBN	Binding	[0]	['root']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	amino-terminal	_	_	JJ	Entity	[13]	['multitoken']	_	_
11	proline	_	_	NN	Entity	[13]	['multitoken']	_	_
12	rich	_	_	JJ	Entity	[13]	['multitoken']	_	_
13	region	_	_	NN	Entity	[7]	['Site']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	Foxp3	_	_	NN	Protein	[7]	['Theme']	_	_
16	is	_	_	VBZ	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	Rel	_	_	NN	O	[-1]	['none']	_	_
19	homology	_	_	NN	O	[-1]	['none']	_	_
20	domain	_	_	NN	O	[-1]	['none']	_	_
21	found	_	_	VBN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	both	_	_	CC	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	NF-AT	_	_	NN	O	[-1]	['none']	_	_
27	family	_	_	NN	O	[-1]	['none']	_	_
28	proteins	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	region	_	_	NN	O	[-1]	['none']	_	_
3	that	_	_	WDT	O	[-1]	['none']	_	_
4	may	_	_	MD	O	[-1]	['none']	_	_
5	also	_	_	RB	O	[-1]	['none']	_	_
6	be	_	_	VB	O	[-1]	['none']	_	_
7	important	_	_	JJ	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	respect	_	_	NN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
12	function	_	_	NN	O	[-1]	['none']	_	_
13	is	_	_	VBZ	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	leucine	_	_	NN	Entity	[17]	['multitoken']	_	_
16	zipper	_	_	NN	Entity	[17]	['multitoken']	_	_
17	domain	_	_	NN	Entity	[0]	['root']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	number	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	mutations	_	_	NNS	O	[-1]	['none']	_	_
26	associated	_	_	VBN	O	[-1]	['none']	_	_
27	with	_	_	IN	O	[-1]	['none']	_	_
28	IPEX	_	_	NNP	O	[-1]	['none']	_	_
29	that	_	_	WDT	O	[-1]	['none']	_	_
30	have	_	_	VBP	O	[-1]	['none']	_	_
31	been	_	_	VBN	O	[-1]	['none']	_	_
32	mapped	_	_	VBN	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	this	_	_	DT	O	[-1]	['none']	_	_
35	region	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	role	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	this	_	_	DT	Anaphora	[5]	['multitoken']	_	_
5	domain	_	_	NN	Anaphora	[0]	['root']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[19]	['Theme']	_	_
8	function	_	_	NN	O	[-1]	['none']	_	_
9	remains	_	_	VBZ	O	[-1]	['none']	_	_
10	uncharacterized	_	_	JJ	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	but	_	_	CC	O	[-1]	['none']	_	_
13	may	_	_	MD	O	[-1]	['none']	_	_
14	play	_	_	VB	Regulation	[16]	['multitoken']	_	_
15	a	_	_	DT	Regulation	[16]	['multitoken']	_	_
16	role	_	_	NN	Regulation	[0]	['root']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	dimer	_	_	NN	Binding	[19]	['multitoken']	_	_
19	formation	_	_	NN	Binding	[16, 22]	['Theme', 'Theme']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	it	_	_	PRP	Anaphora	[0]	['root']	_	_
22	does	_	_	VBZ	Regulation	[0]	['root']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	other	_	_	JJ	O	[-1]	['none']	_	_
25	Foxp	_	_	NN	O	[-1]	['none']	_	_
26	family	_	_	NN	O	[-1]	['none']	_	_
27	members	_	_	NNS	O	[-1]	['none']	_	_
28	[	_	_	VBP	O	[-1]	['none']	_	_
29	44	_	_	CD	O	[-1]	['none']	_	_
30	]	_	_	CD	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Because	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	pathogenesis	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	number	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	retroviral	_	_	JJ	O	[-1]	['none']	_	_
9	induced	_	_	VBN	O	[-1]	['none']	_	_
10	immunologic	_	_	JJ	O	[-1]	['none']	_	_
11	disorders	_	_	NNS	O	[-1]	['none']	_	_
12	such	_	_	JJ	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	HIV-1	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	AIDS	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	HTLV-I/HAM/TSP	_	_	NN	O	[-1]	['none']	_	_
19	have	_	_	VBP	O	[-1]	['none']	_	_
20	been	_	_	VBN	O	[-1]	['none']	_	_
21	associated	_	_	VBN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	dysregulation	_	_	NN	Regulation	[0]	['root']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	Foxp3	_	_	NN	Protein	[26]	['Theme']	_	_
26	expression	_	_	NN	Gene_expression	[23]	['Theme']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	8,45	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	we	_	_	PRP	O	[-1]	['none']	_	_
32	also	_	_	RB	O	[-1]	['none']	_	_
33	examined	_	_	VBD	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	role	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	retroviral	_	_	JJ	O	[-1]	['none']	_	_
40	gene	_	_	NN	O	[-1]	['none']	_	_
41	expression	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	HIV-1	_	_	NNP	O	[-1]	['none']	_	_
2	LTR	_	_	NN	O	[-1]	['none']	_	_
3	activation	_	_	NN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
6	T	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	critically	_	_	RB	O	[-1]	['none']	_	_
10	dependent	_	_	JJ	O	[-1]	['none']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	two	_	_	CD	O	[-1]	['none']	_	_
13	tandem	_	_	JJ	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	sites	_	_	NNS	O	[-1]	['none']	_	_
16	located	_	_	JJ	O	[-1]	['none']	_	_
17	between	_	_	IN	O	[-1]	['none']	_	_
18	nucleotide	_	_	NN	O	[-1]	['none']	_	_
19	positions	_	_	NNS	O	[-1]	['none']	_	_
20	-102	_	_	CD	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	-81	_	_	CD	O	[-1]	['none']	_	_
23	within	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	HIV-1	_	_	NN	O	[-1]	['none']	_	_
26	enhancer	_	_	NN	O	[-1]	['none']	_	_
27	region	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	whereas	_	_	IN	O	[-1]	['none']	_	_
30	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
31	LTR	_	_	NN	O	[-1]	['none']	_	_
32	activation	_	_	NN	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	presence	_	_	NN	O	[-1]	['none']	_	_
36	or	_	_	CC	O	[-1]	['none']	_	_
37	absence	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	HTLV-I-encoded	_	_	JJ	O	[-1]	['none']	_	_
41	transactivator	_	_	NN	O	[-1]	['none']	_	_
42	protein	_	_	NN	O	[-1]	['none']	_	_
43	Tax	_	_	NN	Protein	[0]	['root']	_	_
44	is	_	_	VBZ	O	[-1]	['none']	_	_
45	independent	_	_	JJ	O	[-1]	['none']	_	_
46	of	_	_	IN	O	[-1]	['none']	_	_
47	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
48	[	_	_	CD	O	[-1]	['none']	_	_
49	18	_	_	CD	O	[-1]	['none']	_	_
50	]	_	_	NN	O	[-1]	['none']	_	_
51	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	our	_	_	PRP$	O	[-1]	['none']	_	_
3	knowledge	_	_	NN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	first	_	_	JJ	O	[-1]	['none']	_	_
7	time	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	shown	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	have	_	_	VB	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	direct	_	_	JJ	O	[-1]	['none']	_	_
16	effect	_	_	NN	O	[-1]	['none']	_	_
17	on	_	_	IN	O	[-1]	['none']	_	_
18	HIV-1	_	_	NN	O	[-1]	['none']	_	_
19	LTR	_	_	NN	O	[-1]	['none']	_	_
20	transcription	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Deletion	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	sites	_	_	NNS	O	[-1]	['none']	_	_
6	within	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	HIV-1	_	_	NN	O	[-1]	['none']	_	_
9	enhancer	_	_	NN	O	[-1]	['none']	_	_
10	region	_	_	NN	O	[-1]	['none']	_	_
11	reduced	_	_	VBD	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	responsiveness	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	HIV-1	_	_	NN	O	[-1]	['none']	_	_
17	LTR	_	_	NN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
20	mediated	_	_	VBD	O	[-1]	['none']	_	_
21	suppression	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	FKH	_	_	NN	O	[-1]	['none']	_	_
6	domain	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	required	_	_	VBN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	this	_	_	DT	O	[-1]	['none']	_	_
13	inhibitory	_	_	JJ	O	[-1]	['none']	_	_
14	effect	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	HEK	_	_	NNP	O	[-1]	['none']	_	_
17	293T	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	but	_	_	CC	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	Jurkat	_	_	NN	O	[-1]	['none']	_	_
24	T	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	similar	_	_	JJ	O	[-1]	['none']	_	_
28	to	_	_	TO	O	[-1]	['none']	_	_
29	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
30	mediated	_	_	VBD	O	[-1]	['none']	_	_
31	suppression	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	synthetic	_	_	JJ	O	[-1]	['none']	_	_
35	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
36	reporter	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	direct	_	_	JJ	O	[-1]	['none']	_	_
3	effect	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
6	down-regulating	_	_	JJ	O	[-1]	['none']	_	_
7	HIV-1	_	_	NN	O	[-1]	['none']	_	_
8	gene	_	_	NN	O	[-1]	['none']	_	_
9	expression	_	_	NN	O	[-1]	['none']	_	_
10	correlates	_	_	VBZ	O	[-1]	['none']	_	_
11	well	_	_	RB	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	recently	_	_	RB	O	[-1]	['none']	_	_
14	reported	_	_	VBN	O	[-1]	['none']	_	_
15	evidence	_	_	NN	O	[-1]	['none']	_	_
16	indicating	_	_	VBG	O	[-1]	['none']	_	_
17	that	_	_	IN	O	[-1]	['none']	_	_
18	higher	_	_	JJR	O	[-1]	['none']	_	_
19	regulatory	_	_	JJ	O	[-1]	['none']	_	_
20	activity	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
23	CD25+	_	_	JJ	Protein	[0]	['root']	_	_
24	T	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	from	_	_	IN	O	[-1]	['none']	_	_
27	HIV-1-infected	_	_	JJ	O	[-1]	['none']	_	_
28	patients	_	_	NNS	O	[-1]	['none']	_	_
29	was	_	_	VBD	O	[-1]	['none']	_	_
30	associated	_	_	VBN	O	[-1]	['none']	_	_
31	with	_	_	IN	O	[-1]	['none']	_	_
32	lower	_	_	JJR	O	[-1]	['none']	_	_
33	HIV-1	_	_	NN	O	[-1]	['none']	_	_
34	viral	_	_	JJ	O	[-1]	['none']	_	_
35	loads	_	_	NNS	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	these	_	_	DT	O	[-1]	['none']	_	_
38	patients	_	_	NNS	O	[-1]	['none']	_	_
39	[	_	_	VBP	O	[-1]	['none']	_	_
40	46	_	_	CD	O	[-1]	['none']	_	_
41	]	_	_	CD	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	affected	_	_	VBD	O	[-1]	['none']	_	_
4	two	_	_	CD	O	[-1]	['none']	_	_
5	well-known	_	_	JJ	O	[-1]	['none']	_	_
6	functions	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
9	Tax	_	_	NN	Protein	[0]	['root']	_	_
10	:	_	_	:	O	[-1]	['none']	_	_
11	transactivation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	pathway	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	most	_	_	JJS	O	[-1]	['none']	_	_
19	surprisingly	_	_	RB	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	transactivation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
25	LTR	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Transactivation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
5	LTR	_	_	NN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	Tax	_	_	NN	Protein	[0]	['root']	_	_
8	involves	_	_	VBZ	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	interaction	_	_	NN	Binding	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	ATF/CREB	_	_	NN	O	[-1]	['none']	_	_
13	factors	_	_	NNS	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	Tax	_	_	NN	Protein	[10]	['Theme']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	nucleus	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Binding	_	_	NN	Binding	[8]	['Cause']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Tax	_	_	NN	Protein	[1]	['Theme']	_	_
4	enhances	_	_	VBZ	O	[-1]	['none']	_	_
5	ATF/CREB	_	_	NN	O	[-1]	['none']	_	_
6	dimerization	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	promotes	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
9	assembly	_	_	NN	Binding	[8]	['Theme']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	Tax-ATF	_	_	NN	Protein	[0]	['root']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	CREB	_	_	NN	O	[-1]	['none']	_	_
14	complexes	_	_	NNS	O	[-1]	['none']	_	_
15	onto	_	_	IN	O	[-1]	['none']	_	_
16	specific	_	_	JJ	O	[-1]	['none']	_	_
17	sequences	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	viral	_	_	JJ	O	[-1]	['none']	_	_
21	promoter	_	_	NN	O	[-1]	['none']	_	_
22	known	_	_	VBN	O	[-1]	['none']	_	_
23	as	_	_	IN	O	[-1]	['none']	_	_
24	Tax	_	_	NN	O	[-1]	['none']	_	_
25	responsive	_	_	JJ	O	[-1]	['none']	_	_
26	elements	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	series	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	steps	_	_	NNS	O	[-1]	['none']	_	_
5	allows	_	_	VBZ	O	[-1]	['none']	_	_
6	Tax	_	_	NN	Protein	[8]	['Theme']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	recruit	_	_	VB	Binding	[0]	['root']	_	_
9	coactivator	_	_	NN	O	[-1]	['none']	_	_
10	proteins	_	_	NNS	O	[-1]	['none']	_	_
11	CBP	_	_	NN	Protein	[8]	['Theme']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	p300	_	_	NN	Protein	[8]	['Theme']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	viral	_	_	JJ	O	[-1]	['none']	_	_
17	promoter	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	facilitate	_	_	VB	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	high	_	_	JJ	O	[-1]	['none']	_	_
22	level	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	viral	_	_	JJ	O	[-1]	['none']	_	_
25	gene	_	_	NN	O	[-1]	['none']	_	_
26	expression	_	_	NN	O	[-1]	['none']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	24-26	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Transactivation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	pathway	_	_	NN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	Tax	_	_	NN	Protein	[0]	['root']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	inhibited	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	full-length	_	_	JJ	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[11]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	but	_	_	CC	O	[-1]	['none']	_	_
17	not	_	_	RB	O	[-1]	['none']	_	_
18	deltaFKH	_	_	NN	Protein	[11]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	seen	_	_	VBN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	basal	_	_	JJ	O	[-1]	['none']	_	_
24	activation	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	HIV-1	_	_	NN	O	[-1]	['none']	_	_
28	LTR	_	_	NN	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	synthetic	_	_	JJ	O	[-1]	['none']	_	_
32	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
33	reporter	_	_	NN	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	HEK	_	_	NNP	O	[-1]	['none']	_	_
36	293T	_	_	NN	O	[-1]	['none']	_	_
37	cells	_	_	NNS	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Tax	_	_	NN	Protein	[0]	['root']	_	_
4	mediated	_	_	VBD	O	[-1]	['none']	_	_
5	transactivation	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
9	LTR	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	inhibited	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	overexpression	_	_	NN	Gene_expression	[0]	['root']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	both	_	_	CC	O	[-1]	['none']	_	_
16	full-length	_	_	JJ	O	[-1]	['none']	_	_
17	Foxp3	_	_	NN	Protein	[13]	['Theme']	_	_
18	as	_	_	RB	O	[-1]	['none']	_	_
19	well	_	_	RB	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	deltaFKH	_	_	NN	Protein	[13]	['Theme']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	both	_	_	CC	O	[-1]	['none']	_	_
24	HEK	_	_	NN	O	[-1]	['none']	_	_
25	293T	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
29	T	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
5	did	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	directly	_	_	RB	O	[-1]	['none']	_	_
8	affect	_	_	VB	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	functioning	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	Tax	_	_	NN	Protein	[0]	['root']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	but	_	_	CC	O	[-1]	['none']	_	_
15	rather	_	_	RB	O	[-1]	['none']	_	_
16	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
17	targeted	_	_	VBD	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	transcription	_	_	NN	O	[-1]	['none']	_	_
20	factors	_	_	NNS	O	[-1]	['none']	_	_
21	required	_	_	VBN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	Tax	_	_	NN	Protein	[0]	['root']	_	_
24	transactivation	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	i.e.	_	_	FW	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	then-unknown	_	_	JJ	O	[-1]	['none']	_	_
32	cellular	_	_	JJ	O	[-1]	['none']	_	_
33	factor	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	which	_	_	WDT	O	[-1]	['none']	_	_
36	we	_	_	PRP	O	[-1]	['none']	_	_
37	identified	_	_	VBD	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	this	_	_	DT	O	[-1]	['none']	_	_
40	study	_	_	NN	O	[-1]	['none']	_	_
41	as	_	_	IN	O	[-1]	['none']	_	_
42	CREB	_	_	NN	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	negative	_	_	JJ	O	[-1]	['none']	_	_
3	effect	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
6	on	_	_	IN	O	[-1]	['none']	_	_
7	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
8	gene	_	_	NN	O	[-1]	['none']	_	_
9	expression	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	confirmed	_	_	VBN	O	[-1]	['none']	_	_
12	utilizing	_	_	VBG	O	[-1]	['none']	_	_
13	an	_	_	DT	O	[-1]	['none']	_	_
14	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
15	infectious	_	_	JJ	O	[-1]	['none']	_	_
16	molecular	_	_	JJ	O	[-1]	['none']	_	_
17	clone	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Importantly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	HTLV-I-infected	_	_	JJ	O	[-1]	['none']	_	_
7	individuals	_	_	NNS	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	highest	_	_	JJS	Positive_regulation	[0]	['root']	_	_
11	levels	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Foxp3	_	_	NN	Protein	[15]	['Theme']	_	_
14	protein	_	_	NN	O	[-1]	['none']	_	_
15	expression	_	_	NN	Gene_expression	[10]	['Theme']	_	_
16	within	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
19	CD25+	_	_	JJ	Protein	[0]	['root']	_	_
20	T	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	population	_	_	NN	O	[-1]	['none']	_	_
23	exhibited	_	_	VBD	O	[-1]	['none']	_	_
24	lower	_	_	JJR	O	[-1]	['none']	_	_
25	proviral	_	_	JJ	O	[-1]	['none']	_	_
26	loads	_	_	NNS	O	[-1]	['none']	_	_
27	than	_	_	IN	O	[-1]	['none']	_	_
28	did	_	_	VBD	O	[-1]	['none']	_	_
29	individuals	_	_	NNS	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	lowest	_	_	JJS	Negative_regulation	[0]	['root']	_	_
33	levels	_	_	NNS	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	Foxp3	_	_	NN	Protein	[37]	['Theme']	_	_
36	protein	_	_	NN	O	[-1]	['none']	_	_
37	expression	_	_	NN	Gene_expression	[32]	['Theme']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Previous	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	have	_	_	VBP	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
8	proviral	_	_	JJ	O	[-1]	['none']	_	_
9	load	_	_	NN	O	[-1]	['none']	_	_
10	directly	_	_	RB	O	[-1]	['none']	_	_
11	correlates	_	_	VBZ	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
14	Tax	_	_	NN	Protein	[0]	['root']	_	_
15	mRNA	_	_	NN	O	[-1]	['none']	_	_
16	load	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	frequency	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	immunopathogenic	_	_	JJ	O	[-1]	['none']	_	_
22	virus	_	_	NN	O	[-1]	['none']	_	_
23	specific	_	_	JJ	O	[-1]	['none']	_	_
24	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
25	T	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	disease	_	_	NN	O	[-1]	['none']	_	_
30	severity	_	_	NN	O	[-1]	['none']	_	_
31	in	_	_	IN	O	[-1]	['none']	_	_
32	patients	_	_	NNS	O	[-1]	['none']	_	_
33	with	_	_	IN	O	[-1]	['none']	_	_
34	HAM	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	TSP	_	_	NN	O	[-1]	['none']	_	_
37	[	_	_	CD	O	[-1]	['none']	_	_
38	47	_	_	CD	O	[-1]	['none']	_	_
39	]	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	have	_	_	VBP	O	[-1]	['none']	_	_
4	important	_	_	JJ	O	[-1]	['none']	_	_
5	implications	_	_	NNS	O	[-1]	['none']	_	_
6	on	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	utility	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	controlling	_	_	VBG	O	[-1]	['none']	_	_
13	viral	_	_	JJ	O	[-1]	['none']	_	_
14	gene	_	_	NN	O	[-1]	['none']	_	_
15	expression	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	thus	_	_	RB	O	[-1]	['none']	_	_
18	pathogenesis	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	HAM	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	TSP	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Foxp3	_	_	NN	Protein	[19]	['Theme']	_	_
4	becomes	_	_	VBZ	O	[-1]	['none']	_	_
5	an	_	_	DT	O	[-1]	['none']	_	_
6	attractive	_	_	JJ	O	[-1]	['none']	_	_
7	target	_	_	NN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	development	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	novel	_	_	JJ	O	[-1]	['none']	_	_
13	therapeutic	_	_	JJ	O	[-1]	['none']	_	_
14	applications	_	_	NNS	O	[-1]	['none']	_	_
15	directed	_	_	VBN	O	[-1]	['none']	_	_
16	at	_	_	IN	O	[-1]	['none']	_	_
17	modulating	_	_	VBG	Regulation	[0]	['root']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	expression	_	_	NN	Gene_expression	[17]	['Theme']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	this	_	_	DT	Anaphora	[24]	['multitoken']	_	_
22	important	_	_	JJ	Anaphora	[24]	['multitoken']	_	_
23	regulatory	_	_	JJ	Anaphora	[24]	['multitoken']	_	_
24	protein	_	_	NN	Anaphora	[0]	['root']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	especially	_	_	RB	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	light	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	recent	_	_	JJ	O	[-1]	['none']	_	_
31	observations	_	_	NNS	O	[-1]	['none']	_	_
32	that	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	expression	_	_	NN	Gene_expression	[40]	['Theme']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	Foxp3	_	_	NN	Protein	[34]	['Theme']	_	_
37	can	_	_	MD	O	[-1]	['none']	_	_
38	also	_	_	RB	O	[-1]	['none']	_	_
39	be	_	_	VB	O	[-1]	['none']	_	_
40	down-regulated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
41	by	_	_	IN	O	[-1]	['none']	_	_
42	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
43	Tax	_	_	NN	Protein	[40]	['Cause']	_	_
44	[	_	_	CD	O	[-1]	['none']	_	_
45	8	_	_	CD	O	[-1]	['none']	_	_
46	]	_	_	NN	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	activation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
7	LTR	_	_	NN	O	[-1]	['none']	_	_
8	depends	_	_	VBZ	O	[-1]	['none']	_	_
9	primarily	_	_	RB	O	[-1]	['none']	_	_
10	on	_	_	IN	O	[-1]	['none']	_	_
11	ATF/CREB	_	_	NN	O	[-1]	['none']	_	_
12	proteins	_	_	NNS	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	whether	_	_	IN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	presence	_	_	NN	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	absence	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	Tax	_	_	NN	Protein	[0]	['root']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	we	_	_	PRP	O	[-1]	['none']	_	_
26	investigated	_	_	VBD	O	[-1]	['none']	_	_
27	whether	_	_	IN	O	[-1]	['none']	_	_
28	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
29	could	_	_	MD	O	[-1]	['none']	_	_
30	interact	_	_	VB	O	[-1]	['none']	_	_
31	with	_	_	IN	O	[-1]	['none']	_	_
32	this	_	_	DT	O	[-1]	['none']	_	_
33	additional	_	_	JJ	O	[-1]	['none']	_	_
34	cellular	_	_	JJ	O	[-1]	['none']	_	_
35	signaling	_	_	NN	O	[-1]	['none']	_	_
36	pathway	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	While	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	DNA	_	_	NN	O	[-1]	['none']	_	_
4	binding	_	_	NN	O	[-1]	['none']	_	_
5	activity	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	CREB	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	most	_	_	JJS	O	[-1]	['none']	_	_
12	cases	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	constitutive	_	_	JJ	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	transactivation	_	_	NN	O	[-1]	['none']	_	_
18	potential	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	CREB	_	_	NN	O	[-1]	['none']	_	_
21	is	_	_	VBZ	O	[-1]	['none']	_	_
22	regulated	_	_	VBN	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	CREB	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	recruitment	_	_	NN	Binding	[0]	['root']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	CBP	_	_	NN	Protein	[29]	['Theme']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	p300	_	_	NN	Protein	[29]	['Theme']	_	_
34	[	_	_	CD	O	[-1]	['none']	_	_
35	48	_	_	CD	O	[-1]	['none']	_	_
36	]	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[6]	['Cause']	_	_
6	interferes	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	Anaphora	[13]	['multitoken']	_	_
9	latter	_	_	NN	Anaphora	[13]	['multitoken']	_	_
10	of	_	_	IN	Anaphora	[13]	['multitoken']	_	_
11	these	_	_	DT	Anaphora	[13]	['multitoken']	_	_
12	two	_	_	CD	Anaphora	[13]	['multitoken']	_	_
13	processes	_	_	NNS	Anaphora	[0]	['root']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	that	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	recruitment	_	_	NN	Binding	[29]	['Theme']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	coactivator	_	_	NN	O	[-1]	['none']	_	_
21	protein	_	_	NN	O	[-1]	['none']	_	_
22	p300	_	_	NN	Protein	[17]	['Theme']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	resulting	_	_	VBG	O	[-1]	['none']	_	_
26	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
27	activation	_	_	NN	O	[-1]	['none']	_	_
28	are	_	_	VBP	O	[-1]	['none']	_	_
29	blocked	_	_	VBN	Negative_regulation	[0]	['root']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	Foxp3	_	_	NN	Protein	[29]	['Cause']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	Anaphora	[0]	['root']	_	_
2	may	_	_	MD	O	[-1]	['none']	_	_
3	be	_	_	VB	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	result	_	_	NN	Positive_regulation	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	physical	_	_	JJ	O	[-1]	['none']	_	_
9	interaction	_	_	NN	Binding	[5]	['Cause']	_	_
10	we	_	_	PRP	O	[-1]	['none']	_	_
11	detected	_	_	VBD	O	[-1]	['none']	_	_
12	between	_	_	IN	O	[-1]	['none']	_	_
13	Foxp3	_	_	NN	Protein	[9]	['Theme']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	p300	_	_	NN	Protein	[9]	['Theme']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	With	_	_	IN	O	[-1]	['none']	_	_
2	respect	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
5	LTR	_	_	NN	O	[-1]	['none']	_	_
6	activity	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	while	_	_	IN	O	[-1]	['none']	_	_
9	full-length	_	_	JJ	O	[-1]	['none']	_	_
10	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
11	inhibited	_	_	VBD	O	[-1]	['none']	_	_
12	both	_	_	CC	O	[-1]	['none']	_	_
13	basal	_	_	JJ	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	Tax	_	_	NN	Protein	[0]	['root']	_	_
16	dependent	_	_	JJ	O	[-1]	['none']	_	_
17	transcription	_	_	NN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	~	_	_	NN	O	[-1]	['none']	_	_
20	50	_	_	CD	O	[-1]	['none']	_	_
21	%	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	deltaFKH	_	_	NN	Protein	[0]	['root']	_	_
24	appeared	_	_	VBD	O	[-1]	['none']	_	_
25	less	_	_	RBR	O	[-1]	['none']	_	_
26	effective	_	_	JJ	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	suppressing	_	_	VBG	O	[-1]	['none']	_	_
29	basal	_	_	JJ	O	[-1]	['none']	_	_
30	activation	_	_	NN	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	~	_	_	NN	O	[-1]	['none']	_	_
33	25	_	_	CD	O	[-1]	['none']	_	_
34	%	_	_	NN	O	[-1]	['none']	_	_
35	inhibition	_	_	NN	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	compared	_	_	VBN	O	[-1]	['none']	_	_
38	to	_	_	TO	O	[-1]	['none']	_	_
39	Tax	_	_	NN	Protein	[0]	['root']	_	_
40	dependent	_	_	JJ	O	[-1]	['none']	_	_
41	activation	_	_	NN	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	~	_	_	NN	O	[-1]	['none']	_	_
44	50	_	_	CD	O	[-1]	['none']	_	_
45	%	_	_	NN	O	[-1]	['none']	_	_
46	inhibition	_	_	NN	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	effect	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	deltaFKH	_	_	NN	Protein	[0]	['root']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	basal	_	_	JJ	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
11	LTR	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	HEK	_	_	NNP	O	[-1]	['none']	_	_
14	293T	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	very	_	_	RB	O	[-1]	['none']	_	_
18	similar	_	_	JJ	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	that	_	_	DT	O	[-1]	['none']	_	_
21	shown	_	_	VBN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	a	_	_	DT	O	[-1]	['none']	_	_
24	synthetic	_	_	JJ	O	[-1]	['none']	_	_
25	CREB	_	_	NN	O	[-1]	['none']	_	_
26	reporter	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	suggesting	_	_	VBG	O	[-1]	['none']	_	_
29	that	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	FKH	_	_	NN	O	[-1]	['none']	_	_
32	domain	_	_	NN	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
35	is	_	_	VBZ	O	[-1]	['none']	_	_
36	important	_	_	JJ	O	[-1]	['none']	_	_
37	at	_	_	IN	O	[-1]	['none']	_	_
38	some	_	_	DT	O	[-1]	['none']	_	_
39	level	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	observed	_	_	VBN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	activation	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[10]	['Theme']	_	_
9	mutant	_	_	NN	O	[-1]	['none']	_	_
10	lacking	_	_	VBG	Negative_regulation	[0]	['root']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	FKH	_	_	NN	Entity	[13]	['multitoken']	_	_
13	domain	_	_	NN	Entity	[10]	['Site']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	stronger	_	_	JJR	O	[-1]	['none']	_	_
17	inhibitor	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	CREB	_	_	NN	O	[-1]	['none']	_	_
20	activation	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
23	T	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	than	_	_	IN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	HEK	_	_	NNP	O	[-1]	['none']	_	_
28	293T	_	_	NN	O	[-1]	['none']	_	_
29	epithelial	_	_	JJ	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	it	_	_	PRP	O	[-1]	['none']	_	_
4	appears	_	_	VBZ	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
8	T	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	FKH	_	_	NN	O	[-1]	['none']	_	_
13	domain	_	_	NN	O	[-1]	['none']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	dispensable	_	_	JJ	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	proper	_	_	JJ	O	[-1]	['none']	_	_
19	functioning	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	respect	_	_	NN	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	both	_	_	CC	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	CREB	_	_	NN	O	[-1]	['none']	_	_
29	activation	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	summary	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	this	_	_	DT	O	[-1]	['none']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	our	_	_	PRP$	O	[-1]	['none']	_	_
9	knowledge	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	first	_	_	JJ	O	[-1]	['none']	_	_
13	direct	_	_	JJ	O	[-1]	['none']	_	_
14	evidence	_	_	NN	O	[-1]	['none']	_	_
15	implicating	_	_	VBG	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	role	_	_	NN	O	[-1]	['none']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	Treg	_	_	NNP	O	[-1]	['none']	_	_
21	specific	_	_	JJ	O	[-1]	['none']	_	_
22	transcription	_	_	NN	O	[-1]	['none']	_	_
23	factor	_	_	NN	O	[-1]	['none']	_	_
24	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	regulating	_	_	VBG	O	[-1]	['none']	_	_
27	retroviral	_	_	JJ	O	[-1]	['none']	_	_
28	gene	_	_	NN	O	[-1]	['none']	_	_
29	expression	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	we	_	_	PRP	O	[-1]	['none']	_	_
5	identify	_	_	VBP	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	CREB	_	_	NN	O	[-1]	['none']	_	_
8	pathway	_	_	NN	O	[-1]	['none']	_	_
9	as	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	molecular	_	_	JJ	O	[-1]	['none']	_	_
12	target	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	CREB	_	_	NN	O	[-1]	['none']	_	_
3	has	_	_	VBZ	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	shown	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	regulate	_	_	VB	Regulation	[0]	['root']	_	_
8	multiple	_	_	JJ	Anaphora	[9]	['multitoken']	_	_
9	genes	_	_	NNS	Anaphora	[0]	['root']	_	_
10	involved	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	transcription	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	e.g.	_	_	FW	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	JunD	_	_	NN	Protein	[7]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	c-Fos	_	_	NN	Protein	[7]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	signal	_	_	NN	Protein	[26]	['multitoken']	_	_
21	transducer	_	_	NN	Protein	[26]	['multitoken']	_	_
22	of	_	_	IN	Protein	[26]	['multitoken']	_	_
23	activated	_	_	VBN	Protein	[26]	['multitoken']	_	_
24	T	_	_	NN	Protein	[26]	['multitoken']	_	_
25	cells	_	_	NNS	Protein	[26]	['multitoken']	_	_
26	3	_	_	CD	Protein	[0]	['root']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	STAT3	_	_	NN	Protein	[7]	['Theme']	_	_
29	]	_	_	CD	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	cell	_	_	NN	O	[-1]	['none']	_	_
33	cycle	_	_	NN	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	e.g.	_	_	FW	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	p15INK4b	_	_	NN	Protein	[7]	['Theme']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	cyclin	_	_	NN	Protein	[40]	['multitoken']	_	_
40	A	_	_	NN	Protein	[7]	['Theme']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	cyclin	_	_	NN	Protein	[43]	['multitoken']	_	_
43	D1	_	_	NN	Protein	[7]	['Theme']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	and	_	_	CC	O	[-1]	['none']	_	_
47	immune	_	_	JJ	O	[-1]	['none']	_	_
48	regulation	_	_	NN	O	[-1]	['none']	_	_
49	(	_	_	-LRB-	O	[-1]	['none']	_	_
50	e.g.	_	_	FW	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	IL-2	_	_	NN	Protein	[7]	['Theme']	_	_
53	,	_	_	,	O	[-1]	['none']	_	_
54	IL-6	_	_	NN	Protein	[7]	['Theme']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	T-cell	_	_	NN	Protein	[58]	['multitoken']	_	_
57	receptor	_	_	NN	Protein	[58]	['multitoken']	_	_
58	alpha	_	_	NN	Protein	[7]	['Theme']	_	_
59	)	_	_	-RRB-	O	[-1]	['none']	_	_
60	(	_	_	-LRB-	O	[-1]	['none']	_	_
61	reviewed	_	_	VBN	O	[-1]	['none']	_	_
62	in	_	_	IN	O	[-1]	['none']	_	_
63	[	_	_	CD	O	[-1]	['none']	_	_
64	48	_	_	CD	O	[-1]	['none']	_	_
65	]	_	_	CD	O	[-1]	['none']	_	_
66	)	_	_	-RRB-	O	[-1]	['none']	_	_
67	,	_	_	,	O	[-1]	['none']	_	_
68	the	_	_	DT	O	[-1]	['none']	_	_
69	findings	_	_	NNS	O	[-1]	['none']	_	_
70	presented	_	_	VBN	O	[-1]	['none']	_	_
71	in	_	_	IN	O	[-1]	['none']	_	_
72	this	_	_	DT	O	[-1]	['none']	_	_
73	report	_	_	NN	O	[-1]	['none']	_	_
74	broaden	_	_	VBP	O	[-1]	['none']	_	_
75	the	_	_	DT	O	[-1]	['none']	_	_
76	potential	_	_	JJ	O	[-1]	['none']	_	_
77	range	_	_	NN	O	[-1]	['none']	_	_
78	of	_	_	IN	O	[-1]	['none']	_	_
79	signaling	_	_	NN	O	[-1]	['none']	_	_
80	pathways	_	_	NNS	O	[-1]	['none']	_	_
81	under	_	_	IN	O	[-1]	['none']	_	_
82	the	_	_	DT	O	[-1]	['none']	_	_
83	control	_	_	NN	O	[-1]	['none']	_	_
84	of	_	_	IN	O	[-1]	['none']	_	_
85	the	_	_	DT	O	[-1]	['none']	_	_
86	regulatory	_	_	JJ	O	[-1]	['none']	_	_
87	protein	_	_	NN	O	[-1]	['none']	_	_
88	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
89	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	evidence	_	_	NN	O	[-1]	['none']	_	_
3	stresses	_	_	VBZ	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	importance	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[8]	['Theme']	_	_
8	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	Treg	_	_	NN	O	[-1]	['none']	_	_
11	function	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	development	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	maintenance	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	protective	_	_	JJ	O	[-1]	['none']	_	_
19	immunity	_	_	NN	O	[-1]	['none']	_	_
20	against	_	_	IN	O	[-1]	['none']	_	_
21	HIV-1	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Based	_	_	VBN	O	[-1]	['none']	_	_
2	on	_	_	IN	O	[-1]	['none']	_	_
3	recent	_	_	JJ	O	[-1]	['none']	_	_
4	findings	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
7	may	_	_	MD	O	[-1]	['none']	_	_
8	limit	_	_	VB	O	[-1]	['none']	_	_
9	HIV-1	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
12	transcription	_	_	NN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	interfering	_	_	VBG	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	activation	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	CREB	_	_	NN	O	[-1]	['none']	_	_
21	pathways	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	observing	_	_	VBG	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	this	_	_	DT	O	[-1]	['none']	_	_
6	inhibitory	_	_	JJ	O	[-1]	['none']	_	_
7	effect	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	not	_	_	RB	O	[-1]	['none']	_	_
10	absolute	_	_	JJ	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	low	_	_	JJ	O	[-1]	['none']	_	_
14	level	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	viral	_	_	JJ	O	[-1]	['none']	_	_
17	gene	_	_	NN	O	[-1]	['none']	_	_
18	expression	_	_	NN	O	[-1]	['none']	_	_
19	may	_	_	MD	O	[-1]	['none']	_	_
20	persist	_	_	VB	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
23	T	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	particular	_	_	JJ	O	[-1]	['none']	_	_
28	regulatory	_	_	JJ	O	[-1]	['none']	_	_
29	T	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	which	_	_	WDT	O	[-1]	['none']	_	_
33	are	_	_	VBP	O	[-1]	['none']	_	_
34	known	_	_	VBN	O	[-1]	['none']	_	_
35	reservoirs	_	_	NNS	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	HIV-1	_	_	NN	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	result	_	_	NN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	accumulation	_	_	NN	O	[-1]	['none']	_	_
46	of	_	_	IN	O	[-1]	['none']	_	_
47	viral	_	_	JJ	O	[-1]	['none']	_	_
48	proteins	_	_	NNS	O	[-1]	['none']	_	_
49	that	_	_	WDT	O	[-1]	['none']	_	_
50	either	_	_	CC	O	[-1]	['none']	_	_
51	stimulate	_	_	VBP	O	[-1]	['none']	_	_
52	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
53	and/or	_	_	CC	O	[-1]	['none']	_	_
54	CREB	_	_	NN	O	[-1]	['none']	_	_
55	activation	_	_	NN	O	[-1]	['none']	_	_
56	or	_	_	CC	O	[-1]	['none']	_	_
57	directly	_	_	RB	O	[-1]	['none']	_	_
58	inhibit	_	_	VBP	Negative_regulation	[0]	['root']	_	_
59	Foxp3	_	_	NN	Protein	[60]	['Theme']	_	_
60	expression	_	_	NN	Gene_expression	[58]	['Theme']	_	_
61	or	_	_	CC	O	[-1]	['none']	_	_
62	function	_	_	NN	O	[-1]	['none']	_	_
63	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	imbalance	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	CREB	_	_	NN	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	caused	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	these	_	_	DT	O	[-1]	['none']	_	_
11	viral	_	_	JJ	O	[-1]	['none']	_	_
12	gene	_	_	NN	O	[-1]	['none']	_	_
13	products	_	_	NNS	O	[-1]	['none']	_	_
14	may	_	_	MD	O	[-1]	['none']	_	_
15	be	_	_	VB	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	crucial	_	_	JJ	O	[-1]	['none']	_	_
18	step	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	pathogenesis	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	virus	_	_	NN	O	[-1]	['none']	_	_
24	induced	_	_	VBD	O	[-1]	['none']	_	_
25	immunological	_	_	JJ	O	[-1]	['none']	_	_
26	disorders	_	_	NNS	O	[-1]	['none']	_	_
27	such	_	_	JJ	O	[-1]	['none']	_	_
28	as	_	_	IN	O	[-1]	['none']	_	_
29	AIDS	_	_	NNP	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	HAM	_	_	NNP	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	TSP	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Future	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	will	_	_	MD	O	[-1]	['none']	_	_
4	be	_	_	VB	O	[-1]	['none']	_	_
5	directed	_	_	VBN	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	identifying	_	_	VBG	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	characterizing	_	_	VBG	O	[-1]	['none']	_	_
10	cellular	_	_	JJ	O	[-1]	['none']	_	_
11	proteins	_	_	NNS	O	[-1]	['none']	_	_
12	that	_	_	WDT	O	[-1]	['none']	_	_
13	interact	_	_	VBP	Binding	[0]	['root']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	Foxp3	_	_	NN	Protein	[13]	['Theme']	_	_
16	both	_	_	CC	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	nucleus	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	cytoplasm	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	order	_	_	NN	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	better	_	_	JJR	O	[-1]	['none']	_	_
27	address	_	_	NN	O	[-1]	['none']	_	_
28	how	_	_	WRB	O	[-1]	['none']	_	_
29	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
30	functions	_	_	VBZ	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	guide	_	_	VB	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	development	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	function	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	regulatory	_	_	JJ	O	[-1]	['none']	_	_
39	T	_	_	NN	O	[-1]	['none']	_	_
40	cells	_	_	NNS	O	[-1]	['none']	_	_
41	in	_	_	IN	O	[-1]	['none']	_	_
42	health	_	_	NN	O	[-1]	['none']	_	_
43	and	_	_	CC	O	[-1]	['none']	_	_
44	disease	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vitro	_	_	FW	O	[-1]	['none']	_	_
3	cytokine	_	_	NN	O	[-1]	['none']	_	_
4	secretion	_	_	NN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	BMDC	_	_	NNP	O	[-1]	['none']	_	_
7	The	_	_	NNP	O	[-1]	['none']	_	_
8	BMDC	_	_	NNP	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	cultured	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	triplicate	_	_	JJ	O	[-1]	['none']	_	_
13	wells	_	_	NNS	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	24-well	_	_	JJ	O	[-1]	['none']	_	_
16	or	_	_	CC	O	[-1]	['none']	_	_
17	96-well	_	_	JJ	O	[-1]	['none']	_	_
18	plates	_	_	NNS	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	106	_	_	CD	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	105	_	_	CD	O	[-1]	['none']	_	_
23	cells/mL	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	respectively	_	_	RB	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	RPMI-1640	_	_	NN	O	[-1]	['none']	_	_
29	complete	_	_	JJ	O	[-1]	['none']	_	_
30	medium	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	washed	_	_	VBN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	stimulated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	100	_	_	CD	O	[-1]	['none']	_	_
9	ng/mL	_	_	NN	O	[-1]	['none']	_	_
10	LPS	_	_	NN	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	25	_	_	CD	O	[-1]	['none']	_	_
13	microg/mL	_	_	NN	O	[-1]	['none']	_	_
14	poly	_	_	NN	O	[-1]	['none']	_	_
15	I	_	_	NN	O	[-1]	['none']	_	_
16	:	_	_	:	O	[-1]	['none']	_	_
17	C	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	24	_	_	CD	O	[-1]	['none']	_	_
3	hours	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	supernatants	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	harvested	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	ELISA	_	_	NN	O	[-1]	['none']	_	_
10	analysis	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	presence	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	nitrite	_	_	NN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	supernatants	_	_	NNS	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	determined	_	_	VBN	O	[-1]	['none']	_	_
10	using	_	_	VBG	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	Griess	_	_	NNP	O	[-1]	['none']	_	_
13	reagent	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[0]	['root']	_	_
2	signaling	_	_	NN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	professional	_	_	JJ	O	[-1]	['none']	_	_
5	antigen	_	_	NN	O	[-1]	['none']	_	_
6	presenting	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	including	_	_	VBG	O	[-1]	['none']	_	_
10	B	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	macrophages	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	dendritic	_	_	JJ	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	is	_	_	VBZ	O	[-1]	['none']	_	_
20	critical	_	_	JJ	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	efficient	_	_	JJ	O	[-1]	['none']	_	_
24	activation	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	humoral	_	_	JJ	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	cell	_	_	NN	O	[-1]	['none']	_	_
29	mediated	_	_	JJ	O	[-1]	['none']	_	_
30	immune	_	_	JJ	O	[-1]	['none']	_	_
31	responses	_	_	NNS	O	[-1]	['none']	_	_
32	[	_	_	VBP	O	[-1]	['none']	_	_
33	1	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	CD	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	[	_	_	CD	O	[-1]	['none']	_	_
37	2	_	_	CD	O	[-1]	['none']	_	_
38	]	_	_	CD	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	[	_	_	CD	O	[-1]	['none']	_	_
41	3	_	_	CD	O	[-1]	['none']	_	_
42	]	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[0]	['root']	_	_
2	signaling	_	_	NN	O	[-1]	['none']	_	_
3	is	_	_	VBZ	O	[-1]	['none']	_	_
4	activated	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	dependent	_	_	JJ	O	[-1]	['none']	_	_
10	manner	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	ligand	_	_	NN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	CD40	_	_	NN	Protein	[0]	['root']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	CD154	_	_	NN	Protein	[21]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	is	_	_	VBZ	O	[-1]	['none']	_	_
21	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
22	primarily	_	_	RB	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	activated	_	_	VBN	O	[-1]	['none']	_	_
25	T	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[2]	['Theme']	_	_
2	engagement	_	_	NN	Binding	[0]	['root']	_	_
3	leads	_	_	VBZ	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	activation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	various	_	_	JJ	O	[-1]	['none']	_	_
9	signaling	_	_	VBG	O	[-1]	['none']	_	_
10	molecules	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	including	_	_	VBG	O	[-1]	['none']	_	_
13	stress	_	_	NN	O	[-1]	['none']	_	_
14	activated	_	_	VBN	O	[-1]	['none']	_	_
15	protein	_	_	NN	O	[-1]	['none']	_	_
16	kinases	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	transcription	_	_	NN	O	[-1]	['none']	_	_
20	factor	_	_	NN	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	which	_	_	WDT	O	[-1]	['none']	_	_
24	upregulate	_	_	VBP	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	expression	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	cytokines	_	_	NNS	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	other	_	_	JJ	O	[-1]	['none']	_	_
31	factors	_	_	NNS	O	[-1]	['none']	_	_
32	that	_	_	WDT	O	[-1]	['none']	_	_
33	promote	_	_	VBP	O	[-1]	['none']	_	_
34	immune	_	_	JJ	O	[-1]	['none']	_	_
35	responses	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	mechanism	_	_	NN	O	[-1]	['none']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	which	_	_	WDT	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[0]	['root']	_	_
6	induces	_	_	VBZ	O	[-1]	['none']	_	_
7	these	_	_	DT	O	[-1]	['none']	_	_
8	signaling	_	_	NN	O	[-1]	['none']	_	_
9	pathways	_	_	NNS	O	[-1]	['none']	_	_
10	has	_	_	VBZ	O	[-1]	['none']	_	_
11	not	_	_	RB	O	[-1]	['none']	_	_
12	been	_	_	VBN	O	[-1]	['none']	_	_
13	completely	_	_	RB	O	[-1]	['none']	_	_
14	defined	_	_	VBN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cytoplasmic	_	_	JJ	Entity	[3]	['multitoken']	_	_
3	domain	_	_	NN	Entity	[23]	['Site']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[23]	['Theme']	_	_
6	does	_	_	VBZ	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	appear	_	_	VB	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	have	_	_	VB	O	[-1]	['none']	_	_
11	intrinsic	_	_	JJ	O	[-1]	['none']	_	_
12	enzymatic	_	_	JJ	O	[-1]	['none']	_	_
13	activity	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	but	_	_	CC	O	[-1]	['none']	_	_
16	is	_	_	VBZ	O	[-1]	['none']	_	_
17	able	_	_	JJ	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	mediate	_	_	VB	O	[-1]	['none']	_	_
20	signaling	_	_	NN	O	[-1]	['none']	_	_
21	through	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	recruitment	_	_	NN	Binding	[0]	['root']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	several	_	_	JJ	O	[-1]	['none']	_	_
26	intracellular	_	_	JJ	O	[-1]	['none']	_	_
27	proteins	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Members	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	TNF	_	_	NN	O	[-1]	['none']	_	_
5	receptor	_	_	NN	O	[-1]	['none']	_	_
6	associated	_	_	JJ	O	[-1]	['none']	_	_
7	factor	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	TRAF	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	family	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	including	_	_	VBG	O	[-1]	['none']	_	_
14	TRAF1	_	_	NN	Protein	[0]	['root']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	TRAF3	_	_	NN	Protein	[0]	['root']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	TRAF6	_	_	NN	Protein	[0]	['root']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	appear	_	_	VBP	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	be	_	_	VB	O	[-1]	['none']	_	_
26	particularly	_	_	RB	O	[-1]	['none']	_	_
27	important	_	_	JJ	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	initiation	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	regulation	_	_	NN	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	CD40	_	_	NN	Protein	[0]	['root']	_	_
35	signaling	_	_	NN	O	[-1]	['none']	_	_
36	[	_	_	CD	O	[-1]	['none']	_	_
37	4	_	_	CD	O	[-1]	['none']	_	_
38	]	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	Anaphora	[2]	['multitoken']	_	_
2	proteins	_	_	NNS	Anaphora	[0]	['root']	_	_
3	function	_	_	VBP	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	part	_	_	NN	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	adaptor	_	_	NN	O	[-1]	['none']	_	_
8	molecules	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	binding	_	_	VBG	Binding	[0]	['root']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	cytoplasmic	_	_	JJ	Entity	[14]	['multitoken']	_	_
14	tail	_	_	NN	Entity	[10]	['Site']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	CD40	_	_	NN	Protein	[10]	['Theme']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	recruiting	_	_	VBG	O	[-1]	['none']	_	_
19	other	_	_	JJ	O	[-1]	['none']	_	_
20	proteins	_	_	NNS	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	receptor	_	_	NN	O	[-1]	['none']	_	_
24	associated	_	_	VBN	O	[-1]	['none']	_	_
25	complex	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Some	_	_	DT	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	TRAFs	_	_	NNS	O	[-1]	['none']	_	_
5	also	_	_	RB	O	[-1]	['none']	_	_
6	function	_	_	VBP	O	[-1]	['none']	_	_
7	as	_	_	IN	O	[-1]	['none']	_	_
8	E3	_	_	NN	O	[-1]	['none']	_	_
9	ubiquitin	_	_	NN	O	[-1]	['none']	_	_
10	ligases	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	this	_	_	DT	O	[-1]	['none']	_	_
14	enzymatic	_	_	JJ	O	[-1]	['none']	_	_
15	activity	_	_	NN	O	[-1]	['none']	_	_
16	may	_	_	MD	O	[-1]	['none']	_	_
17	contribute	_	_	VB	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	signal	_	_	VB	O	[-1]	['none']	_	_
20	propagation	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	regulation	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Among	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	Anaphora	[4]	['multitoken']	_	_
3	multiple	_	_	JJ	Anaphora	[4]	['multitoken']	_	_
4	TRAFs	_	_	NNS	Anaphora	[0]	['root']	_	_
5	that	_	_	WDT	Anaphora	[0]	['root']	_	_
6	associate	_	_	VBP	Binding	[0]	['root']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	CD40	_	_	NN	Protein	[6]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	TRAF3	_	_	NN	Protein	[6]	['Theme']	_	_
11	can	_	_	MD	O	[-1]	['none']	_	_
12	function	_	_	VB	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	negative	_	_	JJ	O	[-1]	['none']	_	_
16	regulator	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	signaling	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	while	_	_	IN	O	[-1]	['none']	_	_
21	TRAF2	_	_	NN	Protein	[6]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	TRAF6	_	_	NN	Protein	[6]	['Theme']	_	_
24	promote	_	_	VBP	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	activation	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	downstream	_	_	JJ	O	[-1]	['none']	_	_
29	signaling	_	_	NN	O	[-1]	['none']	_	_
30	pathways	_	_	NNS	O	[-1]	['none']	_	_
31	[	_	_	VBP	O	[-1]	['none']	_	_
32	4	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	CD	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	recently	_	_	RB	O	[-1]	['none']	_	_
3	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	HOIL-1L	_	_	NN	Protein	[7]	['multitoken']	_	_
6	interacting	_	_	VBG	Protein	[7]	['multitoken']	_	_
7	protein	_	_	NN	Protein	[29]	['Theme']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	HOIP	_	_	NN	Protein	[0]	['root']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	ubiquitin	_	_	NN	O	[-1]	['none']	_	_
14	ligase	_	_	NN	O	[-1]	['none']	_	_
15	that	_	_	WDT	O	[-1]	['none']	_	_
16	can	_	_	MD	O	[-1]	['none']	_	_
17	catalyze	_	_	VB	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	assembly	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	linear	_	_	JJ	O	[-1]	['none']	_	_
22	polyubiquitin	_	_	NN	O	[-1]	['none']	_	_
23	chains	_	_	NNS	O	[-1]	['none']	_	_
24	[	_	_	VBP	O	[-1]	['none']	_	_
25	5	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	CD	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	is	_	_	VBZ	O	[-1]	['none']	_	_
29	recruited	_	_	VBN	Binding	[35]	['Theme']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	CD40	_	_	NN	Protein	[29]	['Theme']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	TRAF2	_	_	NN	Protein	[35]	['Cause']	_	_
35	dependent	_	_	JJ	Regulation	[37]	['Theme']	_	_
36	manner	_	_	NN	O	[-1]	['none']	_	_
37	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
38	engagement	_	_	NN	Binding	[37]	['Cause']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	CD40	_	_	NN	Protein	[38]	['Theme']	_	_
41	by	_	_	IN	O	[-1]	['none']	_	_
42	agonistic	_	_	JJ	O	[-1]	['none']	_	_
43	antibody	_	_	NN	O	[-1]	['none']	_	_
44	[	_	_	NN	O	[-1]	['none']	_	_
45	6	_	_	CD	O	[-1]	['none']	_	_
46	]	_	_	NN	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	other	_	_	JJ	O	[-1]	['none']	_	_
4	findings	_	_	NNS	O	[-1]	['none']	_	_
5	led	_	_	VBD	O	[-1]	['none']	_	_
6	us	_	_	PRP	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	hypothesize	_	_	VB	O	[-1]	['none']	_	_
9	that	_	_	DT	O	[-1]	['none']	_	_
10	HOIP	_	_	NN	Protein	[12]	['Cause']	_	_
11	functions	_	_	VBZ	Positive_regulation	[12]	['multitoken']	_	_
12	downstream	_	_	RB	Positive_regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	TRAF2	_	_	NN	Protein	[12]	['Theme']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	CD40	_	_	NN	Protein	[0]	['root']	_	_
18	signaling	_	_	NN	O	[-1]	['none']	_	_
19	pathway	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	HOIP	_	_	NN	Protein	[0]	['root']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	necessary	_	_	JJ	O	[-1]	['none']	_	_
25	for	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	activation	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	possibly	_	_	RB	O	[-1]	['none']	_	_
32	other	_	_	JJ	O	[-1]	['none']	_	_
33	signaling	_	_	VBG	O	[-1]	['none']	_	_
34	molecules	_	_	NNS	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	test	_	_	VB	O	[-1]	['none']	_	_
3	this	_	_	DT	O	[-1]	['none']	_	_
4	hypothesis	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	we	_	_	PRP	O	[-1]	['none']	_	_
7	employed	_	_	VBD	O	[-1]	['none']	_	_
8	somatic	_	_	JJ	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	gene	_	_	NN	O	[-1]	['none']	_	_
11	targeting	_	_	VBG	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	ablate	_	_	VB	Negative_regulation	[0]	['root']	_	_
14	expression	_	_	NN	Gene_expression	[13]	['Theme']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	HOIP	_	_	NNP	Protein	[14]	['Theme']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	mouse	_	_	NN	O	[-1]	['none']	_	_
20	B	_	_	NN	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	line	_	_	NN	O	[-1]	['none']	_	_
23	that	_	_	WDT	O	[-1]	['none']	_	_
24	has	_	_	VBZ	O	[-1]	['none']	_	_
25	proven	_	_	VBN	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	be	_	_	VB	O	[-1]	['none']	_	_
28	a	_	_	DT	O	[-1]	['none']	_	_
29	useful	_	_	JJ	O	[-1]	['none']	_	_
30	model	_	_	NN	O	[-1]	['none']	_	_
31	for	_	_	IN	O	[-1]	['none']	_	_
32	B	_	_	NN	O	[-1]	['none']	_	_
33	cell	_	_	NN	O	[-1]	['none']	_	_
34	CD40	_	_	NN	Protein	[0]	['root']	_	_
35	signaling	_	_	NN	O	[-1]	['none']	_	_
36	[	_	_	NN	O	[-1]	['none']	_	_
37	7	_	_	CD	O	[-1]	['none']	_	_
38	]	_	_	NN	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	[	_	_	CD	O	[-1]	['none']	_	_
41	8	_	_	CD	O	[-1]	['none']	_	_
42	]	_	_	NN	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	[	_	_	CD	O	[-1]	['none']	_	_
45	9	_	_	CD	O	[-1]	['none']	_	_
46	]	_	_	NN	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	found	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[6]	['Cause']	_	_
6	induced	_	_	VBD	Positive_regulation	[19]	['Theme']	_	_
7	upregulation	_	_	NN	Positive_regulation	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	CD80	_	_	NN	Protein	[7]	['Theme']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	costimulatory	_	_	JJ	O	[-1]	['none']	_	_
13	molecule	_	_	NN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	T	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	was	_	_	VBD	O	[-1]	['none']	_	_
19	defective	_	_	JJ	Negative_regulation	[0]	['root']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	HOIP	_	_	NN	Protein	[22]	['Theme']	_	_
22	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Similarly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	CD40	_	_	NN	Protein	[0]	['root']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	IL-4	_	_	NN	Protein	[0]	['root']	_	_
7	driven	_	_	JJ	O	[-1]	['none']	_	_
8	production	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	germline	_	_	NN	O	[-1]	['none']	_	_
11	transcripts	_	_	NNS	O	[-1]	['none']	_	_
12	from	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	immunoglobulin	_	_	NN	O	[-1]	['none']	_	_
15	epsilon	_	_	NN	O	[-1]	['none']	_	_
16	heavy	_	_	JJ	O	[-1]	['none']	_	_
17	chain	_	_	NN	O	[-1]	['none']	_	_
18	locus	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	an	_	_	DT	O	[-1]	['none']	_	_
21	event	_	_	NN	O	[-1]	['none']	_	_
22	that	_	_	WDT	O	[-1]	['none']	_	_
23	precedes	_	_	VBZ	O	[-1]	['none']	_	_
24	immunoglobulin	_	_	NN	O	[-1]	['none']	_	_
25	gene	_	_	NN	O	[-1]	['none']	_	_
26	rearrangement	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	isotype	_	_	NN	O	[-1]	['none']	_	_
29	switching	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	was	_	_	VBD	O	[-1]	['none']	_	_
32	defective	_	_	JJ	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	HOIP	_	_	NN	Protein	[35]	['Theme']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	found	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	CD40	_	_	NN	Protein	[0]	['root']	_	_
7	mediated	_	_	JJ	O	[-1]	['none']	_	_
8	activation	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	stress	_	_	NN	O	[-1]	['none']	_	_
14	activated	_	_	VBN	O	[-1]	['none']	_	_
15	protein	_	_	NN	O	[-1]	['none']	_	_
16	kinase	_	_	NN	O	[-1]	['none']	_	_
17	c-Jun	_	_	NN	O	[-1]	['none']	_	_
18	kinase	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	JNK	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	was	_	_	VBD	O	[-1]	['none']	_	_
23	defective	_	_	JJ	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	HOIP	_	_	NN	Protein	[26]	['Theme']	_	_
26	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Consistent	_	_	JJ	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	impaired	_	_	JJ	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	activation	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	association	_	_	NN	Binding	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	IkappaB	_	_	NN	O	[-1]	['none']	_	_
11	kinase	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	IKK	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	complex	_	_	NN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	CD40	_	_	NN	Protein	[7]	['Theme']	_	_
18	was	_	_	VBD	O	[-1]	['none']	_	_
19	undetectable	_	_	JJ	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	HOIP	_	_	NN	Protein	[22]	['Theme']	_	_
22	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Together	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	results	_	_	NNS	O	[-1]	['none']	_	_
5	indicate	_	_	VBP	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	HOIP	_	_	NN	Protein	[0]	['root']	_	_
8	plays	_	_	VBZ	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	critical	_	_	JJ	O	[-1]	['none']	_	_
11	role	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	signaling	_	_	NN	O	[-1]	['none']	_	_
17	pathways	_	_	NNS	O	[-1]	['none']	_	_
18	that	_	_	WDT	O	[-1]	['none']	_	_
19	regulate	_	_	VBP	O	[-1]	['none']	_	_
20	cellular	_	_	JJ	O	[-1]	['none']	_	_
21	responses	_	_	NNS	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	CD40	_	_	NN	Protein	[24]	['Theme']	_	_
24	engagement	_	_	NN	Binding	[0]	['root']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	down-regulation	_	_	NN	O	[-1]	['none']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	PMA	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	up-regulation	_	_	NN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	heat	_	_	NN	O	[-1]	['none']	_	_
9	killed	_	_	VBD	O	[-1]	['none']	_	_
10	E.	_	_	FW	O	[-1]	['none']	_	_
11	coli	_	_	FW	O	[-1]	['none']	_	_
12	MG1655	_	_	NN	O	[-1]	['none']	_	_
13	following	_	_	VBG	O	[-1]	['none']	_	_
14	long-term	_	_	JJ	O	[-1]	['none']	_	_
15	stimulation	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Transfection	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Jurkat	_	_	NN	O	[-1]	['none']	_	_
4	T-cells	_	_	NNS	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	performed	_	_	VBN	O	[-1]	['none']	_	_
7	using	_	_	VBG	O	[-1]	['none']	_	_
8	luciferase	_	_	NN	Protein	[0]	['root']	_	_
9	reporter	_	_	NN	O	[-1]	['none']	_	_
10	plasmids	_	_	NNS	O	[-1]	['none']	_	_
11	containing	_	_	VBG	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	cis-elements	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Time	_	_	NN	O	[-1]	['none']	_	_
5	dependent	_	_	JJ	O	[-1]	['none']	_	_
6	stimulation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Jurkat	_	_	NN	O	[-1]	['none']	_	_
9	T-cells	_	_	NNS	O	[-1]	['none']	_	_
10	using	_	_	VBG	O	[-1]	['none']	_	_
11	PMA	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	activation	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	evaluated	_	_	VBN	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	HK	_	_	NNP	O	[-1]	['none']	_	_
7	E.	_	_	NNP	O	[-1]	['none']	_	_
8	coli	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	B	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	dose-	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	C	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	time-dependant	_	_	JJ	O	[-1]	['none']	_	_
20	manner	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Calcium	_	_	NN	O	[-1]	['none']	_	_
2	ionophore	_	_	NN	O	[-1]	['none']	_	_
3	increased	_	_	VBD	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	activity	_	_	NN	O	[-1]	['none']	_	_
6	following	_	_	VBG	O	[-1]	['none']	_	_
7	PMA	_	_	NN	O	[-1]	['none']	_	_
8	exposure	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	E	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	resulted	_	_	VBD	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	negative	_	_	JJ	O	[-1]	['none']	_	_
17	regulation	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	response	_	_	NN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	HK	_	_	NNP	O	[-1]	['none']	_	_
22	E.	_	_	NNP	O	[-1]	['none']	_	_
23	coli	_	_	NN	O	[-1]	['none']	_	_
24	stimulation	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	D	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	significance	_	_	NN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	control	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	determined	_	_	VBN	O	[-1]	['none']	_	_
8	using	_	_	VBG	O	[-1]	['none']	_	_
9	Student	_	_	NN	O	[-1]	['none']	_	_
10	's	_	_	POS	O	[-1]	['none']	_	_
11	t-test	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	n	_	_	NN	O	[-1]	['none']	_	_
3	=	_	_	JJ	O	[-1]	['none']	_	_
4	4	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	Controls	_	_	NNP	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	arbitrarily	_	_	RB	O	[-1]	['none']	_	_
4	set	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	1	_	_	CD	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
2	Suppresses	_	_	VBZ	O	[-1]	['none']	_	_
3	HIV-1	_	_	NN	O	[-1]	['none']	_	_
4	Gene	_	_	NN	O	[-1]	['none']	_	_
5	Expression	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	Part	_	_	NN	O	[-1]	['none']	_	_
8	through	_	_	IN	O	[-1]	['none']	_	_
9	Blocking	_	_	VBG	O	[-1]	['none']	_	_
10	Activation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	If	_	_	IN	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
15	functions	_	_	NNS	O	[-1]	['none']	_	_
16	as	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	repressor	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	NF-kappaB-dependent	_	_	JJ	O	[-1]	['none']	_	_
21	gene	_	_	NN	O	[-1]	['none']	_	_
22	expression	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	then	_	_	RB	O	[-1]	['none']	_	_
25	we	_	_	PRP	O	[-1]	['none']	_	_
26	hypothesized	_	_	VBD	O	[-1]	['none']	_	_
27	that	_	_	IN	O	[-1]	['none']	_	_
28	Foxp3	_	_	NN	Protein	[29]	['Theme']	_	_
29	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
30	could	_	_	MD	O	[-1]	['none']	_	_
31	selectively	_	_	RB	O	[-1]	['none']	_	_
32	down-regulate	_	_	VB	O	[-1]	['none']	_	_
33	transcription	_	_	NN	O	[-1]	['none']	_	_
34	from	_	_	IN	O	[-1]	['none']	_	_
35	promoters	_	_	NNS	O	[-1]	['none']	_	_
36	previously	_	_	RB	O	[-1]	['none']	_	_
37	shown	_	_	VBN	O	[-1]	['none']	_	_
38	to	_	_	TO	O	[-1]	['none']	_	_
39	be	_	_	VB	O	[-1]	['none']	_	_
40	responsive	_	_	JJ	O	[-1]	['none']	_	_
41	to	_	_	TO	O	[-1]	['none']	_	_
42	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	address	_	_	VB	O	[-1]	['none']	_	_
3	this	_	_	DT	O	[-1]	['none']	_	_
4	question	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	we	_	_	PRP	O	[-1]	['none']	_	_
7	examined	_	_	VBD	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	HIV-1	_	_	NN	O	[-1]	['none']	_	_
14	LTR	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	which	_	_	WDT	O	[-1]	['none']	_	_
17	contains	_	_	VBZ	O	[-1]	['none']	_	_
18	two	_	_	CD	O	[-1]	['none']	_	_
19	tandem	_	_	JJ	O	[-1]	['none']	_	_
20	cis	_	_	NN	O	[-1]	['none']	_	_
21	acting	_	_	VBG	O	[-1]	['none']	_	_
22	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
23	binding	_	_	NN	O	[-1]	['none']	_	_
24	sites	_	_	NNS	O	[-1]	['none']	_	_
25	located	_	_	JJ	O	[-1]	['none']	_	_
26	between	_	_	IN	O	[-1]	['none']	_	_
27	positions	_	_	NNS	O	[-1]	['none']	_	_
28	-102	_	_	CD	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	-81	_	_	CD	O	[-1]	['none']	_	_
31	with	_	_	IN	O	[-1]	['none']	_	_
32	respect	_	_	NN	O	[-1]	['none']	_	_
33	to	_	_	TO	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	transcription	_	_	NN	O	[-1]	['none']	_	_
36	initiation	_	_	NN	O	[-1]	['none']	_	_
37	site	_	_	NN	O	[-1]	['none']	_	_
38	[	_	_	CD	O	[-1]	['none']	_	_
39	21	_	_	CD	O	[-1]	['none']	_	_
40	]	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	plays	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	crucial	_	_	JJ	O	[-1]	['none']	_	_
5	role	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	regulating	_	_	VBG	O	[-1]	['none']	_	_
8	gene	_	_	NN	O	[-1]	['none']	_	_
9	expression	_	_	NN	O	[-1]	['none']	_	_
10	directed	_	_	VBN	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	HIV-1	_	_	NN	O	[-1]	['none']	_	_
14	LTR	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
17	T	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	[	_	_	VBP	O	[-1]	['none']	_	_
20	21	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	CD	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	full-length	_	_	JJ	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[1]	['Theme']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	but	_	_	CC	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	deltaFKH	_	_	NN	Protein	[1]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	HEK	_	_	NNP	O	[-1]	['none']	_	_
12	293T	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	able	_	_	JJ	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	inhibit	_	_	VB	O	[-1]	['none']	_	_
18	basal	_	_	JJ	O	[-1]	['none']	_	_
19	activation	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	HIV-1	_	_	NN	O	[-1]	['none']	_	_
23	LTR	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	similar	_	_	JJ	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	what	_	_	WP	O	[-1]	['none']	_	_
28	was	_	_	VBD	O	[-1]	['none']	_	_
29	previously	_	_	RB	O	[-1]	['none']	_	_
30	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
31	with	_	_	IN	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	synthetic	_	_	JJ	O	[-1]	['none']	_	_
34	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
35	reporter	_	_	NN	O	[-1]	['none']	_	_
36	vector	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	HIV-1	_	_	NN	O	[-1]	['none']	_	_
4	LTR	_	_	NN	O	[-1]	['none']	_	_
5	activation	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	suppressed	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	full-length	_	_	JJ	O	[-1]	['none']	_	_
10	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	deltaFKH	_	_	NN	Protein	[0]	['root']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	Jurkat	_	_	NN	O	[-1]	['none']	_	_
15	T	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	demonstrate	_	_	VB	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[12]	['Theme']	_	_
5	mediated	_	_	VBD	O	[-1]	['none']	_	_
6	HIV-1	_	_	NN	O	[-1]	['none']	_	_
7	LTR	_	_	NN	O	[-1]	['none']	_	_
8	repression	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	associated	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	interactions	_	_	NNS	Binding	[0]	['root']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	bound	_	_	VBD	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	HIV-1	_	_	NN	O	[-1]	['none']	_	_
19	LTR	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	we	_	_	PRP	O	[-1]	['none']	_	_
22	compared	_	_	VBD	O	[-1]	['none']	_	_
23	basal	_	_	JJ	O	[-1]	['none']	_	_
24	activation	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	HIV-1	_	_	NN	O	[-1]	['none']	_	_
28	LTR	_	_	NN	O	[-1]	['none']	_	_
29	or	_	_	CC	O	[-1]	['none']	_	_
30	an	_	_	DT	O	[-1]	['none']	_	_
31	identical	_	_	JJ	O	[-1]	['none']	_	_
32	HIV-1	_	_	NN	O	[-1]	['none']	_	_
33	LTR	_	_	NN	O	[-1]	['none']	_	_
34	lacking	_	_	VBG	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
37	sites	_	_	NNS	O	[-1]	['none']	_	_
38	located	_	_	JJ	O	[-1]	['none']	_	_
39	between	_	_	IN	O	[-1]	['none']	_	_
40	-102	_	_	CD	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	-81	_	_	CD	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	HIV-1	_	_	NN	O	[-1]	['none']	_	_
45	delta-kappaB	_	_	NN	O	[-1]	['none']	_	_
46	LTR	_	_	NN	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	mutant	_	_	NN	O	[-1]	['none']	_	_
3	HIV-1	_	_	NN	O	[-1]	['none']	_	_
4	LTR	_	_	NN	O	[-1]	['none']	_	_
5	construct	_	_	NN	O	[-1]	['none']	_	_
6	exhibited	_	_	VBD	O	[-1]	['none']	_	_
7	reduced	_	_	VBN	O	[-1]	['none']	_	_
8	levels	_	_	NNS	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	transcription	_	_	NN	O	[-1]	['none']	_	_
11	compared	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	parental	_	_	JJ	O	[-1]	['none']	_	_
15	HIV-1	_	_	NN	O	[-1]	['none']	_	_
16	LTR	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	purified	_	_	VBN	O	[-1]	['none']	_	_
19	healthy	_	_	JJ	O	[-1]	['none']	_	_
20	donor	_	_	NN	O	[-1]	['none']	_	_
21	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
22	T	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	unpublished	_	_	JJ	O	[-1]	['none']	_	_
26	data	_	_	NNS	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	directly	_	_	RB	O	[-1]	['none']	_	_
4	comparing	_	_	VBG	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	effect	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[9]	['Theme']	_	_
9	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
10	on	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	activation	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	these	_	_	DT	O	[-1]	['none']	_	_
15	two	_	_	CD	O	[-1]	['none']	_	_
16	viral	_	_	JJ	O	[-1]	['none']	_	_
17	promoters	_	_	NNS	O	[-1]	['none']	_	_
18	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
19	that	_	_	IN	O	[-1]	['none']	_	_
20	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
21	was	_	_	VBD	O	[-1]	['none']	_	_
22	more	_	_	RBR	O	[-1]	['none']	_	_
23	capable	_	_	JJ	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	suppressing	_	_	VBG	O	[-1]	['none']	_	_
26	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
27	activation	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	HIV-1	_	_	NN	O	[-1]	['none']	_	_
31	LTR	_	_	NN	O	[-1]	['none']	_	_
32	compared	_	_	VBN	O	[-1]	['none']	_	_
33	to	_	_	TO	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	mutated	_	_	JJ	O	[-1]	['none']	_	_
36	HIV-1	_	_	NN	O	[-1]	['none']	_	_
37	LTR	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
6	down-regulation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	HIV-1	_	_	NN	O	[-1]	['none']	_	_
9	LTR	_	_	NN	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	mediated	_	_	VBN	O	[-1]	['none']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	least	_	_	JJS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	part	_	_	NN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	cis	_	_	NN	O	[-1]	['none']	_	_
19	acting	_	_	VBG	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	binding	_	_	NN	O	[-1]	['none']	_	_
22	sites	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Residual	_	_	JJ	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	inhibition	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	HIV-1	_	_	NN	O	[-1]	['none']	_	_
8	delta-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	LTR	_	_	NN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
12	may	_	_	MD	O	[-1]	['none']	_	_
13	be	_	_	VB	O	[-1]	['none']	_	_
14	due	_	_	JJ	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	NF-AT	_	_	NN	O	[-1]	['none']	_	_
17	binding	_	_	NN	O	[-1]	['none']	_	_
18	sites	_	_	NNS	O	[-1]	['none']	_	_
19	located	_	_	JJ	O	[-1]	['none']	_	_
20	upstream	_	_	RB	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	sites	_	_	NNS	O	[-1]	['none']	_	_
25	within	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	HIV-1	_	_	NN	O	[-1]	['none']	_	_
28	LTR	_	_	NN	O	[-1]	['none']	_	_
29	[	_	_	CD	O	[-1]	['none']	_	_
30	22,23	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Antibodies	_	_	NNS	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	reagents	_	_	NNS	O	[-1]	['none']	_	_
4	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	following	_	_	VBG	O	[-1]	['none']	_	_
3	antibodies	_	_	NNS	O	[-1]	['none']	_	_
4	used	_	_	VBN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	intracellular	_	_	JJ	O	[-1]	['none']	_	_
7	or	_	_	CC	O	[-1]	['none']	_	_
8	surface	_	_	NN	O	[-1]	['none']	_	_
9	stains	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	obtained	_	_	VBN	O	[-1]	['none']	_	_
12	from	_	_	IN	O	[-1]	['none']	_	_
13	eBioscience	_	_	NN	O	[-1]	['none']	_	_
14	:	_	_	:	O	[-1]	['none']	_	_
15	anti-IL-2	_	_	NN	Protein	[0]	['root']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	anti-IFN-gamma	_	_	NN	Protein	[0]	['root']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	anti-TNF	_	_	JJ	Protein	[0]	['root']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	anti-granzyme	_	_	JJ	Protein	[22]	['multitoken']	_	_
22	B	_	_	NN	Protein	[0]	['root']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	anti-CD8	_	_	JJ	Protein	[0]	['root']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	anti-CD25	_	_	JJ	Protein	[0]	['root']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	anti-CD44	_	_	NN	Protein	[0]	['root']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Anti-CD69	_	_	NNP	Protein	[0]	['root']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	purchased	_	_	VBN	O	[-1]	['none']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	BD	_	_	NN	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	ChIP	_	_	NN	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	anti-Eomes	_	_	JJ	Protein	[0]	['root']	_	_
7	antibody	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	obtained	_	_	VBN	O	[-1]	['none']	_	_
10	from	_	_	IN	O	[-1]	['none']	_	_
11	Abcam	_	_	NNP	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	anti-Runx3	_	_	JJ	Protein	[0]	['root']	_	_
15	antibody	_	_	NN	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	produced	_	_	VBN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	Groner	_	_	NNP	O	[-1]	['none']	_	_
21	laboratory	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	following	_	_	VBG	O	[-1]	['none']	_	_
3	antibodies	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	used	_	_	VBN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	immunoblotting	_	_	NN	O	[-1]	['none']	_	_
8	:	_	_	:	O	[-1]	['none']	_	_
9	antiperforin	_	_	JJ	Protein	[0]	['root']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Abcam	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	anti-Eomes	_	_	JJ	Protein	[0]	['root']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	Abcam	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	anti-Pol-II	_	_	JJ	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	Santa	_	_	NNP	O	[-1]	['none']	_	_
23	Cruz	_	_	NNP	O	[-1]	['none']	_	_
24	Biotechnology	_	_	NNP	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	Inc.	_	_	NNP	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	T-bet	_	_	JJ	Protein	[0]	['root']	_	_
3	antibody	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	provided	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	L.	_	_	NNP	O	[-1]	['none']	_	_
8	Glimcher	_	_	NNP	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	Harvard	_	_	NNP	O	[-1]	['none']	_	_
11	School	_	_	NNP	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Public	_	_	NNP	O	[-1]	['none']	_	_
14	Health	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	Boston	_	_	NNP	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	MA	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	following	_	_	VBG	O	[-1]	['none']	_	_
3	reagents	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	used	_	_	VBN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	experiments	_	_	NNS	O	[-1]	['none']	_	_
9	presented	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	this	_	_	DT	O	[-1]	['none']	_	_
12	report	_	_	NN	O	[-1]	['none']	_	_
13	:	_	_	:	O	[-1]	['none']	_	_
14	Annexin	_	_	NN	Protein	[15]	['multitoken']	_	_
15	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
16	Apoptosis	_	_	NN	O	[-1]	['none']	_	_
17	Detection	_	_	NN	O	[-1]	['none']	_	_
18	Kit	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	BD	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	CD8	_	_	NN	Protein	[0]	['root']	_	_
24	Negative	_	_	JJ	O	[-1]	['none']	_	_
25	Isolation	_	_	NN	O	[-1]	['none']	_	_
26	Kit	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	CD8	_	_	NN	Protein	[0]	['root']	_	_
32	MicroBeads	_	_	NNS	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	Miltenyi	_	_	NNP	O	[-1]	['none']	_	_
35	Biotec	_	_	NNP	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	SYBR	_	_	NNP	O	[-1]	['none']	_	_
40	Green	_	_	NNP	O	[-1]	['none']	_	_
41	PCR	_	_	NN	O	[-1]	['none']	_	_
42	Core	_	_	NN	O	[-1]	['none']	_	_
43	Reagents	_	_	NNS	O	[-1]	['none']	_	_
44	(	_	_	-LRB-	O	[-1]	['none']	_	_
45	Applied	_	_	NNP	O	[-1]	['none']	_	_
46	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Gp33	_	_	NN	O	[-1]	['none']	_	_
3	peptide	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	KAVYNFATC	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	synthesized	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	Tufts	_	_	NNP	O	[-1]	['none']	_	_
12	University	_	_	NNP	O	[-1]	['none']	_	_
13	Core	_	_	NNP	O	[-1]	['none']	_	_
14	Facility	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	10	_	_	CD	O	[-1]	['none']	_	_
18	mM	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	stock	_	_	NN	O	[-1]	['none']	_	_
21	solutions	_	_	NNS	O	[-1]	['none']	_	_
22	was	_	_	VBD	O	[-1]	['none']	_	_
23	prepared	_	_	VBN	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	DMSO	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Summary	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Analysis	_	_	NN	O	[-1]	['none']	_	_
4	Performed	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	Wild-Type	_	_	JJ	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	LMP1	_	_	NN	Protein	[9]	['Theme']	_	_
9	Transgenic	_	_	JJ	Gene_expression	[0]	['root']	_	_
10	Lymphomas	_	_	NNS	O	[-1]	['none']	_	_

1	HOIP	_	_	NN	Protein	[0]	['root']	_	_
2	mediates	_	_	VBZ	O	[-1]	['none']	_	_
3	CD40	_	_	NN	Protein	[0]	['root']	_	_
4	stimulated	_	_	VBD	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	JNK	_	_	NN	O	[-1]	['none']	_	_
8	activation	_	_	NN	O	[-1]	['none']	_	_
9	The	_	_	DT	O	[-1]	['none']	_	_
10	results	_	_	NNS	O	[-1]	['none']	_	_
11	described	_	_	VBN	O	[-1]	['none']	_	_
12	above	_	_	IN	O	[-1]	['none']	_	_
13	show	_	_	NN	O	[-1]	['none']	_	_
14	that	_	_	IN	O	[-1]	['none']	_	_
15	HOIP	_	_	NN	Protein	[0]	['root']	_	_
16	plays	_	_	VBZ	O	[-1]	['none']	_	_
17	an	_	_	DT	O	[-1]	['none']	_	_
18	important	_	_	JJ	O	[-1]	['none']	_	_
19	role	_	_	NN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	CD40	_	_	NN	Protein	[0]	['root']	_	_
22	mediated	_	_	VBD	O	[-1]	['none']	_	_
23	effector	_	_	NN	O	[-1]	['none']	_	_
24	functions	_	_	NNS	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	B	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	follows	_	_	VBZ	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	HOIP	_	_	NN	Protein	[0]	['root']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	likely	_	_	RB	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	key	_	_	JJ	O	[-1]	['none']	_	_
9	mediator	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	CD40	_	_	NN	Protein	[0]	['root']	_	_
12	signaling	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	test	_	_	VB	O	[-1]	['none']	_	_
3	this	_	_	DT	O	[-1]	['none']	_	_
4	hypothesis	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	we	_	_	PRP	O	[-1]	['none']	_	_
7	stimulated	_	_	VBD	O	[-1]	['none']	_	_
8	A20	_	_	NN	O	[-1]	['none']	_	_
9	.2	_	_	NN	O	[-1]	['none']	_	_
10	J	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	HOIP	_	_	NN	O	[-1]	['none']	_	_
13	deficient	_	_	JJ	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	CD154	_	_	NN	Protein	[21]	['Theme']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	CD40	_	_	NN	Protein	[19]	['multitoken']	_	_
19	ligand	_	_	NN	Protein	[0]	['root']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	HI5	_	_	NN	O	[-1]	['none']	_	_
24	insect	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	[	_	_	VBP	O	[-1]	['none']	_	_
27	7	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	CD	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	[	_	_	CD	O	[-1]	['none']	_	_
31	8	_	_	CD	O	[-1]	['none']	_	_
32	]	_	_	NN	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	measured	_	_	VBN	O	[-1]	['none']	_	_
35	activation	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	JNK	_	_	NN	O	[-1]	['none']	_	_
41	pathways	_	_	NNS	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	two	_	_	CD	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	the	_	_	DT	O	[-1]	['none']	_	_
46	major	_	_	JJ	O	[-1]	['none']	_	_
47	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
48	regulators	_	_	NNS	O	[-1]	['none']	_	_
49	activated	_	_	VBN	O	[-1]	['none']	_	_
50	by	_	_	IN	O	[-1]	['none']	_	_
51	CD40	_	_	NN	Protein	[0]	['root']	_	_
52	[	_	_	CD	O	[-1]	['none']	_	_
53	4	_	_	CD	O	[-1]	['none']	_	_
54	]	_	_	NN	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	associated	_	_	VBD	Binding	[0]	['root']	_	_
3	CD154	_	_	NN	Protein	[2]	['Theme']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	used	_	_	VBN	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	stimulus	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	these	_	_	DT	O	[-1]	['none']	_	_
11	experiments	_	_	NNS	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	it	_	_	PRP	O	[-1]	['none']	_	_
14	typically	_	_	RB	O	[-1]	['none']	_	_
15	provides	_	_	VBZ	O	[-1]	['none']	_	_
16	more	_	_	JJR	O	[-1]	['none']	_	_
17	robust	_	_	JJ	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	therefore	_	_	RB	O	[-1]	['none']	_	_
21	more	_	_	RBR	O	[-1]	['none']	_	_
22	readily	_	_	RB	O	[-1]	['none']	_	_
23	detected	_	_	VBN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	activation	_	_	NN	O	[-1]	['none']	_	_
26	signals	_	_	NNS	O	[-1]	['none']	_	_
27	than	_	_	IN	O	[-1]	['none']	_	_
28	does	_	_	VBZ	O	[-1]	['none']	_	_
29	anti-CD40	_	_	JJ	O	[-1]	['none']	_	_
30	antibody	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Activation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	canonical	_	_	JJ	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	pathway	_	_	NN	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	initiated	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	IkappaB	_	_	NN	O	[-1]	['none']	_	_
14	proteins	_	_	NNS	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	IkappaB	_	_	NN	O	[-1]	['none']	_	_
18	kinase	_	_	NN	O	[-1]	['none']	_	_
19	complex	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	IKK	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	resting	_	_	VBG	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	IkappaB	_	_	NN	O	[-1]	['none']	_	_
6	proteins	_	_	NNS	O	[-1]	['none']	_	_
7	are	_	_	VBP	O	[-1]	['none']	_	_
8	responsible	_	_	JJ	Regulation	[0]	['root']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	sequestering	_	_	VBG	Negative_regulation	[8]	['Theme']	_	_
11	NF-kappaB	_	_	NN	Protein	[12]	['multitoken']	_	_
12	subunits	_	_	NNS	Protein	[10]	['Theme']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	cytoplasm	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Phosphorylation	_	_	NN	O	[-1]	['none']	_	_
2	by	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	IKK	_	_	NN	O	[-1]	['none']	_	_
5	complex	_	_	NN	O	[-1]	['none']	_	_
6	targets	_	_	VBZ	O	[-1]	['none']	_	_
7	IkappaB	_	_	NN	O	[-1]	['none']	_	_
8	proteins	_	_	NNS	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	ubiquitination	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	degradation	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	allowing	_	_	VBG	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	enter	_	_	VB	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	nucleus	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	activate	_	_	VBP	O	[-1]	['none']	_	_
22	gene	_	_	NN	O	[-1]	['none']	_	_
23	expression	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[2]	['Cause']	_	_
2	mediated	_	_	VBD	Positive_regulation	[14]	['Theme']	_	_
3	phosphorylation	_	_	NN	Phosphorylation	[2]	['Theme']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	degradation	_	_	NN	Protein_catabolism	[2]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IkappaBalpha	_	_	NN	Protein	[3, 5]	['Theme', 'Theme']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	HOIP	_	_	NN	Protein	[10]	['Theme']	_	_
10	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	dramatically	_	_	RB	O	[-1]	['none']	_	_
14	impaired	_	_	JJ	Negative_regulation	[0]	['root']	_	_
15	relative	_	_	JJ	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	that	_	_	DT	O	[-1]	['none']	_	_
18	observed	_	_	VBN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	parental	_	_	JJ	O	[-1]	['none']	_	_
21	A20	_	_	NN	O	[-1]	['none']	_	_
22	.2	_	_	NN	O	[-1]	['none']	_	_
23	J	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	assayed	_	_	VBD	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	stress	_	_	NN	O	[-1]	['none']	_	_
8	activated	_	_	VBN	O	[-1]	['none']	_	_
9	protein	_	_	NN	O	[-1]	['none']	_	_
10	kinase	_	_	NN	O	[-1]	['none']	_	_
11	JNK	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	response	_	_	NN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	CD40	_	_	NN	Protein	[16]	['Theme']	_	_
16	engagement	_	_	NN	Binding	[0]	['root']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[0]	['root']	_	_
2	mediated	_	_	VBD	O	[-1]	['none']	_	_
3	JNK	_	_	NN	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	HOIP	_	_	NN	Protein	[7]	['Theme']	_	_
7	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	impaired	_	_	JJ	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	measured	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	Thr183	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	Tyr185	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	JNK	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[0]	['root']	_	_
2	induced	_	_	VBD	O	[-1]	['none']	_	_
3	activation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	JNK	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	HOIP	_	_	NNP	Protein	[10]	['Theme']	_	_
10	reconstituted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	normal	_	_	JJ	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	demonstrating	_	_	VBG	O	[-1]	['none']	_	_
16	that	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	defects	_	_	NNS	O	[-1]	['none']	_	_
19	observed	_	_	VBN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	gene	_	_	NN	O	[-1]	['none']	_	_
22	deficient	_	_	JJ	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	were	_	_	VBD	O	[-1]	['none']	_	_
25	due	_	_	JJ	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	absence	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	HOIP	_	_	NN	Protein	[31]	['Theme']	_	_
31	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Analysis	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
4	Kinase	_	_	NN	O	[-1]	['none']	_	_
5	Activity	_	_	NN	O	[-1]	['none']	_	_
6	Human	_	_	NN	O	[-1]	['none']	_	_
7	MDMs	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	starved	_	_	VBN	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	2	_	_	CD	O	[-1]	['none']	_	_
12	hours	_	_	NNS	O	[-1]	['none']	_	_
13	before	_	_	IN	O	[-1]	['none']	_	_
14	stimulation	_	_	NN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	M-CSF	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	0-60	_	_	CD	O	[-1]	['none']	_	_
19	minutes	_	_	NNS	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	then	_	_	RB	O	[-1]	['none']	_	_
23	washed	_	_	VBN	O	[-1]	['none']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	cold	_	_	JJ	O	[-1]	['none']	_	_
26	PBS	_	_	NNP	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	removed	_	_	VBN	O	[-1]	['none']	_	_
29	from	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	plates	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	resuspended	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	lysis	_	_	NN	O	[-1]	['none']	_	_
7	buffer	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	20	_	_	CD	O	[-1]	['none']	_	_
10	mM	_	_	NN	O	[-1]	['none']	_	_
11	Tris	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	5	_	_	CD	O	[-1]	['none']	_	_
14	mM	_	_	NN	O	[-1]	['none']	_	_
15	MgCl2	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	1	_	_	CD	O	[-1]	['none']	_	_
18	mM	_	_	NN	O	[-1]	['none']	_	_
19	EGTA	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	20	_	_	CD	O	[-1]	['none']	_	_
22	mM	_	_	NN	O	[-1]	['none']	_	_
23	beta-glycerol	_	_	NN	O	[-1]	['none']	_	_
24	phosphate	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	1	_	_	CD	O	[-1]	['none']	_	_
27	mM	_	_	NN	O	[-1]	['none']	_	_
28	PMSF	_	_	NN	O	[-1]	['none']	_	_
29	2	_	_	CD	O	[-1]	['none']	_	_
30	microg/ml	_	_	NN	O	[-1]	['none']	_	_
31	aprotinin	_	_	NN	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	2	_	_	CD	O	[-1]	['none']	_	_
34	microg/ml	_	_	NN	O	[-1]	['none']	_	_
35	leupeptin	_	_	NN	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	pH	_	_	NN	O	[-1]	['none']	_	_
38	7.5	_	_	CD	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	sonicated	_	_	VBN	O	[-1]	['none']	_	_
42	and	_	_	CC	O	[-1]	['none']	_	_
43	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
44	to	_	_	TO	O	[-1]	['none']	_	_
45	obtain	_	_	VB	O	[-1]	['none']	_	_
46	whole	_	_	JJ	O	[-1]	['none']	_	_
47	cell	_	_	NN	O	[-1]	['none']	_	_
48	lysates	_	_	NNS	O	[-1]	['none']	_	_
49	,	_	_	,	O	[-1]	['none']	_	_
50	which	_	_	WDT	O	[-1]	['none']	_	_
51	were	_	_	VBD	O	[-1]	['none']	_	_
52	then	_	_	RB	O	[-1]	['none']	_	_
53	immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
54	with	_	_	IN	O	[-1]	['none']	_	_
55	anti-PKCalpha	_	_	JJ	O	[-1]	['none']	_	_
56	antibody	_	_	NN	O	[-1]	['none']	_	_
57	and	_	_	CC	O	[-1]	['none']	_	_
58	protein	_	_	NN	O	[-1]	['none']	_	_
59	G-agarose	_	_	NN	O	[-1]	['none']	_	_
60	(	_	_	-LRB-	O	[-1]	['none']	_	_
61	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
62	)	_	_	-RRB-	O	[-1]	['none']	_	_
63	.	_	_	.	O	[-1]	['none']	_	_

1	Immune	_	_	JJ	O	[-1]	['none']	_	_
2	complexes	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	washed	_	_	VBN	O	[-1]	['none']	_	_
5	twice	_	_	RB	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
9	activity	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	analyzed	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	non	_	_	JJ	O	[-1]	['none']	_	_
14	radioactive	_	_	JJ	O	[-1]	['none']	_	_
15	Peptag	_	_	NN	O	[-1]	['none']	_	_
16	assay	_	_	NN	O	[-1]	['none']	_	_
17	kit	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	Promega	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	kinase	_	_	NN	O	[-1]	['none']	_	_
4	buffer	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	activator	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	peptide	_	_	NN	O	[-1]	['none']	_	_
9	protection	_	_	NN	O	[-1]	['none']	_	_
10	solution	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	Peptag	_	_	NN	O	[-1]	['none']	_	_
13	peptide	_	_	NN	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	incubated	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	immune	_	_	JJ	O	[-1]	['none']	_	_
19	complexes	_	_	NNS	O	[-1]	['none']	_	_
20	at	_	_	IN	O	[-1]	['none']	_	_
21	30degreesC	_	_	NNP	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	30	_	_	CD	O	[-1]	['none']	_	_
24	minutes	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Reactions	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	stopped	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	boiling	_	_	VBG	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	10	_	_	CD	O	[-1]	['none']	_	_
8	minutes	_	_	NNS	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	samples	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	separated	_	_	VBN	O	[-1]	['none']	_	_
13	on	_	_	IN	O	[-1]	['none']	_	_
14	0.8	_	_	CD	O	[-1]	['none']	_	_
15	%	_	_	NN	O	[-1]	['none']	_	_
16	agarose	_	_	NN	O	[-1]	['none']	_	_
17	gel	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Phosphorylated	_	_	VBN	O	[-1]	['none']	_	_
2	peptide	_	_	NN	O	[-1]	['none']	_	_
3	migrated	_	_	VBD	O	[-1]	['none']	_	_
4	toward	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	anode	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	+	_	_	CC	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	while	_	_	IN	O	[-1]	['none']	_	_
12	non	_	_	JJ	O	[-1]	['none']	_	_
13	phosphorylated	_	_	VBN	O	[-1]	['none']	_	_
14	peptide	_	_	NN	O	[-1]	['none']	_	_
15	migrated	_	_	VBD	O	[-1]	['none']	_	_
16	toward	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	cathode	_	_	NN	O	[-1]	['none']	_	_
19	(-)	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Fluorescein	_	_	NN	O	[-1]	['none']	_	_
2	tagged	_	_	VBD	O	[-1]	['none']	_	_
3	peptides	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	visualized	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	UV	_	_	NN	O	[-1]	['none']	_	_
8	light	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Transient	_	_	JJ	O	[-1]	['none']	_	_
2	Transfection	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	RAW	_	_	NN	O	[-1]	['none']	_	_
5	264.7	_	_	CD	O	[-1]	['none']	_	_
6	Cells	_	_	NNS	O	[-1]	['none']	_	_
7	RAW	_	_	NN	O	[-1]	['none']	_	_
8	264.7	_	_	CD	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	seeded	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	12-well	_	_	JJ	O	[-1]	['none']	_	_
14	plates	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	RPMI	_	_	NN	O	[-1]	['none']	_	_
17	medium	_	_	NN	O	[-1]	['none']	_	_
18	containing	_	_	VBG	O	[-1]	['none']	_	_
19	5	_	_	CD	O	[-1]	['none']	_	_
20	%	_	_	NN	O	[-1]	['none']	_	_
21	FBS	_	_	NN	O	[-1]	['none']	_	_
22	one	_	_	CD	O	[-1]	['none']	_	_
23	day	_	_	NN	O	[-1]	['none']	_	_
24	prior	_	_	RB	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	transfection	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	Secreted	_	_	VBN	O	[-1]	['none']	_	_
29	alkaline	_	_	NN	O	[-1]	['none']	_	_
30	phosphatase	_	_	NN	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	SEAP	_	_	NN	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	reporter	_	_	NN	O	[-1]	['none']	_	_
35	plasmids	_	_	NNS	O	[-1]	['none']	_	_
36	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
37	or	_	_	CC	O	[-1]	['none']	_	_
38	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
39	were	_	_	VBD	O	[-1]	['none']	_	_
40	transfected	_	_	VBN	O	[-1]	['none']	_	_
41	into	_	_	IN	O	[-1]	['none']	_	_
42	cells	_	_	NNS	O	[-1]	['none']	_	_
43	using	_	_	VBG	O	[-1]	['none']	_	_
44	Qiagene	_	_	NNP	O	[-1]	['none']	_	_
45	Effectene	_	_	NNP	O	[-1]	['none']	_	_
46	or	_	_	CC	O	[-1]	['none']	_	_
47	Attractene	_	_	NNP	O	[-1]	['none']	_	_
48	transfection	_	_	NN	O	[-1]	['none']	_	_
49	kit	_	_	NN	O	[-1]	['none']	_	_
50	(	_	_	-LRB-	O	[-1]	['none']	_	_
51	Qiagen	_	_	NNP	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	Valencia	_	_	NNP	O	[-1]	['none']	_	_
54	,	_	_	,	O	[-1]	['none']	_	_
55	CA	_	_	NNP	O	[-1]	['none']	_	_
56	)	_	_	-RRB-	O	[-1]	['none']	_	_
57	according	_	_	VBG	O	[-1]	['none']	_	_
58	to	_	_	TO	O	[-1]	['none']	_	_
59	the	_	_	DT	O	[-1]	['none']	_	_
60	manufacturer	_	_	NN	O	[-1]	['none']	_	_
61	's	_	_	POS	O	[-1]	['none']	_	_
62	protocol	_	_	NN	O	[-1]	['none']	_	_
63	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	co-transfection	_	_	NN	Gene_expression	[0]	['root']	_	_
3	studies	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	PKCalpha	_	_	NN	Protein	[2]	['Theme']	_	_
6	or	_	_	CC	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[2]	['Theme']	_	_
9	constructs	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	mixed	_	_	VBN	O	[-1]	['none']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	ratio	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	5:1	_	_	CD	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	reporter	_	_	NN	O	[-1]	['none']	_	_
20	plasmid	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	siRNA	_	_	NN	O	[-1]	['none']	_	_
3	transfection	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	100	_	_	CD	O	[-1]	['none']	_	_
6	nM	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	PKCalpha	_	_	NN	Protein	[9]	['multitoken']	_	_
9	siRNA	_	_	NN	Protein	[0]	['root']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	control	_	_	NN	O	[-1]	['none']	_	_
12	siRNA	_	_	NN	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	used	_	_	VBN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	incubated	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	transfection	_	_	NN	O	[-1]	['none']	_	_
7	reagents	_	_	NNS	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	16-24	_	_	CD	O	[-1]	['none']	_	_
10	hours	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	washed	_	_	VBN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	starved	_	_	VBN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	RPMI	_	_	NN	O	[-1]	['none']	_	_
17	without	_	_	IN	O	[-1]	['none']	_	_
18	FBS	_	_	NNP	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	4	_	_	CD	O	[-1]	['none']	_	_
21	hours	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Samples	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	then	_	_	RB	O	[-1]	['none']	_	_
4	stimulated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	100	_	_	CD	O	[-1]	['none']	_	_
7	ng/ml	_	_	NN	O	[-1]	['none']	_	_
8	M-CSF	_	_	NN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	4	_	_	CD	O	[-1]	['none']	_	_
11	hours	_	_	NNS	O	[-1]	['none']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	which	_	_	WDT	O	[-1]	['none']	_	_
14	point	_	_	VBP	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	medium	_	_	NN	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	collected	_	_	VBN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	SEAP	_	_	NN	O	[-1]	['none']	_	_
22	analysis	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	inhibition	_	_	NN	O	[-1]	['none']	_	_
3	studies	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	pre-incubated	_	_	JJ	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	30	_	_	CD	O	[-1]	['none']	_	_
12	minutes	_	_	NNS	O	[-1]	['none']	_	_
13	before	_	_	IN	O	[-1]	['none']	_	_
14	M-CSF	_	_	NN	O	[-1]	['none']	_	_
15	treatment	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	On	_	_	IN	O	[-1]	['none']	_	_
2	average	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	we	_	_	PRP	O	[-1]	['none']	_	_
5	realized	_	_	VBD	O	[-1]	['none']	_	_
6	30-40	_	_	CD	O	[-1]	['none']	_	_
7	%	_	_	NN	O	[-1]	['none']	_	_
8	transfection	_	_	NN	O	[-1]	['none']	_	_
9	efficiency	_	_	NN	O	[-1]	['none']	_	_
10	as	_	_	IN	O	[-1]	['none']	_	_
11	confirmed	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	GFP	_	_	NN	Protein	[14]	['Theme']	_	_
14	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	Raw	_	_	NN	O	[-1]	['none']	_	_
17	264.7	_	_	CD	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	effects	_	_	NNS	Regulation	[0]	['root']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	PTX	_	_	NN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	LPS	_	_	NN	O	[-1]	['none']	_	_
7	induced	_	_	VBD	Positive_regulation	[2]	['Theme']	_	_
8	TNF-alpha	_	_	NN	Protein	[9]	['Theme']	_	_
9	production	_	_	NN	Gene_expression	[7]	['Theme']	_	_
10	To	_	_	TO	O	[-1]	['none']	_	_
11	determine	_	_	VB	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	duration	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	PDE	_	_	NN	O	[-1]	['none']	_	_
16	inhibition	_	_	NN	O	[-1]	['none']	_	_
17	on	_	_	IN	O	[-1]	['none']	_	_
18	TNF-alpha	_	_	NN	Protein	[19]	['Theme']	_	_
19	production	_	_	NN	Gene_expression	[22]	['Theme']	_	_
20	after	_	_	IN	O	[-1]	['none']	_	_
21	LPS	_	_	NN	O	[-1]	['none']	_	_
22	stimulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	time	_	_	NN	O	[-1]	['none']	_	_
25	course	_	_	NN	O	[-1]	['none']	_	_
26	studies	_	_	NNS	O	[-1]	['none']	_	_
27	were	_	_	VBD	O	[-1]	['none']	_	_
28	conducted	_	_	VBN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	accordance	_	_	NN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	prior	_	_	JJ	O	[-1]	['none']	_	_
5	work	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	PTX	_	_	NN	O	[-1]	['none']	_	_
8	had	_	_	VBD	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	rapid	_	_	JJ	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	sustained	_	_	JJ	O	[-1]	['none']	_	_
13	effect	_	_	NN	Regulation	[0]	['root']	_	_
14	on	_	_	IN	O	[-1]	['none']	_	_
15	TNF-alpha	_	_	NN	Protein	[16]	['Theme']	_	_
16	production	_	_	NN	Gene_expression	[13]	['Theme']	_	_
17	in	_	_	FW	O	[-1]	['none']	_	_
18	vitro	_	_	FW	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Wild-Type	_	_	NNP	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	LMP1	_	_	NN	Protein	[0]	['root']	_	_
4	Transgenic	_	_	JJ	O	[-1]	['none']	_	_
5	Lymphoma	_	_	NN	O	[-1]	['none']	_	_
6	Cells	_	_	NNS	O	[-1]	['none']	_	_
7	Do	_	_	VBP	O	[-1]	['none']	_	_
8	Not	_	_	RB	O	[-1]	['none']	_	_
9	Require	_	_	VB	O	[-1]	['none']	_	_
10	IL4	_	_	NN	Protein	[0]	['root']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	Stat6	_	_	NN	Protein	[0]	['root']	_	_
13	Signaling	_	_	NN	O	[-1]	['none']	_	_
14	To	_	_	TO	O	[-1]	['none']	_	_
15	investigate	_	_	VB	O	[-1]	['none']	_	_
16	whether	_	_	IN	O	[-1]	['none']	_	_
17	IL4	_	_	NN	Protein	[0]	['root']	_	_
18	independence	_	_	NN	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	due	_	_	JJ	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	endogenous	_	_	JJ	O	[-1]	['none']	_	_
23	IL4	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	IL4	_	_	NN	Protein	[27]	['Theme']	_	_
27	transcription	_	_	NN	Transcription	[0]	['root']	_	_
28	was	_	_	VBD	O	[-1]	['none']	_	_
29	assessed	_	_	VBN	O	[-1]	['none']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	an	_	_	DT	O	[-1]	['none']	_	_
32	Rnase	_	_	NN	O	[-1]	['none']	_	_
33	protection	_	_	NN	O	[-1]	['none']	_	_
34	assay	_	_	NN	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	RPA	_	_	NN	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	IL4	_	_	NN	Protein	[2]	['Theme']	_	_
2	transcription	_	_	NN	Transcription	[0]	['root']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	detectable	_	_	JJ	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	control	_	_	NN	O	[-1]	['none']	_	_
7	RNA	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	faintly	_	_	RB	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	mouse	_	_	NN	O	[-1]	['none']	_	_
13	lymphoma	_	_	NN	O	[-1]	['none']	_	_
14	cell	_	_	NN	O	[-1]	['none']	_	_
15	line	_	_	NN	O	[-1]	['none']	_	_
16	K46mu	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL4	_	_	NN	Protein	[4]	['Theme']	_	_
4	transcription	_	_	NN	Transcription	[0]	['root']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	detectable	_	_	JJ	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
10	MACS	_	_	NNS	O	[-1]	['none']	_	_
11	purified	_	_	VBN	O	[-1]	['none']	_	_
12	B	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	wild-type	_	_	JJ	O	[-1]	['none']	_	_
16	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	unpublished	_	_	JJ	O	[-1]	['none']	_	_
19	data	_	_	NNS	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	LMP1	_	_	NN	Protein	[0]	['root']	_	_
23	transgenic	_	_	JJ	O	[-1]	['none']	_	_
24	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	or	_	_	CC	O	[-1]	['none']	_	_
27	lymphoma	_	_	NN	O	[-1]	['none']	_	_
28	cells	_	_	NNS	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	although	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	GAPDH	_	_	NN	Protein	[0]	['root']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	L32	_	_	NN	Protein	[0]	['root']	_	_
35	controls	_	_	NNS	O	[-1]	['none']	_	_
36	were	_	_	VBD	O	[-1]	['none']	_	_
37	effectively	_	_	RB	O	[-1]	['none']	_	_
38	protected	_	_	VBN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
2	Stat6	_	_	NN	Protein	[1, 8]	['Theme', 'Theme']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	pStat6	_	_	NN	Protein	[0]	['root']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	target	_	_	NN	Regulation	[0]	['root']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	IL4	_	_	NN	Protein	[12]	['multitoken']	_	_
12	receptor	_	_	NN	Protein	[0]	['root']	_	_
13	pathway	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	detected	_	_	VBN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	wild-type	_	_	JJ	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	LMP1	_	_	NN	Protein	[0]	['root']	_	_
22	transgenic	_	_	JJ	O	[-1]	['none']	_	_
23	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	pStat6	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	barely	_	_	RB	O	[-1]	['none']	_	_
7	detected	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	either	_	_	CC	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	wild-type	_	_	JJ	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	LMP1	_	_	NN	Protein	[0]	['root']	_	_
14	transgenic	_	_	JJ	O	[-1]	['none']	_	_
15	lymphoma	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	pathway	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	disabled	_	_	JJ	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	as	_	_	IN	O	[-1]	['none']	_	_
10	treatment	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	lymphoma	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	IL4	_	_	NN	Protein	[17]	['Cause']	_	_
17	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
18	Stat6	_	_	NN	Protein	[19]	['Theme']	_	_
19	phosphorylation	_	_	NN	Phosphorylation	[17]	['Theme']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	wild-type	_	_	JJ	O	[-1]	['none']	_	_
3	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
4	can	_	_	MD	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	be	_	_	VB	O	[-1]	['none']	_	_
7	maintained	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	culture	_	_	NN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	IL4	_	_	NN	Protein	[0]	['root']	_	_
12	supplementation	_	_	NN	O	[-1]	['none']	_	_
13	alone	_	_	RB	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	slight	_	_	JJ	O	[-1]	['none']	_	_
16	enhancement	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	MTS	_	_	NN	O	[-1]	['none']	_	_
19	activity	_	_	NN	O	[-1]	['none']	_	_
20	could	_	_	MD	O	[-1]	['none']	_	_
21	be	_	_	VB	O	[-1]	['none']	_	_
22	detected	_	_	VBN	O	[-1]	['none']	_	_
23	if	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	were	_	_	VBD	O	[-1]	['none']	_	_
27	analyzed	_	_	VBN	O	[-1]	['none']	_	_
28	at	_	_	IN	O	[-1]	['none']	_	_
29	an	_	_	DT	O	[-1]	['none']	_	_
30	earlier	_	_	JJR	O	[-1]	['none']	_	_
31	time	_	_	NN	O	[-1]	['none']	_	_
32	point	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	at	_	_	IN	O	[-1]	['none']	_	_
35	1	_	_	CD	O	[-1]	['none']	_	_
36	d	_	_	NN	O	[-1]	['none']	_	_
37	versus	_	_	CC	O	[-1]	['none']	_	_
38	3	_	_	CD	O	[-1]	['none']	_	_
39	d	_	_	NN	O	[-1]	['none']	_	_
40	post-harvest	_	_	JJ	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	enhancement	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	MTS	_	_	NN	O	[-1]	['none']	_	_
5	activity	_	_	NN	O	[-1]	['none']	_	_
6	induced	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	IL4	_	_	NN	Protein	[0]	['root']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	wild-type	_	_	JJ	O	[-1]	['none']	_	_
11	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
12	could	_	_	MD	O	[-1]	['none']	_	_
13	be	_	_	VB	O	[-1]	['none']	_	_
14	neutralized	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	addition	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	IL4	_	_	NN	Protein	[0]	['root']	_	_
20	antibody	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	neutralizing	_	_	VBG	O	[-1]	['none']	_	_
4	antibodies	_	_	NNS	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	IL4	_	_	NN	Protein	[0]	['root']	_	_
7	did	_	_	VBD	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	affect	_	_	VB	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	MTS	_	_	NN	O	[-1]	['none']	_	_
12	activity	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	LMP1	_	_	NN	Protein	[0]	['root']	_	_
15	transgenic	_	_	JJ	O	[-1]	['none']	_	_
16	lymphoma	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	summary	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	wild-type	_	_	JJ	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	LMP1	_	_	NN	Protein	[0]	['root']	_	_
8	transgenic	_	_	JJ	O	[-1]	['none']	_	_
9	lymphoma	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	grew	_	_	VBD	O	[-1]	['none']	_	_
12	independently	_	_	RB	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	IL4	_	_	NN	Protein	[0]	['root']	_	_
15	treatment	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	did	_	_	VBD	O	[-1]	['none']	_	_
18	not	_	_	RB	O	[-1]	['none']	_	_
19	require	_	_	VB	O	[-1]	['none']	_	_
20	Stat6	_	_	NN	Protein	[0]	['root']	_	_
21	signaling	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	NN	O	[-1]	['none']	_	_
2	blot	_	_	NN	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	Following	_	_	VBG	O	[-1]	['none']	_	_
5	stimulation	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	Jurkat	_	_	NN	O	[-1]	['none']	_	_
8	T-cells	_	_	NNS	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
11	at	_	_	IN	O	[-1]	['none']	_	_
12	1000	_	_	CD	O	[-1]	['none']	_	_
13	x	_	_	CC	O	[-1]	['none']	_	_
14	g	_	_	NN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	8	_	_	CD	O	[-1]	['none']	_	_
17	min	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	lysed	_	_	VBN	O	[-1]	['none']	_	_
20	on	_	_	IN	O	[-1]	['none']	_	_
21	ice	_	_	NN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	2	_	_	CD	O	[-1]	['none']	_	_
24	h	_	_	NN	O	[-1]	['none']	_	_
25	using	_	_	VBG	O	[-1]	['none']	_	_
26	sodium	_	_	NN	O	[-1]	['none']	_	_
27	hydroxide	_	_	NN	O	[-1]	['none']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	addition	_	_	NN	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	a	_	_	DT	O	[-1]	['none']	_	_
33	protease	_	_	NN	O	[-1]	['none']	_	_
34	inhibitor	_	_	NN	O	[-1]	['none']	_	_
35	cocktail	_	_	NN	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	Roche	_	_	NNP	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	Mannheim	_	_	NNP	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	further	_	_	JJ	O	[-1]	['none']	_	_
5	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	8000	_	_	CD	O	[-1]	['none']	_	_
8	x	_	_	CC	O	[-1]	['none']	_	_
9	g	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	4degreesC	_	_	NN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	10	_	_	CD	O	[-1]	['none']	_	_
14	min	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	supernatants	_	_	NNS	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	transferred	_	_	VBN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	new	_	_	JJ	O	[-1]	['none']	_	_
22	tubes	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
2	proteins	_	_	NNS	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	~	_	_	NN	O	[-1]	['none']	_	_
5	8	_	_	CD	O	[-1]	['none']	_	_
6	mug	_	_	NN	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	separated	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	10	_	_	CD	O	[-1]	['none']	_	_
14	%	_	_	NN	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	followed	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	western	_	_	NN	O	[-1]	['none']	_	_
19	blotting	_	_	NN	O	[-1]	['none']	_	_
20	using	_	_	VBG	O	[-1]	['none']	_	_
21	anti-IkappaBbeta	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	phospho-PKC	_	_	JJ	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	pan	_	_	NN	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	zeta	_	_	NN	O	[-1]	['none']	_	_
29	Thr410	_	_	NN	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	190D10	_	_	NN	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	anti-Bcl10	_	_	JJ	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	Cell	_	_	NN	O	[-1]	['none']	_	_
38	Signalling	_	_	NN	O	[-1]	['none']	_	_
39	Technology	_	_	NN	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	Boston	_	_	NNP	O	[-1]	['none']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	and	_	_	CC	O	[-1]	['none']	_	_
44	beta-actin	_	_	NN	Protein	[0]	['root']	_	_
45	(	_	_	-LRB-	O	[-1]	['none']	_	_
46	Abcam	_	_	NNP	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	Cambridge	_	_	NNP	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	Detection	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	performed	_	_	VBN	O	[-1]	['none']	_	_
4	following	_	_	VBG	O	[-1]	['none']	_	_
5	incubation	_	_	NN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	ECL	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	TM	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	Anti-rabbit	_	_	JJ	O	[-1]	['none']	_	_
12	IgG	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	horseradish	_	_	NN	O	[-1]	['none']	_	_
15	peroxidase	_	_	NN	O	[-1]	['none']	_	_
16	linked	_	_	VBN	O	[-1]	['none']	_	_
17	whole	_	_	JJ	O	[-1]	['none']	_	_
18	antibodies	_	_	NNS	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Amersham	_	_	NNP	O	[-1]	['none']	_	_
21	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	Buckinghamshire	_	_	NNP	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	developed	_	_	VBD	O	[-1]	['none']	_	_
27	using	_	_	VBG	O	[-1]	['none']	_	_
28	ECL	_	_	NNP	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	TM	_	_	NNP	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	Western	_	_	NNP	O	[-1]	['none']	_	_
33	Blotting	_	_	NNP	O	[-1]	['none']	_	_
34	Detection	_	_	NN	O	[-1]	['none']	_	_
35	Reagents	_	_	NNS	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	GE	_	_	NNP	O	[-1]	['none']	_	_
38	Healthcare	_	_	NNP	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	UK	_	_	NNP	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Immunological	_	_	JJ	O	[-1]	['none']	_	_
2	tolerance	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	self-antigens	_	_	NNS	O	[-1]	['none']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	result	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	deletion	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	self-reactive	_	_	JJ	O	[-1]	['none']	_	_
13	T	_	_	NN	O	[-1]	['none']	_	_
14	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	thymus	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	central	_	_	JJ	O	[-1]	['none']	_	_
20	tolerance	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	suppression	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	activation	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	potentially	_	_	RB	O	[-1]	['none']	_	_
29	self-reactive	_	_	JJ	O	[-1]	['none']	_	_
30	T	_	_	NN	O	[-1]	['none']	_	_
31	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	periphery	_	_	NN	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	peripheral	_	_	JJ	O	[-1]	['none']	_	_
37	tolerance	_	_	NN	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	[	_	_	NN	O	[-1]	['none']	_	_
40	1	_	_	CD	O	[-1]	['none']	_	_
41	]	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Suppression	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	pathogenic	_	_	JJ	O	[-1]	['none']	_	_
4	T	_	_	NN	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	responses	_	_	NNS	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	mediated	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	naturally	_	_	RB	O	[-1]	['none']	_	_
11	arising	_	_	VBG	O	[-1]	['none']	_	_
12	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
13	CD25+	_	_	JJ	Protein	[0]	['root']	_	_
14	T	_	_	NN	O	[-1]	['none']	_	_
15	regulatory	_	_	JJ	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Tregs	_	_	FW	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	[	_	_	FW	O	[-1]	['none']	_	_
21	2,3	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	CD	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Deficiencies	_	_	NNS	O	[-1]	['none']	_	_
2	in	_	_	IN	O	[-1]	['none']	_	_
3	Treg	_	_	NNP	O	[-1]	['none']	_	_
4	development	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	function	_	_	NN	O	[-1]	['none']	_	_
7	have	_	_	VBP	O	[-1]	['none']	_	_
8	been	_	_	VBN	O	[-1]	['none']	_	_
9	linked	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	severe	_	_	JJ	O	[-1]	['none']	_	_
13	autoimmune	_	_	JJ	O	[-1]	['none']	_	_
14	disorder	_	_	NN	O	[-1]	['none']	_	_
15	known	_	_	VBN	O	[-1]	['none']	_	_
16	as	_	_	IN	O	[-1]	['none']	_	_
17	immune	_	_	JJ	O	[-1]	['none']	_	_
18	dysregulation	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	polyendocrinopathy	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	enteropathy	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	X	_	_	NN	O	[-1]	['none']	_	_
25	linked	_	_	VBN	O	[-1]	['none']	_	_
26	syndrome	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	IPEX	_	_	NNP	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	[	_	_	CD	O	[-1]	['none']	_	_
31	4	_	_	CD	O	[-1]	['none']	_	_
32	]	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	recent	_	_	JJ	O	[-1]	['none']	_	_
5	studies	_	_	NNS	O	[-1]	['none']	_	_
6	have	_	_	VBP	O	[-1]	['none']	_	_
7	provided	_	_	VBN	O	[-1]	['none']	_	_
8	strong	_	_	JJ	O	[-1]	['none']	_	_
9	evidence	_	_	NN	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	dysregulation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Treg	_	_	NNP	O	[-1]	['none']	_	_
14	development	_	_	NN	O	[-1]	['none']	_	_
15	and/or	_	_	CC	O	[-1]	['none']	_	_
16	function	_	_	NN	O	[-1]	['none']	_	_
17	may	_	_	MD	O	[-1]	['none']	_	_
18	be	_	_	VB	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	significant	_	_	JJ	O	[-1]	['none']	_	_
21	factor	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	pathogenesis	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	several	_	_	JJ	O	[-1]	['none']	_	_
27	autoimmune	_	_	JJ	O	[-1]	['none']	_	_
28	disorders	_	_	NNS	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	e.g.	_	_	FW	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	multiple	_	_	JJ	O	[-1]	['none']	_	_
33	sclerosis	_	_	NN	O	[-1]	['none']	_	_
34	[	_	_	CD	O	[-1]	['none']	_	_
35	5	_	_	CD	O	[-1]	['none']	_	_
36	]	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	myasthenia	_	_	NN	O	[-1]	['none']	_	_
39	gravis	_	_	VBZ	O	[-1]	['none']	_	_
40	[	_	_	CD	O	[-1]	['none']	_	_
41	6	_	_	CD	O	[-1]	['none']	_	_
42	]	_	_	NN	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	type	_	_	NN	O	[-1]	['none']	_	_
46	1	_	_	CD	O	[-1]	['none']	_	_
47	diabetes	_	_	NN	O	[-1]	['none']	_	_
48	[	_	_	NN	O	[-1]	['none']	_	_
49	7	_	_	CD	O	[-1]	['none']	_	_
50	]	_	_	CD	O	[-1]	['none']	_	_
51	)	_	_	-RRB-	O	[-1]	['none']	_	_
52	and	_	_	CC	O	[-1]	['none']	_	_
53	virus	_	_	NN	O	[-1]	['none']	_	_
54	induced	_	_	VBD	O	[-1]	['none']	_	_
55	immunologic	_	_	JJ	O	[-1]	['none']	_	_
56	disorders	_	_	NNS	O	[-1]	['none']	_	_
57	(	_	_	-LRB-	O	[-1]	['none']	_	_
58	e.g.	_	_	FW	O	[-1]	['none']	_	_
59	,	_	_	,	O	[-1]	['none']	_	_
60	human	_	_	NN	O	[-1]	['none']	_	_
61	T	_	_	NN	O	[-1]	['none']	_	_
62	lymphotropic	_	_	JJ	O	[-1]	['none']	_	_
63	virus	_	_	NN	O	[-1]	['none']	_	_
64	type	_	_	NN	O	[-1]	['none']	_	_
65	I	_	_	CD	O	[-1]	['none']	_	_
66	[	_	_	CD	O	[-1]	['none']	_	_
67	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
68	]-associated	_	_	JJ	O	[-1]	['none']	_	_
69	myelopathy	_	_	NN	O	[-1]	['none']	_	_
70	and	_	_	CC	O	[-1]	['none']	_	_
71	tropical	_	_	JJ	O	[-1]	['none']	_	_
72	spastic	_	_	JJ	O	[-1]	['none']	_	_
73	paraparesis	_	_	NN	O	[-1]	['none']	_	_
74	[	_	_	CD	O	[-1]	['none']	_	_
75	HAM	_	_	NN	O	[-1]	['none']	_	_
76	and	_	_	CC	O	[-1]	['none']	_	_
77	TSP	_	_	NN	O	[-1]	['none']	_	_
78	]	_	_	NN	O	[-1]	['none']	_	_
79	,	_	_	,	O	[-1]	['none']	_	_
80	and	_	_	CC	O	[-1]	['none']	_	_
81	HIV	_	_	NN	O	[-1]	['none']	_	_
82	induced	_	_	VBD	O	[-1]	['none']	_	_
83	AIDS	_	_	NNP	O	[-1]	['none']	_	_
84	[	_	_	NN	O	[-1]	['none']	_	_
85	8-10	_	_	CD	O	[-1]	['none']	_	_
86	]	_	_	CD	O	[-1]	['none']	_	_
87	)	_	_	-RRB-	O	[-1]	['none']	_	_
88	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	transcription	_	_	NN	O	[-1]	['none']	_	_
3	factor	_	_	NN	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[13]	['Theme']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	a	_	_	DT	Anaphora	[12]	['multitoken']	_	_
7	431-amino	_	_	NN	Anaphora	[12]	['multitoken']	_	_
8	acid	_	_	NN	Anaphora	[12]	['multitoken']	_	_
9	(	_	_	-LRB-	Anaphora	[12]	['multitoken']	_	_
10	48-kDa	_	_	JJ	Anaphora	[12]	['multitoken']	_	_
11	)	_	_	-RRB-	Anaphora	[12]	['multitoken']	_	_
12	protein	_	_	NN	Anaphora	[0]	['root']	_	_
13	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
14	at	_	_	IN	O	[-1]	['none']	_	_
15	very	_	_	RB	O	[-1]	['none']	_	_
16	high	_	_	JJ	O	[-1]	['none']	_	_
17	levels	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
20	CD25hi	_	_	NN	Protein	[0]	['root']	_	_
21	T	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	has	_	_	VBZ	O	[-1]	['none']	_	_
25	previously	_	_	RB	O	[-1]	['none']	_	_
26	been	_	_	VBN	O	[-1]	['none']	_	_
27	shown	_	_	VBN	O	[-1]	['none']	_	_
28	to	_	_	TO	O	[-1]	['none']	_	_
29	be	_	_	VB	O	[-1]	['none']	_	_
30	absolutely	_	_	RB	O	[-1]	['none']	_	_
31	critical	_	_	JJ	O	[-1]	['none']	_	_
32	for	_	_	IN	O	[-1]	['none']	_	_
33	Treg	_	_	NNP	O	[-1]	['none']	_	_
34	development	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	function	_	_	NN	O	[-1]	['none']	_	_
37	[	_	_	CD	O	[-1]	['none']	_	_
38	11-14	_	_	CD	O	[-1]	['none']	_	_
39	]	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[42, 46, 56, 59, 62]	['Cause', 'Theme', 'Cause', 'Theme', 'Theme']	_	_
2	contains	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	proline	_	_	NN	O	[-1]	['none']	_	_
5	rich	_	_	JJ	O	[-1]	['none']	_	_
6	amino-terminal	_	_	JJ	O	[-1]	['none']	_	_
7	domain	_	_	NN	O	[-1]	['none']	_	_
8	reported	_	_	VBD	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	function	_	_	VB	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	nuclear	_	_	JJ	O	[-1]	['none']	_	_
14	factor	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	activated	_	_	VBN	O	[-1]	['none']	_	_
17	T	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	NF-AT	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	nuclear	_	_	JJ	O	[-1]	['none']	_	_
24	factor-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	binding	_	_	NN	O	[-1]	['none']	_	_
29	domain	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	a	_	_	DT	O	[-1]	['none']	_	_
32	central	_	_	JJ	O	[-1]	['none']	_	_
33	region	_	_	NN	O	[-1]	['none']	_	_
34	containing	_	_	VBG	O	[-1]	['none']	_	_
35	a	_	_	DT	O	[-1]	['none']	_	_
36	zinc	_	_	NN	O	[-1]	['none']	_	_
37	finger	_	_	NN	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	leucine	_	_	NN	Entity	[40]	['multitoken']	_	_
40	zipper	_	_	NN	Entity	[42]	['CSite']	_	_
41	potentially	_	_	RB	O	[-1]	['none']	_	_
42	important	_	_	JJ	Positive_regulation	[0]	['root']	_	_
43	for	_	_	IN	O	[-1]	['none']	_	_
44	protein	_	_	NN	O	[-1]	['none']	_	_
45	protein	_	_	NN	O	[-1]	['none']	_	_
46	interactions	_	_	NNS	Binding	[42]	['Theme']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	and	_	_	CC	O	[-1]	['none']	_	_
49	a	_	_	DT	O	[-1]	['none']	_	_
50	carboxyl-terminal	_	_	JJ	Entity	[55]	['multitoken']	_	_
51	forkhead	_	_	NN	Entity	[55]	['multitoken']	_	_
52	(	_	_	-LRB-	Entity	[55]	['multitoken']	_	_
53	FKH	_	_	NN	Entity	[55]	['multitoken']	_	_
54	)	_	_	-RRB-	Entity	[55]	['multitoken']	_	_
55	domain	_	_	NN	Entity	[56]	['CSite']	_	_
56	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
57	for	_	_	IN	O	[-1]	['none']	_	_
58	nuclear	_	_	JJ	Entity	[59]	['ToLoc']	_	_
59	localization	_	_	NN	Localization	[56]	['Theme']	_	_
60	and	_	_	CC	O	[-1]	['none']	_	_
61	DNA	_	_	NN	O	[-1]	['none']	_	_
62	binding	_	_	NN	Binding	[56]	['Theme']	_	_
63	activity	_	_	NN	O	[-1]	['none']	_	_
64	[	_	_	CD	O	[-1]	['none']	_	_
65	14-16	_	_	CD	O	[-1]	['none']	_	_
66	]	_	_	NN	O	[-1]	['none']	_	_
67	.	_	_	.	O	[-1]	['none']	_	_

1	Functional	_	_	JJ	O	[-1]	['none']	_	_
2	inactivation	_	_	NN	Negative_regulation	[0]	['root']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[2]	['Theme']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	genetic	_	_	JJ	O	[-1]	['none']	_	_
7	mutations	_	_	NNS	O	[-1]	['none']	_	_
8	affecting	_	_	VBG	Regulation	[2]	['Cause']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	Foxp3	_	_	NN	Protein	[8]	['Theme']	_	_
11	coding	_	_	VBG	Entity	[12]	['multitoken']	_	_
12	region	_	_	NN	Entity	[8]	['Site']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	IPEX	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	repression	_	_	NN	Negative_regulation	[0]	['root']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	Foxp3	_	_	NN	Protein	[23]	['Theme']	_	_
23	expression	_	_	NN	Gene_expression	[20]	['Theme']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	HTLV-I-encoded	_	_	JJ	O	[-1]	['none']	_	_
27	transactivator	_	_	NN	O	[-1]	['none']	_	_
28	protein	_	_	NN	O	[-1]	['none']	_	_
29	Tax	_	_	NN	Protein	[20]	['Cause']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	as	_	_	IN	O	[-1]	['none']	_	_
32	recently	_	_	RB	O	[-1]	['none']	_	_
33	reported	_	_	VBN	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	patients	_	_	NNS	O	[-1]	['none']	_	_
36	with	_	_	IN	O	[-1]	['none']	_	_
37	HAM	_	_	NN	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	TSP	_	_	NN	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	results	_	_	VBZ	O	[-1]	['none']	_	_
42	in	_	_	IN	O	[-1]	['none']	_	_
43	loss	_	_	NN	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	regulatory	_	_	JJ	O	[-1]	['none']	_	_
46	activity	_	_	NN	O	[-1]	['none']	_	_
47	in	_	_	IN	O	[-1]	['none']	_	_
48	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
49	CD25hi	_	_	NN	Protein	[0]	['root']	_	_
50	T	_	_	NN	O	[-1]	['none']	_	_
51	cells	_	_	NNS	O	[-1]	['none']	_	_
52	[	_	_	VBP	O	[-1]	['none']	_	_
53	4,8,17	_	_	CD	O	[-1]	['none']	_	_
54	]	_	_	CD	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	it	_	_	PRP	O	[-1]	['none']	_	_
3	is	_	_	VBZ	O	[-1]	['none']	_	_
4	clear	_	_	JJ	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
7	regulates	_	_	VBZ	O	[-1]	['none']	_	_
8	T	_	_	NN	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	proliferation	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	cytokine	_	_	NN	O	[-1]	['none']	_	_
13	production	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	very	_	_	RB	O	[-1]	['none']	_	_
16	little	_	_	JJ	O	[-1]	['none']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	known	_	_	VBN	O	[-1]	['none']	_	_
19	concerning	_	_	VBG	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	molecular	_	_	JJ	O	[-1]	['none']	_	_
22	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
25	function	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	first	_	_	JJ	O	[-1]	['none']	_	_
3	evidence	_	_	NN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	indicate	_	_	VB	O	[-1]	['none']	_	_
6	how	_	_	WRB	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
8	promotes	_	_	VBZ	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	development	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	function	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	regulatory	_	_	JJ	O	[-1]	['none']	_	_
15	T	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	came	_	_	VBD	O	[-1]	['none']	_	_
18	from	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	report	_	_	NN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	Ziegler	_	_	NNP	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	colleagues	_	_	NNS	O	[-1]	['none']	_	_
25	[	_	_	VBP	O	[-1]	['none']	_	_
26	16	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	CD	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	which	_	_	WDT	O	[-1]	['none']	_	_
30	suggested	_	_	VBD	O	[-1]	['none']	_	_
31	that	_	_	IN	O	[-1]	['none']	_	_
32	Foxp3	_	_	NN	Protein	[39]	['Theme']	_	_
33	could	_	_	MD	O	[-1]	['none']	_	_
34	inhibit	_	_	VB	Negative_regulation	[0]	['root']	_	_
35	transcriptional	_	_	JJ	Positive_regulation	[36]	['multitoken']	_	_
36	activation	_	_	NN	Positive_regulation	[34]	['Theme']	_	_
37	by	_	_	IN	O	[-1]	['none']	_	_
38	physically	_	_	RB	O	[-1]	['none']	_	_
39	interacting	_	_	VBG	Binding	[34]	['Cause']	_	_
40	with	_	_	IN	O	[-1]	['none']	_	_
41	forkhead	_	_	NN	O	[-1]	['none']	_	_
42	binding	_	_	NN	O	[-1]	['none']	_	_
43	sites	_	_	NNS	O	[-1]	['none']	_	_
44	located	_	_	JJ	O	[-1]	['none']	_	_
45	immediately	_	_	RB	O	[-1]	['none']	_	_
46	adjacent	_	_	JJ	O	[-1]	['none']	_	_
47	to	_	_	TO	O	[-1]	['none']	_	_
48	critical	_	_	JJ	O	[-1]	['none']	_	_
49	cis	_	_	NN	O	[-1]	['none']	_	_
50	acting	_	_	VBG	O	[-1]	['none']	_	_
51	NF-AT	_	_	NN	O	[-1]	['none']	_	_
52	binding	_	_	NN	O	[-1]	['none']	_	_
53	sites	_	_	NNS	O	[-1]	['none']	_	_
54	found	_	_	VBN	O	[-1]	['none']	_	_
55	in	_	_	IN	O	[-1]	['none']	_	_
56	various	_	_	JJ	O	[-1]	['none']	_	_
57	cytokine	_	_	NN	Anaphora	[58]	['multitoken']	_	_
58	promoters	_	_	NNS	Anaphora	[0]	['root']	_	_
59	(	_	_	-LRB-	O	[-1]	['none']	_	_
60	e.g.	_	_	FW	O	[-1]	['none']	_	_
61	,	_	_	,	O	[-1]	['none']	_	_
62	IL-2	_	_	NN	Protein	[36]	['Theme']	_	_
63	promoter	_	_	NN	Entity	[36]	['Site']	_	_
64	)	_	_	-RRB-	O	[-1]	['none']	_	_
65	.	_	_	.	O	[-1]	['none']	_	_

1	That	_	_	DT	O	[-1]	['none']	_	_
2	study	_	_	NN	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
7	could	_	_	MD	O	[-1]	['none']	_	_
8	repress	_	_	VB	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	synthetic	_	_	JJ	O	[-1]	['none']	_	_
13	reporter	_	_	NN	O	[-1]	['none']	_	_
14	vector	_	_	NN	O	[-1]	['none']	_	_
15	containing	_	_	VBG	O	[-1]	['none']	_	_
16	an	_	_	DT	O	[-1]	['none']	_	_
17	SV40	_	_	NN	O	[-1]	['none']	_	_
18	promoter	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	three	_	_	CD	O	[-1]	['none']	_	_
21	tandem	_	_	JJ	O	[-1]	['none']	_	_
22	copies	_	_	NNS	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	forkhead	_	_	NN	O	[-1]	['none']	_	_
26	binding	_	_	NN	O	[-1]	['none']	_	_
27	site	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	provided	_	_	VBD	O	[-1]	['none']	_	_
4	additional	_	_	JJ	O	[-1]	['none']	_	_
5	evidence	_	_	NN	O	[-1]	['none']	_	_
6	suggesting	_	_	VBG	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[14]	['Theme']	_	_
9	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
10	repression	_	_	NN	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	mediated	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	binding	_	_	NN	Binding	[0]	['root']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	sequence	_	_	NN	O	[-1]	['none']	_	_
18	specific	_	_	JJ	O	[-1]	['none']	_	_
19	manner	_	_	NN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	promoters	_	_	NNS	O	[-1]	['none']	_	_
22	containing	_	_	VBG	O	[-1]	['none']	_	_
23	forkhead	_	_	NN	O	[-1]	['none']	_	_
24	binding	_	_	NN	O	[-1]	['none']	_	_
25	sites	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	recent	_	_	JJ	O	[-1]	['none']	_	_
3	study	_	_	NN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	Bettelli	_	_	NNP	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	colleagues	_	_	NNS	O	[-1]	['none']	_	_
8	[	_	_	VBP	O	[-1]	['none']	_	_
9	15	_	_	CD	O	[-1]	['none']	_	_
10	]	_	_	CD	O	[-1]	['none']	_	_
11	further	_	_	JJ	O	[-1]	['none']	_	_
12	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
15	could	_	_	MD	O	[-1]	['none']	_	_
16	inhibit	_	_	VB	O	[-1]	['none']	_	_
17	NF-AT	_	_	NN	O	[-1]	['none']	_	_
18	as	_	_	RB	O	[-1]	['none']	_	_
19	well	_	_	RB	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	activation	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	although	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	mechanism	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	suppression	_	_	NN	O	[-1]	['none']	_	_
29	was	_	_	VBD	O	[-1]	['none']	_	_
30	shown	_	_	VBN	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	involve	_	_	VB	O	[-1]	['none']	_	_
33	direct	_	_	JJ	O	[-1]	['none']	_	_
34	protein	_	_	NN	O	[-1]	['none']	_	_
35	protein	_	_	NN	O	[-1]	['none']	_	_
36	interactions	_	_	NNS	Binding	[0]	['root']	_	_
37	between	_	_	IN	O	[-1]	['none']	_	_
38	NF-AT	_	_	NN	O	[-1]	['none']	_	_
39	or	_	_	CC	O	[-1]	['none']	_	_
40	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	Foxp3	_	_	NN	Protein	[36]	['Theme']	_	_
43	rather	_	_	RB	O	[-1]	['none']	_	_
44	than	_	_	IN	O	[-1]	['none']	_	_
45	binding	_	_	NN	Binding	[0]	['root']	_	_
46	of	_	_	IN	O	[-1]	['none']	_	_
47	Foxp3	_	_	NN	Protein	[45]	['Theme']	_	_
48	to	_	_	TO	O	[-1]	['none']	_	_
49	promoter	_	_	NN	O	[-1]	['none']	_	_
50	elements	_	_	NNS	O	[-1]	['none']	_	_
51	adjacent	_	_	JJ	O	[-1]	['none']	_	_
52	to	_	_	TO	O	[-1]	['none']	_	_
53	cis	_	_	NN	O	[-1]	['none']	_	_
54	acting	_	_	VBG	O	[-1]	['none']	_	_
55	NF-AT	_	_	NN	O	[-1]	['none']	_	_
56	or	_	_	CC	O	[-1]	['none']	_	_
57	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
58	sites	_	_	NNS	O	[-1]	['none']	_	_
59	.	_	_	.	O	[-1]	['none']	_	_

1	Collectively	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	data	_	_	NNS	O	[-1]	['none']	_	_
5	suggested	_	_	VBD	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[26]	['Theme']	_	_
8	may	_	_	MD	O	[-1]	['none']	_	_
9	function	_	_	VB	O	[-1]	['none']	_	_
10	as	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
13	repressor	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	potentially	_	_	RB	O	[-1]	['none']	_	_
16	through	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	formation	_	_	NN	Positive_regulation	[0]	['root']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	both	_	_	CC	O	[-1]	['none']	_	_
21	DNA	_	_	NN	O	[-1]	['none']	_	_
22	protein	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	protein	_	_	NN	O	[-1]	['none']	_	_
25	protein	_	_	NN	O	[-1]	['none']	_	_
26	interactions	_	_	NNS	Binding	[18]	['Theme']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	present	_	_	JJ	O	[-1]	['none']	_	_
4	study	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	we	_	_	PRP	O	[-1]	['none']	_	_
7	expanded	_	_	VBD	O	[-1]	['none']	_	_
8	upon	_	_	IN	O	[-1]	['none']	_	_
9	these	_	_	DT	O	[-1]	['none']	_	_
10	observations	_	_	NNS	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	defining	_	_	VBG	O	[-1]	['none']	_	_
13	additional	_	_	JJ	O	[-1]	['none']	_	_
14	requirements	_	_	NNS	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
17	mediated	_	_	VBD	O	[-1]	['none']	_	_
18	repression	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	activation	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	investigated	_	_	VBD	O	[-1]	['none']	_	_
25	whether	_	_	IN	O	[-1]	['none']	_	_
26	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
27	could	_	_	MD	O	[-1]	['none']	_	_
28	target	_	_	VB	O	[-1]	['none']	_	_
29	additional	_	_	JJ	O	[-1]	['none']	_	_
30	signaling	_	_	NN	O	[-1]	['none']	_	_
31	pathways	_	_	NNS	O	[-1]	['none']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	examining	_	_	VBG	O	[-1]	['none']	_	_
34	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
35	activation	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	NF-kappaB-dependent	_	_	JJ	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	NF-kappaB-independent	_	_	JJ	O	[-1]	['none']	_	_
40	retroviral	_	_	JJ	O	[-1]	['none']	_	_
41	pathogens	_	_	NNS	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	characterization	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	molecular	_	_	JJ	O	[-1]	['none']	_	_
6	targets	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	mechanism	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	s	_	_	NNS	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	utilized	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	support	_	_	VB	O	[-1]	['none']	_	_
20	Treg	_	_	NNP	O	[-1]	['none']	_	_
21	development	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	function	_	_	NN	O	[-1]	['none']	_	_
24	will	_	_	MD	O	[-1]	['none']	_	_
25	aid	_	_	VB	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	our	_	_	PRP$	O	[-1]	['none']	_	_
28	understanding	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	role	_	_	NN	O	[-1]	['none']	_	_
32	Tregs	_	_	NNS	O	[-1]	['none']	_	_
33	play	_	_	VBP	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	pathogenesis	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	human	_	_	NN	O	[-1]	['none']	_	_
39	autoimmune	_	_	JJ	O	[-1]	['none']	_	_
40	disease	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Impaired	_	_	JJ	O	[-1]	['none']	_	_
2	cytokine	_	_	NN	O	[-1]	['none']	_	_
3	production	_	_	NN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	cpdm	_	_	NN	O	[-1]	['none']	_	_
6	BMDC	_	_	NN	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	correlated	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	selective	_	_	JJ	O	[-1]	['none']	_	_
11	defects	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	signaling	_	_	NN	O	[-1]	['none']	_	_
15	There	_	_	EX	O	[-1]	['none']	_	_
16	are	_	_	VBP	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	number	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	possible	_	_	JJ	O	[-1]	['none']	_	_
21	explanations	_	_	NNS	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	defective	_	_	JJ	O	[-1]	['none']	_	_
25	cytokine	_	_	NN	O	[-1]	['none']	_	_
26	secretion	_	_	NN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	stimulated	_	_	VBN	O	[-1]	['none']	_	_
29	cpdm	_	_	NN	O	[-1]	['none']	_	_
30	BMDC	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	including	_	_	VBG	O	[-1]	['none']	_	_
33	1	_	_	CD	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	reduced	_	_	VBD	O	[-1]	['none']	_	_
36	surface	_	_	NN	O	[-1]	['none']	_	_
37	expression	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	LPS	_	_	NN	O	[-1]	['none']	_	_
41	receptor	_	_	NN	O	[-1]	['none']	_	_
42	complex	_	_	NN	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	2	_	_	CD	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	increased	_	_	VBN	O	[-1]	['none']	_	_
47	production	_	_	NN	O	[-1]	['none']	_	_
48	of	_	_	IN	O	[-1]	['none']	_	_
49	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
50	mediators	_	_	NNS	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	3	_	_	CD	O	[-1]	['none']	_	_
53	)	_	_	-RRB-	O	[-1]	['none']	_	_
54	increased	_	_	VBD	O	[-1]	['none']	_	_
55	expression	_	_	NN	O	[-1]	['none']	_	_
56	of	_	_	IN	O	[-1]	['none']	_	_
57	negative	_	_	JJ	O	[-1]	['none']	_	_
58	regulators	_	_	NNS	O	[-1]	['none']	_	_
59	of	_	_	IN	O	[-1]	['none']	_	_
60	TLR	_	_	NN	O	[-1]	['none']	_	_
61	pathways	_	_	NNS	O	[-1]	['none']	_	_
62	,	_	_	,	O	[-1]	['none']	_	_
63	and	_	_	CC	O	[-1]	['none']	_	_
64	4	_	_	CD	O	[-1]	['none']	_	_
65	)	_	_	-RRB-	O	[-1]	['none']	_	_
66	impaired	_	_	JJ	O	[-1]	['none']	_	_
67	TLR	_	_	NN	O	[-1]	['none']	_	_
68	induced	_	_	VBD	O	[-1]	['none']	_	_
69	signaling	_	_	NN	O	[-1]	['none']	_	_
70	activation	_	_	NN	O	[-1]	['none']	_	_
71	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	determined	_	_	VBD	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	surface	_	_	NN	O	[-1]	['none']	_	_
5	expression	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	LPS	_	_	NN	O	[-1]	['none']	_	_
9	receptor	_	_	NN	O	[-1]	['none']	_	_
10	complex	_	_	NN	O	[-1]	['none']	_	_
11	that	_	_	WDT	O	[-1]	['none']	_	_
12	comprises	_	_	VBZ	O	[-1]	['none']	_	_
13	TLR4	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	accessory	_	_	NN	O	[-1]	['none']	_	_
17	proteins	_	_	NNS	O	[-1]	['none']	_	_
18	CD14	_	_	NN	Protein	[0]	['root']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	myeloid	_	_	JJ	Protein	[23]	['multitoken']	_	_
21	differentiation	_	_	NN	Protein	[23]	['multitoken']	_	_
22	factor	_	_	NN	Protein	[23]	['multitoken']	_	_
23	2	_	_	CD	Protein	[0]	['root']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	MD2	_	_	NN	Protein	[0]	['root']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	LY96	_	_	NN	Protein	[0]	['root']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	[	_	_	CD	O	[-1]	['none']	_	_
30	19	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Flow	_	_	NN	O	[-1]	['none']	_	_
2	cytometric	_	_	JJ	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	shows	_	_	VBZ	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
8	levels	_	_	NNS	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	CD14	_	_	NN	Protein	[7]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	TLR4	_	_	NN	Protein	[7]	['Theme']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	MD2	_	_	NN	Protein	[7]	['Theme']	_	_
15	between	_	_	IN	O	[-1]	['none']	_	_
16	WT	_	_	NNP	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	cpdm	_	_	JJ	O	[-1]	['none']	_	_
19	BMDC	_	_	NN	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	similar	_	_	JJ	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	then	_	_	RB	O	[-1]	['none']	_	_
3	quantified	_	_	VBD	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	secretion	_	_	NN	Gene_expression	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	suppressive	_	_	JJ	O	[-1]	['none']	_	_
9	cytokines	_	_	NNS	O	[-1]	['none']	_	_
10	IL10	_	_	NN	Protein	[5]	['Theme']	_	_
11	that	_	_	WDT	O	[-1]	['none']	_	_
12	can	_	_	MD	O	[-1]	['none']	_	_
13	inhibit	_	_	VB	O	[-1]	['none']	_	_
14	IL12	_	_	NN	O	[-1]	['none']	_	_
15	secretion	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	an	_	_	DT	O	[-1]	['none']	_	_
18	autocrine	_	_	JJ	O	[-1]	['none']	_	_
19	manner	_	_	NN	O	[-1]	['none']	_	_
20	[	_	_	IN	O	[-1]	['none']	_	_
21	20	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	CD	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	21	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	supernatants	_	_	NNS	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	LPS	_	_	NN	O	[-1]	['none']	_	_
5	stimulated	_	_	VBD	O	[-1]	['none']	_	_
6	cpdm	_	_	NN	O	[-1]	['none']	_	_
7	BMDC	_	_	NN	O	[-1]	['none']	_	_
8	contained	_	_	VBD	O	[-1]	['none']	_	_
9	significantly	_	_	RB	O	[-1]	['none']	_	_
10	lower	_	_	JJR	Positive_regulation	[0]	['root']	_	_
11	levels	_	_	NNS	Gene_expression	[10]	['Theme']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	IL10	_	_	NN	Protein	[11]	['Theme']	_	_
14	than	_	_	IN	O	[-1]	['none']	_	_
15	stimulated	_	_	VBN	O	[-1]	['none']	_	_
16	WT	_	_	NNP	O	[-1]	['none']	_	_
17	BMDC	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	suggesting	_	_	VBG	O	[-1]	['none']	_	_
20	that	_	_	IN	O	[-1]	['none']	_	_
21	IL10	_	_	NN	Protein	[0]	['root']	_	_
22	was	_	_	VBD	O	[-1]	['none']	_	_
23	not	_	_	RB	O	[-1]	['none']	_	_
24	responsible	_	_	JJ	O	[-1]	['none']	_	_
25	for	_	_	IN	O	[-1]	['none']	_	_
26	decreased	_	_	VBN	O	[-1]	['none']	_	_
27	secretion	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	IL12P70	_	_	NN	O	[-1]	['none']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	cpdm	_	_	NN	O	[-1]	['none']	_	_
32	BMDC	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
2	expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	negative	_	_	JJ	O	[-1]	['none']	_	_
6	regulator	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	TLR	_	_	NN	O	[-1]	['none']	_	_
9	signaling	_	_	NN	O	[-1]	['none']	_	_
10	such	_	_	JJ	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	A20	_	_	NN	Protein	[2]	['Theme']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	22	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	may	_	_	MD	O	[-1]	['none']	_	_
17	also	_	_	RB	O	[-1]	['none']	_	_
18	suppress	_	_	VB	O	[-1]	['none']	_	_
19	cytokine	_	_	NN	O	[-1]	['none']	_	_
20	secretion	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	transcript	_	_	NN	Transcription	[5]	['multitoken']	_	_
5	level	_	_	NN	Transcription	[9]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	A20	_	_	NN	Protein	[5]	['Theme']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	lower	_	_	JJR	Positive_regulation	[0]	['root']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	LPS	_	_	NN	O	[-1]	['none']	_	_
12	activated	_	_	VBD	O	[-1]	['none']	_	_
13	cpdm	_	_	NN	O	[-1]	['none']	_	_
14	BMDC	_	_	NN	O	[-1]	['none']	_	_
15	than	_	_	IN	O	[-1]	['none']	_	_
16	WT	_	_	JJ	O	[-1]	['none']	_	_
17	controls	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	thereby	_	_	RB	O	[-1]	['none']	_	_
20	ruling	_	_	VBG	O	[-1]	['none']	_	_
21	out	_	_	RP	O	[-1]	['none']	_	_
22	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	A20	_	_	NN	Protein	[22]	['Theme']	_	_
25	as	_	_	IN	O	[-1]	['none']	_	_
26	a	_	_	DT	O	[-1]	['none']	_	_
27	factor	_	_	NN	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	reduced	_	_	JJ	O	[-1]	['none']	_	_
31	cytokine	_	_	NN	O	[-1]	['none']	_	_
32	production	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	transcription	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	TLR3/4	_	_	NN	Protein	[0]	['root']	_	_
5	induced	_	_	VBD	O	[-1]	['none']	_	_
6	proinflammatory	_	_	JJ	O	[-1]	['none']	_	_
7	intermediates	_	_	NNS	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	tightly	_	_	RB	O	[-1]	['none']	_	_
10	regulated	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	cellular	_	_	JJ	O	[-1]	['none']	_	_
13	signaling	_	_	NN	O	[-1]	['none']	_	_
14	pathways	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	particular	_	_	JJ	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	TBK1	_	_	NN	Protein	[0]	['root']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	IRF3	_	_	NN	Protein	[0]	['root']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	MAPK	_	_	NN	O	[-1]	['none']	_	_
26	[	_	_	CD	O	[-1]	['none']	_	_
27	23	_	_	CD	O	[-1]	['none']	_	_
28	]-[	_	_	CD	O	[-1]	['none']	_	_
29	27	_	_	CD	O	[-1]	['none']	_	_
30	]	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	next	_	_	IN	O	[-1]	['none']	_	_
3	determined	_	_	VBN	O	[-1]	['none']	_	_
4	if	_	_	IN	O	[-1]	['none']	_	_
5	disrupted	_	_	VBN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	TBK1	_	_	NN	Protein	[0]	['root']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	IRF3	_	_	NN	Protein	[0]	['root']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and/or	_	_	CC	O	[-1]	['none']	_	_
13	MAPK	_	_	NN	O	[-1]	['none']	_	_
14	signaling	_	_	NN	O	[-1]	['none']	_	_
15	may	_	_	MD	O	[-1]	['none']	_	_
16	underlie	_	_	VB	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	impaired	_	_	JJ	O	[-1]	['none']	_	_
19	cytokine	_	_	NN	O	[-1]	['none']	_	_
20	production	_	_	NN	O	[-1]	['none']	_	_
21	from	_	_	IN	O	[-1]	['none']	_	_
22	stimulated	_	_	VBN	O	[-1]	['none']	_	_
23	Sharpin	_	_	NN	Protein	[24]	['Theme']	_	_
24	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
25	BMDC	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Stimulus	_	_	NN	O	[-1]	['none']	_	_
2	induced	_	_	VBD	O	[-1]	['none']	_	_
3	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	IkappaB	_	_	NN	O	[-1]	['none']	_	_
7	kinase	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	IKK1/2	_	_	NN	Protein	[0]	['root']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	an	_	_	DT	O	[-1]	['none']	_	_
13	essential	_	_	JJ	O	[-1]	['none']	_	_
14	step	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
17	signaling	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	allowing	_	_	VBG	Positive_regulation	[0]	['root']	_	_
20	phosphorylation	_	_	NN	Phosphorylation	[19]	['Theme']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	proteasome	_	_	NN	O	[-1]	['none']	_	_
23	mediated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
24	degradation	_	_	NN	Protein_catabolism	[19, 23]	['Theme', 'Theme']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
28	inhibitor	_	_	NN	O	[-1]	['none']	_	_
29	IkappaBalpha	_	_	NN	Protein	[20, 24]	['Theme', 'Theme']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	release	_	_	VB	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
34	transcription	_	_	NN	O	[-1]	['none']	_	_
35	factors	_	_	NNS	O	[-1]	['none']	_	_
36	into	_	_	IN	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	nucleus	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	amount	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	phosphorylated	_	_	VBN	Phosphorylation	[25]	['Theme']	_	_
5	IKK1/2	_	_	NN	Protein	[4]	['Theme']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	p-IKK1/2	_	_	NN	Protein	[0]	['root']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	IkappaBalpha	_	_	NN	Protein	[4]	['Theme']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	p-IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	following	_	_	VBG	O	[-1]	['none']	_	_
15	incubation	_	_	NN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	LPS	_	_	NN	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	poly	_	_	NN	O	[-1]	['none']	_	_
20	I	_	_	NN	O	[-1]	['none']	_	_
21	:	_	_	:	O	[-1]	['none']	_	_
22	C	_	_	NN	O	[-1]	['none']	_	_
23	was	_	_	VBD	O	[-1]	['none']	_	_
24	severely	_	_	RB	O	[-1]	['none']	_	_
25	decreased	_	_	VBN	Negative_regulation	[0]	['root']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	cpdm	_	_	NN	O	[-1]	['none']	_	_
28	BMDC	_	_	NN	O	[-1]	['none']	_	_
29	as	_	_	IN	O	[-1]	['none']	_	_
30	compared	_	_	VBN	O	[-1]	['none']	_	_
31	with	_	_	IN	O	[-1]	['none']	_	_
32	WT	_	_	JJ	O	[-1]	['none']	_	_
33	controls	_	_	NNS	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cpdm	_	_	NN	O	[-1]	['none']	_	_
3	BMDC	_	_	NN	O	[-1]	['none']	_	_
4	exhibited	_	_	VBD	O	[-1]	['none']	_	_
5	similar	_	_	JJ	O	[-1]	['none']	_	_
6	levels	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	TBK1	_	_	NN	Protein	[14]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	ERK1/2	_	_	NN	Protein	[14]	['Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	p38	_	_	NN	O	[-1]	['none']	_	_
14	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	those	_	_	DT	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	WT	_	_	JJ	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	functional	_	_	JJ	O	[-1]	['none']	_	_
9	SHARPIN	_	_	NNP	Protein	[6]	['Theme']	_	_
10	decreased	_	_	VBD	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	activation	_	_	NN	O	[-1]	['none']	_	_
13	but	_	_	CC	O	[-1]	['none']	_	_
14	did	_	_	VBD	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	affect	_	_	VB	O	[-1]	['none']	_	_
17	TBK1	_	_	NN	Protein	[0]	['root']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	IRF3	_	_	NN	Protein	[0]	['root']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	ERK1/2	_	_	NN	Protein	[0]	['root']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	p38	_	_	NN	O	[-1]	['none']	_	_
25	signaling	_	_	NN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	BMDC	_	_	NNP	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Isolation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
4	T	_	_	NN	O	[-1]	['none']	_	_
5	Cells	_	_	NNS	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Splenic	_	_	JJ	O	[-1]	['none']	_	_
9	DC	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	Cell	_	_	NN	O	[-1]	['none']	_	_
12	Culture	_	_	NN	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	T	_	_	NN	O	[-1]	['none']	_	_
15	Cell	_	_	NN	O	[-1]	['none']	_	_
16	Phenotype	_	_	NN	O	[-1]	['none']	_	_
17	Differentiation	_	_	NN	O	[-1]	['none']	_	_
18	T	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	sorted	_	_	VBN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
24	CD62Lhi	_	_	NN	Protein	[0]	['root']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
27	CD62LhiCD25-,	_	_	NN	Protein	[0]	['root']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
30	CD44loCD25-	_	_	NN	Protein	[0]	['root']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	>	_	_	JJR	O	[-1]	['none']	_	_
33	98	_	_	CD	O	[-1]	['none']	_	_
34	%	_	_	NN	O	[-1]	['none']	_	_
35	on	_	_	IN	O	[-1]	['none']	_	_
36	a	_	_	DT	O	[-1]	['none']	_	_
37	Moflo	_	_	NNP	O	[-1]	['none']	_	_
38	cytometer	_	_	NN	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	Cytomation	_	_	NN	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	as	_	_	IN	O	[-1]	['none']	_	_
43	before	_	_	IN	O	[-1]	['none']	_	_
44	(	_	_	-LRB-	O	[-1]	['none']	_	_
45	Shoemaker	_	_	NNP	O	[-1]	['none']	_	_
46	et	_	_	FW	O	[-1]	['none']	_	_
47	al.	_	_	FW	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	2006	_	_	CD	O	[-1]	['none']	_	_
50	;	_	_	:	O	[-1]	['none']	_	_
51	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
52	et	_	_	FW	O	[-1]	['none']	_	_
53	al.	_	_	FW	O	[-1]	['none']	_	_
54	,	_	_	,	O	[-1]	['none']	_	_
55	2009	_	_	CD	O	[-1]	['none']	_	_
56	)	_	_	-RRB-	O	[-1]	['none']	_	_
57	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	most	_	_	JJS	O	[-1]	['none']	_	_
3	cases	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	experiments	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	reproduced	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	each	_	_	DT	O	[-1]	['none']	_	_
10	type	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	purified	_	_	VBN	O	[-1]	['none']	_	_
13	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
14	T	_	_	NN	O	[-1]	['none']	_	_
15	cell	_	_	NN	O	[-1]	['none']	_	_
16	population	_	_	NN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	similar	_	_	JJ	O	[-1]	['none']	_	_
19	results	_	_	NNS	O	[-1]	['none']	_	_
20	obtained	_	_	VBN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Splenic	_	_	JJ	O	[-1]	['none']	_	_
2	DCs	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	prepared	_	_	VBN	O	[-1]	['none']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	described	_	_	VBN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	Hosken	_	_	NNP	O	[-1]	['none']	_	_
9	et	_	_	FW	O	[-1]	['none']	_	_
10	al.	_	_	FW	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	1995	_	_	CD	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	sort	_	_	NN	O	[-1]	['none']	_	_
17	purified	_	_	VBN	O	[-1]	['none']	_	_
18	CD11c+	_	_	JJ	Protein	[0]	['root']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	added	_	_	VBN	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	T	_	_	NN	O	[-1]	['none']	_	_
25	cell	_	_	NN	O	[-1]	['none']	_	_
26	culture	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Purified	_	_	VBN	O	[-1]	['none']	_	_
2	DO11	_	_	NN	O	[-1]	['none']	_	_
3	.10	_	_	CD	O	[-1]	['none']	_	_
4	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	1	_	_	CD	O	[-1]	['none']	_	_
9	x	_	_	CC	O	[-1]	['none']	_	_
10	105	_	_	CD	O	[-1]	['none']	_	_
11	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	cultured	_	_	VBN	O	[-1]	['none']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	before	_	_	IN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Hosken	_	_	NNP	O	[-1]	['none']	_	_
19	et	_	_	FW	O	[-1]	['none']	_	_
20	al.	_	_	FW	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	1995	_	_	CD	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	a	_	_	DT	O	[-1]	['none']	_	_
27	total	_	_	JJ	O	[-1]	['none']	_	_
28	volume	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	1	_	_	CD	O	[-1]	['none']	_	_
31	ml	_	_	NN	O	[-1]	['none']	_	_
32	cRPMI	_	_	NN	O	[-1]	['none']	_	_
33	medium	_	_	NN	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	a	_	_	DT	O	[-1]	['none']	_	_
36	48-well	_	_	JJ	O	[-1]	['none']	_	_
37	plate	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	with	_	_	IN	O	[-1]	['none']	_	_
40	splenic	_	_	JJ	O	[-1]	['none']	_	_
41	DCs	_	_	NNS	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	2	_	_	CD	O	[-1]	['none']	_	_
44	x	_	_	CC	O	[-1]	['none']	_	_
45	104	_	_	CD	O	[-1]	['none']	_	_
46	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	and	_	_	CC	O	[-1]	['none']	_	_
50	varying	_	_	VBG	O	[-1]	['none']	_	_
51	amounts	_	_	NNS	O	[-1]	['none']	_	_
52	of	_	_	IN	O	[-1]	['none']	_	_
53	OVA	_	_	NNP	Protein	[0]	['root']	_	_
54	and	_	_	CC	O	[-1]	['none']	_	_
55	of	_	_	IN	O	[-1]	['none']	_	_
56	IL-12	_	_	NN	Protein	[0]	['root']	_	_
57	.	_	_	.	O	[-1]	['none']	_	_

1	APC	_	_	NN	O	[-1]	['none']	_	_
2	independent	_	_	JJ	O	[-1]	['none']	_	_
3	differentiation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	naive	_	_	JJ	O	[-1]	['none']	_	_
6	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	into	_	_	IN	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	Th2	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	used	_	_	VBN	O	[-1]	['none']	_	_
15	stimulation	_	_	NN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	anti-CD3	_	_	JJ	Protein	[0]	['root']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	anti-CD28	_	_	JJ	Protein	[0]	['root']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	appropriate	_	_	JJ	O	[-1]	['none']	_	_
22	cytokine	_	_	NN	O	[-1]	['none']	_	_
23	conditions	_	_	NNS	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	control	_	_	NN	O	[-1]	['none']	_	_
27	Th1	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	Th2	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	were	_	_	VBD	O	[-1]	['none']	_	_
32	cultured	_	_	VBN	O	[-1]	['none']	_	_
33	as	_	_	IN	O	[-1]	['none']	_	_
34	described	_	_	VBN	O	[-1]	['none']	_	_
35	before	_	_	IN	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	Hosken	_	_	NNP	O	[-1]	['none']	_	_
38	et	_	_	FW	O	[-1]	['none']	_	_
39	al.	_	_	FW	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	1995	_	_	CD	O	[-1]	['none']	_	_
42	;	_	_	:	O	[-1]	['none']	_	_
43	Shoemaker	_	_	NNP	O	[-1]	['none']	_	_
44	et	_	_	FW	O	[-1]	['none']	_	_
45	al.	_	_	FW	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	2006	_	_	CD	O	[-1]	['none']	_	_
48	)	_	_	-RRB-	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	Culture	_	_	NN	O	[-1]	['none']	_	_
2	conditions	_	_	NNS	O	[-1]	['none']	_	_
3	for	_	_	IN	O	[-1]	['none']	_	_
4	Th17	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	as	_	_	IN	O	[-1]	['none']	_	_
8	described	_	_	VBN	O	[-1]	['none']	_	_
9	before	_	_	IN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
12	et	_	_	FW	O	[-1]	['none']	_	_
13	al.	_	_	FW	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	2006	_	_	CD	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Importantly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Th1	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	Th2	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	could	_	_	MD	O	[-1]	['none']	_	_
8	be	_	_	VB	O	[-1]	['none']	_	_
9	differentiated	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	cRPMI	_	_	NN	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	IMDM	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Hosken	_	_	NNP	O	[-1]	['none']	_	_
16	et	_	_	FW	O	[-1]	['none']	_	_
17	al.	_	_	FW	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	1995	_	_	CD	O	[-1]	['none']	_	_
20	;	_	_	:	O	[-1]	['none']	_	_
21	Shoemaker	_	_	NNP	O	[-1]	['none']	_	_
22	et	_	_	FW	O	[-1]	['none']	_	_
23	al.	_	_	FW	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	2006	_	_	CD	O	[-1]	['none']	_	_
26	;	_	_	:	O	[-1]	['none']	_	_
27	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
28	et	_	_	FW	O	[-1]	['none']	_	_
29	al.	_	_	FW	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	2006	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	but	_	_	CC	O	[-1]	['none']	_	_
35	Th17	_	_	NN	O	[-1]	['none']	_	_
36	cells	_	_	NNS	O	[-1]	['none']	_	_
37	were	_	_	VBD	O	[-1]	['none']	_	_
38	only	_	_	RB	O	[-1]	['none']	_	_
39	differentiated	_	_	VBN	O	[-1]	['none']	_	_
40	optimally	_	_	RB	O	[-1]	['none']	_	_
41	in	_	_	IN	O	[-1]	['none']	_	_
42	IMDM	_	_	NNP	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
45	et	_	_	FW	O	[-1]	['none']	_	_
46	al.	_	_	FW	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	2009	_	_	CD	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	When	_	_	WRB	O	[-1]	['none']	_	_
2	indicated	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	U0126	_	_	NN	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	PD184352	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	MEK	_	_	NN	Protein	[9]	['Theme']	_	_
9	inhibitors	_	_	NNS	Negative_regulation	[0]	['root']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	SB203580	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	p38	_	_	NN	Protein	[15]	['Theme']	_	_
15	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	CT99021	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	GSK3beta	_	_	NN	Protein	[21]	['Theme']	_	_
21	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	or	_	_	CC	O	[-1]	['none']	_	_
25	a	_	_	DT	O	[-1]	['none']	_	_
26	similar	_	_	JJ	O	[-1]	['none']	_	_
27	amount	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	DMSO	_	_	NN	O	[-1]	['none']	_	_
30	were	_	_	VBD	O	[-1]	['none']	_	_
31	present	_	_	JJ	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	culture	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	More	_	_	JJR	O	[-1]	['none']	_	_
2	details	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	specific	_	_	JJ	O	[-1]	['none']	_	_
5	culture	_	_	NN	O	[-1]	['none']	_	_
6	conditions	_	_	NNS	O	[-1]	['none']	_	_
7	are	_	_	VBP	O	[-1]	['none']	_	_
8	provided	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	Figures	_	_	NNS	O	[-1]	['none']	_	_
11	S6	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	S7	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	Production	_	_	NN	Gene_expression	[9]	['Theme']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	Th2	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Th17	_	_	NN	O	[-1]	['none']	_	_
7	Cells	_	_	NNS	O	[-1]	['none']	_	_
8	Also	_	_	RB	O	[-1]	['none']	_	_
9	Requires	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
10	ERK1	_	_	NN	Protein	[13]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	ERK2	_	_	NN	Protein	[13]	['Theme']	_	_
13	Activation	_	_	NN	Positive_regulation	[9]	['Cause']	_	_
14	To	_	_	TO	O	[-1]	['none']	_	_
15	address	_	_	VB	O	[-1]	['none']	_	_
16	whether	_	_	IN	O	[-1]	['none']	_	_
17	IL-10	_	_	NN	Protein	[18]	['Theme']	_	_
18	production	_	_	NN	Gene_expression	[26]	['Theme']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	Th2	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	Th17	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	was	_	_	VBD	O	[-1]	['none']	_	_
25	also	_	_	RB	O	[-1]	['none']	_	_
26	dependent	_	_	JJ	Positive_regulation	[0]	['root']	_	_
27	on	_	_	IN	O	[-1]	['none']	_	_
28	ERK1	_	_	NN	Protein	[31]	['Theme']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	ERK2	_	_	NN	Protein	[31]	['Theme']	_	_
31	activation	_	_	NN	Positive_regulation	[26]	['Cause']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	we	_	_	PRP	O	[-1]	['none']	_	_
34	differentiated	_	_	VBD	O	[-1]	['none']	_	_
35	these	_	_	DT	O	[-1]	['none']	_	_
36	cells	_	_	NNS	O	[-1]	['none']	_	_
37	with	_	_	IN	O	[-1]	['none']	_	_
38	anti-CD3	_	_	NN	Protein	[0]	['root']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	anti-CD28	_	_	NN	Protein	[0]	['root']	_	_
41	in	_	_	IN	O	[-1]	['none']	_	_
42	the	_	_	DT	O	[-1]	['none']	_	_
43	absence	_	_	NN	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	APCs	_	_	NNS	O	[-1]	['none']	_	_
46	(	_	_	-LRB-	O	[-1]	['none']	_	_
47	Shoemaker	_	_	NNP	O	[-1]	['none']	_	_
48	et	_	_	FW	O	[-1]	['none']	_	_
49	al.	_	_	FW	O	[-1]	['none']	_	_
50	,	_	_	,	O	[-1]	['none']	_	_
51	2006	_	_	CD	O	[-1]	['none']	_	_
52	;	_	_	:	O	[-1]	['none']	_	_
53	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
54	et	_	_	FW	O	[-1]	['none']	_	_
55	al.	_	_	FW	O	[-1]	['none']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	2009	_	_	CD	O	[-1]	['none']	_	_
58	;	_	_	:	O	[-1]	['none']	_	_
59	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
60	et	_	_	FW	O	[-1]	['none']	_	_
61	al.	_	_	FW	O	[-1]	['none']	_	_
62	,	_	_	,	O	[-1]	['none']	_	_
63	2006	_	_	CD	O	[-1]	['none']	_	_
64	)	_	_	-RRB-	O	[-1]	['none']	_	_
65	,	_	_	,	O	[-1]	['none']	_	_
66	in	_	_	IN	O	[-1]	['none']	_	_
67	the	_	_	DT	O	[-1]	['none']	_	_
68	presence	_	_	NN	O	[-1]	['none']	_	_
69	or	_	_	CC	O	[-1]	['none']	_	_
70	absence	_	_	NN	O	[-1]	['none']	_	_
71	of	_	_	IN	O	[-1]	['none']	_	_
72	the	_	_	DT	O	[-1]	['none']	_	_
73	MEK	_	_	NN	Protein	[74]	['Theme']	_	_
74	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
75	(	_	_	-LRB-	O	[-1]	['none']	_	_
76	PD184352	_	_	NN	O	[-1]	['none']	_	_
77	)	_	_	-RRB-	O	[-1]	['none']	_	_
78	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	showed	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	ERK1	_	_	NN	Protein	[7]	['Theme']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	ERK2	_	_	NN	Protein	[7]	['Theme']	_	_
7	activation	_	_	NN	Positive_regulation	[12]	['Cause']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	common	_	_	JJ	O	[-1]	['none']	_	_
11	pathway	_	_	NN	O	[-1]	['none']	_	_
12	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	induction	_	_	NN	Gene_expression	[12]	['Theme']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IL-10	_	_	NN	Protein	[14]	['Theme']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	different	_	_	JJ	O	[-1]	['none']	_	_
19	Th	_	_	NN	O	[-1]	['none']	_	_
20	cell	_	_	NN	O	[-1]	['none']	_	_
21	subsets	_	_	NNS	O	[-1]	['none']	_	_
22	because	_	_	IN	O	[-1]	['none']	_	_
23	IL-10	_	_	NN	Protein	[24]	['Theme']	_	_
24	production	_	_	NN	Gene_expression	[33]	['Theme']	_	_
25	by	_	_	IN	O	[-1]	['none']	_	_
26	both	_	_	CC	O	[-1]	['none']	_	_
27	Th2	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	Th17	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	was	_	_	VBD	O	[-1]	['none']	_	_
32	markedly	_	_	RB	O	[-1]	['none']	_	_
33	inhibited	_	_	VBN	Negative_regulation	[0]	['root']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	presence	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	the	_	_	DT	O	[-1]	['none']	_	_
39	MEK	_	_	NN	Protein	[40]	['Theme']	_	_
40	inhibitor	_	_	NN	Negative_regulation	[33]	['Cause']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	PD184352	_	_	NN	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	inhibitors	_	_	NNS	Negative_regulation	[14]	['Cause']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	p38	_	_	NN	Protein	[7]	['multitoken']	_	_
7	MAPK	_	_	NN	Protein	[11]	['Theme']	_	_
8	or	_	_	CC	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	GSK-3beta	_	_	NN	Protein	[11]	['Theme']	_	_
11	activation	_	_	NN	Positive_regulation	[4]	['Theme']	_	_
12	did	_	_	VBD	O	[-1]	['none']	_	_
13	not	_	_	RB	O	[-1]	['none']	_	_
14	affect	_	_	VB	Regulation	[0]	['root']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	expression	_	_	NN	Gene_expression	[14]	['Theme']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IL-10	_	_	NN	Protein	[16]	['Theme']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	these	_	_	DT	O	[-1]	['none']	_	_
21	subsets	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Activation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	ERK1	_	_	NN	Protein	[0]	['root']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	ERK2	_	_	NN	Protein	[0]	['root']	_	_
7	signaling	_	_	NN	O	[-1]	['none']	_	_
8	pathway	_	_	NN	O	[-1]	['none']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	therefore	_	_	RB	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	common	_	_	JJ	O	[-1]	['none']	_	_
13	requirement	_	_	NN	Positive_regulation	[0]	['root']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	induction	_	_	NN	Positive_regulation	[13]	['Theme']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IL-10	_	_	NN	Protein	[19]	['Theme']	_	_
19	production	_	_	NN	Gene_expression	[16]	['Theme']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	Th1	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	Th2	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	Th17	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Distinct	_	_	JJ	O	[-1]	['none']	_	_
2	kinetics	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	T-bet	_	_	NN	Protein	[7]	['Theme']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Eomes	_	_	NN	Protein	[7]	['Theme']	_	_
7	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
8	during	_	_	IN	O	[-1]	['none']	_	_
9	CTL	_	_	NN	O	[-1]	['none']	_	_
10	differentiation	_	_	NN	O	[-1]	['none']	_	_
11	The	_	_	DT	O	[-1]	['none']	_	_
12	T-box	_	_	JJ	O	[-1]	['none']	_	_
13	transcription	_	_	NN	O	[-1]	['none']	_	_
14	factors	_	_	NNS	O	[-1]	['none']	_	_
15	T-bet	_	_	JJ	Protein	[20]	['Cause']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	Eomes	_	_	NNS	Protein	[20]	['Cause']	_	_
18	have	_	_	VBP	O	[-1]	['none']	_	_
19	been	_	_	VBN	O	[-1]	['none']	_	_
20	linked	_	_	VBN	Regulation	[0]	['root']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	regulation	_	_	NN	Regulation	[20]	['Theme']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	genes	_	_	NNS	Anaphora	[0]	['root']	_	_
26	encoding	_	_	VBG	O	[-1]	['none']	_	_
27	effector	_	_	NN	O	[-1]	['none']	_	_
28	cytokines	_	_	NNS	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	e.g.	_	_	FW	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	Ifng	_	_	JJ	Protein	[23]	['Theme']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	genes	_	_	NNS	Anaphora	[0]	['root']	_	_
36	important	_	_	JJ	O	[-1]	['none']	_	_
37	for	_	_	IN	O	[-1]	['none']	_	_
38	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
39	function	_	_	NN	O	[-1]	['none']	_	_
40	(	_	_	-LRB-	O	[-1]	['none']	_	_
41	e.g.	_	_	FW	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	Prf1	_	_	NN	Protein	[23]	['Theme']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	GzmB	_	_	NN	Protein	[23]	['Theme']	_	_
46	)	_	_	-RRB-	O	[-1]	['none']	_	_
47	(	_	_	-LRB-	O	[-1]	['none']	_	_
48	20	_	_	CD	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	investigated	_	_	VBD	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	kinetics	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	these	_	_	DT	Anaphora	[10]	['multitoken']	_	_
9	transcription	_	_	NN	Anaphora	[10]	['multitoken']	_	_
10	factors	_	_	NNS	Anaphora	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	our	_	_	PRP$	O	[-1]	['none']	_	_
13	in	_	_	FW	O	[-1]	['none']	_	_
14	vitro	_	_	FW	O	[-1]	['none']	_	_
15	cultures	_	_	NNS	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	T-bet	_	_	JJ	Protein	[7, 17, 27]	['Theme', 'Theme', 'Theme']	_	_
2	mRNA	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	protein	_	_	NN	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	detectable	_	_	JJ	Gene_expression	[0]	['root']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	naive	_	_	JJ	O	[-1]	['none']	_	_
10	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
11	T	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	but	_	_	CC	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	strongly	_	_	RB	O	[-1]	['none']	_	_
17	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
18	upon	_	_	IN	O	[-1]	['none']	_	_
19	TCR	_	_	NN	O	[-1]	['none']	_	_
20	priming	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	day	_	_	NN	O	[-1]	['none']	_	_
23	2	_	_	CD	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	remained	_	_	VBD	Positive_regulation	[0]	['root']	_	_
27	expressed	_	_	VBN	Gene_expression	[26]	['Theme']	_	_
28	through	_	_	IN	O	[-1]	['none']	_	_
29	day	_	_	NN	O	[-1]	['none']	_	_
30	6	_	_	CD	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	differentiation	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	Eomes	_	_	NN	Protein	[5, 35]	['Theme', 'Theme']	_	_
5	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	low	_	_	JJ	Positive_regulation	[9]	['multitoken']	_	_
8	or	_	_	CC	Positive_regulation	[9]	['multitoken']	_	_
9	undetectable	_	_	JJ	Positive_regulation	[0]	['root']	_	_
10	at	_	_	IN	O	[-1]	['none']	_	_
11	both	_	_	CC	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	mRNA	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	protein	_	_	NN	O	[-1]	['none']	_	_
16	levels	_	_	NNS	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	naive	_	_	JJ	O	[-1]	['none']	_	_
19	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
20	T	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	TCR	_	_	NN	O	[-1]	['none']	_	_
25	priming	_	_	NN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	culture	_	_	NN	O	[-1]	['none']	_	_
28	had	_	_	VBD	O	[-1]	['none']	_	_
29	only	_	_	RB	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	modest	_	_	JJ	O	[-1]	['none']	_	_
32	effect	_	_	NN	Regulation	[0]	['root']	_	_
33	on	_	_	IN	O	[-1]	['none']	_	_
34	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
35	expression	_	_	NN	Gene_expression	[32]	['Theme']	_	_
36	at	_	_	IN	O	[-1]	['none']	_	_
37	day	_	_	NN	O	[-1]	['none']	_	_
38	2	_	_	CD	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Strong	_	_	JJ	O	[-1]	['none']	_	_
2	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	Eomes	_	_	NNP	Protein	[2]	['Theme']	_	_
5	mRNA	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	protein	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	only	_	_	RB	O	[-1]	['none']	_	_
10	observed	_	_	VBN	O	[-1]	['none']	_	_
11	at	_	_	IN	O	[-1]	['none']	_	_
12	day	_	_	NN	O	[-1]	['none']	_	_
13	4	_	_	CD	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	later	_	_	RB	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	T-bet	_	_	JJ	Protein	[3]	['Theme']	_	_
2	mRNA	_	_	NN	Transcription	[3]	['multitoken']	_	_
3	expression	_	_	NN	Transcription	[0]	['root']	_	_
4	slightly	_	_	RB	O	[-1]	['none']	_	_
5	preceded	_	_	VBD	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	GzmB	_	_	NN	Protein	[7]	['Theme']	_	_
10	mRNA	_	_	NN	O	[-1]	['none']	_	_
11	;	_	_	:	O	[-1]	['none']	_	_
12	similarly	_	_	RB	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	Eomes	_	_	NN	Protein	[19]	['Theme']	_	_
15	mRNA	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	protein	_	_	NN	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
20	~	_	_	NN	O	[-1]	['none']	_	_
21	1	_	_	CD	O	[-1]	['none']	_	_
22	d	_	_	NN	O	[-1]	['none']	_	_
23	ahead	_	_	RB	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	reexpression	_	_	NN	Gene_expression	[0]	['root']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	perforin	_	_	NN	Protein	[26]	['Theme']	_	_
29	mRNA	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	protein	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	respectively	_	_	RB	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	detailed	_	_	JJ	O	[-1]	['none']	_	_
3	kinetic	_	_	JJ	O	[-1]	['none']	_	_
4	analysis	_	_	NN	O	[-1]	['none']	_	_
5	suggested	_	_	VBD	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	under	_	_	IN	O	[-1]	['none']	_	_
9	our	_	_	PRP$	O	[-1]	['none']	_	_
10	culture	_	_	NN	O	[-1]	['none']	_	_
11	conditions	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	T-bet	_	_	NN	Protein	[0]	['root']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	Eomes	_	_	NNS	Protein	[0]	['root']	_	_
16	contribute	_	_	VBP	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	distinct	_	_	JJ	O	[-1]	['none']	_	_
19	aspects	_	_	NNS	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	gene	_	_	NN	O	[-1]	['none']	_	_
22	transcription	_	_	NN	O	[-1]	['none']	_	_
23	during	_	_	IN	O	[-1]	['none']	_	_
24	CTL	_	_	NN	O	[-1]	['none']	_	_
25	differentiation	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	T-bet	_	_	NN	Protein	[3]	['Cause']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
4	early	_	_	RB	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	IFN-gamma	_	_	NN	Protein	[7]	['Theme']	_	_
7	production	_	_	NN	Gene_expression	[3]	['Theme']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	our	_	_	PRP$	O	[-1]	['none']	_	_
11	data	_	_	NNS	O	[-1]	['none']	_	_
12	suggested	_	_	VBD	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	Eomes	_	_	NNS	Protein	[25]	['Cause']	_	_
15	might	_	_	MD	O	[-1]	['none']	_	_
16	not	_	_	RB	O	[-1]	['none']	_	_
17	function	_	_	VB	O	[-1]	['none']	_	_
18	during	_	_	IN	O	[-1]	['none']	_	_
19	this	_	_	DT	O	[-1]	['none']	_	_
20	early	_	_	JJ	O	[-1]	['none']	_	_
21	period	_	_	NN	O	[-1]	['none']	_	_
22	but	_	_	CC	O	[-1]	['none']	_	_
23	rather	_	_	RB	O	[-1]	['none']	_	_
24	might	_	_	MD	O	[-1]	['none']	_	_
25	contribute	_	_	VB	Positive_regulation	[0]	['root']	_	_
26	later	_	_	RB	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	control	_	_	NN	Regulation	[25]	['Theme']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	perforin	_	_	NN	Protein	[32]	['Theme']	_	_
32	expression	_	_	NN	Gene_expression	[29]	['Theme']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	seemed	_	_	VBD	O	[-1]	['none']	_	_
4	most	_	_	RBS	O	[-1]	['none']	_	_
5	consistent	_	_	JJ	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	model	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	which	_	_	WDT	O	[-1]	['none']	_	_
11	TCR	_	_	NN	O	[-1]	['none']	_	_
12	signals	_	_	NNS	O	[-1]	['none']	_	_
13	induce	_	_	VBP	Positive_regulation	[0]	['root']	_	_
14	T-bet	_	_	NN	Protein	[13, 19]	['Theme', 'Cause']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	which	_	_	WDT	Anaphora	[0]	['root']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	turn	_	_	NN	O	[-1]	['none']	_	_
19	induces	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
20	IFN-gamma	_	_	NN	Protein	[19]	['Theme']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	17	_	_	CD	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	possibly	_	_	RB	O	[-1]	['none']	_	_
26	granzyme	_	_	NN	Protein	[27]	['multitoken']	_	_
27	B	_	_	NN	Protein	[19]	['Theme']	_	_
28	;	_	_	:	O	[-1]	['none']	_	_
29	subsequently	_	_	RB	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	Eomes	_	_	NNS	Protein	[33, 43]	['Theme', 'Cause']	_	_
32	is	_	_	VBZ	O	[-1]	['none']	_	_
33	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
34	during	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	period	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	clonal	_	_	JJ	O	[-1]	['none']	_	_
39	expansion	_	_	NN	O	[-1]	['none']	_	_
40	in	_	_	IN	O	[-1]	['none']	_	_
41	IL-2	_	_	NN	Protein	[0]	['root']	_	_
42	and	_	_	CC	O	[-1]	['none']	_	_
43	activates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
44	perforin	_	_	NN	Protein	[45]	['Theme']	_	_
45	expression	_	_	NN	Gene_expression	[43]	['Theme']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	Inhibition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
4	PKC	_	_	NN	O	[-1]	['none']	_	_
5	reduces	_	_	VBZ	O	[-1]	['none']	_	_
6	NF-kappaB-regulated	_	_	JJ	O	[-1]	['none']	_	_
7	genes	_	_	NNS	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	both	_	_	DT	O	[-1]	['none']	_	_
10	MDMs	_	_	NNS	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	RAW	_	_	NN	O	[-1]	['none']	_	_
13	264.7	_	_	CD	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	MDMs	_	_	NNS	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	A	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	C	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	RAW	_	_	NN	O	[-1]	['none']	_	_
9	264.7	_	_	CD	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	B	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	pretreated	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	solvent	_	_	JJ	O	[-1]	['none']	_	_
20	control	_	_	NN	O	[-1]	['none']	_	_
21	DMSO	_	_	NN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	30	_	_	CD	O	[-1]	['none']	_	_
24	minutes	_	_	NNS	O	[-1]	['none']	_	_
25	prior	_	_	RB	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	M-CSF	_	_	NN	O	[-1]	['none']	_	_
28	stimulation	_	_	NN	O	[-1]	['none']	_	_
29	for	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	indicated	_	_	JJ	O	[-1]	['none']	_	_
32	times	_	_	NNS	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Total	_	_	JJ	O	[-1]	['none']	_	_
2	RNA	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	isolated	_	_	VBN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	converted	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	cDNA	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Real-time	_	_	JJ	O	[-1]	['none']	_	_
2	RT	_	_	NN	O	[-1]	['none']	_	_
3	PCR	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	performed	_	_	VBN	O	[-1]	['none']	_	_
6	using	_	_	VBG	O	[-1]	['none']	_	_
7	primers	_	_	NNS	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	BCL-xl	_	_	NN	Protein	[0]	['root']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	GAPDH	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	expressed	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	relative	_	_	JJ	O	[-1]	['none']	_	_
6	fold	_	_	JJ	O	[-1]	['none']	_	_
7	increase	_	_	NN	Positive_regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	IkappaBalpha	_	_	NN	Protein	[13]	['Theme']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	BCL-xl	_	_	NN	Protein	[13]	['Theme']	_	_
12	gene	_	_	NN	O	[-1]	['none']	_	_
13	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
14	upon	_	_	IN	O	[-1]	['none']	_	_
15	treatment	_	_	NN	O	[-1]	['none']	_	_
16	over	_	_	IN	O	[-1]	['none']	_	_
17	non	_	_	JJ	O	[-1]	['none']	_	_
18	stimulated	_	_	VBN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	represent	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	mean	_	_	NN	O	[-1]	['none']	_	_
5	+/-	_	_	CC	O	[-1]	['none']	_	_
6	S.E.M	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	three	_	_	CD	O	[-1]	['none']	_	_
9	independent	_	_	JJ	O	[-1]	['none']	_	_
10	experiments	_	_	NNS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Many	_	_	JJ	O	[-1]	['none']	_	_
2	genetic	_	_	JJ	O	[-1]	['none']	_	_
3	lesions	_	_	NNS	O	[-1]	['none']	_	_
4	are	_	_	VBP	O	[-1]	['none']	_	_
5	known	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	influence	_	_	VB	O	[-1]	['none']	_	_
8	gene	_	_	NN	O	[-1]	['none']	_	_
9	expression	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	tumor	_	_	NN	O	[-1]	['none']	_	_
12	suppressor	_	_	NN	O	[-1]	['none']	_	_
13	genes	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Whereas	_	_	IN	O	[-1]	['none']	_	_
2	mutations	_	_	NNS	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	deletions	_	_	NNS	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	insertions	_	_	NNS	O	[-1]	['none']	_	_
7	have	_	_	VBP	O	[-1]	['none']	_	_
8	permanent	_	_	JJ	O	[-1]	['none']	_	_
9	effects	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	reversible	_	_	JJ	O	[-1]	['none']	_	_
12	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
13	are	_	_	VBP	O	[-1]	['none']	_	_
14	gene	_	_	NN	O	[-1]	['none']	_	_
15	methylation	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	expression	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	activation	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	transcription	_	_	NN	O	[-1]	['none']	_	_
23	factors	_	_	NNS	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	respectively	_	_	RB	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	studied	_	_	VBD	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	putative	_	_	JJ	O	[-1]	['none']	_	_
5	cause	_	_	NN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	absent	_	_	JJ	Negative_regulation	[0]	['root']	_	_
8	IRF-4	_	_	NN	Protein	[9]	['Theme']	_	_
9	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	leukemia	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	first	_	_	JJ	O	[-1]	['none']	_	_
15	focused	_	_	VBN	O	[-1]	['none']	_	_
16	on	_	_	IN	O	[-1]	['none']	_	_
17	genetic	_	_	JJ	O	[-1]	['none']	_	_
18	aberrations	_	_	NNS	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	promoter	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	observed	_	_	VBD	O	[-1]	['none']	_	_
3	no	_	_	DT	O	[-1]	['none']	_	_
4	genetic	_	_	JJ	O	[-1]	['none']	_	_
5	alterations	_	_	NNS	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
9	promoter	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	which	_	_	WDT	O	[-1]	['none']	_	_
12	can	_	_	MD	O	[-1]	['none']	_	_
13	account	_	_	VB	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	lack	_	_	NN	Negative_regulation	[0]	['root']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IRF-4	_	_	NN	Protein	[19]	['Theme']	_	_
19	expression	_	_	NN	Gene_expression	[16]	['Theme']	_	_
20	:	_	_	:	O	[-1]	['none']	_	_
21	The	_	_	DT	O	[-1]	['none']	_	_
22	detected	_	_	JJ	O	[-1]	['none']	_	_
23	base	_	_	NN	O	[-1]	['none']	_	_
24	pair	_	_	NN	O	[-1]	['none']	_	_
25	changes	_	_	NNS	O	[-1]	['none']	_	_
26	at	_	_	IN	O	[-1]	['none']	_	_
27	position	_	_	NN	O	[-1]	['none']	_	_
28	-1081	_	_	CD	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	T	_	_	NN	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	C	_	_	NN	O	[-1]	['none']	_	_
33	substitution	_	_	NN	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	at	_	_	IN	O	[-1]	['none']	_	_
37	position	_	_	NN	O	[-1]	['none']	_	_
38	-1068	_	_	CD	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	A	_	_	NN	O	[-1]	['none']	_	_
41	to	_	_	TO	O	[-1]	['none']	_	_
42	C	_	_	NN	O	[-1]	['none']	_	_
43	substitution	_	_	NN	O	[-1]	['none']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	and	_	_	CC	O	[-1]	['none']	_	_
46	at	_	_	IN	O	[-1]	['none']	_	_
47	position	_	_	NN	O	[-1]	['none']	_	_
48	-116	_	_	CD	O	[-1]	['none']	_	_
49	(	_	_	-LRB-	O	[-1]	['none']	_	_
50	A	_	_	NN	O	[-1]	['none']	_	_
51	to	_	_	TO	O	[-1]	['none']	_	_
52	C	_	_	NN	O	[-1]	['none']	_	_
53	substitution	_	_	NN	O	[-1]	['none']	_	_
54	)	_	_	-RRB-	O	[-1]	['none']	_	_
55	are	_	_	VBP	O	[-1]	['none']	_	_
56	unlikely	_	_	JJ	O	[-1]	['none']	_	_
57	responsible	_	_	JJ	Positive_regulation	[0]	['root']	_	_
58	for	_	_	IN	O	[-1]	['none']	_	_
59	absent	_	_	JJ	Negative_regulation	[57]	['Theme']	_	_
60	IRF-4-expression	_	_	NN	Gene_expression	[59]	['Theme']	_	_
61	since	_	_	IN	O	[-1]	['none']	_	_
62	the	_	_	DT	O	[-1]	['none']	_	_
63	first	_	_	JJ	O	[-1]	['none']	_	_
64	two	_	_	CD	O	[-1]	['none']	_	_
65	mutations	_	_	NNS	O	[-1]	['none']	_	_
66	were	_	_	VBD	O	[-1]	['none']	_	_
67	found	_	_	VBN	O	[-1]	['none']	_	_
68	both	_	_	CC	O	[-1]	['none']	_	_
69	in	_	_	IN	O	[-1]	['none']	_	_
70	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
71	and	_	_	CC	O	[-1]	['none']	_	_
72	-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
73	cells	_	_	NNS	O	[-1]	['none']	_	_
74	whereas	_	_	IN	O	[-1]	['none']	_	_
75	the	_	_	DT	O	[-1]	['none']	_	_
76	latter	_	_	JJ	O	[-1]	['none']	_	_
77	change	_	_	NN	O	[-1]	['none']	_	_
78	was	_	_	VBD	O	[-1]	['none']	_	_
79	not	_	_	RB	O	[-1]	['none']	_	_
80	detected	_	_	VBN	O	[-1]	['none']	_	_
81	consistently	_	_	RB	O	[-1]	['none']	_	_
82	in	_	_	IN	O	[-1]	['none']	_	_
83	all	_	_	DT	O	[-1]	['none']	_	_
84	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
85	or	_	_	CC	O	[-1]	['none']	_	_
86	-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
87	cells	_	_	NNS	O	[-1]	['none']	_	_
88	and	_	_	CC	O	[-1]	['none']	_	_
89	may	_	_	MD	O	[-1]	['none']	_	_
90	thus	_	_	RB	O	[-1]	['none']	_	_
91	be	_	_	VB	O	[-1]	['none']	_	_
92	a	_	_	DT	O	[-1]	['none']	_	_
93	polymorphism	_	_	NN	O	[-1]	['none']	_	_
94	.	_	_	.	O	[-1]	['none']	_	_

1	All	_	_	DT	O	[-1]	['none']	_	_
2	three	_	_	CD	O	[-1]	['none']	_	_
3	substitutions	_	_	NNS	O	[-1]	['none']	_	_
4	did	_	_	VBD	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	change	_	_	VB	Regulation	[0]	['root']	_	_
7	any	_	_	DT	O	[-1]	['none']	_	_
8	known	_	_	JJ	O	[-1]	['none']	_	_
9	putative	_	_	JJ	O	[-1]	['none']	_	_
10	transcription	_	_	NN	Entity	[13]	['multitoken']	_	_
11	factor	_	_	NN	Entity	[13]	['multitoken']	_	_
12	binding	_	_	VBG	Entity	[13]	['multitoken']	_	_
13	sites	_	_	NNS	Entity	[6]	['Site']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	30,31	_	_	CD	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	also	_	_	RB	O	[-1]	['none']	_	_
19	do	_	_	VBP	O	[-1]	['none']	_	_
20	not	_	_	RB	O	[-1]	['none']	_	_
21	affect	_	_	VB	Regulation	[0]	['root']	_	_
22	any	_	_	DT	O	[-1]	['none']	_	_
23	restriction	_	_	NN	Entity	[24]	['multitoken']	_	_
24	sites	_	_	NNS	Entity	[21]	['Site']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	primer	_	_	NN	Entity	[28]	['multitoken']	_	_
27	binding	_	_	NN	Entity	[28]	['multitoken']	_	_
28	sites	_	_	NNS	Entity	[21]	['Site']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	used	_	_	JJ	O	[-1]	['none']	_	_
32	assays	_	_	NNS	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	permanent	_	_	JJ	O	[-1]	['none']	_	_
4	genetic	_	_	JJ	O	[-1]	['none']	_	_
5	variations	_	_	NNS	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
9	coding	_	_	VBG	O	[-1]	['none']	_	_
10	sequence	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	such	_	_	JJ	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	deletions	_	_	NNS	O	[-1]	['none']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	mutations	_	_	NNS	O	[-1]	['none']	_	_
17	resulting	_	_	VBG	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	stop-codons	_	_	NNS	O	[-1]	['none']	_	_
20	have	_	_	VBP	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	been	_	_	VBN	O	[-1]	['none']	_	_
23	excluded	_	_	VBN	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	sequence	_	_	NN	O	[-1]	['none']	_	_
26	analysis	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	IRF-4	_	_	NN	Protein	[3]	['Theme']	_	_
3	expression	_	_	NN	Gene_expression	[11]	['Theme']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	lines	_	_	NNS	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	CML	_	_	NN	O	[-1]	['none']	_	_
9	can	_	_	MD	O	[-1]	['none']	_	_
10	be	_	_	VB	O	[-1]	['none']	_	_
11	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	demethylation	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	successful	_	_	JJ	O	[-1]	['none']	_	_
16	IFN-alpha	_	_	NN	Protein	[11]	['Cause']	_	_
17	therapy	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	3	_	_	CD	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	respectively	_	_	RB	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	existence	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	such	_	_	JJ	O	[-1]	['none']	_	_
28	genetic	_	_	JJ	O	[-1]	['none']	_	_
29	aberrations	_	_	NNS	O	[-1]	['none']	_	_
30	seems	_	_	VBZ	O	[-1]	['none']	_	_
31	unlikely	_	_	JJ	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	then	_	_	RB	O	[-1]	['none']	_	_
3	investigated	_	_	VBD	O	[-1]	['none']	_	_
4	whether	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	previously	_	_	RB	O	[-1]	['none']	_	_
7	described	_	_	VBN	O	[-1]	['none']	_	_
8	down-regulation	_	_	NN	Negative_regulation	[17]	['Theme']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	IRF-4	_	_	NN	Protein	[11, 29]	['Theme', 'Theme']	_	_
11	expression	_	_	NN	Gene_expression	[8]	['Theme']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	human	_	_	NN	O	[-1]	['none']	_	_
14	myeloid	_	_	JJ	O	[-1]	['none']	_	_
15	leukemias	_	_	NNS	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	due	_	_	JJ	Positive_regulation	[0]	['root']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	differential	_	_	JJ	O	[-1]	['none']	_	_
21	hypermethylation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	promoter	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	since	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	presented	_	_	JJ	O	[-1]	['none']	_	_
29	re-expression	_	_	NN	Gene_expression	[37]	['Theme']	_	_
30	due	_	_	JJ	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	AzadC-treatment	_	_	NNP	O	[-1]	['none']	_	_
33	might	_	_	MD	O	[-1]	['none']	_	_
34	also	_	_	RB	O	[-1]	['none']	_	_
35	be	_	_	VB	O	[-1]	['none']	_	_
36	a	_	_	DT	O	[-1]	['none']	_	_
37	result	_	_	NN	Positive_regulation	[0]	['root']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	activation	_	_	NN	O	[-1]	['none']	_	_
40	of	_	_	IN	O	[-1]	['none']	_	_
41	positive	_	_	JJ	O	[-1]	['none']	_	_
42	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
43	regulators	_	_	NNS	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	Methylation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	CpG	_	_	NN	O	[-1]	['none']	_	_
4	sites	_	_	NNS	O	[-1]	['none']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	common	_	_	JJ	O	[-1]	['none']	_	_
8	mechanism	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	silencing	_	_	NN	O	[-1]	['none']	_	_
11	genes	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	leukemia	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	has	_	_	VBZ	O	[-1]	['none']	_	_
16	also	_	_	RB	O	[-1]	['none']	_	_
17	been	_	_	VBN	O	[-1]	['none']	_	_
18	shown	_	_	VBN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	another	_	_	DT	O	[-1]	['none']	_	_
21	IRF	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	IRF-7	_	_	NN	Protein	[0]	['root']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	35	_	_	CD	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	PU	_	_	NN	Protein	[30]	['multitoken']	_	_
30	.1	_	_	CD	Protein	[36]	['Theme']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	36	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	an	_	_	DT	O	[-1]	['none']	_	_
36	interacting	_	_	VBG	Binding	[0]	['root']	_	_
37	partner	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	IRF-4	_	_	NN	Protein	[36]	['Theme']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	elucidate	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	relevance	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	this	_	_	DT	O	[-1]	['none']	_	_
7	mechanism	_	_	NN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	regulation	_	_	NN	Regulation	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	IRF-4	_	_	NN	Protein	[13]	['Theme']	_	_
13	expression	_	_	NN	Gene_expression	[10]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	various	_	_	JJ	O	[-1]	['none']	_	_
16	leukemic	_	_	JJ	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	treated	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	demethylating	_	_	JJ	O	[-1]	['none']	_	_
22	agents	_	_	NNS	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	promoters	_	_	NNS	O	[-1]	['none']	_	_
25	were	_	_	VBD	O	[-1]	['none']	_	_
26	sequenced	_	_	VBN	O	[-1]	['none']	_	_
27	after	_	_	IN	O	[-1]	['none']	_	_
28	bisulfite	_	_	NN	O	[-1]	['none']	_	_
29	treatment	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	found	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	IRF-4	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
6	could	_	_	MD	O	[-1]	['none']	_	_
7	indeed	_	_	RB	O	[-1]	['none']	_	_
8	be	_	_	VB	O	[-1]	['none']	_	_
9	connected	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	methylation	_	_	NN	O	[-1]	['none']	_	_
13	status	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	distinct	_	_	JJ	O	[-1]	['none']	_	_
16	CpG	_	_	NN	O	[-1]	['none']	_	_
17	motifs	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
21	promoter	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	Figure	_	_	NNP	O	[-1]	['none']	_	_
3	4A	_	_	NNP	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	those	_	_	DT	O	[-1]	['none']	_	_
6	CpG	_	_	NN	O	[-1]	['none']	_	_
7	sites	_	_	NNS	O	[-1]	['none']	_	_
8	are	_	_	VBP	O	[-1]	['none']	_	_
9	shown	_	_	VBN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	bottom	_	_	JJ	O	[-1]	['none']	_	_
12	line	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	whose	_	_	WP$	O	[-1]	['none']	_	_
16	hypermethylation	_	_	NN	O	[-1]	['none']	_	_
17	may	_	_	MD	O	[-1]	['none']	_	_
18	account	_	_	VB	Positive_regulation	[0]	['root']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	absence	_	_	NN	Negative_regulation	[18]	['Theme']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IRF-4	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[21]	['Theme']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	respective	_	_	JJ	O	[-1]	['none']	_	_
28	cells	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	One	_	_	CD	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	them	_	_	PRP	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	#	_	_	#	O	[-1]	['none']	_	_
6	54	_	_	CD	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	adjacent	_	_	JJ	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	an	_	_	DT	O	[-1]	['none']	_	_
12	identified	_	_	VBN	O	[-1]	['none']	_	_
13	regulatory	_	_	JJ	O	[-1]	['none']	_	_
14	element	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	NFkappaB-site	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	indicating	_	_	VBG	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	possible	_	_	JJ	O	[-1]	['none']	_	_
22	involvement	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	this	_	_	DT	O	[-1]	['none']	_	_
25	site	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	two	_	_	CD	O	[-1]	['none']	_	_
3	further	_	_	JJ	O	[-1]	['none']	_	_
4	CpG	_	_	NN	O	[-1]	['none']	_	_
5	sites	_	_	NNS	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	#	_	_	#	O	[-1]	['none']	_	_
8	48	_	_	CD	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	45	_	_	CD	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	methylation	_	_	NN	O	[-1]	['none']	_	_
14	status	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	lower	_	_	JJR	O	[-1]	['none']	_	_
19	than	_	_	IN	O	[-1]	['none']	_	_
20	that	_	_	DT	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	IRF-4-negative	_	_	JJ	Protein	[0]	['root']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	CpG	_	_	NN	O	[-1]	['none']	_	_
3	sites	_	_	NNS	O	[-1]	['none']	_	_
4	are	_	_	VBP	O	[-1]	['none']	_	_
5	located	_	_	JJ	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	an	_	_	DT	O	[-1]	['none']	_	_
8	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	an	_	_	DT	O	[-1]	['none']	_	_
11	SP1	_	_	NN	O	[-1]	['none']	_	_
12	element	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	31	_	_	CD	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	thus	_	_	RB	O	[-1]	['none']	_	_
18	may	_	_	MD	O	[-1]	['none']	_	_
19	also	_	_	RB	O	[-1]	['none']	_	_
20	play	_	_	VB	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	role	_	_	NN	Regulation	[0]	['root']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	regulation	_	_	NN	Regulation	[22]	['Theme']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	IRF-4	_	_	NN	Protein	[27]	['Theme']	_	_
27	expression	_	_	NN	Gene_expression	[24]	['Theme']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	been	_	_	VBN	O	[-1]	['none']	_	_
4	shown	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	NFkappaB	_	_	NN	Entity	[7]	['multitoken']	_	_
7	elements	_	_	NNS	Entity	[11, 20]	['CSite', 'Site']	_	_
8	play	_	_	VBP	O	[-1]	['none']	_	_
9	an	_	_	DT	O	[-1]	['none']	_	_
10	important	_	_	JJ	Regulation	[11]	['multitoken']	_	_
11	role	_	_	NN	Regulation	[0]	['root']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	IRF-4	_	_	NN	Protein	[14]	['Theme']	_	_
14	induction	_	_	NN	Positive_regulation	[11]	['Theme']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	IRF-4	_	_	NN	Protein	[17]	['Theme']	_	_
17	expression	_	_	NN	Gene_expression	[18]	['Theme']	_	_
18	depends	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
19	on	_	_	IN	O	[-1]	['none']	_	_
20	binding	_	_	NN	Binding	[18]	['Cause']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	transactivator	_	_	NN	O	[-1]	['none']	_	_
24	c-Rel	_	_	NN	Protein	[20]	['Theme']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	these	_	_	DT	Anaphora	[27]	['multitoken']	_	_
27	elements	_	_	NNS	Anaphora	[0]	['root']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	IRF-4	_	_	NN	Protein	[11, 20]	['Cause', 'Theme']	_	_
31	promoter	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	31,37	_	_	CD	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	methylation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	central	_	_	JJ	O	[-1]	['none']	_	_
7	CpG	_	_	NN	Entity	[12]	['CSite']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	NFkappaB	_	_	NN	Entity	[11]	['multitoken']	_	_
11	element	_	_	NN	Entity	[13]	['Site']	_	_
12	inhibits	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
13	binding	_	_	NN	Binding	[12]	['Theme']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
17	protein	_	_	NN	O	[-1]	['none']	_	_
18	complexes	_	_	NNS	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	38	_	_	CD	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	promoting	_	_	VBG	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	significance	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	observed	_	_	JJ	O	[-1]	['none']	_	_
29	methylation	_	_	NN	O	[-1]	['none']	_	_
30	differences	_	_	NNS	O	[-1]	['none']	_	_
31	in	_	_	IN	O	[-1]	['none']	_	_
32	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
35	cells	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Via	_	_	NNP	O	[-1]	['none']	_	_
2	in	_	_	FW	O	[-1]	['none']	_	_
3	vitro	_	_	FW	O	[-1]	['none']	_	_
4	methylation	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	reporter	_	_	NN	O	[-1]	['none']	_	_
7	gene	_	_	NN	O	[-1]	['none']	_	_
8	assays	_	_	NNS	O	[-1]	['none']	_	_
9	we	_	_	PRP	O	[-1]	['none']	_	_
10	could	_	_	MD	O	[-1]	['none']	_	_
11	clearly	_	_	RB	O	[-1]	['none']	_	_
12	appoint	_	_	VB	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	silencing	_	_	NN	Negative_regulation	[0]	['root']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	IRF-4	_	_	NN	Protein	[14]	['Theme']	_	_
18	promoter	_	_	NN	Entity	[14]	['Site']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	methylation	_	_	NN	O	[-1]	['none']	_	_
22	effect	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	which	_	_	WDT	O	[-1]	['none']	_	_
25	may	_	_	MD	O	[-1]	['none']	_	_
26	thus	_	_	RB	O	[-1]	['none']	_	_
27	be	_	_	VB	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	mechanism	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	IRF-4	_	_	NN	Protein	[32]	['Theme']	_	_
32	deregulation	_	_	NN	Regulation	[0]	['root']	_	_
33	in	_	_	FW	O	[-1]	['none']	_	_
34	vivo	_	_	FW	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	One	_	_	CD	O	[-1]	['none']	_	_
2	possible	_	_	JJ	O	[-1]	['none']	_	_
3	cause	_	_	NN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	aberrant	_	_	JJ	O	[-1]	['none']	_	_
7	methylation	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	tumorigenesis	_	_	NN	O	[-1]	['none']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	an	_	_	DT	O	[-1]	['none']	_	_
12	increased	_	_	JJ	O	[-1]	['none']	_	_
13	level	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	DNMTs	_	_	NNS	O	[-1]	['none']	_	_
16	during	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	pathogenetic	_	_	JJ	O	[-1]	['none']	_	_
19	process	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	colon	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	lung	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	hematologic	_	_	JJ	O	[-1]	['none']	_	_
7	malignancies	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	DNMT1	_	_	NN	Protein	[9]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	maintenance	_	_	NN	O	[-1]	['none']	_	_
15	DNMT	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	has	_	_	VBZ	O	[-1]	['none']	_	_
18	been	_	_	VBN	O	[-1]	['none']	_	_
19	detected	_	_	VBN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	39-41	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	it	_	_	PRP	O	[-1]	['none']	_	_
4	has	_	_	VBZ	O	[-1]	['none']	_	_
5	been	_	_	VBN	O	[-1]	['none']	_	_
6	shown	_	_	VBN	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	CML	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	acute	_	_	JJ	O	[-1]	['none']	_	_
13	phase	_	_	NN	O	[-1]	['none']	_	_
14	exhibited	_	_	VBD	O	[-1]	['none']	_	_
15	elevated	_	_	JJ	O	[-1]	['none']	_	_
16	levels	_	_	NNS	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	three	_	_	CD	O	[-1]	['none']	_	_
20	known	_	_	VBN	O	[-1]	['none']	_	_
21	DNMTs	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	while	_	_	IN	O	[-1]	['none']	_	_
24	CML	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	chronic	_	_	JJ	O	[-1]	['none']	_	_
28	phase	_	_	NN	O	[-1]	['none']	_	_
29	expressed	_	_	VBD	O	[-1]	['none']	_	_
30	normal	_	_	JJ	O	[-1]	['none']	_	_
31	levels	_	_	NNS	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	DNMTs	_	_	NNS	O	[-1]	['none']	_	_
34	if	_	_	IN	O	[-1]	['none']	_	_
35	compared	_	_	VBN	O	[-1]	['none']	_	_
36	with	_	_	IN	O	[-1]	['none']	_	_
37	normal	_	_	JJ	O	[-1]	['none']	_	_
38	bone	_	_	NN	O	[-1]	['none']	_	_
39	marrow	_	_	NN	O	[-1]	['none']	_	_
40	cells	_	_	NNS	O	[-1]	['none']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	25	_	_	CD	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	positive	_	_	JJ	O	[-1]	['none']	_	_
5	correlation	_	_	NN	O	[-1]	['none']	_	_
6	between	_	_	IN	O	[-1]	['none']	_	_
7	DNMT1	_	_	NN	Protein	[8]	['Theme']	_	_
8	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
9	levels	_	_	NNS	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	hypermethylation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	p15INK4b	_	_	NN	Protein	[0]	['root']	_	_
14	has	_	_	VBZ	O	[-1]	['none']	_	_
15	been	_	_	VBN	O	[-1]	['none']	_	_
16	detected	_	_	VBN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	AML	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	25	_	_	CD	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	work	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	we	_	_	PRP	O	[-1]	['none']	_	_
6	did	_	_	VBD	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	detect	_	_	VB	O	[-1]	['none']	_	_
9	significant	_	_	JJ	O	[-1]	['none']	_	_
10	mRNA	_	_	NN	O	[-1]	['none']	_	_
11	expression	_	_	NN	O	[-1]	['none']	_	_
12	differences	_	_	NNS	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	selected	_	_	VBN	O	[-1]	['none']	_	_
15	DNMT	_	_	NN	O	[-1]	['none']	_	_
16	or	_	_	CC	O	[-1]	['none']	_	_
17	MBP	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	making	_	_	VBG	O	[-1]	['none']	_	_
20	it	_	_	PRP	O	[-1]	['none']	_	_
21	an	_	_	DT	O	[-1]	['none']	_	_
22	unlikely	_	_	JJ	O	[-1]	['none']	_	_
23	cause	_	_	NN	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	observed	_	_	JJ	O	[-1]	['none']	_	_
27	methylation	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	thus	_	_	RB	O	[-1]	['none']	_	_
30	IRF-4	_	_	NN	Protein	[31]	['Theme']	_	_
31	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
32	differences	_	_	NNS	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	leukemia	_	_	NN	O	[-1]	['none']	_	_
35	cells	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	finding	_	_	NN	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	IRF-4	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	silenced	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	promoter	_	_	NN	O	[-1]	['none']	_	_
10	hypermethylation	_	_	NN	O	[-1]	['none']	_	_
11	might	_	_	MD	O	[-1]	['none']	_	_
12	represent	_	_	VB	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	mechanism	_	_	NN	O	[-1]	['none']	_	_
15	that	_	_	WDT	O	[-1]	['none']	_	_
16	accounts	_	_	VBZ	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	previously	_	_	RB	O	[-1]	['none']	_	_
20	observed	_	_	VBN	O	[-1]	['none']	_	_
21	loss	_	_	NN	Negative_regulation	[0]	['root']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IRF-4	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[21]	['Theme']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	CML	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Indeed	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	several	_	_	JJ	O	[-1]	['none']	_	_
4	clinical	_	_	JJ	O	[-1]	['none']	_	_
5	trials	_	_	NNS	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	leukemia	_	_	NN	O	[-1]	['none']	_	_
8	patients	_	_	NNS	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	patients	_	_	NNS	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	myelodysplastic	_	_	JJ	O	[-1]	['none']	_	_
13	syndromes	_	_	NNS	O	[-1]	['none']	_	_
14	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	potential	_	_	JJ	O	[-1]	['none']	_	_
17	clinical	_	_	JJ	O	[-1]	['none']	_	_
18	benefit	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	treatment	_	_	NN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	demethylating	_	_	JJ	O	[-1]	['none']	_	_
24	agents	_	_	NNS	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	42-45	_	_	CD	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	expression	_	_	NN	Gene_expression	[16]	['Theme']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	another	_	_	DT	O	[-1]	['none']	_	_
5	IRF	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	IFN	_	_	NN	Protein	[11]	['multitoken']	_	_
8	consensus	_	_	NN	Protein	[11]	['multitoken']	_	_
9	sequence	_	_	NN	Protein	[11]	['multitoken']	_	_
10	binding	_	_	NN	Protein	[11]	['multitoken']	_	_
11	protein	_	_	NN	Protein	[2]	['Theme']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	ICSBP/IRF-8)	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	is	_	_	VBZ	O	[-1]	['none']	_	_
16	impaired	_	_	JJ	Negative_regulation	[0]	['root']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	myeloid	_	_	JJ	O	[-1]	['none']	_	_
19	leukemias	_	_	NNS	O	[-1]	['none']	_	_
20	especially	_	_	RB	O	[-1]	['none']	_	_
21	CML	_	_	NNP	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	27,46,47	_	_	CD	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	But	_	_	CC	O	[-1]	['none']	_	_
2	in	_	_	IN	O	[-1]	['none']	_	_
3	contrast	_	_	NN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	loss	_	_	NN	Negative_regulation	[15]	['Theme']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	this	_	_	DT	Anaphora	[11]	['multitoken']	_	_
11	IRF	_	_	NN	Anaphora	[0]	['root']	_	_
12	could	_	_	MD	O	[-1]	['none']	_	_
13	not	_	_	RB	O	[-1]	['none']	_	_
14	be	_	_	VB	O	[-1]	['none']	_	_
15	reverted	_	_	VBN	Negative_regulation	[0]	['root']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	ICSBP	_	_	NN	Protein	[18]	['Theme']	_	_
18	negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	lines	_	_	NNS	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	EM-2	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	CML-T1	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	K-562	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	LAMA-84	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	treatment	_	_	NN	O	[-1]	['none']	_	_
32	with	_	_	IN	O	[-1]	['none']	_	_
33	AzadC	_	_	NN	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	AzadC	_	_	NN	O	[-1]	['none']	_	_
36	has	_	_	VBZ	O	[-1]	['none']	_	_
37	no	_	_	DT	O	[-1]	['none']	_	_
38	effect	_	_	NN	Regulation	[0]	['root']	_	_
39	on	_	_	IN	O	[-1]	['none']	_	_
40	ICSBP	_	_	NN	Protein	[41]	['Theme']	_	_
41	levels	_	_	NNS	Gene_expression	[38]	['Theme']	_	_
42	in	_	_	IN	O	[-1]	['none']	_	_
43	ICSBP	_	_	NN	Protein	[44]	['Theme']	_	_
44	positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
45	U-937	_	_	NN	O	[-1]	['none']	_	_
46	cells	_	_	NNS	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	distinct	_	_	JJ	O	[-1]	['none']	_	_
6	regulatory	_	_	JJ	O	[-1]	['none']	_	_
7	mechanism	_	_	NN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	these	_	_	DT	O	[-1]	['none']	_	_
10	two	_	_	CD	O	[-1]	['none']	_	_
11	IRFs	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	IRF-4	_	_	NNP	Protein	[31]	['Theme']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	similar	_	_	JJ	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	many	_	_	JJ	O	[-1]	['none']	_	_
6	other	_	_	JJ	O	[-1]	['none']	_	_
7	classical	_	_	JJ	O	[-1]	['none']	_	_
8	tumor	_	_	NN	O	[-1]	['none']	_	_
9	suppressor	_	_	NN	O	[-1]	['none']	_	_
10	genes	_	_	NNS	O	[-1]	['none']	_	_
11	p15INK4b	_	_	NN	Protein	[0]	['root']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	p16INK4a	_	_	NN	Protein	[0]	['root']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	p53	_	_	NN	Protein	[0]	['root']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	may	_	_	MD	O	[-1]	['none']	_	_
18	thus	_	_	RB	O	[-1]	['none']	_	_
19	be	_	_	VB	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	subject	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	alterations	_	_	NNS	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	promoter	_	_	NN	O	[-1]	['none']	_	_
27	methylation	_	_	NN	O	[-1]	['none']	_	_
28	status	_	_	NN	O	[-1]	['none']	_	_
29	leading	_	_	VBG	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	expression	_	_	NN	Gene_expression	[32]	['Theme']	_	_
32	changes	_	_	NNS	Regulation	[0]	['root']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	which	_	_	WDT	O	[-1]	['none']	_	_
35	might	_	_	MD	O	[-1]	['none']	_	_
36	contribute	_	_	VB	O	[-1]	['none']	_	_
37	to	_	_	TO	O	[-1]	['none']	_	_
38	the	_	_	DT	O	[-1]	['none']	_	_
39	initiation	_	_	NN	O	[-1]	['none']	_	_
40	and/or	_	_	CC	O	[-1]	['none']	_	_
41	progression	_	_	NN	O	[-1]	['none']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	cancer	_	_	NN	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	Still	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	obvious	_	_	JJ	O	[-1]	['none']	_	_
5	functional	_	_	JJ	O	[-1]	['none']	_	_
6	diversity	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
9	remains	_	_	VBZ	O	[-1]	['none']	_	_
10	remarkable	_	_	JJ	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	can	_	_	MD	O	[-1]	['none']	_	_
13	not	_	_	RB	O	[-1]	['none']	_	_
14	be	_	_	VB	O	[-1]	['none']	_	_
15	fully	_	_	RB	O	[-1]	['none']	_	_
16	explained	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
20	promoter	_	_	NN	O	[-1]	['none']	_	_
21	methylation	_	_	NN	O	[-1]	['none']	_	_
22	status	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	example	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	primarily	_	_	RB	O	[-1]	['none']	_	_
7	known	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	its	_	_	PRP$	O	[-1]	['none']	_	_
10	oncogenic	_	_	JJ	O	[-1]	['none']	_	_
11	features	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	multiple	_	_	JJ	O	[-1]	['none']	_	_
3	myeloma	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	MM	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	translocation	_	_	NN	O	[-1]	['none']	_	_
9	on	_	_	IN	O	[-1]	['none']	_	_
10	chromosome	_	_	NN	O	[-1]	['none']	_	_
11	14q	_	_	NN	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	reported	_	_	VBN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	lead	_	_	VB	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	fusion	_	_	NN	O	[-1]	['none']	_	_
19	gene	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	immunoglobulin	_	_	NN	Protein	[22]	['multitoken']	_	_
22	heavy-chain	_	_	JJ	Protein	[0]	['root']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	IgH	_	_	NN	Protein	[0]	['root']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
28	resulting	_	_	VBG	Positive_regulation	[0]	['root']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	subsequent	_	_	JJ	O	[-1]	['none']	_	_
32	overexpression	_	_	NN	Positive_regulation	[28]	['Theme']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	IRF-4	_	_	NN	Protein	[32]	['Theme']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	48,49	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	abundant	_	_	JJ	O	[-1]	['none']	_	_
5	IRF-4	_	_	NN	Protein	[6]	['Theme']	_	_
6	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	found	_	_	VBN	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	be	_	_	VB	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	marker	_	_	NN	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	various	_	_	JJ	O	[-1]	['none']	_	_
15	subsets	_	_	NNS	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	such	_	_	JJ	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	diffuse	_	_	JJ	O	[-1]	['none']	_	_
22	large	_	_	JJ	O	[-1]	['none']	_	_
23	B-cell	_	_	NN	O	[-1]	['none']	_	_
24	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	primary	_	_	JJ	O	[-1]	['none']	_	_
27	effusion	_	_	NN	O	[-1]	['none']	_	_
28	lymphoma	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	marginal	_	_	JJ	O	[-1]	['none']	_	_
32	zone	_	_	NN	O	[-1]	['none']	_	_
33	lymphoma	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	adult	_	_	JJ	O	[-1]	['none']	_	_
37	T-cell	_	_	NN	O	[-1]	['none']	_	_
38	leukemia	_	_	NN	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	11,31,50-52	_	_	CD	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	draws	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	more	_	_	RBR	O	[-1]	['none']	_	_
5	complex	_	_	JJ	O	[-1]	['none']	_	_
6	picture	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	role	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Down-regulation	_	_	NN	Negative_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	IRF-4	_	_	NN	Protein	[1]	['Theme']	_	_
4	may	_	_	MD	O	[-1]	['none']	_	_
5	promote	_	_	VB	O	[-1]	['none']	_	_
6	leukemogenesis	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	myeloid	_	_	JJ	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	context	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	3	_	_	CD	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	which	_	_	WDT	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	recently	_	_	RB	O	[-1]	['none']	_	_
18	confirmed	_	_	VBN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	IRF-4-/-	_	_	JJ	Protein	[0]	['root']	_	_
21	ICSBP-/-	_	_	NN	Protein	[0]	['root']	_	_
22	double	_	_	JJ	O	[-1]	['none']	_	_
23	knock-out	_	_	JJ	Gene_expression	[0]	['root']	_	_
24	mice	_	_	NNS	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	53	_	_	CD	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	while	_	_	IN	O	[-1]	['none']	_	_
30	IRF-4	_	_	NN	Protein	[31]	['Theme']	_	_
31	up-regulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
32	may	_	_	MD	O	[-1]	['none']	_	_
33	induce	_	_	VB	O	[-1]	['none']	_	_
34	a	_	_	DT	O	[-1]	['none']	_	_
35	growth	_	_	NN	O	[-1]	['none']	_	_
36	advantage	_	_	NN	O	[-1]	['none']	_	_
37	in	_	_	IN	O	[-1]	['none']	_	_
38	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
39	or	_	_	CC	O	[-1]	['none']	_	_
40	MM	_	_	NN	O	[-1]	['none']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	48	_	_	CD	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	Taken	_	_	VBN	O	[-1]	['none']	_	_
2	together	_	_	RB	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	our	_	_	PRP$	O	[-1]	['none']	_	_
5	data	_	_	NNS	O	[-1]	['none']	_	_
6	suggest	_	_	VBP	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
9	promoter	_	_	NN	O	[-1]	['none']	_	_
10	methylation	_	_	NN	O	[-1]	['none']	_	_
11	regulates	_	_	VBZ	Regulation	[0]	['root']	_	_
12	IRF-4	_	_	NN	Protein	[13]	['Theme']	_	_
13	expression	_	_	NN	Gene_expression	[11]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	that	_	_	IN	O	[-1]	['none']	_	_
17	aberrant	_	_	JJ	O	[-1]	['none']	_	_
18	expression	_	_	NN	Gene_expression	[29]	['Theme']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	IRF-4	_	_	NN	Protein	[18]	['Theme']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	certain	_	_	JJ	O	[-1]	['none']	_	_
23	types	_	_	NNS	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	leukemia	_	_	NN	O	[-1]	['none']	_	_
26	may	_	_	MD	O	[-1]	['none']	_	_
27	be	_	_	VB	O	[-1]	['none']	_	_
28	a	_	_	DT	O	[-1]	['none']	_	_
29	consequence	_	_	NN	Positive_regulation	[0]	['root']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
32	promoter	_	_	NN	O	[-1]	['none']	_	_
33	hypermethylation	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	JJ	O	[-1]	['none']	_	_
2	Blot	_	_	NN	O	[-1]	['none']	_	_
3	Analysis	_	_	NN	O	[-1]	['none']	_	_
4	Cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	washed	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	PBS	_	_	NNP	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	resuspended	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	cell	_	_	NN	O	[-1]	['none']	_	_
13	lysis	_	_	NN	O	[-1]	['none']	_	_
14	buffer	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	Cell	_	_	NN	O	[-1]	['none']	_	_
3	Signaling	_	_	NN	O	[-1]	['none']	_	_
4	Technology	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	incubated	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	10	_	_	CD	O	[-1]	['none']	_	_
10	minutes	_	_	NNS	O	[-1]	['none']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	ice	_	_	NN	O	[-1]	['none']	_	_
13	then	_	_	RB	O	[-1]	['none']	_	_
14	centrifuged	_	_	VBD	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	remove	_	_	VB	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	insoluble	_	_	JJ	O	[-1]	['none']	_	_
19	fraction	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	protein	_	_	NN	O	[-1]	['none']	_	_
3	concentration	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	determined	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	BCA	_	_	NN	O	[-1]	['none']	_	_
9	protein	_	_	NN	O	[-1]	['none']	_	_
10	assay	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Bio-Rad	_	_	NNP	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	Hercules	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	CA	_	_	NNP	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	lysates	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	separated	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
7	on	_	_	IN	O	[-1]	['none']	_	_
8	10	_	_	CD	O	[-1]	['none']	_	_
9	%	_	_	NN	O	[-1]	['none']	_	_
10	polyacrylamide	_	_	NN	O	[-1]	['none']	_	_
11	gels	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	then	_	_	RB	O	[-1]	['none']	_	_
14	transferred	_	_	VBN	O	[-1]	['none']	_	_
15	onto	_	_	IN	O	[-1]	['none']	_	_
16	nitrocellulose	_	_	NN	O	[-1]	['none']	_	_
17	membranes	_	_	NNS	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	subjected	_	_	VBN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	Western	_	_	NN	O	[-1]	['none']	_	_
22	blotting	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	immunoblotted	_	_	JJ	O	[-1]	['none']	_	_
3	proteins	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	detected	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	ECL	_	_	NN	O	[-1]	['none']	_	_
8	reagent	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	GE	_	_	NNP	O	[-1]	['none']	_	_
11	Healthcare	_	_	NNP	O	[-1]	['none']	_	_
12	Bio-Sciences	_	_	NNP	O	[-1]	['none']	_	_
13	Corp.	_	_	NNP	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	Piscataway	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	NJ	_	_	NNP	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Inhibition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PKC	_	_	NN	O	[-1]	['none']	_	_
4	reduces	_	_	VBZ	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	activity	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	M-CSF	_	_	NN	O	[-1]	['none']	_	_
9	stimulated	_	_	VBN	O	[-1]	['none']	_	_
10	macrophages	_	_	NNS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Human	_	_	NN	O	[-1]	['none']	_	_
5	MDMs	_	_	NNS	O	[-1]	['none']	_	_
6	transfected	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	pre-incubated	_	_	JJ	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
13	;	_	_	:	O	[-1]	['none']	_	_
14	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	Go-6976	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	BAPTA/AM	_	_	NN	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	30	_	_	CD	O	[-1]	['none']	_	_
22	minutes	_	_	NNS	O	[-1]	['none']	_	_
23	prior	_	_	RB	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	6	_	_	CD	O	[-1]	['none']	_	_
26	hours	_	_	NNS	O	[-1]	['none']	_	_
27	M-CSF	_	_	NN	O	[-1]	['none']	_	_
28	stimulation	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	RAW	_	_	NN	O	[-1]	['none']	_	_
5	264.7	_	_	CD	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	transfected	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
11	construct	_	_	NN	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	pre-incubated	_	_	JJ	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	30	_	_	CD	O	[-1]	['none']	_	_
18	minutes	_	_	NNS	O	[-1]	['none']	_	_
19	prior	_	_	RB	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	2	_	_	CD	O	[-1]	['none']	_	_
22	hours	_	_	NNS	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	stimulation	_	_	NN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	mouse	_	_	NN	O	[-1]	['none']	_	_
27	recombinant	_	_	JJ	O	[-1]	['none']	_	_
28	M-CSF	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	activity	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	analyzed	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	measuring	_	_	VBG	O	[-1]	['none']	_	_
8	SEAP	_	_	NN	O	[-1]	['none']	_	_
9	production	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	medium	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	data	_	_	NNS	O	[-1]	['none']	_	_
15	are	_	_	VBP	O	[-1]	['none']	_	_
16	expressed	_	_	VBN	O	[-1]	['none']	_	_
17	as	_	_	IN	O	[-1]	['none']	_	_
18	fold	_	_	JJ	O	[-1]	['none']	_	_
19	increase	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	SEAP	_	_	NN	O	[-1]	['none']	_	_
22	activity	_	_	NN	O	[-1]	['none']	_	_
23	over	_	_	IN	O	[-1]	['none']	_	_
24	that	_	_	DT	O	[-1]	['none']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
27	transfected	_	_	VBN	O	[-1]	['none']	_	_
28	resting	_	_	VBG	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	graph	_	_	NN	O	[-1]	['none']	_	_
3	represents	_	_	VBZ	O	[-1]	['none']	_	_
4	mean	_	_	NN	O	[-1]	['none']	_	_
5	+/-	_	_	CC	O	[-1]	['none']	_	_
6	S.E.M	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	three	_	_	CD	O	[-1]	['none']	_	_
9	independent	_	_	JJ	O	[-1]	['none']	_	_
10	experiments	_	_	NNS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	*	_	_	SYM	O	[-1]	['none']	_	_
2	The	_	_	DT	O	[-1]	['none']	_	_
3	p-values	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	treated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	M-CSF	_	_	NN	O	[-1]	['none']	_	_
11	compared	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	vehicle	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	M-CSF	_	_	NN	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	<	_	_	JJR	O	[-1]	['none']	_	_
18	=	_	_	JJ	O	[-1]	['none']	_	_
19	0.05	_	_	CD	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Transient	_	_	JJ	O	[-1]	['none']	_	_
2	Transfection	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	Primary	_	_	JJ	O	[-1]	['none']	_	_
5	Human	_	_	NN	O	[-1]	['none']	_	_
6	Monocytes	_	_	NNS	O	[-1]	['none']	_	_
7	Monocytes	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	transfected	_	_	VBN	O	[-1]	['none']	_	_
10	using	_	_	VBG	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	human	_	_	NN	O	[-1]	['none']	_	_
13	monocyte	_	_	NN	O	[-1]	['none']	_	_
14	Amaxa	_	_	NN	O	[-1]	['none']	_	_
15	nucleofector	_	_	NN	O	[-1]	['none']	_	_
16	kit	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Lonza	_	_	NNP	O	[-1]	['none']	_	_
19	Walkersville	_	_	NNP	O	[-1]	['none']	_	_
20	Inc	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	Walkersville	_	_	NNP	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	MD	_	_	NNP	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	as	_	_	IN	O	[-1]	['none']	_	_
27	previously	_	_	RB	O	[-1]	['none']	_	_
28	described	_	_	VBN	O	[-1]	['none']	_	_
29	[	_	_	NN	O	[-1]	['none']	_	_
30	51	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	monocytes	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	resuspended	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	Amaxa	_	_	NNP	O	[-1]	['none']	_	_
8	Nucleofactor	_	_	NNP	O	[-1]	['none']	_	_
9	solution	_	_	NN	O	[-1]	['none']	_	_
10	at	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	density	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	20x106	_	_	CD	O	[-1]	['none']	_	_
15	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	2	_	_	CD	O	[-1]	['none']	_	_
19	microg	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	total	_	_	JJ	O	[-1]	['none']	_	_
22	plasmid	_	_	NN	O	[-1]	['none']	_	_
23	DNA	_	_	NN	O	[-1]	['none']	_	_
24	100	_	_	CD	O	[-1]	['none']	_	_
25	nM	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	PKCalpha	_	_	NN	Protein	[28]	['multitoken']	_	_
28	siRNA	_	_	NN	Protein	[0]	['root']	_	_
29	or	_	_	CC	O	[-1]	['none']	_	_
30	control	_	_	NN	O	[-1]	['none']	_	_
31	siRNA	_	_	NN	O	[-1]	['none']	_	_
32	was	_	_	VBD	O	[-1]	['none']	_	_
33	added	_	_	VBN	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	transfected	_	_	VBN	O	[-1]	['none']	_	_
36	using	_	_	VBG	O	[-1]	['none']	_	_
37	program	_	_	NN	O	[-1]	['none']	_	_
38	Amaxa	_	_	NN	O	[-1]	['none']	_	_
39	Y-01	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	co-transfection	_	_	NN	O	[-1]	['none']	_	_
3	studies	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
6	or	_	_	CC	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[0]	['root']	_	_
9	constructs	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	mixed	_	_	VBN	O	[-1]	['none']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	ratio	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	5:1	_	_	CD	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	reporter	_	_	NN	O	[-1]	['none']	_	_
20	plasmid	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Immediately	_	_	RB	O	[-1]	['none']	_	_
2	after	_	_	IN	O	[-1]	['none']	_	_
3	transfection	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	washed	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	1	_	_	CD	O	[-1]	['none']	_	_
10	ml	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	RPMI	_	_	NN	O	[-1]	['none']	_	_
13	medium	_	_	NN	O	[-1]	['none']	_	_
14	containing	_	_	VBG	O	[-1]	['none']	_	_
15	2	_	_	CD	O	[-1]	['none']	_	_
16	mM	_	_	NN	O	[-1]	['none']	_	_
17	glutamine	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	10	_	_	CD	O	[-1]	['none']	_	_
20	%	_	_	NN	O	[-1]	['none']	_	_
21	FBS	_	_	NN	O	[-1]	['none']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	serum	_	_	NN	O	[-1]	['none']	_	_
24	free	_	_	JJ	O	[-1]	['none']	_	_
25	LGM	_	_	NN	O	[-1]	['none']	_	_
26	medium	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	Lonza	_	_	NNP	O	[-1]	['none']	_	_
29	Walkersville	_	_	NNP	O	[-1]	['none']	_	_
30	Inc.	_	_	NNP	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	then	_	_	RB	O	[-1]	['none']	_	_
33	plated	_	_	VBD	O	[-1]	['none']	_	_
34	at	_	_	IN	O	[-1]	['none']	_	_
35	4x105	_	_	CD	O	[-1]	['none']	_	_
36	cells	_	_	NNS	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	well	_	_	RB	O	[-1]	['none']	_	_
39	in	_	_	IN	O	[-1]	['none']	_	_
40	24-well	_	_	JJ	O	[-1]	['none']	_	_
41	plates	_	_	NNS	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	original	_	_	JJ	O	[-1]	['none']	_	_
3	medium	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	replaced	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	serum	_	_	NN	O	[-1]	['none']	_	_
8	free	_	_	JJ	O	[-1]	['none']	_	_
9	LGM	_	_	NN	O	[-1]	['none']	_	_
10	medium	_	_	NN	O	[-1]	['none']	_	_
11	without	_	_	IN	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	M-CSF	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	100	_	_	CD	O	[-1]	['none']	_	_
17	ng/ml	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	one	_	_	CD	O	[-1]	['none']	_	_
20	hour	_	_	NN	O	[-1]	['none']	_	_
21	later	_	_	RB	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	next	_	_	JJ	O	[-1]	['none']	_	_
3	day	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cell-free	_	_	JJ	O	[-1]	['none']	_	_
6	supernatants	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	collected	_	_	VBN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	SEAP	_	_	NN	O	[-1]	['none']	_	_
12	analysis	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	stained	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	Annexin	_	_	NN	Protein	[6]	['multitoken']	_	_
6	V/propidium	_	_	NN	Protein	[0]	['root']	_	_
7	iodide	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	PI	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	inhibition	_	_	NN	O	[-1]	['none']	_	_
4	studies	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	pre-incubated	_	_	JJ	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	inhibitor	_	_	NN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	30	_	_	CD	O	[-1]	['none']	_	_
13	minutes	_	_	NNS	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	X-vivo	_	_	JJ	O	[-1]	['none']	_	_
16	medium	_	_	NN	O	[-1]	['none']	_	_
17	prior	_	_	RB	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	addition	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	M-CSF	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	present	_	_	JJ	O	[-1]	['none']	_	_
4	study	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	IL-6	_	_	NN	Protein	[7]	['Theme']	_	_
7	release	_	_	NN	Localization	[0]	['root']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	found	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	be	_	_	VB	O	[-1]	['none']	_	_
12	associated	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	activity	_	_	NN	O	[-1]	['none']	_	_
16	while	_	_	IN	O	[-1]	['none']	_	_
17	CXCL8	_	_	NN	Protein	[18]	['Theme']	_	_
18	release	_	_	NN	Localization	[0]	['root']	_	_
19	more	_	_	RBR	O	[-1]	['none']	_	_
20	closely	_	_	RB	O	[-1]	['none']	_	_
21	correlated	_	_	VBN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	AP-1	_	_	NN	O	[-1]	['none']	_	_
24	activity	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Treatment	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Jurkat	_	_	NN	O	[-1]	['none']	_	_
4	T-cells	_	_	NNS	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	PMA	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	more	_	_	RBR	O	[-1]	['none']	_	_
9	potent	_	_	JJ	O	[-1]	['none']	_	_
10	than	_	_	IN	O	[-1]	['none']	_	_
11	HK	_	_	JJ	O	[-1]	['none']	_	_
12	E.	_	_	FW	O	[-1]	['none']	_	_
13	coli	_	_	FW	O	[-1]	['none']	_	_
14	at	_	_	IN	O	[-1]	['none']	_	_
15	elevating	_	_	VBG	Positive_regulation	[0]	['root']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	CXCL8	_	_	NN	Protein	[15]	['Theme']	_	_
18	levels	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	PMA	_	_	NN	O	[-1]	['none']	_	_
2	induced	_	_	VBD	O	[-1]	['none']	_	_
3	AP-1	_	_	NN	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	down-regulated	_	_	VBD	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	while	_	_	IN	O	[-1]	['none']	_	_
9	HK	_	_	NNP	O	[-1]	['none']	_	_
10	E.	_	_	NNP	O	[-1]	['none']	_	_
11	coli	_	_	NN	O	[-1]	['none']	_	_
12	up-regulated	_	_	VBD	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	without	_	_	IN	O	[-1]	['none']	_	_
15	affecting	_	_	VBG	O	[-1]	['none']	_	_
16	AP-1	_	_	NN	O	[-1]	['none']	_	_
17	activity	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	temporal	_	_	JJ	O	[-1]	['none']	_	_
6	induction	_	_	NN	O	[-1]	['none']	_	_
7	pattern	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	AP-1	_	_	NN	O	[-1]	['none']	_	_
10	correlated	_	_	VBD	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	release	_	_	NN	Localization	[0]	['root']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	CXCL8	_	_	NN	Protein	[13]	['Theme']	_	_
16	while	_	_	IN	O	[-1]	['none']	_	_
17	IL-6	_	_	NN	Protein	[0]	['root']	_	_
18	followed	_	_	VBD	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	activity	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Likewise	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	blocking	_	_	VBG	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	activation	_	_	NN	O	[-1]	['none']	_	_
6	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	complete	_	_	JJ	O	[-1]	['none']	_	_
10	inhibition	_	_	NN	Negative_regulation	[6]	['Theme']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	IL-6	_	_	NN	Protein	[10]	['Theme']	_	_
13	while	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	CXCL8	_	_	NN	Protein	[18]	['Theme']	_	_
16	levels	_	_	NNS	O	[-1]	['none']	_	_
17	remained	_	_	VBD	Negative_regulation	[0]	['root']	_	_
18	elevated	_	_	JJ	Positive_regulation	[17]	['Theme']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	shown	_	_	VBN	O	[-1]	['none']	_	_
21	both	_	_	DT	O	[-1]	['none']	_	_
22	at	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	protein	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	mRNA	_	_	NN	O	[-1]	['none']	_	_
27	level	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	CXCL8	_	_	NN	Protein	[5]	['Theme']	_	_
5	release	_	_	NN	Localization	[7]	['Theme']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	down-regulated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	inhibition	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	JNK	_	_	NN	O	[-1]	['none']	_	_
12	activity	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	present	_	_	JJ	O	[-1]	['none']	_	_
3	study	_	_	NN	O	[-1]	['none']	_	_
4	indicates	_	_	VBZ	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	Jurkat	_	_	NN	O	[-1]	['none']	_	_
8	T-cells	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	IL-6	_	_	NN	Protein	[12]	['Theme']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
13	through	_	_	IN	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	while	_	_	IN	O	[-1]	['none']	_	_
16	CXCL8	_	_	NN	Protein	[17]	['Theme']	_	_
17	regulation	_	_	NN	Regulation	[19]	['Theme']	_	_
18	is	_	_	VBZ	O	[-1]	['none']	_	_
19	independent	_	_	JJ	Regulation	[0]	['root']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	closely	_	_	RB	O	[-1]	['none']	_	_
24	associated	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	AP-1	_	_	NN	O	[-1]	['none']	_	_
27	activation	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[2]	['Cause']	_	_
2	mediated	_	_	VBD	Positive_regulation	[6]	['Theme']	_	_
3	CD80	_	_	NN	Protein	[4]	['Theme']	_	_
4	upregulation	_	_	NN	Positive_regulation	[2]	['Theme']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	defective	_	_	JJ	Negative_regulation	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	HOIP	_	_	NN	Protein	[9]	['Theme']	_	_
9	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	incubated	_	_	VBN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	72	_	_	CD	O	[-1]	['none']	_	_
6	hrs	_	_	NNS	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	isotype	_	_	NN	O	[-1]	['none']	_	_
10	control	_	_	NN	O	[-1]	['none']	_	_
11	antibody	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	left	_	_	VBD	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	anti-CD40	_	_	JJ	O	[-1]	['none']	_	_
17	antibody	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	right	_	_	JJ	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	then	_	_	RB	O	[-1]	['none']	_	_
23	stained	_	_	VBD	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	CD80	_	_	NN	Protein	[25]	['Theme']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	filled	_	_	VBN	O	[-1]	['none']	_	_
30	profiles	_	_	NNS	O	[-1]	['none']	_	_
31	indicate	_	_	VBP	O	[-1]	['none']	_	_
32	staining	_	_	VBG	O	[-1]	['none']	_	_
33	with	_	_	IN	O	[-1]	['none']	_	_
34	anti-CD80	_	_	JJ	O	[-1]	['none']	_	_
35	antibody	_	_	NN	O	[-1]	['none']	_	_
36	;	_	_	:	O	[-1]	['none']	_	_
37	open	_	_	JJ	O	[-1]	['none']	_	_
38	profiles	_	_	NNS	O	[-1]	['none']	_	_
39	are	_	_	VBP	O	[-1]	['none']	_	_
40	staining	_	_	VBG	O	[-1]	['none']	_	_
41	with	_	_	IN	O	[-1]	['none']	_	_
42	an	_	_	DT	O	[-1]	['none']	_	_
43	isotype	_	_	NN	O	[-1]	['none']	_	_
44	control	_	_	NN	O	[-1]	['none']	_	_
45	antibody	_	_	NN	O	[-1]	['none']	_	_
46	)	_	_	-RRB-	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	Transduction	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	both	_	_	CC	O	[-1]	['none']	_	_
4	HOIP	_	_	NN	Protein	[5]	['Theme']	_	_
5	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	HOIP-/-)	_	_	NN	Protein	[0]	['root']	_	_
8	clones	_	_	NNS	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	retrovirus	_	_	NN	O	[-1]	['none']	_	_
12	encoding	_	_	VBG	O	[-1]	['none']	_	_
13	FLAG-HOIP	_	_	NN	Protein	[0]	['root']	_	_
14	reversed	_	_	VBD	Negative_regulation	[0]	['root']	_	_
15	defective	_	_	JJ	Negative_regulation	[14]	['Theme']	_	_
16	CD80	_	_	NN	Protein	[17]	['Theme']	_	_
17	upregulation	_	_	NN	Positive_regulation	[15]	['Theme']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	while	_	_	IN	O	[-1]	['none']	_	_
20	transduction	_	_	NN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	an	_	_	DT	O	[-1]	['none']	_	_
23	empty	_	_	JJ	O	[-1]	['none']	_	_
24	vector	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	pMIP	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	did	_	_	VBD	O	[-1]	['none']	_	_
29	not	_	_	RB	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	obtained	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	second	_	_	JJ	O	[-1]	['none']	_	_
8	experiment	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Isolation	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	culture	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	primary	_	_	JJ	O	[-1]	['none']	_	_
6	CD8+	_	_	JJ	O	[-1]	['none']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
2	T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	4-8-wk-old	_	_	JJ	O	[-1]	['none']	_	_
6	Tcra-/-	_	_	NN	Protein	[0]	['root']	_	_
7	x	_	_	NN	O	[-1]	['none']	_	_
8	P14	_	_	NN	O	[-1]	['none']	_	_
9	TCR	_	_	NN	O	[-1]	['none']	_	_
10	transgenic	_	_	JJ	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Taconic	_	_	NNP	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	C57BL/6J	_	_	NNP	O	[-1]	['none']	_	_
16	WT	_	_	NNP	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	Tbx21-/-	_	_	JJ	Protein	[0]	['root']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	The	_	_	DT	O	[-1]	['none']	_	_
22	Jackson	_	_	NNP	O	[-1]	['none']	_	_
23	Laboratory	_	_	NNP	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	mice	_	_	NNS	O	[-1]	['none']	_	_
26	were	_	_	VBD	O	[-1]	['none']	_	_
27	purified	_	_	VBN	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	>	_	_	JJR	O	[-1]	['none']	_	_
30	95	_	_	CD	O	[-1]	['none']	_	_
31	%	_	_	NN	O	[-1]	['none']	_	_
32	purity	_	_	NN	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	by	_	_	IN	O	[-1]	['none']	_	_
35	negative	_	_	JJ	O	[-1]	['none']	_	_
36	selection	_	_	NN	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	from	_	_	IN	O	[-1]	['none']	_	_
41	pooled	_	_	JJ	O	[-1]	['none']	_	_
42	spleen	_	_	NN	O	[-1]	['none']	_	_
43	and	_	_	CC	O	[-1]	['none']	_	_
44	lymph	_	_	NN	O	[-1]	['none']	_	_
45	node	_	_	NN	O	[-1]	['none']	_	_
46	cells	_	_	NNS	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
2	T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
6	mice	_	_	NNS	O	[-1]	['none']	_	_
7	on	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	ICR	_	_	NN	O	[-1]	['none']	_	_
10	background	_	_	NN	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	purified	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	positive	_	_	JJ	O	[-1]	['none']	_	_
15	selection	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	Miltenyi	_	_	NNP	O	[-1]	['none']	_	_
18	Biotec	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	All	_	_	DT	O	[-1]	['none']	_	_
2	mice	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	maintained	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	specific	_	_	JJ	O	[-1]	['none']	_	_
7	pathogen-free	_	_	JJ	O	[-1]	['none']	_	_
8	barrier	_	_	NN	O	[-1]	['none']	_	_
9	facilities	_	_	NNS	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	used	_	_	VBN	O	[-1]	['none']	_	_
12	according	_	_	VBG	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	protocols	_	_	NNS	O	[-1]	['none']	_	_
15	approved	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	Immune	_	_	NNP	O	[-1]	['none']	_	_
19	Disease	_	_	NNP	O	[-1]	['none']	_	_
20	Institute	_	_	NNP	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	Harvard	_	_	NNP	O	[-1]	['none']	_	_
24	Medical	_	_	NNP	O	[-1]	['none']	_	_
25	School	_	_	NNP	O	[-1]	['none']	_	_
26	Animal	_	_	NNP	O	[-1]	['none']	_	_
27	Care	_	_	NNP	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	Use	_	_	NNP	O	[-1]	['none']	_	_
30	Committees	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	stimulation	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	purified	_	_	VBN	O	[-1]	['none']	_	_
5	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
6	T	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	cultured	_	_	VBN	O	[-1]	['none']	_	_
10	at	_	_	IN	O	[-1]	['none']	_	_
11	106	_	_	CD	O	[-1]	['none']	_	_
12	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	10	_	_	CD	O	[-1]	['none']	_	_
15	ml	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	T25	_	_	NN	O	[-1]	['none']	_	_
19	flasks	_	_	NNS	O	[-1]	['none']	_	_
20	coated	_	_	VBN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	1	_	_	CD	O	[-1]	['none']	_	_
23	mug/ml	_	_	NN	O	[-1]	['none']	_	_
24	each	_	_	DT	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	anti-CD3	_	_	JJ	Protein	[0]	['root']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	clone	_	_	NN	O	[-1]	['none']	_	_
29	2C11	_	_	NN	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	anti-CD28	_	_	JJ	Protein	[0]	['root']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	clone	_	_	NN	O	[-1]	['none']	_	_
35	37.51	_	_	CD	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	by	_	_	IN	O	[-1]	['none']	_	_
38	pretreatment	_	_	NN	O	[-1]	['none']	_	_
39	with	_	_	IN	O	[-1]	['none']	_	_
40	300	_	_	CD	O	[-1]	['none']	_	_
41	mug/ml	_	_	NN	O	[-1]	['none']	_	_
42	goat	_	_	NN	O	[-1]	['none']	_	_
43	anti-hamster	_	_	JJ	O	[-1]	['none']	_	_
44	IgG	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	48	_	_	CD	O	[-1]	['none']	_	_
3	h	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	removed	_	_	VBN	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	TCR	_	_	NN	O	[-1]	['none']	_	_
11	stimulation	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	recultured	_	_	VBN	O	[-1]	['none']	_	_
14	at	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	concentration	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	5	_	_	CD	O	[-1]	['none']	_	_
19	x	_	_	CC	O	[-1]	['none']	_	_
20	105	_	_	CD	O	[-1]	['none']	_	_
21	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	media	_	_	NNS	O	[-1]	['none']	_	_
24	supplemented	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	100	_	_	CD	O	[-1]	['none']	_	_
27	U/ml	_	_	NN	O	[-1]	['none']	_	_
28	rhIL-2	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Every	_	_	DT	O	[-1]	['none']	_	_
2	24	_	_	CD	O	[-1]	['none']	_	_
3	h	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	viable	_	_	JJ	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	counted	_	_	VBN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	readjusted	_	_	VBN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	5	_	_	CD	O	[-1]	['none']	_	_
13	x	_	_	CC	O	[-1]	['none']	_	_
14	105	_	_	CD	O	[-1]	['none']	_	_
15	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	fresh	_	_	JJ	O	[-1]	['none']	_	_
18	media	_	_	NNS	O	[-1]	['none']	_	_
19	containing	_	_	VBG	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	corresponding	_	_	JJ	O	[-1]	['none']	_	_
22	amount	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	rhIL-2	_	_	NN	Protein	[0]	['root']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Proposed	_	_	VBN	O	[-1]	['none']	_	_
2	model	_	_	NN	O	[-1]	['none']	_	_
3	for	_	_	IN	O	[-1]	['none']	_	_
4	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
5	monocyte	_	_	NN	O	[-1]	['none']	_	_
6	survival	_	_	NN	O	[-1]	['none']	_	_
7	via	_	_	IN	O	[-1]	['none']	_	_
8	PKC	_	_	NN	O	[-1]	['none']	_	_
9	regulation	_	_	NN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	activating	_	_	VBG	Positive_regulation	[0]	['root']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	p65	_	_	NN	Protein	[14]	['Theme']	_	_
14	phosphorylation	_	_	NN	Phosphorylation	[11]	['Theme']	_	_
15	at	_	_	IN	O	[-1]	['none']	_	_
16	Ser276	_	_	NN	Entity	[14]	['Site']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Effect	_	_	NN	Regulation	[10]	['Theme']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PTX	_	_	NN	O	[-1]	['none']	_	_
4	on	_	_	IN	O	[-1]	['none']	_	_
5	TNF-alpha	_	_	NN	Protein	[6]	['Theme']	_	_
6	production	_	_	NN	Gene_expression	[1]	['Theme']	_	_
7	in	_	_	IN	Regulation	[10]	['multitoken']	_	_
8	the	_	_	DT	Regulation	[10]	['multitoken']	_	_
9	presence	_	_	NN	Regulation	[10]	['multitoken']	_	_
10	of	_	_	IN	Regulation	[0]	['root']	_	_
11	PKA	_	_	NN	O	[-1]	['none']	_	_
12	inhibition	_	_	NN	O	[-1]	['none']	_	_
13	The	_	_	DT	O	[-1]	['none']	_	_
14	role	_	_	NN	Regulation	[0]	['root']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	PKA	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	PTX	_	_	NN	O	[-1]	['none']	_	_
19	induced	_	_	VBD	Positive_regulation	[14]	['Theme']	_	_
20	downregulation	_	_	NN	Negative_regulation	[19]	['Theme']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	TNF-alpha	_	_	NN	Protein	[23]	['Theme']	_	_
23	production	_	_	NN	Gene_expression	[20]	['Theme']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	LPS	_	_	NN	O	[-1]	['none']	_	_
26	stimulated	_	_	VBD	O	[-1]	['none']	_	_
27	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
28	cells	_	_	NNS	O	[-1]	['none']	_	_
29	was	_	_	VBD	O	[-1]	['none']	_	_
30	assessed	_	_	VBN	O	[-1]	['none']	_	_
31	by	_	_	IN	O	[-1]	['none']	_	_
32	treating	_	_	VBG	O	[-1]	['none']	_	_
33	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
34	cells	_	_	NNS	O	[-1]	['none']	_	_
35	with	_	_	IN	O	[-1]	['none']	_	_
36	H89	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	a	_	_	DT	O	[-1]	['none']	_	_
39	PKA	_	_	NN	O	[-1]	['none']	_	_
40	inhibitor	_	_	NN	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	prior	_	_	RB	O	[-1]	['none']	_	_
43	to	_	_	TO	O	[-1]	['none']	_	_
44	LPS	_	_	NN	O	[-1]	['none']	_	_
45	and	_	_	CC	O	[-1]	['none']	_	_
46	PTX	_	_	NN	O	[-1]	['none']	_	_
47	exposure	_	_	NN	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	PTX	_	_	NN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	LPS	_	_	NN	O	[-1]	['none']	_	_
6	stimulated	_	_	VBD	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	reduction	_	_	NN	Negative_regulation	[8]	['Theme']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	TNF-alpha	_	_	NN	Protein	[11]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	similar	_	_	JJ	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	that	_	_	DT	O	[-1]	['none']	_	_
18	observed	_	_	VBN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	our	_	_	PRP$	O	[-1]	['none']	_	_
21	previous	_	_	JJ	O	[-1]	['none']	_	_
22	experiments	_	_	NNS	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	529	_	_	CD	O	[-1]	['none']	_	_
25	pg/mL	_	_	NN	O	[-1]	['none']	_	_
26	+/-	_	_	CC	O	[-1]	['none']	_	_
27	112	_	_	CD	O	[-1]	['none']	_	_
28	vs.	_	_	CC	O	[-1]	['none']	_	_
29	37	_	_	CD	O	[-1]	['none']	_	_
30	pg/mL	_	_	NN	O	[-1]	['none']	_	_
31	+/-	_	_	CC	O	[-1]	['none']	_	_
32	10	_	_	CD	O	[-1]	['none']	_	_
33	;	_	_	:	O	[-1]	['none']	_	_
34	P	_	_	NN	O	[-1]	['none']	_	_
35	<	_	_	JJR	O	[-1]	['none']	_	_
36	0.01	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Pre-incubation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	H89	_	_	NN	O	[-1]	['none']	_	_
6	prior	_	_	RB	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	LPS	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	PTX	_	_	NN	O	[-1]	['none']	_	_
11	exposure	_	_	NN	O	[-1]	['none']	_	_
12	did	_	_	VBD	O	[-1]	['none']	_	_
13	not	_	_	RB	O	[-1]	['none']	_	_
14	result	_	_	VB	Regulation	[0]	['root']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	any	_	_	DT	O	[-1]	['none']	_	_
17	significant	_	_	JJ	O	[-1]	['none']	_	_
18	modulation	_	_	NN	Regulation	[14]	['Theme']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	TNF-alpha	_	_	NN	Protein	[21]	['Theme']	_	_
21	production	_	_	NN	Gene_expression	[18]	['Theme']	_	_
22	when	_	_	WRB	O	[-1]	['none']	_	_
23	compared	_	_	VBN	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	that	_	_	DT	O	[-1]	['none']	_	_
26	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
27	with	_	_	IN	O	[-1]	['none']	_	_
28	PTX	_	_	NN	O	[-1]	['none']	_	_
29	alone	_	_	RB	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	P	_	_	NN	O	[-1]	['none']	_	_
32	=	_	_	JJ	O	[-1]	['none']	_	_
33	0.2	_	_	CD	O	[-1]	['none']	_	_
34	;	_	_	:	O	[-1]	['none']	_	_
35	Figure	_	_	NNP	O	[-1]	['none']	_	_
36	5	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	downregulation	_	_	NN	Negative_regulation	[24]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	TNF-alpha	_	_	NN	Protein	[8]	['Theme']	_	_
8	production	_	_	NN	Gene_expression	[5]	['Theme']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	PTX	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	LPS	_	_	NN	O	[-1]	['none']	_	_
13	stimulated	_	_	VBD	O	[-1]	['none']	_	_
14	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	is	_	_	VBZ	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	at	_	_	IN	O	[-1]	['none']	_	_
19	least	_	_	JJS	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	part	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	PKA	_	_	NN	O	[-1]	['none']	_	_
24	independent	_	_	JJ	Regulation	[0]	['root']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	O	[-1]	['none']	_	_
2	expression	_	_	NN	O	[-1]	['none']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	BMDC	_	_	NNP	O	[-1]	['none']	_	_
5	BMDC	_	_	NNP	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	cultured	_	_	VBN	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	106	_	_	CD	O	[-1]	['none']	_	_
10	cells/mL	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	10	_	_	CD	O	[-1]	['none']	_	_
13	mL	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	RPMI-1640	_	_	NN	O	[-1]	['none']	_	_
16	complete	_	_	JJ	O	[-1]	['none']	_	_
17	medium	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	presence	_	_	NN	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	absence	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	100	_	_	CD	O	[-1]	['none']	_	_
25	ng/mL	_	_	NN	O	[-1]	['none']	_	_
26	LPS	_	_	NN	O	[-1]	['none']	_	_
27	or	_	_	CC	O	[-1]	['none']	_	_
28	25	_	_	CD	O	[-1]	['none']	_	_
29	microg/mL	_	_	NN	O	[-1]	['none']	_	_
30	poly	_	_	NN	O	[-1]	['none']	_	_
31	I	_	_	NN	O	[-1]	['none']	_	_
32	:	_	_	:	O	[-1]	['none']	_	_
33	C	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	1	_	_	CD	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	2	_	_	CD	O	[-1]	['none']	_	_
5	hours	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	RNA	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	isolated	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	TRI-reagent	_	_	JJ	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	Sigma	_	_	NNP	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	according	_	_	VBG	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	manufacturer	_	_	NN	O	[-1]	['none']	_	_
19	's	_	_	POS	O	[-1]	['none']	_	_
20	instructions	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	expression	_	_	NN	Transcription	[0]	['root']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	Il6	_	_	NN	Protein	[2]	['Theme']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	Il12p40	_	_	NN	Protein	[2]	['Theme']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	Gmcsf	_	_	NN	Protein	[2]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	Sharpin	_	_	NN	Protein	[2]	['Theme']	_	_
12	mRNA	_	_	NN	O	[-1]	['none']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	determined	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	qRT-PCR	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Primers	_	_	NNS	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	probes	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	purchased	_	_	VBN	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	Applied	_	_	NNP	O	[-1]	['none']	_	_
8	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Reverse	_	_	JJ	O	[-1]	['none']	_	_
2	transcription	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	42degreesC	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	60	_	_	CD	O	[-1]	['none']	_	_
9	minutes	_	_	NNS	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	final	_	_	JJ	O	[-1]	['none']	_	_
13	denaturation	_	_	NN	O	[-1]	['none']	_	_
14	step	_	_	NN	O	[-1]	['none']	_	_
15	at	_	_	IN	O	[-1]	['none']	_	_
16	90degreesC	_	_	NN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	5	_	_	CD	O	[-1]	['none']	_	_
19	minutes	_	_	NNS	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	30	_	_	CD	O	[-1]	['none']	_	_
22	microl	_	_	NN	O	[-1]	['none']	_	_
23	containing	_	_	VBG	O	[-1]	['none']	_	_
24	0.5	_	_	CD	O	[-1]	['none']	_	_
25	microg	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	total	_	_	JJ	O	[-1]	['none']	_	_
28	RNA	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	dNTPs	_	_	NNS	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	oligo	_	_	JJ	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	dT	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	15	_	_	CD	O	[-1]	['none']	_	_
8	primer	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	recombinant	_	_	JJ	O	[-1]	['none']	_	_
11	RNasin	_	_	NNP	O	[-1]	['none']	_	_
12	Ribonuclease	_	_	NNP	O	[-1]	['none']	_	_
13	Inhibitor	_	_	NNP	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	M-MLV	_	_	NN	Protein	[18]	['multitoken']	_	_
17	Reverse	_	_	NN	Protein	[18]	['multitoken']	_	_
18	Transcriptase	_	_	NN	Protein	[0]	['root']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	all	_	_	DT	O	[-1]	['none']	_	_
21	from	_	_	IN	O	[-1]	['none']	_	_
22	Promega	_	_	NNP	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	Madison	_	_	NNP	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	WI	_	_	NNP	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	were	_	_	VBD	O	[-1]	['none']	_	_
29	used	_	_	VBN	O	[-1]	['none']	_	_
30	according	_	_	VBG	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	manufacturer	_	_	NN	O	[-1]	['none']	_	_
34	's	_	_	POS	O	[-1]	['none']	_	_
35	instruction	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Reverse	_	_	JJ	O	[-1]	['none']	_	_
2	transcription	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	done	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	PTC-200	_	_	NN	O	[-1]	['none']	_	_
8	Peltier	_	_	NNP	O	[-1]	['none']	_	_
9	Thermal	_	_	JJ	O	[-1]	['none']	_	_
10	Cycler	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	MJ	_	_	NNP	O	[-1]	['none']	_	_
13	Research	_	_	NNP	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	Watertown	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	MA	_	_	NNP	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	qRT-PCR	_	_	NNP	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	performed	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	ABI	_	_	NNP	O	[-1]	['none']	_	_
6	Prism	_	_	NNP	O	[-1]	['none']	_	_
7	7700	_	_	CD	O	[-1]	['none']	_	_
8	Sequence	_	_	NN	O	[-1]	['none']	_	_
9	Detection	_	_	NN	O	[-1]	['none']	_	_
10	System	_	_	NN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	TaqMan	_	_	NNP	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	R	_	_	NN	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	Gene	_	_	NNP	O	[-1]	['none']	_	_
17	Expression	_	_	NN	O	[-1]	['none']	_	_
18	Assays	_	_	NNS	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Applied	_	_	NNP	O	[-1]	['none']	_	_
21	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	Foster	_	_	NNP	O	[-1]	['none']	_	_
24	City	_	_	NNP	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	CA	_	_	NNP	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	mouse	_	_	NN	O	[-1]	['none']	_	_
30	Actb	_	_	NN	Protein	[0]	['root']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	IL6	_	_	NN	Protein	[0]	['root']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	IL12p40	_	_	NN	Protein	[0]	['root']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	Ifnbeta	_	_	NN	Protein	[0]	['root']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	Gmcsf	_	_	NN	Protein	[0]	['root']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	Sharpin	_	_	NNP	Protein	[0]	['root']	_	_
42	according	_	_	VBG	O	[-1]	['none']	_	_
43	to	_	_	TO	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	manufacturer	_	_	NN	O	[-1]	['none']	_	_
46	's	_	_	POS	O	[-1]	['none']	_	_
47	protocol	_	_	NN	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	endogenous	_	_	JJ	O	[-1]	['none']	_	_
3	standard	_	_	NN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	normalization	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	target	_	_	NN	O	[-1]	['none']	_	_
9	gene	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	beta-actin	_	_	NN	Protein	[0]	['root']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Relative	_	_	JJ	O	[-1]	['none']	_	_
2	gene	_	_	NN	O	[-1]	['none']	_	_
3	expression	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	calculated	_	_	VBN	O	[-1]	['none']	_	_
6	using	_	_	VBG	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	2-deltadeltaCt	_	_	NN	O	[-1]	['none']	_	_
9	method	_	_	NN	O	[-1]	['none']	_	_
10	[	_	_	NN	O	[-1]	['none']	_	_
11	56	_	_	CD	O	[-1]	['none']	_	_
12	]	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	lines	_	_	NNS	O	[-1]	['none']	_	_
3	The	_	_	DT	O	[-1]	['none']	_	_
4	mouse	_	_	NN	O	[-1]	['none']	_	_
5	B	_	_	NN	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	line	_	_	NN	O	[-1]	['none']	_	_
8	A20	_	_	NN	O	[-1]	['none']	_	_
9	.2	_	_	NN	O	[-1]	['none']	_	_
10	J	_	_	NN	O	[-1]	['none']	_	_
11	has	_	_	VBZ	O	[-1]	['none']	_	_
12	been	_	_	VBN	O	[-1]	['none']	_	_
13	previously	_	_	RB	O	[-1]	['none']	_	_
14	described	_	_	VBN	O	[-1]	['none']	_	_
15	[	_	_	NN	O	[-1]	['none']	_	_
16	26	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	[	_	_	CD	O	[-1]	['none']	_	_
20	27	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	grown	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	RPMI	_	_	NN	O	[-1]	['none']	_	_
6	1640	_	_	CD	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	10	_	_	CD	O	[-1]	['none']	_	_
9	%	_	_	NN	O	[-1]	['none']	_	_
10	FCS	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	10	_	_	CD	O	[-1]	['none']	_	_
13	microM	_	_	NN	O	[-1]	['none']	_	_
14	2-ME	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	2	_	_	CD	O	[-1]	['none']	_	_
17	mM	_	_	NN	O	[-1]	['none']	_	_
18	L-glutamine	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	antibiotics	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	HI-5	_	_	NNP	O	[-1]	['none']	_	_
2	insect	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
8	CD154	_	_	NN	Protein	[7]	['Theme']	_	_
9	have	_	_	VBP	O	[-1]	['none']	_	_
10	been	_	_	VBN	O	[-1]	['none']	_	_
11	described	_	_	VBN	O	[-1]	['none']	_	_
12	[	_	_	CD	O	[-1]	['none']	_	_
13	28	_	_	CD	O	[-1]	['none']	_	_
14	]	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	Culture	_	_	NN	O	[-1]	['none']	_	_
3	The	_	_	DT	O	[-1]	['none']	_	_
4	murine	_	_	JJ	O	[-1]	['none']	_	_
5	macrophage	_	_	NN	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	line	_	_	NN	O	[-1]	['none']	_	_
8	RAW	_	_	NN	O	[-1]	['none']	_	_
9	264.7	_	_	CD	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	purchased	_	_	VBN	O	[-1]	['none']	_	_
12	from	_	_	IN	O	[-1]	['none']	_	_
13	ATCC	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Manassas	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	VA	_	_	NNP	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	RAW	_	_	NN	O	[-1]	['none']	_	_
2	264.7	_	_	CD	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	maintained	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	RPMI	_	_	NN	O	[-1]	['none']	_	_
8	supplemented	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	5	_	_	CD	O	[-1]	['none']	_	_
11	%	_	_	NN	O	[-1]	['none']	_	_
12	FBS	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	antibiotic-antimycotic	_	_	JJ	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	1000	_	_	CD	O	[-1]	['none']	_	_
17	U/ml	_	_	NN	O	[-1]	['none']	_	_
18	penicillin	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	1000	_	_	CD	O	[-1]	['none']	_	_
21	microg/ml	_	_	NN	O	[-1]	['none']	_	_
22	streptomycin	_	_	NN	O	[-1]	['none']	_	_
23	sulfate	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	250	_	_	CD	O	[-1]	['none']	_	_
27	ng/ml	_	_	NN	O	[-1]	['none']	_	_
28	amphotericin	_	_	NN	O	[-1]	['none']	_	_
29	B	_	_	NN	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	at	_	_	IN	O	[-1]	['none']	_	_
32	37degreesC	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Mouse	_	_	NN	O	[-1]	['none']	_	_
2	embryonic	_	_	JJ	O	[-1]	['none']	_	_
3	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	MEFs	_	_	NNS	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	cell	_	_	NN	O	[-1]	['none']	_	_
8	line	_	_	NN	O	[-1]	['none']	_	_
9	lacking	_	_	VBG	O	[-1]	['none']	_	_
10	specific	_	_	JJ	O	[-1]	['none']	_	_
11	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
12	signaling	_	_	NN	O	[-1]	['none']	_	_
13	subunits	_	_	NNS	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	p65	_	_	NN	Protein	[0]	['root']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	p65-/-	_	_	JJ	Protein	[0]	['root']	_	_
18	cell	_	_	NN	O	[-1]	['none']	_	_
19	line	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	50	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	were	_	_	VBD	O	[-1]	['none']	_	_
25	cultured	_	_	VBN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	DMEM	_	_	NNP	O	[-1]	['none']	_	_
28	medium	_	_	NN	O	[-1]	['none']	_	_
29	supplemented	_	_	VBN	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	10	_	_	CD	O	[-1]	['none']	_	_
32	%	_	_	NN	O	[-1]	['none']	_	_
33	FBS	_	_	NN	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	antibiotic-antimycotic	_	_	JJ	O	[-1]	['none']	_	_
36	solution	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Ethics	_	_	NNS	O	[-1]	['none']	_	_
2	Statement	_	_	NNP	O	[-1]	['none']	_	_
3	All	_	_	NNP	O	[-1]	['none']	_	_
4	research	_	_	NN	O	[-1]	['none']	_	_
5	involving	_	_	VBG	O	[-1]	['none']	_	_
6	human	_	_	NN	O	[-1]	['none']	_	_
7	blood	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Buffy	_	_	NNP	O	[-1]	['none']	_	_
10	coat	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	ordered	_	_	VBN	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	American	_	_	NNP	O	[-1]	['none']	_	_
16	Red	_	_	NNP	O	[-1]	['none']	_	_
17	cross	_	_	VB	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	have	_	_	VB	O	[-1]	['none']	_	_
20	been	_	_	VBN	O	[-1]	['none']	_	_
21	approved	_	_	VBN	O	[-1]	['none']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	Ohio	_	_	NNP	O	[-1]	['none']	_	_
25	State	_	_	NNP	O	[-1]	['none']	_	_
26	University	_	_	NNP	O	[-1]	['none']	_	_
27	review	_	_	NN	O	[-1]	['none']	_	_
28	board	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	ARC	_	_	NNP	O	[-1]	['none']	_	_
31	IRB	_	_	NNP	O	[-1]	['none']	_	_
32	Protocol	_	_	NNP	O	[-1]	['none']	_	_
33	#	_	_	#	O	[-1]	['none']	_	_
34	2001-26	_	_	CD	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Effect	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PTX	_	_	NN	O	[-1]	['none']	_	_
4	on	_	_	IN	O	[-1]	['none']	_	_
5	LPS	_	_	NN	O	[-1]	['none']	_	_
6	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
7	TNF-alpha	_	_	NN	Protein	[8]	['Theme']	_	_
8	production	_	_	NN	Gene_expression	[6]	['Theme']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	The	_	_	DT	O	[-1]	['none']	_	_
13	concentration	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	TNF-alpha	_	_	NN	Protein	[0]	['root']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	quantitatively	_	_	RB	O	[-1]	['none']	_	_
18	determined	_	_	VBN	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	ELISA	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	media	_	_	NNS	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	exposed	_	_	VBN	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	treatments	_	_	NNS	O	[-1]	['none']	_	_
30	described	_	_	VBN	O	[-1]	['none']	_	_
31	above	_	_	IN	O	[-1]	['none']	_	_
32	after	_	_	IN	O	[-1]	['none']	_	_
33	stimulation	_	_	NN	O	[-1]	['none']	_	_
34	for	_	_	IN	O	[-1]	['none']	_	_
35	up	_	_	RB	O	[-1]	['none']	_	_
36	to	_	_	TO	O	[-1]	['none']	_	_
37	a	_	_	DT	O	[-1]	['none']	_	_
38	maximum	_	_	NN	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	18	_	_	CD	O	[-1]	['none']	_	_
41	hours	_	_	NNS	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	at	_	_	IN	O	[-1]	['none']	_	_
44	3-hour	_	_	JJ	O	[-1]	['none']	_	_
45	intervals	_	_	NNS	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	expressed	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	pg/mL	_	_	NN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Key	_	_	NN	O	[-1]	['none']	_	_
2	role	_	_	NN	O	[-1]	['none']	_	_
3	for	_	_	IN	O	[-1]	['none']	_	_
4	Runx3	_	_	NN	Protein	[0]	['root']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	effector	_	_	NN	O	[-1]	['none']	_	_
7	CTL	_	_	NN	O	[-1]	['none']	_	_
8	differentiation	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Western	_	_	JJ	O	[-1]	['none']	_	_
5	analysis	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Runx3	_	_	NN	Protein	[15]	['Theme']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	Eomes	_	_	NNS	Protein	[15]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	T-bet	_	_	NN	Protein	[15]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	perforin	_	_	NN	Protein	[15]	['Theme']	_	_
15	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	Runx3	_	_	NN	Protein	[0]	['root']	_	_
18	+/+	_	_	CD	O	[-1]	['none']	_	_
19	versus	_	_	CC	O	[-1]	['none']	_	_
20	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
21	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
22	SP	_	_	NN	O	[-1]	['none']	_	_
23	T	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	differentiated	_	_	VBN	O	[-1]	['none']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	6	_	_	CD	O	[-1]	['none']	_	_
28	d.	_	_	NN	O	[-1]	['none']	_	_
29	beta-Actin	_	_	NN	Protein	[0]	['root']	_	_
30	was	_	_	VBD	O	[-1]	['none']	_	_
31	used	_	_	VBN	O	[-1]	['none']	_	_
32	as	_	_	IN	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	loading	_	_	VBG	O	[-1]	['none']	_	_
35	control	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Northern	_	_	NN	O	[-1]	['none']	_	_
5	blot	_	_	NN	O	[-1]	['none']	_	_
6	analysis	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Prf1	_	_	NN	Protein	[10]	['Theme']	_	_
9	mRNA	_	_	NN	Transcription	[10]	['multitoken']	_	_
10	expression	_	_	NN	Transcription	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	Runx3	_	_	NN	Protein	[0]	['root']	_	_
13	+/+	_	_	CD	O	[-1]	['none']	_	_
14	versus	_	_	CC	O	[-1]	['none']	_	_
15	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
16	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
17	T	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	differentiated	_	_	VBN	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	6	_	_	CD	O	[-1]	['none']	_	_
22	d.	_	_	NN	O	[-1]	['none']	_	_
23	beta-Actin	_	_	NN	Protein	[0]	['root']	_	_
24	was	_	_	VBD	O	[-1]	['none']	_	_
25	used	_	_	VBN	O	[-1]	['none']	_	_
26	as	_	_	IN	O	[-1]	['none']	_	_
27	a	_	_	DT	O	[-1]	['none']	_	_
28	loading	_	_	VBG	O	[-1]	['none']	_	_
29	control	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Expression	_	_	NN	Gene_expression	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	granzyme	_	_	NN	Protein	[7]	['multitoken']	_	_
7	B	_	_	NN	Protein	[4]	['Theme']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	IFN-gamma	_	_	NN	Protein	[4]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	TNF	_	_	NN	Protein	[4]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	IL-2	_	_	NN	Protein	[4]	['Theme']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	resting	_	_	VBG	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	restimulated	_	_	VBN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	6	_	_	CD	O	[-1]	['none']	_	_
21	h	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	Runx3	_	_	NN	Protein	[0]	['root']	_	_
24	+/+	_	_	CD	O	[-1]	['none']	_	_
25	versus	_	_	CC	O	[-1]	['none']	_	_
26	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
27	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
28	SP	_	_	NN	O	[-1]	['none']	_	_
29	T	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	differentiated	_	_	VBN	O	[-1]	['none']	_	_
32	for	_	_	IN	O	[-1]	['none']	_	_
33	6	_	_	CD	O	[-1]	['none']	_	_
34	d	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	vertical	_	_	JJ	O	[-1]	['none']	_	_
3	gray	_	_	JJ	O	[-1]	['none']	_	_
4	line	_	_	NN	O	[-1]	['none']	_	_
5	indicates	_	_	VBZ	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	granzyme	_	_	NN	Protein	[8]	['multitoken']	_	_
8	B	_	_	NN	Protein	[0]	['root']	_	_
9	MFI	_	_	NNP	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	WT	_	_	NNP	O	[-1]	['none']	_	_
12	GFP+	_	_	JJ	Protein	[0]	['root']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Results	_	_	NNS	O	[-1]	['none']	_	_
2	in	_	_	IN	O	[-1]	['none']	_	_
3	A-C	_	_	NN	O	[-1]	['none']	_	_
4	are	_	_	VBP	O	[-1]	['none']	_	_
5	representative	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	two	_	_	CD	O	[-1]	['none']	_	_
8	independent	_	_	JJ	O	[-1]	['none']	_	_
9	experiments	_	_	NNS	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	D	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	ChIP	_	_	NN	O	[-1]	['none']	_	_
5	analysis	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	binding	_	_	NN	Binding	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	endogenous	_	_	JJ	O	[-1]	['none']	_	_
10	Runx3	_	_	NN	Protein	[7]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	Eomes	_	_	NNP	Protein	[7]	['Theme']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	Prf1	_	_	NN	Protein	[7]	['Theme']	_	_
16	locus	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Enrichment	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	indicated	_	_	VBN	O	[-1]	['none']	_	_
5	genomic	_	_	JJ	O	[-1]	['none']	_	_
6	regions	_	_	NNS	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	evaluated	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	real-time	_	_	JJ	O	[-1]	['none']	_	_
11	PCR	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	DNA	_	_	NN	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	input	_	_	NN	O	[-1]	['none']	_	_
18	chromatin	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	means	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	duplicate	_	_	VBP	O	[-1]	['none']	_	_
8	measurements	_	_	NNS	O	[-1]	['none']	_	_
9	from	_	_	IN	O	[-1]	['none']	_	_
10	two	_	_	CD	O	[-1]	['none']	_	_
11	chromatin	_	_	NN	O	[-1]	['none']	_	_
12	preparations	_	_	NNS	O	[-1]	['none']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	two	_	_	CD	O	[-1]	['none']	_	_
15	independent	_	_	JJ	O	[-1]	['none']	_	_
16	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
17	T	_	_	NN	O	[-1]	['none']	_	_
18	cell	_	_	NN	O	[-1]	['none']	_	_
19	differentiations	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	efficiency	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	recovery	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	input	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	-1-kb	_	_	JJ	O	[-1]	['none']	_	_
10	region	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	Prf1	_	_	NN	Protein	[0]	['root']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	0.97	_	_	CD	O	[-1]	['none']	_	_
15	%	_	_	NN	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	Runx3	_	_	NN	Protein	[0]	['root']	_	_
19	ChIP	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	0.5	_	_	CD	O	[-1]	['none']	_	_
22	%	_	_	NN	O	[-1]	['none']	_	_
23	for	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	Eomes	_	_	NNP	Protein	[0]	['root']	_	_
26	ChIP	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Inhibition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	activity	_	_	NN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	NAI	_	_	NNP	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Jurkat	_	_	NN	O	[-1]	['none']	_	_
2	T-cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	transfected	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	luciferase	_	_	NN	Protein	[0]	['root']	_	_
7	reporter	_	_	NN	O	[-1]	['none']	_	_
8	plasmids	_	_	NNS	O	[-1]	['none']	_	_
9	containing	_	_	VBG	O	[-1]	['none']	_	_
10	either	_	_	CC	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	AP-1	_	_	NN	O	[-1]	['none']	_	_
14	cis	_	_	NN	O	[-1]	['none']	_	_
15	acting	_	_	VBG	O	[-1]	['none']	_	_
16	elements	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	incubated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	inhibitor	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	NAI	_	_	NNP	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	1	_	_	CD	O	[-1]	['none']	_	_
14	h	_	_	NN	O	[-1]	['none']	_	_
15	followed	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	stimulation	_	_	NN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	PMA	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	162	_	_	CD	O	[-1]	['none']	_	_
22	nM	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	A	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	C	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	HK	_	_	NNP	O	[-1]	['none']	_	_
30	E.	_	_	FW	O	[-1]	['none']	_	_
31	coli	_	_	FW	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	5	_	_	CD	O	[-1]	['none']	_	_
34	x	_	_	CC	O	[-1]	['none']	_	_
35	107	_	_	CD	O	[-1]	['none']	_	_
36	CFU/ml	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	B	_	_	NN	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	D	_	_	NN	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	for	_	_	IN	O	[-1]	['none']	_	_
43	24	_	_	CD	O	[-1]	['none']	_	_
44	h.	_	_	NN	O	[-1]	['none']	_	_
45	(	_	_	-LRB-	O	[-1]	['none']	_	_
46	A	_	_	NN	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	B	_	_	NN	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	but	_	_	CC	O	[-1]	['none']	_	_
53	not	_	_	RB	O	[-1]	['none']	_	_
54	(	_	_	-LRB-	O	[-1]	['none']	_	_
55	C	_	_	NN	O	[-1]	['none']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	D	_	_	NN	O	[-1]	['none']	_	_
58	)	_	_	-RRB-	O	[-1]	['none']	_	_
59	AP-1	_	_	NN	O	[-1]	['none']	_	_
60	was	_	_	VBD	O	[-1]	['none']	_	_
61	inhibited	_	_	VBN	O	[-1]	['none']	_	_
62	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	significance	_	_	NN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	positive	_	_	JJ	O	[-1]	['none']	_	_
6	control	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	PMA/HK	_	_	NN	O	[-1]	['none']	_	_
9	E.	_	_	FW	O	[-1]	['none']	_	_
10	coli	_	_	FW	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	determined	_	_	VBN	O	[-1]	['none']	_	_
14	using	_	_	VBG	O	[-1]	['none']	_	_
15	Student	_	_	NN	O	[-1]	['none']	_	_
16	's	_	_	POS	O	[-1]	['none']	_	_
17	t-test	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	n	_	_	NN	O	[-1]	['none']	_	_
3	=	_	_	JJ	O	[-1]	['none']	_	_
4	4	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	Controls	_	_	NNP	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	set	_	_	VBN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	1	_	_	CD	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	Characterization	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Sharpin	_	_	NNP	Protein	[0]	['root']	_	_
4	Orthologs	_	_	NNP	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
7	protein	_	_	NN	O	[-1]	['none']	_	_
8	are	_	_	VBP	O	[-1]	['none']	_	_
9	found	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	various	_	_	JJ	O	[-1]	['none']	_	_
12	species	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	including	_	_	VBG	O	[-1]	['none']	_	_
15	human	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	mouse	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	rat	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Motif	_	_	NN	O	[-1]	['none']	_	_
2	prediction	_	_	NN	O	[-1]	['none']	_	_
3	programming	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	COILS	_	_	NNP	O	[-1]	['none']	_	_
7	[	_	_	CD	O	[-1]	['none']	_	_
8	11	_	_	CD	O	[-1]	['none']	_	_
9	]	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	MotifScan	_	_	NN	O	[-1]	['none']	_	_
12	[	_	_	CD	O	[-1]	['none']	_	_
13	12	_	_	CD	O	[-1]	['none']	_	_
14	]	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	suggests	_	_	VBZ	O	[-1]	['none']	_	_
17	that	_	_	IN	O	[-1]	['none']	_	_
18	SHARPIN	_	_	NN	Protein	[0]	['root']	_	_
19	contains	_	_	VBZ	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	coiled-coil	_	_	JJ	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	CC	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	domain	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	a	_	_	DT	O	[-1]	['none']	_	_
28	ubiquitin	_	_	NN	O	[-1]	['none']	_	_
29	like	_	_	IN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	UBL	_	_	NN	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	domain	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	a	_	_	DT	O	[-1]	['none']	_	_
37	zinc-finger	_	_	JJ	O	[-1]	['none']	_	_
38	Ran	_	_	NN	O	[-1]	['none']	_	_
39	binding	_	_	NN	O	[-1]	['none']	_	_
40	protein	_	_	NN	O	[-1]	['none']	_	_
41	2	_	_	CD	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	ZFRBP	_	_	NN	O	[-1]	['none']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	domain	_	_	NN	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	functional	_	_	JJ	O	[-1]	['none']	_	_
3	motifs	_	_	NNS	O	[-1]	['none']	_	_
4	constitute	_	_	VBP	O	[-1]	['none']	_	_
5	similar	_	_	JJ	O	[-1]	['none']	_	_
6	domain	_	_	NN	O	[-1]	['none']	_	_
7	profiles	_	_	NNS	O	[-1]	['none']	_	_
8	that	_	_	WDT	O	[-1]	['none']	_	_
9	are	_	_	VBP	O	[-1]	['none']	_	_
10	present	_	_	JJ	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
14	protein	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	all	_	_	DT	O	[-1]	['none']	_	_
17	three	_	_	CD	O	[-1]	['none']	_	_
18	origins	_	_	NNS	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	suggesting	_	_	VBG	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
23	exerts	_	_	VBZ	O	[-1]	['none']	_	_
24	highly	_	_	RB	O	[-1]	['none']	_	_
25	conserved	_	_	VBN	O	[-1]	['none']	_	_
26	functions	_	_	NNS	O	[-1]	['none']	_	_
27	across	_	_	IN	O	[-1]	['none']	_	_
28	species	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Spontaneous	_	_	JJ	O	[-1]	['none']	_	_
2	mutations	_	_	NNS	Negative_regulation	[0]	['root']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	mouse	_	_	NN	O	[-1]	['none']	_	_
6	Sharpin	_	_	NN	Protein	[2]	['Theme']	_	_
7	gene	_	_	NN	O	[-1]	['none']	_	_
8	results	_	_	VBZ	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	complex	_	_	JJ	O	[-1]	['none']	_	_
12	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
13	phenotype	_	_	NN	O	[-1]	['none']	_	_
14	characterized	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	severe	_	_	JJ	O	[-1]	['none']	_	_
17	dermatitis	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	systemic	_	_	JJ	O	[-1]	['none']	_	_
20	inflammation	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	an	_	_	DT	O	[-1]	['none']	_	_
23	enlarged	_	_	JJ	O	[-1]	['none']	_	_
24	spleen	_	_	NN	O	[-1]	['none']	_	_
25	caused	_	_	VBN	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	extramedullary	_	_	JJ	O	[-1]	['none']	_	_
28	hematopoiesis	_	_	NN	O	[-1]	['none']	_	_
29	[	_	_	NN	O	[-1]	['none']	_	_
30	3	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	endogenous	_	_	JJ	O	[-1]	['none']	_	_
3	expression	_	_	NN	Transcription	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Sharpin	_	_	NN	Protein	[3]	['Theme']	_	_
6	mRNA	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	BMDC	_	_	NNP	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	determined	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	quantitative	_	_	JJ	O	[-1]	['none']	_	_
13	real	_	_	JJ	O	[-1]	['none']	_	_
14	time-PCR	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	qRT-PCR	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	following	_	_	VBG	O	[-1]	['none']	_	_
19	culture	_	_	NN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	medium	_	_	NN	O	[-1]	['none']	_	_
22	only	_	_	RB	O	[-1]	['none']	_	_
23	or	_	_	CC	O	[-1]	['none']	_	_
24	after	_	_	IN	O	[-1]	['none']	_	_
25	stimulation	_	_	NN	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	LPS	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Sharpin	_	_	NN	Protein	[4]	['Theme']	_	_
2	mRNA	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	present	_	_	JJ	Transcription	[16]	['Theme']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	BMDC	_	_	NNP	O	[-1]	['none']	_	_
7	generated	_	_	VBD	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	WT	_	_	NNP	O	[-1]	['none']	_	_
10	mice	_	_	NNS	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	its	_	_	PRP$	Anaphora	[13]	['multitoken']	_	_
13	level	_	_	NN	Anaphora	[0]	['root']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	modestly	_	_	RB	O	[-1]	['none']	_	_
16	decreased	_	_	VBN	Negative_regulation	[0]	['root']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	LPS	_	_	NN	O	[-1]	['none']	_	_
19	stimulation	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	There	_	_	EX	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	significant	_	_	JJ	O	[-1]	['none']	_	_
5	reduction	_	_	NN	Negative_regulation	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Sharpin	_	_	NN	Protein	[5]	['Theme']	_	_
8	mRNA	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	6-7-fold	_	_	JJ	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	BMDC	_	_	NNP	O	[-1]	['none']	_	_
14	generated	_	_	VBD	O	[-1]	['none']	_	_
15	from	_	_	IN	O	[-1]	['none']	_	_
16	cpdm	_	_	NN	O	[-1]	['none']	_	_
17	mice	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Transfection	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Flag	_	_	NN	O	[-1]	['none']	_	_
4	tagged	_	_	VBD	O	[-1]	['none']	_	_
5	Sharpin	_	_	NNP	Protein	[0]	['root']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	NIH3T3	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	macrophages	_	_	NNS	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	RAW264	_	_	NN	O	[-1]	['none']	_	_
15	.7	_	_	CD	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	indicated	_	_	VBD	O	[-1]	['none']	_	_
18	cytoplasmic	_	_	JJ	Entity	[19]	['ToLoc']	_	_
19	localization	_	_	NN	Localization	[0]	['root']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	SHARPIN	_	_	NNP	Protein	[19]	['Theme']	_	_
23	protein	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	EBV	_	_	NN	O	[-1]	['none']	_	_
2	Latent	_	_	JJ	Protein	[5]	['multitoken']	_	_
3	Membrane	_	_	NN	Protein	[5]	['multitoken']	_	_
4	Protein	_	_	NN	Protein	[5]	['multitoken']	_	_
5	1	_	_	CD	Protein	[6]	['Cause']	_	_
6	Activates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
7	Akt	_	_	NN	Protein	[6]	['Theme']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	Stat3	_	_	NN	Protein	[6]	['Theme']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	B	_	_	NN	O	[-1]	['none']	_	_
15	Cell	_	_	NN	O	[-1]	['none']	_	_
16	Lymphomas	_	_	NNP	O	[-1]	['none']	_	_
17	Latent	_	_	JJ	Protein	[20]	['multitoken']	_	_
18	membrane	_	_	NN	Protein	[20]	['multitoken']	_	_
19	protein	_	_	NN	Protein	[20]	['multitoken']	_	_
20	1	_	_	CD	Protein	[0]	['root']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	LMP1	_	_	NN	Protein	[0]	['root']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	is	_	_	VBZ	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	major	_	_	JJ	O	[-1]	['none']	_	_
27	oncoprotein	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	Epstein-Barr	_	_	JJ	O	[-1]	['none']	_	_
30	virus	_	_	NN	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	EBV	_	_	NN	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	transgenic	_	_	JJ	O	[-1]	['none']	_	_
3	mice	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[0]	['root']	_	_
6	promotes	_	_	VBZ	O	[-1]	['none']	_	_
7	increased	_	_	VBN	O	[-1]	['none']	_	_
8	lymphoma	_	_	NN	O	[-1]	['none']	_	_
9	development	_	_	NN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	12	_	_	CD	O	[-1]	['none']	_	_
12	mo	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	age	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	study	_	_	NN	O	[-1]	['none']	_	_
3	reveals	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	lymphoma	_	_	NN	O	[-1]	['none']	_	_
6	develops	_	_	VBZ	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	B-1a	_	_	NN	O	[-1]	['none']	_	_
9	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	population	_	_	NN	O	[-1]	['none']	_	_
13	that	_	_	WDT	O	[-1]	['none']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	associated	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	transformation	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	older	_	_	JJR	O	[-1]	['none']	_	_
20	mice	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	lymphoma	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	have	_	_	VBP	O	[-1]	['none']	_	_
5	deregulated	_	_	VBN	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	cycle	_	_	NN	O	[-1]	['none']	_	_
8	markers	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	inhibitors	_	_	NNS	Negative_regulation	[0]	['root']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Akt	_	_	NN	Protein	[11]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	Stat3	_	_	NN	Protein	[11]	['Theme']	_	_
19	block	_	_	VBP	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	enhanced	_	_	JJ	O	[-1]	['none']	_	_
22	viability	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	LMP1	_	_	NN	Protein	[0]	['root']	_	_
25	transgenic	_	_	JJ	O	[-1]	['none']	_	_
26	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	lymphoma	_	_	NN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	in	_	_	FW	O	[-1]	['none']	_	_
31	vitro	_	_	FW	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Lymphoma	_	_	NN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	independent	_	_	JJ	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	IL4	_	_	NN	Protein	[0]	['root']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	Stat6	_	_	NN	Protein	[0]	['root']	_	_
9	signaling	_	_	NN	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	survival	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	proliferation	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	but	_	_	CC	O	[-1]	['none']	_	_
16	have	_	_	VBP	O	[-1]	['none']	_	_
17	constitutively	_	_	RB	O	[-1]	['none']	_	_
18	activated	_	_	VBN	O	[-1]	['none']	_	_
19	Stat3	_	_	NN	Protein	[0]	['root']	_	_
20	signaling	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	Anaphora	[3]	['multitoken']	_	_
2	same	_	_	JJ	Anaphora	[3]	['multitoken']	_	_
3	targets	_	_	NNS	Anaphora	[0]	['root']	_	_
4	are	_	_	VBP	O	[-1]	['none']	_	_
5	also	_	_	RB	O	[-1]	['none']	_	_
6	deregulated	_	_	VBN	Regulation	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	wild-type	_	_	JJ	O	[-1]	['none']	_	_
9	B-1a	_	_	NN	O	[-1]	['none']	_	_
10	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
11	that	_	_	WDT	O	[-1]	['none']	_	_
12	arise	_	_	VBP	O	[-1]	['none']	_	_
13	spontaneously	_	_	RB	O	[-1]	['none']	_	_
14	through	_	_	IN	O	[-1]	['none']	_	_
15	age	_	_	NN	O	[-1]	['none']	_	_
16	predisposition	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	Akt	_	_	NN	Protein	[0]	['root']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	Stat3	_	_	NN	Protein	[0]	['root']	_	_
11	pathways	_	_	NNS	O	[-1]	['none']	_	_
12	may	_	_	MD	O	[-1]	['none']	_	_
13	serve	_	_	VB	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	effective	_	_	JJ	O	[-1]	['none']	_	_
16	targets	_	_	NNS	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	treatment	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	EBV	_	_	NN	O	[-1]	['none']	_	_
22	associated	_	_	VBN	O	[-1]	['none']	_	_
23	B	_	_	NN	O	[-1]	['none']	_	_
24	cell	_	_	NN	O	[-1]	['none']	_	_
25	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Constructs	_	_	NNS	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	transfection	_	_	NN	O	[-1]	['none']	_	_
4	The	_	_	DT	O	[-1]	['none']	_	_
5	complementary	_	_	JJ	O	[-1]	['none']	_	_
6	DNA	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	cDNA	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	mouse	_	_	NN	O	[-1]	['none']	_	_
13	Sharpin	_	_	NN	Protein	[0]	['root']	_	_
14	gene	_	_	NN	O	[-1]	['none']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	cloned	_	_	VBN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	amplified	_	_	VBN	O	[-1]	['none']	_	_
19	from	_	_	IN	O	[-1]	['none']	_	_
20	RAW264	_	_	NN	O	[-1]	['none']	_	_
21	.7	_	_	CD	O	[-1]	['none']	_	_
22	RNA	_	_	NN	O	[-1]	['none']	_	_
23	extracts	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	primer	_	_	NN	O	[-1]	['none']	_	_
3	sequences	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	forward	_	_	RB	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	5	_	_	CD	O	[-1]	['none']	_	_
8	'-CC	_	_	NN	O	[-1]	['none']	_	_
9	ATG	_	_	NN	O	[-1]	['none']	_	_
10	GCG	_	_	NN	O	[-1]	['none']	_	_
11	ATG	_	_	NN	O	[-1]	['none']	_	_
12	TCG	_	_	NNP	O	[-1]	['none']	_	_
13	CCG	_	_	NNP	O	[-1]	['none']	_	_
14	CCC	_	_	NNP	O	[-1]	['none']	_	_
15	GCC	_	_	NNP	O	[-1]	['none']	_	_
16	GGC	_	_	NNP	O	[-1]	['none']	_	_
17	GGT	_	_	NNP	O	[-1]	['none']	_	_
18	;	_	_	:	O	[-1]	['none']	_	_
19	reverse	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	5	_	_	CD	O	[-1]	['none']	_	_
22	'-	_	_	CD	O	[-1]	['none']	_	_
23	AAG	_	_	NNP	O	[-1]	['none']	_	_
24	CTT	_	_	NNP	O	[-1]	['none']	_	_
25	CTA	_	_	NNP	O	[-1]	['none']	_	_
26	GGT	_	_	NNP	O	[-1]	['none']	_	_
27	GGA	_	_	NNP	O	[-1]	['none']	_	_
28	AGC	_	_	NNP	O	[-1]	['none']	_	_
29	TGC	_	_	NNP	O	[-1]	['none']	_	_
30	AGC	_	_	NNP	O	[-1]	['none']	_	_
31	AAG	_	_	NNP	O	[-1]	['none']	_	_
32	A	_	_	NNP	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Sharpin	_	_	NNP	Protein	[0]	['root']	_	_
3	cDNA	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	cloned	_	_	VBN	O	[-1]	['none']	_	_
6	into	_	_	IN	O	[-1]	['none']	_	_
7	expression	_	_	NN	O	[-1]	['none']	_	_
8	vector	_	_	NN	O	[-1]	['none']	_	_
9	pFLAG-CMV-2	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	Murine	_	_	JJ	O	[-1]	['none']	_	_
2	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	macrophages	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	used	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	express	_	_	VB	Gene_expression	[0]	['root']	_	_
10	recombinant	_	_	JJ	O	[-1]	['none']	_	_
11	SHARPIN	_	_	NNP	Protein	[9]	['Theme']	_	_
12	protein	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	2x104	_	_	JJ	O	[-1]	['none']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	seeded	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	96-well	_	_	JJ	O	[-1]	['none']	_	_
9	treated	_	_	JJ	O	[-1]	['none']	_	_
10	plates	_	_	NNS	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	day	_	_	NN	O	[-1]	['none']	_	_
13	before	_	_	IN	O	[-1]	['none']	_	_
14	transfection	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	overnight	_	_	JJ	O	[-1]	['none']	_	_
3	incubation	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	200	_	_	CD	O	[-1]	['none']	_	_
6	ng	_	_	NN	O	[-1]	['none']	_	_
7	pFLAG-SHARPIN	_	_	NN	Protein	[0]	['root']	_	_
8	plasmids	_	_	NNS	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	transfected	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	0.5	_	_	CD	O	[-1]	['none']	_	_
13	ul	_	_	NN	O	[-1]	['none']	_	_
14	Lipofectamine	_	_	NNP	O	[-1]	['none']	_	_
15	2000	_	_	CD	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	24	_	_	CD	O	[-1]	['none']	_	_
2	hours	_	_	NNS	O	[-1]	['none']	_	_
3	later	_	_	RB	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	incubated	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	fresh	_	_	JJ	O	[-1]	['none']	_	_
10	culture	_	_	NN	O	[-1]	['none']	_	_
11	medium	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	another	_	_	DT	O	[-1]	['none']	_	_
3	24	_	_	CD	O	[-1]	['none']	_	_
4	hours	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	lysed	_	_	VBN	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	confirm	_	_	VB	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	FLAG-SHARPIN	_	_	NN	Protein	[13]	['Theme']	_	_
13	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	immunoblots	_	_	NNS	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	anti-FLAG	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	no	_	_	DT	O	[-1]	['none']	_	_
4	transfection	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	transfected	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	empty	_	_	JJ	O	[-1]	['none']	_	_
9	vector	_	_	NN	O	[-1]	['none']	_	_
10	pFLAG-CMV-2	_	_	NN	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	used	_	_	VBN	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	negative	_	_	JJ	O	[-1]	['none']	_	_
15	control	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	all	_	_	DT	O	[-1]	['none']	_	_
18	transfection	_	_	NN	O	[-1]	['none']	_	_
19	experiments	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	High	_	_	JJ	Positive_regulation	[2]	['multitoken']	_	_
2	Levels	_	_	NNS	Positive_regulation	[0]	['root']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[5]	['Theme']	_	_
5	Expression	_	_	NN	Gene_expression	[2]	['Theme']	_	_
6	Correlates	_	_	VBZ	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	Development	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	Lymphoma	_	_	NN	O	[-1]	['none']	_	_
12	LMP1	_	_	NN	Protein	[13]	['Theme']	_	_
13	expression	_	_	NN	Gene_expression	[24]	['Theme']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	IgLMP1	_	_	NN	O	[-1]	['none']	_	_
16	mice	_	_	NNS	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	directed	_	_	VBN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	B	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	under	_	_	IN	Regulation	[24]	['multitoken']	_	_
23	the	_	_	DT	Regulation	[24]	['multitoken']	_	_
24	control	_	_	NN	Regulation	[0]	['root']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	Ig	_	_	NN	O	[-1]	['none']	_	_
28	heavy	_	_	JJ	O	[-1]	['none']	_	_
29	chain	_	_	NN	O	[-1]	['none']	_	_
30	promoter	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	enhancer	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	previously	_	_	RB	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	shown	_	_	VBN	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	these	_	_	DT	O	[-1]	['none']	_	_
9	transgenic	_	_	JJ	O	[-1]	['none']	_	_
10	mice	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	LMP1	_	_	NN	Protein	[13]	['Theme']	_	_
13	expression	_	_	NN	Gene_expression	[15]	['Theme']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	restricted	_	_	JJ	Positive_regulation	[0]	['root']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	B220+	_	_	JJ	O	[-1]	['none']	_	_
18	B	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	lymphoma	_	_	NN	O	[-1]	['none']	_	_
22	detected	_	_	VBN	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	greatly	_	_	RB	O	[-1]	['none']	_	_
25	enlarged	_	_	JJ	O	[-1]	['none']	_	_
26	spleens	_	_	NNS	O	[-1]	['none']	_	_
27	[	_	_	VBP	O	[-1]	['none']	_	_
28	23,26	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	CD	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	investigate	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
6	contributes	_	_	VBZ	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	lymphoma	_	_	NN	O	[-1]	['none']	_	_
9	development	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	B	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	purified	_	_	VBN	O	[-1]	['none']	_	_
15	from	_	_	IN	O	[-1]	['none']	_	_
16	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	positive	_	_	JJ	O	[-1]	['none']	_	_
19	selection	_	_	NN	O	[-1]	['none']	_	_
20	using	_	_	VBG	O	[-1]	['none']	_	_
21	anti-CD19	_	_	NN	Protein	[0]	['root']	_	_
22	MACS	_	_	NNS	O	[-1]	['none']	_	_
23	magnetic	_	_	JJ	O	[-1]	['none']	_	_
24	beads	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	equivalent	_	_	JJ	O	[-1]	['none']	_	_
28	amounts	_	_	NNS	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	B	_	_	NN	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	were	_	_	VBD	O	[-1]	['none']	_	_
33	analyzed	_	_	VBN	O	[-1]	['none']	_	_
34	by	_	_	IN	O	[-1]	['none']	_	_
35	immunoblotting	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[3]	['Theme']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	detectable	_	_	JJ	Gene_expression	[0]	['root']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[0]	['root']	_	_
6	transgenic	_	_	JJ	O	[-1]	['none']	_	_
7	B	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	but	_	_	CC	O	[-1]	['none']	_	_
11	upon	_	_	IN	O	[-1]	['none']	_	_
12	development	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	lymphoma	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	LMP1	_	_	NN	Protein	[17]	['Theme']	_	_
17	expression	_	_	NN	Gene_expression	[19]	['Theme']	_	_
18	was	_	_	VBD	O	[-1]	['none']	_	_
19	stronger	_	_	JJR	Positive_regulation	[0]	['root']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	5/7	_	_	CD	O	[-1]	['none']	_	_
22	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
23	analyzed	_	_	VBN	O	[-1]	['none']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	concomitant	_	_	JJ	O	[-1]	['none']	_	_
26	appearance	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	degradation	_	_	NN	O	[-1]	['none']	_	_
29	products	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	higher	_	_	JJR	Positive_regulation	[6]	['multitoken']	_	_
6	level	_	_	NN	Positive_regulation	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	LMP1	_	_	NN	Protein	[6]	['Theme']	_	_
9	detected	_	_	VBD	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	due	_	_	JJ	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	an	_	_	DT	O	[-1]	['none']	_	_
14	expansion	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	malignant	_	_	JJ	O	[-1]	['none']	_	_
17	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	LMP1	_	_	NN	Protein	[19]	['Theme']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	spleen	_	_	NN	O	[-1]	['none']	_	_
25	was	_	_	VBD	O	[-1]	['none']	_	_
26	further	_	_	JJ	O	[-1]	['none']	_	_
27	evaluated	_	_	VBN	O	[-1]	['none']	_	_
28	by	_	_	IN	O	[-1]	['none']	_	_
29	immunohistochemical	_	_	JJ	O	[-1]	['none']	_	_
30	staining	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Immunohistochemistry	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	spleen	_	_	NN	O	[-1]	['none']	_	_
5	sections	_	_	NNS	O	[-1]	['none']	_	_
6	detected	_	_	VBD	Gene_expression	[0]	['root']	_	_
7	LMP1	_	_	NN	Protein	[6]	['Theme']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	plasma	_	_	NN	O	[-1]	['none']	_	_
11	membrane	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	both	_	_	CC	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	follicular	_	_	JJ	O	[-1]	['none']	_	_
18	white	_	_	JJ	O	[-1]	['none']	_	_
19	pulp	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	circulating	_	_	VBG	O	[-1]	['none']	_	_
22	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	red	_	_	JJ	O	[-1]	['none']	_	_
26	pulp	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[2]	['Theme']	_	_
2	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	heterogeneous	_	_	JJ	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	strong	_	_	JJ	Positive_regulation	[0]	['root']	_	_
7	LMP1	_	_	NN	Protein	[6]	['Theme']	_	_
8	staining	_	_	NN	O	[-1]	['none']	_	_
9	interspersed	_	_	VBD	O	[-1]	['none']	_	_
10	amongst	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	background	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	staining	_	_	VBG	O	[-1]	['none']	_	_
16	weakly	_	_	RB	Positive_regulation	[0]	['root']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	LMP1	_	_	NN	Protein	[16]	['Theme']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Upon	_	_	IN	O	[-1]	['none']	_	_
2	development	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	lymphoma	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	LMP1	_	_	NN	Protein	[7]	['Theme']	_	_
7	expression	_	_	NN	Gene_expression	[10]	['Theme']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	more	_	_	RBR	O	[-1]	['none']	_	_
10	abundantly	_	_	RB	Positive_regulation	[0]	['root']	_	_
11	detected	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	multiple	_	_	JJ	O	[-1]	['none']	_	_
14	foci	_	_	NNS	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	intense	_	_	JJ	Positive_regulation	[0]	['root']	_	_
17	LMP1	_	_	NN	Protein	[16]	['Theme']	_	_
18	staining	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	demonstrates	_	_	VBZ	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	increased	_	_	JJ	Positive_regulation	[0]	['root']	_	_
6	LMP1	_	_	NN	Protein	[5]	['Theme']	_	_
7	detected	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	immunoblotting	_	_	VBG	O	[-1]	['none']	_	_
10	upon	_	_	IN	O	[-1]	['none']	_	_
11	malignant	_	_	JJ	O	[-1]	['none']	_	_
12	progression	_	_	NN	O	[-1]	['none']	_	_
13	reflects	_	_	VBZ	O	[-1]	['none']	_	_
14	an	_	_	DT	O	[-1]	['none']	_	_
15	increase	_	_	NN	Positive_regulation	[0]	['root']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	LMP1	_	_	NN	Protein	[18]	['Theme']	_	_
18	expression	_	_	NN	Gene_expression	[15]	['Theme']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	an	_	_	DT	O	[-1]	['none']	_	_
21	accumulation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	expressing	_	_	VBG	Gene_expression	[26]	['Theme']	_	_
25	high	_	_	JJ	Positive_regulation	[26]	['multitoken']	_	_
26	levels	_	_	NNS	Positive_regulation	[0]	['root']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	LMP1	_	_	NN	Protein	[24]	['Theme']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	correlation	_	_	NN	O	[-1]	['none']	_	_
3	between	_	_	IN	O	[-1]	['none']	_	_
4	high	_	_	JJ	Positive_regulation	[0]	['root']	_	_
5	LMP1	_	_	NN	Protein	[6]	['Theme']	_	_
6	expression	_	_	NN	Gene_expression	[4]	['Theme']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	development	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	lymphoma	_	_	NN	O	[-1]	['none']	_	_
12	suggests	_	_	VBZ	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	progression	_	_	NN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	lymphoma	_	_	NN	O	[-1]	['none']	_	_
17	results	_	_	NNS	O	[-1]	['none']	_	_
18	from	_	_	IN	O	[-1]	['none']	_	_
19	increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
20	levels	_	_	NNS	Gene_expression	[19]	['Theme']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	LMP1	_	_	NN	Protein	[20]	['Theme']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	Analysis	_	_	NN	O	[-1]	['none']	_	_
3	The	_	_	DT	O	[-1]	['none']	_	_
4	experimental	_	_	JJ	O	[-1]	['none']	_	_
5	results	_	_	NNS	O	[-1]	['none']	_	_
6	obtained	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	this	_	_	DT	O	[-1]	['none']	_	_
9	study	_	_	NN	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	derived	_	_	VBN	O	[-1]	['none']	_	_
12	from	_	_	IN	O	[-1]	['none']	_	_
13	four	_	_	CD	O	[-1]	['none']	_	_
14	separate	_	_	JJ	O	[-1]	['none']	_	_
15	experiments	_	_	NNS	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	healthy	_	_	JJ	O	[-1]	['none']	_	_
18	volunteer	_	_	NN	O	[-1]	['none']	_	_
19	donors	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Each	_	_	DT	O	[-1]	['none']	_	_
2	assay	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	duplicate	_	_	VB	O	[-1]	['none']	_	_
7	or	_	_	CC	O	[-1]	['none']	_	_
8	triplicate	_	_	VB	O	[-1]	['none']	_	_
9	where	_	_	WRB	O	[-1]	['none']	_	_
10	appropriate	_	_	JJ	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	presented	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	mean	_	_	NN	O	[-1]	['none']	_	_
7	+/-	_	_	CC	O	[-1]	['none']	_	_
8	SEM	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	differences	_	_	NNS	O	[-1]	['none']	_	_
3	between	_	_	IN	O	[-1]	['none']	_	_
4	groups	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	determined	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	one-way	_	_	JJ	O	[-1]	['none']	_	_
9	analysis	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	variance	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	ANOVA	_	_	NNP	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	Bonferroni	_	_	NNP	O	[-1]	['none']	_	_
18	correction	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	significance	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	defined	_	_	VBN	O	[-1]	['none']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	P	_	_	NN	O	[-1]	['none']	_	_
7	<	_	_	JJR	O	[-1]	['none']	_	_
8	0.05	_	_	CD	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF	_	_	NNP	O	[-1]	['none']	_	_
2	Induces	_	_	VBZ	O	[-1]	['none']	_	_
3	Phosphorylation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	Ser276	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	PKC	_	_	NN	O	[-1]	['none']	_	_
10	dependent	_	_	JJ	O	[-1]	['none']	_	_
11	Fashion	_	_	NN	O	[-1]	['none']	_	_
12	Since	_	_	IN	O	[-1]	['none']	_	_
13	M-CSF	_	_	NN	O	[-1]	['none']	_	_
14	did	_	_	VBD	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	regulate	_	_	VB	O	[-1]	['none']	_	_
17	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
18	activation	_	_	NN	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	influencing	_	_	VBG	O	[-1]	['none']	_	_
21	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	we	_	_	PRP	O	[-1]	['none']	_	_
24	next	_	_	RB	O	[-1]	['none']	_	_
25	sought	_	_	VBD	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	determine	_	_	VB	O	[-1]	['none']	_	_
28	if	_	_	IN	O	[-1]	['none']	_	_
29	M-CSF	_	_	NN	O	[-1]	['none']	_	_
30	affected	_	_	VBD	Regulation	[0]	['root']	_	_
31	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
32	p65	_	_	NN	Protein	[35]	['Theme']	_	_
33	by	_	_	IN	O	[-1]	['none']	_	_
34	post-translational	_	_	JJ	Protein_modification	[35]	['multitoken']	_	_
35	mechanisms	_	_	NNS	Protein_modification	[30]	['Theme']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	examined	_	_	VBD	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	p65	_	_	NN	Protein	[6]	['Theme']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	specific	_	_	JJ	O	[-1]	['none']	_	_
12	phospho-NFkappaB	_	_	NN	O	[-1]	['none']	_	_
13	p65	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Ser276	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	Ser536	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	antibodies	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF	_	_	NNP	O	[-1]	['none']	_	_
2	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	phosphorylation	_	_	NN	Phosphorylation	[2]	['Theme']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Ser276	_	_	NN	Entity	[4]	['Site']	_	_
7	but	_	_	CC	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	Ser536	_	_	NN	Entity	[4]	['Site']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	p65	_	_	NN	Protein	[4]	['Theme']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	MDMs	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Compared	_	_	VBN	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	vehicle	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	general	_	_	JJ	O	[-1]	['none']	_	_
7	PKC	_	_	NN	O	[-1]	['none']	_	_
8	inhibitor	_	_	NN	O	[-1]	['none']	_	_
9	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
10	reduced	_	_	VBD	Negative_regulation	[0]	['root']	_	_
11	Ser276	_	_	NN	Entity	[12]	['Site']	_	_
12	phosphorylation	_	_	NN	Phosphorylation	[10]	['Theme']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	but	_	_	CC	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	Ser536	_	_	NN	Entity	[18]	['Site']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	phosphorylation	_	_	NN	Phosphorylation	[10]	['Theme']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	M-CSF-stimulated	_	_	JJ	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	M-CSF-stimulated	_	_	JJ	Positive_regulation	[17]	['Theme']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	p65	_	_	NN	Protein	[6]	['Theme']	_	_
6	phosphorylation	_	_	NN	Phosphorylation	[3]	['Theme']	_	_
7	at	_	_	IN	O	[-1]	['none']	_	_
8	residue	_	_	NN	O	[-1]	['none']	_	_
9	Ser276	_	_	NN	Entity	[6]	['Site']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	RAW	_	_	NN	O	[-1]	['none']	_	_
12	264.7	_	_	CD	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	also	_	_	RB	O	[-1]	['none']	_	_
16	PKC	_	_	NN	O	[-1]	['none']	_	_
17	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	suggested	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	PKC	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	s	_	_	NNS	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	regulated	_	_	VBN	Regulation	[24]	['Theme']	_	_
10	Ser276	_	_	NN	Entity	[11]	['Site']	_	_
11	phosphorylation	_	_	NN	Phosphorylation	[9]	['Theme']	_	_
12	but	_	_	CC	O	[-1]	['none']	_	_
13	not	_	_	RB	O	[-1]	['none']	_	_
14	Ser536	_	_	NN	Entity	[11]	['Site']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	both	_	_	CC	O	[-1]	['none']	_	_
17	human	_	_	NN	O	[-1]	['none']	_	_
18	MDMs	_	_	NNS	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	mouse	_	_	NN	O	[-1]	['none']	_	_
21	macrophages	_	_	NNS	O	[-1]	['none']	_	_
22	after	_	_	IN	O	[-1]	['none']	_	_
23	M-CSF	_	_	NN	O	[-1]	['none']	_	_
24	stimulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	next	_	_	RB	O	[-1]	['none']	_	_
3	performed	_	_	VBD	O	[-1]	['none']	_	_
4	cellular	_	_	JJ	O	[-1]	['none']	_	_
5	fractionation	_	_	NN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	identify	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	cellular	_	_	JJ	O	[-1]	['none']	_	_
10	location	_	_	NN	Localization	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	p65	_	_	NN	Protein	[10, 12]	['Theme', 'Theme']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	Raw	_	_	NN	O	[-1]	['none']	_	_
17	264.7	_	_	CD	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Non	_	_	JJ	O	[-1]	['none']	_	_
2	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	p65	_	_	NN	Protein	[2, 6]	['Theme', 'Theme']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	located	_	_	JJ	Localization	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	both	_	_	CC	Entity	[12]	['multitoken']	_	_
9	cytosolic	_	_	JJ	Entity	[12]	['multitoken']	_	_
10	and	_	_	CC	Entity	[12]	['multitoken']	_	_
11	nuclear	_	_	JJ	Entity	[12]	['multitoken']	_	_
12	fractions	_	_	NNS	Entity	[6]	['ToLoc']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	but	_	_	CC	O	[-1]	['none']	_	_
15	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
16	Ser276	_	_	NN	Entity	[15]	['Site']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	Ser536	_	_	NN	Entity	[15]	['Site']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	p65	_	_	NN	Protein	[15, 23]	['Theme', 'Theme']	_	_
21	was	_	_	VBD	O	[-1]	['none']	_	_
22	primarily	_	_	RB	O	[-1]	['none']	_	_
23	located	_	_	VBN	Localization	[0]	['root']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	nuclear	_	_	JJ	Entity	[23]	['ToLoc']	_	_
26	fraction	_	_	NN	O	[-1]	['none']	_	_
27	after	_	_	IN	O	[-1]	['none']	_	_
28	M-CSF	_	_	NN	O	[-1]	['none']	_	_
29	stimulation	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Notably	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	constitutive	_	_	JJ	O	[-1]	['none']	_	_
4	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Ser536	_	_	NN	Entity	[4]	['Site']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[4]	['Theme']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	found	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	these	_	_	DT	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Importantly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
4	reduced	_	_	VBD	Negative_regulation	[0]	['root']	_	_
5	M-CSF-induced	_	_	JJ	Positive_regulation	[4]	['Theme']	_	_
6	Ser276	_	_	NN	Entity	[7]	['Site']	_	_
7	phosphorylation	_	_	NN	Phosphorylation	[5]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[7]	['Theme']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	both	_	_	CC	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	cytosolic	_	_	JJ	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	nuclear	_	_	JJ	O	[-1]	['none']	_	_
17	fractions	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	while	_	_	IN	O	[-1]	['none']	_	_
20	M-CSF-induced	_	_	JJ	Positive_regulation	[30]	['Theme']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	p65	_	_	NN	Protein	[24]	['Theme']	_	_
23	Ser536	_	_	NN	Entity	[24]	['Site']	_	_
24	phosphorylation	_	_	NN	Phosphorylation	[20]	['Theme']	_	_
25	was	_	_	VBD	O	[-1]	['none']	_	_
26	present	_	_	JJ	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	nucleus	_	_	NN	O	[-1]	['none']	_	_
30	regardless	_	_	RB	Regulation	[0]	['root']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	PKC	_	_	NN	O	[-1]	['none']	_	_
33	inhibition	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	observations	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	M-CSF-induced	_	_	JJ	Positive_regulation	[10]	['Theme']	_	_
6	Ser276	_	_	NN	Entity	[5]	['Site']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	Ser536	_	_	NN	Entity	[5]	['Site']	_	_
9	are	_	_	VBP	O	[-1]	['none']	_	_
10	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
11	differently	_	_	RB	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	conventional	_	_	JJ	O	[-1]	['none']	_	_
14	PKC	_	_	NN	O	[-1]	['none']	_	_
15	activation	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
18	phagocytes	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	purity	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	cytosol	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	nuclear	_	_	JJ	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	fractions	_	_	NNS	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	confirmed	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	immunoblotting	_	_	VBG	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	GAPDH	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	Lamin	_	_	NN	O	[-1]	['none']	_	_
18	B	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	respectively	_	_	RB	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	HOIP	_	_	NN	Protein	[3]	['Cause']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[0]	['root']	_	_
6	mediated	_	_	VBD	Positive_regulation	[3]	['Theme']	_	_
7	CD80	_	_	NN	Protein	[8]	['Theme']	_	_
8	upregulation	_	_	NN	Positive_regulation	[6]	['Theme']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	activation	_	_	NN	Positive_regulation	[6]	['Theme']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	germline	_	_	NN	Protein	[13]	['multitoken']	_	_
13	epsilon	_	_	NN	Protein	[14]	['Theme']	_	_
14	transcription	_	_	NN	Transcription	[10]	['Theme']	_	_
15	Engagement	_	_	NN	Binding	[21]	['Cause']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	CD40	_	_	NN	Protein	[15]	['Theme']	_	_
18	on	_	_	IN	O	[-1]	['none']	_	_
19	B	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	upregulates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
22	expression	_	_	NN	Gene_expression	[21]	['Theme']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	CD80	_	_	NN	Protein	[22]	['Theme']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	10	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	a	_	_	DT	O	[-1]	['none']	_	_
30	cell	_	_	NN	O	[-1]	['none']	_	_
31	surface	_	_	NN	O	[-1]	['none']	_	_
32	protein	_	_	NN	O	[-1]	['none']	_	_
33	that	_	_	WDT	O	[-1]	['none']	_	_
34	promotes	_	_	VBZ	O	[-1]	['none']	_	_
35	activation	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	T	_	_	NN	O	[-1]	['none']	_	_
38	cells	_	_	NNS	O	[-1]	['none']	_	_
39	interacting	_	_	VBG	O	[-1]	['none']	_	_
40	with	_	_	IN	O	[-1]	['none']	_	_
41	B	_	_	NN	O	[-1]	['none']	_	_
42	cells	_	_	NNS	O	[-1]	['none']	_	_
43	and	_	_	CC	O	[-1]	['none']	_	_
44	other	_	_	JJ	O	[-1]	['none']	_	_
45	APC	_	_	NN	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	begin	_	_	VB	O	[-1]	['none']	_	_
3	evaluating	_	_	VBG	O	[-1]	['none']	_	_
4	potential	_	_	JJ	O	[-1]	['none']	_	_
5	contributions	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	HOIP	_	_	NN	Protein	[0]	['root']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	CD40	_	_	NN	Protein	[0]	['root']	_	_
10	signaling	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	we	_	_	PRP	O	[-1]	['none']	_	_
13	assayed	_	_	VBD	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	upregulation	_	_	NN	Positive_regulation	[18]	['Theme']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	CD80	_	_	NN	Protein	[15]	['Theme']	_	_
18	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	engagement	_	_	NN	Binding	[18]	['Cause']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	CD40	_	_	NN	Protein	[20]	['Theme']	_	_
23	on	_	_	IN	O	[-1]	['none']	_	_
24	parental	_	_	JJ	O	[-1]	['none']	_	_
25	A20	_	_	NN	O	[-1]	['none']	_	_
26	.2	_	_	NN	O	[-1]	['none']	_	_
27	J	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	HOIP	_	_	NN	Protein	[0]	['root']	_	_
30	deficient	_	_	JJ	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	HOIP	_	_	NN	Protein	[34]	['Theme']	_	_
34	reconstituted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
35	cells	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Compared	_	_	VBN	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	parental	_	_	JJ	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	line	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	CD40	_	_	NN	Protein	[10]	['Cause']	_	_
10	stimulated	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	upregulation	_	_	NN	Positive_regulation	[10, 16]	['Theme', 'Theme']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	CD80	_	_	NN	Protein	[11]	['Theme']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	dramatically	_	_	RB	O	[-1]	['none']	_	_
16	reduced	_	_	VBN	Negative_regulation	[0]	['root']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	all	_	_	DT	O	[-1]	['none']	_	_
19	HOIP	_	_	NN	Protein	[20]	['Theme']	_	_
20	deficient	_	_	JJ	Negative_regulation	[16]	['Cause']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	tested	_	_	VBN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	upregulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	CD80	_	_	NN	Protein	[4]	['Theme']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	restored	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	HOIP	_	_	NNP	Protein	[11]	['Theme']	_	_
11	reconstituted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	confirming	_	_	VBG	O	[-1]	['none']	_	_
15	that	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	defect	_	_	NN	Negative_regulation	[27]	['Theme']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	CD80	_	_	NN	Protein	[20]	['Theme']	_	_
20	upregulation	_	_	NN	Positive_regulation	[17]	['Theme']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	HOIP	_	_	NN	Protein	[24]	['Theme']	_	_
24	deficient	_	_	JJ	Negative_regulation	[17]	['Cause']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	was	_	_	VBD	O	[-1]	['none']	_	_
27	due	_	_	JJ	Positive_regulation	[0]	['root']	_	_
28	to	_	_	TO	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	disruption	_	_	NN	Negative_regulation	[27]	['Cause']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	Rnf31	_	_	NN	Protein	[30]	['Theme']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[0]	['root']	_	_
2	signals	_	_	NNS	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	B	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	can	_	_	MD	O	[-1]	['none']	_	_
7	also	_	_	RB	O	[-1]	['none']	_	_
8	contribute	_	_	VB	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	DNA	_	_	NN	O	[-1]	['none']	_	_
14	recombination	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	immunoglobulin	_	_	NN	O	[-1]	['none']	_	_
18	heavy	_	_	JJ	O	[-1]	['none']	_	_
19	chain	_	_	NN	O	[-1]	['none']	_	_
20	locus	_	_	NN	O	[-1]	['none']	_	_
21	[	_	_	NN	O	[-1]	['none']	_	_
22	11	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	12	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	process	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	known	_	_	VBN	O	[-1]	['none']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	immunoglobulin	_	_	NN	O	[-1]	['none']	_	_
7	class	_	_	NN	O	[-1]	['none']	_	_
8	switching	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	isotype	_	_	NN	O	[-1]	['none']	_	_
12	switching	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	allows	_	_	VBZ	O	[-1]	['none']	_	_
16	B	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	initially	_	_	RB	O	[-1]	['none']	_	_
20	expressing	_	_	VBG	O	[-1]	['none']	_	_
21	IgM	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	switch	_	_	VB	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	IgA	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	IgG	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	or	_	_	CC	O	[-1]	['none']	_	_
31	IgE	_	_	NN	O	[-1]	['none']	_	_
32	depending	_	_	VBG	O	[-1]	['none']	_	_
33	on	_	_	IN	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	class	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	antibody	_	_	NN	O	[-1]	['none']	_	_
38	most	_	_	RBS	O	[-1]	['none']	_	_
39	appropriate	_	_	JJ	O	[-1]	['none']	_	_
40	for	_	_	IN	O	[-1]	['none']	_	_
41	a	_	_	DT	O	[-1]	['none']	_	_
42	particular	_	_	JJ	O	[-1]	['none']	_	_
43	immune	_	_	JJ	O	[-1]	['none']	_	_
44	response	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	Switching	_	_	NN	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	IgE	_	_	NN	O	[-1]	['none']	_	_
4	can	_	_	MD	O	[-1]	['none']	_	_
5	be	_	_	VB	O	[-1]	['none']	_	_
6	induced	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	combination	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	IL-4	_	_	NN	Protein	[0]	['root']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	CD40	_	_	NN	Protein	[0]	['root']	_	_
14	signals	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	gene	_	_	NN	O	[-1]	['none']	_	_
3	rearrangement	_	_	NN	O	[-1]	['none']	_	_
4	necessary	_	_	JJ	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	IgE	_	_	NN	O	[-1]	['none']	_	_
7	production	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	preceded	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	production	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	non	_	_	JJ	O	[-1]	['none']	_	_
15	coding	_	_	NN	O	[-1]	['none']	_	_
16	RNA	_	_	NN	O	[-1]	['none']	_	_
17	transcripts	_	_	NNS	O	[-1]	['none']	_	_
18	from	_	_	IN	O	[-1]	['none']	_	_
19	germline	_	_	NN	O	[-1]	['none']	_	_
20	sequences	_	_	NNS	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	IgE	_	_	NN	O	[-1]	['none']	_	_
24	heavy	_	_	JJ	O	[-1]	['none']	_	_
25	chain	_	_	NN	O	[-1]	['none']	_	_
26	locus	_	_	NN	O	[-1]	['none']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	13	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	required	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	initiation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	class	_	_	NN	O	[-1]	['none']	_	_
13	switching	_	_	NN	O	[-1]	['none']	_	_
14	process	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	relevant	_	_	JJ	O	[-1]	['none']	_	_
18	B	_	_	NN	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	lines	_	_	NNS	O	[-1]	['none']	_	_
21	were	_	_	VBD	O	[-1]	['none']	_	_
22	stimulated	_	_	VBN	O	[-1]	['none']	_	_
23	through	_	_	IN	O	[-1]	['none']	_	_
24	CD40	_	_	NN	Protein	[0]	['root']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	presence	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	IL-4	_	_	NN	Protein	[0]	['root']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	tested	_	_	VBN	O	[-1]	['none']	_	_
32	for	_	_	IN	O	[-1]	['none']	_	_
33	production	_	_	NN	Transcription	[0]	['root']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	germline	_	_	NN	Protein	[36]	['multitoken']	_	_
36	epsilon	_	_	NN	Protein	[33]	['Theme']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	GLepsilon	_	_	NN	Protein	[0]	['root']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	transcripts	_	_	NNS	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Anti-CD40	_	_	NNP	O	[-1]	['none']	_	_
2	antibody	_	_	NN	O	[-1]	['none']	_	_
3	stimulation	_	_	NN	O	[-1]	['none']	_	_
4	alone	_	_	RB	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	together	_	_	RB	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	IL-4	_	_	NN	Protein	[0]	['root']	_	_
9	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
10	GLepsilon	_	_	NN	Protein	[11]	['Theme']	_	_
11	transcription	_	_	NN	Transcription	[9]	['Theme']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	parental	_	_	JJ	O	[-1]	['none']	_	_
14	A20	_	_	NN	O	[-1]	['none']	_	_
15	.2	_	_	NN	O	[-1]	['none']	_	_
16	J	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	as	_	_	IN	O	[-1]	['none']	_	_
19	expected	_	_	VBN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	only	_	_	RB	O	[-1]	['none']	_	_
5	low	_	_	JJ	O	[-1]	['none']	_	_
6	levels	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	GLepsilon	_	_	NN	Protein	[9]	['Theme']	_	_
9	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	detected	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	HOIP	_	_	NN	Protein	[14]	['Theme']	_	_
14	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	stimulated	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	either	_	_	CC	O	[-1]	['none']	_	_
19	anti-CD40	_	_	JJ	O	[-1]	['none']	_	_
20	antibody	_	_	NN	O	[-1]	['none']	_	_
21	alone	_	_	RB	O	[-1]	['none']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	anti-CD40	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	IL-4	_	_	NN	Protein	[0]	['root']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Normal	_	_	JJ	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	GLepsilon	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	HOIP	_	_	NNP	Protein	[10]	['Theme']	_	_
10	reconstituted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	stimulated	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	anti-CD40	_	_	JJ	O	[-1]	['none']	_	_
15	antibody	_	_	NN	O	[-1]	['none']	_	_
16	alone	_	_	RB	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	together	_	_	RB	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	IL-4	_	_	NN	Protein	[0]	['root']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Collectively	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	data	_	_	NNS	O	[-1]	['none']	_	_
5	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
8	has	_	_	VBZ	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	critical	_	_	JJ	O	[-1]	['none']	_	_
11	role	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	cellular	_	_	JJ	O	[-1]	['none']	_	_
14	responses	_	_	NNS	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	CD40	_	_	NN	Protein	[0]	['root']	_	_
17	signaling	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Mice	_	_	NNS	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Cytokines	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	Antibodies	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	Other	_	_	JJ	O	[-1]	['none']	_	_
9	Reagents	_	_	NNS	O	[-1]	['none']	_	_
10	BALB/c	_	_	NN	O	[-1]	['none']	_	_
11	DO11	_	_	NN	O	[-1]	['none']	_	_
12	.10	_	_	CD	O	[-1]	['none']	_	_
13	mice	_	_	NNS	O	[-1]	['none']	_	_
14	transgenic	_	_	JJ	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	OVA	_	_	NNP	Protein	[0]	['root']	_	_
17	specific	_	_	JJ	O	[-1]	['none']	_	_
18	TCR	_	_	NN	O	[-1]	['none']	_	_
19	WT	_	_	NN	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	crossed	_	_	VBD	O	[-1]	['none']	_	_
22	back	_	_	RP	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	Rag1-,	_	_	NN	Protein	[0]	['root']	_	_
25	IL-4-,	_	_	NN	Protein	[0]	['root']	_	_
26	IFN-gamma-,	_	_	NN	Protein	[0]	['root']	_	_
27	STAT4-,	_	_	NN	Protein	[0]	['root']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	STAT6	_	_	NN	Protein	[30]	['Theme']	_	_
30	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
31	mice	_	_	NNS	O	[-1]	['none']	_	_
32	were	_	_	VBD	O	[-1]	['none']	_	_
33	used	_	_	VBN	O	[-1]	['none']	_	_
34	as	_	_	IN	O	[-1]	['none']	_	_
35	a	_	_	DT	O	[-1]	['none']	_	_
36	source	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	antigen	_	_	NN	O	[-1]	['none']	_	_
39	specific	_	_	JJ	O	[-1]	['none']	_	_
40	T	_	_	NN	O	[-1]	['none']	_	_
41	cells	_	_	NNS	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	Murphy	_	_	NNP	O	[-1]	['none']	_	_
44	et	_	_	FW	O	[-1]	['none']	_	_
45	al.	_	_	FW	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	1990	_	_	CD	O	[-1]	['none']	_	_
48	;	_	_	:	O	[-1]	['none']	_	_
49	Ouyang	_	_	NNP	O	[-1]	['none']	_	_
50	et	_	_	FW	O	[-1]	['none']	_	_
51	al.	_	_	FW	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	1998	_	_	CD	O	[-1]	['none']	_	_
54	;	_	_	:	O	[-1]	['none']	_	_
55	Shoemaker	_	_	NNP	O	[-1]	['none']	_	_
56	et	_	_	FW	O	[-1]	['none']	_	_
57	al.	_	_	FW	O	[-1]	['none']	_	_
58	,	_	_	,	O	[-1]	['none']	_	_
59	2006	_	_	CD	O	[-1]	['none']	_	_
60	)	_	_	-RRB-	O	[-1]	['none']	_	_
61	and	_	_	CC	O	[-1]	['none']	_	_
62	were	_	_	VBD	O	[-1]	['none']	_	_
63	bred	_	_	VBN	O	[-1]	['none']	_	_
64	and	_	_	CC	O	[-1]	['none']	_	_
65	maintained	_	_	VBN	O	[-1]	['none']	_	_
66	under	_	_	IN	O	[-1]	['none']	_	_
67	SPF	_	_	NN	O	[-1]	['none']	_	_
68	conditions	_	_	NNS	O	[-1]	['none']	_	_
69	at	_	_	IN	O	[-1]	['none']	_	_
70	the	_	_	DT	O	[-1]	['none']	_	_
71	NIMR	_	_	NNP	O	[-1]	['none']	_	_
72	,	_	_	,	O	[-1]	['none']	_	_
73	London	_	_	NNP	O	[-1]	['none']	_	_
74	,	_	_	,	O	[-1]	['none']	_	_
75	Home	_	_	NNP	O	[-1]	['none']	_	_
76	Office	_	_	NNP	O	[-1]	['none']	_	_
77	,	_	_	,	O	[-1]	['none']	_	_
78	UK	_	_	NNP	O	[-1]	['none']	_	_
79	,	_	_	,	O	[-1]	['none']	_	_
80	Animals	_	_	NNS	O	[-1]	['none']	_	_
81	(	_	_	-LRB-	O	[-1]	['none']	_	_
82	Scientific	_	_	NNP	O	[-1]	['none']	_	_
83	Procedures	_	_	NNP	O	[-1]	['none']	_	_
84	)	_	_	-RRB-	O	[-1]	['none']	_	_
85	Act	_	_	NNP	O	[-1]	['none']	_	_
86	1986	_	_	CD	O	[-1]	['none']	_	_
87	or	_	_	CC	O	[-1]	['none']	_	_
88	at	_	_	IN	O	[-1]	['none']	_	_
89	the	_	_	DT	O	[-1]	['none']	_	_
90	Washington	_	_	NNP	O	[-1]	['none']	_	_
91	University	_	_	NNP	O	[-1]	['none']	_	_
92	School	_	_	NNP	O	[-1]	['none']	_	_
93	of	_	_	IN	O	[-1]	['none']	_	_
94	Medicine	_	_	NNP	O	[-1]	['none']	_	_
95	.	_	_	.	O	[-1]	['none']	_	_

1	Female	_	_	JJ	O	[-1]	['none']	_	_
2	mice	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	used	_	_	VBN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	8-12	_	_	CD	O	[-1]	['none']	_	_
7	weeks	_	_	NNS	O	[-1]	['none']	_	_
8	old	_	_	JJ	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	animal	_	_	NN	O	[-1]	['none']	_	_
12	protocols	_	_	NNS	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	approved	_	_	VBN	O	[-1]	['none']	_	_
15	according	_	_	VBG	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	Animals	_	_	NNPS	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Scientific	_	_	NNP	O	[-1]	['none']	_	_
21	Procedures	_	_	NNP	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	Act	_	_	NNP	O	[-1]	['none']	_	_
24	1986	_	_	CD	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	Home	_	_	NNP	O	[-1]	['none']	_	_
27	Office	_	_	NNP	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	UK	_	_	NNP	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Reagents	_	_	NNS	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	including	_	_	VBG	O	[-1]	['none']	_	_
4	antibodies	_	_	NNS	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	T	_	_	NN	O	[-1]	['none']	_	_
7	cell	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	DC	_	_	NN	O	[-1]	['none']	_	_
10	preparation	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	purification	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	culture	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	media	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	cytokines	_	_	NNS	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	cytokine	_	_	NN	O	[-1]	['none']	_	_
22	mAbs	_	_	NNS	O	[-1]	['none']	_	_
23	have	_	_	VBP	O	[-1]	['none']	_	_
24	been	_	_	VBN	O	[-1]	['none']	_	_
25	described	_	_	VBN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	Hosken	_	_	NNP	O	[-1]	['none']	_	_
28	et	_	_	FW	O	[-1]	['none']	_	_
29	al.	_	_	FW	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	1995	_	_	CD	O	[-1]	['none']	_	_
32	;	_	_	:	O	[-1]	['none']	_	_
33	Shoemaker	_	_	NNP	O	[-1]	['none']	_	_
34	et	_	_	FW	O	[-1]	['none']	_	_
35	al.	_	_	FW	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	2006	_	_	CD	O	[-1]	['none']	_	_
38	;	_	_	:	O	[-1]	['none']	_	_
39	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
40	et	_	_	FW	O	[-1]	['none']	_	_
41	al.	_	_	FW	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	2009	_	_	CD	O	[-1]	['none']	_	_
44	;	_	_	:	O	[-1]	['none']	_	_
45	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
46	et	_	_	FW	O	[-1]	['none']	_	_
47	al.	_	_	FW	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	2006	_	_	CD	O	[-1]	['none']	_	_
50	)	_	_	-RRB-	O	[-1]	['none']	_	_
51	.	_	_	.	O	[-1]	['none']	_	_

1	LPS	_	_	NN	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	S.	_	_	NNP	O	[-1]	['none']	_	_
4	minnesota	_	_	NNP	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	Alexis	_	_	NNP	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	chicken	_	_	NN	O	[-1]	['none']	_	_
11	ovalbumin	_	_	NN	Protein	[0]	['root']	_	_
12	protein	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	OVA	_	_	NN	Protein	[0]	['root']	_	_
15	protein	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	from	_	_	IN	O	[-1]	['none']	_	_
19	from	_	_	IN	O	[-1]	['none']	_	_
20	Sigma-Aldrich	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	ovalbumin	_	_	JJ	Protein	[0]	['root']	_	_
24	peptide323-339	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	OVA	_	_	NNP	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	endotoxin-free	_	_	JJ	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	was	_	_	VBD	O	[-1]	['none']	_	_
32	from	_	_	IN	O	[-1]	['none']	_	_
33	Biosynthesis	_	_	NNP	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	U0126	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	BioMol	_	_	NNP	O	[-1]	['none']	_	_
5	International	_	_	NNP	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	PD184352	_	_	NN	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	MEK	_	_	NN	Protein	[4]	['Theme']	_	_
4	inhibitors	_	_	NNS	Negative_regulation	[0]	['root']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	SB203580	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	p38	_	_	NN	Protein	[10]	['Theme']	_	_
10	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	CT99021	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	GSK3beta	_	_	NN	Protein	[17]	['Theme']	_	_
17	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	were	_	_	VBD	O	[-1]	['none']	_	_
20	kind	_	_	JJ	O	[-1]	['none']	_	_
21	gifts	_	_	NNS	O	[-1]	['none']	_	_
22	from	_	_	IN	O	[-1]	['none']	_	_
23	P.	_	_	NNP	O	[-1]	['none']	_	_
24	Cohen	_	_	NNP	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	N.	_	_	NNP	O	[-1]	['none']	_	_
27	Shpiro	_	_	NNP	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	University	_	_	NNP	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	Dundee	_	_	NNP	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	UK	_	_	NNP	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	Statistical	_	_	JJ	O	[-1]	['none']	_	_
4	significant	_	_	JJ	O	[-1]	['none']	_	_
5	differences	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	determined	_	_	VBN	O	[-1]	['none']	_	_
8	using	_	_	VBG	O	[-1]	['none']	_	_
9	two	_	_	CD	O	[-1]	['none']	_	_
10	tailed	_	_	VBD	O	[-1]	['none']	_	_
11	Student	_	_	NN	O	[-1]	['none']	_	_
12	's	_	_	POS	O	[-1]	['none']	_	_
13	t-test	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	*	_	_	SYM	O	[-1]	['none']	_	_
16	p	_	_	NN	O	[-1]	['none']	_	_
17	<	_	_	JJR	O	[-1]	['none']	_	_
18	0.05	_	_	CD	O	[-1]	['none']	_	_
19	;	_	_	:	O	[-1]	['none']	_	_
20	**	_	_	SYM	O	[-1]	['none']	_	_
21	p	_	_	NN	O	[-1]	['none']	_	_
22	<	_	_	JJR	O	[-1]	['none']	_	_
23	0.01	_	_	CD	O	[-1]	['none']	_	_
24	;	_	_	:	O	[-1]	['none']	_	_
25	***	_	_	CD	O	[-1]	['none']	_	_
26	p	_	_	NN	O	[-1]	['none']	_	_
27	<	_	_	JJR	O	[-1]	['none']	_	_
28	0.001	_	_	CD	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Specific	_	_	JJ	O	[-1]	['none']	_	_
2	CpG	_	_	NN	O	[-1]	['none']	_	_
3	sites	_	_	NNS	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
7	promoter	_	_	NN	O	[-1]	['none']	_	_
8	are	_	_	VBP	O	[-1]	['none']	_	_
9	methylated	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	hematopoietic	_	_	JJ	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	In	_	_	IN	O	[-1]	['none']	_	_
14	order	_	_	NN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	exactly	_	_	RB	O	[-1]	['none']	_	_
17	map	_	_	VB	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	methylation	_	_	NN	O	[-1]	['none']	_	_
20	sites	_	_	NNS	O	[-1]	['none']	_	_
21	within	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
24	promoter	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	we	_	_	PRP	O	[-1]	['none']	_	_
27	treated	_	_	VBD	O	[-1]	['none']	_	_
28	DNA	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	Jurkat	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	CML-T1	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	U-937	_	_	NN	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	K-562	_	_	NN	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	EM-2	_	_	NN	O	[-1]	['none']	_	_
39	cells	_	_	NNS	O	[-1]	['none']	_	_
40	as	_	_	RB	O	[-1]	['none']	_	_
41	well	_	_	RB	O	[-1]	['none']	_	_
42	as	_	_	IN	O	[-1]	['none']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	SD-1	_	_	NN	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	RPMI-8226	_	_	NN	O	[-1]	['none']	_	_
47	and	_	_	CC	O	[-1]	['none']	_	_
48	BV-173	_	_	NN	O	[-1]	['none']	_	_
49	control	_	_	NN	O	[-1]	['none']	_	_
50	cells	_	_	NNS	O	[-1]	['none']	_	_
51	with	_	_	IN	O	[-1]	['none']	_	_
52	bisulfite	_	_	NN	O	[-1]	['none']	_	_
53	,	_	_	,	O	[-1]	['none']	_	_
54	which	_	_	WDT	O	[-1]	['none']	_	_
55	chemically	_	_	RB	O	[-1]	['none']	_	_
56	converts	_	_	VBZ	O	[-1]	['none']	_	_
57	unmethylated	_	_	JJ	O	[-1]	['none']	_	_
58	cytosine	_	_	NN	O	[-1]	['none']	_	_
59	to	_	_	TO	O	[-1]	['none']	_	_
60	uracil	_	_	NN	O	[-1]	['none']	_	_
61	,	_	_	,	O	[-1]	['none']	_	_
62	whereas	_	_	IN	O	[-1]	['none']	_	_
63	it	_	_	PRP	O	[-1]	['none']	_	_
64	has	_	_	VBZ	O	[-1]	['none']	_	_
65	no	_	_	DT	O	[-1]	['none']	_	_
66	effect	_	_	NN	O	[-1]	['none']	_	_
67	on	_	_	IN	O	[-1]	['none']	_	_
68	methylated	_	_	VBN	O	[-1]	['none']	_	_
69	cytosine	_	_	NN	O	[-1]	['none']	_	_
70	,	_	_	,	O	[-1]	['none']	_	_
71	i.e.	_	_	FW	O	[-1]	['none']	_	_
72	in	_	_	IN	O	[-1]	['none']	_	_
73	CpG	_	_	NN	O	[-1]	['none']	_	_
74	(	_	_	-LRB-	O	[-1]	['none']	_	_
75	34	_	_	CD	O	[-1]	['none']	_	_
76	)	_	_	-RRB-	O	[-1]	['none']	_	_
77	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	technique	_	_	NN	O	[-1]	['none']	_	_
3	is	_	_	VBZ	O	[-1]	['none']	_	_
4	especially	_	_	RB	O	[-1]	['none']	_	_
5	useful	_	_	JJ	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	detection	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	unknown	_	_	JJ	O	[-1]	['none']	_	_
10	methylation	_	_	NN	O	[-1]	['none']	_	_
11	patterns	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	PCR	_	_	NN	O	[-1]	['none']	_	_
2	amplification	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	cloning	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	sequencing	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	bisulfite	_	_	NN	O	[-1]	['none']	_	_
10	treated	_	_	VBN	O	[-1]	['none']	_	_
11	DNA	_	_	NN	O	[-1]	['none']	_	_
12	showed	_	_	VBD	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	specific	_	_	JJ	O	[-1]	['none']	_	_
15	methylation	_	_	NN	O	[-1]	['none']	_	_
16	pattern	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	analyzed	_	_	VBN	O	[-1]	['none']	_	_
20	62	_	_	CD	O	[-1]	['none']	_	_
21	CpG	_	_	NN	O	[-1]	['none']	_	_
22	sites	_	_	NNS	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	all	_	_	DT	O	[-1]	['none']	_	_
25	cell	_	_	NN	O	[-1]	['none']	_	_
26	lines	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	general	_	_	JJ	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	methylational	_	_	JJ	O	[-1]	['none']	_	_
6	status	_	_	NN	O	[-1]	['none']	_	_
7	ranged	_	_	VBD	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	one	_	_	CD	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	line	_	_	NN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	nearly	_	_	RB	O	[-1]	['none']	_	_
15	non	_	_	JJ	O	[-1]	['none']	_	_
16	methylated	_	_	VBN	O	[-1]	['none']	_	_
17	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
18	promoter	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	SD-1	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	a	_	_	DT	O	[-1]	['none']	_	_
26	completely	_	_	RB	O	[-1]	['none']	_	_
27	methylated	_	_	VBN	O	[-1]	['none']	_	_
28	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
29	promoter	_	_	NN	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	CML-T1	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	percentage	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	CpG	_	_	NN	O	[-1]	['none']	_	_
7	methylation	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
11	promoter	_	_	NN	O	[-1]	['none']	_	_
12	from	_	_	IN	O	[-1]	['none']	_	_
13	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	very	_	_	RB	O	[-1]	['none']	_	_
17	low	_	_	JJ	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	mean	_	_	VB	O	[-1]	['none']	_	_
20	24	_	_	CD	O	[-1]	['none']	_	_
21	%	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	as	_	_	IN	O	[-1]	['none']	_	_
24	compared	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	mean	_	_	VB	O	[-1]	['none']	_	_
30	94	_	_	CD	O	[-1]	['none']	_	_
31	%	_	_	NN	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	5	_	_	CD	O	[-1]	['none']	_	_
3	'-region	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	R1	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	13	_	_	CD	O	[-1]	['none']	_	_
9	hypermethylated	_	_	VBN	O	[-1]	['none']	_	_
10	CpG	_	_	NN	O	[-1]	['none']	_	_
11	sites	_	_	NNS	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	mean	_	_	VB	O	[-1]	['none']	_	_
14	number	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	methylated	_	_	VBN	O	[-1]	['none']	_	_
17	clones	_	_	NNS	O	[-1]	['none']	_	_
18	5.5	_	_	CD	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	8	_	_	CD	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	77	_	_	CD	O	[-1]	['none']	_	_
23	%	_	_	NN	O	[-1]	['none']	_	_
24	methylated	_	_	VBN	O	[-1]	['none']	_	_
25	CpGs	_	_	NNS	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	was	_	_	VBD	O	[-1]	['none']	_	_
28	found	_	_	VBN	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	most	_	_	JJS	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	except	_	_	IN	O	[-1]	['none']	_	_
34	SD-1	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	RPMI-8226	_	_	NN	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	a	_	_	DT	O	[-1]	['none']	_	_
40	3	_	_	CD	O	[-1]	['none']	_	_
41	'-region	_	_	NN	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	R3	_	_	NN	O	[-1]	['none']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	of	_	_	IN	O	[-1]	['none']	_	_
46	6	_	_	CD	O	[-1]	['none']	_	_
47	hypomethylated	_	_	VBN	O	[-1]	['none']	_	_
48	CpG	_	_	NN	O	[-1]	['none']	_	_
49	sites	_	_	NNS	O	[-1]	['none']	_	_
50	(	_	_	-LRB-	O	[-1]	['none']	_	_
51	mean	_	_	VB	O	[-1]	['none']	_	_
52	number	_	_	NN	O	[-1]	['none']	_	_
53	of	_	_	IN	O	[-1]	['none']	_	_
54	methylated	_	_	VBN	O	[-1]	['none']	_	_
55	clones	_	_	NNS	O	[-1]	['none']	_	_
56	1.7	_	_	CD	O	[-1]	['none']	_	_
57	of	_	_	IN	O	[-1]	['none']	_	_
58	8	_	_	CD	O	[-1]	['none']	_	_
59	with	_	_	IN	O	[-1]	['none']	_	_
60	33	_	_	CD	O	[-1]	['none']	_	_
61	%	_	_	NN	O	[-1]	['none']	_	_
62	methylated	_	_	VBN	O	[-1]	['none']	_	_
63	CpGs	_	_	NNS	O	[-1]	['none']	_	_
64	)	_	_	-RRB-	O	[-1]	['none']	_	_
65	was	_	_	VBD	O	[-1]	['none']	_	_
66	found	_	_	VBN	O	[-1]	['none']	_	_
67	in	_	_	IN	O	[-1]	['none']	_	_
68	most	_	_	JJS	O	[-1]	['none']	_	_
69	cells	_	_	NNS	O	[-1]	['none']	_	_
70	(	_	_	-LRB-	O	[-1]	['none']	_	_
71	except	_	_	IN	O	[-1]	['none']	_	_
72	CML-T1	_	_	NN	O	[-1]	['none']	_	_
73	and	_	_	CC	O	[-1]	['none']	_	_
74	U-937	_	_	NN	O	[-1]	['none']	_	_
75	)	_	_	-RRB-	O	[-1]	['none']	_	_
76	.	_	_	.	O	[-1]	['none']	_	_

1	Intriguingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	stretch	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	13	_	_	CD	O	[-1]	['none']	_	_
7	CpG	_	_	NN	O	[-1]	['none']	_	_
8	sites	_	_	NNS	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	#	_	_	#	O	[-1]	['none']	_	_
11	10-22	_	_	CD	O	[-1]	['none']	_	_
12	;	_	_	:	O	[-1]	['none']	_	_
13	R2	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	detected	_	_	VBN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	between	_	_	IN	O	[-1]	['none']	_	_
19	these	_	_	DT	O	[-1]	['none']	_	_
20	regions	_	_	NNS	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	which	_	_	WDT	O	[-1]	['none']	_	_
23	were	_	_	VBD	O	[-1]	['none']	_	_
24	highly	_	_	RB	O	[-1]	['none']	_	_
25	methylated	_	_	VBN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	mean	_	_	VB	O	[-1]	['none']	_	_
30	number	_	_	NN	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	methylated	_	_	VBN	O	[-1]	['none']	_	_
33	clones	_	_	NNS	O	[-1]	['none']	_	_
34	7.1	_	_	CD	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	8	_	_	CD	O	[-1]	['none']	_	_
37	with	_	_	IN	O	[-1]	['none']	_	_
38	89	_	_	CD	O	[-1]	['none']	_	_
39	%	_	_	NN	O	[-1]	['none']	_	_
40	methylated	_	_	VBN	O	[-1]	['none']	_	_
41	CpGs	_	_	NNS	O	[-1]	['none']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	but	_	_	CC	O	[-1]	['none']	_	_
44	totally	_	_	RB	O	[-1]	['none']	_	_
45	non	_	_	JJ	O	[-1]	['none']	_	_
46	methylated	_	_	VBN	O	[-1]	['none']	_	_
47	in	_	_	IN	O	[-1]	['none']	_	_
48	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
49	cells	_	_	NNS	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	three	_	_	CD	O	[-1]	['none']	_	_
4	CpG	_	_	NN	O	[-1]	['none']	_	_
5	sites	_	_	NNS	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	5	_	_	CD	O	[-1]	['none']	_	_
9	'	_	_	''	O	[-1]	['none']	_	_
10	end	_	_	VB	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	#	_	_	#	O	[-1]	['none']	_	_
13	54	_	_	CD	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	56	_	_	CD	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	58	_	_	CD	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	two	_	_	CD	O	[-1]	['none']	_	_
21	CpG	_	_	NN	O	[-1]	['none']	_	_
22	motifs	_	_	NNS	O	[-1]	['none']	_	_
23	at	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	3	_	_	CD	O	[-1]	['none']	_	_
26	'	_	_	''	O	[-1]	['none']	_	_
27	end	_	_	VB	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	#	_	_	#	O	[-1]	['none']	_	_
30	1	_	_	CD	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	2	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	showed	_	_	VBD	O	[-1]	['none']	_	_
35	this	_	_	DT	O	[-1]	['none']	_	_
36	direct	_	_	JJ	O	[-1]	['none']	_	_
37	correlation	_	_	NN	O	[-1]	['none']	_	_
38	between	_	_	IN	O	[-1]	['none']	_	_
39	high	_	_	JJ	O	[-1]	['none']	_	_
40	methylation	_	_	NN	O	[-1]	['none']	_	_
41	status	_	_	NN	O	[-1]	['none']	_	_
42	and	_	_	CC	O	[-1]	['none']	_	_
43	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	IRF-4	_	_	NN	Protein	[46]	['Theme']	_	_
46	expression	_	_	NN	Gene_expression	[43]	['Theme']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	two	_	_	CD	O	[-1]	['none']	_	_
5	CpG	_	_	NN	O	[-1]	['none']	_	_
6	sites	_	_	NNS	O	[-1]	['none']	_	_
7	located	_	_	JJ	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	#	_	_	#	O	[-1]	['none']	_	_
13	48	_	_	CD	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	SP1	_	_	NN	O	[-1]	['none']	_	_
18	element	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	#	_	_	#	O	[-1]	['none']	_	_
21	45	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	are	_	_	VBP	O	[-1]	['none']	_	_
24	less	_	_	RBR	O	[-1]	['none']	_	_
25	methylated	_	_	VBN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
28	than	_	_	IN	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	mean	_	_	JJ	O	[-1]	['none']	_	_
34	number	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	methylated	_	_	VBN	O	[-1]	['none']	_	_
37	clones	_	_	NNS	O	[-1]	['none']	_	_
38	:	_	_	:	O	[-1]	['none']	_	_
39	1/8	_	_	CD	O	[-1]	['none']	_	_
40	versus	_	_	CC	O	[-1]	['none']	_	_
41	8/8	_	_	CD	O	[-1]	['none']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	involvement	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	CpG	_	_	NN	O	[-1]	['none']	_	_
8	methylation	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	regulation	_	_	NN	Regulation	[0]	['root']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	IRF-4	_	_	NN	Protein	[14]	['Theme']	_	_
14	expression	_	_	NN	Gene_expression	[11]	['Theme']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	leukemic	_	_	JJ	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Carboxyl-Terminal	_	_	JJ	O	[-1]	['none']	_	_
3	FKH	_	_	NN	O	[-1]	['none']	_	_
4	Domain	_	_	NN	O	[-1]	['none']	_	_
5	Is	_	_	VBZ	O	[-1]	['none']	_	_
6	Not	_	_	RB	O	[-1]	['none']	_	_
7	Required	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	Suppression	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	Activation	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	T	_	_	NN	O	[-1]	['none']	_	_
15	Cells	_	_	NNS	O	[-1]	['none']	_	_
16	To	_	_	TO	O	[-1]	['none']	_	_
17	define	_	_	VB	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	requirements	_	_	NNS	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	respect	_	_	NN	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	inhibition	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	NF-kappaB-dependent	_	_	JJ	O	[-1]	['none']	_	_
28	transcription	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	we	_	_	PRP	O	[-1]	['none']	_	_
31	utilized	_	_	VBD	O	[-1]	['none']	_	_
32	a	_	_	DT	O	[-1]	['none']	_	_
33	mutant	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	Foxp3	_	_	NN	Protein	[36]	['Theme']	_	_
36	lacking	_	_	VBG	Negative_regulation	[0]	['root']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	FKH	_	_	NN	Entity	[39]	['multitoken']	_	_
39	domain	_	_	NN	Entity	[36]	['Site']	_	_
40	[	_	_	CD	O	[-1]	['none']	_	_
41	16	_	_	CD	O	[-1]	['none']	_	_
42	]	_	_	NN	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	similar	_	_	JJ	O	[-1]	['none']	_	_
45	to	_	_	TO	O	[-1]	['none']	_	_
46	the	_	_	DT	O	[-1]	['none']	_	_
47	scurfy	_	_	NN	O	[-1]	['none']	_	_
48	mutant	_	_	NN	O	[-1]	['none']	_	_
49	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
50	of	_	_	IN	O	[-1]	['none']	_	_
51	mice	_	_	NNS	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	and	_	_	CC	O	[-1]	['none']	_	_
54	a	_	_	DT	O	[-1]	['none']	_	_
55	mutant	_	_	NN	O	[-1]	['none']	_	_
56	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
57	protein	_	_	NN	O	[-1]	['none']	_	_
58	from	_	_	IN	O	[-1]	['none']	_	_
59	a	_	_	DT	O	[-1]	['none']	_	_
60	patient	_	_	NN	O	[-1]	['none']	_	_
61	with	_	_	IN	O	[-1]	['none']	_	_
62	IPEX	_	_	NNP	O	[-1]	['none']	_	_
63	[	_	_	CD	O	[-1]	['none']	_	_
64	4,11,14,17	_	_	CD	O	[-1]	['none']	_	_
65	]	_	_	NN	O	[-1]	['none']	_	_
66	.	_	_	.	O	[-1]	['none']	_	_

1	Unlike	_	_	IN	O	[-1]	['none']	_	_
2	full-length	_	_	JJ	O	[-1]	['none']	_	_
3	Foxp3	_	_	NN	Protein	[6, 14]	['Theme', 'Theme']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	which	_	_	WDT	Anaphora	[0]	['root']	_	_
6	localizes	_	_	VBZ	Localization	[0]	['root']	_	_
7	almost	_	_	RB	O	[-1]	['none']	_	_
8	exclusively	_	_	RB	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	nucleus	_	_	NN	Entity	[6]	['ToLoc']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	can	_	_	MD	O	[-1]	['none']	_	_
14	bind	_	_	VB	Binding	[0]	['root']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	sequence	_	_	NN	O	[-1]	['none']	_	_
18	specific	_	_	JJ	O	[-1]	['none']	_	_
19	manner	_	_	NN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	forkhead	_	_	NN	O	[-1]	['none']	_	_
22	binding	_	_	NN	O	[-1]	['none']	_	_
23	sites	_	_	NNS	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	deltaFKH	_	_	NN	Protein	[27]	['multitoken']	_	_
27	mutant	_	_	NN	Protein	[30, 38]	['Theme', 'Theme']	_	_
28	fails	_	_	VBZ	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	localize	_	_	VB	Localization	[0]	['root']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	nucleus	_	_	NN	Entity	[30]	['ToLoc']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	thus	_	_	RB	O	[-1]	['none']	_	_
36	can	_	_	MD	O	[-1]	['none']	_	_
37	not	_	_	RB	O	[-1]	['none']	_	_
38	interact	_	_	VB	Binding	[0]	['root']	_	_
39	with	_	_	IN	O	[-1]	['none']	_	_
40	promoter	_	_	NN	O	[-1]	['none']	_	_
41	elements	_	_	NNS	O	[-1]	['none']	_	_
42	or	_	_	CC	O	[-1]	['none']	_	_
43	nuclear	_	_	JJ	O	[-1]	['none']	_	_
44	proteins	_	_	NNS	O	[-1]	['none']	_	_
45	[	_	_	VBP	O	[-1]	['none']	_	_
46	16	_	_	CD	O	[-1]	['none']	_	_
47	]	_	_	CD	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	utilized	_	_	VBD	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	deltaFKH	_	_	NN	Protein	[7]	['multitoken']	_	_
7	mutant	_	_	NN	Protein	[0]	['root']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	determine	_	_	VB	O	[-1]	['none']	_	_
10	whether	_	_	IN	O	[-1]	['none']	_	_
11	nuclear	_	_	JJ	Entity	[12]	['ToLoc']	_	_
12	localization	_	_	NN	Localization	[0]	['root']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	other	_	_	JJ	O	[-1]	['none']	_	_
16	function	_	_	NN	O	[-1]	['none']	_	_
17	associated	_	_	VBN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	FKH	_	_	NN	O	[-1]	['none']	_	_
21	domain	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	Foxp3	_	_	NN	Protein	[12]	['Theme']	_	_
25	was	_	_	VBD	O	[-1]	['none']	_	_
26	a	_	_	DT	O	[-1]	['none']	_	_
27	prerequisite	_	_	NN	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	inhibition	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
32	activation	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	Foxp3	_	_	NN	Protein	[3]	['Theme']	_	_
3	interaction	_	_	NN	Binding	[0]	['root']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	presumably	_	_	RB	O	[-1]	['none']	_	_
7	takes	_	_	VBZ	O	[-1]	['none']	_	_
8	place	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	nucleus	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	it	_	_	PRP	O	[-1]	['none']	_	_
14	may	_	_	MD	O	[-1]	['none']	_	_
15	also	_	_	RB	O	[-1]	['none']	_	_
16	be	_	_	VB	O	[-1]	['none']	_	_
17	possible	_	_	JJ	O	[-1]	['none']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
21	Foxp3	_	_	NN	Protein	[24, 32]	['Theme', 'Theme']	_	_
22	protein	_	_	NN	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	bind	_	_	VB	Binding	[31]	['Cause']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	cytoplasm	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	prevent	_	_	VB	Negative_regulation	[0]	['root']	_	_
32	localization	_	_	NN	Localization	[31, 36]	['Theme', 'Theme']	_	_
33	to	_	_	TO	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	nucleus	_	_	NN	Entity	[32]	['ToLoc']	_	_
36	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
37	an	_	_	DT	O	[-1]	['none']	_	_
38	activation	_	_	NN	O	[-1]	['none']	_	_
39	stimulus	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	full-length	_	_	JJ	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[1]	['Theme']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	but	_	_	CC	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	deltaFKH	_	_	NN	Protein	[1]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	able	_	_	JJ	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	suppress	_	_	VB	O	[-1]	['none']	_	_
15	activation	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	cotransfected	_	_	JJ	O	[-1]	['none']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	reporter	_	_	NN	O	[-1]	['none']	_	_
21	vector	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	HEK	_	_	NNP	O	[-1]	['none']	_	_
24	293T	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Both	_	_	DT	O	[-1]	['none']	_	_
2	Foxp3	_	_	NN	Protein	[6]	['Theme']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	deltaFKH	_	_	NN	Protein	[6]	['Theme']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	expressed	_	_	VBN	Positive_regulation	[11]	['Theme']	_	_
7	at	_	_	IN	O	[-1]	['none']	_	_
8	very	_	_	RB	O	[-1]	['none']	_	_
9	high	_	_	JJ	O	[-1]	['none']	_	_
10	levels	_	_	NNS	O	[-1]	['none']	_	_
11	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
12	transfection	_	_	NN	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	detected	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	real-time	_	_	JJ	O	[-1]	['none']	_	_
17	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	unpublished	_	_	JJ	O	[-1]	['none']	_	_
20	data	_	_	NNS	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	appear	_	_	VBP	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	suggest	_	_	VB	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	carboxyl-terminal	_	_	JJ	O	[-1]	['none']	_	_
9	FKH	_	_	NN	O	[-1]	['none']	_	_
10	domain	_	_	NN	O	[-1]	['none']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	critically	_	_	RB	O	[-1]	['none']	_	_
13	important	_	_	JJ	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	down-regulate	_	_	VB	O	[-1]	['none']	_	_
18	NF-kappaB-dependent	_	_	JJ	O	[-1]	['none']	_	_
19	transcription	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	blocked	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	similar	_	_	JJ	O	[-1]	['none']	_	_
10	extent	_	_	NN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	both	_	_	CC	O	[-1]	['none']	_	_
13	full-length	_	_	JJ	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	deltaFKH	_	_	NN	Protein	[0]	['root']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	Jurkat	_	_	NN	O	[-1]	['none']	_	_
19	T	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	primary	_	_	JJ	O	[-1]	['none']	_	_
23	human	_	_	NN	O	[-1]	['none']	_	_
24	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
25	T	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	NN	O	[-1]	['none']	_	_
2	blot	_	_	NN	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	p65	_	_	NN	Protein	[7]	['Theme']	_	_
7	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
8	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
9	that	_	_	IN	O	[-1]	['none']	_	_
10	Foxp3	_	_	NN	Protein	[15]	['Cause']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	deltaFKH	_	_	NN	Protein	[15]	['Cause']	_	_
13	does	_	_	VBZ	O	[-1]	['none']	_	_
14	not	_	_	RB	O	[-1]	['none']	_	_
15	block	_	_	VB	Negative_regulation	[0]	['root']	_	_
16	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
17	activation	_	_	NN	O	[-1]	['none']	_	_
18	at	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	level	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	p65	_	_	NN	Protein	[24]	['Theme']	_	_
23	protein	_	_	NN	O	[-1]	['none']	_	_
24	expression	_	_	NN	Gene_expression	[15]	['Theme']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	very	_	_	RB	O	[-1]	['none']	_	_
5	interesting	_	_	JJ	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	respect	_	_	NN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
10	function	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	because	_	_	IN	O	[-1]	['none']	_	_
13	they	_	_	PRP	O	[-1]	['none']	_	_
14	suggest	_	_	VBP	O	[-1]	['none']	_	_
15	that	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	carboxyl-terminal	_	_	JJ	O	[-1]	['none']	_	_
18	FKH	_	_	NN	O	[-1]	['none']	_	_
19	domain	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	possibly	_	_	RB	O	[-1]	['none']	_	_
23	nuclear	_	_	JJ	Entity	[24]	['ToLoc']	_	_
24	localization	_	_	NN	Localization	[0]	['root']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	are	_	_	VBP	O	[-1]	['none']	_	_
27	dispensable	_	_	JJ	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	Foxp3	_	_	NN	Protein	[24]	['Theme']	_	_
30	function	_	_	NN	O	[-1]	['none']	_	_
31	in	_	_	IN	O	[-1]	['none']	_	_
32	T	_	_	NN	O	[-1]	['none']	_	_
33	cell	_	_	NN	O	[-1]	['none']	_	_
34	populations	_	_	NNS	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Alternative	_	_	JJ	O	[-1]	['none']	_	_
2	interpretations	_	_	NNS	O	[-1]	['none']	_	_
3	may	_	_	MD	O	[-1]	['none']	_	_
4	include	_	_	VB	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	possibility	_	_	NN	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	localization	_	_	NN	Localization	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	deltaFKH	_	_	NN	Protein	[9]	['Theme']	_	_
12	differ	_	_	VBP	O	[-1]	['none']	_	_
13	between	_	_	IN	O	[-1]	['none']	_	_
14	epithelial	_	_	JJ	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	T	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	either	_	_	DT	O	[-1]	['none']	_	_
3	case	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	these	_	_	DT	O	[-1]	['none']	_	_
6	results	_	_	NNS	O	[-1]	['none']	_	_
7	suggest	_	_	VBP	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	type	_	_	NN	O	[-1]	['none']	_	_
11	specific	_	_	JJ	O	[-1]	['none']	_	_
12	mechanism	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	action	_	_	NN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	this	_	_	DT	O	[-1]	['none']	_	_
17	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
18	mutant	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Cytokines	_	_	NNS	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	chemokines	_	_	NNS	O	[-1]	['none']	_	_
4	are	_	_	VBP	O	[-1]	['none']	_	_
5	important	_	_	JJ	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	immune	_	_	JJ	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	recruitment	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	regulation	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
15	responses	_	_	NNS	O	[-1]	['none']	_	_
16	[	_	_	VBP	O	[-1]	['none']	_	_
17	1	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	CD	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	T-cells	_	_	NNS	O	[-1]	['none']	_	_
2	produce	_	_	VBP	Gene_expression	[0]	['root']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	broad	_	_	JJ	O	[-1]	['none']	_	_
5	range	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	inflammatory	_	_	JJ	Anaphora	[8]	['multitoken']	_	_
8	mediators	_	_	NNS	Anaphora	[0]	['root']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	including	_	_	VBG	O	[-1]	['none']	_	_
11	IL-2	_	_	NN	Protein	[2]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	IL-6	_	_	NN	Protein	[2]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	TNF	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	CXCL8	_	_	NN	Protein	[2]	['Theme']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	all	_	_	DT	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	which	_	_	WDT	O	[-1]	['none']	_	_
22	are	_	_	VBP	O	[-1]	['none']	_	_
23	important	_	_	JJ	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	cell	_	_	NN	O	[-1]	['none']	_	_
26	proliferation	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	differentiation	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	communication	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	initiation	_	_	NN	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
35	responses	_	_	NNS	O	[-1]	['none']	_	_
36	[	_	_	VBP	O	[-1]	['none']	_	_
37	2	_	_	CD	O	[-1]	['none']	_	_
38	]	_	_	CD	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Elevated	_	_	JJ	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	pro	_	_	JJ	O	[-1]	['none']	_	_
5	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
6	cytokines	_	_	NNS	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	chemokines	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	such	_	_	JJ	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	TNF	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	IL-6	_	_	NN	Protein	[0]	['root']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	are	_	_	VBP	O	[-1]	['none']	_	_
19	associated	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	several	_	_	JJ	O	[-1]	['none']	_	_
22	human	_	_	NN	O	[-1]	['none']	_	_
23	diseases	_	_	NNS	O	[-1]	['none']	_	_
24	including	_	_	VBG	O	[-1]	['none']	_	_
25	cystic	_	_	JJ	O	[-1]	['none']	_	_
26	fibrosis	_	_	NN	O	[-1]	['none']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	3-5	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	pulmonary	_	_	JJ	O	[-1]	['none']	_	_
32	fibrosis	_	_	NN	O	[-1]	['none']	_	_
33	[	_	_	CD	O	[-1]	['none']	_	_
34	6,7	_	_	CD	O	[-1]	['none']	_	_
35	]	_	_	NN	O	[-1]	['none']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	AIDS	_	_	NN	O	[-1]	['none']	_	_
38	[	_	_	NN	O	[-1]	['none']	_	_
39	8,9	_	_	CD	O	[-1]	['none']	_	_
40	]	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Induction	_	_	NN	Positive_regulation	[9]	['Theme']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	CXCL8	_	_	NN	Protein	[1]	['Theme']	_	_
4	has	_	_	VBZ	O	[-1]	['none']	_	_
5	been	_	_	VBN	O	[-1]	['none']	_	_
6	suggested	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	be	_	_	VB	O	[-1]	['none']	_	_
9	mediated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
10	through	_	_	IN	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	cooperation	_	_	NN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	AP-1	_	_	NN	O	[-1]	['none']	_	_
16	[	_	_	CD	O	[-1]	['none']	_	_
17	10,11	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	however	_	_	RB	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	precise	_	_	JJ	O	[-1]	['none']	_	_
23	mechanism	_	_	NN	O	[-1]	['none']	_	_
24	is	_	_	VBZ	O	[-1]	['none']	_	_
25	not	_	_	RB	O	[-1]	['none']	_	_
26	fully	_	_	RB	O	[-1]	['none']	_	_
27	elucidated	_	_	VBN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	treatment	_	_	NN	O	[-1]	['none']	_	_
31	strategies	_	_	NNS	O	[-1]	['none']	_	_
32	aimed	_	_	VBN	O	[-1]	['none']	_	_
33	at	_	_	IN	O	[-1]	['none']	_	_
34	inhibiting	_	_	VBG	Negative_regulation	[0]	['root']	_	_
35	CXCL8	_	_	NN	Protein	[34]	['Theme']	_	_
36	have	_	_	VBP	O	[-1]	['none']	_	_
37	failed	_	_	VBN	O	[-1]	['none']	_	_
38	[	_	_	CD	O	[-1]	['none']	_	_
39	12	_	_	CD	O	[-1]	['none']	_	_
40	]	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Persistent	_	_	JJ	O	[-1]	['none']	_	_
2	production	_	_	NN	Gene_expression	[0]	['root']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	IL-6	_	_	NN	Protein	[2]	['Theme']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	CXCL8	_	_	NN	Protein	[2]	['Theme']	_	_
7	leads	_	_	VBZ	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	chronic	_	_	JJ	O	[-1]	['none']	_	_
10	inflammation	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	enhanced	_	_	VBD	O	[-1]	['none']	_	_
13	survival	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
16	increasing	_	_	VBG	O	[-1]	['none']	_	_
17	serum	_	_	NN	O	[-1]	['none']	_	_
18	cytokine	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	chemokine	_	_	NN	O	[-1]	['none']	_	_
21	levels	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	forms	_	_	VBZ	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	basis	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	several	_	_	JJ	O	[-1]	['none']	_	_
7	autoimmune	_	_	JJ	O	[-1]	['none']	_	_
8	disorders	_	_	NNS	O	[-1]	['none']	_	_
9	including	_	_	VBG	O	[-1]	['none']	_	_
10	plasmacytosis	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	hyperplasia	_	_	NN	O	[-1]	['none']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	13	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	develop	_	_	VB	O	[-1]	['none']	_	_
3	viable	_	_	JJ	O	[-1]	['none']	_	_
4	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
5	based	_	_	VBN	O	[-1]	['none']	_	_
6	treatment	_	_	NN	O	[-1]	['none']	_	_
7	strategies	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	it	_	_	PRP	O	[-1]	['none']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	necessary	_	_	JJ	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	identify	_	_	VB	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	signalling	_	_	NN	O	[-1]	['none']	_	_
16	pathways	_	_	NNS	O	[-1]	['none']	_	_
17	regulating	_	_	VBG	Regulation	[0]	['root']	_	_
18	CXCL8	_	_	NN	Protein	[17]	['Theme']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	determine	_	_	VB	O	[-1]	['none']	_	_
21	how	_	_	WRB	O	[-1]	['none']	_	_
22	this	_	_	DT	O	[-1]	['none']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	coupled	_	_	VBN	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	AP-1	_	_	NN	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	IL-6	_	_	NN	Protein	[0]	['root']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	signalling	_	_	NN	O	[-1]	['none']	_	_
3	pathways	_	_	NNS	O	[-1]	['none']	_	_
4	leading	_	_	VBG	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	AP-1	_	_	NN	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	are	_	_	VBP	O	[-1]	['none']	_	_
11	overlapping	_	_	VBG	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	where	_	_	WRB	O	[-1]	['none']	_	_
14	both	_	_	DT	O	[-1]	['none']	_	_
15	are	_	_	VBP	O	[-1]	['none']	_	_
16	involved	_	_	VBN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	induction	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	regulation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	cytokines	_	_	NNS	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	chemokines	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	activated	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	response	_	_	NN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	stress	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	such	_	_	JJ	O	[-1]	['none']	_	_
10	as	_	_	IN	O	[-1]	['none']	_	_
11	oxidative	_	_	JJ	O	[-1]	['none']	_	_
12	stress	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	bacterial	_	_	JJ	O	[-1]	['none']	_	_
15	toxins	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	viruses	_	_	NNS	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	UV	_	_	NN	O	[-1]	['none']	_	_
20	light	_	_	JJ	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	14	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	is	_	_	VBZ	O	[-1]	['none']	_	_
27	essential	_	_	JJ	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	differentiation	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	proliferation	_	_	NN	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	survival	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	many	_	_	JJ	O	[-1]	['none']	_	_
36	cell	_	_	NN	O	[-1]	['none']	_	_
37	types	_	_	NNS	O	[-1]	['none']	_	_
38	including	_	_	VBG	O	[-1]	['none']	_	_
39	T-lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
40	[	_	_	VBP	O	[-1]	['none']	_	_
41	15	_	_	CD	O	[-1]	['none']	_	_
42	]	_	_	CD	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	AP-1	_	_	NNP	O	[-1]	['none']	_	_
2	activation	_	_	NN	O	[-1]	['none']	_	_
3	requires	_	_	VBZ	O	[-1]	['none']	_	_
4	Fos	_	_	NN	Anaphora	[0]	['root']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	c-Fos	_	_	NN	Protein	[31]	['Theme']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	FosB	_	_	NN	Protein	[31]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	Fra-1	_	_	NN	Protein	[31]	['Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	Fra-2	_	_	NN	Protein	[31]	['Theme']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	Jun	_	_	NN	Anaphora	[0]	['root']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	c-Jun	_	_	NN	Protein	[31]	['Theme']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	v-Jun	_	_	NN	Protein	[31]	['Theme']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	JunB	_	_	NN	Protein	[31]	['Theme']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	JunD	_	_	NN	Protein	[31]	['Theme']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	through	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	formation	_	_	NN	Binding	[31]	['multitoken']	_	_
28	of	_	_	IN	Binding	[31]	['multitoken']	_	_
29	homo-	_	_	JJ	Binding	[31]	['multitoken']	_	_
30	and	_	_	CC	Binding	[31]	['multitoken']	_	_
31	hetero-dimers	_	_	JJ	Binding	[0]	['root']	_	_
32	[	_	_	NN	O	[-1]	['none']	_	_
33	16,17	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	NN	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	regulates	_	_	VBZ	O	[-1]	['none']	_	_
38	transcription	_	_	NN	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	a	_	_	DT	O	[-1]	['none']	_	_
41	broad	_	_	JJ	O	[-1]	['none']	_	_
42	range	_	_	NN	O	[-1]	['none']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	genes	_	_	NNS	O	[-1]	['none']	_	_
45	involved	_	_	VBN	O	[-1]	['none']	_	_
46	in	_	_	IN	O	[-1]	['none']	_	_
47	immune	_	_	JJ	O	[-1]	['none']	_	_
48	responses	_	_	NNS	O	[-1]	['none']	_	_
49	[	_	_	VBP	O	[-1]	['none']	_	_
50	18-21	_	_	CD	O	[-1]	['none']	_	_
51	]	_	_	CD	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	Both	_	_	DT	O	[-1]	['none']	_	_
2	AP-1	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	binding	_	_	NN	O	[-1]	['none']	_	_
6	sites	_	_	NNS	O	[-1]	['none']	_	_
7	have	_	_	VBP	O	[-1]	['none']	_	_
8	been	_	_	VBN	O	[-1]	['none']	_	_
9	identified	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	promoter	_	_	NN	O	[-1]	['none']	_	_
13	region	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IL-6	_	_	NN	Protein	[31]	['Theme']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	CXCL8	_	_	NN	Protein	[31]	['Theme']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	12,22	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	however	_	_	RB	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	mechanism	_	_	NN	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	which	_	_	WDT	O	[-1]	['none']	_	_
28	these	_	_	DT	Anaphora	[29]	['multitoken']	_	_
29	interleukins	_	_	NNS	Anaphora	[0]	['root']	_	_
30	are	_	_	VBP	O	[-1]	['none']	_	_
31	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	T-cells	_	_	NNS	O	[-1]	['none']	_	_
34	is	_	_	VBZ	O	[-1]	['none']	_	_
35	still	_	_	RB	O	[-1]	['none']	_	_
36	not	_	_	RB	O	[-1]	['none']	_	_
37	clear	_	_	JJ	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	C-X-C	_	_	NN	O	[-1]	['none']	_	_
5	chemokine	_	_	NN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	properties	_	_	NNS	O	[-1]	['none']	_	_
8	enabling	_	_	VBG	O	[-1]	['none']	_	_
9	it	_	_	PRP	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	recruit	_	_	VB	O	[-1]	['none']	_	_
12	T-cells	_	_	NNS	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	basophils	_	_	NNS	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	activate	_	_	VB	O	[-1]	['none']	_	_
18	neutrophils	_	_	NNS	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	monocytes	_	_	NNS	O	[-1]	['none']	_	_
21	[	_	_	VBP	O	[-1]	['none']	_	_
22	23	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	CD	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	IL-6	_	_	NNP	Protein	[0]	['root']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	cytokine	_	_	NN	O	[-1]	['none']	_	_
5	that	_	_	WDT	O	[-1]	['none']	_	_
6	possesses	_	_	VBZ	O	[-1]	['none']	_	_
7	both	_	_	DT	O	[-1]	['none']	_	_
8	pro-	_	_	JJ	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
11	characteristics	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	plays	_	_	VBZ	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	key	_	_	JJ	O	[-1]	['none']	_	_
17	role	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	haematopoiesis	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	acute-phase	_	_	NN	O	[-1]	['none']	_	_
22	responses	_	_	NNS	O	[-1]	['none']	_	_
23	[	_	_	VBP	O	[-1]	['none']	_	_
24	24,25	_	_	CD	O	[-1]	['none']	_	_
25	]	_	_	CD	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	present	_	_	JJ	O	[-1]	['none']	_	_
3	study	_	_	NN	O	[-1]	['none']	_	_
4	suggests	_	_	VBZ	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	regulation	_	_	NN	Regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	CXCL8	_	_	NN	Protein	[7]	['Theme']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	IL-6	_	_	NN	Protein	[7]	['Theme']	_	_
12	is	_	_	VBZ	O	[-1]	['none']	_	_
13	uncoupled	_	_	VBN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Using	_	_	VBG	O	[-1]	['none']	_	_
2	Jurkat	_	_	NN	O	[-1]	['none']	_	_
3	T-cells	_	_	NNS	O	[-1]	['none']	_	_
4	exposed	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	PMA	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	heat	_	_	NN	O	[-1]	['none']	_	_
9	killed	_	_	VBD	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	HK	_	_	JJ	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	Escherichia	_	_	FW	O	[-1]	['none']	_	_
14	coli	_	_	FW	O	[-1]	['none']	_	_
15	MG1655	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	combination	_	_	NN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	JNK	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	PKC	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	we	_	_	PRP	O	[-1]	['none']	_	_
28	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
29	that	_	_	IN	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	regulates	_	_	VBZ	Regulation	[0]	['root']	_	_
32	IL-6	_	_	NN	Protein	[33]	['Theme']	_	_
33	expression	_	_	NN	Gene_expression	[31]	['Theme']	_	_
34	while	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	regulation	_	_	NN	Regulation	[0]	['root']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	CXCL8	_	_	NN	Protein	[36]	['Theme']	_	_
39	more	_	_	RBR	O	[-1]	['none']	_	_
40	closely	_	_	RB	O	[-1]	['none']	_	_
41	correlated	_	_	VBN	O	[-1]	['none']	_	_
42	to	_	_	TO	O	[-1]	['none']	_	_
43	AP-1	_	_	NN	Protein	[0]	['root']	_	_
44	activity	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	inhibition	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	not	_	_	RB	O	[-1]	['none']	_	_
10	an	_	_	DT	O	[-1]	['none']	_	_
11	effective	_	_	JJ	O	[-1]	['none']	_	_
12	strategy	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	countering	_	_	VBG	Negative_regulation	[0]	['root']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	high	_	_	JJ	O	[-1]	['none']	_	_
17	CXCL8	_	_	NN	Protein	[14]	['Theme']	_	_
18	activities	_	_	NNS	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	diseases	_	_	NNS	O	[-1]	['none']	_	_
21	such	_	_	JJ	O	[-1]	['none']	_	_
22	as	_	_	IN	O	[-1]	['none']	_	_
23	cystic	_	_	JJ	O	[-1]	['none']	_	_
24	fibrosis	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	AIDS	_	_	NNP	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	pulmonary	_	_	JJ	O	[-1]	['none']	_	_
29	fibrosis	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[2, 7]	['Cause', 'Cause']	_	_
2	Upregulates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
3	IL10	_	_	NN	Protein	[4]	['Theme']	_	_
4	Expression	_	_	NN	Gene_expression	[2]	['Theme']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Constitutively	_	_	RB	O	[-1]	['none']	_	_
7	Activates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
8	Stat3	_	_	NN	Protein	[7]	['Theme']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	A	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	Relative	_	_	JJ	O	[-1]	['none']	_	_
13	expression	_	_	NN	Transcription	[0]	['root']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IL10	_	_	NN	Protein	[13]	['Theme']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	IL15	_	_	NN	Protein	[13]	['Theme']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	IFNgamma	_	_	NN	Protein	[13]	['Theme']	_	_
21	mRNA	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	WT	_	_	NNP	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	LMP1	_	_	NN	Protein	[0]	['root']	_	_
26	transgenic	_	_	JJ	O	[-1]	['none']	_	_
27	B	_	_	NN	O	[-1]	['none']	_	_
28	cells	_	_	NNS	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	as	_	_	IN	O	[-1]	['none']	_	_
34	detected	_	_	VBN	O	[-1]	['none']	_	_
35	with	_	_	IN	O	[-1]	['none']	_	_
36	an	_	_	DT	O	[-1]	['none']	_	_
37	Rnase	_	_	NN	O	[-1]	['none']	_	_
38	protection	_	_	NN	O	[-1]	['none']	_	_
39	assay	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Mouse	_	_	NN	O	[-1]	['none']	_	_
2	lymphoma	_	_	NN	O	[-1]	['none']	_	_
3	cell	_	_	NN	O	[-1]	['none']	_	_
4	lines	_	_	NNS	O	[-1]	['none']	_	_
5	967	_	_	CD	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	K46mu	_	_	NN	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	used	_	_	VBN	O	[-1]	['none']	_	_
10	as	_	_	IN	O	[-1]	['none']	_	_
11	controls	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	quantified	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	phosphorimager	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	values	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	normalized	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	ribosomal	_	_	JJ	O	[-1]	['none']	_	_
15	housekeeping	_	_	NN	O	[-1]	['none']	_	_
16	gene	_	_	NN	O	[-1]	['none']	_	_
17	L32	_	_	NN	Protein	[0]	['root']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cytokine	_	_	NN	O	[-1]	['none']	_	_
3	:	_	_	:	O	[-1]	['none']	_	_
4	L32	_	_	NN	Protein	[0]	['root']	_	_
5	ratio	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	set	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	1	_	_	CD	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	mouse	_	_	NN	O	[-1]	['none']	_	_
13	B	_	_	NN	O	[-1]	['none']	_	_
14	cell	_	_	NN	O	[-1]	['none']	_	_
15	lymphoma	_	_	NN	O	[-1]	['none']	_	_
16	line	_	_	NN	O	[-1]	['none']	_	_
17	967	_	_	CD	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	C	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
7	analysis	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
10	pStat3	_	_	NN	Protein	[9]	['Theme']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	purified	_	_	VBN	O	[-1]	['none']	_	_
13	B	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	from	_	_	IN	O	[-1]	['none']	_	_
19	WT	_	_	NNP	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	LMP1	_	_	NN	Protein	[0]	['root']	_	_
22	transgenic	_	_	JJ	O	[-1]	['none']	_	_
23	mice	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	B	_	_	NN	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	at	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	time	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	harvest	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	C	_	_	NN	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	4	_	_	CD	O	[-1]	['none']	_	_
38	h	_	_	NN	O	[-1]	['none']	_	_
39	after	_	_	IN	O	[-1]	['none']	_	_
40	culture	_	_	NN	O	[-1]	['none']	_	_
41	with	_	_	IN	O	[-1]	['none']	_	_
42	or	_	_	CC	O	[-1]	['none']	_	_
43	without	_	_	IN	O	[-1]	['none']	_	_
44	IL10	_	_	NN	Protein	[0]	['root']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	a	_	_	DT	O	[-1]	['none']	_	_
47	neutralizing	_	_	VBG	O	[-1]	['none']	_	_
48	antibody	_	_	NN	O	[-1]	['none']	_	_
49	to	_	_	TO	O	[-1]	['none']	_	_
50	IL10	_	_	NN	Protein	[0]	['root']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	or	_	_	CC	O	[-1]	['none']	_	_
53	a	_	_	DT	O	[-1]	['none']	_	_
54	rat	_	_	NN	O	[-1]	['none']	_	_
55	IgG1	_	_	NN	O	[-1]	['none']	_	_
56	isotype	_	_	NN	O	[-1]	['none']	_	_
57	control	_	_	NN	O	[-1]	['none']	_	_
58	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Shown	_	_	VBN	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	results	_	_	NNS	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	WT	_	_	JJ	O	[-1]	['none']	_	_
10	lymphoma	_	_	NN	O	[-1]	['none']	_	_
11	1	_	_	CD	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	LMP1	_	_	NN	Protein	[0]	['root']	_	_
14	transgenic	_	_	JJ	O	[-1]	['none']	_	_
15	lymphoma	_	_	NN	O	[-1]	['none']	_	_
16	1	_	_	CD	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Arrows	_	_	NNS	O	[-1]	['none']	_	_
2	indicate	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	positions	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	alpha	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	beta	_	_	NN	O	[-1]	['none']	_	_
10	isoforms	_	_	NNS	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	Stat3	_	_	NN	Protein	[0]	['root']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Actin	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	loading	_	_	VBG	O	[-1]	['none']	_	_
7	control	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	D	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Immunohistochemistry	_	_	NN	O	[-1]	['none']	_	_
5	detection	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
8	nuclear	_	_	JJ	O	[-1]	['none']	_	_
9	pStat3	_	_	NN	Protein	[7]	['Theme']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	spleens	_	_	NNS	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	WT	_	_	NNP	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	LMP1	_	_	NN	Protein	[0]	['root']	_	_
17	transgenic	_	_	JJ	O	[-1]	['none']	_	_
18	mice	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Scale	_	_	NNP	O	[-1]	['none']	_	_
2	bar	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	20	_	_	CD	O	[-1]	['none']	_	_
5	mum	_	_	NN	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	Epstein-Barr	_	_	NNP	O	[-1]	['none']	_	_
2	virus	_	_	NN	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	EBV	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	ubiquitous	_	_	JJ	O	[-1]	['none']	_	_
9	gamma-herpesvirus	_	_	NN	O	[-1]	['none']	_	_
10	that	_	_	WDT	O	[-1]	['none']	_	_
11	infects	_	_	VBZ	O	[-1]	['none']	_	_
12	humans	_	_	NNS	O	[-1]	['none']	_	_
13	predominantly	_	_	RB	O	[-1]	['none']	_	_
14	at	_	_	IN	O	[-1]	['none']	_	_
15	an	_	_	DT	O	[-1]	['none']	_	_
16	early	_	_	JJ	O	[-1]	['none']	_	_
17	age	_	_	NN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	greater	_	_	JJR	O	[-1]	['none']	_	_
20	than	_	_	IN	O	[-1]	['none']	_	_
21	90	_	_	CD	O	[-1]	['none']	_	_
22	%	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	adult	_	_	JJ	O	[-1]	['none']	_	_
26	population	_	_	NN	O	[-1]	['none']	_	_
27	infected	_	_	VBN	O	[-1]	['none']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	EBV	_	_	NN	O	[-1]	['none']	_	_
30	[	_	_	CD	O	[-1]	['none']	_	_
31	1	_	_	CD	O	[-1]	['none']	_	_
32	]	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	EBV	_	_	NN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	linked	_	_	VBN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	development	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	both	_	_	CC	O	[-1]	['none']	_	_
9	B	_	_	NN	O	[-1]	['none']	_	_
10	lymphocyte	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	epithelial	_	_	JJ	O	[-1]	['none']	_	_
13	cell	_	_	NN	O	[-1]	['none']	_	_
14	malignancies	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	including	_	_	VBG	O	[-1]	['none']	_	_
17	Burkitt	_	_	NN	O	[-1]	['none']	_	_
18	lymphoma	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	Hodgkin	_	_	NN	O	[-1]	['none']	_	_
21	disease	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	HD	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	nasopharyngeal	_	_	JJ	O	[-1]	['none']	_	_
28	carcinoma	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	NPC	_	_	NN	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	cancers	_	_	NNS	O	[-1]	['none']	_	_
35	linked	_	_	VBN	O	[-1]	['none']	_	_
36	to	_	_	TO	O	[-1]	['none']	_	_
37	immunosuppression	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	including	_	_	VBG	O	[-1]	['none']	_	_
40	post-transplant	_	_	JJ	O	[-1]	['none']	_	_
41	lymphoma	_	_	NN	O	[-1]	['none']	_	_
42	and	_	_	CC	O	[-1]	['none']	_	_
43	AIDS	_	_	NN	O	[-1]	['none']	_	_
44	associated	_	_	VBN	O	[-1]	['none']	_	_
45	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
46	[	_	_	VBP	O	[-1]	['none']	_	_
47	2,3	_	_	CD	O	[-1]	['none']	_	_
48	]	_	_	CD	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vitro	_	_	FW	O	[-1]	['none']	_	_
3	infection	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	B	_	_	NN	O	[-1]	['none']	_	_
6	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	EBV	_	_	NN	O	[-1]	['none']	_	_
9	induces	_	_	VBZ	O	[-1]	['none']	_	_
10	permanent	_	_	JJ	O	[-1]	['none']	_	_
11	growth	_	_	NN	O	[-1]	['none']	_	_
12	transformation	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	this	_	_	DT	O	[-1]	['none']	_	_
16	ability	_	_	NN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	affect	_	_	VB	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	growth	_	_	NN	O	[-1]	['none']	_	_
21	regulation	_	_	NN	O	[-1]	['none']	_	_
22	likely	_	_	JJ	O	[-1]	['none']	_	_
23	contributes	_	_	VBZ	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	development	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	cancer	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Many	_	_	JJ	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	viral	_	_	JJ	O	[-1]	['none']	_	_
5	proteins	_	_	NNS	O	[-1]	['none']	_	_
6	expressed	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	transformed	_	_	VBN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	including	_	_	VBG	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	EBV	_	_	NN	O	[-1]	['none']	_	_
14	nuclear	_	_	JJ	O	[-1]	['none']	_	_
15	antigens	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	latent	_	_	JJ	O	[-1]	['none']	_	_
18	membrane	_	_	NN	O	[-1]	['none']	_	_
19	proteins	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	have	_	_	VBP	O	[-1]	['none']	_	_
22	profound	_	_	JJ	O	[-1]	['none']	_	_
23	effects	_	_	NNS	O	[-1]	['none']	_	_
24	on	_	_	IN	O	[-1]	['none']	_	_
25	cell	_	_	NN	O	[-1]	['none']	_	_
26	growth	_	_	NN	O	[-1]	['none']	_	_
27	regulation	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	are	_	_	VBP	O	[-1]	['none']	_	_
30	required	_	_	VBN	O	[-1]	['none']	_	_
31	for	_	_	IN	O	[-1]	['none']	_	_
32	EBV	_	_	NN	O	[-1]	['none']	_	_
33	latent	_	_	JJ	O	[-1]	['none']	_	_
34	infection	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	B	_	_	NN	O	[-1]	['none']	_	_
37	cell	_	_	NN	O	[-1]	['none']	_	_
38	transformation	_	_	NN	O	[-1]	['none']	_	_
39	[	_	_	CD	O	[-1]	['none']	_	_
40	1	_	_	CD	O	[-1]	['none']	_	_
41	]	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Latent	_	_	JJ	Protein	[4]	['multitoken']	_	_
2	membrane	_	_	NN	Protein	[4]	['multitoken']	_	_
3	protein	_	_	NN	Protein	[4]	['multitoken']	_	_
4	1	_	_	CD	Protein	[28]	['Theme']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	LMP1	_	_	NN	Protein	[0]	['root']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	considered	_	_	VBN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	major	_	_	JJ	O	[-1]	['none']	_	_
12	oncoprotein	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	EBV	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	as	_	_	IN	O	[-1]	['none']	_	_
17	it	_	_	PRP	Anaphora	[0]	['root']	_	_
18	transforms	_	_	VBZ	O	[-1]	['none']	_	_
19	rodent	_	_	JJ	O	[-1]	['none']	_	_
20	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	tumorigenicity	_	_	NN	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	nude	_	_	JJ	O	[-1]	['none']	_	_
25	mice	_	_	NNS	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	is	_	_	VBZ	O	[-1]	['none']	_	_
28	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	HD	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	NPC	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	immunosuppression	_	_	NN	O	[-1]	['none']	_	_
36	associated	_	_	JJ	O	[-1]	['none']	_	_
37	tumors	_	_	NNS	O	[-1]	['none']	_	_
38	[	_	_	VBP	O	[-1]	['none']	_	_
39	4-8	_	_	CD	O	[-1]	['none']	_	_
40	]	_	_	CD	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[0]	['root']	_	_
6	mimics	_	_	NNS	O	[-1]	['none']	_	_
7	CD40	_	_	NN	Protein	[0]	['root']	_	_
8	signaling	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	both	_	_	DT	O	[-1]	['none']	_	_
12	LMP1	_	_	NN	Protein	[0]	['root']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	CD40	_	_	NN	Protein	[0]	['root']	_	_
15	are	_	_	VBP	O	[-1]	['none']	_	_
16	essential	_	_	JJ	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	EBV	_	_	NN	O	[-1]	['none']	_	_
19	mediated	_	_	VBN	O	[-1]	['none']	_	_
20	B	_	_	NN	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	transformation	_	_	NN	O	[-1]	['none']	_	_
23	[	_	_	CD	O	[-1]	['none']	_	_
24	9-11	_	_	CD	O	[-1]	['none']	_	_
25	]	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	While	_	_	IN	O	[-1]	['none']	_	_
2	CD40	_	_	NN	Protein	[3]	['Theme']	_	_
3	interacts	_	_	VBZ	Binding	[0]	['root']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[6]	['multitoken']	_	_
6	ligand	_	_	NN	Protein	[3, 7]	['Theme', 'Theme']	_	_
7	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	activated	_	_	VBN	O	[-1]	['none']	_	_
10	T	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	induce	_	_	VB	O	[-1]	['none']	_	_
14	B	_	_	NN	O	[-1]	['none']	_	_
15	cell	_	_	NN	O	[-1]	['none']	_	_
16	activation	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	differentiation	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	LMP1	_	_	NN	Protein	[29]	['Theme']	_	_
21	acts	_	_	VBZ	O	[-1]	['none']	_	_
22	as	_	_	IN	O	[-1]	['none']	_	_
23	a	_	_	DT	O	[-1]	['none']	_	_
24	constitutive	_	_	JJ	O	[-1]	['none']	_	_
25	signal	_	_	NN	O	[-1]	['none']	_	_
26	through	_	_	IN	O	[-1]	['none']	_	_
27	ligand	_	_	NN	O	[-1]	['none']	_	_
28	independent	_	_	JJ	O	[-1]	['none']	_	_
29	oligomerization	_	_	NN	Binding	[0]	['root']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[4]	['Theme']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	CD40	_	_	NN	Protein	[4]	['Theme']	_	_
4	interact	_	_	VBP	Binding	[0]	['root']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	same	_	_	JJ	O	[-1]	['none']	_	_
8	tumor	_	_	NN	Protein	[10]	['multitoken']	_	_
9	necrosis	_	_	NN	Protein	[10]	['multitoken']	_	_
10	factor	_	_	NN	Protein	[0]	['root']	_	_
11	receptor	_	_	NN	O	[-1]	['none']	_	_
12	associated	_	_	VBN	O	[-1]	['none']	_	_
13	factors	_	_	NNS	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	TRAFs	_	_	NNS	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	leading	_	_	VBG	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	activation	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	c-Jun	_	_	NN	Protein	[0]	['root']	_	_
24	N	_	_	NN	O	[-1]	['none']	_	_
25	terminal	_	_	JJ	O	[-1]	['none']	_	_
26	kinase	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	JNK	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	p38	_	_	NN	O	[-1]	['none']	_	_
33	MAPK	_	_	NN	O	[-1]	['none']	_	_
34	signaling	_	_	NN	O	[-1]	['none']	_	_
35	pathways	_	_	NNS	O	[-1]	['none']	_	_
36	[	_	_	VBP	O	[-1]	['none']	_	_
37	12-16	_	_	CD	O	[-1]	['none']	_	_
38	]	_	_	CD	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Activation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	required	_	_	VBN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	EBV	_	_	NN	O	[-1]	['none']	_	_
8	induced	_	_	VBD	O	[-1]	['none']	_	_
9	B	_	_	NN	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	transformation	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	its	_	_	PRP$	O	[-1]	['none']	_	_
14	inhibition	_	_	NN	O	[-1]	['none']	_	_
15	rapidly	_	_	RB	O	[-1]	['none']	_	_
16	results	_	_	VBZ	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	cell	_	_	NN	O	[-1]	['none']	_	_
19	death	_	_	NN	O	[-1]	['none']	_	_
20	[	_	_	CD	O	[-1]	['none']	_	_
21	17,18	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Recent	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[0]	['root']	_	_
6	also	_	_	RB	O	[-1]	['none']	_	_
7	activates	_	_	VBZ	O	[-1]	['none']	_	_
8	phosphatidylinositol	_	_	NN	O	[-1]	['none']	_	_
9	3	_	_	CD	O	[-1]	['none']	_	_
10	kinase	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	PI3K	_	_	NN	O	[-1]	['none']	_	_
13	)/Akt	_	_	NN	Protein	[0]	['root']	_	_
14	signaling	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	that	_	_	IN	O	[-1]	['none']	_	_
17	this	_	_	DT	O	[-1]	['none']	_	_
18	activation	_	_	NN	O	[-1]	['none']	_	_
19	is	_	_	VBZ	O	[-1]	['none']	_	_
20	required	_	_	VBN	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	LMP1	_	_	NN	Protein	[0]	['root']	_	_
23	mediated	_	_	VBD	O	[-1]	['none']	_	_
24	transformation	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	rodent	_	_	JJ	O	[-1]	['none']	_	_
27	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
28	[	_	_	VBP	O	[-1]	['none']	_	_
29	5,19	_	_	CD	O	[-1]	['none']	_	_
30	]	_	_	CD	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vitro	_	_	FW	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	primary	_	_	JJ	O	[-1]	['none']	_	_
5	B	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	can	_	_	MD	O	[-1]	['none']	_	_
8	be	_	_	VB	O	[-1]	['none']	_	_
9	maintained	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	CD40	_	_	NN	Protein	[12]	['Theme']	_	_
12	ligation	_	_	NN	Binding	[0]	['root']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	combination	_	_	NN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	IL4	_	_	NN	Protein	[0]	['root']	_	_
17	treatment	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vivo	_	_	FW	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	CD40	_	_	NN	Protein	[0]	['root']	_	_
5	signaling	_	_	NN	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	necessary	_	_	JJ	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	germinal	_	_	JJ	O	[-1]	['none']	_	_
10	center	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	GC	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	formation	_	_	NN	O	[-1]	['none']	_	_
15	such	_	_	JJ	O	[-1]	['none']	_	_
16	that	_	_	IN	O	[-1]	['none']	_	_
17	mice	_	_	NNS	O	[-1]	['none']	_	_
18	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	CD40	_	_	NN	Protein	[18]	['Theme']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	CD40L	_	_	NN	Protein	[18]	['Theme']	_	_
23	are	_	_	VBP	O	[-1]	['none']	_	_
24	unable	_	_	JJ	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	form	_	_	VB	O	[-1]	['none']	_	_
27	GCs	_	_	NNS	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	response	_	_	NN	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	T	_	_	NN	O	[-1]	['none']	_	_
32	cell	_	_	NN	O	[-1]	['none']	_	_
33	dependent	_	_	JJ	O	[-1]	['none']	_	_
34	antigens	_	_	NNS	O	[-1]	['none']	_	_
35	[	_	_	VBP	O	[-1]	['none']	_	_
36	20,21	_	_	CD	O	[-1]	['none']	_	_
37	]	_	_	CD	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Both	_	_	CC	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	membrane	_	_	NN	Entity	[4]	['multitoken']	_	_
4	proximal	_	_	JJ	Entity	[12]	['Site']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	distal	_	_	JJ	Entity	[8]	['multitoken']	_	_
7	cytoplasmic	_	_	JJ	Entity	[8]	['multitoken']	_	_
8	regions	_	_	NNS	Entity	[12]	['Site']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	CD40	_	_	NN	Protein	[12]	['Theme']	_	_
11	that	_	_	WDT	O	[-1]	['none']	_	_
12	bind	_	_	VBP	Binding	[0]	['root']	_	_
13	TRAF6	_	_	NN	Protein	[12]	['Theme']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	TRAFs2/3/5	_	_	NN	Protein	[12]	['Theme']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	respectively	_	_	RB	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	are	_	_	VBP	O	[-1]	['none']	_	_
20	necessary	_	_	JJ	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	GC	_	_	NN	O	[-1]	['none']	_	_
23	formation	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	but	_	_	CC	O	[-1]	['none']	_	_
26	either	_	_	CC	O	[-1]	['none']	_	_
27	region	_	_	NN	O	[-1]	['none']	_	_
28	is	_	_	VBZ	O	[-1]	['none']	_	_
29	sufficient	_	_	JJ	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	induce	_	_	VB	O	[-1]	['none']	_	_
32	extrafollicular	_	_	JJ	O	[-1]	['none']	_	_
33	B	_	_	NN	O	[-1]	['none']	_	_
34	cell	_	_	NN	O	[-1]	['none']	_	_
35	differentiation	_	_	NN	O	[-1]	['none']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	restore	_	_	VB	O	[-1]	['none']	_	_
38	low	_	_	JJ	O	[-1]	['none']	_	_
39	affinity	_	_	NN	O	[-1]	['none']	_	_
40	antibody	_	_	NN	O	[-1]	['none']	_	_
41	production	_	_	NN	O	[-1]	['none']	_	_
42	[	_	_	CD	O	[-1]	['none']	_	_
43	22	_	_	CD	O	[-1]	['none']	_	_
44	]	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	Functionally	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	LMP1	_	_	NN	Protein	[0]	['root']	_	_
4	can	_	_	MD	O	[-1]	['none']	_	_
5	rescue	_	_	VB	Negative_regulation	[0]	['root']	_	_
6	CD40	_	_	NN	Protein	[7]	['Theme']	_	_
7	deficient	_	_	JJ	Negative_regulation	[5]	['Theme']	_	_
8	mice	_	_	NNS	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	restore	_	_	VB	O	[-1]	['none']	_	_
11	immunoglobulin	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	Ig	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	class	_	_	NN	O	[-1]	['none']	_	_
16	switching	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	most	_	_	RBS	O	[-1]	['none']	_	_
19	likely	_	_	RB	O	[-1]	['none']	_	_
20	because	_	_	IN	O	[-1]	['none']	_	_
21	LMP1	_	_	NN	Protein	[22]	['Theme']	_	_
22	recruits	_	_	VBZ	Binding	[0]	['root']	_	_
23	similar	_	_	JJ	O	[-1]	['none']	_	_
24	TRAF	_	_	NN	O	[-1]	['none']	_	_
25	molecules	_	_	NNS	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	TRAFs	_	_	NNS	Protein	[28]	['multitoken']	_	_
28	1/2/3/5	_	_	CD	Protein	[22]	['Theme']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	TRAF6	_	_	NN	Protein	[22]	['Theme']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	through	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	C-terminal	_	_	JJ	Entity	[37]	['multitoken']	_	_
35	activation	_	_	NN	Entity	[37]	['multitoken']	_	_
36	regions	_	_	NNS	Entity	[37]	['multitoken']	_	_
37	1	_	_	CD	Entity	[22]	['Site']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	2	_	_	CD	Entity	[40]	['multitoken']	_	_
40	domains	_	_	NNS	Entity	[22]	['Site']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	respectively	_	_	RB	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	LMP1	_	_	NN	Protein	[0]	['root']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	unable	_	_	JJ	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	restore	_	_	VB	O	[-1]	['none']	_	_
8	affinity	_	_	NN	O	[-1]	['none']	_	_
9	maturation	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	GC	_	_	NN	O	[-1]	['none']	_	_
12	formation	_	_	NN	O	[-1]	['none']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	23	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Several	_	_	JJ	O	[-1]	['none']	_	_
2	EBV	_	_	NN	O	[-1]	['none']	_	_
3	transforming	_	_	VBG	O	[-1]	['none']	_	_
4	proteins	_	_	NNS	O	[-1]	['none']	_	_
5	have	_	_	VBP	O	[-1]	['none']	_	_
6	been	_	_	VBN	O	[-1]	['none']	_	_
7	studied	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	transgenic	_	_	JJ	O	[-1]	['none']	_	_
10	mouse	_	_	NN	O	[-1]	['none']	_	_
11	models	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	however	_	_	RB	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	only	_	_	RB	O	[-1]	['none']	_	_
16	LMP1	_	_	NN	Protein	[21]	['Theme']	_	_
17	induces	_	_	VBZ	O	[-1]	['none']	_	_
18	tumor	_	_	NN	O	[-1]	['none']	_	_
19	development	_	_	NN	O	[-1]	['none']	_	_
20	when	_	_	WRB	O	[-1]	['none']	_	_
21	expressed	_	_	VBN	Gene_expression	[24]	['Theme']	_	_
22	under	_	_	IN	Positive_regulation	[24]	['multitoken']	_	_
23	the	_	_	DT	Positive_regulation	[24]	['multitoken']	_	_
24	control	_	_	NN	Positive_regulation	[0]	['root']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	Ig	_	_	NN	O	[-1]	['none']	_	_
28	heavy	_	_	JJ	O	[-1]	['none']	_	_
29	chain	_	_	NN	O	[-1]	['none']	_	_
30	promoter	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	enhancer	_	_	NN	O	[-1]	['none']	_	_
33	[	_	_	NN	O	[-1]	['none']	_	_
34	24-26	_	_	CD	O	[-1]	['none']	_	_
35	]	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	LMP1	_	_	NN	Protein	[0]	['root']	_	_
3	transgenic	_	_	JJ	O	[-1]	['none']	_	_
4	mice	_	_	NNS	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	IgLMP1	_	_	NN	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	express	_	_	VBP	Gene_expression	[0]	['root']	_	_
9	LMP1	_	_	NN	Protein	[8]	['Theme']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	B	_	_	NN	O	[-1]	['none']	_	_
12	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	mice	_	_	NNS	O	[-1]	['none']	_	_
17	older	_	_	JJR	O	[-1]	['none']	_	_
18	than	_	_	IN	O	[-1]	['none']	_	_
19	12	_	_	CD	O	[-1]	['none']	_	_
20	mo	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	lymphoma	_	_	NN	O	[-1]	['none']	_	_
23	develops	_	_	VBZ	O	[-1]	['none']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	increased	_	_	VBN	O	[-1]	['none']	_	_
26	incidence	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	40	_	_	CD	O	[-1]	['none']	_	_
29	%-50%	_	_	CD	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	compared	_	_	VBN	O	[-1]	['none']	_	_
32	to	_	_	TO	O	[-1]	['none']	_	_
33	wild-type	_	_	JJ	O	[-1]	['none']	_	_
34	control	_	_	NN	O	[-1]	['none']	_	_
35	mice	_	_	NNS	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	11	_	_	CD	O	[-1]	['none']	_	_
38	%	_	_	NN	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	suggesting	_	_	VBG	O	[-1]	['none']	_	_
42	that	_	_	IN	O	[-1]	['none']	_	_
43	LMP1	_	_	NN	Protein	[0]	['root']	_	_
44	contributes	_	_	VBZ	O	[-1]	['none']	_	_
45	to	_	_	TO	O	[-1]	['none']	_	_
46	tumor	_	_	NN	O	[-1]	['none']	_	_
47	development	_	_	NN	O	[-1]	['none']	_	_
48	[	_	_	CD	O	[-1]	['none']	_	_
49	26	_	_	CD	O	[-1]	['none']	_	_
50	]	_	_	NN	O	[-1]	['none']	_	_
51	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	LMP1	_	_	NN	Protein	[0]	['root']	_	_
3	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
4	have	_	_	VBP	O	[-1]	['none']	_	_
5	rearranged	_	_	VBN	O	[-1]	['none']	_	_
6	Ig	_	_	NN	O	[-1]	['none']	_	_
7	genes	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	have	_	_	VBP	O	[-1]	['none']	_	_
10	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
11	Akt	_	_	NN	Protein	[10]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	JNK	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	p38	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	specific	_	_	JJ	O	[-1]	['none']	_	_
22	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
26	family	_	_	NN	O	[-1]	['none']	_	_
27	member	_	_	NN	O	[-1]	['none']	_	_
28	cRel	_	_	NN	Protein	[22]	['Theme']	_	_
29	[	_	_	CD	O	[-1]	['none']	_	_
30	27	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	study	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	LMP1	_	_	NN	Protein	[0]	['root']	_	_
7	transgenic	_	_	JJ	O	[-1]	['none']	_	_
8	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	further	_	_	RB	O	[-1]	['none']	_	_
13	characterized	_	_	VBN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	their	_	_	PRP$	O	[-1]	['none']	_	_
16	growth	_	_	NN	O	[-1]	['none']	_	_
17	properties	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	FW	O	[-1]	['none']	_	_
19	vitro	_	_	FW	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	determined	_	_	VBN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	obtain	_	_	VB	O	[-1]	['none']	_	_
3	pure	_	_	JJ	O	[-1]	['none']	_	_
4	populations	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	malignant	_	_	JJ	O	[-1]	['none']	_	_
7	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	enable	_	_	VB	O	[-1]	['none']	_	_
11	more	_	_	JJR	O	[-1]	['none']	_	_
12	detailed	_	_	JJ	O	[-1]	['none']	_	_
13	biochemical	_	_	JJ	O	[-1]	['none']	_	_
14	analyses	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	examples	_	_	NNS	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	primary	_	_	JJ	O	[-1]	['none']	_	_
19	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	inoculated	_	_	VBN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	passaged	_	_	VBN	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	SCID	_	_	NN	O	[-1]	['none']	_	_
26	mice	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	lymphoma	_	_	NN	O	[-1]	['none']	_	_
4	development	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	restricted	_	_	JJ	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	B-1a	_	_	JJ	O	[-1]	['none']	_	_
9	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	self	_	_	NN	O	[-1]	['none']	_	_
13	replenishing	_	_	VBG	O	[-1]	['none']	_	_
14	population	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	that	_	_	WDT	O	[-1]	['none']	_	_
18	are	_	_	VBP	O	[-1]	['none']	_	_
19	prone	_	_	JJ	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	malignancy	_	_	NN	O	[-1]	['none']	_	_
22	[	_	_	CD	O	[-1]	['none']	_	_
23	28,29	_	_	CD	O	[-1]	['none']	_	_
24	]	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	transgenic	_	_	JJ	O	[-1]	['none']	_	_
3	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
4	had	_	_	VBD	O	[-1]	['none']	_	_
5	increased	_	_	VBN	O	[-1]	['none']	_	_
6	viability	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	FW	O	[-1]	['none']	_	_
8	vitro	_	_	FW	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	viability	_	_	NN	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	increased	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	addition	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	IL4	_	_	NN	Protein	[0]	['root']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	both	_	_	CC	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[0]	['root']	_	_
6	positive	_	_	JJ	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	-negative	_	_	JJ	O	[-1]	['none']	_	_
9	lymphoma	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	independent	_	_	JJ	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	IL4	_	_	NN	Protein	[0]	['root']	_	_
15	co-stimulation	_	_	NN	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	survival	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	proliferation	_	_	NN	O	[-1]	['none']	_	_
20	in	_	_	FW	O	[-1]	['none']	_	_
21	vitro	_	_	FW	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	a	_	_	DT	O	[-1]	['none']	_	_
24	complete	_	_	JJ	O	[-1]	['none']	_	_
25	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	activated	_	_	VBN	Positive_regulation	[25]	['Theme']	_	_
28	Stat6	_	_	NN	Protein	[27, 32]	['Theme', 'Theme']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	IL4	_	_	NN	Protein	[32]	['Cause']	_	_
32	target	_	_	NN	Regulation	[0]	['root']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	distinguished	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	constitutive	_	_	JJ	O	[-1]	['none']	_	_
8	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Stat3	_	_	NN	Protein	[8]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	deregulation	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	Rb	_	_	NN	Protein	[0]	['root']	_	_
16	cell	_	_	NN	O	[-1]	['none']	_	_
17	cycle	_	_	NN	O	[-1]	['none']	_	_
18	pathway	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Inhibition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	PI3K	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Akt	_	_	NN	Protein	[0]	['root']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	Stat3	_	_	NN	Protein	[0]	['root']	_	_
12	signaling	_	_	NN	O	[-1]	['none']	_	_
13	pathways	_	_	NNS	O	[-1]	['none']	_	_
14	blocked	_	_	VBD	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	enhanced	_	_	JJ	O	[-1]	['none']	_	_
17	growth	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	both	_	_	CC	O	[-1]	['none']	_	_
20	LMP1	_	_	NN	Protein	[0]	['root']	_	_
21	transgenic	_	_	JJ	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	malignant	_	_	JJ	O	[-1]	['none']	_	_
24	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	suggesting	_	_	VBG	O	[-1]	['none']	_	_
27	that	_	_	IN	O	[-1]	['none']	_	_
28	these	_	_	DT	O	[-1]	['none']	_	_
29	pathways	_	_	NNS	O	[-1]	['none']	_	_
30	are	_	_	VBP	O	[-1]	['none']	_	_
31	required	_	_	VBN	O	[-1]	['none']	_	_
32	for	_	_	IN	O	[-1]	['none']	_	_
33	their	_	_	PRP$	O	[-1]	['none']	_	_
34	growth	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	survival	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	appear	_	_	VBP	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	be	_	_	VB	O	[-1]	['none']	_	_
5	the	_	_	DT	Anaphora	[7]	['multitoken']	_	_
6	same	_	_	JJ	Anaphora	[7]	['multitoken']	_	_
7	targets	_	_	NNS	Anaphora	[0]	['root']	_	_
8	that	_	_	WDT	O	[-1]	['none']	_	_
9	are	_	_	VBP	O	[-1]	['none']	_	_
10	deregulated	_	_	VBN	Regulation	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	wild-type	_	_	JJ	O	[-1]	['none']	_	_
13	B-1a	_	_	NN	O	[-1]	['none']	_	_
14	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
15	that	_	_	WDT	O	[-1]	['none']	_	_
16	arise	_	_	VBP	O	[-1]	['none']	_	_
17	spontaneously	_	_	RB	O	[-1]	['none']	_	_
18	through	_	_	IN	O	[-1]	['none']	_	_
19	age	_	_	NN	O	[-1]	['none']	_	_
20	predisposition	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	study	_	_	NN	O	[-1]	['none']	_	_
3	reveals	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[0]	['root']	_	_
6	promotes	_	_	VBZ	O	[-1]	['none']	_	_
7	malignancy	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	inherent	_	_	JJ	O	[-1]	['none']	_	_
13	ability	_	_	NN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	proliferate	_	_	VB	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	that	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	Akt	_	_	NN	Protein	[0]	['root']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	Stat3	_	_	NN	Protein	[0]	['root']	_	_
25	signaling	_	_	NN	O	[-1]	['none']	_	_
26	pathways	_	_	NNS	O	[-1]	['none']	_	_
27	are	_	_	VBP	O	[-1]	['none']	_	_
28	required	_	_	VBN	O	[-1]	['none']	_	_
29	for	_	_	IN	O	[-1]	['none']	_	_
30	its	_	_	PRP$	O	[-1]	['none']	_	_
31	growth	_	_	NN	O	[-1]	['none']	_	_
32	stimulatory	_	_	JJ	O	[-1]	['none']	_	_
33	effects	_	_	NNS	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Interleukin-10	_	_	NNP	Protein	[0]	['root']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	IL-10	_	_	NN	Protein	[0]	['root']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	cytokine	_	_	NN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	broad	_	_	JJ	O	[-1]	['none']	_	_
10	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
11	properties	_	_	NNS	O	[-1]	['none']	_	_
12	that	_	_	WDT	O	[-1]	['none']	_	_
13	inhibits	_	_	VBZ	O	[-1]	['none']	_	_
14	macrophage	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	dendritic	_	_	JJ	O	[-1]	['none']	_	_
17	cell	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	DC	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	function	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	Moore	_	_	NNP	O	[-1]	['none']	_	_
24	et	_	_	FW	O	[-1]	['none']	_	_
25	al.	_	_	FW	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	2001	_	_	CD	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[0]	['root']	_	_
2	limits	_	_	VBZ	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	immune	_	_	JJ	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
7	responses	_	_	NNS	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	pathogens	_	_	NNS	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	gut	_	_	NN	O	[-1]	['none']	_	_
12	flora	_	_	NNS	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	prevents	_	_	VBZ	O	[-1]	['none']	_	_
15	damage	_	_	NN	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	host	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Moore	_	_	NNP	O	[-1]	['none']	_	_
21	et	_	_	FW	O	[-1]	['none']	_	_
22	al.	_	_	FW	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	2001	_	_	CD	O	[-1]	['none']	_	_
25	;	_	_	:	O	[-1]	['none']	_	_
26	O'Garra	_	_	NNP	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	Vieira	_	_	NNP	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	2004	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	but	_	_	CC	O	[-1]	['none']	_	_
34	when	_	_	WRB	O	[-1]	['none']	_	_
35	dysregulated	_	_	VBN	O	[-1]	['none']	_	_
36	may	_	_	MD	O	[-1]	['none']	_	_
37	result	_	_	VB	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	chronic	_	_	JJ	O	[-1]	['none']	_	_
40	infection	_	_	NN	O	[-1]	['none']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	Brooks	_	_	NNP	O	[-1]	['none']	_	_
43	et	_	_	FW	O	[-1]	['none']	_	_
44	al.	_	_	FW	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	2006	_	_	CD	O	[-1]	['none']	_	_
47	;	_	_	:	O	[-1]	['none']	_	_
48	Ejrnaes	_	_	NNP	O	[-1]	['none']	_	_
49	et	_	_	FW	O	[-1]	['none']	_	_
50	al.	_	_	FW	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	2006	_	_	CD	O	[-1]	['none']	_	_
53	;	_	_	:	O	[-1]	['none']	_	_
54	Moore	_	_	NNP	O	[-1]	['none']	_	_
55	et	_	_	FW	O	[-1]	['none']	_	_
56	al.	_	_	FW	O	[-1]	['none']	_	_
57	,	_	_	,	O	[-1]	['none']	_	_
58	2001	_	_	CD	O	[-1]	['none']	_	_
59	)	_	_	-RRB-	O	[-1]	['none']	_	_
60	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[3]	['Theme']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	helper	_	_	NN	O	[-1]	['none']	_	_
7	2	_	_	CD	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Th2	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	B	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	DCs	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	macrophages	_	_	NNS	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	Moore	_	_	NNP	O	[-1]	['none']	_	_
22	et	_	_	FW	O	[-1]	['none']	_	_
23	al.	_	_	FW	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	2001	_	_	CD	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	also	_	_	RB	O	[-1]	['none']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	Th1	_	_	NN	O	[-1]	['none']	_	_
32	cells	_	_	NNS	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	Anderson	_	_	NNP	O	[-1]	['none']	_	_
35	et	_	_	FW	O	[-1]	['none']	_	_
36	al.	_	_	FW	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	2007	_	_	CD	O	[-1]	['none']	_	_
39	;	_	_	:	O	[-1]	['none']	_	_
40	Assenmacher	_	_	NNP	O	[-1]	['none']	_	_
41	et	_	_	FW	O	[-1]	['none']	_	_
42	al.	_	_	FW	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	1994	_	_	CD	O	[-1]	['none']	_	_
45	;	_	_	:	O	[-1]	['none']	_	_
46	Del	_	_	NNP	O	[-1]	['none']	_	_
47	Prete	_	_	NNP	O	[-1]	['none']	_	_
48	et	_	_	FW	O	[-1]	['none']	_	_
49	al.	_	_	FW	O	[-1]	['none']	_	_
50	,	_	_	,	O	[-1]	['none']	_	_
51	1993	_	_	CD	O	[-1]	['none']	_	_
52	;	_	_	:	O	[-1]	['none']	_	_
53	Gerosa	_	_	NNP	O	[-1]	['none']	_	_
54	et	_	_	FW	O	[-1]	['none']	_	_
55	al.	_	_	FW	O	[-1]	['none']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	1996	_	_	CD	O	[-1]	['none']	_	_
58	;	_	_	:	O	[-1]	['none']	_	_
59	Jankovic	_	_	NNP	O	[-1]	['none']	_	_
60	et	_	_	FW	O	[-1]	['none']	_	_
61	al.	_	_	FW	O	[-1]	['none']	_	_
62	,	_	_	,	O	[-1]	['none']	_	_
63	2007	_	_	CD	O	[-1]	['none']	_	_
64	;	_	_	:	O	[-1]	['none']	_	_
65	Pohl-Koppe	_	_	NNP	O	[-1]	['none']	_	_
66	et	_	_	FW	O	[-1]	['none']	_	_
67	al.	_	_	FW	O	[-1]	['none']	_	_
68	,	_	_	,	O	[-1]	['none']	_	_
69	1998	_	_	CD	O	[-1]	['none']	_	_
70	)	_	_	-RRB-	O	[-1]	['none']	_	_
71	and	_	_	CC	O	[-1]	['none']	_	_
72	(	_	_	-LRB-	O	[-1]	['none']	_	_
73	reviewed	_	_	VBN	O	[-1]	['none']	_	_
74	in	_	_	IN	O	[-1]	['none']	_	_
75	O'Garra	_	_	NN	O	[-1]	['none']	_	_
76	and	_	_	CC	O	[-1]	['none']	_	_
77	Vieira	_	_	NNP	O	[-1]	['none']	_	_
78	,	_	_	,	O	[-1]	['none']	_	_
79	2007	_	_	CD	O	[-1]	['none']	_	_
80	;	_	_	:	O	[-1]	['none']	_	_
81	Trinchieri	_	_	NNP	O	[-1]	['none']	_	_
82	,	_	_	,	O	[-1]	['none']	_	_
83	2007	_	_	CD	O	[-1]	['none']	_	_
84	)	_	_	-RRB-	O	[-1]	['none']	_	_
85	,	_	_	,	O	[-1]	['none']	_	_
86	certain	_	_	JJ	O	[-1]	['none']	_	_
87	regulatory	_	_	JJ	O	[-1]	['none']	_	_
88	(	_	_	-LRB-	O	[-1]	['none']	_	_
89	Treg	_	_	NNP	O	[-1]	['none']	_	_
90	)	_	_	-RRB-	O	[-1]	['none']	_	_
91	T	_	_	NN	O	[-1]	['none']	_	_
92	cells	_	_	NNS	O	[-1]	['none']	_	_
93	(	_	_	-LRB-	O	[-1]	['none']	_	_
94	Moore	_	_	NNP	O	[-1]	['none']	_	_
95	et	_	_	FW	O	[-1]	['none']	_	_
96	al.	_	_	FW	O	[-1]	['none']	_	_
97	,	_	_	,	O	[-1]	['none']	_	_
98	2001	_	_	CD	O	[-1]	['none']	_	_
99	;	_	_	:	O	[-1]	['none']	_	_
100	O'Garra	_	_	NNP	O	[-1]	['none']	_	_
101	and	_	_	CC	O	[-1]	['none']	_	_
102	Vieira	_	_	NNP	O	[-1]	['none']	_	_
103	,	_	_	,	O	[-1]	['none']	_	_
104	2004	_	_	CD	O	[-1]	['none']	_	_
105	;	_	_	:	O	[-1]	['none']	_	_
106	Roncarolo	_	_	NNP	O	[-1]	['none']	_	_
107	et	_	_	FW	O	[-1]	['none']	_	_
108	al.	_	_	FW	O	[-1]	['none']	_	_
109	,	_	_	,	O	[-1]	['none']	_	_
110	2006	_	_	CD	O	[-1]	['none']	_	_
111	)	_	_	-RRB-	O	[-1]	['none']	_	_
112	,	_	_	,	O	[-1]	['none']	_	_
113	and	_	_	CC	O	[-1]	['none']	_	_
114	Th17	_	_	NN	O	[-1]	['none']	_	_
115	cells	_	_	NNS	O	[-1]	['none']	_	_
116	(	_	_	-LRB-	O	[-1]	['none']	_	_
117	Awasthi	_	_	NNP	O	[-1]	['none']	_	_
118	et	_	_	FW	O	[-1]	['none']	_	_
119	al.	_	_	FW	O	[-1]	['none']	_	_
120	,	_	_	,	O	[-1]	['none']	_	_
121	2007	_	_	CD	O	[-1]	['none']	_	_
122	;	_	_	:	O	[-1]	['none']	_	_
123	Fitzgerald	_	_	NNP	O	[-1]	['none']	_	_
124	et	_	_	FW	O	[-1]	['none']	_	_
125	al.	_	_	FW	O	[-1]	['none']	_	_
126	,	_	_	,	O	[-1]	['none']	_	_
127	2007	_	_	CD	O	[-1]	['none']	_	_
128	;	_	_	:	O	[-1]	['none']	_	_
129	McGeachy	_	_	NNP	O	[-1]	['none']	_	_
130	et	_	_	FW	O	[-1]	['none']	_	_
131	al.	_	_	FW	O	[-1]	['none']	_	_
132	,	_	_	,	O	[-1]	['none']	_	_
133	2007	_	_	CD	O	[-1]	['none']	_	_
134	;	_	_	:	O	[-1]	['none']	_	_
135	Stumhofer	_	_	NNP	O	[-1]	['none']	_	_
136	et	_	_	FW	O	[-1]	['none']	_	_
137	al.	_	_	FW	O	[-1]	['none']	_	_
138	,	_	_	,	O	[-1]	['none']	_	_
139	2007	_	_	CD	O	[-1]	['none']	_	_
140	)	_	_	-RRB-	O	[-1]	['none']	_	_
141	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vitro	_	_	FW	O	[-1]	['none']	_	_
3	human	_	_	NN	O	[-1]	['none']	_	_
4	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	clones	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	mouse	_	_	NN	O	[-1]	['none']	_	_
13	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
14	T	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	that	_	_	WDT	O	[-1]	['none']	_	_
17	produce	_	_	VBP	Gene_expression	[0]	['root']	_	_
18	both	_	_	DT	O	[-1]	['none']	_	_
19	interferon-gamma	_	_	NN	Protein	[17]	['Theme']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	IFN-gamma	_	_	NN	Protein	[0]	['root']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	IL-10	_	_	NN	Protein	[17]	['Theme']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	can	_	_	MD	O	[-1]	['none']	_	_
27	be	_	_	VB	O	[-1]	['none']	_	_
28	differentiated	_	_	VBN	O	[-1]	['none']	_	_
29	by	_	_	IN	O	[-1]	['none']	_	_
30	T	_	_	NN	O	[-1]	['none']	_	_
31	cell	_	_	NN	O	[-1]	['none']	_	_
32	receptor	_	_	NN	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	TCR	_	_	NN	O	[-1]	['none']	_	_
35	)-stimulation	_	_	NN	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	presence	_	_	NN	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	IL-12	_	_	NN	Protein	[0]	['root']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	Chang	_	_	NNP	O	[-1]	['none']	_	_
43	et	_	_	FW	O	[-1]	['none']	_	_
44	al.	_	_	FW	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	2007	_	_	CD	O	[-1]	['none']	_	_
47	;	_	_	:	O	[-1]	['none']	_	_
48	Gerosa	_	_	NNP	O	[-1]	['none']	_	_
49	et	_	_	FW	O	[-1]	['none']	_	_
50	al.	_	_	FW	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	1996	_	_	CD	O	[-1]	['none']	_	_
53	;	_	_	:	O	[-1]	['none']	_	_
54	Jeannin	_	_	NNP	O	[-1]	['none']	_	_
55	et	_	_	FW	O	[-1]	['none']	_	_
56	al.	_	_	FW	O	[-1]	['none']	_	_
57	,	_	_	,	O	[-1]	['none']	_	_
58	1996	_	_	CD	O	[-1]	['none']	_	_
59	;	_	_	:	O	[-1]	['none']	_	_
60	Meyaard	_	_	NNP	O	[-1]	['none']	_	_
61	et	_	_	FW	O	[-1]	['none']	_	_
62	al.	_	_	FW	O	[-1]	['none']	_	_
63	,	_	_	,	O	[-1]	['none']	_	_
64	1996	_	_	CD	O	[-1]	['none']	_	_
65	;	_	_	:	O	[-1]	['none']	_	_
66	Windhagen	_	_	NNP	O	[-1]	['none']	_	_
67	et	_	_	FW	O	[-1]	['none']	_	_
68	al.	_	_	FW	O	[-1]	['none']	_	_
69	,	_	_	,	O	[-1]	['none']	_	_
70	1996	_	_	CD	O	[-1]	['none']	_	_
71	)	_	_	-RRB-	O	[-1]	['none']	_	_
72	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Th1	_	_	NN	O	[-1]	['none']	_	_
4	cell	_	_	NN	O	[-1]	['none']	_	_
5	clones	_	_	NNS	O	[-1]	['none']	_	_
6	coproducing	_	_	VBG	Gene_expression	[0]	['root']	_	_
7	IFN-gamma	_	_	NN	Protein	[6]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	IL-10	_	_	NN	Protein	[6]	['Theme']	_	_
10	have	_	_	VBP	O	[-1]	['none']	_	_
11	been	_	_	VBN	O	[-1]	['none']	_	_
12	isolated	_	_	VBN	O	[-1]	['none']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	bronchoalveolar	_	_	JJ	O	[-1]	['none']	_	_
15	lavage	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	BAL	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	active	_	_	JJ	O	[-1]	['none']	_	_
21	pulmonary	_	_	JJ	O	[-1]	['none']	_	_
22	tuberculosis	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	TB	_	_	NN	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	patients	_	_	NNS	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	Gerosa	_	_	NNP	O	[-1]	['none']	_	_
29	et	_	_	FW	O	[-1]	['none']	_	_
30	al.	_	_	FW	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	1999	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	production	_	_	NN	Gene_expression	[0]	['root']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	Th1	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	also	_	_	RB	O	[-1]	['none']	_	_
8	reported	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	animals	_	_	NNS	O	[-1]	['none']	_	_
11	infected	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	Toxoplasma	_	_	NNP	O	[-1]	['none']	_	_
14	gondii	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	Jankovic	_	_	NNP	O	[-1]	['none']	_	_
17	et	_	_	FW	O	[-1]	['none']	_	_
18	al.	_	_	FW	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	2002	_	_	CD	O	[-1]	['none']	_	_
21	;	_	_	:	O	[-1]	['none']	_	_
22	Shaw	_	_	NNP	O	[-1]	['none']	_	_
23	et	_	_	FW	O	[-1]	['none']	_	_
24	al.	_	_	FW	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	2006	_	_	CD	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	Leishmania	_	_	NN	O	[-1]	['none']	_	_
31	major	_	_	JJ	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	Anderson	_	_	NNP	O	[-1]	['none']	_	_
34	et	_	_	FW	O	[-1]	['none']	_	_
35	al.	_	_	FW	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	2007	_	_	CD	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	shown	_	_	VBN	O	[-1]	['none']	_	_
41	to	_	_	TO	O	[-1]	['none']	_	_
42	be	_	_	VB	O	[-1]	['none']	_	_
43	required	_	_	VBN	O	[-1]	['none']	_	_
44	for	_	_	IN	O	[-1]	['none']	_	_
45	regulation	_	_	NN	O	[-1]	['none']	_	_
46	of	_	_	IN	O	[-1]	['none']	_	_
47	the	_	_	DT	O	[-1]	['none']	_	_
48	immune	_	_	JJ	O	[-1]	['none']	_	_
49	response	_	_	NN	O	[-1]	['none']	_	_
50	in	_	_	IN	O	[-1]	['none']	_	_
51	these	_	_	DT	O	[-1]	['none']	_	_
52	infections	_	_	NNS	O	[-1]	['none']	_	_
53	(	_	_	-LRB-	O	[-1]	['none']	_	_
54	Anderson	_	_	NNP	O	[-1]	['none']	_	_
55	et	_	_	FW	O	[-1]	['none']	_	_
56	al.	_	_	FW	O	[-1]	['none']	_	_
57	,	_	_	,	O	[-1]	['none']	_	_
58	2007	_	_	CD	O	[-1]	['none']	_	_
59	;	_	_	:	O	[-1]	['none']	_	_
60	Jankovic	_	_	NNP	O	[-1]	['none']	_	_
61	et	_	_	FW	O	[-1]	['none']	_	_
62	al.	_	_	FW	O	[-1]	['none']	_	_
63	,	_	_	,	O	[-1]	['none']	_	_
64	2007	_	_	CD	O	[-1]	['none']	_	_
65	)	_	_	-RRB-	O	[-1]	['none']	_	_
66	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	relative	_	_	JJ	O	[-1]	['none']	_	_
3	amounts	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	IL-10	_	_	NN	Protein	[8]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	IFN-gamma	_	_	NN	Protein	[8]	['Theme']	_	_
8	produced	_	_	VBN	Gene_expression	[0]	['root']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	may	_	_	MD	O	[-1]	['none']	_	_
13	influence	_	_	VB	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	balance	_	_	NN	O	[-1]	['none']	_	_
16	between	_	_	IN	O	[-1]	['none']	_	_
17	clearance	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	persistent	_	_	JJ	O	[-1]	['none']	_	_
20	infection	_	_	NN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	certain	_	_	JJ	O	[-1]	['none']	_	_
23	pathogens	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	Moore	_	_	NNP	O	[-1]	['none']	_	_
26	et	_	_	FW	O	[-1]	['none']	_	_
27	al.	_	_	FW	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	2001	_	_	CD	O	[-1]	['none']	_	_
30	;	_	_	:	O	[-1]	['none']	_	_
31	Trinchieri	_	_	NNP	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	2007	_	_	CD	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	thus	_	_	RB	O	[-1]	['none']	_	_
37	determining	_	_	VBG	O	[-1]	['none']	_	_
38	whether	_	_	IN	O	[-1]	['none']	_	_
39	chronic	_	_	JJ	O	[-1]	['none']	_	_
40	infection	_	_	NN	O	[-1]	['none']	_	_
41	or	_	_	CC	O	[-1]	['none']	_	_
42	immunopathology	_	_	NN	O	[-1]	['none']	_	_
43	ensues	_	_	VBZ	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	Th1	_	_	NN	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Th2	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Th17	_	_	NN	O	[-1]	['none']	_	_
7	cell	_	_	NN	O	[-1]	['none']	_	_
8	responses	_	_	NNS	O	[-1]	['none']	_	_
9	differentiate	_	_	VBP	O	[-1]	['none']	_	_
10	along	_	_	IN	O	[-1]	['none']	_	_
11	distinct	_	_	JJ	O	[-1]	['none']	_	_
12	signaling	_	_	NN	O	[-1]	['none']	_	_
13	pathways	_	_	NNS	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Glimcher	_	_	NNP	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	Murphy	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	2000	_	_	CD	O	[-1]	['none']	_	_
20	;	_	_	:	O	[-1]	['none']	_	_
21	Ivanov	_	_	NNP	O	[-1]	['none']	_	_
22	et	_	_	FW	O	[-1]	['none']	_	_
23	al.	_	_	FW	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	2007	_	_	CD	O	[-1]	['none']	_	_
26	;	_	_	:	O	[-1]	['none']	_	_
27	Stockinger	_	_	NNP	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	2007	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Th1	_	_	NN	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	development	_	_	NN	O	[-1]	['none']	_	_
4	requires	_	_	VBZ	O	[-1]	['none']	_	_
5	signal	_	_	NN	Protein	[15]	['multitoken']	_	_
6	transducer	_	_	NN	Protein	[15]	['multitoken']	_	_
7	and	_	_	CC	Protein	[15]	['multitoken']	_	_
8	activator	_	_	NN	Protein	[15]	['multitoken']	_	_
9	of	_	_	IN	Protein	[15]	['multitoken']	_	_
10	transcription	_	_	NN	Protein	[15]	['multitoken']	_	_
11	(	_	_	-LRB-	Protein	[15]	['multitoken']	_	_
12	STAT	_	_	NN	Protein	[15]	['multitoken']	_	_
13	)	_	_	-RRB-	Protein	[15]	['multitoken']	_	_
14	1	_	_	CD	Protein	[15]	['multitoken']	_	_
15	activation	_	_	NN	Positive_regulation	[17, 50]	['Theme', 'Cause']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	type	_	_	NN	Protein	[21]	['multitoken']	_	_
20	I	_	_	CD	Protein	[21]	['multitoken']	_	_
21	IFN	_	_	NN	Protein	[17]	['Cause']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	IFN-gamma	_	_	NN	Protein	[17]	['Cause']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	transcription	_	_	NN	O	[-1]	['none']	_	_
27	factor	_	_	NN	O	[-1]	['none']	_	_
28	T-box	_	_	NN	Protein	[29]	['multitoken']	_	_
29	21	_	_	CD	Protein	[0]	['root']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	T-bet	_	_	JJ	Protein	[0]	['root']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	IL-12-induced	_	_	JJ	Protein	[0]	['root']	_	_
36	STAT4	_	_	NN	Protein	[0]	['root']	_	_
37	signaling	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	which	_	_	WDT	O	[-1]	['none']	_	_
40	can	_	_	MD	O	[-1]	['none']	_	_
41	couple	_	_	VB	O	[-1]	['none']	_	_
42	with	_	_	IN	O	[-1]	['none']	_	_
43	IL-18-induced	_	_	JJ	Positive_regulation	[0]	['root']	_	_
44	IRAK	_	_	NN	Protein	[43]	['Theme']	_	_
45	and	_	_	CC	O	[-1]	['none']	_	_
46	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
47	transcription	_	_	NN	O	[-1]	['none']	_	_
48	factors	_	_	NNS	O	[-1]	['none']	_	_
49	to	_	_	TO	O	[-1]	['none']	_	_
50	drive	_	_	VB	Positive_regulation	[0]	['root']	_	_
51	the	_	_	DT	O	[-1]	['none']	_	_
52	high	_	_	JJ	O	[-1]	['none']	_	_
53	amounts	_	_	NNS	Gene_expression	[50]	['Theme']	_	_
54	of	_	_	IN	O	[-1]	['none']	_	_
55	IFN-gamma	_	_	NN	Protein	[53]	['Theme']	_	_
56	required	_	_	VBN	O	[-1]	['none']	_	_
57	to	_	_	TO	O	[-1]	['none']	_	_
58	eradicate	_	_	VB	O	[-1]	['none']	_	_
59	intracellular	_	_	JJ	O	[-1]	['none']	_	_
60	pathogens	_	_	NNS	O	[-1]	['none']	_	_
61	(	_	_	-LRB-	O	[-1]	['none']	_	_
62	Glimcher	_	_	NNP	O	[-1]	['none']	_	_
63	and	_	_	CC	O	[-1]	['none']	_	_
64	Murphy	_	_	NNP	O	[-1]	['none']	_	_
65	,	_	_	,	O	[-1]	['none']	_	_
66	2000	_	_	CD	O	[-1]	['none']	_	_
67	)	_	_	-RRB-	O	[-1]	['none']	_	_
68	.	_	_	.	O	[-1]	['none']	_	_

1	Th2	_	_	NN	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	development	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	IL-4	_	_	NN	Protein	[6, 15]	['Theme', 'Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	IL-5	_	_	NN	Protein	[6, 15]	['Theme', 'Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	IL-13	_	_	NN	Protein	[6, 15]	['Theme', 'Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	requires	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
16	IL-4	_	_	NN	Protein	[15]	['Cause']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	STAT6	_	_	NN	Protein	[15]	['Cause']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	transcription	_	_	NN	O	[-1]	['none']	_	_
23	factor	_	_	NN	O	[-1]	['none']	_	_
24	GATA	_	_	NN	Protein	[30]	['multitoken']	_	_
25	binding	_	_	NN	Protein	[30]	['multitoken']	_	_
26	protein	_	_	NN	Protein	[30]	['multitoken']	_	_
27	(	_	_	-LRB-	Protein	[30]	['multitoken']	_	_
28	GATA	_	_	NN	Protein	[30]	['multitoken']	_	_
29	)	_	_	-RRB-	Protein	[30]	['multitoken']	_	_
30	-3	_	_	CD	Protein	[15]	['Cause']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	Glimcher	_	_	NNP	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	Murphy	_	_	NNP	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	2000	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	development	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	Th17	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	requires	_	_	VBZ	O	[-1]	['none']	_	_
7	IL-6	_	_	NN	Protein	[0]	['root']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	TGF-beta	_	_	NN	Protein	[0]	['root']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	STAT3	_	_	NN	Protein	[14]	['Cause']	_	_
14	dependent	_	_	JJ	Positive_regulation	[0]	['root']	_	_
15	expression	_	_	NN	Gene_expression	[14]	['Theme']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	transcription	_	_	NN	O	[-1]	['none']	_	_
19	factor	_	_	NN	O	[-1]	['none']	_	_
20	RORgammat	_	_	NN	Protein	[15]	['Theme']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	Ivanov	_	_	NNP	O	[-1]	['none']	_	_
23	et	_	_	FW	O	[-1]	['none']	_	_
24	al.	_	_	FW	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	2007	_	_	CD	O	[-1]	['none']	_	_
27	;	_	_	:	O	[-1]	['none']	_	_
28	Stockinger	_	_	NNP	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	2007	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Th1	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	Th2	_	_	NN	O	[-1]	['none']	_	_
4	cell	_	_	NN	O	[-1]	['none']	_	_
5	responses	_	_	NNS	O	[-1]	['none']	_	_
6	can	_	_	MD	O	[-1]	['none']	_	_
7	also	_	_	RB	O	[-1]	['none']	_	_
8	be	_	_	VB	O	[-1]	['none']	_	_
9	induced	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	varying	_	_	VBG	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	dose	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	antigen	_	_	NN	O	[-1]	['none']	_	_
16	presented	_	_	VBN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	naive	_	_	JJ	O	[-1]	['none']	_	_
20	T	_	_	NN	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	antigen	_	_	NN	O	[-1]	['none']	_	_
25	presenting	_	_	VBG	O	[-1]	['none']	_	_
26	cell	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	APC	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Whereas	_	_	IN	O	[-1]	['none']	_	_
2	high	_	_	JJ	O	[-1]	['none']	_	_
3	doses	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	antigen	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	sustained	_	_	JJ	O	[-1]	['none']	_	_
9	TCR	_	_	NN	O	[-1]	['none']	_	_
10	signaling	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	extracellular-signal	_	_	JJ	O	[-1]	['none']	_	_
13	regulated	_	_	JJ	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	ERK	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	mitogen	_	_	NN	O	[-1]	['none']	_	_
18	activated	_	_	VBN	O	[-1]	['none']	_	_
19	protein	_	_	NN	O	[-1]	['none']	_	_
20	kinase	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	MAPK	_	_	NN	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	result	_	_	VBP	Positive_regulation	[0]	['root']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	Th1	_	_	NN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	producing	_	_	VBG	Gene_expression	[26, 34]	['Theme', 'Theme']	_	_
31	IFN-gamma	_	_	NN	Protein	[30]	['Theme']	_	_
32	via	_	_	IN	O	[-1]	['none']	_	_
33	an	_	_	DT	O	[-1]	['none']	_	_
34	IL-12-independent	_	_	JJ	Regulation	[0]	['root']	_	_
35	mechanism	_	_	NN	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	low	_	_	JJ	O	[-1]	['none']	_	_
38	doses	_	_	NNS	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	antigen	_	_	NN	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	with	_	_	IN	O	[-1]	['none']	_	_
43	transient	_	_	JJ	O	[-1]	['none']	_	_
44	ERK1	_	_	NN	Protein	[47]	['Theme']	_	_
45	and	_	_	CC	O	[-1]	['none']	_	_
46	ERK2	_	_	NN	Protein	[47]	['Theme']	_	_
47	activation	_	_	NN	Positive_regulation	[49]	['Cause']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	favor	_	_	NN	Positive_regulation	[0]	['root']	_	_
50	Th2	_	_	NN	O	[-1]	['none']	_	_
51	responses	_	_	NNS	O	[-1]	['none']	_	_
52	and	_	_	CC	O	[-1]	['none']	_	_
53	IL-4	_	_	NN	Protein	[54]	['Theme']	_	_
54	secretion	_	_	NN	Localization	[49]	['Theme']	_	_
55	(	_	_	-LRB-	O	[-1]	['none']	_	_
56	Constant	_	_	JJ	O	[-1]	['none']	_	_
57	et	_	_	FW	O	[-1]	['none']	_	_
58	al.	_	_	FW	O	[-1]	['none']	_	_
59	,	_	_	,	O	[-1]	['none']	_	_
60	1995	_	_	CD	O	[-1]	['none']	_	_
61	;	_	_	:	O	[-1]	['none']	_	_
62	Hosken	_	_	NNP	O	[-1]	['none']	_	_
63	et	_	_	FW	O	[-1]	['none']	_	_
64	al.	_	_	FW	O	[-1]	['none']	_	_
65	,	_	_	,	O	[-1]	['none']	_	_
66	1995	_	_	CD	O	[-1]	['none']	_	_
67	;	_	_	:	O	[-1]	['none']	_	_
68	Jorritsma	_	_	NNP	O	[-1]	['none']	_	_
69	et	_	_	FW	O	[-1]	['none']	_	_
70	al.	_	_	FW	O	[-1]	['none']	_	_
71	,	_	_	,	O	[-1]	['none']	_	_
72	2003	_	_	CD	O	[-1]	['none']	_	_
73	;	_	_	:	O	[-1]	['none']	_	_
74	Yamane	_	_	NNP	O	[-1]	['none']	_	_
75	et	_	_	FW	O	[-1]	['none']	_	_
76	al.	_	_	FW	O	[-1]	['none']	_	_
77	,	_	_	,	O	[-1]	['none']	_	_
78	2005	_	_	CD	O	[-1]	['none']	_	_
79	)	_	_	-RRB-	O	[-1]	['none']	_	_
80	.	_	_	.	O	[-1]	['none']	_	_

1	Because	_	_	IN	O	[-1]	['none']	_	_
2	Th1	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	Th2	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	cross	_	_	VBP	O	[-1]	['none']	_	_
7	regulate	_	_	VB	O	[-1]	['none']	_	_
8	each	_	_	DT	O	[-1]	['none']	_	_
9	other	_	_	JJ	O	[-1]	['none']	_	_
10	's	_	_	POS	O	[-1]	['none']	_	_
11	development	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	function	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	can	_	_	MD	O	[-1]	['none']	_	_
16	suppress	_	_	VB	O	[-1]	['none']	_	_
17	Th17	_	_	NN	O	[-1]	['none']	_	_
18	cell	_	_	NN	O	[-1]	['none']	_	_
19	responses	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	all	_	_	DT	O	[-1]	['none']	_	_
23	differentiate	_	_	VBP	O	[-1]	['none']	_	_
24	along	_	_	IN	O	[-1]	['none']	_	_
25	distinct	_	_	JJ	O	[-1]	['none']	_	_
26	signaling	_	_	NN	O	[-1]	['none']	_	_
27	pathways	_	_	NNS	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	Glimcher	_	_	NNP	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	Murphy	_	_	NNP	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	2000	_	_	CD	O	[-1]	['none']	_	_
34	;	_	_	:	O	[-1]	['none']	_	_
35	Stockinger	_	_	NNP	O	[-1]	['none']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	Veldhoen	_	_	NNP	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	2007	_	_	CD	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	IL-10	_	_	NN	Protein	[43, 55]	['Theme', 'Cause']	_	_
43	produced	_	_	VBN	Gene_expression	[55]	['Theme']	_	_
44	by	_	_	IN	O	[-1]	['none']	_	_
45	all	_	_	PDT	O	[-1]	['none']	_	_
46	these	_	_	DT	O	[-1]	['none']	_	_
47	Th	_	_	NN	O	[-1]	['none']	_	_
48	cells	_	_	NNS	O	[-1]	['none']	_	_
49	may	_	_	MD	O	[-1]	['none']	_	_
50	thus	_	_	RB	O	[-1]	['none']	_	_
51	act	_	_	VB	Regulation	[55]	['multitoken']	_	_
52	as	_	_	IN	Regulation	[55]	['multitoken']	_	_
53	a	_	_	DT	Regulation	[55]	['multitoken']	_	_
54	feedback	_	_	NN	Regulation	[55]	['multitoken']	_	_
55	regulator	_	_	NN	Regulation	[0]	['root']	_	_
56	to	_	_	TO	O	[-1]	['none']	_	_
57	control	_	_	VB	O	[-1]	['none']	_	_
58	the	_	_	DT	O	[-1]	['none']	_	_
59	pathology	_	_	NN	O	[-1]	['none']	_	_
60	associated	_	_	VBN	O	[-1]	['none']	_	_
61	with	_	_	IN	O	[-1]	['none']	_	_
62	an	_	_	DT	O	[-1]	['none']	_	_
63	overexuberant	_	_	JJ	O	[-1]	['none']	_	_
64	,	_	_	,	O	[-1]	['none']	_	_
65	albeit	_	_	IN	O	[-1]	['none']	_	_
66	efficacious	_	_	JJ	O	[-1]	['none']	_	_
67	,	_	_	,	O	[-1]	['none']	_	_
68	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
69	response	_	_	NN	O	[-1]	['none']	_	_
70	.	_	_	.	O	[-1]	['none']	_	_

1	Whether	_	_	IN	O	[-1]	['none']	_	_
2	IL-10	_	_	NN	Protein	[3]	['Theme']	_	_
3	production	_	_	NN	Gene_expression	[11]	['Theme']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	these	_	_	DT	O	[-1]	['none']	_	_
6	different	_	_	JJ	O	[-1]	['none']	_	_
7	Th	_	_	NN	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	subsets	_	_	NNS	O	[-1]	['none']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	independent	_	_	JJ	O	[-1]	['none']	_	_
14	and/or	_	_	CC	O	[-1]	['none']	_	_
15	common	_	_	JJ	O	[-1]	['none']	_	_
16	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	unknown	_	_	JJ	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Here	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	showed	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	in	_	_	FW	O	[-1]	['none']	_	_
7	vitro	_	_	FW	O	[-1]	['none']	_	_
8	differentiation	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
11	Th1	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	naive	_	_	JJ	O	[-1]	['none']	_	_
15	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
16	T	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	required	_	_	VBN	O	[-1]	['none']	_	_
19	IL-12-induced	_	_	JJ	Protein	[0]	['root']	_	_
20	STAT4	_	_	NN	Protein	[0]	['root']	_	_
21	signaling	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	strong	_	_	JJ	O	[-1]	['none']	_	_
24	TCR	_	_	NN	O	[-1]	['none']	_	_
25	activation	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	high	_	_	JJ	O	[-1]	['none']	_	_
28	antigen	_	_	NN	O	[-1]	['none']	_	_
29	dose	_	_	NN	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	sustained	_	_	JJ	O	[-1]	['none']	_	_
34	ERK1	_	_	NN	Protein	[37]	['Theme']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	ERK2	_	_	NN	Protein	[37]	['Theme']	_	_
37	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	showed	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	activation	_	_	NN	Positive_regulation	[13]	['Cause']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	ERK1	_	_	NN	Protein	[6]	['Theme']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	ERK2	_	_	NN	Protein	[6]	['Theme']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	requirement	_	_	NN	Positive_regulation	[0]	['root']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	production	_	_	NN	Gene_expression	[13]	['Theme']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	IL-10	_	_	NN	Protein	[15]	['Theme']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	Th1	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	Th2	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	Th17	_	_	NN	O	[-1]	['none']	_	_
25	cell	_	_	NN	O	[-1]	['none']	_	_
26	subsets	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	common	_	_	JJ	O	[-1]	['none']	_	_
3	but	_	_	CC	O	[-1]	['none']	_	_
4	highly	_	_	RB	O	[-1]	['none']	_	_
5	regulated	_	_	VBN	O	[-1]	['none']	_	_
6	pathway	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	IL-10	_	_	NN	Protein	[9]	['Theme']	_	_
9	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	maintenance	_	_	NN	O	[-1]	['none']	_	_
12	ensures	_	_	VBZ	O	[-1]	['none']	_	_
13	its	_	_	PRP$	O	[-1]	['none']	_	_
14	function	_	_	NN	O	[-1]	['none']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	feedback	_	_	NN	O	[-1]	['none']	_	_
18	loop	_	_	NN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	control	_	_	VB	O	[-1]	['none']	_	_
21	damage	_	_	NN	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	host	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	also	_	_	RB	O	[-1]	['none']	_	_
27	allows	_	_	VBZ	O	[-1]	['none']	_	_
28	a	_	_	DT	O	[-1]	['none']	_	_
29	protective	_	_	JJ	O	[-1]	['none']	_	_
30	response	_	_	NN	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	ensue	_	_	VB	O	[-1]	['none']	_	_
33	as	_	_	IN	O	[-1]	['none']	_	_
34	opposed	_	_	VBN	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	chronic	_	_	JJ	O	[-1]	['none']	_	_
37	infection	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	Data	_	_	NNS	O	[-1]	['none']	_	_
4	are	_	_	VBP	O	[-1]	['none']	_	_
5	expressed	_	_	VBN	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	mean	_	_	NN	O	[-1]	['none']	_	_
8	+/-	_	_	CC	O	[-1]	['none']	_	_
9	SD	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	statistical	_	_	JJ	O	[-1]	['none']	_	_
3	significance	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	differences	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	means	_	_	NNS	O	[-1]	['none']	_	_
8	between	_	_	IN	O	[-1]	['none']	_	_
9	experimental	_	_	JJ	O	[-1]	['none']	_	_
10	groups	_	_	NNS	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	determined	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	Students	_	_	NNS	O	[-1]	['none']	_	_
15	'	_	_	POS	O	[-1]	['none']	_	_
16	t-test	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Normal	_	_	JJ	Negative_regulation	[0]	['root']	_	_
2	TLR4	_	_	NN	Protein	[5]	['Theme']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	MD2	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
8	IL10	_	_	NN	Protein	[9]	['Theme']	_	_
9	secretion	_	_	NN	Gene_expression	[7]	['Theme']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	A20	_	_	NN	Protein	[12]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	cpdm	_	_	NN	O	[-1]	['none']	_	_
15	BMDC	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Unstimulated	_	_	JJ	O	[-1]	['none']	_	_
5	WT	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	cpdm	_	_	NN	O	[-1]	['none']	_	_
8	BMDC	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	5x105	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	labeled	_	_	VBN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	PE	_	_	NN	O	[-1]	['none']	_	_
16	labeled	_	_	VBN	O	[-1]	['none']	_	_
17	anti-TLR4	_	_	JJ	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	MD2	_	_	NN	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	anti-CD14	_	_	JJ	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	then	_	_	RB	O	[-1]	['none']	_	_
24	subject	_	_	JJ	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	flow	_	_	NN	O	[-1]	['none']	_	_
27	cytometry	_	_	NN	O	[-1]	['none']	_	_
28	analysis	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Unstained	_	_	JJ	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	serve	_	_	VBP	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	negative	_	_	JJ	O	[-1]	['none']	_	_
6	controls	_	_	NNS	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Cultured	_	_	VBN	O	[-1]	['none']	_	_
5	WT	_	_	NNP	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	cpdm	_	_	JJ	O	[-1]	['none']	_	_
8	BMDC	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	1x105	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	0.1	_	_	CD	O	[-1]	['none']	_	_
14	ml	_	_	NN	O	[-1]	['none']	_	_
15	complete	_	_	JJ	O	[-1]	['none']	_	_
16	medium	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	washed	_	_	VBN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	stimulated	_	_	VBN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	medium	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	100	_	_	CD	O	[-1]	['none']	_	_
26	ng/ml	_	_	NN	O	[-1]	['none']	_	_
27	LPS	_	_	NN	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	25	_	_	CD	O	[-1]	['none']	_	_
30	microg/ml	_	_	NN	O	[-1]	['none']	_	_
31	poly	_	_	NN	O	[-1]	['none']	_	_
32	I	_	_	NN	O	[-1]	['none']	_	_
33	:	_	_	:	O	[-1]	['none']	_	_
34	C	_	_	NN	O	[-1]	['none']	_	_
35	for	_	_	IN	O	[-1]	['none']	_	_
36	24	_	_	CD	O	[-1]	['none']	_	_
37	hours	_	_	NNS	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Supernatants	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	collected	_	_	VBN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	ELISA	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IL10	_	_	NN	Protein	[0]	['root']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Cultured	_	_	VBN	O	[-1]	['none']	_	_
5	WT	_	_	NNP	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	cpdm	_	_	JJ	O	[-1]	['none']	_	_
8	BMDC	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	5x105	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	0.2	_	_	CD	O	[-1]	['none']	_	_
14	ml	_	_	NN	O	[-1]	['none']	_	_
15	complete	_	_	JJ	O	[-1]	['none']	_	_
16	medium	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	washed	_	_	VBN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	stimulated	_	_	VBN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	100	_	_	CD	O	[-1]	['none']	_	_
24	ng/ml	_	_	NN	O	[-1]	['none']	_	_
25	LPS	_	_	NN	O	[-1]	['none']	_	_
26	or	_	_	CC	O	[-1]	['none']	_	_
27	25	_	_	CD	O	[-1]	['none']	_	_
28	microg/ml	_	_	NN	O	[-1]	['none']	_	_
29	poly	_	_	NN	O	[-1]	['none']	_	_
30	I	_	_	NN	O	[-1]	['none']	_	_
31	:	_	_	:	O	[-1]	['none']	_	_
32	C	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	0	_	_	CD	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	1	_	_	CD	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	2	_	_	CD	O	[-1]	['none']	_	_
8	hours	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	total	_	_	JJ	O	[-1]	['none']	_	_
11	RNA	_	_	NN	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	extracted	_	_	VBN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	subject	_	_	JJ	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	qRT-PCR	_	_	NN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	measure	_	_	VB	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	production	_	_	NN	Gene_expression	[0]	['root']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	A20	_	_	NN	Protein	[21]	['Theme']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Chronic	_	_	JJ	O	[-1]	['none']	_	_
2	myeloid	_	_	JJ	O	[-1]	['none']	_	_
3	leukemia	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	CML	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	clonal	_	_	JJ	O	[-1]	['none']	_	_
10	myeloproliferative	_	_	JJ	O	[-1]	['none']	_	_
11	disorder	_	_	NN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	typical	_	_	JJ	O	[-1]	['none']	_	_
15	three	_	_	CD	O	[-1]	['none']	_	_
16	phased	_	_	JJ	O	[-1]	['none']	_	_
17	course	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	chronic	_	_	JJ	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	accelerated	_	_	VBD	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	blastic	_	_	JJ	O	[-1]	['none']	_	_
24	phase	_	_	NN	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	reflecting	_	_	VBG	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	loss	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	differentiation	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	malignant	_	_	JJ	O	[-1]	['none']	_	_
33	progress	_	_	NN	O	[-1]	['none']	_	_
34	which	_	_	WDT	O	[-1]	['none']	_	_
35	inevitably	_	_	RB	O	[-1]	['none']	_	_
36	leads	_	_	VBZ	O	[-1]	['none']	_	_
37	to	_	_	TO	O	[-1]	['none']	_	_
38	death	_	_	NN	O	[-1]	['none']	_	_
39	after	_	_	IN	O	[-1]	['none']	_	_
40	the	_	_	DT	O	[-1]	['none']	_	_
41	blastic	_	_	JJ	O	[-1]	['none']	_	_
42	phase	_	_	NN	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	1,2	_	_	CD	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	hallmark	_	_	NN	O	[-1]	['none']	_	_
3	genetic	_	_	JJ	O	[-1]	['none']	_	_
4	aberration	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	CML	_	_	NN	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	reciprocal	_	_	JJ	O	[-1]	['none']	_	_
10	chromosomal	_	_	JJ	O	[-1]	['none']	_	_
11	translocation	_	_	NN	O	[-1]	['none']	_	_
12	t	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	9	_	_	CD	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	22	_	_	CD	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	leading	_	_	VBG	Positive_regulation	[0]	['root']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	expression	_	_	NN	Gene_expression	[18]	['Theme']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	bcr-abl	_	_	JJ	Protein	[25]	['multitoken']	_	_
24	fusion	_	_	NN	Protein	[25]	['multitoken']	_	_
25	gene	_	_	NN	Protein	[20]	['Theme']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	an	_	_	DT	O	[-1]	['none']	_	_
28	aberrant	_	_	JJ	O	[-1]	['none']	_	_
29	activated	_	_	VBN	O	[-1]	['none']	_	_
30	tyrosine	_	_	NN	O	[-1]	['none']	_	_
31	kinase	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	2	_	_	CD	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Treatment	_	_	NN	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	interferon	_	_	NN	Protein	[4]	['multitoken']	_	_
4	alpha	_	_	NN	Protein	[0]	['root']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	IFN-alpha	_	_	NN	Protein	[0]	['root']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	prolongs	_	_	VBZ	O	[-1]	['none']	_	_
9	survival	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	CML	_	_	NN	O	[-1]	['none']	_	_
12	patients	_	_	NNS	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	associated	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	complete	_	_	JJ	O	[-1]	['none']	_	_
19	cytogenetic	_	_	JJ	O	[-1]	['none']	_	_
20	response	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	5-33	_	_	CD	O	[-1]	['none']	_	_
23	%	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	CML	_	_	NN	O	[-1]	['none']	_	_
26	patients	_	_	NNS	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	1,2	_	_	CD	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Recently	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	described	_	_	VBD	O	[-1]	['none']	_	_
5	an	_	_	DT	O	[-1]	['none']	_	_
6	impaired	_	_	JJ	Negative_regulation	[0]	['root']	_	_
7	expression	_	_	NN	Gene_expression	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	interferon	_	_	NN	Protein	[13]	['multitoken']	_	_
11	regulatory	_	_	JJ	Protein	[13]	['multitoken']	_	_
12	factor	_	_	NN	Protein	[13]	['multitoken']	_	_
13	4	_	_	CD	Protein	[7]	['Theme']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	CML	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	correlating	_	_	VBG	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	poor	_	_	JJ	O	[-1]	['none']	_	_
23	response	_	_	NN	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	IFN-alpha	_	_	NN	Protein	[0]	['root']	_	_
26	treatment	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	3	_	_	CD	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cause	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	silencing	_	_	NN	Negative_regulation	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IRF-4	_	_	NN	Protein	[5]	['Theme']	_	_
8	level	_	_	NN	O	[-1]	['none']	_	_
9	remained	_	_	VBD	O	[-1]	['none']	_	_
10	unclear	_	_	JJ	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Interferon	_	_	NN	O	[-1]	['none']	_	_
2	regulatory	_	_	JJ	O	[-1]	['none']	_	_
3	factors	_	_	NNS	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	IRFs	_	_	NNS	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	are	_	_	VBP	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	family	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
12	regulators	_	_	NNS	O	[-1]	['none']	_	_
13	defined	_	_	VBN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	characteristic	_	_	JJ	O	[-1]	['none']	_	_
17	homology	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	their	_	_	PRP$	O	[-1]	['none']	_	_
20	DNA	_	_	NN	O	[-1]	['none']	_	_
21	binding	_	_	NN	O	[-1]	['none']	_	_
22	domain	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	They	_	_	PRP	O	[-1]	['none']	_	_
2	play	_	_	VBP	O	[-1]	['none']	_	_
3	an	_	_	DT	O	[-1]	['none']	_	_
4	important	_	_	JJ	O	[-1]	['none']	_	_
5	role	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	regulation	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	various	_	_	JJ	O	[-1]	['none']	_	_
11	genes	_	_	NNS	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	such	_	_	JJ	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	IFNs	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	interleukins	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	MHC	_	_	NN	O	[-1]	['none']	_	_
20	class	_	_	NN	O	[-1]	['none']	_	_
21	I/II	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	apoptosis	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	differentiation	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	maturation	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	4-6	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	IRF-4	_	_	NNP	Protein	[11]	['Theme']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	ICSAT/Pip/MUM1/LSIRF	_	_	NN	Protein	[0]	['root']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	one	_	_	CD	O	[-1]	['none']	_	_
7	member	_	_	NN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	very	_	_	RB	O	[-1]	['none']	_	_
10	restricted	_	_	JJ	O	[-1]	['none']	_	_
11	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
12	pattern	_	_	NN	O	[-1]	['none']	_	_
13	:	_	_	:	O	[-1]	['none']	_	_
14	Predominately	_	_	RB	O	[-1]	['none']	_	_
15	B-	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	activated	_	_	VBN	O	[-1]	['none']	_	_
18	T-lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
19	are	_	_	VBP	O	[-1]	['none']	_	_
20	IRF-4	_	_	NN	Protein	[21]	['Theme']	_	_
21	positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	7-11	_	_	CD	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	other	_	_	JJ	O	[-1]	['none']	_	_
5	IRFs	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	expression	_	_	NN	Gene_expression	[13]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	IRF-4	_	_	NN	Protein	[7]	['Theme']	_	_
10	can	_	_	MD	O	[-1]	['none']	_	_
11	not	_	_	RB	O	[-1]	['none']	_	_
12	be	_	_	VB	O	[-1]	['none']	_	_
13	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	IFNs	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	but	_	_	CC	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	antigen	_	_	NN	O	[-1]	['none']	_	_
20	stimulation	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	crosslinking	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	T-	_	_	NN	O	[-1]	['none']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	B-cell	_	_	NN	O	[-1]	['none']	_	_
27	receptors	_	_	NNS	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	phorbol-myristate-acetate	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	10,11	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Consistent	_	_	JJ	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	restriction	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	expression	_	_	NN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	immunocompetent	_	_	JJ	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	mice	_	_	NNS	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	deletion	_	_	NN	Negative_regulation	[0]	['root']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IRF-4	_	_	NN	Protein	[13]	['Theme']	_	_
16	failed	_	_	VBD	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	develop	_	_	VB	O	[-1]	['none']	_	_
19	mature	_	_	JJ	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	functionally	_	_	RB	O	[-1]	['none']	_	_
22	active	_	_	JJ	O	[-1]	['none']	_	_
23	B-	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	T-lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	12	_	_	CD	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	impaired	_	_	JJ	O	[-1]	['none']	_	_
33	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	IRF-4	_	_	NN	Protein	[33]	['Theme']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	CML	_	_	NN	O	[-1]	['none']	_	_
38	was	_	_	VBD	O	[-1]	['none']	_	_
39	predominately	_	_	RB	O	[-1]	['none']	_	_
40	found	_	_	VBN	O	[-1]	['none']	_	_
41	in	_	_	IN	O	[-1]	['none']	_	_
42	T-cells	_	_	NNS	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	3	_	_	CD	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	crucial	_	_	JJ	O	[-1]	['none']	_	_
6	role	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	function	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	immune	_	_	JJ	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Methylation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	dinucleotide	_	_	NN	O	[-1]	['none']	_	_
4	cytosine-guanosine	_	_	NN	O	[-1]	['none']	_	_
5	motifs	_	_	NNS	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	CpG	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	especially	_	_	RB	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	CpG	_	_	NN	O	[-1]	['none']	_	_
13	islands	_	_	NNS	O	[-1]	['none']	_	_
14	located	_	_	JJ	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	promoter	_	_	NN	O	[-1]	['none']	_	_
17	regions	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	is	_	_	VBZ	O	[-1]	['none']	_	_
20	one	_	_	CD	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	gene	_	_	NN	O	[-1]	['none']	_	_
26	regulation	_	_	NN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	mammals	_	_	NNS	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	common	_	_	JJ	O	[-1]	['none']	_	_
32	event	_	_	NN	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	gene	_	_	NN	O	[-1]	['none']	_	_
35	silencing	_	_	NN	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	human	_	_	NN	O	[-1]	['none']	_	_
38	neoplasias	_	_	NNS	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	13,14	_	_	CD	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	opposed	_	_	VBN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	normal	_	_	JJ	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	hypermethylation	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	CpG	_	_	NN	O	[-1]	['none']	_	_
10	islands	_	_	NNS	O	[-1]	['none']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	frequently	_	_	RB	O	[-1]	['none']	_	_
14	observed	_	_	VBN	O	[-1]	['none']	_	_
15	phenomenon	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	every	_	_	DT	O	[-1]	['none']	_	_
18	cancer	_	_	NN	O	[-1]	['none']	_	_
19	type	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	De	_	_	NNP	O	[-1]	['none']	_	_
2	novo	_	_	FW	O	[-1]	['none']	_	_
3	DNA	_	_	NN	O	[-1]	['none']	_	_
4	methylation	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	genes	_	_	NNS	O	[-1]	['none']	_	_
7	such	_	_	JJ	O	[-1]	['none']	_	_
8	as	_	_	IN	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	cycle	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	DNA	_	_	NN	O	[-1]	['none']	_	_
13	repair	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	apoptosis	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	tumor	_	_	NN	O	[-1]	['none']	_	_
18	suppressor	_	_	NN	O	[-1]	['none']	_	_
19	genes	_	_	NNS	O	[-1]	['none']	_	_
20	is	_	_	VBZ	O	[-1]	['none']	_	_
21	therefore	_	_	RB	O	[-1]	['none']	_	_
22	thought	_	_	VBN	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	be	_	_	VB	O	[-1]	['none']	_	_
25	involved	_	_	VBN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	tumorigenesis	_	_	NN	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	15-17	_	_	CD	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Examples	_	_	NNS	O	[-1]	['none']	_	_
2	for	_	_	IN	O	[-1]	['none']	_	_
3	such	_	_	JJ	O	[-1]	['none']	_	_
4	aberrated	_	_	JJ	O	[-1]	['none']	_	_
5	genes	_	_	NNS	O	[-1]	['none']	_	_
6	are	_	_	VBP	O	[-1]	['none']	_	_
7	MGMT	_	_	NNP	Protein	[0]	['root']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	DAPK	_	_	NNP	Protein	[0]	['root']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	p14ARF	_	_	NN	Protein	[0]	['root']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	p15INK4b	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	p16INK4a	_	_	NN	Protein	[0]	['root']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	BRCA1	_	_	NN	Protein	[0]	['root']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	CDH13	_	_	NN	Protein	[0]	['root']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	APAF-1	_	_	NN	Protein	[0]	['root']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	17-19	_	_	CD	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	CML	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	methylation	_	_	NN	O	[-1]	['none']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	known	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	regulate	_	_	VB	Regulation	[0]	['root']	_	_
9	expression	_	_	NN	Gene_expression	[8]	['Theme']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	c-abl	_	_	NN	Protein	[9]	['Theme']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	bcr	_	_	NN	Protein	[9]	['Theme']	_	_
16	gene	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	others	_	_	NNS	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	20-23	_	_	CD	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	extent	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	methylation	_	_	NN	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	c-abl	_	_	NN	Protein	[0]	['root']	_	_
31	promoter	_	_	NN	O	[-1]	['none']	_	_
32	has	_	_	VBZ	O	[-1]	['none']	_	_
33	been	_	_	VBN	O	[-1]	['none']	_	_
34	shown	_	_	VBN	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	be	_	_	VB	O	[-1]	['none']	_	_
37	associated	_	_	VBN	O	[-1]	['none']	_	_
38	with	_	_	IN	O	[-1]	['none']	_	_
39	advanced	_	_	JJ	O	[-1]	['none']	_	_
40	disease	_	_	NN	O	[-1]	['none']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	24	_	_	CD	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	Hypermethylation	_	_	NN	O	[-1]	['none']	_	_
2	due	_	_	JJ	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	overexpression	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	DNA	_	_	NN	O	[-1]	['none']	_	_
7	methyltransferases	_	_	NNS	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	DNMTs	_	_	NNS	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	remains	_	_	VBZ	O	[-1]	['none']	_	_
12	one	_	_	CD	O	[-1]	['none']	_	_
13	possible	_	_	JJ	O	[-1]	['none']	_	_
14	explanation	_	_	NN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	de	_	_	FW	O	[-1]	['none']	_	_
17	novo	_	_	FW	O	[-1]	['none']	_	_
18	methylation	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	tumorigenesis	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Recently	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	DNMTs	_	_	NNS	O	[-1]	['none']	_	_
4	have	_	_	VBP	O	[-1]	['none']	_	_
5	been	_	_	VBN	O	[-1]	['none']	_	_
6	shown	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	be	_	_	VB	O	[-1]	['none']	_	_
9	up-regulated	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	hematopoietic	_	_	JJ	O	[-1]	['none']	_	_
12	malignancies	_	_	NNS	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	25	_	_	CD	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Methyl-CpG-binding	_	_	NNP	O	[-1]	['none']	_	_
2	proteins	_	_	NNS	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	MBPs	_	_	NNS	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	are	_	_	VBP	O	[-1]	['none']	_	_
7	thought	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	inhibit	_	_	VB	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	binding	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
14	factors	_	_	NNS	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	promoter	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	are	_	_	VBP	O	[-1]	['none']	_	_
20	therefore	_	_	RB	O	[-1]	['none']	_	_
21	discussed	_	_	VBN	O	[-1]	['none']	_	_
22	as	_	_	IN	O	[-1]	['none']	_	_
23	one	_	_	CD	O	[-1]	['none']	_	_
24	mechanism	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	transcription	_	_	NN	O	[-1]	['none']	_	_
27	inhibition	_	_	NN	O	[-1]	['none']	_	_
28	by	_	_	IN	O	[-1]	['none']	_	_
29	hypermethylation	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	26	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	work	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	we	_	_	PRP	O	[-1]	['none']	_	_
6	studied	_	_	VBD	O	[-1]	['none']	_	_
7	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	IRF-4	_	_	NN	Protein	[11]	['Theme']	_	_
10	gene	_	_	NN	O	[-1]	['none']	_	_
11	expression	_	_	NN	Gene_expression	[12]	['Theme']	_	_
12	silencing	_	_	NN	Negative_regulation	[0]	['root']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	leukemic	_	_	JJ	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	analyzed	_	_	VBD	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
5	promoter	_	_	NN	O	[-1]	['none']	_	_
6	region	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	genetic	_	_	JJ	O	[-1]	['none']	_	_
9	aberrations	_	_	NNS	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	methylational	_	_	JJ	O	[-1]	['none']	_	_
12	status	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
17	hematopoietic	_	_	JJ	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Enzyme	_	_	NN	O	[-1]	['none']	_	_
2	linked	_	_	JJ	O	[-1]	['none']	_	_
3	immunosorbent	_	_	JJ	O	[-1]	['none']	_	_
4	assay	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	ELISA	_	_	NN	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	ELISA	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	performed	_	_	VBN	O	[-1]	['none']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	supernatants	_	_	NNS	O	[-1]	['none']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	challenged	_	_	VBN	O	[-1]	['none']	_	_
15	Jurkat	_	_	NN	O	[-1]	['none']	_	_
16	T-cells	_	_	NNS	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	quantify	_	_	VB	O	[-1]	['none']	_	_
19	IL-6	_	_	NN	Protein	[0]	['root']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	TNF	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	BD	_	_	NN	O	[-1]	['none']	_	_
26	OptEIA	_	_	NN	O	[-1]	['none']	_	_
27	Human	_	_	NN	O	[-1]	['none']	_	_
28	IL-6	_	_	NN	Protein	[0]	['root']	_	_
29	Elisa	_	_	NNP	O	[-1]	['none']	_	_
30	Set	_	_	VB	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	BD	_	_	NNP	O	[-1]	['none']	_	_
33	OptEIA	_	_	NNP	O	[-1]	['none']	_	_
34	Human	_	_	NN	O	[-1]	['none']	_	_
35	CXCL8	_	_	NNP	Protein	[0]	['root']	_	_
36	Elisa	_	_	NNP	O	[-1]	['none']	_	_
37	Set	_	_	VB	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	BD	_	_	NN	O	[-1]	['none']	_	_
40	OptEIA	_	_	NN	O	[-1]	['none']	_	_
41	Human	_	_	NN	O	[-1]	['none']	_	_
42	TNF	_	_	NN	Protein	[0]	['root']	_	_
43	Elisa	_	_	NNP	O	[-1]	['none']	_	_
44	Set	_	_	VB	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	USA	_	_	NNP	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	according	_	_	VBG	O	[-1]	['none']	_	_
51	to	_	_	TO	O	[-1]	['none']	_	_
52	the	_	_	DT	O	[-1]	['none']	_	_
53	manufacturer	_	_	NN	O	[-1]	['none']	_	_
54	's	_	_	POS	O	[-1]	['none']	_	_
55	instructions	_	_	NNS	O	[-1]	['none']	_	_
56	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Jurkat	_	_	NN	O	[-1]	['none']	_	_
4	T-cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	stimulated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	PMA	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	162	_	_	CD	O	[-1]	['none']	_	_
11	nM	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	1	_	_	CD	O	[-1]	['none']	_	_
15	h	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	1000	_	_	CD	O	[-1]	['none']	_	_
20	x	_	_	NN	O	[-1]	['none']	_	_
21	g	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	8	_	_	CD	O	[-1]	['none']	_	_
24	min	_	_	NN	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	supernatants	_	_	NNS	O	[-1]	['none']	_	_
29	were	_	_	VBD	O	[-1]	['none']	_	_
30	collected	_	_	VBN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	stored	_	_	VBN	O	[-1]	['none']	_	_
33	at	_	_	IN	O	[-1]	['none']	_	_
34	-80	_	_	CD	O	[-1]	['none']	_	_
35	degreesC	_	_	NN	O	[-1]	['none']	_	_
36	until	_	_	IN	O	[-1]	['none']	_	_
37	use	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Following	_	_	VBG	O	[-1]	['none']	_	_
2	centrifugation	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	resuspended	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	1	_	_	CD	O	[-1]	['none']	_	_
10	h	_	_	NN	O	[-1]	['none']	_	_
11	aged	_	_	JJ	O	[-1]	['none']	_	_
12	media	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	where	_	_	WRB	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	have	_	_	VBP	O	[-1]	['none']	_	_
17	been	_	_	VBN	O	[-1]	['none']	_	_
18	grown	_	_	VBN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	containing	_	_	VBG	O	[-1]	['none']	_	_
22	PMA	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	same	_	_	JJ	O	[-1]	['none']	_	_
3	procedure	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	performed	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	collect	_	_	VB	O	[-1]	['none']	_	_
8	media	_	_	NNS	O	[-1]	['none']	_	_
9	after	_	_	IN	O	[-1]	['none']	_	_
10	2	_	_	CD	O	[-1]	['none']	_	_
11	h	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	6	_	_	CD	O	[-1]	['none']	_	_
14	h	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	final	_	_	JJ	O	[-1]	['none']	_	_
3	collection	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	media	_	_	NNS	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	performed	_	_	VBN	O	[-1]	['none']	_	_
8	after	_	_	IN	O	[-1]	['none']	_	_
9	24	_	_	CD	O	[-1]	['none']	_	_
10	h.	_	_	NN	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	culture	_	_	NN	O	[-1]	['none']	_	_
3	.	_	_	.	O	[-1]	['none']	_	_

1	HEK	_	_	NNP	O	[-1]	['none']	_	_
2	293T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	cultured	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	Dulbecco	_	_	NNP	O	[-1]	['none']	_	_
8	's	_	_	POS	O	[-1]	['none']	_	_
9	modified	_	_	VBN	O	[-1]	['none']	_	_
10	Eagle	_	_	NNP	O	[-1]	['none']	_	_
11	medium	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	Carlsbad	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	California	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	United	_	_	NNP	O	[-1]	['none']	_	_
20	States	_	_	NNPS	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Jurkat	_	_	NN	O	[-1]	['none']	_	_
2	T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	primary	_	_	JJ	O	[-1]	['none']	_	_
6	human	_	_	NN	O	[-1]	['none']	_	_
7	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
8	T	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	cultured	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	RPMI-1640	_	_	NN	O	[-1]	['none']	_	_
14	medium	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Media	_	_	NNP	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	supplemented	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	2	_	_	CD	O	[-1]	['none']	_	_
6	mM	_	_	NN	O	[-1]	['none']	_	_
7	L-glutamine	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	100	_	_	CD	O	[-1]	['none']	_	_
10	U/ml	_	_	NN	O	[-1]	['none']	_	_
11	penicillin	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	100	_	_	CD	O	[-1]	['none']	_	_
14	mug/ml	_	_	JJ	O	[-1]	['none']	_	_
15	streptomycin	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	Cambrex	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	East	_	_	NNP	O	[-1]	['none']	_	_
20	Rutherford	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	New	_	_	NNP	O	[-1]	['none']	_	_
23	Jersey	_	_	NNP	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	United	_	_	NNP	O	[-1]	['none']	_	_
26	States	_	_	NNPS	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	10	_	_	CD	O	[-1]	['none']	_	_
31	%	_	_	NN	O	[-1]	['none']	_	_
32	fetal	_	_	JJ	O	[-1]	['none']	_	_
33	bovine	_	_	JJ	O	[-1]	['none']	_	_
34	serum	_	_	NN	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	Atlanta	_	_	NNP	O	[-1]	['none']	_	_
37	Biologicals	_	_	NNP	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	Norcross	_	_	NNP	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	Georgia	_	_	NNP	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	United	_	_	NNP	O	[-1]	['none']	_	_
44	States	_	_	NNPS	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	Wild-Type	_	_	NNP	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	LMP1	_	_	NN	Protein	[0]	['root']	_	_
4	Transgenic	_	_	JJ	O	[-1]	['none']	_	_
5	Lymphoma	_	_	NN	O	[-1]	['none']	_	_
6	Cells	_	_	NNS	O	[-1]	['none']	_	_
7	Survive	_	_	VBP	O	[-1]	['none']	_	_
8	Independently	_	_	RB	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	IL4	_	_	NN	Protein	[0]	['root']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	Stat6	_	_	NN	Protein	[0]	['root']	_	_
13	Signaling	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	Culture	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	A	_	_	DT	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	Rnase	_	_	NN	O	[-1]	['none']	_	_
20	protection	_	_	NN	O	[-1]	['none']	_	_
21	assay	_	_	NN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	IL4	_	_	NN	Protein	[0]	['root']	_	_
24	mRNA	_	_	NN	O	[-1]	['none']	_	_
25	from	_	_	IN	O	[-1]	['none']	_	_
26	purified	_	_	VBN	O	[-1]	['none']	_	_
27	B	_	_	NN	O	[-1]	['none']	_	_
28	cells	_	_	NNS	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	from	_	_	IN	O	[-1]	['none']	_	_
33	WT	_	_	NNP	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	LMP1	_	_	NN	Protein	[0]	['root']	_	_
36	transgenic	_	_	JJ	O	[-1]	['none']	_	_
37	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	L32	_	_	NN	Protein	[0]	['root']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	GAPDH	_	_	NN	Protein	[0]	['root']	_	_
5	housekeeping	_	_	JJ	O	[-1]	['none']	_	_
6	genes	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	used	_	_	VBN	O	[-1]	['none']	_	_
9	as	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	loading	_	_	VBG	O	[-1]	['none']	_	_
12	control	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Arrow	_	_	NNP	O	[-1]	['none']	_	_
2	indicates	_	_	VBZ	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	position	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	protected	_	_	JJ	O	[-1]	['none']	_	_
8	probe	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	C	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
7	analysis	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	WT	_	_	NNP	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	LMP1	_	_	NN	Protein	[0]	['root']	_	_
12	transgenic	_	_	JJ	O	[-1]	['none']	_	_
13	mice	_	_	NNS	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
16	pStat6	_	_	NN	Protein	[15]	['Theme']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	B	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	purified	_	_	VBN	O	[-1]	['none']	_	_
22	B	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	at	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	time	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	harvest	_	_	NN	O	[-1]	['none']	_	_
32	or	_	_	CC	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	C	_	_	NN	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	whole	_	_	JJ	O	[-1]	['none']	_	_
38	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
39	cultured	_	_	VBN	O	[-1]	['none']	_	_
40	with	_	_	IN	O	[-1]	['none']	_	_
41	or	_	_	CC	O	[-1]	['none']	_	_
42	without	_	_	IN	O	[-1]	['none']	_	_
43	IL4	_	_	NN	Protein	[0]	['root']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Actin	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	used	_	_	VBN	O	[-1]	['none']	_	_
7	as	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	loading	_	_	VBG	O	[-1]	['none']	_	_
10	control	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	white	_	_	JJ	O	[-1]	['none']	_	_
15	line	_	_	NN	O	[-1]	['none']	_	_
16	indicates	_	_	VBZ	O	[-1]	['none']	_	_
17	that	_	_	IN	O	[-1]	['none']	_	_
18	intervening	_	_	VBG	O	[-1]	['none']	_	_
19	lanes	_	_	NNS	O	[-1]	['none']	_	_
20	have	_	_	VBP	O	[-1]	['none']	_	_
21	been	_	_	VBN	O	[-1]	['none']	_	_
22	spliced	_	_	VBN	O	[-1]	['none']	_	_
23	out	_	_	RP	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	D	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	E	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	MTS	_	_	NN	O	[-1]	['none']	_	_
7	assay	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	D	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	WT	_	_	JJ	O	[-1]	['none']	_	_
13	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	E	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	LMP1	_	_	NN	Protein	[0]	['root']	_	_
19	transgenic	_	_	JJ	O	[-1]	['none']	_	_
20	lymphoma	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	cultured	_	_	VBN	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	IL4	_	_	NN	Protein	[0]	['root']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	a	_	_	DT	O	[-1]	['none']	_	_
27	neutralizing	_	_	VBG	O	[-1]	['none']	_	_
28	antibody	_	_	NN	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	IL4	_	_	NN	Protein	[0]	['root']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	or	_	_	CC	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	rat	_	_	NN	O	[-1]	['none']	_	_
35	IgG	_	_	NN	O	[-1]	['none']	_	_
36	isotype	_	_	NN	O	[-1]	['none']	_	_
37	control	_	_	NN	O	[-1]	['none']	_	_
38	at	_	_	IN	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	indicated	_	_	JJ	O	[-1]	['none']	_	_
41	concentrations	_	_	NNS	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Shown	_	_	VBN	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	results	_	_	NNS	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	LMP1	_	_	NN	Protein	[0]	['root']	_	_
7	transgenic	_	_	JJ	O	[-1]	['none']	_	_
8	lymphoma	_	_	NN	O	[-1]	['none']	_	_
9	3	_	_	CD	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	mean	_	_	NN	O	[-1]	['none']	_	_
6	+/-	_	_	CC	O	[-1]	['none']	_	_
7	SEM	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	triplicate	_	_	NN	O	[-1]	['none']	_	_
10	samples	_	_	NNS	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	single	_	_	JJ	O	[-1]	['none']	_	_
14	representative	_	_	NN	O	[-1]	['none']	_	_
15	experiment	_	_	NN	O	[-1]	['none']	_	_
16	that	_	_	WDT	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	repeated	_	_	VBN	O	[-1]	['none']	_	_
19	twice	_	_	RB	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	similar	_	_	JJ	O	[-1]	['none']	_	_
22	results	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
2	Foxp3	_	_	NN	Protein	[4]	['Theme']	_	_
3	Protein	_	_	NN	O	[-1]	['none']	_	_
4	Expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
5	Is	_	_	VBZ	O	[-1]	['none']	_	_
6	Associated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	Low	_	_	JJ	O	[-1]	['none']	_	_
9	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
10	Proviral	_	_	JJ	O	[-1]	['none']	_	_
11	Load	_	_	NN	O	[-1]	['none']	_	_
12	Since	_	_	IN	O	[-1]	['none']	_	_
13	Foxp3	_	_	NN	Protein	[15]	['Theme']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
16	almost	_	_	RB	O	[-1]	['none']	_	_
17	exclusively	_	_	RB	O	[-1]	['none']	_	_
18	within	_	_	IN	O	[-1]	['none']	_	_
19	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
20	CD25+	_	_	JJ	Protein	[0]	['root']	_	_
21	T	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	major	_	_	JJ	O	[-1]	['none']	_	_
26	viral	_	_	JJ	O	[-1]	['none']	_	_
27	reservoir	_	_	NN	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
30	[	_	_	CD	O	[-1]	['none']	_	_
31	33	_	_	CD	O	[-1]	['none']	_	_
32	]	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	it	_	_	PRP	O	[-1]	['none']	_	_
35	was	_	_	VBD	O	[-1]	['none']	_	_
36	important	_	_	JJ	O	[-1]	['none']	_	_
37	to	_	_	TO	O	[-1]	['none']	_	_
38	determine	_	_	VB	O	[-1]	['none']	_	_
39	whether	_	_	IN	O	[-1]	['none']	_	_
40	there	_	_	EX	O	[-1]	['none']	_	_
41	was	_	_	VBD	O	[-1]	['none']	_	_
42	an	_	_	DT	O	[-1]	['none']	_	_
43	association	_	_	NN	O	[-1]	['none']	_	_
44	between	_	_	IN	O	[-1]	['none']	_	_
45	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
46	and	_	_	CC	O	[-1]	['none']	_	_
47	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
48	replication	_	_	NN	O	[-1]	['none']	_	_
49	in	_	_	IN	O	[-1]	['none']	_	_
50	infected	_	_	JJ	O	[-1]	['none']	_	_
51	patients	_	_	NNS	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	therefore	_	_	RB	O	[-1]	['none']	_	_
3	quantitated	_	_	VBD	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[7]	['Theme']	_	_
6	protein	_	_	NN	O	[-1]	['none']	_	_
7	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
10	CD25+	_	_	JJ	Protein	[0]	['root']	_	_
11	T	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	flow	_	_	NN	O	[-1]	['none']	_	_
15	cytometry	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
19	proviral	_	_	JJ	O	[-1]	['none']	_	_
20	load	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	surrogate	_	_	JJ	O	[-1]	['none']	_	_
24	marker	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	viral	_	_	JJ	O	[-1]	['none']	_	_
27	replication	_	_	NN	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	by	_	_	IN	O	[-1]	['none']	_	_
30	real-time	_	_	JJ	O	[-1]	['none']	_	_
31	PCR	_	_	NN	O	[-1]	['none']	_	_
32	from	_	_	IN	O	[-1]	['none']	_	_
33	eight	_	_	CD	O	[-1]	['none']	_	_
34	patients	_	_	NNS	O	[-1]	['none']	_	_
35	with	_	_	IN	O	[-1]	['none']	_	_
36	HAM	_	_	NN	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	TSP	_	_	NN	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	eight	_	_	CD	O	[-1]	['none']	_	_
41	asymptomatic	_	_	JJ	O	[-1]	['none']	_	_
42	carriers	_	_	NNS	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	ACs	_	_	NNS	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	this	_	_	DT	O	[-1]	['none']	_	_
5	analysis	_	_	NN	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	summarized	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	Table	_	_	NNP	O	[-1]	['none']	_	_
10	1	_	_	CD	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	patients	_	_	NNS	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	HAM	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	TSP	_	_	NN	O	[-1]	['none']	_	_
9	exhibited	_	_	VBD	O	[-1]	['none']	_	_
10	significantly	_	_	RB	O	[-1]	['none']	_	_
11	higher	_	_	JJR	O	[-1]	['none']	_	_
12	proviral	_	_	JJ	O	[-1]	['none']	_	_
13	loads	_	_	NNS	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	indicated	_	_	VBN	O	[-1]	['none']	_	_
16	as	_	_	IN	O	[-1]	['none']	_	_
17	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
18	proviral	_	_	JJ	O	[-1]	['none']	_	_
19	DNA	_	_	NN	O	[-1]	['none']	_	_
20	copies/100	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	34.68	_	_	CD	O	[-1]	['none']	_	_
25	+/-	_	_	CC	O	[-1]	['none']	_	_
26	23.19	_	_	CD	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	compared	_	_	VBN	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	ACs	_	_	NNP	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	4.75	_	_	CD	O	[-1]	['none']	_	_
33	+/-	_	_	CC	O	[-1]	['none']	_	_
34	5.47	_	_	CD	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	p	_	_	NN	O	[-1]	['none']	_	_
38	=	_	_	JJ	O	[-1]	['none']	_	_
39	0.0008	_	_	CD	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	percentage	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	Foxp3+	_	_	JJ	Protein	[0]	['root']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	within	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
9	CD25+	_	_	JJ	Protein	[0]	['root']	_	_
10	T	_	_	NN	O	[-1]	['none']	_	_
11	cell	_	_	NN	O	[-1]	['none']	_	_
12	population	_	_	NN	O	[-1]	['none']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	significantly	_	_	RB	O	[-1]	['none']	_	_
15	greater	_	_	JJR	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	ACs	_	_	NNP	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	43.23	_	_	CD	O	[-1]	['none']	_	_
20	+/-	_	_	CC	O	[-1]	['none']	_	_
21	12.95	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	than	_	_	IN	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	HAM	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	TSP	_	_	NN	O	[-1]	['none']	_	_
28	patients	_	_	NNS	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	18.59	_	_	CD	O	[-1]	['none']	_	_
31	+/-	_	_	CC	O	[-1]	['none']	_	_
32	5.77	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	p	_	_	NN	O	[-1]	['none']	_	_
36	=	_	_	JJ	O	[-1]	['none']	_	_
37	0.0033	_	_	CD	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	high	_	_	JJ	Positive_regulation	[0]	['root']	_	_
6	levels	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[10]	['Theme']	_	_
9	protein	_	_	NN	O	[-1]	['none']	_	_
10	expression	_	_	NN	Gene_expression	[5]	['Theme']	_	_
11	are	_	_	VBP	O	[-1]	['none']	_	_
12	associated	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	reduced	_	_	VBN	O	[-1]	['none']	_	_
15	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
16	replication	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	FW	O	[-1]	['none']	_	_
18	vivo	_	_	FW	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	They	_	_	PRP	O	[-1]	['none']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	support	_	_	VBP	O	[-1]	['none']	_	_
4	our	_	_	PRP$	O	[-1]	['none']	_	_
5	recent	_	_	JJ	O	[-1]	['none']	_	_
6	reports	_	_	NNS	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	high	_	_	JJ	O	[-1]	['none']	_	_
9	proviral	_	_	JJ	O	[-1]	['none']	_	_
10	loads	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	which	_	_	WDT	O	[-1]	['none']	_	_
13	have	_	_	VBP	O	[-1]	['none']	_	_
14	been	_	_	VBN	O	[-1]	['none']	_	_
15	shown	_	_	VBN	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	correlate	_	_	VB	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	high	_	_	JJ	Positive_regulation	[0]	['root']	_	_
20	Tax	_	_	NN	Protein	[19]	['Theme']	_	_
21	mRNA	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	HTLV-I-infected	_	_	JJ	O	[-1]	['none']	_	_
24	patients	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	are	_	_	VBP	O	[-1]	['none']	_	_
27	associated	_	_	VBN	O	[-1]	['none']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	reduced	_	_	VBN	Negative_regulation	[0]	['root']	_	_
30	Foxp3	_	_	NN	Protein	[31]	['Theme']	_	_
31	expression	_	_	NN	Gene_expression	[29]	['Theme']	_	_
32	[	_	_	CD	O	[-1]	['none']	_	_
33	8,34	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	PCR	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	kappa	_	_	NN	O	[-1]	['none']	_	_
5	chain	_	_	NN	O	[-1]	['none']	_	_
6	rearrangement	_	_	NN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	DNA	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	isolated	_	_	VBN	O	[-1]	['none']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
6	using	_	_	VBG	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	Dneasy	_	_	NNP	O	[-1]	['none']	_	_
9	Tissue	_	_	NN	O	[-1]	['none']	_	_
10	Kit	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Qiagen	_	_	NNP	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	Rnase	_	_	NN	O	[-1]	['none']	_	_
17	treatment	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	PCR	_	_	NN	O	[-1]	['none']	_	_
2	reactions	_	_	NNS	O	[-1]	['none']	_	_
3	contained	_	_	VBD	O	[-1]	['none']	_	_
4	100	_	_	CD	O	[-1]	['none']	_	_
5	ng	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	genomic	_	_	JJ	O	[-1]	['none']	_	_
8	DNA	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	0.2	_	_	CD	O	[-1]	['none']	_	_
11	muM	_	_	JJ	O	[-1]	['none']	_	_
12	each	_	_	DT	O	[-1]	['none']	_	_
13	primer	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	0.2	_	_	CD	O	[-1]	['none']	_	_
16	mM	_	_	NN	O	[-1]	['none']	_	_
17	dNTPs	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	2.5	_	_	CD	O	[-1]	['none']	_	_
21	U	_	_	NNP	O	[-1]	['none']	_	_
22	Taq	_	_	NN	Protein	[24]	['multitoken']	_	_
23	DNA	_	_	NN	Protein	[24]	['multitoken']	_	_
24	polymerase	_	_	NN	Protein	[0]	['root']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	NEB	_	_	NNP	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	performed	_	_	VBN	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	1X	_	_	NN	O	[-1]	['none']	_	_
31	ThermoPol	_	_	NN	O	[-1]	['none']	_	_
32	buffer	_	_	NN	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	NEB	_	_	NNP	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Primers	_	_	NNS	O	[-1]	['none']	_	_
2	used	_	_	VBN	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	Vkappacon	_	_	NNP	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Jkappa5-1degrees	_	_	NNS	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	have	_	_	VBP	O	[-1]	['none']	_	_
9	been	_	_	VBN	O	[-1]	['none']	_	_
10	described	_	_	VBN	O	[-1]	['none']	_	_
11	previously	_	_	RB	O	[-1]	['none']	_	_
12	[	_	_	CD	O	[-1]	['none']	_	_
13	74	_	_	CD	O	[-1]	['none']	_	_
14	]	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	PCR	_	_	NN	O	[-1]	['none']	_	_
2	conditions	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	94	_	_	CD	O	[-1]	['none']	_	_
5	degreesC	_	_	NN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	2	_	_	CD	O	[-1]	['none']	_	_
8	min	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	40	_	_	CD	O	[-1]	['none']	_	_
11	cycles	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	94	_	_	CD	O	[-1]	['none']	_	_
14	degreesC	_	_	NN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	30	_	_	CD	O	[-1]	['none']	_	_
17	s	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	63	_	_	CD	O	[-1]	['none']	_	_
20	degreesC	_	_	NN	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	90	_	_	CD	O	[-1]	['none']	_	_
23	s	_	_	NNS	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	72	_	_	CD	O	[-1]	['none']	_	_
27	degreesC	_	_	NN	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	1	_	_	CD	O	[-1]	['none']	_	_
30	min	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	followed	_	_	VBN	O	[-1]	['none']	_	_
33	by	_	_	IN	O	[-1]	['none']	_	_
34	1	_	_	CD	O	[-1]	['none']	_	_
35	cycle	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	72	_	_	CD	O	[-1]	['none']	_	_
38	degreesC	_	_	NN	O	[-1]	['none']	_	_
39	for	_	_	IN	O	[-1]	['none']	_	_
40	5	_	_	CD	O	[-1]	['none']	_	_
41	min	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Decreased	_	_	VBN	O	[-1]	['none']	_	_
2	mRNA	_	_	NN	O	[-1]	['none']	_	_
3	levels	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
6	cytokines	_	_	NNS	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	cpdm	_	_	FW	O	[-1]	['none']	_	_
9	BMDC	_	_	FW	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	Cultured	_	_	VBN	O	[-1]	['none']	_	_
2	WT	_	_	JJ	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	cpdm	_	_	JJ	O	[-1]	['none']	_	_
5	BMDC	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	5x105	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	0.2	_	_	CD	O	[-1]	['none']	_	_
11	ml	_	_	NN	O	[-1]	['none']	_	_
12	complete	_	_	JJ	O	[-1]	['none']	_	_
13	medium	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	washed	_	_	VBN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	stimulated	_	_	VBN	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	100	_	_	CD	O	[-1]	['none']	_	_
21	ng/ml	_	_	NN	O	[-1]	['none']	_	_
22	LPS	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	A	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	C	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	E	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	G	_	_	NN	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	or	_	_	CC	O	[-1]	['none']	_	_
33	25	_	_	CD	O	[-1]	['none']	_	_
34	microg/ml	_	_	NN	O	[-1]	['none']	_	_
35	poly	_	_	NN	O	[-1]	['none']	_	_
36	I	_	_	NN	O	[-1]	['none']	_	_
37	:	_	_	:	O	[-1]	['none']	_	_
38	C	_	_	NN	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	B	_	_	NN	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	D	_	_	NN	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	F	_	_	NN	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	H	_	_	NN	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	0	_	_	CD	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	1	_	_	CD	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	2	_	_	CD	O	[-1]	['none']	_	_
7	hours	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	total	_	_	JJ	O	[-1]	['none']	_	_
10	RNA	_	_	NN	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	extracted	_	_	VBN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	subject	_	_	JJ	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	qRT-PCR	_	_	NN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	measure	_	_	VB	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	expression	_	_	NN	Transcription	[0]	['root']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	Il12p40	_	_	NN	Protein	[20]	['Theme']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	A	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	B	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	Il6	_	_	NN	Protein	[20]	['Theme']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	C	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	D	_	_	NN	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	Gmcsf	_	_	NNP	Protein	[20]	['Theme']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	E	_	_	NN	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	F	_	_	NN	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	and	_	_	CC	O	[-1]	['none']	_	_
44	Ifnb	_	_	NNP	Protein	[20]	['Theme']	_	_
45	(	_	_	-LRB-	O	[-1]	['none']	_	_
46	G	_	_	NN	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	H	_	_	NN	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	mRNA	_	_	NN	O	[-1]	['none']	_	_
51	.	_	_	.	O	[-1]	['none']	_	_

1	Bars	_	_	NNS	O	[-1]	['none']	_	_
2	represent	_	_	VBP	O	[-1]	['none']	_	_
3	mean	_	_	NN	O	[-1]	['none']	_	_
4	+/-	_	_	CC	O	[-1]	['none']	_	_
5	SD	_	_	NN	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	representative	_	_	JJ	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	two	_	_	CD	O	[-1]	['none']	_	_
6	independent	_	_	JJ	O	[-1]	['none']	_	_
7	experiments	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF	_	_	NNP	O	[-1]	['none']	_	_
2	Induces	_	_	VBZ	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	Transcriptional	_	_	JJ	O	[-1]	['none']	_	_
5	Activity	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	Human	_	_	NN	O	[-1]	['none']	_	_
8	Monocyte	_	_	NN	O	[-1]	['none']	_	_
9	Derived	_	_	JJ	O	[-1]	['none']	_	_
10	Macrophages	_	_	NNS	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	MDMs	_	_	NNS	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	Mouse	_	_	NN	O	[-1]	['none']	_	_
16	Macrophage	_	_	NN	O	[-1]	['none']	_	_
17	Cell	_	_	NN	O	[-1]	['none']	_	_
18	Line	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	RAW	_	_	NN	O	[-1]	['none']	_	_
21	264.7	_	_	CD	O	[-1]	['none']	_	_
22	To	_	_	TO	O	[-1]	['none']	_	_
23	determine	_	_	VB	O	[-1]	['none']	_	_
24	if	_	_	IN	O	[-1]	['none']	_	_
25	M-CSF	_	_	NN	O	[-1]	['none']	_	_
26	induced	_	_	VBD	O	[-1]	['none']	_	_
27	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
28	DNA	_	_	NN	O	[-1]	['none']	_	_
29	binding	_	_	NN	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	human	_	_	NN	O	[-1]	['none']	_	_
32	macrophages	_	_	NNS	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	we	_	_	PRP	O	[-1]	['none']	_	_
35	performed	_	_	VBD	O	[-1]	['none']	_	_
36	EMSA	_	_	NN	O	[-1]	['none']	_	_
37	analysis	_	_	NN	O	[-1]	['none']	_	_
38	on	_	_	IN	O	[-1]	['none']	_	_
39	nuclear	_	_	JJ	O	[-1]	['none']	_	_
40	lysates	_	_	NNS	O	[-1]	['none']	_	_
41	from	_	_	IN	O	[-1]	['none']	_	_
42	M-CSF-treated	_	_	JJ	O	[-1]	['none']	_	_
43	MDMs	_	_	NNS	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	previous	_	_	JJ	O	[-1]	['none']	_	_
4	reports	_	_	NNS	O	[-1]	['none']	_	_
5	[	_	_	VBP	O	[-1]	['none']	_	_
6	11	_	_	CD	O	[-1]	['none']	_	_
7	]	_	_	CD	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	nuclear	_	_	JJ	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	constitutively	_	_	RB	O	[-1]	['none']	_	_
12	bound	_	_	VBD	O	[-1]	['none']	_	_
13	DNA	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	non	_	_	JJ	O	[-1]	['none']	_	_
16	stimulated	_	_	VBN	O	[-1]	['none']	_	_
17	monocytes	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	adding	_	_	VBG	O	[-1]	['none']	_	_
4	M-CSF	_	_	NN	O	[-1]	['none']	_	_
5	did	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	alter	_	_	VB	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	DNA	_	_	NN	O	[-1]	['none']	_	_
10	binding	_	_	NN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	EMSA	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	after	_	_	IN	O	[-1]	['none']	_	_
5	transiently	_	_	RB	O	[-1]	['none']	_	_
6	transfecting	_	_	VBG	O	[-1]	['none']	_	_
7	human	_	_	NN	O	[-1]	['none']	_	_
8	MDMs	_	_	NNS	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
11	constructs	_	_	NNS	O	[-1]	['none']	_	_
12	containing	_	_	VBG	O	[-1]	['none']	_	_
13	four	_	_	CD	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	consensus	_	_	NN	O	[-1]	['none']	_	_
16	binding	_	_	NN	O	[-1]	['none']	_	_
17	sequences	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	M-CSF	_	_	NN	O	[-1]	['none']	_	_
20	treatment	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	transfected	_	_	JJ	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	resulted	_	_	VBD	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	a	_	_	DT	O	[-1]	['none']	_	_
28	2.3-fold	_	_	JJ	O	[-1]	['none']	_	_
29	increase	_	_	NN	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	SEAP	_	_	NN	O	[-1]	['none']	_	_
32	release	_	_	NN	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	culture	_	_	NN	O	[-1]	['none']	_	_
36	media	_	_	NNS	O	[-1]	['none']	_	_
37	compared	_	_	VBN	O	[-1]	['none']	_	_
38	to	_	_	TO	O	[-1]	['none']	_	_
39	PBS	_	_	NNP	O	[-1]	['none']	_	_
40	(	_	_	-LRB-	O	[-1]	['none']	_	_
41	vehicle	_	_	NN	O	[-1]	['none']	_	_
42	)-treated	_	_	JJ	O	[-1]	['none']	_	_
43	transfected	_	_	VBN	O	[-1]	['none']	_	_
44	MDMs	_	_	NNS	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	a	_	_	DT	O	[-1]	['none']	_	_
3	control	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
7	construct	_	_	NN	O	[-1]	['none']	_	_
8	lacking	_	_	VBG	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	binding	_	_	NN	O	[-1]	['none']	_	_
11	sites	_	_	NNS	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	used	_	_	VBN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	transfected	_	_	VBN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
6	construct	_	_	NN	O	[-1]	['none']	_	_
7	did	_	_	VBD	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	produce	_	_	VB	O	[-1]	['none']	_	_
10	SEAP	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	absence	_	_	NN	O	[-1]	['none']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	presence	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	M-CSF	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	next	_	_	RB	O	[-1]	['none']	_	_
3	investigated	_	_	VBD	O	[-1]	['none']	_	_
4	whether	_	_	IN	O	[-1]	['none']	_	_
5	M-CSF	_	_	NN	O	[-1]	['none']	_	_
6	induced	_	_	VBD	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	activity	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	mouse	_	_	NN	O	[-1]	['none']	_	_
12	macrophage	_	_	NN	O	[-1]	['none']	_	_
13	cell	_	_	NN	O	[-1]	['none']	_	_
14	line	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	RAW	_	_	NN	O	[-1]	['none']	_	_
17	264.7	_	_	CD	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	RAW	_	_	NN	O	[-1]	['none']	_	_
2	264.7	_	_	CD	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	transfected	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	either	_	_	CC	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	NF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
10	reporter	_	_	NN	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	control	_	_	NN	O	[-1]	['none']	_	_
13	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
14	construct	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	1C	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	M-CSF	_	_	NN	O	[-1]	['none']	_	_
8	treatment	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	RAW	_	_	NN	O	[-1]	['none']	_	_
11	264.7	_	_	CD	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
14	NF-kappaB	_	_	NN	Protein	[16]	['Theme']	_	_
15	reporter	_	_	NN	O	[-1]	['none']	_	_
16	activity	_	_	NN	Positive_regulation	[13]	['Theme']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	2.5-fold	_	_	RB	O	[-1]	['none']	_	_
19	over	_	_	IN	O	[-1]	['none']	_	_
20	that	_	_	DT	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	non	_	_	JJ	O	[-1]	['none']	_	_
23	treated	_	_	JJ	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Together	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	data	_	_	NNS	O	[-1]	['none']	_	_
5	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	M-CSF	_	_	NN	O	[-1]	['none']	_	_
8	induced	_	_	VBD	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
11	activity	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	macrophages	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Cooperative	_	_	NNP	O	[-1]	['none']	_	_
2	induction	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	cytokines	_	_	NNS	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	AP-1	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	To	_	_	TO	O	[-1]	['none']	_	_
10	further	_	_	RB	O	[-1]	['none']	_	_
11	characterize	_	_	VB	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	involvement	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	cytokine	_	_	NN	O	[-1]	['none']	_	_
18	regulation	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	we	_	_	PRP	O	[-1]	['none']	_	_
21	treated	_	_	VBD	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	an	_	_	DT	O	[-1]	['none']	_	_
25	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
26	activation	_	_	NN	O	[-1]	['none']	_	_
27	inhibitor	_	_	NN	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	NAI	_	_	NNP	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	showed	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	NAI	_	_	NNP	O	[-1]	['none']	_	_
6	selectively	_	_	RB	O	[-1]	['none']	_	_
7	down-regulated	_	_	VBD	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	did	_	_	VBD	O	[-1]	['none']	_	_
12	not	_	_	RB	O	[-1]	['none']	_	_
13	alter	_	_	VB	O	[-1]	['none']	_	_
14	AP-1	_	_	NN	O	[-1]	['none']	_	_
15	activity	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Exposure	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Jurkat	_	_	NN	O	[-1]	['none']	_	_
4	T-cells	_	_	NNS	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	NAI	_	_	NNP	O	[-1]	['none']	_	_
7	resulted	_	_	VBD	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	modest	_	_	JJ	O	[-1]	['none']	_	_
11	reduction	_	_	NN	Negative_regulation	[0]	['root']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	CXCL8	_	_	NN	Protein	[14]	['Theme']	_	_
14	following	_	_	VBG	Positive_regulation	[11]	['Theme']	_	_
15	PMA	_	_	NN	O	[-1]	['none']	_	_
16	exposure	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	while	_	_	IN	O	[-1]	['none']	_	_
19	it	_	_	PRP	O	[-1]	['none']	_	_
20	did	_	_	VBD	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	alter	_	_	VB	Regulation	[0]	['root']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	CXCL8	_	_	NN	Protein	[25]	['Theme']	_	_
25	release	_	_	NN	Localization	[26]	['Theme']	_	_
26	following	_	_	VBG	Positive_regulation	[22]	['Theme']	_	_
27	HK	_	_	NNP	O	[-1]	['none']	_	_
28	E.	_	_	FW	O	[-1]	['none']	_	_
29	coli	_	_	FW	O	[-1]	['none']	_	_
30	exposure	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	NAI	_	_	NNP	O	[-1]	['none']	_	_
2	did	_	_	VBD	O	[-1]	['none']	_	_
3	not	_	_	RB	O	[-1]	['none']	_	_
4	affect	_	_	VB	O	[-1]	['none']	_	_
5	TNF	_	_	NN	O	[-1]	['none']	_	_
6	expression	_	_	NN	O	[-1]	['none']	_	_
7	indicating	_	_	VBG	O	[-1]	['none']	_	_
8	that	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	not	_	_	RB	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	main	_	_	JJ	O	[-1]	['none']	_	_
14	regulator	_	_	NN	Regulation	[0]	['root']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	CXCL8	_	_	NN	Protein	[19]	['Theme']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	TNF	_	_	NN	O	[-1]	['none']	_	_
19	following	_	_	VBG	Positive_regulation	[14]	['Theme']	_	_
20	either	_	_	CC	O	[-1]	['none']	_	_
21	PMA	_	_	NN	O	[-1]	['none']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	HK	_	_	JJ	O	[-1]	['none']	_	_
24	E.	_	_	FW	O	[-1]	['none']	_	_
25	coli	_	_	FW	O	[-1]	['none']	_	_
26	exposure	_	_	NN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	Jurkat	_	_	NN	O	[-1]	['none']	_	_
29	T-cells	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	NAI	_	_	NNP	O	[-1]	['none']	_	_
5	resulted	_	_	VBD	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	complete	_	_	JJ	O	[-1]	['none']	_	_
9	inhibition	_	_	NN	Negative_regulation	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	IL-6	_	_	NN	Protein	[9, 12, 19, 20]	['Theme', 'Theme', 'Theme', 'Theme']	_	_
12	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
13	PMA	_	_	NN	O	[-1]	['none']	_	_
14	exposure	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	45	_	_	CD	O	[-1]	['none']	_	_
18	%	_	_	NN	O	[-1]	['none']	_	_
19	inhibition	_	_	NN	Negative_regulation	[0]	['root']	_	_
20	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
21	HK	_	_	NNP	O	[-1]	['none']	_	_
22	E.	_	_	FW	O	[-1]	['none']	_	_
23	coli	_	_	FW	O	[-1]	['none']	_	_
24	exposure	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	suggesting	_	_	VBG	O	[-1]	['none']	_	_
27	an	_	_	DT	O	[-1]	['none']	_	_
28	involvement	_	_	NN	Regulation	[0]	['root']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	in	_	_	IN	O	[-1]	['none']	_	_
32	IL-6	_	_	NN	Protein	[33]	['Theme']	_	_
33	regulation	_	_	NN	Regulation	[28]	['Theme']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Ca2+	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	observed	_	_	VBN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	increase	_	_	VB	O	[-1]	['none']	_	_
6	AP-1	_	_	NN	O	[-1]	['none']	_	_
7	activity	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	reduce	_	_	VB	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	activity	_	_	NN	O	[-1]	['none']	_	_
12	;	_	_	:	O	[-1]	['none']	_	_
13	therefore	_	_	RB	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	we	_	_	PRP	O	[-1]	['none']	_	_
16	exposed	_	_	VBD	O	[-1]	['none']	_	_
17	T-cells	_	_	NNS	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	PKC	_	_	NN	O	[-1]	['none']	_	_
21	inhibitor	_	_	NN	O	[-1]	['none']	_	_
22	together	_	_	RB	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	PMA	_	_	NN	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	determine	_	_	VB	O	[-1]	['none']	_	_
27	its	_	_	PRP$	O	[-1]	['none']	_	_
28	effect	_	_	NN	O	[-1]	['none']	_	_
29	on	_	_	IN	O	[-1]	['none']	_	_
30	cytokine	_	_	NN	O	[-1]	['none']	_	_
31	expression	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Inhibition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PKC	_	_	NN	O	[-1]	['none']	_	_
4	reduced	_	_	VBD	Negative_regulation	[0]	['root']	_	_
5	CXCL8	_	_	NN	Protein	[6]	['Theme']	_	_
6	release	_	_	NN	Localization	[4]	['Theme']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	7	_	_	CD	O	[-1]	['none']	_	_
9	ng/ml	_	_	NN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	3	_	_	CD	O	[-1]	['none']	_	_
12	ng/ml	_	_	NN	O	[-1]	['none']	_	_
13	while	_	_	IN	O	[-1]	['none']	_	_
14	it	_	_	PRP	O	[-1]	['none']	_	_
15	had	_	_	VBD	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	modest	_	_	JJ	O	[-1]	['none']	_	_
18	effect	_	_	NN	Regulation	[0]	['root']	_	_
19	on	_	_	IN	O	[-1]	['none']	_	_
20	IL-6	_	_	NN	Protein	[18]	['Theme']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	TNF	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	prompted	_	_	VBD	O	[-1]	['none']	_	_
3	us	_	_	PRP	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	test	_	_	VB	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	effect	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	JNK	_	_	NN	O	[-1]	['none']	_	_
10	inhibition	_	_	NN	O	[-1]	['none']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	induced	_	_	VBD	O	[-1]	['none']	_	_
14	cytokine	_	_	NN	O	[-1]	['none']	_	_
15	expression	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	JNK	_	_	NN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	involved	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	regulation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	multitude	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	different	_	_	JJ	O	[-1]	['none']	_	_
12	transcription	_	_	NN	O	[-1]	['none']	_	_
13	factors	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	including	_	_	VBG	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	c-Jun	_	_	NN	Protein	[17, 19]	['Theme', 'Theme']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	c-Fos	_	_	NN	Protein	[17, 19]	['Theme', 'Theme']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	p53	_	_	NN	Protein	[17, 19]	['Theme', 'Theme']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	leading	_	_	VBG	O	[-1]	['none']	_	_
28	to	_	_	TO	O	[-1]	['none']	_	_
29	cellular	_	_	JJ	O	[-1]	['none']	_	_
30	apoptosis	_	_	NN	O	[-1]	['none']	_	_
31	[	_	_	NN	O	[-1]	['none']	_	_
32	26	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Inhibition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	JNK	_	_	NN	O	[-1]	['none']	_	_
5	pathways	_	_	NNS	O	[-1]	['none']	_	_
6	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	down-regulation	_	_	NN	Negative_regulation	[6]	['Theme']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	both	_	_	CC	O	[-1]	['none']	_	_
12	CXCL8	_	_	NN	Protein	[9]	['Theme']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	IL-6	_	_	NN	Protein	[9]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	while	_	_	IN	O	[-1]	['none']	_	_
17	no	_	_	DT	O	[-1]	['none']	_	_
18	clear	_	_	JJ	O	[-1]	['none']	_	_
19	effect	_	_	NN	O	[-1]	['none']	_	_
20	was	_	_	VBD	O	[-1]	['none']	_	_
21	observed	_	_	VBN	O	[-1]	['none']	_	_
22	on	_	_	IN	O	[-1]	['none']	_	_
23	TNF	_	_	NN	O	[-1]	['none']	_	_
24	expression	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Analysis	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	mRNA	_	_	NN	O	[-1]	['none']	_	_
4	levels	_	_	NNS	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	RT-qPCR	_	_	NN	O	[-1]	['none']	_	_
7	showed	_	_	VBD	O	[-1]	['none']	_	_
8	that	_	_	IN	O	[-1]	['none']	_	_
9	PMA	_	_	NN	O	[-1]	['none']	_	_
10	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	both	_	_	CC	O	[-1]	['none']	_	_
12	il-6	_	_	JJ	Protein	[15]	['Theme']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	cxcl8	_	_	NN	Protein	[15]	['Theme']	_	_
15	mRNA	_	_	NN	Transcription	[10]	['Theme']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	5.1-fold	_	_	JJ	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	111.8	_	_	CD	O	[-1]	['none']	_	_
20	fold	_	_	JJ	O	[-1]	['none']	_	_
21	respectively	_	_	RB	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Addition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	inhibitor	_	_	NN	O	[-1]	['none']	_	_
6	NAI	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	JNK	_	_	NN	O	[-1]	['none']	_	_
10	inhibitor	_	_	NN	O	[-1]	['none']	_	_
11	reduced	_	_	VBD	Negative_regulation	[0]	['root']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	il-6	_	_	JJ	Protein	[14]	['Theme']	_	_
14	expression	_	_	NN	Transcription	[11]	['Theme']	_	_
15	below	_	_	IN	O	[-1]	['none']	_	_
16	basal	_	_	JJ	O	[-1]	['none']	_	_
17	levels	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	while	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	cxcl8	_	_	NN	Protein	[7]	['Theme']	_	_
7	levels	_	_	NNS	Transcription	[9, 17]	['Theme', 'Theme']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	suppressed	_	_	VBN	Negative_regulation	[0]	['root']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	same	_	_	JJ	O	[-1]	['none']	_	_
13	treatments	_	_	NNS	O	[-1]	['none']	_	_
14	the	_	_	DT	Anaphora	[15]	['multitoken']	_	_
15	levels	_	_	NNS	Anaphora	[0]	['root']	_	_
16	remained	_	_	VBD	Regulation	[0]	['root']	_	_
17	elevated	_	_	JJ	Positive_regulation	[16]	['Theme']	_	_
18	above	_	_	IN	O	[-1]	['none']	_	_
19	basal	_	_	JJ	O	[-1]	['none']	_	_
20	level	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	c-maf	_	_	NN	Protein	[2]	['Theme']	_	_
2	Expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	Correlates	_	_	VBZ	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	IL-10	_	_	NN	Protein	[6]	['Theme']	_	_
6	Production	_	_	NN	Gene_expression	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	Th1	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	Th2	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	Th17	_	_	NN	O	[-1]	['none']	_	_
14	Cells	_	_	NNS	O	[-1]	['none']	_	_
15	To	_	_	TO	O	[-1]	['none']	_	_
16	investigate	_	_	VB	O	[-1]	['none']	_	_
17	further	_	_	RB	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	downstream	_	_	JJ	O	[-1]	['none']	_	_
20	factors	_	_	NNS	O	[-1]	['none']	_	_
21	involved	_	_	VBN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	regulating	_	_	VBG	Regulation	[0]	['root']	_	_
24	IL-10	_	_	NN	Protein	[25]	['Theme']	_	_
25	production	_	_	NN	Gene_expression	[23]	['Theme']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	we	_	_	PRP	O	[-1]	['none']	_	_
28	differentiated	_	_	VBD	O	[-1]	['none']	_	_
29	DO11	_	_	NN	O	[-1]	['none']	_	_
30	.10	_	_	CD	O	[-1]	['none']	_	_
31	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
32	T	_	_	NN	O	[-1]	['none']	_	_
33	cells	_	_	NNS	O	[-1]	['none']	_	_
34	with	_	_	IN	O	[-1]	['none']	_	_
35	increasing	_	_	VBG	O	[-1]	['none']	_	_
36	doses	_	_	NNS	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	OVA	_	_	NNP	Protein	[0]	['root']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	in	_	_	IN	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	presence	_	_	NN	O	[-1]	['none']	_	_
43	or	_	_	CC	O	[-1]	['none']	_	_
44	absence	_	_	NN	O	[-1]	['none']	_	_
45	of	_	_	IN	O	[-1]	['none']	_	_
46	IL-12	_	_	NN	Protein	[0]	['root']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	and	_	_	CC	O	[-1]	['none']	_	_
49	quantified	_	_	VBD	O	[-1]	['none']	_	_
50	the	_	_	DT	O	[-1]	['none']	_	_
51	expression	_	_	NN	O	[-1]	['none']	_	_
52	of	_	_	IN	O	[-1]	['none']	_	_
53	cytokines	_	_	NNS	O	[-1]	['none']	_	_
54	and	_	_	CC	O	[-1]	['none']	_	_
55	transcription	_	_	NN	O	[-1]	['none']	_	_
56	factors	_	_	NNS	O	[-1]	['none']	_	_
57	by	_	_	IN	O	[-1]	['none']	_	_
58	real-time	_	_	JJ	O	[-1]	['none']	_	_
59	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
60	.	_	_	.	O	[-1]	['none']	_	_

1	Low-dose	_	_	JJ	O	[-1]	['none']	_	_
2	antigen	_	_	NN	O	[-1]	['none']	_	_
3	resulted	_	_	VBD	Positive_regulation	[11]	['Theme']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	transcription	_	_	NN	Transcription	[3]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Il4	_	_	NN	Protein	[5]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	this	_	_	DT	Anaphora	[0]	['root']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	abrogated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	both	_	_	CC	O	[-1]	['none']	_	_
14	high	_	_	JJ	O	[-1]	['none']	_	_
15	antigen	_	_	NN	O	[-1]	['none']	_	_
16	doses	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	IL-12	_	_	NN	Protein	[11]	['Cause']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	low	_	_	JJ	O	[-1]	['none']	_	_
3	amount	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	transcription	_	_	NN	Transcription	[9, 23]	['Theme', 'Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Ifngamma	_	_	NN	Protein	[5]	['Theme']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	IL-12	_	_	NN	Protein	[9]	['Cause']	_	_
12	when	_	_	WRB	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	differentiated	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	low	_	_	JJ	O	[-1]	['none']	_	_
18	antigen	_	_	NN	O	[-1]	['none']	_	_
19	dose	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	but	_	_	CC	O	[-1]	['none']	_	_
22	this	_	_	DT	Positive_regulation	[23]	['multitoken']	_	_
23	effect	_	_	NN	Positive_regulation	[28]	['Theme']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	IL-12	_	_	NN	Protein	[23]	['Cause']	_	_
26	was	_	_	VBD	O	[-1]	['none']	_	_
27	markedly	_	_	RB	O	[-1]	['none']	_	_
28	upregulated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	increasing	_	_	VBG	O	[-1]	['none']	_	_
31	doses	_	_	NNS	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	antigen	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	low	_	_	JJ	O	[-1]	['none']	_	_
3	amount	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Il10	_	_	NN	Protein	[6]	['Theme']	_	_
6	transcription	_	_	NN	Transcription	[26]	['Theme']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	observed	_	_	VBN	O	[-1]	['none']	_	_
9	at	_	_	IN	O	[-1]	['none']	_	_
10	low	_	_	JJ	O	[-1]	['none']	_	_
11	doses	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	antigen	_	_	NN	O	[-1]	['none']	_	_
14	accompanying	_	_	VBG	O	[-1]	['none']	_	_
15	Il4	_	_	NN	Protein	[16]	['Theme']	_	_
16	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Th2	_	_	NN	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	response	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	this	_	_	DT	Anaphora	[0]	['root']	_	_
25	was	_	_	VBD	O	[-1]	['none']	_	_
26	abrogated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
27	by	_	_	IN	O	[-1]	['none']	_	_
28	increased	_	_	VBN	O	[-1]	['none']	_	_
29	doses	_	_	NNS	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	antigen	_	_	NN	O	[-1]	['none']	_	_
32	as	_	_	IN	O	[-1]	['none']	_	_
33	was	_	_	VBD	O	[-1]	['none']	_	_
34	Il4	_	_	NN	Protein	[35]	['Theme']	_	_
35	expression	_	_	NN	Gene_expression	[26]	['Theme']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	low	_	_	JJ	O	[-1]	['none']	_	_
3	doses	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	antigen	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	IL-12	_	_	NN	Protein	[10]	['Cause']	_	_
8	had	_	_	VBD	O	[-1]	['none']	_	_
9	little	_	_	JJ	O	[-1]	['none']	_	_
10	effect	_	_	NN	Regulation	[0]	['root']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	increase	_	_	VB	Positive_regulation	[10]	['Theme']	_	_
13	IL-10	_	_	NN	Protein	[15]	['Theme']	_	_
14	mRNA	_	_	NN	Transcription	[15]	['multitoken']	_	_
15	expression	_	_	NN	Transcription	[12]	['Theme']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	keeping	_	_	VBG	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	protein	_	_	NN	O	[-1]	['none']	_	_
21	data	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL-12	_	_	NN	Protein	[4]	['Cause']	_	_
4	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	high	_	_	JJ	O	[-1]	['none']	_	_
7	amount	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	Il10	_	_	NN	Protein	[10]	['Theme']	_	_
10	transcription	_	_	NN	Transcription	[4]	['Theme']	_	_
11	as	_	_	RB	O	[-1]	['none']	_	_
12	well	_	_	RB	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	Ifngamma	_	_	NN	Protein	[15]	['Theme']	_	_
15	expression	_	_	NN	Gene_expression	[4]	['Theme']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	increased	_	_	VBN	O	[-1]	['none']	_	_
18	antigen	_	_	NN	O	[-1]	['none']	_	_
19	doses	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	again	_	_	RB	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	keeping	_	_	VBG	O	[-1]	['none']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	protein	_	_	NN	O	[-1]	['none']	_	_
27	data	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
2	T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	differentiated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	increasing	_	_	VBG	O	[-1]	['none']	_	_
7	doses	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	antigen	_	_	NN	O	[-1]	['none']	_	_
10	did	_	_	VBD	O	[-1]	['none']	_	_
11	not	_	_	RB	O	[-1]	['none']	_	_
12	express	_	_	VB	Transcription	[0]	['root']	_	_
13	high	_	_	JJ	O	[-1]	['none']	_	_
14	amounts	_	_	NNS	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	Tbx-21	_	_	NN	Protein	[12]	['Theme']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	T-bet	_	_	JJ	Protein	[0]	['root']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	mRNA	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	unless	_	_	IN	O	[-1]	['none']	_	_
23	they	_	_	PRP	O	[-1]	['none']	_	_
24	were	_	_	VBD	O	[-1]	['none']	_	_
25	cocultured	_	_	VBN	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	IL-12	_	_	NN	Protein	[0]	['root']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	high	_	_	JJ	O	[-1]	['none']	_	_
5	amounts	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	GATA-3	_	_	NN	Protein	[9]	['Theme']	_	_
8	mRNA	_	_	NN	Transcription	[9]	['multitoken']	_	_
9	expression	_	_	NN	Transcription	[28]	['Theme']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	only	_	_	RB	O	[-1]	['none']	_	_
12	observed	_	_	VBN	O	[-1]	['none']	_	_
13	under	_	_	IN	O	[-1]	['none']	_	_
14	Th2	_	_	NN	O	[-1]	['none']	_	_
15	cell	_	_	NN	O	[-1]	['none']	_	_
16	differentiation	_	_	NN	O	[-1]	['none']	_	_
17	conditions	_	_	NNS	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	low-dose	_	_	JJ	O	[-1]	['none']	_	_
20	antigen	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	this	_	_	DT	Anaphora	[25]	['multitoken']	_	_
25	expression	_	_	NN	Anaphora	[0]	['root']	_	_
26	was	_	_	VBD	O	[-1]	['none']	_	_
27	markedly	_	_	RB	O	[-1]	['none']	_	_
28	downregulated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
29	by	_	_	IN	O	[-1]	['none']	_	_
30	both	_	_	CC	O	[-1]	['none']	_	_
31	increasing	_	_	VBG	O	[-1]	['none']	_	_
32	antigen	_	_	NN	O	[-1]	['none']	_	_
33	dose	_	_	NN	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	coculture	_	_	NN	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	IL-12	_	_	NN	Protein	[28]	['Cause']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Differentiation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	T	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	under	_	_	IN	O	[-1]	['none']	_	_
6	low	_	_	JJ	O	[-1]	['none']	_	_
7	antigen	_	_	NN	O	[-1]	['none']	_	_
8	dose	_	_	NN	O	[-1]	['none']	_	_
9	led	_	_	VBD	Positive_regulation	[0]	['root']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	expression	_	_	NN	Gene_expression	[9, 34]	['Theme', 'Theme']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	c-maf	_	_	NN	Protein	[11]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	keeping	_	_	VBG	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	Th2	_	_	NN	O	[-1]	['none']	_	_
20	cell	_	_	NN	O	[-1]	['none']	_	_
21	profile	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	Ho	_	_	NNP	O	[-1]	['none']	_	_
24	et	_	_	FW	O	[-1]	['none']	_	_
25	al.	_	_	FW	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	1996	_	_	CD	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	which	_	_	WDT	Anaphora	[0]	['root']	_	_
31	was	_	_	VBD	O	[-1]	['none']	_	_
32	almost	_	_	RB	O	[-1]	['none']	_	_
33	completely	_	_	RB	O	[-1]	['none']	_	_
34	abrogated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
35	by	_	_	IN	O	[-1]	['none']	_	_
36	increasing	_	_	VBG	O	[-1]	['none']	_	_
37	doses	_	_	NNS	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	antigen	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL-12	_	_	NN	Protein	[4]	['Cause']	_	_
4	sustained	_	_	VBD	Positive_regulation	[0]	['root']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	high	_	_	JJ	O	[-1]	['none']	_	_
7	expression	_	_	NN	Transcription	[4]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	c-Maf	_	_	NN	Protein	[7]	['Theme']	_	_
10	mRNA	_	_	NN	O	[-1]	['none']	_	_
11	even	_	_	RB	O	[-1]	['none']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	highest	_	_	JJS	O	[-1]	['none']	_	_
15	antigen	_	_	NN	O	[-1]	['none']	_	_
16	dose	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Moreover	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL-12	_	_	NN	Protein	[4]	['Cause']	_	_
4	maintenance	_	_	NN	Positive_regulation	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	c-maf	_	_	NN	Protein	[7]	['Theme']	_	_
7	expression	_	_	NN	Gene_expression	[4, 8]	['Theme', 'Cause']	_	_
8	required	_	_	VBD	Positive_regulation	[0]	['root']	_	_
9	STAT4	_	_	NN	Protein	[10]	['Theme']	_	_
10	activation	_	_	NN	Positive_regulation	[8]	['Theme']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	data	_	_	NNS	O	[-1]	['none']	_	_
13	not	_	_	RB	O	[-1]	['none']	_	_
14	shown	_	_	VBN	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	Th17	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	that	_	_	WDT	O	[-1]	['none']	_	_
5	expressed	_	_	VBD	Transcription	[0]	['root']	_	_
6	IL-17a	_	_	NN	Protein	[5]	['Theme']	_	_
7	as	_	_	RB	O	[-1]	['none']	_	_
8	well	_	_	RB	O	[-1]	['none']	_	_
9	as	_	_	IN	O	[-1]	['none']	_	_
10	IL-10	_	_	NN	Protein	[5]	['Theme']	_	_
11	mRNA	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	T-bet	_	_	NN	Protein	[16]	['Theme']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	GATA-3	_	_	NN	Protein	[16]	['Theme']	_	_
16	mRNA	_	_	NN	Transcription	[18]	['Theme']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	undetectable	_	_	JJ	Negative_regulation	[0]	['root']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	data	_	_	NNS	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	shown	_	_	VBN	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	whereas	_	_	IN	O	[-1]	['none']	_	_
26	that	_	_	DT	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	ROR-gammat	_	_	NN	Protein	[30]	['Theme']	_	_
29	was	_	_	VBD	O	[-1]	['none']	_	_
30	high	_	_	JJ	Positive_regulation	[0]	['root']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	Ivanov	_	_	NNP	O	[-1]	['none']	_	_
33	et	_	_	FW	O	[-1]	['none']	_	_
34	al.	_	_	FW	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	2007	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Th17	_	_	NN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	expressed	_	_	VBD	Gene_expression	[0]	['root']	_	_
5	high	_	_	JJ	O	[-1]	['none']	_	_
6	amounts	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	c-maf	_	_	NN	Protein	[4]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	confirming	_	_	VBG	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	recent	_	_	JJ	O	[-1]	['none']	_	_
13	report	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Bauquet	_	_	NNP	O	[-1]	['none']	_	_
16	et	_	_	FW	O	[-1]	['none']	_	_
17	al.	_	_	FW	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	2009	_	_	CD	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	c-Maf	_	_	NNP	Protein	[4]	['Theme']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	therefore	_	_	RB	O	[-1]	['none']	_	_
4	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	all	_	_	DT	O	[-1]	['none']	_	_
7	IL-10-expressing	_	_	JJ	Gene_expression	[0]	['root']	_	_
8	T	_	_	NN	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	populations	_	_	NNS	O	[-1]	['none']	_	_
11	tested	_	_	VBN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	may	_	_	MD	O	[-1]	['none']	_	_
14	not	_	_	RB	O	[-1]	['none']	_	_
15	be	_	_	VB	O	[-1]	['none']	_	_
16	just	_	_	RB	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	Th2	_	_	NN	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	specific	_	_	JJ	O	[-1]	['none']	_	_
21	transcription	_	_	NN	O	[-1]	['none']	_	_
22	factor	_	_	NN	O	[-1]	['none']	_	_
23	as	_	_	IN	O	[-1]	['none']	_	_
24	originally	_	_	RB	O	[-1]	['none']	_	_
25	thought	_	_	VBN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	Ho	_	_	NNP	O	[-1]	['none']	_	_
28	et	_	_	FW	O	[-1]	['none']	_	_
29	al.	_	_	FW	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	1996	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	showed	_	_	VBD	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	like	_	_	IN	O	[-1]	['none']	_	_
6	Il10	_	_	NN	Protein	[7]	['Theme']	_	_
7	expression	_	_	NN	Gene_expression	[12]	['Theme']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	c-maf	_	_	NN	Protein	[10]	['Theme']	_	_
10	expression	_	_	NN	Gene_expression	[12]	['Theme']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	inhibited	_	_	VBN	Negative_regulation	[0]	['root']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	Th1	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	Th17	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	presence	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	MEK1	_	_	NN	Protein	[26]	['Theme']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	MEK2	_	_	NN	Protein	[26]	['Theme']	_	_
26	inhibitor	_	_	NN	Negative_regulation	[12, 38]	['Cause', 'Cause']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	PD184352	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	whereas	_	_	IN	O	[-1]	['none']	_	_
32	T-bet	_	_	NN	Protein	[35]	['Theme']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	RORgammat	_	_	NN	Protein	[35]	['Theme']	_	_
35	expression	_	_	NN	Gene_expression	[38]	['Theme']	_	_
36	was	_	_	VBD	O	[-1]	['none']	_	_
37	hardly	_	_	RB	O	[-1]	['none']	_	_
38	affected	_	_	VBN	Regulation	[0]	['root']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	protein	_	_	NN	O	[-1]	['none']	_	_
7	HOIP	_	_	NN	Protein	[0]	['root']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	critical	_	_	JJ	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	CD40	_	_	NN	Protein	[0]	['root']	_	_
12	induced	_	_	VBD	O	[-1]	['none']	_	_
13	signals	_	_	NNS	O	[-1]	['none']	_	_
14	that	_	_	WDT	O	[-1]	['none']	_	_
15	regulate	_	_	VBP	O	[-1]	['none']	_	_
16	B	_	_	NN	O	[-1]	['none']	_	_
17	cell	_	_	NN	O	[-1]	['none']	_	_
18	function	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	show	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[6]	['Cause']	_	_
6	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
7	cellular	_	_	JJ	O	[-1]	['none']	_	_
8	responses	_	_	NNS	O	[-1]	['none']	_	_
9	include	_	_	VBP	O	[-1]	['none']	_	_
10	CD40	_	_	NN	Protein	[11]	['Cause']	_	_
11	mediated	_	_	VBD	Positive_regulation	[6]	['Theme']	_	_
12	upregulation	_	_	NN	Positive_regulation	[11]	['Theme']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	CD80	_	_	NN	Protein	[15]	['Theme']	_	_
15	expression	_	_	NN	Gene_expression	[12]	['Theme']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	synthesis	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	germline	_	_	NN	O	[-1]	['none']	_	_
20	RNA	_	_	NN	O	[-1]	['none']	_	_
21	transcripts	_	_	NNS	O	[-1]	['none']	_	_
22	from	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	immunoglobulin	_	_	NN	O	[-1]	['none']	_	_
25	heavy	_	_	JJ	O	[-1]	['none']	_	_
26	chain	_	_	NN	O	[-1]	['none']	_	_
27	locus	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	two	_	_	CD	O	[-1]	['none']	_	_
30	events	_	_	NNS	O	[-1]	['none']	_	_
31	that	_	_	WDT	O	[-1]	['none']	_	_
32	are	_	_	VBP	O	[-1]	['none']	_	_
33	important	_	_	JJ	O	[-1]	['none']	_	_
34	for	_	_	IN	O	[-1]	['none']	_	_
35	T-cell-dependent	_	_	JJ	O	[-1]	['none']	_	_
36	antibody	_	_	NN	O	[-1]	['none']	_	_
37	mediated	_	_	VBN	O	[-1]	['none']	_	_
38	immune	_	_	JJ	O	[-1]	['none']	_	_
39	responses	_	_	NNS	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	molecular	_	_	JJ	O	[-1]	['none']	_	_
4	level	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	our	_	_	PRP$	O	[-1]	['none']	_	_
7	data	_	_	NNS	O	[-1]	['none']	_	_
8	indicate	_	_	VBP	O	[-1]	['none']	_	_
9	that	_	_	IN	O	[-1]	['none']	_	_
10	HOIP	_	_	NN	Protein	[12]	['Theme']	_	_
11	functions	_	_	NNS	O	[-1]	['none']	_	_
12	downstream	_	_	RB	Regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	TRAF2	_	_	NN	Protein	[12]	['Cause']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	CD40	_	_	NN	Protein	[0]	['root']	_	_
18	signaling	_	_	NN	O	[-1]	['none']	_	_
19	pathway	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	HOIP	_	_	NNP	Protein	[26]	['Cause']	_	_
23	has	_	_	VBZ	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	key	_	_	JJ	O	[-1]	['none']	_	_
26	role	_	_	NN	Regulation	[0]	['root']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	promoting	_	_	VBG	Positive_regulation	[26]	['Theme']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	recruitment	_	_	NN	Binding	[28]	['Theme']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	IKK	_	_	NN	O	[-1]	['none']	_	_
34	complex	_	_	NN	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	CD40	_	_	NN	Protein	[30]	['Theme']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Consistent	_	_	JJ	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	this	_	_	DT	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[0]	['root']	_	_
6	induced	_	_	VBD	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	dependent	_	_	JJ	O	[-1]	['none']	_	_
12	on	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	presence	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	HOIP	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	our	_	_	PRP$	O	[-1]	['none']	_	_
5	data	_	_	NNS	O	[-1]	['none']	_	_
6	show	_	_	VBP	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	HOIP	_	_	NN	Protein	[0]	['root']	_	_
9	facilitates	_	_	VBZ	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	JNK	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	response	_	_	NN	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	CD40	_	_	NN	Protein	[18]	['Theme']	_	_
18	engagement	_	_	NN	Binding	[0]	['root']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Together	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	findings	_	_	NNS	O	[-1]	['none']	_	_
5	provide	_	_	VBP	O	[-1]	['none']	_	_
6	support	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	conclusion	_	_	NN	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	HOIP	_	_	NN	Protein	[0]	['root']	_	_
12	is	_	_	VBZ	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	key	_	_	JJ	O	[-1]	['none']	_	_
15	component	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	CD40	_	_	NN	Protein	[0]	['root']	_	_
19	signaling	_	_	NN	O	[-1]	['none']	_	_
20	pathway	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Given	_	_	VBN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	importance	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[0]	['root']	_	_
6	signaling	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	both	_	_	CC	O	[-1]	['none']	_	_
9	cellular	_	_	JJ	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	humoral	_	_	JJ	O	[-1]	['none']	_	_
12	immune	_	_	JJ	O	[-1]	['none']	_	_
13	responses	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	our	_	_	PRP$	O	[-1]	['none']	_	_
16	results	_	_	NNS	O	[-1]	['none']	_	_
17	indicate	_	_	VBP	O	[-1]	['none']	_	_
18	that	_	_	IN	O	[-1]	['none']	_	_
19	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
20	has	_	_	VBZ	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	critical	_	_	JJ	O	[-1]	['none']	_	_
23	role	_	_	NN	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	regulation	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	immune	_	_	JJ	O	[-1]	['none']	_	_
30	system	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	functional	_	_	JJ	O	[-1]	['none']	_	_
3	properties	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[0]	['root']	_	_
6	have	_	_	VBP	O	[-1]	['none']	_	_
7	only	_	_	RB	O	[-1]	['none']	_	_
8	been	_	_	VBN	O	[-1]	['none']	_	_
9	partially	_	_	RB	O	[-1]	['none']	_	_
10	characterized	_	_	VBN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Initial	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	showed	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[0]	['root']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	related	_	_	JJ	O	[-1]	['none']	_	_
9	protein	_	_	NN	O	[-1]	['none']	_	_
10	HOIL-1	_	_	NN	Protein	[0]	['root']	_	_
11	are	_	_	VBP	O	[-1]	['none']	_	_
12	components	_	_	NNS	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	large	_	_	JJ	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	~	_	_	NN	O	[-1]	['none']	_	_
18	600	_	_	CD	O	[-1]	['none']	_	_
19	kDa	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	protein	_	_	NN	O	[-1]	['none']	_	_
22	complex	_	_	NN	O	[-1]	['none']	_	_
23	capable	_	_	JJ	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	synthesizing	_	_	VBG	O	[-1]	['none']	_	_
26	linear	_	_	JJ	O	[-1]	['none']	_	_
27	polyubiquitin	_	_	NN	O	[-1]	['none']	_	_
28	chains	_	_	NNS	O	[-1]	['none']	_	_
29	[	_	_	VBP	O	[-1]	['none']	_	_
30	5	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	CD	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Subsequent	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	showed	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	HOIP	_	_	NN	O	[-1]	['none']	_	_
7	containing	_	_	VBG	O	[-1]	['none']	_	_
8	complex	_	_	NN	O	[-1]	['none']	_	_
9	can	_	_	MD	O	[-1]	['none']	_	_
10	interact	_	_	VB	Binding	[0]	['root']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	IKKgamma	_	_	NN	Protein	[10]	['Theme']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	facilitate	_	_	VB	O	[-1]	['none']	_	_
15	activation	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
18	via	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	canonical	_	_	JJ	O	[-1]	['none']	_	_
21	pathway	_	_	NN	O	[-1]	['none']	_	_
22	[	_	_	CD	O	[-1]	['none']	_	_
23	16	_	_	CD	O	[-1]	['none']	_	_
24	]	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	considered	_	_	VBN	O	[-1]	['none']	_	_
5	together	_	_	RB	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	ours	_	_	PRP	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	suggest	_	_	VBP	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	HOIP	_	_	NN	O	[-1]	['none']	_	_
13	containing	_	_	VBG	O	[-1]	['none']	_	_
14	complex	_	_	NN	O	[-1]	['none']	_	_
15	mediates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
16	recruitment	_	_	NN	Binding	[15]	['Theme']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IKKgamma	_	_	NN	Protein	[16]	['Theme']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	CD40	_	_	NN	O	[-1]	['none']	_	_
22	signaling	_	_	NN	O	[-1]	['none']	_	_
23	complex	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	CD40	_	_	NN	Protein	[5]	['Theme']	_	_
5	associated	_	_	VBN	Binding	[0]	['root']	_	_
6	HOIP	_	_	NNP	Protein	[5, 10, 16]	['Theme', 'Cause', 'Theme']	_	_
7	could	_	_	MD	O	[-1]	['none']	_	_
8	play	_	_	VB	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	role	_	_	NN	Regulation	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	activating	_	_	VBG	Positive_regulation	[10]	['Theme']	_	_
13	IKKgamma	_	_	NN	Protein	[12]	['Theme']	_	_
14	after	_	_	IN	O	[-1]	['none']	_	_
15	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
16	recruitment	_	_	NN	Binding	[0]	['root']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	signaling	_	_	NN	O	[-1]	['none']	_	_
20	complex	_	_	NN	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	16	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	higher	_	_	JJR	O	[-1]	['none']	_	_
3	molecular	_	_	JJ	O	[-1]	['none']	_	_
4	weight	_	_	NN	O	[-1]	['none']	_	_
5	forms	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IKKgamma	_	_	NN	Protein	[23, 25]	['Theme', 'Theme']	_	_
8	we	_	_	PRP	O	[-1]	['none']	_	_
9	observed	_	_	VBD	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	CD40	_	_	NN	Protein	[0]	['root']	_	_
12	immunoprecipitates	_	_	NNS	O	[-1]	['none']	_	_
13	would	_	_	MD	O	[-1]	['none']	_	_
14	be	_	_	VB	O	[-1]	['none']	_	_
15	consistent	_	_	JJ	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	presence	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	post-transcriptional	_	_	JJ	Anaphora	[21]	['multitoken']	_	_
21	modifications	_	_	NNS	Anaphora	[0]	['root']	_	_
22	including	_	_	VBG	O	[-1]	['none']	_	_
23	phosphorylation	_	_	NN	Phosphorylation	[32, 34]	['Cause', 'Cause']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	ubiquitination	_	_	NN	Ubiquitination	[32, 34]	['Cause', 'Cause']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	which	_	_	WDT	Anaphora	[0]	['root']	_	_
28	have	_	_	VBP	O	[-1]	['none']	_	_
29	been	_	_	VBN	O	[-1]	['none']	_	_
30	suggested	_	_	VBN	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	reduce	_	_	VB	Negative_regulation	[0]	['root']	_	_
33	or	_	_	CC	O	[-1]	['none']	_	_
34	enhance	_	_	VB	Positive_regulation	[0]	['root']	_	_
35	IKKgamma	_	_	NN	Protein	[32, 34]	['Theme', 'Theme']	_	_
36	activity	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	respectively	_	_	RB	O	[-1]	['none']	_	_
39	[	_	_	CD	O	[-1]	['none']	_	_
40	16	_	_	CD	O	[-1]	['none']	_	_
41	]	_	_	NN	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	[	_	_	CD	O	[-1]	['none']	_	_
44	17	_	_	CD	O	[-1]	['none']	_	_
45	]	_	_	NN	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	which	_	_	WDT	O	[-1]	['none']	_	_
5	HOIP	_	_	NNP	Protein	[6]	['Cause']	_	_
6	mediates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
7	recruitment	_	_	NN	Binding	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	IKK	_	_	NN	O	[-1]	['none']	_	_
11	complex	_	_	NN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	CD40	_	_	NN	Protein	[7]	['Theme']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	which	_	_	WDT	O	[-1]	['none']	_	_
17	HOIP	_	_	NNP	Protein	[19]	['Theme']	_	_
18	is	_	_	VBZ	O	[-1]	['none']	_	_
19	recruited	_	_	VBN	Binding	[0]	['root']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	CD40	_	_	NN	Protein	[19]	['Theme']	_	_
22	remain	_	_	VBP	O	[-1]	['none']	_	_
23	unclear	_	_	JJ	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	previous	_	_	JJ	O	[-1]	['none']	_	_
3	study	_	_	NN	O	[-1]	['none']	_	_
4	indicates	_	_	VBZ	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	HOIP	_	_	NN	Protein	[25]	['Cause']	_	_
7	may	_	_	MD	O	[-1]	['none']	_	_
8	mediate	_	_	VB	O	[-1]	['none']	_	_
9	direct	_	_	JJ	O	[-1]	['none']	_	_
10	contacts	_	_	NNS	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	IKK	_	_	NN	O	[-1]	['none']	_	_
14	complex	_	_	NN	O	[-1]	['none']	_	_
15	[	_	_	CD	O	[-1]	['none']	_	_
16	16	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	suggesting	_	_	VBG	O	[-1]	['none']	_	_
20	that	_	_	IN	O	[-1]	['none']	_	_
21	it	_	_	PRP	Anaphora	[0]	['root']	_	_
22	functions	_	_	VBZ	Positive_regulation	[25]	['multitoken']	_	_
23	as	_	_	IN	Positive_regulation	[25]	['multitoken']	_	_
24	an	_	_	DT	Positive_regulation	[25]	['multitoken']	_	_
25	adaptor	_	_	NN	Positive_regulation	[0]	['root']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	recruitment	_	_	NN	Binding	[25]	['Theme']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	IKK	_	_	NN	O	[-1]	['none']	_	_
32	complex	_	_	NN	O	[-1]	['none']	_	_
33	to	_	_	TO	O	[-1]	['none']	_	_
34	CD40	_	_	NN	Protein	[28]	['Theme']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	ubiquitin	_	_	NN	O	[-1]	['none']	_	_
5	ligase	_	_	NN	O	[-1]	['none']	_	_
6	activity	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	HOIP	_	_	NN	Protein	[0]	['root']	_	_
9	suggests	_	_	VBZ	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	it	_	_	PRP	O	[-1]	['none']	_	_
12	is	_	_	VBZ	O	[-1]	['none']	_	_
13	more	_	_	RBR	O	[-1]	['none']	_	_
14	than	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	simple	_	_	JJ	O	[-1]	['none']	_	_
17	adapter	_	_	NN	O	[-1]	['none']	_	_
18	molecule	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	IKKgamma	_	_	NN	Protein	[6]	['Theme']	_	_
3	appears	_	_	VBZ	O	[-1]	['none']	_	_
4	capable	_	_	JJ	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	binding	_	_	VBG	Binding	[0]	['root']	_	_
7	linear	_	_	JJ	O	[-1]	['none']	_	_
8	polyubiquitin	_	_	NN	O	[-1]	['none']	_	_
9	[	_	_	NN	O	[-1]	['none']	_	_
10	18	_	_	CD	O	[-1]	['none']	_	_
11	]	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	19	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	it	_	_	PRP	O	[-1]	['none']	_	_
18	is	_	_	VBZ	O	[-1]	['none']	_	_
19	possible	_	_	JJ	O	[-1]	['none']	_	_
20	that	_	_	IN	O	[-1]	['none']	_	_
21	HOIP	_	_	NN	Protein	[0]	['root']	_	_
22	directs	_	_	VBZ	O	[-1]	['none']	_	_
23	formation	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	linear	_	_	JJ	O	[-1]	['none']	_	_
26	polyubiquitin	_	_	NN	O	[-1]	['none']	_	_
27	chains	_	_	NNS	O	[-1]	['none']	_	_
28	on	_	_	IN	O	[-1]	['none']	_	_
29	a	_	_	DT	O	[-1]	['none']	_	_
30	CD40	_	_	NN	O	[-1]	['none']	_	_
31	associated	_	_	VBN	O	[-1]	['none']	_	_
32	factor	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	it	_	_	PRP	O	[-1]	['none']	_	_
36	is	_	_	VBZ	O	[-1]	['none']	_	_
37	these	_	_	DT	O	[-1]	['none']	_	_
38	chains	_	_	NNS	O	[-1]	['none']	_	_
39	that	_	_	WDT	O	[-1]	['none']	_	_
40	serve	_	_	VBP	Positive_regulation	[0]	['root']	_	_
41	to	_	_	TO	O	[-1]	['none']	_	_
42	recruit	_	_	VB	Binding	[40]	['Theme']	_	_
43	IKKgamma	_	_	NN	Protein	[42]	['Theme']	_	_
44	to	_	_	TO	O	[-1]	['none']	_	_
45	the	_	_	DT	O	[-1]	['none']	_	_
46	CD40	_	_	NN	O	[-1]	['none']	_	_
47	signaling	_	_	NN	O	[-1]	['none']	_	_
48	complex	_	_	NN	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	molecular	_	_	JJ	O	[-1]	['none']	_	_
3	interactions	_	_	NNS	O	[-1]	['none']	_	_
4	necessary	_	_	JJ	Positive_regulation	[0]	['root']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	recruitment	_	_	NN	Binding	[4]	['Theme']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	HOIP	_	_	NNP	Protein	[6]	['Theme']	_	_
9	itself	_	_	PRP	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	CD40	_	_	NN	O	[-1]	['none']	_	_
13	signaling	_	_	NN	O	[-1]	['none']	_	_
14	complex	_	_	NN	O	[-1]	['none']	_	_
15	also	_	_	RB	O	[-1]	['none']	_	_
16	remain	_	_	VBP	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	be	_	_	VB	O	[-1]	['none']	_	_
19	fully	_	_	RB	O	[-1]	['none']	_	_
20	characterized	_	_	VBN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	previously	_	_	RB	O	[-1]	['none']	_	_
3	showed	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	recruitment	_	_	NN	Binding	[15]	['Theme']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	HOIP	_	_	NN	Protein	[6]	['Theme']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	signaling	_	_	NN	O	[-1]	['none']	_	_
12	complex	_	_	NN	O	[-1]	['none']	_	_
13	is	_	_	VBZ	O	[-1]	['none']	_	_
14	TRAF2	_	_	NN	Protein	[15]	['Cause']	_	_
15	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
16	[	_	_	NN	O	[-1]	['none']	_	_
17	8	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Potentially	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	TRAF2	_	_	NN	Protein	[7]	['Theme']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[7]	['Theme']	_	_
6	directly	_	_	RB	O	[-1]	['none']	_	_
7	interact	_	_	VBP	Binding	[0]	['root']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	but	_	_	CC	O	[-1]	['none']	_	_
10	it	_	_	PRP	O	[-1]	['none']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	possible	_	_	JJ	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	ubiquitin	_	_	NN	O	[-1]	['none']	_	_
16	ligase	_	_	NN	O	[-1]	['none']	_	_
17	activity	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
20	[	_	_	CD	O	[-1]	['none']	_	_
21	20	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	or	_	_	CC	O	[-1]	['none']	_	_
25	TRAF2	_	_	NN	O	[-1]	['none']	_	_
26	associated	_	_	JJ	O	[-1]	['none']	_	_
27	proteins	_	_	NNS	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	such	_	_	JJ	O	[-1]	['none']	_	_
30	as	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	cIAPs	_	_	NNS	O	[-1]	['none']	_	_
33	[	_	_	VBP	O	[-1]	['none']	_	_
34	21	_	_	CD	O	[-1]	['none']	_	_
35	]	_	_	CD	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	generates	_	_	VBZ	O	[-1]	['none']	_	_
38	K63	_	_	NN	O	[-1]	['none']	_	_
39	linked	_	_	VBN	O	[-1]	['none']	_	_
40	polyubiquitin	_	_	NN	O	[-1]	['none']	_	_
41	chains	_	_	NNS	O	[-1]	['none']	_	_
42	to	_	_	TO	O	[-1]	['none']	_	_
43	which	_	_	WDT	O	[-1]	['none']	_	_
44	HOIP	_	_	NNP	Protein	[46, 49]	['Theme', 'Theme']	_	_
45	can	_	_	MD	O	[-1]	['none']	_	_
46	bind	_	_	VB	Binding	[0]	['root']	_	_
47	and	_	_	CC	O	[-1]	['none']	_	_
48	thus	_	_	RB	O	[-1]	['none']	_	_
49	associate	_	_	VBP	Binding	[0]	['root']	_	_
50	with	_	_	IN	O	[-1]	['none']	_	_
51	the	_	_	DT	O	[-1]	['none']	_	_
52	CD40	_	_	NN	O	[-1]	['none']	_	_
53	signaling	_	_	NN	O	[-1]	['none']	_	_
54	complex	_	_	NN	O	[-1]	['none']	_	_
55	[	_	_	CD	O	[-1]	['none']	_	_
56	22	_	_	CD	O	[-1]	['none']	_	_
57	]	_	_	NN	O	[-1]	['none']	_	_
58	.	_	_	.	O	[-1]	['none']	_	_

1	While	_	_	IN	O	[-1]	['none']	_	_
2	our	_	_	PRP$	O	[-1]	['none']	_	_
3	previous	_	_	JJ	O	[-1]	['none']	_	_
4	work	_	_	NN	O	[-1]	['none']	_	_
5	indicated	_	_	VBD	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	potentially	_	_	RB	O	[-1]	['none']	_	_
8	important	_	_	JJ	O	[-1]	['none']	_	_
9	link	_	_	NN	O	[-1]	['none']	_	_
10	between	_	_	IN	O	[-1]	['none']	_	_
11	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	HOIP	_	_	NN	Protein	[0]	['root']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	CD40	_	_	NN	Protein	[0]	['root']	_	_
16	signaling	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	signals	_	_	NNS	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	functions	_	_	NNS	O	[-1]	['none']	_	_
22	tested	_	_	VBN	O	[-1]	['none']	_	_
23	here	_	_	RB	O	[-1]	['none']	_	_
24	are	_	_	VBP	O	[-1]	['none']	_	_
25	dependent	_	_	JJ	O	[-1]	['none']	_	_
26	upon	_	_	IN	O	[-1]	['none']	_	_
27	TRAF6	_	_	NN	Protein	[0]	['root']	_	_
28	as	_	_	RB	O	[-1]	['none']	_	_
29	well	_	_	RB	O	[-1]	['none']	_	_
30	as	_	_	IN	O	[-1]	['none']	_	_
31	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	previous	_	_	JJ	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	TRAF	_	_	NN	O	[-1]	['none']	_	_
6	deficient	_	_	JJ	O	[-1]	['none']	_	_
7	A20	_	_	NN	O	[-1]	['none']	_	_
8	.2	_	_	NN	O	[-1]	['none']	_	_
9	J	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	we	_	_	PRP	O	[-1]	['none']	_	_
13	found	_	_	VBD	O	[-1]	['none']	_	_
14	that	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	activation	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	CD40	_	_	NN	Protein	[0]	['root']	_	_
21	could	_	_	MD	O	[-1]	['none']	_	_
22	be	_	_	VB	O	[-1]	['none']	_	_
23	mediated	_	_	VBN	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	either	_	_	CC	O	[-1]	['none']	_	_
26	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
27	or	_	_	CC	O	[-1]	['none']	_	_
28	TRAF6	_	_	NN	Protein	[0]	['root']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	while	_	_	IN	O	[-1]	['none']	_	_
31	activation	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	JNK	_	_	NN	O	[-1]	['none']	_	_
34	by	_	_	IN	O	[-1]	['none']	_	_
35	CD40	_	_	NN	Protein	[0]	['root']	_	_
36	was	_	_	VBD	O	[-1]	['none']	_	_
37	largely	_	_	RB	O	[-1]	['none']	_	_
38	dependent	_	_	JJ	O	[-1]	['none']	_	_
39	on	_	_	IN	O	[-1]	['none']	_	_
40	TRAF6	_	_	NN	Protein	[0]	['root']	_	_
41	alone	_	_	RB	O	[-1]	['none']	_	_
42	[	_	_	RB	O	[-1]	['none']	_	_
43	8	_	_	CD	O	[-1]	['none']	_	_
44	]	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	HOIP	_	_	NN	Protein	[2]	['Theme']	_	_
2	deficiency	_	_	NN	Negative_regulation	[0]	['root']	_	_
3	compromises	_	_	VBZ	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[0]	['root']	_	_
6	mediated	_	_	JJ	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	both	_	_	CC	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	JNK	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	indicating	_	_	VBG	O	[-1]	['none']	_	_
15	that	_	_	IN	O	[-1]	['none']	_	_
16	signals	_	_	NNS	O	[-1]	['none']	_	_
17	mediated	_	_	VBN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	both	_	_	CC	O	[-1]	['none']	_	_
20	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	TRAF6	_	_	NN	Protein	[0]	['root']	_	_
23	likely	_	_	JJ	O	[-1]	['none']	_	_
24	pass	_	_	NN	O	[-1]	['none']	_	_
25	through	_	_	IN	O	[-1]	['none']	_	_
26	HOIP	_	_	NN	Protein	[0]	['root']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	previous	_	_	JJ	O	[-1]	['none']	_	_
3	work	_	_	NN	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	CD40	_	_	NN	Protein	[0]	['root']	_	_
9	mediated	_	_	JJ	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	JNK	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	while	_	_	IN	O	[-1]	['none']	_	_
17	TRAF6	_	_	NN	Protein	[0]	['root']	_	_
18	dependent	_	_	JJ	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	was	_	_	VBD	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	compromised	_	_	VBN	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	disruption	_	_	NN	Negative_regulation	[0]	['root']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	binding	_	_	NN	Entity	[29]	['multitoken']	_	_
29	site	_	_	NN	Entity	[25]	['Site']	_	_
30	for	_	_	IN	O	[-1]	['none']	_	_
31	TRAF6	_	_	NN	Protein	[0]	['root']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
35	domain	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	CD40	_	_	NN	Protein	[25]	['Theme']	_	_
38	or	_	_	CC	O	[-1]	['none']	_	_
39	deletion	_	_	NN	Negative_regulation	[0]	['root']	_	_
40	of	_	_	IN	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	receptor	_	_	NN	Entity	[44]	['multitoken']	_	_
43	binding	_	_	NN	Entity	[44]	['multitoken']	_	_
44	domain	_	_	NN	Entity	[39]	['Site']	_	_
45	(	_	_	-LRB-	O	[-1]	['none']	_	_
46	the	_	_	DT	O	[-1]	['none']	_	_
47	TRAF-C	_	_	NN	O	[-1]	['none']	_	_
48	domain	_	_	NN	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	in	_	_	IN	O	[-1]	['none']	_	_
51	TRAF6	_	_	NN	Protein	[39]	['Theme']	_	_
52	[	_	_	CD	O	[-1]	['none']	_	_
53	8	_	_	CD	O	[-1]	['none']	_	_
54	]	_	_	NN	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	observations	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	TRAF6	_	_	NN	Protein	[9]	['Theme']	_	_
6	need	_	_	MD	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	directly	_	_	RB	O	[-1]	['none']	_	_
9	bind	_	_	VB	Binding	[0]	['root']	_	_
10	CD40	_	_	NN	Protein	[9]	['Theme']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	order	_	_	NN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	mediate	_	_	VB	O	[-1]	['none']	_	_
15	certain	_	_	JJ	O	[-1]	['none']	_	_
16	signals	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	suggesting	_	_	VBG	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	assembly	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	signaling	_	_	NN	O	[-1]	['none']	_	_
24	complex	_	_	NN	O	[-1]	['none']	_	_
25	not	_	_	RB	O	[-1]	['none']	_	_
26	directly	_	_	RB	O	[-1]	['none']	_	_
27	associated	_	_	VBN	O	[-1]	['none']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	receptor	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	If	_	_	IN	O	[-1]	['none']	_	_
2	such	_	_	PDT	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	complex	_	_	JJ	O	[-1]	['none']	_	_
5	exists	_	_	VBZ	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	our	_	_	PRP$	O	[-1]	['none']	_	_
8	results	_	_	NNS	O	[-1]	['none']	_	_
9	indicate	_	_	VBP	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	HOIP	_	_	NN	Protein	[12]	['Theme']	_	_
15	compromises	_	_	VBZ	O	[-1]	['none']	_	_
16	its	_	_	PRP$	O	[-1]	['none']	_	_
17	function	_	_	NN	O	[-1]	['none']	_	_
18	as	_	_	RB	O	[-1]	['none']	_	_
19	well	_	_	RB	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	presented	_	_	VBN	O	[-1]	['none']	_	_
5	here	_	_	RB	O	[-1]	['none']	_	_
6	focus	_	_	VB	O	[-1]	['none']	_	_
7	on	_	_	IN	O	[-1]	['none']	_	_
8	CD40	_	_	NN	Protein	[0]	['root']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	our	_	_	PRP$	O	[-1]	['none']	_	_
11	results	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	those	_	_	DT	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	other	_	_	JJ	O	[-1]	['none']	_	_
16	groups	_	_	NNS	O	[-1]	['none']	_	_
17	[	_	_	VBP	O	[-1]	['none']	_	_
18	16	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	CD	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	22	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	support	_	_	VBP	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	possibility	_	_	NN	O	[-1]	['none']	_	_
27	that	_	_	IN	O	[-1]	['none']	_	_
28	HOIP	_	_	NN	Protein	[0]	['root']	_	_
29	is	_	_	VBZ	O	[-1]	['none']	_	_
30	important	_	_	JJ	O	[-1]	['none']	_	_
31	in	_	_	IN	O	[-1]	['none']	_	_
32	many	_	_	JJ	O	[-1]	['none']	_	_
33	signaling	_	_	NN	O	[-1]	['none']	_	_
34	pathways	_	_	NNS	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	which	_	_	WDT	O	[-1]	['none']	_	_
37	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
38	or	_	_	CC	O	[-1]	['none']	_	_
39	TRAF6	_	_	NN	Protein	[0]	['root']	_	_
40	are	_	_	VBP	O	[-1]	['none']	_	_
41	involved	_	_	VBN	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	including	_	_	VBG	O	[-1]	['none']	_	_
44	those	_	_	DT	O	[-1]	['none']	_	_
45	associated	_	_	VBN	O	[-1]	['none']	_	_
46	with	_	_	IN	O	[-1]	['none']	_	_
47	various	_	_	JJ	O	[-1]	['none']	_	_
48	members	_	_	NNS	O	[-1]	['none']	_	_
49	of	_	_	IN	O	[-1]	['none']	_	_
50	the	_	_	DT	O	[-1]	['none']	_	_
51	TNF	_	_	NN	O	[-1]	['none']	_	_
52	receptor	_	_	NN	O	[-1]	['none']	_	_
53	superfamily	_	_	NN	O	[-1]	['none']	_	_
54	and	_	_	CC	O	[-1]	['none']	_	_
55	the	_	_	DT	O	[-1]	['none']	_	_
56	Toll	_	_	NN	O	[-1]	['none']	_	_
57	like	_	_	IN	O	[-1]	['none']	_	_
58	receptors	_	_	NNS	O	[-1]	['none']	_	_
59	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	potential	_	_	JJ	O	[-1]	['none']	_	_
3	importance	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	immune	_	_	JJ	O	[-1]	['none']	_	_
8	function	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	TNFR	_	_	NN	O	[-1]	['none']	_	_
11	family	_	_	NN	O	[-1]	['none']	_	_
12	signaling	_	_	NN	O	[-1]	['none']	_	_
13	is	_	_	VBZ	O	[-1]	['none']	_	_
14	further	_	_	JJ	O	[-1]	['none']	_	_
15	supported	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	recent	_	_	JJ	O	[-1]	['none']	_	_
19	discovery	_	_	NN	O	[-1]	['none']	_	_
20	that	_	_	WDT	O	[-1]	['none']	_	_
21	HOIP	_	_	NNP	Protein	[22]	['Theme']	_	_
22	interacts	_	_	VBZ	Binding	[0]	['root']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	a	_	_	DT	Anaphora	[25]	['multitoken']	_	_
25	protein	_	_	NN	Anaphora	[0]	['root']	_	_
26	known	_	_	VBN	O	[-1]	['none']	_	_
27	as	_	_	IN	O	[-1]	['none']	_	_
28	SHARPIN	_	_	NNP	Protein	[22]	['Theme']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	SHANK	_	_	NNP	Protein	[38]	['multitoken']	_	_
31	associated	_	_	VBN	Protein	[38]	['multitoken']	_	_
32	RH	_	_	NN	Protein	[38]	['multitoken']	_	_
33	domain	_	_	NN	Protein	[38]	['multitoken']	_	_
34	interacting	_	_	VBG	Protein	[38]	['multitoken']	_	_
35	protein	_	_	NN	Protein	[38]	['multitoken']	_	_
36	in	_	_	IN	Protein	[38]	['multitoken']	_	_
37	postsynaptic	_	_	JJ	Protein	[38]	['multitoken']	_	_
38	density	_	_	NN	Protein	[0]	['root']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	which	_	_	WDT	O	[-1]	['none']	_	_
42	appears	_	_	VBZ	O	[-1]	['none']	_	_
43	capable	_	_	JJ	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	working	_	_	VBG	O	[-1]	['none']	_	_
46	together	_	_	RB	O	[-1]	['none']	_	_
47	with	_	_	IN	O	[-1]	['none']	_	_
48	HOIP	_	_	NN	Protein	[0]	['root']	_	_
49	and	_	_	CC	O	[-1]	['none']	_	_
50	HOIL	_	_	NNP	Protein	[0]	['root']	_	_
51	to	_	_	TO	O	[-1]	['none']	_	_
52	mediate	_	_	VB	O	[-1]	['none']	_	_
53	the	_	_	DT	O	[-1]	['none']	_	_
54	assembly	_	_	NN	O	[-1]	['none']	_	_
55	of	_	_	IN	O	[-1]	['none']	_	_
56	linear	_	_	JJ	O	[-1]	['none']	_	_
57	polyubiquitin	_	_	NN	O	[-1]	['none']	_	_
58	[	_	_	NN	O	[-1]	['none']	_	_
59	14	_	_	CD	O	[-1]	['none']	_	_
60	]	_	_	NN	O	[-1]	['none']	_	_
61	,	_	_	,	O	[-1]	['none']	_	_
62	[	_	_	CD	O	[-1]	['none']	_	_
63	23	_	_	CD	O	[-1]	['none']	_	_
64	]	_	_	NN	O	[-1]	['none']	_	_
65	,	_	_	,	O	[-1]	['none']	_	_
66	[	_	_	CD	O	[-1]	['none']	_	_
67	24	_	_	CD	O	[-1]	['none']	_	_
68	]	_	_	NN	O	[-1]	['none']	_	_
69	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	mice	_	_	NNS	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	spontaneous	_	_	JJ	O	[-1]	['none']	_	_
7	mutation	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	gene	_	_	NN	O	[-1]	['none']	_	_
11	encoding	_	_	VBG	O	[-1]	['none']	_	_
12	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	chronic	_	_	JJ	O	[-1]	['none']	_	_
15	proliferative	_	_	JJ	O	[-1]	['none']	_	_
16	dermatitis	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	cpdm	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	mice	_	_	NNS	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	exhibit	_	_	NN	O	[-1]	['none']	_	_
23	chronic	_	_	JJ	O	[-1]	['none']	_	_
24	inflammation	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	skin	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	internal	_	_	JJ	O	[-1]	['none']	_	_
30	organs	_	_	NNS	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	defective	_	_	JJ	O	[-1]	['none']	_	_
33	development	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	secondary	_	_	JJ	O	[-1]	['none']	_	_
36	lymphoid	_	_	JJ	O	[-1]	['none']	_	_
37	tissue	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	defects	_	_	NNS	O	[-1]	['none']	_	_
41	in	_	_	IN	O	[-1]	['none']	_	_
42	the	_	_	DT	O	[-1]	['none']	_	_
43	production	_	_	NN	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	switched	_	_	VBN	O	[-1]	['none']	_	_
46	immunoglobulin	_	_	NN	O	[-1]	['none']	_	_
47	isotypes	_	_	NNS	O	[-1]	['none']	_	_
48	[	_	_	VBP	O	[-1]	['none']	_	_
49	17	_	_	CD	O	[-1]	['none']	_	_
50	]	_	_	CD	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	[	_	_	CD	O	[-1]	['none']	_	_
53	25	_	_	CD	O	[-1]	['none']	_	_
54	]	_	_	NN	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	apparently	_	_	RB	O	[-1]	['none']	_	_
3	intimate	_	_	JJ	O	[-1]	['none']	_	_
4	functional	_	_	JJ	O	[-1]	['none']	_	_
5	link	_	_	NN	Binding	[0]	['root']	_	_
6	between	_	_	IN	O	[-1]	['none']	_	_
7	SHARPIN	_	_	NNP	Protein	[5]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	HOIP	_	_	NNP	Protein	[5]	['Theme']	_	_
10	strongly	_	_	RB	O	[-1]	['none']	_	_
11	suggests	_	_	VBZ	O	[-1]	['none']	_	_
12	that	_	_	IN	O	[-1]	['none']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	least	_	_	JJS	O	[-1]	['none']	_	_
15	part	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	cpdm	_	_	NN	O	[-1]	['none']	_	_
19	phenotype	_	_	NN	O	[-1]	['none']	_	_
20	stems	_	_	VBZ	O	[-1]	['none']	_	_
21	from	_	_	IN	O	[-1]	['none']	_	_
22	defects	_	_	NNS	Negative_regulation	[0]	['root']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	regulation	_	_	NN	Regulation	[22]	['Theme']	_	_
26	or	_	_	CC	O	[-1]	['none']	_	_
27	function	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	HOIP	_	_	NN	Protein	[25]	['Theme']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Chemicals	_	_	NNS	O	[-1]	['none']	_	_
2	The	_	_	DT	O	[-1]	['none']	_	_
3	following	_	_	JJ	O	[-1]	['none']	_	_
4	chemicals	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	used	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	present	_	_	JJ	O	[-1]	['none']	_	_
10	study	_	_	NN	O	[-1]	['none']	_	_
11	:	_	_	:	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Phorbol	_	_	NN	O	[-1]	['none']	_	_
15	12-myristate	_	_	NN	O	[-1]	['none']	_	_
16	13-acetate	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	Sigma	_	_	NNP	O	[-1]	['none']	_	_
20	#P	_	_	NNP	O	[-1]	['none']	_	_
21	1585	_	_	CD	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	USA	_	_	NNP	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	;	_	_	:	O	[-1]	['none']	_	_
27	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
28	activation	_	_	NN	O	[-1]	['none']	_	_
29	inhibitor	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	NAI	_	_	NNP	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	InSolution	_	_	NNP	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	TM	_	_	NN	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
40	Activation	_	_	NN	O	[-1]	['none']	_	_
41	Inhibitor	_	_	NNP	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	Calbiochem	_	_	NNP	O	[-1]	['none']	_	_
44	#	_	_	#	O	[-1]	['none']	_	_
45	481407	_	_	CD	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	USA	_	_	NNP	O	[-1]	['none']	_	_
48	)	_	_	-RRB-	O	[-1]	['none']	_	_
49	;	_	_	:	O	[-1]	['none']	_	_
50	JNK	_	_	NN	O	[-1]	['none']	_	_
51	inhibitor	_	_	NN	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	(	_	_	-LRB-	O	[-1]	['none']	_	_
54	InSolution	_	_	NNP	O	[-1]	['none']	_	_
55	(	_	_	-LRB-	O	[-1]	['none']	_	_
56	TM	_	_	NN	O	[-1]	['none']	_	_
57	)	_	_	-RRB-	O	[-1]	['none']	_	_
58	JNK	_	_	NN	O	[-1]	['none']	_	_
59	Inhibitor	_	_	NN	O	[-1]	['none']	_	_
60	II	_	_	CD	O	[-1]	['none']	_	_
61	,	_	_	,	O	[-1]	['none']	_	_
62	Calbiochem	_	_	NNP	O	[-1]	['none']	_	_
63	#	_	_	#	O	[-1]	['none']	_	_
64	420128	_	_	CD	O	[-1]	['none']	_	_
65	,	_	_	,	O	[-1]	['none']	_	_
66	USA	_	_	NNP	O	[-1]	['none']	_	_
67	)	_	_	-RRB-	O	[-1]	['none']	_	_
68	;	_	_	:	O	[-1]	['none']	_	_
69	PKC	_	_	NN	O	[-1]	['none']	_	_
70	Inhibitor	_	_	NN	O	[-1]	['none']	_	_
71	,	_	_	,	O	[-1]	['none']	_	_
72	(	_	_	-LRB-	O	[-1]	['none']	_	_
73	InSolution	_	_	NNP	O	[-1]	['none']	_	_
74	(	_	_	-LRB-	O	[-1]	['none']	_	_
75	TM	_	_	NN	O	[-1]	['none']	_	_
76	)	_	_	-RRB-	O	[-1]	['none']	_	_
77	Bisindolylmaleimide	_	_	NN	O	[-1]	['none']	_	_
78	I	_	_	PRP	O	[-1]	['none']	_	_
79	,	_	_	,	O	[-1]	['none']	_	_
80	Calbiochem	_	_	NNP	O	[-1]	['none']	_	_
81	#	_	_	#	O	[-1]	['none']	_	_
82	203293	_	_	CD	O	[-1]	['none']	_	_
83	,	_	_	,	O	[-1]	['none']	_	_
84	USA	_	_	NNP	O	[-1]	['none']	_	_
85	)	_	_	-RRB-	O	[-1]	['none']	_	_
86	;	_	_	:	O	[-1]	['none']	_	_
87	Calcium	_	_	NN	O	[-1]	['none']	_	_
88	Ionophore	_	_	NN	O	[-1]	['none']	_	_
89	,	_	_	,	O	[-1]	['none']	_	_
90	(	_	_	-LRB-	O	[-1]	['none']	_	_
91	Calcium	_	_	NN	O	[-1]	['none']	_	_
92	Ionophore	_	_	NN	O	[-1]	['none']	_	_
93	A23187	_	_	NN	O	[-1]	['none']	_	_
94	mixed	_	_	JJ	O	[-1]	['none']	_	_
95	calcium	_	_	NN	O	[-1]	['none']	_	_
96	magnesium	_	_	NN	O	[-1]	['none']	_	_
97	salt	_	_	NN	O	[-1]	['none']	_	_
98	,	_	_	,	O	[-1]	['none']	_	_
99	Sigma	_	_	NNP	O	[-1]	['none']	_	_
100	#C	_	_	NNP	O	[-1]	['none']	_	_
101	5149	_	_	CD	O	[-1]	['none']	_	_
102	,	_	_	,	O	[-1]	['none']	_	_
103	USA	_	_	NNP	O	[-1]	['none']	_	_
104	)	_	_	-RRB-	O	[-1]	['none']	_	_
105	.	_	_	.	O	[-1]	['none']	_	_

1	Transient	_	_	JJ	O	[-1]	['none']	_	_
2	expression	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	luciferase	_	_	NN	Protein	[0]	['root']	_	_
5	assays	_	_	NNS	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	HEK	_	_	NNP	O	[-1]	['none']	_	_
2	293T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	plated	_	_	VBN	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	density	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	5	_	_	CD	O	[-1]	['none']	_	_
11	x	_	_	CC	O	[-1]	['none']	_	_
12	105	_	_	CD	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	well	_	_	RB	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	six-well	_	_	JJ	O	[-1]	['none']	_	_
18	culture	_	_	NN	O	[-1]	['none']	_	_
19	plates	_	_	VBZ	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	BD	_	_	NNP	O	[-1]	['none']	_	_
22	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	San	_	_	NNP	O	[-1]	['none']	_	_
25	Diego	_	_	NNP	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	California	_	_	NNP	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	United	_	_	NNP	O	[-1]	['none']	_	_
30	States	_	_	NNPS	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	1	_	_	CD	O	[-1]	['none']	_	_
33	d	_	_	NN	O	[-1]	['none']	_	_
34	prior	_	_	RB	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	transfection	_	_	NN	O	[-1]	['none']	_	_
37	with	_	_	IN	O	[-1]	['none']	_	_
38	the	_	_	DT	O	[-1]	['none']	_	_
39	appropriate	_	_	JJ	O	[-1]	['none']	_	_
40	plasmid	_	_	NN	O	[-1]	['none']	_	_
41	DNA	_	_	NN	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	~	_	_	NN	O	[-1]	['none']	_	_
44	2	_	_	CD	O	[-1]	['none']	_	_
45	mug	_	_	NN	O	[-1]	['none']	_	_
46	total	_	_	JJ	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	using	_	_	VBG	O	[-1]	['none']	_	_
49	FuGene	_	_	NNP	O	[-1]	['none']	_	_
50	6	_	_	CD	O	[-1]	['none']	_	_
51	transfection	_	_	NN	O	[-1]	['none']	_	_
52	reagent	_	_	NN	O	[-1]	['none']	_	_
53	(	_	_	-LRB-	O	[-1]	['none']	_	_
54	Roche	_	_	NNP	O	[-1]	['none']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	Basel	_	_	NNP	O	[-1]	['none']	_	_
57	,	_	_	,	O	[-1]	['none']	_	_
58	Switzerland	_	_	NNP	O	[-1]	['none']	_	_
59	)	_	_	-RRB-	O	[-1]	['none']	_	_
60	.	_	_	.	O	[-1]	['none']	_	_

1	Jurkat	_	_	NN	O	[-1]	['none']	_	_
2	T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	plated	_	_	VBN	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	1	_	_	CD	O	[-1]	['none']	_	_
8	x	_	_	CC	O	[-1]	['none']	_	_
9	106	_	_	CD	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	well	_	_	RB	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	six-well	_	_	JJ	O	[-1]	['none']	_	_
15	culture	_	_	NN	O	[-1]	['none']	_	_
16	plates	_	_	VBZ	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	day	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	transfection	_	_	NN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	appropriate	_	_	JJ	O	[-1]	['none']	_	_
24	plasmid	_	_	NN	O	[-1]	['none']	_	_
25	DNA	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	~	_	_	NN	O	[-1]	['none']	_	_
28	2	_	_	CD	O	[-1]	['none']	_	_
29	mug	_	_	NN	O	[-1]	['none']	_	_
30	total	_	_	JJ	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	using	_	_	VBG	O	[-1]	['none']	_	_
33	FuGene	_	_	NNP	O	[-1]	['none']	_	_
34	6	_	_	CD	O	[-1]	['none']	_	_
35	transfection	_	_	NN	O	[-1]	['none']	_	_
36	reagent	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Primary	_	_	JJ	O	[-1]	['none']	_	_
2	human	_	_	NN	O	[-1]	['none']	_	_
3	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
4	T	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	2	_	_	CD	O	[-1]	['none']	_	_
8	x	_	_	CC	O	[-1]	['none']	_	_
9	106	_	_	CD	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	nucleofected	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	specified	_	_	JJ	O	[-1]	['none']	_	_
16	plasmid	_	_	NN	O	[-1]	['none']	_	_
17	DNA	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	5	_	_	CD	O	[-1]	['none']	_	_
20	mug	_	_	NN	O	[-1]	['none']	_	_
21	total	_	_	JJ	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	using	_	_	VBG	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	Human	_	_	NN	O	[-1]	['none']	_	_
26	T	_	_	NN	O	[-1]	['none']	_	_
27	Cell	_	_	NN	O	[-1]	['none']	_	_
28	Nucleofection	_	_	NNP	O	[-1]	['none']	_	_
29	Kit	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	Amaxa	_	_	NNP	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	Gaithersburg	_	_	NNP	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	Maryland	_	_	NNP	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	United	_	_	NNP	O	[-1]	['none']	_	_
38	States	_	_	NNPS	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Forskolin	_	_	NN	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	10	_	_	CD	O	[-1]	['none']	_	_
4	muM	_	_	NN	O	[-1]	['none']	_	_
5	;	_	_	:	O	[-1]	['none']	_	_
6	Calbiochem	_	_	NNP	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	San	_	_	NNP	O	[-1]	['none']	_	_
9	Diego	_	_	NNP	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	California	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	United	_	_	NNP	O	[-1]	['none']	_	_
14	States	_	_	NNPS	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	added	_	_	VBN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	some	_	_	DT	O	[-1]	['none']	_	_
20	experiments	_	_	NNS	O	[-1]	['none']	_	_
21	20	_	_	CD	O	[-1]	['none']	_	_
22	h	_	_	NN	O	[-1]	['none']	_	_
23	posttransfection	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	harvested	_	_	VBN	O	[-1]	['none']	_	_
4	24	_	_	CD	O	[-1]	['none']	_	_
5	h	_	_	NN	O	[-1]	['none']	_	_
6	posttransfection	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	luciferase	_	_	NN	Protein	[0]	['root']	_	_
9	activity	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	analyzed	_	_	VBN	O	[-1]	['none']	_	_
12	using	_	_	VBG	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	Dual-luciferase	_	_	NN	Protein	[0]	['root']	_	_
15	Reporter	_	_	NN	O	[-1]	['none']	_	_
16	Assay	_	_	NN	O	[-1]	['none']	_	_
17	System	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	Promega	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	Monolight	_	_	NNP	O	[-1]	['none']	_	_
24	2010	_	_	CD	O	[-1]	['none']	_	_
25	luminometer	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	Analytical	_	_	NNP	O	[-1]	['none']	_	_
28	Luminescence	_	_	NNP	O	[-1]	['none']	_	_
29	Laboratory	_	_	NNP	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	San	_	_	NNP	O	[-1]	['none']	_	_
32	Diego	_	_	NNP	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	California	_	_	NNP	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	United	_	_	NNP	O	[-1]	['none']	_	_
37	States	_	_	NNPS	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	according	_	_	VBG	O	[-1]	['none']	_	_
40	to	_	_	TO	O	[-1]	['none']	_	_
41	manufacturer	_	_	NN	O	[-1]	['none']	_	_
42	's	_	_	POS	O	[-1]	['none']	_	_
43	guidelines	_	_	NNS	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	pGL4-TKhRluc2	_	_	NNP	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	an	_	_	DT	O	[-1]	['none']	_	_
6	internal	_	_	JJ	O	[-1]	['none']	_	_
7	control	_	_	NN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	normalize	_	_	VB	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	transfection	_	_	NN	O	[-1]	['none']	_	_
12	efficiency	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Nucleofected	_	_	JJ	O	[-1]	['none']	_	_
2	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
3	T	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	also	_	_	RB	O	[-1]	['none']	_	_
7	monitored	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	transfection	_	_	NN	O	[-1]	['none']	_	_
10	efficiency	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	cell	_	_	NN	O	[-1]	['none']	_	_
13	viability	_	_	NN	O	[-1]	['none']	_	_
14	24	_	_	CD	O	[-1]	['none']	_	_
15	h	_	_	NN	O	[-1]	['none']	_	_
16	posttransfection	_	_	NN	O	[-1]	['none']	_	_
17	as	_	_	IN	O	[-1]	['none']	_	_
18	follows	_	_	VBZ	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Transfection	_	_	NN	O	[-1]	['none']	_	_
2	efficiency	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	routinely	_	_	RB	O	[-1]	['none']	_	_
5	~	_	_	CD	O	[-1]	['none']	_	_
6	30	_	_	CD	O	[-1]	['none']	_	_
7	%	_	_	NN	O	[-1]	['none']	_	_
8	as	_	_	IN	O	[-1]	['none']	_	_
9	determined	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	flow	_	_	NN	O	[-1]	['none']	_	_
12	cytometric	_	_	JJ	O	[-1]	['none']	_	_
13	analysis	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	EGFP	_	_	NN	O	[-1]	['none']	_	_
16	expression	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	viability	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	determined	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	staining	_	_	VBG	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	7-amino-actinomycin	_	_	NN	O	[-1]	['none']	_	_
9	D	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	7-AAD	_	_	NN	O	[-1]	['none']	_	_
12	;	_	_	:	O	[-1]	['none']	_	_
13	BD	_	_	NNP	O	[-1]	['none']	_	_
14	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	routinely	_	_	RB	O	[-1]	['none']	_	_
19	~	_	_	CD	O	[-1]	['none']	_	_
20	70	_	_	CD	O	[-1]	['none']	_	_
21	%	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Both	_	_	DT	O	[-1]	['none']	_	_
2	transfection	_	_	NN	O	[-1]	['none']	_	_
3	efficiency	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	viability	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	nucleofected	_	_	JJ	O	[-1]	['none']	_	_
9	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
10	T	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	independent	_	_	JJ	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	plasmids	_	_	NNS	O	[-1]	['none']	_	_
17	used	_	_	VBN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	CD80	_	_	NN	Protein	[2]	['Theme']	_	_
2	upregulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	flow	_	_	NN	O	[-1]	['none']	_	_
5	cytometry	_	_	NN	O	[-1]	['none']	_	_
6	Cells	_	_	NNS	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	5x104	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	2	_	_	CD	O	[-1]	['none']	_	_
11	ml	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	cultured	_	_	VBN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	24-well	_	_	JJ	O	[-1]	['none']	_	_
17	plates	_	_	NNS	O	[-1]	['none']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	3	_	_	CD	O	[-1]	['none']	_	_
20	days	_	_	NNS	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	5	_	_	CD	O	[-1]	['none']	_	_
23	microg/ml	_	_	NN	O	[-1]	['none']	_	_
24	anti-CD40	_	_	NN	O	[-1]	['none']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	an	_	_	DT	O	[-1]	['none']	_	_
27	isotype	_	_	NN	O	[-1]	['none']	_	_
28	control	_	_	NN	O	[-1]	['none']	_	_
29	antibody	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	stained	_	_	VBN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	flow	_	_	NN	O	[-1]	['none']	_	_
6	cytometry	_	_	NN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	FITC-anti-CD80	_	_	NN	O	[-1]	['none']	_	_
9	or	_	_	CC	O	[-1]	['none']	_	_
10	an	_	_	DT	O	[-1]	['none']	_	_
11	appropriate	_	_	JJ	O	[-1]	['none']	_	_
12	control	_	_	NN	O	[-1]	['none']	_	_
13	antibody	_	_	NN	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	described	_	_	VBN	O	[-1]	['none']	_	_
16	[	_	_	NN	O	[-1]	['none']	_	_
17	28	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNP	O	[-1]	['none']	_	_
2	acquired	_	_	VBN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	FACScan	_	_	NN	O	[-1]	['none']	_	_
6	flow	_	_	NN	O	[-1]	['none']	_	_
7	cytometer	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	BD	_	_	NNP	O	[-1]	['none']	_	_
10	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	analyzed	_	_	VBN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	WinMDI	_	_	NN	O	[-1]	['none']	_	_
16	2.8	_	_	CD	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Scripps	_	_	NNP	O	[-1]	['none']	_	_
19	Research	_	_	NNP	O	[-1]	['none']	_	_
20	Institute	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	San	_	_	NNP	O	[-1]	['none']	_	_
23	Diego	_	_	NNP	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	CA	_	_	NNP	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	MTS	_	_	NNP	O	[-1]	['none']	_	_
2	assay	_	_	NN	O	[-1]	['none']	_	_
3	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	3-(	_	_	CD	O	[-1]	['none']	_	_
3	4	_	_	CD	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	5-dimethylthiazol-2-yl	_	_	JJ	O	[-1]	['none']	_	_
6	)-5-(	_	_	CD	O	[-1]	['none']	_	_
7	3-carboxymethoxyphenyl	_	_	JJ	O	[-1]	['none']	_	_
8	)-2-(	_	_	CD	O	[-1]	['none']	_	_
9	4-sulfophenyl	_	_	NN	O	[-1]	['none']	_	_
10	)-2H-tetrazolium	_	_	NN	O	[-1]	['none']	_	_
11	inner	_	_	JJ	O	[-1]	['none']	_	_
12	salt	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	MTS	_	_	NNP	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	cell	_	_	NN	O	[-1]	['none']	_	_
17	cytotoxicity	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	proliferation	_	_	NN	O	[-1]	['none']	_	_
20	assays	_	_	NNS	O	[-1]	['none']	_	_
21	were	_	_	VBD	O	[-1]	['none']	_	_
22	performed	_	_	VBN	O	[-1]	['none']	_	_
23	using	_	_	VBG	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	CellTiter	_	_	NNP	O	[-1]	['none']	_	_
26	96	_	_	CD	O	[-1]	['none']	_	_
27	aqueous	_	_	JJ	O	[-1]	['none']	_	_
28	one-solution	_	_	JJ	O	[-1]	['none']	_	_
29	cell	_	_	NN	O	[-1]	['none']	_	_
30	proliferation	_	_	NN	O	[-1]	['none']	_	_
31	assay	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	Promega	_	_	NNP	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	according	_	_	VBG	O	[-1]	['none']	_	_
37	to	_	_	TO	O	[-1]	['none']	_	_
38	manufacturer	_	_	NN	O	[-1]	['none']	_	_
39	's	_	_	POS	O	[-1]	['none']	_	_
40	instructions	_	_	NNS	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	IL4	_	_	NN	Protein	[0]	['root']	_	_
3	studies	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	cultured	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	3	_	_	CD	O	[-1]	['none']	_	_
10	d	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	presence	_	_	NN	O	[-1]	['none']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	absence	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	100	_	_	CD	O	[-1]	['none']	_	_
18	ng/ml	_	_	NN	O	[-1]	['none']	_	_
19	IL4	_	_	NN	Protein	[0]	['root']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	seeded	_	_	VBN	O	[-1]	['none']	_	_
4	on	_	_	IN	O	[-1]	['none']	_	_
5	day	_	_	NN	O	[-1]	['none']	_	_
6	3	_	_	CD	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	triplicate	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	96-well	_	_	JJ	O	[-1]	['none']	_	_
12	plate	_	_	NN	O	[-1]	['none']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	2.5	_	_	CD	O	[-1]	['none']	_	_
15	x	_	_	CC	O	[-1]	['none']	_	_
16	106	_	_	CD	O	[-1]	['none']	_	_
17	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
18	at	_	_	IN	O	[-1]	['none']	_	_
19	100	_	_	CD	O	[-1]	['none']	_	_
20	mul	_	_	NN	O	[-1]	['none']	_	_
21	per	_	_	IN	O	[-1]	['none']	_	_
22	well	_	_	RB	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	MTS	_	_	NNP	O	[-1]	['none']	_	_
2	reagent	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	added	_	_	VBN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	4	_	_	CD	O	[-1]	['none']	_	_
7	h	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	absorbance	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	read	_	_	VBN	O	[-1]	['none']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	540	_	_	CD	O	[-1]	['none']	_	_
14	nm	_	_	NN	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	values	_	_	NNS	O	[-1]	['none']	_	_
17	plotted	_	_	VBN	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	subtracted	_	_	VBN	O	[-1]	['none']	_	_
20	from	_	_	IN	O	[-1]	['none']	_	_
21	blanks	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	neutralization	_	_	NN	O	[-1]	['none']	_	_
3	assays	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	seeded	_	_	VBN	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	5	_	_	CD	O	[-1]	['none']	_	_
10	x	_	_	CC	O	[-1]	['none']	_	_
11	106	_	_	CD	O	[-1]	['none']	_	_
12	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	100	_	_	CD	O	[-1]	['none']	_	_
15	mul	_	_	NN	O	[-1]	['none']	_	_
16	per	_	_	IN	O	[-1]	['none']	_	_
17	well	_	_	RB	O	[-1]	['none']	_	_
18	on	_	_	IN	O	[-1]	['none']	_	_
19	day	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	harvest	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	IL4	_	_	NN	Protein	[0]	['root']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	rat	_	_	NN	O	[-1]	['none']	_	_
26	IgG1	_	_	NN	O	[-1]	['none']	_	_
27	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
28	IL4	_	_	NN	Protein	[0]	['root']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	or	_	_	CC	O	[-1]	['none']	_	_
31	rat	_	_	NN	O	[-1]	['none']	_	_
32	IgG1	_	_	NN	O	[-1]	['none']	_	_
33	isotype	_	_	NN	O	[-1]	['none']	_	_
34	control	_	_	NN	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	R&D	_	_	NNP	O	[-1]	['none']	_	_
37	Systems	_	_	NNPS	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	were	_	_	VBD	O	[-1]	['none']	_	_
40	added	_	_	VBN	O	[-1]	['none']	_	_
41	at	_	_	IN	O	[-1]	['none']	_	_
42	the	_	_	DT	O	[-1]	['none']	_	_
43	concentrations	_	_	NNS	O	[-1]	['none']	_	_
44	indicated	_	_	VBD	O	[-1]	['none']	_	_
45	in	_	_	IN	O	[-1]	['none']	_	_
46	the	_	_	DT	O	[-1]	['none']	_	_
47	figures	_	_	NNS	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	Cultures	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	pulsed	_	_	JJ	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	4	_	_	CD	O	[-1]	['none']	_	_
6	h	_	_	NN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	MTS	_	_	NNP	O	[-1]	['none']	_	_
9	reagent	_	_	NN	O	[-1]	['none']	_	_
10	1	_	_	CD	O	[-1]	['none']	_	_
11	d	_	_	NN	O	[-1]	['none']	_	_
12	post-seeding	_	_	JJ	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	inhibitor	_	_	NN	O	[-1]	['none']	_	_
3	studies	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	seeded	_	_	VBN	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	1	_	_	CD	O	[-1]	['none']	_	_
10	x	_	_	CC	O	[-1]	['none']	_	_
11	107	_	_	CD	O	[-1]	['none']	_	_
12	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	100	_	_	CD	O	[-1]	['none']	_	_
15	mul	_	_	NN	O	[-1]	['none']	_	_
16	per	_	_	IN	O	[-1]	['none']	_	_
17	well	_	_	RB	O	[-1]	['none']	_	_
18	on	_	_	IN	O	[-1]	['none']	_	_
19	day	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	harvest	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
25	were	_	_	VBD	O	[-1]	['none']	_	_
26	added	_	_	VBN	O	[-1]	['none']	_	_
27	at	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	concentrations	_	_	NNS	O	[-1]	['none']	_	_
30	indicated	_	_	VBD	O	[-1]	['none']	_	_
31	in	_	_	IN	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	figures	_	_	NNS	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
3	BAY11-7085	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	rapamycin	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	triciribine	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	U0126	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	SB202190	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	cucurbitacin	_	_	NN	O	[-1]	['none']	_	_
15	I	_	_	PRP	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	purchased	_	_	VBN	O	[-1]	['none']	_	_
18	from	_	_	IN	O	[-1]	['none']	_	_
19	EMD	_	_	NNP	O	[-1]	['none']	_	_
20	Biosciences	_	_	NNPS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	non	_	_	JJ	O	[-1]	['none']	_	_
3	malignant	_	_	JJ	O	[-1]	['none']	_	_
4	splenocyte	_	_	NN	O	[-1]	['none']	_	_
5	cultures	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	B	_	_	NN	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	induced	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	10	_	_	CD	O	[-1]	['none']	_	_
14	mug/ml	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	goat	_	_	NN	O	[-1]	['none']	_	_
17	F	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	ab	_	_	NN	O	[-1]	['none']	_	_
20	'	_	_	''	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
23	IgM	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	Jackson	_	_	NNP	O	[-1]	['none']	_	_
26	ImmunoResearch	_	_	NNP	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Cultures	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	pulsed	_	_	JJ	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	4	_	_	CD	O	[-1]	['none']	_	_
6	h	_	_	NN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	MTS	_	_	NNP	O	[-1]	['none']	_	_
9	reagent	_	_	NN	O	[-1]	['none']	_	_
10	1	_	_	CD	O	[-1]	['none']	_	_
11	d	_	_	NN	O	[-1]	['none']	_	_
12	post-seeding	_	_	JJ	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	present	_	_	JJ	O	[-1]	['none']	_	_
3	report	_	_	NN	O	[-1]	['none']	_	_
4	showed	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	null	_	_	JJ	Negative_regulation	[7]	['multitoken']	_	_
7	mutations	_	_	NNS	Negative_regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	mouse	_	_	NN	O	[-1]	['none']	_	_
11	Sharpin	_	_	NN	Protein	[7]	['Theme']	_	_
12	gene	_	_	NN	O	[-1]	['none']	_	_
13	did	_	_	VBD	O	[-1]	['none']	_	_
14	not	_	_	RB	O	[-1]	['none']	_	_
15	affect	_	_	VB	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	steady-state	_	_	JJ	O	[-1]	['none']	_	_
18	distribution	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	splenic	_	_	JJ	O	[-1]	['none']	_	_
21	DC	_	_	NN	O	[-1]	['none']	_	_
22	subsets	_	_	NNS	O	[-1]	['none']	_	_
23	nor	_	_	CC	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	development	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	phenotype	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	BMDC	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	loss	_	_	NN	Negative_regulation	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	SHARPIN	_	_	NNP	Protein	[3]	['Theme']	_	_
6	significantly	_	_	RB	O	[-1]	['none']	_	_
7	diminished	_	_	VBD	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	capacity	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	BMDC	_	_	NN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	secrete	_	_	VB	O	[-1]	['none']	_	_
14	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
15	cytokines	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	nitric	_	_	JJ	O	[-1]	['none']	_	_
18	oxide	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	attenuated	_	_	JJ	O	[-1]	['none']	_	_
3	cytokine	_	_	NN	O	[-1]	['none']	_	_
4	production	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	due	_	_	JJ	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	presence	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
13	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	can	_	_	MD	O	[-1]	['none']	_	_
17	be	_	_	VB	O	[-1]	['none']	_	_
18	largely	_	_	RB	O	[-1]	['none']	_	_
19	explained	_	_	VBN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	selective	_	_	JJ	O	[-1]	['none']	_	_
22	inactivation	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	signaling	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Stimulated	_	_	NN	O	[-1]	['none']	_	_
2	cpdm	_	_	NN	O	[-1]	['none']	_	_
3	BMDC	_	_	NN	O	[-1]	['none']	_	_
4	exhibited	_	_	VBD	O	[-1]	['none']	_	_
5	Th2	_	_	NN	O	[-1]	['none']	_	_
6	biased	_	_	VBN	O	[-1]	['none']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	polarizing	_	_	VBG	O	[-1]	['none']	_	_
10	capabilities	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	consistent	_	_	JJ	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	Th2	_	_	NN	O	[-1]	['none']	_	_
16	cytokine	_	_	NN	O	[-1]	['none']	_	_
17	dominant	_	_	JJ	O	[-1]	['none']	_	_
18	phenotype	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	cpdm	_	_	NN	O	[-1]	['none']	_	_
21	mice	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Together	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	results	_	_	NNS	O	[-1]	['none']	_	_
5	indicate	_	_	VBP	O	[-1]	['none']	_	_
6	an	_	_	DT	O	[-1]	['none']	_	_
7	indispensible	_	_	JJ	O	[-1]	['none']	_	_
8	role	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	SHARPIN	_	_	NNP	Protein	[17]	['Theme']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	regulating	_	_	VBG	O	[-1]	['none']	_	_
13	DC	_	_	NN	O	[-1]	['none']	_	_
14	immunological	_	_	JJ	O	[-1]	['none']	_	_
15	functions	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	disruption	_	_	NN	Negative_regulation	[0]	['root']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	which	_	_	WDT	Anaphora	[0]	['root']	_	_
20	may	_	_	MD	O	[-1]	['none']	_	_
21	contribute	_	_	VB	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	development	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	immune	_	_	JJ	O	[-1]	['none']	_	_
27	diseases	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	WT	_	_	NNP	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	cpdm	_	_	NN	O	[-1]	['none']	_	_
5	mice	_	_	NNS	O	[-1]	['none']	_	_
6	are	_	_	VBP	O	[-1]	['none']	_	_
7	both	_	_	CC	O	[-1]	['none']	_	_
8	specific	_	_	JJ	O	[-1]	['none']	_	_
9	pathogen-free	_	_	JJ	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	nature	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	trigger	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	severe	_	_	JJ	O	[-1]	['none']	_	_
19	inflammation	_	_	NN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	cpdm	_	_	NN	O	[-1]	['none']	_	_
22	mice	_	_	NNS	O	[-1]	['none']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	not	_	_	RB	O	[-1]	['none']	_	_
25	obvious	_	_	JJ	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	One	_	_	CD	O	[-1]	['none']	_	_
2	such	_	_	JJ	O	[-1]	['none']	_	_
3	initiating	_	_	VBG	O	[-1]	['none']	_	_
4	factor	_	_	NN	O	[-1]	['none']	_	_
5	could	_	_	MD	O	[-1]	['none']	_	_
6	be	_	_	VB	O	[-1]	['none']	_	_
7	endogenous	_	_	JJ	O	[-1]	['none']	_	_
8	apoptotic	_	_	JJ	O	[-1]	['none']	_	_
9	and/or	_	_	CC	O	[-1]	['none']	_	_
10	necrotic	_	_	JJ	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	that	_	_	WDT	O	[-1]	['none']	_	_
13	can	_	_	MD	O	[-1]	['none']	_	_
14	release	_	_	VB	O	[-1]	['none']	_	_
15	danger	_	_	NN	O	[-1]	['none']	_	_
16	associated	_	_	VBN	O	[-1]	['none']	_	_
17	molecular	_	_	JJ	O	[-1]	['none']	_	_
18	patterns	_	_	NNS	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	DAMPs	_	_	NNS	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	launch	_	_	VB	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	amplify	_	_	VB	O	[-1]	['none']	_	_
26	an	_	_	DT	O	[-1]	['none']	_	_
27	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
28	response	_	_	NN	O	[-1]	['none']	_	_
29	[	_	_	CD	O	[-1]	['none']	_	_
30	32	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Such	_	_	JJ	O	[-1]	['none']	_	_
2	'	_	_	''	O	[-1]	['none']	_	_
3	sterile	_	_	JJ	O	[-1]	['none']	_	_
4	'	_	_	''	O	[-1]	['none']	_	_
5	inflammation	_	_	NN	O	[-1]	['none']	_	_
6	could	_	_	MD	O	[-1]	['none']	_	_
7	be	_	_	VB	O	[-1]	['none']	_	_
8	initiated	_	_	VBN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	take	_	_	VB	O	[-1]	['none']	_	_
11	place	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	all	_	_	DT	O	[-1]	['none']	_	_
14	organs	_	_	NNS	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	tissues	_	_	NNS	O	[-1]	['none']	_	_
17	affected	_	_	VBN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	cpdm	_	_	NN	O	[-1]	['none']	_	_
20	mice	_	_	NNS	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	thus	_	_	RB	O	[-1]	['none']	_	_
23	causing	_	_	VBG	O	[-1]	['none']	_	_
24	multi-organ	_	_	JJ	O	[-1]	['none']	_	_
25	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
26	disorders	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	hypothesis	_	_	NN	O	[-1]	['none']	_	_
3	is	_	_	VBZ	O	[-1]	['none']	_	_
4	supported	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	several	_	_	JJ	O	[-1]	['none']	_	_
7	recent	_	_	JJ	O	[-1]	['none']	_	_
8	studies	_	_	NNS	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	cpdm	_	_	NN	O	[-1]	['none']	_	_
4	mice	_	_	NNS	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	highly	_	_	RB	O	[-1]	['none']	_	_
7	sensitive	_	_	JJ	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
10	induced	_	_	VBD	O	[-1]	['none']	_	_
11	cell	_	_	NN	O	[-1]	['none']	_	_
12	death	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	cpdm	_	_	NN	O	[-1]	['none']	_	_
16	phenotype	_	_	NN	O	[-1]	['none']	_	_
17	can	_	_	MD	O	[-1]	['none']	_	_
18	be	_	_	VB	O	[-1]	['none']	_	_
19	partially	_	_	RB	O	[-1]	['none']	_	_
20	rescued	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	deletion	_	_	NN	Negative_regulation	[0]	['root']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	TNF	_	_	NN	Protein	[22]	['Theme']	_	_
25	[	_	_	NN	O	[-1]	['none']	_	_
26	7	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	[	_	_	CD	O	[-1]	['none']	_	_
30	8	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	suggesting	_	_	VBG	O	[-1]	['none']	_	_
34	that	_	_	IN	O	[-1]	['none']	_	_
35	deficiency	_	_	NN	Negative_regulation	[0]	['root']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	SHARPIN	_	_	NNP	Protein	[35]	['Theme']	_	_
38	compromises	_	_	VBZ	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	anti-apoptotic	_	_	JJ	O	[-1]	['none']	_	_
41	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
42	in	_	_	IN	O	[-1]	['none']	_	_
43	cpdm	_	_	NN	O	[-1]	['none']	_	_
44	mice	_	_	NNS	O	[-1]	['none']	_	_
45	resulting	_	_	VBG	O	[-1]	['none']	_	_
46	in	_	_	IN	O	[-1]	['none']	_	_
47	cell	_	_	NN	O	[-1]	['none']	_	_
48	death	_	_	NN	O	[-1]	['none']	_	_
49	induced	_	_	VBD	O	[-1]	['none']	_	_
50	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
51	disease	_	_	NN	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	Apoptosis	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	keratinocytes	_	_	NNS	O	[-1]	['none']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	prominent	_	_	JJ	O	[-1]	['none']	_	_
7	feature	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	skin	_	_	NN	O	[-1]	['none']	_	_
11	lesions	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	cpdm	_	_	NN	O	[-1]	['none']	_	_
14	mice	_	_	NNS	O	[-1]	['none']	_	_
15	[	_	_	VBP	O	[-1]	['none']	_	_
16	33	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	CD	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	this	_	_	DT	O	[-1]	['none']	_	_
20	is	_	_	VBZ	O	[-1]	['none']	_	_
21	mediated	_	_	VBN	O	[-1]	['none']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	caspase	_	_	NN	O	[-1]	['none']	_	_
24	dependent	_	_	JJ	O	[-1]	['none']	_	_
25	mitochondrial	_	_	JJ	O	[-1]	['none']	_	_
26	pathways	_	_	NNS	O	[-1]	['none']	_	_
27	[	_	_	VBP	O	[-1]	['none']	_	_
28	34	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	CD	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	induced	_	_	VBN	O	[-1]	['none']	_	_
3	and/or	_	_	CC	O	[-1]	['none']	_	_
4	intrinsic	_	_	JJ	O	[-1]	['none']	_	_
5	apoptotic	_	_	JJ	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	can	_	_	MD	O	[-1]	['none']	_	_
8	release	_	_	VB	O	[-1]	['none']	_	_
9	various	_	_	JJ	O	[-1]	['none']	_	_
10	types	_	_	NNS	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	DAMPs	_	_	NNS	O	[-1]	['none']	_	_
13	that	_	_	WDT	O	[-1]	['none']	_	_
14	exert	_	_	VBP	O	[-1]	['none']	_	_
15	their	_	_	PRP$	O	[-1]	['none']	_	_
16	pro	_	_	JJ	O	[-1]	['none']	_	_
17	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
18	properties	_	_	NNS	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	activating	_	_	VBG	O	[-1]	['none']	_	_
21	DC	_	_	NN	O	[-1]	['none']	_	_
22	through	_	_	IN	O	[-1]	['none']	_	_
23	pattern	_	_	NN	O	[-1]	['none']	_	_
24	recognition	_	_	NN	O	[-1]	['none']	_	_
25	receptors	_	_	NNS	O	[-1]	['none']	_	_
26	[	_	_	VBP	O	[-1]	['none']	_	_
27	32	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	CD	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	[	_	_	CD	O	[-1]	['none']	_	_
31	35	_	_	CD	O	[-1]	['none']	_	_
32	]	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	such	_	_	JJ	O	[-1]	['none']	_	_
35	as	_	_	IN	O	[-1]	['none']	_	_
36	HMGB1	_	_	NN	Protein	[37]	['Theme']	_	_
37	recognized	_	_	VBN	Binding	[0]	['root']	_	_
38	by	_	_	IN	O	[-1]	['none']	_	_
39	TLR2/4	_	_	NN	Protein	[0]	['root']	_	_
40	[	_	_	CD	O	[-1]	['none']	_	_
41	36	_	_	CD	O	[-1]	['none']	_	_
42	]	_	_	NN	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	[	_	_	CD	O	[-1]	['none']	_	_
45	37	_	_	CD	O	[-1]	['none']	_	_
46	]	_	_	NN	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	Consistent	_	_	JJ	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	impaired	_	_	JJ	O	[-1]	['none']	_	_
5	Th1	_	_	NN	O	[-1]	['none']	_	_
6	immune	_	_	JJ	O	[-1]	['none']	_	_
7	response	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	cpdm	_	_	NN	O	[-1]	['none']	_	_
10	mice	_	_	NNS	O	[-1]	['none']	_	_
11	[	_	_	VBP	O	[-1]	['none']	_	_
12	5	_	_	CD	O	[-1]	['none']	_	_
13	]	_	_	CD	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	stimulated	_	_	VBN	O	[-1]	['none']	_	_
16	BMDC	_	_	NNP	O	[-1]	['none']	_	_
17	weakly	_	_	RB	O	[-1]	['none']	_	_
18	polarized	_	_	VBN	O	[-1]	['none']	_	_
19	Th1	_	_	NN	O	[-1]	['none']	_	_
20	differentiation	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	but	_	_	CC	O	[-1]	['none']	_	_
23	strongly	_	_	RB	O	[-1]	['none']	_	_
24	supported	_	_	VBD	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	development	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	Th2	_	_	NN	O	[-1]	['none']	_	_
29	effector	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Combined	_	_	VBN	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	dramatic	_	_	JJ	O	[-1]	['none']	_	_
5	effect	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IL12	_	_	NN	O	[-1]	['none']	_	_
8	treatment	_	_	NN	O	[-1]	['none']	_	_
9	on	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	phenotype	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	these	_	_	DT	O	[-1]	['none']	_	_
14	mice	_	_	NNS	O	[-1]	['none']	_	_
15	[	_	_	VBP	O	[-1]	['none']	_	_
16	5	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	CD	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	this	_	_	DT	O	[-1]	['none']	_	_
20	suggests	_	_	VBZ	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	Th2	_	_	NN	O	[-1]	['none']	_	_
24	biased	_	_	VBN	O	[-1]	['none']	_	_
25	systemic	_	_	JJ	O	[-1]	['none']	_	_
26	inflammation	_	_	NN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	cpdm	_	_	NN	O	[-1]	['none']	_	_
29	mice	_	_	NNS	O	[-1]	['none']	_	_
30	is	_	_	VBZ	O	[-1]	['none']	_	_
31	caused	_	_	VBN	O	[-1]	['none']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	reduced	_	_	VBN	O	[-1]	['none']	_	_
34	IL12P70	_	_	NN	O	[-1]	['none']	_	_
35	production	_	_	NN	O	[-1]	['none']	_	_
36	from	_	_	IN	O	[-1]	['none']	_	_
37	DC	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	importance	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	IL12P70	_	_	NN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	regulating	_	_	VBG	O	[-1]	['none']	_	_
7	Th1	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	Th2	_	_	NN	O	[-1]	['none']	_	_
10	immune	_	_	JJ	O	[-1]	['none']	_	_
11	responses	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	mice	_	_	NNS	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	clearly	_	_	RB	O	[-1]	['none']	_	_
16	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	IL12P35-	_	_	NN	Protein	[0]	['root']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	IL12P40	_	_	NN	Protein	[21]	['Theme']	_	_
21	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
22	mice	_	_	NNS	O	[-1]	['none']	_	_
23	[	_	_	VBP	O	[-1]	['none']	_	_
24	38	_	_	CD	O	[-1]	['none']	_	_
25	]	_	_	CD	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	39	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	through	_	_	IN	O	[-1]	['none']	_	_
32	clinical	_	_	JJ	O	[-1]	['none']	_	_
33	studies	_	_	NNS	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	human	_	_	NN	O	[-1]	['none']	_	_
36	patients	_	_	NNS	O	[-1]	['none']	_	_
37	[	_	_	IN	O	[-1]	['none']	_	_
38	40	_	_	CD	O	[-1]	['none']	_	_
39	]-[	_	_	CD	O	[-1]	['none']	_	_
40	42	_	_	CD	O	[-1]	['none']	_	_
41	]	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	TBK	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	IRF3	_	_	NN	Protein	[0]	['root']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	MAPK	_	_	NN	O	[-1]	['none']	_	_
9	signaling	_	_	NN	O	[-1]	['none']	_	_
10	are	_	_	VBP	O	[-1]	['none']	_	_
11	important	_	_	JJ	O	[-1]	['none']	_	_
12	pathways	_	_	NNS	O	[-1]	['none']	_	_
13	activated	_	_	VBN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	LPS	_	_	NN	O	[-1]	['none']	_	_
16	or	_	_	CC	O	[-1]	['none']	_	_
17	poly	_	_	NN	O	[-1]	['none']	_	_
18	I	_	_	NN	O	[-1]	['none']	_	_
19	:	_	_	:	O	[-1]	['none']	_	_
20	C	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	disruption	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	either	_	_	CC	O	[-1]	['none']	_	_
25	pathway	_	_	NN	O	[-1]	['none']	_	_
26	may	_	_	MD	O	[-1]	['none']	_	_
27	lead	_	_	VB	O	[-1]	['none']	_	_
28	to	_	_	TO	O	[-1]	['none']	_	_
29	decreased	_	_	VBN	O	[-1]	['none']	_	_
30	cytokine	_	_	NN	O	[-1]	['none']	_	_
31	expression	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	activation	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	selectively	_	_	RB	O	[-1]	['none']	_	_
5	inhibited	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	LPS	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	poly	_	_	NN	O	[-1]	['none']	_	_
10	I	_	_	NN	O	[-1]	['none']	_	_
11	:	_	_	:	O	[-1]	['none']	_	_
12	C	_	_	NN	O	[-1]	['none']	_	_
13	stimulated	_	_	VBD	O	[-1]	['none']	_	_
14	cpdm	_	_	NN	O	[-1]	['none']	_	_
15	BMDC	_	_	NN	O	[-1]	['none']	_	_
16	compared	_	_	VBN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	wild	_	_	JJ	O	[-1]	['none']	_	_
19	type	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	while	_	_	IN	O	[-1]	['none']	_	_
22	activation	_	_	NN	Positive_regulation	[33]	['Theme']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	TBK1	_	_	NN	Protein	[22]	['Theme']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	IRF3	_	_	NN	Protein	[22]	['Theme']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	ERK1/2	_	_	NN	Protein	[22]	['Theme']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	or	_	_	CC	O	[-1]	['none']	_	_
31	p38	_	_	NN	O	[-1]	['none']	_	_
32	was	_	_	VBD	Negative_regulation	[33]	['multitoken']	_	_
33	not	_	_	RB	Negative_regulation	[0]	['root']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	indicating	_	_	VBG	O	[-1]	['none']	_	_
36	that	_	_	IN	O	[-1]	['none']	_	_
37	disrupted	_	_	VBN	O	[-1]	['none']	_	_
38	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
39	signaling	_	_	NN	O	[-1]	['none']	_	_
40	in	_	_	IN	O	[-1]	['none']	_	_
41	cpdm	_	_	NN	O	[-1]	['none']	_	_
42	DC	_	_	NN	O	[-1]	['none']	_	_
43	is	_	_	VBZ	O	[-1]	['none']	_	_
44	responsible	_	_	JJ	O	[-1]	['none']	_	_
45	for	_	_	IN	O	[-1]	['none']	_	_
46	the	_	_	DT	O	[-1]	['none']	_	_
47	defective	_	_	JJ	O	[-1]	['none']	_	_
48	cytokine	_	_	NN	O	[-1]	['none']	_	_
49	expression	_	_	NN	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	seem	_	_	VBP	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	contradict	_	_	VB	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	recent	_	_	JJ	O	[-1]	['none']	_	_
8	study	_	_	NN	O	[-1]	['none']	_	_
9	that	_	_	WDT	O	[-1]	['none']	_	_
10	found	_	_	VBD	O	[-1]	['none']	_	_
11	increased	_	_	VBN	O	[-1]	['none']	_	_
12	levels	_	_	NNS	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	activation	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	IL1	_	_	NN	O	[-1]	['none']	_	_
18	transcription	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	cpdm	_	_	NN	O	[-1]	['none']	_	_
21	mice	_	_	NNS	O	[-1]	['none']	_	_
22	[	_	_	VBP	O	[-1]	['none']	_	_
23	43	_	_	CD	O	[-1]	['none']	_	_
24	]	_	_	CD	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	difference	_	_	NN	O	[-1]	['none']	_	_
3	can	_	_	MD	O	[-1]	['none']	_	_
4	probably	_	_	RB	O	[-1]	['none']	_	_
5	be	_	_	VB	O	[-1]	['none']	_	_
6	attributed	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	different	_	_	JJ	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	tissues	_	_	NNS	O	[-1]	['none']	_	_
13	used	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	these	_	_	DT	O	[-1]	['none']	_	_
16	studies	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	may	_	_	MD	O	[-1]	['none']	_	_
20	point	_	_	VB	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	cell-	_	_	JJ	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	tissue-	_	_	NN	O	[-1]	['none']	_	_
25	type	_	_	NN	O	[-1]	['none']	_	_
26	specific	_	_	JJ	O	[-1]	['none']	_	_
27	functions	_	_	NNS	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	consistent	_	_	JJ	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	recent	_	_	JJ	O	[-1]	['none']	_	_
6	reports	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	tissue	_	_	NN	O	[-1]	['none']	_	_
9	specific	_	_	JJ	O	[-1]	['none']	_	_
10	effects	_	_	NNS	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	signaling	_	_	NN	O	[-1]	['none']	_	_
14	[	_	_	CD	O	[-1]	['none']	_	_
15	44	_	_	CD	O	[-1]	['none']	_	_
16	]	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Ubiquitous	_	_	JJ	O	[-1]	['none']	_	_
2	activation	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	removing	_	_	VBG	O	[-1]	['none']	_	_
7	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
8	such	_	_	JJ	O	[-1]	['none']	_	_
9	as	_	_	IN	O	[-1]	['none']	_	_
10	A20	_	_	NN	Protein	[0]	['root']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	ITCH	_	_	NN	Protein	[0]	['root']	_	_
13	through	_	_	IN	O	[-1]	['none']	_	_
14	genetic	_	_	JJ	O	[-1]	['none']	_	_
15	manipulation	_	_	NN	O	[-1]	['none']	_	_
16	results	_	_	VBZ	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	widespread	_	_	JJ	O	[-1]	['none']	_	_
19	inflammation	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	consistent	_	_	JJ	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	role	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	production	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	pro	_	_	JJ	O	[-1]	['none']	_	_
32	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
33	mediators	_	_	NNS	O	[-1]	['none']	_	_
34	[	_	_	VBP	O	[-1]	['none']	_	_
35	45	_	_	CD	O	[-1]	['none']	_	_
36	]	_	_	CD	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	[	_	_	CD	O	[-1]	['none']	_	_
39	46	_	_	CD	O	[-1]	['none']	_	_
40	]	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	selective	_	_	JJ	O	[-1]	['none']	_	_
4	inhibition	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	parenchymal	_	_	JJ	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	skin	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	liver	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	intestine	_	_	NN	O	[-1]	['none']	_	_
19	results	_	_	NNS	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	chronic	_	_	JJ	O	[-1]	['none']	_	_
22	inflammation	_	_	NN	O	[-1]	['none']	_	_
23	driven	_	_	VBN	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
26	competent	_	_	JJ	O	[-1]	['none']	_	_
27	leukocytes	_	_	NNS	O	[-1]	['none']	_	_
28	[	_	_	VBP	O	[-1]	['none']	_	_
29	47	_	_	CD	O	[-1]	['none']	_	_
30	]-[	_	_	CD	O	[-1]	['none']	_	_
31	50	_	_	CD	O	[-1]	['none']	_	_
32	]	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	indicates	_	_	VBZ	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	balance	_	_	NN	O	[-1]	['none']	_	_
6	between	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	pro	_	_	JJ	O	[-1]	['none']	_	_
9	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
10	role	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	leukocytes	_	_	NNS	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
18	role	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	parenchymal	_	_	JJ	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	is	_	_	VBZ	O	[-1]	['none']	_	_
23	critical	_	_	JJ	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	maintenance	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	tissue	_	_	NN	O	[-1]	['none']	_	_
29	homeostasis	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Experiments	_	_	NNS	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	mice	_	_	NNS	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	cell-	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	tissue	_	_	NN	O	[-1]	['none']	_	_
8	specific	_	_	JJ	O	[-1]	['none']	_	_
9	deletion	_	_	NN	Negative_regulation	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	Sharpin	_	_	NNP	Protein	[9]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	currently	_	_	RB	O	[-1]	['none']	_	_
14	under	_	_	IN	O	[-1]	['none']	_	_
15	way	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	will	_	_	MD	O	[-1]	['none']	_	_
18	help	_	_	VB	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	elucidate	_	_	VB	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	role	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	inflammation	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Despite	_	_	IN	O	[-1]	['none']	_	_
2	defective	_	_	JJ	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	Sharpin	_	_	NN	Protein	[10]	['Theme']	_	_
10	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	there	_	_	EX	O	[-1]	['none']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	no	_	_	DT	O	[-1]	['none']	_	_
15	significant	_	_	JJ	O	[-1]	['none']	_	_
16	change	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	splenic	_	_	JJ	O	[-1]	['none']	_	_
19	DC	_	_	NN	O	[-1]	['none']	_	_
20	populations	_	_	NNS	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	expression	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	co-stimulatory	_	_	JJ	O	[-1]	['none']	_	_
25	molecules	_	_	NNS	O	[-1]	['none']	_	_
26	on	_	_	IN	O	[-1]	['none']	_	_
27	BMDC	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Different	_	_	JJ	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	subunits	_	_	NNS	O	[-1]	['none']	_	_
4	involved	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	canonical	_	_	JJ	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	non	_	_	JJ	O	[-1]	['none']	_	_
10	canonical	_	_	JJ	O	[-1]	['none']	_	_
11	branches	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	signaling	_	_	NN	O	[-1]	['none']	_	_
16	pathway	_	_	NN	O	[-1]	['none']	_	_
17	have	_	_	VBP	O	[-1]	['none']	_	_
18	distinct	_	_	JJ	O	[-1]	['none']	_	_
19	functions	_	_	NNS	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	control	_	_	VB	O	[-1]	['none']	_	_
22	specific	_	_	JJ	O	[-1]	['none']	_	_
23	aspects	_	_	NNS	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	DC	_	_	NN	O	[-1]	['none']	_	_
26	development	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	function	_	_	NN	O	[-1]	['none']	_	_
29	[	_	_	VBP	O	[-1]	['none']	_	_
30	51	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	CD	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	[	_	_	CD	O	[-1]	['none']	_	_
34	52	_	_	CD	O	[-1]	['none']	_	_
35	]	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	non	_	_	JJ	O	[-1]	['none']	_	_
3	canonical	_	_	JJ	O	[-1]	['none']	_	_
4	pathway	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	p100	_	_	NN	Protein	[0]	['root']	_	_
7	processing	_	_	NN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	produce	_	_	VB	O	[-1]	['none']	_	_
10	p52	_	_	NN	Protein	[0]	['root']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	appears	_	_	VBZ	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	be	_	_	VB	O	[-1]	['none']	_	_
15	intact	_	_	JJ	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	SHARPIN	_	_	NNP	Protein	[18]	['Theme']	_	_
18	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	[	_	_	VBP	O	[-1]	['none']	_	_
21	7	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	CD	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	9	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	suggesting	_	_	VBG	O	[-1]	['none']	_	_
28	that	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	NF	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	kappaB	_	_	NN	O	[-1]	['none']	_	_
33	heterodimer	_	_	NN	O	[-1]	['none']	_	_
34	p52	_	_	NN	Protein	[0]	['root']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	RELB	_	_	NN	Protein	[0]	['root']	_	_
37	is	_	_	VBZ	O	[-1]	['none']	_	_
38	sufficient	_	_	JJ	O	[-1]	['none']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	maintain	_	_	VB	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	normal	_	_	JJ	O	[-1]	['none']	_	_
43	regulation	_	_	NN	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	DC	_	_	NN	O	[-1]	['none']	_	_
46	homeostasis	_	_	NN	O	[-1]	['none']	_	_
47	and	_	_	CC	O	[-1]	['none']	_	_
48	maturation	_	_	NN	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	molecular	_	_	JJ	O	[-1]	['none']	_	_
3	basis	_	_	NN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	which	_	_	WDT	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	Sharpin	_	_	NN	Protein	[8]	['Theme']	_	_
8	mutation	_	_	NN	Negative_regulation	[0]	['root']	_	_
9	causes	_	_	VBZ	O	[-1]	['none']	_	_
10	reduced	_	_	VBN	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	activation	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	BMDC	_	_	NN	O	[-1]	['none']	_	_
15	remains	_	_	VBZ	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	be	_	_	VB	O	[-1]	['none']	_	_
18	determined	_	_	VBN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	LPS	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	poly	_	_	NN	O	[-1]	['none']	_	_
4	I	_	_	NN	O	[-1]	['none']	_	_
5	:	_	_	:	O	[-1]	['none']	_	_
6	C	_	_	NN	O	[-1]	['none']	_	_
7	used	_	_	VBN	O	[-1]	['none']	_	_
8	here	_	_	RB	O	[-1]	['none']	_	_
9	are	_	_	VBP	O	[-1]	['none']	_	_
10	well	_	_	RB	O	[-1]	['none']	_	_
11	defined	_	_	VBN	O	[-1]	['none']	_	_
12	ligands	_	_	NNS	O	[-1]	['none']	_	_
13	that	_	_	WDT	O	[-1]	['none']	_	_
14	specifically	_	_	RB	O	[-1]	['none']	_	_
15	engage	_	_	VBP	Binding	[0]	['root']	_	_
16	TLR4	_	_	NN	Protein	[15]	['Theme']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	TLR3	_	_	NN	Protein	[15]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	respectively	_	_	RB	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	expression	_	_	NN	O	[-1]	['none']	_	_
3	profile	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	surface	_	_	NN	O	[-1]	['none']	_	_
6	TLR4	_	_	NN	O	[-1]	['none']	_	_
7	complexes	_	_	NNS	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	similar	_	_	JJ	O	[-1]	['none']	_	_
10	between	_	_	IN	O	[-1]	['none']	_	_
11	WT	_	_	NNP	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	cpdm	_	_	JJ	O	[-1]	['none']	_	_
14	BMDC	_	_	NN	O	[-1]	['none']	_	_
15	suggesting	_	_	VBG	O	[-1]	['none']	_	_
16	that	_	_	IN	O	[-1]	['none']	_	_
17	defective	_	_	JJ	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	activation	_	_	NN	O	[-1]	['none']	_	_
20	is	_	_	VBZ	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	result	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	differential	_	_	JJ	O	[-1]	['none']	_	_
26	TLR	_	_	NN	O	[-1]	['none']	_	_
27	expression	_	_	NN	O	[-1]	['none']	_	_
28	on	_	_	IN	O	[-1]	['none']	_	_
29	target	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	LPS	_	_	NN	O	[-1]	['none']	_	_
2	engages	_	_	VBZ	Binding	[0]	['root']	_	_
3	TLR4	_	_	NN	Protein	[2]	['Theme']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	activate	_	_	VB	O	[-1]	['none']	_	_
6	MYD88	_	_	NN	Protein	[0]	['root']	_	_
7	dependent	_	_	JJ	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	TRIF	_	_	NN	Protein	[0]	['root']	_	_
10	dependent	_	_	JJ	O	[-1]	['none']	_	_
11	pathways	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	whereas	_	_	IN	O	[-1]	['none']	_	_
14	TLR3	_	_	NN	Protein	[15]	['Theme']	_	_
15	stimulated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	poly	_	_	NN	O	[-1]	['none']	_	_
18	I	_	_	NN	O	[-1]	['none']	_	_
19	:	_	_	:	O	[-1]	['none']	_	_
20	C	_	_	NN	O	[-1]	['none']	_	_
21	only	_	_	RB	O	[-1]	['none']	_	_
22	triggers	_	_	VBZ	O	[-1]	['none']	_	_
23	TRIF	_	_	NN	Protein	[0]	['root']	_	_
24	dependent	_	_	JJ	O	[-1]	['none']	_	_
25	signaling	_	_	NN	O	[-1]	['none']	_	_
26	[	_	_	CD	O	[-1]	['none']	_	_
27	53	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	defective	_	_	JJ	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	both	_	_	CC	O	[-1]	['none']	_	_
7	stimuli	_	_	NNS	O	[-1]	['none']	_	_
8	suggests	_	_	VBZ	O	[-1]	['none']	_	_
9	that	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	Sharpin	_	_	NN	Protein	[12]	['Theme']	_	_
12	mutation	_	_	NN	Negative_regulation	[0]	['root']	_	_
13	interferes	_	_	VBZ	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	protein	_	_	NN	O	[-1]	['none']	_	_
17	adaptors	_	_	NNS	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	kinases	_	_	NNS	O	[-1]	['none']	_	_
20	shared	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	both	_	_	CC	O	[-1]	['none']	_	_
23	signaling	_	_	NN	O	[-1]	['none']	_	_
24	pathways	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	such	_	_	JJ	O	[-1]	['none']	_	_
27	as	_	_	IN	O	[-1]	['none']	_	_
28	RIP1	_	_	NN	Protein	[0]	['root']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	TRAF6	_	_	NN	Protein	[0]	['root']	_	_
31	[	_	_	CD	O	[-1]	['none']	_	_
32	18	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Recent	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	SHARPIN	_	_	NNP	Protein	[6, 16]	['Theme', 'Cause']	_	_
6	interacts	_	_	VBZ	Binding	[0]	['root']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	HOIP	_	_	NN	Protein	[6]	['Theme']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	form	_	_	VB	O	[-1]	['none']	_	_
11	LUBAC	_	_	NNP	O	[-1]	['none']	_	_
12	that	_	_	IN	O	[-1]	['none']	_	_
13	exerts	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
14	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
15	linear-ubiquitin-chain-ligase	_	_	NN	Ubiquitination	[16]	['multitoken']	_	_
16	activity	_	_	NN	Ubiquitination	[13]	['Theme']	_	_
17	on	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	signaling	_	_	NN	O	[-1]	['none']	_	_
20	players	_	_	NNS	O	[-1]	['none']	_	_
21	RIP1	_	_	NN	Protein	[16]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	NEMO	_	_	NN	Protein	[16]	['Theme']	_	_
24	[	_	_	NN	O	[-1]	['none']	_	_
25	7	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	an	_	_	DT	O	[-1]	['none']	_	_
29	essential	_	_	JJ	O	[-1]	['none']	_	_
30	step	_	_	NN	O	[-1]	['none']	_	_
31	for	_	_	IN	O	[-1]	['none']	_	_
32	intact	_	_	JJ	O	[-1]	['none']	_	_
33	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
34	stimulated	_	_	VBD	O	[-1]	['none']	_	_
35	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
36	activation	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Sharpin	_	_	NNP	Protein	[4]	['Theme']	_	_
3	null	_	_	NN	Negative_regulation	[4]	['multitoken']	_	_
4	mutation	_	_	NN	Negative_regulation	[5]	['Cause']	_	_
5	disrupts	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
6	the	_	_	DT	Anaphora	[8]	['multitoken']	_	_
7	ubiquitylation	_	_	NN	Anaphora	[8]	['multitoken']	_	_
8	process	_	_	NN	Anaphora	[0]	['root']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	abrogates	_	_	VBZ	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
13	induced	_	_	VBD	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	signaling	_	_	NN	O	[-1]	['none']	_	_
16	pathway	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	TNFR	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	TLR	_	_	NN	O	[-1]	['none']	_	_
5	partially	_	_	RB	O	[-1]	['none']	_	_
6	share	_	_	VBP	O	[-1]	['none']	_	_
7	their	_	_	PRP$	O	[-1]	['none']	_	_
8	downstream	_	_	JJ	O	[-1]	['none']	_	_
9	signaling	_	_	NN	O	[-1]	['none']	_	_
10	cascades	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	similar	_	_	JJ	O	[-1]	['none']	_	_
14	ubiquitin	_	_	NN	O	[-1]	['none']	_	_
15	mediated	_	_	JJ	O	[-1]	['none']	_	_
16	regulation	_	_	NN	O	[-1]	['none']	_	_
17	may	_	_	MD	O	[-1]	['none']	_	_
18	hold	_	_	VB	O	[-1]	['none']	_	_
19	true	_	_	JJ	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	LPS-	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	poly	_	_	NN	O	[-1]	['none']	_	_
26	I	_	_	NN	O	[-1]	['none']	_	_
27	:	_	_	:	O	[-1]	['none']	_	_
28	C	_	_	NN	O	[-1]	['none']	_	_
29	induced	_	_	VBD	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	activation	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	summary	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	present	_	_	JJ	O	[-1]	['none']	_	_
6	study	_	_	NN	O	[-1]	['none']	_	_
7	identified	_	_	VBD	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	indispensible	_	_	JJ	O	[-1]	['none']	_	_
10	role	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	production	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	pro	_	_	JJ	O	[-1]	['none']	_	_
18	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
19	mediators	_	_	NNS	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	TLR	_	_	NN	O	[-1]	['none']	_	_
22	induced	_	_	VBD	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	signaling	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	impaired	_	_	JJ	O	[-1]	['none']	_	_
3	Th1	_	_	NN	O	[-1]	['none']	_	_
4	stimulating	_	_	NN	O	[-1]	['none']	_	_
5	ability	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Sharpin	_	_	NN	Protein	[8]	['Theme']	_	_
8	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
9	DC	_	_	NN	O	[-1]	['none']	_	_
10	may	_	_	MD	O	[-1]	['none']	_	_
11	account	_	_	VB	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	Th2	_	_	NN	O	[-1]	['none']	_	_
15	dominant	_	_	JJ	O	[-1]	['none']	_	_
16	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
17	phenotype	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	cpdm	_	_	NN	O	[-1]	['none']	_	_
20	mice	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	balance	_	_	NN	O	[-1]	['none']	_	_
3	between	_	_	IN	O	[-1]	['none']	_	_
4	Th1	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Th2	_	_	NN	O	[-1]	['none']	_	_
7	differentiation	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	critical	_	_	JJ	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	immune	_	_	JJ	O	[-1]	['none']	_	_
12	homeostasis	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	better	_	_	JJR	O	[-1]	['none']	_	_
3	understanding	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	how	_	_	WRB	O	[-1]	['none']	_	_
6	such	_	_	JJ	O	[-1]	['none']	_	_
7	balance	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	maintained	_	_	VBN	O	[-1]	['none']	_	_
10	will	_	_	MD	O	[-1]	['none']	_	_
11	help	_	_	VB	O	[-1]	['none']	_	_
12	design	_	_	VB	O	[-1]	['none']	_	_
13	cytokine	_	_	NN	O	[-1]	['none']	_	_
14	treatment	_	_	NN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	human	_	_	NN	O	[-1]	['none']	_	_
17	diseases	_	_	NNS	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	Th2	_	_	NN	O	[-1]	['none']	_	_
20	biased	_	_	VBN	O	[-1]	['none']	_	_
21	cytokine	_	_	NN	O	[-1]	['none']	_	_
22	secretion	_	_	NN	O	[-1]	['none']	_	_
23	similar	_	_	JJ	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	mouse	_	_	NN	O	[-1]	['none']	_	_
27	cpdm	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	such	_	_	JJ	O	[-1]	['none']	_	_
30	as	_	_	IN	O	[-1]	['none']	_	_
31	allergies	_	_	NNS	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	hypereosinophilic	_	_	JJ	O	[-1]	['none']	_	_
34	syndromes	_	_	NNS	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Involvement	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	cytokine	_	_	NN	O	[-1]	['none']	_	_
6	regulation	_	_	NN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Cytokine	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	chemokine	_	_	NN	O	[-1]	['none']	_	_
4	levels	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	determined	_	_	VBN	O	[-1]	['none']	_	_
7	using	_	_	VBG	O	[-1]	['none']	_	_
8	ELISA	_	_	NN	O	[-1]	['none']	_	_
9	following	_	_	VBG	O	[-1]	['none']	_	_
10	incubation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	Jurkat	_	_	NN	O	[-1]	['none']	_	_
13	T-cells	_	_	NNS	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	NAI	_	_	NNP	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	1	_	_	CD	O	[-1]	['none']	_	_
18	h	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	stimulation	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	24	_	_	CD	O	[-1]	['none']	_	_
24	h	_	_	NN	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	CXCL8	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[8, 22, 37]	['Theme', 'Theme', 'Theme']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	partially	_	_	RB	O	[-1]	['none']	_	_
8	inhibited	_	_	VBN	Negative_regulation	[0]	['root']	_	_
9	following	_	_	VBG	O	[-1]	['none']	_	_
10	PMA	_	_	NN	O	[-1]	['none']	_	_
11	stimulation	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	grey	_	_	JJ	O	[-1]	['none']	_	_
14	bars	_	_	NNS	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	whereas	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	Anaphora	[19]	['multitoken']	_	_
19	levels	_	_	NNS	Anaphora	[0]	['root']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	altered	_	_	VBN	Regulation	[0]	['root']	_	_
23	following	_	_	VBG	O	[-1]	['none']	_	_
24	stimulation	_	_	NN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	HK	_	_	JJ	O	[-1]	['none']	_	_
27	E.	_	_	FW	O	[-1]	['none']	_	_
28	coli	_	_	FW	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	black	_	_	JJ	O	[-1]	['none']	_	_
31	bars	_	_	NNS	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	this	_	_	DT	O	[-1]	['none']	_	_
35	indicates	_	_	VBZ	O	[-1]	['none']	_	_
36	an	_	_	DT	O	[-1]	['none']	_	_
37	induction	_	_	NN	Positive_regulation	[39]	['Theme']	_	_
38	mainly	_	_	RB	O	[-1]	['none']	_	_
39	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
40	by	_	_	IN	O	[-1]	['none']	_	_
41	AP-1	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	TNF	_	_	NN	O	[-1]	['none']	_	_
5	expression	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	affected	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	NAI	_	_	NNP	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	IL-6	_	_	NN	Protein	[5]	['Theme']	_	_
5	release	_	_	NN	Localization	[8, 16]	['Theme', 'Theme']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	completely	_	_	RB	O	[-1]	['none']	_	_
8	inhibited	_	_	VBN	Negative_regulation	[0]	['root']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	NAI	_	_	NNP	O	[-1]	['none']	_	_
11	following	_	_	VBG	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	exposure	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	indicating	_	_	VBG	O	[-1]	['none']	_	_
16	regulation	_	_	NN	Regulation	[0]	['root']	_	_
17	through	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	since	_	_	IN	O	[-1]	['none']	_	_
20	IL-6	_	_	NN	Protein	[21]	['Theme']	_	_
21	expression	_	_	NN	Gene_expression	[24]	['Theme']	_	_
22	was	_	_	VBD	O	[-1]	['none']	_	_
23	significantly	_	_	RB	O	[-1]	['none']	_	_
24	increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	response	_	_	NN	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	HK	_	_	NNP	O	[-1]	['none']	_	_
29	E.	_	_	NNP	O	[-1]	['none']	_	_
30	coli	_	_	NN	O	[-1]	['none']	_	_
31	than	_	_	IN	O	[-1]	['none']	_	_
32	PMA	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	significance	_	_	NN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	positive	_	_	JJ	O	[-1]	['none']	_	_
6	control	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	PMA/HK	_	_	NN	O	[-1]	['none']	_	_
9	E.	_	_	FW	O	[-1]	['none']	_	_
10	coli	_	_	FW	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	determined	_	_	VBN	O	[-1]	['none']	_	_
14	using	_	_	VBG	O	[-1]	['none']	_	_
15	Student	_	_	NN	O	[-1]	['none']	_	_
16	's	_	_	POS	O	[-1]	['none']	_	_
17	t-test	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	n	_	_	NN	O	[-1]	['none']	_	_
3	=	_	_	JJ	O	[-1]	['none']	_	_
4	3	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	Transcription	_	_	NN	O	[-1]	['none']	_	_
2	factor	_	_	NN	O	[-1]	['none']	_	_
3	DNA	_	_	NN	O	[-1]	['none']	_	_
4	binding	_	_	NN	O	[-1]	['none']	_	_
5	analysis	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	TF-ELISA	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	CREB-1	_	_	NNP	Protein	[5]	['Theme']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	ATF-2	_	_	NN	Protein	[5]	['Theme']	_	_
4	DNA	_	_	NN	O	[-1]	['none']	_	_
5	binding	_	_	NN	Binding	[0]	['root']	_	_
6	activity	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	analyzed	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	TransFactor	_	_	NNP	O	[-1]	['none']	_	_
12	Profiling	_	_	NNP	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Inflammation	_	_	NN	O	[-1]	['none']	_	_
15	1	_	_	CD	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	Kit	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	BD	_	_	NNP	O	[-1]	['none']	_	_
20	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	according	_	_	VBG	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	manufacturer	_	_	NN	O	[-1]	['none']	_	_
26	's	_	_	POS	O	[-1]	['none']	_	_
27	protocol	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Nuclear	_	_	JJ	O	[-1]	['none']	_	_
2	extracts	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	prepared	_	_	VBN	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	HEK	_	_	NNP	O	[-1]	['none']	_	_
7	293T	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	transfected	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	control	_	_	NN	O	[-1]	['none']	_	_
13	vector	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	EGFP	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	Foxp3	_	_	NN	Protein	[19]	['Theme']	_	_
19	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
20	vector	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	1,000	_	_	CD	O	[-1]	['none']	_	_
23	ng	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	presence	_	_	NN	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	absence	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	forskolin	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	10	_	_	CD	O	[-1]	['none']	_	_
34	muM	_	_	NN	O	[-1]	['none']	_	_
35	for	_	_	IN	O	[-1]	['none']	_	_
36	4	_	_	CD	O	[-1]	['none']	_	_
37	h	_	_	NN	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	using	_	_	VBG	O	[-1]	['none']	_	_
40	the	_	_	DT	O	[-1]	['none']	_	_
41	TransFactor	_	_	NNP	O	[-1]	['none']	_	_
42	Extraction	_	_	NNP	O	[-1]	['none']	_	_
43	Kit	_	_	NN	O	[-1]	['none']	_	_
44	(	_	_	-LRB-	O	[-1]	['none']	_	_
45	BD	_	_	NNP	O	[-1]	['none']	_	_
46	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	Protein	_	_	NN	O	[-1]	['none']	_	_
2	concentration	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	determined	_	_	VBN	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	Biophotometer	_	_	NNP	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Eppendorf	_	_	NNP	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	Hamburg	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	Germany	_	_	NNP	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Nuclear	_	_	JJ	O	[-1]	['none']	_	_
2	extracts	_	_	NNS	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	20	_	_	CD	O	[-1]	['none']	_	_
5	mug	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	incubated	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	preblocked	_	_	JJ	O	[-1]	['none']	_	_
11	wells	_	_	NNS	O	[-1]	['none']	_	_
12	containing	_	_	VBG	O	[-1]	['none']	_	_
13	plate	_	_	NN	O	[-1]	['none']	_	_
14	bound	_	_	VBD	O	[-1]	['none']	_	_
15	double	_	_	JJ	O	[-1]	['none']	_	_
16	stranded	_	_	JJ	O	[-1]	['none']	_	_
17	oligonucleotides	_	_	NNS	O	[-1]	['none']	_	_
18	corresponding	_	_	VBG	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	an	_	_	DT	O	[-1]	['none']	_	_
21	ATF/CREB	_	_	NN	O	[-1]	['none']	_	_
22	consensus	_	_	NN	O	[-1]	['none']	_	_
23	sequence	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	...	_	_	:	O	[-1]	['none']	_	_
26	TGACATCA	_	_	NNP	O	[-1]	['none']	_	_
27	...	_	_	:	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Wells	_	_	NNP	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	washed	_	_	VBN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	incubated	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	appropriate	_	_	JJ	O	[-1]	['none']	_	_
9	primary	_	_	JJ	O	[-1]	['none']	_	_
10	antibody	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	washed	_	_	VBN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	incubated	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	secondary	_	_	JJ	O	[-1]	['none']	_	_
17	antibody	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	HRP	_	_	NN	O	[-1]	['none']	_	_
20	labeled	_	_	VBN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	washed	_	_	VBN	O	[-1]	['none']	_	_
24	again	_	_	RB	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	finally	_	_	RB	O	[-1]	['none']	_	_
28	developed	_	_	VBN	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	TMB	_	_	NN	O	[-1]	['none']	_	_
31	substrate	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Colorimetric	_	_	JJ	O	[-1]	['none']	_	_
2	reactions	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	read	_	_	VBN	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	VersaMax	_	_	NN	O	[-1]	['none']	_	_
8	microplate	_	_	NN	O	[-1]	['none']	_	_
9	reader	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Molecular	_	_	JJ	O	[-1]	['none']	_	_
12	Devices	_	_	NNPS	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	at	_	_	IN	O	[-1]	['none']	_	_
15	an	_	_	DT	O	[-1]	['none']	_	_
16	absorbance	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	655	_	_	CD	O	[-1]	['none']	_	_
19	nm	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Regulation	_	_	NN	Regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	perforin	_	_	NN	Protein	[10]	['Theme']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	granzyme	_	_	NN	Protein	[6]	['multitoken']	_	_
6	B	_	_	NN	Protein	[10]	['Theme']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	IFN-gamma	_	_	NN	Protein	[10]	['Theme']	_	_
10	expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	T-bet	_	_	NN	Protein	[1]	['Cause']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	Eomes	_	_	NNS	Protein	[1]	['Cause']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	differentiating	_	_	VBG	O	[-1]	['none']	_	_
17	CTLs	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	IFN-gamma	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	WT	_	_	NNP	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Tbx21	_	_	NN	Protein	[0]	['root']	_	_
10	+/+	_	_	JJ	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	T-bet-deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Tbx21-/-)	_	_	NN	Protein	[0]	['root']	_	_
16	T	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Naive	_	_	JJ	O	[-1]	['none']	_	_
2	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
3	T	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	or	_	_	CC	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	activated	_	_	VBN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	cultured	_	_	VBN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	4	_	_	CD	O	[-1]	['none']	_	_
13	or	_	_	CC	O	[-1]	['none']	_	_
14	6	_	_	CD	O	[-1]	['none']	_	_
15	d	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	restimulated	_	_	VBN	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	PMA	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	ionomycin	_	_	NN	O	[-1]	['none']	_	_
23	for	_	_	IN	O	[-1]	['none']	_	_
24	6	_	_	CD	O	[-1]	['none']	_	_
25	h	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	IFN-gamma	_	_	NN	Protein	[29]	['Theme']	_	_
29	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
30	was	_	_	VBD	O	[-1]	['none']	_	_
31	assessed	_	_	VBN	O	[-1]	['none']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	intracellular	_	_	JJ	O	[-1]	['none']	_	_
34	staining	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Numbers	_	_	NNS	O	[-1]	['none']	_	_
2	show	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	percentage	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	IFN-gamma+	_	_	JJ	Protein	[0]	['root']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Northern	_	_	NN	O	[-1]	['none']	_	_
5	blot	_	_	NN	O	[-1]	['none']	_	_
6	analysis	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Prf1	_	_	NN	Protein	[12]	['Theme']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	GzmB	_	_	NN	Protein	[12]	['Theme']	_	_
11	mRNA	_	_	NN	Transcription	[12]	['multitoken']	_	_
12	expression	_	_	NN	Transcription	[0]	['root']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	WT	_	_	NNP	O	[-1]	['none']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	T-bet-deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
17	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
18	T	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	activated	_	_	VBN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	either	_	_	CC	O	[-1]	['none']	_	_
23	left	_	_	VBD	O	[-1]	['none']	_	_
24	uninfected	_	_	JJ	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	uninf	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	transduced	_	_	VBN	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	retroviruses	_	_	NNS	O	[-1]	['none']	_	_
32	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
33	Eomes-VP16	_	_	NN	Protein	[32]	['Theme']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	Eo-VP16	_	_	NN	Protein	[0]	['root']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	or	_	_	CC	O	[-1]	['none']	_	_
38	an	_	_	DT	O	[-1]	['none']	_	_
39	empty	_	_	JJ	O	[-1]	['none']	_	_
40	IRES-GFP	_	_	NN	Protein	[0]	['root']	_	_
41	cassette	_	_	NN	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	GFP	_	_	NN	O	[-1]	['none']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	Total	_	_	JJ	O	[-1]	['none']	_	_
2	cellular	_	_	JJ	O	[-1]	['none']	_	_
3	RNA	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	analyzed	_	_	VBN	O	[-1]	['none']	_	_
6	on	_	_	IN	O	[-1]	['none']	_	_
7	day	_	_	NN	O	[-1]	['none']	_	_
8	6	_	_	CD	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	culture	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	frequency	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	transduced	_	_	VBN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	cultures	_	_	NNS	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	equivalent	_	_	JJ	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	both	_	_	DT	O	[-1]	['none']	_	_
13	constructs	_	_	NNS	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	~	_	_	CD	O	[-1]	['none']	_	_
16	65-70	_	_	CD	O	[-1]	['none']	_	_
17	%	_	_	NN	O	[-1]	['none']	_	_
18	GFP+	_	_	JJ	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	;	_	_	:	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	depicted	_	_	VBN	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Granzyme	_	_	NN	Protein	[5]	['multitoken']	_	_
5	B	_	_	NN	Protein	[8]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	IFN-gamma	_	_	NN	Protein	[8]	['Theme']	_	_
8	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	Tbx21	_	_	NN	Protein	[0]	['root']	_	_
11	+/+	_	_	CD	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	Tbx21-/-	_	_	JJ	Protein	[0]	['root']	_	_
14	T	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	analyzed	_	_	VBN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	restimulated	_	_	VBN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	that	_	_	WDT	O	[-1]	['none']	_	_
21	had	_	_	VBD	O	[-1]	['none']	_	_
22	been	_	_	VBN	O	[-1]	['none']	_	_
23	cultured	_	_	VBN	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	5	_	_	CD	O	[-1]	['none']	_	_
26	d.	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	D	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	IFN-gamma	_	_	NN	Protein	[31]	['Theme']	_	_
31	production	_	_	NN	Gene_expression	[0]	['root']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	cells	_	_	NNS	O	[-1]	['none']	_	_
34	transduced	_	_	VBN	O	[-1]	['none']	_	_
35	with	_	_	IN	O	[-1]	['none']	_	_
36	Eo-VP16	_	_	NN	Protein	[0]	['root']	_	_
37	or	_	_	CC	O	[-1]	['none']	_	_
38	control	_	_	NN	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	GFP	_	_	NN	Protein	[0]	['root']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	retroviruses	_	_	NNS	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	RV	_	_	NN	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	measured	_	_	VBN	O	[-1]	['none']	_	_
47	on	_	_	IN	O	[-1]	['none']	_	_
48	day	_	_	NN	O	[-1]	['none']	_	_
49	4	_	_	CD	O	[-1]	['none']	_	_
50	after	_	_	IN	O	[-1]	['none']	_	_
51	6	_	_	CD	O	[-1]	['none']	_	_
52	h	_	_	NN	O	[-1]	['none']	_	_
53	of	_	_	IN	O	[-1]	['none']	_	_
54	restimulation	_	_	NN	O	[-1]	['none']	_	_
55	with	_	_	IN	O	[-1]	['none']	_	_
56	PMA	_	_	NN	O	[-1]	['none']	_	_
57	and	_	_	CC	O	[-1]	['none']	_	_
58	ionomycin	_	_	NN	O	[-1]	['none']	_	_
59	.	_	_	.	O	[-1]	['none']	_	_

1	Numbers	_	_	NNS	O	[-1]	['none']	_	_
2	show	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	percentage	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	GFP+	_	_	JJ	Protein	[0]	['root']	_	_
7	IFN-gamma+	_	_	JJ	Protein	[0]	['root']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Results	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	representative	_	_	JJ	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	three	_	_	CD	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	A	_	_	DT	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	C	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	two	_	_	CD	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	B	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	D	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	independent	_	_	JJ	O	[-1]	['none']	_	_
19	experiments	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Insights	_	_	NNPS	O	[-1]	['none']	_	_
2	into	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	Regulation	_	_	NN	Regulation	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	TNF-alpha	_	_	NN	Protein	[7]	['Theme']	_	_
7	Production	_	_	NN	Gene_expression	[4]	['Theme']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	Human	_	_	NN	O	[-1]	['none']	_	_
10	Mononuclear	_	_	JJ	O	[-1]	['none']	_	_
11	Cells	_	_	NNS	O	[-1]	['none']	_	_
12	:	_	_	:	O	[-1]	['none']	_	_
13	The	_	_	DT	O	[-1]	['none']	_	_
14	Effects	_	_	NNS	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	Non	_	_	NNP	O	[-1]	['none']	_	_
17	Specific	_	_	JJ	O	[-1]	['none']	_	_
18	Phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
19	Inhibition	_	_	NN	O	[-1]	['none']	_	_
20	OBJECTIVE	_	_	NN	O	[-1]	['none']	_	_
21	The	_	_	DT	O	[-1]	['none']	_	_
22	objective	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	this	_	_	DT	O	[-1]	['none']	_	_
25	study	_	_	NN	O	[-1]	['none']	_	_
26	was	_	_	VBD	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	determine	_	_	VB	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	effect	_	_	NN	Regulation	[0]	['root']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	nonspecific	_	_	JJ	O	[-1]	['none']	_	_
33	phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
34	inhibition	_	_	NN	O	[-1]	['none']	_	_
35	on	_	_	IN	O	[-1]	['none']	_	_
36	transcription	_	_	NN	O	[-1]	['none']	_	_
37	factor	_	_	NN	O	[-1]	['none']	_	_
38	activation	_	_	NN	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	tumor	_	_	NN	Protein	[42]	['multitoken']	_	_
41	necrosis	_	_	NN	Protein	[42]	['multitoken']	_	_
42	factor-alpha	_	_	NN	Protein	[46]	['Theme']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	TNF-alpha	_	_	NN	Protein	[0]	['root']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	production	_	_	NN	Gene_expression	[30]	['Theme']	_	_
47	in	_	_	IN	O	[-1]	['none']	_	_
48	lipopolysaccharide	_	_	NN	O	[-1]	['none']	_	_
49	(	_	_	-LRB-	O	[-1]	['none']	_	_
50	LPS	_	_	NN	O	[-1]	['none']	_	_
51	)-stimulated	_	_	JJ	O	[-1]	['none']	_	_
52	human	_	_	NN	O	[-1]	['none']	_	_
53	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
54	cells	_	_	NNS	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	INTRODUCTION	_	_	NN	O	[-1]	['none']	_	_
2	The	_	_	DT	O	[-1]	['none']	_	_
3	production	_	_	NN	Gene_expression	[6]	['Theme']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	TNF-alpha	_	_	NN	Protein	[3]	['Theme']	_	_
6	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
7	LPS	_	_	NN	O	[-1]	['none']	_	_
8	stimulation	_	_	NN	O	[-1]	['none']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	one	_	_	CD	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	key	_	_	JJ	O	[-1]	['none']	_	_
14	steps	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	bacterial	_	_	JJ	O	[-1]	['none']	_	_
17	sepsis	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	inflammation	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	mechanism	_	_	NN	O	[-1]	['none']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	which	_	_	WDT	O	[-1]	['none']	_	_
5	phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
6	inhibition	_	_	NN	O	[-1]	['none']	_	_
7	alters	_	_	VBZ	Regulation	[13]	['Theme']	_	_
8	TNF-alpha	_	_	NN	Protein	[9]	['Theme']	_	_
9	production	_	_	NN	Gene_expression	[7]	['Theme']	_	_
10	in	_	_	IN	Positive_regulation	[13]	['multitoken']	_	_
11	the	_	_	DT	Positive_regulation	[13]	['multitoken']	_	_
12	presence	_	_	NN	Positive_regulation	[13]	['multitoken']	_	_
13	of	_	_	IN	Positive_regulation	[0]	['root']	_	_
14	LPS	_	_	NN	O	[-1]	['none']	_	_
15	remains	_	_	VBZ	O	[-1]	['none']	_	_
16	unclear	_	_	JJ	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	METHODS	_	_	NNS	O	[-1]	['none']	_	_
2	Human	_	_	NN	O	[-1]	['none']	_	_
3	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	stimulated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	LPS	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	1	_	_	CD	O	[-1]	['none']	_	_
11	mug/mL	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	presence	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	absence	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	Pentoxifylline	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	PTX	_	_	NN	O	[-1]	['none']	_	_
23	;	_	_	:	O	[-1]	['none']	_	_
24	20	_	_	CD	O	[-1]	['none']	_	_
25	mM	_	_	NN	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	a	_	_	DT	O	[-1]	['none']	_	_
29	nonspecific	_	_	JJ	O	[-1]	['none']	_	_
30	phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
31	inhibitor	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	NN	O	[-1]	['none']	_	_
2	blotting	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
5	cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
6	I-kappaBalpha	_	_	NN	Protein	[4]	['Theme']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	nuclear	_	_	JJ	O	[-1]	['none']	_	_
9	factor-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[0]	['root']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	nuclear	_	_	JJ	O	[-1]	['none']	_	_
17	cAMP	_	_	NN	O	[-1]	['none']	_	_
18	response	_	_	NN	O	[-1]	['none']	_	_
19	element	_	_	NN	O	[-1]	['none']	_	_
20	binding	_	_	NN	O	[-1]	['none']	_	_
21	protein	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	CREB	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	was	_	_	VBD	O	[-1]	['none']	_	_
26	performed	_	_	VBN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	DNA	_	_	NN	O	[-1]	['none']	_	_
2	binding	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	CREB	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	verified	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	electrophoretic	_	_	JJ	O	[-1]	['none']	_	_
11	mobility	_	_	NN	O	[-1]	['none']	_	_
12	shift	_	_	NN	O	[-1]	['none']	_	_
13	assay	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	TNF-alpha	_	_	NN	Protein	[0]	['root']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	determined	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	supernatant	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	stimulated	_	_	VBN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	presence	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	absence	_	_	NN	O	[-1]	['none']	_	_
16	Protein	_	_	NN	O	[-1]	['none']	_	_
17	kinase	_	_	NN	O	[-1]	['none']	_	_
18	A	_	_	NN	O	[-1]	['none']	_	_
19	inhibition	_	_	NN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	an	_	_	DT	O	[-1]	['none']	_	_
22	enzyme	_	_	NN	O	[-1]	['none']	_	_
23	linked	_	_	JJ	O	[-1]	['none']	_	_
24	immunosorbent	_	_	JJ	O	[-1]	['none']	_	_
25	assay	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	ELISA	_	_	NN	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	RESULTS	_	_	NNS	O	[-1]	['none']	_	_
2	PTX	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	significantly	_	_	RB	O	[-1]	['none']	_	_
7	reduce	_	_	VB	Negative_regulation	[0]	['root']	_	_
8	cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
9	I-kappaBalpha	_	_	NN	Protein	[10]	['Theme']	_	_
10	phosphorylation	_	_	NN	Phosphorylation	[7]	['Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	nuclear	_	_	JJ	O	[-1]	['none']	_	_
13	p65	_	_	NN	Protein	[14]	['Theme']	_	_
14	phosphorylation	_	_	NN	Phosphorylation	[7]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	DNA	_	_	NN	O	[-1]	['none']	_	_
19	binding	_	_	NN	O	[-1]	['none']	_	_
20	activity	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	PTX	_	_	NN	O	[-1]	['none']	_	_
5	markedly	_	_	RB	O	[-1]	['none']	_	_
6	enhanced	_	_	VBD	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	DNA	_	_	NN	O	[-1]	['none']	_	_
11	binding	_	_	NN	O	[-1]	['none']	_	_
12	activity	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	CREB	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	concomitantly	_	_	RB	O	[-1]	['none']	_	_
3	treated	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	PTX	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	LPS	_	_	NN	O	[-1]	['none']	_	_
8	secreted	_	_	VBD	Localization	[15, 17]	['Theme', 'Theme']	_	_
9	similar	_	_	JJ	O	[-1]	['none']	_	_
10	levels	_	_	NNS	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	TNF-alpha	_	_	NN	Protein	[8]	['Theme']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	presence	_	_	NN	Regulation	[0]	['root']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	absence	_	_	NN	Regulation	[0]	['root']	_	_
18	Protein	_	_	NN	O	[-1]	['none']	_	_
19	kinase	_	_	NN	O	[-1]	['none']	_	_
20	A	_	_	NN	O	[-1]	['none']	_	_
21	inhibition	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	DISCUSSION	_	_	NN	O	[-1]	['none']	_	_
2	The	_	_	DT	O	[-1]	['none']	_	_
3	increased	_	_	JJ	O	[-1]	['none']	_	_
4	level	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	cAMP	_	_	NN	O	[-1]	['none']	_	_
7	that	_	_	WDT	O	[-1]	['none']	_	_
8	results	_	_	VBZ	O	[-1]	['none']	_	_
9	from	_	_	IN	O	[-1]	['none']	_	_
10	phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
11	inhibition	_	_	NN	O	[-1]	['none']	_	_
12	affects	_	_	VBZ	O	[-1]	['none']	_	_
13	cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	nuclear	_	_	JJ	O	[-1]	['none']	_	_
16	events	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	resulting	_	_	VBG	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	attenuation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	activation	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	CREB	_	_	NN	O	[-1]	['none']	_	_
29	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
30	DNA	_	_	NN	O	[-1]	['none']	_	_
31	binding	_	_	NN	O	[-1]	['none']	_	_
32	through	_	_	IN	O	[-1]	['none']	_	_
33	pathways	_	_	NNS	O	[-1]	['none']	_	_
34	that	_	_	WDT	O	[-1]	['none']	_	_
35	are	_	_	VBP	O	[-1]	['none']	_	_
36	partially	_	_	RB	O	[-1]	['none']	_	_
37	Protein	_	_	NN	O	[-1]	['none']	_	_
38	kinase	_	_	NN	O	[-1]	['none']	_	_
39	A	_	_	NN	O	[-1]	['none']	_	_
40	independent	_	_	JJ	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	CONCLUSION	_	_	NN	O	[-1]	['none']	_	_
2	PTX	_	_	NN	O	[-1]	['none']	_	_
3	mediated	_	_	VBD	O	[-1]	['none']	_	_
4	phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
5	inhibition	_	_	NN	O	[-1]	['none']	_	_
6	occurs	_	_	VBZ	O	[-1]	['none']	_	_
7	partially	_	_	RB	O	[-1]	['none']	_	_
8	through	_	_	IN	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	Protein	_	_	NN	O	[-1]	['none']	_	_
11	kinase	_	_	NN	O	[-1]	['none']	_	_
12	A	_	_	NN	O	[-1]	['none']	_	_
13	independent	_	_	JJ	O	[-1]	['none']	_	_
14	pathway	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	may	_	_	MD	O	[-1]	['none']	_	_
17	serve	_	_	VB	O	[-1]	['none']	_	_
18	as	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	useful	_	_	JJ	O	[-1]	['none']	_	_
21	tool	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	attenuation	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	LPS	_	_	NN	O	[-1]	['none']	_	_
27	induced	_	_	VBD	O	[-1]	['none']	_	_
28	inflammation	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Retroviral	_	_	JJ	O	[-1]	['none']	_	_
2	transduction	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	primary	_	_	JJ	O	[-1]	['none']	_	_
5	CD8+	_	_	JJ	O	[-1]	['none']	_	_
6	T	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	transduction	_	_	NN	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	viral	_	_	JJ	O	[-1]	['none']	_	_
6	supernatants	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	generated	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	calcium	_	_	NN	O	[-1]	['none']	_	_
11	phosphate	_	_	NN	O	[-1]	['none']	_	_
12	transfection	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Phoenix	_	_	NNP	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	concentration	_	_	NN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	overnight	_	_	JJ	O	[-1]	['none']	_	_
20	centrifugation	_	_	NN	O	[-1]	['none']	_	_
21	at	_	_	IN	O	[-1]	['none']	_	_
22	6,000	_	_	CD	O	[-1]	['none']	_	_
23	g	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	~	_	_	NN	O	[-1]	['none']	_	_
3	42	_	_	CD	O	[-1]	['none']	_	_
4	h	_	_	NN	O	[-1]	['none']	_	_
5	after	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	initial	_	_	JJ	O	[-1]	['none']	_	_
8	TCR	_	_	NN	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	106	_	_	CD	O	[-1]	['none']	_	_
12	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
13	T	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	per	_	_	IN	O	[-1]	['none']	_	_
16	well	_	_	RB	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	12-well	_	_	JJ	O	[-1]	['none']	_	_
19	plates	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	culture	_	_	NN	O	[-1]	['none']	_	_
23	media	_	_	NNS	O	[-1]	['none']	_	_
24	was	_	_	VBD	O	[-1]	['none']	_	_
25	removed	_	_	VBN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	replaced	_	_	VBN	O	[-1]	['none']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	complete	_	_	JJ	O	[-1]	['none']	_	_
30	media	_	_	NNS	O	[-1]	['none']	_	_
31	supplemented	_	_	VBN	O	[-1]	['none']	_	_
32	with	_	_	IN	O	[-1]	['none']	_	_
33	8	_	_	CD	O	[-1]	['none']	_	_
34	mug/ml	_	_	NN	O	[-1]	['none']	_	_
35	polybrene	_	_	NN	O	[-1]	['none']	_	_
36	containing	_	_	VBG	O	[-1]	['none']	_	_
37	fresh	_	_	JJ	O	[-1]	['none']	_	_
38	plus	_	_	CC	O	[-1]	['none']	_	_
39	concentrated	_	_	JJ	O	[-1]	['none']	_	_
40	virus	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	plates	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	700	_	_	CD	O	[-1]	['none']	_	_
7	g	_	_	NN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	1	_	_	CD	O	[-1]	['none']	_	_
10	h	_	_	NN	O	[-1]	['none']	_	_
11	at	_	_	IN	O	[-1]	['none']	_	_
12	RT	_	_	NN	O	[-1]	['none']	_	_
13	before	_	_	IN	O	[-1]	['none']	_	_
14	returning	_	_	VBG	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	37degreesC	_	_	NN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	an	_	_	DT	O	[-1]	['none']	_	_
19	additional	_	_	JJ	O	[-1]	['none']	_	_
20	5	_	_	CD	O	[-1]	['none']	_	_
21	h.	_	_	NN	O	[-1]	['none']	_	_
22	Retroviral	_	_	JJ	O	[-1]	['none']	_	_
23	constructs	_	_	NNS	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	Eomes-VP16	_	_	NN	Protein	[0]	['root']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	MIG	_	_	NN	O	[-1]	['none']	_	_
29	control	_	_	NN	O	[-1]	['none']	_	_
30	empty	_	_	JJ	O	[-1]	['none']	_	_
31	vector	_	_	NN	O	[-1]	['none']	_	_
32	were	_	_	VBD	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	gift	_	_	NN	O	[-1]	['none']	_	_
35	from	_	_	IN	O	[-1]	['none']	_	_
36	S.L.	_	_	NNP	O	[-1]	['none']	_	_
37	Reiner	_	_	NNP	O	[-1]	['none']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	University	_	_	NNP	O	[-1]	['none']	_	_
40	of	_	_	IN	O	[-1]	['none']	_	_
41	Pennsylvania	_	_	NNP	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	Philadelphia	_	_	NNP	O	[-1]	['none']	_	_
44	,	_	_	,	O	[-1]	['none']	_	_
45	PA	_	_	NN	O	[-1]	['none']	_	_
46	)	_	_	-RRB-	O	[-1]	['none']	_	_
47	(	_	_	-LRB-	O	[-1]	['none']	_	_
48	8	_	_	CD	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	To	_	_	TO	O	[-1]	['none']	_	_
4	analyze	_	_	VB	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	IRF-4	_	_	NN	Protein	[7]	['Theme']	_	_
7	transcriptional	_	_	JJ	Transcription	[0]	['root']	_	_
8	level	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	RNA	_	_	NN	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	extracted	_	_	VBN	O	[-1]	['none']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	using	_	_	VBG	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	commercial	_	_	JJ	O	[-1]	['none']	_	_
18	RNAzol-kit	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Paesel	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	Frankfurt	_	_	NNP	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	Germany	_	_	NNP	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	An	_	_	DT	O	[-1]	['none']	_	_
2	aliquot	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	1	_	_	CD	O	[-1]	['none']	_	_
5	mug	_	_	NN	O	[-1]	['none']	_	_
6	total	_	_	JJ	O	[-1]	['none']	_	_
7	RNA	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	used	_	_	VBN	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	cDNA	_	_	NN	O	[-1]	['none']	_	_
12	synthesis	_	_	NN	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	described	_	_	VBN	O	[-1]	['none']	_	_
15	previously	_	_	RB	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	27	_	_	CD	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	Transcription	[2]	['multitoken']	_	_
2	expression	_	_	NN	Transcription	[0]	['root']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	IRF-4	_	_	NN	Protein	[2]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	reference	_	_	NN	O	[-1]	['none']	_	_
9	gene	_	_	NN	O	[-1]	['none']	_	_
10	beta-actin	_	_	NN	Protein	[2]	['Theme']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	carried	_	_	VBN	O	[-1]	['none']	_	_
13	out	_	_	RP	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	semi-quantitative	_	_	JJ	O	[-1]	['none']	_	_
16	PCR	_	_	NN	O	[-1]	['none']	_	_
17	as	_	_	IN	O	[-1]	['none']	_	_
18	described	_	_	VBN	O	[-1]	['none']	_	_
19	previously	_	_	RB	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	3,27	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	PCR	_	_	NN	O	[-1]	['none']	_	_
2	products	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	verified	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	automated	_	_	VBN	O	[-1]	['none']	_	_
7	sequencing	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	PCR	_	_	NN	O	[-1]	['none']	_	_
2	primers	_	_	NNS	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	conditions	_	_	NNS	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
7	analysis	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	DNMT	_	_	NN	O	[-1]	['none']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	MBP	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	Protein	[13]	['multitoken']	_	_
13	DNMT1	_	_	NN	Protein	[6]	['Theme']	_	_
14	DNMT3A	_	_	NN	Protein	[6]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	DNMT3B	_	_	NN	Protein	[6]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	MeCP	_	_	NN	Protein	[6]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	MBD1	_	_	NN	Protein	[6]	['Theme']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	MBD2	_	_	NN	Protein	[6]	['Theme']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	MBD4	_	_	NN	Protein	[6]	['Theme']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	were	_	_	VBD	O	[-1]	['none']	_	_
27	published	_	_	VBN	O	[-1]	['none']	_	_
28	elsewhere	_	_	RB	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	28	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	IRF-4	_	_	NN	Protein	[6]	['Theme']	_	_
5	protein	_	_	NN	O	[-1]	['none']	_	_
6	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	standard	_	_	JJ	O	[-1]	['none']	_	_
10	immunoblotting	_	_	NN	O	[-1]	['none']	_	_
11	assay	_	_	NN	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	performed	_	_	VBN	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	described	_	_	VBN	O	[-1]	['none']	_	_
16	previously	_	_	RB	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	29	_	_	CD	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	protein	_	_	NN	O	[-1]	['none']	_	_
4	lysates	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	generated	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	incubating	_	_	VBG	O	[-1]	['none']	_	_
9	1	_	_	CD	O	[-1]	['none']	_	_
10	x	_	_	CC	O	[-1]	['none']	_	_
11	106	_	_	CD	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	100	_	_	CD	O	[-1]	['none']	_	_
15	microl	_	_	NN	O	[-1]	['none']	_	_
16	RIPA	_	_	NN	O	[-1]	['none']	_	_
17	buffer	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	1	_	_	CD	O	[-1]	['none']	_	_
20	%	_	_	NN	O	[-1]	['none']	_	_
21	NP-40	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	0.5	_	_	CD	O	[-1]	['none']	_	_
24	%	_	_	NN	O	[-1]	['none']	_	_
25	sodiumdesoxycholate	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	0.1	_	_	CD	O	[-1]	['none']	_	_
28	%	_	_	NN	O	[-1]	['none']	_	_
29	SDS	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	100	_	_	CD	O	[-1]	['none']	_	_
32	microg/ml	_	_	NN	O	[-1]	['none']	_	_
33	phenylmethylsulfonyl	_	_	NN	O	[-1]	['none']	_	_
34	fluoride	_	_	NN	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	10	_	_	CD	O	[-1]	['none']	_	_
37	microl/ml	_	_	NN	O	[-1]	['none']	_	_
38	protease-inhibitory-mix	_	_	NN	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	1	_	_	CD	O	[-1]	['none']	_	_
41	micromol/ml	_	_	NN	O	[-1]	['none']	_	_
42	sodiumorthovanadate	_	_	NN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	phosphate	_	_	NN	O	[-1]	['none']	_	_
45	buffered	_	_	VBN	O	[-1]	['none']	_	_
46	saline	_	_	NN	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	for	_	_	IN	O	[-1]	['none']	_	_
49	30	_	_	CD	O	[-1]	['none']	_	_
50	min	_	_	NN	O	[-1]	['none']	_	_
51	on	_	_	IN	O	[-1]	['none']	_	_
52	ice	_	_	NN	O	[-1]	['none']	_	_
53	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	centrifugation	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	protein	_	_	NN	O	[-1]	['none']	_	_
5	concentration	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	supernatant	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	determined	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	BCA-method	_	_	JJ	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Pierce	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	Rockford	_	_	NNP	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	IL	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	recommended	_	_	VBN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Protein	_	_	NN	O	[-1]	['none']	_	_
2	lysates	_	_	NNS	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	70-100	_	_	CD	O	[-1]	['none']	_	_
5	microg	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	electrophoresed	_	_	VBN	O	[-1]	['none']	_	_
9	on	_	_	IN	O	[-1]	['none']	_	_
10	polyacrylamide	_	_	NN	O	[-1]	['none']	_	_
11	gels	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	transferred	_	_	VBN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	PVDF-membrane	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Immobilon	_	_	NN	O	[-1]	['none']	_	_
19	P	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	0.45	_	_	CD	O	[-1]	['none']	_	_
22	microm	_	_	NN	O	[-1]	['none']	_	_
23	;	_	_	:	O	[-1]	['none']	_	_
24	Millipore	_	_	NNP	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	Eschborn	_	_	NNP	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	Germany	_	_	NNP	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Membranes	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	blocked	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	2.5	_	_	CD	O	[-1]	['none']	_	_
6	%	_	_	NN	O	[-1]	['none']	_	_
7	blocking	_	_	VBG	O	[-1]	['none']	_	_
8	reagent	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	Boehringer	_	_	NNP	O	[-1]	['none']	_	_
11	Mannheim	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	Germany	_	_	NNP	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	TBST	_	_	NN	O	[-1]	['none']	_	_
17	buffer	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	4.44	_	_	CD	O	[-1]	['none']	_	_
20	g/l	_	_	NN	O	[-1]	['none']	_	_
21	Tris-HCL	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	2.65	_	_	CD	O	[-1]	['none']	_	_
24	g/l	_	_	NN	O	[-1]	['none']	_	_
25	TrisOH	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	8.07	_	_	CD	O	[-1]	['none']	_	_
28	g/l	_	_	NN	O	[-1]	['none']	_	_
29	NaCl	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	0.2	_	_	CD	O	[-1]	['none']	_	_
32	g/l	_	_	NN	O	[-1]	['none']	_	_
33	KCl	_	_	NN	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	500	_	_	CD	O	[-1]	['none']	_	_
36	microl/l	_	_	NN	O	[-1]	['none']	_	_
37	Tween-20	_	_	NN	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	H2O	_	_	NN	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	subsequently	_	_	RB	O	[-1]	['none']	_	_
43	incubated	_	_	VBN	O	[-1]	['none']	_	_
44	with	_	_	IN	O	[-1]	['none']	_	_
45	primary	_	_	JJ	O	[-1]	['none']	_	_
46	antibody	_	_	NN	O	[-1]	['none']	_	_
47	as	_	_	IN	O	[-1]	['none']	_	_
48	indicated	_	_	VBN	O	[-1]	['none']	_	_
49	and	_	_	CC	O	[-1]	['none']	_	_
50	horseradish	_	_	JJ	O	[-1]	['none']	_	_
51	peroxidase	_	_	NN	O	[-1]	['none']	_	_
52	conjugated	_	_	VBN	O	[-1]	['none']	_	_
53	secondary	_	_	JJ	O	[-1]	['none']	_	_
54	antibody	_	_	NN	O	[-1]	['none']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
57	or	_	_	CC	O	[-1]	['none']	_	_
58	anti-goat	_	_	JJ	O	[-1]	['none']	_	_
59	IgG	_	_	NN	O	[-1]	['none']	_	_
60	(	_	_	-LRB-	O	[-1]	['none']	_	_
61	DAKO	_	_	NNP	O	[-1]	['none']	_	_
62	,	_	_	,	O	[-1]	['none']	_	_
63	Hamburg	_	_	NNP	O	[-1]	['none']	_	_
64	,	_	_	,	O	[-1]	['none']	_	_
65	Germany	_	_	NNP	O	[-1]	['none']	_	_
66	)	_	_	-RRB-	O	[-1]	['none']	_	_
67	,	_	_	,	O	[-1]	['none']	_	_
68	respectively	_	_	RB	O	[-1]	['none']	_	_
69	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	membranes	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	then	_	_	RB	O	[-1]	['none']	_	_
5	developed	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	an	_	_	DT	O	[-1]	['none']	_	_
8	ECL	_	_	NN	O	[-1]	['none']	_	_
9	detection	_	_	NN	O	[-1]	['none']	_	_
10	kit	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Amersham	_	_	NNP	O	[-1]	['none']	_	_
13	Pharmacia	_	_	NNP	O	[-1]	['none']	_	_
14	Biotech	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	Freiburg	_	_	NNP	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	Germany	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	primary	_	_	JJ	O	[-1]	['none']	_	_
3	antibodies	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	goat	_	_	NN	O	[-1]	['none']	_	_
6	anti-IRF-4	_	_	NN	Protein	[0]	['root']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	ICSAT	_	_	NN	Protein	[0]	['root']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	M-17	_	_	NN	Protein	[0]	['root']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	Santa	_	_	NNP	O	[-1]	['none']	_	_
14	Cruz	_	_	NNP	O	[-1]	['none']	_	_
15	Biotechnology	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	Santa	_	_	NNP	O	[-1]	['none']	_	_
18	Cruz	_	_	NNP	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	CA	_	_	NNP	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	mouse	_	_	NN	O	[-1]	['none']	_	_
24	anti-beta-actin	_	_	JJ	Protein	[0]	['root']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	AC-74	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	Sigma	_	_	NNP	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	GLepsilon	_	_	NN	Protein	[2]	['Theme']	_	_
2	transcription	_	_	NN	Transcription	[4]	['Theme']	_	_
3	is	_	_	VBZ	O	[-1]	['none']	_	_
4	defective	_	_	JJ	Negative_regulation	[0]	['root']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	CD40	_	_	NN	Protein	[0]	['root']	_	_
7	stimulated	_	_	VBD	O	[-1]	['none']	_	_
8	HOIP	_	_	NNP	Protein	[9]	['Theme']	_	_
9	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	A20	_	_	NN	O	[-1]	['none']	_	_
2	.2	_	_	NN	O	[-1]	['none']	_	_
3	J	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[6]	['Theme']	_	_
6	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	transduced	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	an	_	_	DT	O	[-1]	['none']	_	_
11	empty	_	_	JJ	O	[-1]	['none']	_	_
12	retroviral	_	_	JJ	O	[-1]	['none']	_	_
13	vector	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	A20	_	_	NN	O	[-1]	['none']	_	_
16	.2	_	_	NN	O	[-1]	['none']	_	_
17	J	_	_	NN	O	[-1]	['none']	_	_
18	+	_	_	CC	O	[-1]	['none']	_	_
19	pMIP	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	HOIP-/-	_	_	NN	Protein	[0]	['root']	_	_
22	+	_	_	CC	O	[-1]	['none']	_	_
23	pMIP	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	respectively	_	_	RB	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	HOIP	_	_	NN	Protein	[30]	['Theme']	_	_
30	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	transduced	_	_	VBN	O	[-1]	['none']	_	_
33	with	_	_	IN	O	[-1]	['none']	_	_
34	a	_	_	DT	O	[-1]	['none']	_	_
35	HOIP	_	_	NN	Protein	[0]	['root']	_	_
36	encoding	_	_	VBG	O	[-1]	['none']	_	_
37	retrovirus	_	_	NN	O	[-1]	['none']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	HOIP-/-	_	_	NN	Protein	[0]	['root']	_	_
40	+	_	_	CC	O	[-1]	['none']	_	_
41	HOIP	_	_	NN	Protein	[0]	['root']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	were	_	_	VBD	O	[-1]	['none']	_	_
44	cultured	_	_	VBN	O	[-1]	['none']	_	_
45	overnight	_	_	JJ	O	[-1]	['none']	_	_
46	with	_	_	IN	O	[-1]	['none']	_	_
47	agonistic	_	_	JJ	O	[-1]	['none']	_	_
48	anti-CD40	_	_	NN	O	[-1]	['none']	_	_
49	or	_	_	CC	O	[-1]	['none']	_	_
50	an	_	_	DT	O	[-1]	['none']	_	_
51	isotype	_	_	NN	O	[-1]	['none']	_	_
52	control	_	_	NN	O	[-1]	['none']	_	_
53	antibody	_	_	NN	O	[-1]	['none']	_	_
54	(	_	_	-LRB-	O	[-1]	['none']	_	_
55	iso	_	_	NN	O	[-1]	['none']	_	_
56	)	_	_	-RRB-	O	[-1]	['none']	_	_
57	,	_	_	,	O	[-1]	['none']	_	_
58	with	_	_	IN	O	[-1]	['none']	_	_
59	or	_	_	CC	O	[-1]	['none']	_	_
60	without	_	_	IN	O	[-1]	['none']	_	_
61	IL-4	_	_	NN	Protein	[0]	['root']	_	_
62	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	isolated	_	_	VBN	O	[-1]	['none']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	reverse	_	_	JJ	O	[-1]	['none']	_	_
9	transcribed	_	_	VBN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	then	_	_	RB	O	[-1]	['none']	_	_
13	subjected	_	_	VBN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	quantitative	_	_	JJ	O	[-1]	['none']	_	_
16	PCR	_	_	NN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	determine	_	_	VB	O	[-1]	['none']	_	_
19	levels	_	_	NNS	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	GLepsilon	_	_	NN	Protein	[22]	['Theme']	_	_
22	transcripts	_	_	NNS	Transcription	[0]	['root']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Results	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	normalized	_	_	VBN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	levels	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Hprt1	_	_	NN	Protein	[9]	['Theme']	_	_
9	transcripts	_	_	NNS	Transcription	[0]	['root']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	each	_	_	DT	O	[-1]	['none']	_	_
12	sample	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Symbols	_	_	NNS	O	[-1]	['none']	_	_
2	indicate	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	values	_	_	NNS	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	duplicate	_	_	VBP	O	[-1]	['none']	_	_
7	cultures	_	_	NNS	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	line	_	_	NN	O	[-1]	['none']	_	_
11	indicates	_	_	VBZ	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	mean	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	two	_	_	CD	O	[-1]	['none']	_	_
17	values	_	_	NNS	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	obtained	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	second	_	_	JJ	O	[-1]	['none']	_	_
8	experiment	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	an	_	_	DT	O	[-1]	['none']	_	_
12	additional	_	_	JJ	O	[-1]	['none']	_	_
13	experiment	_	_	NN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	second	_	_	JJ	O	[-1]	['none']	_	_
17	HOIP	_	_	NN	Protein	[18]	['Theme']	_	_
18	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
19	clone	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Inhibition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PKC	_	_	NN	O	[-1]	['none']	_	_
4	or	_	_	CC	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	induces	_	_	VBZ	O	[-1]	['none']	_	_
7	apoptosis	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	MDMs	_	_	NNS	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	MDMs	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	pre-incubated	_	_	JJ	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	RPMI	_	_	NN	O	[-1]	['none']	_	_
9	medium	_	_	NN	O	[-1]	['none']	_	_
10	containing	_	_	VBG	O	[-1]	['none']	_	_
11	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
14	:	_	_	:	O	[-1]	['none']	_	_
15	5	_	_	CD	O	[-1]	['none']	_	_
16	microM	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	Go-6976	_	_	NN	O	[-1]	['none']	_	_
19	:	_	_	:	O	[-1]	['none']	_	_
20	5	_	_	CD	O	[-1]	['none']	_	_
21	microM	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	BAPTA/AM	_	_	NN	O	[-1]	['none']	_	_
24	:	_	_	:	O	[-1]	['none']	_	_
25	2.5	_	_	CD	O	[-1]	['none']	_	_
26	microM	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	30	_	_	CD	O	[-1]	['none']	_	_
30	minutes	_	_	NNS	O	[-1]	['none']	_	_
31	prior	_	_	RB	O	[-1]	['none']	_	_
32	to	_	_	TO	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	addition	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	M-CSF	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	a	_	_	DT	O	[-1]	['none']	_	_
3	control	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	untreated	_	_	JJ	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	incubated	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	dimethyl	_	_	JJ	O	[-1]	['none']	_	_
11	sulfoxide	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	DMSO	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	lysates	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	resolved	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	immunoblotted	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	antibody	_	_	NN	O	[-1]	['none']	_	_
11	recognizing	_	_	VBG	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	active	_	_	JJ	O	[-1]	['none']	_	_
14	cleaved	_	_	VBN	O	[-1]	['none']	_	_
15	form	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	caspase-3	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	blots	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	reblotted	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	beta-actin	_	_	NN	Protein	[0]	['root']	_	_
7	that	_	_	WDT	O	[-1]	['none']	_	_
8	served	_	_	VBD	O	[-1]	['none']	_	_
9	as	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	loading	_	_	VBG	O	[-1]	['none']	_	_
12	control	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	ratio	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	active	_	_	JJ	Positive_regulation	[0]	['root']	_	_
5	caspase-3	_	_	NN	Protein	[4]	['Theme']	_	_
6	bands	_	_	NNS	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	17	_	_	CD	O	[-1]	['none']	_	_
9	kD	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	19	_	_	CD	O	[-1]	['none']	_	_
12	kD	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	beta-actin	_	_	JJ	Protein	[0]	['root']	_	_
16	control	_	_	NN	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	determined	_	_	VBN	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	densitometry	_	_	NN	O	[-1]	['none']	_	_
21	analysis	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	bottom	_	_	JJ	O	[-1]	['none']	_	_
24	panel	_	_	NN	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	represents	_	_	VBZ	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	mean	_	_	NN	O	[-1]	['none']	_	_
5	+/-	_	_	CC	O	[-1]	['none']	_	_
6	S.E.M	_	_	NN	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	two	_	_	CD	O	[-1]	['none']	_	_
9	independent	_	_	JJ	O	[-1]	['none']	_	_
10	donors	_	_	NNS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Apoptosis	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	treated	_	_	JJ	O	[-1]	['none']	_	_
8	MDMs	_	_	NNS	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	also	_	_	RB	O	[-1]	['none']	_	_
11	measured	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	Annexin	_	_	NN	Protein	[14]	['multitoken']	_	_
14	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	propidium	_	_	NN	O	[-1]	['none']	_	_
17	iodine	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	PI	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	staining	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	analyzed	_	_	VBN	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	flow	_	_	NN	O	[-1]	['none']	_	_
26	cytometry	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	percentage	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	surviving	_	_	VBG	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	Annexin	_	_	NN	Protein	[8]	['multitoken']	_	_
8	V/PI	_	_	NN	Protein	[0]	['root']	_	_
9	negative	_	_	JJ	Negative_regulation	[0]	['root']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	treated	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	vehicle	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	M-CSF	_	_	NN	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	arbitrarily	_	_	RB	O	[-1]	['none']	_	_
21	set	_	_	VBN	O	[-1]	['none']	_	_
22	as	_	_	IN	O	[-1]	['none']	_	_
23	100	_	_	CD	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	represent	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	mean	_	_	NN	O	[-1]	['none']	_	_
6	+/-	_	_	CC	O	[-1]	['none']	_	_
7	S.E.M	_	_	NN	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	three	_	_	CD	O	[-1]	['none']	_	_
10	independent	_	_	JJ	O	[-1]	['none']	_	_
11	experiments	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	*	_	_	SYM	O	[-1]	['none']	_	_
2	The	_	_	DT	O	[-1]	['none']	_	_
3	p-values	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	M-CSF	_	_	NN	O	[-1]	['none']	_	_
8	compared	_	_	VBN	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	vehicle	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	M-CSF	_	_	NN	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	<	_	_	JJR	O	[-1]	['none']	_	_
15	=	_	_	JJ	O	[-1]	['none']	_	_
16	0.05	_	_	CD	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	Activates	_	_	VBZ	O	[-1]	['none']	_	_
3	Akt	_	_	NNP	Protein	[0]	['root']	_	_
4	Signaling	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Deregulates	_	_	VBZ	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	Rb	_	_	NN	Protein	[0]	['root']	_	_
9	Cell	_	_	NN	O	[-1]	['none']	_	_
10	Cycle	_	_	NNP	O	[-1]	['none']	_	_
11	Pathway	_	_	NNP	O	[-1]	['none']	_	_
12	LMP1	_	_	NN	Protein	[0]	['root']	_	_
13	transformation	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	rodent	_	_	JJ	O	[-1]	['none']	_	_
16	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
17	requires	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
18	activation	_	_	NN	Positive_regulation	[17]	['Theme']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	PI3K	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	Akt	_	_	NN	Protein	[18]	['Theme']	_	_
23	[	_	_	CD	O	[-1]	['none']	_	_
24	5	_	_	CD	O	[-1]	['none']	_	_
25	]	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Additionally	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
4	pAkt	_	_	NN	Protein	[3]	['Theme']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	frequently	_	_	RB	O	[-1]	['none']	_	_
7	detected	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	NPC	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	neoplastic	_	_	JJ	O	[-1]	['none']	_	_
13	Reed-Sternberg	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	classical	_	_	JJ	O	[-1]	['none']	_	_
17	HD	_	_	NN	O	[-1]	['none']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	39,40	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	if	_	_	IN	O	[-1]	['none']	_	_
4	Akt	_	_	NN	Protein	[0]	['root']	_	_
5	signaling	_	_	NN	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	activated	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	LMP1	_	_	NN	Protein	[0]	['root']	_	_
10	transgenic	_	_	JJ	O	[-1]	['none']	_	_
11	mice	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	pAkt	_	_	NN	Protein	[0]	['root']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	several	_	_	JJ	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	its	_	_	PRP$	O	[-1]	['none']	_	_
18	targets	_	_	NNS	O	[-1]	['none']	_	_
19	were	_	_	VBD	O	[-1]	['none']	_	_
20	assessed	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	immunoblotting	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	splenic	_	_	JJ	O	[-1]	['none']	_	_
25	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
26	MACS	_	_	NNS	O	[-1]	['none']	_	_
27	purified	_	_	VBN	O	[-1]	['none']	_	_
28	B	_	_	NN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	transgenic	_	_	JJ	O	[-1]	['none']	_	_
3	B	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	had	_	_	VBD	O	[-1]	['none']	_	_
6	increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
7	levels	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	pAkt	_	_	NN	Protein	[6]	['Theme']	_	_
10	compared	_	_	VBN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	wild-type	_	_	JJ	O	[-1]	['none']	_	_
13	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
14	;	_	_	:	O	[-1]	['none']	_	_
15	however	_	_	RB	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	progression	_	_	NN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	lymphoma	_	_	NN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	both	_	_	CC	O	[-1]	['none']	_	_
22	LMP1	_	_	NN	Protein	[0]	['root']	_	_
23	positive	_	_	JJ	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	-negative	_	_	JJ	O	[-1]	['none']	_	_
26	lymphoma	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	did	_	_	VBD	O	[-1]	['none']	_	_
29	not	_	_	RB	O	[-1]	['none']	_	_
30	further	_	_	JJ	O	[-1]	['none']	_	_
31	increase	_	_	NN	Positive_regulation	[0]	['root']	_	_
32	pAkt	_	_	NN	Protein	[31]	['Theme']	_	_
33	levels	_	_	NNS	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Akt	_	_	NN	Protein	[3]	['Theme']	_	_
3	target	_	_	NN	Binding	[12]	['Theme']	_	_
4	glycogen	_	_	NN	Protein	[7]	['multitoken']	_	_
5	synthase	_	_	NN	Protein	[7]	['multitoken']	_	_
6	kinase	_	_	NN	Protein	[7]	['multitoken']	_	_
7	3	_	_	CD	Protein	[3]	['Theme']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	GSK3	_	_	NN	Protein	[0]	['root']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	inactivated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	however	_	_	RB	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
19	phosphorylated	_	_	VBN	Phosphorylation	[18]	['Theme']	_	_
20	GSK3	_	_	NN	Protein	[19]	['Theme']	_	_
21	was	_	_	VBD	O	[-1]	['none']	_	_
22	not	_	_	RB	O	[-1]	['none']	_	_
23	detected	_	_	VBN	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	transgenic	_	_	JJ	O	[-1]	['none']	_	_
27	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	was	_	_	VBD	O	[-1]	['none']	_	_
30	almost	_	_	RB	O	[-1]	['none']	_	_
31	absent	_	_	JJ	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	lymphoma	_	_	NN	O	[-1]	['none']	_	_
35	samples	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	finding	_	_	NN	O	[-1]	['none']	_	_
3	indicates	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	GSK3	_	_	NN	Protein	[9]	['Theme']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	target	_	_	NN	Binding	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
12	Akt	_	_	NN	Protein	[9, 11]	['Theme', 'Theme']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	LMP1	_	_	NN	Protein	[0]	['root']	_	_
16	transgenic	_	_	JJ	O	[-1]	['none']	_	_
17	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	lymphoma	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Similarly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Akt	_	_	NN	Protein	[3]	['Theme']	_	_
6	without	_	_	IN	O	[-1]	['none']	_	_
7	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	GSK3	_	_	NN	Protein	[7]	['Theme']	_	_
10	has	_	_	VBZ	O	[-1]	['none']	_	_
11	been	_	_	VBN	O	[-1]	['none']	_	_
12	previously	_	_	RB	O	[-1]	['none']	_	_
13	shown	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	EBV	_	_	NN	O	[-1]	['none']	_	_
16	positive	_	_	JJ	O	[-1]	['none']	_	_
17	HD	_	_	NN	O	[-1]	['none']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	40	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	wild-type	_	_	JJ	O	[-1]	['none']	_	_
6	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
7	lacked	_	_	VBD	O	[-1]	['none']	_	_
8	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
9	Akt	_	_	NN	Protein	[8]	['Theme']	_	_
10	but	_	_	CC	O	[-1]	['none']	_	_
11	did	_	_	VBD	O	[-1]	['none']	_	_
12	have	_	_	VB	O	[-1]	['none']	_	_
13	detectable	_	_	JJ	O	[-1]	['none']	_	_
14	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
15	GSK3	_	_	NN	Protein	[14]	['Theme']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	further	_	_	JJ	O	[-1]	['none']	_	_
3	suggests	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	additional	_	_	JJ	O	[-1]	['none']	_	_
6	pathways	_	_	NNS	O	[-1]	['none']	_	_
7	are	_	_	VBP	O	[-1]	['none']	_	_
8	involved	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	regulation	_	_	NN	Regulation	[0]	['root']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	GSK3	_	_	NN	Protein	[11]	['Theme']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	identify	_	_	VB	O	[-1]	['none']	_	_
3	other	_	_	JJ	O	[-1]	['none']	_	_
4	potential	_	_	JJ	O	[-1]	['none']	_	_
5	Akt	_	_	NN	Protein	[6]	['Theme']	_	_
6	targets	_	_	NNS	Binding	[0]	['root']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	immunoblot	_	_	NN	O	[-1]	['none']	_	_
9	analysis	_	_	NN	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	p-mTOR	_	_	NN	Protein	[0]	['root']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	performed	_	_	VBN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Activated	_	_	VBN	Positive_regulation	[5, 20]	['Theme', 'Theme']	_	_
2	p-mTOR	_	_	NN	Protein	[1]	['Theme']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	not	_	_	RB	O	[-1]	['none']	_	_
5	increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	LMP1	_	_	NN	Protein	[0]	['root']	_	_
8	transgenic	_	_	JJ	O	[-1]	['none']	_	_
9	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	lymphoma	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	indicating	_	_	VBG	O	[-1]	['none']	_	_
15	that	_	_	IN	O	[-1]	['none']	_	_
16	this	_	_	DT	Anaphora	[17]	['multitoken']	_	_
17	pathway	_	_	NN	Anaphora	[0]	['root']	_	_
18	is	_	_	VBZ	O	[-1]	['none']	_	_
19	not	_	_	RB	O	[-1]	['none']	_	_
20	affected	_	_	VBN	Regulation	[0]	['root']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	LMP1	_	_	NN	Protein	[23]	['Cause']	_	_
23	induced	_	_	VBD	Positive_regulation	[20]	['Cause']	_	_
24	Akt	_	_	NN	Protein	[25]	['Theme']	_	_
25	activation	_	_	NN	Positive_regulation	[23]	['Theme']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	does	_	_	VBZ	O	[-1]	['none']	_	_
28	not	_	_	RB	O	[-1]	['none']	_	_
29	contribute	_	_	VB	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	lymphoma	_	_	NN	O	[-1]	['none']	_	_
32	development	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Akt	_	_	NN	Protein	[0]	['root']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	known	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	phosphorylate	_	_	VB	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	induce	_	_	VB	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	degradation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	pro	_	_	JJ	O	[-1]	['none']	_	_
14	apoptotic	_	_	JJ	O	[-1]	['none']	_	_
15	Forkhead	_	_	NN	O	[-1]	['none']	_	_
16	family	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	transcription	_	_	NN	O	[-1]	['none']	_	_
19	factors	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	leading	_	_	VBG	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	cell	_	_	NN	O	[-1]	['none']	_	_
24	cycle	_	_	NN	O	[-1]	['none']	_	_
25	progression	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	survival	_	_	NN	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	some	_	_	DT	O	[-1]	['none']	_	_
30	human	_	_	NN	O	[-1]	['none']	_	_
31	tumors	_	_	NNS	O	[-1]	['none']	_	_
32	[	_	_	VBP	O	[-1]	['none']	_	_
33	41,42	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	CD	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	splenic	_	_	JJ	O	[-1]	['none']	_	_
5	B	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	did	_	_	VBD	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	consistently	_	_	RB	O	[-1]	['none']	_	_
10	detect	_	_	VB	O	[-1]	['none']	_	_
11	p-FoxO1	_	_	NN	Protein	[0]	['root']	_	_
12	levels	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	signal	_	_	NN	O	[-1]	['none']	_	_
16	that	_	_	WDT	O	[-1]	['none']	_	_
17	targets	_	_	VBZ	Regulation	[0]	['root']	_	_
18	FoxO1	_	_	NN	Protein	[17]	['Theme']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	degradation	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Hence	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	degradation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	FoxO1	_	_	NN	Protein	[0]	['root']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	assessed	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	detection	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	total	_	_	JJ	O	[-1]	['none']	_	_
12	FoxO1	_	_	NN	Protein	[0]	['root']	_	_
13	levels	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	indicated	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	total	_	_	JJ	O	[-1]	['none']	_	_
6	FoxO1	_	_	NN	Protein	[10]	['Theme']	_	_
7	levels	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	greatly	_	_	RB	O	[-1]	['none']	_	_
10	decreased	_	_	VBN	Negative_regulation	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	wild-type	_	_	JJ	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	LMP1	_	_	NN	Protein	[0]	['root']	_	_
15	transgenic	_	_	JJ	O	[-1]	['none']	_	_
16	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	suggesting	_	_	VBG	O	[-1]	['none']	_	_
19	that	_	_	IN	O	[-1]	['none']	_	_
20	inhibition	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	Forkhead	_	_	NN	O	[-1]	['none']	_	_
24	signaling	_	_	NN	O	[-1]	['none']	_	_
25	pathway	_	_	NN	O	[-1]	['none']	_	_
26	is	_	_	VBZ	O	[-1]	['none']	_	_
27	an	_	_	DT	O	[-1]	['none']	_	_
28	important	_	_	JJ	O	[-1]	['none']	_	_
29	target	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	Akt	_	_	NN	Protein	[0]	['root']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	lymphoma	_	_	NN	O	[-1]	['none']	_	_
34	development	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	considering	_	_	VBG	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	Akt	_	_	NN	Protein	[6]	['Theme']	_	_
6	activation	_	_	NN	Positive_regulation	[9]	['Cause']	_	_
7	did	_	_	VBD	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
10	FoxO1	_	_	NN	Protein	[11]	['Theme']	_	_
11	degradation	_	_	NN	Negative_regulation	[9]	['Theme']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	LMP1	_	_	NN	Protein	[0]	['root']	_	_
14	transgenic	_	_	JJ	O	[-1]	['none']	_	_
15	B	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	Akt	_	_	NN	Protein	[24]	['Cause']	_	_
19	may	_	_	MD	O	[-1]	['none']	_	_
20	not	_	_	RB	O	[-1]	['none']	_	_
21	be	_	_	VB	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	sole	_	_	JJ	O	[-1]	['none']	_	_
24	regulator	_	_	NN	Regulation	[0]	['root']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	FoxO1	_	_	NN	Protein	[24]	['Theme']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	it	_	_	PRP	O	[-1]	['none']	_	_
30	may	_	_	MD	O	[-1]	['none']	_	_
31	be	_	_	VB	O	[-1]	['none']	_	_
32	that	_	_	IN	O	[-1]	['none']	_	_
33	progression	_	_	NN	O	[-1]	['none']	_	_
34	to	_	_	TO	O	[-1]	['none']	_	_
35	lymphoma	_	_	NN	O	[-1]	['none']	_	_
36	requires	_	_	VBZ	O	[-1]	['none']	_	_
37	modulation	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	multiple	_	_	JJ	O	[-1]	['none']	_	_
40	pathways	_	_	NNS	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Forkhead	_	_	NN	O	[-1]	['none']	_	_
3	family	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	transcription	_	_	NN	O	[-1]	['none']	_	_
6	factors	_	_	NNS	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	known	_	_	VBN	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	induce	_	_	VB	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	Cdk	_	_	NN	O	[-1]	['none']	_	_
16	inhibitor	_	_	NN	O	[-1]	['none']	_	_
17	p27	_	_	NN	Protein	[12]	['Theme']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	43,44	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	transformed	_	_	VBD	O	[-1]	['none']	_	_
3	rodent	_	_	JJ	O	[-1]	['none']	_	_
4	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
5	have	_	_	VBP	O	[-1]	['none']	_	_
6	decreased	_	_	VBN	O	[-1]	['none']	_	_
7	expression	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	p27	_	_	NN	Protein	[0]	['root']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	upregulation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Cdk2	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	subsequent	_	_	JJ	O	[-1]	['none']	_	_
17	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	inactivation	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	tumor	_	_	NN	O	[-1]	['none']	_	_
23	suppressor	_	_	NN	O	[-1]	['none']	_	_
24	gene	_	_	NN	O	[-1]	['none']	_	_
25	Rb	_	_	NN	Protein	[0]	['root']	_	_
26	[	_	_	CD	O	[-1]	['none']	_	_
27	45	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	investigate	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[0]	['root']	_	_
5	affected	_	_	VBD	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	cycle	_	_	NN	O	[-1]	['none']	_	_
8	regulation	_	_	NN	O	[-1]	['none']	_	_
9	through	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	Rb	_	_	NN	Protein	[0]	['root']	_	_
12	pathway	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	B	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	immunoblot	_	_	NN	O	[-1]	['none']	_	_
18	analyses	_	_	NNS	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	pRb	_	_	NN	Protein	[0]	['root']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	Cdk2	_	_	NN	Protein	[0]	['root']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	p27	_	_	NN	Protein	[0]	['root']	_	_
26	were	_	_	VBD	O	[-1]	['none']	_	_
27	performed	_	_	VBN	O	[-1]	['none']	_	_
28	on	_	_	IN	O	[-1]	['none']	_	_
29	splenic	_	_	JJ	O	[-1]	['none']	_	_
30	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
31	MACS	_	_	NNS	O	[-1]	['none']	_	_
32	purified	_	_	VBN	O	[-1]	['none']	_	_
33	B	_	_	NN	O	[-1]	['none']	_	_
34	cells	_	_	NNS	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	transgenic	_	_	JJ	O	[-1]	['none']	_	_
3	B	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	had	_	_	VBD	O	[-1]	['none']	_	_
6	enhanced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
7	levels	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	pRb	_	_	NN	Protein	[6]	['Theme']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	concomitant	_	_	JJ	O	[-1]	['none']	_	_
12	stabilization	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	total	_	_	JJ	O	[-1]	['none']	_	_
15	Rb	_	_	NN	Protein	[0]	['root']	_	_
16	levels	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	Cdk2	_	_	NN	Protein	[6]	['Theme']	_	_
19	compared	_	_	VBN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	wild-type	_	_	JJ	O	[-1]	['none']	_	_
22	B	_	_	NN	O	[-1]	['none']	_	_
23	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Progression	_	_	NN	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	lymphoma	_	_	NN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	both	_	_	CC	O	[-1]	['none']	_	_
6	wild-type	_	_	JJ	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	LMP1	_	_	NN	Protein	[0]	['root']	_	_
9	transgenic	_	_	JJ	O	[-1]	['none']	_	_
10	lymphoma	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	led	_	_	VBD	Positive_regulation	[0]	['root']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	increased	_	_	VBN	Positive_regulation	[12]	['Theme']	_	_
15	levels	_	_	NNS	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	Rb	_	_	NN	Protein	[14]	['Theme']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	correspondingly	_	_	RB	O	[-1]	['none']	_	_
20	high	_	_	JJ	Positive_regulation	[21]	['multitoken']	_	_
21	levels	_	_	NNS	Positive_regulation	[0]	['root']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	Cdk2	_	_	NN	Protein	[21]	['Theme']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
27	levels	_	_	NNS	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	p27	_	_	NN	Protein	[26]	['Theme']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	Rb	_	_	NN	Protein	[0]	['root']	_	_
7	pathway	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	deregulated	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	LMP1	_	_	NN	Protein	[0]	['root']	_	_
12	transgenic	_	_	JJ	O	[-1]	['none']	_	_
13	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	that	_	_	IN	O	[-1]	['none']	_	_
16	lymphoma	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	are	_	_	VBP	O	[-1]	['none']	_	_
19	distinguished	_	_	VBN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	loss	_	_	NN	Negative_regulation	[0]	['root']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	FoxO1	_	_	NN	Protein	[21]	['Theme']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
26	p27	_	_	NN	Protein	[25]	['Theme']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[14]	['Cause']	_	_
2	controls	_	_	VBZ	O	[-1]	['none']	_	_
3	multiple	_	_	JJ	O	[-1]	['none']	_	_
4	aspects	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	CTL	_	_	NN	O	[-1]	['none']	_	_
8	differentiation	_	_	NN	O	[-1]	['none']	_	_
9	program	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	part	_	_	NN	O	[-1]	['none']	_	_
13	through	_	_	IN	O	[-1]	['none']	_	_
14	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	Eomes	_	_	NNP	Protein	[14]	['Theme']	_	_
17	Because	_	_	IN	O	[-1]	['none']	_	_
18	Runx3	_	_	NN	Protein	[21]	['Theme']	_	_
19	is	_	_	VBZ	O	[-1]	['none']	_	_
20	highly	_	_	RB	O	[-1]	['none']	_	_
21	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	peripheral	_	_	JJ	O	[-1]	['none']	_	_
24	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
25	T	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	because	_	_	IN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	T-bet-Runx3	_	_	NN	Protein	[0]	['root']	_	_
33	cooperation	_	_	NN	O	[-1]	['none']	_	_
34	we	_	_	PRP	O	[-1]	['none']	_	_
35	observed	_	_	VBD	O	[-1]	['none']	_	_
36	earlier	_	_	RBR	O	[-1]	['none']	_	_
37	in	_	_	IN	O	[-1]	['none']	_	_
38	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
39	T	_	_	NN	O	[-1]	['none']	_	_
40	cells	_	_	NNS	O	[-1]	['none']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	15	_	_	CD	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	,	_	_	,	O	[-1]	['none']	_	_
45	we	_	_	PRP	O	[-1]	['none']	_	_
46	examined	_	_	VBD	O	[-1]	['none']	_	_
47	the	_	_	DT	O	[-1]	['none']	_	_
48	role	_	_	NN	O	[-1]	['none']	_	_
49	of	_	_	IN	O	[-1]	['none']	_	_
50	Runx3	_	_	NN	Protein	[0]	['root']	_	_
51	in	_	_	IN	O	[-1]	['none']	_	_
52	effector	_	_	NN	O	[-1]	['none']	_	_
53	CTL	_	_	NN	O	[-1]	['none']	_	_
54	differentiation	_	_	NN	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	isolated	_	_	VBD	O	[-1]	['none']	_	_
3	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
4	T	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	KO	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	mice	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	outbred	_	_	JJ	O	[-1]	['none']	_	_
15	ICR	_	_	NN	O	[-1]	['none']	_	_
16	background	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	their	_	_	PRP$	O	[-1]	['none']	_	_
19	WT	_	_	JJ	O	[-1]	['none']	_	_
20	Runx3	_	_	NN	Protein	[0]	['root']	_	_
21	+/+	_	_	JJ	O	[-1]	['none']	_	_
22	littermates	_	_	NNS	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	positive	_	_	JJ	O	[-1]	['none']	_	_
25	selection	_	_	NN	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	anti-CD8	_	_	JJ	Protein	[0]	['root']	_	_
28	magnetic	_	_	JJ	O	[-1]	['none']	_	_
29	beads	_	_	NNS	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	Figs	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	S1	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	S2	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	available	_	_	JJ	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	http://www.jem.org/cgi/content/full/jem.20081242/DC1	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Strikingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
4	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	strongly	_	_	RB	O	[-1]	['none']	_	_
9	impaired	_	_	JJ	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	their	_	_	PRP$	O	[-1]	['none']	_	_
12	ability	_	_	NN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	differentiate	_	_	VB	O	[-1]	['none']	_	_
15	into	_	_	IN	O	[-1]	['none']	_	_
16	effector	_	_	NN	O	[-1]	['none']	_	_
17	CTLs	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	judged	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	perforin	_	_	NN	Protein	[22]	['Theme']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	granzyme	_	_	NN	Protein	[27]	['multitoken']	_	_
27	B	_	_	NN	Protein	[22]	['Theme']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	IFN-gamma	_	_	NN	Protein	[22]	['Theme']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Compared	_	_	VBN	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	WT	_	_	JJ	O	[-1]	['none']	_	_
4	T	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	perforin	_	_	NN	Protein	[11]	['Theme']	_	_
8	mRNA	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	protein	_	_	NN	O	[-1]	['none']	_	_
11	expression	_	_	NN	Gene_expression	[14]	['Theme']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	essentially	_	_	RB	O	[-1]	['none']	_	_
14	undetectable	_	_	JJ	Positive_regulation	[0]	['root']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
17	T	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	day	_	_	NN	O	[-1]	['none']	_	_
21	6	_	_	CD	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	culture	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
2	T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	had	_	_	VBD	O	[-1]	['none']	_	_
6	no	_	_	DT	O	[-1]	['none']	_	_
7	detectable	_	_	JJ	O	[-1]	['none']	_	_
8	Eomes	_	_	NN	Protein	[9]	['Theme']	_	_
9	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
10	;	_	_	:	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	contrast	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	T-bet	_	_	JJ	Protein	[15]	['Theme']	_	_
15	expression	_	_	NN	Gene_expression	[17]	['Theme']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	unimpaired	_	_	JJ	Negative_regulation	[0]	['root']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Runx3	_	_	NN	Protein	[5]	['Cause']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	maximal	_	_	JJ	O	[-1]	['none']	_	_
8	production	_	_	NN	Gene_expression	[5]	['Theme']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	IFN-gamma	_	_	NN	Protein	[8]	['Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	but	_	_	CC	O	[-1]	['none']	_	_
13	not	_	_	RB	O	[-1]	['none']	_	_
14	TNF	_	_	NN	Protein	[8]	['Theme']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	IL-2	_	_	NN	Protein	[8]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
20	T	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	restimulated	_	_	VBN	O	[-1]	['none']	_	_
23	at	_	_	IN	O	[-1]	['none']	_	_
24	day	_	_	NN	O	[-1]	['none']	_	_
25	6	_	_	CD	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	previously	_	_	RB	O	[-1]	['none']	_	_
3	reported	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	Th1	_	_	NN	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	differentiation	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	regulated	_	_	VBN	O	[-1]	['none']	_	_
10	through	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	feed-forward	_	_	JJ	O	[-1]	['none']	_	_
13	loop	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	which	_	_	WDT	O	[-1]	['none']	_	_
16	T-bet	_	_	NNP	Protein	[18]	['Theme']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	up-regulated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
19	early	_	_	RB	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	induces	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
22	Runx3	_	_	NN	Protein	[21]	['Theme']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	after	_	_	IN	O	[-1]	['none']	_	_
25	which	_	_	WDT	O	[-1]	['none']	_	_
26	T-bet	_	_	NN	Protein	[31, 34]	['Cause', 'Cause']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	Runx3	_	_	NN	Protein	[31, 34]	['Cause', 'Cause']	_	_
29	cooperate	_	_	VBP	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
32	IFN-gamma	_	_	NN	Protein	[31]	['Theme']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	silence	_	_	NN	Negative_regulation	[0]	['root']	_	_
35	IL-4	_	_	NN	Protein	[34]	['Theme']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	thus	_	_	RB	O	[-1]	['none']	_	_
38	promoting	_	_	VBG	O	[-1]	['none']	_	_
39	stable	_	_	JJ	O	[-1]	['none']	_	_
40	differentiation	_	_	NN	O	[-1]	['none']	_	_
41	toward	_	_	IN	O	[-1]	['none']	_	_
42	the	_	_	DT	O	[-1]	['none']	_	_
43	Th1	_	_	NN	O	[-1]	['none']	_	_
44	lineage	_	_	NN	O	[-1]	['none']	_	_
45	(	_	_	-LRB-	O	[-1]	['none']	_	_
46	15	_	_	CD	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	22	_	_	CD	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	Because	_	_	IN	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	Runx3	_	_	NN	Protein	[7]	['Cause']	_	_
6	appeared	_	_	VBD	O	[-1]	['none']	_	_
7	necessary	_	_	JJ	Positive_regulation	[0]	['root']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	Eomes	_	_	NNS	Protein	[10]	['Theme']	_	_
10	induction	_	_	NN	Positive_regulation	[7]	['Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	b	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	kinetics	_	_	NNS	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	Eomes	_	_	NN	Protein	[19]	['Theme']	_	_
19	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
20	paralleled	_	_	VBD	O	[-1]	['none']	_	_
21	those	_	_	DT	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	perforin	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	c	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	overexpression	_	_	NN	Positive_regulation	[40]	['Cause']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	Eo-VP16	_	_	NN	Protein	[30]	['Theme']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	either	_	_	CC	O	[-1]	['none']	_	_
35	WT	_	_	NN	O	[-1]	['none']	_	_
36	or	_	_	CC	O	[-1]	['none']	_	_
37	T-bet-deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
38	T	_	_	NN	O	[-1]	['none']	_	_
39	cells	_	_	NNS	O	[-1]	['none']	_	_
40	led	_	_	VBD	Positive_regulation	[0]	['root']	_	_
41	to	_	_	TO	O	[-1]	['none']	_	_
42	an	_	_	DT	O	[-1]	['none']	_	_
43	increase	_	_	NN	Positive_regulation	[40]	['Theme']	_	_
44	in	_	_	IN	O	[-1]	['none']	_	_
45	both	_	_	CC	O	[-1]	['none']	_	_
46	perforin	_	_	NN	Protein	[49]	['Theme']	_	_
47	and	_	_	CC	O	[-1]	['none']	_	_
48	IFN-gamma	_	_	NN	Protein	[49]	['Theme']	_	_
49	expression	_	_	NN	Gene_expression	[43]	['Theme']	_	_
50	,	_	_	,	O	[-1]	['none']	_	_
51	we	_	_	PRP	O	[-1]	['none']	_	_
52	asked	_	_	VBD	O	[-1]	['none']	_	_
53	whether	_	_	IN	O	[-1]	['none']	_	_
54	CTL	_	_	NN	O	[-1]	['none']	_	_
55	differentiation	_	_	NN	O	[-1]	['none']	_	_
56	was	_	_	VBD	O	[-1]	['none']	_	_
57	also	_	_	RB	O	[-1]	['none']	_	_
58	potentially	_	_	RB	O	[-1]	['none']	_	_
59	regulated	_	_	VBN	O	[-1]	['none']	_	_
60	by	_	_	IN	O	[-1]	['none']	_	_
61	a	_	_	DT	O	[-1]	['none']	_	_
62	feed-forward	_	_	JJ	O	[-1]	['none']	_	_
63	loop	_	_	NN	O	[-1]	['none']	_	_
64	involving	_	_	VBG	O	[-1]	['none']	_	_
65	these	_	_	DT	O	[-1]	['none']	_	_
66	same	_	_	JJ	O	[-1]	['none']	_	_
67	two	_	_	CD	O	[-1]	['none']	_	_
68	classes	_	_	NNS	O	[-1]	['none']	_	_
69	of	_	_	IN	O	[-1]	['none']	_	_
70	Runx	_	_	NN	O	[-1]	['none']	_	_
71	and	_	_	CC	O	[-1]	['none']	_	_
72	T-box	_	_	NN	O	[-1]	['none']	_	_
73	transcription	_	_	NN	O	[-1]	['none']	_	_
74	factors	_	_	NNS	O	[-1]	['none']	_	_
75	.	_	_	.	O	[-1]	['none']	_	_

1	Specifically	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	asked	_	_	VBD	O	[-1]	['none']	_	_
5	whether	_	_	IN	O	[-1]	['none']	_	_
6	Runx3	_	_	NN	Protein	[10, 20]	['Cause', 'Cause']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	which	_	_	WDT	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	necessary	_	_	JJ	Positive_regulation	[0]	['root']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	Eomes	_	_	NNS	Protein	[13]	['Theme']	_	_
13	induction	_	_	NN	Positive_regulation	[10]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	then	_	_	RB	O	[-1]	['none']	_	_
16	cooperated	_	_	VBD	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	Eomes	_	_	NNS	Protein	[20]	['Cause']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	regulate	_	_	VB	Regulation	[0]	['root']	_	_
21	transcription	_	_	NN	Transcription	[20]	['Theme']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	effector	_	_	NN	O	[-1]	['none']	_	_
25	CTL	_	_	NN	O	[-1]	['none']	_	_
26	markers	_	_	NNS	O	[-1]	['none']	_	_
27	perforin	_	_	NN	Protein	[21]	['Theme']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	IFN-gamma	_	_	NN	Protein	[21]	['Theme']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	granzyme	_	_	NN	Protein	[33]	['multitoken']	_	_
33	B.	_	_	NNP	Protein	[0]	['root']	_	_
34	To	_	_	TO	O	[-1]	['none']	_	_
35	test	_	_	VB	O	[-1]	['none']	_	_
36	this	_	_	DT	O	[-1]	['none']	_	_
37	hypothesis	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	we	_	_	PRP	O	[-1]	['none']	_	_
40	used	_	_	VBD	O	[-1]	['none']	_	_
41	chromatin	_	_	NN	O	[-1]	['none']	_	_
42	immunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	ChIP	_	_	NN	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	assays	_	_	NNS	O	[-1]	['none']	_	_
47	to	_	_	TO	O	[-1]	['none']	_	_
48	ask	_	_	VB	O	[-1]	['none']	_	_
49	whether	_	_	IN	O	[-1]	['none']	_	_
50	Eomes	_	_	NNP	Protein	[53]	['Theme']	_	_
51	and	_	_	CC	O	[-1]	['none']	_	_
52	Runx3	_	_	NN	Protein	[53]	['Theme']	_	_
53	bound	_	_	VBD	Binding	[0]	['root']	_	_
54	regulatory	_	_	JJ	Entity	[55]	['multitoken']	_	_
55	regions	_	_	NNS	Entity	[53]	['Site']	_	_
56	of	_	_	IN	O	[-1]	['none']	_	_
57	the	_	_	DT	O	[-1]	['none']	_	_
58	Prf1	_	_	NN	Protein	[53]	['Theme']	_	_
59	,	_	_	,	O	[-1]	['none']	_	_
60	Ifng	_	_	NN	Protein	[53]	['Theme']	_	_
61	,	_	_	,	O	[-1]	['none']	_	_
62	and	_	_	CC	O	[-1]	['none']	_	_
63	Gzmb	_	_	NN	Protein	[53]	['Theme']	_	_
64	genes	_	_	NNS	O	[-1]	['none']	_	_
65	.	_	_	.	O	[-1]	['none']	_	_

1	Both	_	_	DT	Anaphora	[2]	['multitoken']	_	_
2	proteins	_	_	NNS	Anaphora	[0]	['root']	_	_
3	associated	_	_	VBN	Binding	[0]	['root']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	gene	_	_	NN	O	[-1]	['none']	_	_
6	regulatory	_	_	JJ	O	[-1]	['none']	_	_
7	regions	_	_	NNS	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	differentiated	_	_	VBN	O	[-1]	['none']	_	_
10	CTLs	_	_	NNS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[2]	['Theme']	_	_
2	bound	_	_	VBD	Binding	[0]	['root']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	Prf1	_	_	NN	Protein	[2]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	Gzmb	_	_	NN	Protein	[2]	['Theme']	_	_
8	transcription	_	_	NN	Entity	[10]	['multitoken']	_	_
9	start	_	_	NN	Entity	[10]	['multitoken']	_	_
10	sites	_	_	NNS	Entity	[2]	['Site']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	TSS	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	;	_	_	:	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	known	_	_	JJ	O	[-1]	['none']	_	_
18	IL-2	_	_	NN	O	[-1]	['none']	_	_
19	responsive	_	_	JJ	O	[-1]	['none']	_	_
20	enhancer	_	_	NN	O	[-1]	['none']	_	_
21	located	_	_	JJ	O	[-1]	['none']	_	_
22	near	_	_	IN	O	[-1]	['none']	_	_
23	-1	_	_	CD	O	[-1]	['none']	_	_
24	kb	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	Prf1	_	_	NN	Protein	[0]	['root']	_	_
28	gene	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	23	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	;	_	_	:	O	[-1]	['none']	_	_
33	to	_	_	TO	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	distal	_	_	JJ	O	[-1]	['none']	_	_
36	CTL	_	_	NN	O	[-1]	['none']	_	_
37	specific	_	_	JJ	O	[-1]	['none']	_	_
38	DNase	_	_	NN	O	[-1]	['none']	_	_
39	I	_	_	CD	O	[-1]	['none']	_	_
40	hypersensitive	_	_	JJ	O	[-1]	['none']	_	_
41	site	_	_	NN	O	[-1]	['none']	_	_
42	9	_	_	CD	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	Prf1	_	_	NN	Protein	[0]	['root']	_	_
46	locus	_	_	NN	O	[-1]	['none']	_	_
47	(	_	_	-LRB-	O	[-1]	['none']	_	_
48	24	_	_	CD	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	;	_	_	:	O	[-1]	['none']	_	_
51	to	_	_	TO	O	[-1]	['none']	_	_
52	the	_	_	DT	O	[-1]	['none']	_	_
53	Ifng	_	_	NN	Protein	[0]	['root']	_	_
54	promoter	_	_	NN	O	[-1]	['none']	_	_
55	near	_	_	IN	O	[-1]	['none']	_	_
56	the	_	_	DT	O	[-1]	['none']	_	_
57	TSS	_	_	NNP	O	[-1]	['none']	_	_
58	,	_	_	,	O	[-1]	['none']	_	_
59	as	_	_	IN	O	[-1]	['none']	_	_
60	previously	_	_	RB	O	[-1]	['none']	_	_
61	reported	_	_	VBN	O	[-1]	['none']	_	_
62	for	_	_	IN	O	[-1]	['none']	_	_
63	Th1	_	_	NN	O	[-1]	['none']	_	_
64	cells	_	_	NNS	O	[-1]	['none']	_	_
65	(	_	_	-LRB-	O	[-1]	['none']	_	_
66	10	_	_	CD	O	[-1]	['none']	_	_
67	)	_	_	-RRB-	O	[-1]	['none']	_	_
68	;	_	_	:	O	[-1]	['none']	_	_
69	and	_	_	CC	O	[-1]	['none']	_	_
70	to	_	_	TO	O	[-1]	['none']	_	_
71	several	_	_	JJ	O	[-1]	['none']	_	_
72	DNase	_	_	NN	O	[-1]	['none']	_	_
73	I	_	_	CD	O	[-1]	['none']	_	_
74	hypersensitive	_	_	JJ	O	[-1]	['none']	_	_
75	sites	_	_	NNS	O	[-1]	['none']	_	_
76	in	_	_	IN	O	[-1]	['none']	_	_
77	the	_	_	DT	O	[-1]	['none']	_	_
78	Ifng	_	_	NN	Protein	[0]	['root']	_	_
79	locus	_	_	NN	O	[-1]	['none']	_	_
80	(	_	_	-LRB-	O	[-1]	['none']	_	_
81	25	_	_	CD	O	[-1]	['none']	_	_
82	)	_	_	-RRB-	O	[-1]	['none']	_	_
83	.	_	_	.	O	[-1]	['none']	_	_

1	Eomes	_	_	NNS	Protein	[2, 20, 43]	['Theme', 'Theme', 'Theme']	_	_
2	bound	_	_	VBD	Binding	[0]	['root']	_	_
3	primarily	_	_	RB	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	Prf1	_	_	NN	Protein	[2]	['Theme']	_	_
7	TSS	_	_	NN	Entity	[2]	['Site']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	-1	_	_	CD	Entity	[12]	['multitoken']	_	_
11	kb	_	_	NN	Entity	[12]	['multitoken']	_	_
12	enhancer	_	_	NN	Entity	[2]	['Site']	_	_
13	;	_	_	:	O	[-1]	['none']	_	_
14	this	_	_	DT	O	[-1]	['none']	_	_
15	binding	_	_	NN	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	substantially	_	_	RB	O	[-1]	['none']	_	_
18	greater	_	_	JJR	O	[-1]	['none']	_	_
19	than	_	_	IN	O	[-1]	['none']	_	_
20	that	_	_	DT	Binding	[0]	['root']	_	_
21	observed	_	_	VBN	O	[-1]	['none']	_	_
22	at	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	promoter	_	_	NN	Entity	[20, 33]	['Site', 'Site']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	Il2rb	_	_	NN	Protein	[20, 33]	['Theme', 'Theme']	_	_
28	gene	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	known	_	_	JJ	O	[-1]	['none']	_	_
32	direct	_	_	JJ	O	[-1]	['none']	_	_
33	target	_	_	NN	Binding	[0]	['root']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	Eomes	_	_	NNP	Protein	[33]	['Theme']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	8	_	_	CD	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	comparable	_	_	JJ	O	[-1]	['none']	_	_
42	to	_	_	TO	O	[-1]	['none']	_	_
43	that	_	_	DT	Binding	[0]	['root']	_	_
44	observed	_	_	VBN	O	[-1]	['none']	_	_
45	at	_	_	IN	O	[-1]	['none']	_	_
46	the	_	_	DT	O	[-1]	['none']	_	_
47	Ifng	_	_	NNP	Protein	[43, 52]	['Theme', 'Theme']	_	_
48	TSS	_	_	NNP	Entity	[43, 52]	['Site', 'Site']	_	_
49	,	_	_	,	O	[-1]	['none']	_	_
50	a	_	_	DT	O	[-1]	['none']	_	_
51	known	_	_	JJ	O	[-1]	['none']	_	_
52	target	_	_	NN	Binding	[0]	['root']	_	_
53	of	_	_	IN	O	[-1]	['none']	_	_
54	T-box	_	_	JJ	O	[-1]	['none']	_	_
55	proteins	_	_	NNS	O	[-1]	['none']	_	_
56	in	_	_	IN	O	[-1]	['none']	_	_
57	both	_	_	DT	O	[-1]	['none']	_	_
58	Th1	_	_	NN	O	[-1]	['none']	_	_
59	and	_	_	CC	O	[-1]	['none']	_	_
60	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
61	T	_	_	NN	O	[-1]	['none']	_	_
62	cells	_	_	NNS	O	[-1]	['none']	_	_
63	(	_	_	-LRB-	O	[-1]	['none']	_	_
64	17	_	_	CD	O	[-1]	['none']	_	_
65	)	_	_	-RRB-	O	[-1]	['none']	_	_
66	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	Runx3	_	_	NN	Protein	[14]	['Cause']	_	_
5	controlled	_	_	VBD	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	expression	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	CTL	_	_	NN	O	[-1]	['none']	_	_
10	effector	_	_	NN	O	[-1]	['none']	_	_
11	genes	_	_	NNS	O	[-1]	['none']	_	_
12	through	_	_	IN	O	[-1]	['none']	_	_
13	its	_	_	PRP$	O	[-1]	['none']	_	_
14	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	Eomes	_	_	NNS	Protein	[14]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	we	_	_	PRP	O	[-1]	['none']	_	_
19	retrovirally	_	_	RB	O	[-1]	['none']	_	_
20	expressed	_	_	VBD	Gene_expression	[0]	['root']	_	_
21	Runx3	_	_	NN	Protein	[20]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	Eo-VP16	_	_	NN	Protein	[20]	['Theme']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
26	T	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	from	_	_	IN	O	[-1]	['none']	_	_
29	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
30	mice	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Because	_	_	IN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	limited	_	_	JJ	O	[-1]	['none']	_	_
5	number	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
8	T	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	these	_	_	DT	O	[-1]	['none']	_	_
12	mice	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	because	_	_	IN	O	[-1]	['none']	_	_
16	we	_	_	PRP	O	[-1]	['none']	_	_
17	saw	_	_	VBD	O	[-1]	['none']	_	_
18	no	_	_	DT	O	[-1]	['none']	_	_
19	difference	_	_	NN	O	[-1]	['none']	_	_
20	between	_	_	IN	O	[-1]	['none']	_	_
21	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
22	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
23	CD4-	_	_	JJ	Protein	[0]	['root']	_	_
24	SP	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
27	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
28	DP	_	_	NN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	our	_	_	PRP$	O	[-1]	['none']	_	_
32	previous	_	_	JJ	O	[-1]	['none']	_	_
33	experiments	_	_	NNS	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	we	_	_	PRP	O	[-1]	['none']	_	_
36	used	_	_	VBD	O	[-1]	['none']	_	_
37	total	_	_	JJ	O	[-1]	['none']	_	_
38	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
39	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
40	T	_	_	NN	O	[-1]	['none']	_	_
41	cells	_	_	NNS	O	[-1]	['none']	_	_
42	without	_	_	IN	O	[-1]	['none']	_	_
43	further	_	_	JJ	O	[-1]	['none']	_	_
44	fractionation	_	_	NN	O	[-1]	['none']	_	_
45	as	_	_	IN	O	[-1]	['none']	_	_
46	recipients	_	_	NNS	O	[-1]	['none']	_	_
47	for	_	_	IN	O	[-1]	['none']	_	_
48	retroviral	_	_	JJ	O	[-1]	['none']	_	_
49	transduction	_	_	NN	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	Reconstitution	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
4	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	Runx3	_	_	NN	Protein	[9]	['Cause']	_	_
9	restored	_	_	VBD	Positive_regulation	[0]	['root']	_	_
10	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	Eomes	_	_	NNS	Protein	[10]	['Theme']	_	_
13	as	_	_	RB	O	[-1]	['none']	_	_
14	well	_	_	RB	O	[-1]	['none']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	perforin	_	_	NN	Protein	[10]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	granzyme	_	_	NN	Protein	[19]	['multitoken']	_	_
19	B	_	_	NN	Protein	[10]	['Theme']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	IFN-gamma	_	_	NN	Protein	[10]	['Theme']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	showed	_	_	VBD	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	compensatory	_	_	JJ	O	[-1]	['none']	_	_
10	up-regulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	Runx1	_	_	NN	Protein	[10, 16]	['Theme', 'Theme']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	which	_	_	WDT	Anaphora	[0]	['root']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	suppressed	_	_	VBN	Negative_regulation	[0]	['root']	_	_
17	upon	_	_	IN	O	[-1]	['none']	_	_
18	reconstitution	_	_	NN	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	Runx3	_	_	NN	Protein	[16]	['Cause']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	indicating	_	_	VBG	O	[-1]	['none']	_	_
23	that	_	_	IN	O	[-1]	['none']	_	_
24	Runx1	_	_	NN	Protein	[29]	['Theme']	_	_
25	is	_	_	VBZ	O	[-1]	['none']	_	_
26	a	_	_	DT	O	[-1]	['none']	_	_
27	target	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	repression	_	_	NN	Negative_regulation	[0]	['root']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	Runx3	_	_	NN	Protein	[29]	['Cause']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Notably	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Eo-VP16	_	_	NN	Protein	[6, 10, 18]	['Cause', 'Theme', 'Cause']	_	_
4	did	_	_	VBD	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	up-regulate	_	_	VB	Positive_regulation	[0]	['root']	_	_
7	perforin	_	_	NN	Protein	[8]	['Theme']	_	_
8	expression	_	_	NN	Gene_expression	[6]	['Theme']	_	_
9	when	_	_	WRB	O	[-1]	['none']	_	_
10	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	even	_	_	RB	O	[-1]	['none']	_	_
16	though	_	_	IN	O	[-1]	['none']	_	_
17	it	_	_	PRP	Anaphora	[0]	['root']	_	_
18	restored	_	_	VBD	Positive_regulation	[0]	['root']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	capacity	_	_	NN	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	induce	_	_	VB	Positive_regulation	[18]	['Theme']	_	_
23	IFN-gamma	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[22]	['Theme']	_	_
25	upon	_	_	IN	O	[-1]	['none']	_	_
26	TCR	_	_	NN	O	[-1]	['none']	_	_
27	restimulation	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	result	_	_	NN	O	[-1]	['none']	_	_
3	suggests	_	_	VBZ	O	[-1]	['none']	_	_
4	strongly	_	_	RB	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	perforin	_	_	NN	Protein	[7]	['Theme']	_	_
7	expression	_	_	NN	Gene_expression	[8]	['Theme']	_	_
8	requires	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
9	Runx3	_	_	NN	Protein	[8]	['Cause']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	Eomes	_	_	NNS	Protein	[8]	['Cause']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	their	_	_	PRP$	Anaphora	[0]	['root']	_	_
5	defect	_	_	NN	Positive_regulation	[0]	['root']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	perforin	_	_	NN	Protein	[11]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	granzyme	_	_	NN	Protein	[10]	['multitoken']	_	_
10	B	_	_	NN	Protein	[11]	['Theme']	_	_
11	expression	_	_	NN	Gene_expression	[5]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
14	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
15	T	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	showed	_	_	VBD	O	[-1]	['none']	_	_
18	defective	_	_	JJ	O	[-1]	['none']	_	_
19	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
20	activity	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	mixed	_	_	JJ	O	[-1]	['none']	_	_
24	lymphocyte	_	_	NN	O	[-1]	['none']	_	_
25	reaction	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	12	_	_	CD	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	TCR	_	_	NN	O	[-1]	['none']	_	_
4	stimulated	_	_	VBD	O	[-1]	['none']	_	_
5	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
6	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	as	_	_	RB	O	[-1]	['none']	_	_
10	effective	_	_	JJ	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	WT	_	_	JJ	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	killing	_	_	VBG	O	[-1]	['none']	_	_
16	tumor	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	redirected	_	_	JJ	O	[-1]	['none']	_	_
21	CTL	_	_	NN	O	[-1]	['none']	_	_
22	assay	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	12	_	_	CD	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	peritoneal	_	_	JJ	O	[-1]	['none']	_	_
8	cavity	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
11	mice	_	_	NNS	O	[-1]	['none']	_	_
12	immunized	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	certain	_	_	JJ	O	[-1]	['none']	_	_
15	tumor	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	effectively	_	_	RB	O	[-1]	['none']	_	_
18	killed	_	_	VBD	O	[-1]	['none']	_	_
19	these	_	_	DT	O	[-1]	['none']	_	_
20	targets	_	_	NNS	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	13	_	_	CD	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	although	_	_	IN	O	[-1]	['none']	_	_
4	activation	_	_	NN	Positive_regulation	[13]	['Theme']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	perforin	_	_	NN	Protein	[4]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	granzyme	_	_	NN	Protein	[10]	['multitoken']	_	_
10	B	_	_	NN	Protein	[4]	['Theme']	_	_
11	machinery	_	_	NN	O	[-1]	['none']	_	_
12	is	_	_	VBZ	O	[-1]	['none']	_	_
13	defective	_	_	JJ	Negative_regulation	[0]	['root']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
16	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	these	_	_	DT	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	are	_	_	VBP	O	[-1]	['none']	_	_
22	not	_	_	RB	O	[-1]	['none']	_	_
23	entirely	_	_	RB	O	[-1]	['none']	_	_
24	devoid	_	_	JJ	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
27	activity	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	could	_	_	MD	O	[-1]	['none']	_	_
30	still	_	_	RB	O	[-1]	['none']	_	_
31	effectively	_	_	RB	O	[-1]	['none']	_	_
32	kill	_	_	VB	O	[-1]	['none']	_	_
33	targets	_	_	NNS	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	possibly	_	_	RB	O	[-1]	['none']	_	_
36	by	_	_	IN	O	[-1]	['none']	_	_
37	alternative	_	_	JJ	O	[-1]	['none']	_	_
38	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
39	such	_	_	JJ	O	[-1]	['none']	_	_
40	as	_	_	IN	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	Fas-Fas	_	_	JJ	Protein	[43]	['multitoken']	_	_
43	ligand	_	_	NN	Protein	[0]	['root']	_	_
44	pathway	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	p65	_	_	NN	Protein	[0]	['root']	_	_
3	Ser276	_	_	NN	O	[-1]	['none']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	essential	_	_	JJ	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	regulating	_	_	VBG	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	activity	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Raw	_	_	NN	O	[-1]	['none']	_	_
5	264.7	_	_	CD	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	line	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	transiently	_	_	RB	O	[-1]	['none']	_	_
10	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
13	along	_	_	IN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	empty	_	_	JJ	O	[-1]	['none']	_	_
16	vector	_	_	NN	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	plasmid	_	_	NN	O	[-1]	['none']	_	_
19	encoding	_	_	VBG	O	[-1]	['none']	_	_
20	either	_	_	CC	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	p65	_	_	NN	Protein	[10]	['Theme']	_	_
23	WT	_	_	NN	O	[-1]	['none']	_	_
24	or	_	_	CC	O	[-1]	['none']	_	_
25	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
26	p65	_	_	NN	Protein	[10]	['Theme']	_	_
27	276S/A	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	transfected	_	_	VBN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	18-24	_	_	CD	O	[-1]	['none']	_	_
7	hours	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	serum	_	_	NN	O	[-1]	['none']	_	_
10	starved	_	_	VBN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	4	_	_	CD	O	[-1]	['none']	_	_
13	hours	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	then	_	_	RB	O	[-1]	['none']	_	_
17	incubated	_	_	VBN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	10	_	_	CD	O	[-1]	['none']	_	_
20	microM	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
23	for	_	_	IN	O	[-1]	['none']	_	_
24	30	_	_	CD	O	[-1]	['none']	_	_
25	minutes	_	_	NNS	O	[-1]	['none']	_	_
26	prior	_	_	RB	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	treatment	_	_	NN	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	100	_	_	CD	O	[-1]	['none']	_	_
31	ng/ml	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	M-CSF	_	_	NN	O	[-1]	['none']	_	_
34	for	_	_	IN	O	[-1]	['none']	_	_
35	2	_	_	CD	O	[-1]	['none']	_	_
36	hours	_	_	NNS	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	SEAP	_	_	NN	O	[-1]	['none']	_	_
39	secretion	_	_	NN	O	[-1]	['none']	_	_
40	in	_	_	IN	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	medium	_	_	NN	O	[-1]	['none']	_	_
43	was	_	_	VBD	O	[-1]	['none']	_	_
44	measured	_	_	VBN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	p65-/-	_	_	JJ	Protein	[0]	['root']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	line	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	transiently	_	_	RB	O	[-1]	['none']	_	_
10	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
13	along	_	_	IN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	empty	_	_	JJ	O	[-1]	['none']	_	_
16	vector	_	_	NN	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	plasmid	_	_	NN	O	[-1]	['none']	_	_
19	encoding	_	_	VBG	O	[-1]	['none']	_	_
20	either	_	_	CC	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	p65	_	_	NN	Protein	[10]	['Theme']	_	_
23	WT	_	_	NNP	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
26	p65	_	_	NN	Protein	[10]	['Theme']	_	_
27	276S/A	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	or	_	_	CC	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	p65	_	_	NN	Protein	[10]	['Theme']	_	_
32	536S/A	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	cultured	_	_	VBN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	24	_	_	CD	O	[-1]	['none']	_	_
7	hours	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	then	_	_	RB	O	[-1]	['none']	_	_
10	serum	_	_	NN	O	[-1]	['none']	_	_
11	starved	_	_	VBN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	4	_	_	CD	O	[-1]	['none']	_	_
14	hours	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	then	_	_	RB	O	[-1]	['none']	_	_
4	incubated	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	fresh	_	_	JJ	O	[-1]	['none']	_	_
7	DMEM	_	_	NN	O	[-1]	['none']	_	_
8	medium	_	_	NN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	2	_	_	CD	O	[-1]	['none']	_	_
11	hours	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	SEAP	_	_	NN	O	[-1]	['none']	_	_
14	secretion	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	medium	_	_	NN	O	[-1]	['none']	_	_
18	was	_	_	VBD	O	[-1]	['none']	_	_
19	measured	_	_	VBN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	shown	_	_	VBN	O	[-1]	['none']	_	_
4	are	_	_	VBP	O	[-1]	['none']	_	_
5	fold	_	_	JJ	O	[-1]	['none']	_	_
6	change	_	_	NN	O	[-1]	['none']	_	_
7	over	_	_	IN	O	[-1]	['none']	_	_
8	empty	_	_	JJ	O	[-1]	['none']	_	_
9	vector	_	_	NN	O	[-1]	['none']	_	_
10	+	_	_	CC	O	[-1]	['none']	_	_
11	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	p65-/-	_	_	JJ	Protein	[0]	['root']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	line	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	transiently	_	_	RB	O	[-1]	['none']	_	_
10	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	either	_	_	CC	O	[-1]	['none']	_	_
15	empty	_	_	JJ	O	[-1]	['none']	_	_
16	vector	_	_	NN	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	plasmid	_	_	NN	O	[-1]	['none']	_	_
19	encoding	_	_	VBG	O	[-1]	['none']	_	_
20	either	_	_	CC	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	p65	_	_	NN	Protein	[10]	['Theme']	_	_
23	WT	_	_	NN	O	[-1]	['none']	_	_
24	or	_	_	CC	O	[-1]	['none']	_	_
25	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
26	p65	_	_	NN	Protein	[10]	['Theme']	_	_
27	276S/A	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	transfected	_	_	VBN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	24	_	_	CD	O	[-1]	['none']	_	_
7	hours	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	serum	_	_	NN	O	[-1]	['none']	_	_
10	starved	_	_	VBN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	4	_	_	CD	O	[-1]	['none']	_	_
13	hours	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	then	_	_	RB	O	[-1]	['none']	_	_
17	incubated	_	_	VBN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	10	_	_	CD	O	[-1]	['none']	_	_
20	microM	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
23	for	_	_	IN	O	[-1]	['none']	_	_
24	30	_	_	CD	O	[-1]	['none']	_	_
25	minutes	_	_	NNS	O	[-1]	['none']	_	_
26	prior	_	_	RB	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	treatment	_	_	NN	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	10	_	_	CD	O	[-1]	['none']	_	_
31	ng/ml	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	supernatant	_	_	NN	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	collected	_	_	VBN	O	[-1]	['none']	_	_
5	after	_	_	IN	O	[-1]	['none']	_	_
6	2	_	_	CD	O	[-1]	['none']	_	_
7	hours	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	treatment	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	SEAP	_	_	NN	O	[-1]	['none']	_	_
12	secretion	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	medium	_	_	NN	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	measured	_	_	VBN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	shown	_	_	VBN	O	[-1]	['none']	_	_
4	are	_	_	VBP	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	fold	_	_	JJ	O	[-1]	['none']	_	_
7	change	_	_	NN	O	[-1]	['none']	_	_
8	over	_	_	IN	O	[-1]	['none']	_	_
9	empty	_	_	JJ	O	[-1]	['none']	_	_
10	vector	_	_	NN	O	[-1]	['none']	_	_
11	+	_	_	CC	O	[-1]	['none']	_	_
12	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	mean	_	_	NN	O	[-1]	['none']	_	_
5	+/-	_	_	CC	O	[-1]	['none']	_	_
6	S.E.M	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	least	_	_	JJS	O	[-1]	['none']	_	_
10	three	_	_	CD	O	[-1]	['none']	_	_
11	independent	_	_	JJ	O	[-1]	['none']	_	_
12	experiments	_	_	NNS	O	[-1]	['none']	_	_
13	performed	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	duplicate	_	_	VB	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	Production	_	_	NN	Gene_expression	[4]	['Theme']	_	_
3	Is	_	_	VBZ	O	[-1]	['none']	_	_
4	Maintained	_	_	VBN	Positive_regulation	[0]	['root']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	High	_	_	JJ	O	[-1]	['none']	_	_
7	TCR	_	_	NN	O	[-1]	['none']	_	_
8	Signal	_	_	NN	O	[-1]	['none']	_	_
9	Strength	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	IL-12	_	_	NN	Protein	[4]	['Cause']	_	_
12	We	_	_	PRP	O	[-1]	['none']	_	_
13	next	_	_	RB	O	[-1]	['none']	_	_
14	investigated	_	_	VBD	O	[-1]	['none']	_	_
15	whether	_	_	IN	O	[-1]	['none']	_	_
16	repeated	_	_	VBN	O	[-1]	['none']	_	_
17	strong	_	_	JJ	O	[-1]	['none']	_	_
18	TCR	_	_	NN	O	[-1]	['none']	_	_
19	activation	_	_	NN	O	[-1]	['none']	_	_
20	is	_	_	VBZ	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	compensatory	_	_	JJ	O	[-1]	['none']	_	_
23	signal	_	_	NN	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	IL-12-induced	_	_	JJ	Protein	[0]	['root']	_	_
26	STAT4	_	_	NN	Protein	[0]	['root']	_	_
27	signaling	_	_	NN	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	IL-10	_	_	NN	Protein	[30]	['Theme']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	Th1	_	_	NN	O	[-1]	['none']	_	_
35	cells	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	differentiated	_	_	VBN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	2	_	_	CD	O	[-1]	['none']	_	_
11	consecutive	_	_	JJ	O	[-1]	['none']	_	_
12	weeks	_	_	NNS	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	high	_	_	JJ	O	[-1]	['none']	_	_
15	antigen	_	_	NN	O	[-1]	['none']	_	_
16	doses	_	_	NNS	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	presence	_	_	NN	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	absence	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IL-12	_	_	NN	Protein	[0]	['root']	_	_
24	throughout	_	_	IN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	High	_	_	JJ	O	[-1]	['none']	_	_
2	antigen	_	_	NN	O	[-1]	['none']	_	_
3	dose	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	IL-12	_	_	NN	Protein	[8]	['Cause']	_	_
6	cooperated	_	_	VBD	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
9	maximal	_	_	JJ	O	[-1]	['none']	_	_
10	IL-10	_	_	NN	Protein	[11]	['Theme']	_	_
11	production	_	_	NN	Gene_expression	[8]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	given	_	_	VBN	O	[-1]	['none']	_	_
14	that	_	_	IN	O	[-1]	['none']	_	_
15	this	_	_	DT	O	[-1]	['none']	_	_
16	combination	_	_	NN	O	[-1]	['none']	_	_
17	resulted	_	_	VBD	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	highest	_	_	JJS	O	[-1]	['none']	_	_
21	numbers	_	_	NNS	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
24	Th1	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Repeated	_	_	VBN	O	[-1]	['none']	_	_
2	high	_	_	JJ	O	[-1]	['none']	_	_
3	antigen	_	_	NN	O	[-1]	['none']	_	_
4	dose	_	_	NN	O	[-1]	['none']	_	_
5	stimulation	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	absence	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	exogenously	_	_	RB	O	[-1]	['none']	_	_
11	added	_	_	VBN	O	[-1]	['none']	_	_
12	IL-12	_	_	NN	Protein	[0]	['root']	_	_
13	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	production	_	_	NN	Gene_expression	[13]	['Theme']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IL-10	_	_	NN	Protein	[16]	['Theme']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	Th1	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	suggesting	_	_	VBG	O	[-1]	['none']	_	_
24	that	_	_	IN	O	[-1]	['none']	_	_
25	repeated	_	_	VBN	O	[-1]	['none']	_	_
26	strong	_	_	JJ	O	[-1]	['none']	_	_
27	TCR	_	_	NN	O	[-1]	['none']	_	_
28	triggering	_	_	NN	O	[-1]	['none']	_	_
29	may	_	_	MD	O	[-1]	['none']	_	_
30	overcome	_	_	VB	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	need	_	_	NN	Positive_regulation	[0]	['root']	_	_
33	for	_	_	IN	O	[-1]	['none']	_	_
34	IL-12	_	_	NN	Protein	[32]	['Cause']	_	_
35	for	_	_	IN	O	[-1]	['none']	_	_
36	IL-10	_	_	NN	Protein	[37]	['Theme']	_	_
37	induction	_	_	NN	Positive_regulation	[32]	['Theme']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL-10	_	_	NN	Protein	[4]	['Theme']	_	_
4	induction	_	_	NN	Positive_regulation	[9]	['Theme']	_	_
5	under	_	_	IN	O	[-1]	['none']	_	_
6	these	_	_	DT	O	[-1]	['none']	_	_
7	conditions	_	_	NNS	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	abrogated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
10	when	_	_	WRB	O	[-1]	['none']	_	_
11	IL-12p40-deficient	_	_	JJ	Negative_regulation	[9]	['Cause']	_	_
12	DCs	_	_	NNS	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	used	_	_	VBN	O	[-1]	['none']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	APCs	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL-12	_	_	NN	Protein	[5]	['Cause']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	essential	_	_	JJ	Positive_regulation	[0]	['root']	_	_
6	during	_	_	IN	O	[-1]	['none']	_	_
7	both	_	_	DT	O	[-1]	['none']	_	_
8	primary	_	_	JJ	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	secondary	_	_	JJ	O	[-1]	['none']	_	_
11	antigenic	_	_	JJ	O	[-1]	['none']	_	_
12	stimulation	_	_	NN	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	production	_	_	NN	Gene_expression	[5]	['Theme']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IL-10	_	_	NN	Protein	[14]	['Theme']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	Th1	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	requirements	_	_	NNS	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	stability	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	we	_	_	PRP	O	[-1]	['none']	_	_
14	differentiated	_	_	VBD	O	[-1]	['none']	_	_
15	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
16	T	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	1	_	_	CD	O	[-1]	['none']	_	_
20	week	_	_	NN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	high	_	_	JJ	O	[-1]	['none']	_	_
23	antigen	_	_	NN	O	[-1]	['none']	_	_
24	doses	_	_	NNS	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	or	_	_	CC	O	[-1]	['none']	_	_
27	without	_	_	IN	O	[-1]	['none']	_	_
28	IL-12	_	_	NN	Protein	[0]	['root']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	washed	_	_	VBD	O	[-1]	['none']	_	_
31	them	_	_	PRP	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	then	_	_	RB	O	[-1]	['none']	_	_
35	restimulated	_	_	VBD	O	[-1]	['none']	_	_
36	them	_	_	PRP	O	[-1]	['none']	_	_
37	for	_	_	IN	O	[-1]	['none']	_	_
38	an	_	_	DT	O	[-1]	['none']	_	_
39	additional	_	_	JJ	O	[-1]	['none']	_	_
40	week	_	_	NN	O	[-1]	['none']	_	_
41	with	_	_	IN	O	[-1]	['none']	_	_
42	a	_	_	DT	O	[-1]	['none']	_	_
43	low	_	_	JJ	O	[-1]	['none']	_	_
44	antigen	_	_	NN	O	[-1]	['none']	_	_
45	dose	_	_	NN	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	in	_	_	IN	O	[-1]	['none']	_	_
48	the	_	_	DT	O	[-1]	['none']	_	_
49	absence	_	_	NN	O	[-1]	['none']	_	_
50	or	_	_	CC	O	[-1]	['none']	_	_
51	presence	_	_	NN	O	[-1]	['none']	_	_
52	of	_	_	IN	O	[-1]	['none']	_	_
53	IL-12	_	_	NN	Protein	[0]	['root']	_	_
54	.	_	_	.	O	[-1]	['none']	_	_

1	Th1	_	_	NN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	first	_	_	JJ	O	[-1]	['none']	_	_
7	week	_	_	NN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	produce	_	_	VB	Gene_expression	[3]	['Theme']	_	_
10	IL-10	_	_	NN	Protein	[9]	['Theme']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	culture	_	_	NN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	high	_	_	JJ	O	[-1]	['none']	_	_
15	antigen	_	_	NN	O	[-1]	['none']	_	_
16	doses	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	IL-12	_	_	NN	Protein	[3]	['Cause']	_	_
19	lost	_	_	VBD	Negative_regulation	[36]	['Theme']	_	_
20	their	_	_	PRP$	O	[-1]	['none']	_	_
21	ability	_	_	NN	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	express	_	_	VB	Gene_expression	[19]	['Theme']	_	_
24	IL-10	_	_	NN	Protein	[23]	['Theme']	_	_
25	when	_	_	WRB	O	[-1]	['none']	_	_
26	recultured	_	_	VBN	O	[-1]	['none']	_	_
27	with	_	_	IN	O	[-1]	['none']	_	_
28	low	_	_	JJ	O	[-1]	['none']	_	_
29	doses	_	_	NNS	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	OVA	_	_	NNP	Protein	[19]	['Cause']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	which	_	_	WDT	O	[-1]	['none']	_	_
34	could	_	_	MD	O	[-1]	['none']	_	_
35	be	_	_	VB	O	[-1]	['none']	_	_
36	compensated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
37	for	_	_	IN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	some	_	_	DT	O	[-1]	['none']	_	_
41	extent	_	_	NN	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	by	_	_	IN	O	[-1]	['none']	_	_
44	addition	_	_	NN	Positive_regulation	[0]	['root']	_	_
45	of	_	_	IN	O	[-1]	['none']	_	_
46	IL-12	_	_	NN	Protein	[36, 44]	['Cause', 'Theme']	_	_
47	to	_	_	TO	O	[-1]	['none']	_	_
48	the	_	_	DT	O	[-1]	['none']	_	_
49	secondary	_	_	JJ	O	[-1]	['none']	_	_
50	cultures	_	_	NNS	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	again	_	_	RB	O	[-1]	['none']	_	_
53	suggesting	_	_	VBG	O	[-1]	['none']	_	_
54	that	_	_	IN	O	[-1]	['none']	_	_
55	antigen	_	_	NN	O	[-1]	['none']	_	_
56	dose	_	_	NN	O	[-1]	['none']	_	_
57	and	_	_	CC	O	[-1]	['none']	_	_
58	IL-12	_	_	NN	Protein	[0]	['root']	_	_
59	signals	_	_	NNS	O	[-1]	['none']	_	_
60	cooperate	_	_	VBP	Positive_regulation	[0]	['root']	_	_
61	for	_	_	IN	O	[-1]	['none']	_	_
62	the	_	_	DT	O	[-1]	['none']	_	_
63	induction	_	_	NN	Gene_expression	[60]	['Theme']	_	_
64	of	_	_	IN	O	[-1]	['none']	_	_
65	IL-10	_	_	NN	Protein	[63]	['Theme']	_	_
66	.	_	_	.	O	[-1]	['none']	_	_

1	Finally	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	DO11	_	_	NN	O	[-1]	['none']	_	_
4	.10	_	_	CD	O	[-1]	['none']	_	_
5	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	that	_	_	WDT	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	exposed	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	low	_	_	JJ	O	[-1]	['none']	_	_
12	doses	_	_	NNS	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	antigen	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	IL-12	_	_	NN	Protein	[0]	['root']	_	_
17	during	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	primary	_	_	JJ	O	[-1]	['none']	_	_
20	differentiation	_	_	NN	O	[-1]	['none']	_	_
21	phase	_	_	NN	O	[-1]	['none']	_	_
22	produced	_	_	VBD	Gene_expression	[0]	['root']	_	_
23	high	_	_	JJ	O	[-1]	['none']	_	_
24	amounts	_	_	NNS	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	IFN-gamma	_	_	NN	Protein	[22]	['Theme']	_	_
27	but	_	_	CC	O	[-1]	['none']	_	_
28	little	_	_	JJ	O	[-1]	['none']	_	_
29	IL-10	_	_	NN	Protein	[22]	['Theme']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	but	_	_	CC	O	[-1]	['none']	_	_
32	they	_	_	PRP	O	[-1]	['none']	_	_
33	could	_	_	MD	O	[-1]	['none']	_	_
34	be	_	_	VB	O	[-1]	['none']	_	_
35	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
36	to	_	_	TO	O	[-1]	['none']	_	_
37	produce	_	_	VB	Gene_expression	[35]	['Theme']	_	_
38	IL-10	_	_	NN	Protein	[37]	['Theme']	_	_
39	when	_	_	WRB	O	[-1]	['none']	_	_
40	both	_	_	DT	O	[-1]	['none']	_	_
41	high	_	_	JJ	O	[-1]	['none']	_	_
42	antigen	_	_	NN	O	[-1]	['none']	_	_
43	dose	_	_	NN	O	[-1]	['none']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	IL-12	_	_	NN	Protein	[35]	['Cause']	_	_
46	were	_	_	VBD	O	[-1]	['none']	_	_
47	present	_	_	JJ	O	[-1]	['none']	_	_
48	during	_	_	IN	O	[-1]	['none']	_	_
49	the	_	_	DT	O	[-1]	['none']	_	_
50	recall	_	_	NN	O	[-1]	['none']	_	_
51	phase	_	_	NN	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	high	_	_	JJ	O	[-1]	['none']	_	_
4	antigen	_	_	NN	O	[-1]	['none']	_	_
5	dose	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	IL-12	_	_	NN	Protein	[13]	['Cause']	_	_
8	are	_	_	VBP	O	[-1]	['none']	_	_
9	required	_	_	VBN	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	sustaining	_	_	VBG	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IL-10	_	_	NN	Protein	[16]	['Theme']	_	_
16	production	_	_	NN	Gene_expression	[13]	['Theme']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	Th1	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Somatic	_	_	JJ	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	gene	_	_	NN	O	[-1]	['none']	_	_
4	targeting	_	_	VBG	O	[-1]	['none']	_	_
5	The	_	_	DT	O	[-1]	['none']	_	_
6	generation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	HOIP	_	_	NN	Protein	[9]	['Theme']	_	_
9	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	accomplished	_	_	VBN	O	[-1]	['none']	_	_
13	using	_	_	VBG	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	homologous	_	_	JJ	O	[-1]	['none']	_	_
16	recombination	_	_	NN	O	[-1]	['none']	_	_
17	approach	_	_	NN	O	[-1]	['none']	_	_
18	described	_	_	VBD	O	[-1]	['none']	_	_
19	previously	_	_	RB	O	[-1]	['none']	_	_
20	[	_	_	CD	O	[-1]	['none']	_	_
21	7	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	8	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Segments	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Rnf31	_	_	NN	Protein	[0]	['root']	_	_
4	gene	_	_	NN	O	[-1]	['none']	_	_
5	sequence	_	_	NN	O	[-1]	['none']	_	_
6	used	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	targeting	_	_	VBG	O	[-1]	['none']	_	_
10	construct	_	_	NN	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	amplified	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	PCR	_	_	NN	O	[-1]	['none']	_	_
15	from	_	_	IN	O	[-1]	['none']	_	_
16	A20	_	_	NN	O	[-1]	['none']	_	_
17	.2	_	_	NN	O	[-1]	['none']	_	_
18	J	_	_	NN	O	[-1]	['none']	_	_
19	genomic	_	_	JJ	O	[-1]	['none']	_	_
20	DNA	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	oligonucleotide	_	_	NN	O	[-1]	['none']	_	_
3	primers	_	_	NNS	O	[-1]	['none']	_	_
4	used	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	generate	_	_	VB	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	5	_	_	CD	O	[-1]	['none']	_	_
9	'	_	_	''	O	[-1]	['none']	_	_
10	flank	_	_	JJ	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	1224	_	_	CD	O	[-1]	['none']	_	_
13	bp	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	5	_	_	CD	O	[-1]	['none']	_	_
17	'-ttttctagagcggtggcttaagtgaccc-3	_	_	NN	O	[-1]	['none']	_	_
18	'	_	_	''	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	5	_	_	CD	O	[-1]	['none']	_	_
21	'-tattctagatgcagcatctgagaaagcaagc-3	_	_	NN	O	[-1]	['none']	_	_
22	'	_	_	''	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	3	_	_	CD	O	[-1]	['none']	_	_
3	'	_	_	''	O	[-1]	['none']	_	_
4	flank	_	_	JJ	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	6032	_	_	CD	O	[-1]	['none']	_	_
7	bp	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	primers	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	5	_	_	CD	O	[-1]	['none']	_	_
12	'-aaaaccggtgtatgcttctttacgggagaaaaatattag-3	_	_	NN	O	[-1]	['none']	_	_
13	'	_	_	''	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	5	_	_	CD	O	[-1]	['none']	_	_
16	'-tataccggtatgaagccaaaggaacactgagag-3	_	_	NN	O	[-1]	['none']	_	_
17	'	_	_	''	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Restriction	_	_	NN	O	[-1]	['none']	_	_
2	endonuclease	_	_	NN	O	[-1]	['none']	_	_
3	sites	_	_	NNS	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	oligonucleotide	_	_	NN	O	[-1]	['none']	_	_
7	primers	_	_	NNS	O	[-1]	['none']	_	_
8	allowed	_	_	VBD	O	[-1]	['none']	_	_
9	insertion	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	PCR	_	_	NN	O	[-1]	['none']	_	_
13	products	_	_	NNS	O	[-1]	['none']	_	_
14	into	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	targeting	_	_	VBG	O	[-1]	['none']	_	_
17	vector	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	A20	_	_	NN	O	[-1]	['none']	_	_
2	.2	_	_	NN	O	[-1]	['none']	_	_
3	J	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	transfected	_	_	VBN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	electroporation	_	_	NN	O	[-1]	['none']	_	_
10	[	_	_	NN	O	[-1]	['none']	_	_
11	7	_	_	CD	O	[-1]	['none']	_	_
12	]	_	_	CD	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	targeting	_	_	VBG	O	[-1]	['none']	_	_
17	construct	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	subcloned	_	_	VBN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	medium	_	_	NN	O	[-1]	['none']	_	_
22	containing	_	_	VBG	O	[-1]	['none']	_	_
23	600	_	_	CD	O	[-1]	['none']	_	_
24	microg/ml	_	_	NN	O	[-1]	['none']	_	_
25	G418	_	_	NN	O	[-1]	['none']	_	_
26	sulfate	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Homologous	_	_	JJ	O	[-1]	['none']	_	_
2	recombination	_	_	NN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	G418	_	_	NN	O	[-1]	['none']	_	_
5	resistant	_	_	JJ	O	[-1]	['none']	_	_
6	clones	_	_	NNS	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	detected	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	PCR	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	genomic	_	_	JJ	O	[-1]	['none']	_	_
13	DNA	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	described	_	_	VBN	O	[-1]	['none']	_	_
17	[	_	_	NN	O	[-1]	['none']	_	_
18	7	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Oligonucleotide	_	_	NN	O	[-1]	['none']	_	_
2	primers	_	_	NNS	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	screening	_	_	NN	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	5	_	_	CD	O	[-1]	['none']	_	_
8	'-cttcctgatctcagctttaccgtcac-3	_	_	NN	O	[-1]	['none']	_	_
9	'	_	_	''	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	homologous	_	_	JJ	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	genomic	_	_	JJ	O	[-1]	['none']	_	_
14	sequence	_	_	NN	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	approximate	_	_	JJ	O	[-1]	['none']	_	_
17	position	_	_	NN	O	[-1]	['none']	_	_
18	noted	_	_	VBN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	Fig.	_	_	NN	O	[-1]	['none']	_	_
21	1	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	5	_	_	CD	O	[-1]	['none']	_	_
25	'-caatccatcttgttcagccat-3	_	_	NN	O	[-1]	['none']	_	_
26	'	_	_	''	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	homologous	_	_	JJ	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	sequence	_	_	NN	O	[-1]	['none']	_	_
31	in	_	_	IN	O	[-1]	['none']	_	_
32	NeoR	_	_	NN	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Clones	_	_	NNS	O	[-1]	['none']	_	_
2	in	_	_	IN	O	[-1]	['none']	_	_
3	which	_	_	WDT	O	[-1]	['none']	_	_
4	one	_	_	CD	O	[-1]	['none']	_	_
5	copy	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Rnf31	_	_	NN	Protein	[10]	['Theme']	_	_
8	had	_	_	VBD	O	[-1]	['none']	_	_
9	been	_	_	VBN	O	[-1]	['none']	_	_
10	disrupted	_	_	VBN	Negative_regulation	[0]	['root']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	transiently	_	_	RB	O	[-1]	['none']	_	_
13	transfected	_	_	VBN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	an	_	_	DT	O	[-1]	['none']	_	_
16	expression	_	_	NN	O	[-1]	['none']	_	_
17	plasmid	_	_	NN	O	[-1]	['none']	_	_
18	encoding	_	_	VBG	O	[-1]	['none']	_	_
19	Cre	_	_	NNP	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	order	_	_	NN	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	remove	_	_	VB	O	[-1]	['none']	_	_
25	NeoR	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	G418	_	_	NN	O	[-1]	['none']	_	_
2	sensitive	_	_	JJ	O	[-1]	['none']	_	_
3	subclones	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	subjected	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	second	_	_	JJ	O	[-1]	['none']	_	_
9	round	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	targeting	_	_	VBG	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	disrupt	_	_	VB	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	remaining	_	_	VBG	O	[-1]	['none']	_	_
16	copy	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	Rnf31	_	_	NN	Protein	[0]	['root']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	G418	_	_	NN	O	[-1]	['none']	_	_
2	resistant	_	_	JJ	O	[-1]	['none']	_	_
3	clones	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	tested	_	_	VBN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	homologous	_	_	JJ	O	[-1]	['none']	_	_
8	recombination	_	_	NN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	PCR	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	HOIP	_	_	NN	Protein	[14]	['Theme']	_	_
13	protein	_	_	NN	O	[-1]	['none']	_	_
14	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	Western	_	_	NN	O	[-1]	['none']	_	_
17	blot	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	culturing	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	transfection	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	stimulation	_	_	NN	O	[-1]	['none']	_	_
7	Jurkat	_	_	NN	O	[-1]	['none']	_	_
8	T-cells	_	_	NNS	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	wild	_	_	JJ	O	[-1]	['none']	_	_
11	type	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	TCR	_	_	NN	O	[-1]	['none']	_	_
14	deficient-	_	_	JJ	O	[-1]	['none']	_	_
15	TCR-/-)	_	_	NN	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	maintained	_	_	VBN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	90	_	_	CD	O	[-1]	['none']	_	_
20	%	_	_	NN	O	[-1]	['none']	_	_
21	RPMI	_	_	NN	O	[-1]	['none']	_	_
22	1640	_	_	CD	O	[-1]	['none']	_	_
23	medium	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	PAA	_	_	NN	O	[-1]	['none']	_	_
26	laboratories	_	_	NNS	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	Austria	_	_	NNP	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	1.5	_	_	CD	O	[-1]	['none']	_	_
32	mM	_	_	NN	O	[-1]	['none']	_	_
33	L-glutamine	_	_	NN	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	USA	_	_	NNP	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	10	_	_	CD	O	[-1]	['none']	_	_
41	%	_	_	NN	O	[-1]	['none']	_	_
42	foetal	_	_	JJ	O	[-1]	['none']	_	_
43	bovine	_	_	JJ	O	[-1]	['none']	_	_
44	serum	_	_	NN	O	[-1]	['none']	_	_
45	(	_	_	-LRB-	O	[-1]	['none']	_	_
46	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	USA	_	_	NNP	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	and	_	_	CC	O	[-1]	['none']	_	_
51	1	_	_	CD	O	[-1]	['none']	_	_
52	%	_	_	NN	O	[-1]	['none']	_	_
53	antibiotic-antimycotic	_	_	JJ	O	[-1]	['none']	_	_
54	(	_	_	-LRB-	O	[-1]	['none']	_	_
55	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	USA	_	_	NNP	O	[-1]	['none']	_	_
58	)	_	_	-RRB-	O	[-1]	['none']	_	_
59	and	_	_	CC	O	[-1]	['none']	_	_
60	incubated	_	_	VBN	O	[-1]	['none']	_	_
61	in	_	_	IN	O	[-1]	['none']	_	_
62	a	_	_	DT	O	[-1]	['none']	_	_
63	stable	_	_	JJ	O	[-1]	['none']	_	_
64	environment	_	_	NN	O	[-1]	['none']	_	_
65	of	_	_	IN	O	[-1]	['none']	_	_
66	5	_	_	CD	O	[-1]	['none']	_	_
67	%	_	_	NN	O	[-1]	['none']	_	_
68	CO2	_	_	NN	O	[-1]	['none']	_	_
69	at	_	_	IN	O	[-1]	['none']	_	_
70	37degreesC	_	_	NN	O	[-1]	['none']	_	_
71	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	1000	_	_	CD	O	[-1]	['none']	_	_
7	x	_	_	CC	O	[-1]	['none']	_	_
8	g	_	_	NN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	8	_	_	CD	O	[-1]	['none']	_	_
11	min	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	resuspended	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	fresh	_	_	JJ	O	[-1]	['none']	_	_
16	media	_	_	NNS	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	final	_	_	JJ	O	[-1]	['none']	_	_
20	cell	_	_	NN	O	[-1]	['none']	_	_
21	density	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	1.6	_	_	CD	O	[-1]	['none']	_	_
24	x	_	_	CC	O	[-1]	['none']	_	_
25	107	_	_	CD	O	[-1]	['none']	_	_
26	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	a	_	_	DT	O	[-1]	['none']	_	_
29	24-well	_	_	JJ	O	[-1]	['none']	_	_
30	plate	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Reporter	_	_	NN	O	[-1]	['none']	_	_
2	plasmid	_	_	NN	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	pNFkappaB-Luc	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	pAP1	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	PMA	_	_	NN	O	[-1]	['none']	_	_
9	)-TA-Luc	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	pNFkappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	internal	_	_	JJ	O	[-1]	['none']	_	_
15	control	_	_	NN	O	[-1]	['none']	_	_
16	plasmid	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	pRL	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	Promega	_	_	NNP	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	USA	_	_	NNP	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	lipofectamine	_	_	JJ	O	[-1]	['none']	_	_
27	2000	_	_	CD	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	USA	_	_	NNP	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	were	_	_	VBD	O	[-1]	['none']	_	_
34	added	_	_	VBN	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	each	_	_	DT	O	[-1]	['none']	_	_
37	well	_	_	RB	O	[-1]	['none']	_	_
38	at	_	_	IN	O	[-1]	['none']	_	_
39	0.54	_	_	CD	O	[-1]	['none']	_	_
40	mug	_	_	NN	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	well	_	_	RB	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	0.06	_	_	CD	O	[-1]	['none']	_	_
45	mug	_	_	NN	O	[-1]	['none']	_	_
46	and	_	_	CC	O	[-1]	['none']	_	_
47	well	_	_	RB	O	[-1]	['none']	_	_
48	and	_	_	CC	O	[-1]	['none']	_	_
49	1.5	_	_	CD	O	[-1]	['none']	_	_
50	mul	_	_	NN	O	[-1]	['none']	_	_
51	and	_	_	CC	O	[-1]	['none']	_	_
52	well	_	_	RB	O	[-1]	['none']	_	_
53	,	_	_	,	O	[-1]	['none']	_	_
54	respectively	_	_	RB	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	Initially	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	reporter	_	_	NN	O	[-1]	['none']	_	_
5	plasmid	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	pRL	_	_	NN	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	mixed	_	_	JJ	O	[-1]	['none']	_	_
10	separately	_	_	RB	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	OptiMEM	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Gibco	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	USA	_	_	NNP	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	5	_	_	CD	O	[-1]	['none']	_	_
3	min	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	incubation	_	_	NN	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	room	_	_	NN	O	[-1]	['none']	_	_
8	temperature	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	lipofectamine	_	_	NN	O	[-1]	['none']	_	_
11	2000	_	_	CD	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	added	_	_	VBN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	mixture	_	_	NN	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	incubated	_	_	VBN	O	[-1]	['none']	_	_
19	further	_	_	RB	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	20	_	_	CD	O	[-1]	['none']	_	_
22	min	_	_	NN	O	[-1]	['none']	_	_
23	at	_	_	IN	O	[-1]	['none']	_	_
24	room	_	_	NN	O	[-1]	['none']	_	_
25	temperature	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	transfection	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	allowed	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	proceed	_	_	VB	O	[-1]	['none']	_	_
7	overnight	_	_	JJ	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	37degreesC	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	after	_	_	IN	O	[-1]	['none']	_	_
12	which	_	_	WDT	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	media	_	_	NNS	O	[-1]	['none']	_	_
21	removed	_	_	VBD	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	fresh	_	_	JJ	O	[-1]	['none']	_	_
24	pre-warmed	_	_	JJ	O	[-1]	['none']	_	_
25	media	_	_	NNS	O	[-1]	['none']	_	_
26	added	_	_	VBD	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	pre-incubated	_	_	JJ	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	JNK	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	PKC	_	_	NN	O	[-1]	['none']	_	_
11	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	stimulated	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	24-well	_	_	JJ	O	[-1]	['none']	_	_
16	plates	_	_	NNS	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	different	_	_	JJ	O	[-1]	['none']	_	_
19	concentrations	_	_	NNS	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	PMA	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	HK	_	_	NNP	O	[-1]	['none']	_	_
24	E.	_	_	NNP	O	[-1]	['none']	_	_
25	coli	_	_	NN	O	[-1]	['none']	_	_
26	MG1655	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	Calcium	_	_	NN	O	[-1]	['none']	_	_
29	Ionophore	_	_	NN	O	[-1]	['none']	_	_
30	A23187	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	lysed	_	_	VBN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	luciferase	_	_	NN	Protein	[7]	['Theme']	_	_
7	activity	_	_	NN	Positive_regulation	[0]	['root']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	AP-1	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	measured	_	_	VBN	O	[-1]	['none']	_	_
15	using	_	_	VBG	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	Dual-Luciferase	_	_	NNP	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	R	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	reporter	_	_	NN	O	[-1]	['none']	_	_
22	assay	_	_	NN	O	[-1]	['none']	_	_
23	system	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	Promega	_	_	NNP	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	USA	_	_	NNP	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	according	_	_	VBG	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	manufacturer	_	_	NN	O	[-1]	['none']	_	_
33	's	_	_	POS	O	[-1]	['none']	_	_
34	instructions	_	_	NNS	O	[-1]	['none']	_	_
35	on	_	_	IN	O	[-1]	['none']	_	_
36	a	_	_	DT	O	[-1]	['none']	_	_
37	TD	_	_	NN	O	[-1]	['none']	_	_
38	20/20	_	_	CD	O	[-1]	['none']	_	_
39	luminometer	_	_	NN	O	[-1]	['none']	_	_
40	(	_	_	-LRB-	O	[-1]	['none']	_	_
41	Turner	_	_	NNP	O	[-1]	['none']	_	_
42	Designs	_	_	NNS	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	Sunnyvale	_	_	NNP	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	CA	_	_	NNP	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	Secreted	_	_	VBN	O	[-1]	['none']	_	_
2	alkaline	_	_	NN	O	[-1]	['none']	_	_
3	phosphatase	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	NFkappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	figure	_	_	NN	O	[-1]	['none']	_	_
8	4a	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	b	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	levels	_	_	NNS	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	measured	_	_	VBN	O	[-1]	['none']	_	_
15	using	_	_	VBG	O	[-1]	['none']	_	_
16	Great	_	_	JJ	O	[-1]	['none']	_	_
17	EscAPe	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	TM	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	SEAP	_	_	NNP	O	[-1]	['none']	_	_
22	Detection	_	_	NN	O	[-1]	['none']	_	_
23	Kit	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	Clontech	_	_	NNP	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	USA	_	_	NNP	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[0]	['root']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	T-box	_	_	NN	O	[-1]	['none']	_	_
4	factors	_	_	NNS	O	[-1]	['none']	_	_
5	control	_	_	VBP	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	complex	_	_	JJ	O	[-1]	['none']	_	_
8	program	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
11	regulation	_	_	NN	O	[-1]	['none']	_	_
12	during	_	_	IN	O	[-1]	['none']	_	_
13	CTL	_	_	NN	O	[-1]	['none']	_	_
14	differentiation	_	_	NN	O	[-1]	['none']	_	_
15	Collectively	_	_	RB	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	these	_	_	DT	O	[-1]	['none']	_	_
18	data	_	_	NNS	O	[-1]	['none']	_	_
19	provide	_	_	VBP	O	[-1]	['none']	_	_
20	evidence	_	_	NN	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	Runx3	_	_	NN	Protein	[0]	['root']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	together	_	_	RB	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	T-box	_	_	JJ	O	[-1]	['none']	_	_
27	factors	_	_	NNS	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	orchestrates	_	_	VBZ	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	complex	_	_	JJ	O	[-1]	['none']	_	_
32	program	_	_	NN	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
35	regulation	_	_	NN	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	differentiating	_	_	VBG	O	[-1]	['none']	_	_
38	CTL	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[3]	['Theme']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	present	_	_	JJ	Gene_expression	[0]	['root']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	naive	_	_	JJ	O	[-1]	['none']	_	_
6	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	before	_	_	IN	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	12	_	_	CD	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	Anaphora	[0]	['root']	_	_
2	represses	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
3	Runx1	_	_	NN	Protein	[2]	['Theme']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	has	_	_	VBZ	Positive_regulation	[8]	['multitoken']	_	_
6	a	_	_	DT	Positive_regulation	[8]	['multitoken']	_	_
7	positive	_	_	JJ	Positive_regulation	[8]	['multitoken']	_	_
8	role	_	_	NN	Positive_regulation	[0]	['root']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	induction	_	_	NN	Positive_regulation	[8]	['Theme']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Eomes	_	_	NNS	Protein	[11]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	granzyme	_	_	NN	Protein	[16]	['multitoken']	_	_
16	B	_	_	NN	Protein	[11]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	perforin	_	_	NN	Protein	[11]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	IFN-gamma	_	_	NN	Protein	[11]	['Theme']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[2, 18]	['Theme', 'Cause']	_	_
2	binds	_	_	VBZ	Binding	[0]	['root']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	promoters	_	_	NNS	Entity	[2]	['Site']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	putative	_	_	JJ	O	[-1]	['none']	_	_
7	regulatory	_	_	JJ	Entity	[8]	['multitoken']	_	_
8	regions	_	_	NNS	Entity	[2]	['Site']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	Anaphora	[13]	['multitoken']	_	_
11	latter	_	_	JJ	Anaphora	[13]	['multitoken']	_	_
12	three	_	_	CD	Anaphora	[13]	['multitoken']	_	_
13	genes	_	_	NNS	Anaphora	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	suggesting	_	_	VBG	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	direct	_	_	JJ	O	[-1]	['none']	_	_
18	effect	_	_	NN	Regulation	[0]	['root']	_	_
19	on	_	_	IN	O	[-1]	['none']	_	_
20	gene	_	_	NN	O	[-1]	['none']	_	_
21	expression	_	_	NN	Gene_expression	[18]	['Theme']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Additional	_	_	JJ	O	[-1]	['none']	_	_
2	experiments	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	needed	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	determine	_	_	VB	O	[-1]	['none']	_	_
7	whether	_	_	IN	O	[-1]	['none']	_	_
8	Eomes	_	_	NNP	Protein	[14]	['Theme']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	Runx1	_	_	NN	Protein	[14]	['Theme']	_	_
11	are	_	_	VBP	O	[-1]	['none']	_	_
12	also	_	_	RB	O	[-1]	['none']	_	_
13	direct	_	_	JJ	O	[-1]	['none']	_	_
14	target	_	_	NN	Binding	[0]	['root']	_	_
15	genes	_	_	NNS	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	Runx3	_	_	NN	Protein	[14]	['Theme']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Surprisingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Runx3	_	_	NN	Protein	[4]	['Cause']	_	_
4	contributed	_	_	VBD	Positive_regulation	[0]	['root']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	optimal	_	_	JJ	O	[-1]	['none']	_	_
8	expression	_	_	NN	Gene_expression	[4]	['Theme']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	TNF	_	_	NN	Protein	[8]	['Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	IL-2	_	_	NN	Protein	[8]	['Theme']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	IFN-gamma	_	_	NN	Protein	[8]	['Theme']	_	_
16	at	_	_	IN	O	[-1]	['none']	_	_
17	day	_	_	NN	O	[-1]	['none']	_	_
18	4	_	_	CD	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	TNF	_	_	NN	Protein	[7]	['Theme']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	IL-2	_	_	NN	Protein	[7]	['Theme']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	requirement	_	_	NN	Positive_regulation	[10]	['Theme']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	Runx3	_	_	NN	Protein	[7]	['Cause']	_	_
10	subsides	_	_	NNS	Negative_regulation	[0]	['root']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	day	_	_	NN	O	[-1]	['none']	_	_
13	6	_	_	CD	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	possibly	_	_	RB	O	[-1]	['none']	_	_
16	because	_	_	IN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	compensation	_	_	NN	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	Runx1	_	_	NN	Protein	[10, 24]	['Cause', 'Theme']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	which	_	_	WDT	O	[-1]	['none']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	derepressed	_	_	VBN	Negative_regulation	[0]	['root']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[5, 18]	['Cause', 'Cause']	_	_
2	continues	_	_	VBZ	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	be	_	_	VB	O	[-1]	['none']	_	_
5	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	IFN-gamma	_	_	NN	Protein	[8]	['Theme']	_	_
8	expression	_	_	NN	Gene_expression	[5]	['Theme']	_	_
9	even	_	_	RB	O	[-1]	['none']	_	_
10	at	_	_	IN	O	[-1]	['none']	_	_
11	day	_	_	NN	O	[-1]	['none']	_	_
12	6	_	_	CD	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	perhaps	_	_	RB	O	[-1]	['none']	_	_
15	because	_	_	IN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
18	role	_	_	NN	Regulation	[0]	['root']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	induction	_	_	NN	Positive_regulation	[18]	['Theme']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	Eomes	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[21]	['Theme']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	An	_	_	DT	O	[-1]	['none']	_	_
2	unexpected	_	_	JJ	O	[-1]	['none']	_	_
3	finding	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	two	_	_	CD	O	[-1]	['none']	_	_
8	T-box	_	_	JJ	O	[-1]	['none']	_	_
9	transcription	_	_	NN	O	[-1]	['none']	_	_
10	factors	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	T-bet	_	_	NN	Protein	[17]	['Theme']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	Eomes	_	_	NNS	Protein	[17]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	are	_	_	VBP	O	[-1]	['none']	_	_
17	up-regulated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	very	_	_	RB	O	[-1]	['none']	_	_
20	different	_	_	JJ	O	[-1]	['none']	_	_
21	kinetics	_	_	NNS	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
24	T	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	under	_	_	IN	O	[-1]	['none']	_	_
27	our	_	_	PRP$	O	[-1]	['none']	_	_
28	culture	_	_	NN	O	[-1]	['none']	_	_
29	conditions	_	_	NNS	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	have	_	_	VBP	O	[-1]	['none']	_	_
32	nonredundant	_	_	JJ	O	[-1]	['none']	_	_
33	roles	_	_	NNS	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	subsequent	_	_	JJ	O	[-1]	['none']	_	_
37	expression	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	key	_	_	JJ	O	[-1]	['none']	_	_
40	effector	_	_	NN	O	[-1]	['none']	_	_
41	proteins	_	_	NNS	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	T-bet	_	_	NN	Protein	[3]	['Cause']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	needed	_	_	VBN	Positive_regulation	[0]	['root']	_	_
4	early	_	_	RB	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	confer	_	_	VB	O	[-1]	['none']	_	_
7	on	_	_	IN	O	[-1]	['none']	_	_
8	activated	_	_	VBN	O	[-1]	['none']	_	_
9	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
10	T	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	competence	_	_	NN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	produce	_	_	VB	Gene_expression	[3]	['Theme']	_	_
16	IFN-gamma	_	_	NN	Protein	[15]	['Theme']	_	_
17	upon	_	_	IN	O	[-1]	['none']	_	_
18	restimulation	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	but	_	_	CC	O	[-1]	['none']	_	_
21	its	_	_	PRP$	O	[-1]	['none']	_	_
22	function	_	_	NN	O	[-1]	['none']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	less	_	_	RBR	O	[-1]	['none']	_	_
25	important	_	_	JJ	O	[-1]	['none']	_	_
26	at	_	_	IN	O	[-1]	['none']	_	_
27	later	_	_	JJ	O	[-1]	['none']	_	_
28	times	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Eomes	_	_	NNP	Protein	[5, 9, 18]	['Theme', 'Theme', 'Cause']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	which	_	_	WDT	Anaphora	[0]	['root']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
6	late	_	_	RB	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	functions	_	_	VBZ	Regulation	[9]	['multitoken']	_	_
9	downstream	_	_	JJ	Regulation	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	Runx3	_	_	NN	Protein	[9]	['Cause']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	may	_	_	MD	O	[-1]	['none']	_	_
14	substitute	_	_	VB	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	T-bet	_	_	NN	Protein	[18]	['Cause']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	promoting	_	_	VBG	Positive_regulation	[0]	['root']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	acute	_	_	JJ	O	[-1]	['none']	_	_
21	expression	_	_	NN	Gene_expression	[18]	['Theme']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IFN-gamma	_	_	NN	Protein	[21]	['Theme']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	restimulated	_	_	VBN	O	[-1]	['none']	_	_
26	CTLs	_	_	NNS	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	8	_	_	CD	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Indeed	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	T-bet	_	_	NN	Protein	[7]	['Cause']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	Eomes	_	_	NNS	Protein	[7]	['Cause']	_	_
6	both	_	_	CC	O	[-1]	['none']	_	_
7	contribute	_	_	VBP	Positive_regulation	[0]	['root']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	perforin	_	_	NN	Protein	[10]	['Theme']	_	_
10	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	NK	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	8	_	_	CD	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	26	_	_	CD	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	Eomes	_	_	NN	Protein	[22]	['Cause']	_	_
22	induces	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
23	granzyme	_	_	NN	Protein	[24]	['multitoken']	_	_
24	B	_	_	NN	Protein	[22]	['Theme']	_	_
25	as	_	_	IN	O	[-1]	['none']	_	_
26	effectively	_	_	RB	O	[-1]	['none']	_	_
27	as	_	_	IN	O	[-1]	['none']	_	_
28	T-bet	_	_	NN	Protein	[22]	['Cause']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	developing	_	_	VBG	O	[-1]	['none']	_	_
31	Th2	_	_	NN	O	[-1]	['none']	_	_
32	cells	_	_	NNS	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	7	_	_	CD	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	;	_	_	:	O	[-1]	['none']	_	_
37	thus	_	_	RB	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	relative	_	_	JJ	O	[-1]	['none']	_	_
41	roles	_	_	NNS	O	[-1]	['none']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	these	_	_	DT	O	[-1]	['none']	_	_
44	T-box	_	_	JJ	O	[-1]	['none']	_	_
45	transcription	_	_	NN	O	[-1]	['none']	_	_
46	factors	_	_	NNS	O	[-1]	['none']	_	_
47	vary	_	_	VBP	O	[-1]	['none']	_	_
48	depending	_	_	VBG	O	[-1]	['none']	_	_
49	on	_	_	IN	O	[-1]	['none']	_	_
50	cell	_	_	NN	O	[-1]	['none']	_	_
51	type	_	_	NN	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	Surprisingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	however	_	_	RB	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	Eomes	_	_	NNS	Protein	[14]	['Cause']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	T-bet	_	_	NN	Protein	[14]	['Cause']	_	_
8	appeared	_	_	VBD	O	[-1]	['none']	_	_
9	nonredundant	_	_	JJ	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	their	_	_	PRP$	O	[-1]	['none']	_	_
12	ability	_	_	NN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
15	two	_	_	CD	Anaphora	[17]	['multitoken']	_	_
16	other	_	_	JJ	Anaphora	[17]	['multitoken']	_	_
17	markers	_	_	NNS	Anaphora	[0]	['root']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	CTL	_	_	NN	O	[-1]	['none']	_	_
20	function	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	Prf1	_	_	NN	Protein	[14]	['Theme']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	Gzmb	_	_	NN	Protein	[14]	['Theme']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Rather	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	T-bet	_	_	NN	Protein	[9]	['Cause']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	Eomes	_	_	NNS	Protein	[9]	['Cause']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	involved	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	regulating	_	_	VBG	Regulation	[0]	['root']	_	_
10	granzyme	_	_	NN	Protein	[11]	['multitoken']	_	_
11	B	_	_	NN	Protein	[14]	['Theme']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	perforin	_	_	NN	Protein	[14]	['Theme']	_	_
14	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	respectively	_	_	RB	O	[-1]	['none']	_	_
17	:	_	_	:	O	[-1]	['none']	_	_
18	up-regulation	_	_	NN	Positive_regulation	[27]	['Cause']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	T-bet	_	_	NN	Protein	[18]	['Theme']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	Eomes	_	_	NN	Protein	[18]	['Theme']	_	_
23	mRNA	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	protein	_	_	NN	O	[-1]	['none']	_	_
26	closely	_	_	RB	O	[-1]	['none']	_	_
27	preceded	_	_	VBD	Positive_regulation	[0]	['root']	_	_
28	up-regulation	_	_	NN	Positive_regulation	[27]	['Theme']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	Gzmb	_	_	NN	Protein	[28]	['Theme']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	Prf1	_	_	NN	Protein	[28]	['Theme']	_	_
33	mRNA	_	_	NN	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	protein	_	_	NN	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	respectively	_	_	RB	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	T-bet	_	_	NN	Protein	[4]	['Cause']	_	_
2	had	_	_	VBD	Regulation	[4]	['multitoken']	_	_
3	no	_	_	DT	Regulation	[4]	['multitoken']	_	_
4	role	_	_	NN	Regulation	[0]	['root']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	perforin	_	_	NN	Protein	[7]	['Theme']	_	_
7	expression	_	_	NN	Gene_expression	[4]	['Theme']	_	_
8	under	_	_	IN	O	[-1]	['none']	_	_
9	our	_	_	PRP$	O	[-1]	['none']	_	_
10	culture	_	_	NN	O	[-1]	['none']	_	_
11	conditions	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	Eo-VP16	_	_	NN	Protein	[17, 22]	['Cause', 'Theme']	_	_
15	did	_	_	VBD	O	[-1]	['none']	_	_
16	not	_	_	RB	O	[-1]	['none']	_	_
17	affect	_	_	VB	Regulation	[0]	['root']	_	_
18	granzyme	_	_	NN	Protein	[19]	['multitoken']	_	_
19	B	_	_	NN	Protein	[20]	['Theme']	_	_
20	expression	_	_	NN	Gene_expression	[17]	['Theme']	_	_
21	when	_	_	WRB	O	[-1]	['none']	_	_
22	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	T-bet-/-	_	_	JJ	Protein	[0]	['root']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Because	_	_	IN	O	[-1]	['none']	_	_
2	conventional	_	_	JJ	O	[-1]	['none']	_	_
3	Eomes	_	_	NNS	Protein	[4]	['Theme']	_	_
4	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
5	mice	_	_	NNS	O	[-1]	['none']	_	_
6	die	_	_	VBP	O	[-1]	['none']	_	_
7	before	_	_	IN	O	[-1]	['none']	_	_
8	precursor	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	can	_	_	MD	O	[-1]	['none']	_	_
11	be	_	_	VB	O	[-1]	['none']	_	_
12	isolated	_	_	VBN	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	bone	_	_	NN	O	[-1]	['none']	_	_
15	marrow	_	_	NN	O	[-1]	['none']	_	_
16	transfers	_	_	NNS	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	27	_	_	CD	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	because	_	_	IN	O	[-1]	['none']	_	_
22	T	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	conditionally	_	_	RB	O	[-1]	['none']	_	_
25	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	Eomes	_	_	NNS	Protein	[25]	['Theme']	_	_
28	have	_	_	VBP	O	[-1]	['none']	_	_
29	only	_	_	RB	O	[-1]	['none']	_	_
30	recently	_	_	RB	O	[-1]	['none']	_	_
31	been	_	_	VBN	O	[-1]	['none']	_	_
32	described	_	_	VBN	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	9	_	_	CD	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	we	_	_	PRP	O	[-1]	['none']	_	_
38	were	_	_	VBD	O	[-1]	['none']	_	_
39	unable	_	_	JJ	O	[-1]	['none']	_	_
40	to	_	_	TO	O	[-1]	['none']	_	_
41	introduce	_	_	VB	O	[-1]	['none']	_	_
42	Runx3	_	_	NN	Protein	[0]	['root']	_	_
43	into	_	_	IN	O	[-1]	['none']	_	_
44	Eomes	_	_	NNP	Protein	[45]	['Theme']	_	_
45	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
46	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
47	T	_	_	NN	O	[-1]	['none']	_	_
48	cells	_	_	NNS	O	[-1]	['none']	_	_
49	to	_	_	TO	O	[-1]	['none']	_	_
50	test	_	_	VB	O	[-1]	['none']	_	_
51	formally	_	_	RB	O	[-1]	['none']	_	_
52	whether	_	_	IN	O	[-1]	['none']	_	_
53	Eomes	_	_	NNP	Protein	[58]	['Cause']	_	_
54	cooperated	_	_	VBD	O	[-1]	['none']	_	_
55	with	_	_	IN	O	[-1]	['none']	_	_
56	Runx3	_	_	NN	Protein	[58]	['Cause']	_	_
57	to	_	_	TO	O	[-1]	['none']	_	_
58	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
59	perforin	_	_	NN	Protein	[60]	['Theme']	_	_
60	expression	_	_	NN	Gene_expression	[58]	['Theme']	_	_
61	.	_	_	.	O	[-1]	['none']	_	_

1	Collectively	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	data	_	_	NNS	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	consistent	_	_	JJ	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
10	network	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	which	_	_	WDT	O	[-1]	['none']	_	_
13	preexisting	_	_	JJ	O	[-1]	['none']	_	_
14	Runx3	_	_	NN	Protein	[0]	['root']	_	_
15	cooperates	_	_	VBZ	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	induced	_	_	JJ	Positive_regulation	[0]	['root']	_	_
19	T-box	_	_	NN	O	[-1]	['none']	_	_
20	factors	_	_	NNS	O	[-1]	['none']	_	_
21	T-bet	_	_	JJ	Protein	[18]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	Eomes	_	_	NNS	Protein	[18]	['Theme']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	IL-2Rbeta	_	_	NN	Protein	[0]	['root']	_	_
26	signals	_	_	NNS	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	unpublished	_	_	JJ	O	[-1]	['none']	_	_
29	data	_	_	NNS	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	orchestrate	_	_	VB	O	[-1]	['none']	_	_
33	CTL	_	_	NN	O	[-1]	['none']	_	_
34	differentiation	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	recall	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	"	_	_	``	O	[-1]	['none']	_	_
6	feed-forward	_	_	JJ	O	[-1]	['none']	_	_
7	"	_	_	''	O	[-1]	['none']	_	_
8	interaction	_	_	NN	Regulation	[0]	['root']	_	_
9	between	_	_	IN	O	[-1]	['none']	_	_
10	T-bet	_	_	JJ	Protein	[8]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	Runx3	_	_	NN	Protein	[8]	['Cause']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	we	_	_	PRP	O	[-1]	['none']	_	_
15	previously	_	_	RB	O	[-1]	['none']	_	_
16	described	_	_	VBD	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Th1	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	T	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	15	_	_	CD	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	but	_	_	CC	O	[-1]	['none']	_	_
28	are	_	_	VBP	O	[-1]	['none']	_	_
29	distinct	_	_	JJ	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	two	_	_	CD	O	[-1]	['none']	_	_
32	respects	_	_	NNS	O	[-1]	['none']	_	_
33	:	_	_	:	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	differentiating	_	_	VBG	O	[-1]	['none']	_	_
36	Th1	_	_	NN	O	[-1]	['none']	_	_
37	cells	_	_	NNS	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	T-bet	_	_	NN	Protein	[41, 51]	['Theme', 'Cause']	_	_
40	is	_	_	VBZ	O	[-1]	['none']	_	_
41	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
42	by	_	_	IN	O	[-1]	['none']	_	_
43	TCR	_	_	NN	O	[-1]	['none']	_	_
44	signals	_	_	NNS	O	[-1]	['none']	_	_
45	and	_	_	CC	O	[-1]	['none']	_	_
46	IFN-gamma	_	_	NN	Protein	[41]	['Cause']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	and	_	_	CC	O	[-1]	['none']	_	_
49	in	_	_	IN	O	[-1]	['none']	_	_
50	turn	_	_	NN	O	[-1]	['none']	_	_
51	induces	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
52	Runx3	_	_	NN	Protein	[51]	['Theme']	_	_
53	(	_	_	-LRB-	O	[-1]	['none']	_	_
54	15	_	_	CD	O	[-1]	['none']	_	_
55	)	_	_	-RRB-	O	[-1]	['none']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	whereas	_	_	IN	O	[-1]	['none']	_	_
58	in	_	_	IN	O	[-1]	['none']	_	_
59	differentiating	_	_	VBG	O	[-1]	['none']	_	_
60	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
61	T	_	_	NN	O	[-1]	['none']	_	_
62	cells	_	_	NNS	O	[-1]	['none']	_	_
63	,	_	_	,	O	[-1]	['none']	_	_
64	preexisting	_	_	VBG	O	[-1]	['none']	_	_
65	Runx3	_	_	NN	Protein	[67]	['Cause']	_	_
66	is	_	_	VBZ	O	[-1]	['none']	_	_
67	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
68	to	_	_	TO	O	[-1]	['none']	_	_
69	induce	_	_	VB	Positive_regulation	[67]	['Theme']	_	_
70	the	_	_	DT	O	[-1]	['none']	_	_
71	T-box	_	_	JJ	O	[-1]	['none']	_	_
72	transcription	_	_	NN	O	[-1]	['none']	_	_
73	factor	_	_	NN	O	[-1]	['none']	_	_
74	Eomes	_	_	NNS	Protein	[69]	['Theme']	_	_
75	.	_	_	.	O	[-1]	['none']	_	_

1	Whole-genome	_	_	JJ	O	[-1]	['none']	_	_
2	experiments	_	_	NNS	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	these	_	_	DT	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	other	_	_	JJ	O	[-1]	['none']	_	_
7	systems	_	_	NNS	O	[-1]	['none']	_	_
8	will	_	_	MD	O	[-1]	['none']	_	_
9	be	_	_	VB	O	[-1]	['none']	_	_
10	required	_	_	VBN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	establish	_	_	VB	O	[-1]	['none']	_	_
13	whether	_	_	IN	O	[-1]	['none']	_	_
14	cooperation	_	_	NN	O	[-1]	['none']	_	_
15	between	_	_	IN	O	[-1]	['none']	_	_
16	T-box	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	Runx	_	_	NN	O	[-1]	['none']	_	_
19	family	_	_	NN	O	[-1]	['none']	_	_
20	transcription	_	_	NN	O	[-1]	['none']	_	_
21	factors	_	_	NNS	O	[-1]	['none']	_	_
22	is	_	_	VBZ	O	[-1]	['none']	_	_
23	a	_	_	DT	O	[-1]	['none']	_	_
24	general	_	_	JJ	O	[-1]	['none']	_	_
25	feature	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	cellular	_	_	JJ	O	[-1]	['none']	_	_
28	differentiation	_	_	NN	O	[-1]	['none']	_	_
29	programs	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Annexin	_	_	NN	Protein	[2]	['multitoken']	_	_
2	V/PI	_	_	NN	Protein	[0]	['root']	_	_
3	Apoptosis	_	_	NN	O	[-1]	['none']	_	_
4	Assay	_	_	NN	O	[-1]	['none']	_	_
5	Cell	_	_	NN	O	[-1]	['none']	_	_
6	apoptosis	_	_	NN	O	[-1]	['none']	_	_
7	assay	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	performed	_	_	VBN	O	[-1]	['none']	_	_
10	as	_	_	IN	O	[-1]	['none']	_	_
11	described	_	_	VBN	O	[-1]	['none']	_	_
12	previously	_	_	RB	O	[-1]	['none']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	51	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	using	_	_	VBG	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	Annexin	_	_	NN	Protein	[19]	['multitoken']	_	_
19	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
20	apoptosis	_	_	NN	O	[-1]	['none']	_	_
21	detection	_	_	NN	O	[-1]	['none']	_	_
22	kit	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	BD	_	_	NN	O	[-1]	['none']	_	_
25	PharMingen	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	San	_	_	NNP	O	[-1]	['none']	_	_
28	Diego	_	_	NNP	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	CA	_	_	NNP	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	human	_	_	NN	O	[-1]	['none']	_	_
4	monocytes	_	_	NNS	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	5x106	_	_	JJ	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	incubated	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	30	_	_	CD	O	[-1]	['none']	_	_
14	minutes	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	X-vivo	_	_	JJ	O	[-1]	['none']	_	_
17	medium	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	restimulated	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	100	_	_	CD	O	[-1]	['none']	_	_
22	ng/ml	_	_	NN	O	[-1]	['none']	_	_
23	M-CSF	_	_	NN	O	[-1]	['none']	_	_
24	overnight	_	_	JJ	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	removed	_	_	VBN	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	culture	_	_	NN	O	[-1]	['none']	_	_
8	dish	_	_	NN	O	[-1]	['none']	_	_
9	using	_	_	VBG	O	[-1]	['none']	_	_
10	Accutase	_	_	NNP	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	eBioscience	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	San	_	_	NNP	O	[-1]	['none']	_	_
15	Diego	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	CA	_	_	NNP	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	stained	_	_	VBN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	Annexin	_	_	NN	Protein	[23]	['multitoken']	_	_
23	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	PI	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	analyzed	_	_	VBN	O	[-1]	['none']	_	_
28	by	_	_	IN	O	[-1]	['none']	_	_
29	flow	_	_	NN	O	[-1]	['none']	_	_
30	cytometry	_	_	NN	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	FACSCalibur	_	_	NN	O	[-1]	['none']	_	_
33	;	_	_	:	O	[-1]	['none']	_	_
34	BD	_	_	NN	O	[-1]	['none']	_	_
35	PharMingen	_	_	NN	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Annexin	_	_	NN	Protein	[2]	['multitoken']	_	_
2	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	PI	_	_	NN	O	[-1]	['none']	_	_
5	double	_	_	JJ	O	[-1]	['none']	_	_
6	negative	_	_	JJ	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	considered	_	_	VBN	O	[-1]	['none']	_	_
10	non	_	_	JJ	O	[-1]	['none']	_	_
11	apoptotic	_	_	JJ	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	statistical	_	_	JJ	O	[-1]	['none']	_	_
15	analysis	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	O	[-1]	['none']	_	_
2	extraction	_	_	NN	O	[-1]	['none']	_	_
3	Jurkat	_	_	NN	O	[-1]	['none']	_	_
4	T-cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	treated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	JNK	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	PKC	_	_	NN	O	[-1]	['none']	_	_
13	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	2	_	_	CD	O	[-1]	['none']	_	_
16	h	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	6-well	_	_	JJ	O	[-1]	['none']	_	_
19	plates	_	_	NNS	O	[-1]	['none']	_	_
20	followed	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	stimulation	_	_	NN	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	162	_	_	CD	O	[-1]	['none']	_	_
25	nM	_	_	NN	O	[-1]	['none']	_	_
26	PMA	_	_	NN	O	[-1]	['none']	_	_
27	for	_	_	IN	O	[-1]	['none']	_	_
28	24	_	_	CD	O	[-1]	['none']	_	_
29	h	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	sampling	_	_	NN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	pelleted	_	_	JJ	O	[-1]	['none']	_	_
7	followed	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	RNA	_	_	NN	O	[-1]	['none']	_	_
10	extraction	_	_	NN	O	[-1]	['none']	_	_
11	using	_	_	VBG	O	[-1]	['none']	_	_
12	100	_	_	CD	O	[-1]	['none']	_	_
13	mul	_	_	NN	O	[-1]	['none']	_	_
14	TRI-reagent	_	_	JJ	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	Sigma	_	_	NNP	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	USA	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	followed	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	addition	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	100	_	_	CD	O	[-1]	['none']	_	_
8	mul	_	_	NN	O	[-1]	['none']	_	_
9	chloroform	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	isoamylalcohol	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	24/1	_	_	CD	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	solutions	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	mixed	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	vortexing	_	_	VBG	O	[-1]	['none']	_	_
7	followed	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	centrifugation	_	_	NN	O	[-1]	['none']	_	_
10	at	_	_	IN	O	[-1]	['none']	_	_
11	12,000	_	_	CD	O	[-1]	['none']	_	_
12	rpm	_	_	NN	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	15	_	_	CD	O	[-1]	['none']	_	_
15	min	_	_	NN	O	[-1]	['none']	_	_
16	at	_	_	IN	O	[-1]	['none']	_	_
17	4degreesC	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	upper	_	_	JJ	O	[-1]	['none']	_	_
3	phase	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	transferred	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	new	_	_	JJ	O	[-1]	['none']	_	_
9	tube	_	_	NN	O	[-1]	['none']	_	_
10	followed	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	addition	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	100	_	_	CD	O	[-1]	['none']	_	_
15	mul	_	_	NN	O	[-1]	['none']	_	_
16	iso-propanol	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	incubated	_	_	VBN	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	room	_	_	NN	O	[-1]	['none']	_	_
21	temperature	_	_	NN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	10	_	_	CD	O	[-1]	['none']	_	_
24	min	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	then	_	_	RB	O	[-1]	['none']	_	_
4	pelleted	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	centrifugation	_	_	NN	O	[-1]	['none']	_	_
7	at	_	_	IN	O	[-1]	['none']	_	_
8	12,000	_	_	CD	O	[-1]	['none']	_	_
9	rpm	_	_	NN	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	15	_	_	CD	O	[-1]	['none']	_	_
12	min	_	_	NN	O	[-1]	['none']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	4degreesC	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	washed	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	70	_	_	CD	O	[-1]	['none']	_	_
19	%	_	_	NN	O	[-1]	['none']	_	_
20	ethanol	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	RNA	_	_	NN	O	[-1]	['none']	_	_
3	pellet	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	dissolved	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	25	_	_	CD	O	[-1]	['none']	_	_
8	mul	_	_	NN	O	[-1]	['none']	_	_
9	RNase	_	_	NN	O	[-1]	['none']	_	_
10	free	_	_	JJ	O	[-1]	['none']	_	_
11	water	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	yield	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	ratio	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	A260	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	A280	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	was	_	_	VBD	O	[-1]	['none']	_	_
23	determined	_	_	VBN	O	[-1]	['none']	_	_
24	using	_	_	VBG	O	[-1]	['none']	_	_
25	NanoVue	_	_	NNP	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	GE	_	_	NNP	O	[-1]	['none']	_	_
28	Healthcare	_	_	NNP	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	UK	_	_	NNP	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	samples	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	stored	_	_	VBN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	-80	_	_	CD	O	[-1]	['none']	_	_
7	degreesC	_	_	NN	O	[-1]	['none']	_	_
8	until	_	_	IN	O	[-1]	['none']	_	_
9	further	_	_	JJ	O	[-1]	['none']	_	_
10	use	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Defective	_	_	JJ	O	[-1]	['none']	_	_
2	production	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	pro	_	_	JJ	O	[-1]	['none']	_	_
5	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
6	mediators	_	_	NNS	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	stimulated	_	_	VBN	O	[-1]	['none']	_	_
9	cpdm	_	_	NN	O	[-1]	['none']	_	_
10	BMDC	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A-D	_	_	NNP	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Cultured	_	_	VBN	O	[-1]	['none']	_	_
5	WT	_	_	NNP	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	cpdm	_	_	JJ	O	[-1]	['none']	_	_
8	BMDC	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	1x105	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	0.1	_	_	CD	O	[-1]	['none']	_	_
14	ml	_	_	NN	O	[-1]	['none']	_	_
15	complete	_	_	JJ	O	[-1]	['none']	_	_
16	medium	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	washed	_	_	VBN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	stimulated	_	_	VBN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	medium	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	100	_	_	CD	O	[-1]	['none']	_	_
26	ng/ml	_	_	NN	O	[-1]	['none']	_	_
27	LPS	_	_	NN	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	25	_	_	CD	O	[-1]	['none']	_	_
30	microg/ml	_	_	NN	O	[-1]	['none']	_	_
31	poly	_	_	NN	O	[-1]	['none']	_	_
32	I	_	_	NN	O	[-1]	['none']	_	_
33	:	_	_	:	O	[-1]	['none']	_	_
34	C	_	_	NN	O	[-1]	['none']	_	_
35	for	_	_	IN	O	[-1]	['none']	_	_
36	24	_	_	CD	O	[-1]	['none']	_	_
37	hours	_	_	NNS	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Supernatants	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	collected	_	_	VBN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	ELISA	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IL12P70	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	IL6	_	_	NN	Protein	[0]	['root']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	GMCSF	_	_	NNP	Protein	[0]	['root']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	quantification	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	nitric	_	_	JJ	O	[-1]	['none']	_	_
19	oxide	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	NO	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	E-F	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Gradient	_	_	NN	O	[-1]	['none']	_	_
5	numbers	_	_	NNS	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	1x104	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	2x104	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	4x104	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	0.1	_	_	CD	O	[-1]	['none']	_	_
16	mL	_	_	NN	O	[-1]	['none']	_	_
17	complete	_	_	JJ	O	[-1]	['none']	_	_
18	medium	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	BMDC	_	_	NN	O	[-1]	['none']	_	_
22	were	_	_	VBD	O	[-1]	['none']	_	_
23	used	_	_	VBN	O	[-1]	['none']	_	_
24	for100	_	_	NN	O	[-1]	['none']	_	_
25	ng/mL	_	_	NN	O	[-1]	['none']	_	_
26	LPS	_	_	NN	O	[-1]	['none']	_	_
27	stimulation	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	24	_	_	CD	O	[-1]	['none']	_	_
3	hours	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	amounts	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	IL12P70	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	IL6	_	_	NN	Protein	[0]	['root']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	supernatant	_	_	NN	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	measured	_	_	VBN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	G	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	The	_	_	DT	O	[-1]	['none']	_	_
5	cpdm	_	_	NN	O	[-1]	['none']	_	_
6	mice	_	_	NNS	O	[-1]	['none']	_	_
7	rescued	_	_	VBD	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	Sharpin	_	_	NN	Protein	[0]	['root']	_	_
10	containing	_	_	VBG	O	[-1]	['none']	_	_
11	BAC	_	_	NN	O	[-1]	['none']	_	_
12	had	_	_	VBD	O	[-1]	['none']	_	_
13	complete	_	_	JJ	O	[-1]	['none']	_	_
14	remission	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
18	phenotype	_	_	NN	O	[-1]	['none']	_	_
19	[	_	_	NN	O	[-1]	['none']	_	_
20	2	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	BMDC	_	_	NN	O	[-1]	['none']	_	_
2	developed	_	_	VBD	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	cpdm	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	rescued	_	_	VBD	O	[-1]	['none']	_	_
7	cpdm	_	_	NN	O	[-1]	['none']	_	_
8	mice	_	_	NNS	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	plated	_	_	VBN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	1x106	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	0.3	_	_	CD	O	[-1]	['none']	_	_
16	mL	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	stimulated	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	100	_	_	CD	O	[-1]	['none']	_	_
22	ng/mL	_	_	NN	O	[-1]	['none']	_	_
23	LPS	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	24	_	_	CD	O	[-1]	['none']	_	_
3	hours	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	supernatants	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	collected	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	analysis	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	IL12P70	_	_	NN	O	[-1]	['none']	_	_
12	production	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	representative	_	_	JJ	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	three	_	_	CD	O	[-1]	['none']	_	_
6	independent	_	_	JJ	O	[-1]	['none']	_	_
7	experiments	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	*	_	_	SYM	O	[-1]	['none']	_	_
2	P	_	_	NN	O	[-1]	['none']	_	_
3	<	_	_	JJR	O	[-1]	['none']	_	_
4	0.01	_	_	CD	O	[-1]	['none']	_	_
5	;	_	_	:	O	[-1]	['none']	_	_
6	**	_	_	SYM	O	[-1]	['none']	_	_
7	P	_	_	NN	O	[-1]	['none']	_	_
8	<	_	_	JJR	O	[-1]	['none']	_	_
9	0.005	_	_	CD	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	Activates	_	_	VBZ	O	[-1]	['none']	_	_
3	Akt	_	_	NNP	Protein	[0]	['root']	_	_
4	Signaling	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Deregulates	_	_	VBZ	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	Rb	_	_	NN	Protein	[0]	['root']	_	_
9	Cell	_	_	NN	O	[-1]	['none']	_	_
10	Cycle	_	_	NNP	O	[-1]	['none']	_	_
11	Pathway	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	A	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	B	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
18	analysis	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	purified	_	_	VBN	O	[-1]	['none']	_	_
21	B	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	from	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	spleens	_	_	NNS	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	WT	_	_	NNP	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	LMP1	_	_	NN	Protein	[0]	['root']	_	_
33	transgenic	_	_	JJ	O	[-1]	['none']	_	_
34	mice	_	_	NNS	O	[-1]	['none']	_	_
35	for	_	_	IN	O	[-1]	['none']	_	_
36	Akt	_	_	NN	Protein	[0]	['root']	_	_
37	signaling	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	probing	_	_	VBG	O	[-1]	['none']	_	_
40	for	_	_	IN	O	[-1]	['none']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	A	_	_	DT	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	activated	_	_	VBD	O	[-1]	['none']	_	_
45	pAkt	_	_	NN	Protein	[0]	['root']	_	_
46	and	_	_	CC	O	[-1]	['none']	_	_
47	downstream	_	_	JJ	O	[-1]	['none']	_	_
48	targets	_	_	NNS	Regulation	[0]	['root']	_	_
49	,	_	_	,	O	[-1]	['none']	_	_
50	including	_	_	VBG	O	[-1]	['none']	_	_
51	inactivated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
52	pGSK3alpha	_	_	NN	Protein	[48, 51]	['Theme', 'Theme']	_	_
53	and	_	_	CC	O	[-1]	['none']	_	_
54	beta	_	_	NN	Protein	[48, 51]	['Theme', 'Theme']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	and	_	_	CC	O	[-1]	['none']	_	_
57	(	_	_	-LRB-	O	[-1]	['none']	_	_
58	B	_	_	NN	O	[-1]	['none']	_	_
59	)	_	_	-RRB-	O	[-1]	['none']	_	_
60	activated	_	_	VBD	Positive_regulation	[0]	['root']	_	_
61	p-mTOR	_	_	NN	Protein	[60]	['Theme']	_	_
62	,	_	_	,	O	[-1]	['none']	_	_
63	and	_	_	CC	O	[-1]	['none']	_	_
64	total	_	_	JJ	O	[-1]	['none']	_	_
65	levels	_	_	NNS	O	[-1]	['none']	_	_
66	of	_	_	IN	O	[-1]	['none']	_	_
67	FoxO1	_	_	NN	Protein	[0]	['root']	_	_
68	.	_	_	.	O	[-1]	['none']	_	_

1	Arrows	_	_	NNS	O	[-1]	['none']	_	_
2	indicate	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	positions	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	alpha	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	beta	_	_	NN	O	[-1]	['none']	_	_
9	isoforms	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	GSK3	_	_	NN	Protein	[0]	['root']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	white	_	_	JJ	O	[-1]	['none']	_	_
3	line	_	_	NN	O	[-1]	['none']	_	_
4	indicates	_	_	VBZ	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	intervening	_	_	VBG	O	[-1]	['none']	_	_
7	lanes	_	_	NNS	O	[-1]	['none']	_	_
8	have	_	_	VBP	O	[-1]	['none']	_	_
9	been	_	_	VBN	O	[-1]	['none']	_	_
10	spliced	_	_	VBN	O	[-1]	['none']	_	_
11	out	_	_	RP	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
5	analysis	_	_	NN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	cell	_	_	NN	O	[-1]	['none']	_	_
8	cycle	_	_	NN	O	[-1]	['none']	_	_
9	proteins	_	_	NNS	O	[-1]	['none']	_	_
10	regulating	_	_	VBG	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	Rb	_	_	NN	Protein	[0]	['root']	_	_
13	pathway	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	probing	_	_	VBG	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
18	pRb	_	_	NN	Protein	[17]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	total	_	_	JJ	O	[-1]	['none']	_	_
22	levels	_	_	NNS	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	Cdk2	_	_	NN	Protein	[0]	['root']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	Cdk	_	_	NN	O	[-1]	['none']	_	_
28	inhibitor	_	_	NN	O	[-1]	['none']	_	_
29	p27	_	_	NN	Protein	[0]	['root']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Actin	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	loading	_	_	VBG	O	[-1]	['none']	_	_
7	control	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	HOIP	_	_	NN	Protein	[3]	['Cause']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	necessary	_	_	JJ	Positive_regulation	[0]	['root']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	association	_	_	NN	Binding	[3]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	IKK	_	_	NN	O	[-1]	['none']	_	_
9	complex	_	_	NN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	CD40	_	_	NN	Protein	[5]	['Theme']	_	_
12	The	_	_	DT	O	[-1]	['none']	_	_
13	marked	_	_	JJ	O	[-1]	['none']	_	_
14	defects	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	CD40	_	_	NN	Protein	[0]	['root']	_	_
17	mediated	_	_	VBN	O	[-1]	['none']	_	_
18	cell	_	_	NN	O	[-1]	['none']	_	_
19	activation	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	signaling	_	_	NN	O	[-1]	['none']	_	_
22	displayed	_	_	VBN	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	HOIP	_	_	NN	Protein	[25]	['Theme']	_	_
25	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	suggested	_	_	VBD	O	[-1]	['none']	_	_
28	that	_	_	IN	O	[-1]	['none']	_	_
29	HOIP	_	_	NN	Protein	[0]	['root']	_	_
30	mediates	_	_	VBZ	O	[-1]	['none']	_	_
31	recruitment	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	critical	_	_	JJ	O	[-1]	['none']	_	_
34	components	_	_	NNS	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	CD40	_	_	NN	O	[-1]	['none']	_	_
38	signaling	_	_	NN	O	[-1]	['none']	_	_
39	apparatus	_	_	NN	O	[-1]	['none']	_	_
40	to	_	_	TO	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	receptor	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	Previously	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	HOIP	_	_	NNP	Protein	[8]	['Theme']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	recruited	_	_	VBN	Binding	[17]	['Theme']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	CD40	_	_	NN	O	[-1]	['none']	_	_
12	signaling	_	_	NN	O	[-1]	['none']	_	_
13	complex	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	TRAF2	_	_	NN	Protein	[17]	['Cause']	_	_
17	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
18	manner	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	suggesting	_	_	VBG	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	HOIP	_	_	NN	Protein	[24]	['Theme']	_	_
23	functions	_	_	NNS	Regulation	[24]	['multitoken']	_	_
24	downstream	_	_	RB	Regulation	[0]	['root']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	TRAF2	_	_	NN	Protein	[24]	['Cause']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	6	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Studies	_	_	NNS	O	[-1]	['none']	_	_
2	by	_	_	IN	O	[-1]	['none']	_	_
3	others	_	_	NNS	O	[-1]	['none']	_	_
4	suggest	_	_	VBP	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	TRAF2	_	_	NN	Protein	[8]	['Theme']	_	_
8	associated	_	_	VBN	Binding	[0]	['root']	_	_
9	proteins	_	_	NNS	O	[-1]	['none']	_	_
10	cIAP1	_	_	NN	Protein	[8, 15]	['Theme', 'Cause']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	cIAP2	_	_	NN	Protein	[8, 15]	['Theme', 'Cause']	_	_
13	play	_	_	VBP	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	role	_	_	NN	Regulation	[0]	['root']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	recruitment	_	_	NN	Binding	[15]	['Theme']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	HOIP	_	_	NN	Protein	[18]	['Theme']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	TNFR1	_	_	NN	Protein	[18]	['Theme']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	CD40	_	_	NN	Protein	[18]	['Theme']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	14	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	determined	_	_	VBD	O	[-1]	['none']	_	_
5	whether	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	association	_	_	NN	Binding	[18]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	HOIP	_	_	NN	Protein	[7]	['Theme']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	CD40	_	_	NN	Protein	[7]	['Theme']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	A20	_	_	NN	O	[-1]	['none']	_	_
14	.2	_	_	NN	O	[-1]	['none']	_	_
15	J	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	altered	_	_	VBN	Regulation	[0]	['root']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	treatment	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	an	_	_	DT	O	[-1]	['none']	_	_
25	inhibitor	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	cIAP	_	_	NN	O	[-1]	['none']	_	_
28	activity	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	membrane-permeable	_	_	JJ	O	[-1]	['none']	_	_
32	peptide	_	_	NN	O	[-1]	['none']	_	_
33	derived	_	_	VBN	O	[-1]	['none']	_	_
34	from	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	apoptosis	_	_	NN	O	[-1]	['none']	_	_
37	regulator	_	_	NN	O	[-1]	['none']	_	_
38	SMAC	_	_	NN	O	[-1]	['none']	_	_
39	[	_	_	CD	O	[-1]	['none']	_	_
40	15	_	_	CD	O	[-1]	['none']	_	_
41	]	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	found	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	pretreatment	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	SMAC	_	_	NN	O	[-1]	['none']	_	_
10	peptide	_	_	NN	O	[-1]	['none']	_	_
11	dramatically	_	_	RB	O	[-1]	['none']	_	_
12	reduced	_	_	VBD	Negative_regulation	[0]	['root']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	amount	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	cIAP1	_	_	NN	Protein	[17]	['Theme']	_	_
17	associated	_	_	VBN	Binding	[12]	['Theme']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	CD40	_	_	NN	O	[-1]	['none']	_	_
21	signaling	_	_	NN	O	[-1]	['none']	_	_
22	complex	_	_	NN	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	stimulated	_	_	VBN	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	anti-CD40	_	_	JJ	O	[-1]	['none']	_	_
28	antibody	_	_	NN	O	[-1]	['none']	_	_
29	coated	_	_	JJ	O	[-1]	['none']	_	_
30	beads	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	SMAC	_	_	NN	O	[-1]	['none']	_	_
2	peptide	_	_	NN	O	[-1]	['none']	_	_
3	treatment	_	_	NN	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	slight	_	_	JJ	O	[-1]	['none']	_	_
9	but	_	_	CC	O	[-1]	['none']	_	_
10	reproducible	_	_	JJ	O	[-1]	['none']	_	_
11	decrease	_	_	NN	Negative_regulation	[5]	['Theme']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	amount	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	major	_	_	JJ	O	[-1]	['none']	_	_
18	HOIP	_	_	NN	Protein	[11, 29, 20, 35]	['Theme', 'Theme', 'Theme', 'Theme']	_	_
19	form	_	_	NN	O	[-1]	['none']	_	_
20	recovered	_	_	VBN	Binding	[0]	['root']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	CD40	_	_	NN	Protein	[20]	['Theme']	_	_
23	immunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	along	_	_	IN	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	an	_	_	DT	O	[-1]	['none']	_	_
28	apparent	_	_	JJ	O	[-1]	['none']	_	_
29	increase	_	_	NN	Positive_regulation	[5]	['Theme']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	higher	_	_	JJR	O	[-1]	['none']	_	_
32	molecular	_	_	JJ	O	[-1]	['none']	_	_
33	weight	_	_	NN	O	[-1]	['none']	_	_
34	species	_	_	NNS	Anaphora	[0]	['root']	_	_
35	recognized	_	_	VBN	Binding	[0]	['root']	_	_
36	by	_	_	IN	O	[-1]	['none']	_	_
37	anti-HOIP	_	_	JJ	O	[-1]	['none']	_	_
38	antibody	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	treatment	_	_	NN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	SMAC	_	_	NN	O	[-1]	['none']	_	_
8	peptide	_	_	NN	O	[-1]	['none']	_	_
9	did	_	_	VBD	O	[-1]	['none']	_	_
10	not	_	_	RB	O	[-1]	['none']	_	_
11	alter	_	_	VB	Regulation	[0]	['root']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	amount	_	_	NN	O	[-1]	['none']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	molecular	_	_	JJ	O	[-1]	['none']	_	_
16	weight	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	HOIP	_	_	NN	Protein	[11]	['Theme']	_	_
19	present	_	_	JJ	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	lysates	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	SMAC	_	_	NN	O	[-1]	['none']	_	_
6	peptide	_	_	NN	O	[-1]	['none']	_	_
7	treatment	_	_	NN	O	[-1]	['none']	_	_
8	specifically	_	_	RB	O	[-1]	['none']	_	_
9	alters	_	_	VBZ	Regulation	[0]	['root']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	characteristics	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	CD40	_	_	NN	Protein	[14]	['Theme']	_	_
14	associated	_	_	VBN	Binding	[0]	['root']	_	_
15	HOIP	_	_	NN	Protein	[9, 14]	['Theme', 'Theme']	_	_
16	rather	_	_	RB	O	[-1]	['none']	_	_
17	than	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	entire	_	_	JJ	O	[-1]	['none']	_	_
20	cellular	_	_	JJ	O	[-1]	['none']	_	_
21	pool	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	this	_	_	DT	O	[-1]	['none']	_	_
24	protein	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Together	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	results	_	_	NNS	O	[-1]	['none']	_	_
5	support	_	_	VBP	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	idea	_	_	NN	O	[-1]	['none']	_	_
8	that	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	cIAP	_	_	NN	Protein	[12]	['Cause']	_	_
11	proteins	_	_	NNS	O	[-1]	['none']	_	_
12	influence	_	_	VBP	Regulation	[0]	['root']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	recruitment	_	_	NN	Binding	[12]	['Theme']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	post-translational	_	_	JJ	Protein_modification	[17]	['multitoken']	_	_
17	modification	_	_	NN	Protein_modification	[12]	['Theme']	_	_
18	state	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	CD40	_	_	NN	Protein	[21]	['Theme']	_	_
21	associated	_	_	VBN	Binding	[0]	['root']	_	_
22	HOIP	_	_	NNP	Protein	[14, 17, 21]	['Theme', 'Theme', 'Theme']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	test	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	possibility	_	_	NN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	HOIP	_	_	NN	Protein	[8]	['Cause']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	responsible	_	_	JJ	Regulation	[0]	['root']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	recruitment	_	_	NN	Binding	[8]	['Theme']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	other	_	_	JJ	O	[-1]	['none']	_	_
14	critical	_	_	JJ	O	[-1]	['none']	_	_
15	signaling	_	_	NN	O	[-1]	['none']	_	_
16	proteins	_	_	NNS	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	CD40	_	_	NN	Protein	[11]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	we	_	_	PRP	O	[-1]	['none']	_	_
21	immunoprecipitated	_	_	VBD	O	[-1]	['none']	_	_
22	CD40	_	_	NN	O	[-1]	['none']	_	_
23	signaling	_	_	NN	O	[-1]	['none']	_	_
24	complexes	_	_	NNS	O	[-1]	['none']	_	_
25	from	_	_	IN	O	[-1]	['none']	_	_
26	HOIP	_	_	NN	Protein	[27]	['Theme']	_	_
27	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	HOIP	_	_	NN	Protein	[30]	['Theme']	_	_
30	reconstituted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	described	_	_	VBN	O	[-1]	['none']	_	_
3	previously	_	_	RB	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	CD40	_	_	NN	O	[-1]	['none']	_	_
6	signaling	_	_	NN	O	[-1]	['none']	_	_
7	complexes	_	_	NNS	O	[-1]	['none']	_	_
8	immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
9	from	_	_	IN	O	[-1]	['none']	_	_
10	A20	_	_	NN	O	[-1]	['none']	_	_
11	.2	_	_	NN	O	[-1]	['none']	_	_
12	J	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	contained	_	_	VBD	O	[-1]	['none']	_	_
15	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
16	as	_	_	RB	O	[-1]	['none']	_	_
17	well	_	_	RB	O	[-1]	['none']	_	_
18	as	_	_	IN	O	[-1]	['none']	_	_
19	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	TRAF3	_	_	NN	Protein	[0]	['root']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	IKKalpha	_	_	NN	Protein	[0]	['root']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	beta	_	_	NN	Protein	[0]	['root']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
29	[	_	_	CD	O	[-1]	['none']	_	_
30	6	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	amounts	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	TRAF2	_	_	NN	Protein	[36]	['Theme']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	TRAF3	_	_	NN	Protein	[36]	['Theme']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	cIAP1	_	_	NN	Protein	[36]	['Theme']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	CD40	_	_	NN	Protein	[0]	['root']	_	_
12	immunoprecipitates	_	_	NNS	O	[-1]	['none']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	HOIP	_	_	NN	Protein	[0]	['root']	_	_
15	deficient	_	_	JJ	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	similar	_	_	JJ	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	those	_	_	DT	O	[-1]	['none']	_	_
21	from	_	_	IN	O	[-1]	['none']	_	_
22	parental	_	_	JJ	O	[-1]	['none']	_	_
23	A20	_	_	NN	O	[-1]	['none']	_	_
24	.2	_	_	NN	O	[-1]	['none']	_	_
25	J	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	indicating	_	_	VBG	O	[-1]	['none']	_	_
29	that	_	_	IN	O	[-1]	['none']	_	_
30	HOIP	_	_	NN	Protein	[33]	['Cause']	_	_
31	is	_	_	VBZ	O	[-1]	['none']	_	_
32	not	_	_	RB	O	[-1]	['none']	_	_
33	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
34	for	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	association	_	_	NN	Binding	[33]	['Theme']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	these	_	_	DT	Anaphora	[39]	['multitoken']	_	_
39	proteins	_	_	NNS	Anaphora	[0]	['root']	_	_
40	with	_	_	IN	O	[-1]	['none']	_	_
41	CD40	_	_	NN	Protein	[36]	['Theme']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	IKKalpha	_	_	NN	Protein	[0]	['root']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	beta	_	_	NN	Protein	[0]	['root']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	not	_	_	RB	O	[-1]	['none']	_	_
11	detectable	_	_	JJ	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	CD40	_	_	NN	Protein	[0]	['root']	_	_
14	immunoprecipitates	_	_	NNS	O	[-1]	['none']	_	_
15	recovered	_	_	VBD	O	[-1]	['none']	_	_
16	from	_	_	IN	O	[-1]	['none']	_	_
17	HOIP	_	_	NN	Protein	[18]	['Theme']	_	_
18	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	amounts	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	IKKalpha	_	_	NN	Protein	[0]	['root']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	beta	_	_	NN	Protein	[0]	['root']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	CD40	_	_	NN	Protein	[0]	['root']	_	_
11	immunoprecipitates	_	_	NNS	O	[-1]	['none']	_	_
12	from	_	_	IN	O	[-1]	['none']	_	_
13	HOIP	_	_	NN	Protein	[14]	['Theme']	_	_
14	reconstituted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	similar	_	_	JJ	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	those	_	_	DT	O	[-1]	['none']	_	_
20	detected	_	_	VBN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	samples	_	_	NNS	O	[-1]	['none']	_	_
23	prepared	_	_	VBN	O	[-1]	['none']	_	_
24	from	_	_	IN	O	[-1]	['none']	_	_
25	parental	_	_	JJ	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	demonstrating	_	_	VBG	O	[-1]	['none']	_	_
29	that	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	defects	_	_	NNS	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	IKK	_	_	NN	O	[-1]	['none']	_	_
34	recruitment	_	_	NN	O	[-1]	['none']	_	_
35	we	_	_	PRP	O	[-1]	['none']	_	_
36	observed	_	_	VBD	O	[-1]	['none']	_	_
37	were	_	_	VBD	O	[-1]	['none']	_	_
38	due	_	_	JJ	O	[-1]	['none']	_	_
39	specifically	_	_	RB	O	[-1]	['none']	_	_
40	to	_	_	TO	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	HOIP	_	_	NN	Protein	[45]	['Theme']	_	_
45	expression	_	_	NN	Gene_expression	[42]	['Theme']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[0]	['root']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	required	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	recruitment	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	NF	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	kappaB	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	activating	_	_	VBG	O	[-1]	['none']	_	_
18	complex	_	_	NN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	CD40	_	_	NN	O	[-1]	['none']	_	_
22	signaling	_	_	NN	O	[-1]	['none']	_	_
23	complex	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	here	_	_	RB	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	our	_	_	PRP$	O	[-1]	['none']	_	_
7	previous	_	_	JJ	O	[-1]	['none']	_	_
8	study	_	_	NN	O	[-1]	['none']	_	_
9	[	_	_	NN	O	[-1]	['none']	_	_
10	6	_	_	CD	O	[-1]	['none']	_	_
11	]	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
14	present	_	_	JJ	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	CD40	_	_	NN	Protein	[0]	['root']	_	_
17	immunoprecipitates	_	_	NNS	O	[-1]	['none']	_	_
18	appears	_	_	VBZ	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	have	_	_	VB	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	higher	_	_	JJR	O	[-1]	['none']	_	_
23	molecular	_	_	JJ	O	[-1]	['none']	_	_
24	weight	_	_	NN	O	[-1]	['none']	_	_
25	than	_	_	IN	O	[-1]	['none']	_	_
26	that	_	_	DT	O	[-1]	['none']	_	_
27	found	_	_	VBN	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	cell	_	_	NN	O	[-1]	['none']	_	_
30	lysates	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	confirm	_	_	VB	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	this	_	_	DT	O	[-1]	['none']	_	_
5	higher	_	_	JJR	O	[-1]	['none']	_	_
6	molecular	_	_	JJ	O	[-1]	['none']	_	_
7	weight	_	_	NN	O	[-1]	['none']	_	_
8	species	_	_	NNS	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	indeed	_	_	RB	O	[-1]	['none']	_	_
11	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	we	_	_	PRP	O	[-1]	['none']	_	_
14	generated	_	_	VBD	O	[-1]	['none']	_	_
15	A20	_	_	NN	O	[-1]	['none']	_	_
16	.2	_	_	NN	O	[-1]	['none']	_	_
17	J	_	_	NN	O	[-1]	['none']	_	_
18	cell	_	_	NN	O	[-1]	['none']	_	_
19	lines	_	_	NNS	O	[-1]	['none']	_	_
20	containing	_	_	VBG	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	stably	_	_	RB	O	[-1]	['none']	_	_
23	integrated	_	_	VBN	O	[-1]	['none']	_	_
24	retroviral	_	_	JJ	O	[-1]	['none']	_	_
25	vector	_	_	NN	O	[-1]	['none']	_	_
26	that	_	_	WDT	O	[-1]	['none']	_	_
27	encoded	_	_	VBD	O	[-1]	['none']	_	_
28	an	_	_	DT	O	[-1]	['none']	_	_
29	epitope	_	_	NN	O	[-1]	['none']	_	_
30	tagged	_	_	VBD	O	[-1]	['none']	_	_
31	version	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	mouse	_	_	NN	O	[-1]	['none']	_	_
34	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	lysates	_	_	NNS	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	CD40	_	_	NN	Protein	[0]	['root']	_	_
5	immunoprecipitates	_	_	NNS	O	[-1]	['none']	_	_
6	prepared	_	_	VBN	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	these	_	_	DT	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	analyzed	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	Western	_	_	NN	O	[-1]	['none']	_	_
14	blotting	_	_	NN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	epitope	_	_	NN	O	[-1]	['none']	_	_
18	tag	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	produced	_	_	VBD	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	pattern	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	bands	_	_	NNS	O	[-1]	['none']	_	_
8	that	_	_	WDT	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	essentially	_	_	RB	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	same	_	_	JJ	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	that	_	_	DT	O	[-1]	['none']	_	_
15	obtained	_	_	VBN	O	[-1]	['none']	_	_
16	using	_	_	VBG	O	[-1]	['none']	_	_
17	an	_	_	DT	O	[-1]	['none']	_	_
18	antibody	_	_	NN	O	[-1]	['none']	_	_
19	specific	_	_	JJ	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	native	_	_	JJ	O	[-1]	['none']	_	_
22	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	compare	_	_	VBP	O	[-1]	['none']	_	_
25	panels	_	_	NNS	O	[-1]	['none']	_	_
26	B	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	C	_	_	NN	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	Fig.	_	_	NNP	O	[-1]	['none']	_	_
31	5	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Moreover	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
7	epitope	_	_	NN	O	[-1]	['none']	_	_
8	tagged-IKKgamma	_	_	NN	Protein	[6]	['Theme']	_	_
9	confirmed	_	_	VBD	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	recruitment	_	_	NN	Binding	[16]	['Theme']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	IKKgamma	_	_	NN	Protein	[11]	['Theme']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	CD40	_	_	NN	Protein	[11]	['Theme']	_	_
16	requires	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
17	HOIP	_	_	NNP	Protein	[16]	['Cause']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	what	_	_	WP	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	responsible	_	_	JJ	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	increased	_	_	VBN	O	[-1]	['none']	_	_
9	molecular	_	_	JJ	O	[-1]	['none']	_	_
10	weight	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	CD40	_	_	NN	Protein	[0]	['root']	_	_
15	immunoprecipitates	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	protein	_	_	NN	O	[-1]	['none']	_	_
19	samples	_	_	NNS	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	incubated	_	_	VBN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	lambda	_	_	NN	O	[-1]	['none']	_	_
24	phosphatase	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	which	_	_	WDT	O	[-1]	['none']	_	_
27	removes	_	_	VBZ	O	[-1]	['none']	_	_
28	phosphates	_	_	NNS	O	[-1]	['none']	_	_
29	attached	_	_	VBN	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	tyrosine	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	threonine	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	or	_	_	CC	O	[-1]	['none']	_	_
36	serine	_	_	NN	O	[-1]	['none']	_	_
37	residues	_	_	NNS	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	proteins	_	_	NNS	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	treatment	_	_	NN	O	[-1]	['none']	_	_
3	reduced	_	_	VBD	O	[-1]	['none']	_	_
4	much	_	_	RB	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	CD40	_	_	NN	Protein	[7]	['Theme']	_	_
7	associated	_	_	VBN	Binding	[0]	['root']	_	_
8	IKKgamma	_	_	NN	Protein	[7]	['Theme']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	an	_	_	DT	O	[-1]	['none']	_	_
11	apparent	_	_	JJ	O	[-1]	['none']	_	_
12	molecular	_	_	JJ	O	[-1]	['none']	_	_
13	weight	_	_	NN	O	[-1]	['none']	_	_
14	similar	_	_	JJ	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	that	_	_	DT	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	protein	_	_	NN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	lysates	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	at	_	_	IN	O	[-1]	['none']	_	_
4	least	_	_	JJS	O	[-1]	['none']	_	_
5	one	_	_	CD	O	[-1]	['none']	_	_
6	band	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	significantly	_	_	RB	O	[-1]	['none']	_	_
9	higher	_	_	JJR	O	[-1]	['none']	_	_
10	molecular	_	_	JJ	O	[-1]	['none']	_	_
11	weight	_	_	NN	O	[-1]	['none']	_	_
12	remained	_	_	VBD	O	[-1]	['none']	_	_
13	after	_	_	IN	O	[-1]	['none']	_	_
14	phosphatase	_	_	NN	O	[-1]	['none']	_	_
15	treatment	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	suggesting	_	_	VBG	O	[-1]	['none']	_	_
18	that	_	_	IN	O	[-1]	['none']	_	_
19	CD40	_	_	NN	Protein	[20]	['Theme']	_	_
20	associated	_	_	VBN	Binding	[0]	['root']	_	_
21	IKKgamma	_	_	NN	Protein	[20, 33]	['Theme', 'Theme']	_	_
22	is	_	_	VBZ	O	[-1]	['none']	_	_
23	subject	_	_	JJ	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	at	_	_	IN	O	[-1]	['none']	_	_
26	least	_	_	JJS	O	[-1]	['none']	_	_
27	one	_	_	CD	O	[-1]	['none']	_	_
28	other	_	_	JJ	O	[-1]	['none']	_	_
29	modification	_	_	NN	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	addition	_	_	NN	O	[-1]	['none']	_	_
32	to	_	_	TO	O	[-1]	['none']	_	_
33	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Overall	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	data	_	_	NNS	O	[-1]	['none']	_	_
5	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	HOIP	_	_	NN	Protein	[9]	['Cause']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	association	_	_	NN	Binding	[9, 24]	['Theme', 'Cause']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	IKKgamma	_	_	NN	Protein	[12]	['Theme']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	CD40	_	_	NN	Protein	[12]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	suggest	_	_	VBP	O	[-1]	['none']	_	_
20	that	_	_	IN	O	[-1]	['none']	_	_
21	this	_	_	DT	Anaphora	[22]	['multitoken']	_	_
22	event	_	_	NN	Anaphora	[0]	['root']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	coupled	_	_	VBN	Positive_regulation	[0]	['root']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	post-translational	_	_	JJ	Protein_modification	[27]	['multitoken']	_	_
27	modifications	_	_	NNS	Protein_modification	[24]	['Theme']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	IKKgamma	_	_	NN	Protein	[27]	['Theme']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF	_	_	NNP	O	[-1]	['none']	_	_
2	Induces	_	_	VBZ	O	[-1]	['none']	_	_
3	Monocyte	_	_	NN	O	[-1]	['none']	_	_
4	Survival	_	_	NN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	Activating	_	_	VBG	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[9]	['Theme']	_	_
9	Phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
10	at	_	_	IN	O	[-1]	['none']	_	_
11	Ser276	_	_	NN	Entity	[9]	['Site']	_	_
12	via	_	_	IN	O	[-1]	['none']	_	_
13	Protein	_	_	NN	O	[-1]	['none']	_	_
14	Kinase	_	_	NN	O	[-1]	['none']	_	_
15	C	_	_	NN	O	[-1]	['none']	_	_
16	Macrophage	_	_	NN	O	[-1]	['none']	_	_
17	colony	_	_	NN	O	[-1]	['none']	_	_
18	stimulating	_	_	NN	O	[-1]	['none']	_	_
19	factor	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	M-CSF	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	promotes	_	_	VBZ	O	[-1]	['none']	_	_
24	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
25	phagocyte	_	_	NN	O	[-1]	['none']	_	_
26	survival	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	proliferation	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	transcription	_	_	NN	O	[-1]	['none']	_	_
3	factor	_	_	NN	O	[-1]	['none']	_	_
4	Nuclear	_	_	JJ	O	[-1]	['none']	_	_
5	Factor-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	key	_	_	JJ	O	[-1]	['none']	_	_
12	regulator	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	genes	_	_	NNS	O	[-1]	['none']	_	_
15	involved	_	_	VBN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
18	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
19	phagocyte	_	_	NN	O	[-1]	['none']	_	_
20	survival	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	this	_	_	DT	O	[-1]	['none']	_	_
23	study	_	_	NN	O	[-1]	['none']	_	_
24	focused	_	_	VBD	O	[-1]	['none']	_	_
25	at	_	_	IN	O	[-1]	['none']	_	_
26	identifying	_	_	VBG	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	mechanism	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
32	activation	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Here	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	M-CSF	_	_	NN	O	[-1]	['none']	_	_
7	stimulated	_	_	VBD	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
10	activity	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	human	_	_	NN	O	[-1]	['none']	_	_
13	monocyte	_	_	NN	O	[-1]	['none']	_	_
14	derived	_	_	VBN	O	[-1]	['none']	_	_
15	macrophages	_	_	NNS	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	MDMs	_	_	NNS	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	murine	_	_	JJ	O	[-1]	['none']	_	_
22	macrophage	_	_	NN	O	[-1]	['none']	_	_
23	cell	_	_	NN	O	[-1]	['none']	_	_
24	line	_	_	NN	O	[-1]	['none']	_	_
25	RAW	_	_	NN	O	[-1]	['none']	_	_
26	264.7	_	_	CD	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	general	_	_	JJ	O	[-1]	['none']	_	_
3	protein	_	_	NN	O	[-1]	['none']	_	_
4	kinase	_	_	NN	O	[-1]	['none']	_	_
5	C	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	PKC	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	inhibitor	_	_	NN	O	[-1]	['none']	_	_
10	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	conventional	_	_	JJ	O	[-1]	['none']	_	_
14	PKCalpha	_	_	NN	Protein	[17]	['Theme']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	beta	_	_	NN	Protein	[17]	['Theme']	_	_
17	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
18	Go-6976	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	overexpression	_	_	NN	Gene_expression	[0]	['root']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	dominant	_	_	JJ	Protein	[24]	['multitoken']	_	_
23	negative	_	_	JJ	Protein	[24]	['multitoken']	_	_
24	PKCalpha	_	_	NN	Protein	[20]	['Theme']	_	_
25	constructs	_	_	NNS	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	PKCalpha	_	_	NN	Protein	[28]	['multitoken']	_	_
28	siRNA	_	_	NN	Protein	[0]	['root']	_	_
29	reduced	_	_	VBD	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	activity	_	_	NN	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	response	_	_	NN	O	[-1]	['none']	_	_
34	to	_	_	TO	O	[-1]	['none']	_	_
35	M-CSF	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
4	reduced	_	_	VBD	Negative_regulation	[0]	['root']	_	_
5	Ser276	_	_	NN	Entity	[6]	['Site']	_	_
6	phosphorylation	_	_	NN	Phosphorylation	[4]	['Theme']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	NF-kappaBp65	_	_	NN	Protein	[6]	['Theme']	_	_
9	leading	_	_	VBG	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	decreased	_	_	VBN	O	[-1]	['none']	_	_
12	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
13	monocyte	_	_	NN	O	[-1]	['none']	_	_
14	survival	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	report	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	we	_	_	PRP	O	[-1]	['none']	_	_
6	identify	_	_	VBP	O	[-1]	['none']	_	_
7	conventional	_	_	JJ	O	[-1]	['none']	_	_
8	PKCs	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	including	_	_	VBG	O	[-1]	['none']	_	_
11	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	important	_	_	JJ	Regulation	[0]	['root']	_	_
14	upstream	_	_	JJ	O	[-1]	['none']	_	_
15	kinases	_	_	NNS	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	M-CSF-induced	_	_	JJ	Positive_regulation	[13]	['Theme']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
20	activation	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	NF-kappaB-regulated	_	_	JJ	O	[-1]	['none']	_	_
23	gene	_	_	NN	O	[-1]	['none']	_	_
24	expression	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	p65	_	_	NN	Protein	[29]	['Theme']	_	_
28	Ser276	_	_	NN	Entity	[29]	['Site']	_	_
29	phosphorylation	_	_	NN	Phosphorylation	[17]	['Theme']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	macrophage	_	_	NN	O	[-1]	['none']	_	_
33	survival	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Lastly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	find	_	_	VBP	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	p65	_	_	NN	Protein	[0]	['root']	_	_
8	Ser276	_	_	NN	O	[-1]	['none']	_	_
9	plays	_	_	VBZ	O	[-1]	['none']	_	_
10	an	_	_	DT	O	[-1]	['none']	_	_
11	important	_	_	JJ	O	[-1]	['none']	_	_
12	role	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	basal	_	_	JJ	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	M-CSF-stimulated	_	_	JJ	O	[-1]	['none']	_	_
17	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
18	activation	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	human	_	_	NN	O	[-1]	['none']	_	_
21	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
22	phagocytes	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Inhibition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	signaling	_	_	NN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	cpdm	_	_	NN	O	[-1]	['none']	_	_
7	BMDC	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	WT	_	_	JJ	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	cpdm	_	_	JJ	O	[-1]	['none']	_	_
4	BMDC	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	2x106	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	0.5	_	_	CD	O	[-1]	['none']	_	_
10	mL	_	_	NN	O	[-1]	['none']	_	_
11	complete	_	_	JJ	O	[-1]	['none']	_	_
12	medium	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	stimulated	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	100	_	_	CD	O	[-1]	['none']	_	_
18	ng/mL	_	_	NN	O	[-1]	['none']	_	_
19	LPS	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	A	_	_	DT	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	or	_	_	CC	O	[-1]	['none']	_	_
24	25	_	_	CD	O	[-1]	['none']	_	_
25	microg/mL	_	_	NN	O	[-1]	['none']	_	_
26	poly	_	_	NN	O	[-1]	['none']	_	_
27	I	_	_	NN	O	[-1]	['none']	_	_
28	:	_	_	:	O	[-1]	['none']	_	_
29	C	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	B	_	_	NN	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	At	_	_	IN	O	[-1]	['none']	_	_
2	0	_	_	CD	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	15	_	_	CD	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	30	_	_	CD	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	60	_	_	CD	O	[-1]	['none']	_	_
10	minutes	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	whole-cell	_	_	JJ	O	[-1]	['none']	_	_
13	lysates	_	_	NNS	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	obtained	_	_	VBN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	subject	_	_	JJ	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	immunoblots	_	_	NNS	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	antibodies	_	_	NNS	O	[-1]	['none']	_	_
22	against	_	_	IN	O	[-1]	['none']	_	_
23	proteins	_	_	NNS	O	[-1]	['none']	_	_
24	involved	_	_	VBN	O	[-1]	['none']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	TBK1	_	_	NN	Protein	[0]	['root']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	IRF3	_	_	NN	Protein	[0]	['root']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	ERK1/2	_	_	NN	Protein	[0]	['root']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	p38	_	_	NN	O	[-1]	['none']	_	_
36	signaling	_	_	NN	O	[-1]	['none']	_	_
37	pathways	_	_	NNS	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Beta-actin	_	_	NN	Protein	[0]	['root']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	loading	_	_	VBG	O	[-1]	['none']	_	_
6	control	_	_	NN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Cellular	_	_	JJ	O	[-1]	['none']	_	_
5	levels	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	p-IKK1/2	_	_	NN	Protein	[0]	['root']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	p-IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	LPS-	_	_	NN	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	poly	_	_	NN	O	[-1]	['none']	_	_
14	I	_	_	NN	O	[-1]	['none']	_	_
15	:	_	_	:	O	[-1]	['none']	_	_
16	C	_	_	NN	O	[-1]	['none']	_	_
17	stimulated	_	_	VBD	O	[-1]	['none']	_	_
18	BMDC	_	_	NNP	O	[-1]	['none']	_	_
19	were	_	_	VBD	O	[-1]	['none']	_	_
20	quantitated	_	_	VBN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	ImageJ	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	NIH	_	_	NNP	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	presented	_	_	VBN	O	[-1]	['none']	_	_
28	as	_	_	IN	O	[-1]	['none']	_	_
29	trend	_	_	NN	O	[-1]	['none']	_	_
30	lines	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Results	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	representative	_	_	JJ	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	least	_	_	JJS	O	[-1]	['none']	_	_
7	two	_	_	CD	O	[-1]	['none']	_	_
8	independent	_	_	JJ	O	[-1]	['none']	_	_
9	experiments	_	_	NNS	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	Involvement	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PKC	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	JNK	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	cytokine	_	_	NN	O	[-1]	['none']	_	_
8	expression	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Jurkat	_	_	NN	O	[-1]	['none']	_	_
2	T-cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	incubated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	PKC-	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	JNK	_	_	NN	O	[-1]	['none']	_	_
9	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	1	_	_	CD	O	[-1]	['none']	_	_
12	h	_	_	NN	O	[-1]	['none']	_	_
13	followed	_	_	VBN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	stimulation	_	_	NN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	PMA	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	162	_	_	CD	O	[-1]	['none']	_	_
20	nM	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	24	_	_	CD	O	[-1]	['none']	_	_
24	h.	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	A	_	_	DT	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	CXCL8	_	_	NN	Protein	[29]	['Theme']	_	_
29	expression	_	_	NN	Gene_expression	[31]	['Theme']	_	_
30	was	_	_	VBD	O	[-1]	['none']	_	_
31	inhibited	_	_	VBN	Negative_regulation	[35]	['Theme']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	dose	_	_	NN	O	[-1]	['none']	_	_
35	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
36	manner	_	_	NN	O	[-1]	['none']	_	_
37	by	_	_	IN	O	[-1]	['none']	_	_
38	both	_	_	DT	O	[-1]	['none']	_	_
39	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	JNK-I	_	_	NN	O	[-1]	['none']	_	_
5	revealed	_	_	VBD	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	stronger	_	_	JJR	O	[-1]	['none']	_	_
8	inhibitory	_	_	JJ	Negative_regulation	[9]	['multitoken']	_	_
9	effect	_	_	NN	Negative_regulation	[0]	['root']	_	_
10	on	_	_	IN	O	[-1]	['none']	_	_
11	IL-6	_	_	NN	Protein	[12]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
13	than	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	PKC-I	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	TNF	_	_	NN	O	[-1]	['none']	_	_
5	expression	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	affected	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	either	_	_	CC	O	[-1]	['none']	_	_
11	inhibitor	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	significance	_	_	NN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	positive	_	_	JJ	O	[-1]	['none']	_	_
6	control	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	PMA	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	determined	_	_	VBN	O	[-1]	['none']	_	_
12	using	_	_	VBG	O	[-1]	['none']	_	_
13	Student	_	_	NN	O	[-1]	['none']	_	_
14	's	_	_	POS	O	[-1]	['none']	_	_
15	t-test	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	n	_	_	NN	O	[-1]	['none']	_	_
3	=	_	_	JJ	O	[-1]	['none']	_	_
4	3	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	mRNA	_	_	NN	O	[-1]	['none']	_	_
2	expression	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	DNA	_	_	NN	O	[-1]	['none']	_	_
5	methyltransferases	_	_	NNS	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	methyl-CpG-binding	_	_	JJ	O	[-1]	['none']	_	_
8	proteins	_	_	NNS	O	[-1]	['none']	_	_
9	may	_	_	MD	O	[-1]	['none']	_	_
10	not	_	_	RB	O	[-1]	['none']	_	_
11	be	_	_	VB	O	[-1]	['none']	_	_
12	associated	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
15	promoter	_	_	NN	O	[-1]	['none']	_	_
16	methylation	_	_	NN	O	[-1]	['none']	_	_
17	Since	_	_	IN	O	[-1]	['none']	_	_
18	abundance	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	DNMT	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	MBP	_	_	NN	O	[-1]	['none']	_	_
23	contribute	_	_	VBP	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	promoter	_	_	NN	Entity	[26]	['Site']	_	_
26	regulation	_	_	NN	Regulation	[0]	['root']	_	_
27	via	_	_	IN	O	[-1]	['none']	_	_
28	methylation	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	25,26,28	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	we	_	_	PRP	O	[-1]	['none']	_	_
34	studied	_	_	VBD	O	[-1]	['none']	_	_
35	their	_	_	PRP$	O	[-1]	['none']	_	_
36	mRNA	_	_	NN	O	[-1]	['none']	_	_
37	expression	_	_	NN	O	[-1]	['none']	_	_
38	to	_	_	TO	O	[-1]	['none']	_	_
39	investigate	_	_	VB	O	[-1]	['none']	_	_
40	a	_	_	DT	O	[-1]	['none']	_	_
41	possible	_	_	JJ	O	[-1]	['none']	_	_
42	mechanism	_	_	NN	O	[-1]	['none']	_	_
43	for	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	observed	_	_	JJ	O	[-1]	['none']	_	_
46	methylation	_	_	NN	O	[-1]	['none']	_	_
47	differences	_	_	NNS	O	[-1]	['none']	_	_
48	in	_	_	IN	O	[-1]	['none']	_	_
49	the	_	_	DT	O	[-1]	['none']	_	_
50	IRF-4	_	_	NN	Protein	[26]	['Theme']	_	_
51	promoter	_	_	NN	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	end	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	we	_	_	PRP	O	[-1]	['none']	_	_
6	did	_	_	VBD	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	detect	_	_	VB	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	significant	_	_	JJ	O	[-1]	['none']	_	_
11	difference	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	DNMT	_	_	NNP	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	DNMT1	_	_	NN	Protein	[33]	['Theme']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	DNMT3A	_	_	NN	Protein	[33]	['Theme']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	DNMT3B	_	_	NN	Protein	[33]	['Theme']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	MBP	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	MBD1	_	_	NN	Protein	[33]	['Theme']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	MBD2	_	_	NN	Protein	[33]	['Theme']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	MBD4	_	_	NN	Protein	[33]	['Theme']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	MeCP	_	_	NN	Protein	[33]	['Theme']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	mRNA	_	_	NN	Transcription	[33]	['multitoken']	_	_
33	expression	_	_	NN	Transcription	[0]	['root']	_	_
34	between	_	_	IN	O	[-1]	['none']	_	_
35	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
38	cells	_	_	NNS	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	fact	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	all	_	_	DT	O	[-1]	['none']	_	_
5	analyzed	_	_	JJ	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	had	_	_	VBD	O	[-1]	['none']	_	_
8	moderate	_	_	JJ	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	high	_	_	JJ	O	[-1]	['none']	_	_
11	mRNA	_	_	NN	Transcription	[12]	['multitoken']	_	_
12	levels	_	_	NNS	Transcription	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	these	_	_	DT	Anaphora	[16]	['multitoken']	_	_
15	tested	_	_	JJ	Anaphora	[16]	['multitoken']	_	_
16	DNMT	_	_	NN	Anaphora	[0]	['root']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	MBPs	_	_	NNS	Anaphora	[0]	['root']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	differences	_	_	NNS	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	expression	_	_	NN	Transcription	[0]	['root']	_	_
23	were	_	_	VBD	O	[-1]	['none']	_	_
24	not	_	_	RB	O	[-1]	['none']	_	_
25	correlated	_	_	VBN	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
28	status	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	distinct	_	_	JJ	O	[-1]	['none']	_	_
6	cause	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	methylation	_	_	NN	O	[-1]	['none']	_	_
10	differences	_	_	NNS	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	rather	_	_	RB	O	[-1]	['none']	_	_
17	than	_	_	IN	O	[-1]	['none']	_	_
18	changes	_	_	NNS	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	Anaphora	[21]	['multitoken']	_	_
21	DNMT	_	_	NN	Anaphora	[0]	['root']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	MBP	_	_	NN	Anaphora	[0]	['root']	_	_
24	mRNA	_	_	NN	O	[-1]	['none']	_	_
25	transcription	_	_	NN	Transcription	[0]	['root']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	bacterial	_	_	JJ	O	[-1]	['none']	_	_
3	membrane	_	_	NN	O	[-1]	['none']	_	_
4	component	_	_	NN	O	[-1]	['none']	_	_
5	lipopolysaccharide	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	LPS	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	capable	_	_	JJ	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	initiating	_	_	VBG	O	[-1]	['none']	_	_
13	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	activation	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	multiple	_	_	JJ	O	[-1]	['none']	_	_
18	host	_	_	NN	O	[-1]	['none']	_	_
19	intracellular	_	_	JJ	O	[-1]	['none']	_	_
20	protein	_	_	NN	O	[-1]	['none']	_	_
21	kinases	_	_	NNS	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	transcription	_	_	NN	O	[-1]	['none']	_	_
24	factors	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Transcription	_	_	NN	O	[-1]	['none']	_	_
2	factor	_	_	NN	O	[-1]	['none']	_	_
3	activation	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	which	_	_	WDT	O	[-1]	['none']	_	_
6	results	_	_	VBZ	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	modulation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	gene	_	_	NN	O	[-1]	['none']	_	_
12	transcription	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	protein	_	_	NN	O	[-1]	['none']	_	_
15	synthesis	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	critical	_	_	JJ	O	[-1]	['none']	_	_
20	element	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	defense	_	_	NN	O	[-1]	['none']	_	_
24	mechanism	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	host	_	_	NN	O	[-1]	['none']	_	_
28	immune	_	_	JJ	O	[-1]	['none']	_	_
29	system	_	_	NN	O	[-1]	['none']	_	_
30	.1,2	_	_	CD	O	[-1]	['none']	_	_
31	LPS	_	_	NN	O	[-1]	['none']	_	_
32	induced	_	_	VBD	O	[-1]	['none']	_	_
33	transcription	_	_	NN	O	[-1]	['none']	_	_
34	factor	_	_	NN	O	[-1]	['none']	_	_
35	activation	_	_	NN	O	[-1]	['none']	_	_
36	has	_	_	VBZ	O	[-1]	['none']	_	_
37	been	_	_	VBN	O	[-1]	['none']	_	_
38	shown	_	_	VBN	O	[-1]	['none']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	be	_	_	VB	O	[-1]	['none']	_	_
41	a	_	_	DT	O	[-1]	['none']	_	_
42	key	_	_	JJ	O	[-1]	['none']	_	_
43	regulator	_	_	NN	Regulation	[0]	['root']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	tumor	_	_	NN	Protein	[47]	['multitoken']	_	_
46	necrosis	_	_	NN	Protein	[47]	['multitoken']	_	_
47	factor-alpha	_	_	NN	Protein	[51]	['Theme']	_	_
48	(	_	_	-LRB-	O	[-1]	['none']	_	_
49	TNF-alpha	_	_	NN	Protein	[0]	['root']	_	_
50	)	_	_	-RRB-	O	[-1]	['none']	_	_
51	production	_	_	NN	Gene_expression	[43]	['Theme']	_	_
52	.3	_	_	NN	O	[-1]	['none']	_	_
53	TNF-alpha	_	_	NN	Protein	[0]	['root']	_	_
54	is	_	_	VBZ	O	[-1]	['none']	_	_
55	a	_	_	DT	O	[-1]	['none']	_	_
56	potent	_	_	JJ	O	[-1]	['none']	_	_
57	pro	_	_	JJ	O	[-1]	['none']	_	_
58	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
59	cytokine	_	_	NN	O	[-1]	['none']	_	_
60	involved	_	_	VBN	O	[-1]	['none']	_	_
61	in	_	_	IN	O	[-1]	['none']	_	_
62	a	_	_	DT	O	[-1]	['none']	_	_
63	wide	_	_	JJ	O	[-1]	['none']	_	_
64	spectrum	_	_	NN	O	[-1]	['none']	_	_
65	of	_	_	IN	O	[-1]	['none']	_	_
66	cellular	_	_	JJ	O	[-1]	['none']	_	_
67	responses	_	_	NNS	O	[-1]	['none']	_	_
68	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	TNF-alpha	_	_	NN	Protein	[4]	['Theme']	_	_
4	synthesis	_	_	NN	Gene_expression	[7]	['Theme']	_	_
5	can	_	_	MD	O	[-1]	['none']	_	_
6	be	_	_	VB	O	[-1]	['none']	_	_
7	attenuated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	immune	_	_	JJ	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	exposed	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	PDE	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	inhibition	_	_	NN	O	[-1]	['none']	_	_
18	after	_	_	IN	O	[-1]	['none']	_	_
19	challenge	_	_	NN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	variety	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	pro	_	_	JJ	O	[-1]	['none']	_	_
25	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
26	stimulants	_	_	NNS	O	[-1]	['none']	_	_
27	.4	_	_	CD	O	[-1]	['none']	_	_
28	The	_	_	DT	O	[-1]	['none']	_	_
29	signaling	_	_	NN	O	[-1]	['none']	_	_
30	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
31	affected	_	_	VBN	O	[-1]	['none']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	PDE	_	_	NN	O	[-1]	['none']	_	_
34	inhibition	_	_	NN	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	which	_	_	WDT	O	[-1]	['none']	_	_
37	ultimately	_	_	RB	O	[-1]	['none']	_	_
38	lead	_	_	VBP	Positive_regulation	[0]	['root']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	the	_	_	DT	O	[-1]	['none']	_	_
41	downregulation	_	_	NN	Negative_regulation	[38]	['Theme']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	TNF-alpha	_	_	NN	Protein	[44]	['Theme']	_	_
44	production	_	_	NN	Gene_expression	[41]	['Theme']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	have	_	_	VBP	O	[-1]	['none']	_	_
47	not	_	_	RB	O	[-1]	['none']	_	_
48	been	_	_	VBN	O	[-1]	['none']	_	_
49	well	_	_	RB	O	[-1]	['none']	_	_
50	characterized	_	_	VBN	O	[-1]	['none']	_	_
51	in	_	_	IN	O	[-1]	['none']	_	_
52	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
53	cells	_	_	NNS	O	[-1]	['none']	_	_
54	.	_	_	.	O	[-1]	['none']	_	_

1	Classically	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	it	_	_	PRP	O	[-1]	['none']	_	_
4	has	_	_	VBZ	O	[-1]	['none']	_	_
5	been	_	_	VBN	O	[-1]	['none']	_	_
6	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	PDE	_	_	NN	O	[-1]	['none']	_	_
9	inhibition	_	_	NN	O	[-1]	['none']	_	_
10	results	_	_	VBZ	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	intracellular	_	_	JJ	O	[-1]	['none']	_	_
14	accumulation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	second	_	_	JJ	O	[-1]	['none']	_	_
18	messenger	_	_	NN	O	[-1]	['none']	_	_
19	cyclic	_	_	JJ	O	[-1]	['none']	_	_
20	adenosine-3	_	_	JJ	O	[-1]	['none']	_	_
21	,5-monophosphate	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	cAMP	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	subsequent	_	_	JJ	O	[-1]	['none']	_	_
27	activation	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	Protein	_	_	NN	O	[-1]	['none']	_	_
30	kinase	_	_	NN	O	[-1]	['none']	_	_
31	A	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	PKA	_	_	NN	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.5	_	_	CD	O	[-1]	['none']	_	_
36	PKA	_	_	NN	O	[-1]	['none']	_	_
37	activation	_	_	NN	O	[-1]	['none']	_	_
38	then	_	_	RB	O	[-1]	['none']	_	_
39	leads	_	_	VBZ	O	[-1]	['none']	_	_
40	to	_	_	TO	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	transcription	_	_	NN	O	[-1]	['none']	_	_
46	factor	_	_	NN	O	[-1]	['none']	_	_
47	cAMP	_	_	NN	O	[-1]	['none']	_	_
48	response	_	_	NN	O	[-1]	['none']	_	_
49	element	_	_	NN	O	[-1]	['none']	_	_
50	binding	_	_	NN	O	[-1]	['none']	_	_
51	protein	_	_	NN	O	[-1]	['none']	_	_
52	(	_	_	-LRB-	O	[-1]	['none']	_	_
53	CREB	_	_	NN	O	[-1]	['none']	_	_
54	)	_	_	-RRB-	O	[-1]	['none']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	transmission	_	_	NN	O	[-1]	['none']	_	_
57	of	_	_	IN	O	[-1]	['none']	_	_
58	signals	_	_	NNS	O	[-1]	['none']	_	_
59	into	_	_	IN	O	[-1]	['none']	_	_
60	the	_	_	DT	O	[-1]	['none']	_	_
61	nucleus	_	_	NN	O	[-1]	['none']	_	_
62	,	_	_	,	O	[-1]	['none']	_	_
63	and	_	_	CC	O	[-1]	['none']	_	_
64	the	_	_	DT	O	[-1]	['none']	_	_
65	subsequent	_	_	JJ	O	[-1]	['none']	_	_
66	modulation	_	_	NN	O	[-1]	['none']	_	_
67	of	_	_	IN	O	[-1]	['none']	_	_
68	gene	_	_	NN	O	[-1]	['none']	_	_
69	transcription	_	_	NN	O	[-1]	['none']	_	_
70	.6	_	_	CD	O	[-1]	['none']	_	_
71	This	_	_	DT	O	[-1]	['none']	_	_
72	apparently	_	_	RB	O	[-1]	['none']	_	_
73	simple	_	_	JJ	O	[-1]	['none']	_	_
74	linear	_	_	JJ	O	[-1]	['none']	_	_
75	cascade	_	_	NN	O	[-1]	['none']	_	_
76	does	_	_	VBZ	O	[-1]	['none']	_	_
77	not	_	_	RB	O	[-1]	['none']	_	_
78	fully	_	_	RB	O	[-1]	['none']	_	_
79	explain	_	_	VB	O	[-1]	['none']	_	_
80	the	_	_	DT	O	[-1]	['none']	_	_
81	mechanism	_	_	NN	O	[-1]	['none']	_	_
82	by	_	_	IN	O	[-1]	['none']	_	_
83	which	_	_	WDT	O	[-1]	['none']	_	_
84	an	_	_	DT	O	[-1]	['none']	_	_
85	elevation	_	_	NN	O	[-1]	['none']	_	_
86	in	_	_	IN	O	[-1]	['none']	_	_
87	the	_	_	DT	O	[-1]	['none']	_	_
88	intracellular	_	_	JJ	O	[-1]	['none']	_	_
89	cAMP	_	_	NN	O	[-1]	['none']	_	_
90	level	_	_	NN	O	[-1]	['none']	_	_
91	exerts	_	_	VBZ	O	[-1]	['none']	_	_
92	wide	_	_	JJ	O	[-1]	['none']	_	_
93	ranging	_	_	VBG	O	[-1]	['none']	_	_
94	effects	_	_	NNS	O	[-1]	['none']	_	_
95	on	_	_	IN	O	[-1]	['none']	_	_
96	multiple	_	_	JJ	O	[-1]	['none']	_	_
97	cellular	_	_	JJ	O	[-1]	['none']	_	_
98	functions	_	_	NNS	O	[-1]	['none']	_	_
99	.	_	_	.	O	[-1]	['none']	_	_

1	There	_	_	EX	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	growing	_	_	VBG	O	[-1]	['none']	_	_
5	body	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	evidence	_	_	NN	O	[-1]	['none']	_	_
8	suggesting	_	_	VBG	O	[-1]	['none']	_	_
9	that	_	_	IN	O	[-1]	['none']	_	_
10	cAMP	_	_	NN	O	[-1]	['none']	_	_
11	may	_	_	MD	O	[-1]	['none']	_	_
12	function	_	_	VB	O	[-1]	['none']	_	_
13	through	_	_	IN	O	[-1]	['none']	_	_
14	both	_	_	DT	O	[-1]	['none']	_	_
15	PKA	_	_	NN	O	[-1]	['none']	_	_
16	dependent	_	_	JJ	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	-independent	_	_	JJ	O	[-1]	['none']	_	_
19	mechanisms.6-8	_	_	JJ	O	[-1]	['none']	_	_
20	LPS	_	_	NN	O	[-1]	['none']	_	_
21	induced	_	_	VBD	O	[-1]	['none']	_	_
22	activation	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	transcription	_	_	NN	O	[-1]	['none']	_	_
26	factor	_	_	NN	O	[-1]	['none']	_	_
27	nuclear	_	_	JJ	O	[-1]	['none']	_	_
28	factor-kappaB	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	has	_	_	VBZ	O	[-1]	['none']	_	_
33	also	_	_	RB	O	[-1]	['none']	_	_
34	been	_	_	VBN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	focus	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	a	_	_	DT	O	[-1]	['none']	_	_
39	great	_	_	JJ	O	[-1]	['none']	_	_
40	deal	_	_	NN	O	[-1]	['none']	_	_
41	of	_	_	IN	O	[-1]	['none']	_	_
42	research	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	been	_	_	VBN	O	[-1]	['none']	_	_
4	clearly	_	_	RB	O	[-1]	['none']	_	_
5	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	agents	_	_	NNS	O	[-1]	['none']	_	_
8	that	_	_	WDT	O	[-1]	['none']	_	_
9	increase	_	_	VBP	O	[-1]	['none']	_	_
10	intracellular	_	_	JJ	O	[-1]	['none']	_	_
11	cAMP	_	_	NN	O	[-1]	['none']	_	_
12	also	_	_	RB	O	[-1]	['none']	_	_
13	inhibit	_	_	VBP	Negative_regulation	[0]	['root']	_	_
14	NF-kappaB-dependent	_	_	JJ	Regulation	[13]	['Theme']	_	_
15	pro	_	_	JJ	O	[-1]	['none']	_	_
16	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
17	gene	_	_	NN	O	[-1]	['none']	_	_
18	transcription	_	_	NN	Transcription	[14]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	particularly	_	_	RB	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	TNF-alpha	_	_	NN	Protein	[18]	['Theme']	_	_
24	gene	_	_	NN	O	[-1]	['none']	_	_
25	.9	_	_	CD	O	[-1]	['none']	_	_
26	Controversy	_	_	NN	O	[-1]	['none']	_	_
27	exists	_	_	VBZ	O	[-1]	['none']	_	_
28	regarding	_	_	VBG	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	exact	_	_	JJ	O	[-1]	['none']	_	_
31	mechanism	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	s	_	_	VBZ	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	by	_	_	IN	O	[-1]	['none']	_	_
36	which	_	_	WDT	O	[-1]	['none']	_	_
37	PDE	_	_	NN	O	[-1]	['none']	_	_
38	inhibition	_	_	NN	O	[-1]	['none']	_	_
39	down-regulates	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
40	TNF-alpha	_	_	NN	Protein	[41]	['Theme']	_	_
41	production	_	_	NN	Gene_expression	[39]	['Theme']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Possibilities	_	_	NNS	O	[-1]	['none']	_	_
2	include	_	_	VBP	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	but	_	_	CC	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	limited	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	inhibition	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	DNA	_	_	NN	O	[-1]	['none']	_	_
14	binding	_	_	NN	O	[-1]	['none']	_	_
15	activity	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	downregulation	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
21	activity	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	increased	_	_	VBD	O	[-1]	['none']	_	_
24	CREB	_	_	NN	O	[-1]	['none']	_	_
25	activation	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	competition	_	_	NN	O	[-1]	['none']	_	_
29	between	_	_	IN	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	CREB	_	_	NN	O	[-1]	['none']	_	_
33	for	_	_	IN	O	[-1]	['none']	_	_
34	common	_	_	JJ	O	[-1]	['none']	_	_
35	co-activators	_	_	NNS	O	[-1]	['none']	_	_
36	such	_	_	JJ	O	[-1]	['none']	_	_
37	as	_	_	IN	O	[-1]	['none']	_	_
38	CREB	_	_	NN	O	[-1]	['none']	_	_
39	binding	_	_	NN	O	[-1]	['none']	_	_
40	protein	_	_	NN	O	[-1]	['none']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	CBP	_	_	NN	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	not	_	_	RB	O	[-1]	['none']	_	_
5	known	_	_	VBN	O	[-1]	['none']	_	_
6	whether	_	_	IN	O	[-1]	['none']	_	_
7	these	_	_	DT	O	[-1]	['none']	_	_
8	processes	_	_	NNS	O	[-1]	['none']	_	_
9	rely	_	_	VBP	O	[-1]	['none']	_	_
10	solely	_	_	RB	O	[-1]	['none']	_	_
11	upon	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	activation	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	PKA	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	objective	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	present	_	_	JJ	O	[-1]	['none']	_	_
8	study	_	_	NN	O	[-1]	['none']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	determine	_	_	VB	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	effects	_	_	NNS	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	nonspecific	_	_	JJ	O	[-1]	['none']	_	_
16	PDE	_	_	NN	O	[-1]	['none']	_	_
17	inhibition	_	_	NN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	1-[	_	_	CD	O	[-1]	['none']	_	_
20	5-oxohexyl	_	_	NN	O	[-1]	['none']	_	_
21	]	_	_	CD	O	[-1]	['none']	_	_
22	-3,7-dimethylxanthine	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	Pentoxifylline	_	_	NN	O	[-1]	['none']	_	_
25	;	_	_	:	O	[-1]	['none']	_	_
26	PTX	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	on	_	_	IN	O	[-1]	['none']	_	_
29	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	CREB	_	_	NN	O	[-1]	['none']	_	_
32	activation	_	_	NN	O	[-1]	['none']	_	_
33	in	_	_	FW	O	[-1]	['none']	_	_
34	vitro	_	_	FW	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	human	_	_	NN	O	[-1]	['none']	_	_
37	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
38	cells	_	_	NNS	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	With	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	use	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	specific	_	_	JJ	O	[-1]	['none']	_	_
6	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	we	_	_	PRP	O	[-1]	['none']	_	_
9	also	_	_	RB	O	[-1]	['none']	_	_
10	investigated	_	_	VBD	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	role	_	_	NN	Regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	PKA	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	LPS	_	_	NN	O	[-1]	['none']	_	_
17	induced	_	_	VBD	Positive_regulation	[12]	['Theme']	_	_
18	TNF-alpha	_	_	NN	Protein	[19]	['Theme']	_	_
19	production	_	_	NN	Gene_expression	[17]	['Theme']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	Promotes	_	_	VBZ	O	[-1]	['none']	_	_
3	B	_	_	NN	O	[-1]	['none']	_	_
4	Cell	_	_	NN	O	[-1]	['none']	_	_
5	Survival	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	Proliferation	_	_	NN	O	[-1]	['none']	_	_
8	In	_	_	IN	O	[-1]	['none']	_	_
9	Vitro	_	_	NNP	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	A	_	_	DT	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	MTS	_	_	NN	O	[-1]	['none']	_	_
14	assay	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
17	from	_	_	IN	O	[-1]	['none']	_	_
18	WT	_	_	NNP	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	LMP1	_	_	NN	Protein	[0]	['root']	_	_
21	transgenic	_	_	JJ	O	[-1]	['none']	_	_
22	mice	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Splenocytes	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	cultured	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	presence	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	grey	_	_	JJ	O	[-1]	['none']	_	_
9	bars	_	_	NNS	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	absence	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	black	_	_	JJ	O	[-1]	['none']	_	_
15	bars	_	_	NNS	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IL4	_	_	NN	Protein	[0]	['root']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	3	_	_	CD	O	[-1]	['none']	_	_
21	d	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	mean	_	_	NN	O	[-1]	['none']	_	_
6	+/-	_	_	CC	O	[-1]	['none']	_	_
7	SEM	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	triplicate	_	_	NN	O	[-1]	['none']	_	_
10	samples	_	_	NNS	O	[-1]	['none']	_	_
11	averaged	_	_	VBD	O	[-1]	['none']	_	_
12	from	_	_	IN	O	[-1]	['none']	_	_
13	multiple	_	_	JJ	O	[-1]	['none']	_	_
14	mice	_	_	NNS	O	[-1]	['none']	_	_
15	where	_	_	WRB	O	[-1]	['none']	_	_
16	"	_	_	``	O	[-1]	['none']	_	_
17	n	_	_	NN	O	[-1]	['none']	_	_
18	"	_	_	''	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	number	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	mice	_	_	NNS	O	[-1]	['none']	_	_
23	analyzed	_	_	VBN	O	[-1]	['none']	_	_
24	is	_	_	VBZ	O	[-1]	['none']	_	_
25	as	_	_	IN	O	[-1]	['none']	_	_
26	follows	_	_	VBZ	O	[-1]	['none']	_	_
27	:	_	_	:	O	[-1]	['none']	_	_
28	n	_	_	NN	O	[-1]	['none']	_	_
29	=	_	_	JJ	O	[-1]	['none']	_	_
30	2	_	_	CD	O	[-1]	['none']	_	_
31	for	_	_	IN	O	[-1]	['none']	_	_
32	WT	_	_	JJ	O	[-1]	['none']	_	_
33	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	WT	_	_	JJ	O	[-1]	['none']	_	_
36	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	n	_	_	NN	O	[-1]	['none']	_	_
39	=	_	_	JJ	O	[-1]	['none']	_	_
40	11	_	_	CD	O	[-1]	['none']	_	_
41	for	_	_	IN	O	[-1]	['none']	_	_
42	LMP1	_	_	NN	Protein	[0]	['root']	_	_
43	transgenic	_	_	JJ	O	[-1]	['none']	_	_
44	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	and	_	_	CC	O	[-1]	['none']	_	_
47	n	_	_	NN	O	[-1]	['none']	_	_
48	=	_	_	JJ	O	[-1]	['none']	_	_
49	13	_	_	CD	O	[-1]	['none']	_	_
50	for	_	_	IN	O	[-1]	['none']	_	_
51	LMP1	_	_	NN	Protein	[0]	['root']	_	_
52	transgenic	_	_	JJ	O	[-1]	['none']	_	_
53	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
54	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	EMA	_	_	NN	O	[-1]	['none']	_	_
5	exclusion	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
8	gated	_	_	JJ	O	[-1]	['none']	_	_
9	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
10	from	_	_	IN	O	[-1]	['none']	_	_
11	WT	_	_	NNP	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	LMP1	_	_	NN	Protein	[0]	['root']	_	_
14	transgenic	_	_	JJ	O	[-1]	['none']	_	_
15	mice	_	_	NNS	O	[-1]	['none']	_	_
16	showing	_	_	VBG	O	[-1]	['none']	_	_
17	percentage	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	viable	_	_	JJ	O	[-1]	['none']	_	_
20	B	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	cultured	_	_	VBN	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	white	_	_	JJ	O	[-1]	['none']	_	_
26	bars	_	_	NNS	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	without	_	_	IN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	black	_	_	JJ	O	[-1]	['none']	_	_
32	bars	_	_	NNS	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	IL4	_	_	NN	Protein	[0]	['root']	_	_
35	for	_	_	IN	O	[-1]	['none']	_	_
36	2	_	_	CD	O	[-1]	['none']	_	_
37	d.	_	_	NN	O	[-1]	['none']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	C	_	_	NN	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	Flow	_	_	NN	O	[-1]	['none']	_	_
42	cytometry	_	_	NN	O	[-1]	['none']	_	_
43	analysis	_	_	NN	O	[-1]	['none']	_	_
44	for	_	_	IN	O	[-1]	['none']	_	_
45	incorporated	_	_	JJ	O	[-1]	['none']	_	_
46	BrdU	_	_	NN	O	[-1]	['none']	_	_
47	in	_	_	IN	O	[-1]	['none']	_	_
48	WT	_	_	NNP	O	[-1]	['none']	_	_
49	and	_	_	CC	O	[-1]	['none']	_	_
50	LMP1	_	_	NN	Protein	[0]	['root']	_	_
51	transgenic	_	_	JJ	O	[-1]	['none']	_	_
52	lymphoma	_	_	NN	O	[-1]	['none']	_	_
53	cells	_	_	NNS	O	[-1]	['none']	_	_
54	cultured	_	_	VBN	O	[-1]	['none']	_	_
55	with	_	_	IN	O	[-1]	['none']	_	_
56	or	_	_	CC	O	[-1]	['none']	_	_
57	without	_	_	IN	O	[-1]	['none']	_	_
58	IL4	_	_	NN	Protein	[0]	['root']	_	_
59	for	_	_	IN	O	[-1]	['none']	_	_
60	2	_	_	CD	O	[-1]	['none']	_	_
61	d.	_	_	NN	O	[-1]	['none']	_	_
62	Shown	_	_	VBN	O	[-1]	['none']	_	_
63	are	_	_	VBP	O	[-1]	['none']	_	_
64	the	_	_	DT	O	[-1]	['none']	_	_
65	results	_	_	NNS	O	[-1]	['none']	_	_
66	from	_	_	IN	O	[-1]	['none']	_	_
67	WT	_	_	JJ	O	[-1]	['none']	_	_
68	lymphoma	_	_	NN	O	[-1]	['none']	_	_
69	1	_	_	CD	O	[-1]	['none']	_	_
70	and	_	_	CC	O	[-1]	['none']	_	_
71	LMP1	_	_	NN	Protein	[0]	['root']	_	_
72	transgenic	_	_	JJ	O	[-1]	['none']	_	_
73	lymphoma	_	_	NN	O	[-1]	['none']	_	_
74	2	_	_	CD	O	[-1]	['none']	_	_
75	.	_	_	.	O	[-1]	['none']	_	_

1	Percentages	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	each	_	_	DT	O	[-1]	['none']	_	_
6	quadrant	_	_	NN	O	[-1]	['none']	_	_
7	are	_	_	VBP	O	[-1]	['none']	_	_
8	shown	_	_	VBN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Transactivation	_	_	NN	O	[-1]	['none']	_	_
3	Functions	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
6	Tax	_	_	NN	Protein	[0]	['root']	_	_
7	Are	_	_	VBP	O	[-1]	['none']	_	_
8	Suppressed	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
11	Previous	_	_	JJ	O	[-1]	['none']	_	_
12	studies	_	_	NNS	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	Bettelli	_	_	NNP	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	colleagues	_	_	NNS	O	[-1]	['none']	_	_
17	have	_	_	VBP	O	[-1]	['none']	_	_
18	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
19	that	_	_	IN	O	[-1]	['none']	_	_
20	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
21	can	_	_	MD	O	[-1]	['none']	_	_
22	repress	_	_	VB	O	[-1]	['none']	_	_
23	both	_	_	CC	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	basal	_	_	JJ	O	[-1]	['none']	_	_
26	levels	_	_	NNS	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
29	activation	_	_	NN	O	[-1]	['none']	_	_
30	as	_	_	RB	O	[-1]	['none']	_	_
31	well	_	_	RB	O	[-1]	['none']	_	_
32	as	_	_	IN	O	[-1]	['none']	_	_
33	tumor	_	_	NN	Protein	[35]	['multitoken']	_	_
34	necrosis	_	_	NN	Protein	[35]	['multitoken']	_	_
35	factor-alpha-stimulated	_	_	JJ	Protein	[0]	['root']	_	_
36	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
37	activation	_	_	NN	O	[-1]	['none']	_	_
38	[	_	_	CD	O	[-1]	['none']	_	_
39	15	_	_	CD	O	[-1]	['none']	_	_
40	]	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	next	_	_	JJ	O	[-1]	['none']	_	_
3	step	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	determine	_	_	VB	O	[-1]	['none']	_	_
7	whether	_	_	IN	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
9	could	_	_	MD	O	[-1]	['none']	_	_
10	also	_	_	RB	O	[-1]	['none']	_	_
11	suppress	_	_	VB	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	activation	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	caused	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	strong	_	_	JJ	O	[-1]	['none']	_	_
20	viral	_	_	JJ	O	[-1]	['none']	_	_
21	transactivator	_	_	NN	O	[-1]	['none']	_	_
22	protein	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	HTLV-I	_	_	NNP	O	[-1]	['none']	_	_
2	encodes	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	multifunctional	_	_	JJ	O	[-1]	['none']	_	_
5	transactivator	_	_	NN	O	[-1]	['none']	_	_
6	protein	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	Tax	_	_	NN	Protein	[0]	['root']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	capable	_	_	JJ	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	activating	_	_	VBG	O	[-1]	['none']	_	_
13	both	_	_	CC	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	CREB	_	_	NN	O	[-1]	['none']	_	_
18	pathways	_	_	NNS	O	[-1]	['none']	_	_
19	[	_	_	VBP	O	[-1]	['none']	_	_
20	24-29	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	CD	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
4	Tax	_	_	NN	Protein	[0]	['root']	_	_
5	protein	_	_	NN	O	[-1]	['none']	_	_
6	can	_	_	MD	O	[-1]	['none']	_	_
7	function	_	_	VB	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	multiple	_	_	JJ	O	[-1]	['none']	_	_
10	levels	_	_	NNS	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	both	_	_	CC	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	cytoplasm	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	nucleus	_	_	NN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	stimulate	_	_	VB	O	[-1]	['none']	_	_
20	activation	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
23	[	_	_	CD	O	[-1]	['none']	_	_
24	28,29	_	_	CD	O	[-1]	['none']	_	_
25	]	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	we	_	_	PRP	O	[-1]	['none']	_	_
28	hypothesized	_	_	VBD	O	[-1]	['none']	_	_
29	that	_	_	IN	O	[-1]	['none']	_	_
30	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	Foxp3	_	_	NN	Protein	[30]	['Theme']	_	_
33	may	_	_	MD	O	[-1]	['none']	_	_
34	interfere	_	_	VB	O	[-1]	['none']	_	_
35	with	_	_	IN	O	[-1]	['none']	_	_
36	this	_	_	DT	O	[-1]	['none']	_	_
37	process	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	since	_	_	IN	O	[-1]	['none']	_	_
4	Tax	_	_	NN	Protein	[0]	['root']	_	_
5	dependent	_	_	JJ	O	[-1]	['none']	_	_
6	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
7	gene	_	_	NN	O	[-1]	['none']	_	_
8	expression	_	_	NN	O	[-1]	['none']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	independent	_	_	JJ	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	18	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	we	_	_	PRP	O	[-1]	['none']	_	_
18	also	_	_	RB	O	[-1]	['none']	_	_
19	hypothesized	_	_	VBD	O	[-1]	['none']	_	_
20	that	_	_	IN	O	[-1]	['none']	_	_
21	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
22	would	_	_	MD	O	[-1]	['none']	_	_
23	not	_	_	RB	O	[-1]	['none']	_	_
24	affect	_	_	VB	O	[-1]	['none']	_	_
25	Tax	_	_	NN	Protein	[0]	['root']	_	_
26	dependent	_	_	JJ	O	[-1]	['none']	_	_
27	activation	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
31	LTR	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	test	_	_	VB	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	hypotheses	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	we	_	_	PRP	O	[-1]	['none']	_	_
7	overexpressed	_	_	VBD	Positive_regulation	[0]	['root']	_	_
8	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
9	Tax	_	_	NN	Protein	[7]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	full-length	_	_	JJ	O	[-1]	['none']	_	_
12	Foxp3	_	_	NN	Protein	[7]	['Theme']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	and/or	_	_	CC	O	[-1]	['none']	_	_
15	deltaFKH	_	_	NN	Protein	[7]	['Theme']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	HEK	_	_	NNP	O	[-1]	['none']	_	_
18	293T	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	cotransfected	_	_	VBN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	an	_	_	DT	O	[-1]	['none']	_	_
23	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
24	LTR	_	_	NN	O	[-1]	['none']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	reporter	_	_	NN	O	[-1]	['none']	_	_
28	vector	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	4A	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
8	Tax	_	_	NN	Protein	[0]	['root']	_	_
9	strongly	_	_	RB	O	[-1]	['none']	_	_
10	up-regulated	_	_	VBD	O	[-1]	['none']	_	_
11	NF-kappaB-dependent	_	_	JJ	O	[-1]	['none']	_	_
12	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
13	activation	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	~	_	_	NN	O	[-1]	['none']	_	_
16	60-fold	_	_	JJ	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	overexpression	_	_	NN	Gene_expression	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[3]	['Theme']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	but	_	_	CC	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	deltaFKH	_	_	NN	Protein	[3]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	suppressed	_	_	VBD	O	[-1]	['none']	_	_
12	Tax	_	_	NN	Protein	[0]	['root']	_	_
13	mediated	_	_	JJ	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	NF-kappaB-dependent	_	_	JJ	O	[-1]	['none']	_	_
17	transcription	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	observations	_	_	NNS	O	[-1]	['none']	_	_
3	further	_	_	RB	O	[-1]	['none']	_	_
4	suggest	_	_	VBP	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	carboxyl-terminal	_	_	JJ	O	[-1]	['none']	_	_
8	FKH	_	_	NN	O	[-1]	['none']	_	_
9	domain	_	_	NN	O	[-1]	['none']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	required	_	_	VBN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	inhibiting	_	_	VBG	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	presence	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	Tax	_	_	NN	Protein	[0]	['root']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	HEK	_	_	NNP	O	[-1]	['none']	_	_
24	293T	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	strikingly	_	_	RB	O	[-1]	['none']	_	_
28	similar	_	_	JJ	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	requirements	_	_	NNS	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
34	inhibition	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	basal	_	_	JJ	O	[-1]	['none']	_	_
37	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
38	activation	_	_	NN	O	[-1]	['none']	_	_
39	shown	_	_	VBN	O	[-1]	['none']	_	_
40	in	_	_	IN	O	[-1]	['none']	_	_
41	Figure	_	_	NNP	O	[-1]	['none']	_	_
42	2B	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	Transactivation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
5	LTR	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	stimulated	_	_	VBN	O	[-1]	['none']	_	_
8	about	_	_	IN	O	[-1]	['none']	_	_
9	55-fold	_	_	JJ	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Tax	_	_	NN	Protein	[11]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	while	_	_	IN	O	[-1]	['none']	_	_
16	transfection	_	_	NN	Gene_expression	[0]	['root']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	Foxp3	_	_	NN	Protein	[16]	['Theme']	_	_
19	suppressed	_	_	VBD	O	[-1]	['none']	_	_
20	Tax	_	_	NN	Protein	[0]	['root']	_	_
21	dependent	_	_	JJ	O	[-1]	['none']	_	_
22	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
23	LTR	_	_	NN	O	[-1]	['none']	_	_
24	activation	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	although	_	_	IN	O	[-1]	['none']	_	_
27	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
28	LTR	_	_	NN	O	[-1]	['none']	_	_
29	activation	_	_	NN	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	presence	_	_	NN	O	[-1]	['none']	_	_
33	or	_	_	CC	O	[-1]	['none']	_	_
34	absence	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	Tax	_	_	NN	Protein	[0]	['root']	_	_
37	is	_	_	VBZ	O	[-1]	['none']	_	_
38	independent	_	_	JJ	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
41	or	_	_	CC	O	[-1]	['none']	_	_
42	NF-AT	_	_	NN	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	another	_	_	DT	O	[-1]	['none']	_	_
45	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
46	activator	_	_	NN	O	[-1]	['none']	_	_
47	known	_	_	VBN	O	[-1]	['none']	_	_
48	to	_	_	TO	O	[-1]	['none']	_	_
49	interact	_	_	VB	Binding	[0]	['root']	_	_
50	with	_	_	IN	O	[-1]	['none']	_	_
51	Foxp3	_	_	NN	Protein	[49]	['Theme']	_	_
52	)	_	_	-RRB-	O	[-1]	['none']	_	_
53	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	deltaFKH	_	_	NN	Protein	[3]	['Theme']	_	_
6	also	_	_	RB	O	[-1]	['none']	_	_
7	led	_	_	VBD	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	suppression	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
12	transactivation	_	_	NN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	Tax	_	_	NN	Protein	[0]	['root']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	similar	_	_	JJ	O	[-1]	['none']	_	_
18	extent	_	_	NN	O	[-1]	['none']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	full-length	_	_	JJ	O	[-1]	['none']	_	_
21	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	suppressive	_	_	JJ	O	[-1]	['none']	_	_
3	effects	_	_	NNS	O	[-1]	['none']	_	_
4	shown	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	Figure	_	_	NNP	O	[-1]	['none']	_	_
7	4A	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	4B	_	_	NN	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	not	_	_	RB	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	result	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	Foxp3	_	_	NN	Protein	[16]	['Cause']	_	_
16	down-regulating	_	_	VBG	Negative_regulation	[0]	['root']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	expression	_	_	NN	Gene_expression	[16]	['Theme']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	transfected	_	_	JJ	O	[-1]	['none']	_	_
22	Tax	_	_	NN	Protein	[18]	['Theme']	_	_
23	plasmid	_	_	NN	O	[-1]	['none']	_	_
24	as	_	_	IN	O	[-1]	['none']	_	_
25	determined	_	_	VBN	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	real-time	_	_	JJ	O	[-1]	['none']	_	_
28	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	strongly	_	_	RB	O	[-1]	['none']	_	_
4	suggest	_	_	VBP	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	Foxp3	_	_	NN	Protein	[7, 27]	['Theme', 'Theme']	_	_
7	interacts	_	_	VBZ	Binding	[0]	['root']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
10	regulators	_	_	NNS	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	addition	_	_	NN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	NF-AT	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	that	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	carboxyl-terminal	_	_	JJ	O	[-1]	['none']	_	_
22	FKH	_	_	NN	O	[-1]	['none']	_	_
23	domain	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	therefore	_	_	RB	O	[-1]	['none']	_	_
27	localization	_	_	NN	Localization	[0]	['root']	_	_
28	to	_	_	TO	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	nucleus	_	_	NN	Entity	[27]	['ToLoc']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	are	_	_	VBP	O	[-1]	['none']	_	_
33	not	_	_	RB	O	[-1]	['none']	_	_
34	required	_	_	VBN	O	[-1]	['none']	_	_
35	for	_	_	IN	O	[-1]	['none']	_	_
36	inhibition	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	Tax	_	_	NN	Protein	[0]	['root']	_	_
39	mediated	_	_	VBD	O	[-1]	['none']	_	_
40	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
41	LTR	_	_	NN	O	[-1]	['none']	_	_
42	activation	_	_	NN	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	even	_	_	RB	O	[-1]	['none']	_	_
45	in	_	_	IN	O	[-1]	['none']	_	_
46	HEK	_	_	NNP	O	[-1]	['none']	_	_
47	293T	_	_	NN	O	[-1]	['none']	_	_
48	cells	_	_	NNS	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[13]	['Theme']	_	_
5	inhibited	_	_	VBD	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	transactivation	_	_	NN	O	[-1]	['none']	_	_
8	functions	_	_	NNS	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Tax	_	_	NN	Protein	[13]	['Theme']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	directly	_	_	RB	O	[-1]	['none']	_	_
13	associating	_	_	VBG	Binding	[0]	['root']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	this	_	_	DT	Anaphora	[17]	['multitoken']	_	_
16	viral	_	_	JJ	Anaphora	[17]	['multitoken']	_	_
17	protein	_	_	NN	Anaphora	[0]	['root']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	we	_	_	PRP	O	[-1]	['none']	_	_
20	generated	_	_	VBD	O	[-1]	['none']	_	_
21	an	_	_	DT	O	[-1]	['none']	_	_
22	expression	_	_	NN	O	[-1]	['none']	_	_
23	vector	_	_	NN	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	which	_	_	WDT	O	[-1]	['none']	_	_
26	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
27	Tax	_	_	NN	Protein	[0]	['root']	_	_
28	was	_	_	VBD	O	[-1]	['none']	_	_
29	fused	_	_	VBN	O	[-1]	['none']	_	_
30	in-frame	_	_	RB	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	carboxyl	_	_	NN	O	[-1]	['none']	_	_
34	terminus	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	Gal4	_	_	NN	Protein	[0]	['root']	_	_
38	DNA	_	_	NN	O	[-1]	['none']	_	_
39	binding	_	_	NN	O	[-1]	['none']	_	_
40	domain	_	_	NN	O	[-1]	['none']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	Gal4-BD	_	_	NN	Protein	[0]	['root']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	Gal4-BD-Tax	_	_	NN	Protein	[0]	['root']	_	_
3	fusion	_	_	NN	O	[-1]	['none']	_	_
4	protein	_	_	NN	O	[-1]	['none']	_	_
5	activated	_	_	VBD	O	[-1]	['none']	_	_
6	transcription	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	synthetic	_	_	JJ	O	[-1]	['none']	_	_
10	promoter	_	_	NN	O	[-1]	['none']	_	_
11	containing	_	_	VBG	O	[-1]	['none']	_	_
12	five	_	_	CD	O	[-1]	['none']	_	_
13	Gal4	_	_	NN	O	[-1]	['none']	_	_
14	binding	_	_	NN	O	[-1]	['none']	_	_
15	sites	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	while	_	_	IN	O	[-1]	['none']	_	_
18	Gal4-BD	_	_	NN	Protein	[0]	['root']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	insufficient	_	_	JJ	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	stimulate	_	_	VB	O	[-1]	['none']	_	_
23	transcription	_	_	NN	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	itself	_	_	PRP	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Transactivation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	Gal4-resposive	_	_	JJ	O	[-1]	['none']	_	_
5	promoter	_	_	NN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	Gal4-BD-Tax	_	_	NN	Protein	[0]	['root']	_	_
8	remained	_	_	VBD	O	[-1]	['none']	_	_
9	relatively	_	_	RB	O	[-1]	['none']	_	_
10	unaffected	_	_	JJ	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	either	_	_	CC	O	[-1]	['none']	_	_
15	EGFP	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	control	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	Foxp3	_	_	NN	Protein	[12]	['Theme']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	deltaFKH	_	_	NN	Protein	[12]	['Theme']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	suggesting	_	_	VBG	O	[-1]	['none']	_	_
26	that	_	_	IN	O	[-1]	['none']	_	_
27	Foxp3	_	_	NN	Protein	[35]	['Cause']	_	_
28	does	_	_	VBZ	O	[-1]	['none']	_	_
29	not	_	_	RB	O	[-1]	['none']	_	_
30	repress	_	_	VB	O	[-1]	['none']	_	_
31	Tax	_	_	NN	Protein	[0]	['root']	_	_
32	transactivation	_	_	NN	O	[-1]	['none']	_	_
33	by	_	_	IN	O	[-1]	['none']	_	_
34	directly	_	_	RB	O	[-1]	['none']	_	_
35	interfacing	_	_	VBG	Negative_regulation	[0]	['root']	_	_
36	with	_	_	IN	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
39	Tax	_	_	NN	Protein	[35]	['Theme']	_	_
40	protein	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	confirm	_	_	VB	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
5	had	_	_	VBD	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	direct	_	_	JJ	O	[-1]	['none']	_	_
8	effect	_	_	NN	O	[-1]	['none']	_	_
9	on	_	_	IN	O	[-1]	['none']	_	_
10	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
11	replication	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	we	_	_	PRP	O	[-1]	['none']	_	_
14	transfected	_	_	VBD	O	[-1]	['none']	_	_
15	HEK	_	_	NNP	O	[-1]	['none']	_	_
16	293T	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	well	_	_	RB	O	[-1]	['none']	_	_
21	characterized	_	_	VBN	O	[-1]	['none']	_	_
22	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
23	infectious	_	_	JJ	O	[-1]	['none']	_	_
24	molecular	_	_	JJ	O	[-1]	['none']	_	_
25	clone	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	termed	_	_	VBN	O	[-1]	['none']	_	_
28	ACH	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	[	_	_	CD	O	[-1]	['none']	_	_
31	30	_	_	CD	O	[-1]	['none']	_	_
32	]	_	_	NN	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	presence	_	_	NN	O	[-1]	['none']	_	_
36	of	_	_	IN	O	[-1]	['none']	_	_
37	full-length	_	_	JJ	O	[-1]	['none']	_	_
38	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	deltaFKH	_	_	NN	Protein	[0]	['root']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	or	_	_	CC	O	[-1]	['none']	_	_
43	control	_	_	NN	O	[-1]	['none']	_	_
44	vector	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	ACH	_	_	NN	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	been	_	_	VBN	O	[-1]	['none']	_	_
4	previously	_	_	RB	O	[-1]	['none']	_	_
5	shown	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	direct	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	expression	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	viral	_	_	JJ	O	[-1]	['none']	_	_
12	antigens	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	produce	_	_	VBP	O	[-1]	['none']	_	_
15	infectious	_	_	JJ	O	[-1]	['none']	_	_
16	virus	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	transform	_	_	VB	O	[-1]	['none']	_	_
20	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
21	T	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	both	_	_	CC	O	[-1]	['none']	_	_
24	in	_	_	FW	O	[-1]	['none']	_	_
25	vitro	_	_	FW	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	in	_	_	FW	O	[-1]	['none']	_	_
28	vivo	_	_	FW	O	[-1]	['none']	_	_
29	[	_	_	FW	O	[-1]	['none']	_	_
30	31,32	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	CD	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	24	_	_	CD	O	[-1]	['none']	_	_
3	h	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	amount	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	viral	_	_	JJ	Anaphora	[9]	['multitoken']	_	_
9	antigen	_	_	NN	Anaphora	[0]	['root']	_	_
10	expression	_	_	NN	Transcription	[0]	['root']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	this	_	_	DT	O	[-1]	['none']	_	_
14	case	_	_	NN	O	[-1]	['none']	_	_
15	Tax	_	_	NN	Protein	[10]	['Theme']	_	_
16	mRNA	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	was	_	_	VBD	O	[-1]	['none']	_	_
19	detected	_	_	VBN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	sensitive	_	_	JJ	O	[-1]	['none']	_	_
23	real-time	_	_	JJ	O	[-1]	['none']	_	_
24	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
25	assay	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	illustrated	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	5	_	_	CD	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	level	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Tax	_	_	NN	Protein	[12, 26]	['Theme', 'Theme']	_	_
11	mRNA	_	_	NN	O	[-1]	['none']	_	_
12	synthesized	_	_	VBN	Transcription	[16]	['Theme']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	ACH	_	_	NN	O	[-1]	['none']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	down-regulated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	presence	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	Foxp3	_	_	NN	Protein	[16]	['Cause']	_	_
22	compared	_	_	VBN	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	level	_	_	NN	O	[-1]	['none']	_	_
26	produced	_	_	VBN	Transcription	[0]	['root']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	presence	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	control	_	_	NN	O	[-1]	['none']	_	_
33	vector	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	deltaFKH	_	_	NN	Protein	[7]	['Cause']	_	_
2	did	_	_	VBD	O	[-1]	['none']	_	_
3	not	_	_	RB	O	[-1]	['none']	_	_
4	have	_	_	VB	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	discernable	_	_	JJ	O	[-1]	['none']	_	_
7	affect	_	_	NN	Regulation	[0]	['root']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	Tax	_	_	NN	Protein	[10]	['Theme']	_	_
10	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[9]	['Cause']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	capable	_	_	JJ	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	repressing	_	_	VBG	Negative_regulation	[0]	['root']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Tax	_	_	NN	Protein	[11]	['Theme']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	an	_	_	DT	O	[-1]	['none']	_	_
16	infectious	_	_	JJ	O	[-1]	['none']	_	_
17	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
18	molecular	_	_	JJ	O	[-1]	['none']	_	_
19	clone	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Production	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	proinflammatory	_	_	JJ	O	[-1]	['none']	_	_
4	mediators	_	_	NNS	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	cpdm	_	_	NN	O	[-1]	['none']	_	_
7	BMDC	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	impaired	_	_	JJ	O	[-1]	['none']	_	_
10	Incubation	_	_	NN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	LPS	_	_	NN	O	[-1]	['none']	_	_
13	or	_	_	CC	O	[-1]	['none']	_	_
14	poly	_	_	NN	O	[-1]	['none']	_	_
15	I	_	_	NN	O	[-1]	['none']	_	_
16	:	_	_	:	O	[-1]	['none']	_	_
17	C	_	_	NN	O	[-1]	['none']	_	_
18	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	secretion	_	_	NN	Gene_expression	[18]	['Theme']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	IL6	_	_	NN	Protein	[20, 41]	['Theme', 'Theme']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	IL12P70	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	GMCSF	_	_	NNP	Protein	[20, 41]	['Theme', 'Theme']	_	_
28	from	_	_	IN	O	[-1]	['none']	_	_
29	both	_	_	DT	O	[-1]	['none']	_	_
30	WT	_	_	JJ	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	cpdm	_	_	JJ	O	[-1]	['none']	_	_
33	BMDC	_	_	NN	O	[-1]	['none']	_	_
34	;	_	_	:	O	[-1]	['none']	_	_
35	however	_	_	RB	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	BMDC	_	_	NN	O	[-1]	['none']	_	_
38	from	_	_	IN	O	[-1]	['none']	_	_
39	cpdm	_	_	NN	O	[-1]	['none']	_	_
40	mice	_	_	NNS	O	[-1]	['none']	_	_
41	produced	_	_	VBD	Gene_expression	[43]	['Theme']	_	_
42	significantly	_	_	RB	O	[-1]	['none']	_	_
43	less	_	_	JJR	Positive_regulation	[0]	['root']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	all	_	_	DT	Anaphora	[47]	['multitoken']	_	_
46	three	_	_	CD	Anaphora	[47]	['multitoken']	_	_
47	cytokines	_	_	NNS	Anaphora	[0]	['root']	_	_
48	compared	_	_	VBN	O	[-1]	['none']	_	_
49	with	_	_	IN	O	[-1]	['none']	_	_
50	WT	_	_	JJ	O	[-1]	['none']	_	_
51	BMDC	_	_	NN	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	amount	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	nitric	_	_	JJ	O	[-1]	['none']	_	_
5	oxide	_	_	NN	O	[-1]	['none']	_	_
6	generated	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	mutant	_	_	NN	O	[-1]	['none']	_	_
9	BMDC	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	also	_	_	RB	O	[-1]	['none']	_	_
12	significantly	_	_	RB	O	[-1]	['none']	_	_
13	reduced	_	_	VBN	O	[-1]	['none']	_	_
14	compared	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	WT	_	_	JJ	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	indicating	_	_	VBG	O	[-1]	['none']	_	_
20	severely	_	_	RB	O	[-1]	['none']	_	_
21	disrupted	_	_	VBN	O	[-1]	['none']	_	_
22	production	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	proinflammatory	_	_	JJ	O	[-1]	['none']	_	_
25	mediators	_	_	NNS	O	[-1]	['none']	_	_
26	from	_	_	IN	O	[-1]	['none']	_	_
27	Sharpin	_	_	NN	Protein	[28]	['Theme']	_	_
28	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
29	BMDC	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vivo	_	_	FW	O	[-1]	['none']	_	_
3	complementation	_	_	NN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	Sharpin	_	_	NN	Protein	[0]	['root']	_	_
7	gene	_	_	NN	O	[-1]	['none']	_	_
8	containing	_	_	VBG	O	[-1]	['none']	_	_
9	BAC	_	_	NN	O	[-1]	['none']	_	_
10	reversed	_	_	VBD	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	phenotype	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	mutant	_	_	NN	O	[-1]	['none']	_	_
16	mice	_	_	NNS	O	[-1]	['none']	_	_
17	[	_	_	VBP	O	[-1]	['none']	_	_
18	2	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	CD	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	BMDC	_	_	NNP	O	[-1]	['none']	_	_
23	generated	_	_	VBD	O	[-1]	['none']	_	_
24	from	_	_	IN	O	[-1]	['none']	_	_
25	these	_	_	DT	O	[-1]	['none']	_	_
26	rescued	_	_	VBD	O	[-1]	['none']	_	_
27	mice	_	_	NNS	O	[-1]	['none']	_	_
28	secreted	_	_	VBN	O	[-1]	['none']	_	_
29	significantly	_	_	RB	O	[-1]	['none']	_	_
30	more	_	_	RBR	O	[-1]	['none']	_	_
31	IL12P70	_	_	NN	O	[-1]	['none']	_	_
32	than	_	_	IN	O	[-1]	['none']	_	_
33	BMDC	_	_	NN	O	[-1]	['none']	_	_
34	from	_	_	IN	O	[-1]	['none']	_	_
35	cpdm	_	_	NN	O	[-1]	['none']	_	_
36	mice	_	_	NNS	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	supporting	_	_	VBG	O	[-1]	['none']	_	_
39	a	_	_	DT	O	[-1]	['none']	_	_
40	necessary	_	_	JJ	O	[-1]	['none']	_	_
41	role	_	_	NN	O	[-1]	['none']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
44	for	_	_	IN	O	[-1]	['none']	_	_
45	the	_	_	DT	O	[-1]	['none']	_	_
46	production	_	_	NN	O	[-1]	['none']	_	_
47	of	_	_	IN	O	[-1]	['none']	_	_
48	IL12P70	_	_	NN	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	transcript	_	_	NN	O	[-1]	['none']	_	_
6	levels	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
10	cytokines	_	_	NNS	O	[-1]	['none']	_	_
11	Il6	_	_	NN	Protein	[0]	['root']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	Il12p40	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	Gmcsf	_	_	NN	Protein	[0]	['root']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	Ifnb	_	_	NNP	Protein	[0]	['root']	_	_
19	were	_	_	VBD	O	[-1]	['none']	_	_
20	examined	_	_	VBN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	these	_	_	DT	O	[-1]	['none']	_	_
24	were	_	_	VBD	O	[-1]	['none']	_	_
25	all	_	_	DT	O	[-1]	['none']	_	_
26	significantly	_	_	RB	O	[-1]	['none']	_	_
27	reduced	_	_	VBN	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	stimulated	_	_	VBN	O	[-1]	['none']	_	_
30	cpdm	_	_	NN	O	[-1]	['none']	_	_
31	BMDC	_	_	NN	O	[-1]	['none']	_	_
32	when	_	_	WRB	O	[-1]	['none']	_	_
33	compared	_	_	VBN	O	[-1]	['none']	_	_
34	with	_	_	IN	O	[-1]	['none']	_	_
35	WT	_	_	JJ	O	[-1]	['none']	_	_
36	controls	_	_	NNS	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Phenotype	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	BMDC	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	splenic	_	_	JJ	O	[-1]	['none']	_	_
6	DC	_	_	NN	O	[-1]	['none']	_	_
7	subsets	_	_	NNS	O	[-1]	['none']	_	_
8	The	_	_	DT	O	[-1]	['none']	_	_
9	phenotype	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	BMDC	_	_	NN	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	determined	_	_	VBN	O	[-1]	['none']	_	_
14	before	_	_	IN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	after	_	_	IN	O	[-1]	['none']	_	_
17	24	_	_	CD	O	[-1]	['none']	_	_
18	hour	_	_	NN	O	[-1]	['none']	_	_
19	culture	_	_	NN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	presence	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	100	_	_	CD	O	[-1]	['none']	_	_
25	ng/mL	_	_	NN	O	[-1]	['none']	_	_
26	LPS	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	incubated	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	PBS	_	_	NNP	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	0.1	_	_	CD	O	[-1]	['none']	_	_
9	%	_	_	NN	O	[-1]	['none']	_	_
10	NaN3	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	1	_	_	CD	O	[-1]	['none']	_	_
13	%	_	_	NN	O	[-1]	['none']	_	_
14	BSA	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	10	_	_	CD	O	[-1]	['none']	_	_
17	%	_	_	NN	O	[-1]	['none']	_	_
18	normal	_	_	JJ	O	[-1]	['none']	_	_
19	rabbit	_	_	NN	O	[-1]	['none']	_	_
20	serum	_	_	NN	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	20	_	_	CD	O	[-1]	['none']	_	_
23	minutes	_	_	NNS	O	[-1]	['none']	_	_
24	on	_	_	IN	O	[-1]	['none']	_	_
25	ice	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	washed	_	_	VBN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	incubated	_	_	VBN	O	[-1]	['none']	_	_
30	for	_	_	IN	O	[-1]	['none']	_	_
31	30	_	_	CD	O	[-1]	['none']	_	_
32	minutes	_	_	NNS	O	[-1]	['none']	_	_
33	on	_	_	IN	O	[-1]	['none']	_	_
34	ice	_	_	NN	O	[-1]	['none']	_	_
35	with	_	_	IN	O	[-1]	['none']	_	_
36	Alex	_	_	NNP	O	[-1]	['none']	_	_
37	Fluor	_	_	NNP	O	[-1]	['none']	_	_
38	labeled	_	_	VBN	O	[-1]	['none']	_	_
39	anti-CD11c	_	_	JJ	O	[-1]	['none']	_	_
40	(	_	_	-LRB-	O	[-1]	['none']	_	_
41	MCD11C20	_	_	NN	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	CALTAG	_	_	NN	O	[-1]	['none']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	in	_	_	IN	O	[-1]	['none']	_	_
46	combination	_	_	NN	O	[-1]	['none']	_	_
47	with	_	_	IN	O	[-1]	['none']	_	_
48	PE-	_	_	NN	O	[-1]	['none']	_	_
49	anti-CD40	_	_	NN	O	[-1]	['none']	_	_
50	(	_	_	-LRB-	O	[-1]	['none']	_	_
51	3/23	_	_	CD	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	BD	_	_	NNP	O	[-1]	['none']	_	_
54	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
55	)	_	_	-RRB-	O	[-1]	['none']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	PE-anti-CD80	_	_	NN	O	[-1]	['none']	_	_
58	(	_	_	-LRB-	O	[-1]	['none']	_	_
59	16-10A1	_	_	NN	O	[-1]	['none']	_	_
60	,	_	_	,	O	[-1]	['none']	_	_
61	eBioscience	_	_	NN	O	[-1]	['none']	_	_
62	)	_	_	-RRB-	O	[-1]	['none']	_	_
63	,	_	_	,	O	[-1]	['none']	_	_
64	PE-anti-CD86	_	_	NN	O	[-1]	['none']	_	_
65	(	_	_	-LRB-	O	[-1]	['none']	_	_
66	P03	_	_	NN	O	[-1]	['none']	_	_
67	.1	_	_	NN	O	[-1]	['none']	_	_
68	,	_	_	,	O	[-1]	['none']	_	_
69	eBioscience	_	_	NN	O	[-1]	['none']	_	_
70	)	_	_	-RRB-	O	[-1]	['none']	_	_
71	,	_	_	,	O	[-1]	['none']	_	_
72	PE-anti-CD14	_	_	NN	O	[-1]	['none']	_	_
73	(	_	_	-LRB-	O	[-1]	['none']	_	_
74	Sa2	_	_	NN	O	[-1]	['none']	_	_
75	.8	_	_	CD	O	[-1]	['none']	_	_
76	,	_	_	,	O	[-1]	['none']	_	_
77	eBioscience	_	_	NN	O	[-1]	['none']	_	_
78	)	_	_	-RRB-	O	[-1]	['none']	_	_
79	and	_	_	CC	O	[-1]	['none']	_	_
80	biotinylated	_	_	VBN	O	[-1]	['none']	_	_
81	anti-TLR4	_	_	JJ	O	[-1]	['none']	_	_
82	(	_	_	-LRB-	O	[-1]	['none']	_	_
83	BioLegend	_	_	NN	O	[-1]	['none']	_	_
84	)	_	_	-RRB-	O	[-1]	['none']	_	_
85	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	incubated	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	biotinylated	_	_	VBN	O	[-1]	['none']	_	_
6	anti-TLR4	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	MD-2	_	_	NN	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	washed	_	_	VBN	O	[-1]	['none']	_	_
11	twice	_	_	RB	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	incubated	_	_	VBN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	30	_	_	CD	O	[-1]	['none']	_	_
16	minutes	_	_	NNS	O	[-1]	['none']	_	_
17	on	_	_	IN	O	[-1]	['none']	_	_
18	ice	_	_	NN	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	avidin-PE	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	isolate	_	_	VB	O	[-1]	['none']	_	_
3	splenic	_	_	JJ	O	[-1]	['none']	_	_
4	DC	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	spleens	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	collagenase	_	_	NN	O	[-1]	['none']	_	_
9	digested	_	_	VBN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	subject	_	_	JJ	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	Percoll	_	_	NN	O	[-1]	['none']	_	_
14	gradient	_	_	NN	O	[-1]	['none']	_	_
15	centrifugation	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	bands	_	_	NNS	O	[-1]	['none']	_	_
3	at	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	35-55	_	_	CD	O	[-1]	['none']	_	_
6	%	_	_	NN	O	[-1]	['none']	_	_
7	interface	_	_	NN	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	collected	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	stain	_	_	VB	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	PE-anti-CD11c	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	HL3	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	BioLegend	_	_	NNP	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	APC-anti-PDCA-1	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	927	_	_	CD	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	BioLegend	_	_	NNP	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	FITC-anti-CD8alpha	_	_	NN	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	53-6	_	_	CD	O	[-1]	['none']	_	_
30	.7	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	BD	_	_	NNP	O	[-1]	['none']	_	_
33	BioScience	_	_	NNP	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	washed	_	_	VBN	O	[-1]	['none']	_	_
5	twice	_	_	RB	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	fixed	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	2	_	_	CD	O	[-1]	['none']	_	_
10	%	_	_	NN	O	[-1]	['none']	_	_
11	paraformaldehyde	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	stored	_	_	VBD	O	[-1]	['none']	_	_
15	at	_	_	IN	O	[-1]	['none']	_	_
16	4degreesC	_	_	NN	O	[-1]	['none']	_	_
17	until	_	_	IN	O	[-1]	['none']	_	_
18	analysis	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Flow	_	_	NN	O	[-1]	['none']	_	_
2	cytometry	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	an	_	_	DT	O	[-1]	['none']	_	_
7	Excel	_	_	NNP	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Coulter	_	_	NNP	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	instrument	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Dead	_	_	JJ	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	omitted	_	_	VBN	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	analysis	_	_	NN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	gating	_	_	VBG	O	[-1]	['none']	_	_
10	on	_	_	IN	O	[-1]	['none']	_	_
11	forward	_	_	RB	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	90degrees	_	_	RB	O	[-1]	['none']	_	_
14	light	_	_	JJ	O	[-1]	['none']	_	_
15	scatter	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	10,000	_	_	CD	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	analyzed	_	_	VBN	O	[-1]	['none']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	FlowJo	_	_	NN	O	[-1]	['none']	_	_
24	software	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	Production	_	_	NN	Gene_expression	[0]	['root']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	Th1	_	_	NN	O	[-1]	['none']	_	_
5	Cells	_	_	NNS	O	[-1]	['none']	_	_
6	Requires	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
7	ERK1	_	_	NN	Protein	[10]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	ERK2	_	_	NN	Protein	[10]	['Theme']	_	_
10	Activation	_	_	NN	Positive_regulation	[6]	['Cause']	_	_
11	Our	_	_	PRP$	O	[-1]	['none']	_	_
12	data	_	_	NNS	O	[-1]	['none']	_	_
13	showed	_	_	VBD	O	[-1]	['none']	_	_
14	that	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	maintenance	_	_	NN	Positive_regulation	[23]	['Theme']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IL-10	_	_	NN	Protein	[19]	['Theme']	_	_
19	induction	_	_	NN	Gene_expression	[16]	['Theme']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	Th1	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
24	stimulation	_	_	NN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	high	_	_	JJ	O	[-1]	['none']	_	_
27	antigen	_	_	NN	O	[-1]	['none']	_	_
28	dose	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	which	_	_	WDT	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	some	_	_	DT	O	[-1]	['none']	_	_
33	extent	_	_	NN	O	[-1]	['none']	_	_
34	could	_	_	MD	O	[-1]	['none']	_	_
35	be	_	_	VB	O	[-1]	['none']	_	_
36	compensated	_	_	VBN	O	[-1]	['none']	_	_
37	for	_	_	IN	O	[-1]	['none']	_	_
38	by	_	_	IN	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	addition	_	_	NN	Positive_regulation	[0]	['root']	_	_
41	of	_	_	IN	O	[-1]	['none']	_	_
42	IL-12	_	_	NN	Protein	[40]	['Theme']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	Signaling	_	_	NN	O	[-1]	['none']	_	_
2	through	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	TCR	_	_	NN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	high	_	_	JJ	O	[-1]	['none']	_	_
7	doses	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	antigen	_	_	NN	O	[-1]	['none']	_	_
10	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
11	stronger	_	_	JJR	O	[-1]	['none']	_	_
12	ERK1	_	_	NN	Protein	[15]	['Theme']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	ERK2	_	_	NN	Protein	[15]	['Theme']	_	_
15	activation	_	_	NN	Positive_regulation	[10, 18]	['Theme', 'Theme']	_	_
16	than	_	_	IN	O	[-1]	['none']	_	_
17	that	_	_	DT	O	[-1]	['none']	_	_
18	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	low	_	_	JJ	O	[-1]	['none']	_	_
21	antigen	_	_	NN	O	[-1]	['none']	_	_
22	dose	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	not	_	_	RB	O	[-1]	['none']	_	_
25	only	_	_	RB	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	naive	_	_	JJ	O	[-1]	['none']	_	_
28	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
29	T	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	data	_	_	NNS	O	[-1]	['none']	_	_
33	not	_	_	RB	O	[-1]	['none']	_	_
34	shown	_	_	VBN	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	as	_	_	IN	O	[-1]	['none']	_	_
37	previously	_	_	RB	O	[-1]	['none']	_	_
38	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	Jorritsma	_	_	NNP	O	[-1]	['none']	_	_
41	et	_	_	FW	O	[-1]	['none']	_	_
42	al.	_	_	FW	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	2003	_	_	CD	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	but	_	_	CC	O	[-1]	['none']	_	_
47	also	_	_	RB	O	[-1]	['none']	_	_
48	in	_	_	IN	O	[-1]	['none']	_	_
49	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
50	T	_	_	NN	O	[-1]	['none']	_	_
51	cells	_	_	NNS	O	[-1]	['none']	_	_
52	restimulated	_	_	VBN	O	[-1]	['none']	_	_
53	with	_	_	IN	O	[-1]	['none']	_	_
54	the	_	_	DT	O	[-1]	['none']	_	_
55	same	_	_	JJ	O	[-1]	['none']	_	_
56	high	_	_	JJ	O	[-1]	['none']	_	_
57	and	_	_	CC	O	[-1]	['none']	_	_
58	low	_	_	JJ	O	[-1]	['none']	_	_
59	antigen	_	_	NN	O	[-1]	['none']	_	_
60	doses	_	_	NNS	O	[-1]	['none']	_	_
61	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	apparent	_	_	JJ	O	[-1]	['none']	_	_
4	peak	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	amount	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	ERK1	_	_	NN	Protein	[11]	['Theme']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	ERK2	_	_	NN	Protein	[11]	['Theme']	_	_
11	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
12	varied	_	_	VBD	O	[-1]	['none']	_	_
13	slightly	_	_	RB	O	[-1]	['none']	_	_
14	between	_	_	IN	O	[-1]	['none']	_	_
15	experiments	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	consistent	_	_	JJ	O	[-1]	['none']	_	_
19	finding	_	_	NN	O	[-1]	['none']	_	_
20	was	_	_	VBD	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	high	_	_	JJ	O	[-1]	['none']	_	_
23	antigen	_	_	NN	O	[-1]	['none']	_	_
24	dose	_	_	NN	O	[-1]	['none']	_	_
25	differentiated	_	_	VBD	O	[-1]	['none']	_	_
26	Th1	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	always	_	_	RB	O	[-1]	['none']	_	_
29	showed	_	_	VBD	O	[-1]	['none']	_	_
30	enhanced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	prolonged	_	_	VBN	Positive_regulation	[0]	['root']	_	_
33	ERK1	_	_	NN	Protein	[36]	['Theme']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	ERK2	_	_	NN	Protein	[36]	['Theme']	_	_
36	activation	_	_	NN	Positive_regulation	[30, 32]	['Theme', 'Theme']	_	_
37	in	_	_	IN	O	[-1]	['none']	_	_
38	the	_	_	DT	O	[-1]	['none']	_	_
39	presence	_	_	NN	O	[-1]	['none']	_	_
40	of	_	_	IN	O	[-1]	['none']	_	_
41	IL-12	_	_	NN	Protein	[30]	['Cause']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	regardless	_	_	RB	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	whether	_	_	IN	O	[-1]	['none']	_	_
46	they	_	_	PRP	O	[-1]	['none']	_	_
47	were	_	_	VBD	O	[-1]	['none']	_	_
48	restimulated	_	_	VBN	O	[-1]	['none']	_	_
49	with	_	_	IN	O	[-1]	['none']	_	_
50	high	_	_	JJ	O	[-1]	['none']	_	_
51	or	_	_	CC	O	[-1]	['none']	_	_
52	low	_	_	JJ	O	[-1]	['none']	_	_
53	antigen	_	_	NN	O	[-1]	['none']	_	_
54	dose	_	_	NN	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	then	_	_	RB	O	[-1]	['none']	_	_
3	investigated	_	_	VBD	O	[-1]	['none']	_	_
4	whether	_	_	IN	O	[-1]	['none']	_	_
5	ERK1	_	_	NN	Protein	[8]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	ERK2	_	_	NN	Protein	[8]	['Theme']	_	_
8	activation	_	_	NN	Positive_regulation	[10]	['Cause']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	induction	_	_	NN	Positive_regulation	[10]	['Theme']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IL-10	_	_	NN	Protein	[13]	['Theme']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	Th1	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	using	_	_	VBG	O	[-1]	['none']	_	_
21	U0126	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	a	_	_	DT	O	[-1]	['none']	_	_
24	compound	_	_	NN	O	[-1]	['none']	_	_
25	that	_	_	WDT	O	[-1]	['none']	_	_
26	blocks	_	_	VBZ	O	[-1]	['none']	_	_
27	downstream	_	_	JJ	O	[-1]	['none']	_	_
28	ERK	_	_	NN	O	[-1]	['none']	_	_
29	activation	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	ensure	_	_	VB	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	only	_	_	RB	O	[-1]	['none']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	signaling	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	being	_	_	VBG	O	[-1]	['none']	_	_
10	affected	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	U0126	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	we	_	_	PRP	O	[-1]	['none']	_	_
15	used	_	_	VBD	O	[-1]	['none']	_	_
16	an	_	_	DT	O	[-1]	['none']	_	_
17	APC-free	_	_	JJ	O	[-1]	['none']	_	_
18	system	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	which	_	_	WDT	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	T	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	were	_	_	VBD	O	[-1]	['none']	_	_
25	differentiated	_	_	VBN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	presence	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	increasing	_	_	VBG	O	[-1]	['none']	_	_
31	doses	_	_	NNS	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	anti-CD3	_	_	NN	Protein	[0]	['root']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	a	_	_	DT	O	[-1]	['none']	_	_
36	constant	_	_	JJ	O	[-1]	['none']	_	_
37	amount	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	IL-12	_	_	NN	Protein	[0]	['root']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	in	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	APC	_	_	NN	O	[-1]	['none']	_	_
5	driven	_	_	VBN	O	[-1]	['none']	_	_
6	cultures	_	_	NNS	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	stronger	_	_	JJR	O	[-1]	['none']	_	_
9	TCR	_	_	NN	O	[-1]	['none']	_	_
10	stimulation	_	_	NN	O	[-1]	['none']	_	_
11	together	_	_	RB	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	IL-12	_	_	NN	Protein	[0]	['root']	_	_
14	led	_	_	VBD	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	higher	_	_	JJR	O	[-1]	['none']	_	_
17	percentages	_	_	NNS	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	producing	_	_	VBG	Gene_expression	[0]	['root']	_	_
21	both	_	_	CC	O	[-1]	['none']	_	_
22	IL-10	_	_	NN	Protein	[20]	['Theme']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	IFN-gamma	_	_	NN	Protein	[20]	['Theme']	_	_
25	after	_	_	IN	O	[-1]	['none']	_	_
26	1	_	_	CD	O	[-1]	['none']	_	_
27	week	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	culture	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Addition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	U0126	_	_	NN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	cultures	_	_	NNS	O	[-1]	['none']	_	_
7	abrogated	_	_	VBD	Negative_regulation	[0]	['root']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	production	_	_	NN	Gene_expression	[7]	['Theme']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	IL-10	_	_	NN	Protein	[9]	['Theme']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	all	_	_	DT	O	[-1]	['none']	_	_
14	doses	_	_	NNS	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	anti-CD3	_	_	NN	Protein	[0]	['root']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Because	_	_	IN	O	[-1]	['none']	_	_
2	U0126	_	_	NN	O	[-1]	['none']	_	_
3	inhibits	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	MEK5	_	_	NN	Protein	[6]	['Cause']	_	_
6	catalyzed	_	_	VBD	Positive_regulation	[3]	['Theme']	_	_
7	activation	_	_	NN	Positive_regulation	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	ERK5	_	_	NN	Protein	[7]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	as	_	_	RB	O	[-1]	['none']	_	_
12	well	_	_	RB	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	MEK1-	_	_	NN	Protein	[0]	['root']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	MEK2	_	_	NN	Protein	[18]	['Cause']	_	_
18	catalyzed	_	_	VBD	Positive_regulation	[3]	['Theme']	_	_
19	activation	_	_	NN	Positive_regulation	[18]	['Theme']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	ERK1	_	_	NN	Protein	[19]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	ERK2	_	_	NN	Protein	[19]	['Theme']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	Bain	_	_	NNP	O	[-1]	['none']	_	_
26	et	_	_	FW	O	[-1]	['none']	_	_
27	al.	_	_	FW	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	2007	_	_	CD	O	[-1]	['none']	_	_
30	;	_	_	:	O	[-1]	['none']	_	_
31	Mody	_	_	NNP	O	[-1]	['none']	_	_
32	et	_	_	FW	O	[-1]	['none']	_	_
33	al.	_	_	FW	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	2001	_	_	CD	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	we	_	_	PRP	O	[-1]	['none']	_	_
39	also	_	_	RB	O	[-1]	['none']	_	_
40	used	_	_	VBD	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	more	_	_	RBR	O	[-1]	['none']	_	_
43	specific	_	_	JJ	O	[-1]	['none']	_	_
44	,	_	_	,	O	[-1]	['none']	_	_
45	structurally	_	_	RB	O	[-1]	['none']	_	_
46	unrelated	_	_	JJ	O	[-1]	['none']	_	_
47	MEK1	_	_	NN	Protein	[50]	['Theme']	_	_
48	and	_	_	CC	O	[-1]	['none']	_	_
49	MEK2	_	_	NN	Protein	[50]	['Theme']	_	_
50	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
51	PD184352	_	_	NN	O	[-1]	['none']	_	_
52	at	_	_	IN	O	[-1]	['none']	_	_
53	concentrations	_	_	NNS	O	[-1]	['none']	_	_
54	in	_	_	IN	O	[-1]	['none']	_	_
55	which	_	_	WDT	O	[-1]	['none']	_	_
56	it	_	_	PRP	O	[-1]	['none']	_	_
57	inhibits	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
58	MEK1	_	_	NN	Protein	[57]	['Theme']	_	_
59	and	_	_	CC	O	[-1]	['none']	_	_
60	MEK2	_	_	NN	Protein	[57]	['Theme']	_	_
61	but	_	_	CC	O	[-1]	['none']	_	_
62	not	_	_	RB	O	[-1]	['none']	_	_
63	MEK5	_	_	NN	Protein	[57]	['Theme']	_	_
64	(	_	_	-LRB-	O	[-1]	['none']	_	_
65	Bain	_	_	NNP	O	[-1]	['none']	_	_
66	et	_	_	FW	O	[-1]	['none']	_	_
67	al.	_	_	FW	O	[-1]	['none']	_	_
68	,	_	_	,	O	[-1]	['none']	_	_
69	2007	_	_	CD	O	[-1]	['none']	_	_
70	;	_	_	:	O	[-1]	['none']	_	_
71	Mody	_	_	NNP	O	[-1]	['none']	_	_
72	et	_	_	FW	O	[-1]	['none']	_	_
73	al.	_	_	FW	O	[-1]	['none']	_	_
74	,	_	_	,	O	[-1]	['none']	_	_
75	2001	_	_	CD	O	[-1]	['none']	_	_
76	)	_	_	-RRB-	O	[-1]	['none']	_	_
77	.	_	_	.	O	[-1]	['none']	_	_

1	PD184352	_	_	NN	O	[-1]	['none']	_	_
2	caused	_	_	VBD	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	similar	_	_	JJ	O	[-1]	['none']	_	_
5	inhibition	_	_	NN	Negative_regulation	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IL-10	_	_	NN	Protein	[8]	['Theme']	_	_
8	production	_	_	NN	Gene_expression	[5]	['Theme']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	dose	_	_	NN	O	[-1]	['none']	_	_
15	dependent	_	_	JJ	O	[-1]	['none']	_	_
16	fashion	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Upon	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	other	_	_	JJ	O	[-1]	['none']	_	_
7	signaling	_	_	NN	O	[-1]	['none']	_	_
8	pathways	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	including	_	_	VBG	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	p38	_	_	NN	Protein	[13]	['multitoken']	_	_
13	MAPK	_	_	NN	Protein	[14]	['Theme']	_	_
14	inhibitor	_	_	NN	Negative_regulation	[33]	['Cause']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	SB203580	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	GSK3beta	_	_	NN	Protein	[21]	['Theme']	_	_
21	inhibitor	_	_	NN	Negative_regulation	[33]	['Cause']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	CT99021	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	Bain	_	_	NNP	O	[-1]	['none']	_	_
26	et	_	_	FW	O	[-1]	['none']	_	_
27	al.	_	_	FW	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	2007	_	_	CD	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	no	_	_	DT	O	[-1]	['none']	_	_
33	effect	_	_	NN	Regulation	[0]	['root']	_	_
34	on	_	_	IN	O	[-1]	['none']	_	_
35	IL-10	_	_	NN	Protein	[36]	['Theme']	_	_
36	production	_	_	NN	Gene_expression	[33]	['Theme']	_	_
37	was	_	_	VBD	O	[-1]	['none']	_	_
38	observed	_	_	VBN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	thus	_	_	RB	O	[-1]	['none']	_	_
4	suggested	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	IL-10	_	_	NN	Protein	[7]	['Theme']	_	_
7	production	_	_	NN	Gene_expression	[13]	['Theme']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	Th1	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	in	_	_	IN	Positive_regulation	[13]	['multitoken']	_	_
12	response	_	_	NN	Positive_regulation	[13]	['multitoken']	_	_
13	to	_	_	TO	Positive_regulation	[19]	['Theme']	_	_
14	high	_	_	JJ	O	[-1]	['none']	_	_
15	antigen	_	_	NN	O	[-1]	['none']	_	_
16	dose	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	IL-12	_	_	NN	Protein	[13]	['Cause']	_	_
19	requires	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
20	ERK1	_	_	NN	Protein	[0]	['root']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	ERK2	_	_	NN	Protein	[0]	['root']	_	_
23	signaling	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	but	_	_	CC	O	[-1]	['none']	_	_
26	not	_	_	RB	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	activation	_	_	NN	Positive_regulation	[19]	['Cause']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	p38	_	_	NN	Protein	[28]	['Theme']	_	_
32	or	_	_	CC	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	GSK3beta	_	_	NN	Protein	[28]	['Theme']	_	_
35	pathways	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	PKC	_	_	NN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	Essential	_	_	JJ	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	Regulating	_	_	VBG	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	Activity	_	_	NN	O	[-1]	['none']	_	_
8	M-CSF-dependent	_	_	JJ	O	[-1]	['none']	_	_
9	PKC	_	_	NN	O	[-1]	['none']	_	_
10	activity	_	_	NN	O	[-1]	['none']	_	_
11	facilitated	_	_	VBD	Positive_regulation	[0]	['root']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	p65	_	_	NN	Protein	[14]	['Theme']	_	_
14	phosphorylation	_	_	NN	Phosphorylation	[11]	['Theme']	_	_
15	at	_	_	IN	O	[-1]	['none']	_	_
16	Ser276	_	_	NN	Entity	[14]	['Site']	_	_
17	but	_	_	CC	O	[-1]	['none']	_	_
18	not	_	_	RB	O	[-1]	['none']	_	_
19	Ser536	_	_	NN	Entity	[14]	['Site']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	confirm	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	role	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	PKC	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[10]	['Theme']	_	_
9	Ser276	_	_	NN	Entity	[10]	['Site']	_	_
10	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	activity	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	we	_	_	PRP	O	[-1]	['none']	_	_
16	co-transfected	_	_	VBD	Gene_expression	[0]	['root']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	NF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
19	construct	_	_	NN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	either	_	_	CC	O	[-1]	['none']	_	_
22	WT	_	_	JJ	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	p65	_	_	NN	Protein	[16]	['Theme']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	p65	_	_	NN	Protein	[16]	['Theme']	_	_
28	276S/A	_	_	NN	O	[-1]	['none']	_	_
29	constructs	_	_	NNS	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	Raw	_	_	NN	O	[-1]	['none']	_	_
32	264.7	_	_	CD	O	[-1]	['none']	_	_
33	cells	_	_	NNS	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	then	_	_	RB	O	[-1]	['none']	_	_
36	treated	_	_	VBN	O	[-1]	['none']	_	_
37	cells	_	_	NNS	O	[-1]	['none']	_	_
38	with	_	_	IN	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	PKC	_	_	NN	O	[-1]	['none']	_	_
41	inhibitor	_	_	NN	O	[-1]	['none']	_	_
42	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	absence	_	_	NN	O	[-1]	['none']	_	_
46	or	_	_	CC	O	[-1]	['none']	_	_
47	presences	_	_	NNS	O	[-1]	['none']	_	_
48	of	_	_	IN	O	[-1]	['none']	_	_
49	M-CSF	_	_	NN	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	transfected	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	vector	_	_	NN	O	[-1]	['none']	_	_
8	control	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	inhibiting	_	_	VBG	O	[-1]	['none']	_	_
11	PKC	_	_	NN	O	[-1]	['none']	_	_
12	reduced	_	_	VBD	O	[-1]	['none']	_	_
13	M-CSF-stimulated	_	_	JJ	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	activity	_	_	NN	O	[-1]	['none']	_	_
16	compared	_	_	VBN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	treated	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	M-CSF	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	vehicle	_	_	NN	O	[-1]	['none']	_	_
25	DMSO	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	p	_	_	NN	O	[-1]	['none']	_	_
28	=	_	_	JJ	O	[-1]	['none']	_	_
29	0.001	_	_	CD	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
5	WT	_	_	NNP	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	p65	_	_	NN	Protein	[4]	['Theme']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	p65	_	_	NN	Protein	[0]	['root']	_	_
10	WT	_	_	JJ	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	increased	_	_	VBD	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	activity	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	while	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	general	_	_	JJ	O	[-1]	['none']	_	_
19	PKC	_	_	NN	O	[-1]	['none']	_	_
20	inhibitor	_	_	NN	O	[-1]	['none']	_	_
21	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
22	decreased	_	_	VBD	O	[-1]	['none']	_	_
23	this	_	_	DT	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	activity	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	p	_	_	NN	O	[-1]	['none']	_	_
28	=	_	_	JJ	O	[-1]	['none']	_	_
29	0.001	_	_	CD	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Notably	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	introduction	_	_	NN	Gene_expression	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	p65	_	_	NN	Protein	[4]	['Theme']	_	_
8	276	_	_	CD	O	[-1]	['none']	_	_
9	S/A	_	_	NN	O	[-1]	['none']	_	_
10	construct	_	_	NN	O	[-1]	['none']	_	_
11	significantly	_	_	RB	O	[-1]	['none']	_	_
12	reduced	_	_	VBD	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	activity	_	_	NN	O	[-1]	['none']	_	_
15	compared	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	WT	_	_	NNP	O	[-1]	['none']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	p65	_	_	NN	Protein	[0]	['root']	_	_
21	construct	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	p	_	_	NN	O	[-1]	['none']	_	_
24	=	_	_	JJ	O	[-1]	['none']	_	_
25	0.005	_	_	CD	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	M-CSF	_	_	NN	O	[-1]	['none']	_	_
29	treatment	_	_	NN	O	[-1]	['none']	_	_
30	was	_	_	VBD	O	[-1]	['none']	_	_
31	unable	_	_	JJ	O	[-1]	['none']	_	_
32	to	_	_	TO	O	[-1]	['none']	_	_
33	overcome	_	_	VB	O	[-1]	['none']	_	_
34	this	_	_	DT	O	[-1]	['none']	_	_
35	inhibition	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	co-transfected	_	_	VBD	Gene_expression	[0]	['root']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	NF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
7	construct	_	_	NN	O	[-1]	['none']	_	_
8	along	_	_	IN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	either	_	_	CC	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	WT	_	_	NNP	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	p65	_	_	NN	Protein	[0]	['root']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
17	p65	_	_	NN	Protein	[4]	['Theme']	_	_
18	276S/A	_	_	NN	O	[-1]	['none']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	p65	_	_	NN	Protein	[4]	['Theme']	_	_
22	536S/A	_	_	NN	O	[-1]	['none']	_	_
23	constructs	_	_	NNS	O	[-1]	['none']	_	_
24	into	_	_	IN	O	[-1]	['none']	_	_
25	a	_	_	DT	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	p65-/-	_	_	JJ	Gene_expression	[0]	['root']	_	_
28	murine	_	_	JJ	O	[-1]	['none']	_	_
29	fibroblast	_	_	NN	O	[-1]	['none']	_	_
30	cell	_	_	NN	O	[-1]	['none']	_	_
31	line	_	_	NN	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	measured	_	_	VBN	O	[-1]	['none']	_	_
34	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
35	activity	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	predicted	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	WT	_	_	NNP	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[4]	['Theme']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[0]	['root']	_	_
11	WT	_	_	JJ	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	p65-/-	_	_	JJ	Gene_expression	[0]	['root']	_	_
16	cell	_	_	NN	O	[-1]	['none']	_	_
17	line	_	_	NN	O	[-1]	['none']	_	_
18	constitutively	_	_	RB	O	[-1]	['none']	_	_
19	activated	_	_	VBD	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	compared	_	_	VBN	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	transfected	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	vector	_	_	NN	O	[-1]	['none']	_	_
27	control	_	_	NN	O	[-1]	['none']	_	_
28	without	_	_	IN	O	[-1]	['none']	_	_
29	any	_	_	DT	O	[-1]	['none']	_	_
30	stimulation	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	comparison	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	transfecting	_	_	VBG	Gene_expression	[0]	['root']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	p65	_	_	NN	Protein	[4]	['Theme']	_	_
8	276S/A	_	_	NN	O	[-1]	['none']	_	_
9	construct	_	_	NN	O	[-1]	['none']	_	_
10	reduced	_	_	VBD	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	activity	_	_	NN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	5-fold	_	_	JJ	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	p	_	_	NN	O	[-1]	['none']	_	_
17	=	_	_	JJ	O	[-1]	['none']	_	_
18	0.006	_	_	CD	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	WT	_	_	NNP	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	p65	_	_	NN	Protein	[0]	['root']	_	_
23	vs.	_	_	CC	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	p65	_	_	NN	Protein	[0]	['root']	_	_
26	276S/A	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	while	_	_	IN	O	[-1]	['none']	_	_
30	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
33	p65	_	_	NN	Protein	[30]	['Theme']	_	_
34	536S/A	_	_	NN	O	[-1]	['none']	_	_
35	construct	_	_	NN	O	[-1]	['none']	_	_
36	increased	_	_	VBD	O	[-1]	['none']	_	_
37	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
38	activity	_	_	NN	O	[-1]	['none']	_	_
39	in	_	_	IN	O	[-1]	['none']	_	_
40	the	_	_	DT	O	[-1]	['none']	_	_
41	p65-/-	_	_	JJ	Gene_expression	[0]	['root']	_	_
42	cells	_	_	NNS	O	[-1]	['none']	_	_
43	to	_	_	TO	O	[-1]	['none']	_	_
44	levels	_	_	NNS	O	[-1]	['none']	_	_
45	similar	_	_	JJ	O	[-1]	['none']	_	_
46	to	_	_	TO	O	[-1]	['none']	_	_
47	WT	_	_	JJ	O	[-1]	['none']	_	_
48	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
49	p65	_	_	NN	Protein	[50]	['Theme']	_	_
50	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
51	cells	_	_	NNS	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
3	PKC	_	_	NN	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	regulated	_	_	VBD	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	activity	_	_	NN	O	[-1]	['none']	_	_
8	via	_	_	IN	O	[-1]	['none']	_	_
9	Ser276	_	_	NN	O	[-1]	['none']	_	_
10	residue	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	p65	_	_	NN	Protein	[0]	['root']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	primary	_	_	JJ	O	[-1]	['none']	_	_
16	human	_	_	NN	O	[-1]	['none']	_	_
17	MDMs	_	_	NNS	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	RAW	_	_	NN	O	[-1]	['none']	_	_
20	264.7	_	_	CD	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	we	_	_	PRP	O	[-1]	['none']	_	_
24	next	_	_	RB	O	[-1]	['none']	_	_
25	examined	_	_	VBD	O	[-1]	['none']	_	_
26	if	_	_	IN	O	[-1]	['none']	_	_
27	this	_	_	DT	O	[-1]	['none']	_	_
28	occurred	_	_	VBD	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	p65-/-	_	_	JJ	Gene_expression	[0]	['root']	_	_
32	fibroblasts	_	_	NNS	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	response	_	_	NN	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	a	_	_	DT	O	[-1]	['none']	_	_
37	native	_	_	JJ	O	[-1]	['none']	_	_
38	stimulus	_	_	NN	O	[-1]	['none']	_	_
39	for	_	_	IN	O	[-1]	['none']	_	_
40	these	_	_	DT	O	[-1]	['none']	_	_
41	cells	_	_	NNS	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	activity	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	measured	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	WT	_	_	NNP	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	p65	_	_	NN	Protein	[14]	['Theme']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	p65	_	_	NN	Protein	[14]	['Theme']	_	_
13	276S/A	_	_	NN	O	[-1]	['none']	_	_
14	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	treated	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	absence	_	_	NN	O	[-1]	['none']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	presence	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
5	increased	_	_	VBD	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	activity	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p65-/-	_	_	NN	Gene_expression	[0]	['root']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
13	WT	_	_	JJ	O	[-1]	['none']	_	_
14	p65	_	_	NN	Protein	[12]	['Theme']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	p	_	_	NN	O	[-1]	['none']	_	_
18	=	_	_	JJ	O	[-1]	['none']	_	_
19	0.001	_	_	CD	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	PKC	_	_	NN	O	[-1]	['none']	_	_
22	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
23	decreased	_	_	VBD	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	activity	_	_	NN	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	non	_	_	JJ	O	[-1]	['none']	_	_
29	stimulated	_	_	JJ	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	NS	_	_	NN	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	level	_	_	NN	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	p	_	_	NN	O	[-1]	['none']	_	_
36	=	_	_	JJ	O	[-1]	['none']	_	_
37	0.007	_	_	CD	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Introducing	_	_	VBG	Gene_expression	[0]	['root']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	p65	_	_	NN	Protein	[1]	['Theme']	_	_
4	276	_	_	CD	O	[-1]	['none']	_	_
5	S/A	_	_	NN	O	[-1]	['none']	_	_
6	constructs	_	_	NNS	O	[-1]	['none']	_	_
7	significantly	_	_	RB	O	[-1]	['none']	_	_
8	reduced	_	_	VBD	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	activity	_	_	NN	O	[-1]	['none']	_	_
11	compared	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	WT	_	_	NNP	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	p65	_	_	NN	Protein	[0]	['root']	_	_
17	construct	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	p	_	_	NN	O	[-1]	['none']	_	_
20	=	_	_	JJ	O	[-1]	['none']	_	_
21	0.001	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Notably	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
4	failed	_	_	VBD	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	increase	_	_	VB	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	activity	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	p65-/-	_	_	NN	Gene_expression	[0]	['root']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	p65	_	_	NN	Protein	[14]	['Theme']	_	_
17	276S/A	_	_	NN	O	[-1]	['none']	_	_
18	constructs	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	observations	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	similar	_	_	JJ	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	macrophages	_	_	NNS	O	[-1]	['none']	_	_
7	overexpressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[7]	['Theme']	_	_
11	276S/A	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	Ser276	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[0]	['root']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	essential	_	_	JJ	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	regulating	_	_	VBG	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	activity	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	suggests	_	_	VBZ	O	[-1]	['none']	_	_
17	that	_	_	IN	O	[-1]	['none']	_	_
18	PKC	_	_	NN	O	[-1]	['none']	_	_
19	regulates	_	_	VBZ	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	activity	_	_	NN	O	[-1]	['none']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	modulating	_	_	VBG	Regulation	[0]	['root']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	phosphorylation	_	_	NN	Phosphorylation	[23]	['Theme']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
28	p65	_	_	NN	Protein	[25]	['Theme']	_	_
29	at	_	_	IN	O	[-1]	['none']	_	_
30	Ser276	_	_	NN	Entity	[25]	['Site']	_	_
31	residue	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	CREB	_	_	NN	O	[-1]	['none']	_	_
4	Electrophoretic	_	_	JJ	O	[-1]	['none']	_	_
5	Mobility	_	_	NN	O	[-1]	['none']	_	_
6	Shift	_	_	NN	O	[-1]	['none']	_	_
7	Assay	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	EMSA	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	The	_	_	DT	O	[-1]	['none']	_	_
12	non	_	_	JJ	O	[-1]	['none']	_	_
13	radioactive	_	_	JJ	O	[-1]	['none']	_	_
14	LightShift	_	_	NNP	O	[-1]	['none']	_	_
15	Chemiluminescent	_	_	NNP	O	[-1]	['none']	_	_
16	EMSA	_	_	NN	O	[-1]	['none']	_	_
17	Kit	_	_	NN	O	[-1]	['none']	_	_
18	was	_	_	VBD	O	[-1]	['none']	_	_
19	used	_	_	VBN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	detect	_	_	VB	O	[-1]	['none']	_	_
22	DNA	_	_	NN	O	[-1]	['none']	_	_
23	protein	_	_	NN	O	[-1]	['none']	_	_
24	interactions	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	3	_	_	CD	O	[-1]	['none']	_	_
4	'	_	_	''	O	[-1]	['none']	_	_
5	biotin	_	_	NN	O	[-1]	['none']	_	_
6	end	_	_	NN	O	[-1]	['none']	_	_
7	labeled	_	_	VBN	O	[-1]	['none']	_	_
8	DNA	_	_	NN	O	[-1]	['none']	_	_
9	oligonucleotide	_	_	NN	O	[-1]	['none']	_	_
10	used	_	_	VBN	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	probe	_	_	NN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	EMSA	_	_	NN	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	42-bp	_	_	JJ	O	[-1]	['none']	_	_
20	double	_	_	JJ	O	[-1]	['none']	_	_
21	stranded	_	_	JJ	O	[-1]	['none']	_	_
22	construct	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	5	_	_	CD	O	[-1]	['none']	_	_
25	'-TTGTTACAA-GGGGACTTTCCGCTGGGGACTTTCCAGGGAGGC	_	_	NN	O	[-1]	['none']	_	_
26	-	_	_	:	O	[-1]	['none']	_	_
27	3	_	_	CD	O	[-1]	['none']	_	_
28	'	_	_	''	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	containing	_	_	VBG	O	[-1]	['none']	_	_
31	two	_	_	CD	O	[-1]	['none']	_	_
32	tandemly	_	_	RB	O	[-1]	['none']	_	_
33	repeated	_	_	VBN	O	[-1]	['none']	_	_
34	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
35	binding	_	_	VBG	O	[-1]	['none']	_	_
36	sites	_	_	NNS	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	underlined	_	_	VBD	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Specificity	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	determined	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	competition	_	_	NN	O	[-1]	['none']	_	_
7	assay	_	_	NN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	addition	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	200	_	_	CD	O	[-1]	['none']	_	_
13	molar	_	_	JJ	O	[-1]	['none']	_	_
14	excess	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	unlabeled	_	_	JJ	O	[-1]	['none']	_	_
17	double	_	_	JJ	O	[-1]	['none']	_	_
18	stranded	_	_	JJ	O	[-1]	['none']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	oligonucleotide	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	CREB	_	_	NN	O	[-1]	['none']	_	_
3	3	_	_	CD	O	[-1]	['none']	_	_
4	'	_	_	''	O	[-1]	['none']	_	_
5	biotin	_	_	NN	O	[-1]	['none']	_	_
6	end	_	_	NN	O	[-1]	['none']	_	_
7	labeled	_	_	VBN	O	[-1]	['none']	_	_
8	DNA	_	_	NN	O	[-1]	['none']	_	_
9	oligonucleotide	_	_	NN	O	[-1]	['none']	_	_
10	used	_	_	VBN	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	probe	_	_	NN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	EMSA	_	_	NN	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	23-bp	_	_	JJ	O	[-1]	['none']	_	_
20	double	_	_	JJ	O	[-1]	['none']	_	_
21	stranded	_	_	JJ	O	[-1]	['none']	_	_
22	construct	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	5	_	_	CD	O	[-1]	['none']	_	_
25	'-TTT	_	_	NN	O	[-1]	['none']	_	_
26	TCG	_	_	NN	O	[-1]	['none']	_	_
27	AGC	_	_	NN	O	[-1]	['none']	_	_
28	TCTGACGTCAGA-GC	_	_	NN	O	[-1]	['none']	_	_
29	-	_	_	:	O	[-1]	['none']	_	_
30	3	_	_	CD	O	[-1]	['none']	_	_
31	'	_	_	''	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	containing	_	_	VBG	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	CRE	_	_	NN	O	[-1]	['none']	_	_
36	consensus	_	_	NN	O	[-1]	['none']	_	_
37	sequence	_	_	NN	O	[-1]	['none']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	underlined	_	_	VBD	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Specificity	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	determined	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	competition	_	_	NN	O	[-1]	['none']	_	_
7	assay	_	_	NN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	addition	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	200	_	_	CD	O	[-1]	['none']	_	_
13	molar	_	_	JJ	O	[-1]	['none']	_	_
14	excess	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	unlabeled	_	_	JJ	O	[-1]	['none']	_	_
17	double	_	_	JJ	O	[-1]	['none']	_	_
18	stranded	_	_	JJ	O	[-1]	['none']	_	_
19	CREB	_	_	NN	O	[-1]	['none']	_	_
20	oligonucleotide	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Nuclear	_	_	JJ	O	[-1]	['none']	_	_
2	extracts	_	_	NNS	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	10	_	_	CD	O	[-1]	['none']	_	_
5	mug	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	incubated	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	5	_	_	CD	O	[-1]	['none']	_	_
11	nM	_	_	NN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	or	_	_	CC	O	[-1]	['none']	_	_
14	CREB	_	_	NN	O	[-1]	['none']	_	_
15	probe	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	NF-kB	_	_	NN	O	[-1]	['none']	_	_
18	:	_	_	:	O	[-1]	['none']	_	_
19	1x	_	_	NN	O	[-1]	['none']	_	_
20	binding	_	_	NN	O	[-1]	['none']	_	_
21	buffer	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	50	_	_	CD	O	[-1]	['none']	_	_
24	mM	_	_	NN	O	[-1]	['none']	_	_
25	KCl	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	1	_	_	CD	O	[-1]	['none']	_	_
28	mM	_	_	NN	O	[-1]	['none']	_	_
29	EDTA	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	1	_	_	CD	O	[-1]	['none']	_	_
32	mM	_	_	NN	O	[-1]	['none']	_	_
33	DTT	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	0.1	_	_	CD	O	[-1]	['none']	_	_
36	%	_	_	NN	O	[-1]	['none']	_	_
37	NP40	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	10	_	_	CD	O	[-1]	['none']	_	_
40	%	_	_	NN	O	[-1]	['none']	_	_
41	glycerol	_	_	NN	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	and	_	_	CC	O	[-1]	['none']	_	_
44	50	_	_	CD	O	[-1]	['none']	_	_
45	ng/mul	_	_	NN	O	[-1]	['none']	_	_
46	poly	_	_	NN	O	[-1]	['none']	_	_
47	dI-dC	_	_	NN	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	CREB	_	_	NN	O	[-1]	['none']	_	_
50	:	_	_	:	O	[-1]	['none']	_	_
51	1x	_	_	NN	O	[-1]	['none']	_	_
52	binding	_	_	NN	O	[-1]	['none']	_	_
53	buffer	_	_	NN	O	[-1]	['none']	_	_
54	,	_	_	,	O	[-1]	['none']	_	_
55	20	_	_	CD	O	[-1]	['none']	_	_
56	mM	_	_	NN	O	[-1]	['none']	_	_
57	Tris	_	_	NNP	O	[-1]	['none']	_	_
58	,	_	_	,	O	[-1]	['none']	_	_
59	pH	_	_	NN	O	[-1]	['none']	_	_
60	7.5	_	_	CD	O	[-1]	['none']	_	_
61	,	_	_	,	O	[-1]	['none']	_	_
62	50	_	_	CD	O	[-1]	['none']	_	_
63	mM	_	_	NN	O	[-1]	['none']	_	_
64	KCl	_	_	NN	O	[-1]	['none']	_	_
65	,	_	_	,	O	[-1]	['none']	_	_
66	1	_	_	CD	O	[-1]	['none']	_	_
67	mM	_	_	NN	O	[-1]	['none']	_	_
68	EDTA	_	_	NN	O	[-1]	['none']	_	_
69	,	_	_	,	O	[-1]	['none']	_	_
70	1	_	_	CD	O	[-1]	['none']	_	_
71	mM	_	_	NN	O	[-1]	['none']	_	_
72	DTT	_	_	NN	O	[-1]	['none']	_	_
73	,	_	_	,	O	[-1]	['none']	_	_
74	0.10	_	_	CD	O	[-1]	['none']	_	_
75	%	_	_	NN	O	[-1]	['none']	_	_
76	NP40	_	_	NN	O	[-1]	['none']	_	_
77	,	_	_	,	O	[-1]	['none']	_	_
78	6	_	_	CD	O	[-1]	['none']	_	_
79	%	_	_	NN	O	[-1]	['none']	_	_
80	glycerol	_	_	NN	O	[-1]	['none']	_	_
81	,	_	_	,	O	[-1]	['none']	_	_
82	0.1	_	_	CD	O	[-1]	['none']	_	_
83	mg/mL	_	_	NN	O	[-1]	['none']	_	_
84	BSA	_	_	NN	O	[-1]	['none']	_	_
85	and	_	_	CC	O	[-1]	['none']	_	_
86	50	_	_	CD	O	[-1]	['none']	_	_
87	ng/mul	_	_	NN	O	[-1]	['none']	_	_
88	poly	_	_	NN	O	[-1]	['none']	_	_
89	dI-dC	_	_	NN	O	[-1]	['none']	_	_
90	)	_	_	-RRB-	O	[-1]	['none']	_	_
91	and	_	_	CC	O	[-1]	['none']	_	_
92	were	_	_	VBD	O	[-1]	['none']	_	_
93	then	_	_	RB	O	[-1]	['none']	_	_
94	electrophoresed	_	_	VBN	O	[-1]	['none']	_	_
95	through	_	_	IN	O	[-1]	['none']	_	_
96	a	_	_	DT	O	[-1]	['none']	_	_
97	6	_	_	CD	O	[-1]	['none']	_	_
98	%	_	_	NN	O	[-1]	['none']	_	_
99	DNA	_	_	NN	O	[-1]	['none']	_	_
100	retardation	_	_	NN	O	[-1]	['none']	_	_
101	gel	_	_	NN	O	[-1]	['none']	_	_
102	at	_	_	IN	O	[-1]	['none']	_	_
103	100V	_	_	NN	O	[-1]	['none']	_	_
104	for	_	_	IN	O	[-1]	['none']	_	_
105	90	_	_	CD	O	[-1]	['none']	_	_
106	minutes	_	_	NNS	O	[-1]	['none']	_	_
107	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	gels	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	electrophoretically	_	_	RB	O	[-1]	['none']	_	_
5	transferred	_	_	VBN	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	380mA	_	_	NN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	1	_	_	CD	O	[-1]	['none']	_	_
10	hour	_	_	NN	O	[-1]	['none']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	ice	_	_	NN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	positively	_	_	RB	O	[-1]	['none']	_	_
16	charged	_	_	VBN	O	[-1]	['none']	_	_
17	nylon	_	_	NN	O	[-1]	['none']	_	_
18	membrane	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	immediately	_	_	RB	O	[-1]	['none']	_	_
21	cross	_	_	VB	O	[-1]	['none']	_	_
22	linked	_	_	VBN	O	[-1]	['none']	_	_
23	for	_	_	IN	O	[-1]	['none']	_	_
24	15	_	_	CD	O	[-1]	['none']	_	_
25	minutes	_	_	NNS	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	a	_	_	DT	O	[-1]	['none']	_	_
28	UV	_	_	NN	O	[-1]	['none']	_	_
29	transilluminator	_	_	NN	O	[-1]	['none']	_	_
30	equipped	_	_	VBN	O	[-1]	['none']	_	_
31	with	_	_	IN	O	[-1]	['none']	_	_
32	a	_	_	DT	O	[-1]	['none']	_	_
33	312	_	_	CD	O	[-1]	['none']	_	_
34	nm	_	_	NN	O	[-1]	['none']	_	_
35	bulb	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Streptavidin-horseradish	_	_	JJ	O	[-1]	['none']	_	_
2	peroxidase	_	_	NN	O	[-1]	['none']	_	_
3	conjugate	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	LightShift	_	_	NNP	O	[-1]	['none']	_	_
7	Chemiluminescent	_	_	NNP	O	[-1]	['none']	_	_
8	Substrate	_	_	NNP	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	used	_	_	VBN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	detect	_	_	VB	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	biotin	_	_	NN	O	[-1]	['none']	_	_
15	end	_	_	NN	O	[-1]	['none']	_	_
16	labeled	_	_	VBN	O	[-1]	['none']	_	_
17	DNA	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	nylon	_	_	NN	O	[-1]	['none']	_	_
3	membranes	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	exposed	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	x-ray	_	_	VB	O	[-1]	['none']	_	_
8	film	_	_	NN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	1-3	_	_	CD	O	[-1]	['none']	_	_
11	minutes	_	_	NNS	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	detection	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	Promotes	_	_	VBZ	O	[-1]	['none']	_	_
3	B	_	_	NN	O	[-1]	['none']	_	_
4	Cell	_	_	NN	O	[-1]	['none']	_	_
5	Survival	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	Proliferation	_	_	NN	O	[-1]	['none']	_	_
8	In	_	_	IN	O	[-1]	['none']	_	_
9	Vitro	_	_	NNP	O	[-1]	['none']	_	_
10	Primary	_	_	JJ	O	[-1]	['none']	_	_
11	B	_	_	NN	O	[-1]	['none']	_	_
12	cell	_	_	NN	O	[-1]	['none']	_	_
13	cultures	_	_	NNS	O	[-1]	['none']	_	_
14	can	_	_	MD	O	[-1]	['none']	_	_
15	be	_	_	VB	O	[-1]	['none']	_	_
16	maintained	_	_	VBN	O	[-1]	['none']	_	_
17	through	_	_	IN	O	[-1]	['none']	_	_
18	CD40	_	_	NN	Protein	[19]	['Theme']	_	_
19	ligation	_	_	NN	Binding	[0]	['root']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	supplementation	_	_	NN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	IL4	_	_	NN	Protein	[0]	['root']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	32	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	investigate	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[0]	['root']	_	_
5	affects	_	_	VBZ	O	[-1]	['none']	_	_
6	primary	_	_	JJ	O	[-1]	['none']	_	_
7	B	_	_	NN	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	survival	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	proliferation	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	cultured	_	_	VBN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	presence	_	_	NN	O	[-1]	['none']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	absence	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	IL4	_	_	NN	Protein	[0]	['root']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	analyzed	_	_	VBN	O	[-1]	['none']	_	_
25	by	_	_	IN	O	[-1]	['none']	_	_
26	MTS	_	_	NNP	O	[-1]	['none']	_	_
27	as	_	_	IN	O	[-1]	['none']	_	_
28	a	_	_	DT	O	[-1]	['none']	_	_
29	metabolic	_	_	JJ	O	[-1]	['none']	_	_
30	marker	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	ethidium	_	_	NN	O	[-1]	['none']	_	_
34	monoazide	_	_	NN	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	EMA	_	_	NN	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	exclusion	_	_	NN	O	[-1]	['none']	_	_
39	for	_	_	IN	O	[-1]	['none']	_	_
40	viability	_	_	NN	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	and	_	_	CC	O	[-1]	['none']	_	_
43	by	_	_	IN	O	[-1]	['none']	_	_
44	5-bromo-2	_	_	JJ	O	[-1]	['none']	_	_
45	'-deoxy-uridine	_	_	JJ	O	[-1]	['none']	_	_
46	(	_	_	-LRB-	O	[-1]	['none']	_	_
47	BrdU	_	_	NN	O	[-1]	['none']	_	_
48	)	_	_	-RRB-	O	[-1]	['none']	_	_
49	incorporation	_	_	NN	O	[-1]	['none']	_	_
50	for	_	_	IN	O	[-1]	['none']	_	_
51	proliferation	_	_	NN	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	MTS	_	_	NNP	O	[-1]	['none']	_	_
4	assay	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	expected	_	_	VBN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
10	from	_	_	IN	O	[-1]	['none']	_	_
11	wild-type	_	_	JJ	O	[-1]	['none']	_	_
12	mice	_	_	NNS	O	[-1]	['none']	_	_
13	did	_	_	VBD	O	[-1]	['none']	_	_
14	not	_	_	RB	O	[-1]	['none']	_	_
15	survive	_	_	VB	O	[-1]	['none']	_	_
16	even	_	_	RB	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	addition	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	IL4	_	_	NN	Protein	[0]	['root']	_	_
22	due	_	_	JJ	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	lack	_	_	NN	Negative_regulation	[0]	['root']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	CD40	_	_	NN	Protein	[28]	['Theme']	_	_
28	ligation	_	_	NN	Binding	[25]	['Theme']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[0]	['root']	_	_
5	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
6	had	_	_	VBD	O	[-1]	['none']	_	_
7	increased	_	_	VBN	O	[-1]	['none']	_	_
8	metabolism	_	_	NN	O	[-1]	['none']	_	_
9	even	_	_	RB	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	IL4	_	_	NN	Protein	[12]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	which	_	_	WDT	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	further	_	_	RB	O	[-1]	['none']	_	_
19	enhanced	_	_	VBN	O	[-1]	['none']	_	_
20	upon	_	_	IN	O	[-1]	['none']	_	_
21	addition	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IL4	_	_	NN	Protein	[0]	['root']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Wild-type	_	_	JJ	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	LMP1	_	_	NN	Protein	[0]	['root']	_	_
4	transgenic	_	_	JJ	O	[-1]	['none']	_	_
5	lymphoma	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	had	_	_	VBD	O	[-1]	['none']	_	_
8	high	_	_	JJ	O	[-1]	['none']	_	_
9	levels	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	MTS	_	_	NN	O	[-1]	['none']	_	_
12	activity	_	_	NN	O	[-1]	['none']	_	_
13	even	_	_	RB	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IL4	_	_	NN	Protein	[16]	['Theme']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	LMP1	_	_	NN	Protein	[0]	['root']	_	_
3	transgenic	_	_	JJ	O	[-1]	['none']	_	_
4	lymphoma	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	had	_	_	VBD	O	[-1]	['none']	_	_
7	approximately	_	_	RB	O	[-1]	['none']	_	_
8	4-fold	_	_	RB	O	[-1]	['none']	_	_
9	higher	_	_	JJR	O	[-1]	['none']	_	_
10	MTS	_	_	NN	O	[-1]	['none']	_	_
11	activity	_	_	NN	O	[-1]	['none']	_	_
12	than	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	normal	_	_	JJ	O	[-1]	['none']	_	_
15	transgenic	_	_	JJ	O	[-1]	['none']	_	_
16	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	least	_	_	JJS	O	[-1]	['none']	_	_
21	2-fold	_	_	RB	O	[-1]	['none']	_	_
22	higher	_	_	JJR	O	[-1]	['none']	_	_
23	than	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	control	_	_	NN	O	[-1]	['none']	_	_
26	lymphoma	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	previously	_	_	RB	O	[-1]	['none']	_	_
3	published	_	_	VBN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	lymphoma	_	_	NN	O	[-1]	['none']	_	_
6	usually	_	_	RB	O	[-1]	['none']	_	_
7	develops	_	_	VBZ	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	mice	_	_	NNS	O	[-1]	['none']	_	_
10	over	_	_	IN	O	[-1]	['none']	_	_
11	12	_	_	CD	O	[-1]	['none']	_	_
12	mo	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	age	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	all	_	_	DT	O	[-1]	['none']	_	_
17	mice	_	_	NNS	O	[-1]	['none']	_	_
18	are	_	_	VBP	O	[-1]	['none']	_	_
19	sacrificed	_	_	VBN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	18-20	_	_	CD	O	[-1]	['none']	_	_
22	mo.	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	ages	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	transgenic	_	_	JJ	O	[-1]	['none']	_	_
6	mice	_	_	NNS	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	or	_	_	CC	O	[-1]	['none']	_	_
9	without	_	_	IN	O	[-1]	['none']	_	_
10	lymphoma	_	_	NN	O	[-1]	['none']	_	_
11	ranged	_	_	VBD	O	[-1]	['none']	_	_
12	between	_	_	IN	O	[-1]	['none']	_	_
13	6	_	_	CD	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	20	_	_	CD	O	[-1]	['none']	_	_
16	mo	_	_	NN	O	[-1]	['none']	_	_
17	old	_	_	JJ	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	There	_	_	EX	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	no	_	_	DT	O	[-1]	['none']	_	_
4	correlation	_	_	NN	O	[-1]	['none']	_	_
5	between	_	_	IN	O	[-1]	['none']	_	_
6	age	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	MTS	_	_	NN	O	[-1]	['none']	_	_
9	activity	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	EMA	_	_	NN	O	[-1]	['none']	_	_
2	exclusion	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
5	gated	_	_	VBN	O	[-1]	['none']	_	_
6	B	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	prepared	_	_	VBN	O	[-1]	['none']	_	_
9	from	_	_	IN	O	[-1]	['none']	_	_
10	two	_	_	CD	O	[-1]	['none']	_	_
11	wild-type	_	_	JJ	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	two	_	_	CD	O	[-1]	['none']	_	_
14	LMP1	_	_	NN	Protein	[0]	['root']	_	_
15	transgenic	_	_	JJ	O	[-1]	['none']	_	_
16	mice	_	_	NNS	O	[-1]	['none']	_	_
17	indicated	_	_	VBD	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	2-fold	_	_	JJ	O	[-1]	['none']	_	_
20	increase	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	viability	_	_	NN	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	LMP1	_	_	NN	Protein	[0]	['root']	_	_
26	transgenic	_	_	JJ	O	[-1]	['none']	_	_
27	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
28	compared	_	_	VBN	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	wild-type	_	_	JJ	O	[-1]	['none']	_	_
31	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Two	_	_	CD	O	[-1]	['none']	_	_
2	examples	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[0]	['root']	_	_
5	transgenic	_	_	JJ	O	[-1]	['none']	_	_
6	lymphoma	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	had	_	_	VBD	O	[-1]	['none']	_	_
9	greatly	_	_	RB	O	[-1]	['none']	_	_
10	increased	_	_	VBN	O	[-1]	['none']	_	_
11	viability	_	_	NN	O	[-1]	['none']	_	_
12	that	_	_	WDT	O	[-1]	['none']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	not	_	_	RB	O	[-1]	['none']	_	_
15	increased	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	IL4	_	_	NN	Protein	[0]	['root']	_	_
18	treatment	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	indicating	_	_	VBG	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	lymphoma	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	are	_	_	VBP	O	[-1]	['none']	_	_
26	independent	_	_	JJ	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	IL4	_	_	NN	Protein	[0]	['root']	_	_
29	co-stimulation	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Enhancement	_	_	NN	O	[-1]	['none']	_	_
2	in	_	_	IN	O	[-1]	['none']	_	_
3	MTS	_	_	NN	O	[-1]	['none']	_	_
4	activity	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	observed	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	LMP1	_	_	NN	Protein	[0]	['root']	_	_
9	transgenic	_	_	JJ	O	[-1]	['none']	_	_
10	lymphoma	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	addition	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IL4	_	_	NN	Protein	[0]	['root']	_	_
17	;	_	_	:	O	[-1]	['none']	_	_
18	however	_	_	RB	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	EMA	_	_	NN	O	[-1]	['none']	_	_
21	exclusion	_	_	NN	O	[-1]	['none']	_	_
22	did	_	_	VBD	O	[-1]	['none']	_	_
23	not	_	_	RB	O	[-1]	['none']	_	_
24	reveal	_	_	VB	O	[-1]	['none']	_	_
25	a	_	_	DT	O	[-1]	['none']	_	_
26	similar	_	_	JJ	O	[-1]	['none']	_	_
27	increase	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	could	_	_	MD	O	[-1]	['none']	_	_
3	reflect	_	_	VB	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	difference	_	_	NN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	IL4	_	_	NN	Protein	[0]	['root']	_	_
8	requirement	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	metabolic	_	_	JJ	O	[-1]	['none']	_	_
12	activity	_	_	NN	O	[-1]	['none']	_	_
13	versus	_	_	CC	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	viability	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	LMP1	_	_	NN	Protein	[0]	['root']	_	_
18	transgenic	_	_	JJ	O	[-1]	['none']	_	_
19	lymphoma	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[2]	['Theme']	_	_
5	could	_	_	MD	O	[-1]	['none']	_	_
6	enhance	_	_	VB	O	[-1]	['none']	_	_
7	survival	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	non	_	_	JJ	O	[-1]	['none']	_	_
10	malignant	_	_	JJ	O	[-1]	['none']	_	_
11	primary	_	_	JJ	O	[-1]	['none']	_	_
12	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	BrdU	_	_	NN	O	[-1]	['none']	_	_
15	incorporation	_	_	NN	O	[-1]	['none']	_	_
16	revealed	_	_	VBD	O	[-1]	['none']	_	_
17	that	_	_	IN	O	[-1]	['none']	_	_
18	LMP1	_	_	NN	Protein	[19]	['Theme']	_	_
19	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
20	alone	_	_	RB	O	[-1]	['none']	_	_
21	was	_	_	VBD	O	[-1]	['none']	_	_
22	not	_	_	RB	O	[-1]	['none']	_	_
23	sufficient	_	_	JJ	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	induce	_	_	VB	O	[-1]	['none']	_	_
26	proliferation	_	_	NN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	culture	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	unpublished	_	_	JJ	O	[-1]	['none']	_	_
31	data	_	_	NNS	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Only	_	_	RB	O	[-1]	['none']	_	_
2	lymphoma	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	had	_	_	VBD	O	[-1]	['none']	_	_
5	detectable	_	_	JJ	O	[-1]	['none']	_	_
6	levels	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	BrdU	_	_	NN	O	[-1]	['none']	_	_
9	incorporation	_	_	NN	O	[-1]	['none']	_	_
10	detected	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	flow	_	_	NN	O	[-1]	['none']	_	_
13	cytometry	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	LMP1	_	_	NN	Protein	[0]	['root']	_	_
4	lymphoma	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	had	_	_	VBD	O	[-1]	['none']	_	_
7	significantly	_	_	RB	O	[-1]	['none']	_	_
8	higher	_	_	JJR	O	[-1]	['none']	_	_
9	levels	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	proliferation	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	comparison	_	_	NN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	spontaneous	_	_	JJ	O	[-1]	['none']	_	_
17	lymphoma	_	_	NN	O	[-1]	['none']	_	_
18	that	_	_	WDT	O	[-1]	['none']	_	_
19	developed	_	_	VBD	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	an	_	_	DT	O	[-1]	['none']	_	_
22	LMP1	_	_	NN	Protein	[23]	['Theme']	_	_
23	negative	_	_	JJ	Negative_regulation	[0]	['root']	_	_
24	littermate	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	25	_	_	CD	O	[-1]	['none']	_	_
27	%	_	_	NN	O	[-1]	['none']	_	_
28	versus	_	_	CC	O	[-1]	['none']	_	_
29	4	_	_	CD	O	[-1]	['none']	_	_
30	%	_	_	NN	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	higher	_	_	JJR	O	[-1]	['none']	_	_
3	level	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	proliferation	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	observed	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
10	that	_	_	WDT	O	[-1]	['none']	_	_
11	express	_	_	VBP	Gene_expression	[13, 15]	['Theme', 'Theme']	_	_
12	both	_	_	DT	O	[-1]	['none']	_	_
13	high	_	_	JJ	Positive_regulation	[0]	['root']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	low	_	_	JJ	Positive_regulation	[0]	['root']	_	_
16	levels	_	_	NNS	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	LMP1	_	_	NN	Protein	[11]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	suggesting	_	_	VBG	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	even	_	_	RB	O	[-1]	['none']	_	_
23	small	_	_	JJ	O	[-1]	['none']	_	_
24	amounts	_	_	NNS	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	LMP1	_	_	NN	Protein	[0]	['root']	_	_
27	is	_	_	VBZ	O	[-1]	['none']	_	_
28	sufficient	_	_	JJ	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	induce	_	_	VB	O	[-1]	['none']	_	_
31	dramatic	_	_	JJ	O	[-1]	['none']	_	_
32	effects	_	_	NNS	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	proliferation	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	level	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	proliferation	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	enhanced	_	_	VBN	O	[-1]	['none']	_	_
8	upon	_	_	IN	O	[-1]	['none']	_	_
9	IL4	_	_	NN	Protein	[0]	['root']	_	_
10	addition	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	confirming	_	_	VBG	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	IL4	_	_	NN	Protein	[0]	['root']	_	_
15	independence	_	_	NN	O	[-1]	['none']	_	_
16	observed	_	_	VBN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	viability	_	_	NN	O	[-1]	['none']	_	_
20	studies	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
2	Antagonizes	_	_	VBZ	O	[-1]	['none']	_	_
3	CREB	_	_	NN	O	[-1]	['none']	_	_
4	Transcriptional	_	_	JJ	O	[-1]	['none']	_	_
5	Activation	_	_	NN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	Disrupting	_	_	VBG	O	[-1]	['none']	_	_
8	Coactivator	_	_	NN	O	[-1]	['none']	_	_
9	Recruitment	_	_	NN	O	[-1]	['none']	_	_
10	Stimulation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	CREB	_	_	NN	O	[-1]	['none']	_	_
13	dependent	_	_	JJ	O	[-1]	['none']	_	_
14	transcription	_	_	NN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	reagents	_	_	NNS	O	[-1]	['none']	_	_
17	that	_	_	WDT	O	[-1]	['none']	_	_
18	activate	_	_	VBP	O	[-1]	['none']	_	_
19	adenylate	_	_	NN	O	[-1]	['none']	_	_
20	cyclase	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	increase	_	_	NN	O	[-1]	['none']	_	_
23	cAMP	_	_	NN	O	[-1]	['none']	_	_
24	levels	_	_	NNS	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	e.g.	_	_	FW	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	forskolin	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	increase	_	_	VBP	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	transactivation	_	_	NN	O	[-1]	['none']	_	_
33	potential	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	CREB	_	_	NN	O	[-1]	['none']	_	_
36	through	_	_	IN	O	[-1]	['none']	_	_
37	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	serine	_	_	NN	O	[-1]	['none']	_	_
40	133	_	_	CD	O	[-1]	['none']	_	_
41	by	_	_	IN	O	[-1]	['none']	_	_
42	protein	_	_	NN	O	[-1]	['none']	_	_
43	kinase	_	_	NN	O	[-1]	['none']	_	_
44	A	_	_	NN	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	which	_	_	WDT	O	[-1]	['none']	_	_
47	permits	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
48	binding	_	_	NN	Binding	[47]	['Theme']	_	_
49	and	_	_	CC	O	[-1]	['none']	_	_
50	recruitment	_	_	NN	O	[-1]	['none']	_	_
51	of	_	_	IN	O	[-1]	['none']	_	_
52	coactivators	_	_	NNS	O	[-1]	['none']	_	_
53	CBP	_	_	NN	Protein	[48]	['Theme']	_	_
54	and	_	_	CC	O	[-1]	['none']	_	_
55	p300	_	_	NN	Protein	[48]	['Theme']	_	_
56	to	_	_	TO	O	[-1]	['none']	_	_
57	the	_	_	DT	O	[-1]	['none']	_	_
58	promoter	_	_	NN	O	[-1]	['none']	_	_
59	[	_	_	CD	O	[-1]	['none']	_	_
60	37,38	_	_	CD	O	[-1]	['none']	_	_
61	]	_	_	NN	O	[-1]	['none']	_	_
62	.	_	_	.	O	[-1]	['none']	_	_

1	Phosphorylation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	serine	_	_	NN	O	[-1]	['none']	_	_
4	133	_	_	CD	O	[-1]	['none']	_	_
5	does	_	_	VBZ	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	however	_	_	RB	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	affect	_	_	VB	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	DNA	_	_	NN	O	[-1]	['none']	_	_
13	binding	_	_	NN	O	[-1]	['none']	_	_
14	activity	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	CREB	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	most	_	_	JJS	O	[-1]	['none']	_	_
19	cases	_	_	NNS	O	[-1]	['none']	_	_
20	[	_	_	VBP	O	[-1]	['none']	_	_
21	39-41	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	CD	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Addition	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	forskolin	_	_	NN	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	HEK	_	_	NNP	O	[-1]	['none']	_	_
6	293T	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	stimulated	_	_	VBD	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	CREB	_	_	NN	O	[-1]	['none']	_	_
13	reporter	_	_	NN	O	[-1]	['none']	_	_
14	vector	_	_	NN	O	[-1]	['none']	_	_
15	about	_	_	IN	O	[-1]	['none']	_	_
16	65	_	_	CD	O	[-1]	['none']	_	_
17	fold	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Foxp3	_	_	NN	Protein	[1]	['Theme']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	capable	_	_	JJ	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	down-regulating	_	_	JJ	O	[-1]	['none']	_	_
8	forskolin	_	_	NN	O	[-1]	['none']	_	_
9	induced	_	_	VBD	O	[-1]	['none']	_	_
10	CREB	_	_	NN	O	[-1]	['none']	_	_
11	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
12	activation	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	functional	_	_	JJ	O	[-1]	['none']	_	_
3	interaction	_	_	NN	Binding	[10]	['Cause']	_	_
4	between	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[3, 23]	['Theme', 'Cause']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	CREB	_	_	NN	O	[-1]	['none']	_	_
8	did	_	_	VBD	O	[-1]	['none']	_	_
9	not	_	_	RB	O	[-1]	['none']	_	_
10	affect	_	_	VB	Regulation	[0]	['root']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	DNA	_	_	NN	O	[-1]	['none']	_	_
13	binding	_	_	NN	Binding	[10]	['Theme']	_	_
14	activity	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	CREB-1	_	_	NN	Protein	[13]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	but	_	_	CC	O	[-1]	['none']	_	_
19	did	_	_	VBD	O	[-1]	['none']	_	_
20	show	_	_	VB	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	modest	_	_	JJ	O	[-1]	['none']	_	_
23	decrease	_	_	NN	Negative_regulation	[0]	['root']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	activating	_	_	VBG	Protein	[28]	['multitoken']	_	_
26	transcription	_	_	NN	Protein	[28]	['multitoken']	_	_
27	factor	_	_	NN	Protein	[28]	['multitoken']	_	_
28	2	_	_	CD	Protein	[33]	['Theme']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	ATF-2	_	_	NN	Protein	[0]	['root']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	DNA	_	_	NN	O	[-1]	['none']	_	_
33	binding	_	_	NN	Binding	[23]	['Theme']	_	_
34	activity	_	_	NN	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	presence	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	forskolin	_	_	NN	O	[-1]	['none']	_	_
40	as	_	_	IN	O	[-1]	['none']	_	_
41	determined	_	_	VBN	O	[-1]	['none']	_	_
42	by	_	_	IN	O	[-1]	['none']	_	_
43	transcription	_	_	NN	O	[-1]	['none']	_	_
44	factor	_	_	NN	O	[-1]	['none']	_	_
45	ELISA	_	_	NN	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	While	_	_	IN	O	[-1]	['none']	_	_
2	Foxp3	_	_	NN	Protein	[7]	['Theme']	_	_
3	has	_	_	VBZ	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	shown	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	bind	_	_	VB	Binding	[0]	['root']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	repress	_	_	VB	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	both	_	_	CC	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	NF-AT	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	exactly	_	_	RB	O	[-1]	['none']	_	_
19	how	_	_	WRB	O	[-1]	['none']	_	_
20	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
21	functions	_	_	VBZ	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	bring	_	_	VB	O	[-1]	['none']	_	_
24	about	_	_	RB	O	[-1]	['none']	_	_
25	this	_	_	DT	O	[-1]	['none']	_	_
26	affect	_	_	NN	O	[-1]	['none']	_	_
27	has	_	_	VBZ	O	[-1]	['none']	_	_
28	not	_	_	RB	O	[-1]	['none']	_	_
29	been	_	_	VBN	O	[-1]	['none']	_	_
30	elucidated	_	_	VBN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	how	_	_	WRB	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
5	blocks	_	_	VBZ	O	[-1]	['none']	_	_
6	CREB	_	_	NN	O	[-1]	['none']	_	_
7	dependent	_	_	JJ	O	[-1]	['none']	_	_
8	transcription	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	we	_	_	PRP	O	[-1]	['none']	_	_
11	examined	_	_	VBD	O	[-1]	['none']	_	_
12	whether	_	_	IN	O	[-1]	['none']	_	_
13	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	capable	_	_	JJ	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	1	_	_	CD	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	disrupting	_	_	VBG	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	recruitment	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	coactivator	_	_	NN	O	[-1]	['none']	_	_
25	proteins	_	_	NNS	O	[-1]	['none']	_	_
26	and/or	_	_	CC	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	2	_	_	CD	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	preventing	_	_	VBG	O	[-1]	['none']	_	_
31	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	CREB	_	_	NN	O	[-1]	['none']	_	_
34	at	_	_	IN	O	[-1]	['none']	_	_
35	serine	_	_	NN	O	[-1]	['none']	_	_
36	133	_	_	CD	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	which	_	_	WDT	O	[-1]	['none']	_	_
39	is	_	_	VBZ	O	[-1]	['none']	_	_
40	a	_	_	DT	O	[-1]	['none']	_	_
41	prerequisite	_	_	NN	O	[-1]	['none']	_	_
42	for	_	_	IN	O	[-1]	['none']	_	_
43	coactivator	_	_	NN	O	[-1]	['none']	_	_
44	recruitment	_	_	NN	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	both	_	_	DT	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	these	_	_	DT	O	[-1]	['none']	_	_
5	events	_	_	NNS	O	[-1]	['none']	_	_
6	are	_	_	VBP	O	[-1]	['none']	_	_
7	required	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	CREB	_	_	NN	O	[-1]	['none']	_	_
10	dependent	_	_	JJ	O	[-1]	['none']	_	_
11	gene	_	_	NN	O	[-1]	['none']	_	_
12	expression	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	we	_	_	PRP	O	[-1]	['none']	_	_
15	hypothesized	_	_	VBD	O	[-1]	['none']	_	_
16	that	_	_	IN	O	[-1]	['none']	_	_
17	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
18	may	_	_	MD	O	[-1]	['none']	_	_
19	affect	_	_	VB	O	[-1]	['none']	_	_
20	CREB	_	_	NN	O	[-1]	['none']	_	_
21	activation	_	_	NN	O	[-1]	['none']	_	_
22	at	_	_	IN	O	[-1]	['none']	_	_
23	both	_	_	DT	O	[-1]	['none']	_	_
24	steps	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
5	can	_	_	MD	O	[-1]	['none']	_	_
6	disrupt	_	_	VB	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	function	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	recruitment	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	coactivator	_	_	NN	O	[-1]	['none']	_	_
14	protein	_	_	NN	O	[-1]	['none']	_	_
15	p300	_	_	NN	Protein	[0]	['root']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	we	_	_	PRP	O	[-1]	['none']	_	_
18	introduced	_	_	VBD	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	Gal4	_	_	NN	Protein	[0]	['root']	_	_
21	reporter	_	_	NN	O	[-1]	['none']	_	_
22	vector	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	Gal4-BD-CREB-1	_	_	NN	Protein	[26]	['Theme']	_	_
26	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
27	vector	_	_	NN	O	[-1]	['none']	_	_
28	into	_	_	IN	O	[-1]	['none']	_	_
29	HEK	_	_	NNP	O	[-1]	['none']	_	_
30	293T	_	_	NN	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	absence	_	_	NN	O	[-1]	['none']	_	_
35	or	_	_	CC	O	[-1]	['none']	_	_
36	presence	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	Foxp3	_	_	NN	Protein	[44]	['Theme']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	p300	_	_	NN	Protein	[44]	['Theme']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	and/or	_	_	CC	O	[-1]	['none']	_	_
43	control	_	_	NN	O	[-1]	['none']	_	_
44	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
45	vectors	_	_	NNS	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	p300	_	_	NN	Protein	[5]	['Theme']	_	_
5	overexpression	_	_	NN	Positive_regulation	[6]	['Cause']	_	_
6	stimulated	_	_	VBD	Positive_regulation	[0]	['root']	_	_
7	transcription	_	_	NN	Transcription	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	Gal4-BD-CREB-1	_	_	NN	Protein	[7]	['Theme']	_	_
11	fusion	_	_	NN	O	[-1]	['none']	_	_
12	protein	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[5, 18]	['Cause', 'Cause']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	again	_	_	RB	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	repressed	_	_	VBD	Negative_regulation	[0]	['root']	_	_
6	basal	_	_	JJ	O	[-1]	['none']	_	_
7	levels	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	Gal4-BD-CREB-1	_	_	NN	Protein	[10]	['Theme']	_	_
10	activation	_	_	NN	Positive_regulation	[5]	['Theme']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	more	_	_	JJR	O	[-1]	['none']	_	_
13	than	_	_	IN	O	[-1]	['none']	_	_
14	2-fold	_	_	RB	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	while	_	_	IN	O	[-1]	['none']	_	_
17	effectively	_	_	RB	O	[-1]	['none']	_	_
18	neutralizing	_	_	VBG	Negative_regulation	[0]	['root']	_	_
19	Gal4-BD-CREB-1	_	_	NN	Protein	[20]	['Theme']	_	_
20	activation	_	_	NN	Positive_regulation	[18]	['Theme']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	presence	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	p300	_	_	NN	Protein	[0]	['root']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	next	_	_	RB	O	[-1]	['none']	_	_
3	analyzed	_	_	VBD	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	effect	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	CREB	_	_	NN	O	[-1]	['none']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	serine	_	_	NN	O	[-1]	['none']	_	_
14	133	_	_	CD	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	forskolin	_	_	NN	O	[-1]	['none']	_	_
17	treated	_	_	VBN	O	[-1]	['none']	_	_
18	HEK	_	_	NNP	O	[-1]	['none']	_	_
19	293T	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	Western	_	_	NN	O	[-1]	['none']	_	_
23	blot	_	_	NN	O	[-1]	['none']	_	_
24	analysis	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Foxp3	_	_	NN	Protein	[1]	['Theme']	_	_
4	failed	_	_	VBD	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	reduce	_	_	VB	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	detectable	_	_	JJ	O	[-1]	['none']	_	_
9	levels	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	CREB	_	_	NN	O	[-1]	['none']	_	_
12	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
13	using	_	_	VBG	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	phosphospecific	_	_	JJ	O	[-1]	['none']	_	_
16	antibody	_	_	NN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	CREB-1	_	_	NN	Protein	[0]	['root']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	unpublished	_	_	JJ	O	[-1]	['none']	_	_
21	data	_	_	NNS	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	when	_	_	WRB	O	[-1]	['none']	_	_
4	we	_	_	PRP	O	[-1]	['none']	_	_
5	attempted	_	_	VBD	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	determine	_	_	VB	O	[-1]	['none']	_	_
8	whether	_	_	IN	O	[-1]	['none']	_	_
9	Foxp3	_	_	NN	Protein	[12]	['Theme']	_	_
10	could	_	_	MD	O	[-1]	['none']	_	_
11	physically	_	_	RB	O	[-1]	['none']	_	_
12	interact	_	_	VB	Binding	[0]	['root']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	coactivator	_	_	NN	O	[-1]	['none']	_	_
16	protein	_	_	NN	O	[-1]	['none']	_	_
17	p300	_	_	NN	Protein	[12]	['Theme']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	we	_	_	PRP	O	[-1]	['none']	_	_
20	found	_	_	VBD	O	[-1]	['none']	_	_
21	that	_	_	IN	O	[-1]	['none']	_	_
22	p300	_	_	NN	Protein	[23, 29]	['Theme', 'Theme']	_	_
23	immunoprecipitated	_	_	VBN	Binding	[25]	['Theme']	_	_
24	Foxp3	_	_	NN	Protein	[23, 29]	['Theme', 'Theme']	_	_
25	when	_	_	WRB	Positive_regulation	[0]	['root']	_	_
26	both	_	_	DT	Anaphora	[27]	['multitoken']	_	_
27	proteins	_	_	NNS	Anaphora	[0]	['root']	_	_
28	were	_	_	VBD	O	[-1]	['none']	_	_
29	overexpressed	_	_	VBN	Gene_expression	[25]	['Cause']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	HEK	_	_	NNP	O	[-1]	['none']	_	_
32	293T	_	_	NN	O	[-1]	['none']	_	_
33	cells	_	_	NNS	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Collectively	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	results	_	_	NNS	O	[-1]	['none']	_	_
5	suggest	_	_	VBP	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[15]	['Theme']	_	_
8	antagonizes	_	_	VBZ	O	[-1]	['none']	_	_
9	CREB	_	_	NN	O	[-1]	['none']	_	_
10	dependent	_	_	JJ	O	[-1]	['none']	_	_
11	gene	_	_	NN	O	[-1]	['none']	_	_
12	expression	_	_	NN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	directly	_	_	RB	O	[-1]	['none']	_	_
15	interacting	_	_	VBG	Binding	[20]	['Cause']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	coactivator	_	_	NN	O	[-1]	['none']	_	_
18	p300	_	_	NN	Protein	[15, 25]	['Theme', 'Theme']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	interfering	_	_	VBG	Negative_regulation	[0]	['root']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
23	function	_	_	NN	O	[-1]	['none']	_	_
24	and/or	_	_	CC	O	[-1]	['none']	_	_
25	recruitment	_	_	NN	Binding	[20]	['Theme']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	CREB	_	_	NN	O	[-1]	['none']	_	_
28	responsive	_	_	JJ	O	[-1]	['none']	_	_
29	promoter	_	_	NN	O	[-1]	['none']	_	_
30	sequences	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Immunofluorescence	_	_	NN	O	[-1]	['none']	_	_
2	Fibroblast	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	macrophage	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	transfected	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	pFLAG-SHARPIN	_	_	NN	Protein	[0]	['root']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	48	_	_	CD	O	[-1]	['none']	_	_
2	hours	_	_	NNS	O	[-1]	['none']	_	_
3	later	_	_	RB	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	washed	_	_	VBN	O	[-1]	['none']	_	_
8	briefly	_	_	NN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	PBS	_	_	NNP	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	then	_	_	RB	O	[-1]	['none']	_	_
13	fixed	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	cold	_	_	JJ	O	[-1]	['none']	_	_
16	methanol	_	_	NN	O	[-1]	['none']	_	_
17	at	_	_	IN	O	[-1]	['none']	_	_
18	-20	_	_	CD	O	[-1]	['none']	_	_
19	degreesC	_	_	NN	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	10	_	_	CD	O	[-1]	['none']	_	_
22	minutes	_	_	NNS	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	cold	_	_	JJ	O	[-1]	['none']	_	_
25	acetone	_	_	NN	O	[-1]	['none']	_	_
26	at	_	_	IN	O	[-1]	['none']	_	_
27	-20	_	_	CD	O	[-1]	['none']	_	_
28	degreesC	_	_	NN	O	[-1]	['none']	_	_
29	for	_	_	IN	O	[-1]	['none']	_	_
30	1	_	_	CD	O	[-1]	['none']	_	_
31	minute	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Incubate	_	_	JJ	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	PBS	_	_	NNP	O	[-1]	['none']	_	_
5	+1	_	_	CD	O	[-1]	['none']	_	_
6	%	_	_	NN	O	[-1]	['none']	_	_
7	BSA	_	_	NN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	15	_	_	CD	O	[-1]	['none']	_	_
10	minutes	_	_	NNS	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	block	_	_	VB	O	[-1]	['none']	_	_
13	non	_	_	JJ	O	[-1]	['none']	_	_
14	specific	_	_	JJ	O	[-1]	['none']	_	_
15	binding	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Fixed	_	_	VBN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	then	_	_	RB	O	[-1]	['none']	_	_
5	incubated	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	anti-FLAG	_	_	JJ	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	1:100	_	_	CD	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	primary	_	_	JJ	O	[-1]	['none']	_	_
14	antibody	_	_	NN	O	[-1]	['none']	_	_
15	at	_	_	IN	O	[-1]	['none']	_	_
16	room	_	_	NN	O	[-1]	['none']	_	_
17	temperature	_	_	NN	O	[-1]	['none']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	1	_	_	CD	O	[-1]	['none']	_	_
20	hour	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	followed	_	_	VBN	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	three	_	_	CD	O	[-1]	['none']	_	_
25	5-minute	_	_	JJ	O	[-1]	['none']	_	_
26	washes	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	further	_	_	JJ	O	[-1]	['none']	_	_
4	incubated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	goat	_	_	NN	O	[-1]	['none']	_	_
7	anti-rabbit	_	_	JJ	O	[-1]	['none']	_	_
8	IgG-FITC	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	1:100	_	_	CD	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	secondary	_	_	JJ	O	[-1]	['none']	_	_
15	antibody	_	_	NN	O	[-1]	['none']	_	_
16	at	_	_	IN	O	[-1]	['none']	_	_
17	room	_	_	NN	O	[-1]	['none']	_	_
18	temperature	_	_	NN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	30	_	_	CD	O	[-1]	['none']	_	_
21	minutes	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	followed	_	_	VBN	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	three	_	_	CD	O	[-1]	['none']	_	_
26	5-minute	_	_	JJ	O	[-1]	['none']	_	_
27	washes	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	then	_	_	RB	O	[-1]	['none']	_	_
4	examined	_	_	VBN	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	inverse	_	_	JJ	O	[-1]	['none']	_	_
7	fluorescence	_	_	NN	O	[-1]	['none']	_	_
8	microscope	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Cytokine	_	_	NN	O	[-1]	['none']	_	_
2	Detection	_	_	NN	O	[-1]	['none']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	ICS	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	ELISA	_	_	NN	O	[-1]	['none']	_	_
7	At	_	_	IN	O	[-1]	['none']	_	_
8	day	_	_	NN	O	[-1]	['none']	_	_
9	5	_	_	CD	O	[-1]	['none']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	7	_	_	CD	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	restimulated	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	immobilized	_	_	VBN	O	[-1]	['none']	_	_
18	anti-CD3	_	_	JJ	Protein	[0]	['root']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	2	_	_	CD	O	[-1]	['none']	_	_
21	mug/ml	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	anti-CD28	_	_	JJ	Protein	[0]	['root']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	2	_	_	CD	O	[-1]	['none']	_	_
27	mug/ml	_	_	NN	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	4	_	_	CD	O	[-1]	['none']	_	_
31	hr	_	_	NN	O	[-1]	['none']	_	_
32	with	_	_	IN	O	[-1]	['none']	_	_
33	BrefeldinA	_	_	NN	O	[-1]	['none']	_	_
34	[	_	_	CD	O	[-1]	['none']	_	_
35	10	_	_	CD	O	[-1]	['none']	_	_
36	mug/ml	_	_	NN	O	[-1]	['none']	_	_
37	]	_	_	NN	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	last	_	_	JJ	O	[-1]	['none']	_	_
41	2	_	_	CD	O	[-1]	['none']	_	_
42	hr	_	_	NN	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	or	_	_	CC	O	[-1]	['none']	_	_
45	with	_	_	IN	O	[-1]	['none']	_	_
46	PdBU	_	_	NN	O	[-1]	['none']	_	_
47	and	_	_	CC	O	[-1]	['none']	_	_
48	Ionomycin	_	_	NN	O	[-1]	['none']	_	_
49	(	_	_	-LRB-	O	[-1]	['none']	_	_
50	5	_	_	CD	O	[-1]	['none']	_	_
51	hr	_	_	NN	O	[-1]	['none']	_	_
52	with	_	_	IN	O	[-1]	['none']	_	_
53	BrefeldinA	_	_	NN	O	[-1]	['none']	_	_
54	[	_	_	CD	O	[-1]	['none']	_	_
55	1	_	_	CD	O	[-1]	['none']	_	_
56	mug/ml	_	_	NN	O	[-1]	['none']	_	_
57	]	_	_	CD	O	[-1]	['none']	_	_
58	)	_	_	-RRB-	O	[-1]	['none']	_	_
59	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	ICS	_	_	NN	O	[-1]	['none']	_	_
3	FACS	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	data	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	collected	_	_	VBN	O	[-1]	['none']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	FACSCalibur	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Becton	_	_	NNP	O	[-1]	['none']	_	_
13	Dickinson	_	_	NNP	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	analyzed	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	FlowJo	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Tree	_	_	NNP	O	[-1]	['none']	_	_
21	Star	_	_	NNP	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	ELISA	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	similarly	_	_	RB	O	[-1]	['none']	_	_
7	restimulated	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	48	_	_	CD	O	[-1]	['none']	_	_
10	hr	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	supernatant	_	_	NN	O	[-1]	['none']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	collected	_	_	VBN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	analyzed	_	_	VBN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	IL-4	_	_	NN	Protein	[0]	['root']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	IL-10	_	_	NN	Protein	[0]	['root']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	IFN-gamma	_	_	NN	Protein	[0]	['root']	_	_
24	as	_	_	IN	O	[-1]	['none']	_	_
25	described	_	_	VBN	O	[-1]	['none']	_	_
26	before	_	_	IN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	Shoemaker	_	_	NNP	O	[-1]	['none']	_	_
29	et	_	_	FW	O	[-1]	['none']	_	_
30	al.	_	_	FW	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	2006	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	O	[-1]	['none']	_	_
2	Isolation	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	Quantitative	_	_	JJ	O	[-1]	['none']	_	_
5	Real-time	_	_	JJ	O	[-1]	['none']	_	_
6	PCR	_	_	NN	O	[-1]	['none']	_	_
7	MDMs	_	_	NNS	O	[-1]	['none']	_	_
8	or	_	_	CC	O	[-1]	['none']	_	_
9	RAW	_	_	NN	O	[-1]	['none']	_	_
10	264.7	_	_	CD	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	serum	_	_	NN	O	[-1]	['none']	_	_
14	starved	_	_	VBN	O	[-1]	['none']	_	_
15	overnight	_	_	JJ	O	[-1]	['none']	_	_
16	or	_	_	CC	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	2	_	_	CD	O	[-1]	['none']	_	_
19	hours	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	respectively	_	_	RB	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	prior	_	_	RB	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	incubating	_	_	VBG	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	30	_	_	CD	O	[-1]	['none']	_	_
30	minutes	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	restimulated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	100	_	_	CD	O	[-1]	['none']	_	_
7	ng/ml	_	_	NN	O	[-1]	['none']	_	_
8	M-CSF	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	total	_	_	NN	O	[-1]	['none']	_	_
11	mRNA	_	_	NN	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	extracted	_	_	VBN	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	Trizol	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	1-2	_	_	CD	O	[-1]	['none']	_	_
23	microg	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	total	_	_	JJ	O	[-1]	['none']	_	_
26	RNA	_	_	NN	O	[-1]	['none']	_	_
27	was	_	_	VBD	O	[-1]	['none']	_	_
28	used	_	_	VBN	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	synthesized	_	_	VBN	O	[-1]	['none']	_	_
31	cDNA	_	_	NN	O	[-1]	['none']	_	_
32	using	_	_	VBG	O	[-1]	['none']	_	_
33	SuperScript	_	_	NNP	O	[-1]	['none']	_	_
34	III	_	_	NNP	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Quantitative	_	_	JJ	O	[-1]	['none']	_	_
2	real-time	_	_	JJ	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	qRT	_	_	NN	O	[-1]	['none']	_	_
5	)-PCR	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	performed	_	_	VBN	O	[-1]	['none']	_	_
8	using	_	_	VBG	O	[-1]	['none']	_	_
9	SYBR	_	_	NNP	O	[-1]	['none']	_	_
10	Green	_	_	NNP	O	[-1]	['none']	_	_
11	Master	_	_	NNP	O	[-1]	['none']	_	_
12	Mix	_	_	NNP	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Applied	_	_	NNP	O	[-1]	['none']	_	_
15	BioSystems	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	Carlsbad	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	CA	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	reactions	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	an	_	_	DT	O	[-1]	['none']	_	_
7	ABI	_	_	NNP	O	[-1]	['none']	_	_
8	PRIZM	_	_	NNP	O	[-1]	['none']	_	_
9	7700	_	_	CD	O	[-1]	['none']	_	_
10	machine	_	_	NN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	software	_	_	NN	O	[-1]	['none']	_	_
13	Sequence	_	_	NN	O	[-1]	['none']	_	_
14	Detector	_	_	NN	O	[-1]	['none']	_	_
15	version	_	_	NN	O	[-1]	['none']	_	_
16	1.7	_	_	CD	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Applied	_	_	NNP	O	[-1]	['none']	_	_
19	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	target	_	_	NN	O	[-1]	['none']	_	_
3	gene	_	_	NN	O	[-1]	['none']	_	_
4	values	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	normalized	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	values	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	GAPDH	_	_	NN	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	housekeeping	_	_	JJ	O	[-1]	['none']	_	_
15	gene	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	expressed	_	_	VBN	O	[-1]	['none']	_	_
18	as	_	_	IN	O	[-1]	['none']	_	_
19	relative	_	_	JJ	O	[-1]	['none']	_	_
20	fold	_	_	JJ	O	[-1]	['none']	_	_
21	increase	_	_	NN	O	[-1]	['none']	_	_
22	2	_	_	CD	O	[-1]	['none']	_	_
23	(-deltadeltaCt	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	over	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	non	_	_	JJ	O	[-1]	['none']	_	_
28	stimulated	_	_	JJ	O	[-1]	['none']	_	_
29	samples	_	_	NNS	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	NS	_	_	NN	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Electrophoresis	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	Mobility	_	_	NN	O	[-1]	['none']	_	_
5	Shift	_	_	NN	O	[-1]	['none']	_	_
6	Analysis	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	EMSA	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	Nuclear	_	_	JJ	O	[-1]	['none']	_	_
11	extracts	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	isolated	_	_	VBN	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	MDMs	_	_	NNS	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	using	_	_	VBG	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	nuclear	_	_	JJ	O	[-1]	['none']	_	_
20	extraction	_	_	NN	O	[-1]	['none']	_	_
21	kit	_	_	NN	O	[-1]	['none']	_	_
22	according	_	_	VBG	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	manufacturer	_	_	NN	O	[-1]	['none']	_	_
26	's	_	_	POS	O	[-1]	['none']	_	_
27	instruction	_	_	NN	O	[-1]	['none']	_	_
28	from	_	_	IN	O	[-1]	['none']	_	_
29	Active	_	_	JJ	O	[-1]	['none']	_	_
30	Motif	_	_	NN	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	Carlsbad	_	_	NNP	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	CA	_	_	NNP	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	MDMs	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	lysed	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	hypotonic	_	_	JJ	O	[-1]	['none']	_	_
8	lysis	_	_	NN	O	[-1]	['none']	_	_
9	buffer	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	20	_	_	CD	O	[-1]	['none']	_	_
12	mM	_	_	NN	O	[-1]	['none']	_	_
13	Hepes	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	pH	_	_	NN	O	[-1]	['none']	_	_
16	7.5	_	_	CD	O	[-1]	['none']	_	_
17	;	_	_	:	O	[-1]	['none']	_	_
18	5	_	_	CD	O	[-1]	['none']	_	_
19	mM	_	_	NN	O	[-1]	['none']	_	_
20	NaF	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	10	_	_	CD	O	[-1]	['none']	_	_
23	microM	_	_	NN	O	[-1]	['none']	_	_
24	Na2MoO4	_	_	NN	O	[-1]	['none']	_	_
25	0.5	_	_	CD	O	[-1]	['none']	_	_
26	%	_	_	NN	O	[-1]	['none']	_	_
27	NP-40	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	0.1	_	_	CD	O	[-1]	['none']	_	_
30	mM	_	_	NN	O	[-1]	['none']	_	_
31	EDTA	_	_	NN	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	then	_	_	RB	O	[-1]	['none']	_	_
36	nuclei	_	_	NNS	O	[-1]	['none']	_	_
37	were	_	_	VBD	O	[-1]	['none']	_	_
38	resuspended	_	_	VBN	O	[-1]	['none']	_	_
39	in	_	_	IN	O	[-1]	['none']	_	_
40	lysis	_	_	NN	O	[-1]	['none']	_	_
41	buffer	_	_	NN	O	[-1]	['none']	_	_
42	supplemented	_	_	VBN	O	[-1]	['none']	_	_
43	with	_	_	IN	O	[-1]	['none']	_	_
44	0.5	_	_	CD	O	[-1]	['none']	_	_
45	mM	_	_	NN	O	[-1]	['none']	_	_
46	DTT	_	_	NN	O	[-1]	['none']	_	_
47	and	_	_	CC	O	[-1]	['none']	_	_
48	0.2	_	_	CD	O	[-1]	['none']	_	_
49	mM	_	_	NN	O	[-1]	['none']	_	_
50	PMSF	_	_	NN	O	[-1]	['none']	_	_
51	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	consensus	_	_	NN	O	[-1]	['none']	_	_
4	oligonucleotides	_	_	NNS	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	sense	_	_	NN	O	[-1]	['none']	_	_
7	:	_	_	:	O	[-1]	['none']	_	_
8	AGTTGAGGGGACTTTCCCAGGC	_	_	NN	O	[-1]	['none']	_	_
9	;	_	_	:	O	[-1]	['none']	_	_
10	antisense	_	_	NN	O	[-1]	['none']	_	_
11	:	_	_	:	O	[-1]	['none']	_	_
12	GCCTGGGAAAGTCCCCTCAACT	_	_	NNP	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	labeled	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	32P	_	_	NN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	T4	_	_	NN	O	[-1]	['none']	_	_
19	polynucleokinase	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	Promega	_	_	NNP	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	Madison	_	_	NNP	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	WI	_	_	NNP	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	were	_	_	VBD	O	[-1]	['none']	_	_
28	incubated	_	_	VBN	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	nuclear	_	_	JJ	O	[-1]	['none']	_	_
31	extracts	_	_	NNS	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	binding	_	_	NN	O	[-1]	['none']	_	_
34	buffer	_	_	NN	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	10	_	_	CD	O	[-1]	['none']	_	_
37	mM	_	_	NN	O	[-1]	['none']	_	_
38	Tris	_	_	NNP	O	[-1]	['none']	_	_
39	pH	_	_	NN	O	[-1]	['none']	_	_
40	7.6	_	_	CD	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	1	_	_	CD	O	[-1]	['none']	_	_
43	mM	_	_	NN	O	[-1]	['none']	_	_
44	DTT	_	_	NN	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	0.5	_	_	CD	O	[-1]	['none']	_	_
47	mM	_	_	NN	O	[-1]	['none']	_	_
48	EDTA	_	_	NN	O	[-1]	['none']	_	_
49	,	_	_	,	O	[-1]	['none']	_	_
50	2	_	_	CD	O	[-1]	['none']	_	_
51	microg	_	_	NN	O	[-1]	['none']	_	_
52	polydI-dC	_	_	NN	O	[-1]	['none']	_	_
53	and	_	_	CC	O	[-1]	['none']	_	_
54	10	_	_	CD	O	[-1]	['none']	_	_
55	%	_	_	NN	O	[-1]	['none']	_	_
56	Glycerol	_	_	NN	O	[-1]	['none']	_	_
57	)	_	_	-RRB-	O	[-1]	['none']	_	_
58	at	_	_	IN	O	[-1]	['none']	_	_
59	30degreesC	_	_	NNP	O	[-1]	['none']	_	_
60	for	_	_	IN	O	[-1]	['none']	_	_
61	30	_	_	CD	O	[-1]	['none']	_	_
62	minutes	_	_	NNS	O	[-1]	['none']	_	_
63	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	free	_	_	JJ	O	[-1]	['none']	_	_
3	DNA	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	DNA	_	_	NN	O	[-1]	['none']	_	_
6	protein	_	_	NN	O	[-1]	['none']	_	_
7	mixtures	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	resolved	_	_	VBN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	5	_	_	CD	O	[-1]	['none']	_	_
12	%	_	_	NN	O	[-1]	['none']	_	_
13	native	_	_	JJ	O	[-1]	['none']	_	_
14	polyacrylamide	_	_	NN	O	[-1]	['none']	_	_
15	gels	_	_	NNS	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	0.5	_	_	CD	O	[-1]	['none']	_	_
18	x	_	_	CC	O	[-1]	['none']	_	_
19	TBE	_	_	NN	O	[-1]	['none']	_	_
20	buffer	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	45	_	_	CD	O	[-1]	['none']	_	_
23	mM	_	_	NN	O	[-1]	['none']	_	_
24	Tris	_	_	NNP	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	45	_	_	CD	O	[-1]	['none']	_	_
27	mM	_	_	NN	O	[-1]	['none']	_	_
28	boric	_	_	JJ	O	[-1]	['none']	_	_
29	acid	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	1	_	_	CD	O	[-1]	['none']	_	_
32	mM	_	_	NN	O	[-1]	['none']	_	_
33	EDTA	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	pH	_	_	NN	O	[-1]	['none']	_	_
36	8.3	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	by	_	_	IN	O	[-1]	['none']	_	_
39	electrophoresis	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	gel	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	dried	_	_	VBN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	subjected	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	autoradiography	_	_	NN	O	[-1]	['none']	_	_
9	analysis	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	study	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	approved	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	Human	_	_	NN	O	[-1]	['none']	_	_
8	Research	_	_	NNP	O	[-1]	['none']	_	_
9	Protections	_	_	NNP	O	[-1]	['none']	_	_
10	Program	_	_	NNP	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	Institutional	_	_	JJ	O	[-1]	['none']	_	_
14	Review	_	_	NNP	O	[-1]	['none']	_	_
15	Board	_	_	NNP	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Written	_	_	VBN	O	[-1]	['none']	_	_
2	consent	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	participate	_	_	VB	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	study	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	obtained	_	_	VBN	O	[-1]	['none']	_	_
10	from	_	_	IN	O	[-1]	['none']	_	_
11	all	_	_	DT	O	[-1]	['none']	_	_
12	volunteers	_	_	NNS	O	[-1]	['none']	_	_
13	prior	_	_	RB	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	blood	_	_	NN	O	[-1]	['none']	_	_
16	donation.Heparinized	_	_	VBD	O	[-1]	['none']	_	_
17	Vacutainers	_	_	NNS	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	purchased	_	_	VBN	O	[-1]	['none']	_	_
20	from	_	_	IN	O	[-1]	['none']	_	_
21	Becton	_	_	NNP	O	[-1]	['none']	_	_
22	Dickinson	_	_	NNP	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	San	_	_	NNP	O	[-1]	['none']	_	_
25	Jose	_	_	NNP	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	CA	_	_	NNP	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	1.5-mL	_	_	NN	O	[-1]	['none']	_	_
2	Eppendorf	_	_	NN	O	[-1]	['none']	_	_
3	centrifuge	_	_	NN	O	[-1]	['none']	_	_
4	tubes	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	purchased	_	_	VBN	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	Fisher	_	_	NNP	O	[-1]	['none']	_	_
9	Scientific	_	_	NNP	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Pittsburg	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	PA	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Hank	_	_	NN	O	[-1]	['none']	_	_
2	's	_	_	POS	O	[-1]	['none']	_	_
3	balanced	_	_	JJ	O	[-1]	['none']	_	_
4	salt	_	_	NN	O	[-1]	['none']	_	_
5	solution	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	HBSS	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	RPMI	_	_	NN	O	[-1]	['none']	_	_
11	1640	_	_	CD	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	obtained	_	_	VBN	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	Irvine	_	_	NNP	O	[-1]	['none']	_	_
16	Scientific	_	_	NNP	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Santa	_	_	NNP	O	[-1]	['none']	_	_
19	Ana	_	_	NNP	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	CA	_	_	NNP	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	LPS	_	_	NN	O	[-1]	['none']	_	_
2	fromEscherichia	_	_	NN	O	[-1]	['none']	_	_
3	coliserotype	_	_	NN	O	[-1]	['none']	_	_
4	0111	_	_	CD	O	[-1]	['none']	_	_
5	:	_	_	:	O	[-1]	['none']	_	_
6	B4	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	PTX	_	_	NN	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	purchased	_	_	VBN	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	Sigma	_	_	NNP	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	St.	_	_	NNP	O	[-1]	['none']	_	_
15	Louis	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	MO	_	_	NNP	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	PKA	_	_	NN	O	[-1]	['none']	_	_
3	inhibitor	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	N-[	_	_	NN	O	[-1]	['none']	_	_
6	2-(	_	_	CD	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	p-bromocinnamyl	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	amino	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	ethyl	_	_	NN	O	[-1]	['none']	_	_
13	]-5-isoguinolinesulfonamide-2HCl	_	_	NN	O	[-1]	['none']	_	_
14	]	_	_	CD	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	H89	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	purchased	_	_	VBN	O	[-1]	['none']	_	_
21	from	_	_	IN	O	[-1]	['none']	_	_
22	Calbiochem	_	_	NNP	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	La	_	_	NNP	O	[-1]	['none']	_	_
25	Jolla	_	_	NNP	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	CA	_	_	NNP	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Antibodies	_	_	NNS	O	[-1]	['none']	_	_
2	for	_	_	IN	O	[-1]	['none']	_	_
3	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
4	CREB	_	_	NN	Protein	[3]	['Theme']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	serine	_	_	NN	Entity	[7]	['multitoken']	_	_
7	133	_	_	CD	Entity	[3]	['Site']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
11	I-kappaBalpha	_	_	NN	Protein	[10]	['Theme']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	serines	_	_	NNS	Entity	[14]	['multitoken']	_	_
14	32	_	_	CD	Entity	[10]	['Site']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	36	_	_	CD	Entity	[10]	['Site']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	phosphorylated	_	_	VBN	Phosphorylation	[0]	['root']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	p65	_	_	NN	Protein	[19]	['Theme']	_	_
22	subunit	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	serine	_	_	NN	Entity	[25]	['multitoken']	_	_
25	276	_	_	CD	Entity	[19]	['Site']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	secondary	_	_	JJ	O	[-1]	['none']	_	_
30	antibodies	_	_	NNS	O	[-1]	['none']	_	_
31	were	_	_	VBD	O	[-1]	['none']	_	_
32	purchased	_	_	VBN	O	[-1]	['none']	_	_
33	from	_	_	IN	O	[-1]	['none']	_	_
34	Cell	_	_	NN	O	[-1]	['none']	_	_
35	Signaling	_	_	NN	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	Beverly	_	_	NNP	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	MA	_	_	NNP	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Dextran	_	_	NN	O	[-1]	['none']	_	_
2	T500	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	Percoll	_	_	NN	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	received	_	_	VBN	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	GE	_	_	NNP	O	[-1]	['none']	_	_
9	Healthcare	_	_	NNP	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	Amersham	_	_	NNP	O	[-1]	['none']	_	_
12	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Piscataway	_	_	NNP	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	NJ	_	_	NNP	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	enzyme	_	_	NN	O	[-1]	['none']	_	_
3	linked	_	_	JJ	O	[-1]	['none']	_	_
4	immunosorbent	_	_	JJ	O	[-1]	['none']	_	_
5	assay	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	ELISA	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	TNF-alpha	_	_	NN	Protein	[0]	['root']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	obtained	_	_	VBN	O	[-1]	['none']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	Quantikine	_	_	NNP	O	[-1]	['none']	_	_
15	R&D	_	_	NNP	O	[-1]	['none']	_	_
16	Systems	_	_	NNP	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Minneapolis	_	_	NNP	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	MN	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Tris-glycine	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	DNA	_	_	NN	O	[-1]	['none']	_	_
4	retardation	_	_	NN	O	[-1]	['none']	_	_
5	gels	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	nitrocellulose	_	_	NN	O	[-1]	['none']	_	_
8	membranes	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	western	_	_	NN	O	[-1]	['none']	_	_
12	blot	_	_	NN	O	[-1]	['none']	_	_
13	running	_	_	VBG	O	[-1]	['none']	_	_
14	buffers	_	_	NNS	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	obtained	_	_	VBN	O	[-1]	['none']	_	_
17	from	_	_	IN	O	[-1]	['none']	_	_
18	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Carlsbad	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	CA	_	_	NNP	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	NE-PER	_	_	NNP	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	R	_	_	NN	O	[-1]	['none']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	nuclear	_	_	JJ	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
8	extraction	_	_	NN	O	[-1]	['none']	_	_
9	reagents	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	BCA	_	_	NN	O	[-1]	['none']	_	_
13	protein	_	_	NN	O	[-1]	['none']	_	_
14	reagent	_	_	NN	O	[-1]	['none']	_	_
15	kit	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	Supersignal	_	_	NNP	O	[-1]	['none']	_	_
19	West	_	_	NNP	O	[-1]	['none']	_	_
20	Pico	_	_	NNP	O	[-1]	['none']	_	_
21	Chemiluminescent	_	_	NNP	O	[-1]	['none']	_	_
22	Kit	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	LightShift	_	_	NNP	O	[-1]	['none']	_	_
27	Chemiluminescent	_	_	NNP	O	[-1]	['none']	_	_
28	EMSA	_	_	NN	O	[-1]	['none']	_	_
29	Kit	_	_	NN	O	[-1]	['none']	_	_
30	were	_	_	VBD	O	[-1]	['none']	_	_
31	purchased	_	_	VBN	O	[-1]	['none']	_	_
32	from	_	_	IN	O	[-1]	['none']	_	_
33	Pierce	_	_	NNP	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	Rockland	_	_	NNP	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	IL	_	_	NN	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	CREB	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	DNA	_	_	NN	O	[-1]	['none']	_	_
5	oligonucleotide	_	_	NN	O	[-1]	['none']	_	_
6	probes	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	synthesized	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	IDT	_	_	NNP	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Coralville	_	_	NNP	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	IA	_	_	NNP	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Nylon	_	_	NN	O	[-1]	['none']	_	_
2	membranes	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	purchased	_	_	VBN	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	Roche	_	_	NNP	O	[-1]	['none']	_	_
7	Applied	_	_	NNP	O	[-1]	['none']	_	_
8	Sciences	_	_	NNPS	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	Indianapolis	_	_	NNP	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	IN	_	_	IN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	NN	O	[-1]	['none']	_	_
2	blot	_	_	NN	O	[-1]	['none']	_	_
3	band	_	_	NN	O	[-1]	['none']	_	_
4	quantification	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	performed	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	UN-SCAN-IT	_	_	NNP	O	[-1]	['none']	_	_
10	Gel	_	_	NN	O	[-1]	['none']	_	_
11	Digitizing	_	_	VBG	O	[-1]	['none']	_	_
12	software	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Silk	_	_	NNP	O	[-1]	['none']	_	_
15	Scientific	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	Orem	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	UT	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	AP-1	_	_	NNP	O	[-1]	['none']	_	_
2	activation	_	_	NN	O	[-1]	['none']	_	_
3	following	_	_	VBG	O	[-1]	['none']	_	_
4	long-term	_	_	JJ	O	[-1]	['none']	_	_
5	exposure	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Jurkat	_	_	NN	O	[-1]	['none']	_	_
8	T-cells	_	_	NNS	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	PMA	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Jurkat	_	_	NN	O	[-1]	['none']	_	_
2	T-cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	transfected	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	luciferase	_	_	NN	Protein	[0]	['root']	_	_
7	reporter	_	_	NN	O	[-1]	['none']	_	_
8	plasmids	_	_	NNS	O	[-1]	['none']	_	_
9	containing	_	_	VBG	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	AP-1	_	_	NN	O	[-1]	['none']	_	_
12	cis-elements	_	_	NNS	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Time	_	_	NN	O	[-1]	['none']	_	_
5	dependent	_	_	JJ	O	[-1]	['none']	_	_
6	AP-1	_	_	NN	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	response	_	_	NN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	PMA	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	HK	_	_	NNP	O	[-1]	['none']	_	_
5	E.	_	_	NNP	O	[-1]	['none']	_	_
6	coli	_	_	NN	O	[-1]	['none']	_	_
7	does	_	_	VBZ	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	activate	_	_	VB	O	[-1]	['none']	_	_
10	AP-1	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Dose	_	_	NN	O	[-1]	['none']	_	_
5	dependent	_	_	JJ	O	[-1]	['none']	_	_
6	activation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	AP-1	_	_	NN	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	performed	_	_	VBN	O	[-1]	['none']	_	_
11	using	_	_	VBG	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	alone	_	_	RB	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	grey	_	_	JJ	O	[-1]	['none']	_	_
16	bars	_	_	NNS	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	combination	_	_	NN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	calcium	_	_	NN	O	[-1]	['none']	_	_
23	ionophore	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	CaI	_	_	NN	O	[-1]	['none']	_	_
26	955	_	_	CD	O	[-1]	['none']	_	_
27	muM	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	black	_	_	JJ	O	[-1]	['none']	_	_
30	bars	_	_	NNS	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	D	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	TCR-/-	_	_	NN	O	[-1]	['none']	_	_
5	deficient	_	_	JJ	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	responded	_	_	VBD	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	PMA	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	162	_	_	CD	O	[-1]	['none']	_	_
12	nM	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	up-regulating	_	_	VBG	O	[-1]	['none']	_	_
16	AP-1	_	_	NN	O	[-1]	['none']	_	_
17	activity	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	significance	_	_	NN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	control	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	determined	_	_	VBN	O	[-1]	['none']	_	_
8	using	_	_	VBG	O	[-1]	['none']	_	_
9	Student	_	_	NN	O	[-1]	['none']	_	_
10	's	_	_	POS	O	[-1]	['none']	_	_
11	t-test	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	n	_	_	NN	O	[-1]	['none']	_	_
3	=	_	_	JJ	O	[-1]	['none']	_	_
4	4	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	Controls	_	_	NNP	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	arbitrarily	_	_	RB	O	[-1]	['none']	_	_
4	set	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	1	_	_	CD	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Antibodies	_	_	NNS	O	[-1]	['none']	_	_
2	.	_	_	.	O	[-1]	['none']	_	_

1	FITC	_	_	NN	O	[-1]	['none']	_	_
2	conjugated	_	_	VBD	O	[-1]	['none']	_	_
3	goat	_	_	NN	O	[-1]	['none']	_	_
4	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
5	IgM	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	rat	_	_	NN	O	[-1]	['none']	_	_
8	IgG2akappa	_	_	NN	O	[-1]	['none']	_	_
9	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
10	IgD	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	clone	_	_	NN	O	[-1]	['none']	_	_
13	11-26	_	_	CD	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	rat	_	_	NN	O	[-1]	['none']	_	_
17	IgG1kappa	_	_	NN	O	[-1]	['none']	_	_
18	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
19	kappa	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	clone	_	_	NN	O	[-1]	['none']	_	_
22	187.1	_	_	CD	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	rat	_	_	NN	O	[-1]	['none']	_	_
26	IgG2bkappa	_	_	NN	O	[-1]	['none']	_	_
27	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
28	lambda	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	clone	_	_	NN	O	[-1]	['none']	_	_
31	JC5-1	_	_	NN	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	;	_	_	:	O	[-1]	['none']	_	_
34	PE	_	_	NN	O	[-1]	['none']	_	_
35	conjugated	_	_	VBN	O	[-1]	['none']	_	_
36	goat	_	_	NN	O	[-1]	['none']	_	_
37	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
38	IgG	_	_	NN	O	[-1]	['none']	_	_
39	;	_	_	:	O	[-1]	['none']	_	_
40	un	_	_	NN	O	[-1]	['none']	_	_
41	conjugated	_	_	VBN	O	[-1]	['none']	_	_
42	goat	_	_	NN	O	[-1]	['none']	_	_
43	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
44	kappa	_	_	NN	O	[-1]	['none']	_	_
45	and	_	_	CC	O	[-1]	['none']	_	_
46	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
47	lambda	_	_	NN	O	[-1]	['none']	_	_
48	were	_	_	VBD	O	[-1]	['none']	_	_
49	purchased	_	_	VBN	O	[-1]	['none']	_	_
50	from	_	_	IN	O	[-1]	['none']	_	_
51	Southern	_	_	NNP	O	[-1]	['none']	_	_
52	Biotech	_	_	NNP	O	[-1]	['none']	_	_
53	.	_	_	.	O	[-1]	['none']	_	_

1	APC	_	_	NN	O	[-1]	['none']	_	_
2	conjugated	_	_	VBD	O	[-1]	['none']	_	_
3	rat	_	_	NN	O	[-1]	['none']	_	_
4	IgG2akappa	_	_	NN	O	[-1]	['none']	_	_
5	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
6	CD19	_	_	NN	Protein	[0]	['root']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	clone	_	_	NN	O	[-1]	['none']	_	_
9	6D5	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	PE	_	_	NN	O	[-1]	['none']	_	_
13	conjugated	_	_	VBN	O	[-1]	['none']	_	_
14	mouse	_	_	NN	O	[-1]	['none']	_	_
15	IgG2akappa	_	_	NN	O	[-1]	['none']	_	_
16	anti-LMP1	_	_	JJ	Protein	[0]	['root']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	clone	_	_	NN	O	[-1]	['none']	_	_
19	S12	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	un	_	_	JJ	O	[-1]	['none']	_	_
23	conjugated	_	_	VBN	O	[-1]	['none']	_	_
24	mouse	_	_	NN	O	[-1]	['none']	_	_
25	IgG2a	_	_	NN	O	[-1]	['none']	_	_
26	anti-Rb	_	_	JJ	Protein	[0]	['root']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	clone	_	_	NN	O	[-1]	['none']	_	_
29	2	_	_	CD	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	anti-Cdk2	_	_	JJ	Protein	[0]	['root']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	clone	_	_	NN	O	[-1]	['none']	_	_
36	55	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	were	_	_	VBD	O	[-1]	['none']	_	_
39	purchased	_	_	VBN	O	[-1]	['none']	_	_
40	from	_	_	IN	O	[-1]	['none']	_	_
41	BD	_	_	NNP	O	[-1]	['none']	_	_
42	Bioscience	_	_	NNP	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	PE	_	_	NN	O	[-1]	['none']	_	_
2	conjugated	_	_	VBD	O	[-1]	['none']	_	_
3	rat	_	_	NN	O	[-1]	['none']	_	_
4	IgG2akappa	_	_	NN	O	[-1]	['none']	_	_
5	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
6	CD5	_	_	NN	Protein	[0]	['root']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	clone	_	_	NN	O	[-1]	['none']	_	_
9	53-7	_	_	CD	O	[-1]	['none']	_	_
10	.3	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	purchased	_	_	VBN	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	eBioscience	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Rat	_	_	NN	O	[-1]	['none']	_	_
2	anti-LMP1	_	_	JJ	Protein	[0]	['root']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	clones	_	_	NNS	O	[-1]	['none']	_	_
5	8G3	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	1G6	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	7E10	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	7G8	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	purchased	_	_	VBN	O	[-1]	['none']	_	_
16	from	_	_	IN	O	[-1]	['none']	_	_
17	Ascenion	_	_	NNP	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Rabbit	_	_	NN	O	[-1]	['none']	_	_
2	anti-pAkt	_	_	JJ	Protein	[0]	['root']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	Ser473	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	anti-pGSK3alpha	_	_	NN	Protein	[0]	['root']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	beta	_	_	NN	Protein	[0]	['root']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Ser21/9	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	anti-pStat3	_	_	JJ	Protein	[0]	['root']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	Tyr705	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	anti-pStat6	_	_	JJ	Protein	[0]	['root']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	Tyr641	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	anti-pmTOR	_	_	JJ	Protein	[0]	['root']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	Ser2448	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	anti-Stat6	_	_	NN	Protein	[0]	['root']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	anti-Akt	_	_	JJ	Protein	[0]	['root']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	anti-FoxO1	_	_	JJ	Protein	[0]	['root']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	anti-p27	_	_	JJ	Protein	[0]	['root']	_	_
37	were	_	_	VBD	O	[-1]	['none']	_	_
38	purchased	_	_	VBN	O	[-1]	['none']	_	_
39	from	_	_	IN	O	[-1]	['none']	_	_
40	Cell	_	_	NN	O	[-1]	['none']	_	_
41	Signaling	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Rabbit	_	_	NN	O	[-1]	['none']	_	_
2	anti-Stat3	_	_	NN	Protein	[0]	['root']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	H-190	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	anti-IkappaBalpha	_	_	JJ	Protein	[0]	['root']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	C-21	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	goat	_	_	NN	O	[-1]	['none']	_	_
14	anti-beta	_	_	JJ	Protein	[15]	['multitoken']	_	_
15	actin	_	_	NN	Protein	[0]	['root']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	I-19	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	were	_	_	VBD	O	[-1]	['none']	_	_
20	purchased	_	_	VBN	O	[-1]	['none']	_	_
21	from	_	_	IN	O	[-1]	['none']	_	_
22	Santa	_	_	NNP	O	[-1]	['none']	_	_
23	Cruz	_	_	NNP	O	[-1]	['none']	_	_
24	Biotechnology	_	_	NNP	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Mouse	_	_	NN	O	[-1]	['none']	_	_
2	IgG1kappa	_	_	NN	O	[-1]	['none']	_	_
3	anti-GSK3	_	_	NN	Protein	[0]	['root']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	purchased	_	_	VBN	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	Upstate	_	_	NNP	O	[-1]	['none']	_	_
8	Biotechnology	_	_	NNP	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Rabbit	_	_	NN	O	[-1]	['none']	_	_
2	anti-pRb	_	_	JJ	Protein	[0]	['root']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	Thr373	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	purchased	_	_	VBN	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	EMD	_	_	NNP	O	[-1]	['none']	_	_
10	Biosciences	_	_	NNPS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	culture	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	stimulation	_	_	NN	O	[-1]	['none']	_	_
5	All	_	_	DT	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	lines	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	maintained	_	_	VBN	O	[-1]	['none']	_	_
10	at	_	_	IN	O	[-1]	['none']	_	_
11	5	_	_	CD	O	[-1]	['none']	_	_
12	%	_	_	NN	O	[-1]	['none']	_	_
13	CO2	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	RPMI	_	_	NN	O	[-1]	['none']	_	_
16	1640	_	_	CD	O	[-1]	['none']	_	_
17	medium	_	_	NN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	1	_	_	CD	O	[-1]	['none']	_	_
20	%	_	_	NN	O	[-1]	['none']	_	_
21	glutamine	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	Gibco	_	_	NNP	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	BRL	_	_	NN	O	[-1]	['none']	_	_
26	Eggenstein	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	Germany	_	_	NNP	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	supplemented	_	_	VBN	O	[-1]	['none']	_	_
31	with	_	_	IN	O	[-1]	['none']	_	_
32	10	_	_	CD	O	[-1]	['none']	_	_
33	%	_	_	NN	O	[-1]	['none']	_	_
34	fetal	_	_	JJ	O	[-1]	['none']	_	_
35	calf	_	_	NN	O	[-1]	['none']	_	_
36	serum	_	_	NN	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	Gibco	_	_	NNP	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	BRL	_	_	NN	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	1	_	_	CD	O	[-1]	['none']	_	_
44	%	_	_	NN	O	[-1]	['none']	_	_
45	penicillin	_	_	NN	O	[-1]	['none']	_	_
46	and	_	_	CC	O	[-1]	['none']	_	_
47	streptomycin	_	_	NN	O	[-1]	['none']	_	_
48	(	_	_	-LRB-	O	[-1]	['none']	_	_
49	Biochrom	_	_	NNP	O	[-1]	['none']	_	_
50	,	_	_	,	O	[-1]	['none']	_	_
51	Berlin	_	_	NNP	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	Germany	_	_	NNP	O	[-1]	['none']	_	_
54	)	_	_	-RRB-	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	When	_	_	WRB	O	[-1]	['none']	_	_
2	indicated	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	treated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	5-aza-2-deoxycytidine	_	_	JJ	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	AzadC	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	5-azacytidine	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	AzaC	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Sigma	_	_	NNP	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	Taufkirchen	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	Germany	_	_	NNP	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	different	_	_	JJ	O	[-1]	['none']	_	_
26	time	_	_	NN	O	[-1]	['none']	_	_
27	periods	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Owing	_	_	VBG	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	their	_	_	PRP$	O	[-1]	['none']	_	_
4	chemical	_	_	NN	O	[-1]	['none']	_	_
5	instability	_	_	NN	O	[-1]	['none']	_	_
6	fresh	_	_	JJ	O	[-1]	['none']	_	_
7	substances	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	re-added	_	_	JJ	O	[-1]	['none']	_	_
10	every	_	_	DT	O	[-1]	['none']	_	_
11	24	_	_	CD	O	[-1]	['none']	_	_
12	h.	_	_	NN	O	[-1]	['none']	_	_

1	Ethics	_	_	NNS	O	[-1]	['none']	_	_
2	Statement	_	_	NNP	O	[-1]	['none']	_	_
3	All	_	_	NNP	O	[-1]	['none']	_	_
4	mouse	_	_	NN	O	[-1]	['none']	_	_
5	work	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	carried	_	_	VBN	O	[-1]	['none']	_	_
8	out	_	_	RP	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	strict	_	_	JJ	O	[-1]	['none']	_	_
11	accordance	_	_	NN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	protocols	_	_	NNS	O	[-1]	['none']	_	_
14	approved	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	Institutional	_	_	JJ	O	[-1]	['none']	_	_
18	Animal	_	_	NNP	O	[-1]	['none']	_	_
19	Care	_	_	NNP	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	Use	_	_	NNP	O	[-1]	['none']	_	_
22	Committees	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	Production	_	_	NN	Gene_expression	[7]	['Theme']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	Th1	_	_	NN	O	[-1]	['none']	_	_
5	Cells	_	_	NNS	O	[-1]	['none']	_	_
6	Is	_	_	VBZ	O	[-1]	['none']	_	_
7	Dependent	_	_	JJ	Positive_regulation	[0]	['root']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	STAT4	_	_	NN	Protein	[0]	['root']	_	_
10	but	_	_	CC	O	[-1]	['none']	_	_
11	Not	_	_	RB	O	[-1]	['none']	_	_
12	on	_	_	IN	O	[-1]	['none']	_	_
13	STAT6	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	IFN-gamma	_	_	NN	Protein	[0]	['root']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	IL-4	_	_	NN	Protein	[0]	['root']	_	_
19	Signaling	_	_	NN	O	[-1]	['none']	_	_
20	To	_	_	TO	O	[-1]	['none']	_	_
21	further	_	_	RB	O	[-1]	['none']	_	_
22	elucidate	_	_	VB	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
25	required	_	_	VBN	O	[-1]	['none']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	development	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	Th1	_	_	NN	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	producing	_	_	VBG	Gene_expression	[38]	['Theme']	_	_
33	IL-10	_	_	NN	Protein	[32]	['Theme']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	we	_	_	PRP	O	[-1]	['none']	_	_
36	investigated	_	_	VBD	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	role	_	_	NN	Regulation	[0]	['root']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	STAT4	_	_	NN	Protein	[38, 47]	['Cause', 'Theme']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	one	_	_	CD	O	[-1]	['none']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	the	_	_	DT	O	[-1]	['none']	_	_
45	signaling	_	_	NN	O	[-1]	['none']	_	_
46	pathways	_	_	NNS	O	[-1]	['none']	_	_
47	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
48	by	_	_	IN	O	[-1]	['none']	_	_
49	IL-12	_	_	NN	Protein	[47]	['Cause']	_	_
50	(	_	_	-LRB-	O	[-1]	['none']	_	_
51	Murphy	_	_	NNP	O	[-1]	['none']	_	_
52	et	_	_	FW	O	[-1]	['none']	_	_
53	al.	_	_	FW	O	[-1]	['none']	_	_
54	,	_	_	,	O	[-1]	['none']	_	_
55	2000	_	_	CD	O	[-1]	['none']	_	_
56	)	_	_	-RRB-	O	[-1]	['none']	_	_
57	.	_	_	.	O	[-1]	['none']	_	_

1	Naive	_	_	JJ	O	[-1]	['none']	_	_
2	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
3	D011	_	_	NN	O	[-1]	['none']	_	_
4	.10	_	_	CD	O	[-1]	['none']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	STAT4	_	_	NN	Protein	[7]	['Theme']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Ouyang	_	_	NNP	O	[-1]	['none']	_	_
12	et	_	_	FW	O	[-1]	['none']	_	_
13	al.	_	_	FW	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	1998	_	_	CD	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	cultured	_	_	VBN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	presence	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	IL-12	_	_	NN	Protein	[0]	['root']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	OVA	_	_	NN	Protein	[0]	['root']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Again	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
4	Th1	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	differentiated	_	_	VBN	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	high	_	_	JJ	O	[-1]	['none']	_	_
11	antigen	_	_	NN	O	[-1]	['none']	_	_
12	dose	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	presence	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	IL-12	_	_	NN	Protein	[0]	['root']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	DO11	_	_	NN	O	[-1]	['none']	_	_
20	.10	_	_	CD	O	[-1]	['none']	_	_
21	T	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	absence	_	_	NN	Negative_regulation	[18, 25]	['Cause', 'Cause']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	STAT4	_	_	NN	Protein	[6]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	percentage	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	expressing	_	_	VBG	Gene_expression	[18]	['Theme']	_	_
15	IFN-gamma	_	_	NN	Protein	[14]	['Theme']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	dramatically	_	_	RB	O	[-1]	['none']	_	_
18	diminished	_	_	VBN	Negative_regulation	[0]	['root']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	expected	_	_	VBN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	resulted	_	_	VBD	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	an	_	_	DT	O	[-1]	['none']	_	_
25	increase	_	_	NN	Positive_regulation	[0]	['root']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	percentage	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	expressing	_	_	VBG	Gene_expression	[25]	['Theme']	_	_
32	IL-4	_	_	NN	Protein	[31]	['Theme']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	but	_	_	CC	O	[-1]	['none']	_	_
35	not	_	_	RB	O	[-1]	['none']	_	_
36	IL-10	_	_	NN	Protein	[31]	['Theme']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	suggesting	_	_	VBG	O	[-1]	['none']	_	_
39	that	_	_	IN	O	[-1]	['none']	_	_
40	STAT4	_	_	NN	Protein	[41]	['Cause']	_	_
41	contributes	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
42	to	_	_	TO	O	[-1]	['none']	_	_
43	IL-10	_	_	NN	Protein	[44]	['Theme']	_	_
44	expression	_	_	NN	Gene_expression	[41]	['Theme']	_	_
45	by	_	_	IN	O	[-1]	['none']	_	_
46	Th1	_	_	NN	O	[-1]	['none']	_	_
47	cells	_	_	NNS	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	Because	_	_	IN	O	[-1]	['none']	_	_
2	IL-10	_	_	NN	Protein	[3]	['Theme']	_	_
3	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	associated	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	an	_	_	DT	O	[-1]	['none']	_	_
8	IL-4-induced	_	_	JJ	Protein	[0]	['root']	_	_
9	Th2	_	_	NN	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	phenotype	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	we	_	_	PRP	O	[-1]	['none']	_	_
14	investigated	_	_	VBD	O	[-1]	['none']	_	_
15	whether	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	differentiation	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
21	Th1	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	depended	_	_	VBD	O	[-1]	['none']	_	_
24	on	_	_	IN	O	[-1]	['none']	_	_
25	signaling	_	_	NN	O	[-1]	['none']	_	_
26	through	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	IL-4	_	_	NN	Protein	[0]	['root']	_	_
29	receptor	_	_	NN	O	[-1]	['none']	_	_
30	via	_	_	IN	O	[-1]	['none']	_	_
31	STAT6	_	_	NN	Protein	[32]	['Theme']	_	_
32	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	Glimcher	_	_	NNP	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	Murphy	_	_	NNP	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	2000	_	_	CD	O	[-1]	['none']	_	_
39	;	_	_	:	O	[-1]	['none']	_	_
40	Murphy	_	_	NNP	O	[-1]	['none']	_	_
41	et	_	_	FW	O	[-1]	['none']	_	_
42	al.	_	_	FW	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	2000	_	_	CD	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	STAT6	_	_	NN	Protein	[2]	['Theme']	_	_
5	did	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	impair	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	differentiation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	IL-10-producing	_	_	JJ	Gene_expression	[17]	['Theme']	_	_
12	Th1	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	in	_	_	IN	Positive_regulation	[17]	['multitoken']	_	_
15	the	_	_	DT	Positive_regulation	[17]	['multitoken']	_	_
16	presence	_	_	NN	Positive_regulation	[17]	['multitoken']	_	_
17	of	_	_	IN	Positive_regulation	[0]	['root']	_	_
18	IL-12	_	_	NN	Protein	[17]	['Cause']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	OVA	_	_	NN	Protein	[17]	['Cause']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	fact	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	higher	_	_	JJR	O	[-1]	['none']	_	_
6	percentage	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	STAT6	_	_	NN	Protein	[9]	['Theme']	_	_
9	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	compared	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	WT	_	_	JJ	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	produced	_	_	VBD	Gene_expression	[0]	['root']	_	_
16	both	_	_	CC	O	[-1]	['none']	_	_
17	IL-10	_	_	NN	Protein	[15]	['Theme']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	IFN-gamma	_	_	NN	Protein	[15]	['Theme']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	which	_	_	WDT	O	[-1]	['none']	_	_
22	may	_	_	MD	O	[-1]	['none']	_	_
23	be	_	_	VB	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	result	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	loss	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	Th2	_	_	NN	O	[-1]	['none']	_	_
31	cell	_	_	NN	O	[-1]	['none']	_	_
32	control	_	_	NN	O	[-1]	['none']	_	_
33	over	_	_	IN	O	[-1]	['none']	_	_
34	a	_	_	DT	O	[-1]	['none']	_	_
35	Th1	_	_	NN	O	[-1]	['none']	_	_
36	cell	_	_	NN	O	[-1]	['none']	_	_
37	response	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	lack	_	_	NN	Negative_regulation	[7]	['Cause']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	STAT6	_	_	NN	Protein	[4]	['Theme']	_	_
7	abrogated	_	_	VBD	Negative_regulation	[0]	['root']	_	_
8	both	_	_	CC	O	[-1]	['none']	_	_
9	IL-4	_	_	NN	Protein	[12]	['Theme']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	IL-10	_	_	NN	Protein	[12]	['Theme']	_	_
12	production	_	_	NN	Gene_expression	[7]	['Theme']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	T	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	developed	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	IL-4	_	_	NN	Protein	[0]	['root']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	low	_	_	JJ	O	[-1]	['none']	_	_
22	antigen	_	_	NN	O	[-1]	['none']	_	_
23	dose	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	absence	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	STAT4	_	_	NN	Protein	[0]	['root']	_	_
8	signaling	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	IL-10	_	_	NN	Protein	[13]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	IL-4	_	_	NN	Protein	[13]	['Theme']	_	_
13	production	_	_	NN	Gene_expression	[20]	['Theme']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	Th2	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	if	_	_	IN	O	[-1]	['none']	_	_
19	anything	_	_	NN	O	[-1]	['none']	_	_
20	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	contrast	_	_	NN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	what	_	_	WP	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	observed	_	_	VBN	O	[-1]	['none']	_	_
9	under	_	_	IN	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	conditions	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	IL-10	_	_	NN	Protein	[14]	['Theme']	_	_
14	expression	_	_	NN	Gene_expression	[18]	['Theme']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	Th2	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	depended	_	_	VBD	Positive_regulation	[0]	['root']	_	_
19	on	_	_	IN	O	[-1]	['none']	_	_
20	STAT6	_	_	NN	Protein	[0]	['root']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	but	_	_	CC	O	[-1]	['none']	_	_
23	not	_	_	RB	O	[-1]	['none']	_	_
24	on	_	_	IN	O	[-1]	['none']	_	_
25	STAT4	_	_	NN	Protein	[0]	['root']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	signaling	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	investigate	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	inability	_	_	NN	Negative_regulation	[16]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	STAT4	_	_	NN	Protein	[8]	['Theme']	_	_
8	deficient	_	_	JJ	Negative_regulation	[5]	['Cause']	_	_
9	T	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	produce	_	_	VB	Gene_expression	[5]	['Theme']	_	_
13	IL-10	_	_	NN	Protein	[12]	['Theme']	_	_
14	might	_	_	MD	O	[-1]	['none']	_	_
15	be	_	_	VB	O	[-1]	['none']	_	_
16	due	_	_	JJ	Positive_regulation	[0]	['root']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	absence	_	_	NN	Negative_regulation	[16]	['Cause']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	IFN-gamma	_	_	NN	Protein	[19]	['Theme']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	as	_	_	IN	O	[-1]	['none']	_	_
24	suggested	_	_	VBN	O	[-1]	['none']	_	_
25	before	_	_	IN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	Shaw	_	_	NNP	O	[-1]	['none']	_	_
28	et	_	_	FW	O	[-1]	['none']	_	_
29	al.	_	_	FW	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	2006	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	we	_	_	PRP	O	[-1]	['none']	_	_
35	differentiated	_	_	VBD	O	[-1]	['none']	_	_
36	DO11	_	_	NN	O	[-1]	['none']	_	_
37	.10	_	_	CD	O	[-1]	['none']	_	_
38	or	_	_	CC	O	[-1]	['none']	_	_
39	DO11	_	_	NN	O	[-1]	['none']	_	_
40	.10	_	_	CD	O	[-1]	['none']	_	_
41	IFN-gamma-deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
42	naive	_	_	JJ	O	[-1]	['none']	_	_
43	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
44	T	_	_	NN	O	[-1]	['none']	_	_
45	cells	_	_	NNS	O	[-1]	['none']	_	_
46	in	_	_	IN	O	[-1]	['none']	_	_
47	the	_	_	DT	O	[-1]	['none']	_	_
48	presence	_	_	NN	O	[-1]	['none']	_	_
49	of	_	_	IN	O	[-1]	['none']	_	_
50	IL-12	_	_	NN	Protein	[0]	['root']	_	_
51	and	_	_	CC	O	[-1]	['none']	_	_
52	increasing	_	_	VBG	O	[-1]	['none']	_	_
53	doses	_	_	NNS	O	[-1]	['none']	_	_
54	of	_	_	IN	O	[-1]	['none']	_	_
55	OVA	_	_	NNP	Protein	[0]	['root']	_	_
56	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	secretion	_	_	NN	Localization	[6]	['Theme']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	IL-10	_	_	NN	Protein	[2]	['Theme']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	high	_	_	JJ	O	[-1]	['none']	_	_
9	antigen	_	_	NN	O	[-1]	['none']	_	_
10	dose	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	IL-12	_	_	NN	Protein	[16]	['Theme']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	affected	_	_	VBN	Regulation	[0]	['root']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	an	_	_	DT	O	[-1]	['none']	_	_
19	absence	_	_	NN	Negative_regulation	[16]	['Cause']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	IFN-gamma	_	_	NN	Protein	[19]	['Theme']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	showing	_	_	VBG	O	[-1]	['none']	_	_
24	that	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	expression	_	_	NN	Gene_expression	[33]	['Theme']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	IL-10	_	_	NN	Protein	[26]	['Theme']	_	_
29	by	_	_	IN	O	[-1]	['none']	_	_
30	Th1	_	_	NN	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	is	_	_	VBZ	O	[-1]	['none']	_	_
33	independent	_	_	JJ	Regulation	[0]	['root']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	IFN-gamma	_	_	NN	Protein	[33]	['Cause']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	absence	_	_	NN	Negative_regulation	[10]	['Cause']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	IFN-gamma	_	_	NN	Protein	[3]	['Theme']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	we	_	_	PRP	O	[-1]	['none']	_	_
8	observed	_	_	VBD	O	[-1]	['none']	_	_
9	an	_	_	DT	O	[-1]	['none']	_	_
10	increase	_	_	NN	Positive_regulation	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	secreted	_	_	JJ	Localization	[10]	['Theme']	_	_
14	IL-4	_	_	NN	Protein	[13]	['Theme']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	expected	_	_	VBN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	data	_	_	NNS	O	[-1]	['none']	_	_
19	not	_	_	RB	O	[-1]	['none']	_	_
20	shown	_	_	VBN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	tested	_	_	VBD	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	any	_	_	DT	O	[-1]	['none']	_	_
6	potential	_	_	JJ	O	[-1]	['none']	_	_
7	role	_	_	NN	Regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	IL-4	_	_	NN	Protein	[7]	['Cause']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	development	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Th1	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	producing	_	_	VBG	Gene_expression	[7]	['Theme']	_	_
17	IL-10	_	_	NN	Protein	[16]	['Theme']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	culturing	_	_	VBG	O	[-1]	['none']	_	_
20	DO11	_	_	NN	O	[-1]	['none']	_	_
21	.10	_	_	CD	O	[-1]	['none']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	DO11	_	_	NN	O	[-1]	['none']	_	_
24	.10	_	_	CD	O	[-1]	['none']	_	_
25	IL-4-deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
26	naive	_	_	JJ	O	[-1]	['none']	_	_
27	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
28	T	_	_	NN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	IL-12	_	_	NN	Protein	[0]	['root']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	increasing	_	_	VBG	O	[-1]	['none']	_	_
34	doses	_	_	NNS	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	antigen	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	observed	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	STAT6	_	_	NN	Protein	[5]	['Theme']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	IL-4	_	_	NN	Protein	[10]	['Theme']	_	_
10	deficiency	_	_	NN	Negative_regulation	[0]	['root']	_	_
11	had	_	_	VBD	O	[-1]	['none']	_	_
12	no	_	_	DT	O	[-1]	['none']	_	_
13	effect	_	_	NN	O	[-1]	['none']	_	_
14	on	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	development	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	Th1	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	producing	_	_	VBG	Gene_expression	[0]	['root']	_	_
21	IL-10	_	_	NN	Protein	[20]	['Theme']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	but	_	_	CC	O	[-1]	['none']	_	_
24	compromised	_	_	VBD	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	development	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	Th2	_	_	NN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	producing	_	_	VBG	Gene_expression	[0]	['root']	_	_
31	IL-10	_	_	NN	Protein	[30]	['Theme']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	data	_	_	NNS	O	[-1]	['none']	_	_
5	suggested	_	_	VBD	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	IL-10	_	_	NN	Protein	[8]	['Theme']	_	_
8	production	_	_	NN	Gene_expression	[0]	['root']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	Th2	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	dependent	_	_	JJ	O	[-1]	['none']	_	_
16	on	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	specific	_	_	JJ	O	[-1]	['none']	_	_
19	signaling	_	_	NN	O	[-1]	['none']	_	_
20	pathways	_	_	NNS	O	[-1]	['none']	_	_
21	required	_	_	VBN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	their	_	_	PRP$	O	[-1]	['none']	_	_
24	differentiation	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	given	_	_	VBN	O	[-1]	['none']	_	_
27	that	_	_	IN	O	[-1]	['none']	_	_
28	STAT4	_	_	NN	Protein	[33]	['Cause']	_	_
29	is	_	_	VBZ	O	[-1]	['none']	_	_
30	required	_	_	VBN	O	[-1]	['none']	_	_
31	for	_	_	IN	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	IL-10	_	_	NN	Protein	[36]	['Theme']	_	_
36	production	_	_	NN	Gene_expression	[33]	['Theme']	_	_
37	by	_	_	IN	O	[-1]	['none']	_	_
38	Th1	_	_	NN	O	[-1]	['none']	_	_
39	cells	_	_	NNS	O	[-1]	['none']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	STAT6	_	_	NN	Protein	[33]	['Cause']	_	_
42	for	_	_	IN	O	[-1]	['none']	_	_
43	Th2	_	_	NN	O	[-1]	['none']	_	_
44	cells	_	_	NNS	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	Immunoblotting	_	_	NN	O	[-1]	['none']	_	_
2	Differentiated	_	_	VBD	O	[-1]	['none']	_	_
3	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
4	T	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	rested	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	5	_	_	CD	O	[-1]	['none']	_	_
10	hr	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	1	_	_	CD	O	[-1]	['none']	_	_
13	%	_	_	NN	O	[-1]	['none']	_	_
14	FCS	_	_	NN	O	[-1]	['none']	_	_
15	containing	_	_	VBG	O	[-1]	['none']	_	_
16	medium	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	restimulated	_	_	VBN	O	[-1]	['none']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	described	_	_	VBN	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	specific	_	_	JJ	O	[-1]	['none']	_	_
23	experiments	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	lysates	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	prepared	_	_	VBN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	equal	_	_	JJ	O	[-1]	['none']	_	_
7	amounts	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	protein	_	_	NN	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	separated	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	phosphorylated	_	_	VBN	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	total	_	_	JJ	O	[-1]	['none']	_	_
19	ERK	_	_	NN	Protein	[0]	['root']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	actin	_	_	NN	Protein	[0]	['root']	_	_
22	were	_	_	VBD	O	[-1]	['none']	_	_
23	detected	_	_	VBN	O	[-1]	['none']	_	_
24	as	_	_	IN	O	[-1]	['none']	_	_
25	described	_	_	VBN	O	[-1]	['none']	_	_
26	before	_	_	IN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	Beinke	_	_	NNP	O	[-1]	['none']	_	_
29	et	_	_	FW	O	[-1]	['none']	_	_
30	al.	_	_	FW	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	2004	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Northern	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	Western	_	_	NN	O	[-1]	['none']	_	_
4	blot	_	_	NN	O	[-1]	['none']	_	_
5	analyses	_	_	NNS	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	O	[-1]	['none']	_	_
2	isolation	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	Northern	_	_	NN	O	[-1]	['none']	_	_
5	blot	_	_	NN	O	[-1]	['none']	_	_
6	analysis	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	performed	_	_	VBN	O	[-1]	['none']	_	_
9	as	_	_	IN	O	[-1]	['none']	_	_
10	previously	_	_	RB	O	[-1]	['none']	_	_
11	described	_	_	VBN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	29	_	_	CD	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	brief	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	10	_	_	CD	O	[-1]	['none']	_	_
5	mug	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	total	_	_	JJ	O	[-1]	['none']	_	_
8	RNA	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	loaded	_	_	VBN	O	[-1]	['none']	_	_
11	per	_	_	IN	O	[-1]	['none']	_	_
12	lane	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	transferred	_	_	VBN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	positively	_	_	RB	O	[-1]	['none']	_	_
17	charged	_	_	VBN	O	[-1]	['none']	_	_
18	nylon	_	_	NN	O	[-1]	['none']	_	_
19	membranes	_	_	NNS	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	Hybond-N+	_	_	JJ	O	[-1]	['none']	_	_
22	;	_	_	:	O	[-1]	['none']	_	_
23	GE	_	_	NNP	O	[-1]	['none']	_	_
24	Healthcare	_	_	NNP	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	which	_	_	WDT	O	[-1]	['none']	_	_
28	was	_	_	VBD	O	[-1]	['none']	_	_
29	confirmed	_	_	VBN	O	[-1]	['none']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	ethidium	_	_	NN	O	[-1]	['none']	_	_
32	bromide	_	_	NN	O	[-1]	['none']	_	_
33	staining	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	ribosomal	_	_	JJ	O	[-1]	['none']	_	_
36	RNA	_	_	NN	O	[-1]	['none']	_	_
37	species	_	_	NNS	O	[-1]	['none']	_	_
38	on	_	_	IN	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	membrane	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Membranes	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	hybridized	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	1	_	_	CD	O	[-1]	['none']	_	_
6	ng/ml	_	_	NN	O	[-1]	['none']	_	_
7	alpha-[	_	_	NN	O	[-1]	['none']	_	_
8	32P	_	_	NN	O	[-1]	['none']	_	_
9	]	_	_	CD	O	[-1]	['none']	_	_
10	dCTP	_	_	NN	O	[-1]	['none']	_	_
11	labeled	_	_	VBN	O	[-1]	['none']	_	_
12	trichloroacetic	_	_	JJ	O	[-1]	['none']	_	_
13	acid	_	_	NN	O	[-1]	['none']	_	_
14	precipitable	_	_	JJ	O	[-1]	['none']	_	_
15	probe	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	ExpressHyb	_	_	NNP	O	[-1]	['none']	_	_
18	hybridization	_	_	NN	O	[-1]	['none']	_	_
19	buffer	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	Clontech	_	_	NNP	O	[-1]	['none']	_	_
22	Laboratories	_	_	NNPS	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	Inc.	_	_	NNP	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	All	_	_	DT	O	[-1]	['none']	_	_
2	cDNA	_	_	NN	O	[-1]	['none']	_	_
3	probes	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	confirmed	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	have	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	appropriate	_	_	JJ	O	[-1]	['none']	_	_
10	single-copy	_	_	JJ	O	[-1]	['none']	_	_
11	specificity	_	_	NN	O	[-1]	['none']	_	_
12	under	_	_	IN	O	[-1]	['none']	_	_
13	these	_	_	DT	O	[-1]	['none']	_	_
14	conditions	_	_	NNS	O	[-1]	['none']	_	_
15	using	_	_	VBG	O	[-1]	['none']	_	_
16	genomic	_	_	JJ	O	[-1]	['none']	_	_
17	Southern	_	_	NN	O	[-1]	['none']	_	_
18	blot	_	_	NN	O	[-1]	['none']	_	_
19	analysis	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Band	_	_	NN	O	[-1]	['none']	_	_
2	intensities	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	acquired	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	phosphorimaging	_	_	VBG	O	[-1]	['none']	_	_
7	analysis	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	Western	_	_	JJ	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	whole-cell	_	_	JJ	O	[-1]	['none']	_	_
6	protein	_	_	NN	O	[-1]	['none']	_	_
7	lysates	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	obtained	_	_	VBN	O	[-1]	['none']	_	_
10	from	_	_	IN	O	[-1]	['none']	_	_
11	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
12	T	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	at	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	time	_	_	NN	O	[-1]	['none']	_	_
17	points	_	_	NNS	O	[-1]	['none']	_	_
18	indicated	_	_	VBD	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	figures	_	_	NNS	O	[-1]	['none']	_	_
22	during	_	_	IN	O	[-1]	['none']	_	_
23	clonal	_	_	JJ	O	[-1]	['none']	_	_
24	expansion	_	_	NN	O	[-1]	['none']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	100	_	_	CD	O	[-1]	['none']	_	_
27	U/ml	_	_	NN	O	[-1]	['none']	_	_
28	IL-2	_	_	NN	Protein	[0]	['root']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	lysis	_	_	NN	O	[-1]	['none']	_	_
31	buffer	_	_	NN	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	50	_	_	CD	O	[-1]	['none']	_	_
34	mM	_	_	NN	O	[-1]	['none']	_	_
35	Tris	_	_	NNP	O	[-1]	['none']	_	_
36	[	_	_	CD	O	[-1]	['none']	_	_
37	pH	_	_	NN	O	[-1]	['none']	_	_
38	7.5	_	_	CD	O	[-1]	['none']	_	_
39	]	_	_	NN	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	150	_	_	CD	O	[-1]	['none']	_	_
42	mM	_	_	NN	O	[-1]	['none']	_	_
43	NaCl	_	_	NN	O	[-1]	['none']	_	_
44	,	_	_	,	O	[-1]	['none']	_	_
45	10	_	_	CD	O	[-1]	['none']	_	_
46	%	_	_	NN	O	[-1]	['none']	_	_
47	glycerol	_	_	NN	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	5	_	_	CD	O	[-1]	['none']	_	_
50	mM	_	_	NN	O	[-1]	['none']	_	_
51	EDTA	_	_	NN	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	1	_	_	CD	O	[-1]	['none']	_	_
54	%	_	_	NN	O	[-1]	['none']	_	_
55	NP-40	_	_	NN	O	[-1]	['none']	_	_
56	)	_	_	-RRB-	O	[-1]	['none']	_	_
57	by	_	_	IN	O	[-1]	['none']	_	_
58	resuspending	_	_	VBG	O	[-1]	['none']	_	_
59	samples	_	_	NNS	O	[-1]	['none']	_	_
60	in	_	_	IN	O	[-1]	['none']	_	_
61	10	_	_	CD	O	[-1]	['none']	_	_
62	mul	_	_	NN	O	[-1]	['none']	_	_
63	per	_	_	IN	O	[-1]	['none']	_	_
64	106	_	_	CD	O	[-1]	['none']	_	_
65	cells	_	_	NNS	O	[-1]	['none']	_	_
66	and	_	_	CC	O	[-1]	['none']	_	_
67	incubating	_	_	VBG	O	[-1]	['none']	_	_
68	on	_	_	IN	O	[-1]	['none']	_	_
69	ice	_	_	NN	O	[-1]	['none']	_	_
70	for	_	_	IN	O	[-1]	['none']	_	_
71	30	_	_	CD	O	[-1]	['none']	_	_
72	min	_	_	NN	O	[-1]	['none']	_	_
73	in	_	_	IN	O	[-1]	['none']	_	_
74	the	_	_	DT	O	[-1]	['none']	_	_
75	presence	_	_	NN	O	[-1]	['none']	_	_
76	of	_	_	IN	O	[-1]	['none']	_	_
77	protease	_	_	NN	O	[-1]	['none']	_	_
78	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
79	.	_	_	.	O	[-1]	['none']	_	_

1	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	antibodies	_	_	NNS	O	[-1]	['none']	_	_
8	indicated	_	_	VBD	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	figures	_	_	NNS	O	[-1]	['none']	_	_
12	after	_	_	IN	O	[-1]	['none']	_	_
13	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	10-30	_	_	CD	O	[-1]	['none']	_	_
16	mug	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	total	_	_	JJ	O	[-1]	['none']	_	_
19	protein	_	_	NN	O	[-1]	['none']	_	_
20	was	_	_	VBD	O	[-1]	['none']	_	_
21	loaded	_	_	VBN	O	[-1]	['none']	_	_
22	per	_	_	IN	O	[-1]	['none']	_	_
23	well	_	_	RB	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Quantification	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	detected	_	_	VBN	O	[-1]	['none']	_	_
4	protein	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	performed	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	Intelligent	_	_	JJ	O	[-1]	['none']	_	_
10	Dark	_	_	JJ	O	[-1]	['none']	_	_
11	Box	_	_	NNP	O	[-1]	['none']	_	_
12	unit	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	LAS-3000	_	_	NN	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	Fujifilm	_	_	NNP	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	normalized	_	_	VBD	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	loading	_	_	VBG	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	amount	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	RNA	_	_	NN	O	[-1]	['none']	_	_
27	Pol-II	_	_	NN	O	[-1]	['none']	_	_
28	detected	_	_	VBN	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	each	_	_	DT	O	[-1]	['none']	_	_
31	lane	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Identification	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PKCalpha	_	_	NN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	Upstream	_	_	NNP	O	[-1]	['none']	_	_
7	Activator	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	Myeloid	_	_	JJ	O	[-1]	['none']	_	_
12	Cells	_	_	NNS	O	[-1]	['none']	_	_
13	Even	_	_	RB	O	[-1]	['none']	_	_
14	though	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	PKC	_	_	NN	O	[-1]	['none']	_	_
17	family	_	_	NN	O	[-1]	['none']	_	_
18	consists	_	_	VBZ	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	10	_	_	CD	O	[-1]	['none']	_	_
21	members	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	finding	_	_	VBG	O	[-1]	['none']	_	_
24	that	_	_	IN	O	[-1]	['none']	_	_
25	PKCalpha	_	_	NN	Protein	[28]	['Theme']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	beta	_	_	NN	Protein	[28]	['Theme']	_	_
28	inhibitors	_	_	NNS	Negative_regulation	[0]	['root']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	intracellular	_	_	JJ	O	[-1]	['none']	_	_
31	calcium	_	_	NN	O	[-1]	['none']	_	_
32	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
33	reduced	_	_	VBD	O	[-1]	['none']	_	_
34	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
35	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
36	activity	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	suggested	_	_	VBD	O	[-1]	['none']	_	_
39	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
40	was	_	_	VBD	O	[-1]	['none']	_	_
41	involved	_	_	VBN	O	[-1]	['none']	_	_
42	in	_	_	IN	O	[-1]	['none']	_	_
43	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
44	activation	_	_	NN	O	[-1]	['none']	_	_
45	after	_	_	IN	O	[-1]	['none']	_	_
46	M-CSF	_	_	NN	O	[-1]	['none']	_	_
47	treatment	_	_	NN	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	confirm	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	role	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	macrophages	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	constructs	_	_	NNS	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	either	_	_	DT	O	[-1]	['none']	_	_
16	wildtype	_	_	JJ	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	WT	_	_	JJ	O	[-1]	['none']	_	_
19	)-PKCalpha	_	_	NN	Protein	[27]	['Theme']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	kinase	_	_	NN	Negative_regulation	[22]	['multitoken']	_	_
22	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	KD	_	_	NN	O	[-1]	['none']	_	_
25	)-PKCalpha	_	_	NN	Protein	[22]	['Theme']	_	_
26	was	_	_	VBD	O	[-1]	['none']	_	_
27	co-transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
31	reporter	_	_	NN	O	[-1]	['none']	_	_
32	gene	_	_	NN	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	SEAP	_	_	NN	O	[-1]	['none']	_	_
35	secretion	_	_	NN	O	[-1]	['none']	_	_
36	was	_	_	VBD	O	[-1]	['none']	_	_
37	measured	_	_	VBN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	7A	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	MDMs	_	_	NNS	O	[-1]	['none']	_	_
8	co-transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	WT-PKCalpha	_	_	NN	Protein	[8]	['Theme']	_	_
13	had	_	_	VBD	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	1.8-fold	_	_	JJ	O	[-1]	['none']	_	_
16	increase	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
20	activity	_	_	NN	O	[-1]	['none']	_	_
21	after	_	_	IN	O	[-1]	['none']	_	_
22	M-CSF	_	_	NN	O	[-1]	['none']	_	_
23	activation	_	_	NN	O	[-1]	['none']	_	_
24	compared	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	NS	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	p	_	_	NN	O	[-1]	['none']	_	_
30	=	_	_	JJ	O	[-1]	['none']	_	_
31	0.05	_	_	CD	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	similar	_	_	JJ	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	M-CSF-treated	_	_	JJ	O	[-1]	['none']	_	_
37	cells	_	_	NNS	O	[-1]	['none']	_	_
38	expressing	_	_	VBG	O	[-1]	['none']	_	_
39	only	_	_	RB	O	[-1]	['none']	_	_
40	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Transfecting	_	_	VBG	O	[-1]	['none']	_	_
2	human	_	_	NN	O	[-1]	['none']	_	_
3	macrophages	_	_	NNS	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	KD-PKCalpha	_	_	NN	Negative_regulation	[0]	['root']	_	_
7	construct	_	_	NN	O	[-1]	['none']	_	_
8	significantly	_	_	RB	O	[-1]	['none']	_	_
9	reduced	_	_	VBD	O	[-1]	['none']	_	_
10	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	activity	_	_	NN	O	[-1]	['none']	_	_
13	compared	_	_	VBN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	WT-PKCalpha	_	_	NN	Protein	[16]	['Theme']	_	_
16	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	p	_	_	NN	O	[-1]	['none']	_	_
20	=	_	_	JJ	O	[-1]	['none']	_	_
21	0.016	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Similarly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	RAW	_	_	NN	O	[-1]	['none']	_	_
4	264.7	_	_	CD	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	WT-PKCalpha	_	_	NN	Protein	[6]	['Theme']	_	_
9	had	_	_	VBD	O	[-1]	['none']	_	_
10	2.5-fold	_	_	RB	O	[-1]	['none']	_	_
11	more	_	_	RBR	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
14	activity	_	_	NN	O	[-1]	['none']	_	_
15	after	_	_	IN	O	[-1]	['none']	_	_
16	M-CSF	_	_	NN	O	[-1]	['none']	_	_
17	activation	_	_	NN	O	[-1]	['none']	_	_
18	compared	_	_	VBN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	unstimulated	_	_	JJ	O	[-1]	['none']	_	_
21	RAW	_	_	NN	O	[-1]	['none']	_	_
22	264.7	_	_	CD	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	NS	_	_	NN	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	WT-PKCalpha	_	_	NN	Protein	[27]	['Theme']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	KD-PKCalpha	_	_	NN	Negative_regulation	[0]	['root']	_	_
5	construct	_	_	NN	O	[-1]	['none']	_	_
6	into	_	_	IN	O	[-1]	['none']	_	_
7	RAW	_	_	NN	O	[-1]	['none']	_	_
8	264.7	_	_	CD	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	reduced	_	_	VBD	O	[-1]	['none']	_	_
11	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	activity	_	_	NN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	1.5-fold	_	_	RB	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	p	_	_	NN	O	[-1]	['none']	_	_
18	=	_	_	JJ	O	[-1]	['none']	_	_
19	0.045	_	_	CD	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	compared	_	_	VBN	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	transfected	_	_	VBN	Gene_expression	[0]	['root']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	WT	_	_	JJ	O	[-1]	['none']	_	_
27	PKCalpha	_	_	NN	Protein	[24]	['Theme']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	survival	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	examined	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	MDMs	_	_	NNS	O	[-1]	['none']	_	_
8	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
9	either	_	_	CC	O	[-1]	['none']	_	_
10	WT-PKCalpha	_	_	NN	Protein	[8]	['Theme']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	KD-PKCalpha	_	_	NN	Negative_regulation	[0]	['root']	_	_
13	constructs	_	_	NNS	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	Annexin	_	_	NN	Protein	[16]	['multitoken']	_	_
16	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	PI	_	_	NN	O	[-1]	['none']	_	_
19	staining	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	M-CSF	_	_	NN	O	[-1]	['none']	_	_
5	increased	_	_	VBD	O	[-1]	['none']	_	_
6	MDM	_	_	NN	O	[-1]	['none']	_	_
7	survival	_	_	NN	O	[-1]	['none']	_	_
8	as	_	_	IN	O	[-1]	['none']	_	_
9	measured	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	percent	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Annexin	_	_	NN	Protein	[15]	['multitoken']	_	_
15	V/PI	_	_	NN	Protein	[0]	['root']	_	_
16	negative	_	_	JJ	Negative_regulation	[0]	['root']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Similarly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	WT-PKCalpha	_	_	NN	Protein	[3]	['Theme']	_	_
6	protected	_	_	VBD	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	apoptosis	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	expression	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	KD-PKCalpha	_	_	NN	Negative_regulation	[0]	['root']	_	_
7	decreased	_	_	VBD	O	[-1]	['none']	_	_
8	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	survival	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	p	_	_	NN	O	[-1]	['none']	_	_
13	<	_	_	JJR	O	[-1]	['none']	_	_
14	0.01	_	_	CD	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Next	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	examined	_	_	VBD	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	effect	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	PKCalpha	_	_	NN	Protein	[8]	['Theme']	_	_
11	constructs	_	_	NNS	O	[-1]	['none']	_	_
12	on	_	_	IN	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	7D	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	expression	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	KD-PKCalpha	_	_	NN	Negative_regulation	[0]	['root']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	RAW	_	_	NN	O	[-1]	['none']	_	_
12	264.7	_	_	CD	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	did	_	_	VBD	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	affect	_	_	VB	Regulation	[0]	['root']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	constitutive	_	_	JJ	O	[-1]	['none']	_	_
19	phosphorylation	_	_	NN	Phosphorylation	[16]	['Theme']	_	_
20	at	_	_	IN	O	[-1]	['none']	_	_
21	Ser536	_	_	NN	Entity	[19]	['Site']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	p65	_	_	NN	Protein	[19, 29]	['Theme', 'Theme']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	but	_	_	CC	O	[-1]	['none']	_	_
27	attenuated	_	_	VBD	Negative_regulation	[0]	['root']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	phosphorylation	_	_	NN	Phosphorylation	[27]	['Theme']	_	_
30	at	_	_	IN	O	[-1]	['none']	_	_
31	Ser276	_	_	NN	Entity	[29]	['Site']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	Gene_expression	[6]	['Cause']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	WT-PKCalpha	_	_	NN	Protein	[1]	['Theme']	_	_
4	did	_	_	VBD	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	effect	_	_	VB	Regulation	[14]	['Theme']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	phosphorylation	_	_	NN	Phosphorylation	[6]	['Theme']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	either	_	_	CC	Anaphora	[11]	['multitoken']	_	_
11	residue	_	_	NN	Anaphora	[0]	['root']	_	_
12	with	_	_	IN	Regulation	[14]	['multitoken']	_	_
13	or	_	_	CC	Regulation	[14]	['multitoken']	_	_
14	without	_	_	IN	Regulation	[0]	['root']	_	_
15	M-CSF	_	_	NN	O	[-1]	['none']	_	_
16	stimulation	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	observations	_	_	NNS	O	[-1]	['none']	_	_
3	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	important	_	_	JJ	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	M-CSF-regulated	_	_	JJ	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	survival	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	likely	_	_	JJ	O	[-1]	['none']	_	_
17	regulated	_	_	VBN	O	[-1]	['none']	_	_
18	through	_	_	IN	O	[-1]	['none']	_	_
19	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	Ser276	_	_	NN	Entity	[19]	['Site']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	p65	_	_	NN	Protein	[19]	['Theme']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	further	_	_	RB	O	[-1]	['none']	_	_
3	validate	_	_	VB	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	impact	_	_	NN	O	[-1]	['none']	_	_
6	that	_	_	WDT	O	[-1]	['none']	_	_
7	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
8	played	_	_	VBD	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
13	activity	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	we	_	_	PRP	O	[-1]	['none']	_	_
16	next	_	_	RB	O	[-1]	['none']	_	_
17	employed	_	_	VBN	O	[-1]	['none']	_	_
18	PKCalpha	_	_	NN	Protein	[19]	['multitoken']	_	_
19	siRNA	_	_	NN	Protein	[0]	['root']	_	_
20	treatment	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	MDM	_	_	NN	O	[-1]	['none']	_	_
23	or	_	_	CC	O	[-1]	['none']	_	_
24	RAW	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	pool	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	specific	_	_	JJ	O	[-1]	['none']	_	_
5	PKCalpha	_	_	NN	Protein	[6]	['multitoken']	_	_
6	siRNA	_	_	NN	Protein	[0]	['root']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	transfected	_	_	VBN	O	[-1]	['none']	_	_
9	into	_	_	IN	O	[-1]	['none']	_	_
10	MDM	_	_	NN	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	Raw	_	_	NN	O	[-1]	['none']	_	_
13	264.7	_	_	CD	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	presence	_	_	NN	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	absence	_	_	NN	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	M-CSF	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Reducing	_	_	VBG	Negative_regulation	[0]	['root']	_	_
2	native	_	_	JJ	O	[-1]	['none']	_	_
3	PKCalpha	_	_	NN	Protein	[4]	['Theme']	_	_
4	expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
5	decreased	_	_	VBD	O	[-1]	['none']	_	_
6	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
9	activity	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	both	_	_	CC	O	[-1]	['none']	_	_
12	MDM	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	p	_	_	NN	O	[-1]	['none']	_	_
15	=	_	_	JJ	O	[-1]	['none']	_	_
16	0.012	_	_	CD	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	Raw	_	_	NN	O	[-1]	['none']	_	_
20	264.7	_	_	CD	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	p	_	_	NN	O	[-1]	['none']	_	_
24	=	_	_	JJ	O	[-1]	['none']	_	_
25	0.01	_	_	CD	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	examined	_	_	VBD	O	[-1]	['none']	_	_
4	cell	_	_	NN	O	[-1]	['none']	_	_
5	survival	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	MDMs	_	_	NNS	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	Annexin	_	_	NN	Protein	[11]	['multitoken']	_	_
11	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	PI	_	_	NN	O	[-1]	['none']	_	_
14	staining	_	_	NN	O	[-1]	['none']	_	_
15	after	_	_	IN	O	[-1]	['none']	_	_
16	PKCalpha	_	_	NN	Protein	[17]	['multitoken']	_	_
17	siRNA	_	_	NN	Protein	[0]	['root']	_	_
18	transfection	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	7G	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
8	MDM	_	_	NN	O	[-1]	['none']	_	_
9	survival	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	reduced	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	transfected	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	PKCalpha	_	_	NN	Protein	[18]	['multitoken']	_	_
18	siRNA	_	_	NN	Protein	[0]	['root']	_	_
19	compared	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	transfected	_	_	VBN	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	control	_	_	NN	O	[-1]	['none']	_	_
25	siRNA	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	p	_	_	NN	O	[-1]	['none']	_	_
28	=	_	_	JJ	O	[-1]	['none']	_	_
29	0.047	_	_	CD	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	Figure	_	_	NNP	O	[-1]	['none']	_	_
3	7H	_	_	NNP	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	we	_	_	PRP	O	[-1]	['none']	_	_
6	confirmed	_	_	VBD	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	PKCalpha	_	_	NN	Protein	[9]	['multitoken']	_	_
9	siRNA	_	_	NN	Protein	[11]	['Cause']	_	_
10	transfection	_	_	NN	O	[-1]	['none']	_	_
11	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
12	PKCalpha	_	_	NN	Protein	[14]	['Theme']	_	_
13	protein	_	_	NN	O	[-1]	['none']	_	_
14	expression	_	_	NN	Gene_expression	[11]	['Theme']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	both	_	_	CC	O	[-1]	['none']	_	_
17	MDM	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	Raw	_	_	NN	O	[-1]	['none']	_	_
20	264.7	_	_	CD	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	indicated	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
6	regulated	_	_	VBD	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	activation	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	M-CSF-regulated	_	_	JJ	O	[-1]	['none']	_	_
11	cell	_	_	NN	O	[-1]	['none']	_	_
12	survival	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	PTX	_	_	NN	O	[-1]	['none']	_	_
2	upregulates	_	_	VBZ	O	[-1]	['none']	_	_
3	CREB	_	_	NN	O	[-1]	['none']	_	_
4	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	activation	_	_	NN	O	[-1]	['none']	_	_
7	after	_	_	IN	O	[-1]	['none']	_	_
8	LPS	_	_	NN	O	[-1]	['none']	_	_
9	stimulation	_	_	NN	O	[-1]	['none']	_	_
10	Phosphorylation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	nuclear	_	_	JJ	O	[-1]	['none']	_	_
13	CREB	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	used	_	_	VBN	O	[-1]	['none']	_	_
16	as	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	marker	_	_	NN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	CREB	_	_	NN	O	[-1]	['none']	_	_
21	activation	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	LPS	_	_	NN	O	[-1]	['none']	_	_
2	stimulation	_	_	NN	O	[-1]	['none']	_	_
3	caused	_	_	VBD	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	negligible	_	_	JJ	O	[-1]	['none']	_	_
6	increase	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	CREB	_	_	NN	O	[-1]	['none']	_	_
9	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
10	when	_	_	WRB	O	[-1]	['none']	_	_
11	compared	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	control	_	_	VB	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	PTX	_	_	NN	O	[-1]	['none']	_	_
2	alone	_	_	RB	O	[-1]	['none']	_	_
3	caused	_	_	VBD	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	marked	_	_	JJ	O	[-1]	['none']	_	_
6	increase	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	CREB	_	_	NN	O	[-1]	['none']	_	_
9	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	P	_	_	NN	O	[-1]	['none']	_	_
12	<	_	_	JJR	O	[-1]	['none']	_	_
13	0.01	_	_	CD	O	[-1]	['none']	_	_
14	vs.	_	_	CC	O	[-1]	['none']	_	_
15	HBSS	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	When	_	_	WRB	O	[-1]	['none']	_	_
2	LPS	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	PTX	_	_	NN	O	[-1]	['none']	_	_
5	exposure	_	_	NN	O	[-1]	['none']	_	_
6	occurred	_	_	VBD	O	[-1]	['none']	_	_
7	simultaneously	_	_	RB	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	CREB	_	_	NN	O	[-1]	['none']	_	_
10	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	significantly	_	_	RB	O	[-1]	['none']	_	_
13	higher	_	_	JJR	O	[-1]	['none']	_	_
14	than	_	_	IN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	LPS	_	_	NN	O	[-1]	['none']	_	_
17	stimulation	_	_	NN	O	[-1]	['none']	_	_
18	alone	_	_	RB	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	543	_	_	CD	O	[-1]	['none']	_	_
21	+/-	_	_	CC	O	[-1]	['none']	_	_
22	92	_	_	CD	O	[-1]	['none']	_	_
23	vs.	_	_	CC	O	[-1]	['none']	_	_
24	100	_	_	CD	O	[-1]	['none']	_	_
25	+/-	_	_	CC	O	[-1]	['none']	_	_
26	0	_	_	CD	O	[-1]	['none']	_	_
27	;	_	_	:	O	[-1]	['none']	_	_
28	P	_	_	NN	O	[-1]	['none']	_	_
29	<	_	_	JJR	O	[-1]	['none']	_	_
30	0.01	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	amount	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	CREB	_	_	NN	O	[-1]	['none']	_	_
8	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
9	seen	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	concomitant	_	_	JJ	O	[-1]	['none']	_	_
12	LPS	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	PTX	_	_	NN	O	[-1]	['none']	_	_
15	treatment	_	_	NN	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	less	_	_	JJR	O	[-1]	['none']	_	_
18	than	_	_	IN	O	[-1]	['none']	_	_
19	that	_	_	DT	O	[-1]	['none']	_	_
20	seen	_	_	VBN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	PTX	_	_	NN	O	[-1]	['none']	_	_
23	alone	_	_	RB	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	although	_	_	IN	O	[-1]	['none']	_	_
26	this	_	_	DT	O	[-1]	['none']	_	_
27	difference	_	_	NN	O	[-1]	['none']	_	_
28	was	_	_	VBD	O	[-1]	['none']	_	_
29	not	_	_	RB	O	[-1]	['none']	_	_
30	statistically	_	_	RB	O	[-1]	['none']	_	_
31	significant	_	_	JJ	O	[-1]	['none']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	P	_	_	NN	O	[-1]	['none']	_	_
34	=	_	_	JJ	O	[-1]	['none']	_	_
35	0.08	_	_	CD	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	if	_	_	IN	O	[-1]	['none']	_	_
4	CREB-DNA	_	_	NN	O	[-1]	['none']	_	_
5	binding	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	affected	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	PTX	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	manner	_	_	NN	O	[-1]	['none']	_	_
13	similar	_	_	JJ	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	CREB	_	_	NN	O	[-1]	['none']	_	_
16	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	an	_	_	DT	O	[-1]	['none']	_	_
19	EMSA	_	_	NN	O	[-1]	['none']	_	_
20	was	_	_	VBD	O	[-1]	['none']	_	_
21	performed	_	_	VBN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Exposure	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	LPS	_	_	NN	O	[-1]	['none']	_	_
4	stimulated	_	_	VBN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	PTX	_	_	NN	O	[-1]	['none']	_	_
8	similarly	_	_	RB	O	[-1]	['none']	_	_
9	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
10	CREB	_	_	NN	Protein	[12]	['Theme']	_	_
11	DNA	_	_	NN	O	[-1]	['none']	_	_
12	binding	_	_	NN	Binding	[9]	['Theme']	_	_
13	compared	_	_	VBN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	LPS	_	_	NN	O	[-1]	['none']	_	_
16	alone	_	_	RB	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Bisulfite	_	_	JJ	O	[-1]	['none']	_	_
2	treatment	_	_	NN	O	[-1]	['none']	_	_
3	DNA	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	extracted	_	_	VBN	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	described	_	_	VBN	O	[-1]	['none']	_	_
8	above	_	_	IN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Bisulfite	_	_	JJ	O	[-1]	['none']	_	_
2	treatment	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	DNA	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	leading	_	_	VBG	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	conversion	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	unmethylated	_	_	JJ	O	[-1]	['none']	_	_
11	cytosine	_	_	NN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	uracil	_	_	NN	O	[-1]	['none']	_	_
14	residues	_	_	NNS	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	no	_	_	DT	O	[-1]	['none']	_	_
17	change	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	methylated	_	_	VBN	O	[-1]	['none']	_	_
20	cytosine	_	_	NN	O	[-1]	['none']	_	_
21	residues	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	was	_	_	VBD	O	[-1]	['none']	_	_
24	performed	_	_	VBN	O	[-1]	['none']	_	_
25	as	_	_	IN	O	[-1]	['none']	_	_
26	described	_	_	VBN	O	[-1]	['none']	_	_
27	as	_	_	IN	O	[-1]	['none']	_	_
28	follows	_	_	VBZ	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	1	_	_	CD	O	[-1]	['none']	_	_
4	microg	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	DNA	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	2	_	_	CD	O	[-1]	['none']	_	_
9	microg	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	poly	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	dA-dT	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	poly	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	dA-dT	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	copolymers	_	_	NNS	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	Amersham	_	_	NNP	O	[-1]	['none']	_	_
23	Pharmacia	_	_	NNP	O	[-1]	['none']	_	_
24	Biotech	_	_	NNP	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	were	_	_	VBD	O	[-1]	['none']	_	_
27	denaturated	_	_	VBN	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	20	_	_	CD	O	[-1]	['none']	_	_
30	min	_	_	NN	O	[-1]	['none']	_	_
31	at	_	_	IN	O	[-1]	['none']	_	_
32	42degreesC	_	_	NN	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	0.3	_	_	CD	O	[-1]	['none']	_	_
35	M	_	_	NN	O	[-1]	['none']	_	_
36	NaOH	_	_	NN	O	[-1]	['none']	_	_
37	in	_	_	IN	O	[-1]	['none']	_	_
38	a	_	_	DT	O	[-1]	['none']	_	_
39	volume	_	_	NN	O	[-1]	['none']	_	_
40	of	_	_	IN	O	[-1]	['none']	_	_
41	50	_	_	CD	O	[-1]	['none']	_	_
42	microl	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	Fresh	_	_	JJ	O	[-1]	['none']	_	_
2	solutions	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	30	_	_	CD	O	[-1]	['none']	_	_
5	microl	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	10	_	_	CD	O	[-1]	['none']	_	_
8	mM	_	_	NN	O	[-1]	['none']	_	_
9	hydrochinon	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Sigma	_	_	NNP	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	530	_	_	CD	O	[-1]	['none']	_	_
15	microl	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	3	_	_	CD	O	[-1]	['none']	_	_
18	M	_	_	NN	O	[-1]	['none']	_	_
19	sodium	_	_	NN	O	[-1]	['none']	_	_
20	bisulfite	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	pH	_	_	NN	O	[-1]	['none']	_	_
23	5.0	_	_	CD	O	[-1]	['none']	_	_
24	;	_	_	:	O	[-1]	['none']	_	_
25	Sigma	_	_	NNP	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	were	_	_	VBD	O	[-1]	['none']	_	_
28	added	_	_	VBN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	solution	_	_	NN	O	[-1]	['none']	_	_
32	was	_	_	VBD	O	[-1]	['none']	_	_
33	gently	_	_	RB	O	[-1]	['none']	_	_
34	mixed	_	_	JJ	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	overlayed	_	_	VBN	O	[-1]	['none']	_	_
37	with	_	_	IN	O	[-1]	['none']	_	_
38	mineral	_	_	NN	O	[-1]	['none']	_	_
39	oil	_	_	NN	O	[-1]	['none']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	incubated	_	_	VBN	O	[-1]	['none']	_	_
42	in	_	_	IN	O	[-1]	['none']	_	_
43	the	_	_	DT	O	[-1]	['none']	_	_
44	dark	_	_	JJ	O	[-1]	['none']	_	_
45	for	_	_	IN	O	[-1]	['none']	_	_
46	12-13	_	_	CD	O	[-1]	['none']	_	_
47	h	_	_	NN	O	[-1]	['none']	_	_
48	at	_	_	IN	O	[-1]	['none']	_	_
49	50degreesC	_	_	NN	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	aqueous	_	_	JJ	O	[-1]	['none']	_	_
3	phase	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	recovered	_	_	VBN	O	[-1]	['none']	_	_
6	using	_	_	VBG	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	'	_	_	''	O	[-1]	['none']	_	_
9	Wizard	_	_	NNP	O	[-1]	['none']	_	_
10	DNA	_	_	NNP	O	[-1]	['none']	_	_
11	clean-up	_	_	JJ	O	[-1]	['none']	_	_
12	system	_	_	NN	O	[-1]	['none']	_	_
13	'	_	_	''	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Promega	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	Mannheim	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	Germany	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	purified	_	_	JJ	O	[-1]	['none']	_	_
3	DNA	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	subsequently	_	_	RB	O	[-1]	['none']	_	_
6	mixed	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	1	_	_	CD	O	[-1]	['none']	_	_
9	M	_	_	NN	O	[-1]	['none']	_	_
10	NaOH	_	_	NN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	final	_	_	JJ	O	[-1]	['none']	_	_
14	concentration	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	0.3	_	_	CD	O	[-1]	['none']	_	_
17	M	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	incubated	_	_	VBN	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	20	_	_	CD	O	[-1]	['none']	_	_
22	min	_	_	NN	O	[-1]	['none']	_	_
23	at	_	_	IN	O	[-1]	['none']	_	_
24	37degreesC	_	_	NN	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	ensure	_	_	VB	O	[-1]	['none']	_	_
27	complete	_	_	JJ	O	[-1]	['none']	_	_
28	desulfonisation	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	DNA	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	ethanol	_	_	NN	O	[-1]	['none']	_	_
4	precipitated	_	_	JJ	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	presence	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	1/10	_	_	CD	O	[-1]	['none']	_	_
10	vol	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	3	_	_	CD	O	[-1]	['none']	_	_
13	M	_	_	NN	O	[-1]	['none']	_	_
14	sodium	_	_	NN	O	[-1]	['none']	_	_
15	acetate	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	washed	_	_	VBN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	70	_	_	CD	O	[-1]	['none']	_	_
20	%	_	_	NN	O	[-1]	['none']	_	_
21	ethanol	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	resuspended	_	_	VBN	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	50	_	_	CD	O	[-1]	['none']	_	_
26	microl	_	_	NN	O	[-1]	['none']	_	_
27	H2O	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Subsequent	_	_	JJ	O	[-1]	['none']	_	_
2	PCR	_	_	NN	O	[-1]	['none']	_	_
3	amplification	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	4	_	_	CD	O	[-1]	['none']	_	_
6	microl	_	_	NN	O	[-1]	['none']	_	_
7	bisulfite	_	_	NN	O	[-1]	['none']	_	_
8	treated	_	_	VBN	O	[-1]	['none']	_	_
9	DNA	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	used	_	_	VBN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	cloning	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	two	_	_	CD	O	[-1]	['none']	_	_
16	fragments	_	_	NNS	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
20	promoter	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	BS-I	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	BS-II	_	_	NN	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	into	_	_	IN	O	[-1]	['none']	_	_
27	pCR2	_	_	NN	O	[-1]	['none']	_	_
28	.1	_	_	NN	O	[-1]	['none']	_	_
29	vector	_	_	NN	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	'	_	_	''	O	[-1]	['none']	_	_
33	TOPO	_	_	NNP	O	[-1]	['none']	_	_
34	TA	_	_	NNP	O	[-1]	['none']	_	_
35	cloning	_	_	VBG	O	[-1]	['none']	_	_
36	kit	_	_	NN	O	[-1]	['none']	_	_
37	'	_	_	''	O	[-1]	['none']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	primers	_	_	NNS	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	PCR	_	_	NN	O	[-1]	['none']	_	_
6	amplification	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	BS-I	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	BS-II	_	_	NN	O	[-1]	['none']	_	_
12	fragments	_	_	NNS	O	[-1]	['none']	_	_
13	contain	_	_	VBP	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	putative	_	_	JJ	O	[-1]	['none']	_	_
16	altered	_	_	JJ	O	[-1]	['none']	_	_
17	sequence	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	sense	_	_	NN	O	[-1]	['none']	_	_
21	strand	_	_	NN	O	[-1]	['none']	_	_
22	due	_	_	JJ	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	bisulfite	_	_	JJ	O	[-1]	['none']	_	_
25	treatment	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	converted	_	_	VBD	O	[-1]	['none']	_	_
28	cytosine	_	_	NN	O	[-1]	['none']	_	_
29	residues	_	_	NNS	O	[-1]	['none']	_	_
30	are	_	_	VBP	O	[-1]	['none']	_	_
31	written	_	_	VBN	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	bold	_	_	JJ	O	[-1]	['none']	_	_
34	letters	_	_	NNS	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	:	_	_	:	O	[-1]	['none']	_	_
37	BS-I-forward	_	_	JJ	O	[-1]	['none']	_	_
38	5	_	_	CD	O	[-1]	['none']	_	_
39	'-TATTTGGATTTTTAGGGAGTTTTTTTT-3	_	_	NN	O	[-1]	['none']	_	_
40	'	_	_	''	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	BS-I-reverse	_	_	JJ	O	[-1]	['none']	_	_
43	5	_	_	CD	O	[-1]	['none']	_	_
44	'-ACCCAACTCCCTTAAACTATTAAACT-3	_	_	NN	O	[-1]	['none']	_	_
45	'	_	_	''	O	[-1]	['none']	_	_
46	(	_	_	-LRB-	O	[-1]	['none']	_	_
47	187	_	_	CD	O	[-1]	['none']	_	_
48	bp	_	_	NN	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	;	_	_	:	O	[-1]	['none']	_	_
51	BS-II-forward	_	_	JJ	O	[-1]	['none']	_	_
52	5	_	_	CD	O	[-1]	['none']	_	_
53	'-AGTTTAATAGTTTAAGGGAGTTGGGT-3	_	_	NN	O	[-1]	['none']	_	_
54	'	_	_	''	O	[-1]	['none']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	BS-II-reverse	_	_	JJ	O	[-1]	['none']	_	_
57	5	_	_	CD	O	[-1]	['none']	_	_
58	'-CTCACCCTAAACTCAAAACTAAAAAC-3	_	_	NN	O	[-1]	['none']	_	_
59	'	_	_	''	O	[-1]	['none']	_	_
60	(	_	_	-LRB-	O	[-1]	['none']	_	_
61	674	_	_	CD	O	[-1]	['none']	_	_
62	bp	_	_	NN	O	[-1]	['none']	_	_
63	)	_	_	-RRB-	O	[-1]	['none']	_	_
64	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	bacterial	_	_	JJ	O	[-1]	['none']	_	_
3	amplification	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	cloned	_	_	JJ	O	[-1]	['none']	_	_
7	PCR	_	_	NN	O	[-1]	['none']	_	_
8	fragments	_	_	NNS	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	standard	_	_	JJ	O	[-1]	['none']	_	_
11	procedures	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	eight	_	_	CD	O	[-1]	['none']	_	_
14	clones	_	_	NNS	O	[-1]	['none']	_	_
15	from	_	_	IN	O	[-1]	['none']	_	_
16	each	_	_	DT	O	[-1]	['none']	_	_
17	sample	_	_	NN	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	sequenced	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	an	_	_	DT	O	[-1]	['none']	_	_
22	automated	_	_	JJ	O	[-1]	['none']	_	_
23	sequencer	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	ABI	_	_	NNP	O	[-1]	['none']	_	_
26	Prism	_	_	NN	O	[-1]	['none']	_	_
27	377	_	_	CD	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	Applied	_	_	NNP	O	[-1]	['none']	_	_
30	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	FACS	_	_	NN	O	[-1]	['none']	_	_
2	based	_	_	VBN	O	[-1]	['none']	_	_
3	cytotoxicity	_	_	NN	O	[-1]	['none']	_	_
4	assay	_	_	NN	O	[-1]	['none']	_	_
5	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	measure	_	_	VB	O	[-1]	['none']	_	_
3	cytotoxicity	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	EL4	_	_	NN	O	[-1]	['none']	_	_
6	thymoma	_	_	NN	O	[-1]	['none']	_	_
7	target	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	loaded	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	0	_	_	CD	O	[-1]	['none']	_	_
13	or	_	_	CC	O	[-1]	['none']	_	_
14	1	_	_	CD	O	[-1]	['none']	_	_
15	muM	_	_	NN	O	[-1]	['none']	_	_
16	Gp33	_	_	NN	O	[-1]	['none']	_	_
17	peptide	_	_	NN	O	[-1]	['none']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	2	_	_	CD	O	[-1]	['none']	_	_
20	h	_	_	NN	O	[-1]	['none']	_	_
21	before	_	_	IN	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	2-h	_	_	JJ	O	[-1]	['none']	_	_
24	coincubation	_	_	NN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	P14	_	_	NN	O	[-1]	['none']	_	_
27	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
28	T	_	_	NN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	at	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	effector-to-target	_	_	JJ	O	[-1]	['none']	_	_
33	ratios	_	_	NNS	O	[-1]	['none']	_	_
34	indicated	_	_	VBD	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	figures	_	_	NNS	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	96-well	_	_	JJ	O	[-1]	['none']	_	_
40	round-bottom	_	_	JJ	O	[-1]	['none']	_	_
41	plates	_	_	NNS	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	coincubation	_	_	NN	O	[-1]	['none']	_	_
4	period	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	stained	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	Annexin	_	_	NN	Protein	[11]	['multitoken']	_	_
11	V-FITC	_	_	NN	Protein	[0]	['root']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	anti-CD8-allophycocyanin	_	_	NN	Protein	[0]	['root']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	FlowJo	_	_	NN	O	[-1]	['none']	_	_
7	software	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Tree	_	_	NNP	O	[-1]	['none']	_	_
10	Star	_	_	NNP	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	Inc.	_	_	NNP	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	;	_	_	:	O	[-1]	['none']	_	_
15	EL4	_	_	NN	O	[-1]	['none']	_	_
16	target	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	CD8	_	_	NN	Protein	[0]	['root']	_	_
20	negative	_	_	JJ	O	[-1]	['none']	_	_
21	events	_	_	NNS	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	were	_	_	VBD	O	[-1]	['none']	_	_
24	gated	_	_	VBN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	percentage	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	Annexin	_	_	NN	Protein	[31]	['multitoken']	_	_
31	V+	_	_	JJ	Protein	[0]	['root']	_	_
32	target	_	_	NN	O	[-1]	['none']	_	_
33	cells	_	_	NNS	O	[-1]	['none']	_	_
34	was	_	_	VBD	O	[-1]	['none']	_	_
35	determined	_	_	VBN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Transgenic	_	_	JJ	O	[-1]	['none']	_	_
2	mice	_	_	NNS	O	[-1]	['none']	_	_
3	.	_	_	.	O	[-1]	['none']	_	_

1	Generation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	LMP1	_	_	NN	Protein	[0]	['root']	_	_
4	mice	_	_	NNS	O	[-1]	['none']	_	_
5	under	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	Ig	_	_	NN	O	[-1]	['none']	_	_
8	heavy	_	_	JJ	O	[-1]	['none']	_	_
9	chain	_	_	NN	O	[-1]	['none']	_	_
10	promoter	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	enhancer	_	_	NN	O	[-1]	['none']	_	_
13	have	_	_	VBP	O	[-1]	['none']	_	_
14	been	_	_	VBN	O	[-1]	['none']	_	_
15	described	_	_	VBN	O	[-1]	['none']	_	_
16	previously	_	_	RB	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	maintained	_	_	VBN	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	heterozygotes	_	_	NNS	O	[-1]	['none']	_	_
22	on	_	_	IN	O	[-1]	['none']	_	_
23	a	_	_	DT	O	[-1]	['none']	_	_
24	Balbc	_	_	NN	O	[-1]	['none']	_	_
25	background	_	_	NN	O	[-1]	['none']	_	_
26	[	_	_	CD	O	[-1]	['none']	_	_
27	26	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	mice	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	genotyped	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	Southern	_	_	NN	O	[-1]	['none']	_	_
7	blot	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	PCR	_	_	NN	O	[-1]	['none']	_	_
10	analysis	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	tail	_	_	NN	O	[-1]	['none']	_	_
13	DNA	_	_	NN	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	described	_	_	VBN	O	[-1]	['none']	_	_
16	previously	_	_	RB	O	[-1]	['none']	_	_
17	[	_	_	CD	O	[-1]	['none']	_	_
18	26	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Spleen	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	liver	_	_	NN	O	[-1]	['none']	_	_
4	sections	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	fixed	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	4	_	_	CD	O	[-1]	['none']	_	_
9	%	_	_	NN	O	[-1]	['none']	_	_
10	paraformaldehyde	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	embedded	_	_	JJ	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	paraffin	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	5-mum	_	_	JJ	O	[-1]	['none']	_	_
18	sections	_	_	NNS	O	[-1]	['none']	_	_
19	were	_	_	VBD	O	[-1]	['none']	_	_
20	stained	_	_	VBN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	hematoxylin	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	eosin	_	_	NN	O	[-1]	['none']	_	_
25	for	_	_	IN	O	[-1]	['none']	_	_
26	histopathological	_	_	JJ	O	[-1]	['none']	_	_
27	analysis	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Lymphomas	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	passaged	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	intraperitoneal	_	_	JJ	O	[-1]	['none']	_	_
6	injection	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	1	_	_	CD	O	[-1]	['none']	_	_
9	x	_	_	CC	O	[-1]	['none']	_	_
10	108	_	_	CD	O	[-1]	['none']	_	_
11	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
12	into	_	_	IN	O	[-1]	['none']	_	_
13	SCID	_	_	NN	O	[-1]	['none']	_	_
14	mice	_	_	NNS	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	sacrificed	_	_	VBN	O	[-1]	['none']	_	_
17	upon	_	_	IN	O	[-1]	['none']	_	_
18	development	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	an	_	_	DT	O	[-1]	['none']	_	_
21	extended	_	_	JJ	O	[-1]	['none']	_	_
22	abdomen	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Animals	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	housed	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	Association	_	_	NNP	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	Assessment	_	_	NNP	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	Accreditation	_	_	NNP	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	Animal	_	_	NNP	O	[-1]	['none']	_	_
13	Care	_	_	NNP	O	[-1]	['none']	_	_
14	approved	_	_	VBD	O	[-1]	['none']	_	_
15	animal	_	_	NN	O	[-1]	['none']	_	_
16	facility	_	_	NN	O	[-1]	['none']	_	_
17	at	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	University	_	_	NNP	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	North	_	_	NNP	O	[-1]	['none']	_	_
22	Carolina	_	_	NNP	O	[-1]	['none']	_	_
23	at	_	_	IN	O	[-1]	['none']	_	_
24	Chapel	_	_	NN	O	[-1]	['none']	_	_
25	Hill	_	_	NNP	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	All	_	_	DT	O	[-1]	['none']	_	_
2	protocols	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	approved	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	Institutional	_	_	JJ	O	[-1]	['none']	_	_
8	Animal	_	_	NNP	O	[-1]	['none']	_	_
9	Care	_	_	NNP	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	Use	_	_	NNP	O	[-1]	['none']	_	_
12	Committee	_	_	NNP	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Akt	_	_	NNP	Protein	[0]	['root']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Stat3	_	_	NN	Protein	[0]	['root']	_	_
7	Signaling	_	_	NN	O	[-1]	['none']	_	_
8	Are	_	_	VBP	O	[-1]	['none']	_	_
9	Required	_	_	VBN	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	Growth	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	Survival	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	Lymphoma	_	_	NN	O	[-1]	['none']	_	_
17	Cells	_	_	NNS	O	[-1]	['none']	_	_
18	MTS	_	_	NN	O	[-1]	['none']	_	_
19	assay	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
22	from	_	_	IN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	A	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	B	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	WT	_	_	NN	O	[-1]	['none']	_	_
29	or	_	_	CC	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	C	_	_	NN	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	D	_	_	NN	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	LMP1	_	_	NN	Protein	[0]	['root']	_	_
36	transgenic	_	_	JJ	O	[-1]	['none']	_	_
37	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	E	_	_	NN	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	F	_	_	NN	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	LMP1	_	_	NN	Protein	[0]	['root']	_	_
45	transgenic	_	_	JJ	O	[-1]	['none']	_	_
46	lymphoctyes	_	_	NNS	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	Splenocytes	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	cultured	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	without	_	_	IN	O	[-1]	['none']	_	_
7	inhibitors	_	_	NNS	Negative_regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	BAY11	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	mTOR	_	_	NN	Protein	[7]	['Theme']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	rapamycin	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	Akt	_	_	NN	Protein	[7]	['Theme']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	triciribine	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	MEK1/2	_	_	NN	Protein	[7]	['Theme']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	U0126	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	p38	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	SB202190	_	_	NN	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	or	_	_	CC	O	[-1]	['none']	_	_
35	Stat3	_	_	NN	Protein	[7]	['Theme']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	cucurbitacin	_	_	NN	O	[-1]	['none']	_	_
38	I	_	_	NN	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	AG490	_	_	NN	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	at	_	_	IN	O	[-1]	['none']	_	_
43	the	_	_	DT	O	[-1]	['none']	_	_
44	indicated	_	_	JJ	O	[-1]	['none']	_	_
45	concentrations	_	_	NNS	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	mean	_	_	NN	O	[-1]	['none']	_	_
6	+/-	_	_	CC	O	[-1]	['none']	_	_
7	SEM	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	triplicate	_	_	NN	O	[-1]	['none']	_	_
10	samples	_	_	NNS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Shown	_	_	VBN	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	results	_	_	NNS	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	A	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	B	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	WT	_	_	JJ	O	[-1]	['none']	_	_
12	lymphoma	_	_	NN	O	[-1]	['none']	_	_
13	1	_	_	CD	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	C	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	D	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	LMP1	_	_	NN	Protein	[0]	['root']	_	_
21	transgenic	_	_	JJ	O	[-1]	['none']	_	_
22	lymphoma	_	_	NN	O	[-1]	['none']	_	_
23	2	_	_	CD	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	E	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	F	_	_	NN	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	one	_	_	CD	O	[-1]	['none']	_	_
32	out	_	_	IN	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	two	_	_	CD	O	[-1]	['none']	_	_
35	LMP1	_	_	NN	Protein	[0]	['root']	_	_
36	transgenic	_	_	JJ	O	[-1]	['none']	_	_
37	mice	_	_	NNS	O	[-1]	['none']	_	_
38	analyzed	_	_	VBN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	repeated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	LMP1	_	_	NN	Protein	[0]	['root']	_	_
7	transgenic	_	_	JJ	O	[-1]	['none']	_	_
8	lymphoma	_	_	NN	O	[-1]	['none']	_	_
9	4	_	_	CD	O	[-1]	['none']	_	_
10	yielding	_	_	VBG	O	[-1]	['none']	_	_
11	similar	_	_	JJ	O	[-1]	['none']	_	_
12	results	_	_	NNS	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Effect	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Sharpin	_	_	NN	Protein	[4]	['Theme']	_	_
4	mutation	_	_	NN	Negative_regulation	[0]	['root']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	DC	_	_	NN	O	[-1]	['none']	_	_
7	subpopulations	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	maturation	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Spleens	_	_	NNS	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	WT	_	_	NNP	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	cpdm	_	_	NN	O	[-1]	['none']	_	_
9	mice	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	isolated	_	_	VBN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	subject	_	_	JJ	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	collagenase	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	DNase	_	_	NN	O	[-1]	['none']	_	_
18	digestion	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	obtained	_	_	VBN	O	[-1]	['none']	_	_
3	splenic	_	_	JJ	O	[-1]	['none']	_	_
4	homogenates	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
7	over	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	Percoll	_	_	NN	O	[-1]	['none']	_	_
10	gradient	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	35	_	_	CD	O	[-1]	['none']	_	_
13	%	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	55	_	_	CD	O	[-1]	['none']	_	_
16	%	_	_	NN	O	[-1]	['none']	_	_
17	density	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	15	_	_	CD	O	[-1]	['none']	_	_
21	minutes	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	bands	_	_	NNS	O	[-1]	['none']	_	_
3	at	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	35	_	_	CD	O	[-1]	['none']	_	_
6	%-medium	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	35-55	_	_	CD	O	[-1]	['none']	_	_
10	%	_	_	NN	O	[-1]	['none']	_	_
11	interface	_	_	NN	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	pooled	_	_	VBN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	washed	_	_	VBN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	stained	_	_	VBN	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	combination	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	various	_	_	JJ	O	[-1]	['none']	_	_
23	antibodies	_	_	NNS	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	stain	_	_	VB	O	[-1]	['none']	_	_
26	different	_	_	JJ	O	[-1]	['none']	_	_
27	DC	_	_	NN	O	[-1]	['none']	_	_
28	subsets	_	_	NNS	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	conventional	_	_	JJ	O	[-1]	['none']	_	_
31	CD11c+	_	_	JJ	O	[-1]	['none']	_	_
32	CD8alpha+	_	_	JJ	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	CD11c+	_	_	JJ	O	[-1]	['none']	_	_
35	CD8alpha-	_	_	NN	O	[-1]	['none']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	plasmacytoid	_	_	NN	O	[-1]	['none']	_	_
38	DC	_	_	NN	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	CD11c-PDCA-1+	_	_	JJ	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	top	_	_	JJ	O	[-1]	['none']	_	_
3	panels	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	gated	_	_	VBN	O	[-1]	['none']	_	_
6	on	_	_	IN	O	[-1]	['none']	_	_
7	FSChiSSClo	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	show	_	_	VB	O	[-1]	['none']	_	_
11	separate	_	_	JJ	O	[-1]	['none']	_	_
12	populations	_	_	NNS	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	CD11c+	_	_	JJ	O	[-1]	['none']	_	_
15	PDCA-1-	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	CD11c-PDCA-1+	_	_	JJ	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Further	_	_	RB	O	[-1]	['none']	_	_
2	gating	_	_	VBG	O	[-1]	['none']	_	_
3	on	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	CD11c+	_	_	JJ	O	[-1]	['none']	_	_
6	PDCA-1-	_	_	NN	O	[-1]	['none']	_	_
7	subpopulation	_	_	NN	O	[-1]	['none']	_	_
8	gave	_	_	VBD	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	bottom	_	_	JJ	O	[-1]	['none']	_	_
11	panel	_	_	NN	O	[-1]	['none']	_	_
12	that	_	_	WDT	O	[-1]	['none']	_	_
13	showed	_	_	VBD	O	[-1]	['none']	_	_
14	two	_	_	CD	O	[-1]	['none']	_	_
15	distinct	_	_	JJ	O	[-1]	['none']	_	_
16	pools	_	_	NNS	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	CD11c+	_	_	JJ	O	[-1]	['none']	_	_
19	CD8alpha+	_	_	JJ	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	CD11c+	_	_	JJ	O	[-1]	['none']	_	_
22	CD8alpha-	_	_	JJ	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Percentages	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	calculated	_	_	VBN	O	[-1]	['none']	_	_
4	based	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	parental	_	_	JJ	O	[-1]	['none']	_	_
8	population	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	additionally	_	_	RB	O	[-1]	['none']	_	_
12	shown	_	_	VBN	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	bar	_	_	NN	O	[-1]	['none']	_	_
15	graphs	_	_	NNS	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	n	_	_	NN	O	[-1]	['none']	_	_
18	=	_	_	JJ	O	[-1]	['none']	_	_
19	2	_	_	CD	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	B	_	_	NN	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	WT	_	_	NNP	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	cpdm	_	_	JJ	O	[-1]	['none']	_	_
7	BMDC	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	5x105	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	stimulated	_	_	VBN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	medium	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	100	_	_	CD	O	[-1]	['none']	_	_
18	ng/ml	_	_	NN	O	[-1]	['none']	_	_
19	LPS	_	_	NN	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	25	_	_	CD	O	[-1]	['none']	_	_
22	microg/ml	_	_	NN	O	[-1]	['none']	_	_
23	poly	_	_	NN	O	[-1]	['none']	_	_
24	I	_	_	NN	O	[-1]	['none']	_	_
25	:	_	_	:	O	[-1]	['none']	_	_
26	C	_	_	NN	O	[-1]	['none']	_	_
27	for	_	_	IN	O	[-1]	['none']	_	_
28	24	_	_	CD	O	[-1]	['none']	_	_
29	hours	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	labeled	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	PE	_	_	NN	O	[-1]	['none']	_	_
7	labeled	_	_	VBN	O	[-1]	['none']	_	_
8	anti-CD40	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	anti-CD80	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	anti-CD86	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	subjected	_	_	VBN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	flow	_	_	VB	O	[-1]	['none']	_	_
19	cytometry	_	_	NN	O	[-1]	['none']	_	_
20	analysis	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	populations	_	_	NNS	O	[-1]	['none']	_	_
3	shown	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	histograms	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	gated	_	_	VBN	O	[-1]	['none']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	CD11c+	_	_	JJ	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Unstained	_	_	JJ	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	served	_	_	VBD	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	negative	_	_	JJ	O	[-1]	['none']	_	_
6	controls	_	_	NNS	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Results	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	representative	_	_	JJ	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	two	_	_	CD	O	[-1]	['none']	_	_
6	independent	_	_	JJ	O	[-1]	['none']	_	_
7	experiments	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	Promotes	_	_	VBZ	O	[-1]	['none']	_	_
3	B-1a	_	_	NN	O	[-1]	['none']	_	_
4	Lymphomas	_	_	NNS	O	[-1]	['none']	_	_
5	That	_	_	WDT	O	[-1]	['none']	_	_
6	Can	_	_	MD	O	[-1]	['none']	_	_
7	Escape	_	_	NN	O	[-1]	['none']	_	_
8	Allelic	_	_	JJ	O	[-1]	['none']	_	_
9	Exclusion	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	A	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	Flow	_	_	NN	O	[-1]	['none']	_	_
14	cytometry	_	_	NN	O	[-1]	['none']	_	_
15	analysis	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
18	from	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	WT	_	_	NNP	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	LMP1	_	_	NN	Protein	[0]	['root']	_	_
23	transgenic	_	_	JJ	O	[-1]	['none']	_	_
24	lymphoma	_	_	NN	O	[-1]	['none']	_	_
25	for	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	pan-B	_	_	NN	O	[-1]	['none']	_	_
28	cell	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	CD19	_	_	NN	Protein	[0]	['root']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	B-1a	_	_	JJ	O	[-1]	['none']	_	_
34	cell	_	_	NN	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	CD5	_	_	NN	Protein	[0]	['root']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	Ig	_	_	NN	O	[-1]	['none']	_	_
41	heavy	_	_	JJ	O	[-1]	['none']	_	_
42	chain	_	_	NN	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	IgM	_	_	NN	O	[-1]	['none']	_	_
45	and	_	_	CC	O	[-1]	['none']	_	_
46	IgD	_	_	NN	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	and	_	_	CC	O	[-1]	['none']	_	_
49	light	_	_	JJ	O	[-1]	['none']	_	_
50	chain	_	_	NN	O	[-1]	['none']	_	_
51	(	_	_	-LRB-	O	[-1]	['none']	_	_
52	kappa	_	_	NN	O	[-1]	['none']	_	_
53	and	_	_	CC	O	[-1]	['none']	_	_
54	lambda	_	_	NN	O	[-1]	['none']	_	_
55	)	_	_	-RRB-	O	[-1]	['none']	_	_
56	markers	_	_	NNS	O	[-1]	['none']	_	_
57	.	_	_	.	O	[-1]	['none']	_	_

1	Shown	_	_	VBN	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	results	_	_	NNS	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	WT	_	_	JJ	O	[-1]	['none']	_	_
7	lymphoma	_	_	NN	O	[-1]	['none']	_	_
8	1	_	_	CD	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	LMP1	_	_	NN	Protein	[0]	['root']	_	_
11	transgenic	_	_	JJ	O	[-1]	['none']	_	_
12	lymphoma	_	_	NN	O	[-1]	['none']	_	_
13	4	_	_	CD	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	repeated	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	four	_	_	CD	O	[-1]	['none']	_	_
7	other	_	_	JJ	O	[-1]	['none']	_	_
8	LMP1	_	_	NN	Protein	[0]	['root']	_	_
9	transgenic	_	_	JJ	O	[-1]	['none']	_	_
10	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	1	_	_	CD	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	2	_	_	CD	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	3	_	_	CD	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	6	_	_	CD	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	showing	_	_	VBG	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	similar	_	_	JJ	O	[-1]	['none']	_	_
24	B-1a	_	_	NN	O	[-1]	['none']	_	_
25	phenotype	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	which	_	_	WDT	O	[-1]	['none']	_	_
29	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
30	2	_	_	CD	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	4	_	_	CD	O	[-1]	['none']	_	_
33	were	_	_	VBD	O	[-1]	['none']	_	_
34	also	_	_	RB	O	[-1]	['none']	_	_
35	doubly	_	_	RB	O	[-1]	['none']	_	_
36	positive	_	_	JJ	O	[-1]	['none']	_	_
37	for	_	_	IN	O	[-1]	['none']	_	_
38	kappa	_	_	NN	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	lambda	_	_	NN	O	[-1]	['none']	_	_
41	light	_	_	JJ	O	[-1]	['none']	_	_
42	chains	_	_	NNS	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Flow	_	_	NN	O	[-1]	['none']	_	_
5	cytometry	_	_	NN	O	[-1]	['none']	_	_
6	analysis	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	WT	_	_	NNP	O	[-1]	['none']	_	_
9	or	_	_	CC	O	[-1]	['none']	_	_
10	LMP1	_	_	NN	Protein	[0]	['root']	_	_
11	transgenic	_	_	JJ	O	[-1]	['none']	_	_
12	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	B-1a	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
17	CD5+	_	_	JJ	Protein	[0]	['root']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	B-1b	_	_	NN	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	B2	_	_	NN	O	[-1]	['none']	_	_
23	subsets	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
26	CD5-)	_	_	NN	Protein	[0]	['root']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Percentages	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	B-1a	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	B-1b	_	_	NN	O	[-1]	['none']	_	_
6	or	_	_	CC	O	[-1]	['none']	_	_
7	B2	_	_	NN	O	[-1]	['none']	_	_
8	subsets	_	_	NNS	O	[-1]	['none']	_	_
9	are	_	_	VBP	O	[-1]	['none']	_	_
10	shown	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	each	_	_	DT	O	[-1]	['none']	_	_
13	quadrant	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	repeated	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	three	_	_	CD	O	[-1]	['none']	_	_
7	other	_	_	JJ	O	[-1]	['none']	_	_
8	WT	_	_	NNP	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	two	_	_	CD	O	[-1]	['none']	_	_
11	other	_	_	JJ	O	[-1]	['none']	_	_
12	LMP1	_	_	NN	Protein	[0]	['root']	_	_
13	transgenic	_	_	JJ	O	[-1]	['none']	_	_
14	mice	_	_	NNS	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	similar	_	_	JJ	O	[-1]	['none']	_	_
17	results	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
5	analysis	_	_	NN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	kappa	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	lambda	_	_	NN	O	[-1]	['none']	_	_
10	light	_	_	JJ	O	[-1]	['none']	_	_
11	chains	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	B	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	purified	_	_	VBN	O	[-1]	['none']	_	_
19	from	_	_	IN	O	[-1]	['none']	_	_
20	WT	_	_	NNP	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	LMP1	_	_	NN	Protein	[0]	['root']	_	_
23	transgenic	_	_	JJ	O	[-1]	['none']	_	_
24	mice	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Actin	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	loading	_	_	VBG	O	[-1]	['none']	_	_
7	control	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	exposure	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	variety	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	extracellular	_	_	JJ	O	[-1]	['none']	_	_
11	stimuli	_	_	NNS	O	[-1]	['none']	_	_
12	results	_	_	VBZ	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	initiation	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	posttranscriptional	_	_	JJ	O	[-1]	['none']	_	_
20	events	_	_	NNS	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	which	_	_	WDT	O	[-1]	['none']	_	_
23	culminate	_	_	VBP	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	production	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	pro	_	_	JJ	O	[-1]	['none']	_	_
29	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
30	mediators.11-14	_	_	JJ	O	[-1]	['none']	_	_
31	TNF-alpha	_	_	NN	Protein	[33]	['Theme']	_	_
32	is	_	_	VBZ	O	[-1]	['none']	_	_
33	released	_	_	VBN	Localization	[36]	['Theme']	_	_
34	very	_	_	RB	O	[-1]	['none']	_	_
35	early	_	_	RB	O	[-1]	['none']	_	_
36	following	_	_	JJ	Positive_regulation	[0]	['root']	_	_
37	shock	_	_	NN	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	is	_	_	VBZ	O	[-1]	['none']	_	_
40	considered	_	_	VBN	O	[-1]	['none']	_	_
41	an	_	_	DT	O	[-1]	['none']	_	_
42	important	_	_	JJ	O	[-1]	['none']	_	_
43	mediator	_	_	NN	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	the	_	_	DT	O	[-1]	['none']	_	_
46	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
47	cascade	_	_	NN	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	since	_	_	IN	O	[-1]	['none']	_	_
50	it	_	_	PRP	O	[-1]	['none']	_	_
51	regulates	_	_	VBZ	O	[-1]	['none']	_	_
52	the	_	_	DT	O	[-1]	['none']	_	_
53	synthesis	_	_	NN	O	[-1]	['none']	_	_
54	of	_	_	IN	O	[-1]	['none']	_	_
55	several	_	_	JJ	O	[-1]	['none']	_	_
56	other	_	_	JJ	O	[-1]	['none']	_	_
57	critical	_	_	JJ	O	[-1]	['none']	_	_
58	cytokines	_	_	NNS	O	[-1]	['none']	_	_
59	and	_	_	CC	O	[-1]	['none']	_	_
60	chemokines	_	_	NNS	O	[-1]	['none']	_	_
61	.15	_	_	CD	O	[-1]	['none']	_	_
62	A	_	_	DT	O	[-1]	['none']	_	_
63	clear	_	_	JJ	O	[-1]	['none']	_	_
64	relationship	_	_	NN	O	[-1]	['none']	_	_
65	between	_	_	IN	O	[-1]	['none']	_	_
66	increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
67	TNF-alpha	_	_	NN	Protein	[68]	['Theme']	_	_
68	synthesis	_	_	NN	Gene_expression	[66]	['Theme']	_	_
69	and	_	_	CC	O	[-1]	['none']	_	_
70	the	_	_	DT	O	[-1]	['none']	_	_
71	development	_	_	NN	O	[-1]	['none']	_	_
72	of	_	_	IN	O	[-1]	['none']	_	_
73	shock	_	_	NN	O	[-1]	['none']	_	_
74	and	_	_	CC	O	[-1]	['none']	_	_
75	multiple	_	_	JJ	O	[-1]	['none']	_	_
76	organ	_	_	NN	O	[-1]	['none']	_	_
77	dysfunction	_	_	NN	O	[-1]	['none']	_	_
78	has	_	_	VBZ	O	[-1]	['none']	_	_
79	been	_	_	VBN	O	[-1]	['none']	_	_
80	observed	_	_	VBN	O	[-1]	['none']	_	_
81	in	_	_	IN	O	[-1]	['none']	_	_
82	animal	_	_	NN	O	[-1]	['none']	_	_
83	models	_	_	NNS	O	[-1]	['none']	_	_
84	of	_	_	IN	O	[-1]	['none']	_	_
85	sepsis.15-17	_	_	NN	O	[-1]	['none']	_	_
86	Because	_	_	IN	O	[-1]	['none']	_	_
87	of	_	_	IN	O	[-1]	['none']	_	_
88	its	_	_	PRP$	O	[-1]	['none']	_	_
89	importance	_	_	NN	O	[-1]	['none']	_	_
90	in	_	_	IN	O	[-1]	['none']	_	_
91	orchestrating	_	_	VBG	O	[-1]	['none']	_	_
92	multiple	_	_	JJ	O	[-1]	['none']	_	_
93	steps	_	_	NNS	O	[-1]	['none']	_	_
94	of	_	_	IN	O	[-1]	['none']	_	_
95	the	_	_	DT	O	[-1]	['none']	_	_
96	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
97	response	_	_	NN	O	[-1]	['none']	_	_
98	,	_	_	,	O	[-1]	['none']	_	_
99	strategies	_	_	NNS	O	[-1]	['none']	_	_
100	aimed	_	_	VBN	O	[-1]	['none']	_	_
101	at	_	_	IN	O	[-1]	['none']	_	_
102	decreasing	_	_	VBG	Negative_regulation	[0]	['root']	_	_
103	TNF-alpha	_	_	NN	Protein	[102, 108]	['Theme', 'Theme']	_	_
104	levels	_	_	NNS	O	[-1]	['none']	_	_
105	or	_	_	CC	O	[-1]	['none']	_	_
106	attenuating	_	_	VBG	Negative_regulation	[0]	['root']	_	_
107	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
108	production	_	_	NN	Gene_expression	[106]	['Theme']	_	_
109	seem	_	_	VBP	O	[-1]	['none']	_	_
110	attractive	_	_	JJ	O	[-1]	['none']	_	_
111	.	_	_	.	O	[-1]	['none']	_	_

1	PDE	_	_	NN	O	[-1]	['none']	_	_
2	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
3	have	_	_	VBP	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	shown	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	downregulate	_	_	VB	Negative_regulation	[0]	['root']	_	_
8	TNF-alpha	_	_	NN	Protein	[9]	['Theme']	_	_
9	production	_	_	NN	Gene_expression	[7]	['Theme']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	distinct	_	_	JJ	O	[-1]	['none']	_	_
12	human	_	_	NN	O	[-1]	['none']	_	_
13	cell	_	_	NN	O	[-1]	['none']	_	_
14	populations	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	have	_	_	VBP	O	[-1]	['none']	_	_
3	previously	_	_	RB	O	[-1]	['none']	_	_
4	shown	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	general	_	_	JJ	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	TNF-alpha	_	_	NN	Protein	[14]	['Theme']	_	_
11	levels	_	_	NNS	O	[-1]	['none']	_	_
12	continue	_	_	VBP	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	increase	_	_	VB	Positive_regulation	[0]	['root']	_	_
15	after	_	_	IN	O	[-1]	['none']	_	_
16	LPS	_	_	NN	O	[-1]	['none']	_	_
17	exposure	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	that	_	_	IN	O	[-1]	['none']	_	_
20	concomitant	_	_	JJ	O	[-1]	['none']	_	_
21	infusion	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
24	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
25	can	_	_	MD	O	[-1]	['none']	_	_
26	markedly	_	_	RB	O	[-1]	['none']	_	_
27	decrease	_	_	VB	Negative_regulation	[0]	['root']	_	_
28	TNF-alpha	_	_	NN	Protein	[27]	['Theme']	_	_
29	levels.18-19	_	_	NN	O	[-1]	['none']	_	_
30	In	_	_	IN	O	[-1]	['none']	_	_
31	this	_	_	DT	O	[-1]	['none']	_	_
32	in	_	_	FW	O	[-1]	['none']	_	_
33	vitro	_	_	FW	O	[-1]	['none']	_	_
34	study	_	_	NN	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	we	_	_	PRP	O	[-1]	['none']	_	_
37	verified	_	_	VBD	O	[-1]	['none']	_	_
38	the	_	_	DT	O	[-1]	['none']	_	_
39	sustained	_	_	JJ	O	[-1]	['none']	_	_
40	attenuation	_	_	NN	Negative_regulation	[0]	['root']	_	_
41	of	_	_	IN	O	[-1]	['none']	_	_
42	LPS	_	_	NN	O	[-1]	['none']	_	_
43	induced	_	_	VBD	Positive_regulation	[40]	['Theme']	_	_
44	TNF-alpha	_	_	NN	Protein	[45]	['Theme']	_	_
45	expression	_	_	NN	Gene_expression	[43]	['Theme']	_	_
46	over	_	_	IN	O	[-1]	['none']	_	_
47	time	_	_	NN	O	[-1]	['none']	_	_
48	in	_	_	IN	O	[-1]	['none']	_	_
49	an	_	_	DT	O	[-1]	['none']	_	_
50	isolated	_	_	JJ	O	[-1]	['none']	_	_
51	human	_	_	NN	O	[-1]	['none']	_	_
52	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
53	cell	_	_	NN	O	[-1]	['none']	_	_
54	population	_	_	NN	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	which	_	_	WDT	O	[-1]	['none']	_	_
5	PTX	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	non	_	_	JJ	O	[-1]	['none']	_	_
9	specific	_	_	JJ	O	[-1]	['none']	_	_
10	phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
11	inhibitor	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	significantly	_	_	RB	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	consistently	_	_	RB	O	[-1]	['none']	_	_
16	decreases	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
17	TNF-alpha	_	_	NN	Protein	[18]	['Theme']	_	_
18	production	_	_	NN	Gene_expression	[16]	['Theme']	_	_
19	have	_	_	VBP	O	[-1]	['none']	_	_
20	not	_	_	RB	O	[-1]	['none']	_	_
21	been	_	_	VBN	O	[-1]	['none']	_	_
22	completely	_	_	RB	O	[-1]	['none']	_	_
23	elucidated	_	_	VBN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	been	_	_	VBN	O	[-1]	['none']	_	_
4	postulated	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	drugs	_	_	NNS	O	[-1]	['none']	_	_
7	that	_	_	WDT	O	[-1]	['none']	_	_
8	increase	_	_	VBP	O	[-1]	['none']	_	_
9	intracellular	_	_	JJ	O	[-1]	['none']	_	_
10	cAMP	_	_	NN	O	[-1]	['none']	_	_
11	exert	_	_	VBP	O	[-1]	['none']	_	_
12	their	_	_	PRP$	O	[-1]	['none']	_	_
13	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
14	effects	_	_	NNS	O	[-1]	['none']	_	_
15	through	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	activation	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	PKA	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	classic	_	_	JJ	O	[-1]	['none']	_	_
3	pathway	_	_	NN	O	[-1]	['none']	_	_
4	has	_	_	VBZ	O	[-1]	['none']	_	_
5	been	_	_	VBN	O	[-1]	['none']	_	_
6	challenged	_	_	VBN	O	[-1]	['none']	_	_
7	as	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	sole	_	_	JJ	O	[-1]	['none']	_	_
10	mechanism	_	_	NN	O	[-1]	['none']	_	_
11	involved	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	modulation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	inflammation	_	_	NN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	cAMP	_	_	NN	O	[-1]	['none']	_	_
19	enhancing	_	_	VBG	O	[-1]	['none']	_	_
20	drugs	_	_	NNS	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	alternative	_	_	JJ	O	[-1]	['none']	_	_
24	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
25	involving	_	_	VBG	O	[-1]	['none']	_	_
26	PKA	_	_	NN	O	[-1]	['none']	_	_
27	independent	_	_	JJ	O	[-1]	['none']	_	_
28	pathways	_	_	NNS	O	[-1]	['none']	_	_
29	have	_	_	VBP	O	[-1]	['none']	_	_
30	been	_	_	VBN	O	[-1]	['none']	_	_
31	proposed.6-8	_	_	JJ	O	[-1]	['none']	_	_
32	In	_	_	IN	O	[-1]	['none']	_	_
33	this	_	_	DT	O	[-1]	['none']	_	_
34	series	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	experiments	_	_	NNS	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	we	_	_	PRP	O	[-1]	['none']	_	_
39	observed	_	_	VBD	O	[-1]	['none']	_	_
40	a	_	_	DT	O	[-1]	['none']	_	_
41	significant	_	_	JJ	O	[-1]	['none']	_	_
42	attenuation	_	_	NN	Negative_regulation	[52, 56]	['Theme', 'Theme']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	TNF-alpha	_	_	NN	Protein	[45]	['Theme']	_	_
45	production	_	_	NN	Gene_expression	[42]	['Theme']	_	_
46	in	_	_	IN	O	[-1]	['none']	_	_
47	LPS	_	_	NN	O	[-1]	['none']	_	_
48	stimulated	_	_	VBN	O	[-1]	['none']	_	_
49	human	_	_	NN	O	[-1]	['none']	_	_
50	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
51	cells	_	_	NNS	O	[-1]	['none']	_	_
52	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
53	PTX	_	_	NN	O	[-1]	['none']	_	_
54	administration	_	_	NN	O	[-1]	['none']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	independent	_	_	JJ	Regulation	[0]	['root']	_	_
57	of	_	_	IN	O	[-1]	['none']	_	_
58	PKA	_	_	NN	O	[-1]	['none']	_	_
59	activation	_	_	NN	O	[-1]	['none']	_	_
60	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	used	_	_	VBD	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	nonspecific	_	_	JJ	O	[-1]	['none']	_	_
5	phosphodiesterase	_	_	NN	O	[-1]	['none']	_	_
6	inhibitor	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	PTX	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	present	_	_	JJ	O	[-1]	['none']	_	_
13	study	_	_	NN	O	[-1]	['none']	_	_
14	because	_	_	IN	O	[-1]	['none']	_	_
15	it	_	_	PRP	O	[-1]	['none']	_	_
16	has	_	_	VBZ	O	[-1]	['none']	_	_
17	been	_	_	VBN	O	[-1]	['none']	_	_
18	used	_	_	VBN	O	[-1]	['none']	_	_
19	clinically	_	_	RB	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	treatment	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	variety	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	conditions	_	_	NNS	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	which	_	_	WDT	O	[-1]	['none']	_	_
30	inflammation	_	_	NN	O	[-1]	['none']	_	_
31	is	_	_	VBZ	O	[-1]	['none']	_	_
32	an	_	_	DT	O	[-1]	['none']	_	_
33	important	_	_	JJ	O	[-1]	['none']	_	_
34	component	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	pathophysiology	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	disease	_	_	NN	O	[-1]	['none']	_	_
41	process	_	_	NN	O	[-1]	['none']	_	_
42	.19	_	_	CD	O	[-1]	['none']	_	_
43	Additionally	_	_	RB	O	[-1]	['none']	_	_
44	,	_	_	,	O	[-1]	['none']	_	_
45	the	_	_	DT	O	[-1]	['none']	_	_
46	use	_	_	NN	O	[-1]	['none']	_	_
47	of	_	_	IN	O	[-1]	['none']	_	_
48	PTX	_	_	NN	O	[-1]	['none']	_	_
49	in	_	_	IN	O	[-1]	['none']	_	_
50	sepsis	_	_	NN	O	[-1]	['none']	_	_
51	as	_	_	IN	O	[-1]	['none']	_	_
52	an	_	_	DT	O	[-1]	['none']	_	_
53	adjunct	_	_	NN	O	[-1]	['none']	_	_
54	to	_	_	TO	O	[-1]	['none']	_	_
55	other	_	_	JJ	O	[-1]	['none']	_	_
56	treatments	_	_	NNS	O	[-1]	['none']	_	_
57	to	_	_	TO	O	[-1]	['none']	_	_
58	maintain	_	_	VB	O	[-1]	['none']	_	_
59	adequate	_	_	JJ	O	[-1]	['none']	_	_
60	organ	_	_	NN	O	[-1]	['none']	_	_
61	function	_	_	NN	O	[-1]	['none']	_	_
62	has	_	_	VBZ	O	[-1]	['none']	_	_
63	been	_	_	VBN	O	[-1]	['none']	_	_
64	explored	_	_	VBN	O	[-1]	['none']	_	_
65	based	_	_	VBN	O	[-1]	['none']	_	_
66	upon	_	_	IN	O	[-1]	['none']	_	_
67	its	_	_	PRP$	O	[-1]	['none']	_	_
68	effects	_	_	NNS	Regulation	[0]	['root']	_	_
69	on	_	_	IN	O	[-1]	['none']	_	_
70	TNF-alpha	_	_	NN	Protein	[71]	['Theme']	_	_
71	synthesis	_	_	NN	Gene_expression	[68]	['Theme']	_	_
72	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	reported	_	_	VBN	O	[-1]	['none']	_	_
5	beneficial	_	_	JJ	O	[-1]	['none']	_	_
6	effects	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	PTX	_	_	NN	O	[-1]	['none']	_	_
9	are	_	_	VBP	O	[-1]	['none']	_	_
10	not	_	_	RB	O	[-1]	['none']	_	_
11	only	_	_	RB	O	[-1]	['none']	_	_
12	related	_	_	JJ	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	downregulation	_	_	NN	Negative_regulation	[0]	['root']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	TNF-alphabut	_	_	NN	Protein	[0]	['root']	_	_
18	also	_	_	RB	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	PTX	_	_	NN	O	[-1]	['none']	_	_
21	's	_	_	POS	O	[-1]	['none']	_	_
22	hemorrheologic	_	_	JJ	O	[-1]	['none']	_	_
23	properties	_	_	NNS	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	its	_	_	PRP$	O	[-1]	['none']	_	_
26	ability	_	_	NN	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	reduce	_	_	VB	O	[-1]	['none']	_	_
29	neutrophil	_	_	NN	O	[-1]	['none']	_	_
30	activation	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	its	_	_	PRP$	O	[-1]	['none']	_	_
34	beneficial	_	_	JJ	O	[-1]	['none']	_	_
35	effects	_	_	NNS	O	[-1]	['none']	_	_
36	on	_	_	IN	O	[-1]	['none']	_	_
37	microcirculation	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	cardiac	_	_	JJ	O	[-1]	['none']	_	_
40	performance	_	_	NN	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	and	_	_	CC	O	[-1]	['none']	_	_
43	organ	_	_	NN	O	[-1]	['none']	_	_
44	injury.20-25	_	_	NN	O	[-1]	['none']	_	_
45	Herein	_	_	RB	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	we	_	_	PRP	O	[-1]	['none']	_	_
48	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
49	that	_	_	IN	O	[-1]	['none']	_	_
50	the	_	_	DT	O	[-1]	['none']	_	_
51	downregulatory	_	_	JJ	O	[-1]	['none']	_	_
52	effects	_	_	NNS	O	[-1]	['none']	_	_
53	of	_	_	IN	O	[-1]	['none']	_	_
54	PTX	_	_	NN	O	[-1]	['none']	_	_
55	in	_	_	IN	O	[-1]	['none']	_	_
56	human	_	_	NN	O	[-1]	['none']	_	_
57	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
58	cells	_	_	NNS	O	[-1]	['none']	_	_
59	involves	_	_	VBZ	O	[-1]	['none']	_	_
60	modulation	_	_	NN	O	[-1]	['none']	_	_
61	of	_	_	IN	O	[-1]	['none']	_	_
62	pathways	_	_	NNS	O	[-1]	['none']	_	_
63	that	_	_	WDT	O	[-1]	['none']	_	_
64	involve	_	_	VBP	O	[-1]	['none']	_	_
65	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
66	and	_	_	CC	O	[-1]	['none']	_	_
67	CREB	_	_	NN	O	[-1]	['none']	_	_
68	,	_	_	,	O	[-1]	['none']	_	_
69	two	_	_	CD	O	[-1]	['none']	_	_
70	major	_	_	JJ	O	[-1]	['none']	_	_
71	transcription	_	_	NN	O	[-1]	['none']	_	_
72	factors	_	_	NNS	O	[-1]	['none']	_	_
73	involved	_	_	VBN	O	[-1]	['none']	_	_
74	in	_	_	IN	O	[-1]	['none']	_	_
75	the	_	_	DT	O	[-1]	['none']	_	_
76	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
77	cascade	_	_	NN	O	[-1]	['none']	_	_
78	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	Rel	_	_	NN	O	[-1]	['none']	_	_
4	constitutes	_	_	VBZ	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	family	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
9	factors	_	_	NNS	O	[-1]	['none']	_	_
10	involved	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	regulation	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	numerous	_	_	JJ	O	[-1]	['none']	_	_
16	cytokine	_	_	NN	O	[-1]	['none']	_	_
17	genes	_	_	NNS	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	immune	_	_	JJ	O	[-1]	['none']	_	_
20	responses	_	_	NNS	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	different	_	_	JJ	O	[-1]	['none']	_	_
23	cell	_	_	NN	O	[-1]	['none']	_	_
24	populations	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	most	_	_	RBS	O	[-1]	['none']	_	_
3	abundant	_	_	JJ	O	[-1]	['none']	_	_
4	form	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	p50	_	_	NN	Protein	[0]	['root']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	p65	_	_	NN	Protein	[0]	['root']	_	_
12	heterodimer	_	_	NN	O	[-1]	['none']	_	_
13	.26	_	_	CD	O	[-1]	['none']	_	_
14	The	_	_	DT	O	[-1]	['none']	_	_
15	inactive	_	_	JJ	O	[-1]	['none']	_	_
16	form	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	exists	_	_	VBZ	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	cytoplasm	_	_	NN	O	[-1]	['none']	_	_
23	bound	_	_	VBD	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	an	_	_	DT	O	[-1]	['none']	_	_
26	inhibitory	_	_	JJ	O	[-1]	['none']	_	_
27	complex	_	_	NN	O	[-1]	['none']	_	_
28	containing	_	_	VBG	O	[-1]	['none']	_	_
29	I-kappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Following	_	_	VBG	O	[-1]	['none']	_	_
2	cellular	_	_	JJ	O	[-1]	['none']	_	_
3	stimulation	_	_	NN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	LPS	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	chemotactic	_	_	JJ	O	[-1]	['none']	_	_
8	factors	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	inducible	_	_	JJ	O	[-1]	['none']	_	_
12	kinase	_	_	NN	O	[-1]	['none']	_	_
13	phosphorylates	_	_	VBZ	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	activates	_	_	VBZ	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	I-kappaB	_	_	NN	O	[-1]	['none']	_	_
18	kinase	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	IKK	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	complex	_	_	NN	O	[-1]	['none']	_	_
23	consisting	_	_	VBG	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	IKK-1	_	_	NN	Protein	[0]	['root']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	IKK-2	_	_	NN	Protein	[0]	['root']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	which	_	_	WDT	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	turn	_	_	NN	O	[-1]	['none']	_	_
32	phosphorylates	_	_	VBZ	Phosphorylation	[0]	['root']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	I-kappaBalpha	_	_	NN	Protein	[32]	['Theme']	_	_
35	subunit	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	ubiquitination	_	_	NN	Ubiquitination	[0]	['root']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	subsequent	_	_	JJ	O	[-1]	['none']	_	_
7	degradation	_	_	NN	Protein_catabolism	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	I-kappaBalpha	_	_	NN	Protein	[1, 3, 7]	['Theme', 'Theme', 'Theme']	_	_
10	results	_	_	VBZ	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	nuclear	_	_	JJ	O	[-1]	['none']	_	_
14	translocation	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	allows	_	_	VBZ	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	transcription	_	_	NN	O	[-1]	['none']	_	_
5	factor	_	_	NN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	bind	_	_	VB	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	promoter	_	_	NN	O	[-1]	['none']	_	_
10	regions	_	_	NNS	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	specific	_	_	JJ	O	[-1]	['none']	_	_
13	pro	_	_	JJ	O	[-1]	['none']	_	_
14	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
15	genes	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	influence	_	_	VBP	O	[-1]	['none']	_	_
18	transcription	_	_	NN	O	[-1]	['none']	_	_
19	.27,28	_	_	CD	O	[-1]	['none']	_	_
20	Because	_	_	IN	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	number	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	potential	_	_	JJ	O	[-1]	['none']	_	_
25	kappaB	_	_	NN	O	[-1]	['none']	_	_
26	sites	_	_	NNS	O	[-1]	['none']	_	_
27	are	_	_	VBP	O	[-1]	['none']	_	_
28	present	_	_	JJ	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	nucleotide	_	_	NN	O	[-1]	['none']	_	_
32	sequences	_	_	NNS	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	TNF-alpha	_	_	NN	Protein	[0]	['root']	_	_
36	gene	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
39	is	_	_	VBZ	O	[-1]	['none']	_	_
40	considered	_	_	VBN	O	[-1]	['none']	_	_
41	to	_	_	TO	O	[-1]	['none']	_	_
42	be	_	_	VB	O	[-1]	['none']	_	_
43	a	_	_	DT	O	[-1]	['none']	_	_
44	critical	_	_	JJ	O	[-1]	['none']	_	_
45	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
46	factor	_	_	NN	O	[-1]	['none']	_	_
47	involved	_	_	VBN	Regulation	[0]	['root']	_	_
48	in	_	_	IN	O	[-1]	['none']	_	_
49	TNF-alpha	_	_	NN	Protein	[51]	['Theme']	_	_
50	gene	_	_	NN	Gene_expression	[51]	['multitoken']	_	_
51	expression	_	_	NN	Gene_expression	[47]	['Theme']	_	_
52	and	_	_	CC	O	[-1]	['none']	_	_
53	protein	_	_	NN	O	[-1]	['none']	_	_
54	synthesis	_	_	NN	O	[-1]	['none']	_	_
55	.29,30	_	_	CD	O	[-1]	['none']	_	_
56	In	_	_	IN	O	[-1]	['none']	_	_
57	this	_	_	DT	O	[-1]	['none']	_	_
58	set	_	_	NN	O	[-1]	['none']	_	_
59	of	_	_	IN	O	[-1]	['none']	_	_
60	experiments	_	_	NNS	O	[-1]	['none']	_	_
61	,	_	_	,	O	[-1]	['none']	_	_
62	we	_	_	PRP	O	[-1]	['none']	_	_
63	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
64	that	_	_	IN	O	[-1]	['none']	_	_
65	PTX	_	_	NN	O	[-1]	['none']	_	_
66	downregulates	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
67	cytoplasmic	_	_	JJ	O	[-1]	['none']	_	_
68	I-kappaBalpha	_	_	NN	Protein	[69]	['Theme']	_	_
69	phosphorylation	_	_	NN	Phosphorylation	[66]	['Theme']	_	_
70	,	_	_	,	O	[-1]	['none']	_	_
71	nuclear	_	_	JJ	O	[-1]	['none']	_	_
72	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
73	p65	_	_	NN	Protein	[74, 76]	['Theme', 'Theme']	_	_
74	phosphorylation	_	_	NN	Phosphorylation	[66]	['Theme']	_	_
75	and	_	_	CC	O	[-1]	['none']	_	_
76	translocation	_	_	NN	Localization	[66]	['Theme']	_	_
77	,	_	_	,	O	[-1]	['none']	_	_
78	as	_	_	RB	O	[-1]	['none']	_	_
79	well	_	_	RB	O	[-1]	['none']	_	_
80	as	_	_	IN	O	[-1]	['none']	_	_
81	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
82	DNA	_	_	NN	O	[-1]	['none']	_	_
83	binding	_	_	NN	O	[-1]	['none']	_	_
84	after	_	_	IN	O	[-1]	['none']	_	_
85	LPS	_	_	NN	O	[-1]	['none']	_	_
86	stimulation	_	_	NN	O	[-1]	['none']	_	_
87	,	_	_	,	O	[-1]	['none']	_	_
88	suggesting	_	_	VBG	O	[-1]	['none']	_	_
89	that	_	_	IN	O	[-1]	['none']	_	_
90	PTX	_	_	NN	O	[-1]	['none']	_	_
91	exerts	_	_	VBZ	O	[-1]	['none']	_	_
92	its	_	_	PRP$	O	[-1]	['none']	_	_
93	function	_	_	NN	O	[-1]	['none']	_	_
94	proximal	_	_	JJ	O	[-1]	['none']	_	_
95	to	_	_	TO	O	[-1]	['none']	_	_
96	or	_	_	CC	O	[-1]	['none']	_	_
97	at	_	_	IN	O	[-1]	['none']	_	_
98	the	_	_	DT	O	[-1]	['none']	_	_
99	level	_	_	NN	O	[-1]	['none']	_	_
100	of	_	_	IN	O	[-1]	['none']	_	_
101	I-kappaBalpha	_	_	NN	Protein	[102]	['Theme']	_	_
102	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
103	.	_	_	.	O	[-1]	['none']	_	_

1	Previous	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	that	_	_	WDT	O	[-1]	['none']	_	_
4	have	_	_	VBP	O	[-1]	['none']	_	_
5	evaluated	_	_	VBN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	effects	_	_	NNS	Regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	cAMP	_	_	NN	O	[-1]	['none']	_	_
10	elevating	_	_	VBG	O	[-1]	['none']	_	_
11	drugs	_	_	NNS	O	[-1]	['none']	_	_
12	on	_	_	IN	O	[-1]	['none']	_	_
13	I-kappaBalpha	_	_	NN	Protein	[7]	['Theme']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	have	_	_	VBP	O	[-1]	['none']	_	_
17	reported	_	_	VBN	O	[-1]	['none']	_	_
18	conflicting	_	_	JJ	O	[-1]	['none']	_	_
19	results	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Haddad	_	_	NNP	O	[-1]	['none']	_	_
2	et	_	_	FW	O	[-1]	['none']	_	_
3	al.	_	_	FW	O	[-1]	['none']	_	_
4	reported	_	_	VBN	O	[-1]	['none']	_	_
5	results	_	_	NNS	O	[-1]	['none']	_	_
6	similar	_	_	JJ	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	ours	_	_	JJ	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	respect	_	_	NN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	effects	_	_	NNS	Regulation	[0]	['root']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	PTX	_	_	NN	O	[-1]	['none']	_	_
16	on	_	_	IN	O	[-1]	['none']	_	_
17	I-kappaBalpha	_	_	NN	Protein	[13]	['Theme']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	pulmonary	_	_	JJ	O	[-1]	['none']	_	_
22	epithelial	_	_	JJ	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	.31	_	_	CD	O	[-1]	['none']	_	_
25	Conversely	_	_	RB	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	Neumann	_	_	NNP	O	[-1]	['none']	_	_
28	et	_	_	FW	O	[-1]	['none']	_	_
29	al.	_	_	FW	O	[-1]	['none']	_	_
30	proposed	_	_	VBN	O	[-1]	['none']	_	_
31	that	_	_	IN	O	[-1]	['none']	_	_
32	increased	_	_	VBN	O	[-1]	['none']	_	_
33	intracellular	_	_	JJ	O	[-1]	['none']	_	_
34	cAMP	_	_	NN	O	[-1]	['none']	_	_
35	stabilizes	_	_	VBZ	Regulation	[0]	['root']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	interaction	_	_	NN	Binding	[35]	['Theme']	_	_
38	between	_	_	IN	O	[-1]	['none']	_	_
39	I-kappaBalpha	_	_	NN	Protein	[37]	['Theme']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	therefore	_	_	RB	O	[-1]	['none']	_	_
44	reducing	_	_	VBG	O	[-1]	['none']	_	_
45	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
46	activation	_	_	NN	O	[-1]	['none']	_	_
47	.32	_	_	CD	O	[-1]	['none']	_	_
48	In	_	_	IN	O	[-1]	['none']	_	_
49	contrast	_	_	NN	O	[-1]	['none']	_	_
50	,	_	_	,	O	[-1]	['none']	_	_
51	Takahashi	_	_	NNP	O	[-1]	['none']	_	_
52	et	_	_	FW	O	[-1]	['none']	_	_
53	al.	_	_	FW	O	[-1]	['none']	_	_
54	showed	_	_	VBD	O	[-1]	['none']	_	_
55	no	_	_	DT	O	[-1]	['none']	_	_
56	difference	_	_	NN	O	[-1]	['none']	_	_
57	in	_	_	IN	O	[-1]	['none']	_	_
58	I-kappaBalpha	_	_	NN	Protein	[59]	['Theme']	_	_
59	degradation	_	_	NN	Protein_catabolism	[65, 67]	['Theme', 'Theme']	_	_
60	in	_	_	IN	O	[-1]	['none']	_	_
61	Jurkat	_	_	NN	O	[-1]	['none']	_	_
62	T-lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
63	in	_	_	IN	O	[-1]	['none']	_	_
64	the	_	_	DT	O	[-1]	['none']	_	_
65	presence	_	_	NN	Regulation	[0]	['root']	_	_
66	and	_	_	CC	O	[-1]	['none']	_	_
67	absence	_	_	NN	Regulation	[0]	['root']	_	_
68	of	_	_	IN	O	[-1]	['none']	_	_
69	forskolin	_	_	NN	O	[-1]	['none']	_	_
70	,	_	_	,	O	[-1]	['none']	_	_
71	an	_	_	DT	O	[-1]	['none']	_	_
72	alternative	_	_	JJ	O	[-1]	['none']	_	_
73	cAMP	_	_	NN	O	[-1]	['none']	_	_
74	inducing	_	_	VBG	O	[-1]	['none']	_	_
75	compound	_	_	NN	O	[-1]	['none']	_	_
76	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	group	_	_	NN	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	forskolin	_	_	NN	O	[-1]	['none']	_	_
7	did	_	_	VBD	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	inhibit	_	_	VB	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	DNA	_	_	NN	O	[-1]	['none']	_	_
12	binding	_	_	NN	O	[-1]	['none']	_	_
13	activity	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	that	_	_	IN	O	[-1]	['none']	_	_
18	CREB	_	_	NN	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	not	_	_	RB	O	[-1]	['none']	_	_
21	involved	_	_	VBN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	forskolin	_	_	NN	O	[-1]	['none']	_	_
24	induced	_	_	VBD	O	[-1]	['none']	_	_
25	decrease	_	_	NN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	p65	_	_	NN	Protein	[0]	['root']	_	_
28	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
29	activity	_	_	NN	O	[-1]	['none']	_	_
30	.33	_	_	CD	O	[-1]	['none']	_	_
31	Similar	_	_	JJ	O	[-1]	['none']	_	_
32	results	_	_	NNS	O	[-1]	['none']	_	_
33	were	_	_	VBD	O	[-1]	['none']	_	_
34	reported	_	_	VBN	O	[-1]	['none']	_	_
35	by	_	_	IN	O	[-1]	['none']	_	_
36	Ollivier	_	_	NNP	O	[-1]	['none']	_	_
37	et	_	_	FW	O	[-1]	['none']	_	_
38	al.	_	_	FW	O	[-1]	['none']	_	_
39	using	_	_	VBG	O	[-1]	['none']	_	_
40	THP-1	_	_	NN	O	[-1]	['none']	_	_
41	cells	_	_	NNS	O	[-1]	['none']	_	_
42	and	_	_	CC	O	[-1]	['none']	_	_
43	endothelial	_	_	JJ	O	[-1]	['none']	_	_
44	cells	_	_	NNS	O	[-1]	['none']	_	_
45	treated	_	_	VBN	O	[-1]	['none']	_	_
46	with	_	_	IN	O	[-1]	['none']	_	_
47	forskolin	_	_	NN	O	[-1]	['none']	_	_
48	or	_	_	CC	O	[-1]	['none']	_	_
49	dibutyryl	_	_	NN	O	[-1]	['none']	_	_
50	cAMP	_	_	NN	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	two	_	_	CD	O	[-1]	['none']	_	_
53	agents	_	_	NNS	O	[-1]	['none']	_	_
54	known	_	_	VBN	O	[-1]	['none']	_	_
55	to	_	_	TO	O	[-1]	['none']	_	_
56	function	_	_	VB	O	[-1]	['none']	_	_
57	through	_	_	IN	O	[-1]	['none']	_	_
58	cAMP	_	_	NN	O	[-1]	['none']	_	_
59	elevation	_	_	NN	O	[-1]	['none']	_	_
60	and	_	_	CC	O	[-1]	['none']	_	_
61	subsequent	_	_	JJ	O	[-1]	['none']	_	_
62	PKA	_	_	NN	O	[-1]	['none']	_	_
63	activation	_	_	NN	O	[-1]	['none']	_	_
64	.9	_	_	CD	O	[-1]	['none']	_	_
65	The	_	_	DT	O	[-1]	['none']	_	_
66	differences	_	_	NNS	O	[-1]	['none']	_	_
67	between	_	_	IN	O	[-1]	['none']	_	_
68	our	_	_	PRP$	O	[-1]	['none']	_	_
69	results	_	_	NNS	O	[-1]	['none']	_	_
70	and	_	_	CC	O	[-1]	['none']	_	_
71	those	_	_	DT	O	[-1]	['none']	_	_
72	mentioned	_	_	VBN	O	[-1]	['none']	_	_
73	above	_	_	IN	O	[-1]	['none']	_	_
74	may	_	_	MD	O	[-1]	['none']	_	_
75	be	_	_	VB	O	[-1]	['none']	_	_
76	explained	_	_	VBN	O	[-1]	['none']	_	_
77	by	_	_	IN	O	[-1]	['none']	_	_
78	the	_	_	DT	O	[-1]	['none']	_	_
79	use	_	_	NN	O	[-1]	['none']	_	_
80	of	_	_	IN	O	[-1]	['none']	_	_
81	different	_	_	JJ	O	[-1]	['none']	_	_
82	cell	_	_	NN	O	[-1]	['none']	_	_
83	types	_	_	NNS	O	[-1]	['none']	_	_
84	and	_	_	CC	O	[-1]	['none']	_	_
85	exogenous	_	_	JJ	O	[-1]	['none']	_	_
86	stimulants	_	_	NNS	O	[-1]	['none']	_	_
87	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	possible	_	_	JJ	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	PTX	_	_	NN	O	[-1]	['none']	_	_
7	exerts	_	_	VBZ	O	[-1]	['none']	_	_
8	its	_	_	PRP$	O	[-1]	['none']	_	_
9	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
10	effects	_	_	NNS	O	[-1]	['none']	_	_
11	on	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	pathway	_	_	NN	O	[-1]	['none']	_	_
15	independent	_	_	JJ	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	PKA	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	suggested	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	continued	_	_	JJ	O	[-1]	['none']	_	_
24	attenuation	_	_	NN	Negative_regulation	[36]	['Theme']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	LPS	_	_	NN	O	[-1]	['none']	_	_
27	induced	_	_	VBD	Positive_regulation	[24]	['Theme']	_	_
28	TNF-alpha	_	_	NN	Protein	[29]	['Theme']	_	_
29	production	_	_	NN	Gene_expression	[27]	['Theme']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	PTX	_	_	NN	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	presence	_	_	NN	Regulation	[36]	['multitoken']	_	_
35	or	_	_	CC	Regulation	[36]	['multitoken']	_	_
36	absence	_	_	NN	Regulation	[0]	['root']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	PKA	_	_	NN	O	[-1]	['none']	_	_
39	inhibition	_	_	NN	O	[-1]	['none']	_	_
40	observed	_	_	VBN	O	[-1]	['none']	_	_
41	in	_	_	IN	O	[-1]	['none']	_	_
42	this	_	_	DT	O	[-1]	['none']	_	_
43	study	_	_	NN	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	hypothesis	_	_	NN	O	[-1]	['none']	_	_
3	is	_	_	VBZ	O	[-1]	['none']	_	_
4	currently	_	_	RB	O	[-1]	['none']	_	_
5	under	_	_	IN	O	[-1]	['none']	_	_
6	investigation	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	our	_	_	PRP$	O	[-1]	['none']	_	_
9	laboratory	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	utilized	_	_	VBD	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	broad	_	_	JJ	O	[-1]	['none']	_	_
7	PKA	_	_	NN	O	[-1]	['none']	_	_
8	inhibitor	_	_	NN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	this	_	_	DT	O	[-1]	['none']	_	_
11	study	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	addition	_	_	NN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	H89	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	but	_	_	CC	O	[-1]	['none']	_	_
18	did	_	_	VBD	O	[-1]	['none']	_	_
19	not	_	_	RB	O	[-1]	['none']	_	_
20	examine	_	_	VB	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	effect	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	specific	_	_	JJ	O	[-1]	['none']	_	_
25	inhibition	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	various	_	_	JJ	O	[-1]	['none']	_	_
28	PKA	_	_	NN	O	[-1]	['none']	_	_
29	isoforms	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	information	_	_	NN	O	[-1]	['none']	_	_
3	may	_	_	MD	O	[-1]	['none']	_	_
4	yield	_	_	VB	O	[-1]	['none']	_	_
5	more	_	_	JJR	O	[-1]	['none']	_	_
6	insight	_	_	NN	O	[-1]	['none']	_	_
7	into	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	mechanism	_	_	NN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	which	_	_	WDT	O	[-1]	['none']	_	_
12	PTX	_	_	NN	O	[-1]	['none']	_	_
13	exerts	_	_	VBZ	O	[-1]	['none']	_	_
14	its	_	_	PRP$	O	[-1]	['none']	_	_
15	down-regulatory	_	_	JJ	O	[-1]	['none']	_	_
16	effects	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	PDE	_	_	NN	O	[-1]	['none']	_	_
2	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
3	may	_	_	MD	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	downregulate	_	_	VB	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
8	activity	_	_	NN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	altering	_	_	VBG	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	competitive	_	_	JJ	O	[-1]	['none']	_	_
13	binding	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	CREB	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	promoter	_	_	NN	O	[-1]	['none']	_	_
21	regions	_	_	NNS	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	pro	_	_	JJ	O	[-1]	['none']	_	_
24	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
25	genes	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Herein	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	showed	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	DNA	_	_	NN	O	[-1]	['none']	_	_
10	binding	_	_	NN	O	[-1]	['none']	_	_
11	activity	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	CREB	_	_	NN	O	[-1]	['none']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	upregulated	_	_	VBN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	dose	_	_	NN	O	[-1]	['none']	_	_
19	dependent	_	_	JJ	O	[-1]	['none']	_	_
20	manner	_	_	NN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	PTX	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Of	_	_	IN	O	[-1]	['none']	_	_
2	note	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	increase	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	CREB	_	_	NN	O	[-1]	['none']	_	_
8	activity	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	slightly	_	_	RB	O	[-1]	['none']	_	_
11	alleviated	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	addition	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	LPS	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	suggesting	_	_	VBG	O	[-1]	['none']	_	_
19	competition	_	_	NN	O	[-1]	['none']	_	_
20	between	_	_	IN	O	[-1]	['none']	_	_
21	PTX	_	_	NN	O	[-1]	['none']	_	_
22	induced	_	_	VBD	O	[-1]	['none']	_	_
23	CREB	_	_	NN	O	[-1]	['none']	_	_
24	associated	_	_	VBN	O	[-1]	['none']	_	_
25	gene	_	_	NN	O	[-1]	['none']	_	_
26	transcription	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	those	_	_	DT	O	[-1]	['none']	_	_
29	factors	_	_	NNS	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	such	_	_	JJ	O	[-1]	['none']	_	_
32	as	_	_	IN	O	[-1]	['none']	_	_
33	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	which	_	_	WDT	O	[-1]	['none']	_	_
36	may	_	_	MD	O	[-1]	['none']	_	_
37	be	_	_	VB	O	[-1]	['none']	_	_
38	upregulated	_	_	VBN	O	[-1]	['none']	_	_
39	by	_	_	IN	O	[-1]	['none']	_	_
40	LPS	_	_	NN	O	[-1]	['none']	_	_
41	exposure	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	competition	_	_	NN	O	[-1]	['none']	_	_
3	has	_	_	VBZ	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	postulated	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	involve	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	recruitment	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	co-activator	_	_	NN	O	[-1]	['none']	_	_
13	CBP	_	_	NN	Protein	[0]	['root']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	its	_	_	PRP$	O	[-1]	['none']	_	_
16	homologue	_	_	NN	O	[-1]	['none']	_	_
17	p30034	_	_	NN	Protein	[0]	['root']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	suggesting	_	_	VBG	O	[-1]	['none']	_	_
20	an	_	_	DT	O	[-1]	['none']	_	_
21	alternative	_	_	JJ	O	[-1]	['none']	_	_
22	mechanism	_	_	NN	O	[-1]	['none']	_	_
23	that	_	_	WDT	O	[-1]	['none']	_	_
24	may	_	_	MD	O	[-1]	['none']	_	_
25	be	_	_	VB	O	[-1]	['none']	_	_
26	involved	_	_	VBN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
30	actions	_	_	NNS	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	PTX	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Future	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	planned	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	delineate	_	_	VB	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	validity	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	this	_	_	DT	O	[-1]	['none']	_	_
11	potential	_	_	JJ	O	[-1]	['none']	_	_
12	mechanism	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	effects	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	PTX	_	_	NN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	other	_	_	JJ	O	[-1]	['none']	_	_
7	transcription	_	_	NN	O	[-1]	['none']	_	_
8	factors	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	such	_	_	JJ	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	AP-1	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	c-fos	_	_	NN	Protein	[0]	['root']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	c-jun	_	_	NN	Protein	[0]	['root']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	can	_	_	MD	O	[-1]	['none']	_	_
20	not	_	_	RB	O	[-1]	['none']	_	_
21	be	_	_	VB	O	[-1]	['none']	_	_
22	ruled	_	_	VBN	O	[-1]	['none']	_	_
23	out	_	_	RP	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	our	_	_	PRP$	O	[-1]	['none']	_	_
26	experiments	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	AP-1	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	its	_	_	PRP$	Anaphora	[6]	['multitoken']	_	_
6	components	_	_	NNS	Anaphora	[0]	['root']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	c-fos	_	_	NN	Protein	[1]	['Theme']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	c-jun	_	_	NN	Protein	[1]	['Theme']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	agents	_	_	NNS	O	[-1]	['none']	_	_
14	that	_	_	WDT	O	[-1]	['none']	_	_
15	enhance	_	_	VBP	O	[-1]	['none']	_	_
16	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
17	cell	_	_	NN	O	[-1]	['none']	_	_
18	activity	_	_	NN	O	[-1]	['none']	_	_
19	has	_	_	VBZ	O	[-1]	['none']	_	_
20	been	_	_	VBN	O	[-1]	['none']	_	_
21	implicated	_	_	VBN	Regulation	[0]	['root']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	TNF-alpha	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[21]	['Theme']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Moreover	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	AP-1	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	CREB	_	_	NN	O	[-1]	['none']	_	_
6	recognize	_	_	VBP	Binding	[0]	['root']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	similar	_	_	JJ	O	[-1]	['none']	_	_
9	DNA	_	_	NN	Entity	[11]	['multitoken']	_	_
10	binding	_	_	NN	Entity	[11]	['multitoken']	_	_
11	sequence	_	_	NN	Entity	[6]	['Site']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	promoter	_	_	NN	O	[-1]	['none']	_	_
15	region	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	TNF-alpha	_	_	NN	Protein	[6]	['Theme']	_	_
19	gene35	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Given	_	_	VBN	O	[-1]	['none']	_	_
2	these	_	_	DT	O	[-1]	['none']	_	_
3	relationships	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	it	_	_	PRP	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	conceivable	_	_	JJ	O	[-1]	['none']	_	_
8	that	_	_	IN	O	[-1]	['none']	_	_
9	PTX	_	_	NN	O	[-1]	['none']	_	_
10	may	_	_	MD	O	[-1]	['none']	_	_
11	exert	_	_	VB	O	[-1]	['none']	_	_
12	some	_	_	DT	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	its	_	_	PRP$	O	[-1]	['none']	_	_
15	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
16	actions	_	_	NNS	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	affecting	_	_	VBG	O	[-1]	['none']	_	_
19	AP-1	_	_	NN	O	[-1]	['none']	_	_
20	activation	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	favoring	_	_	VBG	O	[-1]	['none']	_	_
23	CREB	_	_	NN	O	[-1]	['none']	_	_
24	binding	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	thus	_	_	RB	O	[-1]	['none']	_	_
27	inhibiting	_	_	VBG	Negative_regulation	[0]	['root']	_	_
28	TNF-alpha	_	_	NN	Protein	[30]	['Theme']	_	_
29	gene	_	_	NN	O	[-1]	['none']	_	_
30	transcription	_	_	NN	Transcription	[27]	['Theme']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Additional	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	necessary	_	_	JJ	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	elucidate	_	_	VB	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	complex	_	_	JJ	O	[-1]	['none']	_	_
9	interactions	_	_	NNS	O	[-1]	['none']	_	_
10	between	_	_	IN	O	[-1]	['none']	_	_
11	CREB	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	AP-1	_	_	NN	O	[-1]	['none']	_	_
17	following	_	_	VBG	O	[-1]	['none']	_	_
18	LPS	_	_	NN	O	[-1]	['none']	_	_
19	exposure	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	PDE	_	_	NN	O	[-1]	['none']	_	_
22	inhibition	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	effect	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	PTX	_	_	NN	O	[-1]	['none']	_	_
7	on	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	cGMP	_	_	NN	O	[-1]	['none']	_	_
10	pathway	_	_	NN	O	[-1]	['none']	_	_
11	after	_	_	IN	O	[-1]	['none']	_	_
12	LPS	_	_	NN	O	[-1]	['none']	_	_
13	stimulation	_	_	NN	O	[-1]	['none']	_	_
14	has	_	_	VBZ	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	been	_	_	VBN	O	[-1]	['none']	_	_
17	explored	_	_	VBN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	although	_	_	IN	O	[-1]	['none']	_	_
20	we	_	_	PRP	O	[-1]	['none']	_	_
21	plan	_	_	VBP	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	do	_	_	VB	O	[-1]	['none']	_	_
24	so	_	_	RB	O	[-1]	['none']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	future	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	summary	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	we	_	_	PRP	O	[-1]	['none']	_	_
5	have	_	_	VBP	O	[-1]	['none']	_	_
6	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	PDE	_	_	NN	O	[-1]	['none']	_	_
9	inhibition	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	human	_	_	NN	O	[-1]	['none']	_	_
12	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	downregulates	_	_	VBZ	Negative_regulation	[26]	['Theme']	_	_
15	TNF-alpha	_	_	NN	Protein	[16]	['Theme']	_	_
16	production	_	_	NN	Gene_expression	[14]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	at	_	_	IN	O	[-1]	['none']	_	_
19	least	_	_	JJS	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	part	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	through	_	_	IN	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	PKA	_	_	NN	O	[-1]	['none']	_	_
26	independent	_	_	JJ	Regulation	[0]	['root']	_	_
27	mechanism	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	PTX	_	_	NN	O	[-1]	['none']	_	_
5	attenuates	_	_	VBZ	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	activity	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-B	_	_	NN	O	[-1]	['none']	_	_
10	while	_	_	IN	O	[-1]	['none']	_	_
11	upregulating	_	_	VBG	O	[-1]	['none']	_	_
12	CREB	_	_	NN	O	[-1]	['none']	_	_
13	activation	_	_	NN	O	[-1]	['none']	_	_
14	after	_	_	IN	O	[-1]	['none']	_	_
15	LPS	_	_	NN	O	[-1]	['none']	_	_
16	stimulation	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	which	_	_	WDT	O	[-1]	['none']	_	_
19	may	_	_	MD	O	[-1]	['none']	_	_
20	result	_	_	VB	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	modulation	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	pro	_	_	JJ	O	[-1]	['none']	_	_
25	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
26	mediator	_	_	NN	O	[-1]	['none']	_	_
27	synthesis	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	PTX	_	_	NN	O	[-1]	['none']	_	_
4	may	_	_	MD	O	[-1]	['none']	_	_
5	serve	_	_	VB	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	potential	_	_	JJ	O	[-1]	['none']	_	_
9	adjunct	_	_	NN	O	[-1]	['none']	_	_
10	therapeutic	_	_	JJ	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	treatment	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	conditions	_	_	NNS	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	which	_	_	WDT	O	[-1]	['none']	_	_
18	TNF-alpha	_	_	NN	Protein	[19]	['Theme']	_	_
19	production	_	_	NN	Gene_expression	[0]	['root']	_	_
20	plays	_	_	VBZ	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	significant	_	_	JJ	O	[-1]	['none']	_	_
23	role	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	inhibition	_	_	NN	O	[-1]	['none']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	PMA	_	_	NN	O	[-1]	['none']	_	_
5	correlated	_	_	VBD	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	PKC	_	_	NN	O	[-1]	['none']	_	_
8	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
9	Bcl10	_	_	NN	Protein	[10]	['Theme']	_	_
10	degradation	_	_	NN	Protein_catabolism	[8]	['Theme']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Levels	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	intracellular	_	_	JJ	O	[-1]	['none']	_	_
4	protein	_	_	NN	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	assessed	_	_	VBN	O	[-1]	['none']	_	_
7	following	_	_	VBG	O	[-1]	['none']	_	_
8	24	_	_	CD	O	[-1]	['none']	_	_
9	h	_	_	NN	O	[-1]	['none']	_	_
10	stimulation	_	_	NN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	162	_	_	CD	O	[-1]	['none']	_	_
15	nM	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	HK	_	_	NNP	O	[-1]	['none']	_	_
19	E.	_	_	FW	O	[-1]	['none']	_	_
20	coli	_	_	FW	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	5	_	_	CD	O	[-1]	['none']	_	_
23	x	_	_	CC	O	[-1]	['none']	_	_
24	107	_	_	CD	O	[-1]	['none']	_	_
25	CFU/ml	_	_	NN	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Phospho-PKC	_	_	NN	O	[-1]	['none']	_	_
5	increased	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	response	_	_	NN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	PMA	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	HK	_	_	NNP	O	[-1]	['none']	_	_
12	E.	_	_	NNP	O	[-1]	['none']	_	_
13	coli	_	_	NN	O	[-1]	['none']	_	_
14	stimulation	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	IkappaB	_	_	NN	O	[-1]	['none']	_	_
5	decreased	_	_	VBD	O	[-1]	['none']	_	_
6	following	_	_	VBG	O	[-1]	['none']	_	_
7	stimulation	_	_	NN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	HK	_	_	NNP	O	[-1]	['none']	_	_
10	E.	_	_	NNP	O	[-1]	['none']	_	_
11	coli	_	_	NN	O	[-1]	['none']	_	_
12	indicating	_	_	VBG	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Bcl10	_	_	NN	Protein	[5]	['Theme']	_	_
5	activation	_	_	NN	Positive_regulation	[7]	['Theme']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	inhibited	_	_	VBN	Negative_regulation	[0]	['root']	_	_
8	following	_	_	VBG	O	[-1]	['none']	_	_
9	long-term	_	_	JJ	O	[-1]	['none']	_	_
10	stimulation	_	_	NN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	which	_	_	WDT	O	[-1]	['none']	_	_
15	explains	_	_	VBZ	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	inhibitory	_	_	JJ	O	[-1]	['none']	_	_
18	effect	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	PMA	_	_	NN	O	[-1]	['none']	_	_
21	on	_	_	IN	O	[-1]	['none']	_	_
22	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
23	activation	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	beta-actin	_	_	NN	Protein	[0]	['root']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	loading	_	_	VBG	O	[-1]	['none']	_	_
7	control	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	n	_	_	NN	O	[-1]	['none']	_	_
3	=	_	_	JJ	O	[-1]	['none']	_	_
4	3	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	Stimulated	_	_	NN	O	[-1]	['none']	_	_
2	cpdm	_	_	NN	O	[-1]	['none']	_	_
3	BMDC	_	_	NN	O	[-1]	['none']	_	_
4	induced	_	_	VBD	O	[-1]	['none']	_	_
5	Th2	_	_	NN	O	[-1]	['none']	_	_
6	biased	_	_	VBN	O	[-1]	['none']	_	_
7	cytokine	_	_	NN	O	[-1]	['none']	_	_
8	production	_	_	NN	O	[-1]	['none']	_	_
9	from	_	_	IN	O	[-1]	['none']	_	_
10	naive	_	_	JJ	O	[-1]	['none']	_	_
11	CD4+	_	_	JJ	O	[-1]	['none']	_	_
12	T	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	WT	_	_	JJ	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	cpdm	_	_	JJ	O	[-1]	['none']	_	_
4	BMDC	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	5x104	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	0.1	_	_	CD	O	[-1]	['none']	_	_
10	mL	_	_	NN	O	[-1]	['none']	_	_
11	complete	_	_	JJ	O	[-1]	['none']	_	_
12	medium	_	_	NN	O	[-1]	['none']	_	_
13	;	_	_	:	O	[-1]	['none']	_	_
14	MHC	_	_	NN	O	[-1]	['none']	_	_
15	haplotype	_	_	NN	O	[-1]	['none']	_	_
16	:	_	_	:	O	[-1]	['none']	_	_
17	H-2b	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	were	_	_	VBD	O	[-1]	['none']	_	_
20	incubated	_	_	VBN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	medium	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	100	_	_	CD	O	[-1]	['none']	_	_
25	ng/mL	_	_	NN	O	[-1]	['none']	_	_
26	LPS	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	25	_	_	CD	O	[-1]	['none']	_	_
29	microg/mL	_	_	NN	O	[-1]	['none']	_	_
30	poly	_	_	NN	O	[-1]	['none']	_	_
31	I	_	_	NN	O	[-1]	['none']	_	_
32	:	_	_	:	O	[-1]	['none']	_	_
33	C	_	_	NN	O	[-1]	['none']	_	_
34	or	_	_	CC	O	[-1]	['none']	_	_
35	5	_	_	CD	O	[-1]	['none']	_	_
36	microg/mL	_	_	NN	O	[-1]	['none']	_	_
37	Pam3CYS	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	24	_	_	CD	O	[-1]	['none']	_	_
3	hours	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	washed	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	PBS	_	_	NNP	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	incubated	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	freshly	_	_	RB	O	[-1]	['none']	_	_
14	isolated	_	_	VBN	O	[-1]	['none']	_	_
15	allogeneic	_	_	JJ	O	[-1]	['none']	_	_
16	naive	_	_	JJ	O	[-1]	['none']	_	_
17	CD4+	_	_	JJ	O	[-1]	['none']	_	_
18	T	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	2.5	_	_	CD	O	[-1]	['none']	_	_
22	x105	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	0.1	_	_	CD	O	[-1]	['none']	_	_
26	mL	_	_	NN	O	[-1]	['none']	_	_
27	complete	_	_	JJ	O	[-1]	['none']	_	_
28	medium	_	_	NN	O	[-1]	['none']	_	_
29	;	_	_	:	O	[-1]	['none']	_	_
30	MHC	_	_	NN	O	[-1]	['none']	_	_
31	haplotype	_	_	NN	O	[-1]	['none']	_	_
32	:	_	_	:	O	[-1]	['none']	_	_
33	H-2d	_	_	NN	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	5	_	_	CD	O	[-1]	['none']	_	_
3	days	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	supernatants	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	collected	_	_	VBN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	secretion	_	_	NN	Gene_expression	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	IFNgamma	_	_	NN	Protein	[10]	['Theme']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	IL4	_	_	NN	Protein	[10]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	IL2	_	_	NN	Protein	[10]	['Theme']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	measured	_	_	VBN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	ELISA	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Negative	_	_	JJ	O	[-1]	['none']	_	_
2	controls	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	1	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	stimulated	_	_	VBN	O	[-1]	['none']	_	_
7	BMDC	_	_	NN	O	[-1]	['none']	_	_
8	without	_	_	IN	O	[-1]	['none']	_	_
9	co-culture	_	_	NN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	allogeneic	_	_	JJ	O	[-1]	['none']	_	_
12	CD4+	_	_	JJ	O	[-1]	['none']	_	_
13	T	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	2	_	_	CD	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	allogeneic	_	_	JJ	O	[-1]	['none']	_	_
19	CD4+	_	_	JJ	O	[-1]	['none']	_	_
20	T	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	without	_	_	IN	O	[-1]	['none']	_	_
23	co-culture	_	_	NN	O	[-1]	['none']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	stimulated	_	_	VBN	O	[-1]	['none']	_	_
26	BMDC	_	_	NNP	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Samples	_	_	NNS	O	[-1]	['none']	_	_
2	from	_	_	IN	O	[-1]	['none']	_	_
3	both	_	_	DT	O	[-1]	['none']	_	_
4	negative	_	_	JJ	O	[-1]	['none']	_	_
5	controls	_	_	NNS	O	[-1]	['none']	_	_
6	had	_	_	VBD	O	[-1]	['none']	_	_
7	no	_	_	DT	O	[-1]	['none']	_	_
8	detectable	_	_	JJ	O	[-1]	['none']	_	_
9	production	_	_	NN	Gene_expression	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	Anaphora	[13]	['multitoken']	_	_
12	aforementioned	_	_	JJ	Anaphora	[13]	['multitoken']	_	_
13	cytokines	_	_	NNS	Anaphora	[0]	['root']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	shown	_	_	VBN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Results	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	analyzed	_	_	VBN	O	[-1]	['none']	_	_
4	based	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	2-4	_	_	CD	O	[-1]	['none']	_	_
7	mice	_	_	NNS	O	[-1]	['none']	_	_
8	per	_	_	IN	O	[-1]	['none']	_	_
9	group	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	*	_	_	SYM	O	[-1]	['none']	_	_
2	P	_	_	NN	O	[-1]	['none']	_	_
3	<	_	_	JJR	O	[-1]	['none']	_	_
4	0.05	_	_	CD	O	[-1]	['none']	_	_
5	.	_	_	.	O	[-1]	['none']	_	_

1	Real-time	_	_	JJ	O	[-1]	['none']	_	_
2	PCR	_	_	NN	O	[-1]	['none']	_	_
3	.	_	_	.	O	[-1]	['none']	_	_

1	Real-time	_	_	JJ	O	[-1]	['none']	_	_
2	PCR	_	_	NN	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	Tax	_	_	NN	Protein	[0]	['root']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	proviral	_	_	JJ	O	[-1]	['none']	_	_
10	load	_	_	NN	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	performed	_	_	VBN	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	previously	_	_	RB	O	[-1]	['none']	_	_
15	described	_	_	VBN	O	[-1]	['none']	_	_
16	[	_	_	CD	O	[-1]	['none']	_	_
17	47,50	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	DNA	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	extracted	_	_	VBN	O	[-1]	['none']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	1	_	_	CD	O	[-1]	['none']	_	_
6	x	_	_	CC	O	[-1]	['none']	_	_
7	106	_	_	CD	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	using	_	_	VBG	O	[-1]	['none']	_	_
10	Puregene	_	_	JJ	O	[-1]	['none']	_	_
11	DNA	_	_	NN	O	[-1]	['none']	_	_
12	Isolation	_	_	NN	O	[-1]	['none']	_	_
13	Kit	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Gentra	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	Minneapolis	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	Minnesota	_	_	NNP	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	United	_	_	NNP	O	[-1]	['none']	_	_
22	States	_	_	NNPS	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	100	_	_	CD	O	[-1]	['none']	_	_
27	ng	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	sample	_	_	NN	O	[-1]	['none']	_	_
31	DNA	_	_	NN	O	[-1]	['none']	_	_
32	solution	_	_	NN	O	[-1]	['none']	_	_
33	was	_	_	VBD	O	[-1]	['none']	_	_
34	analyzed	_	_	VBN	O	[-1]	['none']	_	_
35	by	_	_	IN	O	[-1]	['none']	_	_
36	this	_	_	DT	O	[-1]	['none']	_	_
37	system	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
3	proviral	_	_	JJ	O	[-1]	['none']	_	_
4	DNA	_	_	NN	O	[-1]	['none']	_	_
5	load	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	calculated	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	following	_	_	VBG	O	[-1]	['none']	_	_
11	formula	_	_	NN	O	[-1]	['none']	_	_
12	:	_	_	:	O	[-1]	['none']	_	_
13	copy	_	_	NN	O	[-1]	['none']	_	_
14	number	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	pX	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	per	_	_	IN	O	[-1]	['none']	_	_
21	100	_	_	CD	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	=	_	_	JJ	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	copy	_	_	NN	O	[-1]	['none']	_	_
26	number	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	pX	_	_	NN	O	[-1]	['none']	_	_
29	)/(	_	_	CD	O	[-1]	['none']	_	_
30	copy	_	_	NN	O	[-1]	['none']	_	_
31	number	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	beta-actin/2	_	_	NN	Protein	[0]	['root']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	x	_	_	CC	O	[-1]	['none']	_	_
36	100	_	_	CD	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	JNK	_	_	NN	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	assays	_	_	NNS	O	[-1]	['none']	_	_
6	For	_	_	IN	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	CD40	_	_	NN	Protein	[0]	['root']	_	_
10	signaling	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	5x104	_	_	NN	O	[-1]	['none']	_	_
13	HI5	_	_	NN	O	[-1]	['none']	_	_
14	insect	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	or	_	_	CC	O	[-1]	['none']	_	_
17	HI5	_	_	NN	O	[-1]	['none']	_	_
18	insect	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
21	mouse	_	_	NN	O	[-1]	['none']	_	_
22	CD154	_	_	NN	Protein	[20]	['Theme']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	CD40	_	_	NN	Protein	[25]	['multitoken']	_	_
25	ligand	_	_	NN	Protein	[0]	['root']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	were	_	_	VBD	O	[-1]	['none']	_	_
28	added	_	_	VBN	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	1x106	_	_	VB	O	[-1]	['none']	_	_
31	B	_	_	NN	O	[-1]	['none']	_	_
32	cells	_	_	NNS	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	centrifuged	_	_	VBN	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	1	_	_	CD	O	[-1]	['none']	_	_
6	minute	_	_	NN	O	[-1]	['none']	_	_
7	at	_	_	IN	O	[-1]	['none']	_	_
8	400	_	_	CD	O	[-1]	['none']	_	_
9	x	_	_	CC	O	[-1]	['none']	_	_
10	g	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	promote	_	_	VB	O	[-1]	['none']	_	_
14	contact	_	_	NN	O	[-1]	['none']	_	_
15	between	_	_	IN	O	[-1]	['none']	_	_
16	ligand	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	B	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	then	_	_	RB	O	[-1]	['none']	_	_
23	incubated	_	_	VBN	O	[-1]	['none']	_	_
24	at	_	_	IN	O	[-1]	['none']	_	_
25	37degreesC	_	_	NN	O	[-1]	['none']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	times	_	_	NNS	O	[-1]	['none']	_	_
28	indicated	_	_	VBD	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	Fig.	_	_	NNP	O	[-1]	['none']	_	_
31	4	_	_	CD	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Following	_	_	VBG	O	[-1]	['none']	_	_
2	stimulation	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	chilled	_	_	VBN	O	[-1]	['none']	_	_
7	on	_	_	IN	O	[-1]	['none']	_	_
8	ice	_	_	NN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	2	_	_	CD	O	[-1]	['none']	_	_
11	minutes	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	pellets	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	dissolved	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	2X	_	_	NN	O	[-1]	['none']	_	_
7	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
8	loading	_	_	VBG	O	[-1]	['none']	_	_
9	buffer	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	sonicated	_	_	VBN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	heated	_	_	VBN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	5	_	_	CD	O	[-1]	['none']	_	_
17	minutes	_	_	NNS	O	[-1]	['none']	_	_
18	at	_	_	IN	O	[-1]	['none']	_	_
19	95degreesC	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Total	_	_	JJ	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	lysates	_	_	NNS	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	1x105	_	_	NN	O	[-1]	['none']	_	_
6	cell	_	_	NN	O	[-1]	['none']	_	_
7	equivalents	_	_	NNS	O	[-1]	['none']	_	_
8	per	_	_	IN	O	[-1]	['none']	_	_
9	lane	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	fractionated	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	blotted	_	_	VBD	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	polyvinylidine	_	_	NN	O	[-1]	['none']	_	_
19	fluoride	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	PVDF	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	membranes	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Membranes	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	probed	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	antibodies	_	_	NNS	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	indicated	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	Fig.	_	_	NN	O	[-1]	['none']	_	_
10	4	_	_	CD	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Chemiluminescent	_	_	JJ	O	[-1]	['none']	_	_
2	detection	_	_	NN	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	Pierce	_	_	NNP	O	[-1]	['none']	_	_
5	Biotechnology	_	_	NNP	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	used	_	_	VBN	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	visualization	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	bands	_	_	NNS	O	[-1]	['none']	_	_
14	on	_	_	IN	O	[-1]	['none']	_	_
15	Western	_	_	NN	O	[-1]	['none']	_	_
16	blots	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Images	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	blots	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	recorded	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	low-light	_	_	JJ	O	[-1]	['none']	_	_
9	imaging	_	_	NN	O	[-1]	['none']	_	_
10	system	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	LAS4000	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	Fuji	_	_	NNP	O	[-1]	['none']	_	_
15	Medical	_	_	NNP	O	[-1]	['none']	_	_
16	Systems	_	_	NNPS	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	on	_	_	IN	O	[-1]	['none']	_	_
20	X-ray	_	_	NN	O	[-1]	['none']	_	_
21	film	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Flow	_	_	NN	O	[-1]	['none']	_	_
2	cytometry	_	_	NN	O	[-1]	['none']	_	_
3	.	_	_	.	O	[-1]	['none']	_	_

1	One	_	_	CD	O	[-1]	['none']	_	_
2	million	_	_	CD	O	[-1]	['none']	_	_
3	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	stained	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	appropriate	_	_	JJ	O	[-1]	['none']	_	_
9	primary	_	_	JJ	O	[-1]	['none']	_	_
10	antibody	_	_	NN	O	[-1]	['none']	_	_
11	unconjugated	_	_	JJ	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	conjugated	_	_	VBN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	FITC	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	PE	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	APC	_	_	NN	O	[-1]	['none']	_	_
21	diluted	_	_	VBN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	stain	_	_	VBP	O	[-1]	['none']	_	_
24	buffer	_	_	NN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	PBS	_	_	NNP	O	[-1]	['none']	_	_
27	with	_	_	IN	O	[-1]	['none']	_	_
28	3	_	_	CD	O	[-1]	['none']	_	_
29	%	_	_	NN	O	[-1]	['none']	_	_
30	FBS	_	_	NN	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	BrdU	_	_	NN	O	[-1]	['none']	_	_
3	detection	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	FITC-BrdU	_	_	NN	O	[-1]	['none']	_	_
7	flow	_	_	NN	O	[-1]	['none']	_	_
8	kit	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	used	_	_	VBN	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	instructed	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	manufacturer	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	BD	_	_	NNP	O	[-1]	['none']	_	_
18	Bioscience	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	exposed	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	EMA	_	_	NNP	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Molecular	_	_	JJ	O	[-1]	['none']	_	_
10	Probes	_	_	NNS	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	exclusion	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	dead	_	_	JJ	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	stained	_	_	VBN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	surface	_	_	NN	O	[-1]	['none']	_	_
21	antigens	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	fixed	_	_	VBN	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	paraformaldehyde	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	permeabilized	_	_	JJ	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	saponin	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	expose	_	_	VB	O	[-1]	['none']	_	_
3	BrdU	_	_	NN	O	[-1]	['none']	_	_
4	epitopes	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	treated	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	Dnase	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	stained	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	FITC	_	_	NN	O	[-1]	['none']	_	_
15	conjugated	_	_	VBD	O	[-1]	['none']	_	_
16	anti-BrdU	_	_	JJ	O	[-1]	['none']	_	_
17	antibody	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Flow	_	_	NN	O	[-1]	['none']	_	_
2	cytometry	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	FACScalibur	_	_	NN	O	[-1]	['none']	_	_
7	using	_	_	VBG	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	CellQuest	_	_	NNP	O	[-1]	['none']	_	_
10	program	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Becton	_	_	NNP	O	[-1]	['none']	_	_
13	Dickinson	_	_	NNP	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Further	_	_	JJ	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	conducted	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	Summit	_	_	NNP	O	[-1]	['none']	_	_
8	v4	_	_	NN	O	[-1]	['none']	_	_
9	.2	_	_	NN	O	[-1]	['none']	_	_
10	program	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Dako	_	_	NNP	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Methylation	_	_	NN	O	[-1]	['none']	_	_
2	sensitive	_	_	JJ	O	[-1]	['none']	_	_
3	enzymes	_	_	NNS	O	[-1]	['none']	_	_
4	do	_	_	VBP	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	cut	_	_	VB	O	[-1]	['none']	_	_
7	specific	_	_	JJ	O	[-1]	['none']	_	_
8	sites	_	_	NNS	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
12	promoter	_	_	NN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	hematopoietic	_	_	JJ	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	To	_	_	TO	O	[-1]	['none']	_	_
17	further	_	_	RBR	O	[-1]	['none']	_	_
18	investigate	_	_	VB	O	[-1]	['none']	_	_
19	promoter	_	_	NN	O	[-1]	['none']	_	_
20	methylation	_	_	NN	O	[-1]	['none']	_	_
21	as	_	_	IN	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	regulatory	_	_	JJ	O	[-1]	['none']	_	_
24	mechanism	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	IRF-4	_	_	NN	Protein	[28]	['Theme']	_	_
27	gene	_	_	NN	O	[-1]	['none']	_	_
28	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	restriction-PCR-assays	_	_	NNS	O	[-1]	['none']	_	_
31	were	_	_	VBD	O	[-1]	['none']	_	_
32	performed	_	_	VBN	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	20,24	_	_	CD	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	where	_	_	WRB	O	[-1]	['none']	_	_
38	only	_	_	RB	O	[-1]	['none']	_	_
39	methylated	_	_	VBN	O	[-1]	['none']	_	_
40	DNA	_	_	NN	O	[-1]	['none']	_	_
41	would	_	_	MD	O	[-1]	['none']	_	_
42	not	_	_	RB	O	[-1]	['none']	_	_
43	be	_	_	VB	O	[-1]	['none']	_	_
44	cut	_	_	VBN	O	[-1]	['none']	_	_
45	enabling	_	_	VBG	O	[-1]	['none']	_	_
46	subsequent	_	_	JJ	O	[-1]	['none']	_	_
47	PCR	_	_	NN	O	[-1]	['none']	_	_
48	amplification	_	_	NN	O	[-1]	['none']	_	_
49	and	_	_	CC	O	[-1]	['none']	_	_
50	vice	_	_	NN	O	[-1]	['none']	_	_
51	versa	_	_	RB	O	[-1]	['none']	_	_
52	.	_	_	.	O	[-1]	['none']	_	_

1	Genomic	_	_	JJ	O	[-1]	['none']	_	_
2	DNA	_	_	NN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	leukemic	_	_	JJ	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	Jurkat	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	CML-T1	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	U-937	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	K-562	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	EM-2	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	BV-173	_	_	NN	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	digested	_	_	VBN	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	methylation	_	_	NN	O	[-1]	['none']	_	_
22	sensitive	_	_	JJ	O	[-1]	['none']	_	_
23	enzymes	_	_	NNS	O	[-1]	['none']	_	_
24	HpaII	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	Bsh1236I	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	HaeII-isochizomer	_	_	NN	O	[-1]	['none']	_	_
29	Bsp143II	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	EcoRI	_	_	NN	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	which	_	_	WDT	O	[-1]	['none']	_	_
4	has	_	_	VBZ	O	[-1]	['none']	_	_
5	no	_	_	DT	O	[-1]	['none']	_	_
6	recognition	_	_	NN	O	[-1]	['none']	_	_
7	site	_	_	NN	O	[-1]	['none']	_	_
8	within	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
11	promoter	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	methylation	_	_	NN	O	[-1]	['none']	_	_
16	resistant	_	_	JJ	O	[-1]	['none']	_	_
17	enzyme	_	_	NN	O	[-1]	['none']	_	_
18	MspI	_	_	NN	O	[-1]	['none']	_	_
19	served	_	_	VBD	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	controls	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Two	_	_	CD	O	[-1]	['none']	_	_
2	separate	_	_	JJ	O	[-1]	['none']	_	_
3	amplification	_	_	NN	O	[-1]	['none']	_	_
4	reactions	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	performed	_	_	VBN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	generating	_	_	VBG	O	[-1]	['none']	_	_
9	two	_	_	CD	O	[-1]	['none']	_	_
10	fragments	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	F1	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	F2	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	digestion	_	_	NN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	HpaII	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Bsp143II	_	_	NN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	sufficient	_	_	JJ	O	[-1]	['none']	_	_
9	PCR	_	_	NN	O	[-1]	['none']	_	_
10	amplification	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	F1	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	F2	_	_	NN	O	[-1]	['none']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	detected	_	_	VBN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	DNA	_	_	NN	O	[-1]	['none']	_	_
19	from	_	_	IN	O	[-1]	['none']	_	_
20	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
21	Jurkat	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	CML-T1	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	U-937	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	K-562	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	EM-2	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	suggesting	_	_	VBG	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	promoter	_	_	NN	O	[-1]	['none']	_	_
35	methylation	_	_	NN	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	restriction	_	_	NN	O	[-1]	['none']	_	_
39	protection	_	_	NN	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	at	_	_	IN	O	[-1]	['none']	_	_
42	the	_	_	DT	O	[-1]	['none']	_	_
43	respective	_	_	JJ	O	[-1]	['none']	_	_
44	recognition	_	_	NN	O	[-1]	['none']	_	_
45	sites	_	_	NNS	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	Notably	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
5	SD-1	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	digestion	_	_	NN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	methylation	_	_	NN	O	[-1]	['none']	_	_
11	sensitive	_	_	JJ	O	[-1]	['none']	_	_
12	enzymes	_	_	NNS	O	[-1]	['none']	_	_
13	completely	_	_	RB	O	[-1]	['none']	_	_
14	inhibited	_	_	VBD	O	[-1]	['none']	_	_
15	amplification	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	F1	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	F2	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
3	BV-173	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	HpaII	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	but	_	_	CC	O	[-1]	['none']	_	_
9	not	_	_	RB	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	Bsh1236I	_	_	NN	O	[-1]	['none']	_	_
12	digestion	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	significantly	_	_	RB	O	[-1]	['none']	_	_
15	reduced	_	_	VBD	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	amplifiable	_	_	JJ	O	[-1]	['none']	_	_
18	DNA	_	_	NN	O	[-1]	['none']	_	_
19	message	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	F2	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	whereas	_	_	IN	O	[-1]	['none']	_	_
24	amplification	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	F1	_	_	NN	O	[-1]	['none']	_	_
27	was	_	_	VBD	O	[-1]	['none']	_	_
28	not	_	_	RB	O	[-1]	['none']	_	_
29	affected	_	_	VBN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	implied	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	IRF-4	_	_	NN	Protein	[5]	['Theme']	_	_
5	transcription	_	_	NN	Transcription	[0]	['root']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	SD-1	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	BV-173	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	associated	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	less	_	_	JJR	O	[-1]	['none']	_	_
15	promoter	_	_	NN	O	[-1]	['none']	_	_
16	methylation	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	BV-173	_	_	NN	O	[-1]	['none']	_	_
20	especially	_	_	RB	O	[-1]	['none']	_	_
21	at	_	_	IN	O	[-1]	['none']	_	_
22	HpaII	_	_	NN	O	[-1]	['none']	_	_
23	sites	_	_	NNS	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	as	_	_	IN	O	[-1]	['none']	_	_
26	compared	_	_	VBN	O	[-1]	['none']	_	_
27	with	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	tested	_	_	VBN	O	[-1]	['none']	_	_
30	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF	_	_	NNP	O	[-1]	['none']	_	_
2	induces	_	_	VBZ	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
5	activity	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	macrophages	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Nuclei	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	extracted	_	_	VBN	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	human	_	_	NN	O	[-1]	['none']	_	_
9	MDMs	_	_	NNS	O	[-1]	['none']	_	_
10	treated	_	_	VBN	O	[-1]	['none']	_	_
11	without	_	_	IN	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	M-CSF	_	_	NN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	15	_	_	CD	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	30	_	_	CD	O	[-1]	['none']	_	_
19	minutes	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	DNA	_	_	NN	O	[-1]	['none']	_	_
3	binding	_	_	NN	O	[-1]	['none']	_	_
4	activity	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	analyzed	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	EMSA	_	_	NN	O	[-1]	['none']	_	_
9	Shown	_	_	VBN	O	[-1]	['none']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	representative	_	_	NN	O	[-1]	['none']	_	_
13	blot	_	_	NN	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	three	_	_	CD	O	[-1]	['none']	_	_
16	independent	_	_	JJ	O	[-1]	['none']	_	_
17	experiments	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	NS	_	_	NN	O	[-1]	['none']	_	_
2	:	_	_	:	O	[-1]	['none']	_	_
3	non	_	_	JJ	O	[-1]	['none']	_	_
4	stimulated	_	_	VBN	O	[-1]	['none']	_	_
5	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Human	_	_	NN	O	[-1]	['none']	_	_
5	MDMs	_	_	NNS	O	[-1]	['none']	_	_
6	transiently	_	_	RB	O	[-1]	['none']	_	_
7	transfected	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
12	constructs	_	_	NNS	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	treated	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	M-CSF	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	X-vivo	_	_	JJ	O	[-1]	['none']	_	_
19	medium	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	incubated	_	_	VBN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	6	_	_	CD	O	[-1]	['none']	_	_
24	hours	_	_	NNS	O	[-1]	['none']	_	_
25	before	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	collection	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	medium	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	activity	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	analyzed	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	measuring	_	_	VBG	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	amount	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	SEAP	_	_	NN	O	[-1]	['none']	_	_
11	secreted	_	_	VBN	O	[-1]	['none']	_	_
12	into	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	medium	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	data	_	_	NNS	O	[-1]	['none']	_	_
17	are	_	_	VBP	O	[-1]	['none']	_	_
18	expressed	_	_	VBN	O	[-1]	['none']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	fold	_	_	JJ	O	[-1]	['none']	_	_
21	increase	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	SEAP	_	_	NN	O	[-1]	['none']	_	_
24	activity	_	_	NN	O	[-1]	['none']	_	_
25	over	_	_	IN	O	[-1]	['none']	_	_
26	that	_	_	DT	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
29	transfected	_	_	VBN	O	[-1]	['none']	_	_
30	resting	_	_	VBG	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	RAW	_	_	NN	O	[-1]	['none']	_	_
5	264.7	_	_	CD	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	transiently	_	_	RB	O	[-1]	['none']	_	_
9	transfected	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	pTAL-SEAP	_	_	NN	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
14	construct	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	serum	_	_	NN	O	[-1]	['none']	_	_
4	starved	_	_	VBN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	4	_	_	CD	O	[-1]	['none']	_	_
7	hours	_	_	NNS	O	[-1]	['none']	_	_
8	prior	_	_	RB	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	2	_	_	CD	O	[-1]	['none']	_	_
11	hours	_	_	NNS	O	[-1]	['none']	_	_
12	stimulation	_	_	NN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	mouse	_	_	NN	O	[-1]	['none']	_	_
15	recombinant	_	_	JJ	O	[-1]	['none']	_	_
16	M-CSF	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	100	_	_	CD	O	[-1]	['none']	_	_
19	ng/ml	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Culture	_	_	NN	O	[-1]	['none']	_	_
2	media	_	_	NNS	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	collected	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	measure	_	_	VB	O	[-1]	['none']	_	_
7	SEAP	_	_	NN	O	[-1]	['none']	_	_
8	production	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	expressed	_	_	VBN	O	[-1]	['none']	_	_
4	mean	_	_	NN	O	[-1]	['none']	_	_
5	+/-	_	_	CC	O	[-1]	['none']	_	_
6	S.E.M	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	three	_	_	CD	O	[-1]	['none']	_	_
10	independent	_	_	JJ	O	[-1]	['none']	_	_
11	experiments	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	PKC	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	s	_	_	NNS	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	Mediate	_	_	VB	O	[-1]	['none']	_	_
8	Human	_	_	NN	O	[-1]	['none']	_	_
9	MDM	_	_	NN	O	[-1]	['none']	_	_
10	Survival	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	Response	_	_	NN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	M-CSF	_	_	NN	O	[-1]	['none']	_	_
15	Stimulation	_	_	NN	O	[-1]	['none']	_	_
16	Since	_	_	IN	O	[-1]	['none']	_	_
17	PKC	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	are	_	_	VBP	O	[-1]	['none']	_	_
21	critical	_	_	JJ	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	cell	_	_	NN	O	[-1]	['none']	_	_
24	survival	_	_	NN	O	[-1]	['none']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	37	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	[	_	_	CD	O	[-1]	['none']	_	_
30	38	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	we	_	_	PRP	O	[-1]	['none']	_	_
34	hypothesized	_	_	VBD	O	[-1]	['none']	_	_
35	that	_	_	IN	O	[-1]	['none']	_	_
36	M-CSF	_	_	NN	O	[-1]	['none']	_	_
37	promoted	_	_	VBD	O	[-1]	['none']	_	_
38	cell	_	_	NN	O	[-1]	['none']	_	_
39	survival	_	_	NN	O	[-1]	['none']	_	_
40	through	_	_	IN	O	[-1]	['none']	_	_
41	PKC	_	_	NN	O	[-1]	['none']	_	_
42	in	_	_	IN	O	[-1]	['none']	_	_
43	human	_	_	NN	O	[-1]	['none']	_	_
44	MDMs	_	_	NNS	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	detect	_	_	VB	O	[-1]	['none']	_	_
3	apoptosis	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	expression	_	_	NN	Positive_regulation	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	cleaved	_	_	VBN	Protein_catabolism	[6]	['Theme']	_	_
9	caspase-3	_	_	NN	Protein	[8]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	marker	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	apoptosis	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	analyzed	_	_	VBN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	presence	_	_	NN	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	absence	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	M-CSF	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	PKC	_	_	NN	O	[-1]	['none']	_	_
27	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	MDMs	_	_	NNS	O	[-1]	['none']	_	_
3	pretreated	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	PKC	_	_	NN	O	[-1]	['none']	_	_
6	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	Go-6976	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	BAPTA/AM	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	stimulated	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	M-CSF	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	cleaved	_	_	VBN	Protein_catabolism	[23]	['Theme']	_	_
21	caspase-3	_	_	NN	Protein	[20]	['Theme']	_	_
22	was	_	_	VBD	O	[-1]	['none']	_	_
23	elevated	_	_	JJ	Positive_regulation	[0]	['root']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	levels	_	_	NNS	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	treated	_	_	VBN	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	vehicle	_	_	NN	O	[-1]	['none']	_	_
31	alone	_	_	RB	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	incubated	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	M-CSF	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	vehicle	_	_	NN	O	[-1]	['none']	_	_
10	had	_	_	VBD	O	[-1]	['none']	_	_
11	less	_	_	RBR	Negative_regulation	[0]	['root']	_	_
12	cleaved	_	_	VBN	Protein_catabolism	[11]	['Theme']	_	_
13	caspase-3	_	_	NN	Protein	[12]	['Theme']	_	_
14	than	_	_	IN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	incubated	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	vehicle	_	_	NN	O	[-1]	['none']	_	_
19	alone	_	_	RB	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	M-CSF	_	_	NN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	PKC	_	_	NN	O	[-1]	['none']	_	_
24	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	supported	_	_	VBD	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	hypothesis	_	_	NN	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	activity	_	_	NN	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	regulated	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	conventional	_	_	JJ	O	[-1]	['none']	_	_
14	PKCs	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	not	_	_	RB	O	[-1]	['none']	_	_
17	novel	_	_	JJ	O	[-1]	['none']	_	_
18	PKCs	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	confirm	_	_	VB	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	PKC	_	_	NN	O	[-1]	['none']	_	_
5	inhibition	_	_	NN	O	[-1]	['none']	_	_
6	decreased	_	_	VBD	O	[-1]	['none']	_	_
7	cell	_	_	NN	O	[-1]	['none']	_	_
8	survival	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	treated	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	M-CSF	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	absence	_	_	NN	O	[-1]	['none']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	presence	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	PKC	_	_	NN	O	[-1]	['none']	_	_
22	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	then	_	_	RB	O	[-1]	['none']	_	_
25	also	_	_	RB	O	[-1]	['none']	_	_
26	examined	_	_	VBN	O	[-1]	['none']	_	_
27	for	_	_	IN	O	[-1]	['none']	_	_
28	apoptosis	_	_	NN	O	[-1]	['none']	_	_
29	by	_	_	IN	O	[-1]	['none']	_	_
30	Annexin	_	_	NN	Protein	[31]	['multitoken']	_	_
31	V/PI	_	_	NN	Protein	[0]	['root']	_	_
32	staining	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	PKC	_	_	NN	O	[-1]	['none']	_	_
2	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	presence	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	M-CSF	_	_	NN	O	[-1]	['none']	_	_
8	reduced	_	_	VBD	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	number	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	Annexin	_	_	NN	Protein	[13]	['multitoken']	_	_
13	V/PI	_	_	NN	Protein	[0]	['root']	_	_
14	negative	_	_	JJ	Negative_regulation	[0]	['root']	_	_
15	MDMs	_	_	NNS	O	[-1]	['none']	_	_
16	compared	_	_	VBN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	treated	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	M-CSF	_	_	NN	O	[-1]	['none']	_	_
22	alone	_	_	RB	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	observations	_	_	NNS	O	[-1]	['none']	_	_
3	further	_	_	RB	O	[-1]	['none']	_	_
4	suggested	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	MDM	_	_	NN	O	[-1]	['none']	_	_
7	survival	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	promoted	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	M-CSF	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	critically	_	_	RB	O	[-1]	['none']	_	_
14	involves	_	_	VBZ	O	[-1]	['none']	_	_
15	conventional	_	_	JJ	O	[-1]	['none']	_	_
16	PKCs	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	activity	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Plasmids	_	_	NNS	O	[-1]	['none']	_	_
2	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	Gene_expression	[0]	['root']	_	_
2	vectors	_	_	NNS	O	[-1]	['none']	_	_
3	encoding	_	_	VBG	O	[-1]	['none']	_	_
4	human	_	_	NN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[1]	['Theme']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	pCMV-Foxp3-IRES-EGFP	_	_	NN	Protein	[0]	['root']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	human	_	_	NN	O	[-1]	['none']	_	_
11	Foxp3	_	_	NN	Protein	[1, 12]	['Theme', 'Theme']	_	_
12	lacking	_	_	VBG	Negative_regulation	[0]	['root']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	forkhead	_	_	NN	Entity	[18]	['multitoken']	_	_
15	(	_	_	-LRB-	Entity	[18]	['multitoken']	_	_
16	FKH	_	_	NN	Entity	[18]	['multitoken']	_	_
17	)	_	_	-RRB-	Entity	[18]	['multitoken']	_	_
18	domain	_	_	NN	Entity	[12]	['Site']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	pCMV-deltaFKH-IRES-EGFP	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	were	_	_	VBD	O	[-1]	['none']	_	_
23	generous	_	_	JJ	O	[-1]	['none']	_	_
24	gifts	_	_	NNS	O	[-1]	['none']	_	_
25	from	_	_	IN	O	[-1]	['none']	_	_
26	S.	_	_	NNP	O	[-1]	['none']	_	_
27	Ziegler	_	_	NNP	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	Benaroya	_	_	NNP	O	[-1]	['none']	_	_
30	Research	_	_	NNP	O	[-1]	['none']	_	_
31	Institute	_	_	NNP	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	pEGFP-C2	_	_	NNP	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	provided	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	I.	_	_	NN	O	[-1]	['none']	_	_
6	Lipinski	_	_	NNP	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	NIDDK	_	_	NNP	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	NIH	_	_	NNP	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	pcDNA3	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	provided	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	K.	_	_	NNP	O	[-1]	['none']	_	_
6	T.	_	_	NNP	O	[-1]	['none']	_	_
7	Jeang	_	_	NNP	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	NIAID	_	_	NNP	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	NIH	_	_	NNP	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	pCMV4-Tax	_	_	NNP	Protein	[0]	['root']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	generous	_	_	JJ	O	[-1]	['none']	_	_
5	gift	_	_	NN	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	W.	_	_	NNP	O	[-1]	['none']	_	_
8	Greene	_	_	NNP	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	University	_	_	NNP	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	California	_	_	NNP	O	[-1]	['none']	_	_
13	San	_	_	NNP	O	[-1]	['none']	_	_
14	Francisco	_	_	NNP	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	pGL4-luc2	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	pGL4-TKhRluc2	_	_	NN	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	purchased	_	_	VBN	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	Promega	_	_	NNP	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Madison	_	_	NNP	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	Wisconsin	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	United	_	_	NNP	O	[-1]	['none']	_	_
14	States	_	_	NNPS	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	pUC18	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	purchased	_	_	VBN	O	[-1]	['none']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	Stratagene	_	_	JJ	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	La	_	_	NNP	O	[-1]	['none']	_	_
8	Jolla	_	_	NNP	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	California	_	_	NNP	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	United	_	_	NNP	O	[-1]	['none']	_	_
13	States	_	_	NNPS	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	HIV-1	_	_	NNP	O	[-1]	['none']	_	_
2	wt	_	_	JJ	O	[-1]	['none']	_	_
3	LTR	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	HIV-1	_	_	NN	O	[-1]	['none']	_	_
6	delta-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	LTR	_	_	NN	O	[-1]	['none']	_	_
8	luciferase	_	_	NN	Protein	[0]	['root']	_	_
9	reporter	_	_	NN	O	[-1]	['none']	_	_
10	vectors	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	constructed	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	cloning	_	_	VBG	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	XhoI	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	HindIII	_	_	NN	O	[-1]	['none']	_	_
19	LTR	_	_	NN	O	[-1]	['none']	_	_
20	fragments	_	_	NNS	O	[-1]	['none']	_	_
21	from	_	_	IN	O	[-1]	['none']	_	_
22	pHIV-CAT	_	_	NN	Protein	[0]	['root']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	pdelta-kappaB-HIV-CAT	_	_	NN	Protein	[0]	['root']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	AIDS	_	_	NNP	O	[-1]	['none']	_	_
27	Research	_	_	NNP	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	Reference	_	_	NNP	O	[-1]	['none']	_	_
30	Reagent	_	_	NNP	O	[-1]	['none']	_	_
31	Program	_	_	NNP	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	NIAID	_	_	NNP	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	NIH	_	_	NNP	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	into	_	_	IN	O	[-1]	['none']	_	_
38	the	_	_	DT	O	[-1]	['none']	_	_
39	multiple	_	_	JJ	O	[-1]	['none']	_	_
40	cloning	_	_	NN	O	[-1]	['none']	_	_
41	site	_	_	NN	O	[-1]	['none']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	pGL4-luc2	_	_	NN	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
4	LTR	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	CREB	_	_	NN	O	[-1]	['none']	_	_
8	luciferase	_	_	NN	Protein	[12]	['Theme']	_	_
9	reporter	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	pCMV-p300-HA	_	_	NN	Protein	[0]	['root']	_	_
12	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
13	vectors	_	_	NNS	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	generously	_	_	RB	O	[-1]	['none']	_	_
16	provided	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	B.	_	_	NNP	O	[-1]	['none']	_	_
19	Wigdahl	_	_	NNP	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	Drexel	_	_	NNP	O	[-1]	['none']	_	_
22	University	_	_	NNP	O	[-1]	['none']	_	_
23	College	_	_	NNP	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	Medicine	_	_	NNP	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	HTLV-I	_	_	NNP	O	[-1]	['none']	_	_
2	pACH	_	_	NN	O	[-1]	['none']	_	_
3	infectious	_	_	JJ	O	[-1]	['none']	_	_
4	molecular	_	_	JJ	O	[-1]	['none']	_	_
5	clone	_	_	NN	O	[-1]	['none']	_	_
6	has	_	_	VBZ	O	[-1]	['none']	_	_
7	been	_	_	VBN	O	[-1]	['none']	_	_
8	described	_	_	VBN	O	[-1]	['none']	_	_
9	previously	_	_	RB	O	[-1]	['none']	_	_
10	[	_	_	CD	O	[-1]	['none']	_	_
11	30	_	_	CD	O	[-1]	['none']	_	_
12	]	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	pFR-luc	_	_	NN	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	pFA-CMV	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	pFA2-CREB-1	_	_	NN	Protein	[0]	['root']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	pFA2-c-Jun	_	_	NN	Protein	[0]	['root']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	purchased	_	_	VBN	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	Stratagene	_	_	JJ	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	pFA-Tax	_	_	NNP	Protein	[0]	['root']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	encoding	_	_	VBG	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	fusion	_	_	NN	O	[-1]	['none']	_	_
6	protein	_	_	NN	O	[-1]	['none']	_	_
7	consisting	_	_	VBG	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	Gal4	_	_	NN	Protein	[0]	['root']	_	_
11	DNA	_	_	NN	O	[-1]	['none']	_	_
12	binding	_	_	NN	O	[-1]	['none']	_	_
13	domain	_	_	NN	O	[-1]	['none']	_	_
14	fused	_	_	VBN	O	[-1]	['none']	_	_
15	in-frame	_	_	RB	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
18	Tax	_	_	NN	Protein	[0]	['root']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	was	_	_	VBD	O	[-1]	['none']	_	_
21	constructed	_	_	VBN	O	[-1]	['none']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	PCR	_	_	NN	O	[-1]	['none']	_	_
24	amplification	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
27	Tax	_	_	NN	Protein	[0]	['root']	_	_
28	using	_	_	VBG	O	[-1]	['none']	_	_
29	pCMV4-Tax	_	_	NN	Protein	[0]	['root']	_	_
30	as	_	_	IN	O	[-1]	['none']	_	_
31	a	_	_	DT	O	[-1]	['none']	_	_
32	template	_	_	NN	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	BamHI	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	BglII	_	_	NN	O	[-1]	['none']	_	_
37	tagged	_	_	VBD	O	[-1]	['none']	_	_
38	primers	_	_	NNS	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	amplified	_	_	JJ	O	[-1]	['none']	_	_
3	insert	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	digested	_	_	VBN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	ligated	_	_	VBN	O	[-1]	['none']	_	_
8	into	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	BamHI	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	BglII	_	_	NN	O	[-1]	['none']	_	_
13	sites	_	_	NNS	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	pFA-CMV	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Plasmid	_	_	NN	O	[-1]	['none']	_	_
2	contents	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	confirmed	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	DNA	_	_	NN	O	[-1]	['none']	_	_
7	sequencing	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	Regulation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	AP-1	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	activation	_	_	NN	O	[-1]	['none']	_	_
7	The	_	_	DT	O	[-1]	['none']	_	_
8	transcription	_	_	NN	O	[-1]	['none']	_	_
9	factors	_	_	NNS	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	AP-1	_	_	NN	O	[-1]	['none']	_	_
13	play	_	_	VBP	O	[-1]	['none']	_	_
14	key	_	_	JJ	O	[-1]	['none']	_	_
15	roles	_	_	NNS	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	initiation	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	an	_	_	DT	O	[-1]	['none']	_	_
21	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
22	response	_	_	NN	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	inducing	_	_	VBG	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	expression	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	secretion	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	chemokines	_	_	NNS	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	cytokines	_	_	NNS	O	[-1]	['none']	_	_
33	that	_	_	WDT	O	[-1]	['none']	_	_
34	attract	_	_	VBP	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	activate	_	_	VBP	O	[-1]	['none']	_	_
37	immune	_	_	JJ	O	[-1]	['none']	_	_
38	cells	_	_	NNS	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	signal	_	_	NN	O	[-1]	['none']	_	_
5	transduction	_	_	NN	O	[-1]	['none']	_	_
6	pathways	_	_	NNS	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	subsequent	_	_	JJ	O	[-1]	['none']	_	_
9	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
10	cytokine	_	_	NN	O	[-1]	['none']	_	_
11	induction	_	_	NN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	these	_	_	DT	O	[-1]	['none']	_	_
14	transcription	_	_	NN	O	[-1]	['none']	_	_
15	factors	_	_	NNS	O	[-1]	['none']	_	_
16	is	_	_	VBZ	O	[-1]	['none']	_	_
17	not	_	_	RB	O	[-1]	['none']	_	_
18	fully	_	_	RB	O	[-1]	['none']	_	_
19	elucidated	_	_	VBN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	present	_	_	JJ	O	[-1]	['none']	_	_
3	study	_	_	NN	O	[-1]	['none']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	aimed	_	_	VBN	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	determining	_	_	VBG	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	involvement	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	AP-1	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	cytokine	_	_	NN	O	[-1]	['none']	_	_
16	induction	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	regulation	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	PMA	_	_	NN	O	[-1]	['none']	_	_
2	treatment	_	_	NN	O	[-1]	['none']	_	_
3	resulted	_	_	VBD	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	an	_	_	DT	O	[-1]	['none']	_	_
6	up-regulation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	AP-1	_	_	NN	O	[-1]	['none']	_	_
9	after	_	_	IN	O	[-1]	['none']	_	_
10	2	_	_	CD	O	[-1]	['none']	_	_
11	h	_	_	NN	O	[-1]	['none']	_	_
12	exposure	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	continued	_	_	VBD	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	increase	_	_	VB	O	[-1]	['none']	_	_
17	throughout	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	analysis	_	_	NN	O	[-1]	['none']	_	_
20	period	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	HK	_	_	NNP	O	[-1]	['none']	_	_
2	E.	_	_	NNP	O	[-1]	['none']	_	_
3	coli	_	_	NN	O	[-1]	['none']	_	_
4	treatment	_	_	NN	O	[-1]	['none']	_	_
5	did	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	affect	_	_	VB	O	[-1]	['none']	_	_
8	AP-1	_	_	NN	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	Jurkat	_	_	NN	O	[-1]	['none']	_	_
12	T-cells	_	_	NNS	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	involvement	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	associated	_	_	JJ	O	[-1]	['none']	_	_
7	pathways	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	we	_	_	PRP	O	[-1]	['none']	_	_
10	exposed	_	_	VBD	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	Ca2+	_	_	NN	O	[-1]	['none']	_	_
14	ionophore	_	_	NN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	or	_	_	CC	O	[-1]	['none']	_	_
17	without	_	_	IN	O	[-1]	['none']	_	_
18	PMA	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	observed	_	_	VBD	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	modest	_	_	JJ	O	[-1]	['none']	_	_
23	involvement	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	Ca2+	_	_	NN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	PMA	_	_	NN	O	[-1]	['none']	_	_
28	dependent	_	_	JJ	O	[-1]	['none']	_	_
29	AP-1	_	_	NN	O	[-1]	['none']	_	_
30	activation	_	_	NN	O	[-1]	['none']	_	_
31	while	_	_	IN	O	[-1]	['none']	_	_
32	Ca2+	_	_	NN	O	[-1]	['none']	_	_
33	alone	_	_	RB	O	[-1]	['none']	_	_
34	did	_	_	VBD	O	[-1]	['none']	_	_
35	not	_	_	RB	O	[-1]	['none']	_	_
36	alter	_	_	VB	O	[-1]	['none']	_	_
37	AP-1	_	_	NN	O	[-1]	['none']	_	_
38	activity	_	_	NN	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	data	_	_	NNS	O	[-1]	['none']	_	_
41	not	_	_	RB	O	[-1]	['none']	_	_
42	shown	_	_	VBN	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	AP-1	_	_	NN	O	[-1]	['none']	_	_
4	activity	_	_	NN	O	[-1]	['none']	_	_
5	decreased	_	_	VBD	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	TCR	_	_	NN	O	[-1]	['none']	_	_
9	deficient	_	_	JJ	O	[-1]	['none']	_	_
10	Jurkat	_	_	NN	O	[-1]	['none']	_	_
11	cell	_	_	NN	O	[-1]	['none']	_	_
12	line	_	_	NN	O	[-1]	['none']	_	_
13	when	_	_	WRB	O	[-1]	['none']	_	_
14	exposed	_	_	VBN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	PMA	_	_	NN	O	[-1]	['none']	_	_
17	compared	_	_	VBN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	parent	_	_	NN	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	line	_	_	NN	O	[-1]	['none']	_	_
23	indicating	_	_	VBG	O	[-1]	['none']	_	_
24	that	_	_	IN	O	[-1]	['none']	_	_
25	regulation	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	AP-1	_	_	NN	O	[-1]	['none']	_	_
28	was	_	_	VBD	O	[-1]	['none']	_	_
29	only	_	_	RB	O	[-1]	['none']	_	_
30	partially	_	_	RB	O	[-1]	['none']	_	_
31	T-cell	_	_	NN	O	[-1]	['none']	_	_
32	receptor	_	_	NN	O	[-1]	['none']	_	_
33	dependent	_	_	JJ	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	showed	_	_	VBD	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	transient	_	_	JJ	O	[-1]	['none']	_	_
6	increase	_	_	NN	O	[-1]	['none']	_	_
7	at	_	_	IN	O	[-1]	['none']	_	_
8	1	_	_	CD	O	[-1]	['none']	_	_
9	min	_	_	NN	O	[-1]	['none']	_	_
10	after	_	_	IN	O	[-1]	['none']	_	_
11	exposure	_	_	NN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	PMA	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	1	_	_	CD	O	[-1]	['none']	_	_
4	h	_	_	NN	O	[-1]	['none']	_	_
5	after	_	_	IN	O	[-1]	['none']	_	_
6	exposure	_	_	NN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	levels	_	_	NNS	O	[-1]	['none']	_	_
10	began	_	_	VBD	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	drop	_	_	VB	O	[-1]	['none']	_	_
13	reaching	_	_	VBG	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	lowest	_	_	JJS	O	[-1]	['none']	_	_
16	levels	_	_	NNS	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	6	_	_	CD	O	[-1]	['none']	_	_
19	h	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	after	_	_	IN	O	[-1]	['none']	_	_
22	which	_	_	WDT	O	[-1]	['none']	_	_
23	they	_	_	PRP	O	[-1]	['none']	_	_
24	increased	_	_	VBD	O	[-1]	['none']	_	_
25	again	_	_	RB	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	24	_	_	CD	O	[-1]	['none']	_	_
28	h.	_	_	NN	O	[-1]	['none']	_	_
29	Exposure	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	Jurkat	_	_	NN	O	[-1]	['none']	_	_
32	T-cells	_	_	NNS	O	[-1]	['none']	_	_
33	to	_	_	TO	O	[-1]	['none']	_	_
34	HK	_	_	NNP	O	[-1]	['none']	_	_
35	E.	_	_	NNP	O	[-1]	['none']	_	_
36	coli	_	_	NN	O	[-1]	['none']	_	_
37	resulted	_	_	VBD	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	a	_	_	DT	O	[-1]	['none']	_	_
40	dose	_	_	NN	O	[-1]	['none']	_	_
41	dependent	_	_	JJ	O	[-1]	['none']	_	_
42	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
43	activation	_	_	NN	O	[-1]	['none']	_	_
44	,	_	_	,	O	[-1]	['none']	_	_
45	with	_	_	IN	O	[-1]	['none']	_	_
46	the	_	_	DT	O	[-1]	['none']	_	_
47	highest	_	_	JJS	O	[-1]	['none']	_	_
48	activity	_	_	NN	O	[-1]	['none']	_	_
49	observed	_	_	VBN	O	[-1]	['none']	_	_
50	at	_	_	IN	O	[-1]	['none']	_	_
51	a	_	_	DT	O	[-1]	['none']	_	_
52	relative	_	_	JJ	O	[-1]	['none']	_	_
53	concentration	_	_	NN	O	[-1]	['none']	_	_
54	of	_	_	IN	O	[-1]	['none']	_	_
55	5	_	_	CD	O	[-1]	['none']	_	_
56	x	_	_	CC	O	[-1]	['none']	_	_
57	107	_	_	CD	O	[-1]	['none']	_	_
58	CFU/ml	_	_	NN	O	[-1]	['none']	_	_
59	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	time	_	_	NN	O	[-1]	['none']	_	_
3	dependent	_	_	JJ	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	HK	_	_	NNP	O	[-1]	['none']	_	_
9	E.	_	_	NNP	O	[-1]	['none']	_	_
10	coli	_	_	NN	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	assessed	_	_	VBN	O	[-1]	['none']	_	_
13	further	_	_	RB	O	[-1]	['none']	_	_
14	using	_	_	VBG	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	optimal	_	_	JJ	O	[-1]	['none']	_	_
17	concentration	_	_	NN	O	[-1]	['none']	_	_
18	obtained	_	_	VBN	O	[-1]	['none']	_	_
19	from	_	_	IN	O	[-1]	['none']	_	_
20	figure	_	_	NN	O	[-1]	['none']	_	_
21	2b	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	showed	_	_	VBD	O	[-1]	['none']	_	_
24	that	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	activity	_	_	NN	O	[-1]	['none']	_	_
28	increased	_	_	VBN	O	[-1]	['none']	_	_
29	after	_	_	IN	O	[-1]	['none']	_	_
30	3	_	_	CD	O	[-1]	['none']	_	_
31	h	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	exposure	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	increased	_	_	VBN	O	[-1]	['none']	_	_
4	intracellular	_	_	JJ	O	[-1]	['none']	_	_
5	Ca2+	_	_	NN	O	[-1]	['none']	_	_
6	reversed	_	_	VBD	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	PMA	_	_	NN	O	[-1]	['none']	_	_
9	dependent	_	_	JJ	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	inhibition	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	reduced	_	_	VBD	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	HK	_	_	NNP	O	[-1]	['none']	_	_
16	E.	_	_	NNP	O	[-1]	['none']	_	_
17	coli	_	_	NN	O	[-1]	['none']	_	_
18	-dependent	_	_	JJ	O	[-1]	['none']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	activation	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	HOIP	_	_	NN	Protein	[0]	['root']	_	_
2	gene	_	_	NN	O	[-1]	['none']	_	_
3	targeting	_	_	NN	O	[-1]	['none']	_	_
4	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Regions	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Rnf31	_	_	NN	Protein	[0]	['root']	_	_
7	gene	_	_	NN	O	[-1]	['none']	_	_
8	sequence	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	bottom	_	_	JJ	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	used	_	_	VBN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	HOIP	_	_	NN	Protein	[0]	['root']	_	_
16	gene	_	_	NN	O	[-1]	['none']	_	_
17	targeting	_	_	VBG	O	[-1]	['none']	_	_
18	vector	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	top	_	_	JJ	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	are	_	_	VBP	O	[-1]	['none']	_	_
23	shown	_	_	VBN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Arrows	_	_	NNS	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	F	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	R	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	indicate	_	_	VBP	O	[-1]	['none']	_	_
8	approximate	_	_	JJ	O	[-1]	['none']	_	_
9	positions	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	sequences	_	_	NNS	O	[-1]	['none']	_	_
12	homologous	_	_	JJ	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	oligonucleotides	_	_	NNS	O	[-1]	['none']	_	_
15	used	_	_	VBN	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	PCR	_	_	NN	O	[-1]	['none']	_	_
18	mediated	_	_	JJ	O	[-1]	['none']	_	_
19	detection	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	homologous	_	_	JJ	O	[-1]	['none']	_	_
22	recombination	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Homologous	_	_	JJ	O	[-1]	['none']	_	_
2	recombination	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	vector	_	_	NN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	Rnf31	_	_	NN	Protein	[0]	['root']	_	_
8	resulted	_	_	VBD	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	small	_	_	JJ	O	[-1]	['none']	_	_
12	chromosomal	_	_	JJ	O	[-1]	['none']	_	_
13	deletion	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	in-frame	_	_	RB	O	[-1]	['none']	_	_
17	insertion	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	neomycin	_	_	NN	O	[-1]	['none']	_	_
20	phosphotransferase	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	NeoR	_	_	NN	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	into	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	amino-terminal	_	_	JJ	O	[-1]	['none']	_	_
27	HOIP	_	_	NN	Protein	[0]	['root']	_	_
28	coding	_	_	VBG	O	[-1]	['none']	_	_
29	sequence	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	diphtheria	_	_	NN	O	[-1]	['none']	_	_
3	toxin	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	DT	_	_	NNP	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	cassette	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	vector	_	_	NN	O	[-1]	['none']	_	_
11	facilitates	_	_	VBZ	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	negative	_	_	JJ	O	[-1]	['none']	_	_
14	selection	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	which	_	_	WDT	O	[-1]	['none']	_	_
19	random	_	_	JJ	O	[-1]	['none']	_	_
20	chromosomal	_	_	JJ	O	[-1]	['none']	_	_
21	insertion	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	vector	_	_	NN	O	[-1]	['none']	_	_
25	takes	_	_	VBZ	O	[-1]	['none']	_	_
26	place	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	LoxP	_	_	NN	O	[-1]	['none']	_	_
2	sequences	_	_	NNS	O	[-1]	['none']	_	_
3	allow	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	Cre	_	_	NNP	O	[-1]	['none']	_	_
6	mediated	_	_	VBD	O	[-1]	['none']	_	_
7	deletion	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	NeoR	_	_	NN	O	[-1]	['none']	_	_
11	coding	_	_	VBG	O	[-1]	['none']	_	_
12	sequence	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	SV40pA	_	_	NN	O	[-1]	['none']	_	_
3	sequence	_	_	NN	O	[-1]	['none']	_	_
4	helps	_	_	VBZ	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	ensure	_	_	VB	O	[-1]	['none']	_	_
7	disruption	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	gene	_	_	NN	O	[-1]	['none']	_	_
10	expression	_	_	NN	O	[-1]	['none']	_	_
11	after	_	_	IN	O	[-1]	['none']	_	_
12	deletion	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	NeoR	_	_	NN	O	[-1]	['none']	_	_
16	sequence	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Anti-HOIP	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	anti-FLAG	_	_	JJ	O	[-1]	['none']	_	_
7	Western	_	_	NN	O	[-1]	['none']	_	_
8	blots	_	_	NNS	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	lysates	_	_	NNS	O	[-1]	['none']	_	_
12	from	_	_	IN	O	[-1]	['none']	_	_
13	A20	_	_	NN	O	[-1]	['none']	_	_
14	.2	_	_	NN	O	[-1]	['none']	_	_
15	J	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	HOIP	_	_	NN	Protein	[19]	['Theme']	_	_
19	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	HOIP-/-)	_	_	NN	Protein	[0]	['root']	_	_
22	clones	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	partial	_	_	JJ	O	[-1]	['none']	_	_
3	decrease	_	_	NN	Negative_regulation	[12]	['Theme']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[7]	['Theme']	_	_
6	protein	_	_	NN	O	[-1]	['none']	_	_
7	expression	_	_	NN	Gene_expression	[3]	['Theme']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	evident	_	_	JJ	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
13	disruption	_	_	NN	Negative_regulation	[12]	['Cause']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	one	_	_	CD	O	[-1]	['none']	_	_
16	copy	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	Rnf31	_	_	NN	Protein	[13]	['Theme']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	HOIP-/+	_	_	JJ	Protein	[0]	['root']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	HOIP	_	_	NN	Protein	[2]	['Theme']	_	_
2	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	clones	_	_	NNS	O	[-1]	['none']	_	_
5	reconstituted	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	an	_	_	DT	O	[-1]	['none']	_	_
8	empty	_	_	JJ	O	[-1]	['none']	_	_
9	retroviral	_	_	JJ	O	[-1]	['none']	_	_
10	vector	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	pMIP	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	retroviral	_	_	JJ	O	[-1]	['none']	_	_
17	vector	_	_	NN	O	[-1]	['none']	_	_
18	encoding	_	_	VBG	O	[-1]	['none']	_	_
19	FLAG	_	_	NN	O	[-1]	['none']	_	_
20	tagged	_	_	VBD	O	[-1]	['none']	_	_
21	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
22	is	_	_	VBZ	O	[-1]	['none']	_	_
23	also	_	_	RB	O	[-1]	['none']	_	_
24	shown	_	_	VBN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Approximate	_	_	JJ	O	[-1]	['none']	_	_
2	molecular	_	_	JJ	O	[-1]	['none']	_	_
3	weight	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	HOIP	_	_	NN	Protein	[0]	['root']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	120	_	_	CD	O	[-1]	['none']	_	_
8	kD	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Isolation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	CD8+	_	_	JJ	O	[-1]	['none']	_	_
4	T	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
8	mice	_	_	NNS	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Runx3	_	_	NN	Protein	[2]	['Theme']	_	_
2	deficient	_	_	JJ	Negative_regulation	[7]	['Cause']	_	_
3	T	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	fail	_	_	VBP	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	silence	_	_	NN	Negative_regulation	[0]	['root']	_	_
8	CD4	_	_	NN	Protein	[9]	['Theme']	_	_
9	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
10	normally	_	_	RB	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	12	_	_	CD	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	13	_	_	CD	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	therefore	_	_	RB	O	[-1]	['none']	_	_
3	further	_	_	RB	O	[-1]	['none']	_	_
4	fractionated	_	_	VBD	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	positively	_	_	RB	O	[-1]	['none']	_	_
7	selected	_	_	VBN	O	[-1]	['none']	_	_
8	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
9	T	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	Runx3	_	_	NN	Protein	[0]	['root']	_	_
13	KO	_	_	NN	O	[-1]	['none']	_	_
14	mice	_	_	NNS	O	[-1]	['none']	_	_
15	into	_	_	IN	O	[-1]	['none']	_	_
16	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
17	CD4-	_	_	JJ	Protein	[0]	['root']	_	_
18	SP	_	_	NN	O	[-1]	['none']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
21	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
22	DP	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	separation	_	_	NN	O	[-1]	['none']	_	_
26	using	_	_	VBG	O	[-1]	['none']	_	_
27	anti-CD4	_	_	JJ	Protein	[0]	['root']	_	_
28	magnetic	_	_	JJ	O	[-1]	['none']	_	_
29	beads	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	yielded	_	_	VBD	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	Runx3	_	_	NN	Protein	[0]	['root']	_	_
5	KO	_	_	NN	O	[-1]	['none']	_	_
6	SP	_	_	NN	O	[-1]	['none']	_	_
7	"	_	_	''	O	[-1]	['none']	_	_
8	enriched	_	_	JJ	O	[-1]	['none']	_	_
9	"	_	_	``	O	[-1]	['none']	_	_
10	population	_	_	NN	O	[-1]	['none']	_	_
11	that	_	_	WDT	O	[-1]	['none']	_	_
12	contained	_	_	VBD	O	[-1]	['none']	_	_
13	75	_	_	CD	O	[-1]	['none']	_	_
14	%	_	_	NN	O	[-1]	['none']	_	_
15	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
16	CD4-	_	_	JJ	Protein	[0]	['root']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	KO	_	_	NNP	O	[-1]	['none']	_	_
21	DP	_	_	NN	O	[-1]	['none']	_	_
22	enriched	_	_	JJ	O	[-1]	['none']	_	_
23	population	_	_	NN	O	[-1]	['none']	_	_
24	that	_	_	WDT	O	[-1]	['none']	_	_
25	contained	_	_	VBD	O	[-1]	['none']	_	_
26	85	_	_	CD	O	[-1]	['none']	_	_
27	%	_	_	NN	O	[-1]	['none']	_	_
28	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
29	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	stimulated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	anti-CD3+	_	_	JJ	Protein	[0]	['root']	_	_
7	anti-CD28	_	_	NN	Protein	[0]	['root']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	2	_	_	CD	O	[-1]	['none']	_	_
10	d	_	_	NN	O	[-1]	['none']	_	_
11	before	_	_	IN	O	[-1]	['none']	_	_
12	removing	_	_	VBG	O	[-1]	['none']	_	_
13	them	_	_	PRP	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	TCR	_	_	NN	O	[-1]	['none']	_	_
17	stimulus	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	culturing	_	_	VBG	O	[-1]	['none']	_	_
20	them	_	_	PRP	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	media	_	_	NNS	O	[-1]	['none']	_	_
23	containing	_	_	VBG	O	[-1]	['none']	_	_
24	100	_	_	CD	O	[-1]	['none']	_	_
25	U/ml	_	_	NN	O	[-1]	['none']	_	_
26	IL-2	_	_	NN	Protein	[0]	['root']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	previously	_	_	RB	O	[-1]	['none']	_	_
3	reported	_	_	VBN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	TCR	_	_	NN	O	[-1]	['none']	_	_
6	induced	_	_	VBD	O	[-1]	['none']	_	_
7	proliferation	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
10	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
11	T	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	severely	_	_	RB	O	[-1]	['none']	_	_
15	impaired	_	_	JJ	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	irrespective	_	_	JJ	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	CD4	_	_	NN	Protein	[20]	['Theme']	_	_
20	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	12	_	_	CD	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	13	_	_	CD	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	showed	_	_	VBD	O	[-1]	['none']	_	_
7	cell-surface	_	_	JJ	O	[-1]	['none']	_	_
8	expression	_	_	NN	O	[-1]	['none']	_	_
9	patterns	_	_	NNS	O	[-1]	['none']	_	_
10	indicative	_	_	JJ	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	activated	_	_	VBN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	including	_	_	VBG	O	[-1]	['none']	_	_
16	up-regulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	CD25	_	_	NN	Protein	[16]	['Theme']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	CD69	_	_	NN	Protein	[16]	['Theme']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	their	_	_	PRP$	O	[-1]	['none']	_	_
5	ability	_	_	NN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	up-regulate	_	_	VB	Positive_regulation	[0]	['root']	_	_
8	CD25	_	_	NN	Protein	[7]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	Runx3-/-	_	_	NN	Protein	[0]	['root']	_	_
11	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
12	T	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	responded	_	_	VBD	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	IL-2	_	_	NN	Protein	[0]	['root']	_	_
17	supplementation	_	_	NN	O	[-1]	['none']	_	_
18	after	_	_	IN	O	[-1]	['none']	_	_
19	day	_	_	NN	O	[-1]	['none']	_	_
20	2	_	_	CD	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	efficiently	_	_	RB	O	[-1]	['none']	_	_
23	expanded	_	_	VBN	O	[-1]	['none']	_	_
24	until	_	_	IN	O	[-1]	['none']	_	_
25	day	_	_	NN	O	[-1]	['none']	_	_
26	6	_	_	CD	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	culture	_	_	NN	O	[-1]	['none']	_	_
30	period	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	albeit	_	_	IN	O	[-1]	['none']	_	_
33	at	_	_	IN	O	[-1]	['none']	_	_
34	slower	_	_	JJR	O	[-1]	['none']	_	_
35	rates	_	_	NNS	O	[-1]	['none']	_	_
36	compared	_	_	VBN	O	[-1]	['none']	_	_
37	with	_	_	IN	O	[-1]	['none']	_	_
38	WT	_	_	JJ	O	[-1]	['none']	_	_
39	cells	_	_	NNS	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	a	_	_	DT	O	[-1]	['none']	_	_
3	fraction	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	KO	_	_	NNP	O	[-1]	['none']	_	_
7	DP	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	silenced	_	_	VBD	Negative_regulation	[0]	['root']	_	_
10	CD4	_	_	NN	Protein	[11]	['Theme']	_	_
11	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
12	after	_	_	IN	O	[-1]	['none']	_	_
13	activation	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	ratio	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	SP/DP	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	each	_	_	DT	O	[-1]	['none']	_	_
22	enriched	_	_	JJ	O	[-1]	['none']	_	_
23	population	_	_	NN	O	[-1]	['none']	_	_
24	remained	_	_	VBD	O	[-1]	['none']	_	_
25	constant	_	_	JJ	O	[-1]	['none']	_	_
26	thereafter	_	_	RB	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	we	_	_	PRP	O	[-1]	['none']	_	_
30	did	_	_	VBD	O	[-1]	['none']	_	_
31	not	_	_	RB	O	[-1]	['none']	_	_
32	observe	_	_	VB	O	[-1]	['none']	_	_
33	any	_	_	DT	O	[-1]	['none']	_	_
34	major	_	_	JJ	O	[-1]	['none']	_	_
35	differences	_	_	NNS	O	[-1]	['none']	_	_
36	between	_	_	IN	O	[-1]	['none']	_	_
37	these	_	_	DT	O	[-1]	['none']	_	_
38	two	_	_	CD	O	[-1]	['none']	_	_
39	populations	_	_	NNS	O	[-1]	['none']	_	_
40	throughout	_	_	IN	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	culture	_	_	NN	O	[-1]	['none']	_	_
43	period	_	_	NN	O	[-1]	['none']	_	_
44	,	_	_	,	O	[-1]	['none']	_	_
45	indicating	_	_	VBG	O	[-1]	['none']	_	_
46	that	_	_	IN	O	[-1]	['none']	_	_
47	in	_	_	IN	O	[-1]	['none']	_	_
48	terms	_	_	NNS	O	[-1]	['none']	_	_
49	of	_	_	IN	O	[-1]	['none']	_	_
50	effector	_	_	NN	O	[-1]	['none']	_	_
51	CTL	_	_	NN	O	[-1]	['none']	_	_
52	differentiation	_	_	NN	O	[-1]	['none']	_	_
53	and	_	_	CC	O	[-1]	['none']	_	_
54	under	_	_	IN	O	[-1]	['none']	_	_
55	our	_	_	PRP$	O	[-1]	['none']	_	_
56	culture	_	_	NN	O	[-1]	['none']	_	_
57	conditions	_	_	NNS	O	[-1]	['none']	_	_
58	,	_	_	,	O	[-1]	['none']	_	_
59	Runx3-/-	_	_	JJ	Protein	[0]	['root']	_	_
60	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
61	T	_	_	NN	O	[-1]	['none']	_	_
62	cells	_	_	NNS	O	[-1]	['none']	_	_
63	that	_	_	WDT	O	[-1]	['none']	_	_
64	also	_	_	RB	O	[-1]	['none']	_	_
65	coexpress	_	_	VBP	Gene_expression	[0]	['root']	_	_
66	CD4	_	_	NN	Protein	[65]	['Theme']	_	_
67	are	_	_	VBP	O	[-1]	['none']	_	_
68	indistinguishable	_	_	JJ	O	[-1]	['none']	_	_
69	from	_	_	IN	O	[-1]	['none']	_	_
70	those	_	_	DT	O	[-1]	['none']	_	_
71	that	_	_	WDT	O	[-1]	['none']	_	_
72	do	_	_	VBP	O	[-1]	['none']	_	_
73	not	_	_	RB	O	[-1]	['none']	_	_
74	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	presented	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	Fig	_	_	NN	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	S2	_	_	NN	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	Runx3	_	_	NN	Protein	[0]	['root']	_	_
5	KO	_	_	NN	O	[-1]	['none']	_	_
6	SP	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	whereas	_	_	IN	O	[-1]	['none']	_	_
10	those	_	_	DT	O	[-1]	['none']	_	_
11	shown	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	Figs.	_	_	NNP	O	[-1]	['none']	_	_
14	3	_	_	CD	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	4	_	_	CD	O	[-1]	['none']	_	_
17	are	_	_	VBP	O	[-1]	['none']	_	_
18	from	_	_	IN	O	[-1]	['none']	_	_
19	total	_	_	JJ	O	[-1]	['none']	_	_
20	Runx3	_	_	NN	Protein	[0]	['root']	_	_
21	KO	_	_	NN	O	[-1]	['none']	_	_
22	CD8	_	_	NN	Protein	[0]	['root']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
3	activity	_	_	NN	O	[-1]	['none']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	important	_	_	JJ	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	regulating	_	_	VBG	O	[-1]	['none']	_	_
8	intracellular	_	_	JJ	O	[-1]	['none']	_	_
9	signaling	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	stress	_	_	NN	O	[-1]	['none']	_	_
12	response	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	proliferation	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	survival	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	differentiation	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	inflammation	_	_	NN	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	8	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	regulate	_	_	VB	O	[-1]	['none']	_	_
3	gene	_	_	NN	O	[-1]	['none']	_	_
4	transcription	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	p50	_	_	NN	Protein	[11]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	p65	_	_	NN	Protein	[11]	['Theme']	_	_
10	heterodimers	_	_	NNS	O	[-1]	['none']	_	_
11	translocate	_	_	VB	Localization	[0]	['root']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	nucleus	_	_	NN	Entity	[11]	['ToLoc']	_	_
15	from	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	cytoplasm	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	however	_	_	RB	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	their	_	_	PRP$	Protein	[22]	['Theme']	_	_
22	translocation	_	_	NN	Localization	[0]	['root']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	not	_	_	RB	O	[-1]	['none']	_	_
25	sufficient	_	_	JJ	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	activate	_	_	VB	O	[-1]	['none']	_	_
28	gene	_	_	NN	O	[-1]	['none']	_	_
29	transcription	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Post-translational	_	_	JJ	O	[-1]	['none']	_	_
2	modification	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	heterodimers	_	_	NNS	O	[-1]	['none']	_	_
6	such	_	_	JJ	O	[-1]	['none']	_	_
7	as	_	_	IN	O	[-1]	['none']	_	_
8	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
9	or	_	_	CC	O	[-1]	['none']	_	_
10	acetylation	_	_	NN	O	[-1]	['none']	_	_
11	also	_	_	RB	O	[-1]	['none']	_	_
12	contributes	_	_	VBZ	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	its	_	_	PRP$	O	[-1]	['none']	_	_
15	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
16	activity	_	_	NN	O	[-1]	['none']	_	_
17	[	_	_	CD	O	[-1]	['none']	_	_
18	41	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	42	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	43	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Because	_	_	IN	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	constitutively	_	_	RB	O	[-1]	['none']	_	_
4	translocates	_	_	VBZ	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	nucleus	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	monocytic	_	_	JJ	O	[-1]	['none']	_	_
10	lineage	_	_	NN	O	[-1]	['none']	_	_
11	[	_	_	CD	O	[-1]	['none']	_	_
12	13	_	_	CD	O	[-1]	['none']	_	_
13	]	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	activates	_	_	VBZ	O	[-1]	['none']	_	_
16	gene	_	_	NN	O	[-1]	['none']	_	_
17	transcription	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	survival	_	_	NN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	murine	_	_	JJ	O	[-1]	['none']	_	_
22	macrophages	_	_	NNS	O	[-1]	['none']	_	_
23	[	_	_	VBP	O	[-1]	['none']	_	_
24	11	_	_	CD	O	[-1]	['none']	_	_
25	]	_	_	CD	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	we	_	_	PRP	O	[-1]	['none']	_	_
28	sought	_	_	VBD	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	determine	_	_	VB	O	[-1]	['none']	_	_
31	how	_	_	WRB	O	[-1]	['none']	_	_
32	M-CSF	_	_	NN	O	[-1]	['none']	_	_
33	affected	_	_	VBD	O	[-1]	['none']	_	_
34	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
35	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
36	activity	_	_	NN	O	[-1]	['none']	_	_
37	in	_	_	IN	O	[-1]	['none']	_	_
38	human	_	_	NN	O	[-1]	['none']	_	_
39	MDMs	_	_	NNS	O	[-1]	['none']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	whether	_	_	IN	O	[-1]	['none']	_	_
42	this	_	_	DT	O	[-1]	['none']	_	_
43	activation	_	_	NN	O	[-1]	['none']	_	_
44	regulated	_	_	VBD	O	[-1]	['none']	_	_
45	their	_	_	PRP$	O	[-1]	['none']	_	_
46	survival	_	_	NN	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	present	_	_	JJ	O	[-1]	['none']	_	_
3	study	_	_	NN	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	M-CSF	_	_	NN	O	[-1]	['none']	_	_
7	stimulated	_	_	VBD	Positive_regulation	[0]	['root']	_	_
8	PKCalpha	_	_	NN	Protein	[7]	['Theme']	_	_
9	kinase	_	_	NN	O	[-1]	['none']	_	_
10	upstream	_	_	RB	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
14	activity	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	primary	_	_	JJ	O	[-1]	['none']	_	_
17	human	_	_	NN	O	[-1]	['none']	_	_
18	MDMs	_	_	NNS	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	RAW	_	_	NN	O	[-1]	['none']	_	_
21	264.7	_	_	CD	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	showed	_	_	VBD	O	[-1]	['none']	_	_
3	inhibition	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	conventional	_	_	JJ	O	[-1]	['none']	_	_
6	PKCs	_	_	NNS	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	PKC	_	_	NN	O	[-1]	['none']	_	_
9	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	kinase	_	_	NN	Negative_regulation	[12]	['multitoken']	_	_
12	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
13	PKCalpha	_	_	NN	Protein	[12]	['Theme']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	PKCalpha	_	_	NN	Protein	[16]	['multitoken']	_	_
16	siRNA	_	_	NN	Protein	[0]	['root']	_	_
17	blocked	_	_	VBD	O	[-1]	['none']	_	_
18	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	survival	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	NF-kappaB-regulated	_	_	JJ	O	[-1]	['none']	_	_
23	gene	_	_	NN	O	[-1]	['none']	_	_
24	expression	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	block	_	_	NN	O	[-1]	['none']	_	_
3	correlated	_	_	VBD	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	reduction	_	_	NN	Negative_regulation	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	M-CSF-induced	_	_	JJ	Positive_regulation	[6]	['Theme']	_	_
9	phosphorylation	_	_	NN	Phosphorylation	[8]	['Theme']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	p65	_	_	NN	Protein	[9]	['Theme']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	Ser276	_	_	NN	Entity	[9]	['Site']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Consistent	_	_	JJ	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	findings	_	_	NNS	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	dominant	_	_	JJ	Protein	[8]	['multitoken']	_	_
7	negative	_	_	JJ	Protein	[8]	['multitoken']	_	_
8	PKCalpha	_	_	NN	Protein	[11]	['Cause']	_	_
9	constructs	_	_	NNS	O	[-1]	['none']	_	_
10	also	_	_	RB	O	[-1]	['none']	_	_
11	inhibited	_	_	VBD	Negative_regulation	[0]	['root']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	p65	_	_	NN	Protein	[14]	['Theme']	_	_
14	phosphorylation	_	_	NN	Phosphorylation	[11]	['Theme']	_	_
15	at	_	_	IN	O	[-1]	['none']	_	_
16	Ser276	_	_	NN	Entity	[14]	['Site']	_	_
17	but	_	_	CC	O	[-1]	['none']	_	_
18	not	_	_	RB	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	Ser536	_	_	NN	Entity	[14]	['Site']	_	_
21	resulting	_	_	VBG	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	reduced	_	_	VBN	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
26	activation	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
29	MDM	_	_	NN	O	[-1]	['none']	_	_
30	survival	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	simplified	_	_	VBD	O	[-1]	['none']	_	_
3	proposed	_	_	VBN	O	[-1]	['none']	_	_
4	cartoon	_	_	NN	O	[-1]	['none']	_	_
5	model	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	Figure	_	_	NNP	O	[-1]	['none']	_	_
8	9	_	_	CD	O	[-1]	['none']	_	_
9	demonstrates	_	_	VBZ	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	M-CSF	_	_	NN	O	[-1]	['none']	_	_
12	induced	_	_	VBD	O	[-1]	['none']	_	_
13	monocytes	_	_	NNS	O	[-1]	['none']	_	_
14	survival	_	_	NN	O	[-1]	['none']	_	_
15	is	_	_	VBZ	O	[-1]	['none']	_	_
16	regulated	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	activating	_	_	VBG	Positive_regulation	[0]	['root']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	p65	_	_	NN	Protein	[21]	['Theme']	_	_
21	phosphorylation	_	_	NN	Phosphorylation	[18]	['Theme']	_	_
22	at	_	_	IN	O	[-1]	['none']	_	_
23	Ser276	_	_	NN	Entity	[21]	['Site']	_	_
24	via	_	_	IN	O	[-1]	['none']	_	_
25	PKC	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Finally	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	p65-/-	_	_	NN	Gene_expression	[0]	['root']	_	_
7	fibroblast	_	_	NN	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	line	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	we	_	_	PRP	O	[-1]	['none']	_	_
12	confirmed	_	_	VBD	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	Ser276	_	_	NN	O	[-1]	['none']	_	_
16	residue	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	p65	_	_	NN	Protein	[0]	['root']	_	_
20	is	_	_	VBZ	O	[-1]	['none']	_	_
21	important	_	_	JJ	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	essential	_	_	JJ	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	PKC	_	_	NN	O	[-1]	['none']	_	_
26	modulation	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
29	activity	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	More	_	_	RBR	O	[-1]	['none']	_	_
2	compelling	_	_	JJ	O	[-1]	['none']	_	_
3	is	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	we	_	_	PRP	O	[-1]	['none']	_	_
6	observed	_	_	VBD	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	similar	_	_	JJ	O	[-1]	['none']	_	_
9	regulation	_	_	NN	O	[-1]	['none']	_	_
10	between	_	_	IN	O	[-1]	['none']	_	_
11	two	_	_	CD	O	[-1]	['none']	_	_
12	different	_	_	JJ	O	[-1]	['none']	_	_
13	cell	_	_	NN	O	[-1]	['none']	_	_
14	lineages	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	our	_	_	PRP$	O	[-1]	['none']	_	_
17	study	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Post-translational	_	_	JJ	Protein_modification	[2]	['multitoken']	_	_
2	modification	_	_	NN	Protein_modification	[0]	['root']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	p65	_	_	NN	Protein	[2]	['Theme']	_	_
6	regulates	_	_	VBZ	O	[-1]	['none']	_	_
7	its	_	_	PRP$	O	[-1]	['none']	_	_
8	activating	_	_	NN	O	[-1]	['none']	_	_
9	or	_	_	CC	O	[-1]	['none']	_	_
10	repressing	_	_	VBG	O	[-1]	['none']	_	_
11	effects	_	_	NNS	O	[-1]	['none']	_	_
12	on	_	_	IN	O	[-1]	['none']	_	_
13	gene	_	_	NN	O	[-1]	['none']	_	_
14	expression	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Among	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	seven	_	_	CD	O	[-1]	['none']	_	_
4	reported	_	_	VBD	O	[-1]	['none']	_	_
5	putative	_	_	JJ	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	p65	_	_	NN	Protein	[0]	['root']	_	_
8	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
9	sites	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	five	_	_	CD	O	[-1]	['none']	_	_
12	increase	_	_	NN	O	[-1]	['none']	_	_
13	nuclear	_	_	JJ	O	[-1]	['none']	_	_
14	translocation	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	DNA	_	_	NN	O	[-1]	['none']	_	_
17	binding	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
20	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
21	activity	_	_	NN	O	[-1]	['none']	_	_
22	[	_	_	CD	O	[-1]	['none']	_	_
23	17	_	_	CD	O	[-1]	['none']	_	_
24	]	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	finding	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	Zhong	_	_	NNP	O	[-1]	['none']	_	_
7	et	_	_	FW	O	[-1]	['none']	_	_
8	al.	_	_	FW	O	[-1]	['none']	_	_
9	found	_	_	VBN	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	in	_	_	IN	Positive_regulation	[13]	['multitoken']	_	_
12	response	_	_	NN	Positive_regulation	[13]	['multitoken']	_	_
13	to	_	_	TO	Positive_regulation	[0]	['root']	_	_
14	LPS	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
17	p65	_	_	NN	Protein	[19]	['Theme']	_	_
18	is	_	_	VBZ	O	[-1]	['none']	_	_
19	phosphorylated	_	_	VBN	Phosphorylation	[13]	['Theme']	_	_
20	at	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	highly	_	_	RB	O	[-1]	['none']	_	_
23	conserved	_	_	VBN	O	[-1]	['none']	_	_
24	Ser276	_	_	NN	Entity	[19]	['Site']	_	_
25	residue	_	_	NN	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	catalytic	_	_	JJ	O	[-1]	['none']	_	_
29	subunit	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	PKA	_	_	NN	O	[-1]	['none']	_	_
32	[	_	_	CD	O	[-1]	['none']	_	_
33	16	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	PKA	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	Ser276	_	_	NN	Entity	[9]	['Site']	_	_
7	can	_	_	MD	O	[-1]	['none']	_	_
8	be	_	_	VB	O	[-1]	['none']	_	_
9	phosphorylated	_	_	VBN	Phosphorylation	[15]	['Theme']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	MSK1	_	_	NN	Protein	[9]	['Cause']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	nucleus	_	_	NN	O	[-1]	['none']	_	_
15	upon	_	_	IN	Positive_regulation	[0]	['root']	_	_
16	TNFalpha	_	_	NN	Protein	[15]	['Cause']	_	_
17	treatment	_	_	NN	O	[-1]	['none']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	18	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Phosphorylation	_	_	NN	Phosphorylation	[10]	['Theme']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	p65	_	_	NN	Protein	[1]	['Theme']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	Ser536	_	_	NN	Entity	[1]	['Site']	_	_
7	occurs	_	_	VBZ	O	[-1]	['none']	_	_
8	in	_	_	IN	Positive_regulation	[10]	['multitoken']	_	_
9	response	_	_	NN	Positive_regulation	[10]	['multitoken']	_	_
10	to	_	_	TO	Positive_regulation	[0]	['root']	_	_
11	many	_	_	JJ	O	[-1]	['none']	_	_
12	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
13	stimuli	_	_	NNS	O	[-1]	['none']	_	_
14	as	_	_	RB	O	[-1]	['none']	_	_
15	well	_	_	RB	O	[-1]	['none']	_	_
16	as	_	_	IN	O	[-1]	['none']	_	_
17	kinases	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	IKKalpha	_	_	NN	Protein	[0]	['root']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	IKKbeta	_	_	NN	Protein	[0]	['root']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	RSK1	_	_	NN	Protein	[0]	['root']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	17	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	[	_	_	CD	O	[-1]	['none']	_	_
29	18	_	_	CD	O	[-1]	['none']	_	_
30	]	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	[	_	_	CD	O	[-1]	['none']	_	_
33	19	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	NN	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	[	_	_	CD	O	[-1]	['none']	_	_
37	20	_	_	CD	O	[-1]	['none']	_	_
38	]	_	_	NN	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	[	_	_	CD	O	[-1]	['none']	_	_
41	21	_	_	CD	O	[-1]	['none']	_	_
42	]	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	Notably	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	addition	_	_	NN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	phosphorylating	_	_	VBG	O	[-1]	['none']	_	_
7	Ser276	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	our	_	_	PRP$	O	[-1]	['none']	_	_
12	study	_	_	NN	O	[-1]	['none']	_	_
13	revealed	_	_	VBD	O	[-1]	['none']	_	_
14	that	_	_	IN	O	[-1]	['none']	_	_
15	M-CSF	_	_	NN	O	[-1]	['none']	_	_
16	also	_	_	RB	O	[-1]	['none']	_	_
17	modulated	_	_	VBD	Regulation	[0]	['root']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	phosphorylation	_	_	NN	Phosphorylation	[17]	['Theme']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
23	p65	_	_	NN	Protein	[19]	['Theme']	_	_
24	subunit	_	_	NN	O	[-1]	['none']	_	_
25	at	_	_	IN	O	[-1]	['none']	_	_
26	Ser536	_	_	NN	Entity	[19]	['Site']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	however	_	_	RB	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	PKC	_	_	NN	O	[-1]	['none']	_	_
31	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
32	or	_	_	CC	O	[-1]	['none']	_	_
33	kinase	_	_	NN	Negative_regulation	[34]	['multitoken']	_	_
34	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
35	PKCalpha	_	_	NN	Protein	[34]	['Theme']	_	_
36	constructs	_	_	NNS	O	[-1]	['none']	_	_
37	did	_	_	VBD	O	[-1]	['none']	_	_
38	not	_	_	RB	O	[-1]	['none']	_	_
39	affect	_	_	VB	O	[-1]	['none']	_	_
40	this	_	_	DT	O	[-1]	['none']	_	_
41	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
42	event	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	Moreover	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	mutant	_	_	NN	O	[-1]	['none']	_	_
4	constructs	_	_	NNS	O	[-1]	['none']	_	_
5	containing	_	_	VBG	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	point	_	_	NN	Regulation	[8]	['multitoken']	_	_
8	mutation	_	_	NN	Regulation	[0]	['root']	_	_
9	at	_	_	IN	O	[-1]	['none']	_	_
10	Ser536	_	_	NN	Entity	[8]	['Site']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
13	p65	_	_	NN	Protein	[8]	['Theme']	_	_
14	did	_	_	VBD	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	reduce	_	_	VB	O	[-1]	['none']	_	_
17	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
18	activity	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	lacking	_	_	VBG	Negative_regulation	[0]	['root']	_	_
22	endogenous	_	_	JJ	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	p65	_	_	NN	Protein	[21]	['Theme']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	while	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
29	p65	_	_	NN	Protein	[0]	['root']	_	_
30	276S/A	_	_	NN	O	[-1]	['none']	_	_
31	construct	_	_	NN	O	[-1]	['none']	_	_
32	did	_	_	VBD	O	[-1]	['none']	_	_
33	reduce	_	_	VB	O	[-1]	['none']	_	_
34	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
35	activity	_	_	NN	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	these	_	_	DT	O	[-1]	['none']	_	_
38	cells	_	_	NNS	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	specific	_	_	JJ	O	[-1]	['none']	_	_
4	post-translational	_	_	JJ	Protein_modification	[5]	['multitoken']	_	_
5	modification	_	_	NN	Protein_modification	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[5]	['Theme']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	likely	_	_	JJ	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	regulate	_	_	VB	O	[-1]	['none']	_	_
13	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	response	_	_	NN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	specific	_	_	JJ	O	[-1]	['none']	_	_
19	stimuli	_	_	NNS	O	[-1]	['none']	_	_
20	[	_	_	VBP	O	[-1]	['none']	_	_
21	15	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	CD	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	43	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	notable	_	_	JJ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	M-CSF	_	_	NN	O	[-1]	['none']	_	_
6	activated	_	_	VBD	Positive_regulation	[17]	['Theme']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[10]	['Theme']	_	_
9	Ser276	_	_	NN	Entity	[10]	['Site']	_	_
10	phosphorylation	_	_	NN	Phosphorylation	[6]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
13	activation	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	PKCalpha	_	_	NN	Protein	[17]	['Cause']	_	_
17	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
18	manner	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	member	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	conventional	_	_	JJ	O	[-1]	['none']	_	_
8	PKC	_	_	NN	O	[-1]	['none']	_	_
9	family	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	protein	_	_	NN	O	[-1]	['none']	_	_
12	kinases	_	_	NNS	O	[-1]	['none']	_	_
13	that	_	_	WDT	O	[-1]	['none']	_	_
14	are	_	_	VBP	O	[-1]	['none']	_	_
15	critical	_	_	JJ	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	cell	_	_	NN	O	[-1]	['none']	_	_
18	growth	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	differentiation	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	cell	_	_	NN	O	[-1]	['none']	_	_
23	death	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
2	primarily	_	_	RB	O	[-1]	['none']	_	_
3	modulates	_	_	VBZ	O	[-1]	['none']	_	_
4	anti-apoptotic	_	_	JJ	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	proliferation	_	_	NN	O	[-1]	['none']	_	_
7	signals	_	_	NNS	O	[-1]	['none']	_	_
8	following	_	_	VBG	O	[-1]	['none']	_	_
9	cytokine	_	_	NN	O	[-1]	['none']	_	_
10	treatment	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	various	_	_	JJ	O	[-1]	['none']	_	_
13	cell	_	_	NN	O	[-1]	['none']	_	_
14	types	_	_	NNS	O	[-1]	['none']	_	_
15	[	_	_	VBP	O	[-1]	['none']	_	_
16	42	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	CD	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	Gene_expression	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PKCalpha	_	_	NN	Protein	[1]	['Theme']	_	_
4	attenuates	_	_	VBZ	O	[-1]	['none']	_	_
5	apoptosis	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	many	_	_	JJ	O	[-1]	['none']	_	_
8	different	_	_	JJ	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	types	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	while	_	_	IN	O	[-1]	['none']	_	_
13	PKCalpha	_	_	NN	Protein	[14]	['Theme']	_	_
14	inhibition	_	_	NN	Negative_regulation	[0]	['root']	_	_
15	generally	_	_	RB	O	[-1]	['none']	_	_
16	potentiates	_	_	VBZ	O	[-1]	['none']	_	_
17	apoptosis	_	_	NN	O	[-1]	['none']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	42	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	our	_	_	PRP$	O	[-1]	['none']	_	_
3	studies	_	_	NNS	O	[-1]	['none']	_	_
4	using	_	_	VBG	O	[-1]	['none']	_	_
5	conventional	_	_	JJ	O	[-1]	['none']	_	_
6	PKC	_	_	NN	O	[-1]	['none']	_	_
7	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	dominant	_	_	JJ	Protein	[11]	['multitoken']	_	_
10	negative	_	_	JJ	Protein	[11]	['multitoken']	_	_
11	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
12	constructs	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	PKCalpha	_	_	NN	Protein	[22]	['Cause']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	critical	_	_	JJ	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
19	macrophage	_	_	NN	O	[-1]	['none']	_	_
20	survival	_	_	NN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	inducing	_	_	VBG	Positive_regulation	[0]	['root']	_	_
23	Ser276	_	_	NN	Entity	[24]	['Site']	_	_
24	phosphorylation	_	_	NN	Phosphorylation	[22]	['Theme']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	p65	_	_	NN	Protein	[24]	['Theme']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	both	_	_	CC	O	[-1]	['none']	_	_
30	primary	_	_	JJ	O	[-1]	['none']	_	_
31	human	_	_	NN	O	[-1]	['none']	_	_
32	MDMs	_	_	NNS	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	Raw	_	_	NN	O	[-1]	['none']	_	_
35	264.7	_	_	CD	O	[-1]	['none']	_	_
36	cells	_	_	NNS	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
4	PKC	_	_	NN	O	[-1]	['none']	_	_
5	inhibition	_	_	NN	O	[-1]	['none']	_	_
6	downregulated	_	_	VBD	Negative_regulation	[0]	['root']	_	_
7	NF-kappaB-induction	_	_	NN	Positive_regulation	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	anti-apoptotic	_	_	JJ	O	[-1]	['none']	_	_
11	gene	_	_	NN	O	[-1]	['none']	_	_
12	BCL-xL	_	_	NN	Protein	[7]	['Theme']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Consistent	_	_	JJ	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	finding	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	others	_	_	NNS	O	[-1]	['none']	_	_
7	reported	_	_	VBD	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	regulated	_	_	VBD	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	gene	_	_	NN	O	[-1]	['none']	_	_
12	expression	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	many	_	_	JJ	O	[-1]	['none']	_	_
15	anti-apoptotic	_	_	JJ	O	[-1]	['none']	_	_
16	proteins	_	_	NNS	O	[-1]	['none']	_	_
17	including	_	_	VBG	O	[-1]	['none']	_	_
18	other	_	_	JJ	O	[-1]	['none']	_	_
19	BCL-2	_	_	NN	O	[-1]	['none']	_	_
20	family	_	_	NN	O	[-1]	['none']	_	_
21	members	_	_	NNS	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	inhibitor	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	apoptosis	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	IAP	_	_	NN	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	proteins	_	_	NNS	O	[-1]	['none']	_	_
30	which	_	_	WDT	O	[-1]	['none']	_	_
31	are	_	_	VBP	O	[-1]	['none']	_	_
32	regulators	_	_	NNS	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	apoptosis	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	function	_	_	NN	O	[-1]	['none']	_	_
37	upstream	_	_	JJ	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	caspases	_	_	NNS	O	[-1]	['none']	_	_
40	[	_	_	VBP	O	[-1]	['none']	_	_
41	44	_	_	CD	O	[-1]	['none']	_	_
42	]	_	_	CD	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	been	_	_	VBN	O	[-1]	['none']	_	_
4	shown	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	phosphorylation	_	_	NN	Phosphorylation	[11]	['Cause']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[6, 13, 17]	['Theme', 'Theme', 'Theme']	_	_
9	at	_	_	IN	O	[-1]	['none']	_	_
10	Ser276	_	_	NN	Entity	[6]	['Site']	_	_
11	prevents	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
12	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
13	degradation	_	_	NN	Protein_catabolism	[14]	['Theme']	_	_
14	by	_	_	IN	Positive_regulation	[11]	['Theme']	_	_
15	ubiquitin	_	_	NN	Protein	[16]	['Cause']	_	_
16	mediated	_	_	VBD	Positive_regulation	[14]	['Cause']	_	_
17	proteolysis	_	_	NN	Protein_catabolism	[16]	['Theme']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	promotes	_	_	VBZ	O	[-1]	['none']	_	_
20	cell	_	_	NN	O	[-1]	['none']	_	_
21	survival	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	HeLa	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	[	_	_	VBP	O	[-1]	['none']	_	_
26	24	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	CD	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	BCL-xL	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	examined	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	this	_	_	DT	O	[-1]	['none']	_	_
10	study	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	we	_	_	PRP	O	[-1]	['none']	_	_
13	are	_	_	VBP	O	[-1]	['none']	_	_
14	evaluating	_	_	VBG	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	possibility	_	_	NN	O	[-1]	['none']	_	_
17	that	_	_	IN	O	[-1]	['none']	_	_
18	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
19	regulated	_	_	VBD	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	activity	_	_	NN	O	[-1]	['none']	_	_
22	upregulates	_	_	VBZ	O	[-1]	['none']	_	_
23	additional	_	_	JJ	O	[-1]	['none']	_	_
24	anti-apoptotic	_	_	JJ	O	[-1]	['none']	_	_
25	genes	_	_	NNS	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	an	_	_	DT	O	[-1]	['none']	_	_
28	M-CSF-dependent	_	_	JJ	O	[-1]	['none']	_	_
29	fashion	_	_	NN	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	modulate	_	_	VB	O	[-1]	['none']	_	_
32	cell	_	_	NN	O	[-1]	['none']	_	_
33	survival	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	use	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	siRNA	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	our	_	_	PRP$	O	[-1]	['none']	_	_
9	study	_	_	NN	O	[-1]	['none']	_	_
10	has	_	_	VBZ	O	[-1]	['none']	_	_
11	not	_	_	RB	O	[-1]	['none']	_	_
12	ruled	_	_	VBN	O	[-1]	['none']	_	_
13	out	_	_	RP	O	[-1]	['none']	_	_
14	that	_	_	IN	O	[-1]	['none']	_	_
15	other	_	_	JJ	O	[-1]	['none']	_	_
16	conventional	_	_	JJ	O	[-1]	['none']	_	_
17	PKCs	_	_	NNS	O	[-1]	['none']	_	_
18	might	_	_	MD	O	[-1]	['none']	_	_
19	also	_	_	RB	O	[-1]	['none']	_	_
20	be	_	_	VB	O	[-1]	['none']	_	_
21	important	_	_	JJ	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	activation	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	macrophage	_	_	NN	O	[-1]	['none']	_	_
28	survival	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	actions	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
8	activation	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	other	_	_	JJ	O	[-1]	['none']	_	_
11	conventional	_	_	JJ	O	[-1]	['none']	_	_
12	PKC	_	_	NN	O	[-1]	['none']	_	_
13	isoforms	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	like	_	_	IN	O	[-1]	['none']	_	_
16	PKCbetaI	_	_	NN	Protein	[0]	['root']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	betaII	_	_	NN	Protein	[0]	['root']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	appear	_	_	VBP	O	[-1]	['none']	_	_
21	necessary	_	_	JJ	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	macrophage	_	_	NN	O	[-1]	['none']	_	_
24	apoptosis	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	PKCbetaI	_	_	NN	Protein	[7]	['Theme']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	betaII	_	_	NN	Protein	[7]	['Theme']	_	_
5	isoforms	_	_	NNS	O	[-1]	['none']	_	_
6	are	_	_	VBP	O	[-1]	['none']	_	_
7	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	apoptotic	_	_	JJ	O	[-1]	['none']	_	_
10	U937	_	_	NN	O	[-1]	['none']	_	_
11	myelomonocytic	_	_	JJ	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	[	_	_	VBP	O	[-1]	['none']	_	_
14	45	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	CD	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	human	_	_	NN	O	[-1]	['none']	_	_
3	myeloid	_	_	JJ	O	[-1]	['none']	_	_
4	cell	_	_	NN	O	[-1]	['none']	_	_
5	line	_	_	NN	O	[-1]	['none']	_	_
6	HL-525	_	_	NN	O	[-1]	['none']	_	_
7	which	_	_	WDT	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	devoid	_	_	JJ	Gene_expression	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	endogenous	_	_	JJ	O	[-1]	['none']	_	_
12	PKCbetaII	_	_	NN	Protein	[9]	['Theme']	_	_
13	is	_	_	VBZ	O	[-1]	['none']	_	_
14	resistant	_	_	JJ	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
17	induced	_	_	VBD	O	[-1]	['none']	_	_
18	apoptosis	_	_	NN	O	[-1]	['none']	_	_
19	[	_	_	CD	O	[-1]	['none']	_	_
20	46	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Re-expression	_	_	NN	Gene_expression	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PKCbetaII	_	_	NN	Protein	[1]	['Theme']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	HL-525	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	restores	_	_	VBZ	O	[-1]	['none']	_	_
8	their	_	_	PRP$	O	[-1]	['none']	_	_
9	susceptibility	_	_	NN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
12	induced	_	_	VBD	O	[-1]	['none']	_	_
13	apoptosis	_	_	NN	O	[-1]	['none']	_	_
14	implying	_	_	VBG	O	[-1]	['none']	_	_
15	that	_	_	IN	O	[-1]	['none']	_	_
16	PKCbetaII	_	_	NN	Protein	[0]	['root']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	pro	_	_	JJ	O	[-1]	['none']	_	_
19	apoptotic	_	_	JJ	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	may	_	_	MD	O	[-1]	['none']	_	_
22	be	_	_	VB	O	[-1]	['none']	_	_
23	required	_	_	VBN	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	induce	_	_	VB	O	[-1]	['none']	_	_
26	macrophage	_	_	NN	O	[-1]	['none']	_	_
27	apoptosis	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Recent	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
7	activity	_	_	NN	O	[-1]	['none']	_	_
8	can	_	_	MD	O	[-1]	['none']	_	_
9	be	_	_	VB	O	[-1]	['none']	_	_
10	regulated	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	p65	_	_	NN	Protein	[12]	['Theme']	_	_
17	subunit	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	IkappaBalpha	_	_	NN	Protein	[23]	['Theme']	_	_
23	degradation	_	_	NN	Protein_catabolism	[20]	['Theme']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	47	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	By	_	_	IN	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	pathway	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	regulates	_	_	VBZ	O	[-1]	['none']	_	_
9	its	_	_	PRP$	O	[-1]	['none']	_	_
10	interaction	_	_	NN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	other	_	_	JJ	O	[-1]	['none']	_	_
13	components	_	_	NNS	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	basal	_	_	JJ	O	[-1]	['none']	_	_
17	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
18	machinery	_	_	NN	O	[-1]	['none']	_	_
19	without	_	_	IN	O	[-1]	['none']	_	_
20	affecting	_	_	VBG	O	[-1]	['none']	_	_
21	its	_	_	PRP$	O	[-1]	['none']	_	_
22	capability	_	_	NN	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	bind	_	_	VB	O	[-1]	['none']	_	_
25	DNA	_	_	NN	O	[-1]	['none']	_	_
26	[	_	_	NN	O	[-1]	['none']	_	_
27	21	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	can	_	_	MD	O	[-1]	['none']	_	_
4	bind	_	_	VB	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	promoters	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	numerous	_	_	JJ	O	[-1]	['none']	_	_
9	gene	_	_	NN	O	[-1]	['none']	_	_
10	targets	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	post-translational	_	_	JJ	Protein_modification	[13]	['multitoken']	_	_
13	modification	_	_	NN	Protein_modification	[18]	['Cause']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	p65	_	_	NN	Protein	[13, 20]	['Theme', 'Theme']	_	_
17	may	_	_	MD	O	[-1]	['none']	_	_
18	affect	_	_	VB	Regulation	[0]	['root']	_	_
19	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
20	interaction	_	_	NN	Binding	[18]	['Theme']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	other	_	_	JJ	O	[-1]	['none']	_	_
23	proteins	_	_	NNS	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	refining	_	_	VBG	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	expression	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	gene	_	_	NN	O	[-1]	['none']	_	_
30	targets	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	did	_	_	VBD	O	[-1]	['none']	_	_
3	not	_	_	RB	O	[-1]	['none']	_	_
4	find	_	_	VB	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	PKC	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	involved	_	_	VBN	Regulation	[0]	['root']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	IkappaBalpha	_	_	NN	Protein	[11]	['Theme']	_	_
11	degradation	_	_	NN	Protein_catabolism	[8]	['Theme']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	p65	_	_	NN	Protein	[16]	['Theme']	_	_
15	nuclear	_	_	JJ	Entity	[16]	['ToLoc']	_	_
16	translocation	_	_	NN	Localization	[17]	['Theme']	_	_
17	induced	_	_	VBN	Positive_regulation	[8, 23]	['Theme', 'Theme']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	M-CSF	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	but	_	_	CC	O	[-1]	['none']	_	_
22	that	_	_	IN	O	[-1]	['none']	_	_
23	M-CSF-induced	_	_	JJ	Positive_regulation	[32]	['Theme']	_	_
24	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	p65	_	_	NN	Protein	[24]	['Theme']	_	_
28	at	_	_	IN	O	[-1]	['none']	_	_
29	Ser276	_	_	NN	Entity	[24]	['Site']	_	_
30	was	_	_	VBD	O	[-1]	['none']	_	_
31	dramatically	_	_	RB	O	[-1]	['none']	_	_
32	reduced	_	_	VBN	Negative_regulation	[0]	['root']	_	_
33	by	_	_	IN	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	conventional	_	_	JJ	O	[-1]	['none']	_	_
36	PKC	_	_	NN	O	[-1]	['none']	_	_
37	inhibitor	_	_	NN	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	kinase	_	_	NN	Negative_regulation	[40]	['multitoken']	_	_
40	deficient	_	_	JJ	Negative_regulation	[32]	['Cause']	_	_
41	PKCalpha	_	_	NN	Protein	[40]	['Theme']	_	_
42	and	_	_	CC	O	[-1]	['none']	_	_
43	by	_	_	IN	O	[-1]	['none']	_	_
44	siRNA	_	_	NN	Protein	[32]	['Cause']	_	_
45	towards	_	_	IN	O	[-1]	['none']	_	_
46	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	Current	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	underway	_	_	NN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	delineate	_	_	VB	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	protein	_	_	NN	O	[-1]	['none']	_	_
9	complexes	_	_	NNS	O	[-1]	['none']	_	_
10	formed	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	activated	_	_	VBN	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	other	_	_	JJ	O	[-1]	['none']	_	_
16	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
17	co-activators	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	response	_	_	NN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	M-CSF	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	PKC	_	_	NN	O	[-1]	['none']	_	_
24	activation	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Recently	_	_	RB	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	indicated	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	non	_	_	JJ	O	[-1]	['none']	_	_
7	canonical	_	_	JJ	O	[-1]	['none']	_	_
8	pathway	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	activated	_	_	VBN	O	[-1]	['none']	_	_
11	during	_	_	IN	O	[-1]	['none']	_	_
12	human	_	_	NN	O	[-1]	['none']	_	_
13	monocyte-macrophage	_	_	JJ	O	[-1]	['none']	_	_
14	differentiation	_	_	NN	O	[-1]	['none']	_	_
15	[	_	_	CD	O	[-1]	['none']	_	_
16	48	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	During	_	_	IN	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	process	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	expression	_	_	NN	Gene_expression	[13, 16]	['Theme', 'Cause']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IKKalpha	_	_	NN	Protein	[5]	['Theme']	_	_
8	among	_	_	IN	O	[-1]	['none']	_	_
9	other	_	_	JJ	O	[-1]	['none']	_	_
10	proteins	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	is	_	_	VBZ	O	[-1]	['none']	_	_
13	elevated	_	_	JJ	Positive_regulation	[0]	['root']	_	_
14	leading	_	_	VBG	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	increased	_	_	VBN	Positive_regulation	[23]	['Theme']	_	_
17	p52	_	_	NN	Protein	[22]	['Theme']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	relB	_	_	NN	Protein	[0]	['root']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	expression	_	_	NN	Gene_expression	[16]	['Theme']	_	_
23	through	_	_	IN	Positive_regulation	[0]	['root']	_	_
24	partial	_	_	JJ	O	[-1]	['none']	_	_
25	proteolytic	_	_	JJ	O	[-1]	['none']	_	_
26	degradation	_	_	NN	Protein_catabolism	[23]	['Cause']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	p100	_	_	NN	Protein	[26]	['Theme']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	protein	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	it	_	_	PRP	O	[-1]	['none']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	possible	_	_	JJ	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	M-CSF	_	_	NN	O	[-1]	['none']	_	_
8	regulates	_	_	VBZ	O	[-1]	['none']	_	_
9	monocyte	_	_	NN	O	[-1]	['none']	_	_
10	survival	_	_	NN	O	[-1]	['none']	_	_
11	through	_	_	IN	O	[-1]	['none']	_	_
12	both	_	_	CC	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	canonical	_	_	JJ	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	non	_	_	JJ	O	[-1]	['none']	_	_
17	canonical	_	_	JJ	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	pathways	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	which	_	_	WDT	O	[-1]	['none']	_	_
22	will	_	_	MD	O	[-1]	['none']	_	_
23	be	_	_	VB	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	focus	_	_	NN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	future	_	_	JJ	O	[-1]	['none']	_	_
28	research	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	previously	_	_	RB	O	[-1]	['none']	_	_
3	showed	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	M-CSF	_	_	NN	O	[-1]	['none']	_	_
6	reduced	_	_	VBD	Negative_regulation	[0]	['root']	_	_
7	caspase-3	_	_	NN	Protein	[6]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	-9	_	_	NN	Protein	[6]	['Theme']	_	_
10	activity	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	prevented	_	_	VBD	O	[-1]	['none']	_	_
13	monocyte	_	_	NN	O	[-1]	['none']	_	_
14	apoptosis	_	_	NN	O	[-1]	['none']	_	_
15	[	_	_	CD	O	[-1]	['none']	_	_
16	3	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	study	_	_	NN	O	[-1]	['none']	_	_
3	reveals	_	_	VBZ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	treatment	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	monocytes	_	_	NNS	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	conventional	_	_	JJ	O	[-1]	['none']	_	_
10	PKC	_	_	NN	O	[-1]	['none']	_	_
11	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	or	_	_	CC	O	[-1]	['none']	_	_
14	overexpression	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	kinase	_	_	NN	Negative_regulation	[17]	['multitoken']	_	_
17	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
18	PKCalpha	_	_	NN	Protein	[17]	['Theme']	_	_
19	blocked	_	_	VBD	O	[-1]	['none']	_	_
20	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	survival	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	revealed	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	conventional	_	_	JJ	O	[-1]	['none']	_	_
6	PKCs	_	_	NNS	O	[-1]	['none']	_	_
7	are	_	_	VBP	O	[-1]	['none']	_	_
8	upstream	_	_	JJ	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	response	_	_	NN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	M-CSF	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	mediate	_	_	VB	Positive_regulation	[0]	['root']	_	_
18	post-translational	_	_	JJ	O	[-1]	['none']	_	_
19	activation	_	_	NN	Positive_regulation	[17]	['Theme']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	p65	_	_	NN	Protein	[19, 24]	['Theme', 'Theme']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	phosphorylating	_	_	VBG	Phosphorylation	[19]	['Cause']	_	_
25	Ser276	_	_	NN	Entity	[24]	['Site']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	regulate	_	_	VB	O	[-1]	['none']	_	_
28	gene	_	_	NN	O	[-1]	['none']	_	_
29	transcription	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	cell	_	_	NN	O	[-1]	['none']	_	_
32	survival	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	observation	_	_	NN	O	[-1]	['none']	_	_
5	may	_	_	MD	O	[-1]	['none']	_	_
6	provide	_	_	VB	O	[-1]	['none']	_	_
7	insight	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	potential	_	_	JJ	O	[-1]	['none']	_	_
10	therapeutic	_	_	JJ	O	[-1]	['none']	_	_
11	targets	_	_	NNS	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
14	diseases	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Real-Time	_	_	NNP	O	[-1]	['none']	_	_
2	Quantitative	_	_	JJ	O	[-1]	['none']	_	_
3	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
4	Cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	harvested	_	_	VBN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	restimulated	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	presence	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	immobilized	_	_	VBN	O	[-1]	['none']	_	_
14	anti-CD3	_	_	JJ	Protein	[0]	['root']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	2	_	_	CD	O	[-1]	['none']	_	_
17	mug/ml	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	plus	_	_	CC	O	[-1]	['none']	_	_
20	anti-CD28	_	_	JJ	Protein	[0]	['root']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	2	_	_	CD	O	[-1]	['none']	_	_
23	mug/ml	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	for	_	_	IN	O	[-1]	['none']	_	_
26	3	_	_	CD	O	[-1]	['none']	_	_
27	hr	_	_	NN	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	immediately	_	_	RB	O	[-1]	['none']	_	_
30	lysed	_	_	VBN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	extracted	_	_	VBN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	reverse	_	_	JJ	O	[-1]	['none']	_	_
6	transcribed	_	_	VBN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	cDNA	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	analyzed	_	_	VBN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	expression	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	cytokines	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	transcription	_	_	NN	O	[-1]	['none']	_	_
18	factors	_	_	NNS	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	real-time	_	_	JJ	O	[-1]	['none']	_	_
21	PCR	_	_	NN	O	[-1]	['none']	_	_
22	assay	_	_	NN	O	[-1]	['none']	_	_
23	as	_	_	IN	O	[-1]	['none']	_	_
24	before	_	_	IN	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	Shoemaker	_	_	NNP	O	[-1]	['none']	_	_
27	et	_	_	FW	O	[-1]	['none']	_	_
28	al.	_	_	FW	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	2006	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Target	_	_	NN	O	[-1]	['none']	_	_
2	gene	_	_	NN	O	[-1]	['none']	_	_
3	mRNA	_	_	NN	O	[-1]	['none']	_	_
4	expression	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	quantified	_	_	VBN	O	[-1]	['none']	_	_
7	either	_	_	CC	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	SYBR	_	_	NNP	O	[-1]	['none']	_	_
10	Green	_	_	NNP	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Applied	_	_	NNP	O	[-1]	['none']	_	_
13	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	Master	_	_	NN	O	[-1]	['none']	_	_
18	Mix	_	_	NNP	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	Applied	_	_	NNP	O	[-1]	['none']	_	_
21	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	normalized	_	_	VBD	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	ubiquitin	_	_	NN	Protein	[30]	['Theme']	_	_
27	or	_	_	CC	O	[-1]	['none']	_	_
28	HPRT	_	_	NN	Protein	[30]	['Theme']	_	_
29	mRNA	_	_	NN	Transcription	[30]	['multitoken']	_	_
30	levels	_	_	NNS	Transcription	[0]	['root']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	respectively	_	_	RB	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	study	_	_	NN	O	[-1]	['none']	_	_
3	defines	_	_	VBZ	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	oncogenic	_	_	JJ	O	[-1]	['none']	_	_
6	properties	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	LMP1	_	_	NN	Protein	[0]	['root']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	promoting	_	_	VBG	O	[-1]	['none']	_	_
11	B	_	_	NN	O	[-1]	['none']	_	_
12	cell	_	_	NN	O	[-1]	['none']	_	_
13	lymphomagenesis	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	transgenic	_	_	JJ	O	[-1]	['none']	_	_
3	mice	_	_	NNS	O	[-1]	['none']	_	_
4	have	_	_	VBP	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	higher	_	_	JJR	O	[-1]	['none']	_	_
7	incidence	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	lymphoma	_	_	NN	O	[-1]	['none']	_	_
10	[	_	_	CD	O	[-1]	['none']	_	_
11	26	_	_	CD	O	[-1]	['none']	_	_
12	]	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	progression	_	_	NN	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	lymphoma	_	_	NN	O	[-1]	['none']	_	_
18	correlates	_	_	VBZ	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	higher	_	_	JJR	Positive_regulation	[0]	['root']	_	_
21	expression	_	_	NN	Gene_expression	[20]	['Theme']	_	_
22	levels	_	_	NNS	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	LMP1	_	_	NN	Protein	[21]	['Theme']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	suggesting	_	_	VBG	O	[-1]	['none']	_	_
27	that	_	_	IN	O	[-1]	['none']	_	_
28	LMP1	_	_	NN	Protein	[0]	['root']	_	_
29	is	_	_	VBZ	O	[-1]	['none']	_	_
30	directly	_	_	RB	O	[-1]	['none']	_	_
31	involved	_	_	VBN	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	tumor	_	_	NN	O	[-1]	['none']	_	_
34	development	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Table	_	_	NNP	O	[-1]	['none']	_	_
2	1	_	_	CD	O	[-1]	['none']	_	_
3	summarizes	_	_	VBZ	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	biological	_	_	JJ	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	molecular	_	_	JJ	O	[-1]	['none']	_	_
8	properties	_	_	NNS	O	[-1]	['none']	_	_
9	that	_	_	WDT	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	identified	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	wild-type	_	_	JJ	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	LMP1	_	_	NN	Protein	[0]	['root']	_	_
16	transgenic	_	_	JJ	O	[-1]	['none']	_	_
17	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	many	_	_	JJ	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	molecular	_	_	JJ	O	[-1]	['none']	_	_
6	properties	_	_	NNS	O	[-1]	['none']	_	_
7	studied	_	_	VBN	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	similar	_	_	JJ	O	[-1]	['none']	_	_
10	between	_	_	IN	O	[-1]	['none']	_	_
11	wild-type	_	_	JJ	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	LMP1	_	_	NN	Protein	[0]	['root']	_	_
14	transgenic	_	_	JJ	O	[-1]	['none']	_	_
15	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	there	_	_	EX	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	distinguishing	_	_	VBG	O	[-1]	['none']	_	_
20	biological	_	_	JJ	O	[-1]	['none']	_	_
21	properties	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	namely	_	_	RB	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	ability	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	LMP1	_	_	NN	Protein	[0]	['root']	_	_
28	transgenic	_	_	JJ	O	[-1]	['none']	_	_
29	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	induce	_	_	VB	O	[-1]	['none']	_	_
32	higher	_	_	JJR	O	[-1]	['none']	_	_
33	levels	_	_	NNS	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	survival	_	_	NN	O	[-1]	['none']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	proliferation	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	although	_	_	IN	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[0]	['root']	_	_
5	transgenic	_	_	JJ	O	[-1]	['none']	_	_
6	mice	_	_	NNS	O	[-1]	['none']	_	_
7	develop	_	_	VBP	O	[-1]	['none']	_	_
8	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	same	_	_	JJ	O	[-1]	['none']	_	_
12	B-1a	_	_	NN	O	[-1]	['none']	_	_
13	cell	_	_	NN	O	[-1]	['none']	_	_
14	type	_	_	NN	O	[-1]	['none']	_	_
15	as	_	_	IN	O	[-1]	['none']	_	_
16	spontaneous	_	_	JJ	O	[-1]	['none']	_	_
17	wild-type	_	_	JJ	O	[-1]	['none']	_	_
18	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	some	_	_	DT	O	[-1]	['none']	_	_
21	signaling	_	_	NN	O	[-1]	['none']	_	_
22	effects	_	_	NNS	O	[-1]	['none']	_	_
23	induced	_	_	VBN	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	LMP1	_	_	NN	Protein	[0]	['root']	_	_
26	may	_	_	MD	O	[-1]	['none']	_	_
27	explain	_	_	VB	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	enhanced	_	_	JJ	O	[-1]	['none']	_	_
30	promotion	_	_	NN	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	lymphomagenesis	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	CD40	_	_	NN	Protein	[3]	['Theme']	_	_
3	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
4	mice	_	_	NNS	O	[-1]	['none']	_	_
5	have	_	_	VBP	O	[-1]	['none']	_	_
6	decreased	_	_	VBN	O	[-1]	['none']	_	_
7	numbers	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	IgMhighIgDlow	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	phenotype	_	_	NN	O	[-1]	['none']	_	_
14	associated	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	B-1	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	marginal	_	_	JJ	O	[-1]	['none']	_	_
19	zone	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	memory	_	_	NN	O	[-1]	['none']	_	_
23	B	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	mimicry	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	CD40	_	_	NN	Protein	[0]	['root']	_	_
30	signaling	_	_	NN	O	[-1]	['none']	_	_
31	by	_	_	IN	O	[-1]	['none']	_	_
32	LMP1	_	_	NN	Protein	[0]	['root']	_	_
33	could	_	_	MD	O	[-1]	['none']	_	_
34	possibly	_	_	RB	O	[-1]	['none']	_	_
35	contribute	_	_	VB	O	[-1]	['none']	_	_
36	to	_	_	TO	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	expansion	_	_	NN	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	B-1	_	_	NN	O	[-1]	['none']	_	_
41	cells	_	_	NNS	O	[-1]	['none']	_	_
42	[	_	_	VBP	O	[-1]	['none']	_	_
43	20	_	_	CD	O	[-1]	['none']	_	_
44	]	_	_	CD	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	noteworthy	_	_	JJ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	LMP1	_	_	NN	Protein	[5]	['Theme']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	transgenic	_	_	JJ	O	[-1]	['none']	_	_
10	mice	_	_	NNS	O	[-1]	['none']	_	_
11	has	_	_	VBZ	O	[-1]	['none']	_	_
12	been	_	_	VBN	O	[-1]	['none']	_	_
13	shown	_	_	VBN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	inhibit	_	_	VB	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	formation	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	GCs	_	_	NNS	O	[-1]	['none']	_	_
20	[	_	_	VBP	O	[-1]	['none']	_	_
21	23,49	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	CD	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	preventing	_	_	VBG	O	[-1]	['none']	_	_
25	typical	_	_	JJ	O	[-1]	['none']	_	_
26	B-2	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	from	_	_	IN	O	[-1]	['none']	_	_
29	antigen	_	_	NN	O	[-1]	['none']	_	_
30	driven	_	_	VBN	O	[-1]	['none']	_	_
31	selection	_	_	NN	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	expansion	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	lack	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	GC	_	_	NN	O	[-1]	['none']	_	_
5	reactions	_	_	NNS	O	[-1]	['none']	_	_
6	may	_	_	MD	O	[-1]	['none']	_	_
7	contribute	_	_	VB	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	bias	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	LMP1	_	_	NN	Protein	[0]	['root']	_	_
13	transgenic	_	_	JJ	O	[-1]	['none']	_	_
14	mice	_	_	NNS	O	[-1]	['none']	_	_
15	towards	_	_	IN	O	[-1]	['none']	_	_
16	B-1	_	_	NN	O	[-1]	['none']	_	_
17	cell	_	_	NN	O	[-1]	['none']	_	_
18	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	LMP2	_	_	NN	Protein	[0]	['root']	_	_
4	signaling	_	_	NN	O	[-1]	['none']	_	_
5	also	_	_	RB	O	[-1]	['none']	_	_
6	favors	_	_	VBZ	O	[-1]	['none']	_	_
7	development	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	B-1	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	but	_	_	CC	O	[-1]	['none']	_	_
13	this	_	_	DT	O	[-1]	['none']	_	_
14	occurs	_	_	VBZ	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	absence	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	transformation	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	mimicry	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	B	_	_	NN	O	[-1]	['none']	_	_
9	cell	_	_	NN	O	[-1]	['none']	_	_
10	receptor	_	_	NN	O	[-1]	['none']	_	_
11	signaling	_	_	NN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	LMP2	_	_	NN	Protein	[0]	['root']	_	_
14	promotes	_	_	VBZ	O	[-1]	['none']	_	_
15	B-1	_	_	JJ	O	[-1]	['none']	_	_
16	cell	_	_	NN	O	[-1]	['none']	_	_
17	differentiation	_	_	NN	O	[-1]	['none']	_	_
18	but	_	_	CC	O	[-1]	['none']	_	_
19	not	_	_	RB	O	[-1]	['none']	_	_
20	transformation	_	_	NN	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	24,50,51	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	promotion	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	B-1	_	_	JJ	O	[-1]	['none']	_	_
5	differentiation	_	_	NN	O	[-1]	['none']	_	_
6	may	_	_	MD	O	[-1]	['none']	_	_
7	account	_	_	VB	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	ability	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	LMP2	_	_	NN	Protein	[0]	['root']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	exacerbate	_	_	VB	O	[-1]	['none']	_	_
15	autoimmunity	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	bypass	_	_	NN	O	[-1]	['none']	_	_
18	anergy	_	_	NN	O	[-1]	['none']	_	_
19	induction	_	_	NN	O	[-1]	['none']	_	_
20	[	_	_	CD	O	[-1]	['none']	_	_
21	52,53	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	preponderance	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	tumors	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	B-1a	_	_	NN	O	[-1]	['none']	_	_
10	origin	_	_	NN	O	[-1]	['none']	_	_
11	does	_	_	VBZ	O	[-1]	['none']	_	_
12	not	_	_	RB	O	[-1]	['none']	_	_
13	reflect	_	_	VB	O	[-1]	['none']	_	_
14	effects	_	_	NNS	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	LMP1	_	_	NN	Protein	[0]	['root']	_	_
17	signaling	_	_	NN	O	[-1]	['none']	_	_
18	on	_	_	IN	O	[-1]	['none']	_	_
19	B	_	_	NN	O	[-1]	['none']	_	_
20	cell	_	_	NN	O	[-1]	['none']	_	_
21	differentiation	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	as	_	_	IN	O	[-1]	['none']	_	_
24	splenic	_	_	JJ	O	[-1]	['none']	_	_
25	B	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	from	_	_	IN	O	[-1]	['none']	_	_
28	healthy	_	_	JJ	O	[-1]	['none']	_	_
29	LMP1	_	_	NN	Protein	[0]	['root']	_	_
30	transgenic	_	_	JJ	O	[-1]	['none']	_	_
31	mice	_	_	NNS	O	[-1]	['none']	_	_
32	contain	_	_	VBP	O	[-1]	['none']	_	_
33	similar	_	_	JJ	O	[-1]	['none']	_	_
34	numbers	_	_	NNS	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	B-1	_	_	NN	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	B-2	_	_	NN	O	[-1]	['none']	_	_
39	cells	_	_	NNS	O	[-1]	['none']	_	_
40	as	_	_	IN	O	[-1]	['none']	_	_
41	wild-type	_	_	JJ	O	[-1]	['none']	_	_
42	mice	_	_	NNS	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	support	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	this	_	_	DT	O	[-1]	['none']	_	_
5	lack	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	effect	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	differentiation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	B-1	_	_	NN	O	[-1]	['none']	_	_
13	versus	_	_	CC	O	[-1]	['none']	_	_
14	B-2	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	is	_	_	VBZ	O	[-1]	['none']	_	_
17	thought	_	_	VBN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	be	_	_	VB	O	[-1]	['none']	_	_
20	independent	_	_	JJ	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	CD40	_	_	NN	Protein	[0]	['root']	_	_
23	signaling	_	_	NN	O	[-1]	['none']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	54	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	B-1	_	_	NNP	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	constitute	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	predominant	_	_	JJ	O	[-1]	['none']	_	_
6	lymphocyte	_	_	NN	O	[-1]	['none']	_	_
7	population	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	peritoneal	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	pleuropericardial	_	_	JJ	O	[-1]	['none']	_	_
13	cavities	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	while	_	_	IN	O	[-1]	['none']	_	_
16	B-2	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	are	_	_	VBP	O	[-1]	['none']	_	_
19	mainly	_	_	RB	O	[-1]	['none']	_	_
20	found	_	_	VBN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	spleen	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	lymph	_	_	NN	O	[-1]	['none']	_	_
26	node	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	peripheral	_	_	JJ	O	[-1]	['none']	_	_
30	blood	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	B-1	_	_	NNP	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	produce	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	main	_	_	JJ	O	[-1]	['none']	_	_
6	source	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	IgM	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	IgA	_	_	NN	O	[-1]	['none']	_	_
11	antibodies	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	serum	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	which	_	_	WDT	O	[-1]	['none']	_	_
16	are	_	_	VBP	O	[-1]	['none']	_	_
17	involved	_	_	VBN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	T	_	_	NN	O	[-1]	['none']	_	_
20	cell	_	_	NN	O	[-1]	['none']	_	_
21	independent	_	_	JJ	O	[-1]	['none']	_	_
22	responses	_	_	NNS	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	common	_	_	JJ	O	[-1]	['none']	_	_
25	microbial	_	_	JJ	O	[-1]	['none']	_	_
26	antigens	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Importantly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	B-1	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	have	_	_	VBP	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	unique	_	_	JJ	O	[-1]	['none']	_	_
8	capacity	_	_	NN	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	self	_	_	NN	O	[-1]	['none']	_	_
11	replenish	_	_	VB	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	are	_	_	VBP	O	[-1]	['none']	_	_
14	also	_	_	RB	O	[-1]	['none']	_	_
15	predisposed	_	_	VBN	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	transformation	_	_	NN	O	[-1]	['none']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	28,29	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Clonal	_	_	JJ	O	[-1]	['none']	_	_
2	expansion	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	B-1	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	can	_	_	MD	O	[-1]	['none']	_	_
7	be	_	_	VB	O	[-1]	['none']	_	_
8	detected	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	aging	_	_	NN	O	[-1]	['none']	_	_
11	mice	_	_	NNS	O	[-1]	['none']	_	_
12	above	_	_	IN	O	[-1]	['none']	_	_
13	18	_	_	CD	O	[-1]	['none']	_	_
14	mo	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	age	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	B-1	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	are	_	_	VBP	O	[-1]	['none']	_	_
22	thought	_	_	VBN	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	be	_	_	VB	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	murine	_	_	JJ	O	[-1]	['none']	_	_
27	progenitor	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	B	_	_	NN	O	[-1]	['none']	_	_
30	cell	_	_	NN	O	[-1]	['none']	_	_
31	chronic	_	_	JJ	O	[-1]	['none']	_	_
32	lymphocytic	_	_	JJ	O	[-1]	['none']	_	_
33	leukemia	_	_	NN	O	[-1]	['none']	_	_
34	[	_	_	CD	O	[-1]	['none']	_	_
35	30	_	_	CD	O	[-1]	['none']	_	_
36	]	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	presented	_	_	VBN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	this	_	_	DT	O	[-1]	['none']	_	_
6	study	_	_	NN	O	[-1]	['none']	_	_
7	indicate	_	_	VBP	O	[-1]	['none']	_	_
8	that	_	_	IN	O	[-1]	['none']	_	_
9	although	_	_	IN	O	[-1]	['none']	_	_
10	LMP1	_	_	NN	Protein	[12]	['Theme']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	all	_	_	DT	O	[-1]	['none']	_	_
15	B	_	_	NN	O	[-1]	['none']	_	_
16	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	transgenic	_	_	JJ	O	[-1]	['none']	_	_
20	mice	_	_	NNS	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	malignancy	_	_	NN	O	[-1]	['none']	_	_
23	develops	_	_	VBZ	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	this	_	_	DT	O	[-1]	['none']	_	_
26	specific	_	_	JJ	O	[-1]	['none']	_	_
27	subset	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	B	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	elevated	_	_	JJ	Positive_regulation	[0]	['root']	_	_
3	expression	_	_	NN	Gene_expression	[2]	['Theme']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[3]	['Theme']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	B-1a	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	specific	_	_	JJ	O	[-1]	['none']	_	_
14	pathways	_	_	NNS	O	[-1]	['none']	_	_
15	apparently	_	_	RB	O	[-1]	['none']	_	_
16	induce	_	_	VBP	O	[-1]	['none']	_	_
17	malignant	_	_	JJ	O	[-1]	['none']	_	_
18	growth	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	same	_	_	JJ	O	[-1]	['none']	_	_
3	pathways	_	_	NNS	O	[-1]	['none']	_	_
4	can	_	_	MD	O	[-1]	['none']	_	_
5	also	_	_	RB	O	[-1]	['none']	_	_
6	become	_	_	VB	O	[-1]	['none']	_	_
7	sporadically	_	_	RB	O	[-1]	['none']	_	_
8	activated	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	aged	_	_	JJ	O	[-1]	['none']	_	_
11	mice	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	also	_	_	RB	O	[-1]	['none']	_	_
14	result	_	_	VBP	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	lymphoma	_	_	NN	O	[-1]	['none']	_	_
17	development	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	similar	_	_	JJ	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	EBV	_	_	NN	O	[-1]	['none']	_	_
6	associated	_	_	VBN	O	[-1]	['none']	_	_
7	cancers	_	_	NNS	O	[-1]	['none']	_	_
8	in	_	_	FW	O	[-1]	['none']	_	_
9	vivo	_	_	FW	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	where	_	_	WRB	O	[-1]	['none']	_	_
12	pathways	_	_	NNS	O	[-1]	['none']	_	_
13	that	_	_	WDT	O	[-1]	['none']	_	_
14	are	_	_	VBP	O	[-1]	['none']	_	_
15	activated	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	LMP1	_	_	NN	Protein	[0]	['root']	_	_
18	are	_	_	VBP	O	[-1]	['none']	_	_
19	also	_	_	RB	O	[-1]	['none']	_	_
20	activated	_	_	VBN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	less	_	_	JJR	O	[-1]	['none']	_	_
24	prevalent	_	_	JJ	O	[-1]	['none']	_	_
25	EBV	_	_	NN	O	[-1]	['none']	_	_
26	negative	_	_	JJ	O	[-1]	['none']	_	_
27	forms	_	_	NNS	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	cancers	_	_	NNS	O	[-1]	['none']	_	_
31	[	_	_	VBP	O	[-1]	['none']	_	_
32	40,55-58	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	CD	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	contribution	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	EBV	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	LMP1	_	_	NN	Protein	[0]	['root']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	tumor	_	_	NN	O	[-1]	['none']	_	_
11	development	_	_	NN	O	[-1]	['none']	_	_
12	is	_	_	VBZ	O	[-1]	['none']	_	_
13	apparently	_	_	RB	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	continuous	_	_	JJ	O	[-1]	['none']	_	_
16	activation	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	pathways	_	_	NNS	O	[-1]	['none']	_	_
19	that	_	_	WDT	O	[-1]	['none']	_	_
20	can	_	_	MD	O	[-1]	['none']	_	_
21	also	_	_	RB	O	[-1]	['none']	_	_
22	be	_	_	VB	O	[-1]	['none']	_	_
23	sporadically	_	_	RB	O	[-1]	['none']	_	_
24	activated	_	_	VBN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	contribute	_	_	VBP	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	tumor	_	_	NN	O	[-1]	['none']	_	_
29	development	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	marked	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	upregulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	IL10	_	_	NN	Protein	[7]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	constitutive	_	_	JJ	O	[-1]	['none']	_	_
12	activation	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Stat3	_	_	NN	Protein	[0]	['root']	_	_
15	signaling	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	requirement	_	_	NN	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	activation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	Akt	_	_	NN	Protein	[0]	['root']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	Stat3	_	_	NN	Protein	[0]	['root']	_	_
29	pathways	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	IL10	_	_	NN	Protein	[1]	['Theme']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	associated	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	transformation	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	B-1	_	_	JJ	O	[-1]	['none']	_	_
11	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	mice	_	_	NNS	O	[-1]	['none']	_	_
14	[	_	_	VBP	O	[-1]	['none']	_	_
15	59,60	_	_	CD	O	[-1]	['none']	_	_
16	]	_	_	CD	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	is	_	_	VBZ	O	[-1]	['none']	_	_
19	frequently	_	_	RB	O	[-1]	['none']	_	_
20	associated	_	_	VBN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	EBV	_	_	NN	O	[-1]	['none']	_	_
23	positive	_	_	JJ	O	[-1]	['none']	_	_
24	B	_	_	NN	O	[-1]	['none']	_	_
25	cell	_	_	NN	O	[-1]	['none']	_	_
26	malignancies	_	_	NNS	O	[-1]	['none']	_	_
27	acting	_	_	VBG	O	[-1]	['none']	_	_
28	as	_	_	IN	O	[-1]	['none']	_	_
29	a	_	_	DT	O	[-1]	['none']	_	_
30	B	_	_	NN	O	[-1]	['none']	_	_
31	cell	_	_	NN	O	[-1]	['none']	_	_
32	growth	_	_	NN	O	[-1]	['none']	_	_
33	factor	_	_	NN	O	[-1]	['none']	_	_
34	[	_	_	CD	O	[-1]	['none']	_	_
35	35-38	_	_	CD	O	[-1]	['none']	_	_
36	]	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[9]	['Cause']	_	_
5	has	_	_	VBZ	O	[-1]	['none']	_	_
6	been	_	_	VBN	O	[-1]	['none']	_	_
7	shown	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	stimulate	_	_	VB	Positive_regulation	[0]	['root']	_	_
10	IL10	_	_	NN	Protein	[11]	['Theme']	_	_
11	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	Burkitt	_	_	NN	O	[-1]	['none']	_	_
14	lymphoma	_	_	NN	O	[-1]	['none']	_	_
15	cell	_	_	NN	O	[-1]	['none']	_	_
16	lines	_	_	NNS	O	[-1]	['none']	_	_
17	[	_	_	VBP	O	[-1]	['none']	_	_
18	61,62	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	CD	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	suggests	_	_	VBZ	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	although	_	_	IN	O	[-1]	['none']	_	_
5	Stat3	_	_	NN	Protein	[8]	['Theme']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	constitutively	_	_	RB	O	[-1]	['none']	_	_
8	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	lymphoma	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	induction	_	_	NN	Positive_regulation	[20]	['Cause']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	IL10	_	_	NN	Protein	[15]	['Theme']	_	_
18	may	_	_	MD	O	[-1]	['none']	_	_
19	further	_	_	RB	O	[-1]	['none']	_	_
20	enhance	_	_	VB	Positive_regulation	[0]	['root']	_	_
21	Stat3	_	_	NN	Protein	[22]	['Theme']	_	_
22	activation	_	_	NN	Positive_regulation	[20]	['Theme']	_	_
23	or	_	_	CC	O	[-1]	['none']	_	_
24	may	_	_	MD	O	[-1]	['none']	_	_
25	contribute	_	_	VB	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	other	_	_	JJ	O	[-1]	['none']	_	_
28	IL10	_	_	NN	Protein	[0]	['root']	_	_
29	responsive	_	_	JJ	O	[-1]	['none']	_	_
30	signaling	_	_	NN	O	[-1]	['none']	_	_
31	pathways	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	activates	_	_	VBZ	O	[-1]	['none']	_	_
3	both	_	_	CC	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	canonical	_	_	JJ	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	non	_	_	JJ	O	[-1]	['none']	_	_
8	canonical	_	_	JJ	O	[-1]	['none']	_	_
9	pathways	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
12	signaling	_	_	NN	O	[-1]	['none']	_	_
13	[	_	_	CD	O	[-1]	['none']	_	_
14	14,63-65	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	inhibition	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
21	blocked	_	_	VBD	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	survival	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	LMP1	_	_	NN	Protein	[0]	['root']	_	_
26	transgenic	_	_	JJ	O	[-1]	['none']	_	_
27	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	LMP1	_	_	NN	Protein	[0]	['root']	_	_
30	positive	_	_	JJ	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	-negative	_	_	JJ	O	[-1]	['none']	_	_
33	lymphoma	_	_	NN	O	[-1]	['none']	_	_
34	cells	_	_	NNS	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	PI3K	_	_	NN	O	[-1]	['none']	_	_
4	signaling	_	_	NN	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	crucial	_	_	JJ	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	CD40	_	_	NN	Protein	[0]	['root']	_	_
9	induced	_	_	VBD	O	[-1]	['none']	_	_
10	proliferation	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	mice	_	_	NNS	O	[-1]	['none']	_	_
14	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	cRel	_	_	NN	Protein	[14]	['Theme']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	p85	_	_	NN	Protein	[14]	['Theme']	_	_
20	regulatory	_	_	JJ	O	[-1]	['none']	_	_
21	subunit	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	PI3K	_	_	NN	O	[-1]	['none']	_	_
24	are	_	_	VBP	O	[-1]	['none']	_	_
25	unresponsive	_	_	JJ	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	mitogenic	_	_	JJ	O	[-1]	['none']	_	_
28	stimuli	_	_	NNS	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	including	_	_	VBG	O	[-1]	['none']	_	_
31	CD40	_	_	NN	Protein	[32]	['Theme']	_	_
32	ligation	_	_	NN	Binding	[0]	['root']	_	_
33	[	_	_	CD	O	[-1]	['none']	_	_
34	66-68	_	_	CD	O	[-1]	['none']	_	_
35	]	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	have	_	_	VBP	O	[-1]	['none']	_	_
3	previously	_	_	RB	O	[-1]	['none']	_	_
4	shown	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	cRel	_	_	NN	Protein	[9]	['Theme']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	specifically	_	_	RB	O	[-1]	['none']	_	_
9	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	both	_	_	CC	O	[-1]	['none']	_	_
12	wild-type	_	_	JJ	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	LMP1	_	_	NN	Protein	[0]	['root']	_	_
15	transgenic	_	_	JJ	O	[-1]	['none']	_	_
16	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	suggesting	_	_	VBG	O	[-1]	['none']	_	_
19	that	_	_	IN	O	[-1]	['none']	_	_
20	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	cRel	_	_	NN	Protein	[20]	['Theme']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	associated	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	B	_	_	NN	O	[-1]	['none']	_	_
27	cell	_	_	NN	O	[-1]	['none']	_	_
28	transformation	_	_	NN	O	[-1]	['none']	_	_
29	[	_	_	CD	O	[-1]	['none']	_	_
30	27	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	observations	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	similar	_	_	JJ	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	CD40	_	_	NN	Protein	[0]	['root']	_	_
8	induced	_	_	VBD	O	[-1]	['none']	_	_
9	proliferation	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	LMP1	_	_	NN	Protein	[12]	['Cause']	_	_
12	induces	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
13	proliferation	_	_	NN	O	[-1]	['none']	_	_
14	through	_	_	IN	O	[-1]	['none']	_	_
15	PI3K	_	_	NN	O	[-1]	['none']	_	_
16	mediated	_	_	JJ	O	[-1]	['none']	_	_
17	activation	_	_	NN	Positive_regulation	[12]	['Theme']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	Akt	_	_	NN	Protein	[17]	['Theme']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	activation	_	_	NN	Positive_regulation	[12]	['Theme']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	NFkappaB	_	_	NN	Anaphora	[24]	['multitoken']	_	_
24	components	_	_	NNS	Anaphora	[0]	['root']	_	_
25	such	_	_	JJ	O	[-1]	['none']	_	_
26	as	_	_	IN	O	[-1]	['none']	_	_
27	cRel	_	_	NN	Protein	[21]	['Theme']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[3]	['Cause']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	induces	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
4	downregulation	_	_	NN	Negative_regulation	[3]	['Theme']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	cell	_	_	NN	O	[-1]	['none']	_	_
8	cycle	_	_	NN	O	[-1]	['none']	_	_
9	inhibitor	_	_	NN	O	[-1]	['none']	_	_
10	p27	_	_	NN	Protein	[4]	['Theme']	_	_
11	through	_	_	IN	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	PI3K	_	_	NN	O	[-1]	['none']	_	_
14	dependent	_	_	JJ	O	[-1]	['none']	_	_
15	manner	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	LMP1	_	_	NN	Protein	[0]	['root']	_	_
20	lymphoma	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	also	_	_	RB	O	[-1]	['none']	_	_
23	had	_	_	VBD	O	[-1]	['none']	_	_
24	decreased	_	_	VBN	Negative_regulation	[0]	['root']	_	_
25	levels	_	_	NNS	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	p27	_	_	NN	Protein	[24]	['Theme']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	Rb	_	_	NN	Protein	[29]	['Theme']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
34	Cdk2	_	_	NN	Protein	[33]	['Theme']	_	_
35	[	_	_	CD	O	[-1]	['none']	_	_
36	66	_	_	CD	O	[-1]	['none']	_	_
37	]	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	LMP1	_	_	NN	Protein	[0]	['root']	_	_
3	has	_	_	VBZ	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	shown	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	deregulate	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	Rb	_	_	NN	Protein	[0]	['root']	_	_
10	pathway	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	epithelial	_	_	JJ	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	[	_	_	VBP	O	[-1]	['none']	_	_
15	69	_	_	CD	O	[-1]	['none']	_	_
16	]	_	_	CD	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	our	_	_	PRP$	O	[-1]	['none']	_	_
20	knowledge	_	_	NN	O	[-1]	['none']	_	_
21	this	_	_	DT	O	[-1]	['none']	_	_
22	is	_	_	VBZ	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	first	_	_	JJ	O	[-1]	['none']	_	_
25	demonstration	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	this	_	_	DT	O	[-1]	['none']	_	_
28	property	_	_	NN	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	B	_	_	NN	O	[-1]	['none']	_	_
31	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	requirement	_	_	NN	Positive_regulation	[0]	['root']	_	_
3	for	_	_	IN	O	[-1]	['none']	_	_
4	Akt	_	_	NN	Protein	[5]	['Theme']	_	_
5	activation	_	_	NN	Positive_regulation	[2]	['Theme']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	confirmed	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	striking	_	_	JJ	O	[-1]	['none']	_	_
11	inhibition	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	lymphoma	_	_	NN	O	[-1]	['none']	_	_
14	viability	_	_	NN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	triciribine	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	an	_	_	DT	O	[-1]	['none']	_	_
19	Akt	_	_	NN	Protein	[20]	['Theme']	_	_
20	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	activated	_	_	JJ	Positive_regulation	[8]	['Cause']	_	_
5	pAkt	_	_	NN	Protein	[4]	['Theme']	_	_
6	did	_	_	VBD	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	lead	_	_	VB	Positive_regulation	[0]	['root']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	phosphorylation	_	_	NN	Phosphorylation	[8]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	inactivation	_	_	NN	Negative_regulation	[8]	['Theme']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	downstream	_	_	JJ	O	[-1]	['none']	_	_
16	target	_	_	NN	O	[-1]	['none']	_	_
17	GSK3	_	_	NN	Protein	[10, 12]	['Theme', 'Theme']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	effect	_	_	NN	O	[-1]	['none']	_	_
3	has	_	_	VBZ	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	been	_	_	VBN	O	[-1]	['none']	_	_
6	described	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	EBV	_	_	NN	O	[-1]	['none']	_	_
9	positive	_	_	JJ	O	[-1]	['none']	_	_
10	HD	_	_	NN	O	[-1]	['none']	_	_
11	biopsies	_	_	NNS	O	[-1]	['none']	_	_
12	[	_	_	VBP	O	[-1]	['none']	_	_
13	40	_	_	CD	O	[-1]	['none']	_	_
14	]	_	_	CD	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	rapamycin	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	U0126	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	SB202190	_	_	NN	O	[-1]	['none']	_	_
10	did	_	_	VBD	O	[-1]	['none']	_	_
11	not	_	_	RB	O	[-1]	['none']	_	_
12	affect	_	_	VB	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	survival	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	LMP1	_	_	NN	Protein	[0]	['root']	_	_
17	transgenic	_	_	JJ	O	[-1]	['none']	_	_
18	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	wild-type	_	_	JJ	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	LMP1	_	_	NN	Protein	[0]	['root']	_	_
24	transgenic	_	_	JJ	O	[-1]	['none']	_	_
25	lymphoma	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	lack	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	effect	_	_	NN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	rapamycin	_	_	NN	O	[-1]	['none']	_	_
7	confirmed	_	_	VBD	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	activated	_	_	VBN	Positive_regulation	[9]	['Theme']	_	_
12	p-mTOR	_	_	NN	Protein	[11]	['Theme']	_	_
13	levels	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	findings	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	other	_	_	JJ	O	[-1]	['none']	_	_
6	Akt	_	_	NN	Protein	[0]	['root']	_	_
7	targets	_	_	NNS	O	[-1]	['none']	_	_
8	contribute	_	_	VBP	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	malignant	_	_	JJ	O	[-1]	['none']	_	_
11	progression	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	One	_	_	CD	O	[-1]	['none']	_	_
2	key	_	_	JJ	O	[-1]	['none']	_	_
3	target	_	_	NN	Regulation	[0]	['root']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	likely	_	_	JJ	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	inhibition	_	_	NN	Negative_regulation	[3]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	Fox01	_	_	NN	Protein	[7]	['Theme']	_	_
11	transcription	_	_	NN	O	[-1]	['none']	_	_
12	factors	_	_	NNS	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Repression	_	_	NN	Negative_regulation	[15]	['Cause']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	pro	_	_	JJ	O	[-1]	['none']	_	_
5	apoptotic	_	_	JJ	O	[-1]	['none']	_	_
6	transcription	_	_	NN	O	[-1]	['none']	_	_
7	factor	_	_	NN	O	[-1]	['none']	_	_
8	FoxO1	_	_	NN	Protein	[1]	['Theme']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	PI3K	_	_	NN	O	[-1]	['none']	_	_
12	dependent	_	_	JJ	O	[-1]	['none']	_	_
13	manner	_	_	NN	O	[-1]	['none']	_	_
14	can	_	_	MD	O	[-1]	['none']	_	_
15	inhibit	_	_	VB	Negative_regulation	[0]	['root']	_	_
16	expression	_	_	NN	Gene_expression	[15]	['Theme']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	bcl6	_	_	NN	Protein	[16]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	transcription	_	_	NN	O	[-1]	['none']	_	_
22	factor	_	_	NN	O	[-1]	['none']	_	_
23	necessary	_	_	JJ	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	GC	_	_	NN	O	[-1]	['none']	_	_
26	formation	_	_	NN	O	[-1]	['none']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	49,70	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	been	_	_	VBN	O	[-1]	['none']	_	_
4	shown	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	overstimulation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	CD40	_	_	NN	Protein	[0]	['root']	_	_
9	signaling	_	_	NN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	agonistic	_	_	JJ	O	[-1]	['none']	_	_
12	antibodies	_	_	NNS	O	[-1]	['none']	_	_
13	inhibits	_	_	VBZ	O	[-1]	['none']	_	_
14	GC	_	_	NN	O	[-1]	['none']	_	_
15	formation	_	_	NN	O	[-1]	['none']	_	_
16	[	_	_	CD	O	[-1]	['none']	_	_
17	71	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Similarly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	due	_	_	JJ	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	mimicry	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	CD40	_	_	NN	Protein	[0]	['root']	_	_
8	signaling	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	transgenic	_	_	JJ	O	[-1]	['none']	_	_
11	LMP1	_	_	NN	Protein	[0]	['root']	_	_
12	mice	_	_	NNS	O	[-1]	['none']	_	_
13	are	_	_	VBP	O	[-1]	['none']	_	_
14	also	_	_	RB	O	[-1]	['none']	_	_
15	defective	_	_	JJ	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	GC	_	_	NN	O	[-1]	['none']	_	_
18	formation	_	_	NN	O	[-1]	['none']	_	_
19	[	_	_	CD	O	[-1]	['none']	_	_
20	23,49	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	constitutive	_	_	JJ	O	[-1]	['none']	_	_
3	signaling	_	_	NN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[0]	['root']	_	_
6	likely	_	_	JJ	O	[-1]	['none']	_	_
7	blocks	_	_	NNS	O	[-1]	['none']	_	_
8	GC	_	_	NN	O	[-1]	['none']	_	_
9	formation	_	_	NN	O	[-1]	['none']	_	_
10	through	_	_	IN	O	[-1]	['none']	_	_
11	downregulation	_	_	NN	Negative_regulation	[0]	['root']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	bcl6	_	_	NN	Protein	[11]	['Theme']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	clinical	_	_	JJ	O	[-1]	['none']	_	_
4	studies	_	_	NNS	O	[-1]	['none']	_	_
5	indicate	_	_	VBP	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	expression	_	_	NN	Gene_expression	[14]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	LMP1	_	_	NN	Protein	[7]	['Theme']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	bcl6	_	_	NN	Protein	[7]	['Theme']	_	_
12	are	_	_	VBP	O	[-1]	['none']	_	_
13	mutually	_	_	RB	O	[-1]	['none']	_	_
14	exclusive	_	_	JJ	Negative_regulation	[0]	['root']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	non	_	_	JJ	O	[-1]	['none']	_	_
17	HD	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	classical	_	_	JJ	O	[-1]	['none']	_	_
20	HD	_	_	NN	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	72,73	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[0]	['root']	_	_
5	transgenic	_	_	JJ	O	[-1]	['none']	_	_
6	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
7	mirror	_	_	VBP	O	[-1]	['none']	_	_
8	aspects	_	_	NNS	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	EBV	_	_	NN	O	[-1]	['none']	_	_
11	induced	_	_	VBD	O	[-1]	['none']	_	_
12	HD	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Akt	_	_	NN	Protein	[3]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	lack	_	_	NN	Negative_regulation	[0]	['root']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Fox01	_	_	NN	Protein	[8, 25]	['Theme', 'Theme']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	lymphoma	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	suggest	_	_	VBP	O	[-1]	['none']	_	_
16	that	_	_	IN	O	[-1]	['none']	_	_
17	LMP1	_	_	NN	Protein	[25]	['Cause']	_	_
18	affects	_	_	VBZ	Regulation	[0]	['root']	_	_
19	bcl6	_	_	NN	Protein	[18]	['Theme']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	GC	_	_	NN	O	[-1]	['none']	_	_
22	formation	_	_	NN	O	[-1]	['none']	_	_
23	through	_	_	IN	O	[-1]	['none']	_	_
24	this	_	_	DT	Anaphora	[0]	['root']	_	_
25	pathway	_	_	NN	Regulation	[18]	['Cause']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	regulation	_	_	NN	Regulation	[0]	['root']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	other	_	_	JJ	Anaphora	[31]	['multitoken']	_	_
30	Forkhead	_	_	NN	Anaphora	[31]	['multitoken']	_	_
31	targets	_	_	NNS	Anaphora	[0]	['root']	_	_
32	involved	_	_	VBN	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	cell	_	_	NN	O	[-1]	['none']	_	_
35	cycle	_	_	NN	O	[-1]	['none']	_	_
36	progression	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	such	_	_	JJ	O	[-1]	['none']	_	_
39	as	_	_	IN	O	[-1]	['none']	_	_
40	p27	_	_	NN	Protein	[27]	['Theme']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	CyclinD2	_	_	NN	Protein	[27]	['Theme']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	likely	_	_	JJ	O	[-1]	['none']	_	_
45	contribute	_	_	VBP	O	[-1]	['none']	_	_
46	to	_	_	TO	O	[-1]	['none']	_	_
47	malignant	_	_	JJ	O	[-1]	['none']	_	_
48	transformation	_	_	NN	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	Indeed	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	loss	_	_	NN	Negative_regulation	[10]	['Cause']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	FoxO1	_	_	NN	Protein	[6]	['Theme']	_	_
6	expression	_	_	NN	Gene_expression	[3]	['Theme']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	lymphoma	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	correlated	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	loss	_	_	NN	Negative_regulation	[10]	['Theme']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	p27	_	_	NN	Protein	[13]	['Theme']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	CyclinD2	_	_	NN	Protein	[8]	['Theme']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	shown	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	be	_	_	VB	O	[-1]	['none']	_	_
8	upregulated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	LMP1	_	_	NN	Protein	[0]	['root']	_	_
11	through	_	_	IN	O	[-1]	['none']	_	_
12	release	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	FoxO1	_	_	NN	Protein	[0]	['root']	_	_
15	mediated	_	_	VBD	O	[-1]	['none']	_	_
16	repression	_	_	NN	O	[-1]	['none']	_	_
17	[	_	_	CD	O	[-1]	['none']	_	_
18	70	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	summary	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	this	_	_	DT	O	[-1]	['none']	_	_
6	transgenic	_	_	JJ	O	[-1]	['none']	_	_
7	model	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	lymphomagenesis	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	LMP1	_	_	NN	Protein	[0]	['root']	_	_
12	promotes	_	_	VBZ	O	[-1]	['none']	_	_
13	malignancy	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	B-1a	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	population	_	_	NN	O	[-1]	['none']	_	_
20	that	_	_	WDT	O	[-1]	['none']	_	_
21	is	_	_	VBZ	O	[-1]	['none']	_	_
22	predisposed	_	_	VBN	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	clonal	_	_	JJ	O	[-1]	['none']	_	_
25	expansion	_	_	NN	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	age	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	malignant	_	_	JJ	O	[-1]	['none']	_	_
3	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	distinguished	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	constitutively	_	_	RB	O	[-1]	['none']	_	_
8	active	_	_	JJ	O	[-1]	['none']	_	_
9	Stat3	_	_	NN	Protein	[0]	['root']	_	_
10	signaling	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
13	p27	_	_	NN	Protein	[12]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	activated	_	_	VBD	O	[-1]	['none']	_	_
17	Akt	_	_	NN	Protein	[0]	['root']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
20	pathways	_	_	NNS	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	properties	_	_	NNS	O	[-1]	['none']	_	_
23	that	_	_	WDT	O	[-1]	['none']	_	_
24	are	_	_	VBP	O	[-1]	['none']	_	_
25	associated	_	_	VBN	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	promoting	_	_	VBG	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	growth	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	survival	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	B	_	_	NN	O	[-1]	['none']	_	_
34	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Importantly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Akt	_	_	NN	Protein	[0]	['root']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	Stat3	_	_	NN	Protein	[0]	['root']	_	_
9	pathways	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	critically	_	_	RB	O	[-1]	['none']	_	_
12	required	_	_	VBN	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	growth	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	survival	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	malignant	_	_	JJ	O	[-1]	['none']	_	_
20	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
21	as	_	_	RB	O	[-1]	['none']	_	_
22	well	_	_	RB	O	[-1]	['none']	_	_
23	as	_	_	IN	O	[-1]	['none']	_	_
24	healthy	_	_	JJ	O	[-1]	['none']	_	_
25	LMP1	_	_	NN	Protein	[0]	['root']	_	_
26	transgenic	_	_	JJ	O	[-1]	['none']	_	_
27	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	growth	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	EBV	_	_	NN	O	[-1]	['none']	_	_
5	transformed	_	_	VBN	O	[-1]	['none']	_	_
6	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
7	also	_	_	RB	O	[-1]	['none']	_	_
8	requires	_	_	VBZ	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	these	_	_	DT	O	[-1]	['none']	_	_
15	studies	_	_	NNS	O	[-1]	['none']	_	_
16	provide	_	_	VBP	O	[-1]	['none']	_	_
17	insight	_	_	NN	O	[-1]	['none']	_	_
18	into	_	_	IN	O	[-1]	['none']	_	_
19	how	_	_	WRB	O	[-1]	['none']	_	_
20	LMP1	_	_	NN	Protein	[0]	['root']	_	_
21	contributes	_	_	VBZ	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	EBV	_	_	NN	O	[-1]	['none']	_	_
24	associated	_	_	VBN	O	[-1]	['none']	_	_
25	transformation	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	transgenic	_	_	JJ	O	[-1]	['none']	_	_
3	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
4	mirror	_	_	VBP	O	[-1]	['none']	_	_
5	multiple	_	_	JJ	O	[-1]	['none']	_	_
6	aspects	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	EBV	_	_	NN	O	[-1]	['none']	_	_
9	induced	_	_	VBD	O	[-1]	['none']	_	_
10	tumors	_	_	NNS	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	suggest	_	_	VBP	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	in	_	_	FW	O	[-1]	['none']	_	_
15	vivo	_	_	FW	O	[-1]	['none']	_	_
16	these	_	_	DT	O	[-1]	['none']	_	_
17	properties	_	_	NNS	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	LMP1	_	_	NN	Protein	[0]	['root']	_	_
20	are	_	_	VBP	O	[-1]	['none']	_	_
21	major	_	_	JJ	O	[-1]	['none']	_	_
22	factors	_	_	NNS	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	development	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	cancer	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	inhibition	_	_	NN	O	[-1]	['none']	_	_
3	due	_	_	JJ	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	PKC	_	_	NN	O	[-1]	['none']	_	_
6	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
7	Bcl10	_	_	NN	Protein	[8]	['Theme']	_	_
8	degradation	_	_	NN	Protein_catabolism	[6]	['Theme']	_	_
9	Western	_	_	NN	O	[-1]	['none']	_	_
10	blot	_	_	NN	O	[-1]	['none']	_	_
11	analysis	_	_	NN	O	[-1]	['none']	_	_
12	revealed	_	_	VBD	O	[-1]	['none']	_	_
13	an	_	_	DT	O	[-1]	['none']	_	_
14	up-regulation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	phosphorylated-PKC	_	_	NN	O	[-1]	['none']	_	_
17	after	_	_	IN	O	[-1]	['none']	_	_
18	24	_	_	CD	O	[-1]	['none']	_	_
19	h	_	_	NN	O	[-1]	['none']	_	_
20	treatment	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	Jurkat	_	_	NN	O	[-1]	['none']	_	_
23	T-cells	_	_	NNS	O	[-1]	['none']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	PMA	_	_	NN	O	[-1]	['none']	_	_
26	or	_	_	CC	O	[-1]	['none']	_	_
27	HK	_	_	JJ	O	[-1]	['none']	_	_
28	E.	_	_	FW	O	[-1]	['none']	_	_
29	coli	_	_	FW	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	while	_	_	IN	O	[-1]	['none']	_	_
32	IkappaBbeta	_	_	NN	Protein	[35]	['Theme']	_	_
33	levels	_	_	NNS	O	[-1]	['none']	_	_
34	remained	_	_	VBD	O	[-1]	['none']	_	_
35	unaffected	_	_	JJ	Regulation	[0]	['root']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Bcl10	_	_	NN	Protein	[0]	['root']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	signalling	_	_	NN	O	[-1]	['none']	_	_
5	protein	_	_	NN	O	[-1]	['none']	_	_
6	that	_	_	WDT	O	[-1]	['none']	_	_
7	acts	_	_	VBZ	O	[-1]	['none']	_	_
8	upstream	_	_	RB	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	concert	_	_	NN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	CARMA1	_	_	NN	Protein	[0]	['root']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	MALT1	_	_	NN	Protein	[0]	['root']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	has	_	_	VBZ	O	[-1]	['none']	_	_
19	been	_	_	VBN	O	[-1]	['none']	_	_
20	suggested	_	_	VBN	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	directly	_	_	RB	O	[-1]	['none']	_	_
23	regulate	_	_	VB	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	activity	_	_	NN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	T-cells	_	_	NNS	O	[-1]	['none']	_	_
28	[	_	_	VBP	O	[-1]	['none']	_	_
29	27	_	_	CD	O	[-1]	['none']	_	_
30	]	_	_	CD	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Bcl10	_	_	NN	Protein	[4]	['Theme']	_	_
4	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	evaluated	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	both	_	_	CC	O	[-1]	['none']	_	_
9	control	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	PMA	_	_	NN	O	[-1]	['none']	_	_
12	stimulated	_	_	VBN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	after	_	_	IN	O	[-1]	['none']	_	_
15	10	_	_	CD	O	[-1]	['none']	_	_
16	min	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	1	_	_	CD	O	[-1]	['none']	_	_
19	h	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	6	_	_	CD	O	[-1]	['none']	_	_
22	h	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	24	_	_	CD	O	[-1]	['none']	_	_
26	h	_	_	NN	O	[-1]	['none']	_	_
27	using	_	_	VBG	O	[-1]	['none']	_	_
28	western	_	_	NN	O	[-1]	['none']	_	_
29	blot	_	_	NN	O	[-1]	['none']	_	_
30	analysis	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Bcl10	_	_	NN	Protein	[4]	['Theme']	_	_
3	levels	_	_	NNS	O	[-1]	['none']	_	_
4	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
5	following	_	_	VBG	O	[-1]	['none']	_	_
6	treatment	_	_	NN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	PMA	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	while	_	_	IN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	control	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	Bcl10	_	_	NN	Protein	[18]	['Theme']	_	_
16	returned	_	_	VBD	Positive_regulation	[18]	['multitoken']	_	_
17	to	_	_	TO	Positive_regulation	[18]	['multitoken']	_	_
18	higher	_	_	JJR	Positive_regulation	[0]	['root']	_	_
19	levels	_	_	NNS	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	24	_	_	CD	O	[-1]	['none']	_	_
22	h	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	suggests	_	_	VBZ	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	Bcl10	_	_	NN	Protein	[0]	['root']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	involved	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	PMA	_	_	NN	O	[-1]	['none']	_	_
10	dependent	_	_	JJ	O	[-1]	['none']	_	_
11	inhibition	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	PKC	_	_	NN	O	[-1]	['none']	_	_
2	Inhibition	_	_	NN	O	[-1]	['none']	_	_
3	Reduces	_	_	VBZ	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	Activity	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	Human	_	_	NN	O	[-1]	['none']	_	_
8	MDMs	_	_	NNS	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	RAW	_	_	NN	O	[-1]	['none']	_	_
11	264.7	_	_	CD	O	[-1]	['none']	_	_
12	Cells	_	_	NNS	O	[-1]	['none']	_	_
13	Since	_	_	IN	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	is	_	_	VBZ	O	[-1]	['none']	_	_
16	activated	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	PKC	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	several	_	_	JJ	O	[-1]	['none']	_	_
21	cell	_	_	NN	O	[-1]	['none']	_	_
22	types	_	_	NNS	O	[-1]	['none']	_	_
23	[	_	_	VBP	O	[-1]	['none']	_	_
24	36	_	_	CD	O	[-1]	['none']	_	_
25	]	_	_	CD	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	we	_	_	PRP	O	[-1]	['none']	_	_
28	next	_	_	JJ	O	[-1]	['none']	_	_
29	determined	_	_	VBN	O	[-1]	['none']	_	_
30	if	_	_	IN	O	[-1]	['none']	_	_
31	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
32	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
33	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
34	activity	_	_	NN	O	[-1]	['none']	_	_
35	was	_	_	VBD	O	[-1]	['none']	_	_
36	dependent	_	_	JJ	O	[-1]	['none']	_	_
37	on	_	_	IN	O	[-1]	['none']	_	_
38	PKC	_	_	NN	O	[-1]	['none']	_	_
39	activation	_	_	NN	O	[-1]	['none']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	if	_	_	IN	O	[-1]	['none']	_	_
42	calcium	_	_	NN	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	a	_	_	DT	O	[-1]	['none']	_	_
45	co-factor	_	_	NN	O	[-1]	['none']	_	_
46	for	_	_	IN	O	[-1]	['none']	_	_
47	conventional	_	_	JJ	O	[-1]	['none']	_	_
48	PKC	_	_	NN	O	[-1]	['none']	_	_
49	isoform	_	_	NN	O	[-1]	['none']	_	_
50	activation	_	_	NN	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	was	_	_	VBD	O	[-1]	['none']	_	_
53	important	_	_	JJ	O	[-1]	['none']	_	_
54	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	because	_	_	IN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	number	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	conventional	_	_	JJ	O	[-1]	['none']	_	_
10	PKCs	_	_	NNS	O	[-1]	['none']	_	_
11	existing	_	_	VBG	O	[-1]	['none']	_	_
12	within	_	_	IN	O	[-1]	['none']	_	_
13	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	pharmacological	_	_	JJ	O	[-1]	['none']	_	_
17	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	PKC	_	_	NN	O	[-1]	['none']	_	_
20	family	_	_	NN	O	[-1]	['none']	_	_
21	activation	_	_	NN	O	[-1]	['none']	_	_
22	was	_	_	VBD	O	[-1]	['none']	_	_
23	used	_	_	VBN	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	determine	_	_	VB	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	relationship	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	PKC	_	_	NN	O	[-1]	['none']	_	_
30	activation	_	_	NN	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
33	cellular	_	_	JJ	O	[-1]	['none']	_	_
34	survival	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	MDMs	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	transfected	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	pNF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
7	reporter	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	then	_	_	RB	O	[-1]	['none']	_	_
10	treated	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	general	_	_	JJ	O	[-1]	['none']	_	_
14	PKC	_	_	NN	O	[-1]	['none']	_	_
15	inhibitor	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
18	;	_	_	:	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	conventional	_	_	JJ	O	[-1]	['none']	_	_
21	PKCalpha	_	_	NN	Protein	[24]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	beta	_	_	NN	Protein	[24]	['Theme']	_	_
24	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
25	Go-6976	_	_	NN	O	[-1]	['none']	_	_
26	;	_	_	:	O	[-1]	['none']	_	_
27	or	_	_	CC	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	intracellular	_	_	JJ	O	[-1]	['none']	_	_
30	calcium	_	_	NN	O	[-1]	['none']	_	_
31	blocker	_	_	NN	O	[-1]	['none']	_	_
32	BAPTA/AM	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Ro-31-8220	_	_	NNP	O	[-1]	['none']	_	_
2	significantly	_	_	RB	O	[-1]	['none']	_	_
3	suppressed	_	_	VBD	O	[-1]	['none']	_	_
4	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	activity	_	_	NN	O	[-1]	['none']	_	_
7	compared	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	treated	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	M-CSF	_	_	NN	O	[-1]	['none']	_	_
13	alone	_	_	RB	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	Go-6976	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	BAPTA/AM	_	_	NN	O	[-1]	['none']	_	_
7	also	_	_	RB	O	[-1]	['none']	_	_
8	blocked	_	_	VBD	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	activity	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	M-CSF-treated	_	_	JJ	O	[-1]	['none']	_	_
13	MDMs	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Trypan	_	_	NN	O	[-1]	['none']	_	_
2	blue	_	_	JJ	O	[-1]	['none']	_	_
3	exclusion	_	_	NN	O	[-1]	['none']	_	_
4	analysis	_	_	NN	O	[-1]	['none']	_	_
5	did	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	indicate	_	_	VB	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	death	_	_	NN	O	[-1]	['none']	_	_
10	suggesting	_	_	VBG	O	[-1]	['none']	_	_
11	that	_	_	IN	O	[-1]	['none']	_	_
12	this	_	_	DT	O	[-1]	['none']	_	_
13	suppression	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	due	_	_	JJ	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	non	_	_	JJ	O	[-1]	['none']	_	_
19	specific	_	_	JJ	O	[-1]	['none']	_	_
20	toxicity	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	M-CSF	_	_	NN	O	[-1]	['none']	_	_
6	mediated	_	_	VBD	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	activation	_	_	NN	O	[-1]	['none']	_	_
9	through	_	_	IN	O	[-1]	['none']	_	_
10	calcium	_	_	NN	O	[-1]	['none']	_	_
11	dependent	_	_	JJ	O	[-1]	['none']	_	_
12	conventional	_	_	JJ	O	[-1]	['none']	_	_
13	PKC	_	_	NN	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	next	_	_	RB	O	[-1]	['none']	_	_
3	investigated	_	_	VBD	O	[-1]	['none']	_	_
4	whether	_	_	IN	O	[-1]	['none']	_	_
5	PKC	_	_	NN	O	[-1]	['none']	_	_
6	inhibition	_	_	NN	O	[-1]	['none']	_	_
7	affected	_	_	VBD	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	activity	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	mouse	_	_	NN	O	[-1]	['none']	_	_
13	macrophage	_	_	NN	O	[-1]	['none']	_	_
14	cell	_	_	NN	O	[-1]	['none']	_	_
15	line	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	RAW	_	_	NN	O	[-1]	['none']	_	_
18	264.7	_	_	CD	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	MDMs	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	PKC	_	_	NN	O	[-1]	['none']	_	_
6	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
7	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	Go-6976	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	BAPTA/AM	_	_	NN	O	[-1]	['none']	_	_
12	reduced	_	_	VBD	O	[-1]	['none']	_	_
13	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	activity	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	dose	_	_	NN	O	[-1]	['none']	_	_
19	dependent	_	_	JJ	O	[-1]	['none']	_	_
20	manner	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	RAW	_	_	NN	O	[-1]	['none']	_	_
23	264.7	_	_	CD	O	[-1]	['none']	_	_
24	macrophages	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	ensure	_	_	VB	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	PKC	_	_	NN	O	[-1]	['none']	_	_
5	specifically	_	_	RB	O	[-1]	['none']	_	_
6	regulated	_	_	VBD	Regulation	[0]	['root']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	p65	_	_	NN	Protein	[6]	['Theme']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	not	_	_	RB	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	closely	_	_	RB	O	[-1]	['none']	_	_
13	related	_	_	JJ	O	[-1]	['none']	_	_
14	family	_	_	NN	O	[-1]	['none']	_	_
15	member	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	c-Rel	_	_	NN	Protein	[6]	['Theme']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	we	_	_	PRP	O	[-1]	['none']	_	_
20	co-transfected	_	_	VBD	O	[-1]	['none']	_	_
21	c-Rel	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	NF-kappaB-SEAP	_	_	NN	O	[-1]	['none']	_	_
24	constructs	_	_	NNS	O	[-1]	['none']	_	_
25	into	_	_	IN	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	Raw	_	_	NN	O	[-1]	['none']	_	_
28	264.7	_	_	CD	O	[-1]	['none']	_	_
29	cell	_	_	NN	O	[-1]	['none']	_	_
30	line	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	measured	_	_	VBN	O	[-1]	['none']	_	_
33	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
34	activity	_	_	NN	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	response	_	_	NN	O	[-1]	['none']	_	_
37	to	_	_	TO	O	[-1]	['none']	_	_
38	M-CSF	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	There	_	_	EX	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	no	_	_	DT	O	[-1]	['none']	_	_
4	increased	_	_	JJ	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	activity	_	_	NN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
10	c-Rel	_	_	NN	Protein	[9]	['Theme']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	observations	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	PKC	_	_	NN	O	[-1]	['none']	_	_
6	functioned	_	_	VBD	Regulation	[0]	['root']	_	_
7	upstream	_	_	JJ	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	p65	_	_	NN	Protein	[6]	['Theme']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	MDMs	_	_	NNS	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	RAW	_	_	NN	O	[-1]	['none']	_	_
15	264.7	_	_	CD	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Methylation	_	_	NN	O	[-1]	['none']	_	_
2	specific	_	_	JJ	O	[-1]	['none']	_	_
3	restriction-PCR-assay	_	_	JJ	O	[-1]	['none']	_	_
4	DNA	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	extracted	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	commercial	_	_	JJ	O	[-1]	['none']	_	_
10	kit	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Qiagen	_	_	NNP	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	recommended	_	_	VBN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	restriction	_	_	NN	O	[-1]	['none']	_	_
4	ability	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	several	_	_	JJ	O	[-1]	['none']	_	_
7	endonucleases	_	_	NNS	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	inhibited	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	methylation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	their	_	_	PRP$	O	[-1]	['none']	_	_
14	target	_	_	NN	O	[-1]	['none']	_	_
15	sequence	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	we	_	_	PRP	O	[-1]	['none']	_	_
18	used	_	_	VBD	O	[-1]	['none']	_	_
19	methylation	_	_	NN	O	[-1]	['none']	_	_
20	sensitive	_	_	JJ	O	[-1]	['none']	_	_
21	enzymes	_	_	NNS	O	[-1]	['none']	_	_
22	HpaII	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	HaeII-isochizomer	_	_	NN	O	[-1]	['none']	_	_
25	Bsp143II	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	Bsh1236I	_	_	NN	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	MBI	_	_	NNP	O	[-1]	['none']	_	_
30	Fermentas	_	_	NNP	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	St	_	_	NNP	O	[-1]	['none']	_	_
33	Leon-Rot	_	_	NNP	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	Germany	_	_	NNP	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	20,24	_	_	CD	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	control	_	_	NN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	methylation	_	_	NN	O	[-1]	['none']	_	_
5	resistant	_	_	JJ	O	[-1]	['none']	_	_
6	enzyme	_	_	NN	O	[-1]	['none']	_	_
7	MspI	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	an	_	_	DT	O	[-1]	['none']	_	_
10	enzyme	_	_	NN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	no	_	_	DT	O	[-1]	['none']	_	_
13	recognition	_	_	NN	O	[-1]	['none']	_	_
14	site	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	target	_	_	NN	O	[-1]	['none']	_	_
18	promoter	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	EcoRI	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	were	_	_	VBD	O	[-1]	['none']	_	_
23	used	_	_	VBN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	DNA	_	_	NN	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	0.8	_	_	CD	O	[-1]	['none']	_	_
4	microg	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	digested	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	40	_	_	CD	O	[-1]	['none']	_	_
10	U	_	_	NNP	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	respective	_	_	JJ	O	[-1]	['none']	_	_
13	enzyme	_	_	NN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	6	_	_	CD	O	[-1]	['none']	_	_
16	h	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	ensure	_	_	VB	O	[-1]	['none']	_	_
21	complete	_	_	JJ	O	[-1]	['none']	_	_
22	cleavage	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	additional	_	_	JJ	O	[-1]	['none']	_	_
25	20	_	_	CD	O	[-1]	['none']	_	_
26	U	_	_	NN	O	[-1]	['none']	_	_
27	for	_	_	IN	O	[-1]	['none']	_	_
28	16	_	_	CD	O	[-1]	['none']	_	_
29	h.	_	_	NN	O	[-1]	['none']	_	_
30	Thereafter	_	_	RB	O	[-1]	['none']	_	_
31	100	_	_	CD	O	[-1]	['none']	_	_
32	ng	_	_	NN	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	digested	_	_	VBN	O	[-1]	['none']	_	_
35	DNA	_	_	NN	O	[-1]	['none']	_	_
36	was	_	_	VBD	O	[-1]	['none']	_	_
37	used	_	_	VBN	O	[-1]	['none']	_	_
38	to	_	_	TO	O	[-1]	['none']	_	_
39	a	_	_	DT	O	[-1]	['none']	_	_
40	PCR	_	_	NN	O	[-1]	['none']	_	_
41	amplification	_	_	NN	O	[-1]	['none']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	two	_	_	CD	O	[-1]	['none']	_	_
44	fragments	_	_	NNS	O	[-1]	['none']	_	_
45	(	_	_	-LRB-	O	[-1]	['none']	_	_
46	F1	_	_	NN	O	[-1]	['none']	_	_
47	and	_	_	CC	O	[-1]	['none']	_	_
48	F2	_	_	NN	O	[-1]	['none']	_	_
49	)	_	_	-RRB-	O	[-1]	['none']	_	_
50	spanning	_	_	VBG	O	[-1]	['none']	_	_
51	part	_	_	NN	O	[-1]	['none']	_	_
52	of	_	_	IN	O	[-1]	['none']	_	_
53	the	_	_	DT	O	[-1]	['none']	_	_
54	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
55	promoter	_	_	NN	O	[-1]	['none']	_	_
56	(	_	_	-LRB-	O	[-1]	['none']	_	_
57	30	_	_	CD	O	[-1]	['none']	_	_
58	)	_	_	-RRB-	O	[-1]	['none']	_	_
59	(	_	_	-LRB-	O	[-1]	['none']	_	_
60	GenBank	_	_	NN	O	[-1]	['none']	_	_
61	U52683	_	_	NN	O	[-1]	['none']	_	_
62	;	_	_	:	O	[-1]	['none']	_	_
63	)	_	_	-RRB-	O	[-1]	['none']	_	_
64	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	sequences	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	primers	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	F1-forward	_	_	NN	O	[-1]	['none']	_	_
8	:	_	_	:	O	[-1]	['none']	_	_
9	5	_	_	CD	O	[-1]	['none']	_	_
10	'-TTGAGATGGAGTCTTGCTCTGT-3	_	_	NN	O	[-1]	['none']	_	_
11	'	_	_	''	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	F1-reverse	_	_	NN	O	[-1]	['none']	_	_
14	:	_	_	:	O	[-1]	['none']	_	_
15	ATCACTTCCAGACTTCAGTTCACCT-3	_	_	NN	O	[-1]	['none']	_	_
16	'	_	_	''	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	341	_	_	CD	O	[-1]	['none']	_	_
19	bp	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	;	_	_	:	O	[-1]	['none']	_	_
22	F2-forward	_	_	NN	O	[-1]	['none']	_	_
23	:	_	_	:	O	[-1]	['none']	_	_
24	5	_	_	CD	O	[-1]	['none']	_	_
25	'-AAGGTGAACTGAAGTCTGGAAGTGA-3	_	_	NN	O	[-1]	['none']	_	_
26	'	_	_	''	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	F2-reverse	_	_	NN	O	[-1]	['none']	_	_
29	:	_	_	:	O	[-1]	['none']	_	_
30	5	_	_	CD	O	[-1]	['none']	_	_
31	'-CCAGGACCTCAGGAGGCCAGTCA-3	_	_	NN	O	[-1]	['none']	_	_
32	'	_	_	''	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	474	_	_	CD	O	[-1]	['none']	_	_
35	bp	_	_	NN	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	PCR	_	_	NN	O	[-1]	['none']	_	_
3	conditions	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	described	_	_	VBN	O	[-1]	['none']	_	_
6	elsewhere	_	_	RB	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	3	_	_	CD	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	PCR	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	performed	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	an	_	_	DT	O	[-1]	['none']	_	_
6	annealing	_	_	NN	O	[-1]	['none']	_	_
7	temperature	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	62degreesC	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	35	_	_	CD	O	[-1]	['none']	_	_
12	cycles	_	_	NNS	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	When	_	_	WRB	O	[-1]	['none']	_	_
2	DNA	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	methylated	_	_	VBN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	specific	_	_	JJ	O	[-1]	['none']	_	_
7	sites	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	sensitive	_	_	JJ	O	[-1]	['none']	_	_
11	enzymes	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	not	_	_	RB	O	[-1]	['none']	_	_
14	able	_	_	JJ	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	digest	_	_	VB	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	DNA	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	amplification	_	_	NN	O	[-1]	['none']	_	_
21	took	_	_	VBD	O	[-1]	['none']	_	_
22	place	_	_	NN	O	[-1]	['none']	_	_
23	;	_	_	:	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	case	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	no	_	_	DT	O	[-1]	['none']	_	_
28	methylation	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	DNA	_	_	NN	O	[-1]	['none']	_	_
31	was	_	_	VBD	O	[-1]	['none']	_	_
32	digested	_	_	VBN	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	no	_	_	DT	O	[-1]	['none']	_	_
35	product	_	_	NN	O	[-1]	['none']	_	_
36	was	_	_	VBD	O	[-1]	['none']	_	_
37	generated	_	_	VBN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	PCR	_	_	NN	O	[-1]	['none']	_	_
3	products	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	electrophoresed	_	_	VBN	O	[-1]	['none']	_	_
6	on	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	3	_	_	CD	O	[-1]	['none']	_	_
9	%	_	_	NN	O	[-1]	['none']	_	_
10	agarose	_	_	NN	O	[-1]	['none']	_	_
11	gel	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	stained	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	ethidium	_	_	NN	O	[-1]	['none']	_	_
17	bromide	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	photographed	_	_	VBN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	PCR	_	_	NN	O	[-1]	['none']	_	_
2	products	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	verified	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	automated	_	_	VBN	O	[-1]	['none']	_	_
7	sequencing	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	Perforin	_	_	NN	Protein	[5]	['Theme']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	granzyme	_	_	NN	Protein	[4]	['multitoken']	_	_
4	B	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
6	are	_	_	VBP	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	appreciably	_	_	RB	O	[-1]	['none']	_	_
9	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	T-bet	_	_	JJ	Protein	[9]	['Cause']	_	_
12	To	_	_	TO	O	[-1]	['none']	_	_
13	test	_	_	VB	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	model	_	_	NN	O	[-1]	['none']	_	_
16	outlined	_	_	VBN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	previous	_	_	JJ	O	[-1]	['none']	_	_
20	paragraph	_	_	NN	O	[-1]	['none']	_	_
21	directly	_	_	RB	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	we	_	_	PRP	O	[-1]	['none']	_	_
24	compared	_	_	VBD	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	IFN-gamma	_	_	NN	Protein	[26]	['Theme']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	perforin	_	_	NN	Protein	[26]	['Theme']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	granzyme	_	_	NN	Protein	[34]	['multitoken']	_	_
34	B	_	_	NN	Protein	[26]	['Theme']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
37	T	_	_	NN	O	[-1]	['none']	_	_
38	cells	_	_	NNS	O	[-1]	['none']	_	_
39	from	_	_	IN	O	[-1]	['none']	_	_
40	WT	_	_	NNP	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	Tbx21	_	_	NN	Protein	[45]	['Theme']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	T-bet	_	_	JJ	Protein	[0]	['root']	_	_
45	)-deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
46	mice	_	_	NNS	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	17	_	_	CD	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	21	_	_	CD	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	naive	_	_	JJ	O	[-1]	['none']	_	_
10	Tbx21-/-	_	_	NN	Protein	[0]	['root']	_	_
11	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
12	T	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	produced	_	_	VBD	Gene_expression	[0]	['root']	_	_
15	IFN-gamma	_	_	NN	Protein	[14]	['Theme']	_	_
16	poorly	_	_	RB	O	[-1]	['none']	_	_
17	upon	_	_	IN	O	[-1]	['none']	_	_
18	activation	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Notably	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	this	_	_	DT	O	[-1]	['none']	_	_
4	deleterious	_	_	JJ	O	[-1]	['none']	_	_
5	effect	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	T-bet	_	_	JJ	Protein	[8]	['Theme']	_	_
8	deficiency	_	_	NN	Negative_regulation	[0]	['root']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	only	_	_	RB	O	[-1]	['none']	_	_
11	observed	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	differentiating	_	_	VBG	O	[-1]	['none']	_	_
14	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
15	T	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	until	_	_	IN	O	[-1]	['none']	_	_
18	day	_	_	NN	O	[-1]	['none']	_	_
19	4	_	_	CD	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	culture	_	_	NN	O	[-1]	['none']	_	_
22	but	_	_	CC	O	[-1]	['none']	_	_
23	was	_	_	VBD	O	[-1]	['none']	_	_
24	almost	_	_	RB	O	[-1]	['none']	_	_
25	completely	_	_	RB	O	[-1]	['none']	_	_
26	mitigated	_	_	VBN	O	[-1]	['none']	_	_
27	by	_	_	IN	O	[-1]	['none']	_	_
28	day	_	_	NN	O	[-1]	['none']	_	_
29	6	_	_	CD	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	most	_	_	RBS	O	[-1]	['none']	_	_
3	likely	_	_	JJ	O	[-1]	['none']	_	_
4	reflected	_	_	VBN	O	[-1]	['none']	_	_
5	compensation	_	_	NN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	Eomes	_	_	NNS	Protein	[12]	['Theme']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	which	_	_	WDT	Anaphora	[0]	['root']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	strongly	_	_	RB	O	[-1]	['none']	_	_
12	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
13	between	_	_	IN	O	[-1]	['none']	_	_
14	days	_	_	NNS	O	[-1]	['none']	_	_
15	4	_	_	CD	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	6	_	_	CD	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	T-bet-deficient	_	_	JJ	Negative_regulation	[13]	['Cause']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	cultured	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	6	_	_	CD	O	[-1]	['none']	_	_
10	d	_	_	NN	O	[-1]	['none']	_	_
11	showed	_	_	VBD	O	[-1]	['none']	_	_
12	no	_	_	DT	O	[-1]	['none']	_	_
13	defect	_	_	NN	Negative_regulation	[0]	['root']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	perforin	_	_	NN	Protein	[17]	['Theme']	_	_
16	mRNA	_	_	NN	Transcription	[17]	['multitoken']	_	_
17	expression	_	_	NN	Transcription	[13]	['Theme']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	consistently	_	_	RB	O	[-1]	['none']	_	_
3	observed	_	_	VBD	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	modest	_	_	JJ	O	[-1]	['none']	_	_
6	reduction	_	_	NN	Negative_regulation	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	GzmB	_	_	NN	Protein	[6]	['Theme']	_	_
9	mRNA	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	T-bet-deficient	_	_	JJ	Negative_regulation	[6]	['Cause']	_	_
12	T	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	which	_	_	WDT	O	[-1]	['none']	_	_
16	did	_	_	VBD	O	[-1]	['none']	_	_
17	not	_	_	RB	O	[-1]	['none']	_	_
18	translate	_	_	VB	O	[-1]	['none']	_	_
19	into	_	_	IN	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	decrease	_	_	NN	Negative_regulation	[0]	['root']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	expression	_	_	NN	Gene_expression	[21]	['Theme']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	granzyme	_	_	NN	Protein	[26]	['multitoken']	_	_
26	B	_	_	NN	Protein	[23]	['Theme']	_	_
27	protein	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	examine	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	role	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Eomes	_	_	NNS	Protein	[0]	['root']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	we	_	_	PRP	O	[-1]	['none']	_	_
9	transduced	_	_	VBD	O	[-1]	['none']	_	_
10	naive	_	_	JJ	O	[-1]	['none']	_	_
11	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
12	T	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	WT	_	_	NNP	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	Tbx21-/-	_	_	JJ	Protein	[0]	['root']	_	_
18	mice	_	_	NNS	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	retroviruses	_	_	NNS	O	[-1]	['none']	_	_
21	containing	_	_	VBG	O	[-1]	['none']	_	_
22	internal	_	_	JJ	O	[-1]	['none']	_	_
23	ribosome	_	_	NN	O	[-1]	['none']	_	_
24	entry	_	_	NN	O	[-1]	['none']	_	_
25	site	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	IRES	_	_	NN	O	[-1]	['none']	_	_
28	)-GFP	_	_	NN	Protein	[0]	['root']	_	_
29	that	_	_	WDT	O	[-1]	['none']	_	_
30	were	_	_	VBD	O	[-1]	['none']	_	_
31	either	_	_	DT	O	[-1]	['none']	_	_
32	empty	_	_	JJ	O	[-1]	['none']	_	_
33	or	_	_	CC	O	[-1]	['none']	_	_
34	encoded	_	_	VBN	O	[-1]	['none']	_	_
35	a	_	_	DT	O	[-1]	['none']	_	_
36	strongly	_	_	RB	O	[-1]	['none']	_	_
37	transactivating	_	_	VBG	O	[-1]	['none']	_	_
38	version	_	_	NN	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	Eomes	_	_	NNP	Protein	[0]	['root']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	Eo-VP16	_	_	NN	Protein	[0]	['root']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	(	_	_	-LRB-	O	[-1]	['none']	_	_
45	8	_	_	CD	O	[-1]	['none']	_	_
46	)	_	_	-RRB-	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	and	_	_	CC	O	[-1]	['none']	_	_
49	expanded	_	_	VBD	O	[-1]	['none']	_	_
50	them	_	_	PRP	O	[-1]	['none']	_	_
51	for	_	_	IN	O	[-1]	['none']	_	_
52	6	_	_	CD	O	[-1]	['none']	_	_
53	d	_	_	NN	O	[-1]	['none']	_	_
54	under	_	_	IN	O	[-1]	['none']	_	_
55	our	_	_	PRP$	O	[-1]	['none']	_	_
56	culture	_	_	NN	O	[-1]	['none']	_	_
57	conditions	_	_	NNS	O	[-1]	['none']	_	_
58	.	_	_	.	O	[-1]	['none']	_	_

1	Eo-VP16	_	_	NNP	Protein	[10]	['Cause']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	but	_	_	CC	O	[-1]	['none']	_	_
4	not	_	_	RB	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	empty	_	_	JJ	O	[-1]	['none']	_	_
7	GFP	_	_	NN	Protein	[0]	['root']	_	_
8	retrovirus	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	increased	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	perforin	_	_	NN	Protein	[12]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[10]	['Theme']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	both	_	_	CC	O	[-1]	['none']	_	_
15	WT	_	_	JJ	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	T-bet-deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
18	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
19	T	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	expected	_	_	VBN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	Eo-VP16	_	_	NN	Protein	[6]	['Cause']	_	_
5	also	_	_	RB	O	[-1]	['none']	_	_
6	rescued	_	_	VBD	Negative_regulation	[0]	['root']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	early	_	_	JJ	O	[-1]	['none']	_	_
9	defect	_	_	NN	Negative_regulation	[6]	['Theme']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	IFN-gamma	_	_	NN	Protein	[12]	['Theme']	_	_
12	production	_	_	NN	Gene_expression	[9]	['Theme']	_	_
13	observed	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	T-bet-deficient	_	_	JJ	Negative_regulation	[9]	['Cause']	_	_
16	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
17	T	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Eo-VP16	_	_	NN	Protein	[6]	['Cause']	_	_
4	did	_	_	VBD	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
7	GzmB	_	_	NN	Protein	[9]	['Theme']	_	_
8	mRNA	_	_	NN	Transcription	[9]	['multitoken']	_	_
9	expression	_	_	NN	Transcription	[6]	['Theme']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	either	_	_	CC	O	[-1]	['none']	_	_
12	WT	_	_	NN	O	[-1]	['none']	_	_
13	or	_	_	CC	O	[-1]	['none']	_	_
14	T-bet-deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	;	_	_	:	O	[-1]	['none']	_	_
17	thus	_	_	RB	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	partial	_	_	JJ	O	[-1]	['none']	_	_
21	T-bet	_	_	JJ	Protein	[22]	['Cause']	_	_
22	dependence	_	_	NN	Positive_regulation	[0]	['root']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	GzmB	_	_	NN	Protein	[26]	['Theme']	_	_
25	mRNA	_	_	NN	Transcription	[26]	['multitoken']	_	_
26	expression	_	_	NN	Transcription	[22]	['Theme']	_	_
27	can	_	_	MD	O	[-1]	['none']	_	_
28	not	_	_	RB	O	[-1]	['none']	_	_
29	be	_	_	VB	O	[-1]	['none']	_	_
30	compensated	_	_	VBN	O	[-1]	['none']	_	_
31	for	_	_	IN	O	[-1]	['none']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	Eo-VP16	_	_	NN	Protein	[0]	['root']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Down-regulation	_	_	NN	Negative_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	interferon	_	_	NN	Protein	[6]	['multitoken']	_	_
4	regulatory	_	_	JJ	Protein	[6]	['multitoken']	_	_
5	factor	_	_	NN	Protein	[6]	['multitoken']	_	_
6	4	_	_	CD	Protein	[8]	['Theme']	_	_
7	gene	_	_	NN	O	[-1]	['none']	_	_
8	expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	leukemic	_	_	JJ	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	due	_	_	JJ	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	hypermethylation	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	CpG	_	_	NN	O	[-1]	['none']	_	_
17	motifs	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	promoter	_	_	NN	O	[-1]	['none']	_	_
21	region	_	_	NN	O	[-1]	['none']	_	_
22	Although	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	bcr-abl	_	_	JJ	Protein	[0]	['root']	_	_
25	translocation	_	_	NN	O	[-1]	['none']	_	_
26	has	_	_	VBZ	O	[-1]	['none']	_	_
27	been	_	_	VBN	O	[-1]	['none']	_	_
28	shown	_	_	VBN	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	be	_	_	VB	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	causative	_	_	JJ	O	[-1]	['none']	_	_
33	genetic	_	_	JJ	O	[-1]	['none']	_	_
34	aberration	_	_	NN	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	chronic	_	_	JJ	O	[-1]	['none']	_	_
37	myeloid	_	_	JJ	O	[-1]	['none']	_	_
38	leukemia	_	_	NN	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	CML	_	_	NN	O	[-1]	['none']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	there	_	_	EX	O	[-1]	['none']	_	_
44	is	_	_	VBZ	O	[-1]	['none']	_	_
45	mounting	_	_	VBG	O	[-1]	['none']	_	_
46	evidence	_	_	NN	O	[-1]	['none']	_	_
47	that	_	_	IN	O	[-1]	['none']	_	_
48	the	_	_	DT	O	[-1]	['none']	_	_
49	deregulation	_	_	NN	Regulation	[0]	['root']	_	_
50	of	_	_	IN	O	[-1]	['none']	_	_
51	other	_	_	JJ	Anaphora	[52]	['multitoken']	_	_
52	genes	_	_	NNS	Anaphora	[0]	['root']	_	_
53	,	_	_	,	O	[-1]	['none']	_	_
54	such	_	_	JJ	O	[-1]	['none']	_	_
55	as	_	_	IN	O	[-1]	['none']	_	_
56	the	_	_	DT	O	[-1]	['none']	_	_
57	transcription	_	_	NN	O	[-1]	['none']	_	_
58	factor	_	_	NN	O	[-1]	['none']	_	_
59	interferon	_	_	NN	Protein	[62]	['multitoken']	_	_
60	regulatory	_	_	JJ	Protein	[62]	['multitoken']	_	_
61	factor	_	_	NN	Protein	[62]	['multitoken']	_	_
62	4	_	_	CD	Protein	[49]	['Theme']	_	_
63	(	_	_	-LRB-	O	[-1]	['none']	_	_
64	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
65	)	_	_	-RRB-	O	[-1]	['none']	_	_
66	,	_	_	,	O	[-1]	['none']	_	_
67	is	_	_	VBZ	O	[-1]	['none']	_	_
68	also	_	_	RB	O	[-1]	['none']	_	_
69	implicated	_	_	VBN	O	[-1]	['none']	_	_
70	in	_	_	IN	O	[-1]	['none']	_	_
71	the	_	_	DT	O	[-1]	['none']	_	_
72	pathogenesis	_	_	NN	O	[-1]	['none']	_	_
73	of	_	_	IN	O	[-1]	['none']	_	_
74	CML	_	_	NN	O	[-1]	['none']	_	_
75	.	_	_	.	O	[-1]	['none']	_	_

1	Promoter	_	_	NN	O	[-1]	['none']	_	_
2	methylation	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	CpG	_	_	NN	O	[-1]	['none']	_	_
5	target	_	_	NN	O	[-1]	['none']	_	_
6	sites	_	_	NNS	O	[-1]	['none']	_	_
7	or	_	_	CC	O	[-1]	['none']	_	_
8	direct	_	_	JJ	O	[-1]	['none']	_	_
9	deletions	_	_	NNS	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	insertions	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	genes	_	_	NNS	O	[-1]	['none']	_	_
14	are	_	_	VBP	O	[-1]	['none']	_	_
15	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	reversible	_	_	JJ	O	[-1]	['none']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	permanent	_	_	JJ	O	[-1]	['none']	_	_
21	silencing	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	gene	_	_	NN	O	[-1]	['none']	_	_
24	expression	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	respectively	_	_	RB	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	investigated	_	_	VBD	O	[-1]	['none']	_	_
5	whether	_	_	IN	O	[-1]	['none']	_	_
6	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
7	promoter	_	_	NN	O	[-1]	['none']	_	_
8	methylation	_	_	NN	O	[-1]	['none']	_	_
9	or	_	_	CC	O	[-1]	['none']	_	_
10	mutation	_	_	NN	O	[-1]	['none']	_	_
11	may	_	_	MD	O	[-1]	['none']	_	_
12	be	_	_	VB	O	[-1]	['none']	_	_
13	involved	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	regulation	_	_	NN	Regulation	[0]	['root']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IRF-4	_	_	NN	Protein	[19]	['Theme']	_	_
19	expression	_	_	NN	Gene_expression	[16]	['Theme']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	leukemia	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Whereas	_	_	IN	O	[-1]	['none']	_	_
2	promoter	_	_	NN	O	[-1]	['none']	_	_
3	mutations	_	_	NNS	O	[-1]	['none']	_	_
4	or	_	_	CC	O	[-1]	['none']	_	_
5	structural	_	_	JJ	O	[-1]	['none']	_	_
6	rearrangements	_	_	NNS	O	[-1]	['none']	_	_
7	could	_	_	MD	O	[-1]	['none']	_	_
8	be	_	_	VB	O	[-1]	['none']	_	_
9	excluded	_	_	VBN	O	[-1]	['none']	_	_
10	as	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	cause	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	altered	_	_	JJ	Regulation	[0]	['root']	_	_
15	IRF-4	_	_	NN	Protein	[16]	['Theme']	_	_
16	expression	_	_	NN	Gene_expression	[14]	['Theme']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	hematopoietic	_	_	JJ	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
23	promoter	_	_	NN	O	[-1]	['none']	_	_
24	methylation	_	_	NN	O	[-1]	['none']	_	_
25	status	_	_	NN	O	[-1]	['none']	_	_
26	was	_	_	VBD	O	[-1]	['none']	_	_
27	found	_	_	VBN	O	[-1]	['none']	_	_
28	to	_	_	TO	O	[-1]	['none']	_	_
29	significantly	_	_	RB	O	[-1]	['none']	_	_
30	influence	_	_	VB	Regulation	[0]	['root']	_	_
31	IRF-4	_	_	NN	Protein	[32]	['Theme']	_	_
32	transcription	_	_	NN	Transcription	[30]	['Theme']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	First	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	treatment	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
6	lymphoid	_	_	JJ	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	myeloid	_	_	JJ	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	monocytic	_	_	JJ	O	[-1]	['none']	_	_
11	cell	_	_	NN	O	[-1]	['none']	_	_
12	lines	_	_	NNS	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	methylation-inhibitor	_	_	JJ	O	[-1]	['none']	_	_
16	5-aza-2-deoxycytidine	_	_	NN	O	[-1]	['none']	_	_
17	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	time-	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	concentration	_	_	NN	O	[-1]	['none']	_	_
23	dependent	_	_	JJ	O	[-1]	['none']	_	_
24	increase	_	_	NN	Positive_regulation	[17]	['Theme']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	IRF-4	_	_	NN	Protein	[24]	['Theme']	_	_
27	mRNA	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	protein	_	_	NN	O	[-1]	['none']	_	_
30	levels	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Second	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	using	_	_	VBG	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	restriction-PCR-assay	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	bisulfite	_	_	NN	O	[-1]	['none']	_	_
8	sequencing	_	_	NN	O	[-1]	['none']	_	_
9	we	_	_	PRP	O	[-1]	['none']	_	_
10	identified	_	_	VBD	O	[-1]	['none']	_	_
11	specifically	_	_	RB	O	[-1]	['none']	_	_
12	methylated	_	_	VBN	O	[-1]	['none']	_	_
13	CpG	_	_	NN	O	[-1]	['none']	_	_
14	sites	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
17	but	_	_	CC	O	[-1]	['none']	_	_
18	not	_	_	RB	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Third	_	_	NNP	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	clearly	_	_	RB	O	[-1]	['none']	_	_
5	determined	_	_	VBD	O	[-1]	['none']	_	_
6	promoter	_	_	NN	O	[-1]	['none']	_	_
7	methylation	_	_	NN	O	[-1]	['none']	_	_
8	as	_	_	IN	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	mechanism	_	_	NN	O	[-1]	['none']	_	_
11	for	_	_	IN	O	[-1]	['none']	_	_
12	IRF-4	_	_	NN	Protein	[13]	['Theme']	_	_
13	down-regulation	_	_	NN	Negative_regulation	[0]	['root']	_	_
14	via	_	_	IN	O	[-1]	['none']	_	_
15	reporter	_	_	NN	O	[-1]	['none']	_	_
16	gene	_	_	NN	O	[-1]	['none']	_	_
17	assays	_	_	NNS	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	but	_	_	CC	O	[-1]	['none']	_	_
20	did	_	_	VBD	O	[-1]	['none']	_	_
21	not	_	_	RB	O	[-1]	['none']	_	_
22	detect	_	_	VB	O	[-1]	['none']	_	_
23	an	_	_	DT	O	[-1]	['none']	_	_
24	association	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	methylational	_	_	JJ	O	[-1]	['none']	_	_
27	status	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	mRNA	_	_	NN	O	[-1]	['none']	_	_
30	expression	_	_	NN	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	DNA	_	_	NN	O	[-1]	['none']	_	_
33	methyltransferases	_	_	NNS	O	[-1]	['none']	_	_
34	or	_	_	CC	O	[-1]	['none']	_	_
35	methyl-CpG-binding	_	_	JJ	O	[-1]	['none']	_	_
36	proteins	_	_	NNS	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Together	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	these	_	_	DT	O	[-1]	['none']	_	_
4	data	_	_	NNS	O	[-1]	['none']	_	_
5	suggest	_	_	VBP	O	[-1]	['none']	_	_
6	CpG	_	_	NN	O	[-1]	['none']	_	_
7	site	_	_	NN	O	[-1]	['none']	_	_
8	specific	_	_	JJ	O	[-1]	['none']	_	_
9	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
10	promoter	_	_	NN	O	[-1]	['none']	_	_
11	methylation	_	_	NN	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	putative	_	_	JJ	O	[-1]	['none']	_	_
15	mechanism	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	down-regulated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
18	IRF-4	_	_	NN	Protein	[19]	['Theme']	_	_
19	expression	_	_	NN	Gene_expression	[17]	['Theme']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	leukemia	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Interleukin-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	Production	_	_	NN	Gene_expression	[6]	['Theme']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	Th1	_	_	NN	O	[-1]	['none']	_	_
5	Cells	_	_	NNS	O	[-1]	['none']	_	_
6	Requires	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
7	Interleukin-12-Induced	_	_	JJ	Positive_regulation	[6]	['Cause']	_	_
8	STAT4	_	_	NN	Protein	[7]	['Theme']	_	_
9	Transcription	_	_	NN	O	[-1]	['none']	_	_
10	Factor	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	ERK	_	_	NN	Protein	[15]	['Theme']	_	_
13	MAP	_	_	NN	O	[-1]	['none']	_	_
14	Kinase	_	_	NN	O	[-1]	['none']	_	_
15	Activation	_	_	NN	Positive_regulation	[6]	['Cause']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	High	_	_	JJ	O	[-1]	['none']	_	_
18	Antigen	_	_	NN	O	[-1]	['none']	_	_
19	Dose	_	_	NN	O	[-1]	['none']	_	_
20	Summary	_	_	NN	O	[-1]	['none']	_	_
21	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
22	T	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	producing	_	_	VBG	Gene_expression	[0]	['root']	_	_
25	interleukin-10	_	_	NN	Protein	[24]	['Theme']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	IL-10	_	_	NN	Protein	[0]	['root']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	interferon-gamma	_	_	NN	Protein	[24]	['Theme']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	IFN-gamma	_	_	NN	Protein	[0]	['root']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	are	_	_	VBP	O	[-1]	['none']	_	_
35	reported	_	_	VBN	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	chronic	_	_	JJ	O	[-1]	['none']	_	_
38	infections	_	_	NNS	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	signals	_	_	NNS	O	[-1]	['none']	_	_
5	that	_	_	WDT	O	[-1]	['none']	_	_
6	direct	_	_	VBP	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	development	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
11	T	_	_	NN	O	[-1]	['none']	_	_
12	helper	_	_	NN	O	[-1]	['none']	_	_
13	1	_	_	CD	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Th1	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	are	_	_	VBP	O	[-1]	['none']	_	_
19	undefined	_	_	JJ	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	showed	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	development	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
7	Th1	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	required	_	_	VBD	O	[-1]	['none']	_	_
10	high	_	_	JJ	O	[-1]	['none']	_	_
11	T	_	_	NN	O	[-1]	['none']	_	_
12	cell	_	_	NN	O	[-1]	['none']	_	_
13	receptor	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	TCR	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	ligation	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	sustained	_	_	VBD	O	[-1]	['none']	_	_
20	ERK1	_	_	NN	Protein	[25]	['Theme']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	ERK2	_	_	NN	Protein	[25]	['Theme']	_	_
23	MAP	_	_	NN	O	[-1]	['none']	_	_
24	kinases	_	_	NNS	O	[-1]	['none']	_	_
25	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	IL-12-induced	_	_	JJ	Positive_regulation	[0]	['root']	_	_
29	STAT4	_	_	NN	Protein	[32]	['Theme']	_	_
30	transcription	_	_	NN	O	[-1]	['none']	_	_
31	factor	_	_	NN	O	[-1]	['none']	_	_
32	activation	_	_	NN	Positive_regulation	[28]	['Theme']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Repeated	_	_	JJ	O	[-1]	['none']	_	_
2	TCR	_	_	NN	O	[-1]	['none']	_	_
3	triggering	_	_	NN	O	[-1]	['none']	_	_
4	led	_	_	VBD	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	enhanced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
7	IL-10	_	_	NN	Protein	[8]	['Theme']	_	_
8	production	_	_	NN	Gene_expression	[6]	['Theme']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	continued	_	_	VBD	O	[-1]	['none']	_	_
15	IL-12	_	_	NN	Protein	[0]	['root']	_	_
16	action	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	high-dose	_	_	JJ	O	[-1]	['none']	_	_
19	TCR	_	_	NN	O	[-1]	['none']	_	_
20	signaling	_	_	NN	O	[-1]	['none']	_	_
21	were	_	_	VBD	O	[-1]	['none']	_	_
22	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
23	for	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	development	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	maintenance	_	_	NN	O	[-1]	['none']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	IL-10-producing	_	_	JJ	Gene_expression	[22]	['Theme']	_	_
30	Th1	_	_	NN	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	Th1	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	Th2	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	Th17	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	require	_	_	VBP	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	distinct	_	_	JJ	O	[-1]	['none']	_	_
14	STATs	_	_	NNS	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	their	_	_	PRP$	O	[-1]	['none']	_	_
17	differentiation	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	activation	_	_	NN	Positive_regulation	[27]	['Cause']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	ERK1	_	_	NN	Protein	[19]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	ERK2	_	_	NN	Protein	[19]	['Theme']	_	_
24	was	_	_	VBD	O	[-1]	['none']	_	_
25	a	_	_	DT	O	[-1]	['none']	_	_
26	common	_	_	JJ	O	[-1]	['none']	_	_
27	requirement	_	_	NN	Positive_regulation	[0]	['root']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	production	_	_	NN	Gene_expression	[27]	['Theme']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	IL-10	_	_	NN	Protein	[29]	['Theme']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	all	_	_	DT	O	[-1]	['none']	_	_
34	Th	_	_	NN	O	[-1]	['none']	_	_
35	cell	_	_	NN	O	[-1]	['none']	_	_
36	subsets	_	_	NNS	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	correlated	_	_	VBD	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	c-maf	_	_	NN	Protein	[7]	['Theme']	_	_
7	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	Despite	_	_	IN	O	[-1]	['none']	_	_
2	having	_	_	VBG	O	[-1]	['none']	_	_
3	distinct	_	_	JJ	O	[-1]	['none']	_	_
4	functions	_	_	NNS	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	protection	_	_	NN	O	[-1]	['none']	_	_
7	against	_	_	IN	O	[-1]	['none']	_	_
8	pathogens	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	all	_	_	DT	O	[-1]	['none']	_	_
11	Th	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	share	_	_	VBP	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	important	_	_	JJ	O	[-1]	['none']	_	_
16	task	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	controlling	_	_	VBG	O	[-1]	['none']	_	_
19	overexuberant	_	_	JJ	O	[-1]	['none']	_	_
20	immune	_	_	JJ	O	[-1]	['none']	_	_
21	responses	_	_	NNS	O	[-1]	['none']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	means	_	_	NNS	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	IL-10	_	_	NN	Protein	[26]	['Theme']	_	_
26	production	_	_	NN	Gene_expression	[0]	['root']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	CREB	_	_	NN	O	[-1]	['none']	_	_
2	Is	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	Target	_	_	NN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	Transcriptional	_	_	JJ	O	[-1]	['none']	_	_
7	Repression	_	_	NN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
10	Although	_	_	IN	O	[-1]	['none']	_	_
11	Foxp3	_	_	NN	Protein	[22]	['Cause']	_	_
12	could	_	_	MD	O	[-1]	['none']	_	_
13	down-regulate	_	_	VB	O	[-1]	['none']	_	_
14	Tax	_	_	NN	Protein	[0]	['root']	_	_
15	dependent	_	_	JJ	O	[-1]	['none']	_	_
16	transactivation	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
20	LTR	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	inhibit	_	_	VBP	Negative_regulation	[0]	['root']	_	_
23	Tax	_	_	NN	Protein	[24]	['Theme']	_	_
24	expression	_	_	NN	Gene_expression	[22]	['Theme']	_	_
25	from	_	_	IN	O	[-1]	['none']	_	_
26	an	_	_	DT	O	[-1]	['none']	_	_
27	infectious	_	_	JJ	O	[-1]	['none']	_	_
28	molecular	_	_	JJ	O	[-1]	['none']	_	_
29	clone	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	Foxp3	_	_	NN	Protein	[34]	['Cause']	_	_
32	failed	_	_	VBD	O	[-1]	['none']	_	_
33	to	_	_	TO	O	[-1]	['none']	_	_
34	modulate	_	_	VB	Regulation	[0]	['root']	_	_
35	Tax	_	_	NN	Protein	[34]	['Theme']	_	_
36	function	_	_	NN	O	[-1]	['none']	_	_
37	in	_	_	IN	O	[-1]	['none']	_	_
38	the	_	_	DT	O	[-1]	['none']	_	_
39	absence	_	_	NN	O	[-1]	['none']	_	_
40	of	_	_	IN	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	viral	_	_	JJ	O	[-1]	['none']	_	_
43	promoter	_	_	NN	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	led	_	_	VBD	O	[-1]	['none']	_	_
4	us	_	_	PRP	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	hypothesize	_	_	VB	O	[-1]	['none']	_	_
7	that	_	_	DT	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[15]	['Theme']	_	_
9	acts	_	_	VBZ	O	[-1]	['none']	_	_
10	on	_	_	IN	O	[-1]	['none']	_	_
11	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
12	gene	_	_	NN	O	[-1]	['none']	_	_
13	expression	_	_	NN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	interacting	_	_	VBG	Binding	[0]	['root']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	proteins	_	_	NNS	O	[-1]	['none']	_	_
18	important	_	_	JJ	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	driving	_	_	VBG	O	[-1]	['none']	_	_
21	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
22	LTR	_	_	NN	O	[-1]	['none']	_	_
23	activity	_	_	NN	O	[-1]	['none']	_	_
24	in	_	_	FW	O	[-1]	['none']	_	_
25	vivo	_	_	FW	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Previous	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	have	_	_	VBP	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	Tax	_	_	NN	O	[-1]	['none']	_	_
8	responsive	_	_	JJ	O	[-1]	['none']	_	_
9	elements	_	_	NNS	O	[-1]	['none']	_	_
10	within	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
13	LTR	_	_	NN	O	[-1]	['none']	_	_
14	play	_	_	VBP	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	crucial	_	_	JJ	O	[-1]	['none']	_	_
17	role	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	driving	_	_	VBG	O	[-1]	['none']	_	_
20	Tax	_	_	NN	Protein	[0]	['root']	_	_
21	mediated	_	_	JJ	O	[-1]	['none']	_	_
22	transactivation	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
26	LTR	_	_	NN	O	[-1]	['none']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	18	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Tax	_	_	NN	O	[-1]	['none']	_	_
3	responsive	_	_	JJ	O	[-1]	['none']	_	_
4	elements	_	_	NNS	O	[-1]	['none']	_	_
5	have	_	_	VBP	O	[-1]	['none']	_	_
6	been	_	_	VBN	O	[-1]	['none']	_	_
7	shown	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	resemble	_	_	VB	O	[-1]	['none']	_	_
10	CREB	_	_	NN	O	[-1]	['none']	_	_
11	binding	_	_	NN	O	[-1]	['none']	_	_
12	sites	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	bind	_	_	VBP	O	[-1]	['none']	_	_
15	CREB	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	FW	O	[-1]	['none']	_	_
17	vitro	_	_	FW	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	in	_	_	FW	O	[-1]	['none']	_	_
20	vivo	_	_	FW	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	facilitate	_	_	VB	O	[-1]	['none']	_	_
24	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
25	LTR	_	_	NN	O	[-1]	['none']	_	_
26	activation	_	_	NN	O	[-1]	['none']	_	_
27	both	_	_	CC	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	presence	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	absence	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	Tax	_	_	NN	Protein	[0]	['root']	_	_
37	[	_	_	CD	O	[-1]	['none']	_	_
38	35,36	_	_	CD	O	[-1]	['none']	_	_
39	]	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Ching	_	_	NNP	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	colleagues	_	_	NNS	O	[-1]	['none']	_	_
4	[	_	_	VBP	O	[-1]	['none']	_	_
5	18	_	_	CD	O	[-1]	['none']	_	_
6	]	_	_	CD	O	[-1]	['none']	_	_
7	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
8	that	_	_	IN	O	[-1]	['none']	_	_
9	addition	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	dominant	_	_	JJ	O	[-1]	['none']	_	_
13	negative	_	_	JJ	O	[-1]	['none']	_	_
14	CREB	_	_	NN	O	[-1]	['none']	_	_
15	expression	_	_	NN	O	[-1]	['none']	_	_
16	vector	_	_	NN	O	[-1]	['none']	_	_
17	resulted	_	_	VBD	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	nearly	_	_	RB	O	[-1]	['none']	_	_
20	complete	_	_	JJ	O	[-1]	['none']	_	_
21	inhibition	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	Tax	_	_	NN	Protein	[0]	['root']	_	_
24	mediated	_	_	JJ	O	[-1]	['none']	_	_
25	activation	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
29	LTR	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	while	_	_	IN	O	[-1]	['none']	_	_
32	blocking	_	_	VBG	O	[-1]	['none']	_	_
33	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
34	activation	_	_	NN	O	[-1]	['none']	_	_
35	by	_	_	IN	O	[-1]	['none']	_	_
36	addition	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	a	_	_	DT	O	[-1]	['none']	_	_
39	dominant	_	_	JJ	O	[-1]	['none']	_	_
40	negative	_	_	JJ	O	[-1]	['none']	_	_
41	IKKbeta	_	_	NN	Protein	[42]	['Theme']	_	_
42	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
43	vector	_	_	NN	O	[-1]	['none']	_	_
44	had	_	_	VBD	O	[-1]	['none']	_	_
45	no	_	_	DT	O	[-1]	['none']	_	_
46	effect	_	_	NN	O	[-1]	['none']	_	_
47	on	_	_	IN	O	[-1]	['none']	_	_
48	Tax	_	_	NN	Protein	[0]	['root']	_	_
49	transactivation	_	_	NN	O	[-1]	['none']	_	_
50	of	_	_	IN	O	[-1]	['none']	_	_
51	the	_	_	DT	O	[-1]	['none']	_	_
52	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
53	LTR	_	_	NN	O	[-1]	['none']	_	_
54	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	hypothesized	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
7	may	_	_	MD	O	[-1]	['none']	_	_
8	inhibit	_	_	VB	O	[-1]	['none']	_	_
9	Tax	_	_	NN	Protein	[0]	['root']	_	_
10	transactivation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
14	LTR	_	_	NN	O	[-1]	['none']	_	_
15	via	_	_	IN	O	[-1]	['none']	_	_
16	disruption	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	CREB	_	_	NN	O	[-1]	['none']	_	_
20	signaling	_	_	NN	O	[-1]	['none']	_	_
21	pathway	_	_	NN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	test	_	_	VB	O	[-1]	['none']	_	_
3	this	_	_	DT	O	[-1]	['none']	_	_
4	possibility	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	HEK	_	_	NNP	O	[-1]	['none']	_	_
7	293T	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	transfected	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	an	_	_	DT	O	[-1]	['none']	_	_
13	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
14	LTR	_	_	NN	O	[-1]	['none']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	synthetic	_	_	JJ	O	[-1]	['none']	_	_
17	CREB	_	_	NN	O	[-1]	['none']	_	_
18	reporter	_	_	NN	O	[-1]	['none']	_	_
19	vector	_	_	NN	O	[-1]	['none']	_	_
20	along	_	_	IN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	a	_	_	DT	O	[-1]	['none']	_	_
23	control	_	_	NN	O	[-1]	['none']	_	_
24	expression	_	_	NN	O	[-1]	['none']	_	_
25	vector	_	_	NN	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	EGFP	_	_	NN	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	or	_	_	CC	O	[-1]	['none']	_	_
30	expression	_	_	NN	O	[-1]	['none']	_	_
31	vectors	_	_	NNS	O	[-1]	['none']	_	_
32	encoding	_	_	VBG	O	[-1]	['none']	_	_
33	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
34	or	_	_	CC	O	[-1]	['none']	_	_
35	deltaFKH	_	_	NN	Protein	[0]	['root']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	6A	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
8	down-regulated	_	_	VBD	O	[-1]	['none']	_	_
9	basal	_	_	JJ	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
14	LTR	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	transcription	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	synthetic	_	_	JJ	O	[-1]	['none']	_	_
20	CREB	_	_	NN	O	[-1]	['none']	_	_
21	reporter	_	_	NN	O	[-1]	['none']	_	_
22	vector	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	suggesting	_	_	VBG	O	[-1]	['none']	_	_
25	that	_	_	IN	O	[-1]	['none']	_	_
26	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
27	down-regulates	_	_	VBZ	O	[-1]	['none']	_	_
28	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
29	LTR	_	_	NN	O	[-1]	['none']	_	_
30	activation	_	_	NN	O	[-1]	['none']	_	_
31	by	_	_	IN	O	[-1]	['none']	_	_
32	targeting	_	_	VBG	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	CREB	_	_	NN	O	[-1]	['none']	_	_
35	pathway	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Deletion	_	_	NN	Negative_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	FKH	_	_	NN	Entity	[5]	['multitoken']	_	_
5	domain	_	_	NN	Entity	[1]	['Site']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[1]	['Theme']	_	_
8	dampened	_	_	VBD	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	suppressive	_	_	JJ	O	[-1]	['none']	_	_
11	effect	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	but	_	_	CC	O	[-1]	['none']	_	_
16	did	_	_	VBD	O	[-1]	['none']	_	_
17	not	_	_	RB	O	[-1]	['none']	_	_
18	completely	_	_	RB	O	[-1]	['none']	_	_
19	abrogate	_	_	VBP	O	[-1]	['none']	_	_
20	suppression	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	as	_	_	RB	O	[-1]	['none']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	seen	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	NF-kappaB-responsive	_	_	JJ	O	[-1]	['none']	_	_
27	promoters	_	_	NNS	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	HEK	_	_	NNP	O	[-1]	['none']	_	_
30	293T	_	_	NN	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Like	_	_	IN	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	activation	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	CREB	_	_	NN	O	[-1]	['none']	_	_
6	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	also	_	_	RB	O	[-1]	['none']	_	_
10	suppressed	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[12]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	similar	_	_	JJ	O	[-1]	['none']	_	_
20	extent	_	_	NN	O	[-1]	['none']	_	_
21	deltaFKH	_	_	NN	Protein	[12]	['Theme']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	healthy	_	_	JJ	O	[-1]	['none']	_	_
25	donor	_	_	NN	O	[-1]	['none']	_	_
26	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
27	T	_	_	NN	O	[-1]	['none']	_	_
28	cells	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Similarly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	deltaFKH	_	_	NN	Protein	[0]	['root']	_	_
6	also	_	_	RB	O	[-1]	['none']	_	_
7	repressed	_	_	VBD	O	[-1]	['none']	_	_
8	basal	_	_	JJ	O	[-1]	['none']	_	_
9	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
10	LTR	_	_	NN	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	primary	_	_	JJ	O	[-1]	['none']	_	_
14	human	_	_	NN	O	[-1]	['none']	_	_
15	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
16	T	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	our	_	_	PRP$	O	[-1]	['none']	_	_
3	knowledge	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	this	_	_	DT	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	first	_	_	JJ	O	[-1]	['none']	_	_
9	evidence	_	_	NN	O	[-1]	['none']	_	_
10	implicating	_	_	VBG	O	[-1]	['none']	_	_
11	CREB	_	_	NN	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	molecular	_	_	JJ	O	[-1]	['none']	_	_
15	target	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	observed	_	_	VBN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	activation	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	deltaFKH	_	_	NN	Protein	[12]	['Cause']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	more	_	_	RBR	O	[-1]	['none']	_	_
11	potent	_	_	JJ	O	[-1]	['none']	_	_
12	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	CREB	_	_	NN	Protein	[15]	['Theme']	_	_
15	activation	_	_	NN	Positive_regulation	[12]	['Theme']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
18	T	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	than	_	_	IN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	HEK	_	_	NNP	O	[-1]	['none']	_	_
23	293T	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	further	_	_	RB	O	[-1]	['none']	_	_
27	indicating	_	_	VBG	O	[-1]	['none']	_	_
28	that	_	_	IN	O	[-1]	['none']	_	_
29	a	_	_	DT	O	[-1]	['none']	_	_
30	cell	_	_	NN	O	[-1]	['none']	_	_
31	type	_	_	NN	O	[-1]	['none']	_	_
32	specific	_	_	JJ	O	[-1]	['none']	_	_
33	mechanism	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	action	_	_	NN	O	[-1]	['none']	_	_
36	may	_	_	MD	O	[-1]	['none']	_	_
37	govern	_	_	VB	O	[-1]	['none']	_	_
38	the	_	_	DT	O	[-1]	['none']	_	_
39	function	_	_	NN	O	[-1]	['none']	_	_
40	of	_	_	IN	O	[-1]	['none']	_	_
41	this	_	_	DT	O	[-1]	['none']	_	_
42	Foxp3	_	_	NN	O	[-1]	['none']	_	_
43	mutant	_	_	NN	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	whether	_	_	IN	O	[-1]	['none']	_	_
4	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
5	functioned	_	_	VBD	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	directly	_	_	RB	O	[-1]	['none']	_	_
8	signaling	_	_	VBG	O	[-1]	['none']	_	_
9	through	_	_	IN	O	[-1]	['none']	_	_
10	CREB	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	we	_	_	PRP	O	[-1]	['none']	_	_
13	utilized	_	_	VBD	O	[-1]	['none']	_	_
14	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
15	vectors	_	_	NNS	O	[-1]	['none']	_	_
16	encoding	_	_	VBG	O	[-1]	['none']	_	_
17	CREB-1	_	_	NN	Protein	[0]	['root']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	c-Jun	_	_	NN	Protein	[0]	['root']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	member	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	activator	_	_	NN	Protein	[27]	['multitoken']	_	_
26	protein	_	_	NN	Protein	[27]	['multitoken']	_	_
27	1	_	_	CD	Protein	[0]	['root']	_	_
28	family	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	transcription	_	_	NN	O	[-1]	['none']	_	_
31	factors	_	_	NNS	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	fused	_	_	VBN	O	[-1]	['none']	_	_
34	in-frame	_	_	RB	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	Gal4-BD	_	_	NN	Protein	[0]	['root']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	Gal4-BD-CREB-1	_	_	NN	Protein	[14]	['Theme']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	Gal4-BD-c-Jun	_	_	NN	Protein	[14]	['Theme']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	6D	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	activation	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	Gal4	_	_	NN	Protein	[0]	['root']	_	_
11	responsive	_	_	JJ	O	[-1]	['none']	_	_
12	reporter	_	_	NN	O	[-1]	['none']	_	_
13	vector	_	_	NN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	Gal4-BD-CREB-1	_	_	NN	Protein	[0]	['root']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	down-regulated	_	_	VBN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
20	compared	_	_	VBN	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	control	_	_	VB	O	[-1]	['none']	_	_
23	vector	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	EGFP	_	_	NN	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	indicating	_	_	VBG	O	[-1]	['none']	_	_
29	that	_	_	IN	O	[-1]	['none']	_	_
30	Foxp3	_	_	NN	Protein	[36]	['Theme']	_	_
31	functions	_	_	NNS	O	[-1]	['none']	_	_
32	by	_	_	IN	O	[-1]	['none']	_	_
33	directly	_	_	RB	O	[-1]	['none']	_	_
34	or	_	_	CC	O	[-1]	['none']	_	_
35	indirectly	_	_	RB	O	[-1]	['none']	_	_
36	interacting	_	_	VBG	Binding	[0]	['root']	_	_
37	with	_	_	IN	O	[-1]	['none']	_	_
38	CREB-1	_	_	NN	Protein	[36]	['Theme']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
4	failed	_	_	VBD	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	markedly	_	_	RB	O	[-1]	['none']	_	_
7	affect	_	_	VB	O	[-1]	['none']	_	_
8	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	Gal4-BD-c-Jun	_	_	NN	Protein	[0]	['root']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	c-Jun	_	_	NN	Protein	[19]	['Theme']	_	_
14	has	_	_	VBZ	O	[-1]	['none']	_	_
15	also	_	_	RB	O	[-1]	['none']	_	_
16	been	_	_	VBN	O	[-1]	['none']	_	_
17	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	bind	_	_	VB	Binding	[0]	['root']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
23	LTR	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	Gal4-BD-Tax	_	_	NN	Protein	[0]	['root']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Importantly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	mechanism	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
7	mediated	_	_	VBD	O	[-1]	['none']	_	_
8	inhibition	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	CREB	_	_	NN	O	[-1]	['none']	_	_
11	dependent	_	_	JJ	O	[-1]	['none']	_	_
12	transcription	_	_	NN	O	[-1]	['none']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	not	_	_	RB	O	[-1]	['none']	_	_
15	due	_	_	JJ	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	block	_	_	NN	Negative_regulation	[0]	['root']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	CREB-1	_	_	NN	Protein	[22]	['Theme']	_	_
21	protein	_	_	NN	O	[-1]	['none']	_	_
22	expression	_	_	NN	Gene_expression	[18]	['Theme']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	as	_	_	IN	O	[-1]	['none']	_	_
25	determined	_	_	VBN	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	Western	_	_	NN	O	[-1]	['none']	_	_
28	blot	_	_	NN	O	[-1]	['none']	_	_
29	analysis	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	these	_	_	DT	O	[-1]	['none']	_	_
3	results	_	_	NNS	O	[-1]	['none']	_	_
4	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
7	functions	_	_	NNS	O	[-1]	['none']	_	_
8	as	_	_	IN	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	co-repressor	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	CREB	_	_	NN	O	[-1]	['none']	_	_
13	activation	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	addition	_	_	NN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	NF-AT	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	we	_	_	PRP	O	[-1]	['none']	_	_
24	were	_	_	VBD	O	[-1]	['none']	_	_
25	unable	_	_	JJ	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	detect	_	_	VB	O	[-1]	['none']	_	_
28	a	_	_	DT	O	[-1]	['none']	_	_
29	direct	_	_	JJ	O	[-1]	['none']	_	_
30	physical	_	_	JJ	O	[-1]	['none']	_	_
31	interaction	_	_	NN	Binding	[0]	['root']	_	_
32	between	_	_	IN	O	[-1]	['none']	_	_
33	CREB-1	_	_	NN	Protein	[31]	['Theme']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	Foxp3	_	_	NN	Protein	[31]	['Theme']	_	_
36	by	_	_	IN	O	[-1]	['none']	_	_
37	coimmunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
38	or	_	_	CC	O	[-1]	['none']	_	_
39	mammalian	_	_	JJ	O	[-1]	['none']	_	_
40	two-hybrid	_	_	JJ	O	[-1]	['none']	_	_
41	analysis	_	_	NN	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	unpublished	_	_	JJ	O	[-1]	['none']	_	_
44	data	_	_	NNS	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	Therefore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	data	_	_	NNS	O	[-1]	['none']	_	_
5	suggest	_	_	VBP	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[9]	['Cause']	_	_
8	may	_	_	MD	O	[-1]	['none']	_	_
9	interfere	_	_	VB	Negative_regulation	[0]	['root']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	CREB	_	_	NN	O	[-1]	['none']	_	_
12	signaling	_	_	NN	Positive_regulation	[9]	['Theme']	_	_
13	at	_	_	IN	O	[-1]	['none']	_	_
14	an	_	_	DT	Anaphora	[16]	['multitoken']	_	_
15	upstream	_	_	JJ	Anaphora	[16]	['multitoken']	_	_
16	event	_	_	NN	Anaphora	[0]	['root']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	such	_	_	JJ	O	[-1]	['none']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	phosphorylation	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	CREB	_	_	NN	O	[-1]	['none']	_	_
23	or	_	_	CC	O	[-1]	['none']	_	_
24	recruitment	_	_	NN	Binding	[12]	['Theme']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	function	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	coactivator	_	_	NN	Anaphora	[29]	['multitoken']	_	_
29	proteins	_	_	NNS	Anaphora	[0]	['root']	_	_
30	CREB	_	_	NN	Protein	[32]	['multitoken']	_	_
31	binding	_	_	NN	Protein	[32]	['multitoken']	_	_
32	protein	_	_	NN	Protein	[24]	['Theme']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	CBP	_	_	NN	Protein	[0]	['root']	_	_
35	)/p300	_	_	NN	Protein	[24]	['Theme']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Analysis	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Akt	_	_	NN	Protein	[0]	['root']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	Stat3	_	_	NN	Protein	[0]	['root']	_	_
9	Pathways	_	_	NNS	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	Contribution	_	_	NN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	Growth	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	Survival	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	Lymphoma	_	_	NN	O	[-1]	['none']	_	_
19	Cells	_	_	NNS	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	A-D	_	_	NNP	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
24	analysis	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	wild-type	_	_	JJ	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	LMP1	_	_	NN	Protein	[0]	['root']	_	_
29	transgenic	_	_	JJ	O	[-1]	['none']	_	_
30	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
31	for	_	_	IN	O	[-1]	['none']	_	_
32	Akt	_	_	NN	Protein	[0]	['root']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	Stat3	_	_	NN	Protein	[0]	['root']	_	_
38	signaling	_	_	NN	O	[-1]	['none']	_	_
39	after	_	_	IN	O	[-1]	['none']	_	_
40	treatment	_	_	NN	O	[-1]	['none']	_	_
41	with	_	_	IN	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	A	_	_	NN	O	[-1]	['none']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	an	_	_	DT	O	[-1]	['none']	_	_
46	Akt	_	_	NN	Protein	[47]	['Theme']	_	_
47	inhibitor	_	_	NN	Negative_regulation	[0]	['root']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	triciribine	_	_	NN	O	[-1]	['none']	_	_
50	,	_	_	,	O	[-1]	['none']	_	_
51	(	_	_	-LRB-	O	[-1]	['none']	_	_
52	B	_	_	NN	O	[-1]	['none']	_	_
53	)	_	_	-RRB-	O	[-1]	['none']	_	_
54	an	_	_	DT	O	[-1]	['none']	_	_
55	NFkappaB	_	_	NN	O	[-1]	['none']	_	_
56	inhibitor	_	_	NN	O	[-1]	['none']	_	_
57	,	_	_	,	O	[-1]	['none']	_	_
58	BAY11-7085	_	_	NN	O	[-1]	['none']	_	_
59	,	_	_	,	O	[-1]	['none']	_	_
60	and	_	_	CC	O	[-1]	['none']	_	_
61	the	_	_	DT	O	[-1]	['none']	_	_
62	Stat3	_	_	NN	Protein	[63]	['Theme']	_	_
63	inhibitors	_	_	NNS	Negative_regulation	[0]	['root']	_	_
64	(	_	_	-LRB-	O	[-1]	['none']	_	_
65	C	_	_	NN	O	[-1]	['none']	_	_
66	)	_	_	-RRB-	O	[-1]	['none']	_	_
67	cucurbitacin	_	_	NN	O	[-1]	['none']	_	_
68	I	_	_	NN	O	[-1]	['none']	_	_
69	and	_	_	CC	O	[-1]	['none']	_	_
70	(	_	_	-LRB-	O	[-1]	['none']	_	_
71	D	_	_	NN	O	[-1]	['none']	_	_
72	)	_	_	-RRB-	O	[-1]	['none']	_	_
73	AG490	_	_	NN	O	[-1]	['none']	_	_
74	,	_	_	,	O	[-1]	['none']	_	_
75	at	_	_	IN	O	[-1]	['none']	_	_
76	the	_	_	DT	O	[-1]	['none']	_	_
77	indicated	_	_	JJ	O	[-1]	['none']	_	_
78	concentrations	_	_	NNS	O	[-1]	['none']	_	_
79	.	_	_	.	O	[-1]	['none']	_	_

1	Arrows	_	_	NNS	O	[-1]	['none']	_	_
2	indicate	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	positions	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	alpha	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	beta	_	_	NN	O	[-1]	['none']	_	_
9	isoforms	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	Stat3	_	_	NN	Protein	[0]	['root']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Actin	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	loading	_	_	VBG	O	[-1]	['none']	_	_
7	control	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	ChIP	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	real-time	_	_	JJ	O	[-1]	['none']	_	_
4	PCR	_	_	NN	O	[-1]	['none']	_	_
5	analysis	_	_	NN	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	20	_	_	CD	O	[-1]	['none']	_	_
2	x	_	_	CC	O	[-1]	['none']	_	_
3	106	_	_	CD	O	[-1]	['none']	_	_
4	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
5	T	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	per	_	_	IN	O	[-1]	['none']	_	_
8	immunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	fixed	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	adding	_	_	VBG	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	1/10th	_	_	NN	O	[-1]	['none']	_	_
15	volume	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	fixation	_	_	NN	O	[-1]	['none']	_	_
18	solution	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	11.1	_	_	CD	O	[-1]	['none']	_	_
21	%	_	_	NN	O	[-1]	['none']	_	_
22	formaldehyde	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	100	_	_	CD	O	[-1]	['none']	_	_
25	mM	_	_	NN	O	[-1]	['none']	_	_
26	NaCl	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	1	_	_	CD	O	[-1]	['none']	_	_
29	mM	_	_	NN	O	[-1]	['none']	_	_
30	EDTA	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	0.5	_	_	CD	O	[-1]	['none']	_	_
33	mM	_	_	NN	O	[-1]	['none']	_	_
34	EGTA	_	_	NN	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	50	_	_	CD	O	[-1]	['none']	_	_
37	mM	_	_	NN	O	[-1]	['none']	_	_
38	Hepes	_	_	VBZ	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	to	_	_	TO	O	[-1]	['none']	_	_
41	1	_	_	CD	O	[-1]	['none']	_	_
42	volume	_	_	NN	O	[-1]	['none']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	culture	_	_	NN	O	[-1]	['none']	_	_
45	media	_	_	NNS	O	[-1]	['none']	_	_
46	and	_	_	CC	O	[-1]	['none']	_	_
47	were	_	_	VBD	O	[-1]	['none']	_	_
48	incubated	_	_	VBN	O	[-1]	['none']	_	_
49	for	_	_	IN	O	[-1]	['none']	_	_
50	10	_	_	CD	O	[-1]	['none']	_	_
51	or	_	_	CC	O	[-1]	['none']	_	_
52	30	_	_	CD	O	[-1]	['none']	_	_
53	min	_	_	NN	O	[-1]	['none']	_	_
54	at	_	_	IN	O	[-1]	['none']	_	_
55	RT.	_	_	NNP	O	[-1]	['none']	_	_
56	.	_	_	.	O	[-1]	['none']	_	_

1	Fixation	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	stopped	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	120	_	_	CD	O	[-1]	['none']	_	_
6	mM	_	_	NN	O	[-1]	['none']	_	_
7	glycine	_	_	NN	O	[-1]	['none']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	ice	_	_	NN	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	5	_	_	CD	O	[-1]	['none']	_	_
12	min	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Fixed	_	_	VBN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	washed	_	_	VBN	O	[-1]	['none']	_	_
5	2x	_	_	NN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	cold	_	_	JJ	O	[-1]	['none']	_	_
8	PBS	_	_	NNP	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	1x	_	_	NN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	cold	_	_	JJ	O	[-1]	['none']	_	_
13	solution	_	_	NN	O	[-1]	['none']	_	_
14	I	_	_	PRP	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	10	_	_	CD	O	[-1]	['none']	_	_
17	mM	_	_	NN	O	[-1]	['none']	_	_
18	Tris	_	_	NNP	O	[-1]	['none']	_	_
19	[	_	_	CD	O	[-1]	['none']	_	_
20	pH	_	_	NN	O	[-1]	['none']	_	_
21	7.5	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	10	_	_	CD	O	[-1]	['none']	_	_
25	mM	_	_	NN	O	[-1]	['none']	_	_
26	EDTA	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	0.5	_	_	CD	O	[-1]	['none']	_	_
29	mM	_	_	NN	O	[-1]	['none']	_	_
30	EGTA	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	1	_	_	CD	O	[-1]	['none']	_	_
33	%	_	_	NN	O	[-1]	['none']	_	_
34	Triton	_	_	NNP	O	[-1]	['none']	_	_
35	X-100	_	_	NN	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	1x	_	_	NN	O	[-1]	['none']	_	_
40	with	_	_	IN	O	[-1]	['none']	_	_
41	cold	_	_	JJ	O	[-1]	['none']	_	_
42	solution	_	_	NN	O	[-1]	['none']	_	_
43	II	_	_	CD	O	[-1]	['none']	_	_
44	(	_	_	-LRB-	O	[-1]	['none']	_	_
45	10	_	_	CD	O	[-1]	['none']	_	_
46	mM	_	_	NN	O	[-1]	['none']	_	_
47	Tris	_	_	NNP	O	[-1]	['none']	_	_
48	[	_	_	CD	O	[-1]	['none']	_	_
49	pH	_	_	NN	O	[-1]	['none']	_	_
50	7.5	_	_	CD	O	[-1]	['none']	_	_
51	]	_	_	NN	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	1	_	_	CD	O	[-1]	['none']	_	_
54	mM	_	_	NN	O	[-1]	['none']	_	_
55	EDTA	_	_	NN	O	[-1]	['none']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	0.5	_	_	CD	O	[-1]	['none']	_	_
58	mM	_	_	NN	O	[-1]	['none']	_	_
59	EGTA	_	_	NN	O	[-1]	['none']	_	_
60	,	_	_	,	O	[-1]	['none']	_	_
61	200	_	_	CD	O	[-1]	['none']	_	_
62	mM	_	_	NN	O	[-1]	['none']	_	_
63	NaCl	_	_	NN	O	[-1]	['none']	_	_
64	)	_	_	-RRB-	O	[-1]	['none']	_	_
65	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	washes	_	_	NNS	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	cell	_	_	NN	O	[-1]	['none']	_	_
5	pellets	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	resuspended	_	_	VBN	O	[-1]	['none']	_	_
8	at	_	_	IN	O	[-1]	['none']	_	_
9	40	_	_	CD	O	[-1]	['none']	_	_
10	x	_	_	CC	O	[-1]	['none']	_	_
11	106	_	_	CD	O	[-1]	['none']	_	_
12	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	ChIP	_	_	NN	O	[-1]	['none']	_	_
15	lysis	_	_	NN	O	[-1]	['none']	_	_
16	buffer	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	150	_	_	CD	O	[-1]	['none']	_	_
19	mM	_	_	NN	O	[-1]	['none']	_	_
20	NaCl	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	25	_	_	CD	O	[-1]	['none']	_	_
23	mM	_	_	NN	O	[-1]	['none']	_	_
24	Tris	_	_	NNP	O	[-1]	['none']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	pH	_	_	NN	O	[-1]	['none']	_	_
27	7.5	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	1	_	_	CD	O	[-1]	['none']	_	_
31	%	_	_	NN	O	[-1]	['none']	_	_
32	Triton	_	_	NNP	O	[-1]	['none']	_	_
33	X-100	_	_	NN	O	[-1]	['none']	_	_
34	,	_	_	,	O	[-1]	['none']	_	_
35	0.1	_	_	CD	O	[-1]	['none']	_	_
36	%	_	_	NN	O	[-1]	['none']	_	_
37	SDS	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	0.5	_	_	CD	O	[-1]	['none']	_	_
40	%	_	_	NN	O	[-1]	['none']	_	_
41	deoxycholate	_	_	NN	O	[-1]	['none']	_	_
42	plus	_	_	CC	O	[-1]	['none']	_	_
43	protease	_	_	NN	O	[-1]	['none']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	phosphatase	_	_	NN	O	[-1]	['none']	_	_
46	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	and	_	_	CC	O	[-1]	['none']	_	_
50	chromatin	_	_	NN	O	[-1]	['none']	_	_
51	was	_	_	VBD	O	[-1]	['none']	_	_
52	sheared	_	_	VBN	O	[-1]	['none']	_	_
53	with	_	_	IN	O	[-1]	['none']	_	_
54	a	_	_	DT	O	[-1]	['none']	_	_
55	sonicator	_	_	NN	O	[-1]	['none']	_	_
56	to	_	_	TO	O	[-1]	['none']	_	_
57	yield	_	_	VB	O	[-1]	['none']	_	_
58	0.5-1-kb	_	_	JJ	O	[-1]	['none']	_	_
59	DNA	_	_	NN	O	[-1]	['none']	_	_
60	fragments	_	_	NNS	O	[-1]	['none']	_	_
61	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	preclearing	_	_	VBG	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	sheared	_	_	JJ	O	[-1]	['none']	_	_
5	chromatin	_	_	NN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	protein	_	_	NN	O	[-1]	['none']	_	_
8	A-sepharose	_	_	NN	O	[-1]	['none']	_	_
9	beads	_	_	NNS	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	removing	_	_	VBG	O	[-1]	['none']	_	_
12	5	_	_	CD	O	[-1]	['none']	_	_
13	%	_	_	NN	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	input	_	_	NN	O	[-1]	['none']	_	_
16	chromatin	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	immunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	performed	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	adding	_	_	VBG	O	[-1]	['none']	_	_
23	optimized	_	_	VBN	O	[-1]	['none']	_	_
24	antibody	_	_	NN	O	[-1]	['none']	_	_
25	amounts	_	_	NNS	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	per	_	_	IN	O	[-1]	['none']	_	_
28	20	_	_	CD	O	[-1]	['none']	_	_
29	x	_	_	CC	O	[-1]	['none']	_	_
30	106	_	_	CD	O	[-1]	['none']	_	_
31	cell	_	_	NN	O	[-1]	['none']	_	_
32	equivalents	_	_	NNS	O	[-1]	['none']	_	_
33	:	_	_	:	O	[-1]	['none']	_	_
34	2.5	_	_	CD	O	[-1]	['none']	_	_
35	mug	_	_	NN	O	[-1]	['none']	_	_
36	anti-Eomes	_	_	NNS	Protein	[0]	['root']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	1:100	_	_	CD	O	[-1]	['none']	_	_
39	dilution	_	_	NN	O	[-1]	['none']	_	_
40	anti-Runx3	_	_	JJ	Protein	[0]	['root']	_	_
41	)	_	_	-RRB-	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	followed	_	_	VBN	O	[-1]	['none']	_	_
44	by	_	_	IN	O	[-1]	['none']	_	_
45	overnight	_	_	JJ	O	[-1]	['none']	_	_
46	incubation	_	_	NN	O	[-1]	['none']	_	_
47	at	_	_	IN	O	[-1]	['none']	_	_
48	4degreesC	_	_	NN	O	[-1]	['none']	_	_
49	;	_	_	:	O	[-1]	['none']	_	_
50	protein	_	_	NN	O	[-1]	['none']	_	_
51	A-sepharose	_	_	NN	O	[-1]	['none']	_	_
52	beads	_	_	NNS	O	[-1]	['none']	_	_
53	were	_	_	VBD	O	[-1]	['none']	_	_
54	added	_	_	VBN	O	[-1]	['none']	_	_
55	for	_	_	IN	O	[-1]	['none']	_	_
56	the	_	_	DT	O	[-1]	['none']	_	_
57	last	_	_	JJ	O	[-1]	['none']	_	_
58	3	_	_	CD	O	[-1]	['none']	_	_
59	h	_	_	NN	O	[-1]	['none']	_	_
60	of	_	_	IN	O	[-1]	['none']	_	_
61	the	_	_	DT	O	[-1]	['none']	_	_
62	incubation	_	_	NN	O	[-1]	['none']	_	_
63	period	_	_	NN	O	[-1]	['none']	_	_
64	.	_	_	.	O	[-1]	['none']	_	_

1	Beads	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	washed	_	_	VBN	O	[-1]	['none']	_	_
4	2x	_	_	NN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	RIPA	_	_	NN	O	[-1]	['none']	_	_
7	buffer	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	50	_	_	CD	O	[-1]	['none']	_	_
10	mM	_	_	NN	O	[-1]	['none']	_	_
11	Tris	_	_	NNP	O	[-1]	['none']	_	_
12	[	_	_	CD	O	[-1]	['none']	_	_
13	pH	_	_	NN	O	[-1]	['none']	_	_
14	8	_	_	CD	O	[-1]	['none']	_	_
15	]	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	150	_	_	CD	O	[-1]	['none']	_	_
18	mM	_	_	NN	O	[-1]	['none']	_	_
19	NaCl	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	1	_	_	CD	O	[-1]	['none']	_	_
22	mM	_	_	NN	O	[-1]	['none']	_	_
23	EDTA	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	1	_	_	CD	O	[-1]	['none']	_	_
26	%	_	_	NN	O	[-1]	['none']	_	_
27	NP-40	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	0.1	_	_	CD	O	[-1]	['none']	_	_
30	%	_	_	NN	O	[-1]	['none']	_	_
31	SDS	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	0.5	_	_	CD	O	[-1]	['none']	_	_
34	%	_	_	NN	O	[-1]	['none']	_	_
35	deoxycholate	_	_	NN	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	1x	_	_	NN	O	[-1]	['none']	_	_
39	with	_	_	IN	O	[-1]	['none']	_	_
40	high	_	_	JJ	O	[-1]	['none']	_	_
41	salt	_	_	NN	O	[-1]	['none']	_	_
42	buffer	_	_	NN	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	50	_	_	CD	O	[-1]	['none']	_	_
45	mM	_	_	NN	O	[-1]	['none']	_	_
46	Tris	_	_	NNP	O	[-1]	['none']	_	_
47	[	_	_	CD	O	[-1]	['none']	_	_
48	pH	_	_	NN	O	[-1]	['none']	_	_
49	8	_	_	CD	O	[-1]	['none']	_	_
50	]	_	_	NN	O	[-1]	['none']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	500	_	_	CD	O	[-1]	['none']	_	_
53	mM	_	_	NN	O	[-1]	['none']	_	_
54	NaCl	_	_	NN	O	[-1]	['none']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	1	_	_	CD	O	[-1]	['none']	_	_
57	mM	_	_	NN	O	[-1]	['none']	_	_
58	EDTA	_	_	NN	O	[-1]	['none']	_	_
59	,	_	_	,	O	[-1]	['none']	_	_
60	1	_	_	CD	O	[-1]	['none']	_	_
61	%	_	_	NN	O	[-1]	['none']	_	_
62	NP-40	_	_	NN	O	[-1]	['none']	_	_
63	,	_	_	,	O	[-1]	['none']	_	_
64	0.1	_	_	CD	O	[-1]	['none']	_	_
65	%	_	_	NN	O	[-1]	['none']	_	_
66	SDS	_	_	NN	O	[-1]	['none']	_	_
67	)	_	_	-RRB-	O	[-1]	['none']	_	_
68	,	_	_	,	O	[-1]	['none']	_	_
69	and	_	_	CC	O	[-1]	['none']	_	_
70	1x	_	_	NN	O	[-1]	['none']	_	_
71	with	_	_	IN	O	[-1]	['none']	_	_
72	TE	_	_	NN	O	[-1]	['none']	_	_
73	buffer	_	_	NN	O	[-1]	['none']	_	_
74	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	last	_	_	JJ	O	[-1]	['none']	_	_
4	wash	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	DNA	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	eluted	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	resuspending	_	_	VBG	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	beads	_	_	NNS	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	elution	_	_	NN	O	[-1]	['none']	_	_
15	buffer	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	1	_	_	CD	O	[-1]	['none']	_	_
18	%	_	_	NN	O	[-1]	['none']	_	_
19	SDS	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	100	_	_	CD	O	[-1]	['none']	_	_
22	mM	_	_	NN	O	[-1]	['none']	_	_
23	NaHCO3	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Both	_	_	DT	O	[-1]	['none']	_	_
2	input	_	_	NN	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	ChIP	_	_	NN	O	[-1]	['none']	_	_
5	chromatin	_	_	NN	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	then	_	_	RB	O	[-1]	['none']	_	_
8	treated	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	RNase	_	_	NN	O	[-1]	['none']	_	_
11	A	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	5	_	_	CD	O	[-1]	['none']	_	_
14	mug	_	_	NN	O	[-1]	['none']	_	_
15	total	_	_	JJ	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	1	_	_	CD	O	[-1]	['none']	_	_
19	h	_	_	NN	O	[-1]	['none']	_	_
20	at	_	_	IN	O	[-1]	['none']	_	_
21	37degreesC	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	followed	_	_	VBN	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	addition	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	proteinase	_	_	NN	O	[-1]	['none']	_	_
29	K	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	100	_	_	CD	O	[-1]	['none']	_	_
32	mug	_	_	NN	O	[-1]	['none']	_	_
33	total	_	_	JJ	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	overnight	_	_	JJ	O	[-1]	['none']	_	_
37	incubation	_	_	NN	O	[-1]	['none']	_	_
38	at	_	_	IN	O	[-1]	['none']	_	_
39	65degreesC	_	_	NN	O	[-1]	['none']	_	_
40	to	_	_	TO	O	[-1]	['none']	_	_
41	reverse	_	_	VB	O	[-1]	['none']	_	_
42	cross	_	_	JJ	O	[-1]	['none']	_	_
43	linking	_	_	VBG	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	DNA	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	then	_	_	RB	O	[-1]	['none']	_	_
4	purified	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	QIAquick	_	_	NN	O	[-1]	['none']	_	_
7	columns	_	_	NNS	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Gel	_	_	NN	O	[-1]	['none']	_	_
10	Extraction	_	_	NNP	O	[-1]	['none']	_	_
11	Kit	_	_	NN	O	[-1]	['none']	_	_
12	;	_	_	:	O	[-1]	['none']	_	_
13	QIAGEN	_	_	NNP	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	according	_	_	VBG	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	manufacturer	_	_	NN	O	[-1]	['none']	_	_
19	's	_	_	POS	O	[-1]	['none']	_	_
20	instructions	_	_	NNS	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	resuspended	_	_	VBN	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	50-mul	_	_	JJ	O	[-1]	['none']	_	_
26	volume	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	real-time	_	_	JJ	O	[-1]	['none']	_	_
3	PCR	_	_	NN	O	[-1]	['none']	_	_
4	detection	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
7	targets	_	_	NNS	O	[-1]	['none']	_	_
8	using	_	_	VBG	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	SYBR	_	_	NNP	O	[-1]	['none']	_	_
11	Green	_	_	NNP	O	[-1]	['none']	_	_
12	PCR	_	_	NN	O	[-1]	['none']	_	_
13	Kit	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	standard	_	_	JJ	O	[-1]	['none']	_	_
17	curve	_	_	NN	O	[-1]	['none']	_	_
18	was	_	_	VBD	O	[-1]	['none']	_	_
19	obtained	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	serial	_	_	JJ	O	[-1]	['none']	_	_
22	dilutions	_	_	NNS	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	input	_	_	NN	O	[-1]	['none']	_	_
25	DNA	_	_	NN	O	[-1]	['none']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	each	_	_	DT	O	[-1]	['none']	_	_
28	sample	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	1	_	_	CD	O	[-1]	['none']	_	_
32	mul	_	_	NN	O	[-1]	['none']	_	_
33	ChIP	_	_	NN	O	[-1]	['none']	_	_
34	DNA	_	_	NN	O	[-1]	['none']	_	_
35	was	_	_	VBD	O	[-1]	['none']	_	_
36	used	_	_	VBN	O	[-1]	['none']	_	_
37	per	_	_	IN	O	[-1]	['none']	_	_
38	PCR	_	_	NN	O	[-1]	['none']	_	_
39	reaction	_	_	NN	O	[-1]	['none']	_	_
40	(	_	_	-LRB-	O	[-1]	['none']	_	_
41	performed	_	_	VBN	O	[-1]	['none']	_	_
42	in	_	_	IN	O	[-1]	['none']	_	_
43	duplicates	_	_	NNS	O	[-1]	['none']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	Melt	_	_	VB	O	[-1]	['none']	_	_
2	curves	_	_	NNS	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	agarose	_	_	NN	O	[-1]	['none']	_	_
5	gels	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	analyzed	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	ensure	_	_	VB	O	[-1]	['none']	_	_
10	amplification	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	specific	_	_	JJ	O	[-1]	['none']	_	_
13	target	_	_	NN	O	[-1]	['none']	_	_
14	sequences	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Refer	_	_	VB	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	Table	_	_	NNP	O	[-1]	['none']	_	_
4	S1	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	available	_	_	JJ	O	[-1]	['none']	_	_
7	at	_	_	IN	O	[-1]	['none']	_	_
8	http://www.jem.org/cgi/content/full/jem.20081242/DC1	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	for	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	list	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	primer	_	_	NN	O	[-1]	['none']	_	_
15	sets	_	_	NNS	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	presented	_	_	VBN	O	[-1]	['none']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	number	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
10	target	_	_	NN	O	[-1]	['none']	_	_
11	sequences	_	_	NNS	O	[-1]	['none']	_	_
12	relative	_	_	JJ	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	input	_	_	NN	O	[-1]	['none']	_	_
15	chromatin	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	assuming	_	_	VBG	O	[-1]	['none']	_	_
18	two	_	_	CD	O	[-1]	['none']	_	_
19	copies	_	_	NNS	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	target	_	_	NN	O	[-1]	['none']	_	_
22	sequence	_	_	NN	O	[-1]	['none']	_	_
23	per	_	_	IN	O	[-1]	['none']	_	_
24	cell	_	_	NN	O	[-1]	['none']	_	_
25	equivalent	_	_	JJ	O	[-1]	['none']	_	_
26	used	_	_	VBN	O	[-1]	['none']	_	_
27	for	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	ChIP	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	AP-1	_	_	NN	O	[-1]	['none']	_	_
4	are	_	_	VBP	O	[-1]	['none']	_	_
5	critical	_	_	JJ	O	[-1]	['none']	_	_
6	regulators	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
9	responses	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	proliferation	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	differentiation	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	T-cells	_	_	NNS	O	[-1]	['none']	_	_
16	[	_	_	VBP	O	[-1]	['none']	_	_
17	28-30	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	CD	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	however	_	_	RB	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	signal	_	_	NN	O	[-1]	['none']	_	_
24	transduction	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	subsequent	_	_	JJ	O	[-1]	['none']	_	_
27	cytokine	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	chemokine	_	_	NN	O	[-1]	['none']	_	_
30	expression	_	_	NN	O	[-1]	['none']	_	_
31	is	_	_	VBZ	O	[-1]	['none']	_	_
32	not	_	_	RB	O	[-1]	['none']	_	_
33	fully	_	_	RB	O	[-1]	['none']	_	_
34	understood	_	_	VBN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	aim	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	present	_	_	JJ	O	[-1]	['none']	_	_
6	study	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	investigate	_	_	VB	O	[-1]	['none']	_	_
10	IL-6	_	_	NN	Protein	[13]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	CXCL8	_	_	NN	Protein	[13]	['Theme']	_	_
13	regulation	_	_	NN	Regulation	[0]	['root']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	AP-1	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	Jurkat	_	_	NN	O	[-1]	['none']	_	_
20	T-cells	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	PMA	_	_	NN	O	[-1]	['none']	_	_
6	induced	_	_	VBD	O	[-1]	['none']	_	_
7	AP-1	_	_	NN	O	[-1]	['none']	_	_
8	activation	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	indicating	_	_	VBG	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	specific	_	_	JJ	O	[-1]	['none']	_	_
13	activation	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	MAPK	_	_	NN	O	[-1]	['none']	_	_
17	pathway	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	PMA	_	_	NN	O	[-1]	['none']	_	_
7	dependent	_	_	JJ	O	[-1]	['none']	_	_
8	AP-1	_	_	NN	O	[-1]	['none']	_	_
9	activation	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	T-cells	_	_	NNS	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	delayed	_	_	VBN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	>	_	_	RBR	O	[-1]	['none']	_	_
16	2	_	_	CD	O	[-1]	['none']	_	_
17	h	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	increased	_	_	VBD	O	[-1]	['none']	_	_
21	following	_	_	VBG	O	[-1]	['none']	_	_
22	long-term	_	_	JJ	O	[-1]	['none']	_	_
23	treatment	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	MAPK	_	_	NN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	one	_	_	CD	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	main	_	_	JJ	O	[-1]	['none']	_	_
7	signalling	_	_	NN	O	[-1]	['none']	_	_
8	pathways	_	_	NNS	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	T-cells	_	_	NNS	O	[-1]	['none']	_	_
11	that	_	_	WDT	O	[-1]	['none']	_	_
12	regulate	_	_	VBP	O	[-1]	['none']	_	_
13	cell-	_	_	JJ	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
16	activation	_	_	NN	O	[-1]	['none']	_	_
17	[	_	_	CD	O	[-1]	['none']	_	_
18	31,32	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Several	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	[	_	_	VBP	O	[-1]	['none']	_	_
4	20,33,34	_	_	CD	O	[-1]	['none']	_	_
5	]	_	_	CD	O	[-1]	['none']	_	_
6	have	_	_	VBP	O	[-1]	['none']	_	_
7	indicated	_	_	VBN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	importance	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	AP-1	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	T-cell	_	_	NN	O	[-1]	['none']	_	_
14	activation	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	induction	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
20	responses	_	_	NNS	O	[-1]	['none']	_	_
21	[	_	_	VBP	O	[-1]	['none']	_	_
22	35	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	CD	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	including	_	_	VBG	O	[-1]	['none']	_	_
26	pro	_	_	JJ	O	[-1]	['none']	_	_
27	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
28	cytokine	_	_	NN	O	[-1]	['none']	_	_
29	release	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	AP-1	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	activity	_	_	NN	O	[-1]	['none']	_	_
8	rapidly	_	_	RB	O	[-1]	['none']	_	_
9	increased	_	_	VBD	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	1	_	_	CD	O	[-1]	['none']	_	_
12	min	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	during	_	_	IN	O	[-1]	['none']	_	_
15	PMA	_	_	NN	O	[-1]	['none']	_	_
16	exposure	_	_	NN	O	[-1]	['none']	_	_
17	followed	_	_	VBN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	down-regulation	_	_	NN	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	lowest	_	_	JJS	O	[-1]	['none']	_	_
24	levels	_	_	NNS	O	[-1]	['none']	_	_
25	at	_	_	IN	O	[-1]	['none']	_	_
26	6	_	_	CD	O	[-1]	['none']	_	_
27	h	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	line	_	_	NN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	Park	_	_	NNP	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	colleagues	_	_	NNS	O	[-1]	['none']	_	_
9	[	_	_	VBP	O	[-1]	['none']	_	_
10	36	_	_	CD	O	[-1]	['none']	_	_
11	]	_	_	NN	O	[-1]	['none']	_	_
12	who	_	_	WP	O	[-1]	['none']	_	_
13	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	rapid	_	_	JJ	O	[-1]	['none']	_	_
16	increase	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	activity	_	_	NN	O	[-1]	['none']	_	_
20	following	_	_	VBG	O	[-1]	['none']	_	_
21	short-term	_	_	JJ	O	[-1]	['none']	_	_
22	stimulation	_	_	NN	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	PMA	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	but	_	_	CC	O	[-1]	['none']	_	_
27	prolonged	_	_	VBD	O	[-1]	['none']	_	_
28	challenge	_	_	NN	O	[-1]	['none']	_	_
29	resulted	_	_	VBD	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	a	_	_	DT	O	[-1]	['none']	_	_
32	persistent	_	_	JJ	O	[-1]	['none']	_	_
33	inhibition	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	They	_	_	PRP	O	[-1]	['none']	_	_
2	showed	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	inhibition	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	due	_	_	JJ	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	PKC	_	_	NN	O	[-1]	['none']	_	_
12	dependent	_	_	JJ	Regulation	[22]	['Theme']	_	_
13	degradation	_	_	NN	Protein_catabolism	[12]	['Theme']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IkappaB	_	_	NN	Protein	[17]	['multitoken']	_	_
16	kinase	_	_	NN	Protein	[17]	['multitoken']	_	_
17	beta	_	_	NN	Protein	[13]	['Theme']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	gamma	_	_	NN	Protein	[13]	['Theme']	_	_
20	in	_	_	IN	Positive_regulation	[22]	['multitoken']	_	_
21	response	_	_	NN	Positive_regulation	[22]	['multitoken']	_	_
22	to	_	_	TO	Positive_regulation	[0]	['root']	_	_
23	PMA	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	HK	_	_	NNP	O	[-1]	['none']	_	_
5	E.	_	_	NNP	O	[-1]	['none']	_	_
6	coli	_	_	NN	O	[-1]	['none']	_	_
7	exposure	_	_	NN	O	[-1]	['none']	_	_
8	induced	_	_	VBD	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	without	_	_	IN	O	[-1]	['none']	_	_
12	affecting	_	_	VBG	O	[-1]	['none']	_	_
13	AP-1	_	_	NN	O	[-1]	['none']	_	_
14	activity	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Wang	_	_	NNP	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	colleagues	_	_	NNS	O	[-1]	['none']	_	_
4	[	_	_	VBP	O	[-1]	['none']	_	_
5	37	_	_	CD	O	[-1]	['none']	_	_
6	]	_	_	CD	O	[-1]	['none']	_	_
7	reported	_	_	VBD	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	elevated	_	_	JJ	O	[-1]	['none']	_	_
10	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
11	response	_	_	NN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	obtaining	_	_	VBG	O	[-1]	['none']	_	_
14	expression	_	_	NN	Gene_expression	[17]	['Theme']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IL-6	_	_	NN	Protein	[14]	['Theme']	_	_
17	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	exposure	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	T-cells	_	_	NNS	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	peptidoglycan	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Reduction	_	_	NN	O	[-1]	['none']	_	_
2	in	_	_	IN	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	calcium	_	_	NN	O	[-1]	['none']	_	_
6	ionophore	_	_	NN	O	[-1]	['none']	_	_
7	following	_	_	VBG	O	[-1]	['none']	_	_
8	HK	_	_	NNP	O	[-1]	['none']	_	_
9	E.	_	_	NNP	O	[-1]	['none']	_	_
10	coli	_	_	NN	O	[-1]	['none']	_	_
11	stimulation	_	_	NN	O	[-1]	['none']	_	_
12	may	_	_	MD	O	[-1]	['none']	_	_
13	be	_	_	VB	O	[-1]	['none']	_	_
14	due	_	_	JJ	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	Ca2+	_	_	NN	O	[-1]	['none']	_	_
18	binding	_	_	NN	O	[-1]	['none']	_	_
19	protein	_	_	NN	O	[-1]	['none']	_	_
20	calmodulin	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	CaM	_	_	NN	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	which	_	_	WDT	O	[-1]	['none']	_	_
26	has	_	_	VBZ	O	[-1]	['none']	_	_
27	been	_	_	VBN	O	[-1]	['none']	_	_
28	shown	_	_	VBN	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	negatively	_	_	RB	Negative_regulation	[31]	['multitoken']	_	_
31	regulate	_	_	VB	Negative_regulation	[0]	['root']	_	_
32	c-Rel	_	_	NN	Protein	[31]	['Theme']	_	_
33	when	_	_	WRB	O	[-1]	['none']	_	_
34	activated	_	_	VBN	O	[-1]	['none']	_	_
35	[	_	_	NN	O	[-1]	['none']	_	_
36	38	_	_	CD	O	[-1]	['none']	_	_
37	]	_	_	NN	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	regulation	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	AP-1	_	_	NN	O	[-1]	['none']	_	_
7	observed	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	present	_	_	JJ	O	[-1]	['none']	_	_
11	study	_	_	NN	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	agreement	_	_	NN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	earlier	_	_	JJR	O	[-1]	['none']	_	_
17	studies	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	T-cells	_	_	NNS	O	[-1]	['none']	_	_
2	produce	_	_	VBP	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	broad	_	_	JJ	O	[-1]	['none']	_	_
5	range	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	pro-	_	_	JJ	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
10	cytokines	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	including	_	_	VBG	O	[-1]	['none']	_	_
13	IL-2	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	IL-6	_	_	NN	Protein	[0]	['root']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	TNF	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	IL-10	_	_	NN	Protein	[0]	['root']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	response	_	_	NN	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	infections	_	_	NNS	O	[-1]	['none']	_	_
27	or	_	_	CC	O	[-1]	['none']	_	_
28	other	_	_	JJ	O	[-1]	['none']	_	_
29	stress	_	_	NN	O	[-1]	['none']	_	_
30	factors	_	_	NNS	O	[-1]	['none']	_	_
31	[	_	_	VBP	O	[-1]	['none']	_	_
32	39	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	CD	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	assessment	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	Jurkat	_	_	NN	O	[-1]	['none']	_	_
5	T-cell	_	_	NN	O	[-1]	['none']	_	_
6	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
7	responses	_	_	NNS	O	[-1]	['none']	_	_
8	revealed	_	_	VBD	O	[-1]	['none']	_	_
9	an	_	_	DT	O	[-1]	['none']	_	_
10	enhanced	_	_	JJ	Positive_regulation	[21]	['Theme']	_	_
11	IL-2	_	_	NN	Protein	[12]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[10]	['Theme']	_	_
13	upon	_	_	IN	O	[-1]	['none']	_	_
14	exposure	_	_	NN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	PMA	_	_	NN	O	[-1]	['none']	_	_
17	or	_	_	CC	O	[-1]	['none']	_	_
18	HK	_	_	JJ	O	[-1]	['none']	_	_
19	E.	_	_	FW	O	[-1]	['none']	_	_
20	coli	_	_	FW	O	[-1]	['none']	_	_
21	due	_	_	JJ	Positive_regulation	[0]	['root']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	PKC	_	_	NN	O	[-1]	['none']	_	_
24	activation	_	_	NN	O	[-1]	['none']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	40	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	transcription	_	_	NN	O	[-1]	['none']	_	_
6	factor	_	_	NN	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	AP-1	_	_	NN	O	[-1]	['none']	_	_
10	binding	_	_	NN	O	[-1]	['none']	_	_
11	sites	_	_	NNS	O	[-1]	['none']	_	_
12	have	_	_	VBP	O	[-1]	['none']	_	_
13	been	_	_	VBN	O	[-1]	['none']	_	_
14	identified	_	_	VBN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	IL-6	_	_	NN	Protein	[23]	['Theme']	_	_
18	promoter	_	_	NN	O	[-1]	['none']	_	_
19	region	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	indicating	_	_	VBG	O	[-1]	['none']	_	_
22	multiple	_	_	JJ	O	[-1]	['none']	_	_
23	regulation	_	_	NN	Regulation	[0]	['root']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	22	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	AP-1	_	_	NNP	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	have	_	_	VBP	O	[-1]	['none']	_	_
5	also	_	_	RB	O	[-1]	['none']	_	_
6	been	_	_	VBN	O	[-1]	['none']	_	_
7	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	regulate	_	_	VB	O	[-1]	['none']	_	_
10	CXCL8	_	_	NN	Protein	[11]	['Theme']	_	_
11	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
12	during	_	_	IN	O	[-1]	['none']	_	_
13	induction	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
16	responses	_	_	NNS	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	T-cells	_	_	NNS	O	[-1]	['none']	_	_
19	[	_	_	VBP	O	[-1]	['none']	_	_
20	12	_	_	CD	O	[-1]	['none']	_	_
21	]	_	_	CD	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL-6	_	_	NN	Protein	[7]	['Theme']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	CXCL8	_	_	NN	Protein	[7]	['Theme']	_	_
6	gene	_	_	NN	O	[-1]	['none']	_	_
7	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	associated	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	an	_	_	DT	O	[-1]	['none']	_	_
12	early	_	_	JJ	O	[-1]	['none']	_	_
13	immune	_	_	JJ	O	[-1]	['none']	_	_
14	response	_	_	NN	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	Jurkat	_	_	NN	O	[-1]	['none']	_	_
17	T-cells	_	_	NNS	O	[-1]	['none']	_	_
18	[	_	_	VBP	O	[-1]	['none']	_	_
19	41	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	CD	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	present	_	_	JJ	O	[-1]	['none']	_	_
4	study	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	both	_	_	CC	O	[-1]	['none']	_	_
7	PMA	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	HK	_	_	NNP	O	[-1]	['none']	_	_
10	E.	_	_	NNP	O	[-1]	['none']	_	_
11	coli	_	_	NN	O	[-1]	['none']	_	_
12	resulted	_	_	VBD	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	comparable	_	_	JJ	O	[-1]	['none']	_	_
15	increases	_	_	NNS	Positive_regulation	[0]	['root']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	IL-6	_	_	NN	Protein	[15]	['Theme']	_	_
18	while	_	_	IN	O	[-1]	['none']	_	_
19	PMA	_	_	NN	O	[-1]	['none']	_	_
20	was	_	_	VBD	O	[-1]	['none']	_	_
21	more	_	_	RBR	O	[-1]	['none']	_	_
22	potent	_	_	JJ	O	[-1]	['none']	_	_
23	at	_	_	IN	O	[-1]	['none']	_	_
24	activating	_	_	VBG	Positive_regulation	[0]	['root']	_	_
25	CXCL8	_	_	NN	Protein	[26]	['Theme']	_	_
26	release	_	_	NN	Localization	[24]	['Theme']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	PMA	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	HK	_	_	NNP	O	[-1]	['none']	_	_
4	E.	_	_	NNP	O	[-1]	['none']	_	_
5	coli	_	_	NN	O	[-1]	['none']	_	_
6	treatment	_	_	NN	O	[-1]	['none']	_	_
7	also	_	_	RB	O	[-1]	['none']	_	_
8	induced	_	_	VBD	O	[-1]	['none']	_	_
9	TNF	_	_	NN	O	[-1]	['none']	_	_
10	expression	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	TNF	_	_	NN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	one	_	_	CD	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	first	_	_	JJ	O	[-1]	['none']	_	_
7	cytokines	_	_	NNS	O	[-1]	['none']	_	_
8	induced	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	T-cells	_	_	NNS	O	[-1]	['none']	_	_
11	[	_	_	VBP	O	[-1]	['none']	_	_
12	42	_	_	CD	O	[-1]	['none']	_	_
13	]	_	_	CD	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	its	_	_	PRP$	O	[-1]	['none']	_	_
16	expression	_	_	NN	O	[-1]	['none']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	regulated	_	_	VBN	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	calcineurin	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	NFAT	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	ATF-2	_	_	NN	Protein	[0]	['root']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	Jun	_	_	NN	O	[-1]	['none']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	20	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	PMA	_	_	NN	O	[-1]	['none']	_	_
4	stimulated	_	_	VBD	O	[-1]	['none']	_	_
5	Jurkat	_	_	NN	O	[-1]	['none']	_	_
6	T-cells	_	_	NNS	O	[-1]	['none']	_	_
7	showed	_	_	VBD	Regulation	[9]	['multitoken']	_	_
8	no	_	_	DT	Regulation	[9]	['multitoken']	_	_
9	difference	_	_	NN	Regulation	[0]	['root']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	IL-10	_	_	NN	Protein	[12]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
13	indicating	_	_	VBG	O	[-1]	['none']	_	_
14	an	_	_	DT	O	[-1]	['none']	_	_
15	induced	_	_	VBN	O	[-1]	['none']	_	_
16	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
17	response	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	HK	_	_	NNP	O	[-1]	['none']	_	_
2	E.	_	_	NNP	O	[-1]	['none']	_	_
3	coli	_	_	NN	O	[-1]	['none']	_	_
4	treatment	_	_	NN	O	[-1]	['none']	_	_
5	resulted	_	_	VBD	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	significant	_	_	JJ	O	[-1]	['none']	_	_
9	reduction	_	_	NN	Negative_regulation	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	IL-10	_	_	NN	Protein	[12]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[9]	['Theme']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	anti-inflammatory	_	_	JJ	O	[-1]	['none']	_	_
3	cytokine	_	_	NN	O	[-1]	['none']	_	_
4	IL-10	_	_	NN	Protein	[0]	['root']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	known	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	inhibit	_	_	VB	O	[-1]	['none']	_	_
9	T-cell	_	_	NN	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	proliferation	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	expression	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	pro	_	_	JJ	O	[-1]	['none']	_	_
18	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
19	cytokines	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	such	_	_	JJ	O	[-1]	['none']	_	_
22	as	_	_	IN	O	[-1]	['none']	_	_
23	IL-2	_	_	NN	Protein	[0]	['root']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	IL-5	_	_	NN	Protein	[0]	['root']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	INF-gamma	_	_	NN	Protein	[0]	['root']	_	_
28	[	_	_	CD	O	[-1]	['none']	_	_
29	39,43	_	_	CD	O	[-1]	['none']	_	_
30	]	_	_	NN	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	regulate	_	_	VB	O	[-1]	['none']	_	_
33	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
34	responses	_	_	NNS	O	[-1]	['none']	_	_
35	by	_	_	IN	O	[-1]	['none']	_	_
36	inducing	_	_	VBG	O	[-1]	['none']	_	_
37	T-cell	_	_	NN	O	[-1]	['none']	_	_
38	anergy	_	_	NN	O	[-1]	['none']	_	_
39	[	_	_	CD	O	[-1]	['none']	_	_
40	44	_	_	CD	O	[-1]	['none']	_	_
41	]	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	time	_	_	NN	O	[-1]	['none']	_	_
3	course	_	_	NN	O	[-1]	['none']	_	_
4	analysis	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	cytokine	_	_	NN	O	[-1]	['none']	_	_
7	expression	_	_	NN	O	[-1]	['none']	_	_
8	showed	_	_	VBD	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	correlation	_	_	NN	O	[-1]	['none']	_	_
11	between	_	_	IN	O	[-1]	['none']	_	_
12	AP-1	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	chemokine	_	_	NN	O	[-1]	['none']	_	_
16	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
17	where	_	_	WRB	O	[-1]	['none']	_	_
18	CXCL8	_	_	NN	O	[-1]	['none']	_	_
19	expression	_	_	NN	O	[-1]	['none']	_	_
20	was	_	_	VBD	O	[-1]	['none']	_	_
21	significantly	_	_	RB	O	[-1]	['none']	_	_
22	elevated	_	_	JJ	O	[-1]	['none']	_	_
23	already	_	_	RB	O	[-1]	['none']	_	_
24	at	_	_	IN	O	[-1]	['none']	_	_
25	2-6	_	_	CD	O	[-1]	['none']	_	_
26	h	_	_	NN	O	[-1]	['none']	_	_
27	after	_	_	IN	O	[-1]	['none']	_	_
28	PMA	_	_	NN	O	[-1]	['none']	_	_
29	exposure	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	CXCL8	_	_	NN	O	[-1]	['none']	_	_
3	expression	_	_	NN	O	[-1]	['none']	_	_
4	did	_	_	VBD	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	correlate	_	_	VB	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	early	_	_	JJ	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	1	_	_	CD	O	[-1]	['none']	_	_
14	min	_	_	NN	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	or	_	_	CC	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	down-regulation	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
22	at	_	_	IN	O	[-1]	['none']	_	_
23	2	_	_	CD	O	[-1]	['none']	_	_
24	h	_	_	NN	O	[-1]	['none']	_	_
25	post	_	_	NN	O	[-1]	['none']	_	_
26	exposure	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Both	_	_	DT	O	[-1]	['none']	_	_
2	IL-6	_	_	NN	Protein	[5]	['Theme']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	TNF	_	_	NN	O	[-1]	['none']	_	_
5	expression	_	_	NN	Gene_expression	[8]	['Theme']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	up	_	_	RB	Positive_regulation	[8]	['multitoken']	_	_
8	regulated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
9	between	_	_	IN	O	[-1]	['none']	_	_
10	6-24	_	_	CD	O	[-1]	['none']	_	_
11	h	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	During	_	_	IN	O	[-1]	['none']	_	_
2	this	_	_	DT	O	[-1]	['none']	_	_
3	period	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	increased	_	_	VBD	O	[-1]	['none']	_	_
7	from	_	_	IN	O	[-1]	['none']	_	_
8	its	_	_	PRP$	O	[-1]	['none']	_	_
9	minimum	_	_	JJ	O	[-1]	['none']	_	_
10	level	_	_	NN	O	[-1]	['none']	_	_
11	at	_	_	IN	O	[-1]	['none']	_	_
12	6	_	_	CD	O	[-1]	['none']	_	_
13	h.	_	_	NN	O	[-1]	['none']	_	_
14	PKC	_	_	NN	O	[-1]	['none']	_	_
15	has	_	_	VBZ	O	[-1]	['none']	_	_
16	been	_	_	VBN	O	[-1]	['none']	_	_
17	shown	_	_	VBN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	be	_	_	VB	O	[-1]	['none']	_	_
20	associated	_	_	VBN	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	activation	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	AP-1	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	but	_	_	CC	O	[-1]	['none']	_	_
28	not	_	_	RB	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	IL-2	_	_	NN	Protein	[31]	['Theme']	_	_
35	promoter	_	_	NN	Entity	[31]	['Site']	_	_
36	[	_	_	CD	O	[-1]	['none']	_	_
37	45	_	_	CD	O	[-1]	['none']	_	_
38	]	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Mutation	_	_	NN	Regulation	[8]	['Cause']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	Entity	[5]	['multitoken']	_	_
5	site	_	_	NN	Entity	[1]	['Site']	_	_
6	did	_	_	VBD	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	affect	_	_	VB	Regulation	[0]	['root']	_	_
9	IL-2	_	_	NN	Protein	[1, 10]	['Theme', 'Theme']	_	_
10	expression	_	_	NN	Gene_expression	[8]	['Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	whereas	_	_	IN	O	[-1]	['none']	_	_
13	mutation	_	_	NN	Regulation	[22]	['Cause']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	AP-1	_	_	NN	Entity	[17]	['multitoken']	_	_
17	site	_	_	NN	Entity	[13]	['Site']	_	_
18	or	_	_	CC	O	[-1]	['none']	_	_
19	PKC	_	_	NN	O	[-1]	['none']	_	_
20	depletion	_	_	NN	O	[-1]	['none']	_	_
21	almost	_	_	RB	O	[-1]	['none']	_	_
22	revoked	_	_	VBN	Negative_regulation	[0]	['root']	_	_
23	IL-2	_	_	NN	Protein	[13, 24]	['Theme', 'Theme']	_	_
24	release	_	_	NN	Localization	[22]	['Theme']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	observations	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	MAPK	_	_	NN	O	[-1]	['none']	_	_
7	pathway	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	transcription	_	_	NN	O	[-1]	['none']	_	_
11	factor	_	_	NN	O	[-1]	['none']	_	_
12	AP-1	_	_	NN	O	[-1]	['none']	_	_
13	play	_	_	VBP	O	[-1]	['none']	_	_
14	an	_	_	DT	O	[-1]	['none']	_	_
15	important	_	_	JJ	O	[-1]	['none']	_	_
16	role	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	induction	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
22	responses	_	_	NNS	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	Jurkat	_	_	NN	O	[-1]	['none']	_	_
25	T-cells	_	_	NNS	O	[-1]	['none']	_	_
26	[	_	_	VBP	O	[-1]	['none']	_	_
27	12,20,22	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	CD	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	obtained	_	_	JJ	O	[-1]	['none']	_	_
3	results	_	_	NNS	O	[-1]	['none']	_	_
4	signify	_	_	VBP	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	CXCL8	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	primarily	_	_	RB	O	[-1]	['none']	_	_
9	regulated	_	_	VBN	O	[-1]	['none']	_	_
10	through	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	MAPK	_	_	NN	O	[-1]	['none']	_	_
13	pathway	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	activation	_	_	NN	O	[-1]	['none']	_	_
4	inhibitor	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	NAI	_	_	NNP	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	showed	_	_	VBD	O	[-1]	['none']	_	_
9	specificity	_	_	NN	O	[-1]	['none']	_	_
10	against	_	_	IN	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	complete	_	_	JJ	O	[-1]	['none']	_	_
17	IL-6	_	_	NN	Protein	[18, 20]	['Theme', 'Theme']	_	_
18	inhibition	_	_	NN	Negative_regulation	[13]	['Theme']	_	_
19	following	_	_	VBG	O	[-1]	['none']	_	_
20	induction	_	_	NN	Positive_regulation	[0]	['root']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	PMA	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	significant	_	_	JJ	O	[-1]	['none']	_	_
25	IL-6	_	_	NN	Protein	[26]	['Theme']	_	_
26	reduction	_	_	NN	Negative_regulation	[13]	['Theme']	_	_
27	after	_	_	IN	O	[-1]	['none']	_	_
28	HK	_	_	NNP	O	[-1]	['none']	_	_
29	E.	_	_	NNP	O	[-1]	['none']	_	_
30	coli	_	_	NN	O	[-1]	['none']	_	_
31	treatment	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	CXCL8	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	highly	_	_	RB	O	[-1]	['none']	_	_
4	up	_	_	RB	O	[-1]	['none']	_	_
5	regulated	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	PMA	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	addition	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	NAI	_	_	NNP	O	[-1]	['none']	_	_
13	resulted	_	_	VBD	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	minor	_	_	JJ	O	[-1]	['none']	_	_
17	reduction	_	_	NN	Negative_regulation	[0]	['root']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	CXCL8	_	_	NN	Protein	[20]	['Theme']	_	_
20	expression	_	_	NN	Gene_expression	[17]	['Theme']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	CXCL8	_	_	NN	Protein	[4]	['Theme']	_	_
4	expression	_	_	NN	Gene_expression	[7, 10]	['Theme', 'Theme']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	affected	_	_	VBN	Regulation	[0]	['root']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	NAI	_	_	NNP	O	[-1]	['none']	_	_
10	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
11	HK	_	_	NNP	O	[-1]	['none']	_	_
12	E.	_	_	NNP	O	[-1]	['none']	_	_
13	coli	_	_	NN	O	[-1]	['none']	_	_
14	treatment	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	indicating	_	_	VBG	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	lack	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	correlation	_	_	NN	O	[-1]	['none']	_	_
21	between	_	_	IN	O	[-1]	['none']	_	_
22	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Further	_	_	JJ	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	CXCL8	_	_	NN	Protein	[5]	['Theme']	_	_
5	expression	_	_	NN	Gene_expression	[8, 17]	['Theme', 'Theme']	_	_
6	revealed	_	_	VBD	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	down-regulation	_	_	NN	Negative_regulation	[0]	['root']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	PKC-	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	JNK-	_	_	NN	O	[-1]	['none']	_	_
13	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	suggesting	_	_	VBG	O	[-1]	['none']	_	_
16	an	_	_	DT	O	[-1]	['none']	_	_
17	involvement	_	_	NN	Regulation	[20]	['Theme']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	AP-1	_	_	NN	O	[-1]	['none']	_	_
20	via	_	_	IN	Positive_regulation	[0]	['root']	_	_
21	PKC	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	JNK	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	respectively	_	_	RB	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Analysis	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	gene	_	_	NN	O	[-1]	['none']	_	_
4	expression	_	_	NN	O	[-1]	['none']	_	_
5	further	_	_	RB	O	[-1]	['none']	_	_
6	confirmed	_	_	VBD	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	il-6	_	_	NN	Protein	[12]	['Theme']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	cxcl8	_	_	NN	Protein	[12]	['Theme']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	upregulated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	PMA	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	Gene_expression	[4]	['Theme']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	il-6	_	_	NN	Protein	[1]	['Theme']	_	_
4	dropped	_	_	VBD	Negative_regulation	[0]	['root']	_	_
5	below	_	_	IN	O	[-1]	['none']	_	_
6	basal	_	_	JJ	O	[-1]	['none']	_	_
7	levels	_	_	NNS	O	[-1]	['none']	_	_
8	following	_	_	VBG	O	[-1]	['none']	_	_
9	inhibition	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	JNK	_	_	NN	O	[-1]	['none']	_	_
14	whereas	_	_	IN	O	[-1]	['none']	_	_
15	cxcl8	_	_	NN	Protein	[17]	['Theme']	_	_
16	remained	_	_	VBD	Negative_regulation	[17]	['multitoken']	_	_
17	elevated	_	_	JJ	Negative_regulation	[0]	['root']	_	_
18	above	_	_	IN	O	[-1]	['none']	_	_
19	basal	_	_	JJ	O	[-1]	['none']	_	_
20	levels	_	_	NNS	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	16.5-fold	_	_	RB	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	7.1-fold	_	_	RB	O	[-1]	['none']	_	_
25	respectively	_	_	RB	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	following	_	_	VBG	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	same	_	_	JJ	O	[-1]	['none']	_	_
30	treatment	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Furthermore	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	inhibition	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	PKC	_	_	NN	O	[-1]	['none']	_	_
6	did	_	_	VBD	O	[-1]	['none']	_	_
7	not	_	_	RB	O	[-1]	['none']	_	_
8	result	_	_	VB	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	significant	_	_	JJ	O	[-1]	['none']	_	_
12	decrease	_	_	NN	Negative_regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	il-6	_	_	NN	Protein	[12]	['Theme']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	cxcl8	_	_	NN	Protein	[12]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	which	_	_	WDT	O	[-1]	['none']	_	_
19	is	_	_	VBZ	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	accordance	_	_	NN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	protein	_	_	NN	O	[-1]	['none']	_	_
24	data	_	_	NNS	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	involved	_	_	VBN	Regulation	[0]	['root']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	IL-6	_	_	NN	Protein	[10, 12]	['Theme', 'Theme']	_	_
10	regulation	_	_	NN	Regulation	[7]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	release	_	_	NN	Localization	[7]	['Theme']	_	_
13	while	_	_	IN	O	[-1]	['none']	_	_
14	it	_	_	PRP	O	[-1]	['none']	_	_
15	is	_	_	VBZ	O	[-1]	['none']	_	_
16	not	_	_	RB	O	[-1]	['none']	_	_
17	required	_	_	VBN	Regulation	[0]	['root']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	expression	_	_	NN	Gene_expression	[17]	['Theme']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	CXCL8	_	_	NN	Protein	[20]	['Theme']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	Jurkat	_	_	NN	O	[-1]	['none']	_	_
25	T	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	transcription	_	_	NN	O	[-1]	['none']	_	_
3	factor	_	_	NN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	responsible	_	_	JJ	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	rapid	_	_	JJ	O	[-1]	['none']	_	_
10	immune	_	_	JJ	O	[-1]	['none']	_	_
11	response	_	_	NN	O	[-1]	['none']	_	_
12	which	_	_	WDT	O	[-1]	['none']	_	_
13	is	_	_	VBZ	O	[-1]	['none']	_	_
14	followed	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	an	_	_	DT	O	[-1]	['none']	_	_
17	increase	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	transcription	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	IkappaB	_	_	NN	O	[-1]	['none']	_	_
22	thus	_	_	RB	O	[-1]	['none']	_	_
23	inhibiting	_	_	VBG	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	46	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Activation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	Jurkat	_	_	NN	O	[-1]	['none']	_	_
6	T-cells	_	_	NNS	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	dependent	_	_	JJ	O	[-1]	['none']	_	_
9	on	_	_	IN	O	[-1]	['none']	_	_
10	Bcl10	_	_	NN	Protein	[11]	['Theme']	_	_
11	activation	_	_	NN	Positive_regulation	[17]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	which	_	_	WDT	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	turn	_	_	NN	O	[-1]	['none']	_	_
16	is	_	_	VBZ	O	[-1]	['none']	_	_
17	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	PKC	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Recent	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	have	_	_	VBP	O	[-1]	['none']	_	_
4	established	_	_	VBN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	importance	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	protein	_	_	NN	O	[-1]	['none']	_	_
10	complex	_	_	NN	O	[-1]	['none']	_	_
11	consisting	_	_	VBG	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	CARMA1	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	Bcl10	_	_	NN	Protein	[0]	['root']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	MALT1	_	_	NN	Protein	[0]	['root']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	CBM	_	_	NNP	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	induction	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Investigating	_	_	VBG	O	[-1]	['none']	_	_
2	Bcl10	_	_	NN	Protein	[0]	['root']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	Scharschmidt	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	colleagues	_	_	NNS	O	[-1]	['none']	_	_
7	[	_	_	VBP	O	[-1]	['none']	_	_
8	47	_	_	CD	O	[-1]	['none']	_	_
9	]	_	_	CD	O	[-1]	['none']	_	_
10	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
11	that	_	_	IN	O	[-1]	['none']	_	_
12	it	_	_	PRP	O	[-1]	['none']	_	_
13	is	_	_	VBZ	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	critical	_	_	JJ	O	[-1]	['none']	_	_
16	regulator	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
19	activity	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Down-regulation	_	_	NN	Negative_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Bcl10	_	_	NN	Protein	[1]	['Theme']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	signals	_	_	NNS	O	[-1]	['none']	_	_
6	transduced	_	_	VBN	O	[-1]	['none']	_	_
7	via	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	TCR	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	CD28	_	_	NN	Protein	[1]	['Cause']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	PKC	_	_	NN	O	[-1]	['none']	_	_
14	resulted	_	_	VBD	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	concomitant	_	_	JJ	O	[-1]	['none']	_	_
18	down-regulation	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	They	_	_	PRP	O	[-1]	['none']	_	_
2	suggested	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	Bcl10	_	_	NN	Protein	[7, 23]	['Theme', 'Theme']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	initially	_	_	RB	O	[-1]	['none']	_	_
7	activated	_	_	VBN	Positive_regulation	[21]	['Cause']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	TCR	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	PKC	_	_	NN	O	[-1]	['none']	_	_
12	but	_	_	CC	O	[-1]	['none']	_	_
13	that	_	_	IN	Anaphora	[15]	['multitoken']	_	_
14	continued	_	_	JJ	Anaphora	[15]	['multitoken']	_	_
15	activation	_	_	NN	Anaphora	[0]	['root']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	>	_	_	JJR	O	[-1]	['none']	_	_
18	1	_	_	CD	O	[-1]	['none']	_	_
19	h	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	promotes	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
22	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
23	degradation	_	_	NN	Protein_catabolism	[21]	['Theme']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Narayan	_	_	NNP	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	colleagues	_	_	NNS	O	[-1]	['none']	_	_
4	[	_	_	VBP	O	[-1]	['none']	_	_
5	27	_	_	CD	O	[-1]	['none']	_	_
6	]	_	_	CD	O	[-1]	['none']	_	_
7	suggested	_	_	VBD	O	[-1]	['none']	_	_
8	that	_	_	IN	O	[-1]	['none']	_	_
9	deletion	_	_	NN	Negative_regulation	[0]	['root']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	any	_	_	DT	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	Anaphora	[17]	['multitoken']	_	_
14	three	_	_	CD	Anaphora	[17]	['multitoken']	_	_
15	CBM	_	_	NN	Anaphora	[17]	['multitoken']	_	_
16	complex	_	_	NN	Anaphora	[17]	['multitoken']	_	_
17	proteins	_	_	NNS	Anaphora	[0]	['root']	_	_
18	impairs	_	_	VBZ	O	[-1]	['none']	_	_
19	antigen-receptor	_	_	NN	O	[-1]	['none']	_	_
20	dependent	_	_	JJ	O	[-1]	['none']	_	_
21	activation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	They	_	_	PRP	O	[-1]	['none']	_	_
2	showed	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	activation	_	_	NN	O	[-1]	['none']	_	_
6	via	_	_	IN	O	[-1]	['none']	_	_
7	Akt	_	_	NN	O	[-1]	['none']	_	_
8	requires	_	_	VBZ	O	[-1]	['none']	_	_
9	CARMA1	_	_	NN	Protein	[0]	['root']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	acts	_	_	VBZ	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	cooperation	_	_	NN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	PKC	_	_	NN	O	[-1]	['none']	_	_
16	following	_	_	VBG	O	[-1]	['none']	_	_
17	short-term	_	_	JJ	O	[-1]	['none']	_	_
18	exposure	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	30	_	_	CD	O	[-1]	['none']	_	_
21	min	_	_	NN	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	Jurkat	_	_	NN	O	[-1]	['none']	_	_
25	T-cells	_	_	NNS	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	PMA	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Akt	_	_	NN	O	[-1]	['none']	_	_
2	phosphorylates	_	_	VBZ	Phosphorylation	[0]	['root']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	thus	_	_	RB	O	[-1]	['none']	_	_
5	activates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
6	Bcl10	_	_	NN	Protein	[2, 5]	['Theme', 'Theme']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	PKC	_	_	NN	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	crucial	_	_	JJ	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	following	_	_	VBG	O	[-1]	['none']	_	_
12	short-term	_	_	JJ	O	[-1]	['none']	_	_
13	treatment	_	_	NN	O	[-1]	['none']	_	_
14	through	_	_	IN	O	[-1]	['none']	_	_
15	signals	_	_	NNS	O	[-1]	['none']	_	_
16	via	_	_	IN	O	[-1]	['none']	_	_
17	membrane	_	_	NN	O	[-1]	['none']	_	_
18	bound	_	_	VBD	O	[-1]	['none']	_	_
19	receptors	_	_	NNS	O	[-1]	['none']	_	_
20	such	_	_	JJ	O	[-1]	['none']	_	_
21	as	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	TCR	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	co-stimulatory	_	_	JJ	O	[-1]	['none']	_	_
27	receptor	_	_	NN	O	[-1]	['none']	_	_
28	CD28	_	_	NN	Protein	[0]	['root']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	CBM	_	_	NNP	O	[-1]	['none']	_	_
5	complex	_	_	NN	O	[-1]	['none']	_	_
6	proteins	_	_	NNS	O	[-1]	['none']	_	_
7	play	_	_	VBP	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	key	_	_	JJ	O	[-1]	['none']	_	_
10	role	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	this	_	_	DT	O	[-1]	['none']	_	_
13	signalling	_	_	NN	O	[-1]	['none']	_	_
14	process	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	PMA	_	_	NN	O	[-1]	['none']	_	_
2	diffuses	_	_	VBZ	O	[-1]	['none']	_	_
3	into	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	cytosol	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	directly	_	_	RB	O	[-1]	['none']	_	_
8	activates	_	_	VBZ	O	[-1]	['none']	_	_
9	PKC	_	_	NN	O	[-1]	['none']	_	_
10	since	_	_	IN	O	[-1]	['none']	_	_
11	it	_	_	PRP	O	[-1]	['none']	_	_
12	is	_	_	VBZ	O	[-1]	['none']	_	_
13	an	_	_	DT	O	[-1]	['none']	_	_
14	analogue	_	_	NN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	diacylglycerol	_	_	NN	O	[-1]	['none']	_	_
17	[	_	_	CD	O	[-1]	['none']	_	_
18	48	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Several	_	_	JJ	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	have	_	_	VBP	O	[-1]	['none']	_	_
4	demonstrated	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	inhibition	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	PKC	_	_	NN	O	[-1]	['none']	_	_
9	blocks	_	_	VBZ	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	AP-1	_	_	NN	O	[-1]	['none']	_	_
13	activity	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	suggesting	_	_	VBG	O	[-1]	['none']	_	_
16	a	_	_	DT	O	[-1]	['none']	_	_
17	direct	_	_	JJ	O	[-1]	['none']	_	_
18	regulation	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	these	_	_	DT	O	[-1]	['none']	_	_
21	transcription	_	_	NN	O	[-1]	['none']	_	_
22	factors	_	_	NNS	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	PKC	_	_	NN	O	[-1]	['none']	_	_
25	[	_	_	CD	O	[-1]	['none']	_	_
26	49,50	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	PKC	_	_	NN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	activated	_	_	VBN	O	[-1]	['none']	_	_
4	at	_	_	IN	O	[-1]	['none']	_	_
5	an	_	_	DT	O	[-1]	['none']	_	_
6	early	_	_	JJ	O	[-1]	['none']	_	_
7	stage	_	_	NN	O	[-1]	['none']	_	_
8	following	_	_	VBG	O	[-1]	['none']	_	_
9	T-cell	_	_	NN	O	[-1]	['none']	_	_
10	stimulation	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	is	_	_	VBZ	O	[-1]	['none']	_	_
13	therefore	_	_	RB	O	[-1]	['none']	_	_
14	an	_	_	DT	O	[-1]	['none']	_	_
15	important	_	_	JJ	O	[-1]	['none']	_	_
16	regulator	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	downstream	_	_	JJ	O	[-1]	['none']	_	_
19	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
20	signalling	_	_	NN	O	[-1]	['none']	_	_
21	pathways	_	_	NNS	O	[-1]	['none']	_	_
22	leading	_	_	VBG	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	cytokine	_	_	NN	O	[-1]	['none']	_	_
25	expression	_	_	NN	O	[-1]	['none']	_	_
26	[	_	_	CD	O	[-1]	['none']	_	_
27	50	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	have	_	_	VBP	O	[-1]	['none']	_	_
3	shown	_	_	VBN	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	phosphorylated-PKC	_	_	NN	O	[-1]	['none']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	up	_	_	RB	O	[-1]	['none']	_	_
8	regulated	_	_	VBN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	response	_	_	NN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	HK	_	_	NNP	O	[-1]	['none']	_	_
15	E.	_	_	NNP	O	[-1]	['none']	_	_
16	coli	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	indicating	_	_	VBG	O	[-1]	['none']	_	_
19	an	_	_	DT	O	[-1]	['none']	_	_
20	association	_	_	NN	O	[-1]	['none']	_	_
21	between	_	_	IN	O	[-1]	['none']	_	_
22	PKC	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	transcription	_	_	NN	O	[-1]	['none']	_	_
26	factors	_	_	NNS	O	[-1]	['none']	_	_
27	AP-1	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Bcl10	_	_	NN	Protein	[4]	['Theme']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	down-regulated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
5	following	_	_	VBG	O	[-1]	['none']	_	_
6	extended	_	_	JJ	O	[-1]	['none']	_	_
7	treatment	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	Jurkat	_	_	NN	O	[-1]	['none']	_	_
10	T-cells	_	_	NNS	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	PMA	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	control	_	_	NN	O	[-1]	['none']	_	_
4	groups	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	loss	_	_	NN	Negative_regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	Bcl10	_	_	NN	Protein	[7, 18]	['Theme', 'Theme']	_	_
10	occurred	_	_	VBD	O	[-1]	['none']	_	_
11	after	_	_	IN	O	[-1]	['none']	_	_
12	6	_	_	CD	O	[-1]	['none']	_	_
13	h	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	followed	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	an	_	_	DT	O	[-1]	['none']	_	_
18	increase	_	_	NN	Positive_regulation	[0]	['root']	_	_
19	after	_	_	IN	O	[-1]	['none']	_	_
20	24	_	_	CD	O	[-1]	['none']	_	_
21	h	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	which	_	_	WDT	O	[-1]	['none']	_	_
24	is	_	_	VBZ	O	[-1]	['none']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	accordance	_	_	NN	O	[-1]	['none']	_	_
27	with	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	observed	_	_	JJ	O	[-1]	['none']	_	_
30	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
31	activity	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	supported	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	an	_	_	DT	O	[-1]	['none']	_	_
7	earlier	_	_	JJR	O	[-1]	['none']	_	_
8	study	_	_	NN	O	[-1]	['none']	_	_
9	[	_	_	CD	O	[-1]	['none']	_	_
10	47	_	_	CD	O	[-1]	['none']	_	_
11	]	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	demonstrating	_	_	VBG	O	[-1]	['none']	_	_
14	that	_	_	IN	O	[-1]	['none']	_	_
15	prolonged	_	_	JJ	O	[-1]	['none']	_	_
16	PKC	_	_	NN	O	[-1]	['none']	_	_
17	activation	_	_	NN	O	[-1]	['none']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	PMA	_	_	NN	O	[-1]	['none']	_	_
20	leads	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	an	_	_	DT	O	[-1]	['none']	_	_
23	inhibition	_	_	NN	Negative_regulation	[20]	['Theme']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	Bcl10	_	_	NN	Protein	[23]	['Theme']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	been	_	_	VBN	O	[-1]	['none']	_	_
4	shown	_	_	VBN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	important	_	_	JJ	O	[-1]	['none']	_	_
10	transcription	_	_	NN	O	[-1]	['none']	_	_
11	factor	_	_	NN	O	[-1]	['none']	_	_
12	complex	_	_	NN	O	[-1]	['none']	_	_
13	involved	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	almost	_	_	RB	O	[-1]	['none']	_	_
16	every	_	_	DT	O	[-1]	['none']	_	_
17	aspect	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	regulation	_	_	NN	O	[-1]	['none']	_	_
21	including	_	_	VBG	O	[-1]	['none']	_	_
22	apoptosis	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	differentiation	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	proliferation	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	initiation	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	immune	_	_	JJ	O	[-1]	['none']	_	_
31	responses	_	_	NNS	O	[-1]	['none']	_	_
32	[	_	_	VBP	O	[-1]	['none']	_	_
33	51-53	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	CD	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	constitutively	_	_	RB	O	[-1]	['none']	_	_
4	active	_	_	JJ	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	many	_	_	JJ	O	[-1]	['none']	_	_
7	human	_	_	NN	O	[-1]	['none']	_	_
8	malignancies	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	which	_	_	WDT	O	[-1]	['none']	_	_
11	makes	_	_	VBZ	O	[-1]	['none']	_	_
12	it	_	_	PRP	O	[-1]	['none']	_	_
13	an	_	_	DT	O	[-1]	['none']	_	_
14	attractive	_	_	JJ	O	[-1]	['none']	_	_
15	therapeutic	_	_	JJ	O	[-1]	['none']	_	_
16	target	_	_	NN	O	[-1]	['none']	_	_
17	[	_	_	CD	O	[-1]	['none']	_	_
18	54	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Elevated	_	_	JJ	Positive_regulation	[0]	['root']	_	_
2	CXCL8	_	_	NN	Protein	[1]	['Theme']	_	_
3	levels	_	_	NNS	O	[-1]	['none']	_	_
4	during	_	_	IN	O	[-1]	['none']	_	_
5	chronic	_	_	JJ	O	[-1]	['none']	_	_
6	inflammation	_	_	NN	O	[-1]	['none']	_	_
7	result	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	an	_	_	DT	O	[-1]	['none']	_	_
10	enhanced	_	_	JJ	O	[-1]	['none']	_	_
11	recruitment	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	immune	_	_	JJ	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	site	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	infection	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	which	_	_	WDT	O	[-1]	['none']	_	_
22	may	_	_	MD	O	[-1]	['none']	_	_
23	lead	_	_	VB	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	development	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	autoimmune	_	_	JJ	O	[-1]	['none']	_	_
29	diseases	_	_	NNS	O	[-1]	['none']	_	_
30	following	_	_	VBG	O	[-1]	['none']	_	_
31	secretion	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	pro	_	_	JJ	O	[-1]	['none']	_	_
34	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
35	cytokines	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	HIV	_	_	NN	O	[-1]	['none']	_	_
3	infected	_	_	JJ	O	[-1]	['none']	_	_
4	persons	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	serum	_	_	NN	O	[-1]	['none']	_	_
7	CXCL8	_	_	NN	Protein	[10]	['Theme']	_	_
8	levels	_	_	NNS	O	[-1]	['none']	_	_
9	are	_	_	VBP	O	[-1]	['none']	_	_
10	elevated	_	_	JJ	Positive_regulation	[0]	['root']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	this	_	_	DT	O	[-1]	['none']	_	_
13	could	_	_	MD	O	[-1]	['none']	_	_
14	recruit	_	_	VB	O	[-1]	['none']	_	_
15	more	_	_	RBR	O	[-1]	['none']	_	_
16	T-cells	_	_	NNS	O	[-1]	['none']	_	_
17	potentially	_	_	RB	O	[-1]	['none']	_	_
18	leading	_	_	VBG	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	more	_	_	RBR	O	[-1]	['none']	_	_
22	rapid	_	_	JJ	O	[-1]	['none']	_	_
23	progression	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	disease	_	_	NN	O	[-1]	['none']	_	_
27	since	_	_	IN	O	[-1]	['none']	_	_
28	there	_	_	EX	O	[-1]	['none']	_	_
29	will	_	_	MD	O	[-1]	['none']	_	_
30	be	_	_	VB	O	[-1]	['none']	_	_
31	more	_	_	RBR	O	[-1]	['none']	_	_
32	T-cells	_	_	NNS	O	[-1]	['none']	_	_
33	available	_	_	JJ	O	[-1]	['none']	_	_
34	to	_	_	TO	O	[-1]	['none']	_	_
35	infect	_	_	VB	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Mice	_	_	NNS	O	[-1]	['none']	_	_
2	Specific-pathogen	_	_	JJ	O	[-1]	['none']	_	_
3	free	_	_	JJ	O	[-1]	['none']	_	_
4	colonies	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	C57BL/KaLawRij-Sharpincpdm/RijSunJ	_	_	NN	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	JR	_	_	NN	O	[-1]	['none']	_	_
9	#	_	_	#	O	[-1]	['none']	_	_
10	7599	_	_	CD	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	WT	_	_	JJ	O	[-1]	['none']	_	_
14	mice	_	_	NNS	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	obtained	_	_	VBN	O	[-1]	['none']	_	_
17	from	_	_	IN	O	[-1]	['none']	_	_
18	The	_	_	DT	O	[-1]	['none']	_	_
19	Jackson	_	_	NNP	O	[-1]	['none']	_	_
20	Laboratory	_	_	NNP	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	Bar	_	_	NNP	O	[-1]	['none']	_	_
23	Harbor	_	_	NNP	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	ME	_	_	NNP	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	were	_	_	VBD	O	[-1]	['none']	_	_
29	maintained	_	_	VBN	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	a	_	_	DT	O	[-1]	['none']	_	_
32	barrier	_	_	NN	O	[-1]	['none']	_	_
33	facility	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Normal	_	_	JJ	O	[-1]	['none']	_	_
2	littermate	_	_	NN	O	[-1]	['none']	_	_
3	controls	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	either	_	_	RB	O	[-1]	['none']	_	_
6	+/+	_	_	JJ	O	[-1]	['none']	_	_
7	or	_	_	CC	O	[-1]	['none']	_	_
8	+/Sharpincpdm	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	control	_	_	JJ	O	[-1]	['none']	_	_
3	animals	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	phenotypically	_	_	RB	O	[-1]	['none']	_	_
6	indistinguishable	_	_	JJ	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	are	_	_	VBP	O	[-1]	['none']	_	_
9	referred	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	WT	_	_	NNP	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Sex	_	_	NN	O	[-1]	['none']	_	_
2	matched	_	_	VBD	O	[-1]	['none']	_	_
3	WT	_	_	NNP	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	mutant	_	_	NN	O	[-1]	['none']	_	_
6	mice	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	used	_	_	VBN	O	[-1]	['none']	_	_
9	at	_	_	IN	O	[-1]	['none']	_	_
10	6-10	_	_	CD	O	[-1]	['none']	_	_
11	weeks	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	age	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	some	_	_	DT	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cpdm	_	_	NN	O	[-1]	['none']	_	_
6	mice	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	crossed	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	transgenic	_	_	JJ	O	[-1]	['none']	_	_
11	mice	_	_	NNS	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	bacterial	_	_	JJ	O	[-1]	['none']	_	_
15	artificial	_	_	JJ	O	[-1]	['none']	_	_
16	chromosome	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	BAC	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	containing	_	_	VBG	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	Sharpin	_	_	NN	Protein	[0]	['root']	_	_
23	gene	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	FVB	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	NJ-Tg	_	_	NN	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	RP24-173I23	_	_	NN	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	1Sun/Sun	_	_	NN	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	JR	_	_	NN	O	[-1]	['none']	_	_
34	#	_	_	#	O	[-1]	['none']	_	_
35	8279	_	_	CD	O	[-1]	['none']	_	_
36	)	_	_	-RRB-	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	mice	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	backcrossed	_	_	VBN	O	[-1]	['none']	_	_
5	onto	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	C57BL/KaLawRij-Sharpincpdm/RijSunJ	_	_	NN	O	[-1]	['none']	_	_
8	background	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	N4	_	_	NN	O	[-1]	['none']	_	_
11	mice	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	used	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	experiments	_	_	NNS	O	[-1]	['none']	_	_
17	reported	_	_	VBN	O	[-1]	['none']	_	_
18	here	_	_	RB	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	All	_	_	DT	O	[-1]	['none']	_	_
2	mouse	_	_	NN	O	[-1]	['none']	_	_
3	work	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	carried	_	_	VBN	O	[-1]	['none']	_	_
6	out	_	_	RP	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	strict	_	_	JJ	O	[-1]	['none']	_	_
9	accordance	_	_	NN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	approved	_	_	JJ	O	[-1]	['none']	_	_
13	protocols	_	_	NNS	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	Institutional	_	_	JJ	O	[-1]	['none']	_	_
17	Animal	_	_	NNP	O	[-1]	['none']	_	_
18	Care	_	_	NNP	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	Use	_	_	NNP	O	[-1]	['none']	_	_
21	Committee	_	_	NNP	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	SHARPIN	_	_	NNP	Protein	[25]	['Theme']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	originally	_	_	RB	O	[-1]	['none']	_	_
4	identified	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	post-synaptic	_	_	JJ	O	[-1]	['none']	_	_
7	densities	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	excitatory	_	_	JJ	O	[-1]	['none']	_	_
10	synapses	_	_	NNS	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	brain	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	rats	_	_	NNS	O	[-1]	['none']	_	_
16	[	_	_	VBP	O	[-1]	['none']	_	_
17	1	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	CD	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	but	_	_	CC	O	[-1]	['none']	_	_
21	this	_	_	DT	Anaphora	[22]	['multitoken']	_	_
22	protein	_	_	NN	Anaphora	[0]	['root']	_	_
23	is	_	_	VBZ	O	[-1]	['none']	_	_
24	widely	_	_	RB	O	[-1]	['none']	_	_
25	expressed	_	_	VBN	Gene_expression	[0]	['root']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	a	_	_	DT	O	[-1]	['none']	_	_
28	variety	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	tissues	_	_	NNS	O	[-1]	['none']	_	_
31	[	_	_	VBP	O	[-1]	['none']	_	_
32	2	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	CD	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Two	_	_	CD	O	[-1]	['none']	_	_
2	allelic	_	_	JJ	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	autosomal	_	_	JJ	O	[-1]	['none']	_	_
5	recessive	_	_	JJ	Negative_regulation	[6]	['multitoken']	_	_
6	mutations	_	_	NNS	Negative_regulation	[24]	['Cause']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	Sharpin	_	_	NN	Protein	[6, 32, 30]	['Theme', 'Theme', 'Theme']	_	_
10	gene	_	_	NN	O	[-1]	['none']	_	_
11	occurred	_	_	VBD	O	[-1]	['none']	_	_
12	spontaneously	_	_	RB	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	two	_	_	CD	O	[-1]	['none']	_	_
15	inbred	_	_	JJ	O	[-1]	['none']	_	_
16	strains	_	_	NNS	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	mice	_	_	NNS	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	C57B/KaLawRij-Sharpincpdm/Sharpincpdm	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	CBy.Ocb3/Dem-Sharpincpdm-Dem/Sharpincpdm-Dem	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	resulting	_	_	VBG	Positive_regulation	[0]	['root']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	premature	_	_	JJ	O	[-1]	['none']	_	_
27	termination	_	_	NN	Negative_regulation	[24]	['Theme']	_	_
28	of	_	_	IN	O	[-1]	['none']	_	_
29	mRNA	_	_	NN	Anaphora	[0]	['root']	_	_
30	synthesis	_	_	NN	Transcription	[27]	['Theme']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	absence	_	_	NN	Negative_regulation	[24]	['Theme']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	a	_	_	DT	Anaphora	[37]	['multitoken']	_	_
35	functional	_	_	JJ	Anaphora	[37]	['multitoken']	_	_
36	protein	_	_	NN	Anaphora	[37]	['multitoken']	_	_
37	product	_	_	NN	Anaphora	[0]	['root']	_	_
38	[	_	_	NN	O	[-1]	['none']	_	_
39	2	_	_	CD	O	[-1]	['none']	_	_
40	]	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Despite	_	_	IN	O	[-1]	['none']	_	_
2	different	_	_	JJ	O	[-1]	['none']	_	_
3	genetic	_	_	JJ	O	[-1]	['none']	_	_
4	backgrounds	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	both	_	_	DT	O	[-1]	['none']	_	_
7	mutations	_	_	NNS	O	[-1]	['none']	_	_
8	cause	_	_	VBP	O	[-1]	['none']	_	_
9	similar	_	_	JJ	O	[-1]	['none']	_	_
10	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
11	disease	_	_	NN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	severe	_	_	JJ	O	[-1]	['none']	_	_
14	chronic	_	_	JJ	O	[-1]	['none']	_	_
15	progressive	_	_	JJ	O	[-1]	['none']	_	_
16	dermatitis	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	defective	_	_	JJ	O	[-1]	['none']	_	_
19	development	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	secondary	_	_	JJ	O	[-1]	['none']	_	_
22	lymphoid	_	_	JJ	O	[-1]	['none']	_	_
23	organs	_	_	NNS	O	[-1]	['none']	_	_
24	[	_	_	VBP	O	[-1]	['none']	_	_
25	2	_	_	CD	O	[-1]	['none']	_	_
26	]-[	_	_	CD	O	[-1]	['none']	_	_
27	4	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	dermatitis	_	_	NN	O	[-1]	['none']	_	_
3	becomes	_	_	VBZ	O	[-1]	['none']	_	_
4	clinically	_	_	RB	O	[-1]	['none']	_	_
5	apparent	_	_	JJ	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	about	_	_	IN	O	[-1]	['none']	_	_
8	four	_	_	CD	O	[-1]	['none']	_	_
9	weeks	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	age	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	There	_	_	EX	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	accumulations	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	eosinophils	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	neutrophils	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	macrophages	_	_	NNS	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	skin	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Sharpincpdm	_	_	NNP	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	Sharpincpdm	_	_	NNP	O	[-1]	['none']	_	_
17	mutant	_	_	NN	O	[-1]	['none']	_	_
18	mice	_	_	NNS	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	hereafter	_	_	RB	O	[-1]	['none']	_	_
21	referred	_	_	VBN	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	as	_	_	IN	O	[-1]	['none']	_	_
24	cpdm	_	_	NN	O	[-1]	['none']	_	_
25	mice	_	_	NNS	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	associated	_	_	VBN	O	[-1]	['none']	_	_
28	with	_	_	IN	O	[-1]	['none']	_	_
29	increased	_	_	VBN	O	[-1]	['none']	_	_
30	expression	_	_	NN	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	Th2	_	_	NN	O	[-1]	['none']	_	_
33	cytokines	_	_	NNS	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	skin	_	_	NN	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	supernatants	_	_	NNS	O	[-1]	['none']	_	_
41	of	_	_	IN	O	[-1]	['none']	_	_
42	activated	_	_	VBN	O	[-1]	['none']	_	_
43	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
44	[	_	_	VBP	O	[-1]	['none']	_	_
45	5	_	_	CD	O	[-1]	['none']	_	_
46	]	_	_	CD	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	mice	_	_	NNS	O	[-1]	['none']	_	_
3	have	_	_	VBP	O	[-1]	['none']	_	_
4	an	_	_	DT	O	[-1]	['none']	_	_
5	impaired	_	_	JJ	O	[-1]	['none']	_	_
6	delayed	_	_	VBN	O	[-1]	['none']	_	_
7	type	_	_	NN	O	[-1]	['none']	_	_
8	hypersensitivity	_	_	NN	O	[-1]	['none']	_	_
9	response	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
12	secretion	_	_	NN	Gene_expression	[11]	['Theme']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	IFNgamma	_	_	NN	Protein	[12]	['Theme']	_	_
15	[	_	_	CD	O	[-1]	['none']	_	_
16	5	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	indicating	_	_	VBG	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	defect	_	_	NN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	Th1	_	_	NN	O	[-1]	['none']	_	_
24	immune	_	_	JJ	O	[-1]	['none']	_	_
25	responses	_	_	NNS	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	a	_	_	DT	O	[-1]	['none']	_	_
28	bias	_	_	NN	O	[-1]	['none']	_	_
29	towards	_	_	IN	O	[-1]	['none']	_	_
30	a	_	_	DT	O	[-1]	['none']	_	_
31	Th2	_	_	NN	O	[-1]	['none']	_	_
32	immune	_	_	JJ	O	[-1]	['none']	_	_
33	response	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Systemic	_	_	JJ	O	[-1]	['none']	_	_
2	treatment	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	cpdm	_	_	NN	O	[-1]	['none']	_	_
5	mice	_	_	NNS	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	recombinant	_	_	JJ	O	[-1]	['none']	_	_
8	IL12	_	_	NN	O	[-1]	['none']	_	_
9	caused	_	_	VBD	O	[-1]	['none']	_	_
10	complete	_	_	JJ	O	[-1]	['none']	_	_
11	remission	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	dermatitis	_	_	NN	O	[-1]	['none']	_	_
15	[	_	_	CD	O	[-1]	['none']	_	_
16	5	_	_	CD	O	[-1]	['none']	_	_
17	]	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Neutralization	_	_	NN	Negative_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	IL5	_	_	NN	Protein	[1]	['Theme']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	antibody	_	_	NN	O	[-1]	['none']	_	_
6	treatment	_	_	NN	O	[-1]	['none']	_	_
7	or	_	_	CC	O	[-1]	['none']	_	_
8	crosses	_	_	NNS	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	IL5	_	_	NN	Protein	[11]	['Theme']	_	_
11	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
12	mice	_	_	NNS	O	[-1]	['none']	_	_
13	reduced	_	_	VBD	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	number	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	circulating	_	_	VBG	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	cutaneous	_	_	JJ	O	[-1]	['none']	_	_
20	eosinophils	_	_	NNS	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	but	_	_	CC	O	[-1]	['none']	_	_
23	failed	_	_	VBD	O	[-1]	['none']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	reduce	_	_	VB	O	[-1]	['none']	_	_
26	the	_	_	DT	O	[-1]	['none']	_	_
27	onset	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	severity	_	_	NN	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	dermatitis	_	_	NN	O	[-1]	['none']	_	_
33	[	_	_	NN	O	[-1]	['none']	_	_
34	6	_	_	CD	O	[-1]	['none']	_	_
35	]	_	_	NN	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Recently	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	three	_	_	CD	O	[-1]	['none']	_	_
4	independent	_	_	JJ	O	[-1]	['none']	_	_
5	groups	_	_	NNS	O	[-1]	['none']	_	_
6	identified	_	_	VBN	O	[-1]	['none']	_	_
7	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
8	as	_	_	IN	O	[-1]	['none']	_	_
9	an	_	_	DT	O	[-1]	['none']	_	_
10	essential	_	_	JJ	O	[-1]	['none']	_	_
11	component	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	linear	_	_	JJ	O	[-1]	['none']	_	_
15	ubiquitin	_	_	NN	O	[-1]	['none']	_	_
16	chain	_	_	NN	O	[-1]	['none']	_	_
17	assembly	_	_	NN	O	[-1]	['none']	_	_
18	complex	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	LUBAC	_	_	NNP	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	that	_	_	WDT	O	[-1]	['none']	_	_
23	regulates	_	_	VBZ	O	[-1]	['none']	_	_
24	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
25	induced	_	_	VBD	O	[-1]	['none']	_	_
26	canonical	_	_	JJ	O	[-1]	['none']	_	_
27	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
28	signaling	_	_	NN	O	[-1]	['none']	_	_
29	[	_	_	NN	O	[-1]	['none']	_	_
30	7	_	_	CD	O	[-1]	['none']	_	_
31	]-[	_	_	CD	O	[-1]	['none']	_	_
32	9	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	SHARPIN	_	_	NNP	Protein	[2]	['Theme']	_	_
2	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
3	mouse	_	_	NN	O	[-1]	['none']	_	_
4	embryonic	_	_	JJ	O	[-1]	['none']	_	_
5	fibroblast	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	MEF	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	sensitized	_	_	VBN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	TNFalpha	_	_	NN	Protein	[0]	['root']	_	_
13	induced	_	_	VBD	O	[-1]	['none']	_	_
14	apoptosis	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	cell	_	_	NN	O	[-1]	['none']	_	_
17	death	_	_	NN	O	[-1]	['none']	_	_
18	was	_	_	VBD	O	[-1]	['none']	_	_
19	implicated	_	_	VBN	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	factor	_	_	NN	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	dermatitis	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	cpdm	_	_	NN	O	[-1]	['none']	_	_
28	mice	_	_	NNS	O	[-1]	['none']	_	_
29	[	_	_	VBP	O	[-1]	['none']	_	_
30	7	_	_	CD	O	[-1]	['none']	_	_
31	]-[	_	_	CD	O	[-1]	['none']	_	_
32	9	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Dendritic	_	_	JJ	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	DC	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	have	_	_	VBP	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	sentinel	_	_	NN	O	[-1]	['none']	_	_
9	role	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	sensing	_	_	VBG	O	[-1]	['none']	_	_
12	pathogen	_	_	NN	O	[-1]	['none']	_	_
13	or	_	_	CC	O	[-1]	['none']	_	_
14	danger	_	_	NN	O	[-1]	['none']	_	_
15	signals	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	initiate	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	direct	_	_	JJ	O	[-1]	['none']	_	_
20	activation	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	adaptive	_	_	JJ	O	[-1]	['none']	_	_
24	immune	_	_	JJ	O	[-1]	['none']	_	_
25	response	_	_	NN	O	[-1]	['none']	_	_
26	[	_	_	CD	O	[-1]	['none']	_	_
27	10	_	_	CD	O	[-1]	['none']	_	_
28	]	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Activated	_	_	VBN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	mature	_	_	JJ	O	[-1]	['none']	_	_
4	DC	_	_	NN	O	[-1]	['none']	_	_
5	can	_	_	MD	O	[-1]	['none']	_	_
6	carry	_	_	VB	O	[-1]	['none']	_	_
7	processed	_	_	VBN	O	[-1]	['none']	_	_
8	antigenic	_	_	JJ	O	[-1]	['none']	_	_
9	peptides	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	migrate	_	_	VB	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	lymphoid	_	_	JJ	O	[-1]	['none']	_	_
14	organs	_	_	NNS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	induce	_	_	VBP	O	[-1]	['none']	_	_
18	T-cell-mediated	_	_	JJ	O	[-1]	['none']	_	_
19	immune	_	_	JJ	O	[-1]	['none']	_	_
20	responses	_	_	NNS	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	tolerance	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	DC	_	_	NN	O	[-1]	['none']	_	_
2	direct	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	differentiation	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	CD4+	_	_	JJ	O	[-1]	['none']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	hence	_	_	RB	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	type	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	immune	_	_	JJ	O	[-1]	['none']	_	_
16	response	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	through	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	selective	_	_	JJ	O	[-1]	['none']	_	_
21	secretion	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	cytokines	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	hypothesized	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	defective	_	_	JJ	O	[-1]	['none']	_	_
5	cytokine	_	_	NN	O	[-1]	['none']	_	_
6	secretion	_	_	NN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	DC	_	_	NN	O	[-1]	['none']	_	_
9	contributed	_	_	VBD	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	Th2	_	_	NN	O	[-1]	['none']	_	_
13	biased	_	_	VBN	O	[-1]	['none']	_	_
14	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
15	phenotype	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	SHARPIN	_	_	NNP	Protein	[18]	['Theme']	_	_
18	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
19	mice	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	studies	_	_	NNS	O	[-1]	['none']	_	_
3	reported	_	_	VBN	O	[-1]	['none']	_	_
4	here	_	_	RB	O	[-1]	['none']	_	_
5	found	_	_	VBN	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	lack	_	_	NN	Negative_regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	SHARPIN	_	_	NN	Protein	[7]	['Theme']	_	_
10	protein	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	BMDC	_	_	NN	O	[-1]	['none']	_	_
13	caused	_	_	VBD	O	[-1]	['none']	_	_
14	defective	_	_	JJ	O	[-1]	['none']	_	_
15	expression	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	pro	_	_	JJ	O	[-1]	['none']	_	_
18	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
19	mediators	_	_	NNS	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	impaired	_	_	JJ	O	[-1]	['none']	_	_
22	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
23	activation	_	_	NN	O	[-1]	['none']	_	_
24	upon	_	_	IN	O	[-1]	['none']	_	_
25	ligand	_	_	NN	O	[-1]	['none']	_	_
26	stimulation	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	ability	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	cpdm	_	_	NN	O	[-1]	['none']	_	_
5	BMDC	_	_	NN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	stimulate	_	_	VB	O	[-1]	['none']	_	_
8	Th1	_	_	NN	O	[-1]	['none']	_	_
9	cytokine	_	_	NN	O	[-1]	['none']	_	_
10	production	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	allogeneic	_	_	JJ	O	[-1]	['none']	_	_
13	CD4+	_	_	JJ	O	[-1]	['none']	_	_
14	T	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	compromised	_	_	VBN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Taken	_	_	VBN	O	[-1]	['none']	_	_
2	together	_	_	RB	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	these	_	_	DT	O	[-1]	['none']	_	_
5	results	_	_	NNS	O	[-1]	['none']	_	_
6	reveal	_	_	VBP	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
9	is	_	_	VBZ	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	novel	_	_	JJ	O	[-1]	['none']	_	_
12	regulatory	_	_	JJ	O	[-1]	['none']	_	_
13	molecule	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	DC	_	_	NN	O	[-1]	['none']	_	_
16	biology	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	suggest	_	_	VBP	O	[-1]	['none']	_	_
19	that	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	dysregulated	_	_	JJ	O	[-1]	['none']	_	_
22	function	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	SHARPIN	_	_	NNP	Protein	[25]	['Theme']	_	_
25	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
26	DC	_	_	NN	O	[-1]	['none']	_	_
27	plays	_	_	VBZ	O	[-1]	['none']	_	_
28	a	_	_	DT	O	[-1]	['none']	_	_
29	role	_	_	NN	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	cpdm	_	_	NN	O	[-1]	['none']	_	_
33	phenotype	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	lines	_	_	NNS	O	[-1]	['none']	_	_
3	K-562	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	Jurkat	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	U-937	_	_	NN	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	obtained	_	_	VBN	O	[-1]	['none']	_	_
10	from	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	ATCC	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	American	_	_	JJ	O	[-1]	['none']	_	_
15	Type	_	_	NN	O	[-1]	['none']	_	_
16	Culture	_	_	NN	O	[-1]	['none']	_	_
17	Collection	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	Rockville	_	_	NNP	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	USA	_	_	NNP	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	EM-2	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	LAMA-84	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	CML-T1	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	BV-173	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	SD-1	_	_	NN	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	RPMI-8226	_	_	NN	O	[-1]	['none']	_	_
35	from	_	_	IN	O	[-1]	['none']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	DSMZ	_	_	NN	O	[-1]	['none']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	Deutsche	_	_	NNP	O	[-1]	['none']	_	_
40	Sammlung	_	_	NNP	O	[-1]	['none']	_	_
41	von	_	_	NNP	O	[-1]	['none']	_	_
42	Mikroorganismen	_	_	NNP	O	[-1]	['none']	_	_
43	und	_	_	NN	O	[-1]	['none']	_	_
44	Zellkulturen	_	_	NNP	O	[-1]	['none']	_	_
45	GmbH	_	_	NN	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	Braunschweig	_	_	NNP	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	Germany	_	_	NNP	O	[-1]	['none']	_	_
50	)	_	_	-RRB-	O	[-1]	['none']	_	_
51	.	_	_	.	O	[-1]	['none']	_	_

1	All	_	_	DT	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	lines	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	except	_	_	IN	O	[-1]	['none']	_	_
6	BV-173	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	SD-1	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	RPMI-8226	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Isolation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	primary	_	_	JJ	O	[-1]	['none']	_	_
4	human	_	_	NN	O	[-1]	['none']	_	_
5	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
6	T	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
2	T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	isolated	_	_	VBN	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	cryopreserved	_	_	JJ	O	[-1]	['none']	_	_
8	healthy	_	_	JJ	O	[-1]	['none']	_	_
9	donor	_	_	NN	O	[-1]	['none']	_	_
10	PBMCs	_	_	NNS	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	negative	_	_	JJ	O	[-1]	['none']	_	_
13	selection	_	_	NN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
17	T	_	_	NN	O	[-1]	['none']	_	_
18	Cell	_	_	NN	O	[-1]	['none']	_	_
19	Isolation	_	_	NN	O	[-1]	['none']	_	_
20	Kit	_	_	NN	O	[-1]	['none']	_	_
21	II	_	_	CD	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	Miltenyi	_	_	NNP	O	[-1]	['none']	_	_
24	Biotech	_	_	NNP	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	Bergisch	_	_	NNP	O	[-1]	['none']	_	_
27	Gladbach	_	_	NNP	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	Germany	_	_	NNP	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	according	_	_	VBG	O	[-1]	['none']	_	_
32	to	_	_	TO	O	[-1]	['none']	_	_
33	manufacturer	_	_	NN	O	[-1]	['none']	_	_
34	's	_	_	POS	O	[-1]	['none']	_	_
35	guidelines	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Purity	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	negatively	_	_	RB	O	[-1]	['none']	_	_
4	selected	_	_	VBN	O	[-1]	['none']	_	_
5	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
6	T	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	consistently	_	_	RB	O	[-1]	['none']	_	_
10	higher	_	_	JJR	O	[-1]	['none']	_	_
11	than	_	_	IN	O	[-1]	['none']	_	_
12	96	_	_	CD	O	[-1]	['none']	_	_
13	%	_	_	NN	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	determined	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	flow	_	_	NN	O	[-1]	['none']	_	_
18	cytometry	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Rnase	_	_	NN	O	[-1]	['none']	_	_
2	protection	_	_	NN	O	[-1]	['none']	_	_
3	assay	_	_	NN	O	[-1]	['none']	_	_
4	.	_	_	.	O	[-1]	['none']	_	_

1	Total	_	_	JJ	O	[-1]	['none']	_	_
2	RNA	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	isolated	_	_	VBN	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
7	MACS	_	_	NNS	O	[-1]	['none']	_	_
8	purified	_	_	VBN	O	[-1]	['none']	_	_
9	B	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	using	_	_	VBG	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	Rneasy	_	_	NNP	O	[-1]	['none']	_	_
14	midi	_	_	NN	O	[-1]	['none']	_	_
15	purification	_	_	NN	O	[-1]	['none']	_	_
16	kit	_	_	NN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	Dnase	_	_	NN	O	[-1]	['none']	_	_
19	treatment	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	according	_	_	VBG	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	manufacturer	_	_	NN	O	[-1]	['none']	_	_
25	's	_	_	POS	O	[-1]	['none']	_	_
26	instructions	_	_	NNS	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	Qiagen	_	_	NNP	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	mCK-1	_	_	NN	O	[-1]	['none']	_	_
3	probe	_	_	NN	O	[-1]	['none']	_	_
4	template	_	_	NN	O	[-1]	['none']	_	_
5	set	_	_	VBD	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	BD	_	_	NNP	O	[-1]	['none']	_	_
8	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	labeled	_	_	VBN	O	[-1]	['none']	_	_
12	using	_	_	VBG	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	In	_	_	NNP	O	[-1]	['none']	_	_
15	Vitro	_	_	NNP	O	[-1]	['none']	_	_
16	Transcription	_	_	NN	O	[-1]	['none']	_	_
17	Kit	_	_	NN	O	[-1]	['none']	_	_
18	according	_	_	VBG	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	manufacturer	_	_	NN	O	[-1]	['none']	_	_
22	's	_	_	POS	O	[-1]	['none']	_	_
23	instructions	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	BD	_	_	NNP	O	[-1]	['none']	_	_
26	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	50	_	_	CD	O	[-1]	['none']	_	_
4	ng	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	mCK-1	_	_	NN	O	[-1]	['none']	_	_
7	probe	_	_	NN	O	[-1]	['none']	_	_
8	set	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	labeled	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	[	_	_	CD	O	[-1]	['none']	_	_
13	alpha-32P	_	_	NN	O	[-1]	['none']	_	_
14	]	_	_	CD	O	[-1]	['none']	_	_
15	UTP	_	_	NN	O	[-1]	['none']	_	_
16	using	_	_	VBG	O	[-1]	['none']	_	_
17	T7	_	_	NN	O	[-1]	['none']	_	_
18	RNA	_	_	NN	O	[-1]	['none']	_	_
19	polymerase	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	purified	_	_	VBN	O	[-1]	['none']	_	_
22	using	_	_	VBG	O	[-1]	['none']	_	_
23	Sephadex	_	_	NN	O	[-1]	['none']	_	_
24	G-50	_	_	NN	O	[-1]	['none']	_	_
25	columns	_	_	NNS	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	NucAway	_	_	NNP	O	[-1]	['none']	_	_
28	Spin	_	_	NNP	O	[-1]	['none']	_	_
29	column	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	Ambion	_	_	NNP	O	[-1]	['none']	_	_
32	)	_	_	-RRB-	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	labeled	_	_	JJ	O	[-1]	['none']	_	_
3	probe	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	quantitated	_	_	VBN	O	[-1]	['none']	_	_
6	using	_	_	VBG	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	scintillation	_	_	NN	O	[-1]	['none']	_	_
9	counter	_	_	RB	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	6	_	_	CD	O	[-1]	['none']	_	_
13	x	_	_	CC	O	[-1]	['none']	_	_
14	105	_	_	CD	O	[-1]	['none']	_	_
15	cherenkov	_	_	NN	O	[-1]	['none']	_	_
16	cpm	_	_	NN	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	used	_	_	VBN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	hybridize	_	_	VB	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	4	_	_	CD	O	[-1]	['none']	_	_
23	mug	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	total	_	_	JJ	O	[-1]	['none']	_	_
26	RNA	_	_	NN	O	[-1]	['none']	_	_
27	using	_	_	VBG	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	RPA	_	_	NNP	O	[-1]	['none']	_	_
30	kit	_	_	NN	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	BD	_	_	NNP	O	[-1]	['none']	_	_
33	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Samples	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	denatured	_	_	VBN	O	[-1]	['none']	_	_
4	at	_	_	IN	O	[-1]	['none']	_	_
5	90	_	_	CD	O	[-1]	['none']	_	_
6	degreesC	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	hybridized	_	_	VBD	O	[-1]	['none']	_	_
9	at	_	_	IN	O	[-1]	['none']	_	_
10	56	_	_	CD	O	[-1]	['none']	_	_
11	degreesC	_	_	NN	O	[-1]	['none']	_	_
12	overnight	_	_	JJ	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Single	_	_	JJ	O	[-1]	['none']	_	_
2	stranded	_	_	JJ	O	[-1]	['none']	_	_
3	RNA	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	digested	_	_	VBN	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	mixture	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Rnase	_	_	NNP	Protein	[11]	['multitoken']	_	_
11	A	_	_	NNP	Protein	[0]	['root']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	T1	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	precipitated	_	_	VBD	O	[-1]	['none']	_	_
17	using	_	_	VBG	O	[-1]	['none']	_	_
18	isopropanol	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Protected	_	_	VBN	O	[-1]	['none']	_	_
2	probes	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	resolved	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	denaturing	_	_	VBG	O	[-1]	['none']	_	_
8	4.75	_	_	CD	O	[-1]	['none']	_	_
9	%	_	_	NN	O	[-1]	['none']	_	_
10	acrylamide	_	_	NN	O	[-1]	['none']	_	_
11	gel	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	dried	_	_	VBD	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	imaged	_	_	VBN	O	[-1]	['none']	_	_
17	using	_	_	VBG	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	phosphorImager	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	Molecular	_	_	JJ	O	[-1]	['none']	_	_
22	Dynamics	_	_	NNP	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Densitometry	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	performed	_	_	VBN	O	[-1]	['none']	_	_
4	using	_	_	VBG	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	ImageQuant	_	_	NNP	O	[-1]	['none']	_	_
7	TL	_	_	NN	O	[-1]	['none']	_	_
8	v2005	_	_	NN	O	[-1]	['none']	_	_
9	software	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	GE	_	_	NNP	O	[-1]	['none']	_	_
12	Healthcare	_	_	NNP	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	analyses	_	_	NNS	O	[-1]	['none']	_	_
3	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Mann-Whitney	_	_	NNP	O	[-1]	['none']	_	_
3	U	_	_	NNP	O	[-1]	['none']	_	_
4	test	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	used	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	compare	_	_	VB	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	data	_	_	NNS	O	[-1]	['none']	_	_
11	between	_	_	IN	O	[-1]	['none']	_	_
12	patients	_	_	NNS	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	HAM	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	TSP	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	AC	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF-induced	_	_	NNP	O	[-1]	['none']	_	_
2	PKC	_	_	NN	O	[-1]	['none']	_	_
3	activity	_	_	NN	O	[-1]	['none']	_	_
4	does	_	_	VBZ	O	[-1]	['none']	_	_
5	not	_	_	RB	O	[-1]	['none']	_	_
6	regulate	_	_	VB	Regulation	[0]	['root']	_	_
7	IkappaBalpha	_	_	NN	Protein	[8]	['Theme']	_	_
8	degradation	_	_	NN	Protein_catabolism	[6]	['Theme']	_	_
9	but	_	_	CC	O	[-1]	['none']	_	_
10	regulates	_	_	VBZ	Regulation	[0]	['root']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	phosphorylation	_	_	NN	Phosphorylation	[10]	['Theme']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
15	p65	_	_	NN	Protein	[12]	['Theme']	_	_
16	at	_	_	IN	O	[-1]	['none']	_	_
17	Ser276	_	_	NN	Entity	[12]	['Site']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	MDMs	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	pretreated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	cycloheximide	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	CHX	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	absence	_	_	NN	O	[-1]	['none']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	presence	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	30	_	_	CD	O	[-1]	['none']	_	_
21	minutes	_	_	NNS	O	[-1]	['none']	_	_
22	prior	_	_	RB	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	M-CSF	_	_	NN	O	[-1]	['none']	_	_
25	stimulation	_	_	NN	O	[-1]	['none']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	indicated	_	_	JJ	O	[-1]	['none']	_	_
29	times	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Whole	_	_	JJ	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	lysates	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	subjected	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	Western	_	_	NN	O	[-1]	['none']	_	_
8	blotting	_	_	NN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	anti-IkappaBalpha	_	_	JJ	O	[-1]	['none']	_	_
11	antibody	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	representative	_	_	JJ	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	three	_	_	CD	O	[-1]	['none']	_	_
6	independent	_	_	JJ	O	[-1]	['none']	_	_
7	experiments	_	_	NNS	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	MDMs	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	pretreated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	either	_	_	CC	O	[-1]	['none']	_	_
9	vehicle	_	_	NN	O	[-1]	['none']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	30	_	_	CD	O	[-1]	['none']	_	_
14	minutes	_	_	NNS	O	[-1]	['none']	_	_
15	before	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	addition	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	M-CSF	_	_	NN	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	10	_	_	CD	O	[-1]	['none']	_	_
22	minutes	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Whole	_	_	JJ	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	lysates	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	resolved	_	_	VBN	O	[-1]	['none']	_	_
6	by	_	_	IN	O	[-1]	['none']	_	_
7	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	phospho-Ser276	_	_	NN	Entity	[9]	['Site']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	phospho-Ser536	_	_	NN	Entity	[11]	['Site']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
14	p65	_	_	NN	Protein	[9, 11]	['Theme', 'Theme']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	detected	_	_	VBN	O	[-1]	['none']	_	_
17	using	_	_	VBG	O	[-1]	['none']	_	_
18	phospho	_	_	NN	O	[-1]	['none']	_	_
19	specific	_	_	JJ	O	[-1]	['none']	_	_
20	antibodies	_	_	NNS	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	either	_	_	CC	O	[-1]	['none']	_	_
23	residue	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
26	p65	_	_	NN	Protein	[0]	['root']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Whole	_	_	JJ	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	lysates	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	RAW	_	_	NN	O	[-1]	['none']	_	_
9	264.7	_	_	CD	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	treated	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	vehicle	_	_	NN	O	[-1]	['none']	_	_
14	control	_	_	NN	O	[-1]	['none']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	absence	_	_	NN	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	presence	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	M-CSF	_	_	NN	O	[-1]	['none']	_	_
24	were	_	_	VBD	O	[-1]	['none']	_	_
25	subjected	_	_	VBN	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	Western	_	_	NN	O	[-1]	['none']	_	_
28	blot	_	_	NN	O	[-1]	['none']	_	_
29	analysis	_	_	NN	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	phospho-Ser276	_	_	NN	O	[-1]	['none']	_	_
32	or	_	_	CC	O	[-1]	['none']	_	_
33	phospho-Ser536	_	_	NN	O	[-1]	['none']	_	_
34	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
35	p65	_	_	NN	O	[-1]	['none']	_	_
36	antibodies	_	_	NNS	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	D	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Cytosolic	_	_	JJ	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	nuclear	_	_	JJ	O	[-1]	['none']	_	_
7	fractions	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	RAW	_	_	NN	O	[-1]	['none']	_	_
10	264.7	_	_	CD	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	obtained	_	_	VBN	O	[-1]	['none']	_	_
13	from	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	treated	_	_	JJ	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	immunoblotted	_	_	VBN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	phospho-NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	purity	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	cytosolic	_	_	JJ	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	nuclear	_	_	JJ	O	[-1]	['none']	_	_
8	fractions	_	_	NNS	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	confirmed	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	immunoblotting	_	_	VBG	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	GAPDH	_	_	NN	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	Lamin	_	_	NN	O	[-1]	['none']	_	_
17	B	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	respectively	_	_	RB	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Shown	_	_	VBN	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	representative	_	_	JJ	O	[-1]	['none']	_	_
4	blots	_	_	NNS	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	three	_	_	CD	O	[-1]	['none']	_	_
7	independent	_	_	JJ	O	[-1]	['none']	_	_
8	experiments	_	_	NNS	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	NN	O	[-1]	['none']	_	_
2	blot	_	_	NN	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	.	_	_	.	O	[-1]	['none']	_	_

1	HEK	_	_	NNP	O	[-1]	['none']	_	_
2	293T	_	_	NN	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	plated	_	_	VBN	O	[-1]	['none']	_	_
6	at	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	density	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	5	_	_	CD	O	[-1]	['none']	_	_
11	x	_	_	CC	O	[-1]	['none']	_	_
12	105	_	_	CD	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	well	_	_	RB	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	six-well	_	_	JJ	O	[-1]	['none']	_	_
18	culture	_	_	NN	O	[-1]	['none']	_	_
19	plates	_	_	VBZ	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	BD	_	_	NNP	O	[-1]	['none']	_	_
22	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	1	_	_	CD	O	[-1]	['none']	_	_
25	d	_	_	NN	O	[-1]	['none']	_	_
26	prior	_	_	RB	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	transfection	_	_	NN	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	appropriate	_	_	JJ	O	[-1]	['none']	_	_
32	plasmid	_	_	NN	O	[-1]	['none']	_	_
33	DNA	_	_	NN	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	2	_	_	CD	O	[-1]	['none']	_	_
36	mug	_	_	NN	O	[-1]	['none']	_	_
37	total	_	_	JJ	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	using	_	_	VBG	O	[-1]	['none']	_	_
40	FuGene	_	_	NNP	O	[-1]	['none']	_	_
41	6	_	_	CD	O	[-1]	['none']	_	_
42	transfection	_	_	NN	O	[-1]	['none']	_	_
43	reagent	_	_	NN	O	[-1]	['none']	_	_
44	(	_	_	-LRB-	O	[-1]	['none']	_	_
45	Roche	_	_	NNP	O	[-1]	['none']	_	_
46	)	_	_	-RRB-	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	harvested	_	_	VBN	O	[-1]	['none']	_	_
4	24	_	_	CD	O	[-1]	['none']	_	_
5	h	_	_	NN	O	[-1]	['none']	_	_
6	posttransfection	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	whole-cell	_	_	JJ	O	[-1]	['none']	_	_
9	lysates	_	_	NNS	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	RIPA	_	_	NN	O	[-1]	['none']	_	_
12	buffer	_	_	NN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	50	_	_	CD	O	[-1]	['none']	_	_
15	mM	_	_	NN	O	[-1]	['none']	_	_
16	Tris-HCl	_	_	NN	O	[-1]	['none']	_	_
17	[	_	_	CD	O	[-1]	['none']	_	_
18	pH	_	_	NN	O	[-1]	['none']	_	_
19	7.4	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	150	_	_	CD	O	[-1]	['none']	_	_
23	mM	_	_	NN	O	[-1]	['none']	_	_
24	NaCl	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	1	_	_	CD	O	[-1]	['none']	_	_
27	%	_	_	NN	O	[-1]	['none']	_	_
28	Igepal	_	_	JJ	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	NP-40	_	_	NN	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	0.5	_	_	CD	O	[-1]	['none']	_	_
34	%	_	_	NN	O	[-1]	['none']	_	_
35	sodium	_	_	NN	O	[-1]	['none']	_	_
36	deoxycholate	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	1	_	_	CD	O	[-1]	['none']	_	_
39	mM	_	_	NN	O	[-1]	['none']	_	_
40	EDTA	_	_	NN	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	1	_	_	CD	O	[-1]	['none']	_	_
43	mM	_	_	NN	O	[-1]	['none']	_	_
44	DTT	_	_	NN	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	1	_	_	CD	O	[-1]	['none']	_	_
47	mM	_	_	NN	O	[-1]	['none']	_	_
48	PMSF	_	_	NN	O	[-1]	['none']	_	_
49	,	_	_	,	O	[-1]	['none']	_	_
50	and	_	_	CC	O	[-1]	['none']	_	_
51	1x	_	_	NN	O	[-1]	['none']	_	_
52	Complete	_	_	JJ	O	[-1]	['none']	_	_
53	Mini	_	_	NNP	O	[-1]	['none']	_	_
54	Protease	_	_	NN	O	[-1]	['none']	_	_
55	Inhibitor	_	_	NN	O	[-1]	['none']	_	_
56	[	_	_	CD	O	[-1]	['none']	_	_
57	Roche	_	_	NNP	O	[-1]	['none']	_	_
58	]	_	_	CD	O	[-1]	['none']	_	_
59	)	_	_	-RRB-	O	[-1]	['none']	_	_
60	.	_	_	.	O	[-1]	['none']	_	_

1	Protein	_	_	NN	O	[-1]	['none']	_	_
2	concentration	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	determined	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	Lowry	_	_	NNP	O	[-1]	['none']	_	_
7	assay	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	Bio-Rad	_	_	NNP	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	Hercules	_	_	NNP	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	California	_	_	NNP	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	United	_	_	NNP	O	[-1]	['none']	_	_
16	States	_	_	NNPS	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	colorimetric	_	_	JJ	O	[-1]	['none']	_	_
20	reactions	_	_	NNS	O	[-1]	['none']	_	_
21	were	_	_	VBD	O	[-1]	['none']	_	_
22	read	_	_	VBN	O	[-1]	['none']	_	_
23	using	_	_	VBG	O	[-1]	['none']	_	_
24	a	_	_	DT	O	[-1]	['none']	_	_
25	VersaMax	_	_	NN	O	[-1]	['none']	_	_
26	microplate	_	_	NN	O	[-1]	['none']	_	_
27	reader	_	_	NN	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	Molecular	_	_	JJ	O	[-1]	['none']	_	_
30	Devices	_	_	NNPS	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	Sunnyvale	_	_	NNP	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	California	_	_	NNP	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	United	_	_	NNP	O	[-1]	['none']	_	_
37	States	_	_	NNPS	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	at	_	_	IN	O	[-1]	['none']	_	_
40	an	_	_	DT	O	[-1]	['none']	_	_
41	absorbance	_	_	NN	O	[-1]	['none']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	750	_	_	CD	O	[-1]	['none']	_	_
44	nm	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	Size	_	_	NN	O	[-1]	['none']	_	_
2	fractionation	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	performed	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	20	_	_	CD	O	[-1]	['none']	_	_
7	mug	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	protein	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	sample	_	_	NN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	protein	_	_	NN	O	[-1]	['none']	_	_
18	was	_	_	VBD	O	[-1]	['none']	_	_
19	transferred	_	_	VBN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	nitrocellulose	_	_	NN	O	[-1]	['none']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	PVDF	_	_	NN	O	[-1]	['none']	_	_
24	membranes	_	_	NNS	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	subjected	_	_	VBN	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	immunoblotting	_	_	VBG	O	[-1]	['none']	_	_
29	using	_	_	VBG	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	indicated	_	_	JJ	O	[-1]	['none']	_	_
32	antibodies	_	_	NNS	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	detected	_	_	VBN	O	[-1]	['none']	_	_
4	using	_	_	VBG	O	[-1]	['none']	_	_
5	rabbit	_	_	NN	O	[-1]	['none']	_	_
6	anti-human	_	_	JJ	O	[-1]	['none']	_	_
7	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
8	polyclonal	_	_	JJ	O	[-1]	['none']	_	_
9	antibody	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	ab4728	_	_	NN	O	[-1]	['none']	_	_
12	or	_	_	CC	O	[-1]	['none']	_	_
13	ab10563	_	_	NN	O	[-1]	['none']	_	_
14	;	_	_	:	O	[-1]	['none']	_	_
15	Abcam	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	Cambridge	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	United	_	_	NNP	O	[-1]	['none']	_	_
20	Kingdom	_	_	NNP	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	anti-rabbit	_	_	JJ	O	[-1]	['none']	_	_
24	IgG-HRP	_	_	NN	O	[-1]	['none']	_	_
25	secondary	_	_	JJ	O	[-1]	['none']	_	_
26	antibody	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	Cell	_	_	NN	O	[-1]	['none']	_	_
29	Signaling	_	_	NN	O	[-1]	['none']	_	_
30	Technology	_	_	NN	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	Beverly	_	_	NNP	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	Massachusetts	_	_	NNP	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	United	_	_	NNP	O	[-1]	['none']	_	_
37	States	_	_	NNPS	O	[-1]	['none']	_	_
38	)	_	_	-RRB-	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
2	p65	_	_	NN	Protein	[0]	['root']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	CREB-1	_	_	NN	Protein	[0]	['root']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	detected	_	_	VBN	O	[-1]	['none']	_	_
7	using	_	_	VBG	O	[-1]	['none']	_	_
8	rabbit	_	_	NN	O	[-1]	['none']	_	_
9	anti-human	_	_	JJ	O	[-1]	['none']	_	_
10	polyclonal	_	_	JJ	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	p65	_	_	NN	Protein	[0]	['root']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	monoclonal	_	_	JJ	O	[-1]	['none']	_	_
16	antibody	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	CREB-1	_	_	NN	Protein	[0]	['root']	_	_
19	;	_	_	:	O	[-1]	['none']	_	_
20	48H2	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	Cell	_	_	NN	O	[-1]	['none']	_	_
24	Signaling	_	_	NN	O	[-1]	['none']	_	_
25	Technology	_	_	NN	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Beta-actin	_	_	NN	Protein	[0]	['root']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	detected	_	_	VBN	O	[-1]	['none']	_	_
4	using	_	_	VBG	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	mouse	_	_	NN	O	[-1]	['none']	_	_
7	monoclonal	_	_	JJ	O	[-1]	['none']	_	_
8	antibody	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	AC-15	_	_	NN	O	[-1]	['none']	_	_
11	;	_	_	:	O	[-1]	['none']	_	_
12	Sigma	_	_	NNP	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	St.	_	_	NNP	O	[-1]	['none']	_	_
15	Louis	_	_	NNP	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	Missouri	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	United	_	_	NNP	O	[-1]	['none']	_	_
20	States	_	_	NNPS	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	coimmunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	lysates	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	precleared	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	30	_	_	CD	O	[-1]	['none']	_	_
11	mul	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	protein	_	_	NN	O	[-1]	['none']	_	_
14	A/G	_	_	NN	O	[-1]	['none']	_	_
15	plus-agarose	_	_	JJ	O	[-1]	['none']	_	_
16	beads	_	_	NNS	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Santa	_	_	NNP	O	[-1]	['none']	_	_
19	Cruz	_	_	NNP	O	[-1]	['none']	_	_
20	Biotechnology	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	Santa	_	_	NNP	O	[-1]	['none']	_	_
23	Cruz	_	_	NNP	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	California	_	_	NNP	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	United	_	_	NNP	O	[-1]	['none']	_	_
28	States	_	_	NNPS	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	then	_	_	RB	O	[-1]	['none']	_	_
32	incubated	_	_	VBN	O	[-1]	['none']	_	_
33	with	_	_	IN	O	[-1]	['none']	_	_
34	mouse	_	_	NN	O	[-1]	['none']	_	_
35	monoclonal	_	_	JJ	O	[-1]	['none']	_	_
36	anti-HA	_	_	JJ	O	[-1]	['none']	_	_
37	antibody	_	_	NN	O	[-1]	['none']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	6E2	_	_	NN	O	[-1]	['none']	_	_
40	;	_	_	:	O	[-1]	['none']	_	_
41	1:100	_	_	CD	O	[-1]	['none']	_	_
42	;	_	_	:	O	[-1]	['none']	_	_
43	Cell	_	_	NN	O	[-1]	['none']	_	_
44	Signaling	_	_	NN	O	[-1]	['none']	_	_
45	Technology	_	_	NN	O	[-1]	['none']	_	_
46	)	_	_	-RRB-	O	[-1]	['none']	_	_
47	and	_	_	CC	O	[-1]	['none']	_	_
48	30	_	_	CD	O	[-1]	['none']	_	_
49	mul	_	_	NN	O	[-1]	['none']	_	_
50	of	_	_	IN	O	[-1]	['none']	_	_
51	protein	_	_	NN	O	[-1]	['none']	_	_
52	A/G	_	_	NN	O	[-1]	['none']	_	_
53	plus-agarose	_	_	NN	O	[-1]	['none']	_	_
54	beads	_	_	NNS	O	[-1]	['none']	_	_
55	overnight	_	_	JJ	O	[-1]	['none']	_	_
56	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	immunoprecipitates	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	washed	_	_	VBN	O	[-1]	['none']	_	_
5	four	_	_	CD	O	[-1]	['none']	_	_
6	times	_	_	NNS	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	RIPA	_	_	NN	O	[-1]	['none']	_	_
9	buffer	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	resuspended	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	SDS	_	_	NN	O	[-1]	['none']	_	_
14	sample	_	_	NN	O	[-1]	['none']	_	_
15	buffer	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	heated	_	_	VBN	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	95	_	_	CD	O	[-1]	['none']	_	_
21	degreesC	_	_	NN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	5	_	_	CD	O	[-1]	['none']	_	_
24	min	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Proteins	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	then	_	_	RB	O	[-1]	['none']	_	_
4	treated	_	_	VBN	O	[-1]	['none']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	described	_	_	VBN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	Western	_	_	NN	O	[-1]	['none']	_	_
9	blot	_	_	NN	O	[-1]	['none']	_	_
10	analysis	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	GLepsilon	_	_	NN	Protein	[0]	['root']	_	_
2	transcript	_	_	NN	O	[-1]	['none']	_	_
3	assay	_	_	NN	O	[-1]	['none']	_	_
4	The	_	_	DT	O	[-1]	['none']	_	_
5	CD40	_	_	NN	Protein	[6]	['Cause']	_	_
6	simulated	_	_	JJ	Positive_regulation	[0]	['root']	_	_
7	activation	_	_	NN	Positive_regulation	[6]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	GLepsilon	_	_	NN	Protein	[10]	['Theme']	_	_
10	transcription	_	_	NN	Transcription	[7]	['Theme']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	evaluated	_	_	VBN	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	previously	_	_	RB	O	[-1]	['none']	_	_
15	reported	_	_	VBN	O	[-1]	['none']	_	_
16	[	_	_	NN	O	[-1]	['none']	_	_
17	33	_	_	CD	O	[-1]	['none']	_	_
18	]	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	1x106	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	stimulated	_	_	VBN	O	[-1]	['none']	_	_
7	overnight	_	_	JJ	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	anti-CD40	_	_	JJ	O	[-1]	['none']	_	_
10	antibody	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	10	_	_	CD	O	[-1]	['none']	_	_
13	microg/ml	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	an	_	_	DT	O	[-1]	['none']	_	_
17	isotype	_	_	NN	O	[-1]	['none']	_	_
18	control	_	_	NN	O	[-1]	['none']	_	_
19	antibody	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	with	_	_	IN	O	[-1]	['none']	_	_
22	or	_	_	CC	O	[-1]	['none']	_	_
23	without	_	_	IN	O	[-1]	['none']	_	_
24	500	_	_	CD	O	[-1]	['none']	_	_
25	U/ml	_	_	NN	O	[-1]	['none']	_	_
26	mouse	_	_	NN	O	[-1]	['none']	_	_
27	IL-4	_	_	NN	Protein	[0]	['root']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	BD	_	_	NNP	O	[-1]	['none']	_	_
30	Biosciences	_	_	NNP	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	isolated	_	_	VBN	O	[-1]	['none']	_	_
4	using	_	_	VBG	O	[-1]	['none']	_	_
5	Trizol	_	_	NNP	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	reverse	_	_	VB	O	[-1]	['none']	_	_
12	transcribed	_	_	VBN	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Superscript	_	_	NNP	O	[-1]	['none']	_	_
15	III	_	_	NNP	O	[-1]	['none']	_	_
16	kit	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Quantitative	_	_	JJ	O	[-1]	['none']	_	_
2	PCR	_	_	NN	O	[-1]	['none']	_	_
3	for	_	_	IN	O	[-1]	['none']	_	_
4	GLepsilon	_	_	NN	Protein	[0]	['root']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Hprt1	_	_	NN	Protein	[0]	['root']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	performed	_	_	VBN	O	[-1]	['none']	_	_
9	using	_	_	VBG	O	[-1]	['none']	_	_
10	SYBR	_	_	NNP	O	[-1]	['none']	_	_
11	GREEN	_	_	NNP	O	[-1]	['none']	_	_
12	master	_	_	NN	O	[-1]	['none']	_	_
13	mix	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Applied	_	_	NNP	O	[-1]	['none']	_	_
16	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	an	_	_	DT	O	[-1]	['none']	_	_
21	Applied	_	_	NNP	O	[-1]	['none']	_	_
22	Biosystems	_	_	NNP	O	[-1]	['none']	_	_
23	7900HT	_	_	NNP	O	[-1]	['none']	_	_
24	Fast	_	_	JJ	O	[-1]	['none']	_	_
25	Real-Time	_	_	NNP	O	[-1]	['none']	_	_
26	PCR	_	_	NN	O	[-1]	['none']	_	_
27	instrument	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	Gene_expression	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	GLepsilon	_	_	NN	Protein	[1]	['Theme']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	each	_	_	DT	O	[-1]	['none']	_	_
6	sample	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	normalized	_	_	VBN	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Hprt1	_	_	NN	Protein	[11]	['Theme']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Th2	_	_	NN	O	[-1]	['none']	_	_
2	biased	_	_	VBD	O	[-1]	['none']	_	_
3	immunogenicity	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	stimulated	_	_	VBN	O	[-1]	['none']	_	_
6	cpdm	_	_	NN	O	[-1]	['none']	_	_
7	BMDC	_	_	NN	O	[-1]	['none']	_	_
8	The	_	_	DT	O	[-1]	['none']	_	_
9	defective	_	_	JJ	O	[-1]	['none']	_	_
10	IL12	_	_	NN	O	[-1]	['none']	_	_
11	production	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	Th2	_	_	NN	O	[-1]	['none']	_	_
14	dominant	_	_	JJ	O	[-1]	['none']	_	_
15	cytokine	_	_	NN	O	[-1]	['none']	_	_
16	profile	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	cpdm	_	_	NN	O	[-1]	['none']	_	_
19	mice	_	_	NNS	O	[-1]	['none']	_	_
20	[	_	_	VBP	O	[-1]	['none']	_	_
21	5	_	_	CD	O	[-1]	['none']	_	_
22	]	_	_	CD	O	[-1]	['none']	_	_
23	suggest	_	_	VBP	O	[-1]	['none']	_	_
24	that	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	absence	_	_	NN	Negative_regulation	[0]	['root']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	SHARPIN	_	_	NNP	Protein	[26]	['Theme']	_	_
29	affects	_	_	VBZ	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	ability	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	cpdm	_	_	NN	O	[-1]	['none']	_	_
34	BMDC	_	_	NN	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	induce	_	_	VB	O	[-1]	['none']	_	_
37	T	_	_	NN	O	[-1]	['none']	_	_
38	cell	_	_	NN	O	[-1]	['none']	_	_
39	differentiation	_	_	NN	O	[-1]	['none']	_	_
40	into	_	_	IN	O	[-1]	['none']	_	_
41	effector	_	_	NN	O	[-1]	['none']	_	_
42	cells	_	_	NNS	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	Co-culture	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	allogeneic	_	_	JJ	O	[-1]	['none']	_	_
4	naive	_	_	JJ	O	[-1]	['none']	_	_
5	CD4+	_	_	JJ	O	[-1]	['none']	_	_
6	T	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	WT	_	_	JJ	O	[-1]	['none']	_	_
10	BMDC	_	_	NN	O	[-1]	['none']	_	_
11	stimulated	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	LPS	_	_	NN	O	[-1]	['none']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	poly	_	_	NN	O	[-1]	['none']	_	_
16	I	_	_	NN	O	[-1]	['none']	_	_
17	:	_	_	:	O	[-1]	['none']	_	_
18	C	_	_	NN	O	[-1]	['none']	_	_
19	elicited	_	_	JJ	Positive_regulation	[0]	['root']	_	_
20	robust	_	_	JJ	O	[-1]	['none']	_	_
21	IFNgamma	_	_	NN	Protein	[22]	['Theme']	_	_
22	production	_	_	NN	Gene_expression	[19]	['Theme']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	whereas	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	concentration	_	_	NN	Gene_expression	[36]	['Theme']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	IFNgamma	_	_	NN	Protein	[26]	['Theme']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	cpdm	_	_	NN	O	[-1]	['none']	_	_
31	BMDC-T	_	_	NN	O	[-1]	['none']	_	_
32	cell	_	_	NN	O	[-1]	['none']	_	_
33	cultures	_	_	NNS	O	[-1]	['none']	_	_
34	was	_	_	VBD	O	[-1]	['none']	_	_
35	significantly	_	_	RB	O	[-1]	['none']	_	_
36	lower	_	_	JJR	Positive_regulation	[0]	['root']	_	_
37	after	_	_	IN	O	[-1]	['none']	_	_
38	LPS	_	_	NN	O	[-1]	['none']	_	_
39	stimulation	_	_	NN	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	indicating	_	_	VBG	O	[-1]	['none']	_	_
42	impaired	_	_	JJ	O	[-1]	['none']	_	_
43	Th1	_	_	NN	O	[-1]	['none']	_	_
44	polarizing	_	_	VBG	O	[-1]	['none']	_	_
45	abilities	_	_	NNS	O	[-1]	['none']	_	_
46	of	_	_	IN	O	[-1]	['none']	_	_
47	cpdm	_	_	NN	O	[-1]	['none']	_	_
48	BMDC	_	_	NN	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	TLR3/4	_	_	NN	Protein	[5]	['Theme']	_	_
5	agonists	_	_	NNS	Positive_regulation	[0]	['root']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	TLR2	_	_	NN	Protein	[9]	['Theme']	_	_
9	ligand	_	_	NN	Binding	[0]	['root']	_	_
10	Pam3CYS	_	_	NN	Protein	[9]	['Theme']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	used	_	_	VBN	O	[-1]	['none']	_	_
13	since	_	_	IN	O	[-1]	['none']	_	_
14	it	_	_	PRP	O	[-1]	['none']	_	_
15	has	_	_	VBZ	O	[-1]	['none']	_	_
16	been	_	_	VBN	O	[-1]	['none']	_	_
17	shown	_	_	VBN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	induce	_	_	VB	O	[-1]	['none']	_	_
20	both	_	_	CC	O	[-1]	['none']	_	_
21	Th1	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	Th2	_	_	NN	O	[-1]	['none']	_	_
24	responses	_	_	NNS	O	[-1]	['none']	_	_
25	[	_	_	VBP	O	[-1]	['none']	_	_
26	28	_	_	CD	O	[-1]	['none']	_	_
27	]-[	_	_	CD	O	[-1]	['none']	_	_
28	30	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Pam3CYS	_	_	NN	Protein	[5]	['Cause']	_	_
2	matured	_	_	VBD	O	[-1]	['none']	_	_
3	WT	_	_	NNP	O	[-1]	['none']	_	_
4	BMDC	_	_	NNP	O	[-1]	['none']	_	_
5	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
6	robust	_	_	JJ	O	[-1]	['none']	_	_
7	IFNgamma	_	_	NN	Protein	[8]	['Theme']	_	_
8	production	_	_	NN	Gene_expression	[5]	['Theme']	_	_
9	at	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	significantly	_	_	RB	O	[-1]	['none']	_	_
12	higher	_	_	JJR	O	[-1]	['none']	_	_
13	level	_	_	NN	O	[-1]	['none']	_	_
14	than	_	_	IN	O	[-1]	['none']	_	_
15	cpdm	_	_	JJ	O	[-1]	['none']	_	_
16	BMDC	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	reduced	_	_	JJ	O	[-1]	['none']	_	_
3	Th1	_	_	NN	O	[-1]	['none']	_	_
4	differentiation	_	_	NN	O	[-1]	['none']	_	_
5	following	_	_	VBG	O	[-1]	['none']	_	_
6	Pam3CYS	_	_	NN	Protein	[0]	['root']	_	_
7	stimulation	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	consistent	_	_	JJ	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	recent	_	_	JJ	O	[-1]	['none']	_	_
13	report	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	decreased	_	_	VBN	O	[-1]	['none']	_	_
16	IL12	_	_	NN	O	[-1]	['none']	_	_
17	production	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	cpdm	_	_	JJ	O	[-1]	['none']	_	_
20	macrophages	_	_	NNS	O	[-1]	['none']	_	_
21	following	_	_	VBG	O	[-1]	['none']	_	_
22	TLR2	_	_	NN	Protein	[0]	['root']	_	_
23	stimulation	_	_	NN	O	[-1]	['none']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	31	_	_	CD	O	[-1]	['none']	_	_
26	]	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	more	_	_	JJR	O	[-1]	['none']	_	_
5	Th2	_	_	NN	O	[-1]	['none']	_	_
6	specific	_	_	JJ	O	[-1]	['none']	_	_
7	IL4	_	_	NN	Protein	[10]	['Theme']	_	_
8	cytokine	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	produced	_	_	VBN	Gene_expression	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	cpdm	_	_	NN	O	[-1]	['none']	_	_
14	BMDC	_	_	NN	O	[-1]	['none']	_	_
15	co-cultures	_	_	NNS	O	[-1]	['none']	_	_
16	than	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	WT	_	_	NNP	O	[-1]	['none']	_	_
19	control	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	suggesting	_	_	VBG	O	[-1]	['none']	_	_
22	Th2	_	_	NN	O	[-1]	['none']	_	_
23	skewed	_	_	JJ	O	[-1]	['none']	_	_
24	immunogenicity	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	cpdm	_	_	NN	O	[-1]	['none']	_	_
27	BMDC	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	production	_	_	NN	Gene_expression	[8]	['Theme']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	Th17	_	_	NN	O	[-1]	['none']	_	_
5	specific	_	_	JJ	O	[-1]	['none']	_	_
6	cytokine	_	_	NN	O	[-1]	['none']	_	_
7	IL17A	_	_	NN	Protein	[2]	['Theme']	_	_
8	following	_	_	VBG	Positive_regulation	[0]	['root']	_	_
9	LPS	_	_	NN	O	[-1]	['none']	_	_
10	stimulation	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	dendritic	_	_	JJ	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	similar	_	_	JJ	O	[-1]	['none']	_	_
16	between	_	_	IN	O	[-1]	['none']	_	_
17	stimulated	_	_	VBN	O	[-1]	['none']	_	_
18	WT	_	_	NNP	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	cpdm	_	_	JJ	O	[-1]	['none']	_	_
21	BMDC	_	_	NN	O	[-1]	['none']	_	_
22	cocultures	_	_	NNS	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	data	_	_	NNS	O	[-1]	['none']	_	_
25	not	_	_	RB	O	[-1]	['none']	_	_
26	shown	_	_	VBN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Despite	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	distinct	_	_	JJ	O	[-1]	['none']	_	_
4	Th1-	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	Th2	_	_	NN	O	[-1]	['none']	_	_
7	stimulating	_	_	NN	O	[-1]	['none']	_	_
8	abilities	_	_	NNS	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	WT	_	_	NNP	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	cpdm	_	_	JJ	O	[-1]	['none']	_	_
13	BMDC	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	they	_	_	PRP	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	equally	_	_	RB	O	[-1]	['none']	_	_
18	effective	_	_	JJ	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	IL2	_	_	NN	Protein	[21]	['Theme']	_	_
21	production	_	_	NN	Gene_expression	[0]	['root']	_	_
22	from	_	_	IN	O	[-1]	['none']	_	_
23	BMDC-T	_	_	JJ	O	[-1]	['none']	_	_
24	cell	_	_	NN	O	[-1]	['none']	_	_
25	co-cultures	_	_	NNS	O	[-1]	['none']	_	_
26	except	_	_	IN	O	[-1]	['none']	_	_
27	for	_	_	IN	O	[-1]	['none']	_	_
28	poly	_	_	NN	O	[-1]	['none']	_	_
29	I	_	_	NN	O	[-1]	['none']	_	_
30	:	_	_	:	O	[-1]	['none']	_	_
31	C	_	_	NN	O	[-1]	['none']	_	_
32	stimulation	_	_	NN	O	[-1]	['none']	_	_
33	where	_	_	WRB	O	[-1]	['none']	_	_
34	WT	_	_	NNP	O	[-1]	['none']	_	_
35	BMDC	_	_	NNP	O	[-1]	['none']	_	_
36	induced	_	_	VBD	Positive_regulation	[37]	['Theme']	_	_
37	more	_	_	RBR	Positive_regulation	[0]	['root']	_	_
38	IL2	_	_	NN	Protein	[36]	['Theme']	_	_
39	than	_	_	IN	O	[-1]	['none']	_	_
40	cpdm	_	_	JJ	O	[-1]	['none']	_	_
41	BMDC	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	Th2	_	_	NN	O	[-1]	['none']	_	_
3	biased	_	_	VBN	O	[-1]	['none']	_	_
4	stimulating	_	_	VBG	O	[-1]	['none']	_	_
5	capability	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	cpdm	_	_	NN	O	[-1]	['none']	_	_
8	BMDC	_	_	NN	O	[-1]	['none']	_	_
9	when	_	_	WRB	O	[-1]	['none']	_	_
10	co-cultured	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	allogeneic	_	_	JJ	O	[-1]	['none']	_	_
13	naive	_	_	JJ	O	[-1]	['none']	_	_
14	CD4+	_	_	JJ	O	[-1]	['none']	_	_
15	T	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	consistent	_	_	JJ	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	Th2	_	_	NN	O	[-1]	['none']	_	_
22	dominant	_	_	JJ	O	[-1]	['none']	_	_
23	cytokine	_	_	NN	O	[-1]	['none']	_	_
24	phenotype	_	_	NN	O	[-1]	['none']	_	_
25	observed	_	_	VBN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	cpdm	_	_	NN	O	[-1]	['none']	_	_
28	mice	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	High	_	_	JJ	O	[-1]	['none']	_	_
2	Antigen	_	_	NN	O	[-1]	['none']	_	_
3	Doses	_	_	NNS	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	STAT4	_	_	NN	Protein	[0]	['root']	_	_
6	Are	_	_	VBP	O	[-1]	['none']	_	_
7	Required	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	In	_	_	NNP	O	[-1]	['none']	_	_
11	Vivo	_	_	NNP	O	[-1]	['none']	_	_
12	Generation	_	_	NNP	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	IL-10-Producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
15	Th1	_	_	NN	O	[-1]	['none']	_	_
16	Cells	_	_	NNS	O	[-1]	['none']	_	_
17	To	_	_	TO	O	[-1]	['none']	_	_
18	address	_	_	VB	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
21	regulating	_	_	VBG	Regulation	[0]	['root']	_	_
22	IL-10	_	_	NN	Protein	[23]	['Theme']	_	_
23	production	_	_	NN	Gene_expression	[21]	['Theme']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	Th1	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	in	_	_	FW	O	[-1]	['none']	_	_
28	vivo	_	_	FW	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	we	_	_	PRP	O	[-1]	['none']	_	_
31	transferred	_	_	VBD	O	[-1]	['none']	_	_
32	DO11	_	_	NN	O	[-1]	['none']	_	_
33	.10	_	_	CD	O	[-1]	['none']	_	_
34	cells	_	_	NNS	O	[-1]	['none']	_	_
35	into	_	_	IN	O	[-1]	['none']	_	_
36	BALB/c	_	_	NN	O	[-1]	['none']	_	_
37	recipient	_	_	JJ	O	[-1]	['none']	_	_
38	mice	_	_	NNS	O	[-1]	['none']	_	_
39	and	_	_	CC	O	[-1]	['none']	_	_
40	immunized	_	_	VBD	O	[-1]	['none']	_	_
41	the	_	_	DT	O	[-1]	['none']	_	_
42	recipients	_	_	NNS	O	[-1]	['none']	_	_
43	with	_	_	IN	O	[-1]	['none']	_	_
44	very	_	_	RB	O	[-1]	['none']	_	_
45	high	_	_	JJ	O	[-1]	['none']	_	_
46	doses	_	_	NNS	O	[-1]	['none']	_	_
47	of	_	_	IN	O	[-1]	['none']	_	_
48	OVA	_	_	NN	Protein	[0]	['root']	_	_
49	protein	_	_	NN	O	[-1]	['none']	_	_
50	with	_	_	IN	O	[-1]	['none']	_	_
51	or	_	_	CC	O	[-1]	['none']	_	_
52	without	_	_	IN	O	[-1]	['none']	_	_
53	added	_	_	VBN	O	[-1]	['none']	_	_
54	lipopolysacharide	_	_	NN	O	[-1]	['none']	_	_
55	(	_	_	-LRB-	O	[-1]	['none']	_	_
56	LPS	_	_	NN	O	[-1]	['none']	_	_
57	)	_	_	-RRB-	O	[-1]	['none']	_	_
58	.	_	_	.	O	[-1]	['none']	_	_

1	T	_	_	NN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	recovered	_	_	VBN	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	inguinal	_	_	JJ	O	[-1]	['none']	_	_
8	lymph	_	_	NN	O	[-1]	['none']	_	_
9	nodes	_	_	NNS	O	[-1]	['none']	_	_
10	3	_	_	CD	O	[-1]	['none']	_	_
11	days	_	_	NNS	O	[-1]	['none']	_	_
12	after	_	_	IN	O	[-1]	['none']	_	_
13	priming	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	restimulated	_	_	VBN	O	[-1]	['none']	_	_
16	in	_	_	FW	O	[-1]	['none']	_	_
17	vitro	_	_	FW	O	[-1]	['none']	_	_
18	with	_	_	IN	O	[-1]	['none']	_	_
19	OVA	_	_	NN	Protein	[0]	['root']	_	_
20	peptide	_	_	NN	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	48	_	_	CD	O	[-1]	['none']	_	_
23	hr	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	in	_	_	FW	O	[-1]	['none']	_	_
3	vivo	_	_	FW	O	[-1]	['none']	_	_
4	immunization	_	_	NN	O	[-1]	['none']	_	_
5	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
6	IL-10	_	_	NN	Protein	[9]	['Theme']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	IFN-gamma	_	_	NN	Protein	[9]	['Theme']	_	_
9	production	_	_	NN	Gene_expression	[5]	['Theme']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	amount	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IL-10	_	_	NN	Protein	[16]	['Theme']	_	_
16	production	_	_	NN	Gene_expression	[18]	['Theme']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	enhanced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	addition	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	LPS	_	_	NN	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	immunization	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	with	_	_	IN	O	[-1]	['none']	_	_
28	higher	_	_	JJR	O	[-1]	['none']	_	_
29	doses	_	_	NNS	O	[-1]	['none']	_	_
30	of	_	_	IN	O	[-1]	['none']	_	_
31	OVA	_	_	NNP	Protein	[18]	['Cause']	_	_
32	(	_	_	-LRB-	O	[-1]	['none']	_	_
33	3	_	_	CD	O	[-1]	['none']	_	_
34	muM	_	_	NN	O	[-1]	['none']	_	_
35	versus	_	_	CC	O	[-1]	['none']	_	_
36	1	_	_	CD	O	[-1]	['none']	_	_
37	muM	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	data	_	_	NNS	O	[-1]	['none']	_	_
40	not	_	_	RB	O	[-1]	['none']	_	_
41	shown	_	_	VBN	O	[-1]	['none']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	test	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	role	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	STAT4	_	_	NN	Protein	[0]	['root']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	STAT6	_	_	NN	Protein	[0]	['root']	_	_
9	signaling	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	in	_	_	FW	O	[-1]	['none']	_	_
13	vivo	_	_	FW	O	[-1]	['none']	_	_
14	development	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
17	Th1	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	we	_	_	PRP	O	[-1]	['none']	_	_
21	transferred	_	_	VBD	O	[-1]	['none']	_	_
22	STAT4-	_	_	NN	Protein	[0]	['root']	_	_
23	or	_	_	CC	O	[-1]	['none']	_	_
24	STAT6	_	_	NN	Protein	[25]	['Theme']	_	_
25	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
26	or	_	_	CC	O	[-1]	['none']	_	_
27	WT	_	_	JJ	O	[-1]	['none']	_	_
28	DO11	_	_	NN	O	[-1]	['none']	_	_
29	.10	_	_	CD	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	into	_	_	IN	O	[-1]	['none']	_	_
32	recipient	_	_	JJ	O	[-1]	['none']	_	_
33	BALB/c	_	_	NN	O	[-1]	['none']	_	_
34	mice	_	_	NNS	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	immunized	_	_	VBN	O	[-1]	['none']	_	_
37	with	_	_	IN	O	[-1]	['none']	_	_
38	OVA	_	_	NN	Protein	[0]	['root']	_	_
39	protein	_	_	NN	O	[-1]	['none']	_	_
40	plus	_	_	CC	O	[-1]	['none']	_	_
41	LPS	_	_	NN	O	[-1]	['none']	_	_
42	as	_	_	IN	O	[-1]	['none']	_	_
43	before	_	_	RB	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vivo	_	_	FW	O	[-1]	['none']	_	_
3	expression	_	_	NN	Gene_expression	[11, 15]	['Theme', 'Theme']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	both	_	_	CC	O	[-1]	['none']	_	_
6	IL-10	_	_	NN	Protein	[3]	['Theme']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	IFN-gamma	_	_	NN	Protein	[3]	['Theme']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	markedly	_	_	RB	O	[-1]	['none']	_	_
11	reduced	_	_	VBN	Negative_regulation	[0]	['root']	_	_
12	but	_	_	CC	O	[-1]	['none']	_	_
13	not	_	_	RB	O	[-1]	['none']	_	_
14	completely	_	_	RB	Negative_regulation	[15]	['multitoken']	_	_
15	abrogated	_	_	VBN	Negative_regulation	[0]	['root']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	absence	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	STAT4	_	_	NN	Protein	[0]	['root']	_	_
21	signaling	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	suggesting	_	_	VBG	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	existence	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	compensatory	_	_	JJ	O	[-1]	['none']	_	_
28	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
29	that	_	_	WDT	O	[-1]	['none']	_	_
30	were	_	_	VBD	O	[-1]	['none']	_	_
31	absent	_	_	JJ	O	[-1]	['none']	_	_
32	in	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	in	_	_	FW	O	[-1]	['none']	_	_
35	vitro	_	_	FW	O	[-1]	['none']	_	_
36	system	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Signaling	_	_	NN	O	[-1]	['none']	_	_
2	through	_	_	IN	O	[-1]	['none']	_	_
3	STAT6	_	_	NN	Protein	[0]	['root']	_	_
4	had	_	_	VBD	O	[-1]	['none']	_	_
5	no	_	_	DT	O	[-1]	['none']	_	_
6	effect	_	_	NN	Regulation	[0]	['root']	_	_
7	on	_	_	IN	O	[-1]	['none']	_	_
8	IL-10	_	_	NN	Protein	[9]	['Theme']	_	_
9	production	_	_	NN	Gene_expression	[6]	['Theme']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	Th1	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	shown	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	intracellular	_	_	JJ	O	[-1]	['none']	_	_
17	cytokine	_	_	NN	O	[-1]	['none']	_	_
18	staining	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	ICS	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	immunoassay	_	_	NN	O	[-1]	['none']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	STAT6	_	_	NN	Protein	[27]	['Theme']	_	_
27	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
28	T	_	_	NN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	IKK	_	_	NN	O	[-1]	['none']	_	_
2	recruitment	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	CD40	_	_	NN	O	[-1]	['none']	_	_
6	signaling	_	_	NN	O	[-1]	['none']	_	_
7	complex	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	defective	_	_	JJ	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	HOIP	_	_	NN	Protein	[12]	['Theme']	_	_
12	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	SMAC	_	_	NN	O	[-1]	['none']	_	_
5	peptide	_	_	NN	O	[-1]	['none']	_	_
6	treatment	_	_	NN	O	[-1]	['none']	_	_
7	reduces	_	_	VBZ	Negative_regulation	[0]	['root']	_	_
8	recruitment	_	_	NN	Binding	[7]	['Theme']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	cIAP1	_	_	NN	Protein	[8]	['Theme']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	CD40	_	_	NN	Protein	[8]	['Theme']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	may	_	_	MD	O	[-1]	['none']	_	_
15	modify	_	_	VB	Regulation	[0]	['root']	_	_
16	HOIP	_	_	NNP	Protein	[17]	['Theme']	_	_
17	recruitment	_	_	NN	Binding	[15]	['Theme']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	A20	_	_	NN	O	[-1]	['none']	_	_
2	.2	_	_	NN	O	[-1]	['none']	_	_
3	J	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	incubated	_	_	VBN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	six	_	_	CD	O	[-1]	['none']	_	_
9	hours	_	_	NNS	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	membrane-permeable	_	_	JJ	O	[-1]	['none']	_	_
12	SMAC-N7	_	_	NN	O	[-1]	['none']	_	_
13	peptide	_	_	NN	O	[-1]	['none']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	1.5	_	_	CD	O	[-1]	['none']	_	_
16	%	_	_	NN	O	[-1]	['none']	_	_
17	DMSO	_	_	NN	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	solvent	_	_	JJ	O	[-1]	['none']	_	_
20	used	_	_	VBN	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	peptide	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Following	_	_	VBG	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	incubation	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	lysates	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	prepared	_	_	VBN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	fractionated	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	evaluated	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	Western	_	_	NN	O	[-1]	['none']	_	_
18	blot	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	lanes	_	_	NNS	O	[-1]	['none']	_	_
21	1	_	_	CD	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	2	_	_	CD	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	incubated	_	_	VBN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	DMSO	_	_	NN	O	[-1]	['none']	_	_
5	or	_	_	CC	O	[-1]	['none']	_	_
6	SMAC-N7	_	_	NN	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	also	_	_	RB	O	[-1]	['none']	_	_
9	stimulated	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	magnetic	_	_	JJ	O	[-1]	['none']	_	_
12	beads	_	_	NNS	O	[-1]	['none']	_	_
13	coated	_	_	VBN	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	anti-CD40	_	_	NN	O	[-1]	['none']	_	_
16	or	_	_	CC	O	[-1]	['none']	_	_
17	an	_	_	DT	O	[-1]	['none']	_	_
18	isotype	_	_	NN	O	[-1]	['none']	_	_
19	control	_	_	NN	O	[-1]	['none']	_	_
20	antibody	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	IP	_	_	NNP	O	[-1]	['none']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	material	_	_	NN	O	[-1]	['none']	_	_
6	bound	_	_	VBD	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	beads	_	_	NNS	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	loaded	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	lanes	_	_	NNS	O	[-1]	['none']	_	_
14	3-5	_	_	CD	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Samples	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	cell	_	_	NN	O	[-1]	['none']	_	_
5	lysates	_	_	NNS	O	[-1]	['none']	_	_
6	after	_	_	IN	O	[-1]	['none']	_	_
7	immunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
8	appear	_	_	VBP	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	lanes	_	_	NNS	O	[-1]	['none']	_	_
11	6-8	_	_	CD	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	NN	O	[-1]	['none']	_	_
2	blots	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	probed	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	antibodies	_	_	NNS	O	[-1]	['none']	_	_
7	specific	_	_	JJ	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	cIAP1	_	_	NN	Protein	[0]	['root']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	TRAF3	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	approximate	_	_	JJ	O	[-1]	['none']	_	_
19	molecular	_	_	JJ	O	[-1]	['none']	_	_
20	weights	_	_	NNS	O	[-1]	['none']	_	_
21	indicated	_	_	VBD	O	[-1]	['none']	_	_
22	on	_	_	IN	O	[-1]	['none']	_	_
23	left	_	_	JJ	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	obtained	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	two	_	_	CD	O	[-1]	['none']	_	_
7	additional	_	_	JJ	O	[-1]	['none']	_	_
8	experiments	_	_	NNS	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	CD40	_	_	NN	Protein	[0]	['root']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	isolated	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	immunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	as	_	_	IN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	A	_	_	DT	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	from	_	_	IN	O	[-1]	['none']	_	_
17	A20	_	_	NN	O	[-1]	['none']	_	_
18	.2	_	_	NN	O	[-1]	['none']	_	_
19	J	_	_	NN	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	HOIP	_	_	NN	Protein	[23]	['Theme']	_	_
23	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	transduced	_	_	VBN	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	an	_	_	DT	O	[-1]	['none']	_	_
28	empty	_	_	JJ	O	[-1]	['none']	_	_
29	retroviral	_	_	JJ	O	[-1]	['none']	_	_
30	vector	_	_	NN	O	[-1]	['none']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	pMIP	_	_	NN	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	or	_	_	CC	O	[-1]	['none']	_	_
35	a	_	_	DT	O	[-1]	['none']	_	_
36	retroviral	_	_	JJ	O	[-1]	['none']	_	_
37	vector	_	_	NN	O	[-1]	['none']	_	_
38	encoding	_	_	VBG	O	[-1]	['none']	_	_
39	HOIP	_	_	NN	Protein	[0]	['root']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Material	_	_	NN	O	[-1]	['none']	_	_
2	immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	an	_	_	DT	O	[-1]	['none']	_	_
5	isotype	_	_	NN	O	[-1]	['none']	_	_
6	control	_	_	NN	O	[-1]	['none']	_	_
7	antibody	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	isotype	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	anti-CD40	_	_	JJ	O	[-1]	['none']	_	_
13	antibody	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	examined	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	Western	_	_	NN	O	[-1]	['none']	_	_
18	blotting	_	_	NN	O	[-1]	['none']	_	_
19	for	_	_	IN	O	[-1]	['none']	_	_
20	CD40	_	_	NN	Protein	[0]	['root']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	TRAF3	_	_	NN	Protein	[0]	['root']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	cIAP1	_	_	NN	Protein	[0]	['root']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	HOIP	_	_	NN	Protein	[0]	['root']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	IKKalpha	_	_	NN	Protein	[0]	['root']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	beta	_	_	NN	Protein	[0]	['root']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	right	_	_	JJ	O	[-1]	['none']	_	_
38	panels	_	_	NNS	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	HOIP	_	_	NN	Protein	[2]	['Theme']	_	_
2	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	required	_	_	VBN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	coprecipitation	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	IKK	_	_	NN	O	[-1]	['none']	_	_
9	proteins	_	_	NNS	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	CD40	_	_	NN	Protein	[0]	['root']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	lysates	_	_	NNS	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	unstimulated	_	_	JJ	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	are	_	_	VBP	O	[-1]	['none']	_	_
7	shown	_	_	VBN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	left	_	_	JJ	O	[-1]	['none']	_	_
11	panels	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	obtained	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	second	_	_	JJ	O	[-1]	['none']	_	_
8	experiment	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	two	_	_	CD	O	[-1]	['none']	_	_
12	experiments	_	_	NNS	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	second	_	_	JJ	O	[-1]	['none']	_	_
16	HOIP	_	_	NN	Protein	[17]	['Theme']	_	_
17	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
18	clone	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	To	_	_	TO	O	[-1]	['none']	_	_
5	further	_	_	RB	O	[-1]	['none']	_	_
6	evaluate	_	_	VB	O	[-1]	['none']	_	_
7	HOIP	_	_	NN	Protein	[8]	['Cause']	_	_
8	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
9	recruitment	_	_	NN	Binding	[8]	['Theme']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	IKKgamma	_	_	NN	Protein	[9]	['Theme']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	CD40	_	_	NN	Protein	[9]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	A20	_	_	NN	O	[-1]	['none']	_	_
16	.2	_	_	NN	O	[-1]	['none']	_	_
17	J	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	HOIP	_	_	NN	Protein	[21]	['Theme']	_	_
21	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	HOIP-/-)	_	_	NN	Protein	[0]	['root']	_	_
24	A20	_	_	NN	O	[-1]	['none']	_	_
25	.2	_	_	NN	O	[-1]	['none']	_	_
26	J	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	were	_	_	VBD	O	[-1]	['none']	_	_
29	transduced	_	_	VBN	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	an	_	_	DT	O	[-1]	['none']	_	_
32	empty	_	_	JJ	O	[-1]	['none']	_	_
33	retroviral	_	_	JJ	O	[-1]	['none']	_	_
34	vector	_	_	NN	O	[-1]	['none']	_	_
35	or	_	_	CC	O	[-1]	['none']	_	_
36	a	_	_	DT	O	[-1]	['none']	_	_
37	retroviral	_	_	JJ	O	[-1]	['none']	_	_
38	construct	_	_	NN	O	[-1]	['none']	_	_
39	encoding	_	_	VBG	O	[-1]	['none']	_	_
40	BP	_	_	NN	O	[-1]	['none']	_	_
41	epitope	_	_	NN	O	[-1]	['none']	_	_
42	tagged	_	_	VBD	O	[-1]	['none']	_	_
43	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
44	(	_	_	-LRB-	O	[-1]	['none']	_	_
45	noted	_	_	VBN	O	[-1]	['none']	_	_
46	in	_	_	IN	O	[-1]	['none']	_	_
47	the	_	_	DT	O	[-1]	['none']	_	_
48	figure	_	_	NN	O	[-1]	['none']	_	_
49	as	_	_	IN	O	[-1]	['none']	_	_
50	pMIP	_	_	NN	Protein	[0]	['root']	_	_
51	and	_	_	CC	O	[-1]	['none']	_	_
52	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
53	,	_	_	,	O	[-1]	['none']	_	_
54	respectively	_	_	RB	O	[-1]	['none']	_	_
55	)	_	_	-RRB-	O	[-1]	['none']	_	_
56	.	_	_	.	O	[-1]	['none']	_	_

1	Lysates	_	_	NNS	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	lanes	_	_	NNS	O	[-1]	['none']	_	_
4	1-3	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	immunoprecipitation	_	_	NN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	IP	_	_	NNP	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	samples	_	_	NNS	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	lanes	_	_	NNS	O	[-1]	['none']	_	_
14	4-11	_	_	CD	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	from	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	cell	_	_	NN	O	[-1]	['none']	_	_
19	lines	_	_	NNS	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	fractionated	_	_	VBN	O	[-1]	['none']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	SDS-PAGE	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	evaluated	_	_	VBN	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	Western	_	_	NN	O	[-1]	['none']	_	_
28	blotting	_	_	NN	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	antibodies	_	_	NNS	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	BP	_	_	NNP	O	[-1]	['none']	_	_
34	tag	_	_	NN	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	IKKgamma	_	_	NN	Protein	[0]	['root']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	upper	_	_	JJ	O	[-1]	['none']	_	_
39	panel	_	_	NN	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	TRAF2	_	_	NN	Protein	[0]	['root']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	anti-CD40	_	_	JJ	O	[-1]	['none']	_	_
3	IP	_	_	NNP	O	[-1]	['none']	_	_
4	sample	_	_	NN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	lane	_	_	NN	O	[-1]	['none']	_	_
7	11	_	_	CD	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	treated	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	lambda	_	_	NN	O	[-1]	['none']	_	_
12	phosphatase	_	_	NN	O	[-1]	['none']	_	_
13	;	_	_	:	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	sample	_	_	NN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	lane	_	_	NN	O	[-1]	['none']	_	_
18	10	_	_	CD	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	mock	_	_	JJ	O	[-1]	['none']	_	_
21	treated	_	_	VBN	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Protein	_	_	NN	O	[-1]	['none']	_	_
2	samples	_	_	NNS	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	minus	_	_	CC	O	[-1]	['none']	_	_
5	those	_	_	DT	O	[-1]	['none']	_	_
6	treated	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	phosphatase	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	also	_	_	RB	O	[-1]	['none']	_	_
12	fractionated	_	_	VBN	O	[-1]	['none']	_	_
13	on	_	_	IN	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	separate	_	_	JJ	O	[-1]	['none']	_	_
16	gel	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	lower	_	_	JJR	O	[-1]	['none']	_	_
19	acrylamide	_	_	NN	O	[-1]	['none']	_	_
20	concentration	_	_	NN	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	evaluation	_	_	NN	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	TRAF3	_	_	NN	Protein	[0]	['root']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	HOIP	_	_	NN	Protein	[0]	['root']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	bottom	_	_	JJ	O	[-1]	['none']	_	_
31	two	_	_	CD	O	[-1]	['none']	_	_
32	panels	_	_	NNS	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	obtained	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	two	_	_	CD	O	[-1]	['none']	_	_
7	additional	_	_	JJ	O	[-1]	['none']	_	_
8	experiments	_	_	NNS	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[2, 6]	['Cause', 'Cause']	_	_
2	Upregulates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
3	IL10	_	_	NN	Protein	[2]	['Theme']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	Constitutively	_	_	RB	O	[-1]	['none']	_	_
6	Activates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
7	Stat3	_	_	NN	Protein	[6]	['Theme']	_	_
8	To	_	_	TO	O	[-1]	['none']	_	_
9	identify	_	_	VB	O	[-1]	['none']	_	_
10	cytokines	_	_	NNS	O	[-1]	['none']	_	_
11	that	_	_	WDT	O	[-1]	['none']	_	_
12	may	_	_	MD	O	[-1]	['none']	_	_
13	contribute	_	_	VB	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	increased	_	_	JJ	O	[-1]	['none']	_	_
17	survival	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	growth	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	expression	_	_	NN	O	[-1]	['none']	_	_
25	levels	_	_	NNS	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	a	_	_	DT	O	[-1]	['none']	_	_
28	panel	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	cytokines	_	_	NNS	O	[-1]	['none']	_	_
31	were	_	_	VBD	O	[-1]	['none']	_	_
32	screened	_	_	VBN	O	[-1]	['none']	_	_
33	on	_	_	IN	O	[-1]	['none']	_	_
34	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
35	MACS	_	_	NNS	O	[-1]	['none']	_	_
36	purified	_	_	VBN	O	[-1]	['none']	_	_
37	B	_	_	NN	O	[-1]	['none']	_	_
38	cells	_	_	NNS	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	using	_	_	VBG	O	[-1]	['none']	_	_
41	an	_	_	DT	O	[-1]	['none']	_	_
42	RPA	_	_	NN	O	[-1]	['none']	_	_
43	probe	_	_	NN	O	[-1]	['none']	_	_
44	set	_	_	VBN	O	[-1]	['none']	_	_
45	for	_	_	IN	O	[-1]	['none']	_	_
46	IL4	_	_	NN	Protein	[0]	['root']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	IL5	_	_	NN	Protein	[0]	['root']	_	_
49	,	_	_	,	O	[-1]	['none']	_	_
50	IL10	_	_	NN	Protein	[0]	['root']	_	_
51	,	_	_	,	O	[-1]	['none']	_	_
52	IL13	_	_	NN	Protein	[0]	['root']	_	_
53	,	_	_	,	O	[-1]	['none']	_	_
54	IL15	_	_	NN	Protein	[0]	['root']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	IL9	_	_	NN	Protein	[0]	['root']	_	_
57	,	_	_	,	O	[-1]	['none']	_	_
58	IL2	_	_	NN	Protein	[0]	['root']	_	_
59	,	_	_	,	O	[-1]	['none']	_	_
60	IL6	_	_	NN	Protein	[0]	['root']	_	_
61	,	_	_	,	O	[-1]	['none']	_	_
62	and	_	_	CC	O	[-1]	['none']	_	_
63	IFNgamma	_	_	NN	Protein	[0]	['root']	_	_
64	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	O	[-1]	['none']	_	_
2	levels	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	quantified	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	phosphorimager	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	normalized	_	_	VBD	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	ribosomal	_	_	JJ	O	[-1]	['none']	_	_
13	housekeeping	_	_	NN	O	[-1]	['none']	_	_
14	gene	_	_	NN	O	[-1]	['none']	_	_
15	L32	_	_	NN	Protein	[0]	['root']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	None	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	Anaphora	[5]	['multitoken']	_	_
4	tested	_	_	JJ	Anaphora	[5]	['multitoken']	_	_
5	cytokines	_	_	NNS	Anaphora	[0]	['root']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	detected	_	_	VBN	Gene_expression	[0]	['root']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	wild-type	_	_	JJ	O	[-1]	['none']	_	_
10	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	therefore	_	_	RB	O	[-1]	['none']	_	_
13	cytokine	_	_	NN	O	[-1]	['none']	_	_
14	:	_	_	:	O	[-1]	['none']	_	_
15	L32	_	_	NN	Protein	[0]	['root']	_	_
16	ratios	_	_	NNS	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	set	_	_	VBN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	1	_	_	CD	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	mouse	_	_	NN	O	[-1]	['none']	_	_
24	B	_	_	NN	O	[-1]	['none']	_	_
25	cell	_	_	NN	O	[-1]	['none']	_	_
26	lymphoma	_	_	NN	O	[-1]	['none']	_	_
27	line	_	_	NN	O	[-1]	['none']	_	_
28	967	_	_	CD	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Transcription	_	_	NN	Transcription	[21]	['Theme']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	IL10	_	_	NN	Protein	[1]	['Theme']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	IL15	_	_	NN	Protein	[1]	['Theme']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	IFNgamma	_	_	NN	Protein	[1]	['Theme']	_	_
9	were	_	_	VBD	O	[-1]	['none']	_	_
10	reproducibly	_	_	RB	O	[-1]	['none']	_	_
11	detected	_	_	VBN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	LMP1	_	_	NN	Protein	[0]	['root']	_	_
14	transgenic	_	_	JJ	O	[-1]	['none']	_	_
15	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	lymphoma	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	was	_	_	VBD	O	[-1]	['none']	_	_
21	higher	_	_	JJR	Positive_regulation	[0]	['root']	_	_
22	than	_	_	IN	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	B	_	_	NN	O	[-1]	['none']	_	_
26	cell	_	_	NN	O	[-1]	['none']	_	_
27	lymphoma	_	_	NN	O	[-1]	['none']	_	_
28	cell	_	_	NN	O	[-1]	['none']	_	_
29	lines	_	_	NNS	O	[-1]	['none']	_	_
30	967	_	_	CD	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	K46mu	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	There	_	_	EX	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	no	_	_	DT	O	[-1]	['none']	_	_
4	significant	_	_	JJ	O	[-1]	['none']	_	_
5	difference	_	_	NN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	IL15	_	_	NN	Protein	[8]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	IFNgamma	_	_	NN	Protein	[8]	['Theme']	_	_
13	between	_	_	IN	O	[-1]	['none']	_	_
14	LMP1	_	_	NN	Protein	[0]	['root']	_	_
15	transgenic	_	_	JJ	O	[-1]	['none']	_	_
16	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	lymphoma	_	_	NN	Protein	[19]	['multitoken']	_	_
19	cells	_	_	NNS	Protein	[0]	['root']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	suggesting	_	_	VBG	O	[-1]	['none']	_	_
22	that	_	_	IN	O	[-1]	['none']	_	_
23	upregulation	_	_	NN	Positive_regulation	[29]	['Theme']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	IL15	_	_	NN	Protein	[23]	['Theme']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	IFNgamma	_	_	NN	Protein	[23]	['Theme']	_	_
28	is	_	_	VBZ	O	[-1]	['none']	_	_
29	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
30	by	_	_	IN	O	[-1]	['none']	_	_
31	LMP1	_	_	NN	Protein	[32]	['Theme']	_	_
32	expression	_	_	NN	Gene_expression	[29]	['Cause']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	healthy	_	_	JJ	O	[-1]	['none']	_	_
35	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
36	but	_	_	CC	O	[-1]	['none']	_	_
37	is	_	_	VBZ	O	[-1]	['none']	_	_
38	not	_	_	RB	O	[-1]	['none']	_	_
39	a	_	_	DT	O	[-1]	['none']	_	_
40	unique	_	_	JJ	O	[-1]	['none']	_	_
41	property	_	_	NN	O	[-1]	['none']	_	_
42	of	_	_	IN	O	[-1]	['none']	_	_
43	malignant	_	_	JJ	O	[-1]	['none']	_	_
44	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	Strikingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL10	_	_	NN	Protein	[12]	['Theme']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	B	_	_	NN	O	[-1]	['none']	_	_
7	lymphocyte	_	_	NN	O	[-1]	['none']	_	_
8	stimulatory	_	_	JJ	O	[-1]	['none']	_	_
9	cytokine	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
13	1.5-	_	_	CD	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	5-fold	_	_	RB	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	wild-type	_	_	JJ	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	LMP1	_	_	NN	Protein	[0]	['root']	_	_
21	transgenic	_	_	JJ	O	[-1]	['none']	_	_
22	lymphoma	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	compared	_	_	VBN	O	[-1]	['none']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	LMP1	_	_	NN	Protein	[0]	['root']	_	_
27	transgenic	_	_	JJ	O	[-1]	['none']	_	_
28	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	Production	_	_	NN	Gene_expression	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	IL15	_	_	NN	Protein	[1]	['Theme']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	IFNgamma	_	_	NN	Protein	[1]	['Theme']	_	_
6	has	_	_	VBZ	O	[-1]	['none']	_	_
7	been	_	_	VBN	O	[-1]	['none']	_	_
8	associated	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	induction	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	cytotoxic	_	_	JJ	O	[-1]	['none']	_	_
13	effector	_	_	NN	O	[-1]	['none']	_	_
14	responses	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	latently	_	_	RB	O	[-1]	['none']	_	_
18	infected	_	_	VBN	O	[-1]	['none']	_	_
19	with	_	_	IN	O	[-1]	['none']	_	_
20	EBV	_	_	NN	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	33,34	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	transformation	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	growth	_	_	NN	O	[-1]	['none']	_	_
6	properties	_	_	NNS	O	[-1]	['none']	_	_
7	induced	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	EBV	_	_	NN	O	[-1]	['none']	_	_
10	are	_	_	VBP	O	[-1]	['none']	_	_
11	associated	_	_	VBN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	upregulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IL10	_	_	NN	Protein	[14]	['Theme']	_	_
17	[	_	_	CD	O	[-1]	['none']	_	_
18	35-38	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	NN	O	[-1]	['none']	_	_
20	;	_	_	:	O	[-1]	['none']	_	_
21	hence	_	_	RB	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	effects	_	_	NNS	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	IL10	_	_	NN	Protein	[27]	['Theme']	_	_
27	upregulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
28	on	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	growth	_	_	NN	O	[-1]	['none']	_	_
31	properties	_	_	NNS	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	lymphoma	_	_	NN	O	[-1]	['none']	_	_
35	cells	_	_	NNS	O	[-1]	['none']	_	_
36	were	_	_	VBD	O	[-1]	['none']	_	_
37	further	_	_	RB	O	[-1]	['none']	_	_
38	examined	_	_	VBN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Immunoblot	_	_	NN	O	[-1]	['none']	_	_
2	analysis	_	_	NN	O	[-1]	['none']	_	_
3	indicated	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[0]	['root']	_	_
6	transgenic	_	_	JJ	O	[-1]	['none']	_	_
7	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	wild-type	_	_	JJ	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	LMP1	_	_	NN	Protein	[0]	['root']	_	_
12	transgenic	_	_	JJ	O	[-1]	['none']	_	_
13	lymphoma	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	had	_	_	VBD	O	[-1]	['none']	_	_
16	corresponding	_	_	JJ	O	[-1]	['none']	_	_
17	increased	_	_	VBN	Positive_regulation	[0]	['root']	_	_
18	levels	_	_	NNS	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	phosphorylated	_	_	VBN	Phosphorylation	[17]	['Theme']	_	_
21	alpha	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	beta	_	_	NN	O	[-1]	['none']	_	_
24	isoforms	_	_	NNS	O	[-1]	['none']	_	_
25	of	_	_	IN	O	[-1]	['none']	_	_
26	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
27	Stat3	_	_	NN	Protein	[20, 26, 30]	['Theme', 'Theme', 'Theme']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	a	_	_	DT	O	[-1]	['none']	_	_
30	target	_	_	NN	Regulation	[0]	['root']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	IL10	_	_	NN	Protein	[0]	['root']	_	_
34	receptor	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	when	_	_	WRB	O	[-1]	['none']	_	_
4	comparing	_	_	VBG	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	same	_	_	JJ	O	[-1]	['none']	_	_
7	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	there	_	_	EX	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	no	_	_	DT	O	[-1]	['none']	_	_
12	correlation	_	_	NN	Regulation	[0]	['root']	_	_
13	between	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	levels	_	_	NNS	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	IL10	_	_	NN	Protein	[18]	['Theme']	_	_
18	induction	_	_	NN	Positive_regulation	[12]	['Cause']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	levels	_	_	NNS	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	Stat3	_	_	NN	Protein	[24]	['Theme']	_	_
24	activation	_	_	NN	Positive_regulation	[12]	['Theme']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	suggests	_	_	VBZ	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	activation	_	_	NN	Positive_regulation	[11]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	Stat3	_	_	NN	Protein	[5]	['Theme']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	not	_	_	RB	O	[-1]	['none']	_	_
10	solely	_	_	RB	O	[-1]	['none']	_	_
11	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	IL10	_	_	NN	Protein	[11]	['Cause']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	that	_	_	IN	O	[-1]	['none']	_	_
16	Stat3	_	_	NN	Protein	[0]	['root']	_	_
17	activation	_	_	NN	O	[-1]	['none']	_	_
18	may	_	_	MD	O	[-1]	['none']	_	_
19	be	_	_	VB	O	[-1]	['none']	_	_
20	constitutive	_	_	JJ	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Additionally	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	there	_	_	EX	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	no	_	_	DT	O	[-1]	['none']	_	_
6	correlation	_	_	NN	Regulation	[0]	['root']	_	_
7	between	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	levels	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	LMP1	_	_	NN	Protein	[12]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[6]	['Cause']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	levels	_	_	NNS	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	IL10	_	_	NN	Protein	[18]	['Theme']	_	_
18	induction	_	_	NN	Positive_regulation	[6]	['Theme']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	indicates	_	_	VBZ	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	induction	_	_	NN	Positive_regulation	[21]	['Theme']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IL10	_	_	NN	Protein	[5]	['Theme']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	general	_	_	JJ	O	[-1]	['none']	_	_
11	property	_	_	NN	O	[-1]	['none']	_	_
12	associated	_	_	VBN	O	[-1]	['none']	_	_
13	with	_	_	IN	O	[-1]	['none']	_	_
14	enhanced	_	_	VBN	O	[-1]	['none']	_	_
15	survival	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	may	_	_	MD	O	[-1]	['none']	_	_
18	only	_	_	RB	O	[-1]	['none']	_	_
19	be	_	_	VB	O	[-1]	['none']	_	_
20	indirectly	_	_	RB	O	[-1]	['none']	_	_
21	affected	_	_	VBN	Regulation	[0]	['root']	_	_
22	by	_	_	IN	O	[-1]	['none']	_	_
23	LMP1	_	_	NN	Protein	[21]	['Cause']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Neutralizing	_	_	VBG	Negative_regulation	[0]	['root']	_	_
2	antibodies	_	_	NNS	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	IL10	_	_	NN	Protein	[1]	['Theme']	_	_
5	did	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	affect	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	survival	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	lymphoma	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	determined	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	the	_	_	DT	O	[-1]	['none']	_	_
17	MTS	_	_	NNP	O	[-1]	['none']	_	_
18	assay	_	_	NN	O	[-1]	['none']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	unpublished	_	_	JJ	O	[-1]	['none']	_	_
21	data	_	_	NNS	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	suggesting	_	_	VBG	O	[-1]	['none']	_	_
25	constitutive	_	_	JJ	O	[-1]	['none']	_	_
26	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	Stat3	_	_	NN	Protein	[26]	['Theme']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	confirmed	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	immunoblot	_	_	NN	O	[-1]	['none']	_	_
6	analysis	_	_	NN	O	[-1]	['none']	_	_
7	such	_	_	JJ	O	[-1]	['none']	_	_
8	that	_	_	IN	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	presence	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	anti-IL10	_	_	JJ	Protein	[0]	['root']	_	_
14	neutralizing	_	_	VBG	O	[-1]	['none']	_	_
15	antibodies	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	pStat3	_	_	NN	Protein	[20]	['Theme']	_	_
18	levels	_	_	NNS	O	[-1]	['none']	_	_
19	remained	_	_	VBD	O	[-1]	['none']	_	_
20	activated	_	_	VBN	Positive_regulation	[0]	['root']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	lymphoma	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	isolated	_	_	VBN	O	[-1]	['none']	_	_
25	from	_	_	IN	O	[-1]	['none']	_	_
26	wild-type	_	_	JJ	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	LMP1	_	_	NN	Protein	[0]	['root']	_	_
29	transgenic	_	_	JJ	O	[-1]	['none']	_	_
30	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Exogenous	_	_	JJ	O	[-1]	['none']	_	_
2	addition	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	IL10	_	_	NN	Protein	[5]	['Cause']	_	_
5	enhanced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
6	pStat3	_	_	NN	Protein	[7]	['Theme']	_	_
7	activation	_	_	NN	Positive_regulation	[5]	['Theme']	_	_
8	above	_	_	IN	O	[-1]	['none']	_	_
9	constitutive	_	_	JJ	O	[-1]	['none']	_	_
10	levels	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	indicating	_	_	VBG	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	lymphoma	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	are	_	_	VBP	O	[-1]	['none']	_	_
17	responsive	_	_	JJ	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	IL10	_	_	NN	Protein	[0]	['root']	_	_
20	treatment	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	means	_	_	VBZ	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	although	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	lymphoma	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	have	_	_	VBP	O	[-1]	['none']	_	_
9	constitutive	_	_	JJ	O	[-1]	['none']	_	_
10	Stat3	_	_	NN	Protein	[11]	['Theme']	_	_
11	activation	_	_	NN	Positive_regulation	[17]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	it	_	_	PRP	Anaphora	[0]	['root']	_	_
14	may	_	_	MD	O	[-1]	['none']	_	_
15	be	_	_	VB	O	[-1]	['none']	_	_
16	further	_	_	RB	O	[-1]	['none']	_	_
17	enhanced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	IL10	_	_	NN	Protein	[0]	['root']	_	_
20	induction	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	neutralizing	_	_	VBG	Negative_regulation	[3]	['multitoken']	_	_
3	effect	_	_	NN	Negative_regulation	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	anti-IL10	_	_	JJ	Protein	[3]	['Theme']	_	_
7	antibody	_	_	NN	O	[-1]	['none']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	confirmed	_	_	VBN	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	pre-incubation	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	IL10	_	_	NN	Protein	[0]	['root']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	anti-IL10	_	_	JJ	Protein	[0]	['root']	_	_
16	antibody	_	_	NN	O	[-1]	['none']	_	_
17	compared	_	_	VBN	O	[-1]	['none']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	rat	_	_	NN	O	[-1]	['none']	_	_
21	IgG1	_	_	NN	O	[-1]	['none']	_	_
22	isotype	_	_	NN	O	[-1]	['none']	_	_
23	control	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Nuclear	_	_	JJ	Entity	[2]	['ToLoc']	_	_
2	translocation	_	_	NN	Localization	[7]	['Theme']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	pStat3	_	_	NN	Protein	[2, 9]	['Theme', 'Theme']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	consequence	_	_	NN	Positive_regulation	[0]	['root']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	activation	_	_	NN	Positive_regulation	[7]	['Cause']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	nuclear	_	_	JJ	Entity	[16]	['ToLoc']	_	_
13	pStat3	_	_	NN	Protein	[16]	['Theme']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	not	_	_	RB	O	[-1]	['none']	_	_
16	detected	_	_	VBN	Localization	[0]	['root']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	immunohistochemistry	_	_	NN	O	[-1]	['none']	_	_
19	staining	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	spleen	_	_	NN	O	[-1]	['none']	_	_
22	sections	_	_	NNS	O	[-1]	['none']	_	_
23	from	_	_	IN	O	[-1]	['none']	_	_
24	control	_	_	NN	O	[-1]	['none']	_	_
25	mice	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	nuclear	_	_	JJ	Entity	[6, 16]	['ToLoc', 'ToLoc']	_	_
4	pStat3	_	_	NN	Protein	[6, 16]	['Theme', 'Theme']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	detectable	_	_	JJ	Localization	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	LMP1	_	_	NN	Protein	[0]	['root']	_	_
9	transgenic	_	_	JJ	O	[-1]	['none']	_	_
10	mice	_	_	NNS	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	wild-type	_	_	JJ	O	[-1]	['none']	_	_
13	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	was	_	_	VBD	O	[-1]	['none']	_	_
16	detected	_	_	VBN	Localization	[0]	['root']	_	_
17	more	_	_	RBR	O	[-1]	['none']	_	_
18	homogeneously	_	_	RB	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	LMP1	_	_	NN	Protein	[0]	['root']	_	_
21	transgenic	_	_	JJ	O	[-1]	['none']	_	_
22	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	constitutive	_	_	JJ	O	[-1]	['none']	_	_
3	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	pStat3	_	_	NN	Protein	[3]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	abundant	_	_	JJ	O	[-1]	['none']	_	_
8	nuclear	_	_	JJ	O	[-1]	['none']	_	_
9	Stat3	_	_	NN	Protein	[3]	['Theme']	_	_
10	suggests	_	_	VBZ	O	[-1]	['none']	_	_
11	that	_	_	IN	O	[-1]	['none']	_	_
12	Stat3	_	_	NN	Protein	[0]	['root']	_	_
13	signaling	_	_	NN	O	[-1]	['none']	_	_
14	contributes	_	_	VBZ	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	LMP1	_	_	NN	Protein	[0]	['root']	_	_
17	mediated	_	_	VBD	O	[-1]	['none']	_	_
18	lymphoma	_	_	NN	O	[-1]	['none']	_	_
19	development	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Isolation	_	_	NN	O	[-1]	['none']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	growth	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	B	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Splenocytes	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	prepared	_	_	VBN	O	[-1]	['none']	_	_
4	by	_	_	IN	O	[-1]	['none']	_	_
5	homogenizing	_	_	VBG	O	[-1]	['none']	_	_
6	spleen	_	_	NN	O	[-1]	['none']	_	_
7	tissue	_	_	NN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	two	_	_	CD	O	[-1]	['none']	_	_
10	frosted	_	_	JJ	O	[-1]	['none']	_	_
11	slides	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	debris	_	_	NN	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	filtered	_	_	VBN	O	[-1]	['none']	_	_
16	through	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	100-mum	_	_	JJ	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	strainer	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Erythrocytes	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	lysed	_	_	VBN	O	[-1]	['none']	_	_
4	using	_	_	VBG	O	[-1]	['none']	_	_
5	0.8	_	_	CD	O	[-1]	['none']	_	_
6	%	_	_	NN	O	[-1]	['none']	_	_
7	ammonium	_	_	NN	O	[-1]	['none']	_	_
8	chloride	_	_	NN	O	[-1]	['none']	_	_
9	solution	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	StemCell	_	_	NNP	O	[-1]	['none']	_	_
12	Technologies	_	_	NNPS	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	10	_	_	CD	O	[-1]	['none']	_	_
16	min	_	_	NN	O	[-1]	['none']	_	_
17	on	_	_	IN	O	[-1]	['none']	_	_
18	ice	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	washed	_	_	VBN	O	[-1]	['none']	_	_
21	twice	_	_	RB	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	PBS	_	_	NNP	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	B	_	_	NN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	isolated	_	_	VBN	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	CD19-MACS	_	_	JJ	Protein	[0]	['root']	_	_
7	beads	_	_	NNS	O	[-1]	['none']	_	_
8	according	_	_	VBG	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	manufacturer	_	_	NN	O	[-1]	['none']	_	_
12	's	_	_	POS	O	[-1]	['none']	_	_
13	instructions	_	_	NNS	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Miltenyi	_	_	NNP	O	[-1]	['none']	_	_
16	Biotec	_	_	NNP	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	grown	_	_	VBN	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	Iscove	_	_	NNP	O	[-1]	['none']	_	_
22	's	_	_	POS	O	[-1]	['none']	_	_
23	medium	_	_	NN	O	[-1]	['none']	_	_
24	supplemented	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	heat	_	_	NN	O	[-1]	['none']	_	_
27	inactivated	_	_	VBD	O	[-1]	['none']	_	_
28	10	_	_	CD	O	[-1]	['none']	_	_
29	%	_	_	NN	O	[-1]	['none']	_	_
30	fetal	_	_	JJ	O	[-1]	['none']	_	_
31	bovine	_	_	JJ	O	[-1]	['none']	_	_
32	serum	_	_	NN	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	antibiotic	_	_	JJ	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	antimycotic	_	_	JJ	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	GIBCO	_	_	NN	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Splenocytes	_	_	NNS	O	[-1]	['none']	_	_
2	isolated	_	_	VBN	O	[-1]	['none']	_	_
3	from	_	_	IN	O	[-1]	['none']	_	_
4	SCID	_	_	NN	O	[-1]	['none']	_	_
5	passaged	_	_	VBD	O	[-1]	['none']	_	_
6	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
7	consisted	_	_	VBD	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	80	_	_	CD	O	[-1]	['none']	_	_
10	%-90%	_	_	CD	O	[-1]	['none']	_	_
11	B	_	_	NN	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	determined	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	flow	_	_	NN	O	[-1]	['none']	_	_
17	cytometry	_	_	NN	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	hence	_	_	RB	O	[-1]	['none']	_	_
22	not	_	_	RB	O	[-1]	['none']	_	_
23	further	_	_	JJ	O	[-1]	['none']	_	_
24	purified	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	CD19-MACS	_	_	JJ	Protein	[0]	['root']	_	_
27	beads	_	_	NNS	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Splenocytes	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	seeded	_	_	VBN	O	[-1]	['none']	_	_
4	at	_	_	IN	O	[-1]	['none']	_	_
5	1.25	_	_	CD	O	[-1]	['none']	_	_
6	x	_	_	CC	O	[-1]	['none']	_	_
7	106	_	_	CD	O	[-1]	['none']	_	_
8	cells/ml	_	_	NNS	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	where	_	_	WRB	O	[-1]	['none']	_	_
11	applicable	_	_	JJ	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	recombinant	_	_	JJ	O	[-1]	['none']	_	_
14	mouse	_	_	NN	O	[-1]	['none']	_	_
15	IL4	_	_	NN	Protein	[0]	['root']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	added	_	_	VBN	O	[-1]	['none']	_	_
18	at	_	_	IN	O	[-1]	['none']	_	_
19	100	_	_	CD	O	[-1]	['none']	_	_
20	ng/ml	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	recombinant	_	_	JJ	O	[-1]	['none']	_	_
23	mouse	_	_	NN	O	[-1]	['none']	_	_
24	IL10	_	_	NN	Protein	[0]	['root']	_	_
25	at	_	_	IN	O	[-1]	['none']	_	_
26	10	_	_	CD	O	[-1]	['none']	_	_
27	ng/ml	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	rat	_	_	NN	O	[-1]	['none']	_	_
31	IgG1	_	_	NN	O	[-1]	['none']	_	_
32	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
33	IL10	_	_	NN	Protein	[0]	['root']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	rat	_	_	NN	O	[-1]	['none']	_	_
36	IgG1	_	_	NN	O	[-1]	['none']	_	_
37	isotype	_	_	NN	O	[-1]	['none']	_	_
38	control	_	_	NN	O	[-1]	['none']	_	_
39	at	_	_	IN	O	[-1]	['none']	_	_
40	10	_	_	CD	O	[-1]	['none']	_	_
41	mug/ml	_	_	NN	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	R&D	_	_	NNP	O	[-1]	['none']	_	_
44	Systems	_	_	NNPS	O	[-1]	['none']	_	_
45	)	_	_	-RRB-	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	For	_	_	IN	O	[-1]	['none']	_	_
2	BrdU	_	_	NN	O	[-1]	['none']	_	_
3	incorporation	_	_	NN	O	[-1]	['none']	_	_
4	assays	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	pulsed	_	_	JJ	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	24	_	_	CD	O	[-1]	['none']	_	_
11	h	_	_	NN	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	10	_	_	CD	O	[-1]	['none']	_	_
14	muM	_	_	NN	O	[-1]	['none']	_	_
15	BrdU	_	_	NN	O	[-1]	['none']	_	_
16	1	_	_	CD	O	[-1]	['none']	_	_
17	d	_	_	NN	O	[-1]	['none']	_	_
18	post-harvest	_	_	JJ	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[0]	['root']	_	_
2	induced	_	_	VBD	O	[-1]	['none']	_	_
3	activation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	JNK	_	_	NN	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	defective	_	_	JJ	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	HOIP	_	_	NN	Protein	[12]	['Theme']	_	_
12	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	CD40	_	_	NN	Protein	[0]	['root']	_	_
2	mediated	_	_	VBD	O	[-1]	['none']	_	_
3	signaling	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	defective	_	_	JJ	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	HOIP	_	_	NN	Protein	[8]	['Theme']	_	_
8	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	HOIP-/-	_	_	NN	O	[-1]	['none']	_	_
12	+	_	_	CC	O	[-1]	['none']	_	_
13	pMIP	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	but	_	_	CC	O	[-1]	['none']	_	_
17	intact	_	_	JJ	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	parental	_	_	JJ	O	[-1]	['none']	_	_
20	cells	_	_	NNS	O	[-1]	['none']	_	_
21	transduced	_	_	VBN	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	an	_	_	DT	O	[-1]	['none']	_	_
24	empty	_	_	JJ	O	[-1]	['none']	_	_
25	retroviral	_	_	JJ	O	[-1]	['none']	_	_
26	vector	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	A20	_	_	NN	O	[-1]	['none']	_	_
29	.2	_	_	NN	O	[-1]	['none']	_	_
30	J	_	_	NN	O	[-1]	['none']	_	_
31	+	_	_	CC	O	[-1]	['none']	_	_
32	pMIP	_	_	NN	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	HOIP	_	_	NN	Protein	[37]	['Theme']	_	_
37	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
38	cells	_	_	NNS	O	[-1]	['none']	_	_
39	transduced	_	_	VBN	O	[-1]	['none']	_	_
40	with	_	_	IN	O	[-1]	['none']	_	_
41	a	_	_	DT	O	[-1]	['none']	_	_
42	retroviral	_	_	JJ	O	[-1]	['none']	_	_
43	vector	_	_	NN	O	[-1]	['none']	_	_
44	encoding	_	_	VBG	O	[-1]	['none']	_	_
45	HOIP	_	_	NN	Protein	[0]	['root']	_	_
46	(	_	_	-LRB-	O	[-1]	['none']	_	_
47	HOIP-/-	_	_	NN	Protein	[0]	['root']	_	_
48	+	_	_	CC	O	[-1]	['none']	_	_
49	HOIP	_	_	NN	Protein	[0]	['root']	_	_
50	)	_	_	-RRB-	O	[-1]	['none']	_	_
51	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	activated	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	CD154	_	_	NN	Protein	[6]	['Theme']	_	_
6	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
7	insect	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	times	_	_	NNS	O	[-1]	['none']	_	_
12	indicated	_	_	VBD	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	a	_	_	DT	O	[-1]	['none']	_	_
3	negative	_	_	JJ	O	[-1]	['none']	_	_
4	control	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	were	_	_	VBD	O	[-1]	['none']	_	_
8	stimulated	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	insect	_	_	JJ	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	lacking	_	_	VBG	Negative_regulation	[0]	['root']	_	_
13	CD154	_	_	NN	Protein	[12]	['Theme']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	5	_	_	CD	O	[-1]	['none']	_	_
16	minute	_	_	NN	O	[-1]	['none']	_	_
17	time	_	_	NN	O	[-1]	['none']	_	_
18	point	_	_	NN	O	[-1]	['none']	_	_
19	only	_	_	RB	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Western	_	_	NN	O	[-1]	['none']	_	_
2	blots	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	whole-cell	_	_	JJ	O	[-1]	['none']	_	_
5	lysates	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	probed	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	indicated	_	_	JJ	O	[-1]	['none']	_	_
11	antibodies	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Phospho-IkappaBalpha	_	_	NNP	Protein	[0]	['root']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	pIkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	phospho-JNK	_	_	JJ	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	pJNK	_	_	NN	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	blots	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	stripped	_	_	VBN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	reprobed	_	_	VBN	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	total	_	_	JJ	O	[-1]	['none']	_	_
17	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	total	_	_	NN	O	[-1]	['none']	_	_
20	JNK	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	respectively	_	_	RB	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	anti-JNK	_	_	JJ	O	[-1]	['none']	_	_
25	antibodies	_	_	NNS	O	[-1]	['none']	_	_
26	recognize	_	_	VBP	O	[-1]	['none']	_	_
27	p46	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	p54	_	_	NN	O	[-1]	['none']	_	_
30	isoforms	_	_	NNS	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
2	blots	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	reprobed	_	_	VBN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	actin	_	_	NN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	demonstrate	_	_	VB	O	[-1]	['none']	_	_
10	equal	_	_	JJ	O	[-1]	['none']	_	_
11	lane	_	_	NN	O	[-1]	['none']	_	_
12	loading	_	_	NN	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Molecular	_	_	JJ	O	[-1]	['none']	_	_
2	weights	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	indicated	_	_	VBN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	right	_	_	NN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	obtained	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	second	_	_	JJ	O	[-1]	['none']	_	_
8	experiment	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	two	_	_	CD	O	[-1]	['none']	_	_
12	additional	_	_	JJ	O	[-1]	['none']	_	_
13	experiments	_	_	NNS	O	[-1]	['none']	_	_
14	with	_	_	IN	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	second	_	_	JJ	O	[-1]	['none']	_	_
17	HOIP	_	_	NN	Protein	[18]	['Theme']	_	_
18	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
19	clone	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF	_	_	NNP	O	[-1]	['none']	_	_
2	activates	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
3	PKCalpha	_	_	NN	Protein	[2]	['Theme']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	human	_	_	NN	O	[-1]	['none']	_	_
6	MDMs	_	_	NNS	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	MDMs	_	_	NNS	O	[-1]	['none']	_	_
2	treated	_	_	VBN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	M-CSF	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	100	_	_	CD	O	[-1]	['none']	_	_
7	ng/ml	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	for	_	_	IN	O	[-1]	['none']	_	_
10	varying	_	_	VBG	O	[-1]	['none']	_	_
11	amounts	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	time	_	_	NN	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	lysed	_	_	VBN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
18	using	_	_	VBG	O	[-1]	['none']	_	_
19	anti-PKC	_	_	JJ	O	[-1]	['none']	_	_
20	antibody	_	_	NN	O	[-1]	['none']	_	_
21	or	_	_	CC	O	[-1]	['none']	_	_
22	control	_	_	NN	O	[-1]	['none']	_	_
23	IgG	_	_	NN	O	[-1]	['none']	_	_
24	antibody	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	One	_	_	CD	O	[-1]	['none']	_	_
2	half	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	samples	_	_	NNS	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	used	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	analyze	_	_	VB	O	[-1]	['none']	_	_
10	PKC	_	_	NN	O	[-1]	['none']	_	_
11	kinase	_	_	NN	O	[-1]	['none']	_	_
12	activity	_	_	NN	O	[-1]	['none']	_	_
13	using	_	_	VBG	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	fluorescein	_	_	NN	O	[-1]	['none']	_	_
16	tagged	_	_	VBD	O	[-1]	['none']	_	_
17	peptide	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	visualized	_	_	VBN	O	[-1]	['none']	_	_
20	by	_	_	IN	O	[-1]	['none']	_	_
21	agarose	_	_	NN	O	[-1]	['none']	_	_
22	gel	_	_	NN	O	[-1]	['none']	_	_
23	electrophoresis	_	_	NN	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	top	_	_	JJ	O	[-1]	['none']	_	_
26	panel	_	_	NN	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	while	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	other	_	_	JJ	O	[-1]	['none']	_	_
32	half	_	_	NN	O	[-1]	['none']	_	_
33	was	_	_	VBD	O	[-1]	['none']	_	_
34	subjected	_	_	VBN	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	Western	_	_	NN	O	[-1]	['none']	_	_
37	blot	_	_	NN	O	[-1]	['none']	_	_
38	analysis	_	_	NN	O	[-1]	['none']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	confirm	_	_	VB	O	[-1]	['none']	_	_
41	equal	_	_	JJ	O	[-1]	['none']	_	_
42	amounts	_	_	NNS	O	[-1]	['none']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
45	were	_	_	VBD	O	[-1]	['none']	_	_
46	immunoprecipitated	_	_	VBN	O	[-1]	['none']	_	_
47	from	_	_	IN	O	[-1]	['none']	_	_
48	each	_	_	DT	O	[-1]	['none']	_	_
49	sample	_	_	NN	O	[-1]	['none']	_	_
50	(	_	_	-LRB-	O	[-1]	['none']	_	_
51	middle	_	_	JJ	O	[-1]	['none']	_	_
52	panel	_	_	NN	O	[-1]	['none']	_	_
53	)	_	_	-RRB-	O	[-1]	['none']	_	_
54	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	kinase	_	_	NN	O	[-1]	['none']	_	_
3	assay	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	quantitated	_	_	VBN	O	[-1]	['none']	_	_
6	using	_	_	VBG	O	[-1]	['none']	_	_
7	Quantity	_	_	NNP	O	[-1]	['none']	_	_
8	One	_	_	CD	O	[-1]	['none']	_	_
9	software	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	Bio-Rad	_	_	NNP	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	bottom	_	_	JJ	O	[-1]	['none']	_	_
15	panel	_	_	NN	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	represents	_	_	VBZ	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	average	_	_	JJ	O	[-1]	['none']	_	_
5	fold	_	_	JJ	O	[-1]	['none']	_	_
6	increase	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	PKCalpha	_	_	NN	Protein	[0]	['root']	_	_
9	activity	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	non	_	_	JJ	O	[-1]	['none']	_	_
12	stimulated	_	_	VBN	O	[-1]	['none']	_	_
13	samples	_	_	NNS	O	[-1]	['none']	_	_
14	compared	_	_	VBN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	M-CSF-treated	_	_	JJ	O	[-1]	['none']	_	_
17	MDM	_	_	NN	O	[-1]	['none']	_	_
18	+/-	_	_	CC	O	[-1]	['none']	_	_
19	S.E.M	_	_	NN	O	[-1]	['none']	_	_
20	for	_	_	IN	O	[-1]	['none']	_	_
21	three	_	_	CD	O	[-1]	['none']	_	_
22	independent	_	_	JJ	O	[-1]	['none']	_	_
23	experiments	_	_	NNS	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	NS	_	_	NN	O	[-1]	['none']	_	_
2	:	_	_	:	O	[-1]	['none']	_	_
3	non	_	_	JJ	O	[-1]	['none']	_	_
4	stimulated	_	_	VBN	O	[-1]	['none']	_	_
5	.	_	_	.	O	[-1]	['none']	_	_

1	*	_	_	SYM	O	[-1]	['none']	_	_
2	The	_	_	DT	O	[-1]	['none']	_	_
3	p-values	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	M-CSF	_	_	NN	O	[-1]	['none']	_	_
6	stimulated	_	_	VBD	O	[-1]	['none']	_	_
7	compared	_	_	VBN	O	[-1]	['none']	_	_
8	to	_	_	TO	O	[-1]	['none']	_	_
9	non	_	_	JJ	O	[-1]	['none']	_	_
10	stimulated	_	_	VBN	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	<	_	_	JJR	O	[-1]	['none']	_	_
13	=	_	_	JJ	O	[-1]	['none']	_	_
14	0.05	_	_	CD	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Reverse	_	_	JJ	O	[-1]	['none']	_	_
2	transcription	_	_	NN	O	[-1]	['none']	_	_
3	quantitative	_	_	JJ	O	[-1]	['none']	_	_
4	PCR	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	RT-qPCR	_	_	NN	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	RT-qPCR	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	used	_	_	VBN	O	[-1]	['none']	_	_
11	to	_	_	TO	O	[-1]	['none']	_	_
12	determine	_	_	VB	O	[-1]	['none']	_	_
13	gene	_	_	NN	O	[-1]	['none']	_	_
14	expression	_	_	NN	Gene_expression	[22]	['Theme']	_	_
15	levels	_	_	NNS	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	il-6	_	_	NN	Protein	[14]	['Theme']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	cxcl8	_	_	NN	Protein	[14]	['Theme']	_	_
20	in	_	_	IN	Positive_regulation	[22]	['multitoken']	_	_
21	response	_	_	NN	Positive_regulation	[22]	['multitoken']	_	_
22	to	_	_	TO	Positive_regulation	[24]	['Theme']	_	_
23	PMA	_	_	NN	O	[-1]	['none']	_	_
24	following	_	_	JJ	Positive_regulation	[0]	['root']	_	_
25	inhibition	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	JNK	_	_	NN	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	PKC	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	following	_	_	VBG	O	[-1]	['none']	_	_
3	primer	_	_	NN	O	[-1]	['none']	_	_
4	sequences	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	used	_	_	VBN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	il-6	_	_	NN	Protein	[0]	['root']	_	_
9	:	_	_	:	O	[-1]	['none']	_	_
10	forward-	_	_	JJ	O	[-1]	['none']	_	_
11	TGTGAAAGCAGCAAAGAGGCACTG	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	reverse-	_	_	JJ	O	[-1]	['none']	_	_
14	ACAGCTCTGGCTTGTTCCTCACTA	_	_	NN	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	cxcl8	_	_	NN	Protein	[0]	['root']	_	_
17	:	_	_	:	O	[-1]	['none']	_	_
18	forward-	_	_	JJ	O	[-1]	['none']	_	_
19	ACCACACTGCGCCAACACAGAAAT	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	reverse-	_	_	JJ	O	[-1]	['none']	_	_
22	AAACTTCTCCACAACCCTCTGCAC	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Thermocycling	_	_	VBG	O	[-1]	['none']	_	_
2	conditions	_	_	NNS	O	[-1]	['none']	_	_
3	for	_	_	IN	O	[-1]	['none']	_	_
4	CYBR	_	_	NNP	O	[-1]	['none']	_	_
5	Green	_	_	NNP	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	Quanta	_	_	NNP	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	USA	_	_	NNP	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	consisted	_	_	VBD	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	denaturation	_	_	NN	O	[-1]	['none']	_	_
15	step	_	_	NN	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	10	_	_	CD	O	[-1]	['none']	_	_
18	min	_	_	NN	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	95	_	_	CD	O	[-1]	['none']	_	_
21	degreesC	_	_	NN	O	[-1]	['none']	_	_
22	followed	_	_	VBN	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	60	_	_	CD	O	[-1]	['none']	_	_
25	cycles	_	_	NNS	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	95degreesC	_	_	NN	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	1s	_	_	NNS	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	60degreesC	_	_	NN	O	[-1]	['none']	_	_
32	for	_	_	IN	O	[-1]	['none']	_	_
33	30s	_	_	NNS	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Gene	_	_	NN	O	[-1]	['none']	_	_
2	expression	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	analysed	_	_	VBN	O	[-1]	['none']	_	_
5	using	_	_	VBG	O	[-1]	['none']	_	_
6	Stratagene	_	_	JJ	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	Mx3000p	_	_	NN	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	TM	_	_	NN	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	AH	_	_	NNP	O	[-1]	['none']	_	_
15	diagnostics	_	_	NNS	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	obtained	_	_	JJ	O	[-1]	['none']	_	_
3	Ct	_	_	NN	O	[-1]	['none']	_	_
4	values	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	normalized	_	_	VBN	O	[-1]	['none']	_	_
7	against	_	_	IN	O	[-1]	['none']	_	_
8	18S	_	_	NNP	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Initially	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	all	_	_	DT	O	[-1]	['none']	_	_
4	measured	_	_	JJ	O	[-1]	['none']	_	_
5	18S	_	_	NN	O	[-1]	['none']	_	_
6	Ct	_	_	NN	O	[-1]	['none']	_	_
7	values	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	used	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	calculate	_	_	VB	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	mean	_	_	NN	O	[-1]	['none']	_	_
14	Ct	_	_	NN	O	[-1]	['none']	_	_
15	value	_	_	NN	O	[-1]	['none']	_	_
16	that	_	_	WDT	O	[-1]	['none']	_	_
17	was	_	_	VBD	O	[-1]	['none']	_	_
18	used	_	_	VBN	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	determine	_	_	VB	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	deltaCt	_	_	NN	O	[-1]	['none']	_	_
23	values	_	_	NNS	O	[-1]	['none']	_	_
24	for	_	_	IN	O	[-1]	['none']	_	_
25	each	_	_	DT	O	[-1]	['none']	_	_
26	sample	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Gene	_	_	NN	O	[-1]	['none']	_	_
2	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	patterns	_	_	NNS	O	[-1]	['none']	_	_
4	for	_	_	IN	O	[-1]	['none']	_	_
5	il-6	_	_	JJ	Protein	[2]	['Theme']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	cxcl8	_	_	NN	Protein	[2]	['Theme']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	then	_	_	RB	O	[-1]	['none']	_	_
10	normalized	_	_	VBN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	regard	_	_	NN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	samples	_	_	NNS	O	[-1]	['none']	_	_
16	18S	_	_	NN	O	[-1]	['none']	_	_
17	deltaCt	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Secreted	_	_	VBN	O	[-1]	['none']	_	_
2	Alkaline	_	_	NNP	O	[-1]	['none']	_	_
3	Phosphatase	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	SEAP	_	_	NN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	Analysis	_	_	NN	O	[-1]	['none']	_	_
8	Secreted	_	_	VBN	O	[-1]	['none']	_	_
9	alkaline	_	_	NN	O	[-1]	['none']	_	_
10	phosphatase	_	_	NN	O	[-1]	['none']	_	_
11	activity	_	_	NN	O	[-1]	['none']	_	_
12	was	_	_	VBD	O	[-1]	['none']	_	_
13	analyzed	_	_	VBN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	GreatEscape	_	_	NNP	O	[-1]	['none']	_	_
16	SEAP	_	_	NNP	O	[-1]	['none']	_	_
17	kit	_	_	NN	O	[-1]	['none']	_	_
18	according	_	_	VBG	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	manufacturer	_	_	NN	O	[-1]	['none']	_	_
22	's	_	_	POS	O	[-1]	['none']	_	_
23	instruction	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Briefly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	medium	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	diluted	_	_	VBN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	dilution	_	_	NN	O	[-1]	['none']	_	_
9	buffer	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	heated	_	_	VBN	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	65degreesC	_	_	NN	O	[-1]	['none']	_	_
14	to	_	_	TO	O	[-1]	['none']	_	_
15	inactivate	_	_	VB	O	[-1]	['none']	_	_
16	endogenous	_	_	JJ	O	[-1]	['none']	_	_
17	phosphatases	_	_	NNS	O	[-1]	['none']	_	_
18	then	_	_	RB	O	[-1]	['none']	_	_
19	incubated	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	substrate	_	_	NN	O	[-1]	['none']	_	_
23	for	_	_	IN	O	[-1]	['none']	_	_
24	30	_	_	CD	O	[-1]	['none']	_	_
25	minutes	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	chemiluminence	_	_	NN	O	[-1]	['none']	_	_
3	signal	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	recorded	_	_	VBN	O	[-1]	['none']	_	_
6	using	_	_	VBG	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	luminometer	_	_	NN	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	LMP1	_	_	NN	Protein	[0]	['root']	_	_
2	Promotes	_	_	VBZ	O	[-1]	['none']	_	_
3	B-1a	_	_	NN	O	[-1]	['none']	_	_
4	Lymphomas	_	_	NNS	O	[-1]	['none']	_	_
5	That	_	_	WDT	O	[-1]	['none']	_	_
6	Can	_	_	MD	O	[-1]	['none']	_	_
7	Escape	_	_	NN	O	[-1]	['none']	_	_
8	Allelic	_	_	JJ	O	[-1]	['none']	_	_
9	Exclusion	_	_	NN	O	[-1]	['none']	_	_
10	To	_	_	TO	O	[-1]	['none']	_	_
11	determine	_	_	VB	O	[-1]	['none']	_	_
12	if	_	_	IN	O	[-1]	['none']	_	_
13	LMP1	_	_	NN	Protein	[0]	['root']	_	_
14	signaling	_	_	NN	O	[-1]	['none']	_	_
15	affects	_	_	VBZ	O	[-1]	['none']	_	_
16	B	_	_	NN	O	[-1]	['none']	_	_
17	cell	_	_	NN	O	[-1]	['none']	_	_
18	differentiation	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	immunophenotype	_	_	NN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
24	that	_	_	WDT	O	[-1]	['none']	_	_
25	arise	_	_	VBP	O	[-1]	['none']	_	_
26	from	_	_	IN	O	[-1]	['none']	_	_
27	LMP1	_	_	NN	Protein	[28]	['Theme']	_	_
28	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	surface	_	_	NN	O	[-1]	['none']	_	_
31	Ig	_	_	NN	O	[-1]	['none']	_	_
32	expression	_	_	NN	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	heavy	_	_	JJ	O	[-1]	['none']	_	_
35	chains	_	_	NNS	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	IgM	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	IgG	_	_	NN	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	IgD	_	_	NN	O	[-1]	['none']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	and	_	_	CC	O	[-1]	['none']	_	_
44	light	_	_	JJ	O	[-1]	['none']	_	_
45	chains	_	_	NNS	O	[-1]	['none']	_	_
46	(	_	_	-LRB-	O	[-1]	['none']	_	_
47	kappa	_	_	NN	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	lambda	_	_	NN	O	[-1]	['none']	_	_
50	)	_	_	-RRB-	O	[-1]	['none']	_	_
51	were	_	_	VBD	O	[-1]	['none']	_	_
52	analyzed	_	_	VBN	O	[-1]	['none']	_	_
53	by	_	_	IN	O	[-1]	['none']	_	_
54	flow	_	_	NN	O	[-1]	['none']	_	_
55	cytometry	_	_	NN	O	[-1]	['none']	_	_
56	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	numbers	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	naive	_	_	JJ	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	IgM+	_	_	JJ	O	[-1]	['none']	_	_
7	IgD+	_	_	JJ	O	[-1]	['none']	_	_
8	IgG-)	_	_	NN	O	[-1]	['none']	_	_
9	splenic	_	_	JJ	O	[-1]	['none']	_	_
10	B	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	strong	_	_	JJ	O	[-1]	['none']	_	_
15	bias	_	_	NN	O	[-1]	['none']	_	_
16	towards	_	_	IN	O	[-1]	['none']	_	_
17	kappa	_	_	NN	O	[-1]	['none']	_	_
18	light	_	_	JJ	O	[-1]	['none']	_	_
19	chain	_	_	NN	O	[-1]	['none']	_	_
20	were	_	_	VBD	O	[-1]	['none']	_	_
21	detected	_	_	VBN	O	[-1]	['none']	_	_
22	from	_	_	IN	O	[-1]	['none']	_	_
23	wild-type	_	_	JJ	O	[-1]	['none']	_	_
24	or	_	_	CC	O	[-1]	['none']	_	_
25	LMP1	_	_	NN	Protein	[0]	['root']	_	_
26	transgenic	_	_	JJ	O	[-1]	['none']	_	_
27	mice	_	_	NNS	O	[-1]	['none']	_	_
28	,	_	_	,	O	[-1]	['none']	_	_
29	indicating	_	_	VBG	O	[-1]	['none']	_	_
30	that	_	_	IN	O	[-1]	['none']	_	_
31	LMP1	_	_	NN	Protein	[0]	['root']	_	_
32	signaling	_	_	NN	O	[-1]	['none']	_	_
33	does	_	_	VBZ	O	[-1]	['none']	_	_
34	not	_	_	RB	O	[-1]	['none']	_	_
35	affect	_	_	VB	O	[-1]	['none']	_	_
36	B	_	_	NN	O	[-1]	['none']	_	_
37	cell	_	_	NN	O	[-1]	['none']	_	_
38	maturation	_	_	NN	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	unpublished	_	_	JJ	O	[-1]	['none']	_	_
41	data	_	_	NNS	O	[-1]	['none']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	Flow	_	_	NN	O	[-1]	['none']	_	_
2	cytometry	_	_	NN	O	[-1]	['none']	_	_
3	analysis	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	SCID	_	_	NN	O	[-1]	['none']	_	_
7	passaged	_	_	VBD	O	[-1]	['none']	_	_
8	wild-type	_	_	JJ	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	LMP1	_	_	NN	Protein	[0]	['root']	_	_
11	transgenic	_	_	JJ	O	[-1]	['none']	_	_
12	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
13	revealed	_	_	VBD	O	[-1]	['none']	_	_
14	an	_	_	DT	O	[-1]	['none']	_	_
15	IgMhighIgDlow	_	_	NN	O	[-1]	['none']	_	_
16	phenotype	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	indicative	_	_	JJ	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	marginal	_	_	JJ	O	[-1]	['none']	_	_
21	zone	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	B-1	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	memory	_	_	NN	O	[-1]	['none']	_	_
27	B	_	_	NN	O	[-1]	['none']	_	_
28	cells	_	_	NNS	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	B-1	_	_	NNP	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	further	_	_	JJ	O	[-1]	['none']	_	_
5	separated	_	_	VBN	O	[-1]	['none']	_	_
6	into	_	_	IN	O	[-1]	['none']	_	_
7	CD5+	_	_	JJ	Protein	[0]	['root']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	B-1a	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	CD5-	_	_	JJ	Protein	[0]	['root']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	B-1b	_	_	NN	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	subsets	_	_	NNS	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	differentiate	_	_	VB	O	[-1]	['none']	_	_
3	between	_	_	IN	O	[-1]	['none']	_	_
4	these	_	_	DT	O	[-1]	['none']	_	_
5	cell	_	_	NN	O	[-1]	['none']	_	_
6	types	_	_	NNS	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	lymphoma	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	further	_	_	JJ	O	[-1]	['none']	_	_
12	analyzed	_	_	VBN	O	[-1]	['none']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	B-1a	_	_	NN	O	[-1]	['none']	_	_
16	marker	_	_	NN	O	[-1]	['none']	_	_
17	CD5	_	_	NN	Protein	[0]	['root']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	All	_	_	DT	O	[-1]	['none']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	5/5	_	_	CD	O	[-1]	['none']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	tested	_	_	JJ	O	[-1]	['none']	_	_
8	LMP1	_	_	NN	Protein	[0]	['root']	_	_
9	transgenic	_	_	JJ	O	[-1]	['none']	_	_
10	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
11	displayed	_	_	VBD	O	[-1]	['none']	_	_
12	an	_	_	DT	O	[-1]	['none']	_	_
13	IgMhighIgDlowCD5+	_	_	JJ	Protein	[0]	['root']	_	_
14	phenotype	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	an	_	_	DT	O	[-1]	['none']	_	_
17	expression	_	_	NN	O	[-1]	['none']	_	_
18	pattern	_	_	NN	O	[-1]	['none']	_	_
19	that	_	_	WDT	O	[-1]	['none']	_	_
20	distinguishes	_	_	VBZ	O	[-1]	['none']	_	_
21	B-1a	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	spontaneous	_	_	JJ	O	[-1]	['none']	_	_
5	wild-type	_	_	JJ	O	[-1]	['none']	_	_
6	lymphoma	_	_	NN	O	[-1]	['none']	_	_
7	also	_	_	RB	O	[-1]	['none']	_	_
8	developed	_	_	VBD	O	[-1]	['none']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	B-1a	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	an	_	_	DT	O	[-1]	['none']	_	_
5	interesting	_	_	JJ	O	[-1]	['none']	_	_
6	population	_	_	NN	O	[-1]	['none']	_	_
7	that	_	_	WDT	O	[-1]	['none']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	self	_	_	NN	O	[-1]	['none']	_	_
10	replenishing	_	_	VBG	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	an	_	_	DT	O	[-1]	['none']	_	_
13	increased	_	_	JJ	O	[-1]	['none']	_	_
14	likelihood	_	_	NN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	become	_	_	VB	O	[-1]	['none']	_	_
17	malignant	_	_	JJ	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	aged	_	_	JJ	O	[-1]	['none']	_	_
20	mice	_	_	NNS	O	[-1]	['none']	_	_
21	[	_	_	VBP	O	[-1]	['none']	_	_
22	30	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	CD	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Analysis	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	LMP1	_	_	NN	Protein	[0]	['root']	_	_
4	transgenic	_	_	JJ	O	[-1]	['none']	_	_
5	mice	_	_	NNS	O	[-1]	['none']	_	_
6	before	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	development	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	lymphoma	_	_	NN	O	[-1]	['none']	_	_
11	showed	_	_	VBD	O	[-1]	['none']	_	_
12	similar	_	_	JJ	O	[-1]	['none']	_	_
13	numbers	_	_	NNS	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	splenic	_	_	JJ	O	[-1]	['none']	_	_
16	B-1a	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
19	CD5+	_	_	JJ	Protein	[0]	['root']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	B-1b	_	_	NN	O	[-1]	['none']	_	_
23	or	_	_	CC	O	[-1]	['none']	_	_
24	B-2	_	_	NN	O	[-1]	['none']	_	_
25	populations	_	_	NNS	O	[-1]	['none']	_	_
26	(	_	_	-LRB-	O	[-1]	['none']	_	_
27	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
28	CD5-)	_	_	NN	Protein	[0]	['root']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	indicating	_	_	VBG	O	[-1]	['none']	_	_
31	that	_	_	IN	O	[-1]	['none']	_	_
32	LMP1	_	_	NN	Protein	[0]	['root']	_	_
33	does	_	_	VBZ	O	[-1]	['none']	_	_
34	not	_	_	RB	O	[-1]	['none']	_	_
35	affect	_	_	VB	O	[-1]	['none']	_	_
36	B	_	_	NN	O	[-1]	['none']	_	_
37	cell	_	_	NN	O	[-1]	['none']	_	_
38	differentiation	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Due	_	_	JJ	O	[-1]	['none']	_	_
2	to	_	_	TO	O	[-1]	['none']	_	_
3	allelic	_	_	JJ	O	[-1]	['none']	_	_
4	exclusion	_	_	NN	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	mature	_	_	JJ	O	[-1]	['none']	_	_
7	B	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	that	_	_	WDT	O	[-1]	['none']	_	_
10	have	_	_	VBP	O	[-1]	['none']	_	_
11	been	_	_	VBN	O	[-1]	['none']	_	_
12	exposed	_	_	VBN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	antigen	_	_	NN	O	[-1]	['none']	_	_
15	will	_	_	MD	O	[-1]	['none']	_	_
16	typically	_	_	RB	O	[-1]	['none']	_	_
17	express	_	_	VB	O	[-1]	['none']	_	_
18	only	_	_	RB	O	[-1]	['none']	_	_
19	one	_	_	CD	O	[-1]	['none']	_	_
20	heavy	_	_	JJ	O	[-1]	['none']	_	_
21	chain	_	_	NN	O	[-1]	['none']	_	_
22	isotype	_	_	NN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	IgG	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	IgE	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	or	_	_	CC	O	[-1]	['none']	_	_
29	IgA	_	_	NN	O	[-1]	['none']	_	_
30	)	_	_	-RRB-	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	either	_	_	CC	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	kappa	_	_	NN	O	[-1]	['none']	_	_
35	or	_	_	CC	O	[-1]	['none']	_	_
36	lambda	_	_	NN	O	[-1]	['none']	_	_
37	light	_	_	JJ	O	[-1]	['none']	_	_
38	chain	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	2/5	_	_	CD	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[0]	['root']	_	_
5	transgenic	_	_	JJ	O	[-1]	['none']	_	_
6	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
7	analyzed	_	_	VBN	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
10	2	_	_	CD	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	4	_	_	CD	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	doubly	_	_	RB	O	[-1]	['none']	_	_
16	positive	_	_	JJ	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	low	_	_	JJ	O	[-1]	['none']	_	_
19	levels	_	_	NNS	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	both	_	_	DT	O	[-1]	['none']	_	_
22	kappa	_	_	NN	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	lambda	_	_	NN	O	[-1]	['none']	_	_
25	light	_	_	JJ	O	[-1]	['none']	_	_
26	chains	_	_	NNS	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Previous	_	_	JJ	O	[-1]	['none']	_	_
2	characterization	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	LMP1	_	_	NN	Protein	[0]	['root']	_	_
6	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
7	had	_	_	VBD	O	[-1]	['none']	_	_
8	revealed	_	_	VBN	O	[-1]	['none']	_	_
9	that	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	clonal	_	_	JJ	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	determined	_	_	VBN	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	Ig	_	_	NN	O	[-1]	['none']	_	_
18	heavy	_	_	JJ	O	[-1]	['none']	_	_
19	chain	_	_	NN	O	[-1]	['none']	_	_
20	rearrangement	_	_	NN	O	[-1]	['none']	_	_
21	[	_	_	NN	O	[-1]	['none']	_	_
22	26	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	analysis	_	_	NN	O	[-1]	['none']	_	_
27	of	_	_	IN	O	[-1]	['none']	_	_
28	kappa	_	_	NN	O	[-1]	['none']	_	_
29	chain	_	_	NN	O	[-1]	['none']	_	_
30	rearrangement	_	_	NN	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	samples	_	_	NNS	O	[-1]	['none']	_	_
34	analyzed	_	_	VBN	O	[-1]	['none']	_	_
35	in	_	_	IN	O	[-1]	['none']	_	_
36	this	_	_	DT	O	[-1]	['none']	_	_
37	study	_	_	NN	O	[-1]	['none']	_	_
38	confirmed	_	_	VBD	O	[-1]	['none']	_	_
39	clonality	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	further	_	_	RB	O	[-1]	['none']	_	_
3	assess	_	_	VB	O	[-1]	['none']	_	_
4	light	_	_	JJ	O	[-1]	['none']	_	_
5	chain	_	_	NN	O	[-1]	['none']	_	_
6	expression	_	_	NN	O	[-1]	['none']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	passaged	_	_	JJ	O	[-1]	['none']	_	_
10	samples	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	tested	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	immunoblotting	_	_	VBG	O	[-1]	['none']	_	_
15	for	_	_	IN	O	[-1]	['none']	_	_
16	kappa	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	lambda	_	_	NN	O	[-1]	['none']	_	_
19	light	_	_	JJ	O	[-1]	['none']	_	_
20	chains	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Interestingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	very	_	_	RB	O	[-1]	['none']	_	_
4	low	_	_	JJ	O	[-1]	['none']	_	_
5	levels	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	expression	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	both	_	_	CC	O	[-1]	['none']	_	_
10	light	_	_	JJ	O	[-1]	['none']	_	_
11	chains	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	detected	_	_	VBN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	flow	_	_	NN	O	[-1]	['none']	_	_
16	cytometry	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	low	_	_	JJ	O	[-1]	['none']	_	_
3	levels	_	_	NNS	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	expression	_	_	NN	O	[-1]	['none']	_	_
6	may	_	_	MD	O	[-1]	['none']	_	_
7	reflect	_	_	VB	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	limitation	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	total	_	_	JJ	O	[-1]	['none']	_	_
13	number	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	light	_	_	JJ	O	[-1]	['none']	_	_
16	chains	_	_	NNS	O	[-1]	['none']	_	_
17	that	_	_	WDT	O	[-1]	['none']	_	_
18	can	_	_	MD	O	[-1]	['none']	_	_
19	be	_	_	VB	O	[-1]	['none']	_	_
20	expressed	_	_	VBN	O	[-1]	['none']	_	_
21	on	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	surface	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	a	_	_	DT	O	[-1]	['none']	_	_
26	B	_	_	NN	O	[-1]	['none']	_	_
27	cell	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	agreement	_	_	NN	O	[-1]	['none']	_	_
3	with	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	flow	_	_	NN	O	[-1]	['none']	_	_
6	cytometry	_	_	NN	O	[-1]	['none']	_	_
7	analysis	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	LMP1	_	_	NN	Protein	[0]	['root']	_	_
10	transgenic	_	_	JJ	O	[-1]	['none']	_	_
11	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
12	2	_	_	CD	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	4	_	_	CD	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	also	_	_	RB	O	[-1]	['none']	_	_
17	positive	_	_	JJ	O	[-1]	['none']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	kappa	_	_	NN	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	lambda	_	_	NN	O	[-1]	['none']	_	_
22	light	_	_	JJ	O	[-1]	['none']	_	_
23	chains	_	_	NNS	O	[-1]	['none']	_	_
24	by	_	_	IN	O	[-1]	['none']	_	_
25	immunoblot	_	_	NN	O	[-1]	['none']	_	_
26	analysis	_	_	NN	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	confirming	_	_	VBG	O	[-1]	['none']	_	_
29	that	_	_	IN	O	[-1]	['none']	_	_
30	these	_	_	DT	O	[-1]	['none']	_	_
31	lymphomas	_	_	NNS	O	[-1]	['none']	_	_
32	express	_	_	VBP	O	[-1]	['none']	_	_
33	both	_	_	CC	O	[-1]	['none']	_	_
34	light	_	_	VBP	O	[-1]	['none']	_	_
35	chains	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	previous	_	_	JJ	O	[-1]	['none']	_	_
3	study	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	mice	_	_	NNS	O	[-1]	['none']	_	_
6	that	_	_	WDT	O	[-1]	['none']	_	_
7	developed	_	_	VBD	O	[-1]	['none']	_	_
8	leukemia	_	_	NN	O	[-1]	['none']	_	_
9	due	_	_	JJ	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	an	_	_	DT	O	[-1]	['none']	_	_
12	expansion	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	self-reactive	_	_	JJ	O	[-1]	['none']	_	_
15	B-1a	_	_	NN	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	determined	_	_	VBD	O	[-1]	['none']	_	_
18	that	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	B-1a	_	_	NN	O	[-1]	['none']	_	_
21	leukemias	_	_	NNS	O	[-1]	['none']	_	_
22	were	_	_	VBD	O	[-1]	['none']	_	_
23	also	_	_	RB	O	[-1]	['none']	_	_
24	doubly	_	_	RB	O	[-1]	['none']	_	_
25	positive	_	_	JJ	O	[-1]	['none']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	kappa	_	_	NN	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	lambda	_	_	NN	O	[-1]	['none']	_	_
30	light	_	_	JJ	O	[-1]	['none']	_	_
31	chains	_	_	NNS	O	[-1]	['none']	_	_
32	[	_	_	VBP	O	[-1]	['none']	_	_
33	31	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	CD	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	findings	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	LMP1	_	_	NN	Protein	[5]	['Theme']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	B-1a	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	promotes	_	_	VBZ	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	development	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	malignancy	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	can	_	_	MD	O	[-1]	['none']	_	_
18	result	_	_	VB	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	aberrant	_	_	JJ	O	[-1]	['none']	_	_
22	escape	_	_	NN	O	[-1]	['none']	_	_
23	from	_	_	IN	O	[-1]	['none']	_	_
24	allelic	_	_	JJ	O	[-1]	['none']	_	_
25	exclusion	_	_	NN	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Antibodies	_	_	NNS	O	[-1]	['none']	_	_
2	Mouse	_	_	NN	O	[-1]	['none']	_	_
3	anti-birch	_	_	JJ	O	[-1]	['none']	_	_
4	profilin	_	_	NN	O	[-1]	['none']	_	_
5	antibody	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	4A6	_	_	NN	O	[-1]	['none']	_	_
8	[	_	_	CD	O	[-1]	['none']	_	_
9	29	_	_	CD	O	[-1]	['none']	_	_
10	]	_	_	CD	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	rat	_	_	NN	O	[-1]	['none']	_	_
14	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
15	CD40	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	1C10	_	_	NN	O	[-1]	['none']	_	_
18	[	_	_	CD	O	[-1]	['none']	_	_
19	30	_	_	CD	O	[-1]	['none']	_	_
20	]	_	_	CD	O	[-1]	['none']	_	_
21	)	_	_	-RRB-	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	a	_	_	DT	O	[-1]	['none']	_	_
24	rat	_	_	NN	O	[-1]	['none']	_	_
25	isotype	_	_	NN	O	[-1]	['none']	_	_
26	control	_	_	NN	O	[-1]	['none']	_	_
27	antibody	_	_	NN	O	[-1]	['none']	_	_
28	(	_	_	-LRB-	O	[-1]	['none']	_	_
29	mAb72	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	Developmental	_	_	JJ	O	[-1]	['none']	_	_
32	Studies	_	_	NNS	O	[-1]	['none']	_	_
33	Hybridoma	_	_	NNP	O	[-1]	['none']	_	_
34	Bank	_	_	NNP	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	University	_	_	NNP	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	Iowa	_	_	NNP	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	Iowa	_	_	NNP	O	[-1]	['none']	_	_
41	City	_	_	NNP	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	IA	_	_	NNP	O	[-1]	['none']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	were	_	_	VBD	O	[-1]	['none']	_	_
46	isolated	_	_	VBN	O	[-1]	['none']	_	_
47	from	_	_	IN	O	[-1]	['none']	_	_
48	hybridoma	_	_	NN	O	[-1]	['none']	_	_
49	supernatants	_	_	NNS	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	FITC	_	_	NN	O	[-1]	['none']	_	_
2	labeled	_	_	VBN	O	[-1]	['none']	_	_
3	anti-mouse	_	_	JJ	O	[-1]	['none']	_	_
4	CD80	_	_	NN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	an	_	_	DT	O	[-1]	['none']	_	_
7	isotype	_	_	NN	O	[-1]	['none']	_	_
8	control	_	_	NN	O	[-1]	['none']	_	_
9	Ab	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	eBiosciences	_	_	NNS	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Rabbit	_	_	NN	O	[-1]	['none']	_	_
2	anti-HOIP	_	_	JJ	O	[-1]	['none']	_	_
3	Ab	_	_	NN	O	[-1]	['none']	_	_
4	[	_	_	NN	O	[-1]	['none']	_	_
5	6	_	_	CD	O	[-1]	['none']	_	_
6	]	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	kind	_	_	NN	O	[-1]	['none']	_	_
10	gift	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	Dr.	_	_	NNP	O	[-1]	['none']	_	_
13	Betty	_	_	NNP	O	[-1]	['none']	_	_
14	Eipper	_	_	NNP	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	University	_	_	NNP	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	Connecticut	_	_	NNP	O	[-1]	['none']	_	_
19	Health	_	_	NNP	O	[-1]	['none']	_	_
20	Center	_	_	NNP	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	Farmington	_	_	NNP	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	Connecticut	_	_	NNP	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Goat	_	_	NN	O	[-1]	['none']	_	_
2	anti-rat	_	_	JJ	O	[-1]	['none']	_	_
3	IgG	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	HRP	_	_	NNP	O	[-1]	['none']	_	_
7	labeled	_	_	VBN	O	[-1]	['none']	_	_
8	secondary	_	_	JJ	O	[-1]	['none']	_	_
9	Abs	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	from	_	_	IN	O	[-1]	['none']	_	_
12	Jackson	_	_	NNP	O	[-1]	['none']	_	_
13	ImmunoResearch	_	_	NNP	O	[-1]	['none']	_	_
14	Laboratories	_	_	NNPS	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	Inc.	_	_	NNP	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	All	_	_	DT	O	[-1]	['none']	_	_
2	other	_	_	JJ	O	[-1]	['none']	_	_
3	antibodies	_	_	NNS	O	[-1]	['none']	_	_
4	used	_	_	VBN	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	described	_	_	VBN	O	[-1]	['none']	_	_
7	previously	_	_	RB	O	[-1]	['none']	_	_
8	[	_	_	CD	O	[-1]	['none']	_	_
9	6	_	_	CD	O	[-1]	['none']	_	_
10	]	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	Phenotyping	_	_	VBG	O	[-1]	['none']	_	_
2	splenic	_	_	JJ	O	[-1]	['none']	_	_
3	DC	_	_	NN	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	BMDC	_	_	NN	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	WT	_	_	NNP	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	cpdm	_	_	NN	O	[-1]	['none']	_	_
10	mice	_	_	NNS	O	[-1]	['none']	_	_
11	DC	_	_	NNS	O	[-1]	['none']	_	_
12	are	_	_	VBP	O	[-1]	['none']	_	_
13	heterogeneous	_	_	JJ	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	can	_	_	MD	O	[-1]	['none']	_	_
16	be	_	_	VB	O	[-1]	['none']	_	_
17	categorized	_	_	VBN	O	[-1]	['none']	_	_
18	into	_	_	IN	O	[-1]	['none']	_	_
19	multiple	_	_	JJ	O	[-1]	['none']	_	_
20	subtypes	_	_	NNS	O	[-1]	['none']	_	_
21	based	_	_	VBN	O	[-1]	['none']	_	_
22	on	_	_	IN	O	[-1]	['none']	_	_
23	surface	_	_	NN	O	[-1]	['none']	_	_
24	markers	_	_	NNS	O	[-1]	['none']	_	_
25	[	_	_	VBP	O	[-1]	['none']	_	_
26	13	_	_	CD	O	[-1]	['none']	_	_
27	]	_	_	CD	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	if	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	Sharpin	_	_	NN	Protein	[6]	['Theme']	_	_
6	mutation	_	_	NN	Negative_regulation	[0]	['root']	_	_
7	affects	_	_	VBZ	O	[-1]	['none']	_	_
8	DC	_	_	NN	O	[-1]	['none']	_	_
9	development	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	lymphoid	_	_	JJ	O	[-1]	['none']	_	_
12	tissues	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	mouse	_	_	NN	O	[-1]	['none']	_	_
15	spleens	_	_	NNS	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	examined	_	_	VBN	O	[-1]	['none']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	distribution	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	conventional	_	_	JJ	O	[-1]	['none']	_	_
23	DC	_	_	NNS	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	cDC	_	_	NN	O	[-1]	['none']	_	_
26	;	_	_	:	O	[-1]	['none']	_	_
27	CD11c+	_	_	JJ	Protein	[0]	['root']	_	_
28	CD8alpha+	_	_	JJ	Protein	[0]	['root']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	CD11c+	_	_	JJ	Protein	[0]	['root']	_	_
31	CD8alpha-)	_	_	JJ	Protein	[0]	['root']	_	_
32	[	_	_	NN	O	[-1]	['none']	_	_
33	13	_	_	CD	O	[-1]	['none']	_	_
34	]	_	_	NN	O	[-1]	['none']	_	_
35	and	_	_	CC	O	[-1]	['none']	_	_
36	plasmacytoid	_	_	NN	O	[-1]	['none']	_	_
37	DC	_	_	NN	O	[-1]	['none']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	pDC	_	_	NN	O	[-1]	['none']	_	_
40	;	_	_	:	O	[-1]	['none']	_	_
41	CD11c-PDCA-1+	_	_	JJ	Protein	[0]	['root']	_	_
42	)	_	_	-RRB-	O	[-1]	['none']	_	_
43	[	_	_	CD	O	[-1]	['none']	_	_
44	14	_	_	CD	O	[-1]	['none']	_	_
45	]	_	_	NN	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	percentages	_	_	NNS	O	[-1]	['none']	_	_
3	for	_	_	IN	O	[-1]	['none']	_	_
4	splenic	_	_	JJ	O	[-1]	['none']	_	_
5	cDC	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	pDC	_	_	NN	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	both	_	_	DT	O	[-1]	['none']	_	_
10	reduced	_	_	VBN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	cpdm	_	_	NN	O	[-1]	['none']	_	_
13	mice	_	_	NNS	O	[-1]	['none']	_	_
14	when	_	_	WRB	O	[-1]	['none']	_	_
15	compared	_	_	VBN	O	[-1]	['none']	_	_
16	with	_	_	IN	O	[-1]	['none']	_	_
17	WT	_	_	JJ	O	[-1]	['none']	_	_
18	controls	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	when	_	_	WRB	O	[-1]	['none']	_	_
4	gated	_	_	VBN	O	[-1]	['none']	_	_
5	on	_	_	IN	O	[-1]	['none']	_	_
6	CD11c+	_	_	JJ	O	[-1]	['none']	_	_
7	cDC	_	_	NN	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	percentages	_	_	NNS	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	CD8alpha+	_	_	JJ	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	CD8alpha-	_	_	JJ	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	not	_	_	RB	O	[-1]	['none']	_	_
18	affected	_	_	VBN	O	[-1]	['none']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	SHARPIN	_	_	NNP	Protein	[21]	['Theme']	_	_
21	deficiency	_	_	NN	Negative_regulation	[0]	['root']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	spleen	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	cpdm	_	_	NN	O	[-1]	['none']	_	_
6	mice	_	_	NNS	O	[-1]	['none']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	markedly	_	_	RB	O	[-1]	['none']	_	_
9	enlarged	_	_	JJ	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	contains	_	_	VBZ	O	[-1]	['none']	_	_
12	three	_	_	CD	O	[-1]	['none']	_	_
13	times	_	_	NNS	O	[-1]	['none']	_	_
14	as	_	_	IN	O	[-1]	['none']	_	_
15	many	_	_	JJ	O	[-1]	['none']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	different	_	_	JJ	O	[-1]	['none']	_	_
20	percentages	_	_	NNS	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	splenic	_	_	JJ	O	[-1]	['none']	_	_
23	cDC	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	pDC	_	_	NN	O	[-1]	['none']	_	_
26	between	_	_	IN	O	[-1]	['none']	_	_
27	WT	_	_	NNP	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	mutant	_	_	NN	O	[-1]	['none']	_	_
30	mice	_	_	NNS	O	[-1]	['none']	_	_
31	reflect	_	_	VBP	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	increased	_	_	JJ	O	[-1]	['none']	_	_
34	number	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	total	_	_	JJ	O	[-1]	['none']	_	_
37	spleen	_	_	NN	O	[-1]	['none']	_	_
38	cells	_	_	NNS	O	[-1]	['none']	_	_
39	rather	_	_	RB	O	[-1]	['none']	_	_
40	than	_	_	IN	O	[-1]	['none']	_	_
41	a	_	_	DT	O	[-1]	['none']	_	_
42	reduction	_	_	NN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	cDC	_	_	NN	O	[-1]	['none']	_	_
45	and	_	_	CC	O	[-1]	['none']	_	_
46	pDC	_	_	NN	O	[-1]	['none']	_	_
47	numbers	_	_	NNS	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	indicate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	Sharpin	_	_	NN	Protein	[7]	['Theme']	_	_
7	mutation	_	_	NN	Negative_regulation	[0]	['root']	_	_
8	does	_	_	VBZ	O	[-1]	['none']	_	_
9	not	_	_	RB	O	[-1]	['none']	_	_
10	affect	_	_	VB	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	distribution	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	examined	_	_	JJ	O	[-1]	['none']	_	_
16	DC	_	_	NN	O	[-1]	['none']	_	_
17	subsets	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	spleen	_	_	NN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	BMDC	_	_	NN	O	[-1]	['none']	_	_
2	from	_	_	IN	O	[-1]	['none']	_	_
3	in	_	_	FW	O	[-1]	['none']	_	_
4	vitro	_	_	FW	O	[-1]	['none']	_	_
5	cultures	_	_	NNS	O	[-1]	['none']	_	_
6	functionally	_	_	RB	O	[-1]	['none']	_	_
7	resemble	_	_	VBP	O	[-1]	['none']	_	_
8	non	_	_	JJ	O	[-1]	['none']	_	_
9	lymphoid	_	_	JJ	O	[-1]	['none']	_	_
10	tissue	_	_	NN	O	[-1]	['none']	_	_
11	DC	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	monocyte	_	_	NN	O	[-1]	['none']	_	_
14	derived	_	_	VBN	O	[-1]	['none']	_	_
15	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
16	DC	_	_	NN	O	[-1]	['none']	_	_
17	[	_	_	VBP	O	[-1]	['none']	_	_
18	15	_	_	CD	O	[-1]	['none']	_	_
19	]	_	_	CD	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	[	_	_	CD	O	[-1]	['none']	_	_
22	16	_	_	CD	O	[-1]	['none']	_	_
23	]	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	yields	_	_	NNS	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	BMDC	_	_	NN	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	WT	_	_	NNP	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	cpdm	_	_	NN	O	[-1]	['none']	_	_
9	mice	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	similar	_	_	JJ	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	BMDC	_	_	NN	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	CD11c+	_	_	JJ	Protein	[0]	['root']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	MHC	_	_	NN	O	[-1]	['none']	_	_
6	II+	_	_	JJ	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	low	_	_	JJ	O	[-1]	['none']	_	_
9	expression	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	co-stimulatory	_	_	JJ	O	[-1]	['none']	_	_
12	molecules	_	_	NNS	O	[-1]	['none']	_	_
13	CD40	_	_	NN	Protein	[0]	['root']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	CD80	_	_	NN	Protein	[0]	['root']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	CD86	_	_	NN	Protein	[0]	['root']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	TLR3	_	_	NN	Protein	[3]	['Theme']	_	_
3	ligand	_	_	NN	Binding	[0]	['root']	_	_
4	poly	_	_	NN	O	[-1]	['none']	_	_
5	I	_	_	NN	O	[-1]	['none']	_	_
6	:	_	_	:	O	[-1]	['none']	_	_
7	C	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	TLR4	_	_	NN	Protein	[11]	['Theme']	_	_
11	ligand	_	_	NN	Binding	[0]	['root']	_	_
12	LPS	_	_	NN	O	[-1]	['none']	_	_
13	each	_	_	DT	O	[-1]	['none']	_	_
14	activate	_	_	VBP	O	[-1]	['none']	_	_
15	overlapping	_	_	VBG	O	[-1]	['none']	_	_
16	but	_	_	CC	O	[-1]	['none']	_	_
17	different	_	_	JJ	O	[-1]	['none']	_	_
18	signaling	_	_	NN	O	[-1]	['none']	_	_
19	pathways	_	_	NNS	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	were	_	_	VBD	O	[-1]	['none']	_	_
22	used	_	_	VBN	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	induce	_	_	VB	O	[-1]	['none']	_	_
25	DC	_	_	NN	O	[-1]	['none']	_	_
26	maturation	_	_	NN	O	[-1]	['none']	_	_
27	[	_	_	CD	O	[-1]	['none']	_	_
28	17	_	_	CD	O	[-1]	['none']	_	_
29	]	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	[	_	_	CD	O	[-1]	['none']	_	_
32	18	_	_	CD	O	[-1]	['none']	_	_
33	]	_	_	NN	O	[-1]	['none']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	Incubation	_	_	NN	O	[-1]	['none']	_	_
2	with	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	TLR	_	_	NN	O	[-1]	['none']	_	_
5	agonists	_	_	NNS	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	24	_	_	CD	O	[-1]	['none']	_	_
8	hours	_	_	NNS	O	[-1]	['none']	_	_
9	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	increased	_	_	VBN	Positive_regulation	[9]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[11]	['Theme']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	CD40	_	_	NN	Protein	[12, 31]	['Theme', 'Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	CD80	_	_	NN	Protein	[12, 31]	['Theme', 'Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	CD86	_	_	NN	Protein	[12, 31]	['Theme', 'Theme']	_	_
20	on	_	_	IN	O	[-1]	['none']	_	_
21	BMDC	_	_	NN	O	[-1]	['none']	_	_
22	;	_	_	:	O	[-1]	['none']	_	_
23	however	_	_	RB	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	there	_	_	EX	O	[-1]	['none']	_	_
26	was	_	_	VBD	O	[-1]	['none']	_	_
27	no	_	_	DT	O	[-1]	['none']	_	_
28	difference	_	_	NN	Regulation	[0]	['root']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	expression	_	_	NN	Gene_expression	[28]	['Theme']	_	_
32	levels	_	_	NNS	O	[-1]	['none']	_	_
33	of	_	_	IN	O	[-1]	['none']	_	_
34	these	_	_	DT	Anaphora	[35]	['multitoken']	_	_
35	markers	_	_	NNS	Anaphora	[0]	['root']	_	_
36	between	_	_	IN	O	[-1]	['none']	_	_
37	WT	_	_	NNP	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	cpdm	_	_	JJ	O	[-1]	['none']	_	_
40	BMDC	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	Thus	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	SHARPIN	_	_	NNP	Protein	[4]	['Theme']	_	_
4	deficiency	_	_	NN	Negative_regulation	[0]	['root']	_	_
5	did	_	_	VBD	O	[-1]	['none']	_	_
6	not	_	_	RB	O	[-1]	['none']	_	_
7	influence	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	expression	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	co-stimulatory	_	_	JJ	O	[-1]	['none']	_	_
12	molecules	_	_	NNS	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	BMDC	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Multiplex	_	_	JJ	O	[-1]	['none']	_	_
2	cytokine	_	_	NN	O	[-1]	['none']	_	_
3	assay	_	_	NN	O	[-1]	['none']	_	_
4	Quantification	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	levels	_	_	NNS	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	cytokines	_	_	NNS	O	[-1]	['none']	_	_
10	IL-2	_	_	NN	Protein	[0]	['root']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	IL-6	_	_	NN	Protein	[0]	['root']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	IL-10	_	_	NN	Protein	[0]	['root']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	TNF	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	chemokine	_	_	NN	O	[-1]	['none']	_	_
20	CXCL8	_	_	NN	Protein	[0]	['root']	_	_
21	was	_	_	VBD	O	[-1]	['none']	_	_
22	performed	_	_	VBN	O	[-1]	['none']	_	_
23	on	_	_	IN	O	[-1]	['none']	_	_
24	culture	_	_	NN	O	[-1]	['none']	_	_
25	supernatants	_	_	NNS	O	[-1]	['none']	_	_
26	using	_	_	VBG	O	[-1]	['none']	_	_
27	multiplexed	_	_	JJ	O	[-1]	['none']	_	_
28	biomarker	_	_	NN	O	[-1]	['none']	_	_
29	immunoassay	_	_	NN	O	[-1]	['none']	_	_
30	kits	_	_	NNS	O	[-1]	['none']	_	_
31	according	_	_	VBG	O	[-1]	['none']	_	_
32	to	_	_	TO	O	[-1]	['none']	_	_
33	manufacturer	_	_	NN	O	[-1]	['none']	_	_
34	's	_	_	POS	O	[-1]	['none']	_	_
35	instructions	_	_	NNS	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	Bio-Rad	_	_	NNP	O	[-1]	['none']	_	_
38	Laboratories	_	_	NNPS	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	Hercules	_	_	NNP	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	CA	_	_	NNP	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	Bio-Plex	_	_	JJ	O	[-1]	['none']	_	_
3	(	_	_	-LRB-	O	[-1]	['none']	_	_
4	TM	_	_	NN	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	200	_	_	CD	O	[-1]	['none']	_	_
7	readout	_	_	NN	O	[-1]	['none']	_	_
8	System	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	used	_	_	VBN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	Bio-Rad	_	_	NNP	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	which	_	_	WDT	O	[-1]	['none']	_	_
16	utilizes	_	_	VBZ	O	[-1]	['none']	_	_
17	Luminex	_	_	NNP	O	[-1]	['none']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	R	_	_	NN	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	xMAP	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	TM	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	fluorescent	_	_	JJ	O	[-1]	['none']	_	_
26	bead	_	_	NN	O	[-1]	['none']	_	_
27	based	_	_	VBN	O	[-1]	['none']	_	_
28	technology	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	Luminex	_	_	NNP	O	[-1]	['none']	_	_
31	Corp.	_	_	NNP	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	Austin	_	_	NNP	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Levels	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	automatically	_	_	RB	O	[-1]	['none']	_	_
4	calculated	_	_	VBN	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	standard	_	_	JJ	O	[-1]	['none']	_	_
7	curves	_	_	NNS	O	[-1]	['none']	_	_
8	using	_	_	VBG	O	[-1]	['none']	_	_
9	Bio-Plex	_	_	NNP	O	[-1]	['none']	_	_
10	Manager	_	_	NNP	O	[-1]	['none']	_	_
11	software	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	v.	_	_	CC	O	[-1]	['none']	_	_
14	4.1.1	_	_	CD	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	Bio-Rad	_	_	NNP	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vitro	_	_	FW	O	[-1]	['none']	_	_
3	methylation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	an	_	_	DT	O	[-1]	['none']	_	_
6	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
7	promoter	_	_	NN	O	[-1]	['none']	_	_
8	reporter	_	_	NN	O	[-1]	['none']	_	_
9	construct	_	_	NN	O	[-1]	['none']	_	_
10	decreases	_	_	VBZ	O	[-1]	['none']	_	_
11	its	_	_	PRP$	O	[-1]	['none']	_	_
12	activity	_	_	NN	O	[-1]	['none']	_	_
13	To	_	_	TO	O	[-1]	['none']	_	_
14	provide	_	_	VB	O	[-1]	['none']	_	_
15	evidence	_	_	NN	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	direct	_	_	JJ	O	[-1]	['none']	_	_
19	effect	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	methylational	_	_	JJ	O	[-1]	['none']	_	_
22	status	_	_	NN	O	[-1]	['none']	_	_
23	on	_	_	IN	O	[-1]	['none']	_	_
24	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
25	promoter	_	_	NN	O	[-1]	['none']	_	_
26	activity	_	_	NN	O	[-1]	['none']	_	_
27	we	_	_	PRP	O	[-1]	['none']	_	_
28	performed	_	_	VBD	O	[-1]	['none']	_	_
29	reporter	_	_	NN	O	[-1]	['none']	_	_
30	gene	_	_	NN	O	[-1]	['none']	_	_
31	assays	_	_	NNS	O	[-1]	['none']	_	_
32	with	_	_	IN	O	[-1]	['none']	_	_
33	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
34	promoter	_	_	NN	O	[-1]	['none']	_	_
35	constructs	_	_	NNS	O	[-1]	['none']	_	_
36	before	_	_	IN	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	after	_	_	IN	O	[-1]	['none']	_	_
39	their	_	_	PRP$	O	[-1]	['none']	_	_
40	in	_	_	FW	O	[-1]	['none']	_	_
41	vitro	_	_	FW	O	[-1]	['none']	_	_
42	methylation	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	complete	_	_	JJ	O	[-1]	['none']	_	_
3	methylation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	these	_	_	DT	O	[-1]	['none']	_	_
6	constructs	_	_	NNS	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	checked	_	_	VBN	O	[-1]	['none']	_	_
9	via	_	_	IN	O	[-1]	['none']	_	_
10	restriction	_	_	NN	O	[-1]	['none']	_	_
11	assays	_	_	NNS	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	methylation	_	_	NN	O	[-1]	['none']	_	_
14	sensitive	_	_	JJ	O	[-1]	['none']	_	_
15	endonucleases	_	_	NNS	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Intriguingly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	methylation	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	IRF-4	_	_	NN	Protein	[9]	['Theme']	_	_
7	promoter	_	_	NN	O	[-1]	['none']	_	_
8	significantly	_	_	RB	O	[-1]	['none']	_	_
9	decreased	_	_	VBD	Negative_regulation	[0]	['root']	_	_
10	promoter	_	_	NN	Entity	[9]	['Site']	_	_
11	activity	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
14	SD-1	_	_	NN	O	[-1]	['none']	_	_
15	cells	_	_	NNS	O	[-1]	['none']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	85.0	_	_	CD	O	[-1]	['none']	_	_
18	%	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	silencing	_	_	NN	O	[-1]	['none']	_	_
3	effect	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	CpG	_	_	NN	O	[-1]	['none']	_	_
6	methylation	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	restricted	_	_	JJ	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	IRF-4-positive	_	_	JJ	Gene_expression	[0]	['root']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	since	_	_	IN	O	[-1]	['none']	_	_
15	in	_	_	FW	O	[-1]	['none']	_	_
16	vitro	_	_	FW	O	[-1]	['none']	_	_
17	methylation	_	_	NN	O	[-1]	['none']	_	_
18	led	_	_	VBD	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	a	_	_	DT	O	[-1]	['none']	_	_
21	92.9	_	_	CD	O	[-1]	['none']	_	_
22	%	_	_	NN	O	[-1]	['none']	_	_
23	abrogation	_	_	NN	Negative_regulation	[0]	['root']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	promoter	_	_	NN	Entity	[23]	['Site']	_	_
26	activity	_	_	NN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	IRF-4-negative	_	_	JJ	Gene_expression	[0]	['root']	_	_
29	Jurkat	_	_	NN	O	[-1]	['none']	_	_
30	cells	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	contrast	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	control	_	_	NN	O	[-1]	['none']	_	_
5	methylation	_	_	NN	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	reporter	_	_	NN	O	[-1]	['none']	_	_
9	construct	_	_	NN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	different	_	_	JJ	O	[-1]	['none']	_	_
13	promoter	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	FasL	_	_	NN	Protein	[0]	['root']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	as	_	_	RB	O	[-1]	['none']	_	_
18	well	_	_	RB	O	[-1]	['none']	_	_
19	as	_	_	IN	O	[-1]	['none']	_	_
20	an	_	_	DT	O	[-1]	['none']	_	_
21	empty	_	_	JJ	O	[-1]	['none']	_	_
22	vector	_	_	NN	O	[-1]	['none']	_	_
23	had	_	_	VBD	O	[-1]	['none']	_	_
24	no	_	_	DT	O	[-1]	['none']	_	_
25	effect	_	_	NN	O	[-1]	['none']	_	_
26	on	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	reporter	_	_	NN	O	[-1]	['none']	_	_
29	activity	_	_	NN	O	[-1]	['none']	_	_
30	(	_	_	-LRB-	O	[-1]	['none']	_	_
31	data	_	_	NNS	O	[-1]	['none']	_	_
32	not	_	_	RB	O	[-1]	['none']	_	_
33	shown	_	_	VBN	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	data	_	_	NNS	O	[-1]	['none']	_	_
3	proved	_	_	VBD	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	direct	_	_	JJ	O	[-1]	['none']	_	_
6	association	_	_	NN	O	[-1]	['none']	_	_
7	between	_	_	IN	O	[-1]	['none']	_	_
8	methylation	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	activity	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	IRF-4	_	_	NN	Protein	[0]	['root']	_	_
14	promoter	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Human	_	_	NN	O	[-1]	['none']	_	_
2	Peripheral	_	_	JJ	O	[-1]	['none']	_	_
3	Blood	_	_	NN	O	[-1]	['none']	_	_
4	Mononuclear	_	_	JJ	O	[-1]	['none']	_	_
5	Cell	_	_	NN	O	[-1]	['none']	_	_
6	Isolation	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	Stimulation	_	_	NN	O	[-1]	['none']	_	_
9	Human	_	_	NN	O	[-1]	['none']	_	_
10	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	were	_	_	VBD	O	[-1]	['none']	_	_
13	isolated	_	_	VBN	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	peripheral	_	_	JJ	O	[-1]	['none']	_	_
17	blood	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	four	_	_	CD	O	[-1]	['none']	_	_
20	healthy	_	_	JJ	O	[-1]	['none']	_	_
21	human	_	_	NN	O	[-1]	['none']	_	_
22	volunteers	_	_	NNS	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	sample	_	_	NN	O	[-1]	['none']	_	_
3	size	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	chosen	_	_	VBN	O	[-1]	['none']	_	_
6	from	_	_	IN	O	[-1]	['none']	_	_
7	our	_	_	PRP$	O	[-1]	['none']	_	_
8	previously	_	_	RB	O	[-1]	['none']	_	_
9	published	_	_	VBN	O	[-1]	['none']	_	_
10	work	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	which	_	_	WDT	O	[-1]	['none']	_	_
13	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
14	reliable	_	_	JJ	O	[-1]	['none']	_	_
15	results	_	_	NNS	O	[-1]	['none']	_	_
16	.10	_	_	CD	O	[-1]	['none']	_	_
17	Cell	_	_	NN	O	[-1]	['none']	_	_
18	isolation	_	_	NN	O	[-1]	['none']	_	_
19	and	_	_	CC	O	[-1]	['none']	_	_
20	all	_	_	DT	O	[-1]	['none']	_	_
21	subsequent	_	_	JJ	O	[-1]	['none']	_	_
22	experiments	_	_	NNS	O	[-1]	['none']	_	_
23	were	_	_	VBD	O	[-1]	['none']	_	_
24	conducted	_	_	VBN	O	[-1]	['none']	_	_
25	under	_	_	IN	O	[-1]	['none']	_	_
26	sterile	_	_	JJ	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	pyrogen-free	_	_	JJ	O	[-1]	['none']	_	_
29	conditions	_	_	NNS	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Blood	_	_	NN	O	[-1]	['none']	_	_
2	collected	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	heparin	_	_	NN	O	[-1]	['none']	_	_
5	tubes	_	_	NNS	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	incubated	_	_	VBN	O	[-1]	['none']	_	_
8	with	_	_	IN	O	[-1]	['none']	_	_
9	Dextran	_	_	NN	O	[-1]	['none']	_	_
10	T500	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	red	_	_	JJ	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	sedimented	_	_	VBN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	40	_	_	CD	O	[-1]	['none']	_	_
19	minutes	_	_	NNS	O	[-1]	['none']	_	_
20	at	_	_	IN	O	[-1]	['none']	_	_
21	room	_	_	NN	O	[-1]	['none']	_	_
22	temperature	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	resultant	_	_	JJ	O	[-1]	['none']	_	_
3	serum	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	then	_	_	RB	O	[-1]	['none']	_	_
6	washed	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	HBSS	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	separated	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	Percoll	_	_	NN	O	[-1]	['none']	_	_
13	gradient	_	_	NN	O	[-1]	['none']	_	_
14	centrifugation	_	_	NN	O	[-1]	['none']	_	_
15	according	_	_	VBG	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	manufacturer	_	_	NN	O	[-1]	['none']	_	_
19	's	_	_	POS	O	[-1]	['none']	_	_
20	instructions	_	_	NNS	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Cell	_	_	NN	O	[-1]	['none']	_	_
2	viability	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	assessed	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	trypan	_	_	NN	O	[-1]	['none']	_	_
7	blue	_	_	JJ	O	[-1]	['none']	_	_
8	dye	_	_	VB	O	[-1]	['none']	_	_
9	exclusion	_	_	NN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	purity	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	greater	_	_	JJR	O	[-1]	['none']	_	_
15	than	_	_	IN	O	[-1]	['none']	_	_
16	95	_	_	CD	O	[-1]	['none']	_	_
17	%	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Isolated	_	_	VBN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	resuspended	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	RPMI	_	_	NN	O	[-1]	['none']	_	_
7	1640	_	_	CD	O	[-1]	['none']	_	_
8	supplemented	_	_	VBN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	10	_	_	CD	O	[-1]	['none']	_	_
11	%	_	_	NN	O	[-1]	['none']	_	_
12	FBS	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	5	_	_	CD	O	[-1]	['none']	_	_
15	mM	_	_	NN	O	[-1]	['none']	_	_
16	HEPES	_	_	NN	O	[-1]	['none']	_	_
17	at	_	_	IN	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	concentration	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	1	_	_	CD	O	[-1]	['none']	_	_
22	x	_	_	CC	O	[-1]	['none']	_	_
23	107cells/mL	_	_	NN	O	[-1]	['none']	_	_
24	.	_	_	.	O	[-1]	['none']	_	_

1	Each	_	_	DT	O	[-1]	['none']	_	_
2	subsequent	_	_	JJ	O	[-1]	['none']	_	_
3	experiment	_	_	NN	O	[-1]	['none']	_	_
4	listed	_	_	VBN	O	[-1]	['none']	_	_
5	below	_	_	RB	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	conducted	_	_	VBN	O	[-1]	['none']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	samples	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	5	_	_	CD	O	[-1]	['none']	_	_
12	x	_	_	CC	O	[-1]	['none']	_	_
13	106	_	_	CD	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	per	_	_	IN	O	[-1]	['none']	_	_
16	treatment	_	_	NN	O	[-1]	['none']	_	_
17	group	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Isolated	_	_	VBN	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	stimulated	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	either	_	_	CC	O	[-1]	['none']	_	_
7	HBSS	_	_	NN	O	[-1]	['none']	_	_
8	as	_	_	IN	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	negative	_	_	JJ	O	[-1]	['none']	_	_
11	control	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	LPS	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	1	_	_	CD	O	[-1]	['none']	_	_
16	mug/mL	_	_	NN	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	PTX	_	_	NN	O	[-1]	['none']	_	_
20	(	_	_	-LRB-	O	[-1]	['none']	_	_
21	20	_	_	CD	O	[-1]	['none']	_	_
22	mM	_	_	NN	O	[-1]	['none']	_	_
23	)	_	_	-RRB-	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	concomitant	_	_	JJ	O	[-1]	['none']	_	_
27	LPS	_	_	NN	O	[-1]	['none']	_	_
28	/	_	_	:	O	[-1]	['none']	_	_
29	PTX	_	_	NN	O	[-1]	['none']	_	_
30	,	_	_	,	O	[-1]	['none']	_	_
31	at	_	_	IN	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	above	_	_	JJ	O	[-1]	['none']	_	_
34	mentioned	_	_	VBN	O	[-1]	['none']	_	_
35	concentrations	_	_	NNS	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	for	_	_	IN	O	[-1]	['none']	_	_
38	30	_	_	CD	O	[-1]	['none']	_	_
39	minutes	_	_	NNS	O	[-1]	['none']	_	_
40	at	_	_	IN	O	[-1]	['none']	_	_
41	37degreesC	_	_	NN	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	placed	_	_	VBN	O	[-1]	['none']	_	_
4	on	_	_	IN	O	[-1]	['none']	_	_
5	ice	_	_	NN	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	10	_	_	CD	O	[-1]	['none']	_	_
8	minutes	_	_	NNS	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	stop	_	_	VB	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	reaction	_	_	NN	O	[-1]	['none']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	samples	_	_	NNS	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	then	_	_	RB	O	[-1]	['none']	_	_
18	stored	_	_	VBN	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	-70	_	_	CD	O	[-1]	['none']	_	_
21	degreesC	_	_	NN	O	[-1]	['none']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	further	_	_	JJ	O	[-1]	['none']	_	_
24	analysis	_	_	NN	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	stimulation	_	_	NN	O	[-1]	['none']	_	_
3	times	_	_	NNS	O	[-1]	['none']	_	_
4	and	_	_	CC	O	[-1]	['none']	_	_
5	concentrations	_	_	NNS	O	[-1]	['none']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	LPS	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	PTX	_	_	NN	O	[-1]	['none']	_	_
10	utilized	_	_	VBD	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	this	_	_	DT	O	[-1]	['none']	_	_
13	study	_	_	NN	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	determined	_	_	VBN	O	[-1]	['none']	_	_
16	in	_	_	IN	O	[-1]	['none']	_	_
17	previous	_	_	JJ	O	[-1]	['none']	_	_
18	pilot	_	_	NN	O	[-1]	['none']	_	_
19	studies	_	_	NNS	O	[-1]	['none']	_	_
20	done	_	_	VBN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	our	_	_	PRP$	O	[-1]	['none']	_	_
23	laboratory	_	_	NN	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	which	_	_	WDT	O	[-1]	['none']	_	_
26	examined	_	_	VBD	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	effects	_	_	NNS	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	increasing	_	_	VBG	O	[-1]	['none']	_	_
31	concentrations	_	_	NNS	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	PTX	_	_	NN	O	[-1]	['none']	_	_
34	on	_	_	IN	O	[-1]	['none']	_	_
35	LPS	_	_	NN	O	[-1]	['none']	_	_
36	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
37	TNF-alpha	_	_	NN	Protein	[38]	['Theme']	_	_
38	production	_	_	NN	Gene_expression	[36]	['Theme']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	LPS	_	_	NN	O	[-1]	['none']	_	_
2	at	_	_	IN	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	concentration	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	1	_	_	CD	O	[-1]	['none']	_	_
7	mug/mL	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	PTX	_	_	NN	O	[-1]	['none']	_	_
10	at	_	_	IN	O	[-1]	['none']	_	_
11	a	_	_	DT	O	[-1]	['none']	_	_
12	concentration	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	20	_	_	CD	O	[-1]	['none']	_	_
15	mM	_	_	NN	O	[-1]	['none']	_	_
16	were	_	_	VBD	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	minimum	_	_	JJ	O	[-1]	['none']	_	_
19	concentrations	_	_	NNS	O	[-1]	['none']	_	_
20	necessary	_	_	JJ	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	produce	_	_	VB	O	[-1]	['none']	_	_
23	a	_	_	DT	O	[-1]	['none']	_	_
24	reproducible	_	_	JJ	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	reliable	_	_	JJ	O	[-1]	['none']	_	_
27	up-regulation	_	_	NN	Positive_regulation	[0]	['root']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	down-regulation	_	_	NN	Negative_regulation	[0]	['root']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	TNF-alpha	_	_	NN	Protein	[32]	['Theme']	_	_
32	production	_	_	NN	Gene_expression	[27, 29]	['Theme', 'Theme']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	respectively	_	_	RB	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	quantitative	_	_	JJ	O	[-1]	['none']	_	_
38	assays	_	_	NNS	O	[-1]	['none']	_	_
39	(	_	_	-LRB-	O	[-1]	['none']	_	_
40	data	_	_	NNS	O	[-1]	['none']	_	_
41	not	_	_	RB	O	[-1]	['none']	_	_
42	shown	_	_	VBN	O	[-1]	['none']	_	_
43	)	_	_	-RRB-	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
2	Suppresses	_	_	VBZ	O	[-1]	['none']	_	_
3	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
4	Dependent	_	_	JJ	O	[-1]	['none']	_	_
5	Transcriptional	_	_	JJ	O	[-1]	['none']	_	_
6	Activation	_	_	NN	O	[-1]	['none']	_	_
7	To	_	_	TO	O	[-1]	['none']	_	_
8	ascertain	_	_	VB	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	molecular	_	_	JJ	O	[-1]	['none']	_	_
11	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	which	_	_	WDT	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
15	functions	_	_	VBZ	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	promote	_	_	VB	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	regulatory	_	_	JJ	O	[-1]	['none']	_	_
20	function	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
23	CD25hi	_	_	NN	Protein	[0]	['root']	_	_
24	T	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	we	_	_	PRP	O	[-1]	['none']	_	_
28	first	_	_	RB	O	[-1]	['none']	_	_
29	confirmed	_	_	VBD	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	function	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
34	as	_	_	IN	O	[-1]	['none']	_	_
35	a	_	_	DT	O	[-1]	['none']	_	_
36	repressor	_	_	NN	O	[-1]	['none']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	activation	_	_	NN	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	previously	_	_	RB	O	[-1]	['none']	_	_
43	implicated	_	_	VBN	O	[-1]	['none']	_	_
44	as	_	_	IN	O	[-1]	['none']	_	_
45	a	_	_	DT	O	[-1]	['none']	_	_
46	target	_	_	NN	O	[-1]	['none']	_	_
47	of	_	_	IN	O	[-1]	['none']	_	_
48	other	_	_	JJ	O	[-1]	['none']	_	_
49	forkhead	_	_	NN	O	[-1]	['none']	_	_
50	and	_	_	CC	O	[-1]	['none']	_	_
51	winged-helix	_	_	NN	O	[-1]	['none']	_	_
52	family	_	_	NN	O	[-1]	['none']	_	_
53	transcription	_	_	NN	O	[-1]	['none']	_	_
54	factors	_	_	NNS	O	[-1]	['none']	_	_
55	(	_	_	-LRB-	O	[-1]	['none']	_	_
56	e.g.	_	_	FW	O	[-1]	['none']	_	_
57	,	_	_	,	O	[-1]	['none']	_	_
58	Foxj1	_	_	NN	Protein	[0]	['root']	_	_
59	and	_	_	CC	O	[-1]	['none']	_	_
60	Foxo3a	_	_	NN	Protein	[0]	['root']	_	_
61	)	_	_	-RRB-	O	[-1]	['none']	_	_
62	[	_	_	CD	O	[-1]	['none']	_	_
63	19,20	_	_	CD	O	[-1]	['none']	_	_
64	]	_	_	NN	O	[-1]	['none']	_	_
65	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	analyzed	_	_	VBD	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	effect	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Foxp3	_	_	NN	Protein	[7]	['Theme']	_	_
7	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
10	activation	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	HEK	_	_	NNP	O	[-1]	['none']	_	_
13	293T	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	in	_	_	IN	O	[-1]	['none']	_	_
16	dose	_	_	NN	O	[-1]	['none']	_	_
17	response	_	_	NN	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	time	_	_	NN	O	[-1]	['none']	_	_
20	course	_	_	NN	O	[-1]	['none']	_	_
21	analyses	_	_	NNS	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Transfection	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	HEK	_	_	NNP	O	[-1]	['none']	_	_
4	293T	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	with	_	_	IN	O	[-1]	['none']	_	_
7	an	_	_	DT	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	luciferase	_	_	NN	Protein	[0]	['root']	_	_
10	reporter	_	_	NN	O	[-1]	['none']	_	_
11	vector	_	_	NN	O	[-1]	['none']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	presence	_	_	NN	O	[-1]	['none']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	absence	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	increasing	_	_	VBG	O	[-1]	['none']	_	_
19	concentrations	_	_	NNS	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	Foxp3	_	_	NN	Protein	[23]	['Theme']	_	_
23	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
24	vector	_	_	NN	O	[-1]	['none']	_	_
25	or	_	_	CC	O	[-1]	['none']	_	_
26	a	_	_	DT	O	[-1]	['none']	_	_
27	control	_	_	NN	O	[-1]	['none']	_	_
28	vector	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	enhanced	_	_	VBD	O	[-1]	['none']	_	_
31	green	_	_	JJ	Protein	[33]	['multitoken']	_	_
32	fluorescent	_	_	JJ	Protein	[33]	['multitoken']	_	_
33	protein	_	_	NN	Protein	[0]	['root']	_	_
34	[	_	_	CD	O	[-1]	['none']	_	_
35	EGFP	_	_	NN	O	[-1]	['none']	_	_
36	]	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	was	_	_	VBD	O	[-1]	['none']	_	_
39	performed	_	_	VBN	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	cells	_	_	NNS	O	[-1]	['none']	_	_
43	were	_	_	VBD	O	[-1]	['none']	_	_
44	harvested	_	_	VBN	O	[-1]	['none']	_	_
45	after	_	_	IN	O	[-1]	['none']	_	_
46	24	_	_	CD	O	[-1]	['none']	_	_
47	h	_	_	NN	O	[-1]	['none']	_	_
48	to	_	_	TO	O	[-1]	['none']	_	_
49	assay	_	_	NN	O	[-1]	['none']	_	_
50	for	_	_	IN	O	[-1]	['none']	_	_
51	luciferase	_	_	NN	Protein	[0]	['root']	_	_
52	activity	_	_	NN	O	[-1]	['none']	_	_
53	and	_	_	CC	O	[-1]	['none']	_	_
54	Foxp3	_	_	NN	Protein	[56]	['Theme']	_	_
55	mRNA	_	_	NN	Transcription	[56]	['multitoken']	_	_
56	expression	_	_	NN	Transcription	[0]	['root']	_	_
57	.	_	_	.	O	[-1]	['none']	_	_

1	Results	_	_	NNS	O	[-1]	['none']	_	_
2	indicated	_	_	VBD	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	concentration	_	_	NN	Gene_expression	[12]	['Theme']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[6]	['Theme']	_	_
9	transfected	_	_	VBN	O	[-1]	['none']	_	_
10	into	_	_	IN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	increases	_	_	VBZ	Positive_regulation	[0]	['root']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	from	_	_	IN	O	[-1]	['none']	_	_
15	50	_	_	CD	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	2,400	_	_	CD	O	[-1]	['none']	_	_
18	ng	_	_	NN	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	level	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	activation	_	_	NN	O	[-1]	['none']	_	_
26	decreases	_	_	VBZ	O	[-1]	['none']	_	_
27	proportionally	_	_	RB	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
2	mRNA	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	also	_	_	RB	O	[-1]	['none']	_	_
5	assayed	_	_	VBN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	monitor	_	_	VB	O	[-1]	['none']	_	_
8	activity	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	Foxp3	_	_	NN	Protein	[12]	['Theme']	_	_
12	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
13	vector	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
3	activation	_	_	NN	O	[-1]	['none']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	partially	_	_	RB	O	[-1]	['none']	_	_
6	affected	_	_	VBN	O	[-1]	['none']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	transfection	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	high	_	_	JJ	O	[-1]	['none']	_	_
11	concentrations	_	_	NNS	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	control	_	_	NN	O	[-1]	['none']	_	_
15	vector	_	_	NN	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	we	_	_	PRP	O	[-1]	['none']	_	_
18	determined	_	_	VBD	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	fold	_	_	JJ	O	[-1]	['none']	_	_
21	inhibition	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
24	activation	_	_	NN	O	[-1]	['none']	_	_
25	by	_	_	IN	O	[-1]	['none']	_	_
26	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
27	compared	_	_	VBN	O	[-1]	['none']	_	_
28	to	_	_	TO	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	control	_	_	NN	O	[-1]	['none']	_	_
31	vector	_	_	NN	O	[-1]	['none']	_	_
32	at	_	_	IN	O	[-1]	['none']	_	_
33	each	_	_	DT	O	[-1]	['none']	_	_
34	concentration	_	_	NN	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	Fold	_	_	JJ	O	[-1]	['none']	_	_
2	inhibition	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
5	activation	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	directly	_	_	RB	O	[-1]	['none']	_	_
8	proportional	_	_	JJ	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	level	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	Foxp3	_	_	NN	Protein	[15]	['Theme']	_	_
14	mRNA	_	_	NN	Transcription	[15]	['multitoken']	_	_
15	expression	_	_	NN	Transcription	[0]	['root']	_	_
16	detected	_	_	VBN	O	[-1]	['none']	_	_
17	by	_	_	IN	O	[-1]	['none']	_	_
18	real-time	_	_	JJ	O	[-1]	['none']	_	_
19	RT-PCR	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	determine	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	level	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
7	mediated	_	_	VBD	O	[-1]	['none']	_	_
8	suppression	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	over	_	_	IN	O	[-1]	['none']	_	_
13	time	_	_	NN	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	HEK	_	_	NNP	O	[-1]	['none']	_	_
16	293T	_	_	NN	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	were	_	_	VBD	O	[-1]	['none']	_	_
19	transfected	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	an	_	_	DT	O	[-1]	['none']	_	_
22	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
23	luciferase	_	_	NN	Protein	[0]	['root']	_	_
24	reporter	_	_	NN	O	[-1]	['none']	_	_
25	vector	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	an	_	_	DT	O	[-1]	['none']	_	_
28	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
29	vector	_	_	NN	O	[-1]	['none']	_	_
30	encoding	_	_	VBG	O	[-1]	['none']	_	_
31	Foxp3	_	_	NN	Protein	[28]	['Theme']	_	_
32	or	_	_	CC	O	[-1]	['none']	_	_
33	EGFP	_	_	NN	O	[-1]	['none']	_	_
34	(	_	_	-LRB-	O	[-1]	['none']	_	_
35	control	_	_	NN	O	[-1]	['none']	_	_
36	vector	_	_	NN	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	harvested	_	_	VBN	O	[-1]	['none']	_	_
40	over	_	_	IN	O	[-1]	['none']	_	_
41	4	_	_	CD	O	[-1]	['none']	_	_
42	d	_	_	NN	O	[-1]	['none']	_	_
43	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	1C	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
8	activation	_	_	NN	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	suppressed	_	_	VBN	O	[-1]	['none']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[12]	['Theme']	_	_
15	at	_	_	IN	O	[-1]	['none']	_	_
16	all	_	_	DT	O	[-1]	['none']	_	_
17	time	_	_	NN	O	[-1]	['none']	_	_
18	points	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Extending	_	_	VBG	O	[-1]	['none']	_	_
2	these	_	_	DT	O	[-1]	['none']	_	_
3	results	_	_	NNS	O	[-1]	['none']	_	_
4	from	_	_	IN	O	[-1]	['none']	_	_
5	established	_	_	VBN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	in	_	_	FW	O	[-1]	['none']	_	_
8	vitro	_	_	FW	O	[-1]	['none']	_	_
9	HEK	_	_	NN	O	[-1]	['none']	_	_
10	cell	_	_	NN	O	[-1]	['none']	_	_
11	lines	_	_	NNS	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	primary	_	_	JJ	O	[-1]	['none']	_	_
14	human	_	_	NN	O	[-1]	['none']	_	_
15	lymphocytes	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	Foxp3	_	_	NN	Protein	[17]	['Theme']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	purified	_	_	VBN	O	[-1]	['none']	_	_
22	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
23	T	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	from	_	_	IN	O	[-1]	['none']	_	_
26	three	_	_	CD	O	[-1]	['none']	_	_
27	healthy	_	_	JJ	O	[-1]	['none']	_	_
28	donors	_	_	NNS	O	[-1]	['none']	_	_
29	also	_	_	RB	O	[-1]	['none']	_	_
30	down-regulated	_	_	VBD	O	[-1]	['none']	_	_
31	the	_	_	DT	O	[-1]	['none']	_	_
32	steady-state	_	_	JJ	O	[-1]	['none']	_	_
33	level	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
36	activation	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	recapitulate	_	_	VBP	O	[-1]	['none']	_	_
4	those	_	_	DT	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	Bettelli	_	_	NNP	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	colleagues	_	_	NNS	O	[-1]	['none']	_	_
9	[	_	_	VBP	O	[-1]	['none']	_	_
10	15	_	_	CD	O	[-1]	['none']	_	_
11	]	_	_	CD	O	[-1]	['none']	_	_
12	demonstrating	_	_	VBG	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
15	functions	_	_	NNS	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	part	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	block	_	_	VB	O	[-1]	['none']	_	_
22	NF-kappaB-dependent	_	_	JJ	O	[-1]	['none']	_	_
23	transcription	_	_	NN	O	[-1]	['none']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	human	_	_	NN	O	[-1]	['none']	_	_
26	cell	_	_	NN	O	[-1]	['none']	_	_
27	lines	_	_	NNS	O	[-1]	['none']	_	_
28	as	_	_	RB	O	[-1]	['none']	_	_
29	well	_	_	RB	O	[-1]	['none']	_	_
30	as	_	_	IN	O	[-1]	['none']	_	_
31	in	_	_	IN	O	[-1]	['none']	_	_
32	primary	_	_	JJ	O	[-1]	['none']	_	_
33	human	_	_	NN	O	[-1]	['none']	_	_
34	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
35	T	_	_	NN	O	[-1]	['none']	_	_
36	cells	_	_	NNS	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	Analysis	_	_	NN	O	[-1]	['none']	_	_
3	Statistical	_	_	JJ	O	[-1]	['none']	_	_
4	comparisons	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	performed	_	_	VBN	O	[-1]	['none']	_	_
7	using	_	_	VBG	O	[-1]	['none']	_	_
8	analysis	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	variance	_	_	NN	O	[-1]	['none']	_	_
11	testing	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	Minitab	_	_	NNP	O	[-1]	['none']	_	_
14	software	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	State	_	_	NNP	O	[-1]	['none']	_	_
17	Park	_	_	NNP	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	PA	_	_	NN	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	SPSS16	_	_	NN	O	[-1]	['none']	_	_
22	software	_	_	NN	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	SPSS	_	_	NNP	O	[-1]	['none']	_	_
25	Inc.	_	_	NNP	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Chicago	_	_	NNP	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	IL	_	_	NN	O	[-1]	['none']	_	_
4	)	_	_	-RRB-	O	[-1]	['none']	_	_
5	.	_	_	.	O	[-1]	['none']	_	_

1	Statistical	_	_	JJ	O	[-1]	['none']	_	_
2	significance	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	defined	_	_	VBN	O	[-1]	['none']	_	_
5	as	_	_	IN	O	[-1]	['none']	_	_
6	p	_	_	NN	O	[-1]	['none']	_	_
7	<	_	_	JJR	O	[-1]	['none']	_	_
8	=	_	_	JJ	O	[-1]	['none']	_	_
9	0.05	_	_	CD	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	Purification	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Peripheral	_	_	JJ	O	[-1]	['none']	_	_
4	Blood	_	_	NN	O	[-1]	['none']	_	_
5	Monocytes	_	_	NNS	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	Monocyte	_	_	NN	O	[-1]	['none']	_	_
8	Derived	_	_	JJ	O	[-1]	['none']	_	_
9	Macrophages	_	_	NNS	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	MDMs	_	_	NNS	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	Monocytes	_	_	NNS	O	[-1]	['none']	_	_
14	were	_	_	VBD	O	[-1]	['none']	_	_
15	isolated	_	_	VBN	O	[-1]	['none']	_	_
16	from	_	_	IN	O	[-1]	['none']	_	_
17	source	_	_	NN	O	[-1]	['none']	_	_
18	leukocyte	_	_	NN	O	[-1]	['none']	_	_
19	packs	_	_	VBZ	O	[-1]	['none']	_	_
20	obtained	_	_	VBN	O	[-1]	['none']	_	_
21	from	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	American	_	_	NNP	O	[-1]	['none']	_	_
24	Red	_	_	NNP	O	[-1]	['none']	_	_
25	Cross	_	_	NNP	O	[-1]	['none']	_	_
26	as	_	_	IN	O	[-1]	['none']	_	_
27	described	_	_	VBN	O	[-1]	['none']	_	_
28	previously	_	_	RB	O	[-1]	['none']	_	_
29	[	_	_	CD	O	[-1]	['none']	_	_
30	51	_	_	CD	O	[-1]	['none']	_	_
31	]	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Monocytes	_	_	NNS	O	[-1]	['none']	_	_
2	used	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	real	_	_	JJ	O	[-1]	['none']	_	_
5	time	_	_	NN	O	[-1]	['none']	_	_
6	PCR	_	_	NN	O	[-1]	['none']	_	_
7	experiments	_	_	NNS	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	transfection	_	_	NN	O	[-1]	['none']	_	_
10	experiments	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	purified	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	positive	_	_	JJ	O	[-1]	['none']	_	_
15	selection	_	_	NN	O	[-1]	['none']	_	_
16	using	_	_	VBG	O	[-1]	['none']	_	_
17	CD14	_	_	NN	Protein	[0]	['root']	_	_
18	Monocyte	_	_	NN	O	[-1]	['none']	_	_
19	Isolation	_	_	NN	O	[-1]	['none']	_	_
20	Kit	_	_	NN	O	[-1]	['none']	_	_
21	from	_	_	IN	O	[-1]	['none']	_	_
22	Miltenyi	_	_	NNP	O	[-1]	['none']	_	_
23	Biotech	_	_	NNP	O	[-1]	['none']	_	_
24	(	_	_	-LRB-	O	[-1]	['none']	_	_
25	Auburn	_	_	NNP	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	CA	_	_	NNP	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	>	_	_	JJR	O	[-1]	['none']	_	_
31	90	_	_	CD	O	[-1]	['none']	_	_
32	%	_	_	NN	O	[-1]	['none']	_	_
33	pure	_	_	JJ	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	some	_	_	DT	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	monocytes	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	isolated	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	clumping	_	_	VBG	O	[-1]	['none']	_	_
10	method	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	70	_	_	CD	O	[-1]	['none']	_	_
13	%	_	_	NN	O	[-1]	['none']	_	_
14	pure	_	_	JJ	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	obtain	_	_	VB	O	[-1]	['none']	_	_
3	monocyte	_	_	NN	O	[-1]	['none']	_	_
4	derived	_	_	VBN	O	[-1]	['none']	_	_
5	macrophages	_	_	NNS	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	MDMs	_	_	NNS	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	monocytes	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	cultured	_	_	VBN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	RPMI-1640	_	_	JJ	O	[-1]	['none']	_	_
15	medium	_	_	NN	O	[-1]	['none']	_	_
16	containing	_	_	VBG	O	[-1]	['none']	_	_
17	10	_	_	CD	O	[-1]	['none']	_	_
18	%	_	_	NN	O	[-1]	['none']	_	_
19	FBS	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	10	_	_	CD	O	[-1]	['none']	_	_
23	microg/ml	_	_	NN	O	[-1]	['none']	_	_
24	polymyxin	_	_	NN	O	[-1]	['none']	_	_
25	B	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	20	_	_	CD	O	[-1]	['none']	_	_
28	ng/ml	_	_	NN	O	[-1]	['none']	_	_
29	M-CSF	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Immunoblots	_	_	NNS	O	[-1]	['none']	_	_
2	After	_	_	IN	O	[-1]	['none']	_	_
3	adding	_	_	VBG	O	[-1]	['none']	_	_
4	stimulating	_	_	VBG	O	[-1]	['none']	_	_
5	ligands	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	100	_	_	CD	O	[-1]	['none']	_	_
8	ng/mL	_	_	NN	O	[-1]	['none']	_	_
9	LPS	_	_	NN	O	[-1]	['none']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	25	_	_	CD	O	[-1]	['none']	_	_
12	microg/mL	_	_	NN	O	[-1]	['none']	_	_
13	poly	_	_	NN	O	[-1]	['none']	_	_
14	I	_	_	NN	O	[-1]	['none']	_	_
15	:	_	_	:	O	[-1]	['none']	_	_
16	C	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	BMDC	_	_	NN	O	[-1]	['none']	_	_
19	were	_	_	VBD	O	[-1]	['none']	_	_
20	collected	_	_	VBN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	lysed	_	_	VBN	O	[-1]	['none']	_	_
23	at	_	_	IN	O	[-1]	['none']	_	_
24	0-,	_	_	CD	O	[-1]	['none']	_	_
25	15-,	_	_	CD	O	[-1]	['none']	_	_
26	30-,	_	_	CD	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	60-minute	_	_	JJ	O	[-1]	['none']	_	_
29	time	_	_	NN	O	[-1]	['none']	_	_
30	points	_	_	NNS	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Immunoblots	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	performed	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	antibodies	_	_	NNS	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	Cell	_	_	NN	O	[-1]	['none']	_	_
8	Signaling	_	_	NN	O	[-1]	['none']	_	_
9	Technology	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	against	_	_	IN	O	[-1]	['none']	_	_
12	p-IKK1/2	_	_	NN	Protein	[0]	['root']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	#	_	_	#	O	[-1]	['none']	_	_
15	2697	_	_	CD	O	[-1]	['none']	_	_
16	)	_	_	-RRB-	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	p-IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
19	(	_	_	-LRB-	O	[-1]	['none']	_	_
20	#	_	_	#	O	[-1]	['none']	_	_
21	9246	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	IkappaBalpha	_	_	NN	Protein	[0]	['root']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	#	_	_	#	O	[-1]	['none']	_	_
27	4814	_	_	CD	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	p-TBK1	_	_	NN	Protein	[0]	['root']	_	_
31	(	_	_	-LRB-	O	[-1]	['none']	_	_
32	#	_	_	#	O	[-1]	['none']	_	_
33	5483	_	_	CD	O	[-1]	['none']	_	_
34	)	_	_	-RRB-	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	p-p38	_	_	JJ	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	#	_	_	#	O	[-1]	['none']	_	_
39	9216	_	_	CD	O	[-1]	['none']	_	_
40	)	_	_	-RRB-	O	[-1]	['none']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	p38	_	_	NN	O	[-1]	['none']	_	_
43	(	_	_	-LRB-	O	[-1]	['none']	_	_
44	#	_	_	#	O	[-1]	['none']	_	_
45	9212	_	_	CD	O	[-1]	['none']	_	_
46	)	_	_	-RRB-	O	[-1]	['none']	_	_
47	,	_	_	,	O	[-1]	['none']	_	_
48	p-ERK1/2	_	_	NN	Protein	[0]	['root']	_	_
49	(	_	_	-LRB-	O	[-1]	['none']	_	_
50	#	_	_	#	O	[-1]	['none']	_	_
51	4376	_	_	CD	O	[-1]	['none']	_	_
52	)	_	_	-RRB-	O	[-1]	['none']	_	_
53	,	_	_	,	O	[-1]	['none']	_	_
54	and	_	_	CC	O	[-1]	['none']	_	_
55	ERK1/2	_	_	NN	Protein	[0]	['root']	_	_
56	(	_	_	-LRB-	O	[-1]	['none']	_	_
57	#	_	_	#	O	[-1]	['none']	_	_
58	4695	_	_	CD	O	[-1]	['none']	_	_
59	)	_	_	-RRB-	O	[-1]	['none']	_	_
60	.	_	_	.	O	[-1]	['none']	_	_

1	Beta-actin	_	_	JJ	Protein	[0]	['root']	_	_
2	(	_	_	-LRB-	O	[-1]	['none']	_	_
3	sc-47778	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	Santa	_	_	NNP	O	[-1]	['none']	_	_
6	Cruz	_	_	NNP	O	[-1]	['none']	_	_
7	Biotechnology	_	_	NNP	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	was	_	_	VBD	O	[-1]	['none']	_	_
10	used	_	_	VBN	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	loading	_	_	VBG	O	[-1]	['none']	_	_
13	control	_	_	NN	O	[-1]	['none']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
2	Represses	_	_	VBZ	O	[-1]	['none']	_	_
3	Retroviral	_	_	JJ	O	[-1]	['none']	_	_
4	Transcription	_	_	NN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	Targeting	_	_	NN	O	[-1]	['none']	_	_
7	Both	_	_	CC	O	[-1]	['none']	_	_
8	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	CREB	_	_	NN	O	[-1]	['none']	_	_
11	Pathways	_	_	NNPS	O	[-1]	['none']	_	_
12	Forkhead	_	_	NNP	O	[-1]	['none']	_	_
13	box	_	_	NN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Fox	_	_	NNP	O	[-1]	['none']	_	_
16	)/winged-helix	_	_	JJ	O	[-1]	['none']	_	_
17	transcription	_	_	NN	O	[-1]	['none']	_	_
18	factors	_	_	NNS	O	[-1]	['none']	_	_
19	regulate	_	_	VBP	O	[-1]	['none']	_	_
20	multiple	_	_	JJ	O	[-1]	['none']	_	_
21	aspects	_	_	NNS	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	immune	_	_	JJ	O	[-1]	['none']	_	_
24	responsiveness	_	_	NN	O	[-1]	['none']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
27	is	_	_	VBZ	O	[-1]	['none']	_	_
28	recognized	_	_	VBN	O	[-1]	['none']	_	_
29	as	_	_	IN	O	[-1]	['none']	_	_
30	an	_	_	DT	O	[-1]	['none']	_	_
31	essential	_	_	JJ	O	[-1]	['none']	_	_
32	functional	_	_	JJ	O	[-1]	['none']	_	_
33	marker	_	_	NN	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	regulatory	_	_	JJ	O	[-1]	['none']	_	_
36	T	_	_	NN	O	[-1]	['none']	_	_
37	cells	_	_	NNS	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Herein	_	_	RB	O	[-1]	['none']	_	_
2	we	_	_	PRP	O	[-1]	['none']	_	_
3	describe	_	_	VBP	O	[-1]	['none']	_	_
4	downstream	_	_	JJ	O	[-1]	['none']	_	_
5	signaling	_	_	NN	O	[-1]	['none']	_	_
6	pathways	_	_	NNS	O	[-1]	['none']	_	_
7	targeted	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
10	that	_	_	WDT	O	[-1]	['none']	_	_
11	may	_	_	MD	O	[-1]	['none']	_	_
12	negatively	_	_	RB	O	[-1]	['none']	_	_
13	impact	_	_	VB	O	[-1]	['none']	_	_
14	retroviral	_	_	JJ	O	[-1]	['none']	_	_
15	pathogenesis	_	_	NN	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	Overexpression	_	_	NN	Positive_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Foxp3	_	_	NN	Protein	[1]	['Theme']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	HEK	_	_	NNP	O	[-1]	['none']	_	_
6	293T	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	purified	_	_	VBN	O	[-1]	['none']	_	_
9	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
10	T	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	resulted	_	_	VBD	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	dose	_	_	NN	O	[-1]	['none']	_	_
16	dependent	_	_	JJ	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	time	_	_	NN	O	[-1]	['none']	_	_
19	dependent	_	_	JJ	O	[-1]	['none']	_	_
20	decrease	_	_	NN	O	[-1]	['none']	_	_
21	in	_	_	IN	O	[-1]	['none']	_	_
22	basal	_	_	JJ	O	[-1]	['none']	_	_
23	levels	_	_	NNS	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	nuclear	_	_	JJ	O	[-1]	['none']	_	_
26	factor-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	activation	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	Deletion	_	_	NN	Negative_regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	carboxyl-terminal	_	_	JJ	Entity	[9]	['multitoken']	_	_
5	forkhead	_	_	NN	Entity	[9]	['multitoken']	_	_
6	(	_	_	-LRB-	Entity	[9]	['multitoken']	_	_
7	FKH	_	_	NN	Entity	[9]	['multitoken']	_	_
8	)	_	_	-RRB-	Entity	[9]	['multitoken']	_	_
9	domain	_	_	NN	Entity	[1, 11]	['Site', 'CSite']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	critical	_	_	JJ	Positive_regulation	[0]	['root']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	nuclear	_	_	JJ	Entity	[14]	['ToLoc']	_	_
14	localization	_	_	NN	Localization	[11]	['Theme']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	DNA	_	_	NN	O	[-1]	['none']	_	_
17	binding	_	_	NN	Binding	[11]	['Theme']	_	_
18	activity	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	abrogated	_	_	VBD	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	ability	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	Foxp3	_	_	NN	Protein	[1, 11, 14, 17]	['Theme', 'Cause', 'Theme', 'Theme']	_	_
25	to	_	_	TO	O	[-1]	['none']	_	_
26	suppress	_	_	VB	O	[-1]	['none']	_	_
27	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
28	activity	_	_	NN	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	HEK	_	_	NNP	O	[-1]	['none']	_	_
31	293T	_	_	NN	O	[-1]	['none']	_	_
32	cells	_	_	NNS	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	but	_	_	CC	O	[-1]	['none']	_	_
35	not	_	_	RB	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	Jurkat	_	_	NN	O	[-1]	['none']	_	_
38	or	_	_	CC	O	[-1]	['none']	_	_
39	primary	_	_	JJ	O	[-1]	['none']	_	_
40	human	_	_	NN	O	[-1]	['none']	_	_
41	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
42	T	_	_	NN	O	[-1]	['none']	_	_
43	cells	_	_	NNS	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	further	_	_	RB	O	[-1]	['none']	_	_
3	demonstrate	_	_	VBP	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
6	suppressed	_	_	VBD	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	transcription	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	two	_	_	CD	O	[-1]	['none']	_	_
11	human	_	_	NN	O	[-1]	['none']	_	_
12	retroviral	_	_	JJ	O	[-1]	['none']	_	_
13	promoters	_	_	NNS	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	HIV-1	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	human	_	_	NN	O	[-1]	['none']	_	_
18	T	_	_	NN	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	lymphotropic	_	_	JJ	O	[-1]	['none']	_	_
21	virus	_	_	NN	O	[-1]	['none']	_	_
22	type	_	_	NN	O	[-1]	['none']	_	_
23	I	_	_	CD	O	[-1]	['none']	_	_
24	[	_	_	CD	O	[-1]	['none']	_	_
25	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
26	]	_	_	CD	O	[-1]	['none']	_	_
27	)	_	_	-RRB-	O	[-1]	['none']	_	_
28	utilizing	_	_	VBG	O	[-1]	['none']	_	_
29	NF-kappaB-dependent	_	_	JJ	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	NF-kappaB-independent	_	_	JJ	O	[-1]	['none']	_	_
32	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Examination	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	latter	_	_	JJ	O	[-1]	['none']	_	_
5	identified	_	_	VBD	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	cAMP	_	_	NN	O	[-1]	['none']	_	_
8	responsive	_	_	JJ	O	[-1]	['none']	_	_
9	element	_	_	NN	O	[-1]	['none']	_	_
10	binding	_	_	NN	O	[-1]	['none']	_	_
11	protein	_	_	NN	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	CREB	_	_	NN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	pathway	_	_	NN	O	[-1]	['none']	_	_
16	as	_	_	IN	O	[-1]	['none']	_	_
17	a	_	_	DT	O	[-1]	['none']	_	_
18	target	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Finally	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	comparison	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	percent	_	_	NN	O	[-1]	['none']	_	_
7	Foxp3+	_	_	JJ	Protein	[0]	['root']	_	_
8	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
9	CD25+	_	_	JJ	Protein	[0]	['root']	_	_
10	T	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	to	_	_	TO	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	HTLV-I	_	_	NN	O	[-1]	['none']	_	_
15	proviral	_	_	JJ	O	[-1]	['none']	_	_
16	load	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	HTLV-I-infected	_	_	JJ	O	[-1]	['none']	_	_
19	asymptomatic	_	_	JJ	O	[-1]	['none']	_	_
20	carriers	_	_	NNS	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	patients	_	_	NNS	O	[-1]	['none']	_	_
23	with	_	_	IN	O	[-1]	['none']	_	_
24	HTLV-I-associated	_	_	JJ	O	[-1]	['none']	_	_
25	myelopathy	_	_	NN	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	tropical	_	_	JJ	O	[-1]	['none']	_	_
28	spastic	_	_	JJ	O	[-1]	['none']	_	_
29	paraparesis	_	_	NN	O	[-1]	['none']	_	_
30	suggested	_	_	VBD	O	[-1]	['none']	_	_
31	that	_	_	IN	O	[-1]	['none']	_	_
32	high	_	_	JJ	Positive_regulation	[0]	['root']	_	_
33	Foxp3	_	_	NN	Protein	[34]	['Theme']	_	_
34	expression	_	_	NN	Gene_expression	[32]	['Theme']	_	_
35	is	_	_	VBZ	O	[-1]	['none']	_	_
36	associated	_	_	VBN	O	[-1]	['none']	_	_
37	with	_	_	IN	O	[-1]	['none']	_	_
38	low	_	_	JJ	O	[-1]	['none']	_	_
39	proviral	_	_	JJ	O	[-1]	['none']	_	_
40	load	_	_	NN	O	[-1]	['none']	_	_
41	and	_	_	CC	O	[-1]	['none']	_	_
42	absence	_	_	NN	O	[-1]	['none']	_	_
43	of	_	_	IN	O	[-1]	['none']	_	_
44	disease	_	_	NN	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	suggest	_	_	VBP	O	[-1]	['none']	_	_
4	an	_	_	DT	O	[-1]	['none']	_	_
5	expanded	_	_	JJ	O	[-1]	['none']	_	_
6	role	_	_	NN	O	[-1]	['none']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	Foxp3	_	_	NN	Protein	[0]	['root']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	regulating	_	_	VBG	O	[-1]	['none']	_	_
11	NF-kappaB-	_	_	NN	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	CREB	_	_	NN	O	[-1]	['none']	_	_
14	dependent	_	_	JJ	O	[-1]	['none']	_	_
15	cellular	_	_	JJ	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	viral	_	_	JJ	O	[-1]	['none']	_	_
18	gene	_	_	NN	O	[-1]	['none']	_	_
19	expression	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	M-CSF-Dependent	_	_	NNP	O	[-1]	['none']	_	_
2	Activation	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	PKC	_	_	NN	O	[-1]	['none']	_	_
5	Does	_	_	VBZ	O	[-1]	['none']	_	_
6	Not	_	_	RB	O	[-1]	['none']	_	_
7	Regulate	_	_	VB	Regulation	[0]	['root']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	Classical	_	_	JJ	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	p65	_	_	NN	Protein	[12]	['Theme']	_	_
12	Activation	_	_	NN	Positive_regulation	[7]	['Theme']	_	_
13	Pathway	_	_	NN	O	[-1]	['none']	_	_
14	Canonical	_	_	JJ	O	[-1]	['none']	_	_
15	activation	_	_	NN	O	[-1]	['none']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
18	occurs	_	_	VBZ	O	[-1]	['none']	_	_
19	via	_	_	IN	O	[-1]	['none']	_	_
20	phosphorylation	_	_	NN	Phosphorylation	[0]	['root']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	degradation	_	_	NN	Protein_catabolism	[0]	['root']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	IkappaBalpha	_	_	NN	Protein	[20, 22]	['Theme', 'Theme']	_	_
25	leading	_	_	VBG	O	[-1]	['none']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	release	_	_	NN	O	[-1]	['none']	_	_
29	and	_	_	CC	O	[-1]	['none']	_	_
30	nuclear	_	_	JJ	O	[-1]	['none']	_	_
31	translocation	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
35	p50	_	_	NN	Protein	[0]	['root']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	p65	_	_	NN	Protein	[0]	['root']	_	_
38	heterodimer	_	_	NN	O	[-1]	['none']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	transactivate	_	_	VB	O	[-1]	['none']	_	_
41	target	_	_	NN	O	[-1]	['none']	_	_
42	genes	_	_	NNS	O	[-1]	['none']	_	_
43	[	_	_	VBP	O	[-1]	['none']	_	_
44	37	_	_	CD	O	[-1]	['none']	_	_
45	]	_	_	CD	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	[	_	_	CD	O	[-1]	['none']	_	_
48	39	_	_	CD	O	[-1]	['none']	_	_
49	]	_	_	NN	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	Since	_	_	IN	O	[-1]	['none']	_	_
2	conventional	_	_	JJ	O	[-1]	['none']	_	_
3	PKC	_	_	NN	O	[-1]	['none']	_	_
4	activity	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	important	_	_	JJ	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	regulating	_	_	VBG	O	[-1]	['none']	_	_
9	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
10	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	we	_	_	PRP	O	[-1]	['none']	_	_
14	next	_	_	RB	O	[-1]	['none']	_	_
15	investigated	_	_	VBD	O	[-1]	['none']	_	_
16	whether	_	_	IN	O	[-1]	['none']	_	_
17	IkappaBalpha	_	_	NN	Protein	[18]	['Theme']	_	_
18	degradation	_	_	NN	Protein_catabolism	[20]	['Theme']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	PKC	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	treated	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	cyclohexamide	_	_	NN	O	[-1]	['none']	_	_
6	(	_	_	-LRB-	O	[-1]	['none']	_	_
7	CHX	_	_	NN	O	[-1]	['none']	_	_
8	)	_	_	-RRB-	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	inhibit	_	_	VB	Negative_regulation	[0]	['root']	_	_
11	protein	_	_	NN	O	[-1]	['none']	_	_
12	synthesis	_	_	NN	Gene_expression	[10]	['Theme']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	IkappaBalpha	_	_	NN	Protein	[12]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	its	_	_	PRP$	O	[-1]	['none']	_	_
18	degradation	_	_	NN	O	[-1]	['none']	_	_
19	was	_	_	VBD	O	[-1]	['none']	_	_
20	followed	_	_	VBN	O	[-1]	['none']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	As	_	_	IN	O	[-1]	['none']	_	_
2	shown	_	_	VBN	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	Figure	_	_	NNP	O	[-1]	['none']	_	_
5	5A	_	_	NNP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	PKC	_	_	NN	O	[-1]	['none']	_	_
8	inhibition	_	_	NN	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	Ro-31-8220	_	_	NN	O	[-1]	['none']	_	_
11	did	_	_	VBD	O	[-1]	['none']	_	_
12	not	_	_	RB	O	[-1]	['none']	_	_
13	alter	_	_	VB	Regulation	[0]	['root']	_	_
14	M-CSF-induced	_	_	JJ	Positive_regulation	[13]	['Theme']	_	_
15	IkappaBalpha	_	_	NN	Protein	[16]	['Theme']	_	_
16	degradation	_	_	NN	Protein_catabolism	[14]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	suggesting	_	_	VBG	O	[-1]	['none']	_	_
19	that	_	_	IN	O	[-1]	['none']	_	_
20	M-CSF-induced	_	_	JJ	O	[-1]	['none']	_	_
21	PKC	_	_	NN	O	[-1]	['none']	_	_
22	activity	_	_	NN	O	[-1]	['none']	_	_
23	augmented	_	_	VBD	Regulation	[0]	['root']	_	_
24	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
25	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
26	activity	_	_	NN	O	[-1]	['none']	_	_
27	by	_	_	IN	O	[-1]	['none']	_	_
28	an	_	_	DT	Anaphora	[30]	['multitoken']	_	_
29	alternative	_	_	JJ	Anaphora	[30]	['multitoken']	_	_
30	pathway	_	_	NN	Anaphora	[0]	['root']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	like	_	_	IN	O	[-1]	['none']	_	_
33	post-translational	_	_	JJ	Protein_modification	[34]	['multitoken']	_	_
34	modification	_	_	NN	Protein_modification	[23]	['Theme']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
37	p65	_	_	NN	Protein	[34]	['Theme']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Generation	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	HOIP	_	_	NN	Protein	[4]	['Theme']	_	_
4	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
5	B	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	via	_	_	IN	O	[-1]	['none']	_	_
8	targeted	_	_	VBN	O	[-1]	['none']	_	_
9	disruption	_	_	NN	Negative_regulation	[0]	['root']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	Rnf31	_	_	NN	Protein	[9]	['Theme']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	gene	_	_	NN	O	[-1]	['none']	_	_
15	encoding	_	_	VBG	O	[-1]	['none']	_	_
16	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
17	In	_	_	IN	O	[-1]	['none']	_	_
18	our	_	_	PRP$	O	[-1]	['none']	_	_
19	previous	_	_	JJ	O	[-1]	['none']	_	_
20	study	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	we	_	_	PRP	O	[-1]	['none']	_	_
23	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
24	that	_	_	IN	O	[-1]	['none']	_	_
25	HOIP	_	_	NNP	Protein	[27]	['Theme']	_	_
26	is	_	_	VBZ	O	[-1]	['none']	_	_
27	recruited	_	_	VBN	Binding	[0]	['root']	_	_
28	to	_	_	TO	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	CD40	_	_	NN	O	[-1]	['none']	_	_
31	signaling	_	_	NN	O	[-1]	['none']	_	_
32	complex	_	_	NN	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	two	_	_	CD	O	[-1]	['none']	_	_
35	mouse	_	_	NN	O	[-1]	['none']	_	_
36	B	_	_	NN	O	[-1]	['none']	_	_
37	cell	_	_	NN	O	[-1]	['none']	_	_
38	lines	_	_	NNS	O	[-1]	['none']	_	_
39	[	_	_	VBP	O	[-1]	['none']	_	_
40	6	_	_	CD	O	[-1]	['none']	_	_
41	]	_	_	CD	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	Similar	_	_	JJ	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	obtained	_	_	VBN	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	mouse	_	_	NN	O	[-1]	['none']	_	_
7	splenocytes	_	_	NNS	O	[-1]	['none']	_	_
8	,	_	_	,	O	[-1]	['none']	_	_
9	indicating	_	_	VBG	O	[-1]	['none']	_	_
10	that	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	interaction	_	_	NN	Binding	[0]	['root']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	CD40	_	_	NN	Protein	[12]	['Theme']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	HOIP	_	_	NN	Protein	[12]	['Theme']	_	_
17	is	_	_	VBZ	O	[-1]	['none']	_	_
18	not	_	_	RB	O	[-1]	['none']	_	_
19	limited	_	_	VBN	O	[-1]	['none']	_	_
20	to	_	_	TO	O	[-1]	['none']	_	_
21	transformed	_	_	VBN	O	[-1]	['none']	_	_
22	B	_	_	NN	O	[-1]	['none']	_	_
23	cell	_	_	NN	O	[-1]	['none']	_	_
24	lines	_	_	NNS	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	unpublished	_	_	JJ	O	[-1]	['none']	_	_
27	observations	_	_	NNS	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	also	_	_	RB	O	[-1]	['none']	_	_
3	found	_	_	VBD	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	recruitment	_	_	NN	Binding	[13]	['Theme']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	HOIP	_	_	NN	Protein	[6]	['Theme']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	CD40	_	_	NN	Protein	[6]	['Theme']	_	_
11	was	_	_	VBD	O	[-1]	['none']	_	_
12	TRAF2	_	_	NN	Protein	[13]	['Cause']	_	_
13	dependent	_	_	JJ	Regulation	[0]	['root']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	that	_	_	IN	O	[-1]	['none']	_	_
16	overexpression	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	a	_	_	DT	O	[-1]	['none']	_	_
19	truncated	_	_	JJ	O	[-1]	['none']	_	_
20	HOIP	_	_	NN	Protein	[0]	['root']	_	_
21	mutant	_	_	NN	O	[-1]	['none']	_	_
22	partially	_	_	RB	O	[-1]	['none']	_	_
23	inhibited	_	_	VBD	O	[-1]	['none']	_	_
24	CD40	_	_	NN	Protein	[0]	['root']	_	_
25	mediated	_	_	VBD	O	[-1]	['none']	_	_
26	NF-kappaB	_	_	NN	O	[-1]	['none']	_	_
27	activation	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	support	_	_	VBP	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	hypothesis	_	_	NN	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	HOIP	_	_	NN	Protein	[0]	['root']	_	_
8	plays	_	_	VBZ	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	role	_	_	NN	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	CD40	_	_	NN	Protein	[0]	['root']	_	_
13	signal	_	_	NN	O	[-1]	['none']	_	_
14	transduction	_	_	NN	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	further	_	_	RB	O	[-1]	['none']	_	_
3	define	_	_	VB	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	role	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	evaluate	_	_	VB	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	importance	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
12	in	_	_	IN	O	[-1]	['none']	_	_
13	CD40	_	_	NN	Protein	[0]	['root']	_	_
14	signaling	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	we	_	_	PRP	O	[-1]	['none']	_	_
17	used	_	_	VBD	O	[-1]	['none']	_	_
18	somatic	_	_	JJ	O	[-1]	['none']	_	_
19	cell	_	_	NN	O	[-1]	['none']	_	_
20	gene	_	_	NN	O	[-1]	['none']	_	_
21	targeting	_	_	VBG	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	disrupt	_	_	VB	Negative_regulation	[0]	['root']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	gene	_	_	NN	O	[-1]	['none']	_	_
26	encoding	_	_	VBG	O	[-1]	['none']	_	_
27	HOIP	_	_	NN	Protein	[23]	['Theme']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	mouse	_	_	NN	O	[-1]	['none']	_	_
31	B	_	_	NN	O	[-1]	['none']	_	_
32	cell	_	_	NN	O	[-1]	['none']	_	_
33	line	_	_	NN	O	[-1]	['none']	_	_
34	A20	_	_	NN	O	[-1]	['none']	_	_
35	.2	_	_	NN	O	[-1]	['none']	_	_
36	J	_	_	NN	O	[-1]	['none']	_	_
37	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	line	_	_	NN	O	[-1]	['none']	_	_
4	has	_	_	VBZ	O	[-1]	['none']	_	_
5	been	_	_	VBN	O	[-1]	['none']	_	_
6	particularly	_	_	RB	O	[-1]	['none']	_	_
7	useful	_	_	JJ	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	characterization	_	_	NN	O	[-1]	['none']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	CD40	_	_	NN	Protein	[0]	['root']	_	_
13	signaling	_	_	NN	O	[-1]	['none']	_	_
14	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
15	due	_	_	JJ	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	relative	_	_	JJ	O	[-1]	['none']	_	_
19	ease	_	_	NN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	which	_	_	WDT	O	[-1]	['none']	_	_
22	its	_	_	PRP$	O	[-1]	['none']	_	_
23	genome	_	_	NN	O	[-1]	['none']	_	_
24	can	_	_	MD	O	[-1]	['none']	_	_
25	be	_	_	VB	O	[-1]	['none']	_	_
26	modified	_	_	VBN	O	[-1]	['none']	_	_
27	by	_	_	IN	O	[-1]	['none']	_	_
28	homologous	_	_	JJ	O	[-1]	['none']	_	_
29	recombination	_	_	NN	O	[-1]	['none']	_	_
30	[	_	_	NN	O	[-1]	['none']	_	_
31	7	_	_	CD	O	[-1]	['none']	_	_
32	]	_	_	NN	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	[	_	_	CD	O	[-1]	['none']	_	_
35	8	_	_	CD	O	[-1]	['none']	_	_
36	]	_	_	NN	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	[	_	_	CD	O	[-1]	['none']	_	_
39	9	_	_	CD	O	[-1]	['none']	_	_
40	]	_	_	NN	O	[-1]	['none']	_	_
41	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	used	_	_	VBD	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	targeting	_	_	VBG	O	[-1]	['none']	_	_
5	vector	_	_	NN	O	[-1]	['none']	_	_
6	capable	_	_	JJ	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	undergoing	_	_	VBG	O	[-1]	['none']	_	_
9	homologous	_	_	JJ	O	[-1]	['none']	_	_
10	recombination	_	_	NN	O	[-1]	['none']	_	_
11	with	_	_	IN	O	[-1]	['none']	_	_
12	Rnf31	_	_	NN	Protein	[0]	['root']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	gene	_	_	NN	O	[-1]	['none']	_	_
16	encoding	_	_	VBG	O	[-1]	['none']	_	_
17	HOIP	_	_	NNP	Protein	[0]	['root']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	disrupt	_	_	VB	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	coding	_	_	NN	O	[-1]	['none']	_	_
23	sequence	_	_	NN	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	the	_	_	DT	O	[-1]	['none']	_	_
26	gene	_	_	NN	O	[-1]	['none']	_	_
27	in	_	_	IN	O	[-1]	['none']	_	_
28	exon	_	_	NN	O	[-1]	['none']	_	_
29	5	_	_	CD	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Following	_	_	VBG	O	[-1]	['none']	_	_
2	introduction	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	vector	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	neomycin	_	_	NN	O	[-1]	['none']	_	_
9	resistant	_	_	JJ	O	[-1]	['none']	_	_
10	clones	_	_	NNS	O	[-1]	['none']	_	_
11	that	_	_	WDT	O	[-1]	['none']	_	_
12	arose	_	_	VBD	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	screened	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	PCR	_	_	NN	O	[-1]	['none']	_	_
17	amplification	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	genomic	_	_	JJ	O	[-1]	['none']	_	_
20	DNA	_	_	NN	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	identify	_	_	VB	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	containing	_	_	VBG	O	[-1]	['none']	_	_
25	a	_	_	DT	O	[-1]	['none']	_	_
26	disrupted	_	_	JJ	Negative_regulation	[0]	['root']	_	_
27	Rnf31	_	_	NN	Protein	[26]	['Theme']	_	_
28	allele	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	remove	_	_	VB	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	selectable	_	_	JJ	O	[-1]	['none']	_	_
5	marker	_	_	NN	O	[-1]	['none']	_	_
6	gene	_	_	NN	O	[-1]	['none']	_	_
7	cassette	_	_	NN	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	disrupted	_	_	JJ	Negative_regulation	[0]	['root']	_	_
11	Rnf31	_	_	NN	Protein	[10]	['Theme']	_	_
12	allele	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	recombinant	_	_	JJ	O	[-1]	['none']	_	_
15	cell	_	_	NN	O	[-1]	['none']	_	_
16	lines	_	_	NNS	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	transiently	_	_	RB	O	[-1]	['none']	_	_
19	transfected	_	_	VBN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	a	_	_	DT	O	[-1]	['none']	_	_
22	plasmid	_	_	NN	O	[-1]	['none']	_	_
23	that	_	_	WDT	O	[-1]	['none']	_	_
24	encodes	_	_	VBZ	O	[-1]	['none']	_	_
25	Cre	_	_	NN	Protein	[26]	['multitoken']	_	_
26	recombinase	_	_	NN	Protein	[0]	['root']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	step	_	_	NN	O	[-1]	['none']	_	_
3	allowed	_	_	VBD	O	[-1]	['none']	_	_
4	us	_	_	PRP	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	perform	_	_	VB	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	second	_	_	JJ	O	[-1]	['none']	_	_
9	round	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	targeting	_	_	VBG	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	drug	_	_	NN	O	[-1]	['none']	_	_
14	selection	_	_	NN	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	generating	_	_	VBG	O	[-1]	['none']	_	_
17	cells	_	_	NNS	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	which	_	_	WDT	O	[-1]	['none']	_	_
20	both	_	_	CC	O	[-1]	['none']	_	_
21	copies	_	_	NNS	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	Rnf31	_	_	NN	Protein	[25]	['Theme']	_	_
24	were	_	_	VBD	O	[-1]	['none']	_	_
25	disrupted	_	_	VBN	Negative_regulation	[0]	['root']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Two	_	_	CD	O	[-1]	['none']	_	_
2	independent	_	_	JJ	O	[-1]	['none']	_	_
3	clonal	_	_	JJ	O	[-1]	['none']	_	_
4	cell	_	_	NN	O	[-1]	['none']	_	_
5	lines	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	chosen	_	_	VBN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	further	_	_	JJ	O	[-1]	['none']	_	_
10	analysis	_	_	NN	O	[-1]	['none']	_	_
11	.	_	_	.	O	[-1]	['none']	_	_

1	HOIP	_	_	NN	Protein	[3]	['Theme']	_	_
2	protein	_	_	NN	O	[-1]	['none']	_	_
3	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	undetectable	_	_	JJ	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	both	_	_	DT	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	lines	_	_	NNS	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	as	_	_	IN	O	[-1]	['none']	_	_
12	determined	_	_	VBN	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	Western	_	_	NN	O	[-1]	['none']	_	_
15	blot	_	_	NN	O	[-1]	['none']	_	_
16	analysis	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	cell	_	_	NN	O	[-1]	['none']	_	_
19	lysates	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	demonstrating	_	_	VBG	O	[-1]	['none']	_	_
22	that	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	targeting	_	_	VBG	O	[-1]	['none']	_	_
25	process	_	_	NN	O	[-1]	['none']	_	_
26	was	_	_	VBD	O	[-1]	['none']	_	_
27	successful	_	_	JJ	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	text	_	_	NN	O	[-1]	['none']	_	_
4	that	_	_	WDT	O	[-1]	['none']	_	_
5	follows	_	_	VBZ	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	two	_	_	CD	O	[-1]	['none']	_	_
9	gene	_	_	NN	O	[-1]	['none']	_	_
10	targeted	_	_	VBN	O	[-1]	['none']	_	_
11	cell	_	_	NN	O	[-1]	['none']	_	_
12	lines	_	_	NNS	O	[-1]	['none']	_	_
13	are	_	_	VBP	O	[-1]	['none']	_	_
14	referred	_	_	VBN	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	as	_	_	IN	O	[-1]	['none']	_	_
17	HOIP	_	_	NN	Protein	[18]	['Theme']	_	_
18	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	To	_	_	TO	O	[-1]	['none']	_	_
2	enable	_	_	VB	O	[-1]	['none']	_	_
3	us	_	_	PRP	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	confirm	_	_	VB	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	any	_	_	DT	O	[-1]	['none']	_	_
8	signaling	_	_	NN	O	[-1]	['none']	_	_
9	or	_	_	CC	O	[-1]	['none']	_	_
10	functional	_	_	JJ	O	[-1]	['none']	_	_
11	defects	_	_	NNS	O	[-1]	['none']	_	_
12	observed	_	_	VBN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	HOIP	_	_	NN	Protein	[15]	['Theme']	_	_
15	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
16	cells	_	_	NNS	O	[-1]	['none']	_	_
17	were	_	_	VBD	O	[-1]	['none']	_	_
18	due	_	_	JJ	O	[-1]	['none']	_	_
19	to	_	_	TO	O	[-1]	['none']	_	_
20	disruption	_	_	NN	Negative_regulation	[0]	['root']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	Rnf31	_	_	NN	Protein	[20]	['Theme']	_	_
24	gene	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	both	_	_	CC	O	[-1]	['none']	_	_
27	HOIP	_	_	NN	Protein	[28]	['Theme']	_	_
28	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
29	cell	_	_	NN	O	[-1]	['none']	_	_
30	lines	_	_	NNS	O	[-1]	['none']	_	_
31	were	_	_	VBD	O	[-1]	['none']	_	_
32	transduced	_	_	VBN	O	[-1]	['none']	_	_
33	with	_	_	IN	O	[-1]	['none']	_	_
34	a	_	_	DT	O	[-1]	['none']	_	_
35	retrovirus	_	_	NN	O	[-1]	['none']	_	_
36	encoding	_	_	VBG	O	[-1]	['none']	_	_
37	FLAG	_	_	NN	O	[-1]	['none']	_	_
38	tagged	_	_	VBD	O	[-1]	['none']	_	_
39	wild-type	_	_	JJ	O	[-1]	['none']	_	_
40	HOIP	_	_	NN	Protein	[0]	['root']	_	_
41	,	_	_	,	O	[-1]	['none']	_	_
42	thus	_	_	RB	O	[-1]	['none']	_	_
43	restoring	_	_	VBG	Positive_regulation	[0]	['root']	_	_
44	HOIP	_	_	NN	Protein	[46]	['Theme']	_	_
45	protein	_	_	NN	O	[-1]	['none']	_	_
46	expression	_	_	NN	Gene_expression	[43]	['Theme']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	These	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	referred	_	_	VBN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	as	_	_	IN	O	[-1]	['none']	_	_
7	HOIP	_	_	NN	Protein	[8]	['Theme']	_	_
8	reconstituted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	experiments	_	_	NNS	O	[-1]	['none']	_	_
4	that	_	_	WDT	O	[-1]	['none']	_	_
5	follow	_	_	VBP	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	responses	_	_	NNS	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	these	_	_	DT	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	were	_	_	VBD	O	[-1]	['none']	_	_
12	compared	_	_	VBN	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	those	_	_	DT	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	A20	_	_	NN	O	[-1]	['none']	_	_
17	.2	_	_	NN	O	[-1]	['none']	_	_
18	J	_	_	NN	O	[-1]	['none']	_	_
19	cells	_	_	NNS	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	HOIP	_	_	NN	Protein	[22]	['Theme']	_	_
22	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	transduced	_	_	VBN	O	[-1]	['none']	_	_
25	with	_	_	IN	O	[-1]	['none']	_	_
26	a	_	_	DT	O	[-1]	['none']	_	_
27	retroviral	_	_	JJ	O	[-1]	['none']	_	_
28	vector	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	pMIP	_	_	NN	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	lacking	_	_	VBG	O	[-1]	['none']	_	_
33	a	_	_	DT	O	[-1]	['none']	_	_
34	cDNA	_	_	NN	O	[-1]	['none']	_	_
35	insert	_	_	NN	O	[-1]	['none']	_	_
36	(	_	_	-LRB-	O	[-1]	['none']	_	_
37	empty	_	_	JJ	O	[-1]	['none']	_	_
38	vector	_	_	NN	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	Role	_	_	NN	Regulation	[0]	['root']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	PKA	_	_	NN	O	[-1]	['none']	_	_
4	on	_	_	IN	O	[-1]	['none']	_	_
5	LPS	_	_	NN	O	[-1]	['none']	_	_
6	induced	_	_	VBD	Positive_regulation	[1]	['Theme']	_	_
7	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	TNF-alpha	_	_	NN	Protein	[10]	['Theme']	_	_
10	production	_	_	NN	Gene_expression	[6]	['Theme']	_	_
11	To	_	_	TO	O	[-1]	['none']	_	_
12	evaluate	_	_	VB	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	role	_	_	NN	Regulation	[0]	['root']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	PKA	_	_	NN	O	[-1]	['none']	_	_
17	on	_	_	IN	O	[-1]	['none']	_	_
18	TNF-alpha	_	_	NN	Protein	[19]	['Theme']	_	_
19	production	_	_	NN	Gene_expression	[14]	['Theme']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	its	_	_	PRP$	O	[-1]	['none']	_	_
25	involvement	_	_	NN	Regulation	[0]	['root']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	attenuation	_	_	NN	Negative_regulation	[25]	['Theme']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	LPS	_	_	NN	O	[-1]	['none']	_	_
31	induced	_	_	VBD	Positive_regulation	[28]	['Theme']	_	_
32	TNF-alpha	_	_	NN	Protein	[33]	['Theme']	_	_
33	production	_	_	NN	Gene_expression	[31]	['Theme']	_	_
34	observed	_	_	VBN	O	[-1]	['none']	_	_
35	following	_	_	VBG	O	[-1]	['none']	_	_
36	PTX	_	_	NN	O	[-1]	['none']	_	_
37	treatment	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	H89	_	_	NN	O	[-1]	['none']	_	_
40	,	_	_	,	O	[-1]	['none']	_	_
41	a	_	_	DT	O	[-1]	['none']	_	_
42	specific	_	_	JJ	O	[-1]	['none']	_	_
43	PKA	_	_	NN	O	[-1]	['none']	_	_
44	inhibitor	_	_	NN	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	was	_	_	VBD	O	[-1]	['none']	_	_
47	utilized	_	_	VBN	O	[-1]	['none']	_	_
48	.	_	_	.	O	[-1]	['none']	_	_

1	Isolated	_	_	VBN	O	[-1]	['none']	_	_
2	mononuclear	_	_	JJ	O	[-1]	['none']	_	_
3	cells	_	_	NNS	O	[-1]	['none']	_	_
4	were	_	_	VBD	O	[-1]	['none']	_	_
5	incubated	_	_	VBN	O	[-1]	['none']	_	_
6	according	_	_	VBG	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	treatment	_	_	NN	O	[-1]	['none']	_	_
10	groups	_	_	NNS	O	[-1]	['none']	_	_
11	described	_	_	VBN	O	[-1]	['none']	_	_
12	above	_	_	IN	O	[-1]	['none']	_	_
13	in	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	presence	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	absence	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	pretreatment	_	_	NN	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	H89	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	10	_	_	CD	O	[-1]	['none']	_	_
24	muM	_	_	JJ	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	1	_	_	CD	O	[-1]	['none']	_	_
28	hour	_	_	NN	O	[-1]	['none']	_	_
29	at	_	_	IN	O	[-1]	['none']	_	_
30	37degreesC	_	_	NN	O	[-1]	['none']	_	_
31	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	dose	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	H89	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	chosen	_	_	VBN	O	[-1]	['none']	_	_
7	based	_	_	VBN	O	[-1]	['none']	_	_
8	on	_	_	IN	O	[-1]	['none']	_	_
9	previous	_	_	JJ	O	[-1]	['none']	_	_
10	work	_	_	NN	O	[-1]	['none']	_	_
11	which	_	_	WDT	O	[-1]	['none']	_	_
12	demonstrated	_	_	VBD	O	[-1]	['none']	_	_
13	specific	_	_	JJ	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	complete	_	_	JJ	O	[-1]	['none']	_	_
16	inhibition	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	PKA	_	_	NN	O	[-1]	['none']	_	_
19	at	_	_	IN	O	[-1]	['none']	_	_
20	this	_	_	DT	O	[-1]	['none']	_	_
21	concentration	_	_	NN	O	[-1]	['none']	_	_
22	.10	_	_	CD	O	[-1]	['none']	_	_
23	Since	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	activity	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	this	_	_	DT	O	[-1]	['none']	_	_
28	inhibitor	_	_	NN	O	[-1]	['none']	_	_
29	is	_	_	VBZ	O	[-1]	['none']	_	_
30	both	_	_	CC	O	[-1]	['none']	_	_
31	specific	_	_	JJ	O	[-1]	['none']	_	_
32	and	_	_	CC	O	[-1]	['none']	_	_
33	consistent	_	_	JJ	O	[-1]	['none']	_	_
34	at	_	_	IN	O	[-1]	['none']	_	_
35	this	_	_	DT	O	[-1]	['none']	_	_
36	specified	_	_	JJ	O	[-1]	['none']	_	_
37	dose	_	_	NN	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	we	_	_	PRP	O	[-1]	['none']	_	_
40	did	_	_	VBD	O	[-1]	['none']	_	_
41	not	_	_	RB	O	[-1]	['none']	_	_
42	include	_	_	VB	O	[-1]	['none']	_	_
43	experiments	_	_	NNS	O	[-1]	['none']	_	_
44	with	_	_	IN	O	[-1]	['none']	_	_
45	additional	_	_	JJ	O	[-1]	['none']	_	_
46	PKA	_	_	NN	O	[-1]	['none']	_	_
47	inhibitors	_	_	NNS	O	[-1]	['none']	_	_
48	with	_	_	IN	O	[-1]	['none']	_	_
49	this	_	_	DT	O	[-1]	['none']	_	_
50	set	_	_	NN	O	[-1]	['none']	_	_
51	of	_	_	IN	O	[-1]	['none']	_	_
52	experiments	_	_	NNS	O	[-1]	['none']	_	_
53	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	TNF-alpha	_	_	NN	Protein	[0]	['root']	_	_
3	concentration	_	_	NN	O	[-1]	['none']	_	_
4	in	_	_	IN	O	[-1]	['none']	_	_
5	the	_	_	DT	O	[-1]	['none']	_	_
6	supernatant	_	_	NN	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	measured	_	_	VBN	O	[-1]	['none']	_	_
9	quantitatively	_	_	RB	O	[-1]	['none']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	ELISA	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	results	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	expressed	_	_	VBN	O	[-1]	['none']	_	_
5	in	_	_	IN	O	[-1]	['none']	_	_
6	pg/mL	_	_	NN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	innate	_	_	JJ	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	adaptive	_	_	JJ	O	[-1]	['none']	_	_
10	immune	_	_	JJ	O	[-1]	['none']	_	_
11	systems	_	_	NNS	O	[-1]	['none']	_	_
12	reflects	_	_	VBZ	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	importance	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	this	_	_	DT	O	[-1]	['none']	_	_
17	cytokine	_	_	NN	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	tight	_	_	JJ	O	[-1]	['none']	_	_
21	regulation	_	_	NN	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	immune	_	_	JJ	O	[-1]	['none']	_	_
25	response	_	_	NN	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	minimize	_	_	VB	O	[-1]	['none']	_	_
29	pathology	_	_	NN	O	[-1]	['none']	_	_
30	during	_	_	IN	O	[-1]	['none']	_	_
31	infection	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	Th1	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	has	_	_	VBZ	O	[-1]	['none']	_	_
7	been	_	_	VBN	O	[-1]	['none']	_	_
8	reported	_	_	VBN	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	regulate	_	_	VB	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	immune	_	_	JJ	O	[-1]	['none']	_	_
13	response	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	leishmaniasis	_	_	NN	O	[-1]	['none']	_	_
16	and	_	_	CC	O	[-1]	['none']	_	_
17	toxoplasmosis	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	many	_	_	JJ	O	[-1]	['none']	_	_
5	situations	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	IL-10	_	_	NN	Protein	[10]	['Theme']	_	_
8	is	_	_	VBZ	O	[-1]	['none']	_	_
9	not	_	_	RB	O	[-1]	['none']	_	_
10	produced	_	_	VBN	Gene_expression	[16]	['Theme']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	Th1	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	in	_	_	IN	Positive_regulation	[16]	['multitoken']	_	_
15	response	_	_	NN	Positive_regulation	[16]	['multitoken']	_	_
16	to	_	_	TO	Positive_regulation	[0]	['root']	_	_
17	antigenic	_	_	JJ	O	[-1]	['none']	_	_
18	stimulation	_	_	NN	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	goal	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	to	_	_	TO	O	[-1]	['none']	_	_
5	address	_	_	VB	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	molecular	_	_	JJ	O	[-1]	['none']	_	_
8	signals	_	_	NNS	O	[-1]	['none']	_	_
9	that	_	_	WDT	O	[-1]	['none']	_	_
10	determine	_	_	VBP	O	[-1]	['none']	_	_
11	whether	_	_	IN	O	[-1]	['none']	_	_
12	Th1	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	develop	_	_	VBP	O	[-1]	['none']	_	_
15	to	_	_	TO	O	[-1]	['none']	_	_
16	produce	_	_	VB	Gene_expression	[0]	['root']	_	_
17	IL-10	_	_	NN	Protein	[16]	['Theme']	_	_
18	(	_	_	-LRB-	O	[-1]	['none']	_	_
19	Trinchieri	_	_	NNP	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	2007	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Here	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	we	_	_	PRP	O	[-1]	['none']	_	_
4	showed	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	Th1	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
9	high-antigen-dose-induced	_	_	JJ	O	[-1]	['none']	_	_
10	ERK1	_	_	NN	Protein	[13]	['Theme']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	ERK2	_	_	NN	Protein	[13]	['Theme']	_	_
13	phosphorylation	_	_	NN	Phosphorylation	[8]	['Cause']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	IL-12-induced	_	_	JJ	Positive_regulation	[0]	['root']	_	_
16	STAT-4	_	_	NN	Protein	[17]	['Theme']	_	_
17	activation	_	_	NN	Positive_regulation	[8, 15]	['Cause', 'Theme']	_	_
18	to	_	_	TO	O	[-1]	['none']	_	_
19	produce	_	_	VB	Gene_expression	[8]	['Theme']	_	_
20	IL-10	_	_	NN	Protein	[19]	['Theme']	_	_
21	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	findings	_	_	NNS	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	ERK1	_	_	NN	Protein	[7]	['Theme']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	ERK2	_	_	NN	Protein	[7]	['Theme']	_	_
7	activation	_	_	NN	Positive_regulation	[12]	['Cause']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	common	_	_	JJ	O	[-1]	['none']	_	_
11	pathway	_	_	NN	O	[-1]	['none']	_	_
12	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
13	for	_	_	IN	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	production	_	_	NN	Gene_expression	[12, 42]	['Theme', 'Theme']	_	_
16	of	_	_	IN	O	[-1]	['none']	_	_
17	IL-10	_	_	NN	Protein	[15]	['Theme']	_	_
18	by	_	_	IN	O	[-1]	['none']	_	_
19	Th1	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	Th2	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	Th17	_	_	NN	O	[-1]	['none']	_	_
25	cell	_	_	NN	O	[-1]	['none']	_	_
26	subsets	_	_	NNS	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	which	_	_	WDT	O	[-1]	['none']	_	_
29	differentiate	_	_	VBP	O	[-1]	['none']	_	_
30	along	_	_	IN	O	[-1]	['none']	_	_
31	distinct	_	_	JJ	O	[-1]	['none']	_	_
32	pathways	_	_	NNS	O	[-1]	['none']	_	_
33	,	_	_	,	O	[-1]	['none']	_	_
34	such	_	_	JJ	O	[-1]	['none']	_	_
35	that	_	_	IN	O	[-1]	['none']	_	_
36	IL-10	_	_	NN	Protein	[42]	['Cause']	_	_
37	provides	_	_	VBZ	Regulation	[42]	['multitoken']	_	_
38	a	_	_	DT	Regulation	[42]	['multitoken']	_	_
39	highly	_	_	RB	Regulation	[42]	['multitoken']	_	_
40	regulated	_	_	VBN	Regulation	[42]	['multitoken']	_	_
41	feedback	_	_	NN	Regulation	[42]	['multitoken']	_	_
42	loop	_	_	NN	Regulation	[0]	['root']	_	_
43	to	_	_	TO	O	[-1]	['none']	_	_
44	avoid	_	_	VB	O	[-1]	['none']	_	_
45	the	_	_	DT	O	[-1]	['none']	_	_
46	extremes	_	_	NNS	O	[-1]	['none']	_	_
47	of	_	_	IN	O	[-1]	['none']	_	_
48	excessive	_	_	JJ	O	[-1]	['none']	_	_
49	inflammation	_	_	NN	O	[-1]	['none']	_	_
50	or	_	_	CC	O	[-1]	['none']	_	_
51	chronic	_	_	JJ	O	[-1]	['none']	_	_
52	infections	_	_	NNS	O	[-1]	['none']	_	_
53	and	_	_	CC	O	[-1]	['none']	_	_
54	also	_	_	RB	O	[-1]	['none']	_	_
55	allow	_	_	VBP	O	[-1]	['none']	_	_
56	a	_	_	DT	O	[-1]	['none']	_	_
57	protective	_	_	JJ	O	[-1]	['none']	_	_
58	response	_	_	NN	O	[-1]	['none']	_	_
59	to	_	_	TO	O	[-1]	['none']	_	_
60	diverse	_	_	JJ	O	[-1]	['none']	_	_
61	pathogens	_	_	NNS	O	[-1]	['none']	_	_
62	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	certain	_	_	JJ	O	[-1]	['none']	_	_
3	viral	_	_	JJ	O	[-1]	['none']	_	_
4	or	_	_	CC	O	[-1]	['none']	_	_
5	parasitic	_	_	JJ	O	[-1]	['none']	_	_
6	infections	_	_	NNS	O	[-1]	['none']	_	_
7	(	_	_	-LRB-	O	[-1]	['none']	_	_
8	Anderson	_	_	NNP	O	[-1]	['none']	_	_
9	et	_	_	FW	O	[-1]	['none']	_	_
10	al.	_	_	FW	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	2007	_	_	CD	O	[-1]	['none']	_	_
13	;	_	_	:	O	[-1]	['none']	_	_
14	Brooks	_	_	NNP	O	[-1]	['none']	_	_
15	et	_	_	FW	O	[-1]	['none']	_	_
16	al.	_	_	FW	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	2006	_	_	CD	O	[-1]	['none']	_	_
19	;	_	_	:	O	[-1]	['none']	_	_
20	Ejrnaes	_	_	NNP	O	[-1]	['none']	_	_
21	et	_	_	FW	O	[-1]	['none']	_	_
22	al.	_	_	FW	O	[-1]	['none']	_	_
23	,	_	_	,	O	[-1]	['none']	_	_
24	2006	_	_	CD	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	high	_	_	JJ	O	[-1]	['none']	_	_
28	amounts	_	_	NNS	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	stimulation	_	_	NN	O	[-1]	['none']	_	_
31	may	_	_	MD	O	[-1]	['none']	_	_
32	lead	_	_	VB	O	[-1]	['none']	_	_
33	to	_	_	TO	O	[-1]	['none']	_	_
34	the	_	_	DT	O	[-1]	['none']	_	_
35	chronic	_	_	JJ	O	[-1]	['none']	_	_
36	nonhealing	_	_	JJ	O	[-1]	['none']	_	_
37	infection	_	_	NN	O	[-1]	['none']	_	_
38	shown	_	_	VBN	O	[-1]	['none']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	be	_	_	VB	O	[-1]	['none']	_	_
41	regulated	_	_	VBN	O	[-1]	['none']	_	_
42	by	_	_	IN	O	[-1]	['none']	_	_
43	IL-10	_	_	NN	Protein	[0]	['root']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	During	_	_	IN	O	[-1]	['none']	_	_
2	the	_	_	DT	O	[-1]	['none']	_	_
3	course	_	_	NN	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	infection	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	after	_	_	IN	O	[-1]	['none']	_	_
8	initial	_	_	JJ	O	[-1]	['none']	_	_
9	triggering	_	_	NN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	antigen	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	T	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	migrate	_	_	VBP	O	[-1]	['none']	_	_
16	to	_	_	TO	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	tissue	_	_	NN	O	[-1]	['none']	_	_
19	encountering	_	_	VBG	O	[-1]	['none']	_	_
20	high	_	_	JJ	O	[-1]	['none']	_	_
21	doses	_	_	NNS	O	[-1]	['none']	_	_
22	of	_	_	IN	O	[-1]	['none']	_	_
23	antigen	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	factors	_	_	NNS	O	[-1]	['none']	_	_
26	produced	_	_	VBN	O	[-1]	['none']	_	_
27	by	_	_	IN	O	[-1]	['none']	_	_
28	the	_	_	DT	O	[-1]	['none']	_	_
29	innate	_	_	JJ	O	[-1]	['none']	_	_
30	immune	_	_	JJ	O	[-1]	['none']	_	_
31	response	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Under	_	_	IN	O	[-1]	['none']	_	_
2	these	_	_	DT	O	[-1]	['none']	_	_
3	conditions	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	we	_	_	PRP	O	[-1]	['none']	_	_
6	speculate	_	_	VBP	O	[-1]	['none']	_	_
7	that	_	_	IN	O	[-1]	['none']	_	_
8	Th1	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	will	_	_	MD	O	[-1]	['none']	_	_
11	be	_	_	VB	O	[-1]	['none']	_	_
12	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	express	_	_	VB	Gene_expression	[12]	['Theme']	_	_
15	high	_	_	JJ	O	[-1]	['none']	_	_
16	amounts	_	_	NNS	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	IL-10	_	_	NN	Protein	[14]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	keeping	_	_	VBG	O	[-1]	['none']	_	_
22	with	_	_	IN	O	[-1]	['none']	_	_
23	reports	_	_	NNS	O	[-1]	['none']	_	_
24	that	_	_	IN	O	[-1]	['none']	_	_
25	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
26	Th1	_	_	NN	O	[-1]	['none']	_	_
27	cells	_	_	NNS	O	[-1]	['none']	_	_
28	were	_	_	VBD	O	[-1]	['none']	_	_
29	found	_	_	VBN	O	[-1]	['none']	_	_
30	in	_	_	IN	O	[-1]	['none']	_	_
31	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
32	clones	_	_	NNS	O	[-1]	['none']	_	_
33	isolated	_	_	VBN	O	[-1]	['none']	_	_
34	from	_	_	IN	O	[-1]	['none']	_	_
35	BAL	_	_	NN	O	[-1]	['none']	_	_
36	but	_	_	CC	O	[-1]	['none']	_	_
37	not	_	_	RB	O	[-1]	['none']	_	_
38	blood	_	_	NN	O	[-1]	['none']	_	_
39	of	_	_	IN	O	[-1]	['none']	_	_
40	TB	_	_	NN	O	[-1]	['none']	_	_
41	patients	_	_	NNS	O	[-1]	['none']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	Gerosa	_	_	NNP	O	[-1]	['none']	_	_
44	et	_	_	FW	O	[-1]	['none']	_	_
45	al.	_	_	FW	O	[-1]	['none']	_	_
46	,	_	_	,	O	[-1]	['none']	_	_
47	1999	_	_	CD	O	[-1]	['none']	_	_
48	)	_	_	-RRB-	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	Similarly	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	immune	_	_	JJ	O	[-1]	['none']	_	_
5	response	_	_	NN	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	a	_	_	DT	O	[-1]	['none']	_	_
8	clinical	_	_	JJ	O	[-1]	['none']	_	_
9	isolate	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	L.	_	_	NNP	O	[-1]	['none']	_	_
12	major	_	_	JJ	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	which	_	_	WDT	O	[-1]	['none']	_	_
15	produces	_	_	VBZ	O	[-1]	['none']	_	_
16	heavily	_	_	RB	O	[-1]	['none']	_	_
17	infected	_	_	JJ	O	[-1]	['none']	_	_
18	nonhealing	_	_	JJ	O	[-1]	['none']	_	_
19	lesions	_	_	NNS	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	was	_	_	VBD	O	[-1]	['none']	_	_
22	found	_	_	VBN	O	[-1]	['none']	_	_
23	to	_	_	TO	O	[-1]	['none']	_	_
24	be	_	_	VB	O	[-1]	['none']	_	_
25	regulated	_	_	VBN	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	IL-10	_	_	NN	Protein	[0]	['root']	_	_
28	derived	_	_	VBN	O	[-1]	['none']	_	_
29	from	_	_	IN	O	[-1]	['none']	_	_
30	Foxp3-	_	_	JJ	Protein	[0]	['root']	_	_
31	Th1	_	_	NN	O	[-1]	['none']	_	_
32	cells	_	_	NNS	O	[-1]	['none']	_	_
33	that	_	_	WDT	O	[-1]	['none']	_	_
34	coproduce	_	_	VBP	Gene_expression	[0]	['root']	_	_
35	IL-10	_	_	NN	Protein	[34]	['Theme']	_	_
36	and	_	_	CC	O	[-1]	['none']	_	_
37	IFN-gamma	_	_	NN	Protein	[34]	['Theme']	_	_
38	(	_	_	-LRB-	O	[-1]	['none']	_	_
39	Anderson	_	_	NNP	O	[-1]	['none']	_	_
40	et	_	_	FW	O	[-1]	['none']	_	_
41	al.	_	_	FW	O	[-1]	['none']	_	_
42	,	_	_	,	O	[-1]	['none']	_	_
43	2007	_	_	CD	O	[-1]	['none']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	and	_	_	CC	O	[-1]	['none']	_	_
47	the	_	_	DT	O	[-1]	['none']	_	_
48	immune	_	_	JJ	O	[-1]	['none']	_	_
49	response	_	_	NN	O	[-1]	['none']	_	_
50	during	_	_	IN	O	[-1]	['none']	_	_
51	T.	_	_	NNP	O	[-1]	['none']	_	_
52	gondii	_	_	NN	O	[-1]	['none']	_	_
53	infection	_	_	NN	O	[-1]	['none']	_	_
54	was	_	_	VBD	O	[-1]	['none']	_	_
55	found	_	_	VBN	O	[-1]	['none']	_	_
56	also	_	_	RB	O	[-1]	['none']	_	_
57	to	_	_	TO	O	[-1]	['none']	_	_
58	be	_	_	VB	O	[-1]	['none']	_	_
59	regulated	_	_	VBN	O	[-1]	['none']	_	_
60	by	_	_	IN	O	[-1]	['none']	_	_
61	Foxp3-	_	_	NN	Protein	[0]	['root']	_	_
62	Th1	_	_	NN	O	[-1]	['none']	_	_
63	cells	_	_	NNS	O	[-1]	['none']	_	_
64	(	_	_	-LRB-	O	[-1]	['none']	_	_
65	Jankovic	_	_	NNP	O	[-1]	['none']	_	_
66	et	_	_	FW	O	[-1]	['none']	_	_
67	al.	_	_	FW	O	[-1]	['none']	_	_
68	,	_	_	,	O	[-1]	['none']	_	_
69	2007	_	_	CD	O	[-1]	['none']	_	_
70	)	_	_	-RRB-	O	[-1]	['none']	_	_
71	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	likely	_	_	JJ	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	IL-10	_	_	NN	Protein	[6]	['Theme']	_	_
6	production	_	_	NN	Gene_expression	[0]	['root']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	Th1	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	is	_	_	VBZ	O	[-1]	['none']	_	_
11	evoked	_	_	VBN	O	[-1]	['none']	_	_
12	under	_	_	IN	O	[-1]	['none']	_	_
13	conditions	_	_	NNS	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	high	_	_	JJ	O	[-1]	['none']	_	_
16	inflammation	_	_	NN	O	[-1]	['none']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	antigenic	_	_	JJ	O	[-1]	['none']	_	_
19	stimulation	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	whereas	_	_	IN	O	[-1]	['none']	_	_
22	regulatory	_	_	JJ	O	[-1]	['none']	_	_
23	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
24	T	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	producing	_	_	VBG	Gene_expression	[0]	['root']	_	_
27	IL-10	_	_	NN	Protein	[26]	['Theme']	_	_
28	may	_	_	MD	O	[-1]	['none']	_	_
29	operate	_	_	VB	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	regulate	_	_	VB	O	[-1]	['none']	_	_
32	the	_	_	DT	O	[-1]	['none']	_	_
33	immune	_	_	JJ	O	[-1]	['none']	_	_
34	response	_	_	NN	O	[-1]	['none']	_	_
35	under	_	_	IN	O	[-1]	['none']	_	_
36	conditions	_	_	NNS	O	[-1]	['none']	_	_
37	in	_	_	IN	O	[-1]	['none']	_	_
38	which	_	_	WDT	O	[-1]	['none']	_	_
39	the	_	_	DT	O	[-1]	['none']	_	_
40	pathogen	_	_	NN	O	[-1]	['none']	_	_
41	is	_	_	VBZ	O	[-1]	['none']	_	_
42	clinically	_	_	RB	O	[-1]	['none']	_	_
43	controlled	_	_	VBN	O	[-1]	['none']	_	_
44	,	_	_	,	O	[-1]	['none']	_	_
45	such	_	_	JJ	O	[-1]	['none']	_	_
46	as	_	_	IN	O	[-1]	['none']	_	_
47	in	_	_	IN	O	[-1]	['none']	_	_
48	infection	_	_	NN	O	[-1]	['none']	_	_
49	with	_	_	IN	O	[-1]	['none']	_	_
50	L.	_	_	NNP	O	[-1]	['none']	_	_
51	major	_	_	JJ	O	[-1]	['none']	_	_
52	(	_	_	-LRB-	O	[-1]	['none']	_	_
53	Friedlin	_	_	NN	O	[-1]	['none']	_	_
54	strain	_	_	NN	O	[-1]	['none']	_	_
55	)	_	_	-RRB-	O	[-1]	['none']	_	_
56	(	_	_	-LRB-	O	[-1]	['none']	_	_
57	Belkaid	_	_	NNP	O	[-1]	['none']	_	_
58	et	_	_	FW	O	[-1]	['none']	_	_
59	al.	_	_	FW	O	[-1]	['none']	_	_
60	,	_	_	,	O	[-1]	['none']	_	_
61	2002	_	_	CD	O	[-1]	['none']	_	_
62	;	_	_	:	O	[-1]	['none']	_	_
63	Suffia	_	_	NNP	O	[-1]	['none']	_	_
64	et	_	_	FW	O	[-1]	['none']	_	_
65	al.	_	_	FW	O	[-1]	['none']	_	_
66	,	_	_	,	O	[-1]	['none']	_	_
67	2006	_	_	CD	O	[-1]	['none']	_	_
68	)	_	_	-RRB-	O	[-1]	['none']	_	_
69	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	now	_	_	RB	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	reported	_	_	VBD	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	cultured	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	high	_	_	JJ	O	[-1]	['none']	_	_
12	antigen	_	_	NN	O	[-1]	['none']	_	_
13	dose	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	IL-12	_	_	NN	Protein	[0]	['root']	_	_
16	differentiate	_	_	VBP	O	[-1]	['none']	_	_
17	into	_	_	IN	O	[-1]	['none']	_	_
18	canonical	_	_	JJ	O	[-1]	['none']	_	_
19	Th1	_	_	NN	O	[-1]	['none']	_	_
20	effector	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	which	_	_	WDT	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	addition	_	_	NN	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	expressing	_	_	VBG	Gene_expression	[0]	['root']	_	_
29	large	_	_	JJ	O	[-1]	['none']	_	_
30	amounts	_	_	NNS	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	IFN-gamma	_	_	NN	Protein	[28]	['Theme']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	IL-10	_	_	NN	Protein	[28]	['Theme']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	lose	_	_	VBP	Negative_regulation	[0]	['root']	_	_
37	their	_	_	PRP$	O	[-1]	['none']	_	_
38	IL-2	_	_	NN	Protein	[39]	['Theme']	_	_
39	expression	_	_	NN	Gene_expression	[36]	['Theme']	_	_
40	as	_	_	IN	O	[-1]	['none']	_	_
41	described	_	_	VBN	O	[-1]	['none']	_	_
42	before	_	_	IN	O	[-1]	['none']	_	_
43	in	_	_	IN	O	[-1]	['none']	_	_
44	certain	_	_	JJ	O	[-1]	['none']	_	_
45	chronic	_	_	JJ	O	[-1]	['none']	_	_
46	infection	_	_	NN	O	[-1]	['none']	_	_
47	models	_	_	NNS	O	[-1]	['none']	_	_
48	(	_	_	-LRB-	O	[-1]	['none']	_	_
49	Sallusto	_	_	NNP	O	[-1]	['none']	_	_
50	et	_	_	FW	O	[-1]	['none']	_	_
51	al.	_	_	FW	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	2004	_	_	CD	O	[-1]	['none']	_	_
54	)	_	_	-RRB-	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	Our	_	_	PRP$	O	[-1]	['none']	_	_
2	demonstration	_	_	NN	O	[-1]	['none']	_	_
3	that	_	_	IN	O	[-1]	['none']	_	_
4	loss	_	_	NN	Negative_regulation	[0]	['root']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	IL-2	_	_	NN	Protein	[4]	['Theme']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	accompanied	_	_	VBN	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	production	_	_	NN	Gene_expression	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	IL-10	_	_	NN	Protein	[10]	['Theme']	_	_
13	offers	_	_	VBZ	O	[-1]	['none']	_	_
14	potential	_	_	JJ	O	[-1]	['none']	_	_
15	additional	_	_	JJ	O	[-1]	['none']	_	_
16	mechanisms	_	_	NNS	O	[-1]	['none']	_	_
17	whereby	_	_	WRB	O	[-1]	['none']	_	_
18	effector	_	_	NN	O	[-1]	['none']	_	_
19	T	_	_	NN	O	[-1]	['none']	_	_
20	cell	_	_	NN	O	[-1]	['none']	_	_
21	responses	_	_	NNS	O	[-1]	['none']	_	_
22	may	_	_	MD	O	[-1]	['none']	_	_
23	be	_	_	VB	O	[-1]	['none']	_	_
24	dampened	_	_	VBN	O	[-1]	['none']	_	_
25	during	_	_	IN	O	[-1]	['none']	_	_
26	chronic	_	_	JJ	O	[-1]	['none']	_	_
27	disease	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	Using	_	_	VBG	O	[-1]	['none']	_	_
2	an	_	_	DT	O	[-1]	['none']	_	_
3	in	_	_	FW	O	[-1]	['none']	_	_
4	vivo	_	_	FW	O	[-1]	['none']	_	_
5	transfer	_	_	NN	O	[-1]	['none']	_	_
6	model	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	DO11	_	_	NN	O	[-1]	['none']	_	_
9	.10	_	_	CD	O	[-1]	['none']	_	_
10	TCR	_	_	NN	O	[-1]	['none']	_	_
11	transgenic	_	_	JJ	O	[-1]	['none']	_	_
12	cells	_	_	NNS	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	Castro	_	_	NNP	O	[-1]	['none']	_	_
15	et	_	_	FW	O	[-1]	['none']	_	_
16	al.	_	_	FW	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	2000	_	_	CD	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	we	_	_	PRP	O	[-1]	['none']	_	_
22	showed	_	_	VBD	O	[-1]	['none']	_	_
23	that	_	_	IN	O	[-1]	['none']	_	_
24	IL-10-producing	_	_	JJ	Protein	[0]	['root']	_	_
25	Th1	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	were	_	_	VBD	O	[-1]	['none']	_	_
28	differentiated	_	_	VBN	O	[-1]	['none']	_	_
29	in	_	_	IN	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	presence	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	high	_	_	JJ	O	[-1]	['none']	_	_
34	doses	_	_	NNS	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	OVA	_	_	NN	Protein	[0]	['root']	_	_
37	protein	_	_	NN	O	[-1]	['none']	_	_
38	and	_	_	CC	O	[-1]	['none']	_	_
39	LPS	_	_	NN	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	showed	_	_	VBD	O	[-1]	['none']	_	_
3	here	_	_	RB	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	this	_	_	DT	O	[-1]	['none']	_	_
6	induction	_	_	NN	Positive_regulation	[21]	['Theme']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	IL-10	_	_	NN	Protein	[6]	['Theme']	_	_
9	in	_	_	IN	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	in	_	_	FW	O	[-1]	['none']	_	_
13	vivo	_	_	FW	O	[-1]	['none']	_	_
14	was	_	_	VBD	O	[-1]	['none']	_	_
15	markedly	_	_	RB	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	but	_	_	CC	O	[-1]	['none']	_	_
18	not	_	_	RB	O	[-1]	['none']	_	_
19	totally	_	_	RB	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	reduced	_	_	VBN	Negative_regulation	[0]	['root']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	STAT4	_	_	NN	Protein	[24]	['Theme']	_	_
24	deficient	_	_	JJ	Negative_regulation	[21]	['Cause']	_	_
25	T	_	_	NN	O	[-1]	['none']	_	_
26	cells	_	_	NNS	O	[-1]	['none']	_	_
27	as	_	_	IN	O	[-1]	['none']	_	_
28	observed	_	_	VBN	O	[-1]	['none']	_	_
29	during	_	_	IN	O	[-1]	['none']	_	_
30	T.	_	_	NNP	O	[-1]	['none']	_	_
31	gondii	_	_	NN	O	[-1]	['none']	_	_
32	infection	_	_	NN	O	[-1]	['none']	_	_
33	(	_	_	-LRB-	O	[-1]	['none']	_	_
34	Jankovic	_	_	NNP	O	[-1]	['none']	_	_
35	et	_	_	FW	O	[-1]	['none']	_	_
36	al.	_	_	FW	O	[-1]	['none']	_	_
37	,	_	_	,	O	[-1]	['none']	_	_
38	2002	_	_	CD	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	high	_	_	JJ	O	[-1]	['none']	_	_
3	antigenic	_	_	JJ	O	[-1]	['none']	_	_
4	activation	_	_	NN	O	[-1]	['none']	_	_
5	during	_	_	IN	O	[-1]	['none']	_	_
6	T.	_	_	NNP	O	[-1]	['none']	_	_
7	gondii	_	_	NN	O	[-1]	['none']	_	_
8	infection	_	_	NN	O	[-1]	['none']	_	_
9	or	_	_	CC	O	[-1]	['none']	_	_
10	high	_	_	JJ	O	[-1]	['none']	_	_
11	antigen	_	_	NN	O	[-1]	['none']	_	_
12	doses	_	_	NNS	O	[-1]	['none']	_	_
13	delivered	_	_	VBN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	the	_	_	DT	O	[-1]	['none']	_	_
16	presence	_	_	NN	O	[-1]	['none']	_	_
17	of	_	_	IN	O	[-1]	['none']	_	_
18	LPS	_	_	NN	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	as	_	_	IN	O	[-1]	['none']	_	_
21	seen	_	_	VBN	O	[-1]	['none']	_	_
22	in	_	_	IN	O	[-1]	['none']	_	_
23	our	_	_	PRP$	O	[-1]	['none']	_	_
24	system	_	_	NN	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	may	_	_	MD	O	[-1]	['none']	_	_
27	compensate	_	_	VB	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	an	_	_	DT	O	[-1]	['none']	_	_
30	absolute	_	_	JJ	O	[-1]	['none']	_	_
31	requirement	_	_	NN	Positive_regulation	[0]	['root']	_	_
32	for	_	_	IN	O	[-1]	['none']	_	_
33	IL-12	_	_	NN	Protein	[31]	['Cause']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	the	_	_	DT	O	[-1]	['none']	_	_
36	induction	_	_	NN	Positive_regulation	[31]	['Theme']	_	_
37	of	_	_	IN	O	[-1]	['none']	_	_
38	IL-10	_	_	NN	Protein	[36]	['Theme']	_	_
39	by	_	_	IN	O	[-1]	['none']	_	_
40	Th1	_	_	NN	O	[-1]	['none']	_	_
41	cells	_	_	NNS	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	our	_	_	PRP$	O	[-1]	['none']	_	_
3	in	_	_	FW	O	[-1]	['none']	_	_
4	vitro	_	_	FW	O	[-1]	['none']	_	_
5	system	_	_	NN	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	repeated	_	_	VBN	O	[-1]	['none']	_	_
8	stimulation	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	high	_	_	JJ	O	[-1]	['none']	_	_
14	antigen	_	_	NN	O	[-1]	['none']	_	_
15	doses	_	_	NNS	O	[-1]	['none']	_	_
16	allowed	_	_	VBD	O	[-1]	['none']	_	_
17	the	_	_	DT	O	[-1]	['none']	_	_
18	development	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	Th1	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	producing	_	_	VBG	Gene_expression	[0]	['root']	_	_
23	IL-10	_	_	NN	Protein	[22]	['Theme']	_	_
24	in	_	_	IN	O	[-1]	['none']	_	_
25	an	_	_	DT	O	[-1]	['none']	_	_
26	IL-12-dependent	_	_	JJ	Protein	[0]	['root']	_	_
27	manner	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	IL-10	_	_	NNP	Protein	[2]	['Theme']	_	_
2	production	_	_	NN	Gene_expression	[6]	['Theme']	_	_
3	by	_	_	IN	O	[-1]	['none']	_	_
4	Th1	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	induced	_	_	VBN	Positive_regulation	[14]	['Theme']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	high	_	_	JJ	O	[-1]	['none']	_	_
9	antigen	_	_	NN	O	[-1]	['none']	_	_
10	dose	_	_	NN	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	IL-12	_	_	NN	Protein	[6]	['Cause']	_	_
13	was	_	_	VBD	O	[-1]	['none']	_	_
14	independent	_	_	JJ	Regulation	[0]	['root']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IFN-gamma	_	_	NN	Protein	[14]	['Cause']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	keeping	_	_	VBG	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	previous	_	_	JJ	O	[-1]	['none']	_	_
22	findings	_	_	NNS	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	Jankovic	_	_	NNP	O	[-1]	['none']	_	_
25	et	_	_	FW	O	[-1]	['none']	_	_
26	al.	_	_	FW	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	2002	_	_	CD	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	role	_	_	NN	O	[-1]	['none']	_	_
5	for	_	_	IN	O	[-1]	['none']	_	_
6	IFN-gamma	_	_	NN	Protein	[8]	['Cause']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	mediating	_	_	VBG	Positive_regulation	[0]	['root']	_	_
9	IL-10	_	_	NN	Protein	[10]	['Theme']	_	_
10	reactivation	_	_	NN	Positive_regulation	[8]	['Theme']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	Th1	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	during	_	_	IN	O	[-1]	['none']	_	_
15	secondary	_	_	JJ	O	[-1]	['none']	_	_
16	infection	_	_	NN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	T.	_	_	NNP	O	[-1]	['none']	_	_
19	gondii	_	_	NNP	O	[-1]	['none']	_	_
20	has	_	_	VBZ	O	[-1]	['none']	_	_
21	been	_	_	VBN	O	[-1]	['none']	_	_
22	suggested	_	_	VBN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	Shaw	_	_	NNP	O	[-1]	['none']	_	_
25	et	_	_	FW	O	[-1]	['none']	_	_
26	al.	_	_	FW	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	2006	_	_	CD	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	have	_	_	VBP	O	[-1]	['none']	_	_
3	found	_	_	VBN	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
6	T	_	_	NN	O	[-1]	['none']	_	_
7	cells	_	_	NNS	O	[-1]	['none']	_	_
8	exposed	_	_	VBN	O	[-1]	['none']	_	_
9	to	_	_	TO	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	high	_	_	JJ	O	[-1]	['none']	_	_
12	dose	_	_	NN	O	[-1]	['none']	_	_
13	of	_	_	IN	O	[-1]	['none']	_	_
14	antigen	_	_	NN	O	[-1]	['none']	_	_
15	do	_	_	VBP	O	[-1]	['none']	_	_
16	not	_	_	RB	O	[-1]	['none']	_	_
17	express	_	_	VB	Gene_expression	[0]	['root']	_	_
18	IL-10	_	_	NN	Protein	[17]	['Theme']	_	_
19	upon	_	_	IN	O	[-1]	['none']	_	_
20	restimulation	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	but	_	_	CC	O	[-1]	['none']	_	_
23	can	_	_	MD	O	[-1]	['none']	_	_
24	be	_	_	VB	O	[-1]	['none']	_	_
25	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
26	to	_	_	TO	O	[-1]	['none']	_	_
27	produce	_	_	VB	Gene_expression	[25]	['Theme']	_	_
28	IL-10	_	_	NN	Protein	[27]	['Theme']	_	_
29	upon	_	_	IN	O	[-1]	['none']	_	_
30	re-exposure	_	_	NN	O	[-1]	['none']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	a	_	_	DT	O	[-1]	['none']	_	_
33	high	_	_	JJ	O	[-1]	['none']	_	_
34	dose	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	antigen	_	_	NN	O	[-1]	['none']	_	_
37	in	_	_	IN	O	[-1]	['none']	_	_
38	the	_	_	DT	O	[-1]	['none']	_	_
39	recall	_	_	NN	O	[-1]	['none']	_	_
40	phase	_	_	NN	O	[-1]	['none']	_	_
41	in	_	_	IN	O	[-1]	['none']	_	_
42	the	_	_	DT	O	[-1]	['none']	_	_
43	absence	_	_	NN	O	[-1]	['none']	_	_
44	of	_	_	IN	O	[-1]	['none']	_	_
45	added	_	_	VBN	O	[-1]	['none']	_	_
46	IL-12	_	_	NN	Protein	[0]	['root']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	this	_	_	DT	Anaphora	[0]	['root']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	dependent	_	_	JJ	Positive_regulation	[0]	['root']	_	_
6	on	_	_	IN	O	[-1]	['none']	_	_
7	the	_	_	DT	O	[-1]	['none']	_	_
8	induction	_	_	NN	Positive_regulation	[5]	['Cause']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	IL-12	_	_	NN	Protein	[8]	['Theme']	_	_
11	by	_	_	IN	O	[-1]	['none']	_	_
12	antigen	_	_	NN	O	[-1]	['none']	_	_
13	presenting	_	_	VBG	O	[-1]	['none']	_	_
14	DCs	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	combination	_	_	NN	O	[-1]	['none']	_	_
3	of	_	_	IN	O	[-1]	['none']	_	_
4	both	_	_	DT	O	[-1]	['none']	_	_
5	high	_	_	JJ	O	[-1]	['none']	_	_
6	antigen	_	_	NN	O	[-1]	['none']	_	_
7	dose	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	IL-12	_	_	NN	Protein	[10]	['Cause']	_	_
10	resulted	_	_	VBD	Positive_regulation	[0]	['root']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	highest	_	_	JJS	O	[-1]	['none']	_	_
14	levels	_	_	NNS	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IL-10	_	_	NN	Protein	[17]	['Theme']	_	_
17	production	_	_	NN	Gene_expression	[10]	['Theme']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	correlated	_	_	VBD	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	the	_	_	DT	O	[-1]	['none']	_	_
22	high	_	_	JJ	O	[-1]	['none']	_	_
23	levels	_	_	NNS	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	ERK1	_	_	NN	Protein	[28]	['Theme']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	ERK2	_	_	NN	Protein	[28]	['Theme']	_	_
28	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	increased	_	_	JJ	Positive_regulation	[12]	['Cause']	_	_
3	expression	_	_	NN	Gene_expression	[2]	['Theme']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	IFN-gamma	_	_	NN	Protein	[3]	['Theme']	_	_
6	observed	_	_	VBN	O	[-1]	['none']	_	_
7	during	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	secondary	_	_	JJ	O	[-1]	['none']	_	_
10	phase	_	_	NN	O	[-1]	['none']	_	_
11	will	_	_	MD	O	[-1]	['none']	_	_
12	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
13	increased	_	_	VBN	Positive_regulation	[12]	['Theme']	_	_
14	IL-12	_	_	NN	Protein	[15]	['Theme']	_	_
15	production	_	_	NN	Gene_expression	[13]	['Theme']	_	_
16	by	_	_	IN	O	[-1]	['none']	_	_
17	DCs	_	_	NNS	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	suggests	_	_	VBZ	O	[-1]	['none']	_	_
20	that	_	_	IN	O	[-1]	['none']	_	_
21	repeated	_	_	VBN	O	[-1]	['none']	_	_
22	high-level	_	_	JJ	O	[-1]	['none']	_	_
23	TCR	_	_	NN	O	[-1]	['none']	_	_
24	activation	_	_	NN	O	[-1]	['none']	_	_
25	feeds	_	_	VBZ	O	[-1]	['none']	_	_
26	back	_	_	RB	O	[-1]	['none']	_	_
27	to	_	_	TO	O	[-1]	['none']	_	_
28	upregulate	_	_	VB	Positive_regulation	[0]	['root']	_	_
29	IL-12	_	_	NN	Protein	[30]	['Theme']	_	_
30	production	_	_	NN	Gene_expression	[28]	['Theme']	_	_
31	by	_	_	IN	O	[-1]	['none']	_	_
32	DC	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	is	_	_	VBZ	O	[-1]	['none']	_	_
3	thus	_	_	RB	O	[-1]	['none']	_	_
4	likely	_	_	JJ	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	T.	_	_	NNP	O	[-1]	['none']	_	_
8	gondii	_	_	NN	O	[-1]	['none']	_	_
9	infection	_	_	NN	O	[-1]	['none']	_	_
10	in	_	_	FW	O	[-1]	['none']	_	_
11	vivo	_	_	FW	O	[-1]	['none']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	Shaw	_	_	NNP	O	[-1]	['none']	_	_
14	et	_	_	FW	O	[-1]	['none']	_	_
15	al.	_	_	FW	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	2006	_	_	CD	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	the	_	_	DT	O	[-1]	['none']	_	_
21	requirement	_	_	NN	Positive_regulation	[0]	['root']	_	_
22	for	_	_	IN	O	[-1]	['none']	_	_
23	IFN-gamma	_	_	NN	Protein	[21]	['Cause']	_	_
24	to	_	_	TO	O	[-1]	['none']	_	_
25	induce	_	_	VB	Positive_regulation	[21]	['Theme']	_	_
26	IL-10	_	_	NN	Protein	[25]	['Theme']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	was	_	_	VBD	O	[-1]	['none']	_	_
29	for	_	_	IN	O	[-1]	['none']	_	_
30	feedback	_	_	NN	O	[-1]	['none']	_	_
31	upregulation	_	_	NN	Positive_regulation	[40]	['Cause']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	IL-12	_	_	NN	Protein	[31]	['Theme']	_	_
34	by	_	_	IN	O	[-1]	['none']	_	_
35	DCs	_	_	NNS	O	[-1]	['none']	_	_
36	,	_	_	,	O	[-1]	['none']	_	_
37	which	_	_	WDT	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	turn	_	_	NN	O	[-1]	['none']	_	_
40	induced	_	_	VBD	Positive_regulation	[0]	['root']	_	_
41	IL-10	_	_	NN	Protein	[40]	['Theme']	_	_
42	in	_	_	IN	O	[-1]	['none']	_	_
43	the	_	_	DT	O	[-1]	['none']	_	_
44	Th1	_	_	NN	O	[-1]	['none']	_	_
45	cells	_	_	NNS	O	[-1]	['none']	_	_
46	.	_	_	.	O	[-1]	['none']	_	_

1	Although	_	_	IN	O	[-1]	['none']	_	_
2	IL-10	_	_	NN	Protein	[6]	['Theme']	_	_
3	may	_	_	MD	O	[-1]	['none']	_	_
4	be	_	_	VB	O	[-1]	['none']	_	_
5	differentially	_	_	RB	O	[-1]	['none']	_	_
6	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	Th1	_	_	NN	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	Th2	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	as	_	_	IN	O	[-1]	['none']	_	_
13	has	_	_	VBZ	O	[-1]	['none']	_	_
14	been	_	_	VBN	O	[-1]	['none']	_	_
15	reported	_	_	VBN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	Chang	_	_	NNP	O	[-1]	['none']	_	_
18	et	_	_	FW	O	[-1]	['none']	_	_
19	al.	_	_	FW	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	2007	_	_	CD	O	[-1]	['none']	_	_
22	;	_	_	:	O	[-1]	['none']	_	_
23	Wang	_	_	NNP	O	[-1]	['none']	_	_
24	et	_	_	FW	O	[-1]	['none']	_	_
25	al.	_	_	FW	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	2005	_	_	CD	O	[-1]	['none']	_	_
28	)	_	_	-RRB-	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	some	_	_	DT	O	[-1]	['none']	_	_
31	studies	_	_	NNS	O	[-1]	['none']	_	_
32	suggest	_	_	VBP	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	existence	_	_	NN	O	[-1]	['none']	_	_
35	of	_	_	IN	O	[-1]	['none']	_	_
36	common	_	_	JJ	O	[-1]	['none']	_	_
37	pathways	_	_	NNS	O	[-1]	['none']	_	_
38	,	_	_	,	O	[-1]	['none']	_	_
39	but	_	_	CC	O	[-1]	['none']	_	_
40	the	_	_	DT	O	[-1]	['none']	_	_
41	molecular	_	_	JJ	O	[-1]	['none']	_	_
42	basis	_	_	NN	O	[-1]	['none']	_	_
43	for	_	_	IN	O	[-1]	['none']	_	_
44	these	_	_	DT	O	[-1]	['none']	_	_
45	is	_	_	VBZ	O	[-1]	['none']	_	_
46	as	_	_	RB	O	[-1]	['none']	_	_
47	yet	_	_	RB	O	[-1]	['none']	_	_
48	unclear	_	_	JJ	O	[-1]	['none']	_	_
49	.	_	_	.	O	[-1]	['none']	_	_

1	Costimulatory	_	_	JJ	O	[-1]	['none']	_	_
2	OX-40	_	_	NN	Protein	[0]	['root']	_	_
3	signals	_	_	NNS	O	[-1]	['none']	_	_
4	have	_	_	VBP	O	[-1]	['none']	_	_
5	been	_	_	VBN	O	[-1]	['none']	_	_
6	shown	_	_	VBN	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	negatively	_	_	RB	Negative_regulation	[9]	['multitoken']	_	_
9	regulate	_	_	VB	Negative_regulation	[0]	['root']	_	_
10	IL-10	_	_	NN	Protein	[11]	['Theme']	_	_
11	production	_	_	NN	Gene_expression	[9]	['Theme']	_	_
12	(	_	_	-LRB-	O	[-1]	['none']	_	_
13	Ito	_	_	NNP	O	[-1]	['none']	_	_
14	et	_	_	FW	O	[-1]	['none']	_	_
15	al.	_	_	FW	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	2005	_	_	CD	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	both	_	_	DT	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	Th1	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	Th2	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	whereas	_	_	IN	O	[-1]	['none']	_	_
27	ICOS	_	_	NN	Protein	[0]	['root']	_	_
28	signaling	_	_	NN	O	[-1]	['none']	_	_
29	has	_	_	VBZ	O	[-1]	['none']	_	_
30	been	_	_	VBN	O	[-1]	['none']	_	_
31	suggested	_	_	VBN	O	[-1]	['none']	_	_
32	to	_	_	TO	O	[-1]	['none']	_	_
33	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
34	IL-10	_	_	NN	Protein	[33]	['Theme']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	Ito	_	_	NNP	O	[-1]	['none']	_	_
37	et	_	_	FW	O	[-1]	['none']	_	_
38	al.	_	_	FW	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	2007	_	_	CD	O	[-1]	['none']	_	_
41	;	_	_	:	O	[-1]	['none']	_	_
42	Witsch	_	_	NNP	O	[-1]	['none']	_	_
43	et	_	_	FW	O	[-1]	['none']	_	_
44	al.	_	_	FW	O	[-1]	['none']	_	_
45	,	_	_	,	O	[-1]	['none']	_	_
46	2002	_	_	CD	O	[-1]	['none']	_	_
47	)	_	_	-RRB-	O	[-1]	['none']	_	_
48	in	_	_	IN	O	[-1]	['none']	_	_
49	both	_	_	CC	O	[-1]	['none']	_	_
50	Th1	_	_	NN	O	[-1]	['none']	_	_
51	and	_	_	CC	O	[-1]	['none']	_	_
52	Th2	_	_	NN	O	[-1]	['none']	_	_
53	cells	_	_	NNS	O	[-1]	['none']	_	_
54	.	_	_	.	O	[-1]	['none']	_	_

1	However	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	in	_	_	IN	O	[-1]	['none']	_	_
4	some	_	_	DT	O	[-1]	['none']	_	_
5	cases	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	ICOS	_	_	NN	Protein	[0]	['root']	_	_
8	signaling	_	_	NN	O	[-1]	['none']	_	_
9	also	_	_	RB	O	[-1]	['none']	_	_
10	regulates	_	_	VBZ	Regulation	[0]	['root']	_	_
11	IL-4	_	_	NN	Protein	[12]	['Theme']	_	_
12	production	_	_	NN	Gene_expression	[10]	['Theme']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	Th2	_	_	NN	O	[-1]	['none']	_	_
15	responses	_	_	NNS	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	Greenwald	_	_	NNP	O	[-1]	['none']	_	_
18	et	_	_	FW	O	[-1]	['none']	_	_
19	al.	_	_	FW	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	2005	_	_	CD	O	[-1]	['none']	_	_
22	)	_	_	-RRB-	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	now	_	_	RB	O	[-1]	['none']	_	_
3	provide	_	_	VBP	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	common	_	_	JJ	O	[-1]	['none']	_	_
6	mechanism	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	ERK1	_	_	NN	Protein	[11, 14]	['Theme', 'Cause']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	ERK2	_	_	NN	Protein	[11, 14]	['Theme', 'Cause']	_	_
11	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	the	_	_	DT	O	[-1]	['none']	_	_
14	regulation	_	_	NN	Regulation	[0]	['root']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	IL-10	_	_	NN	Protein	[17]	['Theme']	_	_
17	production	_	_	NN	Gene_expression	[14]	['Theme']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	Th1	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	Th2	_	_	NN	O	[-1]	['none']	_	_
22	,	_	_	,	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	Th17	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	,	_	_	,	O	[-1]	['none']	_	_
27	although	_	_	IN	O	[-1]	['none']	_	_
28	each	_	_	DT	O	[-1]	['none']	_	_
29	subset	_	_	NN	O	[-1]	['none']	_	_
30	differentiates	_	_	VBZ	O	[-1]	['none']	_	_
31	along	_	_	IN	O	[-1]	['none']	_	_
32	a	_	_	DT	O	[-1]	['none']	_	_
33	distinct	_	_	JJ	O	[-1]	['none']	_	_
34	and	_	_	CC	O	[-1]	['none']	_	_
35	subset	_	_	NN	O	[-1]	['none']	_	_
36	specific	_	_	JJ	O	[-1]	['none']	_	_
37	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
38	pathway	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	reinforces	_	_	VBZ	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	fact	_	_	NN	O	[-1]	['none']	_	_
5	that	_	_	IN	O	[-1]	['none']	_	_
6	IL-10	_	_	NN	Protein	[17]	['Theme']	_	_
7	is	_	_	VBZ	O	[-1]	['none']	_	_
8	not	_	_	RB	O	[-1]	['none']	_	_
9	a	_	_	DT	O	[-1]	['none']	_	_
10	Th	_	_	NN	O	[-1]	['none']	_	_
11	cell-subset-specific	_	_	JJ	O	[-1]	['none']	_	_
12	cytokine	_	_	NN	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	but	_	_	CC	O	[-1]	['none']	_	_
15	instead	_	_	RB	O	[-1]	['none']	_	_
16	is	_	_	VBZ	O	[-1]	['none']	_	_
17	produced	_	_	VBN	Gene_expression	[21]	['Theme']	_	_
18	in	_	_	IN	O	[-1]	['none']	_	_
19	a	_	_	DT	O	[-1]	['none']	_	_
20	tightly	_	_	RB	O	[-1]	['none']	_	_
21	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
22	fashion	_	_	NN	O	[-1]	['none']	_	_
23	during	_	_	IN	O	[-1]	['none']	_	_
24	each	_	_	DT	O	[-1]	['none']	_	_
25	differentiation	_	_	NN	O	[-1]	['none']	_	_
26	pathway	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Of	_	_	IN	O	[-1]	['none']	_	_
2	note	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	a	_	_	DT	O	[-1]	['none']	_	_
5	role	_	_	NN	Regulation	[0]	['root']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	ERK1	_	_	NN	Protein	[10]	['Theme']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	ERK2	_	_	NN	Protein	[10]	['Theme']	_	_
10	activation	_	_	NN	Positive_regulation	[5]	['Cause']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	induction	_	_	NN	Positive_regulation	[5]	['Theme']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	IL-10	_	_	NN	Protein	[16]	['Theme']	_	_
16	production	_	_	NN	Gene_expression	[13]	['Theme']	_	_
17	has	_	_	VBZ	O	[-1]	['none']	_	_
18	already	_	_	RB	O	[-1]	['none']	_	_
19	been	_	_	VBN	O	[-1]	['none']	_	_
20	described	_	_	VBN	O	[-1]	['none']	_	_
21	for	_	_	IN	O	[-1]	['none']	_	_
22	macrophages	_	_	NNS	O	[-1]	['none']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	DC	_	_	NNS	O	[-1]	['none']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	Agrawal	_	_	NNP	O	[-1]	['none']	_	_
27	et	_	_	FW	O	[-1]	['none']	_	_
28	al.	_	_	FW	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	2006	_	_	CD	O	[-1]	['none']	_	_
31	;	_	_	:	O	[-1]	['none']	_	_
32	Hacker	_	_	NNP	O	[-1]	['none']	_	_
33	et	_	_	FW	O	[-1]	['none']	_	_
34	al.	_	_	FW	O	[-1]	['none']	_	_
35	,	_	_	,	O	[-1]	['none']	_	_
36	1999	_	_	CD	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	.	_	_	.	O	[-1]	['none']	_	_

1	Differential	_	_	JJ	O	[-1]	['none']	_	_
2	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
3	regulation	_	_	NN	Regulation	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	IL-10	_	_	NN	Protein	[3]	['Theme']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	Th1	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	Th2	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	has	_	_	VBZ	O	[-1]	['none']	_	_
12	been	_	_	VBN	O	[-1]	['none']	_	_
13	suggested	_	_	VBN	O	[-1]	['none']	_	_
14	(	_	_	-LRB-	O	[-1]	['none']	_	_
15	Chang	_	_	NNP	O	[-1]	['none']	_	_
16	et	_	_	FW	O	[-1]	['none']	_	_
17	al.	_	_	FW	O	[-1]	['none']	_	_
18	,	_	_	,	O	[-1]	['none']	_	_
19	2007	_	_	CD	O	[-1]	['none']	_	_
20	;	_	_	:	O	[-1]	['none']	_	_
21	Wang	_	_	NNP	O	[-1]	['none']	_	_
22	et	_	_	FW	O	[-1]	['none']	_	_
23	al.	_	_	FW	O	[-1]	['none']	_	_
24	,	_	_	,	O	[-1]	['none']	_	_
25	2005	_	_	CD	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	and	_	_	CC	O	[-1]	['none']	_	_
29	extensive	_	_	JJ	O	[-1]	['none']	_	_
30	histone	_	_	NN	Protein	[0]	['root']	_	_
31	acetylation	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	the	_	_	DT	O	[-1]	['none']	_	_
34	IL-10	_	_	NN	Protein	[0]	['root']	_	_
35	gene	_	_	NN	O	[-1]	['none']	_	_
36	is	_	_	VBZ	O	[-1]	['none']	_	_
37	detectable	_	_	JJ	O	[-1]	['none']	_	_
38	in	_	_	IN	O	[-1]	['none']	_	_
39	fully	_	_	RB	O	[-1]	['none']	_	_
40	polarized	_	_	VBN	O	[-1]	['none']	_	_
41	Th2	_	_	NN	O	[-1]	['none']	_	_
42	cells	_	_	NNS	O	[-1]	['none']	_	_
43	,	_	_	,	O	[-1]	['none']	_	_
44	but	_	_	CC	O	[-1]	['none']	_	_
45	not	_	_	RB	O	[-1]	['none']	_	_
46	Th1	_	_	NN	O	[-1]	['none']	_	_
47	cells	_	_	NNS	O	[-1]	['none']	_	_
48	(	_	_	-LRB-	O	[-1]	['none']	_	_
49	Chang	_	_	NNP	O	[-1]	['none']	_	_
50	et	_	_	FW	O	[-1]	['none']	_	_
51	al.	_	_	FW	O	[-1]	['none']	_	_
52	,	_	_	,	O	[-1]	['none']	_	_
53	2007	_	_	CD	O	[-1]	['none']	_	_
54	)	_	_	-RRB-	O	[-1]	['none']	_	_
55	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	provide	_	_	VBP	O	[-1]	['none']	_	_
3	evidence	_	_	NN	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	IL-10	_	_	NN	Protein	[7, 15]	['Theme', 'Theme']	_	_
6	is	_	_	VBZ	O	[-1]	['none']	_	_
7	produced	_	_	VBN	Gene_expression	[0]	['root']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	canonical	_	_	JJ	O	[-1]	['none']	_	_
10	Th1	_	_	NN	O	[-1]	['none']	_	_
11	cells	_	_	NNS	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	that	_	_	IN	O	[-1]	['none']	_	_
14	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
15	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
16	correlates	_	_	VBZ	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	T-bet	_	_	NN	Protein	[19]	['Theme']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	the	_	_	DT	O	[-1]	['none']	_	_
24	highest	_	_	JJS	O	[-1]	['none']	_	_
25	IFN-gamma	_	_	NN	Protein	[26]	['Theme']	_	_
26	production	_	_	NN	Gene_expression	[0]	['root']	_	_
27	,	_	_	,	O	[-1]	['none']	_	_
28	in	_	_	IN	O	[-1]	['none']	_	_
29	keeping	_	_	VBG	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	our	_	_	PRP$	O	[-1]	['none']	_	_
32	observations	_	_	NNS	O	[-1]	['none']	_	_
33	that	_	_	WDT	O	[-1]	['none']	_	_
34	high-dose	_	_	JJ	O	[-1]	['none']	_	_
35	antigen	_	_	NN	O	[-1]	['none']	_	_
36	stimulation	_	_	NN	O	[-1]	['none']	_	_
37	and	_	_	CC	O	[-1]	['none']	_	_
38	IL-12	_	_	NN	Protein	[0]	['root']	_	_
39	signaling	_	_	NN	O	[-1]	['none']	_	_
40	are	_	_	VBP	O	[-1]	['none']	_	_
41	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
42	for	_	_	IN	O	[-1]	['none']	_	_
43	IL-10	_	_	NN	Protein	[46]	['Theme']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	IFN-gamma	_	_	NN	Protein	[46]	['Theme']	_	_
46	expression	_	_	NN	Gene_expression	[41]	['Theme']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	It	_	_	PRP	O	[-1]	['none']	_	_
2	has	_	_	VBZ	O	[-1]	['none']	_	_
3	also	_	_	RB	O	[-1]	['none']	_	_
4	been	_	_	VBN	O	[-1]	['none']	_	_
5	shown	_	_	VBN	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	maintenance	_	_	NN	Positive_regulation	[12]	['Theme']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	IL-10	_	_	NN	Protein	[10]	['Theme']	_	_
10	expression	_	_	NN	Gene_expression	[7]	['Theme']	_	_
11	is	_	_	VBZ	O	[-1]	['none']	_	_
12	conditional	_	_	JJ	Positive_regulation	[0]	['root']	_	_
13	on	_	_	IN	O	[-1]	['none']	_	_
14	IL-12	_	_	NN	Protein	[12]	['Cause']	_	_
15	or	_	_	CC	O	[-1]	['none']	_	_
16	IL-4	_	_	NN	Protein	[12]	['Cause']	_	_
17	unless	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	IL-10	_	_	NN	Protein	[0]	['root']	_	_
20	gene	_	_	NN	O	[-1]	['none']	_	_
21	is	_	_	VBZ	O	[-1]	['none']	_	_
22	imprinted	_	_	VBN	O	[-1]	['none']	_	_
23	by	_	_	IN	O	[-1]	['none']	_	_
24	GATA-3	_	_	NN	Protein	[0]	['root']	_	_
25	(	_	_	-LRB-	O	[-1]	['none']	_	_
26	Chang	_	_	NNP	O	[-1]	['none']	_	_
27	et	_	_	FW	O	[-1]	['none']	_	_
28	al.	_	_	FW	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	2007	_	_	CD	O	[-1]	['none']	_	_
31	)	_	_	-RRB-	O	[-1]	['none']	_	_
32	,	_	_	,	O	[-1]	['none']	_	_
33	which	_	_	WDT	O	[-1]	['none']	_	_
34	can	_	_	MD	O	[-1]	['none']	_	_
35	remodel	_	_	VB	O	[-1]	['none']	_	_
36	the	_	_	DT	O	[-1]	['none']	_	_
37	IL-10	_	_	NN	Protein	[0]	['root']	_	_
38	locus	_	_	NN	O	[-1]	['none']	_	_
39	,	_	_	,	O	[-1]	['none']	_	_
40	thus	_	_	RB	O	[-1]	['none']	_	_
41	explaining	_	_	VBG	O	[-1]	['none']	_	_
42	the	_	_	DT	O	[-1]	['none']	_	_
43	highest	_	_	JJS	O	[-1]	['none']	_	_
44	amounts	_	_	NNS	O	[-1]	['none']	_	_
45	of	_	_	IN	O	[-1]	['none']	_	_
46	IL-10	_	_	NN	Protein	[47]	['Theme']	_	_
47	produced	_	_	VBN	Gene_expression	[0]	['root']	_	_
48	by	_	_	IN	O	[-1]	['none']	_	_
49	Th2	_	_	NN	O	[-1]	['none']	_	_
50	cells	_	_	NNS	O	[-1]	['none']	_	_
51	(	_	_	-LRB-	O	[-1]	['none']	_	_
52	Chang	_	_	NNP	O	[-1]	['none']	_	_
53	et	_	_	FW	O	[-1]	['none']	_	_
54	al.	_	_	FW	O	[-1]	['none']	_	_
55	,	_	_	,	O	[-1]	['none']	_	_
56	2007	_	_	CD	O	[-1]	['none']	_	_
57	;	_	_	:	O	[-1]	['none']	_	_
58	Shoemaker	_	_	NNP	O	[-1]	['none']	_	_
59	et	_	_	FW	O	[-1]	['none']	_	_
60	al.	_	_	FW	O	[-1]	['none']	_	_
61	,	_	_	,	O	[-1]	['none']	_	_
62	2006	_	_	CD	O	[-1]	['none']	_	_
63	)	_	_	-RRB-	O	[-1]	['none']	_	_
64	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	show	_	_	VBP	O	[-1]	['none']	_	_
3	here	_	_	RB	O	[-1]	['none']	_	_
4	that	_	_	IN	O	[-1]	['none']	_	_
5	high	_	_	JJ	O	[-1]	['none']	_	_
6	antigen	_	_	NN	O	[-1]	['none']	_	_
7	dose	_	_	NN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	IL-12	_	_	NN	Protein	[11]	['Cause']	_	_
10	drastically	_	_	RB	O	[-1]	['none']	_	_
11	downregulate	_	_	VBP	Negative_regulation	[0]	['root']	_	_
12	Gata-3	_	_	NN	Protein	[13]	['Theme']	_	_
13	expression	_	_	NN	Gene_expression	[11]	['Theme']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	suggesting	_	_	VBG	O	[-1]	['none']	_	_
16	that	_	_	IN	O	[-1]	['none']	_	_
17	additional	_	_	JJ	O	[-1]	['none']	_	_
18	factors	_	_	NNS	O	[-1]	['none']	_	_
19	are	_	_	VBP	O	[-1]	['none']	_	_
20	in	_	_	IN	O	[-1]	['none']	_	_
21	place	_	_	NN	O	[-1]	['none']	_	_
22	to	_	_	TO	O	[-1]	['none']	_	_
23	induce	_	_	VB	Positive_regulation	[0]	['root']	_	_
24	IL-10	_	_	NN	Protein	[25]	['Theme']	_	_
25	expression	_	_	NN	Gene_expression	[23]	['Theme']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	Th1	_	_	NN	O	[-1]	['none']	_	_
28	cells	_	_	NNS	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	albeit	_	_	IN	O	[-1]	['none']	_	_
31	transiently	_	_	RB	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	Expression	_	_	NN	Gene_expression	[6, 18]	['Theme', 'Theme']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	c-maf	_	_	NN	Protein	[1]	['Theme']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	greatly	_	_	RB	O	[-1]	['none']	_	_
6	diminished	_	_	VBN	Negative_regulation	[0]	['root']	_	_
7	by	_	_	IN	O	[-1]	['none']	_	_
8	high	_	_	JJ	O	[-1]	['none']	_	_
9	antigen	_	_	NN	O	[-1]	['none']	_	_
10	doses	_	_	NNS	O	[-1]	['none']	_	_
11	in	_	_	IN	O	[-1]	['none']	_	_
12	T	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	yet	_	_	RB	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	unexpectedly	_	_	RB	O	[-1]	['none']	_	_
18	maintained	_	_	VBN	Positive_regulation	[0]	['root']	_	_
19	by	_	_	IN	O	[-1]	['none']	_	_
20	IL-12	_	_	NN	Protein	[18]	['Cause']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	present	_	_	JJ	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	Th17	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	That	_	_	DT	O	[-1]	['none']	_	_
2	c-maf	_	_	NN	Protein	[3, 32]	['Theme', 'Theme']	_	_
3	expression	_	_	NN	Gene_expression	[21]	['Theme']	_	_
4	is	_	_	VBZ	O	[-1]	['none']	_	_
5	common	_	_	JJ	O	[-1]	['none']	_	_
6	to	_	_	TO	O	[-1]	['none']	_	_
7	IL-10-producing	_	_	JJ	Gene_expression	[0]	['root']	_	_
8	Th1	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	Th2	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	Th17	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	,	_	_	,	O	[-1]	['none']	_	_
17	like	_	_	IN	O	[-1]	['none']	_	_
18	IL-10	_	_	NN	Protein	[21]	['Theme']	_	_
19	,	_	_	,	O	[-1]	['none']	_	_
20	is	_	_	VBZ	O	[-1]	['none']	_	_
21	dependent	_	_	JJ	Positive_regulation	[0]	['root']	_	_
22	on	_	_	IN	O	[-1]	['none']	_	_
23	ERK	_	_	NN	Protein	[24]	['Theme']	_	_
24	activation	_	_	NN	Positive_regulation	[21]	['Cause']	_	_
25	in	_	_	IN	O	[-1]	['none']	_	_
26	Th1	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	Th17	_	_	NN	O	[-1]	['none']	_	_
29	cells	_	_	NNS	O	[-1]	['none']	_	_
30	for	_	_	IN	O	[-1]	['none']	_	_
31	its	_	_	PRP$	Anaphora	[0]	['root']	_	_
32	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
33	is	_	_	VBZ	O	[-1]	['none']	_	_
34	of	_	_	IN	O	[-1]	['none']	_	_
35	interest	_	_	NN	O	[-1]	['none']	_	_
36	because	_	_	IN	O	[-1]	['none']	_	_
37	c-Maf	_	_	NN	Protein	[44]	['Cause']	_	_
38	has	_	_	VBZ	O	[-1]	['none']	_	_
39	been	_	_	VBN	O	[-1]	['none']	_	_
40	shown	_	_	VBN	O	[-1]	['none']	_	_
41	to	_	_	TO	O	[-1]	['none']	_	_
42	be	_	_	VB	O	[-1]	['none']	_	_
43	an	_	_	DT	O	[-1]	['none']	_	_
44	essential	_	_	JJ	Positive_regulation	[0]	['root']	_	_
45	transcription	_	_	NN	O	[-1]	['none']	_	_
46	factor	_	_	NN	O	[-1]	['none']	_	_
47	for	_	_	IN	O	[-1]	['none']	_	_
48	IL-10	_	_	NN	Protein	[49]	['Theme']	_	_
49	expression	_	_	NN	Gene_expression	[44]	['Theme']	_	_
50	in	_	_	IN	O	[-1]	['none']	_	_
51	macrophages	_	_	NNS	O	[-1]	['none']	_	_
52	(	_	_	-LRB-	O	[-1]	['none']	_	_
53	Cao	_	_	NNP	O	[-1]	['none']	_	_
54	et	_	_	FW	O	[-1]	['none']	_	_
55	al.	_	_	FW	O	[-1]	['none']	_	_
56	,	_	_	,	O	[-1]	['none']	_	_
57	2005	_	_	CD	O	[-1]	['none']	_	_
58	)	_	_	-RRB-	O	[-1]	['none']	_	_
59	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	summary	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	we	_	_	PRP	O	[-1]	['none']	_	_
5	show	_	_	VBP	O	[-1]	['none']	_	_
6	that	_	_	IN	O	[-1]	['none']	_	_
7	although	_	_	IN	O	[-1]	['none']	_	_
8	Th1	_	_	NN	O	[-1]	['none']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	Th2	_	_	NN	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	Th17	_	_	NN	O	[-1]	['none']	_	_
14	CD4+	_	_	JJ	Protein	[0]	['root']	_	_
15	T	_	_	NN	O	[-1]	['none']	_	_
16	cell	_	_	NN	O	[-1]	['none']	_	_
17	subsets	_	_	NNS	O	[-1]	['none']	_	_
18	differentiate	_	_	VBP	O	[-1]	['none']	_	_
19	along	_	_	IN	O	[-1]	['none']	_	_
20	distinct	_	_	JJ	O	[-1]	['none']	_	_
21	signaling	_	_	NN	O	[-1]	['none']	_	_
22	and	_	_	CC	O	[-1]	['none']	_	_
23	transcriptional	_	_	JJ	O	[-1]	['none']	_	_
24	pathways	_	_	NNS	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	they	_	_	PRP	O	[-1]	['none']	_	_
27	can	_	_	MD	O	[-1]	['none']	_	_
28	all	_	_	RB	O	[-1]	['none']	_	_
29	be	_	_	VB	O	[-1]	['none']	_	_
30	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
31	to	_	_	TO	O	[-1]	['none']	_	_
32	make	_	_	VB	Gene_expression	[30]	['Theme']	_	_
33	IL-10	_	_	NN	Protein	[32]	['Theme']	_	_
34	.	_	_	.	O	[-1]	['none']	_	_

1	ERK1	_	_	NN	Protein	[4, 6]	['Theme', 'Cause']	_	_
2	and	_	_	CC	O	[-1]	['none']	_	_
3	ERK2	_	_	NN	Protein	[4, 6]	['Theme', 'Cause']	_	_
4	activation	_	_	NN	Positive_regulation	[0]	['root']	_	_
5	is	_	_	VBZ	O	[-1]	['none']	_	_
6	required	_	_	VBN	Positive_regulation	[0]	['root']	_	_
7	for	_	_	IN	O	[-1]	['none']	_	_
8	IL-10	_	_	NN	Protein	[9]	['Theme']	_	_
9	production	_	_	NN	Gene_expression	[6]	['Theme']	_	_
10	by	_	_	IN	O	[-1]	['none']	_	_
11	all	_	_	PDT	O	[-1]	['none']	_	_
12	these	_	_	DT	O	[-1]	['none']	_	_
13	Th	_	_	NN	O	[-1]	['none']	_	_
14	cell	_	_	NN	O	[-1]	['none']	_	_
15	subsets	_	_	NNS	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	With	_	_	IN	O	[-1]	['none']	_	_
2	regard	_	_	NN	O	[-1]	['none']	_	_
3	to	_	_	TO	O	[-1]	['none']	_	_
4	the	_	_	DT	O	[-1]	['none']	_	_
5	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
6	of	_	_	IN	O	[-1]	['none']	_	_
7	IL-10	_	_	NN	Protein	[5]	['Theme']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	Th1	_	_	NN	O	[-1]	['none']	_	_
10	cells	_	_	NNS	O	[-1]	['none']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	our	_	_	PRP$	O	[-1]	['none']	_	_
13	data	_	_	NNS	O	[-1]	['none']	_	_
14	provide	_	_	VBP	O	[-1]	['none']	_	_
15	a	_	_	DT	O	[-1]	['none']	_	_
16	mechanism	_	_	NN	O	[-1]	['none']	_	_
17	for	_	_	IN	O	[-1]	['none']	_	_
18	how	_	_	WRB	O	[-1]	['none']	_	_
19	IL-10	_	_	NN	Protein	[20]	['Theme']	_	_
20	expression	_	_	NN	Gene_expression	[22, 25, 27]	['Theme', 'Theme', 'Theme']	_	_
21	is	_	_	VBZ	O	[-1]	['none']	_	_
22	induced	_	_	VBN	Positive_regulation	[0]	['root']	_	_
23	and	_	_	CC	O	[-1]	['none']	_	_
24	then	_	_	RB	O	[-1]	['none']	_	_
25	amplified	_	_	VBD	Positive_regulation	[0]	['root']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	regulated	_	_	VBN	Regulation	[0]	['root']	_	_
28	by	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	levels	_	_	NNS	O	[-1]	['none']	_	_
31	of	_	_	IN	O	[-1]	['none']	_	_
32	antigen	_	_	NN	O	[-1]	['none']	_	_
33	and	_	_	CC	O	[-1]	['none']	_	_
34	IL-12	_	_	NN	Protein	[25, 27]	['Cause', 'Cause']	_	_
35	encountered	_	_	VBD	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	the	_	_	DT	O	[-1]	['none']	_	_
38	environment	_	_	NN	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	This	_	_	DT	O	[-1]	['none']	_	_
2	provides	_	_	VBZ	O	[-1]	['none']	_	_
3	a	_	_	DT	O	[-1]	['none']	_	_
4	mechanism	_	_	NN	O	[-1]	['none']	_	_
5	whereby	_	_	WRB	O	[-1]	['none']	_	_
6	a	_	_	DT	O	[-1]	['none']	_	_
7	Th1	_	_	NN	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	responds	_	_	VBZ	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	extrinsic	_	_	JJ	O	[-1]	['none']	_	_
12	signals	_	_	NNS	O	[-1]	['none']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	reflecting	_	_	VBG	O	[-1]	['none']	_	_
15	increased	_	_	VBN	O	[-1]	['none']	_	_
16	inflammation	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	tissue	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	to	_	_	TO	O	[-1]	['none']	_	_
22	tightly	_	_	RB	O	[-1]	['none']	_	_
23	regulate	_	_	VB	Regulation	[0]	['root']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	production	_	_	NN	Gene_expression	[23]	['Theme']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	IL-10	_	_	NN	Protein	[25]	['Theme']	_	_
28	so	_	_	RB	O	[-1]	['none']	_	_
29	as	_	_	IN	O	[-1]	['none']	_	_
30	to	_	_	TO	O	[-1]	['none']	_	_
31	allow	_	_	VB	O	[-1]	['none']	_	_
32	a	_	_	DT	O	[-1]	['none']	_	_
33	protective	_	_	JJ	O	[-1]	['none']	_	_
34	response	_	_	NN	O	[-1]	['none']	_	_
35	to	_	_	TO	O	[-1]	['none']	_	_
36	eradicate	_	_	VB	O	[-1]	['none']	_	_
37	a	_	_	DT	O	[-1]	['none']	_	_
38	pathogen	_	_	NN	O	[-1]	['none']	_	_
39	with	_	_	IN	O	[-1]	['none']	_	_
40	minimal	_	_	JJ	O	[-1]	['none']	_	_
41	damage	_	_	NN	O	[-1]	['none']	_	_
42	to	_	_	TO	O	[-1]	['none']	_	_
43	the	_	_	DT	O	[-1]	['none']	_	_
44	host	_	_	NN	O	[-1]	['none']	_	_
45	and	_	_	CC	O	[-1]	['none']	_	_
46	also	_	_	RB	O	[-1]	['none']	_	_
47	prevent	_	_	VBP	O	[-1]	['none']	_	_
48	chronic	_	_	JJ	O	[-1]	['none']	_	_
49	infection	_	_	NN	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	Moreover	_	_	RB	O	[-1]	['none']	_	_
2	,	_	_	,	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	findings	_	_	NNS	O	[-1]	['none']	_	_
5	have	_	_	VBP	O	[-1]	['none']	_	_
6	important	_	_	JJ	O	[-1]	['none']	_	_
7	implications	_	_	NNS	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	regulation	_	_	NN	Regulation	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	IL-10	_	_	NN	Protein	[13]	['Theme']	_	_
13	production	_	_	NN	Gene_expression	[10]	['Theme']	_	_
14	during	_	_	IN	O	[-1]	['none']	_	_
15	an	_	_	DT	O	[-1]	['none']	_	_
16	inflammatory	_	_	JJ	O	[-1]	['none']	_	_
17	Th1	_	_	NN	O	[-1]	['none']	_	_
18	response	_	_	NN	O	[-1]	['none']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	infection	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	may	_	_	MD	O	[-1]	['none']	_	_
23	be	_	_	VB	O	[-1]	['none']	_	_
24	of	_	_	IN	O	[-1]	['none']	_	_
25	relevance	_	_	NN	O	[-1]	['none']	_	_
26	for	_	_	IN	O	[-1]	['none']	_	_
27	the	_	_	DT	O	[-1]	['none']	_	_
28	design	_	_	NN	O	[-1]	['none']	_	_
29	of	_	_	IN	O	[-1]	['none']	_	_
30	vaccines	_	_	NNS	O	[-1]	['none']	_	_
31	and	_	_	CC	O	[-1]	['none']	_	_
32	for	_	_	IN	O	[-1]	['none']	_	_
33	strategies	_	_	NNS	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	immunotherapy	_	_	NN	O	[-1]	['none']	_	_
36	in	_	_	IN	O	[-1]	['none']	_	_
37	infectious	_	_	JJ	O	[-1]	['none']	_	_
38	diseases	_	_	NNS	O	[-1]	['none']	_	_
39	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	culture	_	_	NN	O	[-1]	['none']	_	_
4	system	_	_	NN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	monitor	_	_	VB	O	[-1]	['none']	_	_
7	effector	_	_	NN	O	[-1]	['none']	_	_
8	CTL	_	_	NN	O	[-1]	['none']	_	_
9	differentiation	_	_	NN	O	[-1]	['none']	_	_
10	We	_	_	PRP	O	[-1]	['none']	_	_
11	used	_	_	VBD	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	simple	_	_	JJ	O	[-1]	['none']	_	_
14	cell	_	_	NN	O	[-1]	['none']	_	_
15	culture	_	_	NN	O	[-1]	['none']	_	_
16	system	_	_	NN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	examine	_	_	VB	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	kinetics	_	_	NNS	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	effector	_	_	NN	O	[-1]	['none']	_	_
23	gene	_	_	NN	O	[-1]	['none']	_	_
24	expression	_	_	NN	O	[-1]	['none']	_	_
25	during	_	_	IN	O	[-1]	['none']	_	_
26	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
27	T	_	_	NN	O	[-1]	['none']	_	_
28	cell	_	_	NN	O	[-1]	['none']	_	_
29	differentiation	_	_	NN	O	[-1]	['none']	_	_
30	.	_	_	.	O	[-1]	['none']	_	_

1	Naive	_	_	JJ	O	[-1]	['none']	_	_
2	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
3	T	_	_	NN	O	[-1]	['none']	_	_
4	cells	_	_	NNS	O	[-1]	['none']	_	_
5	from	_	_	IN	O	[-1]	['none']	_	_
6	P14	_	_	NN	O	[-1]	['none']	_	_
7	TCR	_	_	NN	O	[-1]	['none']	_	_
8	transgenic	_	_	JJ	O	[-1]	['none']	_	_
9	mice	_	_	NNS	O	[-1]	['none']	_	_
10	were	_	_	VBD	O	[-1]	['none']	_	_
11	activated	_	_	VBN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	2	_	_	CD	O	[-1]	['none']	_	_
14	d	_	_	NN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	anti-CD3	_	_	JJ	Protein	[0]	['root']	_	_
17	and	_	_	CC	O	[-1]	['none']	_	_
18	anti-CD28	_	_	JJ	Protein	[0]	['root']	_	_
19	or	_	_	CC	O	[-1]	['none']	_	_
20	with	_	_	IN	O	[-1]	['none']	_	_
21	splenic	_	_	JJ	O	[-1]	['none']	_	_
22	APCs	_	_	NNS	O	[-1]	['none']	_	_
23	in	_	_	IN	O	[-1]	['none']	_	_
24	the	_	_	DT	O	[-1]	['none']	_	_
25	presence	_	_	NN	O	[-1]	['none']	_	_
26	of	_	_	IN	O	[-1]	['none']	_	_
27	Gp33	_	_	NN	O	[-1]	['none']	_	_
28	peptide	_	_	NN	O	[-1]	['none']	_	_
29	,	_	_	,	O	[-1]	['none']	_	_
30	and	_	_	CC	O	[-1]	['none']	_	_
31	were	_	_	VBD	O	[-1]	['none']	_	_
32	cultured	_	_	VBN	O	[-1]	['none']	_	_
33	in	_	_	IN	O	[-1]	['none']	_	_
34	media	_	_	NNS	O	[-1]	['none']	_	_
35	containing	_	_	VBG	O	[-1]	['none']	_	_
36	100	_	_	CD	O	[-1]	['none']	_	_
37	U/ml	_	_	NN	O	[-1]	['none']	_	_
38	of	_	_	IN	O	[-1]	['none']	_	_
39	recombinant	_	_	JJ	O	[-1]	['none']	_	_
40	human	_	_	NN	O	[-1]	['none']	_	_
41	IL-2	_	_	NN	Protein	[0]	['root']	_	_
42	(	_	_	-LRB-	O	[-1]	['none']	_	_
43	rhIL-2	_	_	NN	Protein	[0]	['root']	_	_
44	)	_	_	-RRB-	O	[-1]	['none']	_	_
45	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	used	_	_	VBD	O	[-1]	['none']	_	_
3	TCR	_	_	NN	O	[-1]	['none']	_	_
4	transgenic	_	_	JJ	O	[-1]	['none']	_	_
5	mice	_	_	NNS	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	these	_	_	DT	O	[-1]	['none']	_	_
8	experiments	_	_	NNS	O	[-1]	['none']	_	_
9	because	_	_	IN	O	[-1]	['none']	_	_
10	they	_	_	PRP	O	[-1]	['none']	_	_
11	provide	_	_	VBP	O	[-1]	['none']	_	_
12	a	_	_	DT	O	[-1]	['none']	_	_
13	reliable	_	_	JJ	O	[-1]	['none']	_	_
14	source	_	_	NN	O	[-1]	['none']	_	_
15	of	_	_	IN	O	[-1]	['none']	_	_
16	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
17	T	_	_	NN	O	[-1]	['none']	_	_
18	cells	_	_	NNS	O	[-1]	['none']	_	_
19	that	_	_	WDT	O	[-1]	['none']	_	_
20	are	_	_	VBP	O	[-1]	['none']	_	_
21	truly	_	_	RB	O	[-1]	['none']	_	_
22	naive	_	_	JJ	O	[-1]	['none']	_	_
23	;	_	_	:	O	[-1]	['none']	_	_
24	however	_	_	RB	O	[-1]	['none']	_	_
25	,	_	_	,	O	[-1]	['none']	_	_
26	we	_	_	PRP	O	[-1]	['none']	_	_
27	chose	_	_	VBD	O	[-1]	['none']	_	_
28	not	_	_	RB	O	[-1]	['none']	_	_
29	to	_	_	TO	O	[-1]	['none']	_	_
30	stimulate	_	_	VB	O	[-1]	['none']	_	_
31	cells	_	_	NNS	O	[-1]	['none']	_	_
32	with	_	_	IN	O	[-1]	['none']	_	_
33	antigen	_	_	NN	O	[-1]	['none']	_	_
34	in	_	_	IN	O	[-1]	['none']	_	_
35	most	_	_	JJS	O	[-1]	['none']	_	_
36	experiments	_	_	NNS	O	[-1]	['none']	_	_
37	so	_	_	RB	O	[-1]	['none']	_	_
38	as	_	_	IN	O	[-1]	['none']	_	_
39	to	_	_	TO	O	[-1]	['none']	_	_
40	avoid	_	_	VB	O	[-1]	['none']	_	_
41	contamination	_	_	NN	O	[-1]	['none']	_	_
42	with	_	_	IN	O	[-1]	['none']	_	_
43	proteins	_	_	NNS	O	[-1]	['none']	_	_
44	and	_	_	CC	O	[-1]	['none']	_	_
45	nucleic	_	_	JJ	O	[-1]	['none']	_	_
46	acids	_	_	NNS	O	[-1]	['none']	_	_
47	derived	_	_	VBN	O	[-1]	['none']	_	_
48	from	_	_	IN	O	[-1]	['none']	_	_
49	APCs	_	_	NNS	O	[-1]	['none']	_	_
50	.	_	_	.	O	[-1]	['none']	_	_

1	There	_	_	EX	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	only	_	_	RB	O	[-1]	['none']	_	_
4	minor	_	_	JJ	O	[-1]	['none']	_	_
5	differences	_	_	NNS	O	[-1]	['none']	_	_
6	in	_	_	IN	O	[-1]	['none']	_	_
7	gene	_	_	NN	O	[-1]	['none']	_	_
8	expression	_	_	NN	O	[-1]	['none']	_	_
9	during	_	_	IN	O	[-1]	['none']	_	_
10	differentiation	_	_	NN	O	[-1]	['none']	_	_
11	induced	_	_	VBN	O	[-1]	['none']	_	_
12	by	_	_	IN	O	[-1]	['none']	_	_
13	antigen	_	_	NN	O	[-1]	['none']	_	_
14	and	_	_	CC	O	[-1]	['none']	_	_
15	APC	_	_	NN	O	[-1]	['none']	_	_
16	versus	_	_	CC	O	[-1]	['none']	_	_
17	anti-CD3	_	_	NN	Protein	[0]	['root']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	anti-CD28	_	_	NN	Protein	[0]	['root']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	the	_	_	DT	O	[-1]	['none']	_	_
23	major	_	_	JJ	O	[-1]	['none']	_	_
24	conclusions	_	_	NNS	O	[-1]	['none']	_	_
25	presented	_	_	VBN	O	[-1]	['none']	_	_
26	in	_	_	IN	O	[-1]	['none']	_	_
27	this	_	_	DT	O	[-1]	['none']	_	_
28	report	_	_	NN	O	[-1]	['none']	_	_
29	are	_	_	VBP	O	[-1]	['none']	_	_
30	the	_	_	DT	O	[-1]	['none']	_	_
31	same	_	_	JJ	O	[-1]	['none']	_	_
32	for	_	_	IN	O	[-1]	['none']	_	_
33	both	_	_	DT	O	[-1]	['none']	_	_
34	activating	_	_	VBG	O	[-1]	['none']	_	_
35	conditions	_	_	NNS	O	[-1]	['none']	_	_
36	.	_	_	.	O	[-1]	['none']	_	_

1	Under	_	_	IN	O	[-1]	['none']	_	_
2	our	_	_	PRP$	O	[-1]	['none']	_	_
3	culture	_	_	NN	O	[-1]	['none']	_	_
4	conditions	_	_	NNS	O	[-1]	['none']	_	_
5	,	_	_	,	O	[-1]	['none']	_	_
6	activated	_	_	VBN	O	[-1]	['none']	_	_
7	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
8	T	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	expanded	_	_	VBD	O	[-1]	['none']	_	_
11	exponentially	_	_	RB	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	accumulated	_	_	VBN	O	[-1]	['none']	_	_
14	for	_	_	IN	O	[-1]	['none']	_	_
15	>	_	_	JJR	O	[-1]	['none']	_	_
16	8	_	_	CD	O	[-1]	['none']	_	_
17	d	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	We	_	_	PRP	O	[-1]	['none']	_	_
2	limited	_	_	VBD	O	[-1]	['none']	_	_
3	our	_	_	PRP$	O	[-1]	['none']	_	_
4	analysis	_	_	NN	O	[-1]	['none']	_	_
5	to	_	_	TO	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	first	_	_	JJ	O	[-1]	['none']	_	_
8	6-8	_	_	CD	O	[-1]	['none']	_	_
9	d	_	_	NN	O	[-1]	['none']	_	_
10	after	_	_	IN	O	[-1]	['none']	_	_
11	activation	_	_	NN	O	[-1]	['none']	_	_
12	,	_	_	,	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	period	_	_	NN	O	[-1]	['none']	_	_
15	that	_	_	WDT	O	[-1]	['none']	_	_
16	coincides	_	_	VBZ	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	clonal	_	_	JJ	O	[-1]	['none']	_	_
19	expansion	_	_	NN	O	[-1]	['none']	_	_
20	of	_	_	IN	O	[-1]	['none']	_	_
21	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
22	T	_	_	NN	O	[-1]	['none']	_	_
23	cells	_	_	NNS	O	[-1]	['none']	_	_
24	after	_	_	IN	O	[-1]	['none']	_	_
25	activation	_	_	NN	O	[-1]	['none']	_	_
26	in	_	_	FW	O	[-1]	['none']	_	_
27	vivo	_	_	FW	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	FW	O	[-1]	['none']	_	_
2	vivo	_	_	FW	O	[-1]	['none']	_	_
3	and	_	_	CC	O	[-1]	['none']	_	_
4	in	_	_	FW	O	[-1]	['none']	_	_
5	vitro	_	_	FW	O	[-1]	['none']	_	_
6	features	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	COILS	_	_	NNS	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	MotifScan	_	_	NN	O	[-1]	['none']	_	_
7	programs	_	_	NNS	O	[-1]	['none']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	used	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	predict	_	_	VB	O	[-1]	['none']	_	_
12	the	_	_	DT	O	[-1]	['none']	_	_
13	presence	_	_	NN	O	[-1]	['none']	_	_
14	of	_	_	IN	O	[-1]	['none']	_	_
15	CC	_	_	NN	O	[-1]	['none']	_	_
16	(	_	_	-LRB-	O	[-1]	['none']	_	_
17	coiled-coil	_	_	JJ	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	domain	_	_	NN	O	[-1]	['none']	_	_
20	,	_	_	,	O	[-1]	['none']	_	_
21	UBL	_	_	NNP	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	ubiquitin	_	_	NN	O	[-1]	['none']	_	_
24	like	_	_	IN	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	domain	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	ZFRBP	_	_	NN	O	[-1]	['none']	_	_
29	(	_	_	-LRB-	O	[-1]	['none']	_	_
30	zinc-finger	_	_	NN	O	[-1]	['none']	_	_
31	Ran	_	_	NN	O	[-1]	['none']	_	_
32	Binding	_	_	NN	O	[-1]	['none']	_	_
33	protein	_	_	NN	O	[-1]	['none']	_	_
34	2	_	_	CD	O	[-1]	['none']	_	_
35	)	_	_	-RRB-	O	[-1]	['none']	_	_
36	domain	_	_	NN	O	[-1]	['none']	_	_
37	which	_	_	WDT	O	[-1]	['none']	_	_
38	form	_	_	VBP	O	[-1]	['none']	_	_
39	similar	_	_	JJ	O	[-1]	['none']	_	_
40	motif	_	_	NN	O	[-1]	['none']	_	_
41	patterns	_	_	NNS	O	[-1]	['none']	_	_
42	in	_	_	IN	O	[-1]	['none']	_	_
43	the	_	_	DT	O	[-1]	['none']	_	_
44	SHARPIN	_	_	NNP	Protein	[0]	['root']	_	_
45	protein	_	_	NN	O	[-1]	['none']	_	_
46	of	_	_	IN	O	[-1]	['none']	_	_
47	human	_	_	NN	O	[-1]	['none']	_	_
48	,	_	_	,	O	[-1]	['none']	_	_
49	mouse	_	_	NN	O	[-1]	['none']	_	_
50	and	_	_	CC	O	[-1]	['none']	_	_
51	rat	_	_	NN	O	[-1]	['none']	_	_
52	origins	_	_	NNS	O	[-1]	['none']	_	_
53	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Eight	_	_	CD	O	[-1]	['none']	_	_
5	week-old	_	_	JJ	O	[-1]	['none']	_	_
6	females	_	_	NNS	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	WT	_	_	NNP	O	[-1]	['none']	_	_
9	and	_	_	CC	O	[-1]	['none']	_	_
10	cpdm	_	_	NN	O	[-1]	['none']	_	_
11	mice	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	mutant	_	_	NN	O	[-1]	['none']	_	_
3	mice	_	_	NNS	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	above	_	_	IN	O	[-1]	['none']	_	_
6	)	_	_	-RRB-	O	[-1]	['none']	_	_
7	develop	_	_	VBP	O	[-1]	['none']	_	_
8	progressive	_	_	JJ	O	[-1]	['none']	_	_
9	skin	_	_	NN	O	[-1]	['none']	_	_
10	inflammation	_	_	NN	O	[-1]	['none']	_	_
11	starting	_	_	VBG	O	[-1]	['none']	_	_
12	at	_	_	IN	O	[-1]	['none']	_	_
13	about	_	_	IN	O	[-1]	['none']	_	_
14	four	_	_	CD	O	[-1]	['none']	_	_
15	weeks	_	_	NNS	O	[-1]	['none']	_	_
16	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Extramedullary	_	_	JJ	O	[-1]	['none']	_	_
5	hematopoiesis	_	_	NN	O	[-1]	['none']	_	_
6	causes	_	_	VBZ	O	[-1]	['none']	_	_
7	marked	_	_	JJ	O	[-1]	['none']	_	_
8	enlargement	_	_	NN	O	[-1]	['none']	_	_
9	of	_	_	IN	O	[-1]	['none']	_	_
10	the	_	_	DT	O	[-1]	['none']	_	_
11	spleen	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	cpdm	_	_	NN	O	[-1]	['none']	_	_
14	mice	_	_	NNS	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	D	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	BMDC	_	_	NN	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	incubated	_	_	VBN	O	[-1]	['none']	_	_
7	in	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	absence	_	_	NN	O	[-1]	['none']	_	_
10	or	_	_	CC	O	[-1]	['none']	_	_
11	presence	_	_	NN	O	[-1]	['none']	_	_
12	of	_	_	IN	O	[-1]	['none']	_	_
13	100	_	_	CD	O	[-1]	['none']	_	_
14	ng/ml	_	_	NN	O	[-1]	['none']	_	_
15	LPS	_	_	NN	O	[-1]	['none']	_	_
16	for	_	_	IN	O	[-1]	['none']	_	_
17	4	_	_	CD	O	[-1]	['none']	_	_
18	hours	_	_	NNS	O	[-1]	['none']	_	_
19	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	mRNA	_	_	NN	Transcription	[3]	['multitoken']	_	_
3	level	_	_	NN	Transcription	[0]	['root']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	Sharpin	_	_	NNP	Protein	[3]	['Theme']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	measured	_	_	VBN	O	[-1]	['none']	_	_
8	by	_	_	IN	O	[-1]	['none']	_	_
9	qRT-PCR	_	_	NN	O	[-1]	['none']	_	_
10	and	_	_	CC	O	[-1]	['none']	_	_
11	presented	_	_	VBD	O	[-1]	['none']	_	_
12	relative	_	_	JJ	O	[-1]	['none']	_	_
13	to	_	_	TO	O	[-1]	['none']	_	_
14	the	_	_	DT	O	[-1]	['none']	_	_
15	mRNA	_	_	NN	O	[-1]	['none']	_	_
16	expression	_	_	NN	O	[-1]	['none']	_	_
17	in	_	_	IN	O	[-1]	['none']	_	_
18	non	_	_	JJ	O	[-1]	['none']	_	_
19	stimulated	_	_	VBN	O	[-1]	['none']	_	_
20	WT	_	_	NNP	O	[-1]	['none']	_	_
21	BMDC	_	_	NNP	O	[-1]	['none']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	Bars	_	_	NNS	O	[-1]	['none']	_	_
2	represent	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	mean	_	_	NN	O	[-1]	['none']	_	_
5	+/-	_	_	CC	O	[-1]	['none']	_	_
6	s.d.	_	_	NN	O	[-1]	['none']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	3	_	_	CD	O	[-1]	['none']	_	_
9	mice	_	_	NNS	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	*	_	_	SYM	O	[-1]	['none']	_	_
2	P	_	_	NN	O	[-1]	['none']	_	_
3	<	_	_	JJR	O	[-1]	['none']	_	_
4	0.05	_	_	CD	O	[-1]	['none']	_	_
5	;	_	_	:	O	[-1]	['none']	_	_
6	**	_	_	SYM	O	[-1]	['none']	_	_
7	P	_	_	NN	O	[-1]	['none']	_	_
8	<	_	_	JJR	O	[-1]	['none']	_	_
9	0.001	_	_	CD	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	E	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Fibroblast	_	_	NN	O	[-1]	['none']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	NIH3T3	_	_	NN	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	macrophages	_	_	NNS	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	RAW264	_	_	NN	O	[-1]	['none']	_	_
12	.7	_	_	CD	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	were	_	_	VBD	O	[-1]	['none']	_	_
16	transfected	_	_	VBN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	the	_	_	DT	O	[-1]	['none']	_	_
19	expression	_	_	NN	O	[-1]	['none']	_	_
20	plasmid	_	_	NN	O	[-1]	['none']	_	_
21	pFLAG-SHARPIN	_	_	NN	Protein	[0]	['root']	_	_
22	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	48	_	_	CD	O	[-1]	['none']	_	_
3	hours	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	fixed	_	_	VBN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	probed	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	anti-FLAG	_	_	JJ	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	FITC	_	_	NN	O	[-1]	['none']	_	_
14	conjugated	_	_	VBD	O	[-1]	['none']	_	_
15	secondary	_	_	JJ	O	[-1]	['none']	_	_
16	antibody	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Nuclei	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	stained	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	DAPI	_	_	NN	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	both	_	_	DT	O	[-1]	['none']	_	_
3	transfected	_	_	JJ	O	[-1]	['none']	_	_
4	cell	_	_	NN	O	[-1]	['none']	_	_
5	lines	_	_	NNS	O	[-1]	['none']	_	_
6	,	_	_	,	O	[-1]	['none']	_	_
7	FLAG-SHARPIN	_	_	NN	Protein	[13]	['Theme']	_	_
8	was	_	_	VBD	O	[-1]	['none']	_	_
9	found	_	_	VBN	O	[-1]	['none']	_	_
10	to	_	_	TO	O	[-1]	['none']	_	_
11	be	_	_	VB	O	[-1]	['none']	_	_
12	cytoplasm	_	_	NN	Entity	[13]	['ToLoc']	_	_
13	localized	_	_	JJ	Localization	[0]	['root']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Kinetics	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	gene	_	_	NN	O	[-1]	['none']	_	_
4	expression	_	_	NN	O	[-1]	['none']	_	_
5	during	_	_	IN	O	[-1]	['none']	_	_
6	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
7	T	_	_	NN	O	[-1]	['none']	_	_
8	cell	_	_	NN	O	[-1]	['none']	_	_
9	differentiation	_	_	NN	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Kinetics	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	Prf1	_	_	NN	Protein	[18]	['Theme']	_	_
7	,	_	_	,	O	[-1]	['none']	_	_
8	Gzmb	_	_	NN	Protein	[18]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	Tbx21	_	_	NN	Protein	[18]	['Theme']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	T-bet	_	_	JJ	Protein	[0]	['root']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	,	_	_	,	O	[-1]	['none']	_	_
15	and	_	_	CC	O	[-1]	['none']	_	_
16	Eomes	_	_	NNP	Protein	[18]	['Theme']	_	_
17	mRNA	_	_	NN	Transcription	[18]	['multitoken']	_	_
18	expression	_	_	NN	Transcription	[0]	['root']	_	_
19	in	_	_	IN	O	[-1]	['none']	_	_
20	differentiating	_	_	VBG	O	[-1]	['none']	_	_
21	P14	_	_	NN	O	[-1]	['none']	_	_
22	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
23	T	_	_	NN	O	[-1]	['none']	_	_
24	cells	_	_	NNS	O	[-1]	['none']	_	_
25	analyzed	_	_	VBN	O	[-1]	['none']	_	_
26	by	_	_	IN	O	[-1]	['none']	_	_
27	Northern	_	_	NN	O	[-1]	['none']	_	_
28	blotting	_	_	NN	O	[-1]	['none']	_	_
29	.	_	_	.	O	[-1]	['none']	_	_

1	RNA	_	_	NN	O	[-1]	['none']	_	_
2	from	_	_	IN	O	[-1]	['none']	_	_
3	day	_	_	NN	O	[-1]	['none']	_	_
4	7	_	_	CD	O	[-1]	['none']	_	_
5	Th1	_	_	NN	O	[-1]	['none']	_	_
6	cells	_	_	NNS	O	[-1]	['none']	_	_
7	was	_	_	VBD	O	[-1]	['none']	_	_
8	used	_	_	VBN	O	[-1]	['none']	_	_
9	as	_	_	IN	O	[-1]	['none']	_	_
10	a	_	_	DT	O	[-1]	['none']	_	_
11	control	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Sizes	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	mRNA	_	_	NN	O	[-1]	['none']	_	_
4	transcripts	_	_	NNS	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	indicated	_	_	VBN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Quantification	_	_	NN	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	relative	_	_	JJ	O	[-1]	['none']	_	_
7	mRNA	_	_	NN	O	[-1]	['none']	_	_
8	amounts	_	_	NNS	O	[-1]	['none']	_	_
9	by	_	_	IN	O	[-1]	['none']	_	_
10	phosphorimager	_	_	NN	O	[-1]	['none']	_	_
11	analysis	_	_	NN	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	C	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Kinetics	_	_	NNS	O	[-1]	['none']	_	_
5	of	_	_	IN	O	[-1]	['none']	_	_
6	protein	_	_	NN	O	[-1]	['none']	_	_
7	expression	_	_	NN	O	[-1]	['none']	_	_
8	in	_	_	IN	O	[-1]	['none']	_	_
9	differentiating	_	_	VBG	O	[-1]	['none']	_	_
10	P14	_	_	NN	O	[-1]	['none']	_	_
11	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
12	T	_	_	NN	O	[-1]	['none']	_	_
13	cells	_	_	NNS	O	[-1]	['none']	_	_
14	analyzed	_	_	VBN	O	[-1]	['none']	_	_
15	by	_	_	IN	O	[-1]	['none']	_	_
16	immunoblotting	_	_	NN	O	[-1]	['none']	_	_
17	.	_	_	.	O	[-1]	['none']	_	_

1	Sizes	_	_	NNS	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	protein	_	_	NN	O	[-1]	['none']	_	_
4	bands	_	_	NNS	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	indicated	_	_	VBN	O	[-1]	['none']	_	_
7	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	D	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Relative	_	_	JJ	O	[-1]	['none']	_	_
5	protein	_	_	NN	O	[-1]	['none']	_	_
6	amounts	_	_	VBZ	O	[-1]	['none']	_	_
7	quantified	_	_	VBN	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	Western	_	_	NN	O	[-1]	['none']	_	_
11	blots	_	_	NNS	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	E	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Intracellular	_	_	JJ	O	[-1]	['none']	_	_
5	staining	_	_	NN	Gene_expression	[0]	['root']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	granzyme	_	_	NN	Protein	[8]	['multitoken']	_	_
8	B	_	_	NN	Protein	[5]	['Theme']	_	_
9	,	_	_	,	O	[-1]	['none']	_	_
10	IFN-gamma	_	_	NN	Protein	[5]	['Theme']	_	_
11	,	_	_	,	O	[-1]	['none']	_	_
12	and	_	_	CC	O	[-1]	['none']	_	_
13	TNF	_	_	NN	Protein	[5]	['Theme']	_	_
14	.	_	_	.	O	[-1]	['none']	_	_

1	Granzyme	_	_	NN	Protein	[2]	['multitoken']	_	_
2	B	_	_	NN	Protein	[3]	['Theme']	_	_
3	staining	_	_	NN	Gene_expression	[0]	['root']	_	_
4	was	_	_	VBD	O	[-1]	['none']	_	_
5	specific	_	_	JJ	O	[-1]	['none']	_	_
6	relative	_	_	JJ	O	[-1]	['none']	_	_
7	to	_	_	TO	O	[-1]	['none']	_	_
8	an	_	_	DT	O	[-1]	['none']	_	_
9	isotype	_	_	NN	O	[-1]	['none']	_	_
10	control	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	not	_	_	RB	O	[-1]	['none']	_	_
13	depicted	_	_	VBN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	.	_	_	.	O	[-1]	['none']	_	_

1	Cells	_	_	NNS	O	[-1]	['none']	_	_
2	were	_	_	VBD	O	[-1]	['none']	_	_
3	restimulated	_	_	VBN	O	[-1]	['none']	_	_
4	with	_	_	IN	O	[-1]	['none']	_	_
5	PMA	_	_	NN	O	[-1]	['none']	_	_
6	and	_	_	CC	O	[-1]	['none']	_	_
7	ionomycin	_	_	NN	O	[-1]	['none']	_	_
8	for	_	_	IN	O	[-1]	['none']	_	_
9	4	_	_	CD	O	[-1]	['none']	_	_
10	h.	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	F	_	_	NN	O	[-1]	['none']	_	_
13	)	_	_	-RRB-	O	[-1]	['none']	_	_
14	FACS	_	_	NN	O	[-1]	['none']	_	_
15	based	_	_	VBN	O	[-1]	['none']	_	_
16	assay	_	_	NN	O	[-1]	['none']	_	_
17	to	_	_	TO	O	[-1]	['none']	_	_
18	measure	_	_	VB	O	[-1]	['none']	_	_
19	cytolytic	_	_	JJ	O	[-1]	['none']	_	_
20	activity	_	_	NN	O	[-1]	['none']	_	_
21	of	_	_	IN	O	[-1]	['none']	_	_
22	P14	_	_	NN	O	[-1]	['none']	_	_
23	CD8+	_	_	JJ	Protein	[0]	['root']	_	_
24	T	_	_	NN	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	against	_	_	IN	O	[-1]	['none']	_	_
27	EL4	_	_	NN	O	[-1]	['none']	_	_
28	targets	_	_	NNS	O	[-1]	['none']	_	_
29	loaded	_	_	VBN	O	[-1]	['none']	_	_
30	with	_	_	IN	O	[-1]	['none']	_	_
31	0	_	_	CD	O	[-1]	['none']	_	_
32	(-)	_	_	CD	O	[-1]	['none']	_	_
33	or	_	_	CC	O	[-1]	['none']	_	_
34	1	_	_	CD	O	[-1]	['none']	_	_
35	(	_	_	-LRB-	O	[-1]	['none']	_	_
36	+	_	_	CC	O	[-1]	['none']	_	_
37	)	_	_	-RRB-	O	[-1]	['none']	_	_
38	muM	_	_	JJ	O	[-1]	['none']	_	_
39	Gp33	_	_	NN	O	[-1]	['none']	_	_
40	peptide	_	_	NN	O	[-1]	['none']	_	_
41	(	_	_	-LRB-	O	[-1]	['none']	_	_
42	effector-to-target	_	_	JJ	O	[-1]	['none']	_	_
43	ratio	_	_	NN	O	[-1]	['none']	_	_
44	=	_	_	JJ	O	[-1]	['none']	_	_
45	5:1	_	_	CD	O	[-1]	['none']	_	_
46	)	_	_	-RRB-	O	[-1]	['none']	_	_
47	.	_	_	.	O	[-1]	['none']	_	_

1	Percentage	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	Annexin	_	_	NN	Protein	[4]	['multitoken']	_	_
4	V+	_	_	JJ	Protein	[0]	['root']	_	_
5	(	_	_	-LRB-	O	[-1]	['none']	_	_
6	apoptotic	_	_	JJ	O	[-1]	['none']	_	_
7	)	_	_	-RRB-	O	[-1]	['none']	_	_
8	target	_	_	NN	O	[-1]	['none']	_	_
9	cells	_	_	NNS	O	[-1]	['none']	_	_
10	in	_	_	IN	O	[-1]	['none']	_	_
11	the	_	_	DT	O	[-1]	['none']	_	_
12	CD8	_	_	NN	Protein	[0]	['root']	_	_
13	negative	_	_	JJ	O	[-1]	['none']	_	_
14	EL4	_	_	NN	O	[-1]	['none']	_	_
15	target	_	_	NN	O	[-1]	['none']	_	_
16	population	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	dot	_	_	NN	O	[-1]	['none']	_	_
19	plots	_	_	NNS	O	[-1]	['none']	_	_
20	)	_	_	-RRB-	O	[-1]	['none']	_	_
21	was	_	_	VBD	O	[-1]	['none']	_	_
22	determined	_	_	VBN	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	histograms	_	_	VBZ	O	[-1]	['none']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	.	_	_	.	O	[-1]	['none']	_	_

1	Cytolytic	_	_	JJ	O	[-1]	['none']	_	_
2	activity	_	_	NN	O	[-1]	['none']	_	_
3	was	_	_	VBD	O	[-1]	['none']	_	_
4	blocked	_	_	VBN	O	[-1]	['none']	_	_
5	by	_	_	IN	O	[-1]	['none']	_	_
6	incubation	_	_	NN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	2	_	_	CD	O	[-1]	['none']	_	_
9	mM	_	_	NN	O	[-1]	['none']	_	_
10	EGTA	_	_	NN	O	[-1]	['none']	_	_
11	(	_	_	-LRB-	O	[-1]	['none']	_	_
12	not	_	_	RB	O	[-1]	['none']	_	_
13	depicted	_	_	VBN	O	[-1]	['none']	_	_
14	)	_	_	-RRB-	O	[-1]	['none']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	confirming	_	_	VBG	O	[-1]	['none']	_	_
17	involvement	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	the	_	_	DT	O	[-1]	['none']	_	_
20	granule	_	_	NN	O	[-1]	['none']	_	_
21	exocytosis	_	_	NN	O	[-1]	['none']	_	_
22	(	_	_	-LRB-	O	[-1]	['none']	_	_
23	perforin-granzyme	_	_	NN	Protein	[24]	['multitoken']	_	_
24	B	_	_	NN	Protein	[0]	['root']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	pathway	_	_	NN	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Data	_	_	NNS	O	[-1]	['none']	_	_
2	are	_	_	VBP	O	[-1]	['none']	_	_
3	representative	_	_	JJ	O	[-1]	['none']	_	_
4	of	_	_	IN	O	[-1]	['none']	_	_
5	at	_	_	IN	O	[-1]	['none']	_	_
6	least	_	_	JJS	O	[-1]	['none']	_	_
7	five	_	_	CD	O	[-1]	['none']	_	_
8	(	_	_	-LRB-	O	[-1]	['none']	_	_
9	A-E	_	_	NN	O	[-1]	['none']	_	_
10	)	_	_	-RRB-	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	three	_	_	CD	O	[-1]	['none']	_	_
13	(	_	_	-LRB-	O	[-1]	['none']	_	_
14	F	_	_	NN	O	[-1]	['none']	_	_
15	)	_	_	-RRB-	O	[-1]	['none']	_	_
16	independent	_	_	JJ	O	[-1]	['none']	_	_
17	experiments	_	_	NNS	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	BMDC-T	_	_	NNP	O	[-1]	['none']	_	_
2	cell	_	_	NN	O	[-1]	['none']	_	_
3	in	_	_	FW	O	[-1]	['none']	_	_
4	vitro	_	_	FW	O	[-1]	['none']	_	_
5	interaction	_	_	NN	O	[-1]	['none']	_	_
6	WT	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	cpdm	_	_	NN	O	[-1]	['none']	_	_
9	BMDC	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	5x104	_	_	NN	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	were	_	_	VBD	O	[-1]	['none']	_	_
14	stimulated	_	_	VBN	O	[-1]	['none']	_	_
15	with	_	_	IN	O	[-1]	['none']	_	_
16	medium	_	_	NN	O	[-1]	['none']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	1	_	_	CD	O	[-1]	['none']	_	_
19	microg/mL	_	_	NN	O	[-1]	['none']	_	_
20	LPS	_	_	NN	O	[-1]	['none']	_	_
21	,	_	_	,	O	[-1]	['none']	_	_
22	25	_	_	CD	O	[-1]	['none']	_	_
23	microg/mL	_	_	NN	O	[-1]	['none']	_	_
24	and	_	_	CC	O	[-1]	['none']	_	_
25	5	_	_	CD	O	[-1]	['none']	_	_
26	microg/mL	_	_	NN	O	[-1]	['none']	_	_
27	Pam3CYS	_	_	NN	O	[-1]	['none']	_	_
28	.	_	_	.	O	[-1]	['none']	_	_

1	24	_	_	CD	O	[-1]	['none']	_	_
2	hours	_	_	NNS	O	[-1]	['none']	_	_
3	later	_	_	RB	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	collected	_	_	VBN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	washed	_	_	VBN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	PBS	_	_	NNP	O	[-1]	['none']	_	_
12	.	_	_	.	O	[-1]	['none']	_	_

1	Allogeneic	_	_	JJ	O	[-1]	['none']	_	_
2	naive	_	_	JJ	O	[-1]	['none']	_	_
3	CD4+	_	_	JJ	O	[-1]	['none']	_	_
4	T	_	_	NN	O	[-1]	['none']	_	_
5	cells	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	isolated	_	_	VBN	O	[-1]	['none']	_	_
8	from	_	_	IN	O	[-1]	['none']	_	_
9	spleens	_	_	NNS	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	BALB/c	_	_	NN	O	[-1]	['none']	_	_
12	mice	_	_	NNS	O	[-1]	['none']	_	_
13	by	_	_	IN	O	[-1]	['none']	_	_
14	negative	_	_	JJ	O	[-1]	['none']	_	_
15	selection	_	_	NN	O	[-1]	['none']	_	_
16	kit	_	_	NN	O	[-1]	['none']	_	_
17	(	_	_	-LRB-	O	[-1]	['none']	_	_
18	Invitrogen	_	_	NNP	O	[-1]	['none']	_	_
19	)	_	_	-RRB-	O	[-1]	['none']	_	_
20	and	_	_	CC	O	[-1]	['none']	_	_
21	were	_	_	VBD	O	[-1]	['none']	_	_
22	then	_	_	RB	O	[-1]	['none']	_	_
23	added	_	_	VBN	O	[-1]	['none']	_	_
24	at	_	_	IN	O	[-1]	['none']	_	_
25	2.5	_	_	CD	O	[-1]	['none']	_	_
26	x105	_	_	NN	O	[-1]	['none']	_	_
27	and	_	_	CC	O	[-1]	['none']	_	_
28	co-cultured	_	_	VBN	O	[-1]	['none']	_	_
29	with	_	_	IN	O	[-1]	['none']	_	_
30	activated	_	_	VBN	O	[-1]	['none']	_	_
31	BMDC	_	_	NN	O	[-1]	['none']	_	_
32	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	5	_	_	CD	O	[-1]	['none']	_	_
3	days	_	_	NNS	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	supernatant	_	_	NN	O	[-1]	['none']	_	_
6	was	_	_	VBD	O	[-1]	['none']	_	_
7	collected	_	_	VBN	O	[-1]	['none']	_	_
8	and	_	_	CC	O	[-1]	['none']	_	_
9	the	_	_	DT	O	[-1]	['none']	_	_
10	secretion	_	_	NN	Gene_expression	[0]	['root']	_	_
11	of	_	_	IN	O	[-1]	['none']	_	_
12	IFNgamma	_	_	NN	Protein	[10]	['Theme']	_	_
13	,	_	_	,	O	[-1]	['none']	_	_
14	IL4	_	_	NN	Protein	[10]	['Theme']	_	_
15	,	_	_	,	O	[-1]	['none']	_	_
16	IL2	_	_	NN	Protein	[10]	['Theme']	_	_
17	,	_	_	,	O	[-1]	['none']	_	_
18	and	_	_	CC	O	[-1]	['none']	_	_
19	IL17A	_	_	NN	Protein	[10]	['Theme']	_	_
20	measured	_	_	VBN	O	[-1]	['none']	_	_
21	by	_	_	IN	O	[-1]	['none']	_	_
22	ELISA	_	_	NN	O	[-1]	['none']	_	_
23	.	_	_	.	O	[-1]	['none']	_	_

1	Negative	_	_	JJ	O	[-1]	['none']	_	_
2	controls	_	_	NNS	O	[-1]	['none']	_	_
3	are	_	_	VBP	O	[-1]	['none']	_	_
4	1	_	_	CD	O	[-1]	['none']	_	_
5	)	_	_	-RRB-	O	[-1]	['none']	_	_
6	stimulated	_	_	VBN	O	[-1]	['none']	_	_
7	BMDC	_	_	NN	O	[-1]	['none']	_	_
8	without	_	_	IN	O	[-1]	['none']	_	_
9	co-culture	_	_	NN	O	[-1]	['none']	_	_
10	with	_	_	IN	O	[-1]	['none']	_	_
11	allogeneic	_	_	JJ	O	[-1]	['none']	_	_
12	CD4+	_	_	JJ	O	[-1]	['none']	_	_
13	T	_	_	NN	O	[-1]	['none']	_	_
14	cells	_	_	NNS	O	[-1]	['none']	_	_
15	;	_	_	:	O	[-1]	['none']	_	_
16	2	_	_	CD	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	allogeneic	_	_	JJ	O	[-1]	['none']	_	_
19	CD4+	_	_	JJ	O	[-1]	['none']	_	_
20	T	_	_	NN	O	[-1]	['none']	_	_
21	cells	_	_	NNS	O	[-1]	['none']	_	_
22	without	_	_	IN	O	[-1]	['none']	_	_
23	co-culture	_	_	NN	O	[-1]	['none']	_	_
24	with	_	_	IN	O	[-1]	['none']	_	_
25	stimulated	_	_	VBN	O	[-1]	['none']	_	_
26	BMDC	_	_	NNP	O	[-1]	['none']	_	_
27	.	_	_	.	O	[-1]	['none']	_	_

1	Both	_	_	DT	O	[-1]	['none']	_	_
2	negative	_	_	JJ	O	[-1]	['none']	_	_
3	controls	_	_	NNS	O	[-1]	['none']	_	_
4	show	_	_	VBP	O	[-1]	['none']	_	_
5	no	_	_	DT	O	[-1]	['none']	_	_
6	production	_	_	NN	Gene_expression	[0]	['root']	_	_
7	of	_	_	IN	O	[-1]	['none']	_	_
8	aforementioned	_	_	JJ	Anaphora	[9]	['multitoken']	_	_
9	cytokines	_	_	NNS	Anaphora	[0]	['root']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	High	_	_	JJ	Positive_regulation	[0]	['root']	_	_
2	LMP1	_	_	NN	Protein	[3]	['Theme']	_	_
3	Expression	_	_	NN	Gene_expression	[1]	['Theme']	_	_
4	Correlates	_	_	VBZ	O	[-1]	['none']	_	_
5	with	_	_	IN	O	[-1]	['none']	_	_
6	the	_	_	DT	O	[-1]	['none']	_	_
7	Development	_	_	NN	O	[-1]	['none']	_	_
8	of	_	_	IN	O	[-1]	['none']	_	_
9	Lymphoma	_	_	NN	O	[-1]	['none']	_	_
10	LMP1	_	_	NN	Protein	[11]	['Theme']	_	_
11	expression	_	_	NN	Gene_expression	[0]	['root']	_	_
12	is	_	_	VBZ	O	[-1]	['none']	_	_
13	shown	_	_	VBN	O	[-1]	['none']	_	_
14	by	_	_	IN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	A	_	_	DT	O	[-1]	['none']	_	_
17	)	_	_	-RRB-	O	[-1]	['none']	_	_
18	immunoblotting	_	_	NN	O	[-1]	['none']	_	_
19	of	_	_	IN	O	[-1]	['none']	_	_
20	purified	_	_	VBN	O	[-1]	['none']	_	_
21	B	_	_	NN	O	[-1]	['none']	_	_
22	cells	_	_	NNS	O	[-1]	['none']	_	_
23	(	_	_	-LRB-	O	[-1]	['none']	_	_
24	CD19+	_	_	JJ	Protein	[0]	['root']	_	_
25	)	_	_	-RRB-	O	[-1]	['none']	_	_
26	and	_	_	CC	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	B	_	_	NN	O	[-1]	['none']	_	_
29	)	_	_	-RRB-	O	[-1]	['none']	_	_
30	immunohistochemistry	_	_	NN	O	[-1]	['none']	_	_
31	staining	_	_	NN	O	[-1]	['none']	_	_
32	of	_	_	IN	O	[-1]	['none']	_	_
33	spleen	_	_	NN	O	[-1]	['none']	_	_
34	tissue	_	_	NN	O	[-1]	['none']	_	_
35	from	_	_	IN	O	[-1]	['none']	_	_
36	wild-type	_	_	JJ	O	[-1]	['none']	_	_
37	(	_	_	-LRB-	O	[-1]	['none']	_	_
38	WT	_	_	JJ	O	[-1]	['none']	_	_
39	)	_	_	-RRB-	O	[-1]	['none']	_	_
40	and	_	_	CC	O	[-1]	['none']	_	_
41	LMP1	_	_	NN	Protein	[0]	['root']	_	_
42	transgenic	_	_	JJ	O	[-1]	['none']	_	_
43	mice	_	_	NNS	O	[-1]	['none']	_	_
44	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	A	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	Lymphomas	_	_	NNS	O	[-1]	['none']	_	_
5	are	_	_	VBP	O	[-1]	['none']	_	_
6	identified	_	_	VBN	O	[-1]	['none']	_	_
7	with	_	_	IN	O	[-1]	['none']	_	_
8	a	_	_	DT	O	[-1]	['none']	_	_
9	number	_	_	NN	O	[-1]	['none']	_	_
10	(	_	_	-LRB-	O	[-1]	['none']	_	_
11	1-7	_	_	CD	O	[-1]	['none']	_	_
12	)	_	_	-RRB-	O	[-1]	['none']	_	_
13	.	_	_	.	O	[-1]	['none']	_	_

1	Arrows	_	_	NNS	O	[-1]	['none']	_	_
2	indicate	_	_	VBP	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	LMP1	_	_	NN	Protein	[0]	['root']	_	_
5	specific	_	_	JJ	O	[-1]	['none']	_	_
6	band	_	_	NN	O	[-1]	['none']	_	_
7	and	_	_	CC	O	[-1]	['none']	_	_
8	its	_	_	PRP$	O	[-1]	['none']	_	_
9	degradation	_	_	NN	O	[-1]	['none']	_	_
10	products	_	_	NNS	O	[-1]	['none']	_	_
11	as	_	_	RB	O	[-1]	['none']	_	_
12	well	_	_	RB	O	[-1]	['none']	_	_
13	as	_	_	IN	O	[-1]	['none']	_	_
14	a	_	_	DT	O	[-1]	['none']	_	_
15	non	_	_	JJ	O	[-1]	['none']	_	_
16	specific	_	_	JJ	O	[-1]	['none']	_	_
17	band	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	Actin	_	_	NN	O	[-1]	['none']	_	_
2	was	_	_	VBD	O	[-1]	['none']	_	_
3	used	_	_	VBN	O	[-1]	['none']	_	_
4	as	_	_	IN	O	[-1]	['none']	_	_
5	a	_	_	DT	O	[-1]	['none']	_	_
6	loading	_	_	VBG	O	[-1]	['none']	_	_
7	control	_	_	NN	O	[-1]	['none']	_	_
8	.	_	_	.	O	[-1]	['none']	_	_

1	(	_	_	-LRB-	O	[-1]	['none']	_	_
2	B	_	_	NN	O	[-1]	['none']	_	_
3	)	_	_	-RRB-	O	[-1]	['none']	_	_
4	White	_	_	NNP	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	red	_	_	JJ	O	[-1]	['none']	_	_
7	pulps	_	_	NNS	O	[-1]	['none']	_	_
8	are	_	_	VBP	O	[-1]	['none']	_	_
9	shown	_	_	VBN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	but	_	_	CC	O	[-1]	['none']	_	_
12	this	_	_	DT	O	[-1]	['none']	_	_
13	architecture	_	_	NN	O	[-1]	['none']	_	_
14	is	_	_	VBZ	O	[-1]	['none']	_	_
15	lost	_	_	VBN	O	[-1]	['none']	_	_
16	upon	_	_	IN	O	[-1]	['none']	_	_
17	development	_	_	NN	O	[-1]	['none']	_	_
18	of	_	_	IN	O	[-1]	['none']	_	_
19	lymphoma	_	_	NN	O	[-1]	['none']	_	_
20	.	_	_	.	O	[-1]	['none']	_	_

1	Scale	_	_	NNP	O	[-1]	['none']	_	_
2	bar	_	_	NN	O	[-1]	['none']	_	_
3	,	_	_	,	O	[-1]	['none']	_	_
4	20	_	_	CD	O	[-1]	['none']	_	_
5	mum	_	_	NN	O	[-1]	['none']	_	_
6	.	_	_	.	O	[-1]	['none']	_	_

1	In	_	_	IN	O	[-1]	['none']	_	_
2	Vivo	_	_	NNP	O	[-1]	['none']	_	_
3	Studies	_	_	NNPS	O	[-1]	['none']	_	_
4	BALB/c	_	_	NN	O	[-1]	['none']	_	_
5	mice	_	_	NNS	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	injected	_	_	VBN	O	[-1]	['none']	_	_
8	intravenously	_	_	RB	O	[-1]	['none']	_	_
9	(	_	_	-LRB-	O	[-1]	['none']	_	_
10	i.v.	_	_	VB	O	[-1]	['none']	_	_
11	)	_	_	-RRB-	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	a	_	_	DT	O	[-1]	['none']	_	_
14	red	_	_	JJ	O	[-1]	['none']	_	_
15	blood	_	_	NN	O	[-1]	['none']	_	_
16	cell	_	_	NN	O	[-1]	['none']	_	_
17	depleted	_	_	VBN	O	[-1]	['none']	_	_
18	single-cell	_	_	JJ	O	[-1]	['none']	_	_
19	spleen	_	_	NN	O	[-1]	['none']	_	_
20	suspension	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	2.5	_	_	CD	O	[-1]	['none']	_	_
23	x	_	_	CC	O	[-1]	['none']	_	_
24	107	_	_	CD	O	[-1]	['none']	_	_
25	cells	_	_	NNS	O	[-1]	['none']	_	_
26	)	_	_	-RRB-	O	[-1]	['none']	_	_
27	(	_	_	-LRB-	O	[-1]	['none']	_	_
28	Castro	_	_	NNP	O	[-1]	['none']	_	_
29	et	_	_	FW	O	[-1]	['none']	_	_
30	al.	_	_	FW	O	[-1]	['none']	_	_
31	,	_	_	,	O	[-1]	['none']	_	_
32	2000	_	_	CD	O	[-1]	['none']	_	_
33	)	_	_	-RRB-	O	[-1]	['none']	_	_
34	from	_	_	IN	O	[-1]	['none']	_	_
35	DO11	_	_	NN	O	[-1]	['none']	_	_
36	.10	_	_	CD	O	[-1]	['none']	_	_
37	WT	_	_	NNP	O	[-1]	['none']	_	_
38	or	_	_	CC	O	[-1]	['none']	_	_
39	STAT	_	_	NN	Protein	[40]	['Theme']	_	_
40	deficient	_	_	JJ	Negative_regulation	[0]	['root']	_	_
41	mice	_	_	NNS	O	[-1]	['none']	_	_
42	.	_	_	.	O	[-1]	['none']	_	_

1	After	_	_	IN	O	[-1]	['none']	_	_
2	48	_	_	CD	O	[-1]	['none']	_	_
3	hr	_	_	NN	O	[-1]	['none']	_	_
4	,	_	_	,	O	[-1]	['none']	_	_
5	they	_	_	PRP	O	[-1]	['none']	_	_
6	were	_	_	VBD	O	[-1]	['none']	_	_
7	injected	_	_	VBN	O	[-1]	['none']	_	_
8	subcutaneously	_	_	RB	O	[-1]	['none']	_	_
9	with	_	_	IN	O	[-1]	['none']	_	_
10	PBS	_	_	NNP	O	[-1]	['none']	_	_
11	or	_	_	CC	O	[-1]	['none']	_	_
12	with	_	_	IN	O	[-1]	['none']	_	_
13	OVA	_	_	NN	Protein	[0]	['root']	_	_
14	protein	_	_	NN	O	[-1]	['none']	_	_
15	(	_	_	-LRB-	O	[-1]	['none']	_	_
16	5	_	_	CD	O	[-1]	['none']	_	_
17	mg	_	_	NN	O	[-1]	['none']	_	_
18	)	_	_	-RRB-	O	[-1]	['none']	_	_
19	plus	_	_	CC	O	[-1]	['none']	_	_
20	LPS	_	_	NN	O	[-1]	['none']	_	_
21	(	_	_	-LRB-	O	[-1]	['none']	_	_
22	5	_	_	CD	O	[-1]	['none']	_	_
23	mug	_	_	NN	O	[-1]	['none']	_	_
24	)	_	_	-RRB-	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	inguinal	_	_	JJ	O	[-1]	['none']	_	_
3	lymph	_	_	NN	O	[-1]	['none']	_	_
4	nodes	_	_	NNS	O	[-1]	['none']	_	_
5	were	_	_	VBD	O	[-1]	['none']	_	_
6	removed	_	_	VBN	O	[-1]	['none']	_	_
7	48	_	_	CD	O	[-1]	['none']	_	_
8	hr	_	_	NN	O	[-1]	['none']	_	_
9	later	_	_	RB	O	[-1]	['none']	_	_
10	.	_	_	.	O	[-1]	['none']	_	_

1	A	_	_	DT	O	[-1]	['none']	_	_
2	single-cell	_	_	JJ	O	[-1]	['none']	_	_
3	suspension	_	_	NN	O	[-1]	['none']	_	_
4	(	_	_	-LRB-	O	[-1]	['none']	_	_
5	1	_	_	CD	O	[-1]	['none']	_	_
6	x	_	_	CC	O	[-1]	['none']	_	_
7	106	_	_	CD	O	[-1]	['none']	_	_
8	cells	_	_	NNS	O	[-1]	['none']	_	_
9	)	_	_	-RRB-	O	[-1]	['none']	_	_
10	was	_	_	VBD	O	[-1]	['none']	_	_
11	restimulated	_	_	VBN	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	24	_	_	CD	O	[-1]	['none']	_	_
14	or	_	_	CC	O	[-1]	['none']	_	_
15	48	_	_	CD	O	[-1]	['none']	_	_
16	hr	_	_	NN	O	[-1]	['none']	_	_
17	with	_	_	IN	O	[-1]	['none']	_	_
18	1	_	_	CD	O	[-1]	['none']	_	_
19	muM	_	_	NN	O	[-1]	['none']	_	_
20	or	_	_	CC	O	[-1]	['none']	_	_
21	3	_	_	CD	O	[-1]	['none']	_	_
22	muM	_	_	NN	O	[-1]	['none']	_	_
23	of	_	_	IN	O	[-1]	['none']	_	_
24	OVA	_	_	NNP	Protein	[0]	['root']	_	_
25	and	_	_	CC	O	[-1]	['none']	_	_
26	with	_	_	IN	O	[-1]	['none']	_	_
27	BrefeldinA	_	_	NN	O	[-1]	['none']	_	_
28	for	_	_	IN	O	[-1]	['none']	_	_
29	the	_	_	DT	O	[-1]	['none']	_	_
30	last	_	_	JJ	O	[-1]	['none']	_	_
31	6	_	_	CD	O	[-1]	['none']	_	_
32	hr	_	_	NN	O	[-1]	['none']	_	_
33	.	_	_	.	O	[-1]	['none']	_	_

1	Half	_	_	NN	O	[-1]	['none']	_	_
2	of	_	_	IN	O	[-1]	['none']	_	_
3	the	_	_	DT	O	[-1]	['none']	_	_
4	supernatant	_	_	NN	O	[-1]	['none']	_	_
5	was	_	_	VBD	O	[-1]	['none']	_	_
6	removed	_	_	VBN	O	[-1]	['none']	_	_
7	before	_	_	IN	O	[-1]	['none']	_	_
8	the	_	_	DT	O	[-1]	['none']	_	_
9	addition	_	_	NN	O	[-1]	['none']	_	_
10	of	_	_	IN	O	[-1]	['none']	_	_
11	BrefeldinA	_	_	NNP	O	[-1]	['none']	_	_
12	for	_	_	IN	O	[-1]	['none']	_	_
13	use	_	_	NN	O	[-1]	['none']	_	_
14	in	_	_	IN	O	[-1]	['none']	_	_
15	an	_	_	DT	O	[-1]	['none']	_	_
16	ELISA	_	_	NN	O	[-1]	['none']	_	_
17	assay	_	_	NN	O	[-1]	['none']	_	_
18	.	_	_	.	O	[-1]	['none']	_	_

1	The	_	_	DT	O	[-1]	['none']	_	_
2	cells	_	_	NNS	O	[-1]	['none']	_	_
3	were	_	_	VBD	O	[-1]	['none']	_	_
4	fixed	_	_	VBN	O	[-1]	['none']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	stained	_	_	VBN	O	[-1]	['none']	_	_
7	as	_	_	IN	O	[-1]	['none']	_	_
8	before	_	_	RB	O	[-1]	['none']	_	_
9	.	_	_	.	O	[-1]	['none']	_	_

1	Those	_	_	DT	O	[-1]	['none']	_	_
2	positive	_	_	JJ	O	[-1]	['none']	_	_
3	for	_	_	IN	O	[-1]	['none']	_	_
4	KJ1-26-Bio	_	_	NN	Protein	[0]	['root']	_	_
5	and	_	_	CC	O	[-1]	['none']	_	_
6	for	_	_	IN	O	[-1]	['none']	_	_
7	CD4-PerCP	_	_	NN	Protein	[0]	['root']	_	_
8	were	_	_	VBD	O	[-1]	['none']	_	_
9	gated	_	_	VBN	O	[-1]	['none']	_	_
10	,	_	_	,	O	[-1]	['none']	_	_
11	and	_	_	CC	O	[-1]	['none']	_	_
12	IFN-gamma	_	_	NN	Protein	[0]	['root']	_	_
13	and	_	_	CC	O	[-1]	['none']	_	_
14	IL-10	_	_	NN	Protein	[0]	['root']	_	_
15	staining	_	_	NN	O	[-1]	['none']	_	_
16	was	_	_	VBD	O	[-1]	['none']	_	_
17	examined	_	_	VBN	O	[-1]	['none']	_	_
18	for	_	_	IN	O	[-1]	['none']	_	_
19	this	_	_	DT	O	[-1]	['none']	_	_
20	population	_	_	NN	O	[-1]	['none']	_	_
21	and	_	_	CC	O	[-1]	['none']	_	_
22	analyzed	_	_	VBN	O	[-1]	['none']	_	_
23	as	_	_	IN	O	[-1]	['none']	_	_
24	before	_	_	RB	O	[-1]	['none']	_	_
25	.	_	_	.	O	[-1]	['none']	_	_
